PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rigali, S; Derouaux, A; Giannotta, F; Dusart, J				Rigali, S; Derouaux, A; Giannotta, F; Dusart, J			Subdivision of the helix-turn-helix GntR family of bacterial regulators in the FadR, HutC, MocR, and YtrA subfamilies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE TRANSCRIPTION FACTOR; MULTIPLE SEQUENCE ALIGNMENT; FATTY-ACID METABOLISM; DNA-BINDING DOMAINS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; NUCLEOTIDE-SEQUENCE; ACINETOBACTER-CALCOACETICUS; PSEUDOMONAS-PUTIDA; MOLECULAR ANALYSIS	Haydon and Guest (Haydon, D. J, and Guest, J. R. (1991) FEMS Microbiol Lett. 63, 291-295) first described the helix-turn-helix GntR family of bacterial regulators. They presented them as transcription factors sharing a similar N-terminal DNA-binding (D-b) domain, but they observed near-maximal divergence in the C-terminal effector-binding and oligomerization (E-b/O) domain. To elucidate this C-terminal heterogeneity, structural, phylogenetic, and functional analyses were performed on a family that now comprises about 270 members. Our comparative study first focused on the C-terminal E-b/O domains and next on DNA-binding domains and palindromic operator sequences, has classified the GntR members into four subfamilies that we called FadR, HutC, MocR, and YtrA. Among these subfamilies a degree of similarity of about 55% was observed throughout the entire sequence. Structure/function associations were highlighted although they were not absolutely stringent. The consensus sequences deduced for the DNA-binding domain were slightly different for each subfamily, suggesting that fusion between the D-b and E-b/O domains have occurred separately, with each subfamily having its own D-b domain ancestor. Moreover, the compilation of the known or predicted palindromic cis-acting elements has highlighted different operator sequences according to our subfamily subdivision. The observed C-terminal E-b/O domain heterogeneity was therefore reflected on the DNA-binding domain and on the cis-acting elements, suggesting the existence of a tight link between the three regions involved in the regulating process.	Univ Liege, Inst Chim B6, Ctr Ingn Prot, B-4000 Liege, Belgium	University of Liege	Rigali, S (corresponding author), Univ Liege, Inst Chim B6, Ctr Ingn Prot, B-4000 Liege, Belgium.	srigali@student.ulg.ac.be		Rigali, Sebastien/0000-0003-4022-7325				ALLISON SL, 1990, J BACTERIOL, V172, P5470, DOI 10.1128/jb.172.9.5470-5476.1990; Arai H, 1999, MOL MICROBIOL, V33, P1132, DOI 10.1046/j.1365-2958.1999.01554.x; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BUCK D, 1989, BIOCHEM J, V260, P737, DOI 10.1042/bj2600737; Burklen L, 1998, MOL GEN GENET, V260, P48, DOI 10.1007/s004380050869; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DIRUSSO CC, 1988, NUCLEIC ACIDS RES, V16, P7995, DOI 10.1093/nar/16.16.7995; DIRUSSO CC, 1993, MOL MICROBIOL, V7, P311, DOI 10.1111/j.1365-2958.1993.tb01122.x; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; DUNN TM, 1984, P NATL ACAD SCI-BIOL, V81, P5017, DOI 10.1073/pnas.81.16.5017; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; FUJITA Y, 1986, J BIOL CHEM, V261, P3744; GALLEGOS MT, 1993, NUCLEIC ACIDS RES, V21, P807, DOI 10.1093/nar/21.4.807; GIANNOTTA F, 1998, THESIS U LIEGE BELGI; HAGEGE J, 1993, J BACTERIOL, V175, P5529; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Harmer T, 2001, P NATL ACAD SCI USA, V98, P427, DOI 10.1073/pnas.98.2.427; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HAYDON DJ, 1991, FEMS MICROBIOL LETT, V79, P291, DOI 10.1016/0378-1097(91)90101-F; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; HU L, 1989, J BACTERIOL, V171, P4189, DOI 10.1128/JB.171.8.4189-4195.1989; KATAOKA M, 1994, J BACTERIOL, V176, P7291, DOI 10.1128/JB.176.23.7291-7298.1994; KENDALL KJ, 1988, J BACTERIOL, V170, P4634, DOI 10.1128/jb.170.10.4634-4651.1988; Knobel HR, 1996, J BACTERIOL, V178, P6123, DOI 10.1128/jb.178.21.6123-6132.1996; Ko TP, 1999, ACTA CRYSTALLOGR D, V55, P1474, DOI 10.1107/S0907444999006630; Koo JH, 2000, J BACTERIOL, V182, P6382, DOI 10.1128/JB.182.22.6382-6390.2000; Koo JH, 1999, EUR J BIOCHEM, V266, P683, DOI 10.1046/j.1432-1327.1999.00924.x; Lee HY, 2000, EUR J BIOCHEM, V267, P7224, DOI 10.1046/j.1432-1327.2000.01834.x; Lin JW, 1997, BIOCHEM BIOPH RES CO, V239, P228, DOI 10.1006/bbrc.1997.7461; Magarvey N, 2001, MICROBIOL-SGM, V147, P2103, DOI 10.1099/00221287-147-8-2103; Mahenthiralingam E, 1997, J CLIN MICROBIOL, V35, P808, DOI 10.1128/JCM.35.4.808-816.1997; MAKINO K, 1991, J BACTERIOL, V173, P2665, DOI 10.1128/jb.173.8.2665-2672.1991; Morawski B, 2000, FEMS MICROBIOL LETT, V187, P65, DOI 10.1111/j.1574-6968.2000.tb09138.x; Mota LJ, 1999, MOL MICROBIOL, V33, P476, DOI 10.1046/j.1365-2958.1999.01484.x; Nguyen CC, 1995, FEBS LETT, V377, P98, DOI 10.1016/0014-5793(95)01344-X; Nunez MF, 2001, MICROBIOL-UK, V147, P1069, DOI 10.1099/00221287-147-4-1069; OERTELBUCHHEIT P, 1993, J MOL BIOL, V229, P1, DOI 10.1006/jmbi.1993.1001; Ortuno-Olea L, 2000, FEMS MICROBIOL LETT, V189, P177, DOI 10.1016/S0378-1097(00)00275-5; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pellicer MT, 1996, J BACTERIOL, V178, P2051, DOI 10.1128/jb.178.7.2051-2059.1996; Pellicer MT, 1999, J BIOL CHEM, V274, P1745, DOI 10.1074/jbc.274.3.1745; Poupin P, 1999, J BACTERIOL, V181, P3419, DOI 10.1128/JB.181.11.3419-3426.1999; QUAIL MA, 1995, MOL MICROBIOL, V15, P519, DOI 10.1111/j.1365-2958.1995.tb02265.x; QUAIL MA, 1994, FEBS LETT, V356, P183, DOI 10.1016/0014-5793(94)01264-4; Raman N, 1997, J BIOL CHEM, V272, P30645, DOI 10.1074/jbc.272.49.30645; REIZER A, 1991, MOL MICROBIOL, V5, P1081, DOI 10.1111/j.1365-2958.1991.tb01880.x; ROBERTBAUDOUY J, 1981, J BACTERIOL, V145, P211, DOI 10.1128/JB.145.1.211-220.1981; Rodionov DA, 2000, MOL MICROBIOL, V38, P673, DOI 10.1046/j.1365-2958.2000.02115.x; Rosinski JA, 1999, J MOL EVOL, V49, P301, DOI 10.1007/PL00006552; ROSSBACH S, 1994, MOL GEN GENET, V245, P11, DOI 10.1007/BF00279746; Ryding NJ, 1998, MOL MICROBIOL, V29, P343, DOI 10.1046/j.1365-2958.1998.00939.x; Schock F, 1996, J BACTERIOL, V178, P4576, DOI 10.1128/jb.178.15.4576-4581.1996; Schock F, 1996, GENE, V175, P59, DOI 10.1016/0378-1119(96)00120-5; SERVINGONZALEZ L, 1995, MICROBIOL-UK, V141, P2499, DOI 10.1099/13500872-141-10-2499; Sezonov G, 2000, J BACTERIOL, V182, P1243, DOI 10.1128/JB.182.5.1243-1250.2000; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P155, DOI 10.1111/j.1432-1033.1983.tb07441.x; SUNG MH, 1991, J BIOL CHEM, V266, P2567; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TITGEMEYER F, 1995, DNA SEQUENCE, V5, P145, DOI 10.3109/10425179509029354; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Watanabe T, 2000, J BIOL CHEM, V275, P31016, DOI 10.1074/jbc.M003023200; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514; YOSHIDA KI, 1995, J BACTERIOL, V177, P4813, DOI 10.1128/jb.177.16.4813-4816.1995; YOSHIDA KI, 1993, J MOL BIOL, V231, P167, DOI 10.1006/jmbi.1993.1270; Yoshida KI, 2000, J BACTERIOL, V182, P5454, DOI 10.1128/JB.182.19.5454-5461.2000; YOUNG CL, 1978, ATLAS PROTEIN SEQ S3, V5, P73	75	275	289	5	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2002	277	15					12507	12515		10.1074/jbc.M110968200	http://dx.doi.org/10.1074/jbc.M110968200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	542GZ	11756427	Green Published, hybrid			2022-12-27	WOS:000175036300006
J	Stepanova, V; Jerke, U; Sagach, V; Lindschau, C; Dietz, R; Haller, H; Dumler, I				Stepanova, V; Jerke, U; Sagach, V; Lindschau, C; Dietz, R; Haller, H; Dumler, I			Urokinase-dependent human vascular smooth muscle cell adhesion requires selective vitronectin phosphorylation by ectoprotein kinase CK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CASEIN KINASE-2; RECEPTOR; SURFACE; IDENTIFICATION; RELEASE	Urokinase (uPA)- and urokinase receptor (uPAR)-dependent cell adhesion to the extracellular matrix protein vitronectin (Vn) is an important event in wound healing, tissue remodeling, immune response, and cancer. We recently demonstrated that in human vascular smooth muscle cells (VSMC) uPA/uPAR are functionally associated with the ectoprotein kinase casein kinase-2 (CK2). We now asked whether CK2 regulates uPA-dependent cell adhesion to Vn, since the latter is a natural CK2 substrate. We found that Vn is indeed selectively phosphorylated by CK2 and that this phosphorylation is uPA-regulated in VSMC. Vn induces release of ecto-CK2 from the cell surface via a process termed as "shedding." CK2-mediated Vn phosphorylation was decisive for the uPA-dependent VSMC adhesion. Specific inhibition of CK2 completely abolished the uPA-induced cell adhesion to Vn. This effect was specific for cell adhesion to Vn and required participation of both uPAR and alpha(v)beta(3) integrins as adhesion receptors. CK2 localization at the cell surface was highly dynamic; Vn induced formation of clusters where CK2 colocalized with uPAR and alpha(v)beta(3) integrins. These results indicate that the uPA-dependent VSMC adhesion is a function of selective Vn phosphorylation by the ectoprotein kinase CK2 and suggest a regulatory role for Vn phosphorylation in the uPA-directed adhesive process.	Humboldt Univ, Franz Volhard Clin, Charite, Fac Med, D-13125 Berlin, Germany; Humboldt Univ, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Hannover Med Sch, D-30625 Hannover, Germany	Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Hannover Medical School	Dumler, I (corresponding author), Humboldt Univ, Franz Volhard Clin, Charite, Fac Med, Wiltbergstr 50, D-13125 Berlin, Germany.	dumler@fvk-berlin.de	Lindschau, Carsten/G-1798-2011; Lindschau, Carsten/AAE-6721-2020; Dietz, Rune/F-9154-2015	Lindschau, Carsten/0000-0003-1960-099X; Dietz, Rune/0000-0001-9652-317X; Jerke, Uwe/0000-0001-6887-8010				Ahmed K, 2000, J CELL BIOCHEM, P130; Blasi F, 1999, APMIS, V107, P96, DOI 10.1111/j.1699-0463.1999.tb01531.x; BOGATCHEVA NV, 1993, BIOCHEM J, V290, P437, DOI 10.1042/bj2900437; Chang AW, 1998, ARTERIOSCL THROM VAS, V18, P1855, DOI 10.1161/01.ATV.18.12.1855; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Degryse B, 2001, ONCOGENE, V20, P2032, DOI 10.1038/sj.onc.1204261; Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475; Dumler I, 1998, J BIOL CHEM, V273, P315, DOI 10.1074/jbc.273.1.315; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; Ekdahl KN, 1997, BIOCHEM J, V328, P625, DOI 10.1042/bj3280625; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Gechtman Z, 1997, EUR J BIOCHEM, V243, P493, DOI 10.1111/j.1432-1033.1997.0493a.x; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HARTMANN M, 1992, BIOCHIM BIOPHYS ACTA, V1136, P189, DOI 10.1016/0167-4889(92)90256-B; HOOPER NM, 1999, BIOCHEM SOC T, V27, P211; Kiessling LL, 1998, CHEM BIOL, V5, pR49, DOI 10.1016/S1074-5521(98)90056-4; KORCGRODZICKI B, 1990, ANAL BIOCHEM, V188, P288, DOI 10.1016/0003-2697(90)90608-C; KUBLER D, 1983, P NATL ACAD SCI-BIOL, V80, P4021, DOI 10.1073/pnas.80.13.4021; MARTIN SC, 1990, FEBS LETT, V272, P103, DOI 10.1016/0014-5793(90)80458-U; MCGUIRE EA, 1988, J BIOL CHEM, V263, P1942; Merlos-Suarez A, 1999, BIOCHEM SOC T, V27, P243, DOI 10.1042/bst0270243; PAAS Y, 1995, ARCH BIOCHEM BIOPHYS, V316, P780, DOI 10.1006/abbi.1995.1104; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Redegeld FA, 1999, TRENDS PHARMACOL SCI, V20, P453, DOI 10.1016/S0165-6147(99)01399-1; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Seger D, 1998, J BIOL CHEM, V273, P24805, DOI 10.1074/jbc.273.38.24805; Seger D, 2001, J BIOL CHEM, V276, P16998, DOI 10.1074/jbc.M003766200; Sitrin RG, 2000, J IMMUNOL, V165, P3341, DOI 10.4049/jimmunol.165.6.3341; Veis A, 1997, CRIT REV ORAL BIOL M, V8, P360, DOI 10.1177/10454411970080040101; Walter J, 1996, J BIOL CHEM, V271, P111, DOI 10.1074/jbc.271.1.111; Walz K, 1997, ARCH BIOCHEM BIOPHYS, V340, P347, DOI 10.1006/abbi.1997.9923; WEI Y, 1994, J BIOL CHEM, V269, P32380; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089	33	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10265	10272		10.1074/jbc.M109057200	http://dx.doi.org/10.1074/jbc.M109057200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11756447	hybrid			2022-12-27	WOS:000174549200088
J	Arai, K; Masutomi, K; Khurts, S; Kaneko, S; Kobayashi, K; Murakami, S				Arai, K; Masutomi, K; Khurts, S; Kaneko, S; Kobayashi, K; Murakami, S			Two independent regions of human telomerase reverse transcriptase are important for its oligomerization and telomerase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; HEPATITIS-C VIRUS; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; TERMINAL REGION; HUMAN-CELLS; LIFE-SPAN; IN-VITRO; IMMORTALIZATION; DIMERIZATION	Human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase, contains motifs conserved among reverse transcriptases. Several nucleic acid-dependent polymerases that share a "fingers, palm, and thumb substructure" were shown to oligomerize. Here we demonstrate that hTERT also has this ability using partially purified recombinant hTERTs and mammalian cells co-expressing differently tagged hTERTs. Human template RNA (hTR), by contrast, has no effect on the structural oligomerization of hTERTs. Therefore, hTERT has an intrinsic ability of oligomerization in the absence of hTR. We identified two separate regions as essential for the oligomerization. The regions, amino acids 301-538 (amino-terminal region) and amino acids 914-928 (carboxyl-terminal region), are outside the fingers and palm substructure covering motif T to D and interact with each other in vivo. A substituted mutant of hTERT, hTERT-D712A-V713I, which was reported as a dominant negative form of hTERT, bound to the wildtype hTERT and inhibited its telomerase activity transiently expressed in telomerase-negative finite normal human fibroblast. The truncated forms of hTERT containing the binding region to the wild-type hTERT partially inhibited the telomerase activity, probably by preventing the wild-type hTERT from forming an oligomer. Taken together, the oligomerization of hTERT is an important step for telomerase activity.	Kanazawa Univ, Canc Res Inst, Dept Mol Oncol, Kanazawa, Ishikawa 9200934, Japan; Kanazawa Univ, Dept Internal Med 1, Kanazawa, Ishikawa 9200934, Japan	Kanazawa University; Kanazawa University	Murakami, S (corresponding author), Kanazawa Univ, Canc Res Inst, Dept Mol Oncol, Takarama Machi 13-1, Kanazawa, Ishikawa 9200934, Japan.							Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Bachand F, 2001, MOL CELL BIOL, V21, P1888, DOI 10.1128/MCB.21.5.1888-1897.2001; Beattie TL, 2000, MOL BIOL CELL, V11, P3329, DOI 10.1091/mbc.11.10.3329; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; DIVITA G, 1994, J BIOL CHEM, V269, P13080; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Harris D, 1998, BIOCHEMISTRY-US, V37, P5903, DOI 10.1021/bi9728452; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lin Y, 1997, CANCER RES, V57, P5137; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Morris MC, 1999, J BIOL CHEM, V274, P24941, DOI 10.1074/jbc.274.35.24941; MULLER B, 1989, J BIOL CHEM, V264, P13975; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Ramakrishnan S, 1998, CANCER RES, V58, P622; RESTLE T, 1990, J BIOL CHEM, V265, P8986; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2; Tachedjian G, 2000, P NATL ACAD SCI USA, V97, P6334, DOI 10.1073/pnas.97.12.6334; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Xia JQ, 2000, MOL CELL BIOL, V20, P5196, DOI 10.1128/MCB.20.14.5196-5207.2000; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	36	48	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8538	8544		10.1074/jbc.M111068200	http://dx.doi.org/10.1074/jbc.M111068200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751869	hybrid			2022-12-27	WOS:000174268000116
J	Jagannathan, S; Punt, EL; Gu, Y; Arnoult, C; Sakkas, D; Barratt, CLR; Publicover, SJ				Jagannathan, S; Punt, EL; Gu, Y; Arnoult, C; Sakkas, D; Barratt, CLR; Publicover, SJ			Identification and localization of T-type voltage-operated calcium channel subunits in human male germ cells - Expression of multiple isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERMATOGENIC CELLS; INDUCED ACROSOME REACTION; MARROW STROMAL CELLS; CA2+ CHANNELS; IN-VITRO; ZONA-PELLUCIDA; MAMMALIAN FERTILIZATION; FUNCTIONAL EXPRESSION; INTRACELLULAR CA2+; ION CHANNELS	Low voltage activated, voltage-operated Ca2+ channels are expressed in rodent male germ cells and are believed to be pivotal in induction of the acrosome reaction in mouse spermatozoa. However, in humans, very little is known about expression of voltage-operated Ca2+ channels in male germ cells or their function. We have used reverse transcription-polymerase chain reaction, in situ hybridization, and patch clamp recording to investigate the expression of low voltage activated voltage-operated Ca2+ channels in human male germ cells. We report that full-length transcripts for both alpha(1G) and alpha(1H) low voltage activated channel subunits are expressed in human testis. Multiple isoforms Of alpha(1G) are present in the testis and at least two isoforms of alpha(1H), including a splice variant not previously described in the human. Transcripts for all the isoforms of both alpha(1G) and alpha(1H) were detected by reverse transcription-polymerase chain reaction on mRNA isolated from human spermatogenic cells. In situ hybridization for alpha(1G) and all, localized transcripts both in germ cells and in other cell types in the testis. Within the seminiferous tubules, alpha(1H) was detected primarily in germ cells. Using the whole cell patch clamp technique, we detected T-type voltage-operated Ca2+ channel currents in isolated human male germ cells, although the current amplitude and frequency of occurrence were low in comparison to the occurrence of T-currents in murine male germ cells. We conclude that low voltage activated voltage-operated Ca2+ channels are expressed in cells of the human male germ line.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; CNRS, Commiss Energie Atom, Grenoble DBMS, CIS, F-38054 Grenoble, France; Birmingham Womens Hosp, Assisted Concept Unit, Reprod Biol & Genet Res Grp, Birmingham B15 2TG, W Midlands, England	University of Birmingham; CEA; Centre National de la Recherche Scientifique (CNRS); Birmingham Women's Hospital; University of Birmingham	Jagannathan, S (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.		Publicover, Steve J/E-7970-2018; ARNOULT, christophe/E-8312-2013	ARNOULT, christophe/0000-0002-3753-5901; Barratt, christopher/0000-0003-0062-9979				Aitken RJ, 1996, ENDOCRINOLOGY, V137, P3999, DOI 10.1210/en.137.9.3999; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; Baldi E, 1999, STEROIDS, V64, P143, DOI 10.1016/S0039-128X(98)00100-7; Baldi Elisabetta, 1998, Frontiers in Bioscience, V3, pD1051; BELTRAN C, 1994, FEBS LETT, V338, P23, DOI 10.1016/0014-5793(94)80109-6; Benoff Susan, 1998, Frontiers in Bioscience, V3, pD1220; Blackmore PF, 1999, MOL HUM REPROD, V5, P498, DOI 10.1093/molehr/5.6.498; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; BRANDELLI A, 1995, HUM REPROD, V10, P1751, DOI 10.1093/oxfordjournals.humrep.a136168; Brandelli A, 1996, J ANDROL, V17, P522; Bronson RA, 1999, MOL HUM REPROD, V5, P507, DOI 10.1093/molehr/5.6.507; Calogero AE, 2000, HUM REPROD, V15, P28, DOI 10.1093/humrep/15.suppl_1.28; Chan HC, 1997, BBA-BIOMEMBRANES, V1323, P117, DOI 10.1016/S0005-2736(96)00127-7; Chemin J, 2001, BIOPHYS J, V80, P1238, DOI 10.1016/S0006-3495(01)76100-0; CHESNOYMARCHAIS D, 1988, J PHYSIOL-LONDON, V398, P291, DOI 10.1113/jphysiol.1988.sp017043; Clozel JP, 1999, P ASSOC AM PHYSICIAN, V111, P429, DOI 10.1111/paa.1999.111.5.429; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Espinosa F, 1999, DEV GENET, V25, P103, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;103::AID-DVG4&gt;3.0.CO;2-B; Espinosa F, 1998, FEBS LETT, V426, P47, DOI 10.1016/S0014-5793(98)00305-6; Esterhuizen AD, 2001, HUM REPROD, V16, P138, DOI 10.1093/humrep/16.1.138; FLORMAN HM, 1994, DEV BIOL, V165, P152, DOI 10.1006/dbio.1994.1242; Florman HM, 1998, BIOL REPROD, V59, P12, DOI 10.1095/biolreprod59.1.12; FORESTA C, 1993, BIOCHEM J, V294, P279, DOI 10.1042/bj2940279; Fragale A, 2000, MOL CELL ENDOCRINOL, V162, P25, DOI 10.1016/S0303-7207(00)00213-6; Garcia MA, 1999, BIOL REPROD, V60, P102, DOI 10.1095/biolreprod60.1.102; Goodwin LO, 1998, MOL HUM REPROD, V4, P215, DOI 10.1093/molehr/4.3.215; Goodwin LO, 1997, MOL HUM REPROD, V3, P255, DOI 10.1093/molehr/3.3.255; Gu Y, 1999, PFLUG ARCH EUR J PHY, V438, P553, DOI 10.1007/s004240051075; HAGIWARA S, 1984, J PHYSIOL-LONDON, V356, P135, DOI 10.1113/jphysiol.1984.sp015457; Hughes DC, 1999, BBA-GENE STRUCT EXPR, V1447, P303, DOI 10.1016/S0167-4781(99)00181-5; JACOB A, 2000, J ANDROLOGY S, V56, P48; Johnson L, 1999, BIOL REPROD, V61, P927, DOI 10.1095/biolreprod61.4.927; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; KIRKMANBROWN KC, 2000, J ANDROL, V91, P57; Klockner U, 1999, EUR J NEUROSCI, V11, P4171, DOI 10.1046/j.1460-9568.1999.00849.x; KRAUSZ C, 1995, HUM REPROD, V10, P120, DOI 10.1093/humrep/10.1.120; Lacinova L, 2000, GEN PHYSIOL BIOPHYS, V19, P121; Lievano A, 1996, FEBS LETT, V388, P150, DOI 10.1016/0014-5793(96)00515-7; Liu DY, 2000, HUM REPROD, V15, P702, DOI 10.1093/humrep/15.3.702; Loeser CR, 1999, BIOL REPROD, V61, P629, DOI 10.1095/biolreprod61.3.629; Ma Xue-Hai, 1999, Shengli Xuebao, V51, P571; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Meehan T, 2000, DEV BIOL, V220, P225, DOI 10.1006/dbio.2000.9625; Monteil A, 2000, J BIOL CHEM, V275, P6090, DOI 10.1074/jbc.275.9.6090; Morales P, 2000, BIOL REPROD, V63, P635, DOI 10.1095/biolreprod63.2.635; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Patrat C, 2000, BIOL CELL, V92, P255, DOI 10.1016/S0248-4900(00)01072-8; PATRAT C, 2000, P SOC STUD REPR 33 A; Preston MR, 1996, BONE, V19, P101, DOI 10.1016/8756-3282(96)00136-6; Publicover SJ, 1995, J PHYSIOL-LONDON, V489, P649, DOI 10.1113/jphysiol.1995.sp021080; Publicover SJ, 1999, HUM REPROD, V14, P873, DOI 10.1093/humrep/14.4.873; PUBLICOVER SJ, 1994, CALCIFIED TISSUE INT, V54, P125, DOI 10.1007/BF00296063; Sakata Y, 2001, BIOCHEM BIOPH RES CO, V288, P1032, DOI 10.1006/bbrc.2001.5871; Santi CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1583, DOI 10.1152/ajpcell.1996.271.5.C1583; Serrano CJ, 1999, FEBS LETT, V462, P171, DOI 10.1016/S0014-5793(99)01518-5; Shirakawa H, 1999, DEV BIOL, V208, P70, DOI 10.1006/dbio.1998.9194; Son WY, 2000, MOL HUM REPROD, V6, P893, DOI 10.1093/molehr/6.10.893; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Steuerwald N, 1999, MOL HUM REPROD, V5, P1034, DOI 10.1093/molehr/5.11.1034; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Westenbroek RE, 1999, DEV BIOL, V207, P457, DOI 10.1006/dbio.1998.9172; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; WOODRUFF SKT, 1995, AM J PHYSIOL, V268, pC1284	69	55	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8449	8456		10.1074/jbc.M105345200	http://dx.doi.org/10.1074/jbc.M105345200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751928	hybrid			2022-12-27	WOS:000174268000105
J	Nemeth, ZH; Deitch, EA; Szabo, C; Fekete, Z; Hauser, CJ; Hasko, G				Nemeth, ZH; Deitch, EA; Szabo, C; Fekete, Z; Hauser, CJ; Hasko, G			Lithium induces NF-kappa B activation and interleukin-8 production in human intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER NHE3; NECROSIS-FACTOR-ALPHA; HAMSTER OVARY CELLS; IN-VITRO; CYTOKINE PRODUCTION; INTERFERON-GAMMA; GENE-EXPRESSION; PC12 CELLS; BRAIN; LIPOPOLYSACCHARIDE	Lithium has been documented to regulate apoptosis and apoptotic gene expression via NF-kappaB and mitogen-activated protein (MAP) kinase-dependent mechanisms. Since both NF-kappaB and MAP kinases are also important mediators of inflammatory gene expression, we investigated the effect of lithium on NF-kappaB- and MAP kinase-mediated inflammatory gene expression. Incubation of human intestinal epithelial cells with lithium induced both enhanced NF-kappaB DNA binding and NF-kappaB-dependent transcriptional activity. In addition, lithium stimulated activation of both the p38 and p42/44 MAP kinases. This lithium-induced up-regulation of NF-kappaB and MAP kinase activation was associated with an enhancement of interleukin-8 mRNA accumulation as well as an increase in interleukin-8 protein release. These proinflammatory effects of lithium were, in large part, mediated by activation of Na+/H+ exchangers, because selective blockade of Na+/H+ exchangers prevented the lithium-induced intestinal cell inflammatory response. These results demonstrate that lithium stimulates inflammatory gene expression via NF-kappaB and MAP kinase activation.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Hasko, G (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, 185 S Orange Ave,Univ Hts, Newark, NJ 07103 USA.		Szabo, Csaba/D-1882-2013; Hauser, Carl J./Y-1189-2019; Szabo, Csaba/ABG-2644-2021	Hauser, Carl/0000-0003-3167-1846				Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Aderem A, 2001, CRIT CARE MED, V29, pS16, DOI 10.1097/00003246-200107001-00008; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; AVISSAR S, 1988, NATURE, V331, P440, DOI 10.1038/331440a0; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; BARABAN JM, 1994, P NATL ACAD SCI USA, V91, P5738, DOI 10.1073/pnas.91.13.5738; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BEYAERT R, 1993, J IMMUNOL, V151, P291; BEYAERT R, 1991, CYTOKINE, V3, P284, DOI 10.1016/1043-4666(91)90496-Z; Bocker U, 2000, J BIOL CHEM, V275, P12207, DOI 10.1074/jbc.275.16.12207; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; BULLOCK BP, 1994, MOL BRAIN RES, V27, P232, DOI 10.1016/0169-328X(94)90005-1; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Chen G, 1998, J NEUROCHEM, V70, P1768; CIVITELLI R, 1989, J IMMUNOL, V143, P4000; DAVIS BA, 1992, AM J PHYSIOL, V263, pC246, DOI 10.1152/ajpcell.1992.263.1.C246; DEMAUREX N, 1995, J GEN PHYSIOL, V106, P85, DOI 10.1085/jgp.106.1.85; DEMAUREX N, 1994, J EXP BIOL, V196, P389; Feinstein DL, 1998, J NEUROCHEM, V71, P883; GRINSTEIN S, 1994, J EXP BIOL, V196, P307; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hobbie S, 1997, J IMMUNOL, V159, P5550; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Janecki AJ, 1999, AM J PHYSIOL-GASTR L, V277, pG292, DOI 10.1152/ajpgi.1999.277.2.G292; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Jobin C, 1999, J IMMUNOL, V163, P3474; JOPE RS, 1994, BIOCHEM PHARMACOL, V47, P429, DOI 10.1016/0006-2952(94)90172-4; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kobayashi Y, 2000, PFLUG ARCH EUR J PHY, V439, P455, DOI 10.1007/s004240050963; LAMMERS KM, 1994, GUT, V35, P338, DOI 10.1136/gut.35.3.338; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; Maes M, 1999, PSYCHOPHARMACOLOGY, V143, P401, DOI 10.1007/s002130050965; Maouyo D, 2000, AM J PHYSIOL-CELL PH, V278, pC973, DOI 10.1152/ajpcell.2000.278.5.C973; Mastronarde JG, 1996, AM J PHYSIOL-LUNG C, V271, pL201, DOI 10.1152/ajplung.1996.271.2.L201; Nemeth ZH, 2001, BBA-MOL CELL RES, V1539, P233, DOI 10.1016/S0167-4889(01)00111-2; Nilsen EM, 1998, GUT, V42, P635, DOI 10.1136/gut.42.5.635; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; ORLINSKA U, 1995, IMMUNOPHARMACOLOGY, V30, P41, DOI 10.1016/0162-3109(95)00006-F; Ozaki N, 1997, J NEUROCHEM, V69, P2336; PARKER JC, 1986, J GEN PHYSIOL, V87, P189, DOI 10.1085/jgp.87.2.189; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; PRPIC V, 1989, SCIENCE, V244, P469, DOI 10.1126/science.2541500; ROLFE MW, 1992, AM J RESP CELL MOL, V6, P576, DOI 10.1165/ajrcmb/6.6.576; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; Turner JR, 2000, AM J PHYSIOL-CELL PH, V279, pC1918, DOI 10.1152/ajpcell.2000.279.6.C1918; VAIRO G, 1992, J CELL PHYSIOL, V151, P630, DOI 10.1002/jcp.1041510324; WU YY, 1991, P SOC EXP BIOL MED, V198, P620; YU FH, 1993, J BIOL CHEM, V268, P25536; Yuan PX, 1999, J NEUROCHEM, V73, P2299, DOI 10.1046/j.1471-4159.1999.0732299.x; YUN CHC, 1995, AM J PHYSIOL-GASTR L, V269, pG1, DOI 10.1152/ajpgi.1995.269.1.G1	52	52	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7713	7719		10.1074/jbc.M109711200	http://dx.doi.org/10.1074/jbc.M109711200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756416	hybrid			2022-12-27	WOS:000174268000014
J	O'Brien, KB; O'Shea, JJ; Carter-Su, C				O'Brien, KB; O'Shea, JJ; Carter-Su, C			SH2-B family members differentially regulate JAK family tyrosine kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR KINASE; MICE LACKING JAK3; GROWTH-HORMONE; ADAPTER PROTEIN; SIGNAL-TRANSDUCTION; C-CBL; MOLECULAR-CLONING; PROMOTER ACTIVITY; INTERFERON-GAMMA; PDGF RECEPTOR	Activation of JAK tyrosine kinases is an essential step in cell signaling by multiple hormones, cytokines, and growth factors, including growth hormone (GH) and interferon-gamma. Previously, we identified SH2-1313 as a potent activator of JAK2 (Rui, L., and Carter-Su, C. (1999) Proc. Natl. Acad. Sci. U. S. A 96, 7172-7177). Here, we investigated whether the activation of JAK2 by SH2-Bbeta is specific to JAK2 and SH2-Bbeta or extends to other JAKs or other members of the SH2-1313 family. When SH2-1313 was overexpressed with JAK1 or JAK3, SH2-Bbeta failed to increase their activity. However, SH2-Bbeta bound to both and was tyrosyl-phosphorylated by JAK1. In contrast to SH2-Bbeta,6, APS decreased tyrosyl phosphorylation of GH-stimulated JAK2 as well as Stat5B, a substrate of JAK2. APS also decreased tyrosyl phosphorylation of JAK1, but did not affect the activity or tyrosyl phosphorylation of JAK3. Overexpressed APS bound to and was tyrosylphosphorylated by all three JAKs. Consistent with these data, in 3T3-F442A adipocytes, endogenous APS was tyrosyl-phosphorylated in response to GH and interferon-gamma. These results suggest that 1) SH2-Bbeta specifically activates JAK2, 2) APS negatively regulates both JAK2 and JAK1, and 3) both SH2-Bbeta and APS may serve as adapter proteins for all three JAKs independent of any role they have in JAK activity.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA; NIAMS, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Carter-Su, C (corresponding author), Univ Michigan, Sch Med, Dept Physiol, 6804 Med Sci 2,1301 E Catherine St, Ann Arbor, MI 48109 USA.				NCI NIH HHS [T32CAO96760] Funding Source: Medline; NIDDK NIH HHS [DK54222, DK34171, R01 DK054222, R01 DK034171] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034171, R37DK034171, R56DK054222, R01DK054222] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed Z, 2000, FEBS LETT, V475, P31, DOI 10.1016/S0014-5793(00)01621-5; Ahmed Z, 1999, BIOCHEM J, V341, P665, DOI 10.1042/0264-6021:3410665; ARGETSINGER LS, 1995, J BIOL CHEM, V270, P14685, DOI 10.1074/jbc.270.24.14685; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Argetsinger LS, 1996, J BIOL CHEM, V271, P29415, DOI 10.1074/jbc.271.46.29415; Aringer M, 1999, LIFE SCI, V64, P2173, DOI 10.1016/S0024-3205(98)00538-4; Benbassat C, 1999, ENDOCRINOLOGY, V140, P3073, DOI 10.1210/en.140.7.3073; BERGAD PL, 1995, J BIOL CHEM, V270, P24903, DOI 10.1074/jbc.270.42.24903; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAVID M, 1995, MOL CELL BIOL, V15, P7050; EMTNER M, 1990, MOL ENDOCRINOL, V4, P2014, DOI 10.1210/mend-4-12-2014; Galsgaard ED, 1996, MOL ENDOCRINOL, V10, P652, DOI 10.1210/me.10.6.652; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Hansen LH, 1996, J BIOL CHEM, V271, P12669, DOI 10.1074/jbc.271.21.12669; Herrington J, 1999, J BIOL CHEM, V274, P5138, DOI 10.1074/jbc.274.8.5138; HUANG XM, 1995, P NATL ACAD SCI USA, V92, P11618, DOI 10.1073/pnas.92.25.11618; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Ihle JN, 1995, ADV IMMUNOL, V60, P1, DOI 10.1016/S0065-2776(08)60582-9; Iseki M, 2000, BIOCHEM BIOPH RES CO, V272, P45, DOI 10.1006/bbrc.2000.2736; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Kotani K, 1998, BIOCHEM J, V335, P103, DOI 10.1042/bj3350103; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Meton I, 1999, FEBS LETT, V444, P155, DOI 10.1016/S0014-5793(99)00064-2; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Moodie SA, 1999, J BIOL CHEM, V274, P11186, DOI 10.1074/jbc.274.16.11186; Nelms K, 1999, MAMM GENOME, V10, P1160, DOI 10.1007/s003359901183; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Ooi GT, 1997, MOL ENDOCRINOL, V11, P997, DOI 10.1210/me.11.7.997; OSBORNE MA, 1995, BIO-TECHNOL, V13, P1474, DOI 10.1038/nbt1295-1474; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; PATTERSON PH, 1993, CELL, V72, P123, DOI 10.1016/S0092-8674(05)80032-7; Qian XZ, 2001, MOL CELL BIOL, V21, P1613, DOI 10.1128/MCB.21.5.1613-1620.2001; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Riedel H, 1997, J BIOCHEM-TOKYO, V122, P1105; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Rui LY, 2000, MOL CELL BIOL, V20, P3168, DOI 10.1128/MCB.20.9.3168-3177.2000; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Rui LY, 1999, J BIOL CHEM, V274, P26485, DOI 10.1074/jbc.274.37.26485; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; Smit LS, 1996, MOL ENDOCRINOL, V10, P519, DOI 10.1210/me.10.5.519; SMIT LS, 1999, HDB PHYSL, V5, P445; SUBRAMANIAN A, 1995, MOL CELL BIOL, V15, P4672; SUMANTRAN VN, 1992, ENDOCRINOLOGY, V130, P2016, DOI 10.1210/en.130.4.2016; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Takemoto S, 1997, P NATL ACAD SCI USA, V94, P13897, DOI 10.1073/pnas.94.25.13897; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; VANDERKUUR J, 1995, J BIOL CHEM, V270, P7587, DOI 10.1074/jbc.270.13.7587; Wakioka T, 1999, LEUKEMIA, V13, P760, DOI 10.1038/sj.leu.2401397; Witthuhn BA, 1999, LEUKEMIA LYMPHOMA, V32, P289, DOI 10.3109/10428199909167389; WOOD TJJ, 1995, J BIOL CHEM, V270, P9448, DOI 10.1074/jbc.270.16.9448; YANG XJ, 1993, J NEUROSCI, V13, P3006; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163; Yokouchi M, 1999, ONCOGENE, V18, P759, DOI 10.1038/sj.onc.1202326; Zhou YJ, 1997, P NATL ACAD SCI USA, V94, P13850, DOI 10.1073/pnas.94.25.13850; Zhu T, 1998, J BIOL CHEM, V273, P10682, DOI 10.1074/jbc.273.17.10682	67	45	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8673	8681		10.1074/jbc.M109165200	http://dx.doi.org/10.1074/jbc.M109165200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751854	hybrid			2022-12-27	WOS:000174268000133
J	Knapp, O; Benz, R; Gibert, M; Marvaud, JC; Popoff, MR				Knapp, O; Benz, R; Gibert, M; Marvaud, JC; Popoff, MR			Interaction of Clostridium perfringens iota-toxin with lipid bilayer membranes - Demonstration of channel formation by the activated binding component Ib and channel block by the enzyme component Ia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM C2 TOXIN; SYMMETRICAL TETRAALKYLAMMONIUM IONS; VOLTAGE-DEPENDENT BLOCK; MATRIX PROTEIN PORIN; DIPHTHERIA-TOXIN; ANTHRAX TOXIN; BINARY TOXIN; PROTECTIVE ANTIGEN; ADP-RIBOSYLTRANSFERASE; SPIROFORME TOXIN	The interaction between model lipid membranes and the binding component (Ib) of the ADP-ribosylating iota-toxin of Clostridium perfringens was studied in detail. Ib had to be activated by trypsin to result in channel formation in artificial lipid bilayers. The channels formed readily by Ib had a small single-channel conductance of about 85 picosiemens in 1 M KCl. Channel function was blocked in single-channel and multichannel experiments by the enzymatic component Ia in a pH-dependent manner. The strong Ia-mediated channel block of Ib occurred only when the pH was at least lowered to pH 5.6. The single-channel conductance showed a linear dependence on the bulk aqueous KCl concentration, which indicated that the channel properties were more general than specific. Zero current membrane potential measurements suggested the Ib channel has an similar to6-fold higher permeability for potassium ions than for chloride. The selectivity ratio changed for salts composed of cations and anions of different mobility in the aqueous phase, again suggesting that Ib formed a water-filled general diffusion pore. Asymmetric addition of activated Ib to lipid bilayer membranes resulted in an asymmetric voltage dependence, indicating its fall orientation within the membrane. Titration experiments with chloroquine and different tetraalkylammonium ions suggested that the Ib channel was blocked by these compounds but had only a weak affinity to them. In vivo measurements using Vero cells demonstrate that chloroquine and related molecules also did not efficiently block intoxication of the cells by iota-toxin. The possible role of Ib in the trauslocation of iota-toxin across the target cell membrane is discussed.	Univ Wurzburg, Biozentrum, Theodor Boveri Inst, Lehrstuhl Biotechnol, D-97074 Wurzburg, Germany; Inst Pasteur, F-75724 Paris 15, France	University of Wurzburg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Benz, R (corresponding author), Univ Wurzburg, Biozentrum, Theodor Boveri Inst, Lehrstuhl Biotechnol, Hubland, D-97074 Wurzburg, Germany.	roland.benz@mail.uni-wuerzburg.de		Benz, Roland/0000-0002-9510-9265				AKTORIES K, 1994, MOL CELL BIOCHEM, V138, P167, DOI 10.1007/BF00928459; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; AKTORIES K, 1992, CURR TOP MICROBIOL, V175, P97; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P905, DOI 10.1085/jgp.96.5.905; BOQUET P, 1982, P NATL ACAD SCI-BIOL, V79, P7614, DOI 10.1073/pnas.79.24.7614; BOROCHOVNEORI H, 1984, BIOPHYS J, V45, P83, DOI 10.1016/S0006-3495(84)84117-X; CONSIDINE RV, 1991, TOXICON, V29, P913, DOI 10.1016/0041-0101(91)90076-4; DONOVAN JJ, 1981, P NATL ACAD SCI-BIOL, V78, P172, DOI 10.1073/pnas.78.1.172; DONOVAN JJ, 1986, BIOCHEMISTRY-US, V25, P2872, DOI 10.1021/bi00358a020; Freer J.H, 1998, COMPREHENSIVE SOURCE, V2nd, P243; GAMBALE F, 1988, BIOPHYS J, V53, P771, DOI 10.1016/S0006-3495(88)83157-6; GEIPEL U, 1989, EUR J BIOCHEM, V179, P229, DOI 10.1111/j.1432-1033.1989.tb14545.x; Gibert M, 2000, INFECT IMMUN, V68, P3848, DOI 10.1128/IAI.68.7.3848-3853.2000; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; KAGAN BL, 1981, P NATL ACAD SCI-BIOL, V78, P4950, DOI 10.1073/pnas.78.8.4950; Kimura K, 1998, VET MICROBIOL, V62, P27, DOI 10.1016/S0378-1135(98)00195-3; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Oh KJ, 1999, P NATL ACAD SCI USA, V96, P8467, DOI 10.1073/pnas.96.15.8467; OHISHI I, 1987, INFECT IMMUN, V55, P1461, DOI 10.1128/IAI.55.6.1461-1465.1987; PAPINI E, 1988, EMBO J, V7, P3353, DOI 10.1002/j.1460-2075.1988.tb03207.x; Perelle S, 1997, FEMS MICROBIOL LETT, V146, P117, DOI [10.1016/S0378-1097(96)00463-6, 10.1111/j.1574-6968.1997.tb10180.x]; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; PERELLE S, 1993, INFECT IMMUN, V61, P5147, DOI 10.1128/IAI.61.12.5147-5156.1993; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Popoff MR, 2000, HANDB EXP PHARM, V145, P275; POPOFF MR, 1988, BIOCHEM BIOPH RES CO, V152, P1361, DOI 10.1016/S0006-291X(88)80435-2; POPOFF MR, 1989, INFECT IMMUN, V57, P2462, DOI 10.1128/IAI.57.8.2462-2469.1989; SANDVIG K, 1988, J BIOL CHEM, V263, P12352; SCHERING B, 1988, EUR J BIOCHEM, V171, P225, DOI 10.1111/j.1432-1033.1988.tb13780.x; SCHMID A, 1994, J BIOL CHEM, V269, P16706; SCHMID MF, 1993, NATURE, V364, P827, DOI 10.1038/364827a0; Senzel L, 2000, J GEN PHYSIOL, V115, P421, DOI 10.1085/jgp.115.4.421; SIMPSON LI, 1989, J PHARMACOL EXP THER, V251, P1223; SIMPSON LL, 1989, INFECT IMMUN, V57, P255, DOI 10.1128/IAI.57.1.255-261.1989; STILES BG, 1986, INFECT IMMUN, V54, P683, DOI 10.1128/IAI.54.3.683-688.1986; Stiles BG, 2000, INFECT IMMUN, V68, P3475, DOI 10.1128/IAI.68.6.3475-3484.2000; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; WEGNER A, 1988, J BIOL CHEM, V263, P13739; WEIGT C, 1989, FEBS LETT, V246, P181, DOI 10.1016/0014-5793(89)80279-0; WELKOS SL, 1988, GENE, V69, P287, DOI 10.1016/0378-1119(88)90439-8; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i	50	66	68	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6143	6152		10.1074/jbc.M103939200	http://dx.doi.org/10.1074/jbc.M103939200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741922	hybrid			2022-12-27	WOS:000173989200061
J	Ren, YG; Martinez, J; Virtanen, A				Ren, YG; Martinez, J; Virtanen, A			Identification of the active site of poly(A)-specific ribonuclease by site-directed mutagenesis and Fe2+-mediated cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; MAMMALIAN MESSENGER-RNA; METAL-BINDING SITE; AFFINITY CLEAVAGE; ISOCITRATE DEHYDROGENASE; OXIDATIVE CLEAVAGE; CATALYTIC CENTER; EXONUCLEASE; RESIDUES; DEADENYLATION	Poly(A)-specific ribonuclease (PARN) is the only mammalian exoribonuclease characterized thus far with high specificity for degrading the mRNA poly(A) tail. PARN belongs to the RNase D family of nucleases, a family characterized by the presence of four conserved acidic amino acid residues. Here, we show by site-directed mutagenesis that these residues of human PARN, i.e. Asp(28), GlU(30), Asp(292), and Asp(382), are essential for catalysis but are not required for stabilization of the PARN.RNA substrate complex. We have used iron(II)-induced hydroxyl radical cleavage to map Fe2+ binding sites in PARN. Two Fe2+ binding sites were identified, and three of the conserved acidic amino acid residues were important for Fe2+ binding at these sites. Furthermore, we show that the apparent dissociation constant (K-app(d)) values for Fe2+ binding at both sites were affected in PARN polypeptides in which the conserved acidic amino acid residues were substituted to alanine. This suggests that these residues coordinate divalent metal ions. We conclude that the four conserved acidic amino acids are essential residues of the PARN active site and that the active site of PARN functionally and structurally resembles the active site for 3'-exonuclease domain of Escherichia coli DNA polymerase L.	Uppsala Univ, Dept Cell & Mol Biol, BMC, SE-75124 Uppsala, Sweden	Uppsala University	Virtanen, A (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, SE-75124 Uppsala, Sweden.	anders.virtanen@icm.uu.se		Martinez, Javier/0000-0001-9152-7323				ASTROM J, 1991, EMBO J, V10, P3067, DOI 10.1002/j.1460-2075.1991.tb07858.x; ASTROM J, 1992, J BIOL CHEM, V267, P18154; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; BROWN ID, 1988, ACTA CRYSTALLOGR B, V44, P545, DOI 10.1107/S0108768188007712; Cao WG, 1998, J BIOL CHEM, V273, P33002, DOI 10.1074/jbc.273.49.33002; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; ERMACORA MR, 1992, P NATL ACAD SCI USA, V89, P6383, DOI 10.1073/pnas.89.14.6383; ETTNER N, 1995, BIOCHEMISTRY-US, V34, P22, DOI 10.1021/bi00001a004; FARBER JM, 1986, J BIOL CHEM, V261, P4574; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; Godson GN, 2000, BIOCHEMISTRY-US, V39, P332, DOI 10.1021/bi9916628; Grodsky NB, 2000, BIOCHEMISTRY-US, V39, P2193, DOI 10.1021/bi9919753; Hlavaty JJ, 2000, BIOCHEMISTRY-US, V39, P3097, DOI 10.1021/bi992268c; Hlavaty JJ, 1997, BIOCHEMISTRY-US, V36, P15514, DOI 10.1021/bi970574p; Huang YC, 2000, PROTEIN SCI, V9, P104; JOYCE CM, 1995, J BACTERIOL, V177, P6321, DOI 10.1128/jb.177.22.6321-6329.1995; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; LykkeAndersen J, 1997, EMBO J, V16, P3272, DOI 10.1093/emboj/16.11.3272; Martinez J, 2001, J BIOL CHEM, V276, P27923, DOI 10.1074/jbc.M102270200; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; SOUNDAR S, 1993, J BIOL CHEM, V268, P5264; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; WEI CH, 1994, BIOCHEMISTRY-US, V33, P7931, DOI 10.1021/bi00191a021; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107	34	47	49	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5982	5987		10.1074/jbc.M111515200	http://dx.doi.org/10.1074/jbc.M111515200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11742007	hybrid			2022-12-27	WOS:000173989200038
J	Spinazzola, A; Marti, R; Nishino, I; Andreu, AL; Naini, A; Tadesse, S; Pela, I; Zammarchi, E; Donati, MA; Oliver, JA; Hirano, M				Spinazzola, A; Marti, R; Nishino, I; Andreu, AL; Naini, A; Tadesse, S; Pela, I; Zammarchi, E; Donati, MA; Oliver, JA; Hirano, M			Altered thymidine metabolism due to defects of thymidine phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; BORDER MEMBRANE-VESICLES; NUCLEOSIDE TRANSPORT; HUMAN KIDNEY; CELLS; INFUSIONS; DISORDER; MNGIE; INHIBITION; MUTATIONS	Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive human disease due to mutations in the thymidine phosphorylase (TP) gene. TP enzyme catalyzes the reversible phosphorolysis of thymidine to thymine and 2-deoxy-D-ribose I-phosphate. We present evidence that thymidine metabolism is altered in MNGIE. TP activities in buffy coats were reduced drastically in all 27 MNGIE patients compared with 19 controls. All MNGIE patients had much higher plasma levels of thymidine than normal individuals and asymptomatic TP mutation carriers. In two patients, the renal clearance of thymidine was similar to20% that of creatinine, and because hemodialysis demonstrated that thymidine is ultrafiltratable, most of the filtered thymidine is likely to be reabsorbed by the kidney. In vitro, fibroblasts from controls catabolized thymidine in medium; by contrast, MNGIE fibroblasts released thymidine. In MNGIE, severe impairment of TP enzyme activity leads to increased plasma thymidine. In patients who are suspected of having MNGIE, determination of TP activity in buffy coats and thymidine levels in plasma are diagnostic. We hypothesize that excess thymidine alters mitochondrial nucleoside and nucleotide pools leading to impaired mitochondrial DNA replication, repair, or both. Therapies to reduce thymidine levels may be beneficial to MNGIE patients.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Univ Florence, Dept Pediat, Meyer Childrens Hosp, I-50132 Florence, Italy; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	Columbia University; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Columbia University	Hirano, M (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, P&S 4-443,630 W 168th St, New York, NY 10032 USA.		Spinazzola, Antonella/P-5791-2019; Martí, Ramon/Q-3442-2016; Nishino, Ichizo/G-2676-2010; Spinazzola, Antonella/P-5298-2017	Spinazzola, Antonella/0000-0003-4242-8091; Martí, Ramon/0000-0002-8273-9540; Nishino, Ichizo/0000-0001-9452-112X; Spinazzola, Antonella/0000-0003-4242-8091; ANDREU, antonio luis/0000-0002-3936-3234; Hirano, Michio/0000-0002-7070-7402	NICHD NIH HHS [HD37529] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037529] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; BERK AJ, 1973, J BIOL CHEM, V248, P2722; BESTWICK RK, 1982, J BIOL CHEM, V257, P9305; BESTWICK RK, 1982, J BIOL CHEM, V257, P9300; BOGENHAGEN D, 1976, J BIOL CHEM, V251, P2938; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown NS, 1998, BIOCHEM J, V334, P1; DiMauro S, 1999, ANN NEUROL, V45, P693, DOI 10.1002/1531-8249(199906)45:6<693::AID-ANA2>3.0.CO;2-#; DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3; DUDMAN NPB, 1981, ANAL BIOCHEM, V115, P428, DOI 10.1016/0003-2697(81)90029-4; ENSMINGER WD, 1977, CANCER RES, V37, P1857; FRIEDKIN M, 1954, J BIOL CHEM, V207, P245; GALLO RC, 1967, J BIOL CHEM, V242, P5059; GRIFFITH DA, 1990, BIOCHEM PHARMACOL, V40, P2297, DOI 10.1016/0006-2952(90)90726-2; GUTIERREZ MM, 1993, BIOCHIM BIOPHYS ACTA, V1149, P202, DOI 10.1016/0005-2736(93)90202-B; GUTIERREZ MM, 1992, BIOCHIM BIOPHYS ACTA, V1105, P1, DOI 10.1016/0005-2736(92)90156-G; HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721; Hirano M, 1998, AM J HUM GENET, V63, P526, DOI 10.1086/301979; HOLDEN L, 1980, EUR J CANCER, V16, P115, DOI 10.1016/0014-2964(80)90116-4; Johansson M, 1997, J BIOL CHEM, V272, P8454, DOI 10.1074/jbc.272.13.8454; KUBILUS J, 1978, BIOCHIM BIOPHYS ACTA, V527, P221, DOI 10.1016/0005-2744(78)90271-1; MARSH JC, 1964, J CLIN INVEST, V43, P267, DOI 10.1172/JCI104911; MIYAZONO K, 1989, BIOCHEMISTRY-US, V28, P1704, DOI 10.1021/bi00430a042; Nishino I, 2000, ANN NEUROL, V47, P792; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086; Servidei S, 2001, Neuromuscul Disord, V11, P230; Smith PG, 2000, BRIT J CANCER, V82, P924, DOI 10.1054/bjoc.1999.1020; Van Aubel RAMH, 2000, AM J PHYSIOL-RENAL, V279, pF216, DOI 10.1152/ajprenal.2000.279.2.F216; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; ZAHARKO DS, 1979, CANCER TREAT REP, V63, P945; ZAHARKO DS, 1979, CANCER RES, V39, P4777	33	175	181	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4128	4133		10.1074/jbc.M111028200	http://dx.doi.org/10.1074/jbc.M111028200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733540	hybrid			2022-12-27	WOS:000173813900046
J	Saito, K; Murai, J; Kajiho, H; Kontani, K; Kurosu, H; Katada, T				Saito, K; Murai, J; Kajiho, H; Kontani, K; Kurosu, H; Katada, T			A novel binding protein composed of homophilic tetramer exhibits unique properties for the small GTPase Rab5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC MEMBRANE-FUSION; GDP DISSOCIATION INHIBITOR; EPIDERMAL GROWTH-FACTOR; ENDOSOME FUSION; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; TRANSPORT; RABAPTIN-5; REGULATOR; EFFECTORS	The small GTPase Rab family, which cycles between GTP-bound active and GDP-bound inactive states, plays an important role in membrane trafficking. Among them, Rab5 is involved in early endocytic pathway, and several Rab5-binding proteins have been identified as regulators or effectors to coordinate the docking and fusion processes of endocytic vesicles. We describe a novel binding protein exhibiting unique biochemical properties for Rab5. The Rab5-binding protein enhances GDP-GTP exchange reaction on Rab5 but preferentially interacts with its GTP-bound form. Gel filtration and immunoprecipitation analyses indicate that the Rab5-binding protein functions as a tetramer composed of anti-parallel linkage of two parallel dimers. These results suggest that the newly identified protein may function as an upstream activator and/or downstream effector for Rab5 in endocytic pathway. Possible roles of the quaternary structure have been discussed in terms of the Rab5-mediated signaling.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1130033, Japan	University of Tokyo	Katada, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1130033, Japan.			Kajiho, Hiroaki/0000-0001-6376-7629; Saito, Kota/0000-0003-2478-2687				ARAKI S, 1990, J BIOL CHEM, V265, P13007; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Callaghan J, 1999, BIOCHEM J, V338, P539, DOI 10.1042/0264-6021:3380539; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; COLICELLI J, 1991, P NATL ACAD SCI USA, V88, P2913, DOI 10.1073/pnas.88.7.2913; Cupers P, 1997, J BIOL CHEM, V272, P33430, DOI 10.1074/jbc.272.52.33430; Daitoku H, 2001, INT J MOL MED, V8, P397; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINKELSTEIN DB, 1983, MOL CELL BIOL, V3, P1625, DOI 10.1128/MCB.3.9.1625; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; HAN LM, 1995, MOL CELL BIOL, V15, P1318; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Hoffenberg S, 2000, J BIOL CHEM, V275, P24661, DOI 10.1074/jbc.M909600199; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; HORIUCHI H, 1995, METHOD ENZYMOL, V257, P9; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Kurosu H, 2001, J BIOCHEM-TOKYO, V130, P73, DOI 10.1093/oxfordjournals.jbchem.a002964; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; MERESSE S, 1995, J CELL SCI, V108, P3349; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Rodman JS, 2000, J CELL SCI, V113, P183; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tebar F, 1997, J BIOL CHEM, V272, P15413, DOI 10.1074/jbc.272.24.15413; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	49	83	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 1	2002	277	5					3412	3418		10.1074/jbc.M106276200	http://dx.doi.org/10.1074/jbc.M106276200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	518VF	11733506	hybrid			2022-12-27	WOS:000173688000048
J	Pal, A; Hall, BS; Nesbeth, DN; Field, HI; Field, MC				Pal, A; Hall, BS; Nesbeth, DN; Field, HI; Field, MC			Differential Endocytic functions of Trypanosoma brucei Rab5 isoforms reveal a glycosylphosphatidylinositol-specific endosomal pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; AFRICAN TRYPANOSOMES; ENDOPLASMIC-RETICULUM; MEMBRANE GLYCOPROTEIN; GTPASE ACTIVITY; PROCYCLIC FORM; BLOOD-STREAM; PROTEIN; IDENTIFICATION; LIPOPROTEIN	We demonstrate the presence of a glycosylphosphatidylinositol (GPI) anchor-specific endosomal pathway in the protozoan pathogen Trypanosoma brucei. In higher eukaryotes evidence indicates that GPI-anchored proteins are transported in both the endocytic and exocytic systems by mechanisms involving sequestration into specific membrane microdomains and consequently sorting into distinct compartments. This is potentially extremely important in trypanosomatids as the GPI anchor is the predominant mechanism for membrane attachment of surface macromolecules, including the variant surface glycoprotein (VSG). A highly complex developmentally regulated endocytic network, vital for nutrient uptake and evasion of the immune response, exists in T. brucei. In common with mammalian cells an early endosomal compartment is defined by Rab5 small GTPases, which control transport processes through the endosomal system. We investigate the function of two trypanosome Rab5 homologues. ThRAB5A and ThRAB5B, which colocalize in the procyclic stage, are distinct in the bloodstream form of the parasite. TbRAB5A endosomes contain VSG and transferrin, endocytosed by the T. brucei GPI-anchored transferrin receptor, whereas ThRAB5B endosomes contain the transmembrane protein ISG(100) but neither VSG nor transferrin. These findings indicate the presence of trypanosome endosomal pathways trafficking proteins through specific routes depending on the mode of membrane attachment. Ectopic expression of mutant ThRAB5A or -5B indicates that TbP-kB5A plays a role in LDL endocytosis, whereas TbRAB5B does not, but both have a role in fluid phase endocytosis. Hence TbRAB5A and TbRAB5B have distinct functions in the endosomal system of T. brucei. A developmentally regulated GPI-specific endosomal pathway in the bloodstream form suggests that specialized transport of GPI-anchored proteins is required for survival in the mammalian host.	Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Labs Mol Parasitol, Dept Biol Sci, London SW7 2AY, England; Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Labs Mol Parasitol, Ctr Mol Microbiol & Infect, London SW7 2AY, England	Imperial College London; Imperial College London	Field, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Labs Mol Parasitol, Dept Biol Sci, Exhibit Rd, London SW7 2AY, England.		Hall, Belinda/AGU-6214-2022; Field, Mark/AAD-6455-2021	Hall, Belinda/0000-0002-3753-1978; Field, Mark/0000-0002-4866-2885; Nesbeth, Darren/0000-0003-1596-9407				Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; BRUN R, 1979, ACTA TROP, V36, P286; BURLEIGH BA, 1993, J CELL BIOL, V120, P339, DOI 10.1083/jcb.120.2.339; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; COPPENS I, 1987, J PROTOZOOL, V34, P465, DOI 10.1111/j.1550-7408.1987.tb03216.x; COPPENS I, 1995, MOL BIOCHEM PARASIT, V73, P179, DOI 10.1016/0166-6851(95)00114-G; COPPENS I, 1998, P NATL ACAD SCI USA, V83, P6753; CROSS GAM, 1990, ANNU REV IMMUNOL, V8, P83, DOI 10.1146/annurev.iy.08.040190.000503; Denny PW, 2001, FEBS LETT, V491, P148, DOI 10.1016/S0014-5793(01)02172-X; Ferguson MAJ, 2000, P NATL ACAD SCI USA, V97, P10673, DOI 10.1073/pnas.97.20.10673; Field H, 1996, MOL BIOCHEM PARASIT, V82, P67, DOI 10.1016/0166-6851(96)02723-5; Field H, 1998, J BIOL CHEM, V273, P32102, DOI 10.1074/jbc.273.48.32102; Field H, 1999, J CELL SCI, V112, P147; Foster R, 1996, MOL CELL BIOL, V16, P2689; Hager KM, 1997, NATURE, V385, P823, DOI 10.1038/385823a0; HAJDUK SL, 1994, ANNU REV MICROBIOL, V48, P139, DOI 10.1146/annurev.mi.48.100194.001035; Jeffries TR, 2001, J CELL SCI, V114, P2617; Kelley RJ, 1995, MOL BIOCHEM PARASIT, V74, P167, DOI 10.1016/0166-6851(95)02493-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGRETH SG, 1975, J PROTOZOOL, V22, P40, DOI 10.1111/j.1550-7408.1975.tb00943.x; Liu JY, 2000, J BIOL CHEM, V275, P12032, DOI 10.1074/jbc.275.16.12032; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Morgan GW, 2001, J CELL SCI, V114, P2605; Nolan DP, 1997, J BIOL CHEM, V272, P29212, DOI 10.1074/jbc.272.46.29212; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Pays E, 2001, MOL BIOCHEM PARASIT, V114, P1, DOI 10.1016/S0166-6851(01)00242-0; PITAS RE, 1979, P NATL ACAD SCI USA, V76, P2311, DOI 10.1073/pnas.76.5.2311; Raper J, 2001, CURR OPIN MICROBIOL, V4, P402, DOI 10.1016/S1369-5274(00)00226-5; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Salmon D, 1997, EMBO J, V16, P7272, DOI 10.1093/emboj/16.24.7272; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Steverding Dietmar, 2000, Parasitology International, V48, P191, DOI 10.1016/S1383-5769(99)00018-5; Weise F, 2000, J CELL SCI, V113, P4587; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	43	73	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9529	9539		10.1074/jbc.M110055200	http://dx.doi.org/10.1074/jbc.M110055200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11751913	hybrid			2022-12-27	WOS:000174400600106
J	Valor, LM; Campos-Caro, A; Carrasco-Serrano, C; Ortiz, JA; Ballesta, JJ; Criado, M				Valor, LM; Campos-Caro, A; Carrasco-Serrano, C; Ortiz, JA; Ballesta, JJ; Criado, M			Transcription factors NF-Y and Sp1 are important determinants of the promoter activity of the bovine and human neuronal nicotinic receptor beta 4 subunit genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR-Y; ACETYLCHOLINE-RECEPTORS; CHROMAFFIN CELLS; GENOMIC ORGANIZATION; REGULATORY ELEMENTS; ALPHA-7 SUBUNIT; FAMILY MEMBERS; EXPRESSION; ACTIVATION; PROTEIN	The beta4 subunit is a component of the neuronal nicotinic acetylcholine receptors which control catecholamine secretion in bovine adrenomedullary chromaffin cells. The promoter of the gene coding for this subunit was characterized. A proximal region (from -99 to -64) was responsible for the transcriptional activity observed in chromaffin, C2C12, and COS cells. Within this region two cis-acting elements that bind transcription factors Sp1 and NF-Y were identified. Mutagenesis of the two elements indicated that they cooperate for the basal transcription activity of the promoter. The human beta4 promoter, that was also characterized, shared structural and functional homologies with the bovine promoter. Thus, two adjacent binding elements for Sp1 and NF-Y were detected. Whereas the Sp1 site was an important determinant of the promoter activity, the NF-Y site may have cell-specific effects. Given that these promoters showed no structural or functional homology with the previously characterized rat beta4 subunit promoter (Bigger, C. B., Casanova, E. A., and Gardner, P. D. (1996) J. Biol. Chem. 271, 32842-32848) except for the involvement of an Sp1 binding element, we propose that constitutive expression of the beta4 subunit gene in these three close species may be controlled by the general transcription factor Sp1. Nevertheless, other components could determine species-specific beta4 subunit expression.	Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alicante 03550, Spain; Univ Miguel Hernandez, CSIC, Dept Biochem & Mol Biol, Alicante 03550, Spain; Univ Miguel Hernandez, CSIC, Dept Pharmacol, Alicante 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Criado, M (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alicante 03550, Spain.	Manuel.Criado@umh.es	Campos-Caro, Antonio/T-2807-2019; Criado, Manuel/K-5109-2014; Ortiz Salcedo, José Antonio/HHN-7691-2022; Valor, Luis/ABG-1754-2020	Campos-Caro, Antonio/0000-0001-8532-2153; Criado, Manuel/0000-0002-3953-0346; Ortiz Salcedo, José Antonio/0000-0003-0505-3032; Valor, Luis M./0000-0002-1229-0565				BESSIS A, 1993, NUCLEIC ACIDS RES, V21, P2185, DOI 10.1093/nar/21.9.2185; Bigger CB, 1996, J BIOL CHEM, V271, P32842, DOI 10.1074/jbc.271.51.32842; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; BOULTER J, 1990, J BIOL CHEM, V265, P4472; Boyd RT, 1997, CRIT REV TOXICOL, V27, P299, DOI 10.3109/10408449709089897; Campos-Caro A, 1999, J BIOL CHEM, V274, P4693, DOI 10.1074/jbc.274.8.4693; CamposCaro A, 1997, J NEUROCHEM, V68, P488; Carrasco-Serrano C, 1998, J BIOL CHEM, V273, P20021, DOI 10.1074/jbc.273.32.20021; Chang ZF, 1999, J CELL BIOCHEM, V75, P300, DOI 10.1002/(SICI)1097-4644(19991101)75:2<300::AID-JCB12>3.0.CO;2-Z; Changeux JP, 1998, BRAIN RES REV, V26, P198, DOI 10.1016/S0165-0173(97)00040-4; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; Criado M, 1997, J NEUROSCI, V17, P6554; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Du Q, 1997, J BIOL CHEM, V272, P14990, DOI 10.1074/jbc.272.23.14990; Flora A, 2000, J NEUROCHEM, V75, P18, DOI 10.1046/j.1471-4159.2000.0750018.x; FORNASARI D, 1998, NEURONAL NICOTINIC R, P25; GANDIA L, 1991, BRIT J PHARMACOL, V103, P1073, DOI 10.1111/j.1476-5381.1991.tb12302.x; GARCIAGUZMAN M, 1995, EUR J NEUROSCI, V7, P647, DOI 10.1111/j.1460-9568.1995.tb00668.x; GARDNER PD, 1987, MOL BRAIN RES, V3, P69, DOI 10.1016/0169-328X(87)90046-5; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GrootKormelink PJ, 1997, FEBS LETT, V400, P309, DOI 10.1016/S0014-5793(96)01383-X; Hu Z, 2000, J BIOL CHEM, V275, P2979, DOI 10.1074/jbc.275.4.2979; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kim JH, 2001, J BIOL CHEM, V276, P18153, DOI 10.1074/jbc.M101661200; Liu Q, 1999, J NEUROSCI, V19, P9747; LUKAS RJ, 1993, MOL CELL NEUROSCI, V4, P1, DOI 10.1006/mcne.1993.1001; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; MANTOVANI R, 1999, GENE, V237, P15; MATTERSADZINSKI L, 1992, EMBO J, V11, P4529, DOI 10.1002/j.1460-2075.1992.tb05554.x; McDonough J, 2000, J BIOL CHEM, V275, P28962, DOI 10.1074/jbc.M004181200; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Melnikova IN, 2000, NEUROPHARMACOLOGY, V39, P2615, DOI 10.1016/S0028-3908(00)00125-8; Melnikova IN, 2000, EUR J PHARMACOL, V393, P75, DOI 10.1016/S0014-2999(99)00884-5; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Terzano S, 2000, J BIOL CHEM, V275, P41495, DOI 10.1074/jbc.M006197200; Xiong SB, 2000, P NATL ACAD SCI USA, V97, P3948, DOI 10.1073/pnas.040574197; Yamada K, 2000, J BIOL CHEM, V275, P18129, DOI 10.1074/jbc.M001543200; YANG XD, 1994, J BIOL CHEM, V269, P10252; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514; YU L, 1986, NUCLEIC ACIDS RES, V14, P3539, DOI 10.1093/nar/14.8.3539	47	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8866	8876		10.1074/jbc.M110454200	http://dx.doi.org/10.1074/jbc.M110454200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11742001	hybrid			2022-12-27	WOS:000174400600019
J	Dua, R; Levy, DL; Li, CM; Snow, PM; Campbell, JL				Dua, R; Levy, DL; Li, CM; Snow, PM; Campbell, JL			In vivo reconstitution of Saccharomyces cerevisiae DNA polymerase epsilon in insect cells - Purification and characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FACTOR-C; NUCLEAR ANTIGEN; POL-EPSILON; YEAST; SUBUNIT; DOMAIN; DELTA	DNA polymerase epsilon (pot epsilon) is a multiple subunit complex consisting of at least four proteins, including catalytic Po12p, Dpb2p, Dpb3p, and Dpb4p. Pot epsilon has been shown to play essential roles in chromosomal DNA replication. Here, we report reconstitution of the yeast pol epsilon complex, which was expressed and purified from baculovirus-infected insect cells. During the purification, we were able to resolve the pol epsilon complex and truncated Po12p (140 kDa), as was observed initially with the pot epsilon purified from yeast. Biochemical characterization of subunit stoichiometry, salt sensitivity, processivity, and stimulation by proliferating cell nuclear antigen indicates that the reconstituted pot epsilon is functionally identical to native pot epsilon purified from yeast and is therefore useful for biochemical characterization of the interactions of pol epsilon with other replication, recombination, and repair proteins. Identification and characterization of a proliferating cell nuclear antigen consensus interaction domain on Po12p indicates that the motif is dispensable for DNA replication but is important for methyl methanesulfonate damage-induced DNA repair. Analysis of the putative zinc finger domain of Po12p for zinc binding capacity demonstrates that it binds zinc. Mutations of the conserved cysteines in the putative zinc finger domain reduced zinc binding, indicating that cysteine ligands are directly involved in binding zinc.	CALTECH, Braun Labs 147 75, Pasadena, CA 91125 USA	California Institute of Technology	Campbell, JL (corresponding author), CALTECH, Braun Labs 147 75, 1200 E Calif Blvd, Pasadena, CA 91125 USA.		Levy, Daniel/AAA-7205-2019	Levy, Daniel/0000-0002-7853-3275	NIGMS NIH HHS [GM25508, F32 GM63374-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025508, F32GM063374] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Bambara RA, 1995, METHOD ENZYMOL, V262, P270; BROWN WC, 1993, J BIOL CHEM, V268, P21706; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Dua R, 2000, J BIOL CHEM, V275, P28816, DOI 10.1074/jbc.M002376200; Dua R, 1998, J BIOL CHEM, V273, P30046, DOI 10.1074/jbc.273.45.30046; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; LEE SH, 1991, J BIOL CHEM, V266, P22707; Liu W, 2000, NUCLEIC ACIDS RES, V28, P4180, DOI 10.1093/nar/28.21.4180; Maki S, 1998, J BIOL CHEM, V273, P21332, DOI 10.1074/jbc.273.33.21332; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; Naiki T, 2001, MOL CELL BIOL, V21, P5838, DOI 10.1128/MCB.21.17.5838-5845.2001; Ohya T, 2000, NUCLEIC ACIDS RES, V28, P3846, DOI 10.1093/nar/28.20.3846; Schmidt SLG, 2001, J BIOL CHEM, V276, P34792, DOI 10.1074/jbc.M011671200; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; TRIECH I, 1991, J BIOL CHEM, V266, P21971; Waga S, 2001, P NATL ACAD SCI USA, V98, P4978, DOI 10.1073/pnas.081088798; Warbrick E, 1998, NUCLEIC ACIDS RES, V26, P3925, DOI 10.1093/nar/26.17.3925; YODER BL, 1991, J BIOL CHEM, V266, P22689	28	32	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7889	7896		10.1074/jbc.M108546200	http://dx.doi.org/10.1074/jbc.M108546200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756442	Green Accepted, hybrid			2022-12-27	WOS:000174268000035
J	Lin, R; LeCouter, J; Kowalski, J; Ferrara, N				Lin, R; LeCouter, J; Kowalski, J; Ferrara, N			Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NITRIC-OXIDE SYNTHASE; PERMEABILITY FACTOR; FLT-1 VEGFR-1; SNAKE-VENOM; ACTIVATION; IDENTIFICATION; PATHWAYS; HOMOLOG; BV8	Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) has been recently identified as a mitogen specific for the endothelium of steroidogenic glands. Here we report a characterization of the signal transduction of EG-VEGF in a responsive cell type, bovine adrenal cortex-derived endothelial (ACE) cells. EG-VEGF led to a time- and dose-dependent phosphorylation of p44/42 MAPK. This effect was blocked by pretreatment with pertussis toxin, suggesting that Galpha(i) plays an important role in mediating EG-VEGF-induced activation of MAPK signaling. The inhibitor of p44/42 MAPK phosphorylation PD 98059 resulted in suppression of both proliferation and migration in response to EG-VEGF. EG-VEGF also increased the phosphorylation of Akt in a phosphatidylinositol 3-kinase-dependent manner. Consistent with such an effect, EG-VEGF was a potent survival factor for ACE cells. We also identified endothelial nitric-oxide synthase as one of the downstream targets of Akt activation. Phosphorylation of endothelial nitric-oxide synthase in ACE cells was stimulated by EG-VEGF with a time course correlated to the Akt phosphorylation. Our data demonstrate that EG-VEGF, possibly through binding to a G-protein coupled receptor, results in the activation of MA-PK p44/42 and phosphatidylinositol 3-kinase signaling pathways, leading to proliferation, migration, and survival of responsive endothelial cells.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ferrara, N (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	nf@gene.com	Mordwinkin, Nicholas M/A-4347-2010					Aird WC, 1997, J CELL BIOL, V138, P1117, DOI 10.1083/jcb.138.5.1117; Aravind L, 1998, CURR BIOL, V8, pR477, DOI 10.1016/S0960-9822(98)70309-4; Boisbouvier J, 1998, J MOL BIOL, V283, P205, DOI 10.1006/jmbi.1998.2057; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; DAngelo G, 1997, J CELL BIOCHEM, V67, P353, DOI 10.1002/(SICI)1097-4644(19971201)67:3<353::AID-JCB7>3.3.CO;2-2; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Dellian M, 1996, AM J PATHOL, V149, P59; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; GARCIA JGN, 1995, J INVEST MED, V43, P117; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HERBERT JM, 1994, BIOCHEM J, V303, P227, DOI 10.1042/bj3030227; Hla T, 2001, PROSTAG OTH LIPID M, V64, P135, DOI 10.1016/S0090-6980(01)00109-5; HOLLENBERG MD, 1994, TRENDS PHARMACOL SCI, V15, P108, DOI 10.1016/0165-6147(94)90046-9; JOUBERT FJ, 1980, H-S Z PHYSIOL CHEM, V361, P1787, DOI 10.1515/bchm2.1980.361.2.1787; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; KU DD, 1993, AM J PHYSIOL, V265, pH586, DOI 10.1152/ajpheart.1993.265.2.H586; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Melchiorri D, 2001, EUR J NEUROSCI, V13, P1694, DOI 10.1046/j.1460-9568.2001.01549.x; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Murthy KS, 2000, AM J PHYSIOL-GASTR L, V279, pG201, DOI 10.1152/ajpgi.2000.279.1.G201; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Schweitz H, 1999, FEBS LETT, V461, P183, DOI 10.1016/S0014-5793(99)01459-3; Senger DR, 1996, AM J PATHOL, V149, P293; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; VAN BT, 1995, NATURE, V376, P781; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; Wechselberger C, 1999, FEBS LETT, V462, P177, DOI 10.1016/S0014-5793(99)01473-8; Wu HM, 1996, AM J PHYSIOL-HEART C, V271, pH2735, DOI 10.1152/ajpheart.1996.271.6.H2735; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang RH, 1998, J PHARMACOL EXP THER, V284, P103; Ziche M, 1997, J CLIN INVEST, V99, P2625, DOI 10.1172/JCI119451; ZUCKER S, 1995, J BIOL CHEM, V270, P23730, DOI 10.1074/jbc.270.40.23730	52	87	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8724	8729		10.1074/jbc.M110594200	http://dx.doi.org/10.1074/jbc.M110594200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751915	hybrid			2022-12-27	WOS:000174268000139
J	Mueller, S; Cao, XM; Welker, R; Wimmer, E				Mueller, S; Cao, XM; Welker, R; Wimmer, E			Interaction of the poliovirus receptor CD155 with the dynein light chain Tctex-1 and its implication for poliovirus pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; COMPLEX STERILITY LOCUS; CYTOPLASMIC DYNEIN; PARALYTIC POLIOMYELITIS; TRANSGENIC MICE; DIFFERENTIAL EXPRESSION; SUBUNIT HETEROGENEITY; PROTEIN; VIRUS; GENE	The cellular receptor for poliovirus CD155 (or PVR) is the founding member of a new class of membrane-associated immunoglobulin-like proteins, which include the mouse tumor-associated antigen E4 (Tage4) and three proteins termed "nectins." Using a yeast two-hybrid screen we have discovered that the cytoplasmic domain of CD155 associates strongly and specifically with Tctex-1, a light chain of the dynein motor complex, the latter representing the major driving force for retrograde transport of endocytic vesicles and membranous organelles. We confirmed the interaction biochemically and by co-immunoprecipitation, and we mapped the Tctex-1 binding site to a SKCSR motif within the juxtamembrane region of CD155. Tctex-1 immunoreactivity was detected in mouse sciatic nerve and spinal cord (two tissues of central importance for poliovirus pathogenesis) in punctate, possibly vesicular, patterns. We propose that the cytoplasmic domain may target CD155-containing endocytic vesicles to the microtubular network. Neurotropic viruses like poliovirus, herpesvirus, rabies virus, and pseudorabies virus all utilize neuronal retrograde transport to invade the central nervous system. Association with Tctex-1 and, hence, with the dynein motor complex may offer an explanation for how poliovirus hijacks the cellular transport machinery to retrogradely ascend along the axon to the neuronal cell body.	SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wimmer, E (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	ewimmer@ms.cc.sunysb.cd	Mueller, Steffen/HGE-0738-2022	Mueller, Steffen/0000-0003-2660-258X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032100] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI-32100] Funding Source: Medline; PHS HHS [A1-15122] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aoki J, 1997, EXP CELL RES, V235, P374, DOI 10.1006/excr.1997.3685; Ausubel FM, 1998, CURRENT PROTOCOLS MO; BODIAN D, 1956, AM J HYG, V64, P181, DOI 10.1093/oxfordjournals.aje.a119833; Bodian D, 1940, BRAIN, V63, P135, DOI 10.1093/brain/63.2.135; Campbell KS, 1998, J IMMUNOL, V161, P1728; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Chuang JZ, 2001, J NEUROSCI, V21, P5501, DOI 10.1523/JNEUROSCI.21-15-05501.2001; Cuconati A, 1998, J VIROL, V72, P1297, DOI 10.1128/JVI.72.2.1297-1307.1998; DiBella LM, 2001, J BIOL CHEM, V276, P14366, DOI 10.1074/jbc.M011456200; Fairbrother RW, 1930, J PATHOL BACTERIOL, V33, P17, DOI 10.1002/path.1700330103; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gromeier M, 1998, J VIROL, V72, P5056, DOI 10.1128/JVI.72.6.5056-5060.1998; Gromeier M, 2000, VIROLOGY, V273, P248, DOI 10.1006/viro.2000.0418; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Harrison A, 1998, J CELL BIOL, V140, P1137, DOI 10.1083/jcb.140.5.1137; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; Kagami O, 1998, GENE, V211, P383, DOI 10.1016/S0378-1119(98)00128-0; King SM, 1996, J BIOL CHEM, V271, P32281, DOI 10.1074/jbc.271.50.32281; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; KOIKE S, 1994, COLD SPRING HARBOR M, P463; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P951, DOI 10.1073/pnas.88.3.951; LADER E, 1989, CELL, V58, P969, DOI 10.1016/0092-8674(89)90948-3; LENTZ TL, 1982, SCIENCE, V215, P182, DOI 10.1126/science.7053569; LEONMONZON ME, 1995, ANN NY ACAD SCI, V753, P48, DOI 10.1111/j.1749-6632.1995.tb27530.x; Loewy Arthur D., 1995, P349, DOI 10.1016/B978-012397570-6/50021-6; MCCLOSKEY BP, 1950, LANCET, V1, P659; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Mou T, 1998, FEBS LETT, V435, P275, DOI 10.1016/S0014-5793(98)01069-2; MURPHY FA, 1974, INTERVIROLOGY, V3, P256, DOI 10.1159/000149762; NATHANSON N, 1963, AM J HYG, V78, P61, DOI 10.1093/oxfordjournals.aje.a120329; NOBIS P, 1985, J GEN VIROL, V66, P2563, DOI 10.1099/0022-1317-66-12-2563; Ohka S, 1998, VIROLOGY, V250, P67, DOI 10.1006/viro.1998.9360; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; REN R, 1992, J VIROL, V66, P296, DOI 10.1128/JVI.66.1.296-304.1992; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; REN RB, 1992, J INFECT DIS, V166, P747, DOI 10.1093/infdis/166.4.747; Sabin AB, 1941, J EXP MED, V73, P757, DOI 10.1084/jem.73.6.757; Sambrook J., 2002, MOL CLONING LAB MANU; STRACK AM, 1989, BRAIN RES, V491, P156, DOI 10.1016/0006-8993(89)90098-X; STREBEL PM, 1995, NEW ENGL J MED, V332, P500, DOI 10.1056/NEJM199502233320804; SUTTER RW, 1992, J INFECT DIS, V165, P444, DOI 10.1093/infdis/165.3.444; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Watanabe TK, 1996, CYTOGENET CELL GENET, V73, P153, DOI 10.1159/000134329; Yang WX, 1997, VIROLOGY, V229, P421, DOI 10.1006/viro.1997.8450; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; Ye GJ, 2000, P NATL ACAD SCI USA, V97, P11002, DOI 10.1073/pnas.97.20.11002	54	111	117	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7897	7904		10.1074/jbc.M111937200	http://dx.doi.org/10.1074/jbc.M111937200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751937	hybrid			2022-12-27	WOS:000174268000036
J	Kim, YM; Kim, YM; Lee, YM; Kim, HS; Kim, JD; Choi, Y; Kim, KW; Lee, SY; Kwon, YG				Kim, YM; Kim, YM; Lee, YM; Kim, HS; Kim, JD; Choi, Y; Kim, KW; Lee, SY; Kwon, YG			TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; STIMULATES TYROSINE PHOSPHORYLATION; FAMILY MEMBER; DENDRITIC-CELL; GROWTH-FACTOR; T-CELLS; OSTEOPROTEGERIN LIGAND; LYMPHOCYTE DEVELOPMENT; NITRIC-OXIDE; RECEPTOR	Angiogenesis is an essential step for many physiological and pathological processes. Tumor necrosis factor (TNF) superfamily cytokines are increasingly recognized as key modulators of angiogenesis. In this study, we tested whether TNF-related activation-induced cytokine (TRANCE), a new member of the TNF superfamily, possesses angiogenic activity in vitro and in vivo. TRANCE stimulated DNA synthesis, chemotactic motility, and capillary-like tube formation in primary cultured human umbilical vein endothelial cells (HUVECs). Both Matrigel plug assay in mice and chick chorioallantoic membrane assay revealed that TRANCE potently induced neovascularization in vivo. TRANCE had no effect on vascular endothelial growth factor (VEGF) expression in HUVECs and TRANCE-induced angiogenic activity was not suppressed by VEGF-neutralizing antibody, implying that TRANCE-induced angiogenesis may be the result of its direct action on endothelial cells. TRANCE evoked a time- and dose-dependent activation of the mitogen-activated protein kinases ERK1/2 and focal adhesion kinase p125(FAK) in HUVECs, which are closely linked to angiogenesis. These signaling events were blocked by the Src inhibitor PP1 or the phospholipase C (PLC) inhibitor U73122. Furthermore, these inhibitors and the Ca(2+) chelator BAPTA-AM suppressed TRANCE-induced HUVEC migration. These results indicate that the angiogenic activity of TRANCE is mediated through the Src-PLC-Ca(2+) signaling cascade upon receptor engagement in endothelial cells, suggesting the role of TRANCE in neovessel formation under physiological and pathological conditions.	Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; Kangweon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, Kwangwon Do, South Korea; Kangweon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Technol, Chunchon 200701, Kwangwon Do, South Korea; Kangweon Natl Univ, Sch Med, Dept Mol & Cellular Biol, Chunchon 200701, Kwangwon Do, South Korea; Seoul Natl Univ, Coll Pharm, Biochem Lab, Seoul 151742, South Korea; Univ Penn, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Ewha Womans University; Ewha Womans University; Kangwon National University; Kangwon National University; Kangwon National University; Seoul National University (SNU); University of Pennsylvania; Pennsylvania Medicine	Kwon, YG (corresponding author), Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea.	ygkwon@cc.kangwon.ac.kr						ABEDI H, 1995, CARDIOVASC RES, V30, P544, DOI 10.1016/0008-6363(95)00092-5; Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Green EA, 1999, J EXP MED, V189, P1017; Groskopf JC, 1997, ENDOCRINOLOGY, V138, P2835, DOI 10.1210/en.138.7.2835; Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kim MS, 2000, INT J CANCER, V87, P269, DOI 10.1002/1097-0215(20000715)87:2&lt;269::AID-IJC19&gt;3.0.CO;2-W; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 2000, IMMUNOL TODAY, V21, P495, DOI 10.1016/S0167-5699(00)01718-7; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kuzuya M, 1999, EXP CELL RES, V248, P498, DOI 10.1006/excr.1999.4422; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lee OH, 2000, BIOCHEM BIOPH RES CO, V268, P47, DOI 10.1006/bbrc.2000.2087; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Liu F, 2001, AM J RESP CELL MOL, V24, P711, DOI 10.1165/ajrcmb.24.6.4323; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shono T, 2001, EXP CELL RES, V264, P275, DOI 10.1006/excr.2001.5154; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Wong BR, 1999, J LEUKOCYTE BIOL, V65, P715, DOI 10.1002/jlb.65.6.715; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; Xing LP, 2001, GENE DEV, V15, P241, DOI 10.1101/gad.840301; Yu Y, 1999, J CELL PHYSIOL, V178, P235, DOI 10.1002/(SICI)1097-4652(199902)178:2<235::AID-JCP13>3.3.CO;2-J; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375	40	101	105	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6799	6805		10.1074/jbc.M109434200	http://dx.doi.org/10.1074/jbc.M109434200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741951	hybrid			2022-12-27	WOS:000174104300008
J	Nonekowski, ST; Kung, FL; Garcia, GA				Nonekowski, ST; Kung, FL; Garcia, GA			The Escherichia coli tRNA-guanine transglycosylase can recognize and modify DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TRNA(PHE) ANTICODON; TRANSFER-RNA; CONFORMATIONAL TRANSITION; TRANSFER RNA(PHE); SITE; DOMAIN; REQUIREMENTS; SEQUENCE; RIBOZYME; BINDING	tRNA-guanine transglycosylase (TGT) catalyzes the exchange of queuine (or a precursor) for guanine 34 in tRNA. The minimal RNA recognition motif for TGT has been found to involve a UGU sequence in the anticodon loop of the queuine-cognate tRNAs. Recent studies have shown that the enzyme is capable of recognizing the UGU sequence in alternative contexts (Kung, F. L., Nonekowski, S., and Garcia, G. A. (2000) RNA 6,233-244) and have investigated the role of the first U of the UGU sequence in tRNA recognition by TGT (Nonekowski, S. T., and Garcia, G. A (2001) RNA 7,1432-1441). The TGT reaction involves the breakage and re-formation of a glycosidic bond. To rule out a potential chemical mechanism involving the 2'-hydroxyl at position 34, we synthesized and evaluated an RNA minihelix with 2'-deoxy-G at 34. The high level of activity exhibited by this analogue indicates that the 2'-hydroxyl of G 34 is not required for catalysis. Furthermore, we find that TGT can recognize analogues composed entirely of DNA, but only when 2'-deoxyuridines replace the thymidines in the DNA. The requirement for uridine bases for recognition is perhaps not surprising given the UGU recognition motif for TGT. However, it is not clear if the uracil requirement is due to specific recognition by TGT or due to the effect of uracils on the conformation of the oligonucleotide.	Univ Michigan, Coll Pharm, Dept Med Chem, Interdepartmental Program Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Garcia, GA (corresponding author), Univ Michigan, Coll Pharm, Dept Med Chem, Interdepartmental Program Med Chem, Ann Arbor, MI 48109 USA.			KUNG, FAN-LU/0000-0002-7822-7200				Aphasizhev R, 1997, RNA, V3, P893; Basti MM, 1996, NAT STRUCT BIOL, V3, P38, DOI 10.1038/nsb0196-38; CURNOW AW, 1994, BIOCHIMIE, V76, P1183, DOI 10.1016/0300-9084(94)90048-5; CURNOW AW, 1993, BIOCHEMISTRY-US, V32, P5239, DOI 10.1021/bi00070a036; CURNOW AW, 1995, J BIOL CHEM, V270, P17264, DOI 10.1074/jbc.270.29.17264; DAHM SC, 1990, BIOCHIMIE, V72, P819, DOI 10.1016/0300-9084(90)90191-I; DAO V, 1992, BIOCHEMISTRY-US, V31, P11012, DOI 10.1021/bi00160a010; DAO V, 1994, P NATL ACAD SCI USA, V91, P2125, DOI 10.1073/pnas.91.6.2125; Grosjean H., 1998, MODIFICATION EDITING, DOI [10.1128/9781555818296, DOI 10.1128/9781555818296]; GUENTHER RH, 1994, BIOCHIMIE, V76, P1143, DOI 10.1016/0300-9084(94)90043-4; GUENTHER RH, 1992, BIOCHEMISTRY-US, V31, P11004, DOI 10.1021/bi00160a009; HERSCHLAG D, 1990, NATURE, V344, P405, DOI 10.1038/344405a0; HOLMES CE, 1993, J BIOL CHEM, V268, P25909; KHAN AS, 1988, SCIENCE, V241, P74, DOI 10.1126/science.2455342; Kittendorf JD, 2001, BIOCHEMISTRY-US, V40, P14123, DOI 10.1021/bi0110589; Kung FL, 1998, FEBS LETT, V431, P427, DOI 10.1016/S0014-5793(98)00801-1; Kung FL, 2000, RNA, V6, P233, DOI 10.1017/S135583820099191X; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEE JY, 1991, CHARACTERIZATION SAC; LIM AC, 1993, BIOCHEMISTRY-US, V32, P11029, DOI 10.1021/bi00092a012; NAKANISHI S, 1994, J BIOL CHEM, V269, P32221; Nonekowski ST, 2001, RNA, V7, P1432; PAQUETTE J, 1990, EUR J BIOCHEM, V189, P259, DOI 10.1111/j.1432-1033.1990.tb15485.x; PERREAULT JP, 1992, J MOL BIOL, V226, P399, DOI 10.1016/0022-2836(92)90955-J; PERREAULT JP, 1989, EUR J BIOCHEM, V186, P87, DOI 10.1111/j.1432-1033.1989.tb15181.x; PYLE AM, 1991, NATURE, V350, P628, DOI 10.1038/350628a0; QUIGLEY GJ, 1978, P NATL ACAD SCI USA, V75, P64, DOI 10.1073/pnas.75.1.64; Romier C, 1996, BIOCHEMISTRY-US, V35, P15734, DOI 10.1021/bi962003n; SAENGER W, 1984, PRINCIPLES NUCLEIC A, P55; Sengupta R, 2000, NUCLEIC ACIDS RES, V28, P1374, DOI 10.1093/nar/28.6.1374; Shi PY, 1998, RNA, V4, P276; YANG JH, 1992, BIOCHEMISTRY-US, V31, P5005, DOI 10.1021/bi00136a013; YANG JH, 1990, BIOCHEMISTRY-US, V29, P11156, DOI 10.1021/bi00503a002	33	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7178	7182		10.1074/jbc.M111077200	http://dx.doi.org/10.1074/jbc.M111077200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751936	hybrid			2022-12-27	WOS:000174104300056
J	Peterson, YK; Hazard, S; Graber, SG; Lanier, SM				Peterson, YK; Hazard, S; Graber, SG; Lanier, SM			Identification of structural features in the G-protein regulatory motif required for regulation of heterotrimeric G-proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; G-ALPHA(O); DROSOPHILA; DIVISIONS; ALPHA	The G-protein regulatory (GPR) motif, a conserved 25-30 amino acid domain found in multiple mammalian proteins, stabilizes the GDP-bound conformation of Galpha(i), inhibits guanosine 5'-O-(3-thiotriphosphate) (GTPgammaS) binding to Gai and competes for Gbetagamma binding to Galpha. To define the core GPR motif and key amino acid residues within a GPR peptide (TMGEEDFFDLLAKSQSKRMDDQRVDLAG), we determined the effect of truncation, insertion, and alanine substitutions on peptide-mediated inhibition of GTPgammaS binding to purified Galpha(i1). The bioactive core GPR peptide consists of 17 amino acids (F-7-R-23). Within this core motif, two hydrophobic sectors ((FF8)-F-7 and (LL11)-L-10) and Q(22) are required for bioactivity, whereas M19A and R23A increased IC50 values by 70-fold. Disruption of spatial relationships between the required sectors in the amino and carboxyl regions of the peptide also resulted in a loss of biological activity. Mutation of three charged sectors ((EED6)-E-4, R-18, (DD21)-D-20) within the 28-amino acid GPR decreased peptide affinity by similar to10-fold. Alanine substitutions of selected residues within the core GPR peptide differently influenced peptide inhibition of GTPgammaS binding to Gai versus Galpha(o). These data provide a platform for the development of novel, G-protein-selective therapeutics that inhibit Galpha(i)-mediated signaling, selectively activate Gbetagamma-sensitive effectors, and/or disrupt specific regulatory input to G-proteins mediated by GPR-containing proteins.	Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70118 USA; Med Univ S Carolina, Dept Lib & Informat, Charleston, SC 29425 USA; W Virginia Univ, Sch Med, Dept Mol Pharmacol & Biochem, Morgantown, WV 26506 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Medical University of South Carolina; West Virginia University	Lanier, SM (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, MEB Suite 7103,1901 Perdido St, New Orleans, LA 70112 USA.			Lanier, Stephen/0000-0002-2740-7607	NIMH NIH HHS [MH 5993] Funding Source: Medline; NINDS NIH HHS [NS 24821] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS024821, R01NS024821] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; BOWERS S, 2001, ANN M SOC NEUR NOV 1; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Clawges HM, 1997, BIOCHEMISTRY-US, V36, P12930, DOI 10.1021/bi970112b; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Luo Y, 1999, J BIOL CHEM, V274, P10685, DOI 10.1074/jbc.274.16.10685; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	22	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6767	6770		10.1074/jbc.C100699200	http://dx.doi.org/10.1074/jbc.C100699200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11756403	hybrid, Green Published			2022-12-27	WOS:000174104300003
J	Shi, CZ; Soldatov, NM				Shi, CZ; Soldatov, NM			Molecular determinants of voltage-dependent slow inactivation of the Ca2+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL; ALPHA(1C) SUBUNIT; POTASSIUM CHANNEL; K+ CHANNEL; MECHANISM; BLOCK; SEGMENT; PHENYLALKYLAMINES; CONDUCTANCE; MEGAPRIMER	Ba2+ current through the L-type Ca2+ channel inactivates essentially by voltage-dependent mechanisms with fast and slow kinetics. Here we found that slow inactivation is mediated by an annular determinant composed of hydrophobic amino acids located near the cytoplasmic ends of transmembrane segments S6 of each repeat of the ale subunit. We have determined the molecular requirements that completely obstruct slow inactivation. Critical interventions include simultaneous substitution of A752T in IIS6, V1165T in IIIS6, and I1475T in IVS6, each preventing in additive manner a considerable fraction of Ba2+ current from inactivation. In addition, it requires the S405I mutation in segment IS6. The fractional inhibition of slow inactivation in tested mutants caused an acceleration of fast inactivation, suggesting that fast and slow inactivation mechanisms are linked. The channel lacking slow inactivation showed similar to45% of the sustained Ba2+ or Ca2+ current with no indication of decay. The remaining fraction of the current was inactivated with a single-exponential decay (tau(f) similar to 10 ms), completely recovered from inactivation within 100 ms and did not exhibit Ca2+-dependent inactivation properties. No voltage-dependent characteristics were significantly changed, consistent with the C-type inactivation model suggesting constriction of the pore as the main mechanism possibly targeted by Ca2+ sensors of inactivation.	NIA, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Soldatov, NM (corresponding author), NIA, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.				NATIONAL INSTITUTE ON AGING [ZIAAG000294, Z01AG000294] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Berjukow S, 1999, J BIOL CHEM, V274, P6154, DOI 10.1074/jbc.274.10.6154; Berjukow S, 2000, J BIOL CHEM, V275, P22114, DOI 10.1074/jbc.M908836199; Bernatchez G, 1998, BIOPHYS J, V75, P1727, DOI 10.1016/S0006-3495(98)77614-3; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; DATTA AK, 1995, NUCLEIC ACIDS RES, V23, P4530, DOI 10.1093/nar/23.21.4530; Doring F, 1996, J BIOL CHEM, V271, P11745, DOI 10.1074/jbc.271.20.11745; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ECKERT R, 1984, PROG BIOPHYS MOL BIO, V44, P215, DOI 10.1016/0079-6107(84)90009-9; Espinosa F, 2001, J GEN PHYSIOL, V118, P157, DOI 10.1085/jgp.118.2.157; Guia A, 2001, BIOPHYS J, V80, P2742, DOI 10.1016/S0006-3495(01)76242-X; HADLEY RW, 1991, J PHYSIOL-LONDON, V444, P257, DOI 10.1113/jphysiol.1991.sp018876; Hering S, 1997, P NATL ACAD SCI USA, V94, P13323, DOI 10.1073/pnas.94.24.13323; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Hering S, 1998, TRENDS PHARMACOL SCI, V19, P439, DOI 10.1016/S0165-6147(98)01258-9; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Kepplinger KJF, 2000, FEBS LETT, V477, P161, DOI 10.1016/S0014-5793(00)01791-9; LOPEZ GA, 1994, NATURE, V367, P179, DOI 10.1038/367179a0; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Motoike HK, 1999, J BIOL CHEM, V274, P9409, DOI 10.1074/jbc.274.14.9409; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; NEELY A, 1994, BIOPHYS J, V66, P1895, DOI 10.1016/S0006-3495(94)80983-X; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Restituito S, 2000, J NEUROSCI, V20, P9046; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SOLDATOV NM, 1992, P NATL ACAD SCI USA, V89, P4628, DOI 10.1073/pnas.89.10.4628; Soldatov NM, 1998, J BIOL CHEM, V273, P957, DOI 10.1074/jbc.273.2.957; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Soldatov NM, 2000, J MEMBRANE BIOL, V177, P129, DOI 10.1007/s002320001106; Spaetgens RL, 1999, J BIOL CHEM, V274, P22428, DOI 10.1074/jbc.274.32.22428; Stotz SC, 2000, J BIOL CHEM, V275, P24575, DOI 10.1074/jbc.M000399200; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	40	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6813	6821		10.1074/jbc.M110524200	http://dx.doi.org/10.1074/jbc.M110524200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751866	hybrid			2022-12-27	WOS:000174104300010
J	Wappl, E; Koschak, A; Poteser, M; Sinnegger, MJ; Walter, D; Eberhart, A; Groschner, K; Glossmann, H; Kraus, RL; Grabner, M; Striessnig, J				Wappl, E; Koschak, A; Poteser, M; Sinnegger, MJ; Walter, D; Eberhart, A; Groschner, K; Glossmann, H; Kraus, RL; Grabner, M; Striessnig, J			Functional consequences of P/Q-type Ca2+ channel Ca(v)2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; CALCIUM-CHANNEL; NEUROTRANSMITTER RELEASE; G-PROTEINS; SUBUNITS; EPILEPSY; GENE; MODULATION; KINETICS	We have investigated the functional consequences of three P/Q-type Ca2+ channel alpha1A (Ca(v)2.1alpha(1)) subunit mutations associated with different forms of ataxia (episodic ataxia type 2 (EA-2), R1279Stop, AY1593/1594D; progressive ataxia (PA), G293R). Mutations were introduced into human a1A cDNA and heterologously expressed in Xenopus oocytes or tsA-201 cells (with alpha(2)delta and beta1a) for electrophysiological and biochemical analysis. G293R reduced current density in both expression systems without changing single channel conductance. R1279Stop and AY1593/1594D protein were expressed in tsA-201 cells but failed to yield inward barium currents (I-Ba). However, AY1593/1594D mediated I-Ba when expressed in oocytes. G293R and AY1593/1594D shifted the current-voltage relationship to more positive potentials and enhanced inactivation during depolarizing pulses (3 s) and pulse trains (100 ms, 1 Hz). Mutation AY1593/ 1594D also slowed recovery from inactivation. Single channel recordings revealed a change in fast channel gating for G293R evident as a decrease in the mean open time. Our data support the hypothesis that a pronounced loss of P/Q-type Ca2+ channel function underlies the pathophysiology of EA-2 and PA. In contrast to other EA-2 mutations, AY1593/1594D and G293R form at least partially functional channels.	Univ Innsbruck, Inst Pharm, Abt Pharmakol & Toxikol, A-6020 Innsbruck, Austria; Univ Innsbruck, Inst Biochem Pharmakol, A-6020 Innsbruck, Austria; Graz Univ, Inst Pharmakol & Toxikol, A-8010 Graz, Austria	University of Innsbruck; University of Innsbruck; University of Graz	Striessnig, J (corresponding author), Univ Innsbruck, Inst Pharm, Abt Pharmakol & Toxikol, Peter Matrstr 1-I, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at	Striessnig, Joerg/S-9334-2017; Glossmann, Hartmut/AAL-9790-2020; Tuluc, Petronel/C-2527-2011; Groschner, Klaus/A-2550-2010	Striessnig, Joerg/0000-0002-9406-7120; Groschner, Klaus/0000-0002-8659-377X; Brauns, Martina/0000-0002-0547-2731; Poteser, Michael/0000-0002-9962-1098; glossmann, hartmut h./0000-0002-7392-3266				Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Baumgartner W, 1997, BIOPHYS J, V72, P1143, DOI 10.1016/S0006-3495(97)78763-0; Baumgartner W, 1998, J NEUROSCI METH, V82, P175, DOI 10.1016/S0165-0270(98)00057-0; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; DUEROS A, 2001, NEW ENGL J MED, V345, P17; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Guida S, 2001, AM J HUM GENET, V68, P759, DOI 10.1086/318804; Hans M, 1999, J NEUROSCI, V19, P1610; Hans M, 1999, BIOPHYS J, V76, P1384, DOI 10.1016/S0006-3495(99)77300-5; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Jen J, 1999, NEUROLOGY, V53, P34, DOI 10.1212/WNL.53.1.34; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Kullmann DM, 2001, NEUROSCIENTIST, V7, P80, DOI 10.1177/107385840100700111; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qian J, 2001, J NEUROSCI, V21, P3721, DOI 10.1523/JNEUROSCI.21-11-03721.2001; Wappl E, 2001, J BIOL CHEM, V276, P12730, DOI 10.1074/jbc.M010164200; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Yue Q, 1998, AM J MED GENET, V77, P298, DOI 10.1002/(SICI)1096-8628(19980526)77:4<298::AID-AJMG9>3.0.CO;2-J; Yue Q, 1997, AM J HUM GENET, V61, P1078, DOI 10.1086/301613; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	32	81	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6960	6966		10.1074/jbc.M110948200	http://dx.doi.org/10.1074/jbc.M110948200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11742003	hybrid			2022-12-27	WOS:000174104300029
J	Begum, N; Sandu, OA; Ito, M; Lohmann, SM; Smolenski, A				Begum, N; Sandu, OA; Ito, M; Lohmann, SM; Smolenski, A			Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CA2+ SENSITIZATION; MYOSIN PHOSPHATASE; I-ALPHA; BINDING; PHOSPHORYLATION; ACTIVATION; DOMAIN; CONTRACTION; PATHWAY	Recent studies from our laboratory have shown that insulin stimulates myosin-bound phosphatase (MBP) in vascular smooth muscle cells (VSMCs) by decreasing site-specific phosphorylation of the myosin-bound subunit (MBS) of MBP via nitric oxide/cGMP-mediated Rho/Rho kinase inactivation. Here we tested potential interactions between Rho kinase and insulin signaling pathways. In control VSMCs, insulin inactivates ROK-alpha, the major Rho kinase isoform in VSMCs, and inhibits thrombin-induced increase in ROK-alpha association with the insulin receptor substrate-1 (IRS-1). Hypertension (in spontaneous hypertensive rats) or expression of an active RhoA(V14) up-regulates Rho kinase activity and increases ROK-alpha/IRS-1 association resulting in ERS-1 serine phosphorylation that leads to inhibition of both insulin-induced IRS-1 tyrosine phosphorylation and phosphatidylinositol 3-kinase (P13-kinase) activation. In contrast, expression of dominant negative RhoA or cGMP-dependent protein kinase type Ialpha inactivates Rho kinase, abolishes ROK-alpha/IRS-1 association, and potentiates insulin-induced tyrosine phosphorylation and P13-kinase activation leading to decreased MBST695. phosphorylation and decreased MBP inhibition. Collectively, these results suggest a novel function for ROK-alpha in insulin signal transduction at the level of IRS-1 and potential cross-talk between cGMP-dependent protein kinase type Ialpha, Rho/Rho kinase signaling, and insulin signaling at the level of ERS-I/P13-kinase.	Winthrop Univ Hosp, Diabet Res Lab, Mineola, NY 11501 USA; SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; Mie Univ, Sch Med, Dept Internal Med 1, Tsu, Mie 5148507, Japan; Univ Wurzburg, Med Klin, Inst Klin Biochem & Pathobiochem, D-97080 Wurzburg, Germany	Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Mie University; University of Wurzburg	Begum, N (corresponding author), Winthrop Univ Hosp, Diabet Res Lab, 222 Stn Plaza N,Ste 511-B, Mineola, NY 11501 USA.	nbegum@winthrop.org	Sandu, Oana/AAH-4771-2019	Sandu, Oana/0000-0002-4198-7249; Smolenski, Albert/0000-0001-9210-9406				Begum N, 1998, AM J PHYSIOL-CELL PH, V275, pC42, DOI 10.1152/ajpcell.1998.275.1.C42; Begum N, 1998, J BIOL CHEM, V273, P25164, DOI 10.1074/jbc.273.39.25164; Begum N, 2000, AM J PHYSIOL-CELL PH, V278, pC81, DOI 10.1152/ajpcell.2000.278.1.C81; Begum N, 2000, MOL ENDOCRINOL, V14, P1365, DOI 10.1210/me.14.9.1365; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; COHEN P, 1983, METHOD ENZYMOL, V99, P243; Craparo A, 1997, J BIOL CHEM, V272, P11663; Farah S, 1998, J BIOL CHEM, V273, P4740, DOI 10.1074/jbc.273.8.4740; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Folli F, 1999, EXP CLIN ENDOCR DIAB, V107, P133, DOI 10.1055/s-0029-1212088; FRANCIS SH, 1991, METHOD ENZYMOL, V200, P332; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Lee MR, 1997, J BIOL CHEM, V272, P5063, DOI 10.1074/jbc.272.8.5063; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Loirand G, 1999, J PHYSIOL-LONDON, V516, P825, DOI 10.1111/j.1469-7793.1999.0825u.x; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MYERS MG, 1995, J BIOL CHEM, V270, P11715, DOI 10.1074/jbc.270.20.11715; Nakamura M, 1999, CELL SIGNAL, V11, P671, DOI 10.1016/S0898-6568(99)00036-4; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Ohan N, 1999, J CELL SCI, V112, P2177; Sandu OA, 2001, J APPL PHYSIOL, V91, P1475, DOI 10.1152/jappl.2001.91.3.1475; Sandu OA, 2000, DIABETES, V49, P2178, DOI 10.2337/diabetes.49.12.2178; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Seasholtz TM, 1999, MOL PHARMACOL, V55, P949, DOI 10.1124/mol.55.6.949; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Somlyo A P, 1999, Rev Physiol Biochem Pharmacol, V134, P201; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Vaandrager AB, 1997, J BIOL CHEM, V272, P4195, DOI 10.1074/jbc.272.7.4195	42	136	141	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6214	6222		10.1074/jbc.M110508200	http://dx.doi.org/10.1074/jbc.M110508200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11739394	hybrid			2022-12-27	WOS:000173989200070
J	Yang, J; Hodel, A; Holman, GD				Yang, J; Hodel, A; Holman, GD			Insulin and isoproterenol have opposing roles in the maintenance of cytosol pH and optimal fusion of GLUT4 vesicles with the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; GLUCOSE-TRANSPORTER GLUT4; PROTEIN-KINASE-C; SUBCELLULAR TRAFFICKING; 3T3-L1 ADIPOCYTES; RECEPTORS; SURFACE; TRANSLOCATION; ACIDIFICATION; STIMULATION	Insulin treatment of rat adipocytes increases both cytoplasmic alkalinity and glucose transport activity. Both processes are blocked by the phosphatidylinositol 3-kinase inhibitor wortmannin. Isoproterenol pre-treatment reverses the alkalinizing effects of insulin and leads to attenuation of insulin-stimulated glucose transport activity and exposure of GLUT4 to photolabeling reagents at the cell surface. These effects of isoproterenol are mimicked by acid loading and are reversed by cell-alkalinizing conditions. However, neither isoproterenol nor acid loading alters the total level of GLUT4 at the plasma membrane as revealed by Western blotting of plasma membrane fractions or immunodetection of GLUT4 in plasma membrane lawns. GLUT4 is therefore occluded from participation in glucose transport catalysis by a pH-sensitive process. To examine the kinetics of trafficking that lead to these changes in cell surface GLUT4 occlusion, we have utilized a new biotinylated photolabel, GP15. This reagent has a 70-atom spacer between the biotin and the photolabeling diazirine group, and this allows quenching of the surface signal of biotinylated GLUT4 by extracellular avidin. The rates of GLUT4 internalization are only slightly altered by isoproterenol or acidification, mainly due to reduced recycling over long internalization times. By contrast, insulin stimulation of GLUT4 exocytosis is slowed by isoproterenol or acidification pre-treatments. Biphasic time courses are evident, with an initial burst of exposure at the cell surface followed by a slow phase. It is hypothesized that the burst kinetics are a consequence of a two-phase fusion reaction that is rapid in the presence of insulin but slowed by cytosol acidification.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Holman, GD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	g.d.holman@bath.ac.uk		Holman, Geoffrey/0000-0001-7045-1358				BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; CARPENE C, 1993, BIOCHEM J, V296, P99, DOI 10.1042/bj2960099; Civelek VN, 1996, P NATL ACAD SCI USA, V93, P10139, DOI 10.1073/pnas.93.19.10139; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Elmendorf JS, 1999, J BIOL CHEM, V274, P37357, DOI 10.1074/jbc.274.52.37357; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Ferrara CM, 1999, BIOCHEM J, V343, P571, DOI 10.1042/0264-6021:3430571; FIDELMAN ML, 1982, AM J PHYSIOL, V242, pC87, DOI 10.1152/ajpcell.1982.242.1.C87; GOTO Y, 1993, DIABETES RES CLIN PR, V20, P1, DOI 10.1016/0168-8227(93)90015-W; Hashimoto M, 2001, CHEMBIOCHEM, V2, P52, DOI 10.1002/1439-7633(20010105)2:1<52::AID-CBIC52>3.0.CO;2-F; Holman GD, 2001, TRENDS CELL BIOL, V11, P173, DOI 10.1016/S0962-8924(01)01953-5; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; HONNOR RC, 1992, CELL SIGNAL, V4, P87, DOI 10.1016/0898-6568(92)90010-6; INCERPI S, 1994, J CELL PHYSIOL, V159, P205, DOI 10.1002/jcp.1041590203; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; KLIP A, 1986, AM J PHYSIOL, V250, pC720, DOI 10.1152/ajpcell.1986.250.5.C720; KLIP A, 1988, ENDOCRINOLOGY, V123, P296, DOI 10.1210/endo-123-1-296; Kurashima K, 1996, LAB INVEST, V75, P689; Martinez-Arca S, 2000, J CELL SCI, V113, P1705; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Mukherjee S.P., 1981, ANN NY ACAD SCI, V372, P347, DOI [10.1111/j.1749-6632.1981.tb15486.x, DOI 10.1111/J.1749-6632.1981.TB15486.X]; NISHIMURA H, 1993, J BIOL CHEM, V268, P19246; PEAK M, 1992, BIOCHEM J, V282, P797, DOI 10.1042/bj2820797; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; REAVES B, 1994, FEBS LETT, V345, P61, DOI 10.1016/0014-5793(94)00437-4; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Ryder JW, 2000, DIABETES, V49, P647, DOI 10.2337/diabetes.49.4.647; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; SATOH S, 1993, J BIOL CHEM, V268, P17820; Sauvage M, 2000, EUR J BIOCHEM, V267, P955, DOI 10.1046/j.1432-1327.2000.01084.x; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Stegmann T, 2000, TRAFFIC, V1, P598, DOI 10.1034/j.1600-0854.2000.010803.x; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; TAYLOR LP, 1981, BIOCHIM BIOPHYS ACTA, V642, P325, DOI 10.1016/0005-2736(81)90449-1; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; VANNUCCI SJ, 1992, BIOCHEM J, V288, P325, DOI 10.1042/bj2880325; WEBER TM, 1991, CELL SIGNAL, V3, P51, DOI 10.1016/0898-6568(91)90007-H; Whitehead JP, 2001, J BIOL CHEM, V276, P27816, DOI 10.1074/jbc.M011590200; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YANG J, 1992, BIOCHEM J, V281, P809, DOI 10.1042/bj2810809; YANG J, 1993, J BIOL CHEM, V268, P4600; Yokoyama H, 1998, CIRC RES, V82, P1078, DOI 10.1161/01.RES.82.10.1078; ZEUZEM S, 1992, P NATL ACAD SCI USA, V89, P6619, DOI 10.1073/pnas.89.14.6619	48	24	25	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6559	6566		10.1074/jbc.M108610200	http://dx.doi.org/10.1074/jbc.M108610200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751852	hybrid			2022-12-27	WOS:000173989200114
J	Landis, MS; Patel, HV; Capone, JP				Landis, MS; Patel, HV; Capone, JP			Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-alpha from human monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; LXR-ALPHA; NUCLEAR RECEPTOR; MESSENGER-RNA; CHOLESTEROL EFFLUX; RESPONSE PATHWAY; OXIDIZED LDL; EXPRESSION; MACROPHAGES; ATHEROSCLEROSIS	Liver X receptor alpha (LXRalpha), is a nuclear hormone receptor that is activated by oxysterols and plays a crucial role in regulating cholesterol and lipid metabolism in liver and cholesterol efflux from lipid-loaded macrophages. Here we show that treatment of human peripheral blood monocytes or monocytic THP-1 cells with the LXR ligand 22(R)-hydroxycholesterol (22(R)-HC), in combination with 9-cis-retinoic acid (9cRA), a ligand for the LXR heterodimerization partner retinoid X receptor (RXR), results in the specific induction of the potent pro-apoptotic and pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). Promoter analysis, inhibitor studies, and order-of-addition experiments demonstrated that TNF-alpha induction by 22(R)-HC and 9cRA occurs by a novel two-step process. The initial step involves 22(R)-HC-dependent induction of TNF-alpha mRNA, and intracellular accumulation of TNF-alpha protein, mediated by binding of LXRalpha/RXRalpha to an LXR response element at position -879 of the TNF-alpha promoter. Subsequent cell release of TNF-alpha protein occurs via a separable 9cRA-dependent, LXRalpha-independent step that requires de novo transcription and protein synthesis. Our findings reveal a potentially new dimension of the physiological role of LXRalpha and identify a unique multistep pathway of TNF-alpha production that may be of consequence to the normal function of LXR in monocyte/macrophages and in disease conditions such as atherosclerosis.	McMaster Univ, Fac Hlth Sci, Dept Biochem, Hamilton, ON L8N 3Z5, Canada	McMaster University	Capone, JP (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Biochem, Hamilton, ON L8N 3Z5, Canada.	caponej@mcmaster.ca						ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 1996, J LIPID RES, V37, P320; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chertow BS, 1997, METABOLISM, V46, P656, DOI 10.1016/S0026-0495(97)90009-3; Claudel T, 2001, P NATL ACAD SCI USA, V98, P2610, DOI 10.1073/pnas.041609298; Costet P, 2000, J BIOL CHEM, V275, P28240; Crisby M, 1997, ATHEROSCLEROSIS, V130, P17, DOI 10.1016/S0021-9150(96)06037-6; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; DIXON R, 1970, BIOCHEM BIOPH RES CO, V40, P161, DOI 10.1016/0006-291X(70)91060-0; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Englund MCO, 2001, ATHEROSCLEROSIS, V158, P61, DOI 10.1016/S0021-9150(01)00407-5; FONG LG, 1991, J LIPID RES, V32, P1899; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; HAMILTON TA, 1990, J IMMUNOL, V144, P2343; Huang Y, 2001, ATHEROSCLEROSIS, V156, P119, DOI 10.1016/S0021-9150(00)00638-9; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P2225, DOI 10.1161/01.ATV.17.10.2225; KANDUTSCH AA, 1978, SCIENCE, V201, P498, DOI 10.1126/science.663671; Kotamraju S, 2001, J BIOL CHEM, V276, P17316, DOI 10.1074/jbc.M011731200; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MARCUS SL, 1993, P NATL ACAD SCI USA, V90, P5723, DOI 10.1073/pnas.90.12.5723; Miyata KS, 1996, J BIOL CHEM, V271, P9189, DOI 10.1074/jbc.271.16.9189; Niemann-Jonsson A, 2000, ARTERIOSCL THROM VAS, V20, P2205, DOI 10.1161/01.ATV.20.10.2205; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; RHOADES KL, 1992, J BIOL CHEM, V267, P22102; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; van Reyk DM, 1999, J LEUKOCYTE BIOL, V66, P557, DOI 10.1002/jlb.66.4.557; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289	45	68	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4713	4721		10.1074/jbc.M108807200	http://dx.doi.org/10.1074/jbc.M108807200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741944	hybrid			2022-12-27	WOS:000173962900023
J	Prado, F; Koop, R; Beato, M				Prado, F; Koop, R; Beato, M			Accurate chromatin organization of the mouse mammary tumor virus promoter determines the nature of the synergism between transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR-I; MMTV PROMOTER; PROGESTERONE-RECEPTOR; REGULATORY ELEMENT; BINDING; ACTIVATION; DNA; NUCLEOSOME; YEAST; PROTEINS	The mechanism underlying the synergism between transcription factors in eukaryotic gene expression is not fully understood. In minichromosomes assembled in vitro the synergism between steroid hormone receptors (SHRs) and nuclear factor 1 (NF1) on the mouse mammary tumor virus (MMTV) promoter does not require the proline-rich transactivation domain (PRD) of NF1. Here we show that similar results are obtained in yeast. In contrast, replacing the native hormone-responsive elements (HREs) by a single HRE results in a more accessible chromatin and makes the synergism with SHR dependent on the PRD of NF1. Following hormone induction, in addition to glucocorticoid receptor, the DNA binding domain of NF1 is needed and sufficient for establishing an open chromatin conformation on the wild type MMTV promoter. Thus, NF1 acts as a classical transcription factor in a relaxed chromatin context, whereas in the context of the wild type chromatin DNA binding of NF1 is sufficient to cooperate with SHRs by stabilizing an open chromatin conformation.	Univ Marburg, Inst Mol Biol & Tumorforsch, D-35033 Marburg, Germany	Philipps University Marburg	Beato, M (corresponding author), Univ Marburg, Inst Mol Biol & Tumorforsch, Emil Mannkopff Str 2, D-35033 Marburg, Germany.	beato@imt.uni-marburg.de	Prado, Felix/G-7700-2015; Beato, Miguel/B-5564-2015	Prado, Felix/0000-0001-9805-782X; Beato, Miguel/0000-0002-2878-2222				ADAMS R, 1997, METHODS YEAST GENETI; ALTMANN H, 1994, P NATL ACAD SCI USA, V91, P3901, DOI 10.1073/pnas.91.9.3901; Beato M, 1996, ANN NY ACAD SCI, V784, P93, DOI 10.1111/j.1749-6632.1996.tb16231.x; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BRUGGEMEIER U, 1990, EMBO J, V9, P2233, DOI 10.1002/j.1460-2075.1990.tb07393.x; Cairns BR, 1998, TRENDS BIOCHEM SCI, V23, P20, DOI 10.1016/S0968-0004(97)01160-2; Candau R, 1996, J STEROID BIOCHEM, V57, P19, DOI 10.1016/0960-0760(96)00262-2; CHALEPAKIS G, 1988, CELL, V53, P371, DOI 10.1016/0092-8674(88)90157-2; CHAVEZ S, 1995, MOL CELL BIOL, V15, P6987; Chavez S, 1997, P NATL ACAD SCI USA, V94, P2885, DOI 10.1073/pnas.94.7.2885; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; Eisfeld K, 1997, NUCLEIC ACIDS RES, V25, P3733, DOI 10.1093/nar/25.18.3733; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; HAGER GL, 1993, COLD SPRING HARB SYM, V58, P63, DOI 10.1101/SQB.1993.058.01.010; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KALFF M, 1990, NATURE, V344, P360, DOI 10.1038/344360a0; KIM TK, 1993, J BIOL CHEM, V268, P20866; KNOX JJ, 1991, MOL CELL BIOL, V11, P2946, DOI 10.1128/MCB.11.6.2946; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; KRUSE U, 1994, J MOL BIOL, V238, P860, DOI 10.1006/jmbi.1994.1343; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; MEISTERERNST M, 1989, BIOCHEMISTRY-US, V28, P8191, DOI 10.1021/bi00446a034; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MIKSICEK R, 1987, EMBO J, V6, P1355, DOI 10.1002/j.1460-2075.1987.tb02375.x; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; SCHEIDEREIT C, 1984, P NATL ACAD SCI-BIOL, V81, P3029, DOI 10.1073/pnas.81.10.3029; SIKORSKI RS, 1989, GENETICS, V122, P19; Spangenberg C, 1998, J MOL BIOL, V278, P725, DOI 10.1006/jmbi.1998.1718; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Venditti P, 1998, NUCLEIC ACIDS RES, V26, P3657, DOI 10.1093/nar/26.16.3657; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; WEINTRAUB H, 1988, P NATL ACAD SCI USA, V85, P5819, DOI 10.1073/pnas.85.16.5819; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3	41	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4911	4917		10.1074/jbc.M110094200	http://dx.doi.org/10.1074/jbc.M110094200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733499	hybrid			2022-12-27	WOS:000173962900049
J	Kim, SA; Taylor, GS; Torgersen, KM; Dixon, JE				Kim, SA; Taylor, GS; Torgersen, KM; Dixon, JE			Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST; LOCALIZATION; MUTATIONS; PROTEINS; BINDING; DOMAINS; FAMILY	Myotubularin is the archetype of a family of highly conserved protein-tyrosine phosphatase-like enzymes. The myotubularin gene, MTM1, is mutated in the genetic disorder, X-linked myotubular myopathy. We and others have previously shown that myotubularin utilizes the lipid second messenger, phosphatidylinositol 3-phosphate (PI(3)P), as a physiologic substrate. We demonstrate here that the myotubularin-related protein MTMR2, which is mutated in the neurodegenerative disorder, type 4B Charcot-Marie-Tooth disease, is also highly specific for PI(3)P as a substrate. Furthermore, the MTM-related phosphatases MTMR1, MTMR3, and MTMR6 also dephosphorylate PI(3)P, suggesting that activity toward this substrate is common to all myotubularin family enzymes. A direct comparison of the lipid phosphatase activities of recombinant myotubularin and MTMR2 demonstrates that their enzymatic properties are indistinguishable, indicating that the lack of functional redundancy between these proteins is likely to be due to factors other than the utilization of different physiologic substrates. To this end, we have analyzed myotubularin and MTMR2 transcripts during induced differentiation of cultured murine C2C12 myoblasts and find that their expression is divergently regulated. In addition, myotubularin and MTMR2 enhanced green fluorescent protein fusion proteins exhibit overlapping but distinct patterns of subcellular localization. Finally, we provide evidence that myotubularin, but not MTMR2, can modulate the levels of endosomal PIMP. From these data, we conclude that the developmental expression and subcellular localization of myotubularin and MTMR2 are differentially regulated, resulting in their utilization of specific cellular pools of PI(3)P.	Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dixon, JE (corresponding author), Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA.			Kim, Soo-A/0000-0001-6777-739X				Appel S, 2001, GENOMICS, V75, P6, DOI 10.1006/geno.2001.6591; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bolino A, 1996, HUM MOL GENET, V5, P1051, DOI 10.1093/hmg/5.7.1051; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Houlden H, 2001, BRAIN, V124, P907, DOI 10.1093/brain/124.5.907; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kikuno R, 2000, NUCLEIC ACIDS RES, V28, P331, DOI 10.1093/nar/28.1.331; Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703; Laporte J, 2000, HUM MUTAT, V15, P393, DOI 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Laporte J, 2001, TRENDS GENET, V17, P221, DOI 10.1016/S0168-9525(01)02245-4; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Nandurkar HH, 2001, P NATL ACAD SCI USA, V98, P9499, DOI 10.1073/pnas.171306098; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; SPIRO AJ, 1966, ARCH NEUROL-CHICAGO, V14, P1, DOI 10.1001/archneur.1966.00470070005001; Taylor GS, 2001, ANAL BIOCHEM, V295, P122, DOI 10.1006/abio.2001.5179; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wishart MJ, 2001, CURR OPIN CELL BIOL, V13, P172, DOI 10.1016/S0955-0674(00)00195-2; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Zhao RX, 2001, EXP CELL RES, V265, P329, DOI 10.1006/excr.2001.5185	28	89	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4526	4531		10.1074/jbc.M111087200	http://dx.doi.org/10.1074/jbc.M111087200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733541	hybrid			2022-12-27	WOS:000173813900096
J	Dao-Thi, MH; Charlier, D; Loris, R; Maes, D; Messens, J; Wyns, L; Backmann, J				Dao-Thi, MH; Charlier, D; Loris, R; Maes, D; Messens, J; Wyns, L; Backmann, J			Intricate interactions within the ccd plasmid addiction system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							42.84-43.6 F-SEGMENT; COLI DNA GYRASE; SEX FACTOR-F; ESCHERICHIA-COLI; KILLER PROTEIN; CELL-DIVISION; LETD CCDB; BINDING; OPERON; PHD	The ccd addiction system plays a crucial role in the stable maintenance of the Escherichia coli F plasmid. It codes for a stable toxin (CcdB) and a less stable antidote (CcdA). Both are expressed at low levels during normal cell growth. Upon plasmid loss, CcdB outlives CcdA and kills the cell by poisoning gyrase. The interactions between CcdB, CcdA, and its promoter DNA were analyzed. In solution, the CcdA-CcdB interaction is complex, leading to various complexes with different stoichiometry. CcdA has two binding sites for CcdB and vice versa, permitting soluble hexamer formation but also causing precipitation, especially at CcdA:CcdB ratios close to one. CcdA alone, but not CcdB, binds to promoter DNA with high on and off rates. The presence of CcdB enhances the affinity and the specificity of CcdA-DNA binding and results in a stable CcdA.CcdB.DNA complex with a CcdA.CcdB ratio of one. This (CcdA,CcdB,), complex has multiple DNA-binding sites and spirals around the 120-bp promoter region.	Free Univ Brussels VIB, Lab Ultrastruct, B-1640 Rhode St Genese, Belgium; Free Univ Brussels, Erfelijkheidsleer Microbiol, B-1070 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Wyns, L (corresponding author), Free Univ Brussels VIB, Lab Ultrastruct, Paardenstr 65, B-1640 Rhode St Genese, Belgium.	ljwyns@vub.ac.be	Messens, Joris/AAH-3008-2020; Loris, Remy/GPG-0894-2022	Messens, Joris/0000-0002-2128-8264; Charlier, Daniel/0000-0002-6844-376X; Backmann, Jan/0000-0002-3323-8838; Loris, Remy/0000-0002-8862-3338; Maes, Dominique/0000-0002-9179-3186				Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; BAHASSI EM, 1995, MOL MICROBIOL, V15, P1031, DOI 10.1111/j.1365-2958.1995.tb02278.x; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; CHARLIER D, 1995, J MOL BIOL, V250, P392, DOI 10.1006/jmbi.1995.0385; Critchlow SE, 1997, J MOL BIOL, V273, P826, DOI 10.1006/jmbi.1997.1357; Dao-Thi MH, 2000, J MOL BIOL, V299, P1373, DOI 10.1006/jmbi.2000.3815; DEFEYTER R, 1989, MOL GEN GENET, V218, P481, DOI 10.1007/BF00332413; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; FRIED MG, 1983, NUCLEIC ACIDS RES, V11, P141, DOI 10.1093/nar/11.1.141; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gazit E, 1999, J BIOL CHEM, V274, P16813, DOI 10.1074/jbc.274.24.16813; GOLUB EI, 1988, MOL GEN GENET, V214, P353, DOI 10.1007/BF00337735; HAGIHARA Y, 1994, PROTEIN SCI, V3, P1418, DOI 10.1002/pro.5560030908; JAFFE A, 1985, J BACTERIOL, V163, P841; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Maki S, 1996, J MOL BIOL, V256, P473, DOI 10.1006/jmbi.1996.0102; MAKI S, 1992, J BIOL CHEM, V267, P12244; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Messens J, 1999, BIOCHEMISTRY-US, V38, P16857, DOI 10.1021/bi9911841; MIKI T, 1984, J MOL BIOL, V174, P627, DOI 10.1016/0022-2836(84)90087-1; MIKI T, 1984, J MOL BIOL, V174, P605, DOI 10.1016/0022-2836(84)90086-X; NIELSEN AK, 1991, MOL MICROBIOL, V5, P1961, DOI 10.1111/j.1365-2958.1991.tb00818.x; Oberer M, 1999, BIOL CHEM, V380, P1413, DOI 10.1515/BC.1999.181; ROBERTS RC, 1993, J BIOL CHEM, V268, P27109; STEYAERT J, 1993, J MOL BIOL, V231, P513, DOI 10.1006/jmbi.1993.1301; TAM JE, 1989, J BACTERIOL, V171, P2353, DOI 10.1128/jb.171.5.2353-2360.1989; TAM JE, 1989, MOL GEN GENET, V219, P26, DOI 10.1007/BF00261153; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; VANMELDEREN L, 1995, THESIS U LIBRE BRUXE; Weber G., 1992, PROTEIN INTERACTIONS, P1; Xu Y, 2000, J BACTERIOL, V182, P1609, DOI 10.1128/JB.182.6.1609-1615.2000	39	58	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2002	277	5					3733	3742		10.1074/jbc.M105505200	http://dx.doi.org/10.1074/jbc.M105505200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	518VF	11741897	hybrid			2022-12-27	WOS:000173688000088
J	Jang, MJ; Jwa, M; Kim, JH; Song, K				Jang, MJ; Jwa, M; Kim, JH; Song, K			Selective inhibition of MAPKK Wis1 in the stress-activated MAPK cascade of Schizosaccharomyces pombe by novel berberine derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE KINASE; FISSION YEAST; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; HYPHAL DEVELOPMENT; STRUCTURAL BASIS; IN-VITRO; TARGET; CALCINEURIN; RESISTANCE	Intracellular molecular targets of novel berberine derivatives, HWY 289 and HWY 336, were identified by a screen of a variety of mutants in fission yeast Schizosaccharomyces pombe. HWY 289 and HWY 336 completely inhibited the proliferation of wild type as well as various mutant fission yeast cells (minimal inhibitory concentrations were 29.52 muM for HWY 289 and 11.83 muM for HWY 336), but did not affect the proliferation of Wis1 mitogen-activated protein kinase kinase (MAPKK) deletion mutants. In addition, HWY 289 with an IC50 value of 7.3 muM or HWY 336 with IC50 of 5.7 muM specifically inhibited in vitro kinase activities of purified Wis1, whereas either compound did not affect the activities of other kinases in the mitogen-activated protein kinase (MAPK) cascades of fission yeast. These genetic and biochemical results demonstrate the high degree of specificity of HWY 289 and HWY 336 to MAPKK Wis1 and suggest that the cytotoxicity of these compounds is not simply due to the inhibition of Wis1 kinase activity. High salt wash experiments have shown that strong noncovalent binding occurs between Wis1 and either HWY 289 or HWY 336. The preincubation of Wis1 kinase with ATP did not affect the inhibition of Wis1 by HWY 289 and HWY 336, but when Wis1 was preincubated with MBP, a protein substrate, Wis1 kinase activity was no longer inhibited. These observations demonstrate that HWY 289/HWY 336 do inhibit Wis1 kinase, not by binding to the ATP-binding site but by disturbing the binding of substrate to the kinase. Target validation of the complex of HWY 289/HWY 336 and Wis1 kinase will provide important clues for the mechanism of specific cytotoxicity of these compounds in S. pombe. On a broader aspect, it would create an initiative to further modify and develop compounds that selectively inhibit kinases and cause cytotoxicity in various MAPK cascades including those of mammals.	Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120749, South Korea; Yonsei Univ, Coll Sci, Inst Life Sci & Biotechnol, Seoul 120749, South Korea; Hanwha Chem Res & Dev Ctr, Taejon 305345, South Korea	Yonsei University; Yonsei University	Song, K (corresponding author), Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120749, South Korea.	bc5012@yonsei.ac.kr						ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BREUDER T, 1994, P NATL ACAD SCI USA, V91, P5372, DOI 10.1073/pnas.91.12.5372; Cardenas ME, 1999, CLIN MICROBIOL REV, V12, P583, DOI 10.1128/CMR.12.4.583; CARDENAS ME, 1995, J BIOL CHEM, V270, P20997, DOI 10.1074/jbc.270.36.20997; Cardenas ME, 1998, TRENDS BIOTECHNOL, V16, P427, DOI 10.1016/S0167-7799(98)01239-6; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; CUTLER JE, 1991, ANNU REV MICROBIOL, V45, P187, DOI 10.1146/annurev.mi.45.100191.001155; Degos F, 1996, NEPHROL DIAL TRANSPL, V11, P16; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; GOTOH Y, 1993, MOL CELL BIOL, V13, P6427, DOI 10.1128/MCB.13.10.6427; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Guhad FA, 1998, FEMS MICROBIOL LETT, V166, P135, DOI 10.1111/j.1574-6968.1998.tb13194.x; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HUGHES DA, 1993, NATURE, V364, P349, DOI 10.1038/364349a0; IBRAHIM MAK, 1976, HEREDITY, V37, P179, DOI 10.1038/hdy.1976.81; Iizuka N, 2000, BRIT J CANCER, V83, P1209, DOI 10.1054/bjoc.2000.1436; JOHNSTON PA, 1982, MOL GEN GENET, V185, P311, DOI 10.1007/BF00330803; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718; Loewith R, 2000, J CELL SCI, V113, P153; MASUDA T, 1995, J BIOL CHEM, V270, P1979, DOI 10.1074/jbc.270.5.1979; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NAKAMOTO K, 1990, J PROSTHET DENT, V64, P691, DOI 10.1016/0022-3913(90)90298-Q; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Orfila L, 2000, J ETHNOPHARMACOL, V71, P449, DOI 10.1016/S0378-8741(00)00177-X; Park KS, 1999, J ANTIMICROB CHEMOTH, V43, P667, DOI 10.1093/jac/43.5.667; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Samejima I, 1997, EMBO J, V16, P6162, DOI 10.1093/emboj/16.20.6162; Samejima I, 1998, MOL BIOL CELL, V9, P2325, DOI 10.1091/mbc.9.8.2325; Sengar AS, 1997, MOL CELL BIOL, V17, P3508, DOI 10.1128/MCB.17.7.3508; Shin JS, 2000, NEUROCHEM RES, V25, P363, DOI 10.1023/A:1007541020736; ULASZEWSKI S, 1987, J BIOL CHEM, V262, P223; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; Wilson KP, 1997, CHEM BIOL, V4, P423, DOI 10.1016/S1074-5521(97)90194-0; ZaitsevskayaCarter T, 1997, EMBO J, V16, P1318, DOI 10.1093/emboj/16.6.1318	46	15	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2002	277	14					12388	12395		10.1074/jbc.M111018200	http://dx.doi.org/10.1074/jbc.M111018200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539AC	11744736	hybrid			2022-12-27	WOS:000174846400104
J	Liu, J; Wang, XB; Park, DS; Lisanti, MP				Liu, J; Wang, XB; Park, DS; Lisanti, MP			Caveolin-1 expression enhances endothelial capillary tubule formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENICALLY TRANSFORMED-CELLS; TARGETED DOWN-REGULATION; MAP KINASE CASCADE; GROWTH-FACTOR; TUMOR-GROWTH; IN-VIVO; SUBCELLULAR-DISTRIBUTION; BASEMENT-MEMBRANE; TYROSINE KINASES; PROTEIN-KINASE	The level of caveolin-1 expression closely correlates with the oncogenic transformation of NIH 3T3 cells, the proliferation of human cancer cells, and the differentiation of adipocytes and muscle cells. However, the role of caveolin-1 in endothelial cell proliferation and differentiation remains unknown. Here, we have shown that angiogenic growth factors that stimulate endothelial cell proliferation lead to dramatic reductions in eaveolin-1 expression. In addition, using an in vitro Matrigel assay system, we studied the potential role of caveolin-1 in capillary-like tubule formation (i.e. endothelial cell differentiation) using human microvascular endothelial cells (HMEC-1). We showed that the level of endogenous eaveolin-1 expression increased in a time-dependent manner when endothelial cells underwent differentiation and that the maximum level of caveolin-1 expression occurred just prior to the formation of capillary like tubules. Interestingly, overexpression of caveolin-1, via an adenoviral gene delivery system, clearly accelerated endothelial cell differentiation/tubule formation and led to a dramatic similar to3-fold increase in the number of capillary-like tubular structures. Conversely, down-regulation of caveolin-1 expression, via an antisense adenoviral approach, reduced the number of capillary-like tubules formed by >10-fold. Consistent with the unique function of caveolin-1 in interacting with key signaling molecules, delivery of the caveolin-1 scaffolding domain into the cytoplasm of living endothelial cells was also sufficient to enhance capillary-like tubule formation. Taken together, these results clearly demonstrate that caveolin-1 and the caveolin-1 scaffolding domain play an important positive role in the regulation of endothelial cell differentiation, a prerequisite step in the process of angiogenesis.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Comprehens Canc Ctr, Div Hormone Dependent Tumor Biol, Bronx, NY 10461 USA; W Virginia Univ, Dept Physiol, Morgantown, WV 26506 USA; W Virginia Univ, MBR Canc Ctr, Morgantown, WV 26506 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; West Virginia University; West Virginia University	Lisanti, MP (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Lisanti, Michael P/C-6866-2013; Lisanti, Michael/B-6131-2018	Lisanti, Michael/0000-0003-2034-1382	NCI NIH HHS [TG-CA09475] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009475] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Baatout S, 1997, ANTICANCER RES, V17, P451; Beck L, 1997, FASEB J, V11, P365, DOI 10.1096/fasebj.11.5.9141503; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; DENEKAMP J, 1990, CANCER METAST REV, V9, P267, DOI 10.1007/BF00046365; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; FERRARA N, 1995, ANN NY ACAD SCI, V752, P246, DOI 10.1111/j.1749-6632.1995.tb17435.x; FOLKMAN J, 1995, MOL MED, V1, P120, DOI 10.1007/BF03401559; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Griffoni C, 2000, BIOCHEM BIOPH RES CO, V276, P756, DOI 10.1006/bbrc.2000.3484; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Landgren E, 1998, ONCOGENE, V16, P359, DOI 10.1038/sj.onc.1201545; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Liu J, 1999, J BIOL CHEM, V274, P15781, DOI 10.1074/jbc.274.22.15781; Manoussaki D, 1996, ACTA BIOTHEOR, V44, P271, DOI 10.1007/BF00046533; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; ORTEGA N, 1999, FRONT BIOSCI, V4, P141; Park DS, 2001, BIOCHEMISTRY-US, V40, P3354, DOI 10.1021/bi002787b; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; Razani B, 2001, BIOCHEM SOC T, V29, P494, DOI 10.1042/BST0290494; Rivard A, 1998, MOL MED, V4, P429, DOI 10.1007/BF03401749; Rosen EM, 1997, CIBA F SYMP, V212, P215; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; SCHNAPER HW, 1993, KIDNEY INT, V43, P20, DOI 10.1038/ki.1993.5; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252; Volonte D, 1999, FEBS LETT, V445, P431, DOI 10.1016/S0014-5793(99)00164-7; Ware JA, 1997, NAT MED, V3, P158, DOI 10.1038/nm0297-158; Zhang W, 2000, J BIOL CHEM, V275, P20717, DOI 10.1074/jbc.M909895199	51	144	160	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10661	10668		10.1074/jbc.M110354200	http://dx.doi.org/10.1074/jbc.M110354200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11748236	hybrid, Green Published			2022-12-27	WOS:000174549200139
J	Zhang, F; Nakanishi, G; Kurebayashi, S; Yoshino, K; Perantoni, A; Kim, YS; Jetten, AM				Zhang, F; Nakanishi, G; Kurebayashi, S; Yoshino, K; Perantoni, A; Kim, YS; Jetten, AM			Characterization of Glis2, a novel gene encoding a Gli-related, Kruppel-like transcription factor with Transactivation and repressor functions - Roles in kidney development and neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; HEDGEHOG-PATCHED-GLI; SONIC-HEDGEHOG; CUBITUS-INTERRUPTUS; MOLECULAR-GENETICS; SIGNALING PATHWAY; DROSOPHILA EMBRYO; MOUSE ZIC1; FAMILY; EXPRESSION	In this study, we describe the characterization of a gene encoding a novel Kruppel-like protein, named Glis2. Glis2 encodes a relatively proline-rich, basic 55.8-kDa protein. Its five tandem Cys(2)-His(2) zinc finger motifs exhibit the highest homology to those of members of the Gli and Zic subfamilies of Kruppel-like proteins. Confocal microscopic analysis demonstrated that Glis2 localizes to the nucleus. Analysis of the genomic structure of the Glis2 gene showed that it is composed of 6 exons separated by 5 introns spanning a genomic region of more than 7.5 kb. Fluorescence in situ hybridization mapped the mouse Glis2 gene to chromosome 16A3-B1. Northern blot analysis showed that the Glis2 gene encodes a 3.8-kb transcript that is most abundant in adult mouse kidney. By in situ hybridization, expression was localized to somites and neural tube, and during metanephric development predominantly to the ureteric bud, precursor of the collecting duct, and inductor of nephronic tubule formation. One-hybrid analysis using Glis2 deletion mutants identified a novel activation function (AF) at the N terminus. The activation of transcription through this AF domain was totally suppressed by two repressor functions just downstream from the AF. One of the repressor functions is contained within the first zinc finger motif. The level of transcriptional activation and repression varied with the cell line tested, which might be due to differences in cell type-specific expression of co-activators and co-repressors. Our results suggest that Glis2 behaves as a bifunctional transcriptional regulator. Both the activation and repressor functions may play an important role in the regulation of gene expression during embryonic development.	NIEHS, NIH, Div Intramural Res, Cell Biol Sect, Res Triangle Pk, NC 27709 USA; NCI, Comparat Carcinogenesis Lab, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jetten, AM (corresponding author), NIEHS, NIH, Div Intramural Res, Cell Biol Sect, POB 12233, Res Triangle Pk, NC 27709 USA.		Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445; Yoshino, Kiyoshi/0000-0002-5732-5215	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100485, Z01ES100485] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Aruga J, 1999, MECH DEVELOP, V89, P141, DOI 10.1016/S0925-4773(99)00220-8; Aruga J, 1998, J NEUROSCI, V18, P284; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; AUSUBEL FM, 2001, CURRENT PROTOCOLS MO; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bailey EC, 2000, E SCHERING RES FDN W, V29, P211; Bellusci S, 1997, DEVELOPMENT, V124, P53; Borycki AG, 2000, DEVELOPMENT, V127, P2075; BUCKLER AJ, 1991, MOL CELL BIOL, V11, P1707, DOI 10.1128/MCB.11.3.1707; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Calvet JP, 1998, J NEPHROL, V11, P24; Chen Y, 1999, DEVELOPMENT, V126, P3607; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; He GP, 1999, J BIOL CHEM, V274, P14678, DOI 10.1074/jbc.274.21.14678; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Kaesler S, 2000, BIOL CHEM, V381, P545, DOI 10.1515/BC.2000.070; Kalff-Suske M, 1999, HUM MOL GENET, V8, P1769, DOI 10.1093/hmg/8.9.1769; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Karavanova ID, 1996, DEVELOPMENT, V122, P4159; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kitaguchi T, 2000, DEVELOPMENT, V127, P4787; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lamar E, 2001, DEVELOPMENT, V128, P1335; Le Douarin B, 1998, J STEROID BIOCHEM, V65, P43, DOI 10.1016/S0960-0760(97)00175-1; Lee J, 1997, DEVELOPMENT, V124, P2537; Lessing D, 1998, DEVELOPMENT, V125, P1469; Lin YF, 2001, DEVELOPMENT, V128, P1573; Liu CZ, 1998, GENE, V209, P1, DOI 10.1016/S0378-1119(97)00668-9; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; Mizugishi K, 2001, J BIOL CHEM, V276, P2180, DOI 10.1074/jbc.M004430200; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nakata K, 1997, P NATL ACAD SCI USA, V94, P11980, DOI 10.1073/pnas.94.22.11980; NELSON HCM, 1995, CURR OPIN GENET DEV, V5, P180, DOI 10.1016/0959-437X(95)80006-9; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Poncelet DA, 1998, DNA CELL BIOL, V17, P931, DOI 10.1089/dna.1998.17.931; POWERS MA, 1994, CELL, V79, P931, DOI 10.1016/0092-8674(94)90024-8; PREISS A, 1985, NATURE, V313, P27, DOI 10.1038/313027a0; Rohr KB, 1999, MECH DEVELOP, V85, P147, DOI 10.1016/S0925-4773(99)00044-1; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Sasaki H, 1999, DEVELOPMENT, V126, P3915; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; SCHWABE JWR, 1991, TRENDS BIOCHEM SCI, V16, P291, DOI 10.1016/0968-0004(91)90121-B; STRUHL K, 1989, TRENDS BIOCHEM SCI, V14, P137, DOI 10.1016/0968-0004(89)90145-X; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; WALTERHOUSE D, 1993, DEV DYNAM, V196, P91, DOI 10.1002/aja.1001960203; Walterhouse DO, 1999, ENVIRON HEALTH PERSP, V107, P167, DOI 10.2307/3434504; WIESCHAUS E, 1984, DEV BIOL, V104, P172, DOI 10.1016/0012-1606(84)90046-0; WILKINSON DG, 1990, IN SITU HYBRIDIZATIO, P155; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P22143, DOI 10.1074/jbc.270.38.22143; Witzgall R, 1998, AM J PHYSIOL-RENAL, V275, pF928, DOI 10.1152/ajprenal.1998.275.6.F928; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Yamashita Y, 2000, BIOCHEM BIOPH RES CO, V275, P134, DOI 10.1006/bbrc.2000.3280; Yoon JW, 1998, J BIOL CHEM, V273, P3496, DOI 10.1074/jbc.273.6.3496; Zhang F, 2001, GENE, V280, P49, DOI 10.1016/S0378-1119(01)00764-8	78	54	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10139	10149		10.1074/jbc.M108062200	http://dx.doi.org/10.1074/jbc.M108062200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11741991	hybrid			2022-12-27	WOS:000174549200072
J	Mukai, S; Ghaedi, K; Fujiki, Y				Mukai, S; Ghaedi, K; Fujiki, Y			Intracellular localization, function, and dysfunction of the peroxisome-targeting signal type 2 receptor, Pex7p, in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; DEFECTIVE ZELLWEGER-SYNDROME; RAT-LIVER PEROXISOMES; ASSEMBLY FACTOR-II; COMPLEMENTATION GROUP; BIOGENESIS DISORDERS; 3-KETOACYL-COA THIOLASE; PROTEIN IMPORT; PTS2 RECEPTOR; CDNA CLONING	We previously isolated and characterized a Chinese hamster ovary (CHO) cell mutant, ZPG207, that is defective in import of proteins carrying a peroxisome-targeting signal type 2 (PTS2) nonapeptide. Herein we have cloned Chinese hamster (Cl) PEX7 encoding the PTS2 receptor. ClPex7p consists of 318 amino acids, shorter than human Pex7p by 5 residues, showing 91 and 30% identity with Pex7p from humans and the yeast Saccharomyces cerevisiae, respectively. Expression of ClPEX7 rescued the impaired PTS2 import in pex7 ZPG207. Mutation in ZPG207 PEX7 was determined by reverse transcription PCR; a G-to-A transition caused a 1-amino acid substitution, W221ter. We investigated the molecular dysfunction of Pex7p variants in mammals, including Pex7p-W221ter and Pex7p with one site mutation at G2171t, A218V, or L292ter, which frequently occurs in the human fatal genetic peroxisomal disease rhizomelic chondrodysplasia punctata, showing a cell phenotype of PTS2 import defect. All types of the mutations affected Pex7p in binding to both PTS2 cargo protein and the longer isoform. of PTS1 receptor Pex5pl, that is responsible for transport of the Pex7p-PTS2 complex. Subcellular fractionation and protease protection studies demonstrated bimodal distribution of Pex7p between the cytoplasm and peroxisomes in CHO and human cells. Moreover, expression of Pex5pL, but not of the shorter isoform Pex5pS, enhanced translocation of Pex7p-PTS2 proteins into peroxisomes, thereby implying that both PTS receptors shuttle between peroxisomes and the cytosol. Furthermore, a ClPex7p mutant with a deletion of 7 amino acids from the N terminus retained peroxisome-restoring activity, whereas an 11-amino acid truncation abrogated the activity. ClPex7p with a C-terminal 9-amino acid truncation, comprising residues 1-309, maintained the activity, whereas a 14-amino acid shorter form lacking several amino acids of the sixth WD motif lost the activity. Therefore, nearly the full length of Pex7p, including all WD motifs, is required for its function.	Kyushu Univ, Grad Sch, Dept Biol, Fac Sci,Higashi Ku, Fukuoka 8128581, Japan; Japan Sci & Technol Corp, SORST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Grad Sch, Dept Biol, Fac Sci,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.		Ghaedi, Kamran/X-9824-2018	Ghaedi, Kamran/0000-0002-9790-5644				Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Elgersma Y, 1998, J CELL BIOL, V140, P807, DOI 10.1083/jcb.140.4.807; FUJIKI Y, 1985, BIOCHEM J, V226, P697, DOI 10.1042/bj2260697; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; Fujiki Y, 1997, BBA-MOL BASIS DIS, V1361, P235, DOI 10.1016/S0925-4439(97)00051-3; Fukuda S, 1996, AM J HUM GENET, V59, P1210; Ghaedi K, 2000, AM J HUM GENET, V67, P976, DOI 10.1086/303086; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; Ghaedi K, 1999, EXP CELL RES, V248, P482, DOI 10.1006/excr.1999.4412; Ghaedi K, 1999, EXP CELL RES, V248, P489, DOI 10.1006/excr.1999.4413; Gould SJ, 2000, TRENDS GENET, V16, P340, DOI 10.1016/S0168-9525(00)02056-4; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; Kunau WH, 1998, CURR OPIN MICROBIOL, V1, P232, DOI 10.1016/S1369-5274(98)80016-7; Legakis JE, 2001, TRAFFIC, V2, P252, DOI 10.1034/j.1600-0854.2001.90165.x; Matsumoto N, 2001, J HUM GENET, V46, P273, DOI 10.1007/s100380170078; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; MIURA S, 1994, J BIOCHEM-TOKYO, V115, P1064, DOI 10.1093/oxfordjournals.jbchem.a124458; MIURA S, 1992, J BIOL CHEM, V267, P14405; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MORAND OH, 1990, BIOCHIM BIOPHYS ACTA, V1034, P132, DOI 10.1016/0304-4165(90)90066-6; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; RACHUBINSKI RA, 1984, J CELL BIOL, V99, P2241, DOI 10.1083/jcb.99.6.2241; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Shimozawa N, 2000, HUM MOL GENET, V9, P1995, DOI 10.1093/hmg/9.13.1995; Shimozawa N, 1999, HUM MOL GENET, V8, P1077, DOI 10.1093/hmg/8.6.1077; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; Shimozawa N, 1998, AM J HUM GENET, V63, P1898, DOI 10.1086/302142; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tabak HF, 1999, TRENDS CELL BIOL, V9, P447, DOI 10.1016/S0962-8924(99)01650-5; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Tateishi K, 1997, EUR J CELL BIOL, V73, P352; Toyama R, 1999, HUM MOL GENET, V8, P1673, DOI 10.1093/hmg/8.9.1673; TSUKAMOTO T, 1994, J BIOL CHEM, V269, P6001; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	58	71	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9548	9561		10.1074/jbc.M108635200	http://dx.doi.org/10.1074/jbc.M108635200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11756410	hybrid			2022-12-27	WOS:000174400600108
J	Beard, WA; Shock, DD; Yang, XP; DeLauder, SF; Wilson, SH				Beard, WA; Shock, DD; Yang, XP; DeLauder, SF; Wilson, SH			Loss of DNA polymerase beta stacking interactions with templating purines, but not pyrimidines, alters catalytic efficiency and fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; BASE EXCISION-REPAIR; CRYSTAL-STRUCTURE; NUCLEOTIDE INCORPORATION; TERNARY COMPLEXES; LARGE FRAGMENT; MINOR-GROOVE; ACTIVE-SITE; B-DNA; REPLICATION	Structures of DNA polymerases bound with DNA reveal that the 5'-trajectory of the template strand is dramatically altered as it exits the polymerase active site. This distortion provides the polymerase access to the nascent base pair to interrogate proper Watson-Crick geometry. Upon binding a correct deoxynucleoside triphosphate, a-helix N of DNA polymerase 13 is observed to form one face of the binding pocket for the new base pair. Asp-276 and Lys-280 stack with the bases of the incoming nucleotide and template, respectively. To determine the role of Lys-280, site-directed mutants were constructed at this position, and the proteins were expressed and purified, and their catalytic efficiency and fidelity were assessed. The catalytic efficiency for single-nucleotide gap filling with the glycine mutant (K280G) was strongly diminished relative to wild type for templating purines (>15-fold) due to a decreased binding affinity for the incoming nucleotide. In contrast, catalytic efficiency was hardly affected by glycine substitution for templating pyrimidines (<4-fold). The fidelity of the glycine mutant was identical to the wild type enzyme for misinsertion opposite a template thymidine, whereas the fidelity of misinsertion opposite a template guanine was modestly altered. The nature of the Lys-280 side-chain substitution for thymidine triphosphate insertion (templating adenine) indicates that Lys-280 "stabilizes" templating purines through van der Waals interactions.	NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; N Carolina Cent Univ, Dept Chem, Durham, NC 27707 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; North Carolina Central University	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293				Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 1995, METHOD ENZYMOL, V262, P98; BEARD WA, 1993, BIOCHEMISTRY-US, V32, P9745, DOI 10.1021/bi00088a029; Beard WA, 1998, CHEM BIOL, V5, pR7, DOI 10.1016/S1074-5521(98)90081-3; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; BEARD WA, 1995, PRACTICAL APPROACH H, P15; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Creighton TE, 1993, PROTEINS STRUCTURES, P140; DAVIES JF, 1994, CELL, V76, P1123, DOI 10.1016/0092-8674(94)90388-3; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kraynov VS, 1997, BIOCHEM J, V323, P103, DOI 10.1042/bj3230103; Kraynov VS, 2000, BIOCHEMISTRY-US, V39, P16008, DOI 10.1021/bi0008480; Lavrik OI, 1996, J BIOL CHEM, V271, P21891, DOI 10.1074/jbc.271.36.21891; LEONARD GA, 1990, NUCLEIC ACIDS RES, V18, P5617, DOI 10.1093/nar/18.19.5617; Lewis DA, 1999, J BIOL CHEM, V274, P32924, DOI 10.1074/jbc.274.46.32924; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Li Y, 2001, PROTEIN SCI, V10, P1225, DOI 10.1110/ps.250101; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MESNER LD, 1992, P NATL ACAD SCI USA, V89, P2521, DOI 10.1073/pnas.89.7.2521; Morales JC, 2000, J AM CHEM SOC, V122, P1001, DOI 10.1021/ja993464+; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oliveros M, 1997, J BIOL CHEM, V272, P30899, DOI 10.1074/jbc.272.49.30899; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Osheroff WP, 1999, J BIOL CHEM, V274, P20749, DOI 10.1074/jbc.274.30.20749; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Patterson TA, 2000, PROTEIN EXPRES PURIF, V18, P100, DOI 10.1006/prep.1999.1167; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Vaisman A, 2001, J BIOL CHEM, V276, P18999, DOI 10.1074/jbc.M007805200	44	71	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8235	8242		10.1074/jbc.M107286200	http://dx.doi.org/10.1074/jbc.M107286200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756435	hybrid			2022-12-27	WOS:000174268000078
J	Fuss, J; Linn, S				Fuss, J; Linn, S			Human DNA polymerase epsilon colocalizes with proliferating cell nuclear antigen and DNA replication late, but not early, in S phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INTRACELLULAR-LOCALIZATION; CHROMOSOMAL REPLICATION; CATALYTIC DOMAINS; ALPHA; DELTA; CLONING; SUBUNIT; PROTEIN; REPAIR	DNA polymerase epsilon (pol epsilon) has been implicated in DNA replication, DNA repair, and cell cycle control, but its precise roles are unclear. When the subcellular localization of human pol epsilon was examined by indirect immunofluorescence, pol epsilon appeared in discrete nuclear foci that colocalized with proliferating cell nuclear antigen (PCNA) foci and sites of DNA synthesis only late in S phase. Early in S phase, pol epsilon foci were adjacent to PCNA foci. In contrast to PCNA foci that were only present in S phase, pol epsilon foci were present throughout mitosis and the G(1) phase of cycling cells. It is hypothesized from these observations that pol epsilon and PCNA have separate but associated functions early in S phase and that pol epsilon participates with PCNA in DNA replication late in S phase.	Univ Calif Berkeley, Dept Cell & Mol Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Linn, S (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Div Biochem & Mol Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	slinn@socrates.berkeley.edu			NIEHS NIH HHS [P30ES08196] Funding Source: Medline; NIGMS NIH HHS [1R01GM30415] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030415] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; ARAKI H, 1991, NUCLEIC ACIDS RES, V19, P4867, DOI 10.1093/nar/19.18.4867; ARAKI H, 1992, EMBO J, V11, P733, DOI 10.1002/j.1460-2075.1992.tb05106.x; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; BAUER KD, 1994, METHOD CELL BIOL, V41, P351; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; BENSCH KG, 1982, J BIOL CHEM, V257, P8391; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; BUDD ME, 1993, MOL CELL BIOL, V13, P496, DOI 10.1128/MCB.13.1.496; CELIS JE, 1985, P NATL ACAD SCI USA, V82, P3262, DOI 10.1073/pnas.82.10.3262; CHUI G, 1995, J BIOL CHEM, V270, P7799, DOI 10.1074/jbc.270.14.7799; CHUI G, 1995, THESIS U CALIFORNIA; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; DUrso G, 1997, P NATL ACAD SCI USA, V94, P12491, DOI 10.1073/pnas.94.23.12491; EDENBERG HJ, 1975, ANNU REV GENET, V9, P245, DOI 10.1146/annurev.ge.09.120175.001333; Ehrenhofer-Murray AE, 1999, GENETICS, V153, P1171; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; Harlow E., 1988, ANTIBODIES LAB MANUA, P298; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; HUMBERT C, 1992, CYTOMETRY, V13, P603, DOI 10.1002/cyto.990130608; HWANG P, 1995, THESIS U CALIFORNIA; JACKSON DA, 1995, BIOESSAYS, V17, P587, DOI 10.1002/bies.950170704; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; JESSBERGER R, 1993, J BIOL CHEM, V268, P15070; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; KESTI T, 1993, J BIOL CHEM, V268, P10238; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; LEE SH, 1991, J BIOL CHEM, V266, P22707; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LEHMAN IR, 1989, J BIOL CHEM, V264, P4265; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Levine N, 2000, CRIMESTAT VERSION 1; Li Y, 1997, J BIOL CHEM, V272, P32337, DOI 10.1074/jbc.272.51.32337; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; LI Y, 1998, ASSOCIATED SUBUNITS; LIAPUNOVA NA, 1994, INT REV CYTOL, V154, P261, DOI 10.1016/S0074-7696(08)62201-9; MAGA G, 1995, BIOCHEMISTRY-US, V34, P891, DOI 10.1021/bi00003a023; Maki S, 1998, J BIOL CHEM, V273, P21332, DOI 10.1074/jbc.273.33.21332; MORRISON A, 1990, CELL, V62, P1143, DOI 10.1016/0092-8674(90)90391-Q; NAKAMURA H, 1984, EXP CELL RES, V151, P123, DOI 10.1016/0014-4827(84)90362-8; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Neff NF, 1999, MOL BIOL CELL, V10, P665, DOI 10.1091/mbc.10.3.665; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; Ohya T, 2000, NUCLEIC ACIDS RES, V28, P3846, DOI 10.1093/nar/28.20.3846; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Pospiech H, 1999, NUCLEIC ACIDS RES, V27, P3799, DOI 10.1093/nar/27.19.3799; Rhind N, 2000, CURR BIOL, V10, pR908, DOI 10.1016/S0960-9822(00)00849-6; *SAS I, 1998, STAT VERS 6 12; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Smith JS, 1999, MOL CELL BIOL, V19, P3184; SUGASAWARA RJ, 1985, J IMMUNOL METHODS, V79, P263, DOI 10.1016/0022-1759(85)90106-1; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Tate P, 1998, J CELL SCI, V111, P2575; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; TUUSA J, 1995, NUCLEIC ACIDS RES, V23, P2178, DOI 10.1093/nar/23.12.2178; Waga S, 2001, P NATL ACAD SCI USA, V98, P4978, DOI 10.1073/pnas.081088798; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; WANG ZG, 1993, MOL CELL BIOL, V13, P1051, DOI 10.1128/MCB.13.2.1051; WRIGHT SJ, 1993, METHOD CELL BIOL, V38, P1; Zlotkin T, 1996, EMBO J, V15, P2298, DOI 10.1002/j.1460-2075.1996.tb00583.x	72	72	74	6	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8658	8666		10.1074/jbc.M110615200	http://dx.doi.org/10.1074/jbc.M110615200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741962	hybrid			2022-12-27	WOS:000174268000131
J	Garavaglia, S; D'Angelo, I; Emanuelli, M; Carnevali, F; Pierella, F; Magni, G; Rizzi, M				Garavaglia, S; D'Angelo, I; Emanuelli, M; Carnevali, F; Pierella, F; Magni, G; Rizzi, M			Structure of human NMN adenylyltransferase - A key nuclear enzyme for NAD homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; CRYSTAL-STRUCTURE; BINDING; SITE; CYTIDYLYLTRANSFERASE; BIOSYNTHESIS; SULFURYLASE; SUPERFAMILY; SYNTHETASE; TIAZOFURIN	Nicotinamide mononucleotide adenylyltransferase (NMNAT), a member of the nucleotidyltransferase alpha/beta-phosphodiesterases superfamily, catalyzes a universal step (NMN + ATP = NAD + PPi) in NAD biosynthesis. Localized within the nucleus, the activity of the human enzyme is greatly altered in tumor cells, rendering it a promising target for cancer chemotherapy. By using a combination of single isomorphous replacement and density modification techniques, the human NMNAT structure was solved by x-ray crystallography to a 2.5-Angstrom resolution, revealing a hexamer that is composed of alpha/beta-topology subunits. The active site topology of the enzyme, analyzed through homology modeling and structural comparison with other NMNATs, yielded convincing evidence for a substrate-induced conformational change. We also observed remarkable structural conservation in the ATP-recognition motifs GXXXPX(T/H)XXH and SXTXXR, which we take to be the universal signature for NMNATs. Structural comparison of human and prokaryotic NMNATs may also lead to the rational design of highly selective antimicrobial drugs.	Univ Pavia, Dept Genet & Microbiol A Buzzati Traverso, I-27100 Pavia, Italy; Univ Ancona, Inst Biochem, I-60131 Ancona, Italy; Univ Piemonte Orientale Amedeo Avogadro, DISCAFF, I-28100 Novara, Italy	University of Pavia; Marche Polytechnic University; University of Eastern Piedmont Amedeo Avogadro	Magni, G (corresponding author), Univ Ancona, Inst Biochem, Via Ranieri, I-60131 Ancona, Italy.	magnig@mta01.unian.it; rizzi@ipvgen.unipv.it	garavaglia, silvia/C-5588-2013	garavaglia, silvia/0000-0001-8494-1729				BALDUCCI E, 1992, BIOCHEM BIOPH RES CO, V189, P1275, DOI 10.1016/0006-291X(92)90211-3; BORK P, 1995, PROTEINS, V22, P259, DOI 10.1002/prot.340220306; Boulton S, 1997, BRIT J CANCER, V76, P845, DOI 10.1038/bjc.1997.473; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bruser T, 2000, J BIOL CHEM, V275, P1691, DOI 10.1074/jbc.275.3.1691; *COLL COMP PROJ 4, 1994, ACTA CRYSTALLOGR D, V50, pD760; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; D'Angelo I, 2000, STRUCTURE, V8, P993, DOI 10.1016/S0969-2126(00)00190-8; DEMURCIA G, 2001, DNA DAMAGE STRESS SI; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; EMANUELLI M, 1992, ARCH BIOCHEM BIOPHYS, V298, P29, DOI 10.1016/0003-9861(92)90089-F; EMANUELLI M, 1995, BIOCHEM PHARMACOL, V49, P575, DOI 10.1016/0006-2952(94)00478-5; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P8031, DOI 10.1021/bi00399a001; Holm L, 1997, STRUCTURE, V5, P165, DOI 10.1016/S0969-2126(97)00176-7; HUGHES KT, 1983, J BACTERIOL, V155, P213, DOI 10.1128/JB.155.1.213-221.1983; Izard T, 1999, EMBO J, V18, P2021, DOI 10.1093/emboj/18.8.2021; Jayaram HN, 1999, CURR MED CHEM, V6, P561; JAYARAM HN, 1986, BIOCHEM PHARMACOL, V35, P587, DOI 10.1016/0006-2952(86)90352-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; LESIE AGW, 1992, JOINT CCP4 ESF EACMB; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; LOWE G, 1983, EUR J BIOCHEM, V132, P117, DOI 10.1111/j.1432-1033.1983.tb07334.x; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Mattevi A, 1999, STRUCTURE, V7, P745, DOI 10.1016/S0969-2126(99)80099-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Okazaki I J, 1996, Adv Pharmacol, V35, P247, DOI 10.1016/S1054-3589(08)60277-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Rizzi M, 1996, EMBO J, V15, P5125, DOI 10.1002/j.1460-2075.1996.tb00896.x; RUGGIERI S, 1990, BIOCHEMISTRY-US, V29, P2501, DOI 10.1021/bi00462a010; Saridakis V, 2001, J BIOL CHEM, V276, P7225, DOI 10.1074/jbc.M008810200; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; SCHWEIGER M, 2001, TARGETING ADP RIBOSY, P89; SHELDRICK GM, 1991, P CCP4 STUDY WEEKEND, P23; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; TONG L, 1990, ACTA CRYSTALLOGR A, V46, P783, DOI 10.1107/S0108767390005530; Ullrich TC, 2001, EMBO J, V20, P316, DOI 10.1093/emboj/20.3.316; Venkatachalam KV, 1999, J BIOL CHEM, V274, P2601, DOI 10.1074/jbc.274.5.2601; von Delft F, 2001, STRUCTURE, V9, P439, DOI 10.1016/S0969-2126(01)00604-9; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6	48	70	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8524	8530		10.1074/jbc.M111589200	http://dx.doi.org/10.1074/jbc.M111589200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751893	hybrid			2022-12-27	WOS:000174268000114
J	Klotz, DM; Hewitt, SC; Ciana, P; Raviscioni, M; Lindzey, JK; Foley, J; Maggi, A; DiAugustine, RP; Korach, KS				Klotz, DM; Hewitt, SC; Ciana, P; Raviscioni, M; Lindzey, JK; Foley, J; Maggi, A; DiAugustine, RP; Korach, KS			Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-I; SIGNALING PATHWAYS; GENE-EXPRESSION; RAT UTERUS; ESTRADIOL; PHOSPHORYLATION; MOUSE; TRANSCRIPTION; BINDING	In the uterus insulin-like growth factor-1 (IGF-1) signaling can be initiated by estradiol acting through its nuclear receptor (estrogen receptor (ER)) to stimulate the local synthesis of IGF-1. Conversely, in vitro studies have demonstrated that estradiol-independent ER transcriptional activity can be induced by IGF-1 signaling, providing evidence for a cross-talk mechanism between IGF-1 and ER. To investigate whether ERalpha is required for uterine responses to IGF-1 in vivo, both wild-type (WT) and ERalpha knockout (alphaERKO) mice were administered IGF-1, and various uterine responses to IGF-1 were compared. In both WT and alphaERKO mice, IGF-1 treatment resulted in phosphorylation of uterine IGF-1 receptor (IGF-1R) and formation of an IGF-1R/insulin receptor substrate-1/ phosphatidylinositol 3-kinase signaling complex. In addition, IGF-1 stimulated phosphorylation of uterine Akt and MAPK in both WT and alphaERKO mice. However, IGF-1 treatment stimulated BrdUrd incorporation and proliferating cell nuclear antigen expression in WT uteri only. To determine whether ERalpha can be activated in vivo by IGF-1 signaling, transgenic mice carrying a luciferase gene driven by two estrogen response elements (ERE-luciferase mice) were utilized. Treatment of ovariectomized ERE-luciferase mice with IGF-1 resulted in an increase in uterine luciferase activity that was attenuated in the presence of the ER antagonist ICI 182,780. Together these data demonstrate that 1) functional signaling proximal to IGF-1R is maintained in the alphaERKO mouse uterus, 2) ERalpha is necessary for IGF-1 induction of uterine nuclear proliferative responses, and 3) cross-talk between IGF-1R and ER signaling pathways exists in vivo.	NIEHS, Lab Expt Pathol, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ S Florida, Dept Biol, Tampa, FL 33620 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Milan; State University System of Florida; University of South Florida	Korach, KS (corresponding author), NIEHS, Lab Expt Pathol, NIH, POB 12233,Maildrop B3-02, Res Triangle Pk, NC 27709 USA.		Hewitt, Sylvia/W-8752-2019; Ciana, Paolo/F-9224-2012	Hewitt, Sylvia/0000-0001-7713-0805; Foley, Julie/0000-0001-9726-2821; Maggi, Adriana/0000-0001-5700-5273; Korach, Kenneth/0000-0002-7765-418X; CIANA, PAOLO/0000-0001-5771-5638	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adesanya OO, 1999, P NATL ACAD SCI USA, V96, P3287, DOI 10.1073/pnas.96.6.3287; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; ARNOLD SF, 1995, J STEROID BIOCHEM, V55, P163, DOI 10.1016/0960-0760(95)00177-2; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; BRIGSTOCK DR, 1991, BAILLIERE CLIN ENDOC, V5, P791, DOI 10.1016/S0950-351X(10)80015-1; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cenni B, 1999, TRENDS ENDOCRIN MET, V10, P41, DOI 10.1016/S1043-2760(98)00121-0; Ciana P, 2001, MOL ENDOCRINOL, V15, P1104, DOI 10.1210/me.15.7.1104; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Curtis SW, 1996, P NATL ACAD SCI USA, V93, P12626, DOI 10.1073/pnas.93.22.12626; GARDNER RM, 1989, J STEROID BIOCHEM, V32, P339, DOI 10.1016/0022-4731(89)90205-7; GHAHARY A, 1990, MOL ENDOCRINOL, V4, P191, DOI 10.1210/mend-4-2-191; IGNARTROWBRIDGE DM, 1995, ENVIRON HEALTH PERSP, V103, P35, DOI 10.2307/3432505; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; IgnarTrowbridge DM, 1996, ENDOCRINOLOGY, V137, P1735, DOI 10.1210/en.137.5.1735; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; Improta-Brears T, 1999, P NATL ACAD SCI USA, V96, P4686, DOI 10.1073/pnas.96.8.4686; KAPUR S, 1992, BIOL REPROD, V46, P208, DOI 10.1095/biolreprod46.2.208; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Klotz DM, 2000, ENDOCRINOLOGY, V141, P3430, DOI 10.1210/en.141.9.3430; MA ZQ, 1994, MOL ENDOCRINOL, V8, P910, DOI 10.1210/me.8.7.910; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Murphy L C, 1990, Semin Cancer Biol, V1, P305; MURPHY LJ, 1990, ENDOCR REV, V11, P443, DOI 10.1210/edrv-11-3-443; MURPHY LJ, 1987, MOL ENDOCRINOL, V1, P445, DOI 10.1210/mend-1-7-445; QUARMBY VE, 1984, ENDOCRINOLOGY, V114, P694, DOI 10.1210/endo-114-3-694; Rajkumar K, 1996, ENDOCRINOLOGY, V137, P1258, DOI 10.1210/en.137.4.1258; Richards RG, 1998, J BIOL CHEM, V273, P11962, DOI 10.1074/jbc.273.19.11962; Richards RG, 1996, P NATL ACAD SCI USA, V93, P12002, DOI 10.1073/pnas.93.21.12002; Stancel G M, 1987, Adv Exp Med Biol, V230, P99; Stoica A, 2000, J CELL BIOCHEM, V76, P605, DOI 10.1002/(SICI)1097-4644(20000315)76:4<605::AID-JCB9>3.0.CO;2-T	32	226	235	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8531	8537		10.1074/jbc.M109592200	http://dx.doi.org/10.1074/jbc.M109592200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751931	hybrid, Green Submitted			2022-12-27	WOS:000174268000115
J	Razani, B; Combs, TP; Wang, XB; Frank, PG; Park, DS; Russell, RG; Li, MM; Tang, BY; Jelicks, LA; Scherer, PE; Lisanti, MP				Razani, B; Combs, TP; Wang, XB; Frank, PG; Park, DS; Russell, RG; Li, MM; Tang, BY; Jelicks, LA; Scherer, PE; Lisanti, MP			Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING PROTEIN; FATTY-ACID; LIPOPROTEIN-LIPASE; ADIPOSE-TISSUE; INSULIN-RECEPTOR; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; IN-VIVO; EXPRESSION; CAVEOLIN	Caveolae organelles and caveolin-1 protein expression are most abundant in adipocytes and endothelial cells. Our initial report on mice lacking caveolin-1 (Cav-1) demonstrated a loss of caveolae and perturbations in endothelial cell function. More recently, however, observation of the Cav-1-deficient cohorts into old age revealed significantly lower body weights, as compared with wild-type controls. These results suggest that Cav-1 null mice may have problems with lipid metabolism and/or adipocyte functioning. To test this hypothesis directly, we placed a cohort of wild-type and Cav-1 null mice on a high fat diet. Interestingly, despite being hyperphagic, Cav-1 null mice show overt resistance to diet-induced obesity. As predicted, adipocytes from Cav-1 null null mice lack caveolae membranes. Early on, a lack of caveolin-1 selectively affects only the female mammary gland fat pad and results in a near complete ablation of the hypo-dermal fat layer. There are also indications of generalized adipose tissue pathology. With increasing age, a systemic decompensation in lipid accumulation occurs resulting in dramatically smaller fat pads, histologically reduced adipocyte cell diameter, and a poorly differentiated/hypercellular white adipose parenchyma. To gain mechanistic insights into this phenotype, we show that, although serum insulin, glucose, and cholesterol levels are entirely normal, Cav-1 null mice have severely elevated triglyceride and free fatty acid levels, especially in the postprandial state. However, this build-up of triglyceride-rich chylomicrons/very low density lipoproteins is not due to perturbed lipoprotein lipase activity, a major culprit of isolated hypertriglyceridemia. The lean body phenotype and metabolic defects observed in Cav-1 null mice are consistent with the previously proposed functions of caveolin-1 and caveolae in adipocytes. Our results show for the first time a clear role for caveolins in systemic lipid homeostasis in vivo and place caveolin-1/ caveolae as major factors in hyperlipidemias and obesity.	Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Inst Anim Studies, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Lisanti, MP (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Jelicks, Linda/L-9740-2019; Lisanti, Michael P/C-6866-2013; Frank, Philippe G/A-3463-2011; Lisanti, Michael/B-6131-2018; Scherer, Philipp E/K-7819-2012	Jelicks, Linda/0000-0002-6438-1792; Frank, Philippe G/0000-0003-4857-5279; Lisanti, Michael/0000-0003-2034-1382; Scherer, Philipp E/0000-0003-0680-3392; Razani, Babak/0000-0002-7172-9240	NCI NIH HHS [TG-CA09475] Funding Source: Medline; NIDDK NIH HHS [R01-DK55785, T32 DK 07513-15] Funding Source: Medline; NIGMS NIH HHS [T32-GM07288] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUMRAD NA, 1984, J BIOL CHEM, V259, P8945; AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bernlohr DA, 1999, SEMIN CELL DEV BIOL, V10, P43, DOI 10.1006/scdb.1998.0271; Brunzell J.D., 1995, METABOLIC MOL BASES, P1913; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; FAN JY, 1983, J CELL SCI, V61, P219; Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; GERBER GE, 1993, MOL CELL BIOCHEM, V123, P39, DOI 10.1007/BF01076473; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Kim S, 2000, J NUTR, V130, p3110S; KRAUSE BR, 1984, J LIPID RES, V25, P97; Levak-Frank S, 1999, P NATL ACAD SCI USA, V96, P3165, DOI 10.1073/pnas.96.6.3165; Li SW, 1996, J BIOL CHEM, V271, P28647, DOI 10.1074/jbc.271.45.28647; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Muller G, 2001, MOL CELL BIOL, V21, P4553, DOI 10.1128/MCB.21.14.4553-4567.2001; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; NAPOLITANO L, 1963, J CELL BIOL, V18, P663, DOI 10.1083/jcb.18.3.663; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; PALADE GE, 1953, J APPL PHYS, V24, P1424; PETERSON J, 1986, BIOCHIM BIOPHYS ACTA, V878, P65, DOI 10.1016/0005-2760(86)90344-9; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Razani B, 1999, J BIOL CHEM, V274, P26353, DOI 10.1074/jbc.274.37.26353; Razani B, 2001, J BIOL CHEM, V276, P38121; RAZANI B, 2002, IN PRESS MOL CELL BI; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Schwencke C, 1999, MOL ENDOCRINOL, V13, P1061, DOI 10.1210/me.13.7.1061; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smith RM, 1998, CELL SIGNAL, V10, P355, DOI 10.1016/S0898-6568(97)00170-8; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Soukas A, 2000, GENE DEV, V14, P963; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123; Weinstock PH, 1997, P NATL ACAD SCI USA, V94, P10261, DOI 10.1073/pnas.94.19.10261; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; ZHOU SL, 1992, J BIOL CHEM, V267, P14456	52	449	464	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8635	8647		10.1074/jbc.M110970200	http://dx.doi.org/10.1074/jbc.M110970200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11739396	hybrid			2022-12-27	WOS:000174268000129
J	Meissner, W; Thomae, R; Seifart, KH				Meissner, W; Thomae, R; Seifart, KH			The activity of transcription factor IIIC1 is impaired during differentiation of F9 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-III; MAMMALIAN U6 GENES; PROXIMAL SEQUENCE ELEMENT; HUMAN TFIIIB; TATA-LESS; IN-VITRO; BINDING; PROMOTERS; PROTEIN; COMPLEX	Differentiation in vitro of mouse F9 embryonal carcinoma (EC) cells to the parietal endoderm (PE) mimics processes of development of the early mouse embryo. This differentiation is accompanied by a dramatic down-regulation of all genes transcribed by RNA polymerase III (pol III). Complementation of extracts from cells, differentiated for various time periods with purified pol III transcription factors show for the first time that TFIIIC1 can substantially restore this impaired transcription, particularly in the early stages of differentiation. At later stages (day 7) the TBP (TATA-binding protein)-TAF complex, TFIIIBbeta, may also become limiting, which can contribute to but cannot account for the reduced transcription of type 2 promoters in PE cells. Because TFIIIBbeta is not required for the expression of type 3 promoters, other components must necessarily be involved, and our results show that U6 transcription can significantly be reactivated by TFIIIC1. By employing a variant type 3 promoter construct, which essentially requires a mutant form of TBP (TBP-DR2), we show that TBP is not limiting in PE extracts. The partial purification of pol III transcription factors from PE and EC cells revealed that TFIIIC2 activity could be purified from both cell types, whereas TFIIIC1 activity was dramatically reduced in extracts from PE cells.	Univ Marburg, Inst Mol Biol & Tumorforsch, D-35037 Marburg, Germany	Philipps University Marburg	Seifart, KH (corresponding author), Univ Marburg, Inst Mol Biol & Tumorforsch, Lahnstr 3, D-35037 Marburg, Germany.							Alzuherri HM, 1998, J BIOL CHEM, V273, P17166, DOI 10.1074/jbc.273.27.17166; Cairns CA, 1998, EMBO J, V17, P3112, DOI 10.1093/emboj/17.11.3112; CHIANG CM, 1993, EMBO J, V12, P2749, DOI 10.1002/j.1460-2075.1993.tb05936.x; Chong SS, 2001, J BIOL CHEM, V276, P20727, DOI 10.1074/jbc.M100088200; Eichhorn K, 2001, J BIOL CHEM, V276, P21158, DOI 10.1074/jbc.M102295200; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; JAHN D, 1987, J MOL BIOL, V193, P303, DOI 10.1016/0022-2836(87)90221-X; Kober I, 1998, J MOL BIOL, V284, P7, DOI 10.1006/jmbi.1998.2165; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; MEISSNER W, 1995, MOL CELL BIOL, V15, P5888; Meissner W, 2001, NUCLEIC ACIDS RES, V29, P1672, DOI 10.1093/nar/29.8.1672; Mital R, 1996, MOL CELL BIOL, V16, P7031; MURPHY D, 1983, CELL, V35, P865, DOI 10.1016/0092-8674(83)90119-8; Oettel S, 1997, NUCLEIC ACIDS RES, V25, P2440, DOI 10.1093/nar/25.12.2440; Oettel S, 1998, NUCLEIC ACIDS RES, V26, P4324, DOI 10.1093/nar/26.19.4324; PALMER JM, 1990, TRENDS BIOCHEM SCI, V15, P300, DOI 10.1016/0968-0004(90)90018-7; SCHNEIDER HR, 1989, NUCLEIC ACIDS RES, V17, P5003, DOI 10.1093/nar/17.13.5003; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; TEICHMANN M, 1995, EMBO J, V14, P5974, DOI 10.1002/j.1460-2075.1995.tb00286.x; Teichmann M, 1997, EMBO J, V16, P4708, DOI 10.1093/emboj/16.15.4708; Teichmann M, 2000, P NATL ACAD SCI USA, V97, P14200, DOI 10.1073/pnas.97.26.14200; WALDSCHMIDT R, 1991, EMBO J, V10, P2595, DOI 10.1002/j.1460-2075.1991.tb07801.x; WALDSCHMIDT R, 1992, J BIOL CHEM, V267, P16359; Wang ZX, 1996, MOL CELL BIOL, V16, P6841; WEIL PA, 1979, J BIOL CHEM, V254, P6163; WHITE RJ, 1989, CELL, V59, P1081, DOI 10.1016/0092-8674(89)90764-2; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; WHITE RJ, 1995, MOL CELL BIOL, V15, P1983; YOON JB, 1995, MOL CELL BIOL, V15, P2019; YOSHINAGA SK, 1987, P NATL ACAD SCI USA, V84, P3585, DOI 10.1073/pnas.84.11.3585	30	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7148	7156		10.1074/jbc.M108721200	http://dx.doi.org/10.1074/jbc.M108721200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741993	hybrid			2022-12-27	WOS:000174104300052
J	Dan, I; Ong, SE; Watanabe, NM; Blagoev, B; Nielsen, MM; Kajikawa, E; Kristiansen, TZ; Mann, M; Pandey, A				Dan, I; Ong, SE; Watanabe, NM; Blagoev, B; Nielsen, MM; Kajikawa, E; Kristiansen, TZ; Mann, M; Pandey, A			Cloning of MASK, a novel member of the mammalian germinal center kinase III subfamily, with apoptosis-inducing properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; CASPASE-MEDIATED CLEAVAGE; NF-KAPPA-B; GROWTH-FACTOR; MOLECULAR-CLONING; OXIDANT STRESS; CELL-DEATH; ACTIVATION; FAMILY; IDENTIFICATION	We have cloned a novel human GCK family kinase that has been designated as MASK ((M) under bar st3 (a) under bar nd (S) under bar OK1-related (k) under bar inase). MASK is widely expressed and encodes a protein of 416 amino acid residues, with an N-terminal kinase domain and a unique C-terminal region. Like other GCK-III subfamily kinases, MASK does not activate any mitogen-activated protein kinase pathways. Wild type MASK, but not a form lacking the C terminus, exhibits homophilic binding in the yeast two-hybrid system and in coimmunoprecipitation experiments. Additionally, deletion of this C-terminal region of MASK leads to an increased kinase activity toward itself as well as toward an exogenous substrate, myelin basic protein. A potential caspase 3 cleavage site (DESDS) is present in the C-terminal region of MASK, and we show that MASK is cleaved in vitro by caspase 3. Finally, wild type and C-terminally truncated forms of MASK can both induce apoptosis upon overexpression in mammalian cells that is abrogated by CrmA, suggesting involvement of MASK in the apoptotic machinery in mammalian cells.	Univ So Denmark, Ctr Expt Bioinformat, Prot Interact Lab, DK-5230 Odense M, Denmark; Japan Sci & Technol Corp, Exploratory Res Adv Technol, Kusumi Membrane Organizer Project, Nagoya, Aichi 4600012, Japan; Nagoya Univ, Grad Sch Sci, Dept Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Southern Denmark; Japan Science & Technology Agency (JST); Nagoya University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Pandey, A (corresponding author), Univ So Denmark, Ctr Expt Bioinformat, Prot Interact Lab, Campusvej 55, DK-5230 Odense M, Denmark.	pandey@cebi.sdu.dk	Pandey, Akhilesh/B-4127-2009; Mann, Matthias/A-3454-2013; Dan, Ippeita/F-9179-2011	Pandey, Akhilesh/0000-0001-9943-6127; Mann, Matthias/0000-0003-1292-4799; Dan, Ippeita/0000-0002-1779-9205; Blagoev, Blagoy/0000-0002-3596-0066				Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA; Dose AC, 2000, GENOMICS, V67, P333, DOI 10.1006/geno.2000.6256; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kuramochi S, 1997, J BIOL CHEM, V272, P22679, DOI 10.1074/jbc.272.36.22679; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LARRICK JW, 1990, FASEB J, V4, P3215, DOI 10.1096/fasebj.4.14.2172061; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Liu BL, 2001, ONCOGENE, V20, P1913, DOI 10.1038/sj.onc.1204277; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Osada S, 1997, ONCOGENE, V14, P2047, DOI 10.1038/sj.onc.1201043; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Pandey A, 2000, J BIOL CHEM, V275, P38633, DOI 10.1074/jbc.M007849200; Pombo CM, 1997, J BIOL CHEM, V272, P29372, DOI 10.1074/jbc.272.46.29372; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Qian ZJ, 2001, J BIOL CHEM, V276, P22439, DOI 10.1074/jbc.M009323200; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Schinkmann K, 1997, J BIOL CHEM, V272, P28695, DOI 10.1074/jbc.272.45.28695; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Taglialatela G, 1997, J NEUROSCI RES, V47, P155; Tamari M, 1999, J HUM GENET, V44, P116, DOI 10.1007/s100380050121; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Ushiro H, 1998, ARCH BIOCHEM BIOPHYS, V355, P233, DOI 10.1006/abbi.1998.0736; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513	41	53	57	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5929	5939		10.1074/jbc.M110882200	http://dx.doi.org/10.1074/jbc.M110882200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741893	hybrid			2022-12-27	WOS:000173989200031
J	Sasaki, M; Suzuki, H; Ito, K; Abe, T; Sugiyama, Y				Sasaki, M; Suzuki, H; Ito, K; Abe, T; Sugiyama, Y			Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and multidrug resistance-associated protein 2 (MRP2/ABCC2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT EXPORT PUMP; RAT-LIVER; SUBSTRATE-SPECIFICITY; CANALICULAR MEMBRANE; DRUG-RESISTANCE; MDCK CELLS; BILE-ACID; FAMILY; IDENTIFICATION; CMOAT	Human organic anion transporting polypeptide 2 (OATP2/SLC21A6) and multidrug resistance-associated protein 2 (MRP2/ABCC2) play important roles in the vectorial transport of organic anions across hepatocytes. In the present study, we have established a double-transfected Madin-Darby canine kidney (MDCK II) cell monolayer, which expresses both OATP2 and MRP2 on basal and apical membranes, respectively. The basalto-apical transport of 170 estradiol 17beta-D-glucuronide (E(2)17betaG), pravastatin, and leukotriene C-4(LTC4), which are substrates of OATP2 and MRP2, was significantly higher than that in the opposite direction in the double-transfected cells. Such vectorial transport was also observed for taurolithocholate sulfate, which is transported by rat oatp1 and Mrp2. The K-m values of E(2)17betaG and pravastatin for the basal-to-apical flux were 27.9 and 24.3 muM, respectively, which were comparable with those reported for OATP2. Moreover, the MRP2-mediated export of E(2)17betaG across the apical membrane was not saturated. In contrast, basal-to-apical transport of estrone-3-sulfate and dehydroepiandrosterone sulfate, which are significantly transported by OATP2, but not by MRP2, was not stimulated by MRP2 expression. The double-transfected MDCK II monolayer expressing both OATP2 and MRP2 may be used to analyze the hepatic vectorial transport of organic anions and to screen the transport profiles of new drug candidates.	Univ Tokyo, Sch Pharmaceut Sci, Dept Biopharmaceut, Bunkyo Ku, Tokyo 1130033, Japan; Chiba Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Inage Ku, Chiba 2638522, Japan; Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Endocrinol & Vasc Med,Aoba Ku, Sendai, Miyagi 9808575, Japan	University of Tokyo; Chiba University; Tohoku University	Suzuki, H (corresponding author), Univ Tokyo, Sch Pharmaceut Sci, Dept Biopharmaceut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hsuzuki@mol.f.u-tokyo.ac.jp						Abe T, 1999, J BIOL CHEM, V274, P17159, DOI 10.1074/jbc.274.24.17159; Akita H, 2001, BBA-BIOMEMBRANES, V1511, P7, DOI 10.1016/S0005-2736(00)00355-2; Cattori V, 2000, FEBS LETT, V474, P242, DOI 10.1016/S0014-5793(00)01596-9; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; Cui YH, 1999, MOL PHARMACOL, V55, P929; Cui YH, 2001, MOL PHARMACOL, V60, P934, DOI 10.1124/mol.60.5.934; Evers R, 1998, J CLIN INVEST, V101, P1310, DOI 10.1172/JCI119886; GANT TW, 1991, MOL CARCINOGEN, V4, P499, DOI 10.1002/mc.2940040614; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Keppler D, 2000, SEMIN LIVER DIS, V20, P265, DOI 10.1055/s-2000-9391; Keppler D, 1997, FASEB J, V11, P15, DOI 10.1096/fasebj.11.1.9034161; Kinoshita S, 1998, PHARMACEUT RES, V15, P1851, DOI 10.1023/A:1011953906065; Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156; Konig J, 1999, BBA-BIOMEMBRANES, V1461, P377, DOI 10.1016/S0005-2736(99)00169-8; Kullak-Ublick GA, 2000, J HEPATOL, V32, P3, DOI 10.1016/S0168-8278(00)80411-0; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meier PJ, 1997, HEPATOLOGY, V26, P1667, DOI 10.1002/hep.510260641; Nakai D, 2001, J PHARMACOL EXP THER, V297, P861; Niinuma K, 1997, J PHARMACOL EXP THER, V282, P866; Stieger B, 2000, GASTROENTEROLOGY, V118, P422, DOI 10.1016/S0016-5085(00)70224-1; Suzuki H, 1998, SEMIN LIVER DIS, V18, P359, DOI 10.1055/s-2007-1007170; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Yamazaki M, 1997, DRUG METAB DISPOS, V25, P1123; Zhang J, 1997, J LABELLED COMPD RAD, V39, P159	28	189	195	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6497	6503		10.1074/jbc.M109081200	http://dx.doi.org/10.1074/jbc.M109081200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748225	hybrid			2022-12-27	WOS:000173989200106
J	Yamaji, T; Teranishi, T; Alphey, MS; Crocker, PR; Hashimoto, Y				Yamaji, T; Teranishi, T; Alphey, MS; Crocker, PR; Hashimoto, Y			A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues - A comparison with Siglec-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALOADHESIN FAMILY; IMMUNOGLOBULIN SUPERFAMILY; MYELOID CELLS; SIALIC ACIDS; RECOGNITION; MEMBER; OLIGOSACCHARIDES; IDENTIFICATION; SPECIFICITIES; MOLECULES	Siglec-7 is a sialic acid-binding lectin recently identified as an inhibitory receptor on natural killer cells. Here we characterize the sugar-binding specificity of Siglec-7 expressed on Chinese hamster ovary cells using polyvalent streptavidin-based glyco-probes. Glycoprobes carrying unique oligosaccharide structures such as GD3 (NeuAcalpha2,8NeuAcalpha2,3Galbeta1,4Glc) and LSTb (Galbeta1,3[NeuAcalpha2,6]GlcNAcbeta1,3Galbeta1,4Glc) oligosaccharides bound to Siglec-7 better than those carrying LSTc (NeuAcalpha2,6Galbeta1,4GlcNAcbeta1,3Galbeta1,4Glc) or GD1a (NeuAcalpha2,3 Galbeta1,3GalNAcbeta1,4[NeuAcalpha2,3]Gal-beta1,4Glc) oligosaccharides. In contrast, Siglee-9, which is 84% identical to Siglec-7, did not bind to the GD3 and LSTb probes but did bind to the LSTc and GD1a probes. To identify a region(s) responsible for their difference in binding specificity, we prepared a series of V-set domain chimeras between Siglecs-7 and -9. Substitution of a small region, Asn(70)-Lys(75), of Siglec-7 with the equivalent region of Siglec-9 resulted in loss of Siglec-7-like binding specificity and acquisition of Siglec-9-like binding properties. In comparison, a Siglec-9-based chimera, which contains Asn(70)-Lys(75) with additional amino acids derived from Siglec-7, exhibited Siglec-7-like specificity. These results, combined with molecular modeling, suggest that the C-C' loop in the sugar-binding domain plays a major role in determining the binding specificities of Siglecs-7 and -9.	Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	University of Dundee		yasua@postman.riken.go.jp		Crocker, Paul/0000-0001-6230-0293				Angata T, 2000, GLYCOBIOLOGY, V10, P431, DOI 10.1093/glycob/10.4.431; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8625, DOI 10.1074/jbc.275.12.8625; Coddeville B, 2000, BBA-GEN SUBJECTS, V1475, P321, DOI 10.1016/S0304-4165(00)00083-0; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Crocker P R, 1998, Glycobiology, V8, pv; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Floyd H, 2000, IMMUNOLOGY, V101, P342, DOI 10.1046/j.1365-2567.2000.00103.x; FREEMAN SD, 1995, BLOOD, V85, P2005, DOI 10.1182/blood.V85.8.2005.bloodjournal8582005; Hashimoto Y, 1998, J BIOCHEM-TOKYO, V123, P468; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Ito A, 2001, FEBS LETT, V498, P116, DOI 10.1016/S0014-5793(01)02476-0; Ito A, 2001, J BIOL CHEM, V276, P16695, DOI 10.1074/jbc.M011791200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlsson KA, 1998, MOL MICROBIOL, V29, P1, DOI 10.1046/j.1365-2958.1998.00854.x; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Nakamura K, 2000, EUR J BIOCHEM, V267, P5198, DOI 10.1046/j.1432-1327.2000.01590.x; NICHOLLS A, 1993, GRASP MANUAL VERSION; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; POWELL LD, 1993, J BIOL CHEM, V268, P7019; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; Sato C, 2001, J BIOL CHEM, V276, P28849, DOI 10.1074/jbc.M104148200; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Vitale C, 1999, P NATL ACAD SCI USA, V96, P15091, DOI 10.1073/pnas.96.26.15091; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WIEGANDT H, 1968, ANGEW CHEM INT EDIT, V7, P87, DOI 10.1002/anie.196800871; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200	33	142	145	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6324	6332		10.1074/jbc.M110146200	http://dx.doi.org/10.1074/jbc.M110146200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741958	hybrid			2022-12-27	WOS:000173989200084
J	Chang, HC; Chou, WY; Chang, GG				Chang, HC; Chou, WY; Chang, GG			Effect of metal binding on the structural stability of pigeon liver malic enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	15th Symposium of the Protein-Society	JUL 28-AUG 01, 2001	PHILADELPHIA, PA	Protein Soc			ALKALINE-PHOSPHATASE; MOLTEN GLOBULE; SLOW-BINDING; SITE; MECHANISM; DISSOCIATION; FLUORESCENCE; INHIBITION; EXPRESSION; MAGNESIUM	The cytosolic malic enzyme from the pigeon liver is sensitive to chemical denaturant urea. When monitored by protein intrinsic fluorescence or circular dichroism spectral changes, an unfolding of the enzyme in urea at 25 degreesC and pH 7.4 revealed a biphasic phenomenon with an intermediate state detected at 4-5 M urea. The enzyme activity was activated by urea up to 1 M but was completely lost before the intermediate state was detected. This suggests that the active site region of the enzyme was more sensitive to chemical denaturant than other structural scaffolds. In the presence of 4 mm Mn2+, the urea denaturation pattern of malic enzyme changed to monophasic. Mn2+ helped the enzyme to resist phase I urea denaturation. The [urea](0.5) for the enzyme inactivation shifted from 2.2 to 3.8 M. Molecular weight determined by the analytical ultracentrifuge indicated that the tetrameric enzyme was dissociated to dimers in the early stage of phase I denaturation. In the intermediate state at 4-5 M urea, the enzyme showed polymerization. However, the polymer forms were dissociated to unfolded monomers at a urea concentration greater than 6 M. Mn2+ retarded the polymerization of the malic enzyme. Three mutants of the enzyme with a defective metal ligand (E234Q, D235N, E234Q/D235N) were cloned and purified to homogeneity. These mutant malic enzymes showed a biphasic urea denaturation pattern in the absence or presence of Mn2+. These results indicate that the Mn2+ has dual roles in the malic enzyme. The metal ion not only plays a catalytic role in stabilization of the reaction intermediate, enol-pyruvate, but also stabilizes the overall tetrameric protein architecture.	Natl Def Med Ctr, Grad Inst Life Sci & Biochem, Taipei 11490, Taiwan	National Defense Medical Center	Chang, GG (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci & Biochem, Taipei 11490, Taiwan.	ggchang@ndmctsgh.edu.tw						Asante-Appiah E, 1998, J BIOL CHEM, V273, P35078, DOI 10.1074/jbc.273.52.35078; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALHOUN DB, 1983, BIOCHEMISTRY-US, V22, P1533, DOI 10.1021/bi00276a003; CHANG GG, 1988, BIOCHEM J, V254, P123, DOI 10.1042/bj2540123; Chou WY, 1997, PROTEIN ENG, V10, P1205, DOI 10.1093/protein/10.10.1205; CHOU WY, 1994, ARCH BIOCHEM BIOPHYS, V310, P158, DOI 10.1006/abbi.1994.1152; CHOU WY, 2001, J MED SCI, V21, P201; Christianson DW, 1997, PROG BIOPHYS MOL BIO, V67, P217, DOI 10.1016/S0079-6107(97)88477-5; delPino MMS, 1997, BIOCHEMISTRY-US, V36, P5560, DOI 10.1021/bi963133z; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Frenkel R, 1975, Curr Top Cell Regul, V9, P157; Goodridge AG, 1996, PROG NUCLEIC ACID RE, V52, P89, DOI 10.1016/S0079-6603(08)60965-4; Grillo AO, 2001, BIOCHEMISTRY-US, V40, P586, DOI 10.1021/bi001547t; Hellman ES, 1998, MRS INTERNET J N S R, V3; HIGAKI JN, 1992, TRENDS BIOCHEM SCI, V17, P100, DOI 10.1016/0968-0004(92)90245-5; HSU RY, 1976, J BIOL CHEM, V251, P6574; Hung HC, 2000, BIOCHEMISTRY-US, V39, P14095, DOI 10.1021/bi001534f; Hung HC, 2001, BIOPHYS J, V81, P3456, DOI 10.1016/S0006-3495(01)75977-2; Hung HC, 2001, PROTEIN SCI, V10, P34, DOI 10.1110/ps.35201; JANEWAY CML, 1993, BIOCHEMISTRY-US, V32, P1601, DOI 10.1021/bi00057a026; KLEMBA M, 1995, NAT STRUCT BIOL, V2, P368, DOI 10.1038/nsb0595-368; KOVACEVIC Z, 1972, CANCER RES, V32, P326; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; LABOWICZ JR, 1999, PRINCIPLES FLUORESCE, P237; LEE HJ, 1988, BIOCHIM BIOPHYS ACTA, V955, P119, DOI 10.1016/0167-4838(88)90185-9; Lu Y, 1997, CURR OPIN STRUC BIOL, V7, P495, DOI 10.1016/S0959-440X(97)80112-1; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; NEVALDINE BH, 1974, BIOCHIM BIOPHYS ACTA, V336, P283; OCHOA S, 1947, J BIOL CHEM, V167, P871; OLEARY MH, 1992, ENZYMES, V20, P236; Peracchi A, 2001, TRENDS BIOCHEM SCI, V26, P497, DOI 10.1016/S0968-0004(01)01911-9; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; RUTTER WJ, 1958, J BIOL CHEM, V233, P374; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scolnick LR, 1997, BIOCHEMISTRY-US, V36, P10558, DOI 10.1021/bi970800v; WEI CH, 1994, BIOCHEMISTRY-US, V33, P7931, DOI 10.1021/bi00191a021; WEI CH, 1995, BIOCHEMISTRY-US, V34, P7949, DOI 10.1021/bi00024a020; Xu YW, 1999, STRUCT FOLD DES, V7, P877, DOI 10.1016/S0969-2126(99)80115-4; Yang ZR, 2000, BIOCHEM BIOPH RES CO, V274, P440, DOI 10.1006/bbrc.2000.3163; Yang ZR, 2000, NAT STRUCT BIOL, V7, P251; Yang ZR, 2002, PROTEIN SCI, V11, P332, DOI 10.1110/ps.38002	46	22	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4663	4671		10.1074/jbc.M111156200	http://dx.doi.org/10.1074/jbc.M111156200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	523NX	11739398	hybrid			2022-12-27	WOS:000173962900017
J	de Groof, AJC; Fransen, JAM; Errington, RJ; Willems, PHGM; Wieringa, B; Koopman, WJH				de Groof, AJC; Fransen, JAM; Errington, RJ; Willems, PHGM; Wieringa, B; Koopman, WJH			The creatine kinase system is essential for optimal refill of the sarcoplasmic reticulum Ca2+ store in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTORS; CALCIUM TRANSIENTS; CELL-LINES; MITOCHONDRIAL; DEFICIENT; MICE; MYOGENESIS; COMPARTMENTATION; DERIVATION; ION	Muscle function depends on an adequate ATP supply to sustain the energy consumption associated with Ca2+ cycling and actomyosin sliding during contraction. In this regulation of energy homeostasis, the creatine kinase (CK) circuit for high energy phosphoryl transfer between ATP and phosphocreatine plays an important role. We earlier established a functional connection between the activity of the CK system and Ca2+ homeostasis during depolarization and contractile activity of muscle. Here, we show how CK activity is coupled to the kinetics of spontaneous and electrically induced Ca2+ transients in the sarcoplasm of myotubes. Using the UV ratiometric Ca2+ probe Indo-1 and video-rate confocal microscopy in CK-proficient and -deficient cultured cells, we found that spontaneous and electrically induced transients were dependent on ryanodine-sensitive Ca2+ release channels, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase pumps, extracellular calcium, and functional mitochondria in both cell types. However, at increasing sarcoplasmic Ca2+ load (induced by electrical stimulation at 0.1, 1, and 10 Hz), the Ca2+ removal rate and the amount of Ca2+ released per transient were gradually reduced in CK-deficient (but not wild-type) myotubes. We conclude that the CK/phosphocreatine circuit is essential for efficient delivery of ATP to the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase pumps and thereby directly influences sarcoplasmic reticulum refilling and the kinetics of the sarcoplasmic Ca2+ signals.	Univ Nijmegen, Med Ctr St Radboud, NCMLS, Dept Biochem 160, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Med Ctr St Radboud, NCMLS, Dept Cell Biol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Med Ctr St Radboud, NCMLS, Dept Cell Physiol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Med Ctr St Radboud, NCMLS, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Med Ctr St Radboud, NCMLS, Microscop Imaging Ctr, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Koopman, WJH (corresponding author), Univ Nijmegen, Med Ctr St Radboud, NCMLS, Dept Biochem 160, Geert Grooteplein 28,POB 9101, NL-6500 HB Nijmegen, Netherlands.	w.koopman@ncmls.kun.nl	Koopman, Werner J.H./AAC-9668-2020; Willems, P.H.G.M./L-4759-2015; Fransen, Jack/E-8924-2010	Koopman, Werner J.H./0000-0002-5340-6747; Willems, P.H.G.M./0000-0002-0915-1599; Fransen, Jack/0000-0002-0571-7639				Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Brini M, 1997, MOL BIOL CELL, V8, P129, DOI 10.1091/mbc.8.1.129; COGNARD C, 1993, CELL CALCIUM, V14, P333, DOI 10.1016/0143-4160(93)90054-A; Cooper E, 2001, J CELL BIOL, V153, pF9, DOI 10.1083/jcb.153.4.F9; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; de Groof AJC, 2001, FEBS LETT, V506, P73, DOI 10.1016/S0014-5793(01)02879-4; de Groof AJC, 2001, MUSCLE NERVE, V24, P1188, DOI 10.1002/mus.1131; Duke AM, 1999, J PHYSIOL-LONDON, V517, P447, DOI 10.1111/j.1469-7793.1999.0447t.x; Dzeja PP, 1998, MOL CELL BIOCHEM, V184, P169, DOI 10.1023/A:1006859632730; Ebashi S, 1999, CALCIUM AS A CELLULAR REGULATOR, P579; FLUCHER BE, 1993, DEV BIOL, V160, P135, DOI 10.1006/dbio.1993.1292; FLUCHER BE, 1994, MOL BIOL CELL, V5, P1105, DOI 10.1091/mbc.5.10.1105; Guerini D, 1999, CALCIUM AS A CELLULAR REGULATOR, P249; INCE C, 1985, PFLUG ARCH EUR J PHY, V403, P240, DOI 10.1007/BF00583594; JAIMOVICH E, 1994, CELL CALCIUM, V15, P356, DOI 10.1016/0143-4160(94)90011-6; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kay L, 2000, J BIOL CHEM, V275, P6937, DOI 10.1074/jbc.275.10.6937; Koopman WJH, 2001, BIOPHYS J, V81, P57, DOI 10.1016/S0006-3495(01)75679-2; KORGE P, 1994, AM J PHYSIOL, V267, pC357, DOI 10.1152/ajpcell.1994.267.2.C357; Lamb GD, 2000, CLIN EXP PHARMACOL P, V27, P216, DOI 10.1046/j.1440-1681.2000.03224.x; Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4; Lieste JR, 1998, J BIOL CHEM, V273, P25686, DOI 10.1074/jbc.273.40.25686; Lorenzon P, 1997, EUR J NEUROSCI, V9, P800, DOI 10.1111/j.1460-9568.1997.tb01429.x; McCormack JG, 1999, CALCIUM AS A CELLULAR REGULATOR, P529; Minajeva A, 1996, PFLUG ARCH EUR J PHY, V432, P904, DOI 10.1007/s004240050214; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; PRESS WH, 1992, NUMERICAL RECIPES PR; PRZYBYLSKI RJ, 1989, IN VITRO CELL DEV B, V25, P830; PRZYBYLSKI RJ, 1994, CELL CALCIUM, V15, P132, DOI 10.1016/0143-4160(94)90052-3; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; ROSSI AM, 1990, J BIOL CHEM, V265, P5258; Seppet EK, 2001, BBA-BIOENERGETICS, V1504, P379, DOI 10.1016/S0005-2728(00)00269-3; Sitsapesan R, 1997, J MEMBRANE BIOL, V159, P179, DOI 10.1007/s002329900281; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; 't Zandt HJAI, 1999, NMR BIOMED, V12, P327, DOI 10.1002/(SICI)1099-1492(199910)12:6<327::AID-NBM570>3.0.CO;2-9; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; VENTURACLAPIER R, 1995, J BIOL CHEM, V270, P19914, DOI 10.1074/jbc.270.34.19914; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WEGMANN G, 1992, J MUSCLE RES CELL M, V13, P420, DOI 10.1007/BF01738037; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	46	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5275	5284		10.1074/jbc.M108157200	http://dx.doi.org/10.1074/jbc.M108157200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11734556	hybrid			2022-12-27	WOS:000173962900093
J	Skildum, AJ; Mukherjee, S; Conrad, SE				Skildum, AJ; Mukherjee, S; Conrad, SE			The cyclin-dependent kinase inhibitor p21(WAF1/Cip1) is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA PROTEIN-PHOSPHORYLATION; E-CDK2 ACTIVATION; G(1) CYCLINS; P21; D1; MCF-7; ACCUMULATION; PROGRESSION; P27(KIP1); TAMOXIFEN	The MCF-7 cell line is a model of estrogen-dependent, antiestrogen-sensitive human breast cancer. Antiestrogen treatment of MCF-7 cells causes dramatic decreases in both Cdk4 and Cdk2 activities, which leads to a G(1) phase cell cycle arrest. In this report, we investigate the mechanism(s) by which Cdk4 activity is regulated in MCF-7 cells. Through time course analysis, we demonstrate that changes in Cdk4 activity in response to estrogen or antiestrogen treatment do not correlate directly with cyclin D1 protein levels or association. In contrast, Cdk4 activity does correlate with changes in the level of the Cdk inhibitor p21(WAF1/Cip1). Furthermore, we show that extracts of antiestrogen-treated cells contain a factor capable of inhibiting the Cdk4 activity present in extracts of estrogen-treated cells, and immunodepletion experiments identify this factor as p21(WAF1/Cip1). These results identify p21(WAF1/Cip1) as an important physiological regulator of Cdk4 complexes in human breast cancer cells.	Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University	Conrad, SE (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	conrad@msu.edu			NATIONAL CANCER INSTITUTE [R01CA076647] Funding Source: NIH RePORTER; NCI NIH HHS [CA76647] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adkins JN, 2000, BIOCHEMISTRY-US, V39, P13925, DOI 10.1021/bi001524e; Altucci L, 1996, ONCOGENE, V12, P2315; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; DRAETTA GF, 1994, CURR OPIN CELL BIOL, V6, P842, DOI 10.1016/0955-0674(94)90054-X; Estanyol JM, 1999, J BIOL CHEM, V274, P33161, DOI 10.1074/jbc.274.46.33161; Foster JS, 1996, MOL ENDOCRINOL, V10, P488, DOI 10.1210/me.10.5.488; Foster JS, 2001, MOL CELL BIOL, V21, P794, DOI 10.1128/MCB.21.3.794-810.2001; HALL M, 1995, ONCOGENE, V11, P1581; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hatakeyama M, 1995, Prog Cell Cycle Res, V1, P9; HATAKEYAMA M, 1994, GENE DEV, V8, P1759, DOI 10.1101/gad.8.15.1759; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Jaumot M, 1997, BIOCHEM BIOPH RES CO, V241, P434, DOI 10.1006/bbrc.1997.7787; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; Koff A, 1995, Prog Cell Cycle Res, V1, P141; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LIPPMAN M, 1976, CANCER RES, V36, P4595; Lukas J, 1996, MOL CELL BIOL, V16, P6917; LYKKESFELDT AE, 1986, BREAST CANCER RES TR, V7, P83; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Nakanishi Makoto, 1997, Leukemia (Basingstoke), V11, P356; OSBORNE CK, 1984, CANCER RES, V44, P1433; OSBORNE CK, 1983, CANCER RES, V43, P3583; Pacilio C, 1998, CANCER RES, V58, P871; Parry D, 1999, MOL CELL BIOL, V19, P1775; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; QUELLE DE, 1995, ONCOGENE, V11, P635; Rao S, 1999, EXP CELL RES, V252, P211, DOI 10.1006/excr.1999.4620; Reed SI, 1997, CANCER SURV, V29, P7; Rose C, 1980, Recent Results Cancer Res, V71, P134; RUTQVIST LE, 1987, BREAST CANCER RES TR, V10, P255, DOI 10.1007/BF01805762; Sherr CJ, 2000, CANCER RES, V60, P3689; SHERR CJ, 1994, COLD SPRING HARB SYM, V59, P11, DOI 10.1101/SQB.1994.059.01.004; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SUTHERLAND RL, 1983, EUR J CANCER CLIN ON, V19, P615, DOI 10.1016/0277-5379(83)90177-3; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5; WATTS CKW, 1994, BREAST CANCER RES TR, V31, P95, DOI 10.1007/BF00689680; WATTS CKW, 1995, MOL ENDOCRINOL, V9, P1804, DOI 10.1210/me.9.12.1804; Wilcken NRC, 1997, CLIN CANCER RES, V3, P849; WILLIAMS F, 1986, REASONING STAT READ, P173; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917	52	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5145	5152		10.1074/jbc.M109179200	http://dx.doi.org/10.1074/jbc.M109179200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741909	hybrid			2022-12-27	WOS:000173962900078
J	Zebboudj, AF; Imura, M; Bostrom, K				Zebboudj, AF; Imura, M; Bostrom, K			Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIFICATION; EXPRESSION; SIGNALS; CELLS; INHIBITION; RECEPTORS; BINDS; GENE	Matrix GLA protein (MGP) has been identified as a calcification inhibitor in cartilage and vasculature. Part of this effect may be attributed to its influence on osteoinductive activity of bone morphogenetic protein-2 (BMP-2). To detect binding between MGP and BMP-2, we performed immunoprecipitation using MGP and BMP-2 tagged with FLAG and c-Myc. The results showed co-precipitation of BMP-2 with MGP. To quantify the effect of MGP on BMP-2 activity, we assayed for alkaline phosphatase activity and showed a dose-dependent effect. Low levels of MGP relative to BMP-2 (<1-fold excess) resulted in mild enhancement of osteoinduction, whereas intermediate levels (1-15-fold excess) resulted in strong inhibition. High levels of MGP (>15-fold excess), however, resulted in pronounced enhancement of the osteoinductive effect of BMP-2. Cross-linking studies showed that inhibitory levels of MGP abolished BMP-2 receptor binding. Immunoblotting showed a corresponding decrease in activation of Smad1, part of the BMP signaling system. Enhancing levels of MGP resulted in increased Smad1 activation. To determine the cellular localization of BMP-2 in the presence of MGP, binding assays were performed on whole cells and cell-synthesized matrix. Inhibitory levels of MGP yielded increased matrix binding of BMP-2, suggesting that MGP inhibits BMP-2 in part via matrix association. These results suggest that MGP is a BMP-2 regulatory protein.	Univ Calif Los Angeles, Sch Med, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bostrom, K (corresponding author), Univ Calif Los Angeles, Sch Med, Div Cardiol, Dept Med, Box 951679,Room 47-123 CHS, Los Angeles, CA 90095 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004270] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL04270] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; CHEN L, 1990, ONCOGENE, V5, P1391; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Kaplan FS, 1996, BONE, V19, pS13, DOI 10.1016/S8756-3282(96)00129-9; Lawton DM, 1999, J CLIN PATHOL-MOL PA, V52, P92, DOI 10.1136/mp.52.2.92; LOESER RF, 1992, J BIOL CHEM, V267, P9459; LUO GB, 1995, J BONE MINER RES, V10, P325; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MASSAGUE J, 1987, METHOD ENZYMOL, V146, P174; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; OTAWARA Y, 1986, J BIOL CHEM, V261, P828; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; PRICE PA, 1985, J BIOL CHEM, V260, P4971; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Tsuji H, 1998, BIOCHEM BIOPH RES CO, V245, P583, DOI 10.1006/bbrc.1998.8489; URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Watson KE, 1998, ARTERIOSCL THROM VAS, V18, P1964, DOI 10.1161/01.ATV.18.12.1964; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yagami K, 1999, J CELL BIOL, V147, P1097, DOI 10.1083/jcb.147.5.1097; Yazaki Y, 1998, ANTICANCER RES, V18, P2339; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	31	285	294	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4388	4394		10.1074/jbc.M109683200	http://dx.doi.org/10.1074/jbc.M109683200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11741887	hybrid			2022-12-27	WOS:000173813900080
J	De Val, S; Ponticos, M; Antoniv, TT; Wells, DJ; Abraham, D; Partridge, T; Bou-Gharios, G				De Val, S; Ponticos, M; Antoniv, TT; Wells, DJ; Abraham, D; Partridge, T; Bou-Gharios, G			Identification of the key regions within the mouse pro-alpha 2(I) collagen gene far-upstream enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; TRANSGENIC MICE; ALPHA-1(I) COLLAGEN; REPORTER GENES; CELL LINEAGE; EXPRESSION; PROMOTER; BETA; ELEMENTS; CHROMATIN	Studies using transgenic mice have shown that the mouse pro-alpha2(I) collagen gene contains a far-upstream enhancer, which directs expression in the majority of collagen I-producing cells during development and in response to tissue injury. In this study, we have investigated the minimal functional region required for the enhancer effect and studied the role of the three hypersensitive sites (HS3-HS5) that overlap this region. The results of deletion experiments indicate that the minimal functional unit of this enhancer is a 1.5-kb region between -17.0 and -15.45 kb from the transcription start site. This region includes the core sequences of HS3 and HS4 but not HS5. The HS4 sequences are essential for the functional integrity of the enhancer, whereas HS3 represents tissue-specific elements that direct expression in mesenchymal cells of internal tissues and body wall muscles. The HS3 region appears to bind a complex of transcription factors illustrated by large regions of protected sequences. A 400-bp sequence located between -17.0 and -16.6 is also essential for the enhancer because its deletion results in increased susceptibility to the chromatin environment.	Univ London Imperial Coll Sci & Technol, Fac Med, MRC Clin Sci Ctr, Muscle Cell Biol, London W12 0NN, England; UCL, Ctr Rheumatol, London NW3 2PF, England; New York Univ, Mt Sinai Sch Med, Dept Biochem & Mol Biol, Brookdale Ctr, New York, NY 10029 USA; Univ London Imperial Coll Sci & Technol, Dept Neuromusc Dis, Gene Targeting Unit, London W6 8RP, England	Imperial College London; University of London; University College London; Icahn School of Medicine at Mount Sinai; New York University; Imperial College London	Bou-Gharios, G (corresponding author), Univ London Imperial Coll Sci & Technol, Fac Med, MRC Clin Sci Ctr, Muscle Cell Biol, Hammersmith Campus, London W12 0NN, England.	george.bou-gharios@csc.mrc.ac.uk		Ponticos, Markella/0000-0001-5957-5851; Wells, Dominic/0000-0002-1425-6344				Antoniv TT, 2001, J BIOL CHEM, V276, P21754, DOI 10.1074/jbc.M101397200; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bonifer C, 1999, GENE, V238, P277, DOI 10.1016/S0378-1119(99)00340-6; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; FRIES KM, 1994, CLIN IMMUNOL IMMUNOP, V72, P283, DOI 10.1006/clin.1994.1144; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hogan B, 1994, MANIPULATING MOUSE E; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; IRVING NG, 1989, CYTOGENET CELL GENET, V50, P121, DOI 10.1159/000132737; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Krempen K, 1999, GENE EXPRESSION, V8, P151; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; MUNKE M, 1986, CYTOGENET CELL GENET, V43, P140, DOI 10.1159/000132312; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; Niederreither K, 1995, MATRIX BIOL, V14, P705, DOI 10.1016/S0945-053X(05)80013-7; NIEDERREITHER K, 1992, J CELL BIOL, V119, P1361, DOI 10.1083/jcb.119.5.1361; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Rossert JA, 1996, P NATL ACAD SCI USA, V93, P1027, DOI 10.1073/pnas.93.3.1027; SAMBROOK J, 1989, MOL CLONING, V2, P9; SILVERA MR, 1994, LYMPHOKINE CYTOK RES, V13, P277; VUUST J, 1985, EUR J BIOCHEM, V151, P449, DOI 10.1111/j.1432-1033.1985.tb09122.x; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	25	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9286	9292		10.1074/jbc.M111040200	http://dx.doi.org/10.1074/jbc.M111040200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11756428	hybrid			2022-12-27	WOS:000174400600075
J	Jump, DB				Jump, DB			The biochemistry of n-3 polyunsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ELEMENT-BINDING PROTEIN-1C; ACTIVATED RECEPTOR-ALPHA; LIPOGENIC GENE-EXPRESSION; SREBP-1C MESSENGER-RNA; DOCOSAHEXAENOIC ACID; ARACHIDONIC-ACID; EICOSAPENTAENOIC ACID; INSULIN SENSITIVITY; RAFT LOCALIZATION; FISH-OIL		Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Jump, DB (corresponding author), Michigan State Univ, Dept Physiol, 115 Giltner Hall, E Lansing, MI 48824 USA.	Jump@msu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043220] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK043220] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], [No title captured]; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; Berge RK, 1999, BIOCHEM J, V343, P191, DOI 10.1042/0264-6021:3430191; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Capdevila JH, 2000, J LIPID RES, V41, P163; Cheema SK, 1997, J LIPID RES, V38, P315; Cheema SK, 1999, J NUTR, V129, P1718, DOI 10.1093/jn/129.9.1718; Contreras MA, 2000, J NEUROCHEM, V75, P2392, DOI 10.1046/j.1471-4159.2000.0752392.x; Dallongeville J, 2001, J BIOL CHEM, V276, P4634, DOI 10.1074/jbc.M008809200; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DEURQUIZA AM, 2001, SICENCE, V290, P2140; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Froyland L, 1997, J LIPID RES, V38, P1851; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Hamilton J, 2000, LIPIDS, V35, P863, DOI 10.1007/S11745-000-0595-x; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; Harris WS, 1997, J LIPID RES, V38, P503; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Hwang D, 2000, ANNU REV NUTR, V20, P431, DOI 10.1146/annurev.nutr.20.1.431; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; JUMP DB, 1993, P NATL ACAD SCI USA, V90, P8454, DOI 10.1073/pnas.90.18.8454; JUMP DB, 1994, J LIPID RES, V35, P1076; Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; Kim HY, 2000, J BIOL CHEM, V275, P35215, DOI 10.1074/jbc.M004446200; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Leaf A, 2001, J Nutr Health Aging, V5, P173; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Litman BJ, 2001, J MOL NEUROSCI, V16, P237, DOI 10.1385/JMN:16:2-3:237; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Mater MK, 1999, J LIPID RES, V40, P1045; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Mori TA, 2000, AM J CLIN NUTR, V71, P1085; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Niu SL, 2001, J BIOL CHEM, V276, P42807, DOI 10.1074/jbc.M105778200; Nordoy A, 1999, LIPIDS, V34, pS19, DOI 10.1007/BF02562223; OLIW EH, 1991, BIOCHIM BIOPHYS ACTA, V1086, P287, DOI 10.1016/0005-2760(91)90172-E; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pan DA, 2000, J LIPID RES, V41, P742; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Pound EM, 2001, J LIPID RES, V42, P346; Rambjor GS, 1996, LIPIDS, V31, pS45, DOI 10.1007/BF02637050; Ren B, 1997, J BIOL CHEM, V272, P26827, DOI 10.1074/jbc.272.43.26827; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Salem N, 2001, J MOL NEUROSCI, V16, P299, DOI 10.1385/JMN:16:2-3:299; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Sellmayer A, 1999, LIPIDS, V34, pS13, DOI 10.1007/BF02562222; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Spector AA, 1999, LIPIDS, V34, pS1, DOI 10.1007/BF02562220; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; STINSON AM, 1991, EXP EYE RES, V52, P213, DOI 10.1016/0014-4835(91)90261-C; Storlien L H, 1998, Curr Opin Clin Nutr Metab Care, V1, P559, DOI 10.1097/00075197-199811000-00014; Storlien LH, 1997, PROSTAG LEUKOTR ESS, V57, P379, DOI 10.1016/S0952-3278(97)90414-2; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; THORP JM, 1963, J ATHEROSCLER RES, V3, P351, DOI 10.1016/S0368-1319(63)80017-4; VANDERHEIDE JJH, 1993, NEW ENGL J MED, V329, P769, DOI 10.1056/NEJM199309093291105; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; VONSCHACKY C, 1993, BIOCHIM BIOPHYS ACTA, V1166, P20, DOI 10.1016/0005-2760(93)90278-H; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200	78	467	504	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8755	8758		10.1074/jbc.R100062200	http://dx.doi.org/10.1074/jbc.R100062200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11748246	hybrid			2022-12-27	WOS:000174400600001
J	Alt, JR; Gladden, AB; Diehl, JA				Alt, JR; Gladden, AB; Diehl, JA			p21(Cip1) promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE; G1 PHASE; PHOSPHORYLATION; P27(KIP1); SIGNAL; EXPRESSION; UBIQUITINATION; IDENTIFICATION; PROLIFERATION; LOCALIZATION	There is increasing evidence that p21(Cip1) and p27(Kip1) are requisite positive regulators of cyclin D1(.)CDK4 assembly and nuclear accumulation. Both Cip and Kip proteins can promote nuclear accumulation of cyclin D1, but the underlying mechanism has not been elucidated. We now provide evidence that p21(Cip1) promotes the nuclear accumulation of cyclin D1 complexes via inhibition of cyclin D1 nuclear export. In vivo, we demonstrate that p21(Cip1) can inhibit glycogen synthase kinase 3beta-triggered cyclin D1 nuclear export and phosphorylation-dependent nucleocytoplasmic shuttling. Furthermore, we find that cyclin D1 nuclear accumulation in p21/p27 null cells can be restored through inhibition of CRM1-depenendent nuclear export. The ability of P21(Cip1) to inhibit cyclin D1 nuclear export correlates with its ability to bind to Thr-286-phosphorylated cyclin D1 and thereby prevents cyclin D1-CRM1 association.	Univ Penn, Ctr Canc, Leonard & Madlyn Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Pennsylvania; Pennsylvania Medicine; University of Nebraska System; University of Nebraska Medical Center	Diehl, JA (corresponding author), Univ Penn, Ctr Canc, Leonard & Madlyn Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA.	adiehl@mail.med.upenn.edu			NCI NIH HHS [CA93237] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093237] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; GOUBIN F, 1995, ONCOGENE, V10, P2281; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Leng XH, 1997, CURR BIOL, V7, P709, DOI 10.1016/S0960-9822(06)00301-0; LUKAS J, 1994, ONCOGENE, V9, P2159; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MICHAEL WM, 1995, CELL, V83, P415; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; NAKANISHI M, 1995, EMBO J, V14, P555, DOI 10.1002/j.1460-2075.1995.tb07031.x; NISHI K, 1994, J BIOL CHEM, V269, P6320; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Robles SJ, 1998, DNA CELL BIOL, V17, P9, DOI 10.1089/dna.1998.17.9; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SUMMERS MD, 1987, TEX AGR EXP STN B, V1555; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Treinies I, 1999, MOL CELL BIOL, V19, P321; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	37	155	160	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8517	8523		10.1074/jbc.M108867200	http://dx.doi.org/10.1074/jbc.M108867200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751903	hybrid			2022-12-27	WOS:000174268000113
J	Brodbeck, J; Davies, A; Courtney, JM; Meir, A; Balaguero, N; Canti, C; Moss, FJ; Page, KM; Pratt, WS; Hunt, SP; Barclay, J; Rees, M; Dolphin, AC				Brodbeck, J; Davies, A; Courtney, JM; Meir, A; Balaguero, N; Canti, C; Moss, FJ; Page, KM; Pratt, WS; Hunt, SP; Barclay, J; Rees, M; Dolphin, AC			The ducky mutation in Cacna2d2 results in altered Purkinje cell morphology and is associated with the expression of a truncated alpha 2 delta-2 protein with abnormal function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CALCIUM-CHANNEL; FAMILIAL HEMIPLEGIC MIGRAINE; GATED CA2+ CHANNELS; G-BETA-GAMMA; ALPHA(2)DELTA SUBUNIT; MUTANT MICE; ALPHA(1) SUBUNITS; SIGNAL SEQUENCES; MOUSE; IDENTIFICATION	The mouse mutant ducky, a model for absence epilepsy, is characterized by spike-wave seizures and cerebellar ataxia. A mutation in Cacna2d2, the gene encoding the alpha2delta-2 voltage-dependent calcium channel accessory subunit, has been found to underlie the ducky phenotype. The alpha2delta-2 mRNA is strongly expressed in cerebellar Purkinje cells. We show that du/du mice have abnormalities in their Purkinje cell dendritic tree. The mutation in alpha2delta-2 results in the introduction of a premature stop codon and predicts the expression of a truncated protein encoded by the first three exons of Cacna2d2, followed by 8 novel amino acids. We show that both mRNA and protein corresponding to this predicted transcript are expressed in du/du cerebellum and present in Purkinje cells. Whereas the alpha2delta-2 subunit increased the peak current density of the Ca(V)2.1/beta(4) channel combination when co-expressed in vitro, co-expression with the truncated mutant alpha2delta-2 protein reduced current density, indicating that it may contribute to the du phenotype.	UCL, Dept Pharmacol, London WC1E 6BT, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Sch Med, Rayne Inst, Dept Paediat & Child Hlth, London WC1E 6JJ, England	University of London; University College London; University of London; University College London; University of London; King's College London; University College London; UCL Medical School	Dolphin, AC (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	a.dolphin@ucl.ac.uk	Moss, Fraser J/AAA-2436-2021; Brodbeck, Jens/AAB-9275-2020; HUNT, STEPHEN P/C-1646-2008; Tuluc, Petronel/C-2527-2011; Dolphin, Annette C/F-7416-2010; Cantí, Carles/A-5989-2010	Moss, Fraser J/0000-0002-8519-6991; Dolphin, Annette C/0000-0003-4626-4856; Cantí, Carles/0000-0003-3854-9712; Courtney, Jo-Maree/0000-0003-4461-4197; Hunt, Stephen/0000-0001-9453-5505				Barclay J, 2000, MAMM GENOME, V11, P1142, DOI 10.1007/s003350010211; BARELAY J, 2001, J NEUROSCI, V21, P6095; Berrow NS, 1997, EUR J NEUROSCI, V9, P739, DOI 10.1111/j.1460-9568.1997.tb01422.x; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; BRICKLEY K, 1995, FEBS LETT, V364, P129, DOI 10.1016/0014-5793(95)00371-F; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Felix R, 1997, J NEUROSCI, V17, P6884; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FUJITA S, 1967, J CELL BIOL, V32, P272; Gurnett CA, 1997, J BIOL CHEM, V272, P18508, DOI 10.1074/jbc.272.29.18508; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Hans M, 1999, J NEUROSCI, V19, P1610; Hans M, 1999, BIOPHYS J, V76, P1384, DOI 10.1016/S0006-3495(99)77300-5; HECKROTH JA, 1994, BRAIN RES, V658, P93, DOI 10.1016/S0006-8993(09)90014-2; Hobom M, 2000, EUR J NEUROSCI, V12, P1217, DOI 10.1046/j.1460-9568.2000.01009.x; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Klugbauer N, 1999, J NEUROSCI, V19, P684; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; LI Y, 1994, VIROLOGY, V204, P266, DOI 10.1006/viro.1994.1531; MACART M, 1982, CLIN CHIM ACTA, V122, P93, DOI 10.1016/0009-8981(82)90100-0; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MEIER H, 1968, ACTA NEUROPATHOL, V11, P15, DOI 10.1007/BF00692792; Meir A, 2000, BIOPHYS J, V79, P731, DOI 10.1016/S0006-3495(00)76331-4; Meir A, 1998, NEURON, V20, P341, DOI 10.1016/S0896-6273(00)80461-4; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neher Erwin, 1995, P147; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; SADLER M, 1984, PROC R SOC SER B-BIO, V221, P349, DOI 10.1098/rspb.1984.0037; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; SHISTIK E, 1995, J PHYSIOL-LONDON, V489, P55, DOI 10.1113/jphysiol.1995.sp021029; SNELL GEORGE D., 1955, JOUR HEREDITY, V46, P27; SOTELO C, 1975, ADV NEUROL, V12, P335; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Zwingman TA, 2001, J NEUROSCI, V21, P1169	47	105	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7684	7693		10.1074/jbc.M109404200	http://dx.doi.org/10.1074/jbc.M109404200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756448	hybrid			2022-12-27	WOS:000174268000011
J	Carlini, LE; Getz, MJ; Strauch, AR; Kelm, RJ				Carlini, LE; Getz, MJ; Strauch, AR; Kelm, RJ			Cryptic MCAT enhancer regulation in fibroblasts and smooth muscle cells - Suppression of TEF-1 mediated activation by the single-stranded DNA-binding proteins, Pur alpha, Pur beta, and MSY1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; ACTIN GENE PROMOTER; M-CAT ELEMENTS; TRANSCRIPTIONAL REGULATION; CELLULAR PROTEIN; ASSOCIATION; MYOFIBROBLAST; SEQUENCE; RNA; SPECIFICITY	An asymmetric polypurine-polypyrimidine cis-element located in the 5' region of the mouse vascular smooth muscle a-actin gene serves as a binding site for multiple proteins with specific affinity for either single-or double-stranded DNA. Here, we test the hypothesis that single-stranded DNA-binding proteins are responsible for preventing a cryptic MCAT enhancer centered within this element from cooperating with a nearby serum response factor-interacting CArG motif to trans-activate the minimal promoter in fibroblasts and smooth muscle cells. DNA binding studies revealed that the core MCAT sequence mediates binding of transcription enhancer factor-1 to the double-stranded polypurine-polypyrimidine element while flanking nucleotides account for interaction of Puralpha and Purbeta with the purine-rich strand and MSY1 with the complementary pyrimidine-rich strand. Mutations that selectively impaired high affinity single-stranded DNA binding by fibroblast or smooth muscle cell-derived Puralpha, Purbeta, and MSY1 in vitro, released the cryptic MCAT enhancer from repression in transfected cells. Additional experiments indicated that Puralpha, Purbeta, and MSY1 also interact specifically, albeit weakly, with double-stranded DNA and with transcription enhancer factor-1. These results are consistent with two plausible models of cryptic MCAT enhancer regulation by Puralpha, Purbeta, and MSY1 involving either competitive single-stranded DNA binding or masking of MCAT-bound transcription enhancer factor-1.	Univ Vermont, Dept Med, Colchester Res Facil, Coll Med, Colchester, VT 05446 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	University of Vermont; Mayo Clinic; University System of Ohio; Ohio State University	Kelm, RJ (corresponding author), Univ Vermont, Dept Med, Colchester Res Facil, Coll Med, 208 S Pk Dr,Suite 2, Colchester, VT 05446 USA.	rkelm@zoo.uvm.edu			NATIONAL CANCER INSTITUTE [T32CA009441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054281] Funding Source: NIH RePORTER; NCI NIH HHS [CA09441] Funding Source: Medline; NHLBI NIH HHS [HL54281] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Becker NA, 2000, J BIOL CHEM, V275, P15384, DOI 10.1074/jbc.M909687199; Butler AJ, 1999, MOL CELL BIOL, V19, P296; COGAN JG, 1995, J BIOL CHEM, V270, P11310, DOI 10.1074/jbc.270.19.11310; Darbinian N, 1999, ONCOGENE, V18, P6398, DOI 10.1038/sj.onc.1203011; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; FOSTER DN, 1992, J BIOL CHEM, V267, P11995; Fry CJ, 1999, J BIOL CHEM, V274, P29583, DOI 10.1074/jbc.274.42.29583; Gallia GL, 1998, J BIOL CHEM, V273, P32662, DOI 10.1074/jbc.273.49.32662; Gallia GL, 1999, P NATL ACAD SCI USA, V96, P11572, DOI 10.1073/pnas.96.20.11572; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gupta M, 2001, J BIOL CHEM, V276, P10413, DOI 10.1074/jbc.M008625200; Hautmann MB, 1998, J BIOL CHEM, V273, P8398, DOI 10.1074/jbc.273.14.8398; Itoh H, 1998, CELL GROWTH DIFFER, V9, P651; Jacquemin P, 1997, TRENDS CARDIOVAS MED, V7, P192, DOI 10.1016/S1050-1738(97)00052-2; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; JOHNSON AD, 1995, CELL, V81, P655, DOI 10.1016/0092-8674(95)90524-3; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; Kelm RJ, 1999, J BIOL CHEM, V274, P14238, DOI 10.1074/jbc.274.20.14238; Kelm RJ, 1999, J BIOL CHEM, V274, P38268, DOI 10.1074/jbc.274.53.38268; Kelm RJ, 1996, J BIOL CHEM, V271, P24278, DOI 10.1074/jbc.271.39.24278; Kelm RJ, 1997, J BIOL CHEM, V272, P26727, DOI 10.1074/jbc.272.42.26727; Krachmarov CP, 1996, P NATL ACAD SCI USA, V93, P14112, DOI 10.1073/pnas.93.24.14112; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; Lasham A, 2000, GENE, V252, P1, DOI 10.1016/S0378-1119(00)00220-1; Li C, 1998, MOL CELL BIOL, V18, P3771, DOI 10.1128/MCB.18.7.3771; Mack CP, 2000, CIRC RES, V86, P221, DOI 10.1161/01.RES.86.2.221; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; Melnikova IN, 2000, EUR J PHARMACOL, V393, P75, DOI 10.1016/S0014-2999(99)00884-5; Muralidharan V, 1997, J CELL BIOCHEM, V66, P524, DOI 10.1002/(SICI)1097-4644(19970915)66:4<524::AID-JCB11>3.0.CO;2-B; Ogbourne S, 1998, BIOCHEM J, V331, P1; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; Safak R, 1999, MOL CELL BIOL, V19, P2712; Schurch W, 1999, CURR TOPICS PATHOL, V93, P135; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; STOFLET ES, 1992, MOL BIOL CELL, V3, P1073, DOI 10.1091/mbc.3.10.1073; Strauch AR, 1997, TRANSPL IMMUNOL, V5, P261, DOI 10.1016/S0966-3274(97)80006-8; SUN SQ, 1995, MOL CELL BIOL, V15, P2429; Swartz EA, 1998, AM J PHYSIOL-CELL PH, V275, pC608, DOI 10.1152/ajpcell.1998.275.2.C608; Tretiakova A, 1999, J CELL PHYSIOL, V181, P160, DOI 10.1002/(SICI)1097-4652(199910)181:1<160::AID-JCP17>3.0.CO;2-H; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; YAGIL G, 1991, CRIT REV BIOCHEM MOL, V26, P475, DOI 10.3109/10409239109086791	48	44	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8682	8692		10.1074/jbc.M109754200	http://dx.doi.org/10.1074/jbc.M109754200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751932	hybrid			2022-12-27	WOS:000174268000134
J	Haataja, L; Kaartinen, V; Groffen, J; Heisterkamp, N				Haataja, L; Kaartinen, V; Groffen, J; Heisterkamp, N			The small GTPase Rac3 interacts with the integrin-binding protein CIB and promotes integrin alpha(IIb)beta(3)-mediated adhesion and spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DOMAIN; NADPH OXIDASE; RHO GTPASES; ACTIVATION; IDENTIFICATION; EXPRESSION; MULTIPLE; AFFINITY; KINASE; CDC42	There are only three human isoforms of the small GTPase Rae, which together regulate a variety of cellular processes, including those related to actin cytoskeletal reorganization. A role for Rac3 in integrin-mediated adhesion and spreading has not been defined. We here report that CIB, a protein that binds to the alpha(IIb)beta(3) fibrinogen receptor, interacts exclusively with activated (V12) Rac3 but not Rac1 or Rac2. Binding of V12Rac3 to CIB was mediated by the C-terminal end of Rac3 and by Rac3 membrane localization. Adhesion of cells on fibrinogen was accompanied by a specific increase in the levels of Rac3 but not Rac1 or Rac2 in the Triton-insoluble fraction of the cell. Also, CIB co-localized with active Rac3 to the periphery of cells adhering to fibrinogen. Expression of V12Rac3 and CIB stimulated alpha(IIb)beta(3)-mediated adhesion and spreading on fibrinogen. Moreover, adhesion through alpha(IIb)beta(3) caused a marked increase in the levels of endogenous GTP-bound Rac3 but not Rac1. These combined results strongly implicate Rac3 and CIB in integrin-associated cytoskeletal reorganization during alpha(IIb)beta(3)-mediated adhesion.	Univ So Calif, Childrens Hosp Los Angeles, Div Hematol Oncol, Sect Mol Carcinogenesis,Res Inst, Los Angeles, CA 90027 USA; Univ So Calif, Childrens Hosp Los Angeles, Inst Res, Dept Pathol, Los Angeles, CA 90027 USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Southern California	Heisterkamp, N (corresponding author), Univ So Calif, Childrens Hosp Los Angeles, Div Hematol Oncol, Sect Mol Carcinogenesis,Res Inst, MS 54,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	heisterk@hsc.usc.edu	Heisterkamp, Nora/C-1698-2012; Kaartinen, Vesa/AAU-5396-2021	Heisterkamp, Nora/0000-0003-2769-2273; Kaartinen, Vesa/0000-0002-9432-510X	NCI NIH HHS [CA90321] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090321] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASPENSTROM P, 1995, METHOD ENZYMOL, V256, P228; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOKOCH GM, 1994, CURR OPIN CELL BIOL, V6, P212, DOI 10.1016/0955-0674(94)90138-4; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; DIEKMANN D, 1995, EMBO J, V14, P5297, DOI 10.1002/j.1460-2075.1995.tb00214.x; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Haataja L, 1998, INT J MOL MED, V1, P665; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Holtrich U, 2000, ONCOGENE, V19, P4832, DOI 10.1038/sj.onc.1203845; JOSEPH G, 1995, J BIOL CHEM, V270, P29079, DOI 10.1074/jbc.270.49.29079; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; KRECK ML, 1994, J BIOL CHEM, V269, P4161; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Shock DD, 1999, BIOCHEM J, V342, P729, DOI 10.1042/0264-6021:3420729; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; VAN AL, 1997, GENE DEV, V11, P2295; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Wu XT, 1997, MUTAT RES-DNA REPAIR, V385, P13, DOI 10.1016/S0921-8777(97)00035-9	34	54	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8321	8328		10.1074/jbc.M105363200	http://dx.doi.org/10.1074/jbc.M105363200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756406	hybrid			2022-12-27	WOS:000174268000090
J	Jacob, R; Peters, K; Naim, HY				Jacob, R; Peters, K; Naim, HY			The prosequence of human lactase-phlorizin hydrolase modulates the folding of the mature enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; DISULFIDE BOND FORMATION; 2 CATALYTIC SITES; PHLORHIZIN HYDROLASE; ENDOPLASMIC-RETICULUM; INTRAMOLECULAR CHAPERONE; INTERMEDIATE COMPARTMENT; INTRACELLULAR-TRANSPORT; SEQUENTIAL INTERACTION; SUCRASE-ISOMALTASE	The efficient transport of proteins along the secretory pathway requires that the polypeptide adopts a stably folded conformation to egress the endoplasmic reticulum. (ER). The transport-competent precursor of the brush border enzyme LPH, pro-LPH, undergoes an intracellular cleavage process in the trans-Golgi network between Are(734) and LeU(735) to yield LPHbeta(initial). The role of the prodomain comprising the N-terminally located 734 amino acids of pro-LPH, LPHalpha, in the folding events of LPHbeta(initial) has been analyzed by the individual expression of both forms in COS-1 cells. Following synthesis at 37 degreesC LPHbeta(initial) acquires a misfolded and enzymatically inactive conformation that is degraded by trypsin. A temperature shift to 20 degreesC generates a stable, trypsin-resistant, and enzymatically active LPHbeta(initial) indicating that the individual expression of LPHbeta(initial) results in a temperature-sensitive conformation. This form interacts at non-permissive temperatures sequentially with the ER chaperones immunoglobulin-binding protein and calnexin resulting in an ER retention. The LPHalpha prodomain resides in the ER when individually expressed. It reveals compact structural features that are stabilized by disulfide bridges. LPHalpha and LPHbeta(initial) readily interact with each other upon coexpression, and this interaction appears to trigger the formation of a trypsin-resistant, correctly folded, enzymatically active, and transport-competent LPHbeta(initial) polypeptide. These data clearly demonstrate that the proregion of pro-LPH is an intramolecular chaperone that is critically essential in facilitating the folding of the intermediate form LPHbeta(initial) in the context of the pro-LPH polypeptide.	Hannover Sch Vet Med, Dept Physiol Chem, D-30559 Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Naim, HY (corresponding author), Hannover Sch Vet Med, Dept Physiol Chem, Bunteweg 17, D-30559 Hannover, Germany.		Jacob, Ralf/B-8163-2011					ALLEN S, 1995, J BIOL CHEM, V270, P4797, DOI 10.1074/jbc.270.9.4797; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; Cao J, 2000, J BIOL CHEM, V275, P29648, DOI 10.1074/jbc.M001920200; CHEN SSL, 1986, J VIROL, V59, P210, DOI 10.1128/JVI.59.2.210-215.1986; Cigic B, 2000, BIOCHEMISTRY-US, V39, P12382, DOI 10.1021/bi0008837; DAHLQVIST A, 1968, ANAL BIOCHEM, V22, P99, DOI 10.1016/0003-2697(68)90263-7; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOLDENBERG DP, 1984, ANAL BIOCHEM, V138, P1, DOI 10.1016/0003-2697(84)90761-9; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; GRUNBERG J, 1992, FEBS LETT, V314, P224, DOI 10.1016/0014-5793(92)81476-3; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; High S, 2000, FEBS LETT, V476, P38, DOI 10.1016/S0014-5793(00)01666-5; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; INOUYE M, 1991, ENZYME, V45, P314, DOI 10.1159/000468904; JACOB R, 1995, J BIOL CHEM, V270, P18678, DOI 10.1074/jbc.270.31.18678; Jacob R, 1996, EUR J BIOCHEM, V236, P789, DOI 10.1111/j.1432-1033.1996.t01-1-00789.x; Jacob R, 2000, J BIOL CHEM, V275, P10630, DOI 10.1074/jbc.275.14.10630; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; JACOB R, 1994, J BIOL CHEM, V269, P2712; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; MAIURI L, 1991, GASTROENTEROLOGY, V100, P359, DOI 10.1016/0016-5085(91)90203-W; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; NAIM HY, 1991, J BIOL CHEM, V266, P12313; NAIM HY, 1994, J BIOL CHEM, V269, P26933; OBERHOLZER T, 1993, FEBS LETT, V333, P127, DOI 10.1016/0014-5793(93)80389-C; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; Panzer P, 1998, J BIOL CHEM, V273, P13861, DOI 10.1074/jbc.273.22.13861; SEGAL MS, 1992, J CELL BIOL, V118, P227, DOI 10.1083/jcb.118.2.227; SKOVBJERG H, 1984, BIOCHIM BIOPHYS ACTA, V798, P247, DOI 10.1016/0304-4165(84)90312-X; STEINER DF, 1984, J CELL BIOCHEM, V24, P121, DOI 10.1002/jcb.240240204; TATU U, 1995, EMBO J, V14, P1340, DOI 10.1002/j.1460-2075.1995.tb07120.x; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; WACKER H, 1992, J BIOL CHEM, V267, P18744; WEISSMAN JS, 1992, CELL, V71, P841, DOI 10.1016/0092-8674(92)90559-U; WELPLY JK, 1983, J BIOL CHEM, V258, P1856; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Wuthrich M, 1996, ARCH BIOCHEM BIOPHYS, V336, P27, DOI 10.1006/abbi.1996.0528; YEH KY, 1991, AM J PHYSIOL, V260, pG379, DOI 10.1152/ajpgi.1991.260.3.G379; Zecca L, 1998, FEBS LETT, V435, P225, DOI 10.1016/S0014-5793(98)01076-X; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	48	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8217	8225		10.1074/jbc.M111500200	http://dx.doi.org/10.1074/jbc.M111500200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751874	hybrid			2022-12-27	WOS:000174268000076
J	Katsura, M; Mohri, Y; Shuto, K; Hai-Du, Y; Amano, T; Tsujimura, A; Sasa, M; Ohkuma, S				Katsura, M; Mohri, Y; Shuto, K; Hai-Du, Y; Amano, T; Tsujimura, A; Sasa, M; Ohkuma, S			Up-regulation of L-type voltage-dependent calcium channels after long term exposure to nicotine in cerebral cortical neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIAZEPAM-BINDING INHIBITOR; ACETYLCHOLINE-RECEPTORS; MESSENGER-RNA; CA2+ CHANNELS; BETA 2; BRAIN; MECHANISMS; SITES; DESENSITIZATION; PHARMACOLOGY	Effects of long term (72-h) exposure to low concentration (0.1 mum) of nicotine on various types of voltage-dependent Ca2+ channels (VDCCs) and neuronal nicotinic acetylcholine receptors (nnAChRs) were examined using primary cultures of mouse cerebral cortical neurons. High potassium (30 mm KCI)-stimulated Ca-45(2+) influx into the neurons increased with increasing the duration of nicotine exposure and its concentrations. The maximal increase of the KCI-stimulated Ca-45(2+) influx was found 24 h after the initiation of exposure and thereafter maintained up to 72 h. This enhancement of KCI-induced Ca-45(2+) influx after 72-h exposure to 0.1 mum nicotine was completely abolished by concomitant exposure with mecamylamine, an inhibitor for nnAChRs. Only the component of the KCI-induced Ca-45(2+) influx observed after long term exposure to nicotine, which was sensitive to nifedipine, an inhibitor of L-type VDCCs, was facilitated, while the Ca-45(2+) influx through P/Q- and N-type VDCCs showed no changes. Moreover, enhanced immunoreactivity against antibody for the alpha(1C) subunit of L-type VDCCs was recognized, whereas no changes in immunoreactivities against antibodies for alpha(1A) and alpha(1beta) subunits of other types of VDCCs were noted. In addition, a Western blot analysis showed an increase of immunoreactivities against antibodies for alpha(1D) and alpha(2)/delta(1), and expression of mRNA for L-type VDCC subunit, alpha(1F), was also enhanced, although 134 mRNA expression was not changed. Whole cell patch clamp analysis revealed that the increase of the amplitude of Ba2+ currents was also recognized in the neurons exposed to nicotine, and nicardipine reduced this increased amplitude to the level of the amplitude detected in nontreated neurons with nicardipine. The up-regulation of alpha(4) and beta(2) subunits, but not the alpha(3) subunit of nnAChRs, was also noted after the nicotine exposure when examining by the Western blot analysis. Taken together, these results indicate that the long term exposure of the neurons to a low concentration of nicotine induces both increased Ca-45(2+) influx through up-regulated L-type VDCCs and nnAChR up-regulation.	Kawasaki Med Sch, Dept Pharmacol, Kurashiki, Okayama 7010192, Japan; Kawasaki Med Sch, Dept Urol, Kurashiki, Okayama 7010192, Japan; Hiroshima Univ, Sch Med, Dept Pharmacol, Hiroshima 7348551, Japan; Kyoto Prefectural Univ Med, Dept Biochem & Mol Genet, Res Inst Neurol Dis & Geriatr, Hyoto 6028041, Japan	Kawasaki Medical School; Kawasaki Medical School; Hiroshima University; Kyoto Prefectural University of Medicine	Ohkuma, S (corresponding author), Kawasaki Med Sch, Dept Pharmacol, Kurashiki, Okayama 7010192, Japan.	sohkuma@bcc.kawasaki-m.ac.jp						BALFOUR DJK, 1994, ADDICTION, V89, P1419, DOI 10.1111/j.1360-0443.1994.tb03738.x; BENCHERIF M, 1995, J PHARMACOL EXP THER, V275, P987; Bonci A, 1998, J NEUROSCI, V18, P6693; BOYD ND, 1987, J PHYSIOL-LONDON, V389, P45, DOI 10.1113/jphysiol.1987.sp016646; BRENNAN CH, 1991, NEUROPHARMACOLOGY, V30, P199, DOI 10.1016/0028-3908(91)90204-O; BRISSON A, 1985, NATURE, V315, P474, DOI 10.1038/315474a0; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; CLARKE PBS, 1987, PSYCHOPHARMACOLOGY, V92, P135; CONNOLLY JG, 1989, COMP BIOCHEM PHYS A, V93, P221, DOI 10.1016/0300-9629(89)90210-7; Currie KPM, 1997, J NEUROSCI, V17, P4570; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; DIAZ A, 1995, J PHARMACOL EXP THER, V274, P1545; Fenster CP, 1999, J NEUROSCI, V19, P4804; FERRANTE J, 1989, BIOCHEM BIOPH RES CO, V158, P149, DOI 10.1016/S0006-291X(89)80190-1; FERRARESE C, 1993, PSYCHONEUROENDOCRINO, V18, P3, DOI 10.1016/0306-4530(93)90051-L; Fossier P, 1999, TRENDS NEUROSCI, V22, P161, DOI 10.1016/S0166-2236(98)01307-1; Gerstin EH, 1998, J BIOL CHEM, V273, P16409, DOI 10.1074/jbc.273.26.16409; Gopalakrishnan M, 1997, MOL PHARMACOL, V52, P524, DOI 10.1124/mol.52.3.524; Hsu YN, 1996, J NEUROCHEM, V66, P667; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; KADOUS A, 1994, J ENVIRON SCI HEAL B, V29, P855, DOI 10.1080/03601239409372907; Katsura M, 1998, MOL BRAIN RES, V55, P345, DOI 10.1016/S0169-328X(98)00019-9; KATSURA M, 1994, NEUROSCI LETT, V168, P1, DOI 10.1016/0304-3940(94)90401-4; Katsura M, 2000, MOL BRAIN RES, V80, P132, DOI 10.1016/S0169-328X(00)00119-4; Ke L, 1998, J PHARMACOL EXP THER, V286, P825; Knoflach F, 1996, J NEUROSCI, V16, P6657; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert NA, 1996, J PHYSIOL-LONDON, V492, P115, DOI 10.1113/jphysiol.1996.sp021294; LITTLE HJ, 1991, PHARMACOL THERAPEUT, V50, P347, DOI 10.1016/0163-7258(91)90050-V; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUKAS RJ, 1991, J NEUROCHEM, V56, P1134, DOI 10.1111/j.1471-4159.1991.tb11403.x; LUKAS RJ, 1996, DRUG DEVELOP RES, V38, P36; MARANGOS PJ, 1982, LIFE SCI, V31, P1575, DOI 10.1016/0024-3205(82)90049-2; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; Miao H, 1998, J NEUROCHEM, V70, P752; Monjaraz E, 2000, J PHYSIOL-LONDON, V523, P45, DOI 10.1111/j.1469-7793.2000.00045.x; Mori Y, 1996, JPN J PHARMACOL, V72, P83, DOI 10.1254/jjp.72.83; NAYOR MJ, 2000, GENOMICS, V66, P324; OCHOA ELM, 1994, CELL MOL NEUROBIOL, V14, P195, DOI 10.1007/BF02088321; Ohkuma S, 1998, MOL BRAIN RES, V54, P133, DOI 10.1016/S0169-328X(97)00331-8; OHKUMA S, 1986, INT J DEV NEUROSCI, V4, P383, DOI 10.1016/0736-5748(86)90056-0; PENG X, 1994, MOL PHARMACOL, V46, P523; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; Protti DA, 1998, J NEUROSCI, V18, P3715; REYNOLDS IJ, 1983, EUR J PHARMACOL, V95, P319, DOI 10.1016/0014-2999(83)90655-6; Robidoux J, 2000, J CLIN ENDOCR METAB, V85, P3356, DOI 10.1210/jc.85.9.3356; Role L W, 1992, Curr Opin Neurobiol, V2, P254, DOI 10.1016/0959-4388(92)90112-X; Rowell PP, 1997, J NEUROCHEM, V68, P1982; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; SMALL DL, 1995, NEUROREPORT, V6, P1617, DOI 10.1097/00001756-199508000-00007; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TAREILUS E, 1995, NEUROCHEM INT, V26, P539, DOI 10.1016/0197-0186(94)00149-O; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; Toner CC, 1997, BRAIN RES, V748, P85, DOI 10.1016/S0006-8993(96)01247-4; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; Vizi ES, 1999, BRAIN RES REV, V30, P219, DOI 10.1016/S0165-0173(99)00016-8; Warpman U, 1998, J NEUROCHEM, V70, P2028; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WONNACOTT S, 1990, TRENDS PHARMACOL SCI, V11, P216, DOI 10.1016/0165-6147(90)90242-Z; Xu YF, 1998, J NEUROPHYSIOL, V80, P1056, DOI 10.1152/jn.1998.80.3.1056; ZHANG X, 1993, N-S ARCH PHARMACOL, V348, P28, DOI 10.1007/BF00168533	62	34	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7979	7988		10.1074/jbc.M109466200	http://dx.doi.org/10.1074/jbc.M109466200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756415	hybrid			2022-12-27	WOS:000174268000046
J	Onodera, S; Nishihira, J; Iwabuchi, K; Koyama, Y; Yoshida, K; Tanaka, S; Minami, A				Onodera, S; Nishihira, J; Iwabuchi, K; Koyama, Y; Yoshida, K; Tanaka, S; Minami, A			Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and-13 in rat osteoblasts - Relevance to intracellular signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTITIAL COLLAGENASE EXPRESSION; PARATHYROID-HORMONE; C-JUN; FACTOR MIF; MATRIX METALLOPROTEINASES; MOLECULAR-CLONING; PROMOTER ACTIVITY; TYROSINE KINASES; TISSUE INHIBITOR; GENE-EXPRESSION	Neutral matrix metalloproteinases (MMPs) play an important role in bone matrix degradation accompanied by bone remodeling. We herein show for the first time that macrophage migration inhibitory factor (MIF) up-regulates MMP-13 (collagenase-3) mRNA of rat calvaria. derived osteoblasts. The mRNA up-regulation was seen at 3 h in response to MIF (10 mug/ml), reached the maximum level at 6-12 h, and returned to the basal level at 36 h. MMP-13 mRNA up-regulation was preceded by up-regulation of c-jun and C-fos mRNA. Tissue inhibitor of metalloproteinase (TIMP)-1 and MMP-9 (92-kDa type IV collagenase) were also up-regulated, but to a lesser extent. The MMP-13 mRNA up-regulation was significantly suppressed by genistein, herbimycin A and 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine. Similarly, a selective mitogen-activated protein kinase (MAPK) kinase (MEK)1/2 inhibitor (PD98059) and c-jun/activator protein (AP)-1 inhibitor (curcumin) suppressed MMP-13 mRNA up-regulation induced by MIF. The mRNA levels of c-jun and c-fos in response to MIF were also inhibited by PD98059. Consistent with these results, MIF stimulated phosphorylation of tyrosine, autophosphorylation of Src, activation of Ras, activation of extracellular signal-regulated kinases (ERK) 1/2, a MAPK, but not c-Jun N-terminal kinase or p38, and phosphorylation of c-Jun. Osteoblasts obtained from calvariae of newborn JunAA mice, defective in phosphorylation of c-Jun, or newborn c-Fos knockout (Fos-/-) mice, showed much less induction of MMP-13 with the addition of MIF than osteoblasts obtained from wild-type or littermate control mice. Taken together, these results suggest that MIF increases the MMP-13 mRNA level of rat osteoblasts via the Src-related tyrosine kinase-, Ras-, ERK1/2-, and AP-1-dependent pathway.	Hokkaido Univ, Grad Sch Med, Dept Orthopaed, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Grad Sch Med, Cent Res Inst, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Grad Sch Med, Dept Biochem, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Div Immunobiol, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 1130033, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; University of Tokyo	Nishihira, J (corresponding author), Hokkaido Univ, Sch Med, Cent Res Inst, Sapporo, Hokkaido 0608638, Japan.	j_nisihi@med.hokudai.ac.jp	Tanaka, Shinya/D-3586-2011; Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414				Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Bucala Richard, 1996, Cytokine and Growth Factor Reviews, V7, P19, DOI 10.1016/1359-6101(96)00008-1; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CHAMBERS TJ, 1985, J CELL SCI, V76, P155; CIVITELLI R, 1989, ENDOCRINOLOGY, V124, P2928, DOI 10.1210/endo-124-6-2928; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Delany AM, 1996, ENDOCRINOLOGY, V137, P4665, DOI 10.1210/en.137.11.4665; DELANY AM, 1995, J BIOL CHEM, V270, P26607, DOI 10.1074/jbc.270.44.26607; EDWARDS DR, 1992, BIOCHIM BIOPHYS ACTA, V1171, P41, DOI 10.1016/0167-4781(92)90138-P; EVERTS V, 1993, BONE MINER, V22, P43, DOI 10.1016/S0169-6009(08)80080-3; Franchimont N, 1997, J BIOL CHEM, V272, P12144, DOI 10.1074/jbc.272.18.12144; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Gazzerro E, 1999, ENDOCRINOLOGY, V140, P562, DOI 10.1210/en.140.2.562; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Iwabuchi K, 1997, EUR J IMMUNOL, V27, P742, DOI 10.1002/eji.1830270324; Kadono Y, 1998, CANCER RES, V58, P2240; KAHN AJ, 1987, AM J OTOLARYNG, V8, P258, DOI 10.1016/S0196-0709(87)80044-3; KASUGA M, 1985, METHOD ENZYMOL, V109, P609; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Matrisian L.M., 1990, Current Topics in Developmental Biology, V24, P219, DOI 10.1016/S0070-2153(08)60089-7; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; Meyer-Siegler K, 2000, CYTOKINE, V12, P914, DOI 10.1006/cyto.2000.0682; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Miyazaki T, 2000, J BONE MINER RES, V15, P41, DOI 10.1359/jbmr.2000.15.1.41; Mizue Y, 2000, INT J MOL MED, V5, P397; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; NISHIHIRA J, 1995, BBA-PROTEIN STRUCT M, V1247, P159, DOI 10.1016/0167-4838(94)00215-3; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; Onodera S, 1996, IMMUNOLOGY, V89, P430, DOI 10.1046/j.1365-2567.1996.d01-751.x; PARTRIDGE NC, 1987, ENDOCRINOLOGY, V120, P1956, DOI 10.1210/endo-120-5-1956; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; QUINN CO, 1990, J BIOL CHEM, V265, P22342; Rydziel S, 1997, J CELL BIOCHEM, V67, P176, DOI 10.1002/(SICI)1097-4644(19971101)67:2<176::AID-JCB3>3.0.CO;2-U; Rydziel S, 1997, J CELL PHYSIOL, V170, P145, DOI 10.1002/(SICI)1097-4652(199702)170:2<145::AID-JCP6>3.0.CO;2-O; Rydziel S, 2000, J CELL PHYSIOL, V184, P326, DOI 10.1002/1097-4652(200009)184:3<326::AID-JCP6>3.0.CO;2-S; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; UEHARA Y, 1991, METHOD ENZYMOL, V201, P370; Varghese S, 1996, ENDOCRINOLOGY, V137, P431, DOI 10.1210/en.137.2.431; VARGHESE S, 1994, ENDOCRINOLOGY, V134, P2438, DOI 10.1210/en.134.6.2438; VARGHESE S, 1995, ENDOCRINOLOGY, V136, P2156, DOI 10.1210/en.136.5.2156; Varghese S, 2000, ENDOCRINOLOGY, V141, P2185, DOI 10.1210/en.141.6.2185; VARGHESE S, 1999, AM J PHYSIOL, V276, P465; Vincenti MP, 1996, ARTHRITIS RHEUM-US, V39, P574, DOI 10.1002/art.1780390406; Vincenti MP, 1998, MOL CARCINOGEN, V21, P194, DOI 10.1002/(SICI)1098-2744(199803)21:3<194::AID-MC7>3.0.CO;2-M; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; WOLFE GC, 1993, ARTHRITIS RHEUM-US, V36, P1540, DOI 10.1002/art.1780361108; WONG G, 1974, NATURE, V252, P713, DOI 10.1038/252713a0; Zhao WG, 1999, J CLIN INVEST, V103, P517, DOI 10.1172/JCI5481	62	140	151	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7865	7874		10.1074/jbc.M106020200	http://dx.doi.org/10.1074/jbc.M106020200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751895	hybrid			2022-12-27	WOS:000174268000032
J	Watanabe, E; Shimada, T; Kuroyanagi, M; Nishimura, M; Hara-Nishimura, I				Watanabe, E; Shimada, T; Kuroyanagi, M; Nishimura, M; Hara-Nishimura, I			Calcium-mediated association of a putative vacuolar sorting receptor PV72 with a propeptide of 2S albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STORAGE VACUOLES; PROCESSING ENZYME; INTRACELLULAR-TRANSPORT; MEMBRANE-PROTEIN; GOLGI-APPARATUS; 11S GLOBULIN; PLANT-CELLS; PRECURSOR; DOMAIN; BIOSYNTHESIS	PV72, a type I membrane protein with three epidermal-growth factor (EGF)-like motifs, was found to be localized on the membranes of the precursor-accumulating (PAC) vesicles that accumulated precursors of various seed storage proteins. To clarify the function of PV72 as a sorting receptor, we expressed four modified PV72s and analyzed their ability to bind the internal propeptide (the 2S-I peptide) of pro2S albumin by affinity chromatography and surface plasmon resonance. The recombinant PV72 specifically bound to the 2S.I peptide with a K-D value of 0.2 mum, which was low enough for it to function as a receptor. The EGF-like motifs modulated the Ca2+-dependent, conformational change of PV72 to form a functional pocket for the ligand binding. The binding of Ca2+ stabilizes the receptor-ligand complex even at pH 4.0. The association and dissociation of PV72 with the ligand is modulated by the Ca2+ concentration (EC50 value = 40 mum) rather than the environmental pH. Overall results suggest that Ca2+ regulates the vacuolar sorting mechanism in higher plants.	Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Life Sci, Dept Mol Biomech, Okazaki, Aichi 444, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Hara-Nishimura, I (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp		Nishimura, Mikio/0000-0001-7960-9721; Kuroyanagi, Miwa/0000-0003-4362-8415				Ahmed SU, 2000, J CELL BIOL, V149, P1335, DOI 10.1083/jcb.149.7.1335; Ahmed SU, 1997, PLANT PHYSIOL, V114, P325, DOI 10.1104/pp.114.1.325; CAO X, 2002, PLANT CELL, V12, P493; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Dirlam-Schatz KA, 1998, J LIPID RES, V39, P402; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; FUKASAWA T, 1988, PLANT CELL PHYSIOL, V29, P339; Hara-Nishimura I, 1998, PLANT CELL, V10, P825, DOI 10.1105/tpc.10.5.825; Hara-Nishimura I, 1998, J PLANT PHYSIOL, V152, P668, DOI 10.1016/S0176-1617(98)80028-X; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; HARANISHIMURA I, 1987, PLANT PHYSIOL, V85, P440, DOI 10.1104/pp.85.2.440; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; HARANISHIMURA I, 1995, J PLANT PHYSIOL, V145, P632, DOI 10.1016/S0176-1617(11)81275-7; HARANISHIMURA I, 1985, PLANT PHYSIOL, V77, P747, DOI 10.1104/pp.77.3.747; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; Hayashi H, 1999, J BIOL CHEM, V274, P12715, DOI 10.1074/jbc.274.18.12715; Hinz G, 1999, PLANT CELL, V11, P1509, DOI 10.1105/tpc.11.8.1509; HOH B, 1995, J CELL SCI, V108, P299; Hohl I, 1996, J CELL SCI, V109, P2539; Humair D, 2001, PLANT CELL, V13, P781, DOI 10.1105/tpc.13.4.781; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kirsch T, 1996, PLANT PHYSIOL, V111, P469, DOI 10.1104/pp.111.2.469; KIRSCH T, 1994, P NATL ACAD SCI USA, V91, P3403, DOI 10.1073/pnas.91.8.3403; Luo XM, 2001, TRENDS BIOCHEM SCI, V26, P147, DOI 10.1016/S0968-0004(00)01768-0; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Mitsuhashi N, 2000, PLANT CELL PHYSIOL, V41, P993, DOI 10.1093/pcp/pcd040; Montero M, 1997, J CELL BIOL, V139, P601, DOI 10.1083/jcb.139.3.601; Paris N, 1996, CELL, V85, P563, DOI 10.1016/S0092-8674(00)81256-8; Paris N, 1997, PLANT PHYSIOL, V115, P29, DOI 10.1104/pp.115.1.29; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Sanderfoot AA, 1998, P NATL ACAD SCI USA, V95, P9920, DOI 10.1073/pnas.95.17.9920; Schmid FX., 1989, SPECTRAL METHODS CHA, P251; Shimada T, 1997, PLANT CELL PHYSIOL, V38, P1414, DOI 10.1093/oxfordjournals.pcp.a029138; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563	38	56	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8708	8715		10.1074/jbc.M109346200	http://dx.doi.org/10.1074/jbc.M109346200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11748226	hybrid			2022-12-27	WOS:000174268000137
J	Hayakawa, M; Sakashita, E; Ueno, E; Tominaga, S; Hamamoto, T; Kagawa, Y; Endo, H				Hayakawa, M; Sakashita, E; Ueno, E; Tominaga, S; Hamamoto, T; Kagawa, Y; Endo, H			Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACT-BINDING-PROTEIN; IMMUNODEFICIENCY-VIRUS TYPE-1; T ALTERNATIVE EXON; MESSENGER-RNA; POLYPYRIMIDINE TRACT; SR-PROTEINS; PREMESSENGER RNA; REGULATORY ELEMENTS; ENHANCER; SEQUENCES	Mitochondrial ATP synthase gamma-subunit (F(1)gamma) pre-mRNA undergoes alternative splicing in a tissue- or cell type-specific manner. Exon 9 of F(1)gamma pre-mRNA is specifically excluded in heart and skeletal muscle tissues and in acid-stimulated human fibrosarcoma HT1080 cells, rhabdomyosarcoma KYM-1 cells, and mouse myoblast C2C12 cells. Recently, we found a purine-rich exonic splicing enhancer (ESE) element on exon 9 via transgenic mice bearing F(1)gamma mutant minigenes and demonstrated that this ESE functions ubiquitously with exception of muscle tissue (Ichida, M., Hakamata, Y., Hayakawa, M., Ueno E., Ikeda, U., Shimada, K., Hamamoto, T., Kagawa, Y., Endo, H. (2000) J. Biol. Chent. 275, 15992-16001). Here, we identified an exonic negative regulatory element responsible for muscle-specific exclusion of exon 9 using both in vitro and in vivo splicing systems. A supplementation assay with nuclear extracts from HeLa cells and acid-stimulated HT1080 cells was performed for an in vitro reaction of muscle-specific alternative splicing of F(1)gamma minigene and revealed that the splicing reaction between exons 8 and 9 was the key step for regulation of muscle-specific exon exclusion. Polypyrimidine tract in intron 8 requires ESE on exon 9 for constitutive splice site selection. Mutation analyses on the F(1)gammaEx8-9 minigene using a supplementation assay demonstrated that the muscle-specific negative regulatory element is positioned in the middle region of exon 9, immediately downstream from ESE. Detailed mutation analyses identified seven nucleotides (5'-AGUUCCA-3') as a negative regulatory element responsible for muscle-specific exon exclusion. This element was shown to cause exon skipping in in vivo splicing systems using acid-stimulated HT1080 cells after transient transfection of several mutant F(1)gammaEx8-9-10 minigenes. These results demonstrated that the 5'- AGUUCCA-3' immediately downstream from ESE is a muscle-specific exonic splicing silencer (MS-ESS) responsible for exclusion of exon 9 in vivo and in vitro.	Jichi Med Sch, Dept Biochem, Minami Kawachi, Tochigi 3290498, Japan; Womens Univ Nutr, Grad Sch, Sakado, Saitama 3500288, Japan	Jichi Medical University; Tokyo Women's Medical University	Endo, H (corresponding author), Jichi Med Sch, Dept Biochem, Minami Kawachi, Tochigi 3290498, Japan.			Hayakawa, Morisada/0000-0002-1869-2450				AMENDT BA, 1995, MOL CELL BIOL, V15, P4606; Ashiya M, 1997, RNA, V3, P996; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; DELGATTO F, 1995, MOL CELL BIOL, V15, P4825; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DIRKSEN WP, 1994, J BIOL CHEM, V269, P6431; ENDO H, 1994, J BIOL CHEM, V269, P12488; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Gontarek RR, 1996, MOL CELL BIOL, V16, P2325; Hayakawa M, 1998, BIOCHEM BIOPH RES CO, V251, P603, DOI 10.1006/bbrc.1998.9525; Ichida M, 1998, J BIOL CHEM, V273, P8492, DOI 10.1074/jbc.273.14.8492; Ichida M, 2000, J BIOL CHEM, V275, P15992, DOI 10.1074/jbc.275.21.15992; Kagawa Y, 1997, BIOSCIENCE REP, V17, P115, DOI 10.1023/A:1027329328504; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; LYNCH KW, 1995, GENE DEV, V9, P284, DOI 10.1101/gad.9.3.284; MATSUDA C, 1993, J BIOL CHEM, V268, P24950; MATSUDA C, 1993, FEBS LETT, V325, P281, DOI 10.1016/0014-5793(93)81089-I; MULLIGAN GJ, 1992, J BIOL CHEM, V267, P25480; NORTON PA, 1994, NUCLEIC ACIDS RES, V22, P3854, DOI 10.1093/nar/22.19.3854; PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; SUN Q, 1993, GENE DEV, V7, P2598, DOI 10.1101/gad.7.12b.2598; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; TIAN M, 1993, CELL, V74, P105, DOI 10.1016/0092-8674(93)90298-5; Wang J, 1997, CURR OPIN GENET DEV, V7, P205, DOI 10.1016/S0959-437X(97)80130-X; WANG YC, 1997, EUKARYOTIC MRNA PROC, P242; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660; YEAKLEY JM, 1993, MOL CELL BIOL, V13, P5999, DOI 10.1128/MCB.13.10.5999; Zheng ZM, 1996, J VIROL, V70, P4691, DOI 10.1128/JVI.70.7.4691-4699.1996; Zheng ZM, 1998, P NATL ACAD SCI USA, V95, P14088, DOI 10.1073/pnas.95.24.14088	45	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6974	6984		10.1074/jbc.M110138200	http://dx.doi.org/10.1074/jbc.M110138200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744705	hybrid			2022-12-27	WOS:000174104300031
J	Kishi, S; Lu, KP				Kishi, S; Lu, KP			A critical role for Pin2/TRF1 in ATM-dependent regulation - Inhibition of Pin2/TRF1 function complements telomere shortening, radiosensitivity, and the G(2)/M checkpoint defect of ataxia-telangiectasia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; IONIZING-RADIATION; SACCHAROMYCES-CEREVISIAE; CYCLE REGULATION; DEFICIENT MICE; BUDDING YEAST; C-ABL; PROTEIN; PHOSPHORYLATION; KINASE	Cells derived from patients with the human genetic disorder ataxia-telangiectasia (A-T) display many abnormalities, including telomere shortening, premature senescence, and defects in the activation of S phase and G(2)/M checkpoints in response to double-strand DNA breaks induced by ionizing radiation. We have previously demonstrated that one of the ATM substrates is Pin2/TRF1, a telomeric protein that binds the potent telomerase inhibitor PinX1, negatively regulates telomere elongation, and specifically affects mitotic progression. Following DNA damage, ATM phosphorylates Pin2/TRF1 and suppresses its ability to induce abortive mitosis and apoptosis (Kishi, S., Zhou, X Z., Nakamura, N., Ziv, Y., Khoo, C., Hill, D. E., Shiloh, Y., and Lu, K. P. (2001) J. Biol. Chem. 276, 29282-29291). However, the functional importance of Pin2/TRF1 in mediating ATM-dependent regulation remains to be established. To address this question, we directly inhibited the function of endogenous Pin2/TRF1 in A-T cells by stable expression of two different dominant-negative Pin2/TRF1 mutants and then examined their effects on telontere length and DNA damage response. Both the Pin2/TRF1 mutants increased telomere length in A-T cells, as shown in other cells. Surprisingly, both the Pin2/TRF1 mutants reduced radiosensitivity and complemented the G2/M checkpoint defect without inhibiting Cdc2 activity in A-T cells. In contrast, neither of the Pin2/TRF1 mutants corrected the S phase checkpoint defect in the same cells. These results indicate that inhibition of Pin2/TRF1 in A-T cells is able to bypass the requirement for ATM in specifically restoring telomere shortening, the G2/M checkpoint defect, and radiosensitivity and demonstrate a critical role for Pin2/TRF1 in the ATM-dependent regulation of telomeres and DNA damage response.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lu, KP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Canc Biol Program, HIM 1047,330 Brookline Ave, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058556, R01GM056230] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 58556, R01 GM 56230] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahmad K, 1999, GENETICS, V151, P1041; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Beamish H, 1996, J BIOL CHEM, V271, P20486, DOI 10.1074/jbc.271.34.20486; BEAMISH H, 1994, RADIAT RES, V138, pS130, DOI 10.2307/3578780; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan SWL, 2001, CURR BIOL, V11, P1240, DOI 10.1016/S0960-9822(01)00391-8; Chen P, 1999, ONCOGENE, V18, P249, DOI 10.1038/sj.onc.1202257; CHEN PC, 1978, NATURE, V274, P484, DOI 10.1038/274484a0; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Fritz E, 2000, MOL BIOL CELL, V11, P2605, DOI 10.1091/mbc.11.8.2605; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; GOTOFF SP, 1967, AM J DIS CHILD, V114, P617, DOI 10.1001/archpedi.1967.02090270073006; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HOULDSWORTH J, 1980, NUCLEIC ACIDS RES, V8, P3709, DOI 10.1093/nar/8.16.3709; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Kishi S, 2001, ONCOGENE, V20, P1497, DOI 10.1038/sj.onc.1204229; Kishi S, 2001, J BIOL CHEM, V276, P29282, DOI 10.1074/jbc.M011534200; KLINGELHUTZ AJ, 1994, MOL CELL BIOL, V14, P961, DOI 10.1128/MCB.14.2.961; KONIG K, 1980, RADIAT ENVIRON BIOPH, V18, P257, DOI 10.1007/BF01324268; Lakin ND, 1996, ONCOGENE, V13, P2707; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LEEPER DB, 1972, RADIAT RES, V50, P401, DOI 10.2307/3573498; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lu K P, 2000, Prog Cell Cycle Res, V4, P83; Lu KP, 1996, NATURE, V380, P544; LU KP, 1995, CELL, V81, P413, DOI 10.1016/0092-8674(95)90394-1; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; MORGAN JL, 1968, AM J DIS CHILD, V116, P557, DOI 10.1001/archpedi.1968.02100020561022; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PANDITA TK, 1995, CYTOGENET CELL GENET, V71, P86, DOI 10.1159/000134069; PAULES RS, 1995, CANCER RES, V55, P1763; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; RUDOLPH NS, 1989, MUTAT RES, V211, P31, DOI 10.1016/0027-5107(89)90104-8; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Smilenov LB, 1997, ONCOGENE, V15, P2659, DOI 10.1038/sj.onc.1201449; Smilenov LB, 1999, MOL CELL BIOL, V19, P6963; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; WEINERT TA, 1990, MOL CELL BIOL, V10, P6554, DOI 10.1128/MCB.10.12.6554; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Wood LD, 2001, ONCOGENE, V20, P278, DOI 10.1038/sj.onc.1204072; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Xia SJJ, 1996, MUTAT RES-DNA REPAIR, V364, P1, DOI 10.1016/0921-8777(96)00015-8; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Young AC, 1997, SOMAT CELL MOLEC GEN, V23, P275, DOI 10.1007/BF02674418; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; ZIV Y, 1989, CANCER RES, V49, P2495; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319; ZIV Y, 1995, SOMAT CELL MOLEC GEN, V21, P99, DOI 10.1007/BF02255785	76	57	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7420	7429		10.1074/jbc.M111365200	http://dx.doi.org/10.1074/jbc.M111365200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744712	hybrid			2022-12-27	WOS:000174104300087
J	Pind, S; Slominski, E; Mauthe, J; Pearlman, K; Swoboda, KJ; Wilkins, JA; Sauder, P; Natowicz, MR				Pind, S; Slominski, E; Mauthe, J; Pearlman, K; Swoboda, KJ; Wilkins, JA; Sauder, P; Natowicz, MR			V490M, a common mutation in 3-phosphoglycerate dehydrogenase deficiency, causes enzyme deficiency by decreasing the yield of mature enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; L-SERINE; D-3-PHOSPHOGLYCERATE DEHYDROGENASE; AMINO-ACIDS; D-ASPARTATE; HIPPOCAMPAL-NEURONS; DOMAIN INTERFACE; BIOSYNTHESIS; EXPRESSION; GLYCINE	A deficiency of 3-phosphoglycerate dehydrogenase (PHGDH) is a disorder of serine biosynthesis identified in children with congenital microcephaly, seizures, and severe psychomotor retardation. We report here the identification of the 1468G-->A (V490M) mutation of this gene in two siblings of an Ashkenazi Jewish family, providing further evidence that the V490M mutation is a common, panethnic cause of this deficiency. Using a novel, DNA-based diagnostic test, the mutation was not detected in 400 non-Jewish controls; one heterozygote was found among 400 persons of Ashkenazi Jewish ethnicity. Extensive biochemical studies were undertaken to characterize the effect of this mutation on enzyme activity, turnover, and stability. The V490M PHGDH yielded less than 35% of the activity observed for the wild-type enzyme when overexpressed by transient transfection or when comparing the endogenous activity in fibroblast cells from the patients with controls. Immunoblotting studies showed a comparable reduction in the level of immunoreactive PHGDH in cells expressing the mutant enzyme. Pulse-chase experiments with metabolically labeled PHGDH indicated that this resulted from an increased rate of degradation of the mutant enzyme following its synthesis. Thermolability analyses of mutant and wild-type enzyme activity revealed no significant differences. While others have proposed that the V490M mutation decreases the V-max of the enzyme, we conclude that this mutation impairs the folding and/or assembly of PHGDH but has minimal effects on the activity or stability of that portion of the V490M mutant that reaches a mature conformation.	Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Internal Med, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0W3, Canada; Eunice Kennedy Shriver Ctr Mental Retardat Inc, Div Med Genet, Waltham, MA 02452 USA; Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84132 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Manitoba; University of Manitoba; University of Manitoba; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Pind, S (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 0W3, Canada.			Swoboda, Kathryn/0000-0002-4593-6342				Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; AlRabiee R, 1996, J BIOL CHEM, V271, P13013, DOI 10.1074/jbc.271.22.13013; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Baek JY, 2000, CYTOGENET CELL GENET, V89, P6, DOI 10.1159/000015577; CHASIN LA, 1974, P NATL ACAD SCI USA, V71, P718, DOI 10.1073/pnas.71.3.718; Cho HM, 2000, GENE, V245, P193, DOI 10.1016/S0378-1119(00)00009-3; COTTEN M, 1993, METHOD ENZYMOL, V217, P618; de Koning TJ, 1999, NEUROPEDIATRICS, V30, P1, DOI 10.1055/s-2007-973447; de Koning TJ, 1998, ANN NEUROL, V44, P261, DOI 10.1002/ana.410440219; de Koning TJ, 2000, NEUROPEDIATRICS, V31, P287, DOI 10.1055/s-2000-12944; Dobson CM, 2001, BIOCHEM SOC SYMP, V68, P1; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Grant GA, 2000, BIOCHEMISTRY-US, V39, P7316, DOI 10.1021/bi000218y; Grant GA, 1996, PROTEIN SCI, V5, P34; GRANT GA, 1981, BIOSCIENCE REP, V1, P733, DOI 10.1007/BF01116472; Grant GA, 1998, J BIOL CHEM, V273, P22389, DOI 10.1074/jbc.273.35.22389; Gregersen N, 2001, J INHERIT METAB DIS, V24, P189, DOI 10.1023/A:1010319001722; Gressens P, 2000, PEDIATR RES, V48, P725, DOI 10.1203/00006450-200012000-00004; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; Ho CL, 1999, J BIOL CHEM, V274, P397, DOI 10.1074/jbc.274.1.397; Jaeken J, 1996, ARCH DIS CHILD, V74, P542, DOI 10.1136/adc.74.6.542; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; KOLODNY EH, 1976, CLIN CHIM ACTA, V70, P247, DOI 10.1016/0009-8981(76)90426-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; Mitoma J, 1998, J BIOL CHEM, V273, P19363, DOI 10.1074/jbc.273.31.19363; Mitoma J, 1998, NEUROSCI RES, V30, P195, DOI 10.1016/S0168-0102(97)00113-2; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Narkewicz MR, 1996, BIOCHEM J, V313, P991, DOI 10.1042/bj3130991; OLDENDORF WH, 1976, AM J PHYSIOL, V230, P94, DOI 10.1152/ajplegacy.1976.230.1.94; Pineda M, 2000, DEV MED CHILD NEUROL, V42, P629, DOI 10.1017/S0012162200001171; SAVOCA R, 1995, J NEUROSCI METH, V61, P159, DOI 10.1016/0165-0270(95)00038-V; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; SNELL K, 1986, TRENDS BIOCHEM SCI, V11, P241, DOI 10.1016/0968-0004(86)90184-2; Snyder SH, 2000, AM J PSYCHIAT, V157, P1738, DOI 10.1176/appi.ajp.157.11.1738; Snyder SH, 2000, NEUROCHEM RES, V25, P553, DOI 10.1023/A:1007586314648; STUPACK DG, 1991, SCAND J IMMUNOL, V34, P761, DOI 10.1111/j.1365-3083.1991.tb01601.x; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Verleysdonk S, 2000, GLIA, V30, P19, DOI 10.1002/(SICI)1098-1136(200003)30:1<19::AID-GLIA3>3.0.CO;2-3; Waters P J, 2001, Curr Issues Mol Biol, V3, P57; WILLIAMSON R, 1981, LANCET, V2, P1125; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Yamasaki M, 2001, J NEUROSCI, V21, P7691, DOI 10.1523/JNEUROSCI.21-19-07691.2001	50	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7136	7143		10.1074/jbc.M111419200	http://dx.doi.org/10.1074/jbc.M111419200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751922	hybrid			2022-12-27	WOS:000174104300050
J	Rosemond, E; Peltekova, V; Naples, M; Thogersen, H; Hampson, DR				Rosemond, E; Peltekova, V; Naples, M; Thogersen, H; Hampson, DR			Molecular determinants of high affinity binding to group III metabotropic glutamate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL DOMAINS; L-PHOSPHOSERINE; MGLUR4 SUBTYPE; L-2-AMINO-4-PHOSPHONOBUTYRATE; SELECTIVITY; PERFORMANCE; ACTIVATION; AGONIST	The amino-terminal domain containing the ligand binding site of the G protein-coupled metabotropic glutamate receptors (mGluRs) consists of two lobes that close upon agonist binding. In this study, we explored the ligand binding pocket of the Group III mGluR4 receptor subtype using site-directed mutagenesis and radioligand binding. The selection of 16 mutations was guided by a molecular model of mGluR4, which was based on the crystal structure of the mGluR1 receptor. Lysines 74 and 405 are present on lobe I of mGluR4. The mutation of lysine 405 to alanine virtually eliminated the binding of the agonist [H-3]L-amino-4-phosphonobutyrate ([H-3]L-AP4). Thus lysine 405, which is conserved in all eight mGluRs, likely represents a fundamental recognition residue for ligand binding to the mGluRs. Single point mutations of lysines 74 or 317, which are not conserved in the mGluRs, to alanine had no effect on agonist affinity, whereas mutation of both residues together caused a loss of ligand binding. Mutation of lysine 74 in mGluR4, or the analogous lysine in mGluR8, to tyrosine (mimicking mGluR1 at this position) produced a large decrease in binding. The reduction in binding is likely due to steric hindrance of the phenolic side chain of tyrosine. The mutation of glutamate 287 to alanine, which is present on lobe II and is not conserved in the mGluR family, caused a loss of [H-3]L-AP4 binding. We conclude that the determinants of high affinity ligand binding are dispersed across lobes I and II. Our results define a microenvironment within the binding pocket that encompasses several positively charged amino acids that recognize the negatively charged phosphonate group Of L-AP4 or the endogenous compound L-serine-O-phosphate.	Univ Toronto, Dept Pharmaceut Sci, Toronto, ON M5S 2S2, Canada; Univ Toronto, Inst Drug Res, Toronto, ON M5S 2S2, Canada; Novo Nordisk AS, Dept Med Chem, DK-2760 Malov, Denmark	University of Toronto; University of Toronto; Novo Nordisk	Hampson, DR (corresponding author), Univ Toronto, Dept Pharmaceut Sci, 19 Russell St, Toronto, ON M5S 2S2, Canada.							AbdulGhani AS, 1997, BRAIN RES, V755, P202, DOI 10.1016/S0006-8993(97)00098-X; Bessis AS, 2000, PROTEIN SCI, V9, P2200, DOI 10.1110/ps.9.11.2200; Bhave G, 2001, NAT NEUROSCI, V4, P417, DOI 10.1038/86075; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; Bruno V, 2000, J NEUROSCI, V20, P6413, DOI 10.1523/JNEUROSCI.20-17-06413.2000; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Costantino G, 1999, J MED CHEM, V42, P5390, DOI 10.1021/jm990353c; Eriksen L, 1995, BRIT J PHARMACOL, V116, P3279, DOI 10.1111/j.1476-5381.1995.tb15136.x; Gasparini F, 1999, J PHARMACOL EXP THER, V289, P1678; GOODNOUGH DB, 1995, J CHROMATOGR B, V672, P290, DOI 10.1016/0378-4347(95)00221-4; Hampson DR, 1999, J BIOL CHEM, V274, P33488, DOI 10.1074/jbc.274.47.33488; Han GM, 1999, J BIOL CHEM, V274, P10008, DOI 10.1074/jbc.274.15.10008; Jensen AA, 2000, EUR J PHARMACOL, V397, P247, DOI 10.1016/S0014-2999(00)00283-1; KLUNK WE, 1991, J NEUROCHEM, V56, P1997, DOI 10.1111/j.1471-4159.1991.tb03458.x; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Naples MA, 2001, NEUROPHARMACOLOGY, V40, P170, DOI 10.1016/S0028-3908(00)00128-3; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Pekhletski R, 1996, J NEUROSCI, V16, P6364; Peltekova V, 2000, MOL BRAIN RES, V76, P180, DOI 10.1016/S0169-328X(00)00029-2; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; RISSOBRADLEY S, 1999, J COMP NEUROL, V407, P33; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Tang E, 1997, EUR J PHARMACOL, V327, P109, DOI 10.1016/S0014-2999(97)89649-5; Thomsen C, 1997, NEUROPHARMACOLOGY, V36, P21, DOI 10.1016/S0028-3908(96)00153-0; Walker K, 2001, NEUROPHARMACOLOGY, V40, P1, DOI 10.1016/S0028-3908(00)00113-1; Yip PK, 2001, J NEUROCHEM, V78, P13, DOI 10.1046/j.1471-4159.2001.00418.x	31	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7333	7340		10.1074/jbc.M110476200	http://dx.doi.org/10.1074/jbc.M110476200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744707	hybrid			2022-12-27	WOS:000174104300076
J	Yamaguchi, N; Okui, A; Yamada, T; Nakazato, H; Mitsui, S				Yamaguchi, N; Okui, A; Yamada, T; Nakazato, H; Mitsui, S			Spinesin/TMPRSS5, a novel transmembrane serine protease, cloned from human spinal cord	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CDNA; BRAIN; EXPRESSION; CELLS; LOCALIZATION; ENTEROKINASE; MATRIPTASE; ACTIVATOR; PROSTATE	A cDNA encoding a novel serine protease, which we designated spinesin, has been cloned from human spinal cord. The longest open reading frame was 457 amino acids. A homology search revealed that the human spinesin gene was located at chromosome 11q23 and contained 13 exons, the gene structure being similar to that of TMPRSS3 whose gene is also located on 11q23. Spinesin has a simple type 11 transmembrane structure, consisting of, from the N terminus, a short cytoplasmic domain, a transmembrane domain, a stem region containing a scavenger receptor-like domain, and a serine protease domain. Unlike TMPRSS3, it carries no low density lipoprotein receptor domain in the stem region. The extracellular region carries five N-glycosylation sites. The sequence of the protease domain carried the essential triad His, Asp, and Ser and showed some similarity to that of TMPRSS2, hepsin, HAT, MT-SP1, TMPRSS3, and corin, sharing 45.5, 41.9, 41.3, 40.3, 39.1, and 38.5% identity, respectively. The putative mature protease domain preceded by H6DDDDK was produced in Escherichia coli, purified, and successfully activated by immobilized enterokinase. Its optimal pH was about 10. It cleaved synthetic substrates for trypsin, which is inhibited by p-amidinophenylmethanesulfonyl fluoride hydrochloride but not by antipain or leupeptin. Northern blot analysis against mRNA from human tissues including liver, lung, placenta, and heart demonstrated a specific expression of spinesin mRNA in the brain. Immunohistochemically, spinesin was predominantly expressed in neurons, in their axons, and at the synapses of motoneurons in the spinal cord. In addition, some oligodendrocytes were clearly stained. These results indicate that spinesin is transported to the synapses through the axons after its synthesis in the cytoplasm and may play important roles at the synapses. Further analyses are required to clarify its roles at the synapses and in oligodendrocytes.	Kyoto Prefectural Univ Med, Res Inst Neurol Dis & Geriatr, Dept Cell Biol, Kyoto 6028566, Japan; Fuso Pharmaceut Co, Ctr Res & Dev, Joto Ku, Osaka 5368523, Japan; Fukuoka Univ, Dept Internal Med & Hlth Care, Hakata 8140180, Japan; Ctr Appl Toxicol, BR-05503900 Sao Paulo, SP, Brazil	Kyoto Prefectural University of Medicine; Fuso Pharmaceutical Industries, Ltd.; Fukuoka University	Yamaguchi, N (corresponding author), Kyoto Prefectural Univ Med, Res Inst Neurol Dis & Geriatr, Dept Cell Biol, Kyoto 6028566, Japan.							Goldstein LA, 1997, BBA-MOL BASIS DIS, V1361, P11, DOI 10.1016/S0925-4439(97)00032-X; HOOP TP, 1983, MOL IMMUNOL, V20, P483; Hooper JD, 2000, EUR J BIOCHEM, V267, P6931, DOI 10.1046/j.1432-1327.2000.01806.x; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Iijima N, 1999, MOL BRAIN RES, V66, P141, DOI 10.1016/S0169-328X(99)00008-X; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; KITAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P4562, DOI 10.1021/bi00014a008; LAVALLIE ER, 1993, J BIOL CHEM, V268, P23311; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; LEYTUS SP, 1988, BIOCHEMISTRY-US, V27, P1067, DOI 10.1021/bi00403a032; Lin BY, 1999, CANCER RES, V59, P4180; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Mitsui S, 1999, EUR J BIOCHEM, V260, P627, DOI 10.1046/j.1432-1327.1999.00213.x; Mitsui S, 2000, BIOCHEM BIOPH RES CO, V272, P205, DOI 10.1006/bbrc.2000.2761; Mitsui S, 2000, BBA-GENE STRUCT EXPR, V1494, P206, DOI 10.1016/S0167-4781(00)00206-2; PaoloniGiacobino A, 1997, GENOMICS, V44, P309, DOI 10.1006/geno.1997.4845; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Tanimoto H, 2001, TUMOR BIOL, V22, P104, DOI 10.1159/000050604; Underwood LJ, 2000, BBA-MOL BASIS DIS, V1502, P337, DOI 10.1016/S0925-4439(00)00058-2; Wallrapp C, 2000, CANCER RES, V60, P2602; Yamamura Y, 1997, BIOCHEM BIOPH RES CO, V239, P386, DOI 10.1006/bbrc.1997.7417; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; YAMASHIRO K, 1997, BIOCHIM BIOPHYS ACTA, V1352, P11; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097	25	46	49	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6806	6812		10.1074/jbc.M103645200	http://dx.doi.org/10.1074/jbc.M103645200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741986	hybrid			2022-12-27	WOS:000174104300009
J	Colige, A; Vandenberghe, I; Thiry, M; Lambert, CA; Van Beeumen, J; Li, SW; Prockop, DJ; Lapiere, CM; Nusgens, BV				Colige, A; Vandenberghe, I; Thiry, M; Lambert, CA; Van Beeumen, J; Li, SW; Prockop, DJ; Lapiere, CM; Nusgens, BV			Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I N-PROTEINASE; PROCOLLAGEN; COLLAGEN; FAMILY; METALLOPROTEINASES; FIBROBLASTS; PROTEOGLYCAN; ORGANIZATION; AGGRECANASE; EXPRESSION	The processing of amino- and carboxyl-propeptides of fibrillar collagens is required to generate collagen monomers that correctly assemble into fibrils. Mutations in the ADAMTS2 gene, the aminopropeptidase of procollagen I and II, result in the accumulation of non-fully processed type I procollagen, causing human Ehlers-Danlos syndrome type VIIC and animal dermatosparaxis. In this study, we show that the aminopropeptide of type I procollagen can be cleaved in vivo in absence of ADAMTS-2 activity and that this processing is performed at the cleavage site for ADAMTS-2. In an attempt to identify the enzyme responsible for this alternative aminoprocollagen peptidase activity, we have cloned the cDNA and determined the primary structure of human and mouse ADAMTS-14, a novel ADAMTS displaying striking homologies with ADAMTS-2 and -3. The structure of the human gene, which maps to 10q21.3, and the mechanisms of generation of the various transcripts are described. The existence of two sites of initiation of transcription, in two different promoter contexts, suggests that transcripts resulting from these two sites can be differently regulated. The tissue distribution of ADAMTS-14, the regulation of the gene expression by various cytokines and the activity of the recombinant enzyme are evaluated. The potential function of ADAMTS-14 as a physiological aminoprocollagen peptidase in vivo is discussed.	Univ Liege, Lab Connect Tissues Biol, B-4000 Liege, Belgium; Univ Liege, Expt Cancerol Res Ctr, B-4000 Liege, Belgium; Univ Ghent, Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium; Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70112 USA; Univ Liege, Lab Biol Cellulaire & Tissulaire, B-4020 Liege, Belgium	University of Liege; University of Liege; Ghent University; Tulane University; University of Liege	Nusgens, BV (corresponding author), Univ Liege, Lab Connect Tissues Biol, Tour Pathol B23-3, B-4000 Liege, Belgium.	LCTB@ulg.ac.be						Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; BATEMAN JF, 1990, BIOCHEM J, V267, P573, DOI 10.1042/bj2670573; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Cal S, 2001, J BIOL CHEM, V276, P17932, DOI 10.1074/jbc.M100534200; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Colige A, 1997, P NATL ACAD SCI USA, V94, P2374, DOI 10.1073/pnas.94.6.2374; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; COLIGE AC, 1992, BIOCHEM J, V285, P215, DOI 10.1042/bj2850215; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Flannery CR, 2000, MATRIX BIOL, V19, P549, DOI 10.1016/S0945-053X(00)00111-6; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krane SM, 1996, J BIOL CHEM, V271, P28509, DOI 10.1074/jbc.271.45.28509; Kuno K, 1997, GENOMICS, V46, P466, DOI 10.1006/geno.1997.5064; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Lambert CA, 1998, J BIOL CHEM, V273, P23143, DOI 10.1074/jbc.273.36.23143; Lambert CA, 2001, EUR J CELL BIOL, V80, P479, DOI 10.1078/0171-9335-00181; LAPIERE C M, 1977, Connective Tissue Research, V5, P21; LAPIERE CM, 1971, P NATL ACAD SCI USA, V68, P3054, DOI 10.1073/pnas.68.12.3054; Li SW, 2001, BIOCHEM J, V355, P271, DOI 10.1042/0264-6021:3550271; NUSGENS BV, 1992, NAT GENET, V1, P214, DOI 10.1038/ng0692-214; PIERARD GE, 1976, J INVEST DERMATOL, V66, P2, DOI 10.1111/1523-1747.ep12477969; Prockop DJ, 1998, MATRIX BIOL, V16, P399, DOI 10.1016/S0945-053X(98)90013-0; Sasaki M, 2001, MOL BRAIN RES, V89, P158, DOI 10.1016/S0169-328X(01)00046-8; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349	30	141	150	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5756	5766		10.1074/jbc.M105601200	http://dx.doi.org/10.1074/jbc.M105601200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741898	hybrid			2022-12-27	WOS:000173989200011
J	Krogh, BO; Shuman, S				Krogh, BO; Shuman, S			Proton relay mechanism of general acid catalysis by DNA topoisomerase IB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; VACCINIA TOPOISOMERASE; CRYSTAL-STRUCTURE; COVALENT; TRANSESTERIFICATION; INTEGRASE; COMPLEX	Type IB topoisomerases cleave and rejoin DNA through a DNA. (3'-phosphotyrosyl)-enzyme intermediate. A constellation of conserved amino acids (Arg-130, Lys-167, Arg-223, and His-265 in vaccinia topoisomerase) catalyzes the attack of the tyrosine nucleophile (Tyr-274) at the scissile phosphodiester. Previous studies implicated Arg-223 and His-265 in transition state stabilization and Lys-167 in proton donation to the 5'-O of the leaving DNA strand. Here we find that Arg-130 also plays a major role in leaving group expulsion. The rate of DNA cleavage by vaccinia topoisomerase mutant R130K, which was slower than wild-type topoisomerase by a factor of 10(-4.3), was stimulated 2600-fold by a 5'-bridging phosphorothiolate at the cleavage site. The catalytic defect of the R130A mutant was also rescued by the 5'-S modification (190-fold stimulation), albeit to a lesser degree than R130K. We surmise that Arg-130 plays dual roles in transition state stabilization and general acid catalysis. Whereas the R130A mutation abolishes both functions, R130K permits the transition state stabilization function (via contact of lysine with the scissile phosphate) but not the proton transfer function. Our results show that the process of general acid catalysis is complex and suggest that Lys-167 and Arg-130 comprise a proton relay from the topoisomerase to the 5'-O of the leaving DNA strand.	Sloan Kettering Inst, Mol Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Mol Biol Program, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046330, R01GM046330] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURGIN AB, 1995, NUCLEIC ACIDS RES, V15, P2973; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Cheng CH, 1997, J BIOL CHEM, V272, P8263, DOI 10.1074/jbc.272.13.8263; CHRISTIANSEN K, 1994, J BIOL CHEM, V269, P11367; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hickman AB, 1997, CELL, V89, P227, DOI 10.1016/S0092-8674(00)80202-0; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 1999, VIROLOGY, V264, P441, DOI 10.1006/viro.1999.0022; Krogh BO, 2001, J BIOL CHEM, V276, P20907, DOI 10.1074/jbc.M102312200; Kwon HJ, 1997, SCIENCE, V276, P126, DOI 10.1126/science.276.5309.126; Petersen BO, 1997, J BIOL CHEM, V272, P3891, DOI 10.1074/jbc.272.7.3891; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; SEKIGUCHI J, 1995, J BIOL CHEM, V270, P11636, DOI 10.1074/jbc.270.19.11636; SHUMAN S, 1988, J BIOL CHEM, V263, P16401; Shuman S, 1998, BBA-GENE STRUCT EXPR, V1400, P321, DOI 10.1016/S0167-4781(98)00144-4; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P15449, DOI 10.1021/bi00255a027; Stivers JT, 2000, BIOCHEMISTRY-US, V39, P5561, DOI 10.1021/bi992429c; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; WEBER DJ, 1992, PROTEINS, V13, P275, DOI 10.1002/prot.340130402; Wittschieben J, 1997, NUCLEIC ACIDS RES, V25, P3001, DOI 10.1093/nar/25.15.3001; Woods KC, 2001, J MOL BIOL, V313, P49, DOI 10.1006/jmbi.2001.5012	24	56	58	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5711	5714		10.1074/jbc.C100681200	http://dx.doi.org/10.1074/jbc.C100681200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11756402	hybrid			2022-12-27	WOS:000173989200004
J	Tobaben, S; Sudhof, TC; Stahl, B				Tobaben, S; Sudhof, TC; Stahl, B			Genetic analysis of alpha-latrotoxin receptors reveals functional interdependence of CIRL/latrophilin 1 and neurexin 1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; WIDOW SPIDER VENOM; SYNAPTIC VESICLES; SYNAPSIN-I; RELEASE; FAMILY; SYNAPTOSOMES; GLUTAMATE; CALCIUM; MEMBER	alpha-Latrotoxin triggers massive neurotransmitter release from nerve terminals by binding to at least two distinct presynaptic receptors, neurexin la and CIRL1/ latrophilinl (CL1). We have now generated knockout (KO) mice that lack CL1 and analyzed them alone or in combination with neurexin la KO mice. Mice lacking only CL1, or both CL1 and neurexin 1alpha, were viable and fertile. Ca2+-independent binding of alpha-latrotoxin to brain membranes was impaired similarly in CL1 single and in CL1/neurexin 1alpha double KO mice (similar to75% decrease) but not in neurexin 1alpha single KO mice. In contrast, Ca2+ dependent binding (similar to2 times above Ca2+-independent binding) was altered in both CL1 (similar to50% decrease) and neurexin 1alpha single KO mice (similar to25% decrease) and was decreased further in double KO mice (similar to75% decrease). Synaptosomes lacking CL1 exhibited the same decrease in alpha-latrotoxin-stimulated glutamate release in the presence and absence of Ca2+ (similar to75%). In contrast, synaptosomes lacking neurexin 1alpha exhibited only a small decrease in alpha-latrotoxin-triggered release in the absence of Ca2+ (similar to20%) but a major decrease in the presence of Ca2+ (similar to75%). Surprisingly, synaptosomes lacking both CL1 and neurexin 1alpha displayed a relatively smaller decrease in alpha-latrotoxin-stimulated glutamate release than synaptosomes lacking only CL1 in the absence of Ca2+ (similar to50 versus similar to75%), but the same decrease in the presence of Ca2+ (similar to75%). Our data suggest the following two major conclusions. 1) CL1 and neurexin 1alpha together account for the majority (75%) of alpha-latrotoxin receptors in brain, with the remaining receptor activity possibly due to other CL and neurexin isoforms, and 2) the two receptors act additively in binding alpha-latrotoxin but not in triggering release. Together these data suggest that the two receptors act autonomously in binding of alpha-latrotoxin but cooperatively in transducing the stimulation of neurotransmitter release by alpha-latrotoxin.	Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA	Max Planck Society; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Stahl, B (corresponding author), Migragen AG, Spemannstr 34, D-72076 Tubingen, Germany.	bernd.stahl@migragen.de						Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Capogna M, 1996, J NEUROPHYSIOL, V76, P3149, DOI 10.1152/jn.1996.76.5.3149; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; DAVLETOV BA, 1995, J BIOL CHEM, V270, P23903, DOI 10.1074/jbc.270.41.23903; Davletov BA, 1996, J BIOL CHEM, V271, P23239, DOI 10.1074/jbc.271.38.23239; Dulubova IE, 1996, J BIOL CHEM, V271, P7535, DOI 10.1074/jbc.271.13.7535; FRONTALI N, 1976, J CELL BIOL, V68, P462, DOI 10.1083/jcb.68.3.462; Geppert M, 1998, J BIOL CHEM, V273, P1705, DOI 10.1074/jbc.273.3.1705; Ichtchenko K, 1999, J BIOL CHEM, V274, P5491, DOI 10.1074/jbc.274.9.5491; Ichtchenko K, 1998, EMBO J, V17, P6188, DOI 10.1093/emboj/17.21.6188; Khvotchev M, 2000, EMBO J, V19, P3250, DOI 10.1093/emboj/19.13.3250; Khvotchev M, 2000, NEUROSCIENCE, V101, P793, DOI 10.1016/S0306-4522(00)00378-X; KIYATKIN N, 1993, EUR J BIOCHEM, V213, P121, DOI 10.1111/j.1432-1033.1993.tb17741.x; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; LISHKO V K, 1990, Biokhimiya, V55, P1578; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Sambrook J., 1989, IMMUNOLOGY, V2nd; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; SUDHOF TC, 1990, J BIOL CHEM, V265, P7849; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZENG MC, 1978, P NATL ACAD SCI USA, V75, P4016, DOI 10.1073/pnas.75.8.4016; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094	30	40	43	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6359	6365		10.1074/jbc.M111231200	http://dx.doi.org/10.1074/jbc.M111231200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741895	hybrid			2022-12-27	WOS:000173989200088
J	Degousee, N; Ghomashchi, F; Stefanski, E; Singer, A; Smart, BP; Borregaard, N; Reithmeier, R; Lindsay, TF; Lichtenberger, C; Reinisch, W; Lambeau, G; Arm, J; Tischfield, J; Gelb, MH; Rubin, BB				Degousee, N; Ghomashchi, F; Stefanski, E; Singer, A; Smart, BP; Borregaard, N; Reithmeier, R; Lindsay, TF; Lichtenberger, C; Reinisch, W; Lambeau, G; Arm, J; Tischfield, J; Gelb, MH; Rubin, BB			Groups IV, V, and X phospholipases A(2)s in human neutrophils - Role in eicosanoid production and gram-negative bacterial, phospholipid hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INCREASING PROTEIN BPI; GROUP-II PHOSPHOLIPASE-A2; ARACHIDONIC-ACID; ESCHERICHIA-COLI; POLYMORPHONUCLEAR LEUKOCYTES; INFLAMMATORY EXUDATE; MESSENGER-RNA; MAST-CELLS; SUBCELLULAR FRACTIONATION; PROSTAGLANDIN PRODUCTION	The bacterial tripeptide formyl-Met-Leu-Phe (fMLP) induces the secretion of enzyme(s) with phospholipase A(2) (PLA(2)) activity from human neutrophils. We show that circulating human neutrophils express groups V and X sPLA(2) (GV and GX sPLA(2)) mRNA and contain GV and GX sPLA(2) proteins, whereas GIB, GIIA, GILD, GIIE, GIIF, GIII, and GXII sPLA(2)s are undetectable. GV sPLA(2) is a component of both azurophilic and specific granules, whereas GX sPLA(2) is confined to azurophilic granules. Exposure to fMLP or opsonized zymosan results in the release of GV but not GX sPLA(2) and most, if not all, of the PLA(2) activity in the extracellular fluid of fMLP-stimulated neutrophils is due to GV sPLA(2). GV sPLA(2) does not contribute to fMLP-stimulated leukotriene B-4 production but may support the anti-bacterial properties of the neutrophil, because 10-100 ng per ml concentrations of this enzyme lead to Gram-negative bacterial membrane phospholipid hydrolysis in the presence of human serum. By use of a recently described and specific inhibitor of cytosolic PLA(2)-alpha (group IV PLA(2)alpha), we show that this enzyme produces virtually all of the arachidonic acid used for the biosynthesis of leukotriene B-4 in fMLP- and opsonized zymosan-stimulated neutrophils, the major eicosanoid produced by these pro-inflammatory cells.	Univ Toronto, Toronto Gen Hosp, Max Bell Res Ctr,Hlth Network, Div Vasc Surg, Toronto, ON M5G 2C4, Canada; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Copenhagen Univ Hosp, Dept Hematol, Granulocyte Res Lab, DK-2100 Copenhagen, Denmark; Univ Toronto, MRC, Grp Membrane Biol, Dept Med & Biochem, Toronto, ON M5S 1A8, Canada; Univ Vienna, Dept Gastroenterol & Hepatol, Clin Internal Med 4, A-1090 Vienna, Austria; Inst Pharmacol Mol & Cellulaire, CNRS UPR 411, F-06560 Valbonne, France; Harvard Univ, Sch Med, Dept Allergy & Immunol, Boston, MA 02115 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Copenhagen; University of Toronto; University of Vienna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Harvard University; Harvard Medical School; Rutgers State University New Brunswick	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Campus Box 351700, Seattle, WA 98195 USA.	gelb@chem.washington.edu	Lambeau, Gerard/GRJ-5624-2022	gelb, michael/0000-0001-7000-5219; Lambeau, Gerard/0000-0002-9239-518X; Tischfield, Jay/0000-0003-3217-8287	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110, R23HL036238, R01HL050040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038185] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36238, P01 HL36110, HL50040] Funding Source: Medline; NIDDK NIH HHS [DK38185] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANCIAN P, 1995, BIOCHEMISTRY-US, V34, P13146, DOI 10.1021/bi00040a028; ANCIAN P, 1995, J BIOL CHEM, V270, P8963, DOI 10.1074/jbc.270.15.8963; Arbibe L, 1997, J IMMUNOL, V159, P391; Balboa MA, 1996, J BIOL CHEM, V271, P32381, DOI 10.1074/jbc.271.50.32381; BALSINDE J, 1988, J BIOL CHEM, V263, P1929; Bauldry SA, 1996, BBA-LIPID LIPID MET, V1303, P63, DOI 10.1016/0005-2760(96)00077-X; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Bingham CO, 1999, J BIOL CHEM, V274, P31476, DOI 10.1074/jbc.274.44.31476; Blackwood RA, 1996, J LEUKOCYTE BIOL, V59, P663, DOI 10.1002/jlb.59.5.663; Blom M, 1998, BLOOD, V91, P3037; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1488, P71, DOI 10.1016/S1388-1981(00)00111-6; Calafat J, 2000, APMIS, V108, P201, DOI 10.1034/j.1600-0463.2000.d01-45.x; CAMPANELLI D, 1990, J CLIN INVEST, V85, P904, DOI 10.1172/JCI114518; CHEN J, 1994, J BIOL CHEM, V269, P2365; Cho W, 2000, BBA-MOL CELL BIOL L, V1488, P48, DOI 10.1016/S1388-1981(00)00109-8; CHOCK SP, 1994, BIOCHEM J, V300, P619, DOI 10.1042/bj3000619; Cifone MG, 1996, CELL IMMUNOL, V170, P274, DOI 10.1006/cimm.1996.0161; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DIEZ E, 1990, BIOCHIM BIOPHYS ACTA, V1047, P83, DOI 10.1016/0005-2760(90)90264-X; ELSBACH P, 1991, METHOD ENZYMOL, V197, P24; ELSBACH P, 1979, J BIOL CHEM, V254, P1000; Elsner J, 1996, BLOOD, V88, P4684, DOI 10.1182/blood.V88.12.4684.bloodjournal88124684; Enomoto A, 2000, J IMMUNOL, V165, P4007, DOI 10.4049/jimmunol.165.7.4007; Fonteh AN, 2000, J IMMUNOL, V165, P2773, DOI 10.4049/jimmunol.165.5.2773; Foreman-Wykert AK, 2000, INFECT IMMUN, V68, P1259, DOI 10.1128/IAI.68.3.1259-1264.2000; FORST S, 1986, BIOCHEMISTRY-US, V25, P8381, DOI 10.1021/bi00374a008; GABAY JE, 1986, J EXP MED, V164, P1407, DOI 10.1084/jem.164.5.1407; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Gelb MH, 2000, J BIOL CHEM, V275, P39823, DOI 10.1074/jbc.C000671200; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; Gronroos JO, 2001, J IMMUNOL, V166, P4029, DOI 10.4049/jimmunol.166.6.4029; HALBAN PA, 1994, BIOCHEM J, V299, P1; HALE G, 1983, BLOOD, V62, P873; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; HUIZINGA TWJ, 1988, NATURE, V333, P667, DOI 10.1038/333667a0; INADA M, 1991, EUR J BIOCHEM, V197, P323, DOI 10.1111/j.1432-1033.1991.tb15914.x; Ishizaki J, 1999, J BIOL CHEM, V274, P24973, DOI 10.1074/jbc.274.35.24973; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Koduri RS, 1998, J BIOL CHEM, V273, P32142, DOI 10.1074/jbc.273.48.32142; KODURI RS, 2001, IN PRESS J BIOL CHEM, V276; KORTEKANGAS P, 1994, SCAND J RHEUMATOL, V23, P68, DOI 10.3109/03009749409103030; Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lichtenberger C, 1999, J IMMUNOL METHODS, V227, P75, DOI 10.1016/S0022-1759(99)00076-9; Madsen LM, 1996, INFECT IMMUN, V64, P2425, DOI 10.1128/IAI.64.7.2425-2430.1996; MARKI F, 1986, BIOCHIM BIOPHYS ACTA, V879, P149, DOI 10.1016/0005-2760(86)90097-4; Marshall J, 2000, J IMMUNOL, V164, P2084, DOI 10.4049/jimmunol.164.4.2084; Maury E, 2000, J INVEST DERMATOL, V114, P960, DOI 10.1046/j.1523-1747.2000.00965.x; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; Morioka Y, 2000, FEBS LETT, V487, P262, DOI 10.1016/S0014-5793(00)02350-4; Munoz NM, 2000, HYBRIDOMA, V19, P171, DOI 10.1089/02724570050031220; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PAIETTA E, 1990, CANCER RES, V50, P2049; Pruzanski W, 1998, BBA-MOL CELL RES, V1403, P47, DOI 10.1016/S0167-4889(98)00029-9; PRUZANSKI W, 1994, J RHEUMATOL, V21, P1951; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Raeder EMB, 1999, BLOOD, V93, P686, DOI 10.1182/blood.V93.2.686.402k27_686_693; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; ROSENTHAL MD, 1995, BIOCHEM BIOPH RES CO, V208, P650, DOI 10.1006/bbrc.1995.1388; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; Sengelov H, 1999, J IMMUNOL METHODS, V232, P145, DOI 10.1016/S0022-1759(99)00172-6; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sorensen O, 1999, J IMMUNOL METHODS, V232, P179, DOI 10.1016/S0022-1759(99)00175-1; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Thomas G, 2000, J BIOL CHEM, V275, P10876, DOI 10.1074/jbc.275.15.10876; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; TOJO H, 1988, J BIOL CHEM, V263, P5724; Underwood KW, 1998, J BIOL CHEM, V273, P21926, DOI 10.1074/jbc.273.34.21926; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; VADAS P, 1993, J LIPID MEDIATOR, V8, P1; Valentin E, 2000, BIOCHEM BIOPH RES CO, V279, P223, DOI 10.1006/bbrc.2000.3908; Valentin E, 2000, J BIOL CHEM, V275, P7492, DOI 10.1074/jbc.275.11.7492; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; van der Helm HA, 2001, BBA-MOL CELL BIOL L, V1530, P86, DOI 10.1016/S1388-1981(00)00171-2; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; Weinrauch Y, 1998, J CLIN INVEST, V102, P633, DOI 10.1172/JCI3121; WEISS J, 1994, J BIOL CHEM, V269, P26331; WEISS J, 1987, BLOOD, V69, P652; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wheelan P, 1997, ANAL BIOCHEM, V244, P110, DOI 10.1006/abio.1996.9885; Wiese A, 1997, BIOCHEMISTRY-US, V36, P10311, DOI 10.1021/bi970177e; Wiese A, 1997, BIOCHEMISTRY-US, V36, P10301, DOI 10.1021/bi970176m; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; WRIGHT GW, 1990, J BIOL CHEM, V265, P6675; Yokota Y, 1999, BBA-MOL CELL BIOL L, V1438, P213, DOI 10.1016/S1388-1981(99)00053-0	101	158	161	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5061	5073		10.1074/jbc.M109083200	http://dx.doi.org/10.1074/jbc.M109083200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741884	hybrid			2022-12-27	WOS:000173962900068
J	Furia, B; Deng, L; Wu, KL; Baylor, S; Kehn, K; Li, H; Donnelly, R; Coleman, T; Kashanchi, F				Furia, B; Deng, L; Wu, KL; Baylor, S; Kehn, K; Li, H; Donnelly, R; Coleman, T; Kashanchi, F			Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; TRANSCRIPTION FACTORS; HISTONE ACETYLTRANSFERASES; IN-VITRO; RECEPTOR COACTIVATOR; GENE-EXPRESSION; B/REL PROTEINS; VIRAL GROWTH; DNA-BINDING	Nuclear factor (NF)-kappaB transcription factors are involved in the control of a large number of normal cellular and organismal processes, such as immune and inflammatory responses, developmental processes, cellular growth, and apoptosis. Transcription of the human immunodeficiency virus type 1 (HIV-1) genome depends on the intracellular environment where the integrate viral DNA is regulated by a complex interplay among viral regulatory proteins, such as Tat, and host cellular transcription factors, such as NF-kappaB, interacting with the viral long terminal repeat region. CBP (CREB-binding protein) and p300, containing an intrinsic histone acetyltransferase (HAT) activity, have emerged as coactivators for various DNA-binding transcription factors. Here, we show that the p50 subunit as well as the p50/p65 of NF-kappaB, and not other factors such as SP1, TFIIB, polymerase II, TFIIA, or p65, can be acetylated by CBP/p300 HAT domain. Acetylation of p50 was completely dependent on the presence of both HAT domain and Tat proteins, implying that Tat influences the transcription machinery by aiding CBP/p300 to acquire new partners and increase its functional repertoire. Three lysines, Lys-431, Lys-440, and Lys-441 in p50 were all acetylated an vitro, and a sequence similarity among p50, p53, Tat, and activin receptor type I on these particular lysines was observed. All proteins have been shown to be acetylated by the CBP/p300 HAT domain. Acetylated p50 increases its DNA binding properties, as evident by streptavidin/biotin pull-down assays when using labeled NF-kappaB oligonucleotides. Increased DNA binding on HIV-1 long terminal repeat coincided with increases in the rate of transcription. Therefore, we propose that acetylation of the DNA binding domain of NF-kappaB aids in nuclear translocation and enhanced transcription and also suggest that the substrate specificity of CBP/p300 can be altered by small peptide molecules, such as HIV-encoded Tat.	George Washington Univ, Sch Med, Washington, DC 20037 USA; Univ Med & Dent New Jersey, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, Dept Pathol & Pediat, Newark, NJ 07103 USA; Human Genome Sci Inc, Rockville, MD 20850 USA	George Washington University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; GlaxoSmithKline; Human Genome Sciences Inc	Kashanchi, F (corresponding author), George Washington Univ, Sch Med, 2300 Eye St,NW,Ross Hall,Rm 552, Washington, DC 20037 USA.		Kehn-Hall, Kylene/I-5752-2013; wu, kaili/A-1227-2011	Li, Hong/0000-0001-5731-5335; Wu, Kaili/0000-0003-3606-683X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI044357, R01AI043894] Funding Source: NIH RePORTER; NIAID NIH HHS [AI13969, AI44357, AI43894] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chen BK, 1997, J VIROL, V71, P5495, DOI 10.1128/JVI.71.7.5495-5504.1997; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Coleman TA, 1997, PROTEIN EXPRES PURIF, V9, P40, DOI 10.1006/prep.1996.0670; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; Deng LW, 2001, VIROLOGY, V289, P312, DOI 10.1006/viro.2001.1129; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Ghosh S, 1999, IMMUNOL RES, V19, P183, DOI 10.1007/BF02786486; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Goldman PS, 1997, RECENT PROG HORM RES, V52, P103; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HAUBER J, 1989, J VIROL, V63, P1181, DOI 10.1128/JVI.63.3.1181-1187.1989; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Jacque JM, 1996, J VIROL, V70, P2930; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; KASHANCHI F, 1994, J VIROL, V68, P3298, DOI 10.1128/JVI.68.5.3298-3307.1994; KASHANCHI F, 1992, NUCLEIC ACIDS RES, V20, P4673, DOI 10.1093/nar/20.17.4673; KASHANCHI F, 1994, NATURE, V367, P295, DOI 10.1038/367295a0; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; KIM JYH, 1993, J VIROL, V67, P1658, DOI 10.1128/JVI.67.3.1658-1662.1993; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; KRETZSCHMAR M, 1992, GENE DEV, V6, P761, DOI 10.1101/gad.6.5.761; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; LIN RT, 1995, J BIOL CHEM, V270, P3123, DOI 10.1074/jbc.270.7.3123; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; QIAN JH, 1994, J IMMUNOL, V152, P4183; ROSS EK, 1991, J VIROL, V65, P4350, DOI 10.1128/JVI.65.8.4350-4358.1991; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Tomita A, 2000, ONCOGENE, V19, P444, DOI 10.1038/sj.onc.1203329; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Weissman JD, 1998, P NATL ACAD SCI USA, V95, P11601, DOI 10.1073/pnas.95.20.11601; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	51	132	137	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4973	4980		10.1074/jbc.M107848200	http://dx.doi.org/10.1074/jbc.M107848200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739381	hybrid			2022-12-27	WOS:000173962900057
J	Shieh, JJ; Terzioglu, M; Hiraiwa, H; Marsh, J; Pan, CJ; Chen, LY; Chou, JY				Shieh, JJ; Terzioglu, M; Hiraiwa, H; Marsh, J; Pan, CJ; Chen, LY; Chou, JY			The molecular basis of glycogen storage disease type 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-6-PHOSPHATASE GENE; PROTEASOME; MUTATIONS; DEGRADATION; CFTR; 1A; TOPOLOGY; IA; 1B	Glycogen storage disease type la is caused by a deficiency in glucose-6-phosphatase (G6Pase), a nine-helical endoplasmic reticulum transmembrane protein required for maintenance of glucose homeostasis. To date, 75 G6Pase mutations have been identified, including 48 mutations resulting in single-amino acid substitutions. However, only 19 missense mutations have been functionally characterized. Here, we report the results of structure and function studies of the 48 missense mutations and the DeltaF327 codon deletion mutation, grouped as active site, helical, and nonhelical mutations. The 5 active site mutations and 22 of the 31 helical mutations completely abolished G6Pase activity, but only 5 of the 13 nonhelical mutants were devoid of activity. Whereas the active site and nonhelical mutants supported the synthesis of G6Pase protein in a manner similar to that of the wild-type enzyme, immunoblot analysis showed that the majority (64.5%) of helical mutations destabilized G6Pase. Furthermore, we show that degradation of both wild-type and mutant G6Pase is inhibited by lactacystin, a potent proteasome inhibitor. Taken together, we have generated a data base of residual G6Pase activity retained by G6Pase mutants, established the critical roles of transmembrane helices in the stability and activity of this phosphatase, and shown that G6Pase is a substrate for proteasome-mediated degradation.	NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chou, JY (corresponding author), NICHHD, Heritable Disorders Branch, NIH, Bldg 10,Rm 9S241, Bethesda, MD 20892 USA.	chou@helix.nih.gov	Shieh, Jeng-Jer/AAX-6903-2020	Shieh, Jeng-Jer/0000-0001-8412-3603; Terzioglu, Mugen/0000-0003-0872-3046	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000912] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000912] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akanuma J, 2000, AM J MED GENET, V91, P107, DOI 10.1002/(SICI)1096-8628(20000313)91:2<107::AID-AJMG5>3.3.CO;2-P; Antinozzi PA, 1999, ANNU REV NUTR, V19, P511, DOI 10.1146/annurev.nutr.19.1.511; AUSUBEL F. M., 1992, CURRENT PROTOCOL MOL, P4757; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; Bruni N, 1999, ANN HUM GENET, V63, P141, DOI 10.1046/j.1469-1809.1999.6320141.x; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chou Janice Yang, 2001, Current Molecular Medicine (Hilversum), V1, P25; Chou JY, 1999, TRENDS ENDOCRIN MET, V10, P104; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Hemrika W, 1997, FEBS LETT, V409, P317, DOI 10.1016/S0014-5793(97)00530-9; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; HERS H. G., 1964, ADVAN METAB DISORDERS, V1, P1; Huner G, 1998, J INHERIT METAB DIS, V21, P445, DOI 10.1023/A:1005339616074; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Kozak L, 2000, Hum Mutat, V16, P89; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEI KJ, 1995, J CLIN INVEST, V95, P234, DOI 10.1172/JCI117645; LEI KJ, 1995, J BIOL CHEM, V270, P11882, DOI 10.1074/jbc.270.20.11882; LEI KJ, 1995, AM J HUM GENET, V57, P766; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Pan CJ, 1998, J BIOL CHEM, V273, P21658, DOI 10.1074/jbc.273.34.21658; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Parvari R, 1997, AM J MED GENET, V72, P286, DOI 10.1002/(SICI)1096-8628(19971031)72:3<286::AID-AJMG6>3.0.CO;2-P; Parvari R, 1997, EUR J HUM GENET, V5, P191, DOI 10.1159/000484762; Scriver C.R., 2001, METABOLIC MOL BASIS, VEighth; STRUCK DK, 1977, J BIOL CHEM, V252, P1007; Stukey J, 1997, PROTEIN SCI, V6, P469; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Weston BW, 2000, PEDIATR RES, V48, P329, DOI 10.1203/00006450-200009000-00011; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wu M C, 2000, Hum Mutat, V16, P447, DOI 10.1002/1098-1004(200011)16:5<447::AID-HUMU17>3.0.CO;2-M	36	44	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5047	5053		10.1074/jbc.M110486200	http://dx.doi.org/10.1074/jbc.M110486200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739393	hybrid			2022-12-27	WOS:000173962900066
J	Scheideler, M; Schlaich, NL; Fellenberg, K; Beissbarth, T; Hauser, NC; Vingron, M; Slusarenko, AJ; Hoheisel, JD				Scheideler, M; Schlaich, NL; Fellenberg, K; Beissbarth, T; Hauser, NC; Vingron, M; Slusarenko, AJ; Hoheisel, JD			Monitoring the switch from housekeeping to pathogen defense metabolism in Arabidopsis thaliana using cDNA arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; DIFFERENTIAL GENE-EXPRESSION; HYPERSENSITIVE RESPONSE; SIGNAL-TRANSDUCTION; DISEASE RESISTANCE; PLANT-DISEASE; ACTIVATION; SEQUENCE	Plants respond to pathogen attack by deploying several defense reactions. Some rely on the activation of preformed components, whereas others depend on changes in transcriptional activity. Using cDNA arrays comprising 13,000 unique expressed sequence tags, changes in the transcriptome of Arabidopsis thaliana were monitored after attempted infection with the bacterial plant pathogen Pseudomonas syringae pv. tomato carrying the avirulence gene avrRpt2. Sampling at four time points during the first 24 h after infiltration revealed significant changes in the steady state transcript levels of similar to650 genes within 10 min and a massive shift in gene expression patterns by 7 h involving similar to2,000 genes representing many cellular processes. This shift from housekeeping to defense metabolism results from changes in regulatory and signaling circuits and from an increased demand for energy and biosynthetic capacity in plants fighting off a pathogenic attack. Concentrating our detailed analysis on the genes encoding enzymes in glycolysis, the Krebs cycle, the pentose phosphate pathway, the biosynthesis of aromatic amino acids, phenylpropanoids, and ethylene, we observed interesting differential regulation patterns. Furthermore, our data showed potentially important changes in areas of metabolism, such as the glyoxylate metabolism, hitherto not suspected to be components of plant defense.	Rhein Westfal TH Aachen, Inst Pflanzenphysiol, D-52074 Aachen, Germany; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany	RWTH Aachen University; Helmholtz Association; German Cancer Research Center (DKFZ)	Schlaich, NL (corresponding author), Rhein Westfal TH Aachen, Inst Pflanzenphysiol, Worringerweg 1, D-52074 Aachen, Germany.	schlaich@bio3.rwth-aachen.de; hoheisel@dkfz-heidelberg.de	Slusarenko, Alan/AAD-2785-2020; Fellenberg, Kurt/F-1887-2011; Scheideler, Marcel/B-3087-2015	Scheideler, Marcel/0000-0003-4650-7387				ALVAREZ ME, 1997, OXIDATIVE STRESS MOL, P815; Bailey J. A., 1982, PHYTOALEXINS; Beissbarth T, 2000, BIOINFORMATICS, V16, P1014; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; CAMERON RK, 1994, PLANT J, V5, P715, DOI 10.1111/j.1365-313X.1994.00715.x; Cao H, 1998, P NATL ACAD SCI USA, V95, P6531, DOI 10.1073/pnas.95.11.6531; COLLINGE DB, 1987, PLANT MOL BIOL, V9, P389, DOI 10.1007/BF00014913; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; Desprez T, 1998, PLANT J, V14, P643, DOI 10.1046/j.1365-313X.1998.00160.x; Dhondt S, 2000, PLANT J, V23, P431, DOI 10.1046/j.1365-313x.2000.00802.x; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Gilchrist DG, 1998, ANNU REV PHYTOPATHOL, V36, P393, DOI 10.1146/annurev.phyto.36.1.393; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; Halterman DA, 1997, ESSAYS BIOCHEM, V32, P87; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hauser NC, 1998, YEAST, V14, P1209, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1209::AID-YEA311>3.0.CO;2-N; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; Jabs T, 1999, BIOCHEM PHARMACOL, V57, P231, DOI 10.1016/S0006-2952(98)00227-5; Jabs T., 2000, MECH RESISTANCE PLAN, P279; Lam E, 1999, CURR OPIN PLANT BIOL, V2, P502, DOI 10.1016/S1369-5266(99)00026-6; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; NEWMAN T, 1994, PLANT PHYSIOL, V106, P1241, DOI 10.1104/pp.106.4.1241; NGUYEN C, 1995, GENOMICS, V29, P207, DOI 10.1006/geno.1995.1233; Richberg MH, 1998, CURR OPIN PLANT BIOL, V1, P480, DOI 10.1016/S1369-5266(98)80039-3; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Shirasu K, 1996, CURR OPIN IMMUNOL, V8, P3, DOI 10.1016/S0952-7915(96)80097-5; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; SLUSARENKO AJ, 1986, PHYSIOL MOL PLANT P, V29, P79, DOI 10.1016/S0048-4059(86)80040-6; Taylor ATS, 1997, BIOCHEM BIOPH RES CO, V237, P10, DOI 10.1006/bbrc.1997.6965; VERNOOIJ B, 1994, CURR OPIN CELL BIOL, V6, P275, DOI 10.1016/0955-0674(94)90147-3	39	162	169	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10555	10561		10.1074/jbc.M104863200	http://dx.doi.org/10.1074/jbc.M104863200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11748215	hybrid			2022-12-27	WOS:000174549200125
J	Belzar, KJ; Zhou, AW; Carrell, RW; Gettins, PGW; Huntington, JA				Belzar, KJ; Zhou, AW; Carrell, RW; Gettins, PGW; Huntington, JA			Helix D elongation and allosteric activation of antithrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING; ANGSTROM STRUCTURE; KINETIC CHARACTERIZATION; CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; FACTOR XA; COMPLEX; SERPIN; INHIBITION; MECHANISM	Antithrombin requires allosteric activation by heparin for efficient inhibition of its target protease, factor Xa. A pentasaccharide sequence found in heparin activates antithrombin by inducing conformational changes that affect the reactive center of the inhibitor resulting in optimal recognition by factor Xa. The mechanism of transmission of the activating conformational change from the heparin-binding region to the reactive center loop remains unresolved. To investigate the role of helix D elongation in the allosteric activation of antithrombin, we substituted a proline residue for Lys(133). Heparin binding affinity was reduced by 25-fold for the proline variant compared with the control, and a significant decrease in the associated intrinsic fluorescence enhancement was also observed. Rapid kinetic studies revealed that the main reason for the reduced affinity for heparin was an increase in the rate of the reverse conformational change step. The pentasaccharide-accelerated rate of factor Xa inhibition for the proline variant was 10-fold lower than control, demonstrating that the proline variant cannot be fully activated toward factor Xa. We conclude that helix D elongation is critical for the full conversion of antithrombin to its high affinity, activated state, and we propose a mechanism to explain how helix D elongation is coupled to allosteric activation.	Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 2XY, England; Univ Illinois, Dept Biochem & Mol Biol, Chicago, IL 60612 USA	University of Cambridge; Wellcome Trust Sanger Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust, MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	jah52@cam.ac.uk		ZHOU, Aiwu/0000-0002-2555-5091	NHLBI NIH HHS [HL49234, HL68629] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068629, R01HL049234, R37HL049234] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AERTGEERTS K, 1995, PROTEINS, V23, P118, DOI 10.1002/prot.340230114; BAGLIN TP, 2001, THROMB HAEMOSTASIS S; BJORK I, 1992, J BIOL CHEM, V267, P19047; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; Herbert JM, 1998, BLOOD, V91, P4197, DOI 10.1182/blood.V91.11.4197.411k09_4197_4205; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huntington JA, 2000, J BIOL CHEM, V275, P15377, DOI 10.1074/jbc.275.20.15377; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; JESTY J, 1978, ARCH BIOCHEM BIOPHYS, V185, P165, DOI 10.1016/0003-9861(78)90156-X; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Meagher JL, 1996, J BIOL CHEM, V271, P29353, DOI 10.1074/jbc.271.46.29353; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; Meagher JL, 1998, J BIOL CHEM, V273, P23283, DOI 10.1074/jbc.273.36.23283; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; MOUREY L, 1993, J MOL BIOL, V232, P223, DOI 10.1006/jmbi.1993.1378; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; OKAJIMA K, 1993, BLOOD, V81, P1300; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1981, J BIOL CHEM, V256, P1073; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; OLSON ST, 1994, SEMIN THROMB HEMOST, V20, P373, DOI 10.1055/s-2007-1001928; OSCARSSON LG, 1989, J BIOL CHEM, V264, P296; Pike RN, 1997, J BIOL CHEM, V272, P19652, DOI 10.1074/jbc.272.32.19652; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Skinner R, 1998, J MOL BIOL, V283, P9, DOI 10.1006/jmbi.1998.2083; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; TURKO IV, 1993, FEBS LETT, V335, P9, DOI 10.1016/0014-5793(93)80429-X; VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423; WOOLFSON DN, 1990, FEBS LETT, V277, P185, DOI 10.1016/0014-5793(90)80839-B; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1; Zhou A, 2001, J BIOL CHEM, V276, P9115, DOI 10.1074/jbc.M010631200	43	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8551	8558		10.1074/jbc.M110807200	http://dx.doi.org/10.1074/jbc.M110807200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741963	hybrid			2022-12-27	WOS:000174268000118
J	Hatters, DM; Minton, AP; Howlett, GJ				Hatters, DM; Minton, AP; Howlett, GJ			Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PROTEIN; AGGREGATION; FIBRILS; EQUILIBRIUM; EVOLUTION	Human apolipoprotein C-II (apoC-H) slowly forms amyloid fibers in lipid-firee solutions at physiological pH and salt concentrations (Hatters, D. M., MacPhec, C. E., Lawrence, L. J., Sawyer, W. H., and Howlett, G. J. (2000) Biochemistry 39, 8276-8283). Measurements of the time dependence of solution turbidity, thioflavin T reactivity, and the amount of sedimentable aggregate reveal that the rate and extent of amyloid formation are significantly increased by the addition of an inert polymer, dextran T10, at concentrations exceeding 20 g/liter. High dextran concentrations do not alter the secondary structure of the protein, fiber morphology, or the thioflavin T and Congo Red binding capacity of apoC-H amyloid. Analytical ultracentrifugation studies show that monomeric apoC-II does not associate significantly with dextran. The observed dependence of the overall rate of amyloid formation on dextran concentration may be accounted for quantitatively by a simple model for nonspecific volume exclusion. The model predicts that an increase in the fractional volume occupancy of macromolecules in a physiological fluid can nonspecifically accelerate the formation of amyloid fibers by any amyloidogenic protein.	Univ Melbourne, Dept Biochem & Mol Biol, Russell Grimwade Sch Biochem & Mol Biol, Parkville, Vic 3010, Australia; NIDDK, Sect Phys Biochem, Lab Biochem & Genet, Bethesda, MD 20892 USA	University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Howlett, GJ (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Russell Grimwade Sch Biochem & Mol Biol, Parkville, Vic 3010, Australia.	ghowlett@unimelb.edu.au		Hatters, Danny/0000-0002-9965-2847; Minton, Allen/0000-0001-8459-1247	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK024150] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARBER BJ, 1995, J GERONTOL A-BIOL, V50, pB282, DOI 10.1093/gerona/50A.5.B282; Benson MD, 2001, GENOMICS, V72, P272, DOI 10.1006/geno.2000.6499; Bergstrom J, 2001, BIOCHEM BIOPH RES CO, V285, P903, DOI 10.1006/bbrc.2001.5260; BOHLEN P, 1973, ARCH BIOCHEM BIOPHYS, V155, P213, DOI 10.1016/S0003-9861(73)80023-2; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; El-Agnaf OMA, 2000, J STRUCT BIOL, V130, P300, DOI 10.1006/jsbi.2000.4262; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; GIDDINGS JC, 1968, J PHYS CHEM-US, V72, P4397, DOI 10.1021/j100859a008; Hatters DM, 2001, FEBS LETT, V494, P220, DOI 10.1016/S0014-5793(01)02355-9; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; HATTERS DM, 2002, IN PRESS EUR BIOPHYS; HAVEL RJ, 1973, BIOCHEMISTRY-US, V12, P1828, DOI 10.1021/bi00733a026; HIGUCHI K, 1991, BIOCHEM J, V279, P427, DOI 10.1042/bj2790427; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; JACKSON RL, 1986, METHOD ENZYMOL, V128, P288; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; MacRaild CA, 2001, BIOCHEMISTRY-US, V40, P5414, DOI 10.1021/bi002821m; Minton AP, 1998, METHOD ENZYMOL, V295, P127; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; MINTON AP, 1983, MOL CELL BIOCHEM, V55, P119, DOI 10.1007/BF00673707; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Minton AP, 2001, BIOPHYS J, V80, P1641, DOI 10.1016/S0006-3495(01)76136-X; NABER D, 1979, EXP GERONTOL, V14, P59, DOI 10.1016/0531-5565(79)90010-X; Nagy I Z, 1982, Exp Brain Res, VSuppl 5, P118; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; OGSTON AG, 1958, T FARADAY SOC, V54, P1754, DOI 10.1039/tf9585401754; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 1998, BIOPHYS J, V74, P466, DOI 10.1016/S0006-3495(98)77804-X; TANFORD C, 1963, PHYSICAL CHEM MACROM, P317; Wang CS, 1996, BBA-LIPID LIPID MET, V1302, P224, DOI 10.1016/0005-2760(96)00065-3; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; WISNIEWSKI T, 1995, LANCET, V345, P956, DOI 10.1016/S0140-6736(95)90701-7; WISNIEWSKI T, 1995, AM J PATHOL, V147, P238; ZIMMERMAN SB, 1993, BIOCHIM BIOPHYS ACTA, V1216, P175, DOI 10.1016/0167-4781(93)90142-Z; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331; ZSNAGY I, 1981, EXP GERONTOL, V16, P229, DOI 10.1016/0531-5565(81)90018-8	46	217	221	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7824	7830		10.1074/jbc.M110429200	http://dx.doi.org/10.1074/jbc.M110429200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751863	hybrid			2022-12-27	WOS:000174268000027
J	Shin, JN; Kim, I; Lee, JS; Koh, GY; Lee, ZH; Kim, HH				Shin, JN; Kim, I; Lee, JS; Koh, GY; Lee, ZH; Kim, HH			A novel zinc finger protein that inhibits osteoclastogenesis and the function of tumor necrosis factor receptor-associated factor 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEFECTIVE INTERLEUKIN-1; NEUROTROPHIN RECEPTOR; JNK/SAPK ACTIVATION; SIGNAL-TRANSDUCTION; ADAPTER PROTEINS; TERMINAL KINASE; FAMILY-MEMBER; TRAF FAMILY; DOMAIN	A variety of surface receptors eliciting diverse cellular responses have been shown to recruit tumor necrosis factor receptor-associated factor (TRAF) adaptor molecules. However, a few TRAF-interacting intracellular proteins that serve as downstream targets or regulators of TRA-F function have been identified. In search of new intracellular molecules that bind TRAF6, we carried out a yeast two-hybrid cDNA library screening with an N-terminal segment of TRAF6 as the bait. A novel human C2H2-type zinc finger family protein was identified, which when coexpressed with TRAF6 led to a suppression of TRAN6-induced activation of NF-kappaB and c-Jun N-terminal kinase. This novel protein was designated TIZ (for TRAF6-inhibitory Zinc finger protein). TIZ expression also inhibited the signaling of RANK (receptor activator of NF-kappaB), which together with TRAF6 has been shown to be essential for osteoclastogenesis. Furthermore, the expression level of TIZ appeared to be regulated during the differentiation of human peripheral blood monocytes into osteoclasts. More significantly, transfection of TIZ into the monocyte/ macrophage cell line Raw264.7 reduced the RANK ligand-induced osteoclastogenesis of this cell line. Our findings suggest that the novel zinc finger protein TIZ may play a role during osteoclast differentiation by modulating TRAF6 signaling activity.	Chosun Univ, Sch Dent, Dong Gu, Kwangju 501759, South Korea; Chosun Univ, Natl Res Lab Bone Metab, Dong Gu, Kwangju 501759, South Korea; Chosun Univ, Res Ctr Proteineous Mat, Dong Gu, Kwangju 501759, South Korea; Pohang Univ Sci & Technol, Natl Creat Res Initiat Ctr Endothelial Cells, Pohang 790784, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea	Chosun University; Chosun University; Chosun University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, HH (corresponding author), Chosun Univ, Sch Dent, Dong Gu, 375 Seosuk Dong, Kwangju 501759, South Korea.	hhkim@mail.chosun.ac.kr	Koh, Gou Young/C-1615-2011; Kim, Injune/C-1710-2011	Kim, Injune/0000-0001-9244-815X				Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; Caunt CJ, 2001, J BIOL CHEM, V276, P6280, DOI 10.1074/jbc.M006772200; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Grech A, 2000, MOL IMMUNOL, V37, P721, DOI 10.1016/S0161-5890(00)00098-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Kim HH, 1998, J BIOL CHEM, V273, P296, DOI 10.1074/jbc.273.1.296; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lee ZH, 2000, MOL PHARMACOL, V58, P1536, DOI 10.1124/mol.58.6.1536; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Van Huffel S, 2001, J BIOL CHEM, V276, P30216, DOI 10.1074/jbc.M100048200; Wada S, 2001, ENDOCRINOLOGY, V142, P1471, DOI 10.1210/en.142.4.1471; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	47	23	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8346	8353		10.1074/jbc.M110964200	http://dx.doi.org/10.1074/jbc.M110964200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751921	hybrid			2022-12-27	WOS:000174268000093
J	Mitchelmore, C; Kjaerulff, KM; Pedersen, HC; Nielsen, JV; Rasmussen, TE; Fisker, MF; Finsen, B; Pedersen, KM; Jensen, NA				Mitchelmore, C; Kjaerulff, KM; Pedersen, HC; Nielsen, JV; Rasmussen, TE; Fisker, MF; Finsen, B; Pedersen, KM; Jensen, NA			Characterization of two novel nuclear BTB/POZ domain zinc finger isoforms - Association with differentiation of hippocampal neurons, cerebellar granule cells, and macroglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOREBRAIN SUBVENTRICULAR ZONE; ACUTE PROMYELOCYTIC LEUKEMIA; PROTEIN INTERACTION MOTIF; TRANSGENIC MICE; TRANSCRIPTIONAL REPRESSOR; SEXUAL ORIENTATION; FATE DETERMINATION; OLFACTORY-BULB; DROSOPHILA EYE; ENCODING GENE	BTB/POZ (broad complex tramtrack bric-a-brac/poxvirus and zinc finger) zinc finger factors are a class of nuclear DNA-binding proteins involved in development, chromatin remodeling, and cancer. However, BTB/POZ domain zinc finger factors linked to development of the mammalian cerebral cortex, cerebellum, and macroglia have not been described previously. We report here the isolation and characterization of two novel nuclear BTB/POZ domain zinc finger isoforms, designated HOFL and HOFS, that are specifically expressed in early hippocampal neurons, cerebellar granule cells, and gliogenic progenitors as well as in differentiated glia. During embryonic development of the murine cerebral cortex, HOF expression is restricted to the hippocampal subdivision. Expression coincides with early differentiation of presumptive CA1 and CA3 pyramidal neurons and dentate gyrus granule cells, with a sharp decline in expression at the CA1/subicular border. By using bromodeoxyuridine labeling and immunohistochemistry, we show that HOF expression coincides with immature non-dividing cells and is down-regulated in differentiated cells, suggesting a role for HOF in hippocampal neurogenesis. Consistent with the postulated role of the POZ domain as a site for protein-protein interactions, both HOF isoforms are able to dimerize. The HOF zinc fingers bind specifically to the binding site for the related promyelocytic leukemia zinc finger protein as well as to a newly identified DNA sequence.	Univ Copenhagen, Panum Inst 65, Lab Mammalian Mol Genet, DK-2200 Copenhagen N, Denmark; Odense Univ, Dept Anat & Neurobiol, DK-5000 Odense, Denmark	University of Copenhagen; University of Southern Denmark	Jensen, NA (corresponding author), Univ Copenhagen, Panum Inst 65, Lab Mammalian Mol Genet, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.		Rasmussen, Todd/Y-2122-2019	Rasmussen, Todd/0000-0003-1120-4116; Mitchelmore, Cathy/0000-0001-7292-8252; Finsen, Bente/0000-0002-8323-9329; Nielsen, Jakob Vennike/0000-0003-4589-7299				ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Amaral David G., 1995, P443; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; AVANTAGGIATO V, 1995, J NEUROSCI, V15, P4927; Badenhorst P, 1996, GENES CELLS, V1, P707, DOI 10.1111/j.1365-2443.1996.tb00011.x; Bailey MS, 1999, J COMP NEUROL, V415, P423; Bajalica-Lagercrantz S, 1998, BIOCHEM BIOPH RES CO, V247, P357, DOI 10.1006/bbrc.1998.8551; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; CHEN Z, 1994, P NATL ACAD SCI USA, V91, P1178, DOI 10.1073/pnas.91.3.1178; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; COOK M, 1995, P NATL ACAD SCI USA, V92, P2249, DOI 10.1073/pnas.92.6.2249; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Giesen K, 1997, DEVELOPMENT, V124, P2307; GINIGER E, 1994, DEVELOPMENT, V120, P1385; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Grove EA, 1999, CEREB CORTEX, V9, P551, DOI 10.1093/cercor/9.6.551; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JENSEN NA, 1993, J NEUROSCI RES, V34, P257, DOI 10.1002/jnr.490340302; JENSEN NA, 1993, J NEUROSCI RES, V35, P288, DOI 10.1002/jnr.490350308; Jensen NA, 1999, J BIOL CHEM, V274, P29921, DOI 10.1074/jbc.274.42.29921; Jensen NA, 1998, ONCOGENE, V16, P2123, DOI 10.1038/sj.onc.1201739; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lai ZC, 1999, GENETICS, V152, P299; Levitt P, 1997, ANNU REV NEUROSCI, V20, P1, DOI 10.1146/annurev.neuro.20.1.1; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Lumsden A, 1997, SCIENCE, V278, P402, DOI 10.1126/science.278.5337.402; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Luskin MB, 1998, J NEUROBIOL, V36, P221; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; Okabe S, 1998, MOL CELL BIOL, V18, P4235, DOI 10.1128/MCB.18.7.4235; OLSEN J, 1991, J BIOL CHEM, V266, P18089; ORourke NA, 1996, NEURON, V16, P1061, DOI 10.1016/S0896-6273(00)80130-0; Pedersen KM, 1999, ELECTROPHORESIS, V20, P249, DOI 10.1002/(SICI)1522-2683(19990201)20:2<249::AID-ELPS249>3.0.CO;2-F; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Rubenstein JLR, 1999, CEREB CORTEX, V9, P521, DOI 10.1093/cercor/9.6.521; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SALZBERG A, 1994, NEURON, V13, P269, DOI 10.1016/0896-6273(94)90346-8; SCHULZ TC, 1995, BIOCHEM J, V311, P219, DOI 10.1042/bj3110219; Tole S, 1997, DEVELOPMENT, V124, P4959; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Wasserman SA, 2000, NAT CELL BIOL, V2, pE145, DOI 10.1038/35019626; Wen Y, 2000, GENETICS, V156, P195; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yokoro K, 1998, BIOCHEM BIOPH RES CO, V246, P668, DOI 10.1006/bbrc.1998.8675	58	63	69	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7598	7609		10.1074/jbc.M110023200	http://dx.doi.org/10.1074/jbc.M110023200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744704	hybrid			2022-12-27	WOS:000174104300107
J	Song, CZ; Keller, K; Murata, K; Asano, H; Stamatoyannopoulos, G				Song, CZ; Keller, K; Murata, K; Asano, H; Stamatoyannopoulos, G			Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; P300/CBP-ASSOCIATED FACTOR; HISTONE ACETYLATION; FACTOR GATA-1; 3 FINGERS; P300; ACTIVATION; COMPLEX; FAMILY; ACETYLTRANSFERASES	The Sp1/KLF family of factors regulates diverse cellular processes, including growth and development. Fetal Kruppel-like factor (FKLF2) is a new member of this family. In this study, we characterized the coactivators involved in FKLF2 transcriptional activation. Our results show that both CBP/p300 and p300/CBP-associated factor (PCAF) enhance FKLF2 transcriptional activity. We demonstrate that the acetyltransferase activity of PCAF but not that of CBP/p300 is required for stimulating FKLF2 transcription activity. We further show that p300 and PCAF act cooperatively in stimulating FKLF2 transcriptional activation. FKLF2 interacts with both CBP and PCAF through specific domains, and CBP and PCAF acetylate FKLF2. Both CBP/p300 and PCAF stimulate FKLF2 DNA binding activity. The integrity of the acetyltransferase domain of PCAF but not that of CBP/p300 is required for stimulating FKLF2 DNA binding activity. These results demonstrate that CBP/p300 and PCAF stimulate FKLF2 transcriptional activity at least by enhancing its DNA binding. The acetyltransferase activities of CBP/p300 and PCAF play a distinct role in stimulating FKLF2 transcription and DNA binding.	Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; Nagoya Univ, Dept Internal Med 1, Nagoya, Aichi 4618673, Japan	University of Washington; University of Washington Seattle; Nagoya University	Stamatoyannopoulos, G (corresponding author), Univ Washington, Div Med Genet, Dept Med, Box 357720, Seattle, WA 98195 USA.	gstam@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045365] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL020899-23, R01 HL020899] Funding Source: Medline; NIDDK NIH HHS [R01 DK045365, R01 DK045365-06S1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Asano H, 1998, MOL CELL BIOL, V18, P102, DOI 10.1128/MCB.18.1.102; Asano H, 2000, BLOOD, V95, P3578, DOI 10.1182/blood.V95.11.3578.011k48_3578_3584; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; BIEKER JJ, 1995, MOL BIOL HEMOGLOBIN, P231; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Chen XY, 2001, MOL CELL BIOL, V21, P3118, DOI 10.1128/MCB.21.9.3118-3125.2001; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Goodman RH, 2000, GENE DEV, V14, P1553; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Liu L, 1999, MOL CELL BIOL, V19, P1202; Martin KM, 2000, BIOCHEM J, V345, P529, DOI 10.1042/0264-6021:3450529; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PERKINS AC, 1995, NATURE, V375, P318; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Schiltz RL, 2000, BBA-REV CANCER, V1470, pM37, DOI 10.1016/S0304-419X(99)00037-2; Scolnick DM, 1997, CANCER RES, V57, P3693; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Song A, 1999, IMMUNITY, V10, P93, DOI 10.1016/S1074-7613(00)80010-2; Song CZ, 1998, J BIOL CHEM, V273, P29287, DOI 10.1074/jbc.273.45.29287; Song CZ, 1997, MOL CELL BIOL, V17, P2186, DOI 10.1128/MCB.17.4.2186; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wade PA, 1997, CURR BIOL, V7, pR82, DOI 10.1016/S0960-9822(06)00042-X; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001	48	62	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7029	7036		10.1074/jbc.M108826200	http://dx.doi.org/10.1074/jbc.M108826200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11748222	Green Accepted, hybrid			2022-12-27	WOS:000174104300037
J	Kasrayan, A; Persson, AL; Sahlin, M; Sjoberg, BM				Kasrayan, A; Persson, AL; Sahlin, M; Sjoberg, BM			The conserved active site asparagine in class I ribonucleotide reductase is essential for catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL TRANSFER PATHWAY; 3'-C-H BOND-CLEAVAGE; ESCHERICHIA-COLI; DIPHOSPHATE REDUCTASE; PROTEIN R2; 2'-AZIDO-2'-DEOXYURIDINE 5'-DIPHOSPHATE; DIRECTED MUTAGENESIS; PHENOTYPIC SELECTION; ELECTRON-TRANSFER; MECHANISM	The active site residue Asn-437 in protein R1 of the Escherichia coli ribonucleotide reductase makes a hydrogen bond to the 2'-OH group of the substrate. To elucidate its role(s) during catalysis, Asn-437 was engineered by site-directed mutagenesis to several other side chains (Ala, Ser, Asp, Gln). All mutant proteins were incapable of enzymatic turnover but promoted rapid protein R2 tyrosyl radical decay in the presence of the k(cat) inhibitor 2'-azido-2'-deoxy-CDP with similar decay rate constants as the wild-type R1. These results show that all Asn-437 mutants can perform T-H abstraction, the first substrate-related step in the reaction mechanism. The most interesting observation was that three of the mutant proteins (N437A/S/D) behaved as suicidal enzymes by catalyzing a rapid tyrosyl radical decay also in reaction mixtures containing the natural substrate CDP. The suicidal CDP-dependent reaction was interpreted to suggest elimination of the substrate's protonated 2'-OH group in the form of water, a step that has been proposed to drive the 3'-H abstraction step. A furanone-related chromophore was formed in the N437D reaction, which is indicative of stalling of the reaction mechanism at the reduction step. We conclude that Asn-437 is essential for catalysis but not for T-H abstraction. We propose that the suicidal N437A, N437S, and N437D mutants can also catalyze the water elimination step, whereas the inert N437Q mutant cannot. Our results suggest that Asn-437, apart from hydrogen bonding to the substrate, also participates in the reduction steps of catalysis by class I ribonucleotide reductase.	Univ Stockholm, Dept Mol Biol & Functional Genom, SE-10691 Stockholm, Sweden	Stockholm University	Sjoberg, BM (corresponding author), Univ Stockholm, Dept Mol Biol & Functional Genom, SE-10691 Stockholm, Sweden.	Britt-Marie.Sjoberg@molbio.su.se		Sjoberg, Britt-Marie/0000-0001-5953-3360				ABERG A, 1989, J BIOL CHEM, V264, P12249; ATOR MA, 1985, BIOCHEMISTRY-US, V24, P7214, DOI 10.1021/bi00346a029; BOLLINGER JM, 1994, J AM CHEM SOC, V116, P8015, DOI 10.1021/ja00097a008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; Ekberg M, 1996, J BIOL CHEM, V271, P20655, DOI 10.1074/jbc.271.34.20655; Ekberg M, 1998, J BIOL CHEM, V273, P21003, DOI 10.1074/jbc.273.33.21003; Eklund H, 1999, STRUCT FOLD DES, V7, pR257, DOI 10.1016/S0969-2126(00)80019-2; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; ERIKSSON S, 1977, J BIOL CHEM, V252, P6132; HARRIS G, 1984, BIOCHEMISTRY-US, V23, P5214, DOI 10.1021/bi00317a020; Himo F, 2000, J PHYS CHEM B, V104, P7502, DOI 10.1021/jp000752f; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LARSSON A, 1986, EMBO J, V5, P2037, DOI 10.1002/j.1460-2075.1986.tb04461.x; LARSSON A, 1988, J BIOL CHEM, V263, P17780; Lawrence CC, 1999, P NATL ACAD SCI USA, V96, P8979, DOI 10.1073/pnas.96.16.8979; Lenz R, 1997, J AM CHEM SOC, V119, P2784, DOI 10.1021/ja962974q; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; LUNN CA, 1984, J BIOL CHEM, V259, P469; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9752, DOI 10.1021/bi00155a031; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9744, DOI 10.1021/bi00155a030; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Persson AL, 1998, J BIOL CHEM, V273, P31016, DOI 10.1074/jbc.273.47.31016; Persson AL, 1997, J BIOL CHEM, V272, P31533, DOI 10.1074/jbc.272.50.31533; Persson BO, 1996, J BIOL INORG CHEM, V1, P247, DOI 10.1007/s007750050050; PETERSSON L, 1980, J BIOL CHEM, V255, P6706; Robins MJ, 1999, J AM CHEM SOC, V121, P1425, DOI 10.1021/ja983449p; Rova U, 1999, J BIOL CHEM, V274, P23746, DOI 10.1074/jbc.274.34.23746; ROVA U, 1995, BIOCHEMISTRY-US, V34, P4267, DOI 10.1021/bi00013a016; RUSSEL M, 1985, J BACTERIOL, V163, P238, DOI 10.1128/JB.163.1.238-242.1985; SALOWE SP, 1987, BIOCHEMISTRY-US, V26, P3408, DOI 10.1021/bi00386a024; Schmidt PP, 1998, J BIOL CHEM, V273, P21463, DOI 10.1074/jbc.273.34.21463; Siegbahn PEM, 1998, J AM CHEM SOC, V120, P8417, DOI 10.1021/ja9736065; Sjoberg BM, 1997, STRUCT BOND, V88, P139; SJOBERG BM, 1983, J BIOL CHEM, V258, P8060; SJOBERG BM, 1986, J BIOL CHEM, V261, P5658; STUBBE J, 1983, J BIOL CHEM, V258, P1625; STUBBE J, 1990, ADV ENZYMOL RAMB, V63, P349; Stubbe JA, 1995, CHEM BIOL, V2, P793, DOI 10.1016/1074-5521(95)90084-5; STUBBE JA, 1980, J BIOL CHEM, V255, P8027; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; THELANDER L, 1976, J BIOL CHEM, V251, P1398; Uhlin U, 1996, J MOL BIOL, V262, P358, DOI 10.1006/jmbi.1996.0519; vanderDonk WA, 1996, BIOCHEMISTRY-US, V35, P10058, DOI 10.1021/bi952869d; VANDERDONK WA, 1995, J AM CHEM SOC, V117, P8908, DOI 10.1021/ja00140a003; vanderDonk WA, 1996, BIOCHEMISTRY-US, V35, P8381, DOI 10.1021/bi960190j; WEHRLI WE, 1965, J AM CHEM SOC, V87, P2265, DOI 10.1021/ja01088a028	52	21	21	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5749	5755		10.1074/jbc.M106538200	http://dx.doi.org/10.1074/jbc.M106538200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11733508	hybrid			2022-12-27	WOS:000173989200010
J	Oetke, C; Brossmer, R; Mantey, LR; Hinderlich, S; Isecke, R; Reutter, W; Keppler, OT; Pawlita, M				Oetke, C; Brossmer, R; Mantey, LR; Hinderlich, S; Isecke, R; Reutter, W; Keppler, OT; Pawlita, M			Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCOLYLNEURAMINIC ACID; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; MYELIN-ASSOCIATED GLYCOPROTEIN; B-LYMPHOTROPIC PAPOVAVIRUS; INFLUENZA-A VIRUS; IMMUNOGLOBULIN SUPERFAMILY; ACETYLNEURAMINIC ACID; FUNCTIONAL-GROUPS; SURFACE RECEPTOR; O-ACETYLATION	Sialic acids are critical components of many glycoconjugates involved in biologically important ligand-receptor interactions. Quantitative and structural variations of sialic acid residues can profoundly affect specific cell-cell, pathogen-cell, or drug-cell interactions, but manipulation of sialic acids in mammalian cells has been technically limited. We describe the finding of a previously unrecognized and efficient uptake and incorporation of sialic acid analogues in mammalian cells. We added 16 synthetic sialic acid analogues carrying distinct C-1, C-5, or C-9 substitutions individually to cell cultures of which 10 were readily taken up and incorporated. Uptake of C-5- and C-9-substituted sialic acids resulted in the structural modification of up to 95% of sialic acids on the cell surface. Functionally, binding of murine sialic acid-binding immunoglobulin-like lectin-2 (Siglec-2, CD22) to cells increased after N-glycolylneuraminic acid treatment, whereas 9-iodo-N-acetylneuraminic acid abolished binding. Furthermore, susceptibility to infection by the B-lymphotropic papovavirus via a sialylated receptor was markedly enhanced following pretreatment of host cells with selected sialic acid analogues including 9-iodo-N-acetylneuraminic acid. This novel experimental strategy allows for an efficient biosynthetic engineering of surface sialylation in living cells. It is versatile, extending the repertoire of modification sites at least to C-9 and enables detailed structure-function studies of sialic acid-dependent ligand-receptor interactions in their native context.	Deutsch Krebsforschungszentrum, Angewande Tumorvirol, D-69120 Heidelberg, Germany; Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; Free Univ Berlin, Inst Mol Biol & Biochem, D-14195 Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Free University of Berlin	Pawlita, M (corresponding author), Deutsch Krebsforschungszentrum, Angewande Tumorvirol, Neuenheimer Feld 280,ATV F0200, D-69120 Heidelberg, Germany.	m.pawlita@dkfz.de	Pawlita, Labor/C-9720-2011	Pawlita, Michael/0000-0002-4720-8306				BABAL P, 1994, BIOCHEM J, V299, P341, DOI 10.1042/bj2990341; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; BROSSMER R, 1994, METHOD ENZYMOL, V247, P153; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Collins BE, 2000, GLYCOBIOLOGY, V10, P11, DOI 10.1093/glycob/10.1.11; Corfield AP, 1999, GLYCOCONJUGATE J, V16, P307, DOI 10.1023/A:1007026314792; DEVINE PL, 1991, BIOCHEM BIOPH RES CO, V178, P593, DOI 10.1016/0006-291X(91)90149-2; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; ERIKSTEIN BK, 1992, EUR J IMMUNOL, V22, P1149, DOI 10.1002/eji.1830220507; FISCHER E, 1995, GLYCOCONJUGATE J, V12, P707, DOI 10.1007/BF00731268; FURUKAWA K, 1988, J BIOL CHEM, V263, P18507; GALLAGHER R, 1979, BLOOD, V54, P713; GROSS HJ, 1989, BIOCHEMISTRY-US, V28, P7386, DOI 10.1021/bi00444a036; GROSS HJ, 1987, EUR J BIOCHEM, V168, P595, DOI 10.1111/j.1432-1033.1987.tb13458.x; GROSS HJ, 1995, GLYCOCONJUGATE J, V12, P739, DOI 10.1007/BF00731233; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; HARMS E, 1974, CANCER RES, V34, P3165; HAUN G, 1993, J VIROL, V67, P7482, DOI 10.1128/JVI.67.12.7482-7492.1993; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P251; HOLZER CT, 1993, GLYCOCONJUGATE J, V10, P40, DOI 10.1007/BF00731185; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; ISECKE R, 1995, CARBOHYD RES, V274, P303, DOI 10.1016/0008-6215(95)00133-E; ISECKE R, 1994, TETRAHEDRON, V50, P7445, DOI 10.1016/S0040-4020(01)90473-9; JANAKIRAMAN MN, 1994, BIOCHEMISTRY-US, V33, P8172, DOI 10.1021/bi00193a002; KARLSSON KA, 1995, CURR OPIN STRUC BIOL, V5, P622, DOI 10.1016/0959-440X(95)80054-9; KAYSER H, 1992, J BIOL CHEM, V267, P16934; KELM S, 1992, EUR J BIOCHEM, V205, P147, DOI 10.1111/j.1432-1033.1992.tb16762.x; Kelm S, 1998, EUR J BIOCHEM, V255, P663, DOI 10.1046/j.1432-1327.1998.2550663.x; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Keppler OT, 1998, BIOCHEM BIOPH RES CO, V253, P437, DOI 10.1006/bbrc.1998.9650; Keppler OT, 1999, GLYCOBIOLOGY, V9, P557, DOI 10.1093/glycob/9.6.557; KEPPLER OT, 1994, J VIROL, V68, P6933, DOI 10.1128/JVI.68.11.6933-6939.1994; KEPPLER OT, 1995, J BIOL CHEM, V270, P1308, DOI 10.1074/jbc.270.3.1308; KEPPLER OT, 1992, EUR J IMMUNOL, V22, P2777, DOI 10.1002/eji.1830221104; KNIBBS RN, 1993, J BIOL CHEM, V268, P18524; Lawrence SM, 2000, J BIOL CHEM, V275, P17869, DOI 10.1074/jbc.M000217200; LOWE JB, 1990, CELL, V63, P475, DOI 10.1016/0092-8674(90)90444-J; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Mann B, 1997, INT J CANCER, V72, P258, DOI 10.1002/(SICI)1097-0215(19970717)72:2<258::AID-IJC10>3.3.CO;2-0; Mantey LR, 2001, FEBS LETT, V503, P80, DOI 10.1016/S0014-5793(01)02701-6; Marquina G, 1996, CANCER RES, V56, P5165; May AP, 1997, PROTEIN SCI, V6, P717; MENEZES J, 1975, BIOMEDICINE, V22, P276; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Munday J, 1999, J LEUKOCYTE BIOL, V66, P705, DOI 10.1002/jlb.66.5.705; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; PAULSON JC, 1987, METHOD ENZYMOL, V138, P162; Sarkar AK, 1997, J BIOL CHEM, V272, P25608, DOI 10.1074/jbc.272.41.25608; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; SCHULTZE B, 1990, VIRUS RES, V16, P185, DOI 10.1016/0168-1702(90)90022-4; SGROI D, 1993, J BIOL CHEM, V268, P7011; SIMMONS DL, 1993, CELLULAR INTERACTION, P93; Sommer U, 1999, GLYCOCONJUGATE J, V16, P425, DOI 10.1023/A:1007030627948; Stehle T, 1996, STRUCTURE, V4, P183, DOI 10.1016/S0969-2126(96)00021-4; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Takimoto T, 2000, VIROLOGY, V270, P208, DOI 10.1006/viro.2000.0263; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; TENEBERG S, 1990, FEBS LETT, V263, P10, DOI 10.1016/0014-5793(90)80693-D; TOLLEFSEN SE, 1983, J BIOL CHEM, V258, P5165; Ulloa-Aguirre A, 1999, ENDOCRINE, V11, P205, DOI 10.1385/ENDO:11:3:205; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Varki A, 2001, BIOCHIMIE, V83, P615, DOI 10.1016/S0300-9084(01)01309-8; Yarema KJ, 1998, J BIOL CHEM, V273, P31168, DOI 10.1074/jbc.273.47.31168; YEDNOCK TA, 1989, ADV IMMUNOL, V44, P313, DOI 10.1016/S0065-2776(08)60645-8	70	73	86	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6688	6695		10.1074/jbc.M109973200	http://dx.doi.org/10.1074/jbc.M109973200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751912	hybrid			2022-12-27	WOS:000173989200130
J	Sanchez, DJ; Coscoy, L; Ganem, D				Sanchez, DJ; Coscoy, L; Ganem, D			Functional organization of MIR2, a novel viral regulator of selective endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; ANTIGEN PRESENTATION; PROTEINS; INHIBITION; DOMAINS	Kaposi's sarcoma-associated herpesvirus encodes two related proteins, MIR1. and MIR2, that lead to reduction of the cell surface levels of major histocompatibility complex class 1 and other polypeptides involved in immune recognition. MIR1 and MIR2 do not affect the assembly or transport of their target proteins through the secretory pathway; rather, they act to enhance the selective endocytosis of target chains from the cell surface. Sequence inspection reveals that the modulator of immune recognition (MIR) proteins contain an NH2-terminal zinc finger of the plant homeodomain (PHD) subfamily, two transmembrane (TM) domains, and a C-terminal conserved region (CR). Here we examine the transmembrane topology and functional organization of MIR2. Both the PHD domain and the CR are disposed cytosolically and are essential for MIR-mediated endocytosis. MIR proteins form homo-oligomers; this activity is independent of the PHD and CR elements and maps instead to the TM regions. Analysis of chimeras between MIR1 and MIR2 reveals that the TM regions also mediate target selectivity. Mutations that ablate the PHD or CR regions generate dominant negative phenotypes for major histocompatibility complex class 1 endocytosis. These findings suggest a domain organization for the MIR proteins, with the TM regions involved in target selection and the cytosolic PHD and CR domains involved in the possible recruitment of cellular machinery that directly or indirectly regulates internalization of target molecules.	Univ Calif San Francisco, Howard Hughes Med Inst, Biomed Sci Grad Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ganem, D (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Biomed Sci Grad Program, San Francisco, CA 94143 USA.	ganem@cgl.ucsf.edu		Sanchez, David/0000-0002-6032-4600				Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Ganem D, 1997, CELL, V91, P157, DOI 10.1016/S0092-8674(00)80398-0; Haque M, 2000, J VIROL, V74, P2867, DOI 10.1128/JVI.74.6.2867-2875.2000; Haque M, 2001, J GEN VIROL, V82, P1175, DOI 10.1099/0022-1317-82-5-1175; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Lagunoff M, 2001, J VIROL, V75, P5891, DOI 10.1128/JVI.75.13.5891-5898.2001; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Linder B, 2000, J MOL BIOL, V299, P369, DOI 10.1006/jmbi.2000.3766; Mziaut H, 1999, J BIOL CHEM, V274, P14122, DOI 10.1074/jbc.274.20.14122; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Whitby Denise, 1998, Current Opinion in Oncology, V10, P405, DOI 10.1097/00001622-199809000-00007; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001	20	72	73	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6124	6130		10.1074/jbc.M110265200	http://dx.doi.org/10.1074/jbc.M110265200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751860	hybrid			2022-12-27	WOS:000173989200058
J	Ton, VK; Mandal, D; Vahadji, C; Rao, R				Ton, VK; Mandal, D; Vahadji, C; Rao, R			Functional expression in yeast of the human secretory pathway Ca2+, Mn2+-ATPase defective in Hailey-Hailey disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SARCOPLASMIC-RETICULUM; YARROWIA-LIPOLYTICA; MOLECULAR-CLONING; H+/CA2+ EXCHANGE; CALCIUM-PUMP; LACKING PMR1; GOLGI; MUTATIONS; HOMOLOG	The discovery and biochemical characterization of the secretory pathway Ca2+-ATPase, PMR1, in Saccharomyces cerevisiae, has paved the way for identification of PMR1 homologues in many species including rat, Caenorhabditis elegans, and Homo sapiens. In yeast, PMR1 has been shown to function as a high affinity Ca2+/Mn2+ pump and has been localized to the Golgi compartment where it is important for protein sorting, processing, and glycosylation. However, little is known about PMR1 homologues in higher organisms. Loss of one functional allale of the human gene, hSPCA1, has been linked to Hailey-Hailey disease, characterized by skin ulceration and improper keratinocyte adhesion. We demonstrate that expression of hSPCA1 in yeast fully complements pmr1 phenotypes of hypersensitivity to Ca2+ chelators and Mn2+ toxicity. Similar to PMR1, epitope-tagged hSPCA1 also resides in the Golgi when expressed in yeast or in chinese hamster ovary cells. Ca-45(2+) transport by hSPCA1 into isolated yeast Golgi vesicles shows an apparent Ca2+ affinity of 0.26 mum, is inhibitable by Mn2+, but is thapsigargin-insensitive. In contrast, heterologous expression of vertebrate sarcoplasmic reticulum and plasma membrane Ca2+-ATPases in yeast complement the Ca2+- but not Mn2+-related phenotypes of the pmr1-null strain, suggesting that high affinity Mn2+ transport is a unique feature of the secretory pathway Ca2+-ATPases.	Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rrao@jhmi.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062142] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; CHIESI M, 1980, BIOCHEMISTRY-US, V19, P2912, DOI 10.1021/bi00554a015; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; DACOSTA AG, 1986, ARCH BIOCHEM BIOPHYS, V249, P199, DOI 10.1016/0003-9861(86)90575-8; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; East JM, 2000, MOL MEMBR BIOL, V17, P189, DOI 10.1080/09687680010009646; GUNTESKIHAMBLIN AM, 1992, BIOCHEMISTRY-US, V31, P7600, DOI 10.1021/bi00148a023; Halachmi D, 1996, FEBS LETT, V392, P194, DOI 10.1016/0014-5793(96)00799-5; Hearn AS, 2001, BIOCHEMISTRY-US, V40, P12051, DOI 10.1021/bi011047f; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; LOUKIN S, 1995, J CELL BIOL, V131, P1025, DOI 10.1083/jcb.131.4.1025; LOW W, 1991, BIOCHEM PHARMACOL, V42, P1537, DOI 10.1016/0006-2952(91)90422-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; Marchi V, 1999, FEBS LETT, V454, P181, DOI 10.1016/S0014-5793(99)00803-0; Missiaen L, 2001, J BIOL CHEM, V276, P39161, DOI 10.1074/jbc.M104044200; Park CS, 1998, GENE, V206, P107, DOI 10.1016/S0378-1119(97)00573-8; Reinhardt TA, 1999, AM J PHYSIOL-CELL PH, V276, pC796, DOI 10.1152/ajpcell.1999.276.4.C796; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; Shull GE, 2000, EUR J BIOCHEM, V267, P5284, DOI 10.1046/j.1432-1327.2000.01568.x; Sohn YS, 1998, J BACTERIOL, V180, P6736, DOI 10.1128/JB.180.24.6736-6742.1998; Sorin A, 1997, J BIOL CHEM, V272, P9895; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Uccelletti D, 1999, MICROBIOL-SGM, V145, P1079, DOI 10.1099/13500872-145-5-1079; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; Wei Y, 1999, BIOCHEMISTRY-US, V38, P14534, DOI 10.1021/bi9911233; Wei Y, 2000, J BIOL CHEM, V275, P23927, DOI 10.1074/jbc.M002618200	34	118	127	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6422	6427		10.1074/jbc.M110612200	http://dx.doi.org/10.1074/jbc.M110612200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741891	hybrid			2022-12-27	WOS:000173989200096
J	Wieden, HJ; Gromadski, K; Rodnin, D; Rodnina, MV				Wieden, HJ; Gromadski, K; Rodnin, D; Rodnina, MV			Mechanism of elongation factor (EF)-Ts-catalyzed nucleotide exchange in EF-Tu - Contribution of contacts at the guanine base	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FACTOR TS; CRYSTAL-STRUCTURE; COMPLEX; ACTIVATION; RESIDUES	Nucleotide exchange in elongation factor Tu (EF-Tu) is catalyzed by elongation factor Ts (EF-Ts). Similarly to other GTP-binding proteins, the structural changes in the P loop and the Mg2+ binding site are known to be important for nucleotide release from EF-Tu. In the present paper, we determine the contribution of the contacts between helix D of EF-Tu at the base side of the nucleotide and the N-terminal domain of EF-Ts to the catalysis. The rate constants of the multistep reaction between Escherichia coli EF-Tu, EF-Ts, and GDP were determined by stopped-flow kinetic analysis monitoring the fluorescence of either Trp-184 in EF-Tu or mant-GDP. Mutational analysis shows that contacts between helix D of EF-Tu and the N-terminal domain of EF-Ts are important for both complex formation and the acceleration of GDP dissociation. The kinetic results suggest that the initial contact of EF-Ts with helix D of EF-Tu weakens binding interactions around the guanine base, whereas contacts of EF-Ts with the phosphate binding side that promotes the release of the phosphate moiety of GDP appear to take place later. This "base-side-first" mechanism of guanine nucleotide release resembles that found for Ran.RCC1 and differs from mechanisms described for other GTPase.GEF complexes where interactions at the phosphate side of the nucleotide are released first.	Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany	Witten Herdecke University	Rodnina, MV (corresponding author), Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany.	rodnina@uni-wh.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879				BLOCK W, 1981, ANAL BIOCHEM, V114, P112, DOI 10.1016/0003-2697(81)90460-7; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Fersht A, 1998, STRUCTURE MECH PROTE, P123; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; JAMESON DM, 1987, BIOCHEMISTRY-US, V26, P3894, DOI 10.1021/bi00387a023; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Knudsen C, 2001, J BIOL CHEM, V276, P22183, DOI 10.1074/jbc.M102186200; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; TOMBS MP, 1959, BIOCHEM J, V73, P167, DOI 10.1042/bj0730167; Wang Y, 1997, NAT STRUCT BIOL, V4, P650, DOI 10.1038/nsb0897-650; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zhang YL, 1996, FEBS LETT, V391, P330, DOI 10.1016/0014-5793(96)00789-2; Zhang YL, 1998, J BIOL CHEM, V273, P4556, DOI 10.1074/jbc.273.8.4556; Zhang YL, 1997, J BIOL CHEM, V272, P21956, DOI 10.1074/jbc.272.35.21956	18	38	41	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6032	6036		10.1074/jbc.M110888200	http://dx.doi.org/10.1074/jbc.M110888200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744709	hybrid			2022-12-27	WOS:000173989200045
J	Johnson, LR; Johnson, TK; Desler, M; Luster, TA; Nowling, T; Lewis, RE; Rizzino, A				Johnson, LR; Johnson, TK; Desler, M; Luster, TA; Nowling, T; Lewis, RE; Rizzino, A			Effects of B-Myb on gene transcription - Phosphorylation-dependent activity and acetylation by p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; DNA-BINDING DOMAIN; TERMINAL CONSERVED DOMAIN; C-MYB; FGF-4 GENE; A-MYB; NF-Y; REGULATORY ELEMENTS; CYCLIN A/CDK2; FACTOR SOX-2	The transcription factor B-Myb is a cell-cycle regulated phosphoprotein involved in cell cycle progression through the transcriptional regulation of many genes. In this study, we show that the promoter of the fibroblast growth factor-4 (FGF-4) gene is strongly activated by B-Myb in HeLa cells and it can serve as a novel diagnostic tool for assessing B-Myb activity. Specifically, B-Myb deletion mutants were examined and domains of B-Myb required for activation of the FGF-4 promoter were identified. Using phosphorylation-deficient mutant forms of B-Myb, we also show that phosphorylation is essential for B-Myb activity. Moreover, a mutant form of B-Myb, which lacks all identified phosphorylation sites and which has little activity, can function as a dominant-negative and suppress wild-type B-Myb activity. Acetylation is another post-translational modification known to affect the activity of other Myb family members. We show that B-Myb is acetylated by the coactivator p300. We also show that the bromo and histone acetyltransferase domains of p300 are sufficient to interact with and acetylate B-Myb. These data indicate that phosphorylation of B-Myb is an essential modification for activity and that acetylation of B-Myb may play a role in B-Myb activity.	Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Rizzino, A (corresponding author), Univ Nebraska, Med Ctr, Eppley Canc Inst, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	arizzino@unmc.edu	Lewis, Robert E./H-3404-2019		NATIONAL CANCER INSTITUTE [R01CA079491, R01CA074771, T32CA009476, P30CA036727] Funding Source: NIH RePORTER; NCI NIH HHS [CA79491, CA74771, CA36727, CA09476] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAM SE, 1993, ONCOGENE, V8, P1639; AKIYAMA T, 1991, METHOD ENZYMOL, V201, P362; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bartsch O, 1999, EUR J BIOCHEM, V260, P384, DOI 10.1046/j.1432-1327.1999.00191.x; Bessa M, 2001, ONCOGENE, V20, P3376, DOI 10.1038/sj.onc.1204439; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Bruno MD, 1999, J BIOL CHEM, V274, P27523, DOI 10.1074/jbc.274.39.27523; BRYANS M, 1995, BIOCHEM BIOPH RES CO, V211, P519, DOI 10.1006/bbrc.1995.1844; Carr MD, 1996, EUR J BIOCHEM, V235, P721, DOI 10.1111/j.1432-1033.1996.00721.x; CERNEUS DP, 1991, J CELL BIOL, V114, P1149, DOI 10.1083/jcb.114.6.1149; Cervellera M, 2000, J BIOL CHEM, V275, P21055, DOI 10.1074/jbc.M002055200; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; CURATOLA AM, 1990, MOL CELL BIOL, V10, P2475, DOI 10.1128/MCB.10.6.2475; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; DAILEY L, 1994, MOL CELL BIOL, V14, P7758, DOI 10.1128/MCB.14.12.7758; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Facchinetti V, 1997, BIOCHEM J, V324, P729, DOI 10.1042/bj3240729; FOOS G, 1993, ONCOGENE, V8, P1775; GOLAY J, 1991, BLOOD, V77, P149; HASAN S, 1994, J BIOL CHEM, V269, P25042; Horstmann S, 2000, ONCOGENE, V19, P298, DOI 10.1038/sj.onc.1203302; HOWE KM, 1990, EMBO J, V9, P161, DOI 10.1002/j.1460-2075.1990.tb08092.x; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Johnson LR, 1998, MOL REPROD DEV, V50, P377; Johnson TK, 1999, J BIOL CHEM, V274, P36741, DOI 10.1074/jbc.274.51.36741; Kamano H, 1997, ONCOGENE, V14, P1223, DOI 10.1038/sj.onc.1200945; KANEIISHII C, 1992, P NATL ACAD SCI USA, V89, P3088, DOI 10.1073/pnas.89.7.3088; Kee BL, 1996, J BIOL CHEM, V271, P2373, DOI 10.1074/jbc.271.5.2373; Kelly DL, 2000, MOL REPROD DEV, V56, P113, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;113::AID-MRD1&gt;3.0.CO;2-Q; KRAUS VB, 1992, MOL CELL BIOL, V12, P4391, DOI 10.1128/MCB.12.10.4391; LAM EWF, 1992, ONCOGENE, V7, P1885; Lamb K, 1996, MOL REPROD DEV, V44, P460; Lamb KA, 1997, MOL REPROD DEV, V48, P301; Lane S, 1997, ONCOGENE, V14, P2445, DOI 10.1038/sj.onc.1201086; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luster TA, 2000, MOL REPROD DEV, V57, P4, DOI 10.1002/1098-2795(200009)57:1<4::AID-MRD3>3.0.CO;2-I; MA YG, 1992, DEV BIOL, V154, P45, DOI 10.1016/0012-1606(92)90046-J; McIntosh PB, 1998, BIOCHEMISTRY-US, V37, P9619, DOI 10.1021/bi972861z; Muller-Tidow C, 2001, BLOOD, V97, P2091, DOI 10.1182/blood.V97.7.2091; NAKAGOSHI H, 1992, ONCOGENE, V7, P1233; NAKAGOSHI H, 1993, J BIOL CHEM, V268, P14161; Ness SA, 1996, BBA-REV CANCER, V1288, pF123, DOI 10.1016/S0304-419X(96)00027-3; Ness SA, 1999, ONCOGENE, V18, P3039, DOI 10.1038/sj.onc.1202726; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oh IH, 1998, MOL CELL BIOL, V18, P499, DOI 10.1128/MCB.18.1.499; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Robinson C, 1996, ONCOGENE, V12, P1855; SAIKUMAR P, 1990, P NATL ACAD SCI USA, V87, P8452, DOI 10.1073/pnas.87.21.8452; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sala A, 1999, ONCOGENE, V18, P1333, DOI 10.1038/sj.onc.1202421; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Sala A, 1999, J CELL PHYSIOL, V179, P245; Saville MK, 1998, ONCOGENE, V17, P2679, DOI 10.1038/sj.onc.1202503; Saville MK, 1998, ADV CANCER RES, V72, P109; Scholtz B, 1996, J BIOL CHEM, V271, P32375, DOI 10.1074/jbc.271.50.32375; Scolnick DM, 1997, CANCER RES, V57, P3693; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; TAKEMOTO Y, 1994, FEBS LETT, V350, P55, DOI 10.1016/0014-5793(94)00733-0; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; TASHIRO S, 1995, ONCOGENE, V10, P1699; Tomita A, 2000, ONCOGENE, V19, P444, DOI 10.1038/sj.onc.1203329; Volle DJ, 1999, BIOCHEMISTRY-US, V38, P5130, DOI 10.1021/bi983050d; WATSON RJ, 1993, NUCLEIC ACIDS RES, V21, P267, DOI 10.1093/nar/21.2.267; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; ZANTEMA A, 1995, CURR TOP MICROBIOL, V199, P1; Ziebold U, 1997, CURR BIOL, V7, P253, DOI 10.1016/S0960-9822(06)00121-7	74	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4088	4097		10.1074/jbc.M105112200	http://dx.doi.org/10.1074/jbc.M105112200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733503	hybrid			2022-12-27	WOS:000173813900040
J	Wang, ZJ; Lazarov, E; O'Donnell, M; Goodman, MF				Wang, ZJ; Lazarov, E; O'Donnell, M; Goodman, MF			Resolving a fidelity paradox - Why Escherichia coli DNA polymerase II makes more base substitution errors in at- compared with GC-RICH DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC ACID POLYMERASES; MISPAIR EXTENSION KINETICS; SPONTANEOUS MUTATION; BIOCHEMICAL BASIS; WILD-TYPE; TRANSIENT MISALIGNMENT; REVERSE-TRANSCRIPTASE; INSERTION FIDELITY; POL-II; HOLOENZYME	The activity of DNA polymerase-associated proofreading 3'-exonucleases is generally enhanced in less stable DNA regions leading to a reduction in base substitution error frequencies in AT- versus GC-rich sequences. Unexpectedly, however, the opposite result was found for Escherichia coli DNA polymerase 11 (pol II). Nucleotide misincorporation frequencies for pol 11 were found to be 3-5-fold higher in AT- compared with GC-rich DNA, both in the presence and absence of polymerase processivity subunits, beta dimer and gamma complex. In contrast, E. coli pol III holoenzyme, behaving "as expected," exhibited 3-5-fold lower misincorporation frequencies in AT-rich DNA. A reduction in fidelity in AT-rich regions occurred for pol 11 despite having an associated X-exonuclease proofreading activity that preferentially degrades AT-rich compared with GC-rich DNA primer-template in the absence of DNA synthesis. Concomitant with a reduction in fidelity, pol 11 polymerization efficiencies were 2-6-fold higher in AT-rich DNA, depending on sequence context. Pol II paradoxical fidelity behavior can be accounted for by the enzyme's preference for forward polymerization in AT-rich sequences. The more efficient polymerization suppresses proofreading thereby causing a significant increase in base substitution error rates in AT-rich regions.	Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA; Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	University of Southern California; Rockefeller University; Howard Hughes Medical Institute	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, SHS Rm 172,Univ Pk, Los Angeles, CA 90089 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R37GM021422, R01GM021422, R01GM038839] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 38839, GM21422, GM42554] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BESSMAN MJ, 1974, J MOL BIOL, V88, P409, DOI 10.1016/0022-2836(74)90491-4; BESSMAN MJ, 1977, J MOL BIOL, V116, P115, DOI 10.1016/0022-2836(77)90122-X; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; BLOOM LB, 1993, BIOCHEMISTRY-US, V32, P11247, DOI 10.1021/bi00092a039; BONNER CA, 1992, J BIOL CHEM, V267, P11431; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; Cai H, 1995, METHOD ENZYMOL, V262, P13; CLAYTON LK, 1979, J BIOL CHEM, V254, P1902; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; CREIGHTON S, 1992, J BIOL CHEM, V267, P2633; CREIGHTON S, 1995, J BIOL CHEM, V270, P4759, DOI 10.1074/jbc.270.9.4759; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Efrati E, 1997, J BIOL CHEM, V272, P2559; Fersht A, 1985, ENZYME STRUCTURE MEC, P105; FERSHT AR, 1979, P NATL ACAD SCI USA, V76, P4946, DOI 10.1073/pnas.76.10.4946; FOSTER PL, 1995, P NATL ACAD SCI USA, V92, P7951, DOI 10.1073/pnas.92.17.7951; Foster PL, 2000, COLD SPRING HARB SYM, V65, P21, DOI 10.1101/sqb.2000.65.21; Fygenson DK, 1997, J BIOL CHEM, V272, P27931, DOI 10.1074/jbc.272.44.27931; GALAS DJ, 1978, J MOL BIOL, V88, P653; Goodman MF, 1998, GENETICS, V148, P1475; IWASAKI H, 1990, J BACTERIOL, V172, P6268, DOI 10.1128/jb.172.11.6268-6273.1990; KNIPPERS R, 1970, NATURE, V228, P1050, DOI 10.1038/2281050a0; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A., 1992, DNA REPLICATION, P165; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MUZYCZKA N, 1972, J BIOL CHEM, V247, P7116; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; PETRUSKA J, 1985, J BIOL CHEM, V260, P7533; PLESS RC, 1983, BIOCHEMISTRY-US, V22, P4905, DOI 10.1021/bi00290a006; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; TESSMAN I, 1993, GENETICS, V136, P439	43	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4446	4454		10.1074/jbc.M110006200	http://dx.doi.org/10.1074/jbc.M110006200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733526	hybrid			2022-12-27	WOS:000173813900087
J	Goldhaber-Gordon, I; Williams, TL; Baker, TA				Goldhaber-Gordon, I; Williams, TL; Baker, TA			DNA recognition sites activate MuA transposase to perform transposition of non-Mu DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-MU; STRAND TRANSFER; PHAGE-MU; SYNAPTIC COMPLEX; CLEAVAGE; PROTEIN; ENDS; RECOMBINATION; TETRAMER; INTERMEDIATE	Mu transposition occurs within a large protein-DNA complex called a transpososome. This stable complex includes four subunits of MuA transposase, each contacting a 22-base pair recognition site located near an end of the transposon DNA. These MuA recognition sites are critical for assembling the transpososome. Here we report that when concentrations of Mu DNA are limited, the MuA recognition sites permit assembly of transpososomes in which non-Mu DNA substitutes for some of the Mu sequences. These "hybrid" transpososomes are stable to competitor DNA, actively transpose the non-Mu DNA, and produce transposition products that had been previously observed but not explained. The strongest activator of non-Mu transposition is a DNA fragment containing two MuA recognition sites and no cleavage site, but a shorter fragment with just one recognition site is sufficient. Based on our results, we propose that MuA recognition sites drive assembly of functional transpososomes in two complementary ways. Multiple recognition sites help physically position MuA subunits in the transpososome plus each individual site allosterically activates transposase.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave,68-523, Cambridge, MA 02139 USA.				NIGMS NIH HHS [R01 GM049224, GM499224, R01 GM049224-09] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049224] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Aldaz H, 1996, CELL, V85, P257, DOI 10.1016/S0092-8674(00)81102-2; ARTHUR A, 1984, EMBO J, V3, P1723, DOI 10.1002/j.1460-2075.1984.tb02038.x; ASTROMOFF A, 1995, P NATL ACAD SCI USA, V92, P8110, DOI 10.1073/pnas.92.18.8110; AVILA P, 1984, MOL GEN GENET, V195, P288, DOI 10.1007/BF00332761; BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; BAKER TA, 1994, P NATL ACAD SCI USA, V91, P6654, DOI 10.1073/pnas.91.14.6654; BAKER TA, 1994, GENE DEV, V8, P2416, DOI 10.1101/gad.8.20.2416; Bhasin A, 2000, J MOL BIOL, V302, P49, DOI 10.1006/jmbi.2000.4048; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Chaconas G, 1999, BIOCHEM CELL BIOL, V77, P487, DOI 10.1139/bcb-77-6-487; Coros CJ, 2001, J MOL BIOL, V310, P299; CRAIGIE R, 1986, CELL, V45, P793, DOI 10.1016/0092-8674(86)90554-4; CRAIGIE R, 1984, CELL, V39, P387, DOI 10.1016/0092-8674(84)90017-5; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Goldhaber-Gordon I, 2002, J BIOL CHEM, V277, P7703, DOI 10.1074/jbc.M110342200; GROENEN MAM, 1986, EMBO J, V5, P3687, DOI 10.1002/j.1460-2075.1986.tb04700.x; GROENEN MAM, 1986, J MOL BIOL, V189, P597, DOI 10.1016/0022-2836(86)90490-0; Hallet B, 1997, FEMS MICROBIOL REV, V21, P157, DOI 10.1016/S0168-6445(97)00055-7; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; KIM K, 1995, J BIOL CHEM, V270, P1472, DOI 10.1074/jbc.270.3.1472; KUO CF, 1991, EMBO J, V10, P1585, DOI 10.1002/j.1460-2075.1991.tb07679.x; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; Lavoie BD, 1996, CELL, V85, P761, DOI 10.1016/S0092-8674(00)81241-6; Lee I, 2001, J MOL BIOL, V314, P433, DOI 10.1006/jmbi.2001.5177; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lewis SM, 1997, MOL CELL BIOL, V17, P3125, DOI 10.1128/MCB.17.6.3125; MAXWELL A, 1987, P NATL ACAD SCI USA, V84, P699, DOI 10.1073/pnas.84.3.699; Messer W, 2001, BIOCHIMIE, V83, P5, DOI 10.1016/S0300-9084(00)01216-5; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; MIZUUCHI M, 1991, P NATL ACAD SCI USA, V88, P9031, DOI 10.1073/pnas.88.20.9031; MIZUUCHI M, 1993, COLD SPRING HARB SYM, V58, P515, DOI 10.1101/SQB.1993.058.01.058; MOTSCH S, 1984, MOL GEN GENET, V195, P281, DOI 10.1007/BF00332760; NAKAYAMA C, 1987, P NATL ACAD SCI USA, V84, P1809, DOI 10.1073/pnas.84.7.1809; NAMGOONG S, 1994, J MOL BIOL, V238, P514, DOI 10.1006/jmbi.1994.1311; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; Sixma TK, 2001, CURR OPIN STRUC BIOL, V11, P47, DOI 10.1016/S0959-440X(00)00169-X; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; Wah DA, 1997, NATURE, V388, P97, DOI 10.1038/40446; Watson MA, 1996, CELL, V85, P435, DOI 10.1016/S0092-8674(00)81121-6; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725; Yamauchi M, 1998, EMBO J, V17, P5509, DOI 10.1093/emboj/17.18.5509; ZOU A, 1991, J BIOL CHEM, V266, P20476	49	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7694	7702		10.1074/jbc.M110341200	http://dx.doi.org/10.1074/jbc.M110341200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756423	hybrid			2022-12-27	WOS:000174268000012
J	Hwang, JS; Bogner, E				Hwang, JS; Bogner, E			ATPase activity of the terminase subunit pUL56 of human cytomegalovirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX VIRUS TYPE-1; GENE-PRODUCT; A-SEQUENCE; UL28 GENE; DNA; BACTERIOPHAGE-T4; CLEAVAGE; GENOME; UL56; IDENTIFICATION	Herpesviral DNA packaging is a complex process resulting in unit-length genomes packed into preformed procapsids. This process is believed to be mediated by two packaging proteins, the terminase subunits. In the case of double-stranded DNA bacteriophages, the translocation of DNA was shown to be an energy-dependent process associated with an ATPase activity of the large terminase subunit. In the case of human cytomegalovirus it was not known which protein has the ability to hydrolyze ATP. In this study we expressed human cytomegalovirus terminase subunits, pUL89 and the carboxyl-terminal half of pUL56, as GST fusion proteins and purified these by affinity chromatography. ATPase assays demonstrated that the enzymatic activity is exclusively associated with pUL56. The characterization of the ATP hydrolysis showed that the enzymatic reaction is a fast process, whereas the spontaneous ATP decay followed slow kinetics. Interestingly, although pUL89 did not show any ATPase activity, it was capable of enhancing the UL56-associated ATP hydrolysis. Furthermore, a specific association of in vitro translated pUL89 with the carboxyl-terminal half of GST-UL56C was detected. This interaction was confirmed by co-immunoprecipitations of infected cells. Our results clearly demonstrated that (i) both terminase subunits interact with each other and (ii) the subunit pUL56 has an ATPase activity.	Univ Erlangen Nurnberg, Inst Klin & Mol Virol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Bogner, E (corresponding author), Univ Erlangen Nurnberg, Inst Klin & Mol Virol, Schlossgarten 4, D-91054 Erlangen, Germany.		Bogner, Elke/AAG-2207-2019	Bogner, Elke/0000-0001-7622-2900				ADDISON C, 1990, J GEN VIROL, V71, P2377, DOI 10.1099/0022-1317-71-10-2377; Adelman K, 2001, P NATL ACAD SCI USA, V98, P3086, DOI 10.1073/pnas.061555698; BHATTACHARYYA SP, 1994, GENE, V146, P67, DOI 10.1016/0378-1119(94)90834-6; BHATTACHARYYA SP, 1993, VIROLOGY, V196, P34, DOI 10.1006/viro.1993.1452; BLACK LW, 1995, BIOESSAYS, V17, P1025, DOI 10.1002/bies.950171206; BLACK LW, 1988, BACTERIOPHAGES, V2, P321; BLACK LW, 1994, MOL BIOL BACTERIOP T, V4, P218; BOGNER E, 1993, VIROLOGY, V196, P290, DOI 10.1006/viro.1993.1477; Bogner E, 1998, J VIROL, V72, P2259, DOI 10.1128/JVI.72.3.2259-2264.1998; BOGNER E, 1999, GENE THER MOL BIOL, V3, P75; Casjens S., 1988, BACTERIOPHAGES, V1, P16; CHOU J, 1985, CELL, V41, P803, DOI 10.1016/S0092-8674(85)80061-1; DAVISON AJ, 1992, VIROLOGY, V186, P9, DOI 10.1016/0042-6822(92)90056-U; DEISS LP, 1986, J VIROL, V59, P605, DOI 10.1128/JVI.59.3.605-618.1986; EPPLER K, 1991, VIROLOGY, V183, P519, DOI 10.1016/0042-6822(91)90981-G; FEISS M, 1983, LAMBDA, V2, P305; FUJISAWA H, 1994, SEMIN VIROL, V5, P5, DOI 10.1006/smvy.1994.1002; Giesen K, 2000, J GEN VIROL, V81, P2231, DOI 10.1099/0022-1317-81-9-2231; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; HIGGINS RR, 1994, EMBO J, V13, P6152, DOI 10.1002/j.1460-2075.1994.tb06962.x; Krosky PM, 1998, J VIROL, V72, P4721, DOI 10.1128/JVI.72.6.4721-4728.1998; Kuebler D, 1998, J MOL BIOL, V281, P803, DOI 10.1006/jmbi.1998.1952; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; METTENLEITER TC, 1993, J VIROL, V67, P1236, DOI 10.1128/JVI.67.3.1236-1245.1993; POWELL D, 1990, NUCLEIC ACIDS RES, V18, P4005, DOI 10.1093/nar/18.13.4005; RAO VB, 1996, 11 EV INT BACT T4 M; SHIBATA H, 1987, J MOL BIOL, V196, P845, DOI 10.1016/0022-2836(87)90409-8; SMITH MP, 1993, J BACTERIOL, V175, P2393, DOI 10.1128/JB.175.8.2393-2399.1993; SPAETE RR, 1985, J VIROL, V54, P817, DOI 10.1128/JVI.54.3.817-824.1985; TENGELSEN LA, 1993, J VIROL, V67, P3470, DOI 10.1128/JVI.67.6.3470-3480.1993; TOWNSEND LB, 1995, J MED CHEM, V38, P4098, DOI 10.1021/jm00020a025; Underwood MR, 1998, J VIROL, V72, P717, DOI 10.1128/JVI.72.1.717-725.1998; Yu D, 1998, VIROLOGY, V243, P32, DOI 10.1006/viro.1998.9041	33	58	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6943	6948		10.1074/jbc.M108984200	http://dx.doi.org/10.1074/jbc.M108984200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744697	hybrid			2022-12-27	WOS:000174104300027
J	Ratnikov, BI; Rozanov, DV; Postnova, TI; Baciu, PG; Zhang, H; DiScipio, RG; Chestukhina, GG; Smith, JW; Deryugina, EI; Strongin, AY				Ratnikov, BI; Rozanov, DV; Postnova, TI; Baciu, PG; Zhang, H; DiScipio, RG; Chestukhina, GG; Smith, JW; Deryugina, EI; Strongin, AY			An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE-A MMP-2; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MELANOMA-CELLS; LIGAND-BINDING; ACTIVATED FORM; B MMP-9; INVASION; FIBRONECTIN; COLLAGENASE	Membrane type-1 matrix metalloproteinase (MT1-MMP) and alpha(v)beta(3), integrin are both essential to cell invasion. Maturation of integrin pro-alpha(v) chain (pro-a(v)) involves its cleavage by proprotein convertases (PC) to form the disulfide-bonded 125-kDa heavy and 25-kDa light a chains. Our report presents evidence of an alternative pathway of pro-av processing involving MT1-MMP. In breast carcinoma MCF7 cells deficient in MT1-MMP, pro-a, is processed by a conventional furin-like PC, and the mature a, integrin subunit is represented by the 125-kDa heavy chain and the 25-kDa light chain commencing from the N-terminal Asp(891). In contrast, in cells co-expressing alpha(v)beta(3) and MT1-MMP, MT1-MMP functions as an integrin convertase. MT1-MMP specifically cleaves pro-av, generating a 115-kDa heavy chain with the truncated C terminus and a 25-kDa light chain commencing from the N-terminal Leu(892). PC-cleavable a. and a, but not the PC-resistant alpha(2) integrin subunit are also susceptible to MT1-MMP cleavage. These novel mechanisms involved in the processing of integrin a subunits underscore the significance and complexity of interactions between MT1-MMP and adhesion receptors and suggest that regulation of integrin functionality may be an important role of MT1-MMP in migrating tumor cells.	Burnham Inst, La Jolla, CA 92037 USA; Allergan Pharmaceut Inc, Irvine, CA 92612 USA; La Jolla Inst Mol Med, San Diego, CA 92121 USA; Fed Res Ctr Genetika, Moscow 113545, Russia	Sanford Burnham Prebys Medical Discovery Institute; AbbVie; Allergan	Strongin, AY (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER; NCI NIH HHS [CA 83017, CA 77470] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrez M, 1999, INT J CANCER, V81, P90, DOI 10.1002/(SICI)1097-0215(19990331)81:1<90::AID-IJC16>3.0.CO;2-K; AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Bafetti LM, 1998, J BIOL CHEM, V273, P143, DOI 10.1074/jbc.273.1.143; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P10003, DOI 10.1073/pnas.90.21.10003; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Berthet V, 2000, J BIOL CHEM, V275, P33308, DOI 10.1074/jbc.M004834200; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, EUR J CANCER, V32A, P2423, DOI 10.1016/S0959-8049(96)00381-4; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; DELCOMMENNE M, 1995, J BIOL CHEM, V270, P26794, DOI 10.1074/jbc.270.45.26794; Delwel GO, 1996, J BIOL CHEM, V271, P7293, DOI 10.1074/jbc.271.13.7293; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; DERYUGINA EI, 2002, IN PRESS J BIOL CHEM, V277; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hofmann UB, 2000, INT J CANCER, V87, P12, DOI 10.1002/1097-0215(20000701)87:1<12::AID-IJC3>3.0.CO;2-A; Holly SP, 2000, EXP CELL RES, V261, P69, DOI 10.1006/excr.2000.5040; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Kubota S, 1997, INT J CANCER, V70, P106; Lehmann M, 1996, BIOCHEM J, V317, P803, DOI 10.1042/bj3170803; Lissitzky JC, 2000, BIOCHEM J, V346, P133, DOI 10.1042/0264-6021:3460133; Madri J A, 2000, Dev Immunol, V7, P103, DOI 10.1155/2000/79045; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Ohkubo S, 1999, BIOCHEM BIOPH RES CO, V266, P308, DOI 10.1006/bbrc.1999.1816; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Shalinsky DR, 1999, CLIN CANCER RES, V5, P1905; SMITH JW, 1994, J BIOL CHEM, V269, P32788; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; SUZUKI S, 1986, P NATL ACAD SCI USA, V83, P8614, DOI 10.1073/pnas.83.22.8614; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; TREMBLE P, 1994, MOL BIOL CELL, V5, P439, DOI 10.1091/mbc.5.4.439; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3; Xu FP, 2001, EXP CELL RES, V262, P49, DOI 10.1006/excr.2000.5075; Yakubenko VP, 2000, EXP CELL RES, V260, P73, DOI 10.1006/excr.2000.5002	43	127	133	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7377	7385		10.1074/jbc.M109580200	http://dx.doi.org/10.1074/jbc.M109580200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741954	hybrid			2022-12-27	WOS:000174104300082
J	Stros, M; Ozaki, T; Bacikova, A; Kageyama, H; Nakagawara, A				Stros, M; Ozaki, T; Bacikova, A; Kageyama, H; Nakagawara, A			HMGB1 and HMGB2 cell-specifically down-regulate the p53-and p73-dependent sequence-specific transactivation from the human Bax gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; DNA-BENDING PROTEINS; MAMMALIAN-CELLS; V(D)J RECOMBINATION; INDUCE APOPTOSIS; BINDING PROTEIN; TERMINAL DOMAIN; P73 FUNCTION; HMG-1; TRANSCRIPTION	The recently cloned gene p73 is a close homologue of p53, which is a crucial tumor suppressor gene for preventing the malignant transformation of cells by inducing cell cycle arrest and apoptosis. Previous reports have shown that architectural DNA-bending/looping chromosomal proteins HMGB1 and HMGB2 (formerly known as HMG1 and HMG2), which function in a number of biological processes including transcription and DNA repair, interact in vitro with p53 and stimulate p53 binding to DNA containing p53 consensus sites. Here, we report that HMGB1 physically interacts with two splicing variants of p73, alpha and beta (pull-down assay), and enhances binding of p73 to specific cognate DNA sites (gel-shift assay). Both HMG box domains of HMGB1, A and B, interact with p73alpha. Association of HMGB1 with p73, like the demonstrated ability of HMGB1 to stimulate p73 binding to different p53-responsive elements, requires the oligomerization region and/or region between DNA-binding domain and oligomerization domain of p73 (residues 312-381). Transient transfections revealed that ectopically expressed or endogenous HMGB1 and HMGB2 (antisense strategy) significantly inhibit in vivo both p73alpha/beta- and p53-dependent transactivation from the Bax gene promoter (and much less from Mdm2 and p21(waf1) promoters) in p53-deficient SAOS-2 cells. In contrast, HMGB1 and HGMB2 stimulate p73- or p53-dependent transactivation in p53-deficient H1299 cells, irrespective of the promoter used. Our results suggest that ubiquitously expressed HMGB1 and HMGB2 have potential to cell- and promoter-specifically down- or up-regulate in vivo transcriptional activity of different members of the p53 family. A possible mechanism of HMGB1-mediated modulation of p73- and p53-dependent transactivation is discussed.	Chiba Canc Ctr, Res Inst, Div Biochem, Chuoh Ku, Chiba 2608717, Japan; Acad Sci Czech Republ, Inst Biophys, Brno 61265, Czech Republic	Chiba Cancer Center; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Nakagawara, A (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem, Chuoh Ku, 666-2 Nitona, Chiba 2608717, Japan.							Agami R, 1999, NATURE, V399, P809; Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Brickman JM, 1999, P NATL ACAD SCI USA, V96, P10679, DOI 10.1073/pnas.96.19.10679; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Das D, 2001, J BIOL CHEM, V276, P32597, DOI 10.1074/jbc.M011792200; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Ellwood KB, 2000, MOL CELL BIOL, V20, P4359, DOI 10.1128/MCB.20.12.4359-4370.2000; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; GE H, 1994, J BIOL CHEM, V269, P17136; He Q, 2000, P NATL ACAD SCI USA, V97, P5768, DOI 10.1073/pnas.100108697; Ichimiya S, 2000, PATHOL INT, V50, P589, DOI 10.1046/j.1440-1827.2000.01090.x; Imamura T, 2001, J BIOL CHEM, V276, P7534, DOI 10.1074/jbc.M008143200; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kaelin WG, 1999, J NATL CANCER I, V91, P594, DOI 10.1093/jnci/91.7.594; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kaku S, 2001, NUCLEIC ACIDS RES, V29, P1989, DOI 10.1093/nar/29.9.1989; Kasparkova J, 2001, J BIOL CHEM, V276, P16064, DOI 10.1074/jbc.M101224200; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; MIYASHITA T, 1995, CELL, V80, P293; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Nagaich AK, 1997, J BIOL CHEM, V272, P14842, DOI 10.1074/jbc.272.23.14842; Nagatani G, 2001, CANCER RES, V61, P1592; Naka M, 2001, ONCOGENE, V20, P3568, DOI 10.1038/sj.onc.1204470; ONATE SA, 1994, MOL CELL BIOL, V14, P3376, DOI 10.1128/MCB.14.5.3376; Oren M, 1997, CELL, V90, P829, DOI 10.1016/S0092-8674(00)80347-5; Ozaki T, 1999, CANCER RES, V59, P5902; Pasheva EA, 1998, J BIOL CHEM, V273, P24730, DOI 10.1074/jbc.273.38.24730; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; Sawchuk DJ, 1997, J EXP MED, V185, P2025, DOI 10.1084/jem.185.11.2025; Shibata MA, 1999, EMBO J, V18, P2692, DOI 10.1093/emboj/18.10.2692; Shu HKG, 1998, P NATL ACAD SCI USA, V95, P14453, DOI 10.1073/pnas.95.24.14453; Strano S, 2001, FEBS LETT, V490, P163, DOI 10.1016/S0014-5793(01)02119-6; Stros M, 1998, J BIOL CHEM, V273, P10355; Stros M, 2001, BIOCHEMISTRY-US, V40, P4769, DOI 10.1021/bi002741i; Stros M, 2000, J BIOL CHEM, V275, P35699, DOI 10.1074/jbc.M007167200; Sutrias-Grau M, 1999, J BIOL CHEM, V274, P1628, DOI 10.1074/jbc.274.3.1628; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Thornborrow EC, 1999, J BIOL CHEM, V274, P33747, DOI 10.1074/jbc.274.47.33747; Ueda Y, 1999, ONCOGENE, V18, P4993, DOI 10.1038/sj.onc.1202817; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	54	157	162	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7157	7164		10.1074/jbc.M110233200	http://dx.doi.org/10.1074/jbc.M110233200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11748232	hybrid			2022-12-27	WOS:000174104300053
J	Zhou, YT; Soh, UJK; Shang, X; Guy, GR; Low, BC				Zhou, YT; Soh, UJK; Shang, X; Guy, GR; Low, BC			The BNIP-2 and Cdc42GAP homology/Sec14p-like domain of BNIP-S alpha is a novel apoptosis-inducing sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; MOLECULAR-CLONING; HOMOLOGY DOMAIN; DEATH; GENE; FAMILY; IDENTIFICATION; TRANSLOCATION; EXPRESSION; INHIBITOR	We have cloned the cDNAs for two novel human proteins, designated BNIP-Sa and 13 (for BNIP-2 Similar) that are homologous to BNIP-2, a previously known Bcl-2 and E1B-associated protein. The BNIP-S gene encodes two protein isoforms; the longer protein (BNIP-Salpha) contains a complete BNIP-2 and Cdc42GAP Homology (BCH) domain, a novel protein domain that we recently identified, whereas its shorter variant (BNIP-Sbeta) lacks the full BCH domain as a result of an alternative RNA splicing that introduces a nonsense intron. Primer-specific reverse-transcription PCR revealed that both BNIP-Salpha and BNIP-Sbeta mRNA are differentially expressed in various cells and tissues. The expression of BNIP-Sa or the complete BCH domain, but not BNIP-Sbeta, causes extensive apoptosis in cells. Furthermore, BNIP-Salpha can form a homophilic complex via a unique sequence motif within its BCH domain, and deletion of this interacting motif prevents its pro-apoptotic effect. These results indicate the presence of two BNIP-S splicing variants as cellular regulators and that the BCH domain of BNIP-Sa confers a novel apoptotic function. The significance of this is discussed.	Natl Univ Singapore, Cell Signaling & Dev Biol Lab, Dept Biol Sci, Singapore 117543, Singapore; Inst Mol & Cell Biol, Signal Transduct Lab, Singapore 117609, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Low, BC (corresponding author), Natl Univ Singapore, Cell Signaling & Dev Biol Lab, Dept Biol Sci, Blk S2,14 Sci Dr 4, Singapore 117543, Singapore.	dbslowbc@nus.edu.sg	Low, Boon Chuan/AAU-7685-2021; Low, Boon Chuan/H-8049-2012	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Zhou, Yi-Ting/0000-0003-4543-3099				Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Aravind L, 1999, CURR BIOL, V9, pR195, DOI 10.1016/S0960-9822(99)80127-4; Ashhab Y, 2001, FEBS LETT, V495, P56, DOI 10.1016/S0014-5793(01)02366-3; Baltimore D, 2001, NATURE, V409, P814, DOI 10.1038/35057267; BARFOD ET, 1993, J BIOL CHEM, V268, P26059; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Chan SL, 1999, J BIOL CHEM, V274, P32461, DOI 10.1074/jbc.274.45.32461; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; IIDA Y, 1990, J THEOR BIOL, V145, P523, DOI 10.1016/S0022-5193(05)80486-2; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; LANCASTER CA, 1994, J BIOL CHEM, V269, P1137; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Low BC, 1999, J BIOL CHEM, V274, P33123, DOI 10.1074/jbc.274.46.33123; Low BC, 2000, J BIOL CHEM, V275, P14415, DOI 10.1074/jbc.275.19.14415; Low BC, 2000, J BIOL CHEM, V275, P37742, DOI 10.1074/jbc.M004897200; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Otomo T, 2000, NAT STRUCT BIOL, V7, P658, DOI 10.1038/77957; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2000, GENE DEV, V14, P1027; Phillips SE, 1999, MOL CELL, V4, P187, DOI 10.1016/S1097-2765(00)80366-4; Porter AG, 1999, TRENDS CELL BIOL, V9, P394, DOI 10.1016/S0962-8924(99)01624-4; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Sambrook J., 2001, MOL CLONING LAB MANU; Spector D. L., 1998, CELLS LAB MANUAL; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sun YF, 2001, J BIOL CHEM, V276, P16240, DOI 10.1074/jbc.M010419200; Takayama S, 1996, GENOMICS, V35, P494, DOI 10.1006/geno.1996.0389; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	43	37	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7483	7492		10.1074/jbc.M109459200	http://dx.doi.org/10.1074/jbc.M109459200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741952	hybrid			2022-12-27	WOS:000174104300094
J	Dutertre, S; Sekhri, R; Tintignac, LA; Onclercq-Delic, R; Chatton, B; Jaulin, C; Amor-Gueret, M				Dutertre, S; Sekhri, R; Tintignac, LA; Onclercq-Delic, R; Chatton, B; Jaulin, C; Amor-Gueret, M			Dephosphorylation and subcellular compartment change of the mitotic Bloom's syndrome DNA helicase in response to ionizing radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME GENE-PRODUCT; CYCLIN-DEPENDENT KINASES; TOPOISOMERASE-III; DAMAGE CHECKPOINT; NUCLEAR MATRIX; PROTEIN; CELLS; CDC2; TRANSCRIPTION; ROSCOVITINE	Bloom's syndrome is a rare human autosomal recessive disorder that combines a marked genetic instability and an increased risk of developing all types of cancers and which results from mutations in both copies of the BLM gene encoding a RecQ 3'-5' DNA helicase. We recently showed that BLM is phosphorylated and excluded from the nuclear matrix during mitosis. We now show that the phosphorylated mitotic BLM protein is associated with a 3'-5' DNA helicase activity and interacts with topoisomerase IIIalpha. We demonstrate that in mitosis-arrested cells, ionizing radiation and roscovitine treatment both result in the reversion of BLM phosphorylation, suggesting that BLM could be dephosphorylated through the inhibition of cdc2 kinase. This was supported further by our data showing that cdc2 kinase activity is inhibited in gamma-irradiated mitotic cells. Finally we show that after ionizing radiation, BLM is not involved in the establishment of the mitotic DNA damage checkpoint but is subjected to a subcellular compartment change. These findings lead us to propose that BLM may be phosphorylated during mitosis, probably through the cdc2 pathway, to form a pool of rapidly available active protein. Inhibition of cdc2 kinase after ionizing radiation would lead to BLM dephosphorylation and possibly to BLM recruitment to some specific sites for repair.	Inst Gustave Roussy, CNRS, UMR 1598, F-94805 Villejuif, France; Inst Gustave Roussy, UMR 1599, F-94805 Villejuif, France; Ecole Super Biotechnol Strasbourg, UMR 7100, CNRS, F-67400 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Amor-Gueret, M (corresponding author), Inst Gustave Roussy, CNRS, UMR 1598, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	amor@igr.fr	CHATTON, Bruno/R-3813-2019; Jaulin, Christian/L-9126-2018	Tintignac, Lionel/0000-0001-5902-1138; CHATTON, Bruno/0000-0003-4515-7119				Ababou M, 2000, ONCOGENE, V19, P5955, DOI 10.1038/sj.onc.1204003; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Bischof O, 2001, J BIOL CHEM, V276, P12068, DOI 10.1074/jbc.M006462200; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Frei C, 2000, GENE DEV, V14, P81; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Koehler DR, 1996, NUCLEIC ACIDS RES, V24, P2877, DOI 10.1093/nar/24.15.2877; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; Nigg E A, 1991, Semin Cell Biol, V2, P261; Poon RYC, 1997, CANCER RES, V57, P5168; Roti JLR, 1997, CRIT REV EUKAR GENE, V7, P343, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.30; Sirri V, 2000, J CELL BIOL, V148, P259, DOI 10.1083/jcb.148.2.259; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Wang Y, 2000, GENE DEV, V14, P927; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	31	30	30	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6280	6286		10.1074/jbc.M105735200	http://dx.doi.org/10.1074/jbc.M105735200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741924	hybrid, Green Published			2022-12-27	WOS:000173989200078
J	Iso, T; Chung, G; Hamamori, Y; Kedes, L				Iso, T; Chung, G; Hamamori, Y; Kedes, L			HERP1 is a cell type-specific primary target of Notch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RBP-J-KAPPA; DROSOPHILA HAIRY; DELTA-HOMOLOG; HEY GENES; DIFFERENTIATION; EXPRESSION; ENHANCER; PROMOTER; SPLIT; TRANSCRIPTION	Notch signaling is involved in many cell fate determination events in metazoans. Ligand binding results in proteolytic cleavage to release the signal-transducing Notch intracellular domain (NICD). The nuclear protein RBP-Jkappa, when complexed with NICD, acts as a transcriptional activator which, in turn, induces a target gene of Notch such as the repressors HES/E(spl) and HERP2. Under physiological stimulation using co-culture with Notch ligand-expressing cells and target cells expressing Notch receptors, the HES1 gene and the HERP2 gene have been shown to be directly up-regulated by Notch ligand binding. However, expression of another member of the HERP family, HERP1, was not induced by ligand stimulation in any cells tested, leading to the suggestion that HERP1 may not be an immediate target of Notch or that Notch pathways can be cell type-specific. Because HERP1 appears to play a central role in the development of the aorta (Zhong, T. P., Rosenberg, M., Mohideen, M. A., Weinstein, B., and Fishman, M. C. (2000) Science 287, 1820-1824), we re-addressed the issue of its relationship with the Notch pathway by examining its expression in A10 smooth muscle cells derived from thoracic aorta. We show that in these specific cells HERP1 is also a direct target gene of Notch. NICD activates the HERP1 promoter in an RBP-Jkappa-dependent manner, and induces expression of endogenous HERP1 mRNA as well as HERP1 protein in A10 cells. Co-culture with Notch ligand-bearing cells induces endogenous HERP1 mRNA expression in A10 cells, and these events occur even in the absence of de novo protein synthesis. In addition, RBP-Jkappa proved essential for induction of HERP1 m-RNA in Notch signaling because exogenous RBP-Jkappa was sufficient to rescue HERP1 mRNA expression in RBP-Jkappa-deficient cells. These findings provide the first solid evidence that HERP1 is a novel primary target of Notch and underscores the cell-specific complexity of the Notch regulatory pathway. Given that Notch signaling plays a crucial role in vascular development, Notch may derive its function via HERP family members.	Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90089 USA; Baylor Coll Med, Dept Med, Ctr Cardiovasc Dev, Houston, TX 77030 USA	University of Southern California; University of Southern California; University of Southern California; Baylor College of Medicine	Kedes, L (corresponding author), 1 Baylor Plaza,506D, Houston, TX 77030 USA.	hamamori@bcm.tmc.edu; kedes@hsc.usc.edu		Iso, Tatsuya/0000-0001-5045-1676				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; Chen YY, 1997, J BIOL CHEM, V272, P14110, DOI 10.1074/jbc.272.22.14110; Chin MT, 2000, J BIOL CHEM, V275, P6381, DOI 10.1074/jbc.275.9.6381; CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Egan SE, 1998, CURR TOP MICROBIOL, V228, P273; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Hsieh JJD, 1997, J VIROL, V71, P1938, DOI 10.1128/JVI.71.3.1938-1945.1997; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Iso T, 2001, MOL CELL BIOL, V21, P6071, DOI 10.1128/MCB.21.17.6071-6079.2001; ISRAEL A, 1989, NUCLEIC ACIDS RES, V17, P5245, DOI 10.1093/nar/17.13.5245; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kannabiran C, 1997, MOL CELL BIOL, V17, P1, DOI 10.1128/MCB.17.1.1; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1997, DEVELOPMENT, V124, P4133; Kitagawa M, 2001, MOL CELL BIOL, V21, P4337, DOI 10.1128/MCB.21.13.4337-4346.2001; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Krebs LT, 2000, GENE DEV, V14, P1343; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Lam LT, 1998, J BIOL CHEM, V273, P24223, DOI 10.1074/jbc.273.37.24223; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lin MH, 2000, DEVELOPMENT, V127, P2421; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; LING PD, 1994, J VIROL, V68, P5375, DOI 10.1128/JVI.68.9.5375-5383.1994; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirakata Y, 1996, J IMMUNOL, V156, P4672; Shutter JR, 2000, GENE DEV, V14, P1313; TAKEBAYASHI K, 1995, J BIOL CHEM, V270, P1342, DOI 10.1074/jbc.270.3.1342; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Uyttendaele H, 2000, MICROVASC RES, V60, P91, DOI 10.1006/mvre.2000.2254; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Weinmaster G, 1998, CURR OPIN GENET DEV, V8, P436, DOI 10.1016/S0959-437X(98)80115-9; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	71	87	89	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6598	6607		10.1074/jbc.M110495200	http://dx.doi.org/10.1074/jbc.M110495200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741889	hybrid			2022-12-27	WOS:000173989200119
J	Moran, AP; Knirel, YA; Senchenkova, SN; Widmalm, G; Hynes, SO; Jansson, PE				Moran, AP; Knirel, YA; Senchenkova, SN; Widmalm, G; Hynes, SO; Jansson, PE			Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms - Acid-induced phase variation in Lewis(X) and Lewis(Y) expression by H. Pylori lipopolysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP ANTIGENS; LIPID-A COMPONENT; O-ANTIGEN; PHOSPHOLIPID CLASSES; GENOME SEQUENCE; DUODENAL-ULCER; STRAINS; INFECTION; CHAIN; TYPE-1	Helicobacter pylori is an important gastroduodenal pathogen of humans whose survival in the gastric environment below pH 4 is dependent on bacterial production of urease, whereas above pH 4 urease-independent mechanisms are involved in survival, but that remain to be elucidated fully. Previous structural investigations on the lipopolysaccharides (LPSs) of H. pylori have shown that the majority of these surface glycolipids express partially fucosylated, glucosylated, or galactosylated N-acetyllactosamine (LacNAc) O-polysaccharide chains containing Lewis(x) (Le(x)) and/or Lewis(y) (Le(y)), although some strains also express type 1 determinants, Lewis(a), Lewis(b), and H-1 antigen. In this study, we investigated acid-induced changes in the structure and composition of LPS and cellular lipids of the genome-sequenced strain, H. pylori 26695. When grown in liquid medium at pH 7, the O-chain consisted of a type 2 LacNAc polysaccharide, which was glycosylated with alpha-L-fucose at O-3 of the majority of N-acetylglucosamine residues forming Le(x) units, including chain termination by a Le(x) unit. However, growth in liquid medium at pH 5 resulted in production of a more complex O-chain whose backbone of type 2 LacNAc units was partially glycosylated with alpha-L-fucose, thus forming Le(x), whereas the majority of the nonfucosylated N-acetylglucosamine residues were substituted at O-6 by alpha-D-galactose residues, and the chain was terminated by a Le(y) unit. In contrast, detailed chemical analysis of the core and lipid A components of LPS and analysis of cellular lipids did not show significant differences between H. pylori 26695 grown at pH 5 and 7. Although putative molecular mechanisms affecting Le(x) and Le(y) expression have been investigated previously, this is the first report identifying an environmental trigger inducing phase variation of Le(x) and Le(y) in H. pylori that can aid adaptation of the bacterium to its ecological niche.	Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, S-14186 Huddinge, Sweden; Natl Univ Ireland Univ Coll Galway, Dept Microbiol, Galway, Ireland; Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow 119991, Russia; Univ Stockholm, Dept Organ Chem, Arrhenius Lab, S-10691 Stockholm, Sweden	Karolinska Institutet; Ollscoil na Gaillimhe-University of Galway; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; Stockholm University	Jansson, PE (corresponding author), Huddinge Univ Hosp, Karolinska Inst, Clin Res Ctr, S-14186 Huddinge, Sweden.	pererik.jansson@kfc.hs.sll.se	Knirel, Yuriy A/E-2058-2014	Hynes, Sean/0000-0002-3092-7945; Widmalm, Goran/0000-0001-8303-4481				Appelmelk BJ, 1999, INFECT IMMUN, V67, P5361, DOI 10.1128/IAI.67.10.5361-5366.1999; Appelmelk BJ, 1996, INFECT IMMUN, V64, P2031, DOI 10.1128/IAI.64.6.2031-2040.1996; Aspinall G. O., 1994, CARBOHYDR LETT, V1, P156; Aspinall GO, 1997, EUR J BIOCHEM, V248, P592, DOI 10.1111/j.1432-1033.1997.00592.x; Aspinall GO, 1996, BIOCHEMISTRY-US, V35, P2489, DOI 10.1021/bi951852s; Aspinall GO, 1996, BIOCHEMISTRY-US, V35, P2498, DOI 10.1021/bi951853k; Aspinall GO, 1999, GLYCOBIOLOGY, V9, P1235; Berg DE, 1997, TRENDS MICROBIOL, V5, P468, DOI 10.1016/S0966-842X(97)01164-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BREG J, 1988, CARBOHYD RES, V183, P19, DOI 10.1016/0008-6215(88)80042-9; Bukholm G, 1997, SCAND J GASTROENTERO, V32, P445, DOI 10.3109/00365529709025079; CHEN HC, 1993, APPL ENVIRON MICROB, V59, P1058, DOI 10.1128/AEM.59.4.1058-1064.1993; CLYNE M, 1995, INFECT IMMUN, V63, P1669, DOI 10.1128/IAI.63.5.1669-1673.1995; Doig P, 1999, MICROBIOL MOL BIOL R, V63, P675, DOI 10.1128/MMBR.63.3.675-707.1999; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; EATON KA, 1994, INFECT IMMUN, V62, P3604, DOI 10.1128/IAI.62.9.3604-3607.1994; Edwards NJ, 2000, MOL MICROBIOL, V35, P1530, DOI 10.1046/j.1365-2958.2000.01823.x; ELOMAR E, 1993, GUT, V34, P1060, DOI 10.1136/gut.34.8.1060; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; GRAHAM DY, 1992, ANN INTERN MED, V116, P705, DOI 10.7326/0003-4819-116-9-705; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; Heneghan MA, 2000, INFECT IMMUN, V68, P937, DOI 10.1128/IAI.68.2.937-941.2000; HERMANSSON K, 1992, CARBOHYD RES, V235, P69, DOI 10.1016/0008-6215(92)80079-G; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hynes SO, 2000, FEMS MICROBIOL LETT, V190, P67, DOI 10.1016/S0378-1097(00)00323-2; Jansson P-E., 1976, CHEM COMMUN U STOCKH, V8, P1; KATES M, 1986, TECHNIQUES LIPIDOLOG, P239; Knirel YA, 1999, EUR J BIOCHEM, V266, P123, DOI 10.1046/j.1432-1327.1999.00831.x; KOBAYASHI K, 1993, AM J GASTROENTEROL, V88, P919; LEE A, 1993, INFECT IMMUN, V61, P1601, DOI 10.1128/IAI.61.5.1601-1610.1993; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; LINDNER B, 1990, ANAL MICROBIOLOGY ME, P149; LONDON E, 1979, J LIPID RES, V20, P408; MALLINGER AG, 1993, J CHROMATOGR-BIOMED, V614, P67, DOI 10.1016/0378-4347(93)80224-R; Marais A, 1999, MICROBIOL MOL BIOL R, V63, P642, DOI 10.1128/MMBR.63.3.642-674.1999; MARSHALL BJ, 1984, LANCET, V1, P1311; Marshall DG, 1999, FEMS IMMUNOL MED MIC, V24, P79, DOI 10.1111/j.1574-695X.1999.tb01268.x; MCCOLL KLE, 1997, PATHOGENESIS HOST RE, P119; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; MOLLICONE R, 1985, LAB INVEST, V53, P219; Monteiro MA, 2000, EUR J BIOCHEM, V267, P305, DOI 10.1046/j.1432-1327.2000.01007.x; Monteiro MA, 1998, J BIOL CHEM, V273, P11533, DOI 10.1074/jbc.273.19.11533; Monteiro MA, 1998, GLYCOBIOLOGY, V8, P107, DOI 10.1093/glycob/8.1.107; Monteiro MA, 2000, GLYCOBIOLOGY, V10, P701, DOI 10.1093/glycob/10.7.701; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Moran AP, 1996, SCAND J GASTROENTERO, V31, P22, DOI 10.3109/00365529609094530; MORAN AP, 1995, FEMS IMMUNOL MED MIC, V10, P271; MORAN AP, 1991, EUR J BIOCHEM, V198, P459, DOI 10.1111/j.1432-1033.1991.tb16036.x; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Moran AP, 2000, FEMS IMMUNOL MED MIC, V29, P263; Moran AP, 1999, J PHYSIOL PHARMACOL, V50, P787; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Pece S, 1995, J ENDOTOXIN RES, V2, P455, DOI 10.1177/096805199600200609; PETTIT RK, 1995, INFECT IMMUN, V63, P2773, DOI 10.1128/IAI.63.7.2773-2775.1995; PIETSCH A, 1993, LIPIDS, V28, P945, DOI 10.1007/BF02537505; QUIGLEY EMM, 1987, GASTROENTEROLOGY, V92, P1876, DOI 10.1016/0016-5085(87)90619-6; Rasko DA, 2000, J INFECT DIS, V181, P1089, DOI 10.1086/315354; RIETSCHEL ET, 1972, EUR J BIOCHEM, V28, P166, DOI 10.1111/j.1432-1033.1972.tb01899.x; Ryan KA, 2000, FEMS IMMUNOL MED MIC, V28, P113, DOI 10.1111/j.1574-695X.2000.tb01464.x; Sakai T, 2000, BUNSEKI KAGAKU, V49, P745, DOI 10.2116/bunsekikagaku.49.745; SAWARDEKER JS, 1965, ANAL CHEM, V37, P1602, DOI 10.1021/ac60231a048; SCHWARZMANN GO, 1974, CARBOHYD RES, V34, P161, DOI 10.1016/S0008-6215(00)80378-X; Shashkov AS, 1997, CARBOHYD RES, V303, P333, DOI 10.1016/S0008-6215(97)00165-1; SimoonsSmit IM, 1996, J CLIN MICROBIOL, V34, P2196, DOI 10.1128/JCM.34.9.2196-2200.1996; Slonczewski J. L, 1996, ESCHERICHIA COLI SAL, P1539; TAO H, 1992, J BACTERIOL, V174, P2222, DOI 10.1128/JB.174.7.2222-2229.1992; Taylor DE, 1998, GASTROENTEROLOGY, V115, P1113, DOI 10.1016/S0016-5085(98)70082-4; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Walsh EJ, 1997, J APPL MICROBIOL, V83, P67, DOI 10.1046/j.1365-2672.1997.00164.x; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wirth HP, 1997, GASTROENTEROLOGY, V113, P1091, DOI 10.1053/gast.1997.v113.pm9322503; Wirth HP, 1996, INFECT IMMUN, V64, P4598, DOI 10.1128/IAI.64.11.4598-4605.1996; Wirth HP, 1999, J LAB CLIN MED, V133, P488, DOI 10.1016/S0022-2143(99)90026-4; WOLLENWEBER HW, 1982, EUR J BIOCHEM, V124, P191, DOI 10.1111/j.1432-1033.1982.tb05924.x; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65	81	80	82	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5785	5795		10.1074/jbc.M108574200	http://dx.doi.org/10.1074/jbc.M108574200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741906	hybrid			2022-12-27	WOS:000173989200014
J	Cote, PD; Moukhles, H; Carbonetto, S				Cote, PD; Moukhles, H; Carbonetto, S			Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha(7B) expression and caveolin-3 distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; COOH-TERMINAL DOMAINS; SKELETAL-MUSCLE; GLYCOPROTEIN-COMPLEX; SARCOGLYCAN COMPLEX; ALPHA-7-BETA-1 INTEGRIN; MOLECULAR-ORGANIZATION; BASEMENT-MEMBRANE; CYSTEINE-RICH; MDX MOUSE	Dystroglycan is part of the dystrophin-associated protein complex, which joins laminin in the extracellular matrix to dystrophin within the subsarcolemmal cytoskeleton. We have investigated how mutations in the components of the laminin-dystroglycan-dystrophin axis affect the organization and expression of dystrophin-associated proteins by comparing mice mutant for merosin (alpha(2)-laminin, dy), dystrophin (mdx), and dystroglycan (Dag1) using immunohistochemistry and immunoblots. We report that syntrophin and neuronal nitric-oxide synthase are depleted in muscle fibers lacking both dystrophin and dystroglycan. Some fibers deficient in dystroglycan, however, localize dystrophin at the cell surface at levels similar to that in wild-type muscle. Nevertheless, these fibers have signs of degeneration/regeneration including increased cell surface permeability and central nuclei. In these fibers, syntrophin and nitric-oxide synthase are also localized to the plasma membrane, whereas the sarcoglycan complex is disrupted. These results suggest a mechanism of membrane attachment for dystrophin independent of dystroglycan and that the interaction of sarcoglycans with dystrophin requires dystroglycan. The distribution of caveolin-3, a muscle-specific component of caveolae recently found to bind dystroglycan, was affected in dystroglycan- and dystrophin-deficient mice. We also examined alternative mechanisms of cell-extracellular matrix attachment to elucidate how the muscle basement membrane may subsist in the absence of dystroglycan, and we found the alpha(7B) splice variant of the alpha(7) integrin receptor subunit to be up-regulated. These results support the possibility that alpha(7B) integrin compensates in mediating cell-extracellular matrix attachment but cannot rescue the dystrophic phenotype.	McGill Univ, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; Univ Montreal, Dept Biol Sci, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; Universite de Montreal	Carbonetto, S (corresponding author), McGill Univ, Montreal Gen Hosp, Neurosci Res Ctr, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	sal.carbonetto@mcgill.ca		Cote, Patrice/0000-0002-4189-7526				Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; BIES RD, 1992, J CLIN INVEST, V90, P666, DOI 10.1172/JCI115909; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207; CARPENTER S, 1984, PATHOLOGY SKELETAL M, P314; CARTAUD A, 1993, J BIOL CHEM, V268, P13019; Chan YM, 1998, J CELL BIOL, V143, P2033, DOI 10.1083/jcb.143.7.2033; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Chockalingam PS, 1999, BIOCHEMISTRY-US, V38, P5596, DOI 10.1021/bi982564+; Cohen I, 1997, MOL CELL NEUROSCI, V9, P237, DOI 10.1006/mcne.1997.0623; COHEN MW, 1995, J CELL BIOL, V129, P1093, DOI 10.1083/jcb.129.4.1093; Cohn RD, 1999, J NEUROL SCI, V163, P140, DOI 10.1016/S0022-510X(99)00012-X; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87; Crosbie RH, 1998, FEBS LETT, V427, P279, DOI 10.1016/S0014-5793(98)00442-6; CULLEN MJ, 1988, ACTA NEUROPATHOL, V77, P69, DOI 10.1007/BF00688245; Cullen PJ, 2000, CURR BIOL, V10, pR876, DOI 10.1016/S0960-9822(00)00818-6; DELORENZO RJ, 1969, BIOCHEM GENET, V3, P151, DOI 10.1007/BF00520350; DeWolf C, 1997, BIOPHYS J, V72, P2599, DOI 10.1016/S0006-3495(97)78903-3; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; ENGEL AG, 1972, MAYO CLIN PROC, V47, P377; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Galbiati F, 2000, P NATL ACAD SCI USA, V97, P9689, DOI 10.1073/pnas.160249097; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; Gullberg Donald, 1998, Frontiers in Bioscience, V3, pD1039; Hack AA, 2000, J CELL SCI, V113, P2535; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; HELLIWELL TR, 1992, AM J HUM GENET, V50, P508; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926; Hodges BL, 1997, J CELL SCI, V110, P2873; HOFFMAN EP, 1991, ANN NEUROL, V30, P605, DOI 10.1002/ana.410300414; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Matsumura K, 1999, CELL MOL BIOL, V45, P751; MATSUMURA K, 1993, J CLIN INVEST, V92, P866, DOI 10.1172/JCI116661; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Metzinger L, 1997, HUM MOL GENET, V6, P1185, DOI 10.1093/hmg/6.7.1185; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Miosge N, 1999, LAB INVEST, V79, P1591; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Moukhles H, 2000, J COMP NEUROL, V420, P182, DOI 10.1002/(SICI)1096-9861(20000501)420:2<182::AID-CNE3>3.0.CO;2-2; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Rafael JA, 1996, J CELL BIOL, V134, P93, DOI 10.1083/jcb.134.1.93; Razani B, 2000, J CELL SCI, V113, P2103; RECAN D, 1992, J CLIN INVEST, V89, P712, DOI 10.1172/JCI115640; Rentschler S, 1999, BIOL CHEM, V380, P431, DOI 10.1515/BC.1999.057; Repetto S, 1999, BIOCHEM BIOPH RES CO, V261, P547, DOI 10.1006/bbrc.1999.1055; Sotgia F, 2000, J BIOL CHEM, V275, P38048, DOI 10.1074/jbc.M005321200; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Taverna D, 1998, J CELL BIOL, V143, P849, DOI 10.1083/jcb.143.3.849; Toniolo D, 1999, CURR OPIN GENET DEV, V9, P275, DOI 10.1016/S0959-437X(99)80041-0; Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716; Vaghy PL, 1998, FEBS LETT, V431, P125, DOI 10.1016/S0014-5793(98)00738-8; Vainzof M, 1996, HUM MOL GENET, V5, P1963, DOI 10.1093/hmg/5.12.1963; Venema VJ, 1997, J BIOL CHEM, V272, P28187, DOI 10.1074/jbc.272.45.28187; WATKINS SC, 1987, J NEUROL SCI, V82, P181, DOI 10.1016/0022-510X(87)90017-7; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; XU H, 1994, P NATL ACAD SCI USA, V91, P5572, DOI 10.1073/pnas.91.12.5572; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	78	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4672	4679		10.1074/jbc.M106879200	http://dx.doi.org/10.1074/jbc.M106879200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741881	hybrid			2022-12-27	WOS:000173962900018
J	Duggan, A; Garcia-Anoveros, J; Corey, DP				Duggan, A; Garcia-Anoveros, J; Corey, DP			The PDZ domain protein PICK1 and the sodium channel BNaC1 interact and localize at mechanosensory terminals of dorsal root ganglion neurons and dendrites of central neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN DEGENERIN MDEG; NMDA RECEPTOR SUBUNITS; YEAST 2-HYBRID SYSTEM; GATED CATION CHANNEL; SENSING ION CHANNELS; KINASE-C-ALPHA; NA+ CHANNEL; MOLECULAR-CLONING; CAENORHABDITIS-ELEGANS; GUANYLATE KINASES	Members of the BNaC/ASIC family of ion channels have been implicated in mechanotransduction and nociception mediated by dorsal root ganglion (DRG) neurons. These ion channels are also expressed in the CNS. We identified the PDZ domain protein PICK1 as an interactor of BNaC1(ASIC2) in a yeast two-hybrid screen. We show by two-hybrid assays, glutathione S-transferase pull-down assays, and coimmunoprecipitations that the BNaC1(.)PICK1 interaction is specific, and that coexpression of both proteins leads to their clustering in intracellular compartments. The interaction between BNaC1 and PICK1 requires the PDZ domain of PICK1 and the last four amino acids of BNaC1. BNaC1 is similar to two other BNaC/ASIC family members, BNaC2 (ASIC1) and ASIC4, at its extreme C terminus, and we show that PICK1 also interacts with BNaC2. We found that PICK1, like BNaC1 and BNaC2, is expressed by DRG neurons and, like the BNaC1alpha isoform, is present at their peripheral mechanosensory endings. Both PICK1 and BNaC1alpha are also coexpressed by some pyramidal neurons of the cortex, by pyramidal neurons of the CA3 region of hippocampus, and by cerebellar Purkinje neurons, localizing to their dendrites and cell bodies. Therefore, PICK1 interacts with BNaC/ASIC channels and may regulate their subcellular distribution or function in both peripheral and central neurons.	Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Corey, DP (corresponding author), Massachusetts Gen Hosp, Dept Neurobiol, WEL414, Boston, MA 02114 USA.	corey@helix.mgh.harvard.edu		Garcia-Anoveros, Jaime/0000-0001-6561-9048; Corey, David/0000-0003-4497-6016				Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Babinski K, 2000, J BIOL CHEM, V275, P28519, DOI 10.1074/jbc.M004114200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bezprozvanny I, 2001, P NATL ACAD SCI USA, V98, P787, DOI 10.1073/pnas.98.3.787; Borrell-Pages M, 2000, MOL BIOL CELL, V11, P4217, DOI 10.1091/mbc.11.12.4217; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen G, 1999, J NEUROPHYSIOL, V81, P1992, DOI 10.1152/jn.1999.81.4.1992; Corey DP, 1996, SCIENCE, V273, P323, DOI 10.1126/science.273.5273.323; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dev KK, 2000, J NEUROSCI, V20, P7252; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Drummond HA, 2000, BRAIN RES, V884, P1, DOI 10.1016/S0006-8993(00)02831-6; Drummond HA, 1998, NEURON, V21, P1435, DOI 10.1016/S0896-6273(00)80661-3; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Fricke B, 2000, CELL TISSUE RES, V299, P327; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Grunder S, 2000, NEUROREPORT, V11, P1607; Harris BZ, 2001, J CELL SCI, V114, P3219; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V245, P589, DOI 10.1006/bbrc.1998.8483; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jaulin-Bastard F, 2001, J BIOL CHEM, V276, P15256, DOI 10.1074/jbc.M010032200; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; LI XJ, 1994, P NATL ACAD SCI USA, V91, P1814, DOI 10.1073/pnas.91.5.1814; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Niethammer M, 1996, J NEUROSCI, V16, P2157; Niethammer M, 1998, METHOD ENZYMOL, V293, P104; Olson TH, 1998, NEUROREPORT, V9, P1109, DOI 10.1097/00001756-199804200-00028; PALMER LG, 1992, ANNU REV PHYSIOL, V54, P51, DOI 10.1146/annurev.ph.54.030192.000411; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; RENARD S, 1994, J BIOL CHEM, V269, P12981; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Takeya R, 2000, BIOCHEM BIOPH RES CO, V267, P149, DOI 10.1006/bbrc.1999.1932; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wyszynski M, 1999, Methods Enzymol, V294, P371; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zhang P, 2001, J GEN PHYSIOL, V117, P563, DOI 10.1085/jgp.117.6.563	67	104	111	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5203	5208		10.1074/jbc.M104748200	http://dx.doi.org/10.1074/jbc.M104748200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739374	hybrid			2022-12-27	WOS:000173962900085
J	Liu, Y; Liggitt, HD; Dow, S; Handumrongkul, C; Heath, TD; Debs, RJ				Liu, Y; Liggitt, HD; Dow, S; Handumrongkul, C; Heath, TD; Debs, RJ			Strain-based genetic differences regulate the efficiency of systemic gene delivery as well as expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; LIPID-DNA COMPLEXES; IN-VIVO; PLASMID DNA; TRANSGENE EXPRESSION; CATIONIC LIPOSOMES; MOUSE STRAIN; TRANSFECTION; ENHANCEMENT; MECHANISM	We have characterized the impact of strain-based genetic differences on the efficiency of the intravenous cationic liposome(.)DNA complex (CLDC)-based gene transfer and expression in mice. We also investigated what steps in the gene delivery and expression pathway appeared responsible for these strain-related differences and whether such differences could be compensated for either by agents that alter host pathways important in CLDC-mediated gene transfer and expression, or by changes in CLDC formulation. We found that different mouse strains can exhibit different expression levels and/or differences in the amount of plasmid DNA delivered to the organs where the DNA is expressed. Furthermore, drug pretreatment or reformulation of the CLDC could improve DNA delivery and/or gene expression in a strain-specific fashion. We conclude that genetic factors critically modify both the tissue deposition and the expression of genetic materials delivered by CLDC. Because manipulation of either the host or the CLDC could at least partially compensate for these strain-related differences, such strategies may be required to effectively use non-viral gene transfer approaches in genetically diverse populations.	Calif Pacific Med Res Inst, San Francisco, CA 94115 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Washington; University of Washington Seattle; National Jewish Health; University of Wisconsin System; University of Wisconsin Madison	Debs, RJ (corresponding author), Calif Pacific Med Res Inst, 2330 Clay St, San Francisco, CA 94115 USA.				NATIONAL CANCER INSTITUTE [R01CA082575] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 82575] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azzouz M, 1999, NEUROREPORT, V10, P1013, DOI 10.1097/00001756-199904060-00022; BARR D, 1995, GENE THER, V2, P151; Barron LG, 1998, HUM GENE THER, V9, P315, DOI 10.1089/hum.1998.9.3-315; Bebok Z, 1996, J PHARMACOL EXP THER, V279, P1462; Brisson M, 1999, HUM GENE THER, V10, P2601, DOI 10.1089/10430349950016645; Coonrod A, 1997, GENE THER, V4, P1313, DOI 10.1038/sj.gt.3300536; De Geest B, 2001, GENE THER, V8, P121, DOI 10.1038/sj.gt.3301374; de Lima MCP, 1999, MOL MEMBR BIOL, V16, P103; DEMENEIX BA, 1994, BIOTECHNIQUES, V16, P496; Dow SW, 1999, J IMMUNOL, V163, P1552; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fasbender A, 1997, GENE THER, V4, P1173, DOI 10.1038/sj.gt.3300524; FASSATI A, 1995, HUM GENE THER, V6, P1177, DOI 10.1089/hum.1995.6.9-1177; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Gryglewski RJ, 1996, EUR J PHARMACOL, V308, P61, DOI 10.1016/0014-2999(96)00256-7; Holschneider DP, 2000, INT J DEV NEUROSCI, V18, P615, DOI 10.1016/S0736-5748(00)00026-5; Hong KL, 1997, FEBS LETT, V400, P233, DOI 10.1016/S0014-5793(96)01397-X; Jiang CW, 1998, HUM GENE THER, V9, P1531, DOI 10.1089/hum.1998.9.11-1531; LabatMoleur F, 1996, GENE THER, V3, P1010; Lanuti M, 2000, CANCER RES, V60, P2955; Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867; Li S, 1999, AM J PHYSIOL-LUNG C, V276, pL796, DOI 10.1152/ajplung.1999.276.5.L796; Li S, 1998, GENE THER, V5, P930, DOI 10.1038/sj.gt.3300683; LIU Y, 1995, J BIOL CHEM, V270, P24864, DOI 10.1074/jbc.270.42.24864; Liu Y, 1997, NAT BIOTECHNOL, V15, P167, DOI 10.1038/nbt0297-167; MADER S, 1993, P NATL ACAD SCI USA, V90, P5603, DOI 10.1073/pnas.90.12.5603; MALONE RW, 1994, J BIOL CHEM, V269, P29903; Matsui H, 1997, J BIOL CHEM, V272, P1117, DOI 10.1074/jbc.272.2.1117; McLean JW, 1997, AM J PHYSIOL-HEART C, V273, pH387, DOI 10.1152/ajpheart.1997.273.1.H387; Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269; Michou AI, 1997, GENE THER, V4, P473, DOI 10.1038/sj.gt.3300412; Rudginsky S, 2001, MOL THER, V4, P347, DOI 10.1006/mthe.2001.0463; SOLODIN I, 1995, BIOCHEMISTRY-US, V34, P13537, DOI 10.1021/bi00041a033; Suzuki M, 1998, HUM GENE THER, V9, P1223, DOI 10.1089/hum.1998.9.8-1223; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Templeton NS, 1999, MOL BIOTECHNOL, V11, P175, DOI 10.1007/BF02915810; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; THIERRY AR, 1995, P NATL ACAD SCI USA, V92, P9742, DOI 10.1073/pnas.92.21.9742; Tseng WC, 1999, BBA-GENE STRUCT EXPR, V1445, P53, DOI 10.1016/S0167-4781(99)00039-1; Wheeler CJ, 1996, P NATL ACAD SCI USA, V93, P11454, DOI 10.1073/pnas.93.21.11454; Whitmore M, 1999, GENE THER, V6, P1867, DOI 10.1038/sj.gt.3301026; Wu M, 1997, BRIT J CANCER, V75, P1347, DOI 10.1038/bjc.1997.228; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; Zelphati O, 1999, HUM GENE THER, V10, P15, DOI 10.1089/10430349950019156	46	10	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4966	4972		10.1074/jbc.M110285200	http://dx.doi.org/10.1074/jbc.M110285200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733533	hybrid			2022-12-27	WOS:000173962900056
J	Nishimura, M; Kakizaki, M; Ono, Y; Morimoto, K; Takeuchi, M; Inoue, Y; Imai, T; Takai, Y				Nishimura, M; Kakizaki, M; Ono, Y; Morimoto, K; Takeuchi, M; Inoue, Y; Imai, T; Takai, Y			JEAP, a novel component of tight junctions in exocrine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ DOMAIN; ADHESION MOLECULE; EPITHELIAL-CELLS; ADHERENS JUNCTIONS; GUANYLATE-KINASE; IMMUNOGLOBULIN SUPERFAMILY; TUMOR-SUPPRESSOR; BINDING PROTEIN; CDNA CLONING; COILED COILS	Tight junctions (TJs) consist of transmembrane proteins and many peripheral membrane proteins. To further characterize the molecular organization of Us, we attempted here to screen for novel TJ proteins by the fluorescence localization-based expression cloning method. We identified a novel peripheral membrane protein at TJs and named it junction-enriched and -associated protein (JEAP). JEAP consists of 882 amino acids with a calculated molecular weight of 98,444. JEAP contained a polyglutamic acid repeat at the N-terminal region, a coiled-coil domain at the middle region, and a consensus motif for binding to PDZ domains at the C-terminal region. Exogenously expressed JEAP co-localized with ZO-1 and occludin at TJs in polarized Madin-Darby canine kidney cells, but not with claudin-1, JAM, or ZO-1 in L cells. Endogenous JEAP localized at TJs of exocrine cells including pancreas, sub. mandibular gland, lacrimal gland, parotid gland, and sublingual gland, but not at TJs of epithelial cells of small intestine or endothelial cells of blood vessels. The present results indicate that JEAP is a novel component of TJs, which is specifically expressed in exocrine cells.	KAN Res Inst Inc, Shimogyo Ku, Kyoto 6008815, Japan; Osaka Univ, Grad Sch Med, Fac Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan	KAN Research Institute; Osaka University	Takai, Y (corresponding author), KAN Res Inst Inc, Shimogyo Ku, 1 Chudoji Awata Cho, Kyoto 6008815, Japan.							AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Asakura T, 1999, GENES CELLS, V4, P573, DOI 10.1046/j.1365-2443.1999.00283.x; Aurrand-Lions MA, 2000, CURR TOP MICROBIOL, V251, P91; BAKER BW, 1992, NUCLEIC ACIDS RES, V20, P5234, DOI 10.1093/nar/20.19.5234; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Cereijido M, 1998, ANNU REV PHYSIOL, V60, P161, DOI 10.1146/annurev.physiol.60.1.161; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Keon BH, 1996, J CELL BIOL, V134, P1003, DOI 10.1083/jcb.134.4.1003; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Misawa K, 2000, P NATL ACAD SCI USA, V97, P3062, DOI 10.1073/pnas.060489597; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nusrat A, 2000, J BIOL CHEM, V275, P29816, DOI 10.1074/jbc.M002450200; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Onishi M, 1996, EXP HEMATOL, V24, P324; Ono Y, 2000, ONCOGENE, V19, P3050, DOI 10.1038/sj.onc.1203631; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Spring KR, 1998, ANNU REV PHYSIOL, V60, P105, DOI 10.1146/annurev.physiol.60.1.105; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; WEBER E, 1994, J CELL BIOL, V125, P583, DOI 10.1083/jcb.125.3.583; Wittchen ES, 2000, J CELL BIOL, V151, P825, DOI 10.1083/jcb.151.4.825; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Yap AS, 1998, J MEMBRANE BIOL, V163, P159, DOI 10.1007/s002329900380; ZHONG Y, 1993, J CELL BIOL, V120, P477, DOI 10.1083/jcb.120.2.477	57	55	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5583	5587		10.1074/jbc.M110154200	http://dx.doi.org/10.1074/jbc.M110154200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733531	hybrid			2022-12-27	WOS:000173962900133
J	Samoilova, RI; Kolling, D; Uzawa, T; Iwasaki, T; Crofts, AR; Dikanov, SA				Samoilova, RI; Kolling, D; Uzawa, T; Iwasaki, T; Crofts, AR; Dikanov, SA			The interaction of the Rieske iron-sulfur protein with occupants of the Q(o)-site of the bc(1) complex, probed by electron spin echo envelope modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; BC1 COMPLEX; Q(O) SITE; SPECTROSCOPY; UBIQUINONE; RESONANCE; MECHANISM; UBIHYDROQUINONE; COORDINATION	The bifurcated reaction at the Q(o)-site of the bc(1) complex provides the mechanistic basis of the proton pumping activity through which the complex conserves redox energy in the proton gradient. Structural information about the binding of quinone at the site is lacking, because the site is vacant in crystals of the native complexes. We now report the first structural characterization of the interaction of the native quinone occupant with the Rieske iron-sulfur protein in the bc(1) complex of Rhodobacter sphaeroides, using high resolution EPR. We have compared the binding configuration in the presence of quinone with the known structures for the complex with stigmatellin and myxothiazol. We have shown by using EPR and orientation-selective electron spin echo envelope modulation (ESEEM) measurements of the iron-sulfur protein that when quinone is present in the site, the isotropic hyperfine constant of one of the N-delta atoms of a liganding histidine of the [2Fe-2S] cluster is similar to that observed when stigmatellin is present and different from the configuration in the presence of myxothiazol. The spectra also show complementary differences in nitrogen quadrupole splittings in some orientations. We suggest that the EPR characteristics, the ESEEM spectra, and the hyperfine couplings reflect a similar interaction between the iron-sulfur protein and the quinone or stigmatellin and that the N-delta involved is that of a histidine (equivalent to His-161 in the chicken mitochondrial complex) that forms both a ligand to the cluster and a hydrogen bond with a carbonyl oxygen atom of the Q(o)-site occupant.	Univ Illinois, Illinois EPR Res Ctr, Urbana, IL 61801 USA; Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; Nippon Med Coll, Dept Biochem & Mol Biol, Tokyo 1138062, Japan; Osaka Kyoiku Univ, Div Nat Sci, Osaka 5828582, Japan; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Russian Acad Sci, Inst Chem Kinet & Combust, Novosibirsk 630090, Russia	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Nippon Medical School; Osaka University of Education; University of Illinois System; University of Illinois Urbana-Champaign; Russian Academy of Sciences; Voevodsky Institute of Chemical Kinetics & Combustion SB RAS	Dikanov, SA (corresponding author), Univ Illinois, Illinois EPR Res Ctr, Urbana, IL 61801 USA.	dikanov@uiuc.edu	Samoilova, Rimma Ivanovna/T-7956-2017	Samoilova, Rimma Ivanovna/0000-0002-1649-1487; Iwasaki, Toshio/0000-0001-9562-4649	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035438] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01811] Funding Source: Medline; NIGMS NIH HHS [GM35438] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1985, ENZYMES BIOL MEMBRAN, DOI DOI 10.1007/978-1-4684-4604-3_10; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BERTRAND P, 1985, BIOCHIM BIOPHYS ACTA, V831, P261, DOI 10.1016/0167-4838(85)90044-5; BERTRAND P, 1991, NEW J CHEM, V15, P445; BLUMBERG WE, 1974, ARCH BIOCHEM BIOPHYS, V162, P502, DOI 10.1016/0003-9861(74)90210-0; BRITT RD, 1991, BIOCHEMISTRY-US, V30, P1892, DOI 10.1021/bi00221a023; Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; Crofts AR, 2000, BBA-BIOENERGETICS, V1459, P456, DOI 10.1016/S0005-2728(00)00184-5; DEVRIES S, 1983, BIOCHIM BIOPHYS ACTA, V723, P91, DOI 10.1016/0005-2728(83)90013-0; DEVRIES S, 1982, BIOCHIM BIOPHYS ACTA, V681, P41, DOI 10.1016/0005-2728(82)90276-6; DIKANOV SA, 1995, J AM CHEM SOC, V117, P4976, DOI 10.1021/ja00122a029; Dikanov SA, 1996, J AM CHEM SOC, V118, P8408, DOI 10.1021/ja960781x; DIKANOV SA, 2000, ENW ADV ANAL TECHNIQ, P536; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; DING HG, 1992, BIOCHEMISTRY-US, V31, P3144, DOI 10.1021/bi00127a015; Guergova-Kuras M, 1999, PROTEIN EXPRES PURIF, V15, P370, DOI 10.1006/prep.1998.1018; Gurbiel RJ, 1996, BIOCHEMISTRY-US, V35, P7834, DOI 10.1021/bi960380u; HOFER P, 1986, CHEM PHYS LETT, V132, P279, DOI 10.1016/0009-2614(86)80124-5; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; SHERGILL JK, 1994, BBA-BIOENERGETICS, V1185, P35, DOI 10.1016/0005-2728(94)90190-2; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yu CA, 1998, BBA-BIOENERGETICS, V1365, P151, DOI 10.1016/S0005-2728(98)00055-3; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	30	49	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4605	4608		10.1074/jbc.C100664200	http://dx.doi.org/10.1074/jbc.C100664200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11748214	hybrid, Green Submitted			2022-12-27	WOS:000173962900009
J	Mishra, A; Hogan, SP; Brandt, EB; Wagner, N; Crossman, MW; Foster, PS; Rothenberg, ME				Mishra, A; Hogan, SP; Brandt, EB; Wagner, N; Crossman, MW; Foster, PS; Rothenberg, ME			Enterocyte expression of the eotaxin and interleukin-5 transgenes induces compartmentalized dysregulation of eosinophil trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; COLONY-STIMULATING FACTOR; TISSUE EOSINOPHILIA; IN-VIVO; GASTROINTESTINAL-TRACT; CHEMOTACTIC CYTOKINES; ADHESION MOLECULES; CHEMOKINE EOTAXIN; EPITHELIAL-CELLS; MUCOSAL TISSUES	Eosinophils accumulate in the gastrointestinal tract in a number of medical disorders, but the mechanisms involved are largely unknown. To understand the significance of cytokine expression by enterocytes, enterocyte transgenic mice that overexpressed the eosinophil-selective cytokines eotaxin and interleukin (IL)-5 were generated. Transgenic mice, generated by utilizing the rat intestinal fatty acid-binding protein promoter (Fabpi), overexpressed the mRNA for these cytokines in the small intestine. Overexpression of IL-5 resulted in marked increases of eosinophils in the bone marrow and blood, whereas eotaxin overexpression resulted in similar levels compared with nontransgenic control mice. In contrast, both IL-5 and eotaxin transgenic mice had significant accumulation of eosinophils in the gastrointestinal mucosa compared with control mice. Eotaxin-induced gastrointestinal eosinophilia was substantially higher than that induced by IL-5 and was especially prominent within the lamina propria of the villi. Interestingly, genetic rescue of eotaxin deficiency (by transgenic overexpression of eotaxin in eotaxin gene-targeted mice) resulted in significant restoration of gastrointestinal eosinophil levels. Finally, the intestinal eosinophilia induced by the eotaxin transgene was 137 integrin-dependent. Taken together, these results demonstrate that expression of eotaxin and IL-5 in intestinal epithelium induces compartmentalized dysregulation of eosinophil trafficking and the important role of the 07 integrin in gastrointestinal allergic responses.	Childrens Hosp, Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH 45229 USA; Univ Cologne, Cologne Inst Genet, D-50931 Cologne, Germany; Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Cologne; Australian National University; John Curtin School of Medical Research	Rothenberg, ME (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH 45229 USA.	rothenberg@chmcc.org	MISHRA, ANIL/S-7983-2017; Foster, Paul/G-5057-2013	MISHRA, ANIL/0000-0003-4266-4684; , Paul/0000-0002-0827-8299; Brandt, Eric/0000-0003-0617-4100	NIAID NIH HHS [R01 AI45898-02, R01 AI42242-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045898, R01AI042242] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Artis D, 2000, EUR J IMMUNOL, V30, P1656, DOI 10.1002/1521-4141(200006)30:6&lt;1656::AID-IMMU1656&gt;3.0.CO;2-Z; Bischoff SC, 1996, BAILLIERE CLIN GASTR, V10, P443, DOI 10.1016/S0950-3528(96)90052-4; BOCHNER BS, 1994, J ALLERGY CLIN IMMUN, V94, P427, DOI 10.1016/0091-6749(94)90195-3; Bochner BS, 2001, IMMUNOL REV, V179, P5, DOI 10.1034/j.1600-065X.2001.790101.x; COHN SM, 1992, J CELL BIOL, V119, P27, DOI 10.1083/jcb.119.1.27; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Desreumaux P, 1996, GASTROENTEROLOGY, V110, P768, DOI 10.1053/gast.1996.v110.pm8608886; Desreumaux P, 1999, AM J GASTROENTEROL, V94, P3396, DOI 10.1016/S0002-9270(99)00716-9; DISCOMBE G, 1946, LANCET, V250, P195; ERLE DJ, 1994, J IMMUNOL, V153, P517; FURUTA GT, 1995, CURR OPIN GASTROEN, V11, P541, DOI 10.1097/00001574-199511000-00013; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Gutierrez-Ramos JC, 1999, IMMUNOL TODAY, V20, P500, DOI 10.1016/S0167-5699(99)01522-4; HAMANN A, 1994, J IMMUNOL, V152, P3282; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Hogan SP, 2000, P NATL ACAD SCI USA, V97, P6681, DOI 10.1073/pnas.97.12.6681; Hogan SP, 2001, NAT IMMUNOL, V2, P353, DOI 10.1038/86365; Kato M, 1998, ANAT REC, V252, P418, DOI 10.1002/(SICI)1097-0185(199811)252:3<418::AID-AR10>3.0.CO;2-1; Keates S, 1997, AM J PHYSIOL-GASTR L, V273, pG75, DOI 10.1152/ajpgi.1997.273.1.G75; Kitayama J, 1997, J IMMUNOL, V159, P3929; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Lowichik A, 1996, MODERN PATHOL, V9, P110; Lundahl J, 2000, ALLERGY, V55, P865, DOI 10.1034/j.1398-9995.2000.00574.x; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MacDermott RP, 1999, J CLIN IMMUNOL, V19, P266, DOI 10.1023/A:1020583306627; MacDermott RP, 1998, INFLAMM BOWEL DIS, V4, P54, DOI 10.1097/00054725-199802000-00009; Matsumoto T, 1999, ANN ALLERG ASTHMA IM, V82, P253, DOI 10.1016/S1081-1206(10)62605-1; Matthews AN, 1998, P NATL ACAD SCI USA, V95, P6273, DOI 10.1073/pnas.95.11.6273; Mishra A, 2000, BLOOD, V96, P1538, DOI 10.1182/blood.V96.4.1538.h8001538_1538_1544; Mishra A, 2001, J BIOL CHEM, V276, P8453, DOI 10.1074/jbc.M009481200; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; Papakonstanti EA, 2000, MOL MED, V6, P303, DOI 10.1007/BF03401939; Pascal RR, 1997, MODERN PATHOL, V10, P363; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rothenberg ME, 1999, AM J RESP CELL MOL, V21, P291, DOI 10.1165/ajrcmb.21.3.f160; Rothenberg ME, 1997, J EXP MED, V185, P785, DOI 10.1084/jem.185.4.785; Rothenberg ME, 1996, MOL MED, V2, P334, DOI 10.1007/BF03401631; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; Rothenberg ME, 2001, ADV IMMUNOL, V78, P291, DOI 10.1016/S0065-2776(01)78007-8; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P981, DOI 10.1016/S0091-6749(99)70167-3; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Schleimer RP, 1998, CLIN EXP ALLERGY, V28, P15; Shaw S K, 1995, Semin Immunol, V7, P335, DOI 10.1016/1044-5323(95)90014-4; Simon HU, 2000, ALLERGY, V55, P791, DOI 10.1034/j.1398-9995.2000.00030.x; SWEETSER DA, 1988, P NATL ACAD SCI USA, V85, P9611, DOI 10.1073/pnas.85.24.9611; SWEETSER DA, 1987, J BIOL CHEM, V262, P16060; Van Deventer SJH, 1997, ALIMENT PHARM THERAP, V11, P116; Vandezande LM, 1999, CLIN EXP ALLERGY, V29, P652, DOI [10.1046/j.1365-2222.1999.00514.x, 10.1046/j.1365-2222.1999.00511.x]; Vignola AM, 2000, ALLERGY, V55, P931, DOI 10.1034/j.1398-9995.2000.00239.x; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; WALLAERT B, 1995, J EXP MED, V182, P1897, DOI 10.1084/jem.182.6.1897	53	71	72	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4406	4412		10.1074/jbc.M110424200	http://dx.doi.org/10.1074/jbc.M110424200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733500	Green Published, hybrid			2022-12-27	WOS:000173813900082
J	Swertfeger, DK; Bu, GJ; Hui, DY				Swertfeger, DK; Bu, GJ; Hui, DY			Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROKINASE RECEPTOR; LDL RECEPTOR; ALPHA-2-MACROGLOBULIN RECEPTOR; PLASMINOGEN-ACTIVATOR; NEURITE OUTGROWTH; PROTEIN-ALPHA-2-MACROGLOBULIN RECEPTOR; SIGNAL-TRANSDUCTION; APOPROTEIN-E; GROWTH; GENE	This research was undertaken to identify the cell surface receptor responsible for mediating apolipoprotein E (apoE) inhibition of platelet-derived growth factor (PDGF)-directed smooth muscle cell migration. Initial studies revealed the expression of the low density Iipoprotein receptor (LDLR), the LDL receptor-related protein (LRP), the very low density lipoprotein receptor (VLDL), and apoE receptor-2 in mouse aortic smooth muscle cells. Smooth muscle cells isolated from LDLR-null, VLDL-null, and apoE receptor-2-null mice were responsive to apoE inhibition of PDGF-directed smooth muscle cell migration, suggesting that these receptors were not involved. An antisense RNA expression knockdown strategy, utilizing morpholino antisense RNA against LRP, was used to reduce LRP expression in smooth muscle cells to assess the role of this receptor in apoE inhibition of cell migration. Results showed that apoE was unable to inhibit PDGF-directed migration of LRP-deficient smooth muscle cells. The role of LRP in mediating apoE inhibition of PDGF-directed smooth muscle cell migration was confirmed by experiments showing that antibodies against LRP effectively suppressed apoE inhibition of PDGF-directed smooth muscle cell migration. Taken together, these results document that apoE binding to LRP is required for its inhibition of PDGF-directed smooth muscled cell migration.	Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Ctr Lipid & Arteriosclerosis Studies, Cincinnati, OH 45267 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; St Louis Childrens Hosp, St Louis, MO 63110 USA	University of Cincinnati; Washington University (WUSTL); Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Ctr Lipid & Arteriosclerosis Studies, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.		Swertfeger, Debi/AAN-6490-2021	Swertfeger, Debi/0000-0002-0570-0271	NHLBI NIH HHS [HL61332, HL59150] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061332, R01HL059150] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044; BU GJ, 1993, J BIOL CHEM, V268, P13002; CARDIN AD, 1984, METHOD PHARMACOL, V5, P141; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHOI SY, 1993, J BIOL CHEM, V268, P15804; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cospedal R, 1999, CARDIOVASC RES, V41, P708, DOI 10.1016/S0008-6363(98)00232-6; Curtiss LK, 2000, CURR OPIN LIPIDOL, V11, P243, DOI 10.1097/00041433-200006000-00004; Curtiss LK, 2000, ARTERIOSCL THROM VAS, V20, P1852, DOI 10.1161/01.ATV.20.8.1852; CURTISS LK, 1978, J CLIN INVEST, V61, P1298, DOI 10.1172/JCI109047; DeMattos RB, 1998, J BIOL CHEM, V273, P4206, DOI 10.1074/jbc.273.7.4206; Fagan AM, 1996, J BIOL CHEM, V271, P30121, DOI 10.1074/jbc.271.47.30121; GAFVELS ME, 1994, ENDOCRINOLOGY, V135, P387, DOI 10.1210/en.135.1.387; Gliemann J, 1998, BIOL CHEM, V379, P951; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; GROBMYER SR, 1993, J BIOL CHEM, V268, P13291; HARMONY JAK, 1981, CANCER RES, V41, P3799; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; HOFFER MJV, 1993, BIOCHEM BIOPH RES CO, V191, P880, DOI 10.1006/bbrc.1993.1299; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; HUI DY, 1980, J BIOL CHEM, V255, P1775; HUI DY, 1980, P NATL ACAD SCI-BIOL, V77, P4764, DOI 10.1073/pnas.77.8.4764; HUSSAIN MM, 1991, J BIOL CHEM, V266, P13936; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Ishigami M, 1998, J BIOL CHEM, V273, P20156, DOI 10.1074/jbc.273.32.20156; Kim HJ, 1998, J BIOCHEM-TOKYO, V124, P451, DOI 10.1093/oxfordjournals.jbchem.a022134; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Law RE, 1996, J CLIN INVEST, V98, P1897, DOI 10.1172/JCI118991; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; LUND H, 1989, P NATL ACAD SCI USA, V86, P9318, DOI 10.1073/pnas.86.23.9318; Mahley RW, 1999, J LIPID RES, V40, P1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MIMURA Y, 1995, BIOL PHARM BULL, V18, P1373; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Okada SS, 1996, ARTERIOSCL THROM VAS, V16, P1269, DOI 10.1161/01.ATV.16.10.1269; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; Paka L, 1999, J BIOL CHEM, V274, P36403, DOI 10.1074/jbc.274.51.36403; PEPE MG, 1986, J IMMUNOL, V136, P3716; Riddell DR, 1996, THROMB RES, V81, P597, DOI 10.1016/0049-3848(96)87301-4; Riddell DR, 1997, J BIOL CHEM, V272, P89; Schneider WJ, 1997, CURR OPIN LIPIDOL, V8, P315, DOI 10.1097/00041433-199710000-00011; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Swertfeger DK, 2001, FRONT BIOSCI-LANDMRK, V6, pD526, DOI 10.2741/Swertfeg; Swertfeger DK, 2001, J BIOL CHEM, V276, P25043, DOI 10.1074/jbc.M102357200; VANLEUVEN F, 1993, BIOCHIM BIOPHYS ACTA, V1173, P71, DOI 10.1016/0167-4781(93)90244-8; Weaver AM, 1997, J BIOL CHEM, V272, P14372, DOI 10.1074/jbc.272.22.14372; Webb DJ, 2000, J CELL SCI, V113, P123; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Yamamoto T, 1996, CURR OPIN LIPIDOL, V7, P298, DOI 10.1097/00041433-199610000-00007; YlaHerttuala S, 1996, CURR OPIN LIPIDOL, V7, P292, DOI 10.1097/00041433-199610000-00006; Yu KCW, 2001, J CLIN INVEST, V107, P1387, DOI 10.1172/JCI11750	54	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4141	4146		10.1074/jbc.M109124200	http://dx.doi.org/10.1074/jbc.M109124200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11739389	hybrid			2022-12-27	WOS:000173813900048
J	Goenrich, M; Bartoschek, S; Hagemeier, CH; Griesinger, C; Vorholt, JA				Goenrich, M; Bartoschek, S; Hagemeier, CH; Griesinger, C; Vorholt, JA			A glutathione-dependent formaldehyde-activating enzyme (Gfa) from Paracoccus denitrificans detected and purified via two-dimensional proton exchange NMR spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III ALCOHOL-DEHYDROGENASE; RHODOBACTER-SPHAEROIDES; ESCHERICHIA-COLI; DETOXIFICATION; ELUCIDATION; METABOLISM; OXIDATION; GROWTH; FORMS	The formation of S-hydroxymethylglutathione from formaldehyde and glutathione is a central reaction in the consumption of the cytotoxin formaldehyde in some methylotrophic bacteria as well as in many other organisms. We describe here the discovery of an enzyme from Paracoccus denitrificans that accelerates this spontaneous condensation reaction. The rates of S-hydroxymethylglutathione formation and cleavage were determined under equilibrium conditions via two-dimensional proton exchange NMR spectroscopy. The pseudo first order rate constants k(1)* were estimated from the temperature dependence of the reaction and the signal to noise ratio of the uncatalyzed reaction. At 303 K and pH 6.0 k(1)* was found to be 0.02 s(-1) for the spontaneous reaction. A 10-fold increase of the rate constant was observed upon addition of cell extract from P. denitrificans grown in the presence of methanol corresponding to a specific activity of 35 units mg(-1). Extracts of cells grown in the presence of succinate revealed a lower specific activity of 11 units mg(-1). The enzyme catalyzing the conversion of formaldehyde and glutathione was purified and named glutathione-dependent formaldehyde-activating enzyme (Gfa). The gene gfa is located directly upstream of the gene for glutathione-dependent formaldehyde dehydrogenase, which catalyzes the subsequent oxidation of S-hydroxymethylglutathione. Putative proteins with sequence identity to Gfa from P. denitrificans are present also in Rhodobacter sphaeroides, Sinorhizobium meliloti, and Mesorhizobium loti.	Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany; Goethe Univ Frankfurt, Inst Organ Chem, D-60439 Frankfurt, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society; Goethe University Frankfurt; Max Planck Society	Vorholt, JA (corresponding author), INRA, CNRS, BP27 Chemin Borde Rouge, F-31326 Castanet Tolosan, France.	vorholt@toulouse.inra.fr	Vorholt, Julia/K-3514-2016	Vorholt, Julia/0000-0002-6011-4910				Barber RD, 1996, J BACTERIOL, V178, P1386, DOI 10.1128/jb.178.5.1386-1393.1996; Barber RD, 1998, BIOCHEMISTRY-US, V37, P530, DOI 10.1021/bi971463t; Bartoschek S, 2000, EUR J BIOCHEM, V267, P3130, DOI 10.1046/j.1432-1327.2000.01331.x; FERNANDEZ MR, 1995, FEBS LETT, V370, P23; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; GOULD WD, 1992, J GEN MICROBIOL, V138, P217, DOI 10.1099/00221287-138-1-217; GRAFSTROM RC, 1983, SCIENCE, V220, P216, DOI 10.1126/science.6828890; Gutheil WG, 1997, BIOCHEM BIOPH RES CO, V238, P693, DOI 10.1016/S0006-291X(00)90000-7; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; JONES DP, 1978, J BIOL CHEM, V253, P6031; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; MASON RP, 1986, BIOCHEMISTRY-US, V25, P4504, DOI 10.1021/bi00364a008; NAYLOR S, 1988, BIOCHEM J, V249, P573, DOI 10.1042/bj2490573; RAS J, 1995, J BACTERIOL, V177, P247, DOI 10.1128/jb.177.1.247-251.1995; SCHLEUCHER J, 1995, J AM CHEM SOC, V117, P2941, DOI 10.1021/ja00115a035; SCOTT JH, 1994, J BACTERIOL, V176, P3408, DOI 10.1128/jb.176.11.3408-3411.1994; Shafqat J, 1996, P NATL ACAD SCI USA, V93, P5595, DOI 10.1073/pnas.93.11.5595; Uotila L, 1981, Methods Enzymol, V77, P314; VANOPHEM PW, 1994, FEMS MICROBIOL LETT, V116, P87, DOI 10.1016/0378-1097(94)90112-0; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; ZIMMERMAN PR, 1978, GEOPHYS RES LETT, V5, P679, DOI 10.1029/GL005i008p00679	22	47	56	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 1	2002	277	5					3069	3072		10.1074/jbc.C100579200	http://dx.doi.org/10.1074/jbc.C100579200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	518VF	11741920	hybrid, Green Published			2022-12-27	WOS:000173688000003
J	Gazaryan, IG; Krasnikov, BF; Ashby, GA; Thorneley, RNF; Kristal, BS; Brown, AM				Gazaryan, IG; Krasnikov, BF; Ashby, GA; Thorneley, RNF; Kristal, BS; Brown, AM			Zinc is a potent inhibitor of thiol oxidoreductase activity and stimulates reactive oxygen species production by lipoamide dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LIPOIC ACID; PERMEABILITY TRANSITION; GLUTATHIONE-REDUCTASE; SUPEROXIDE PRODUCTION; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; NEURONAL DEATH; PIG-HEART; BRAIN	Submicromolar zinc inhibits alpha-ketoglutarate-dependent mitochondrial respiration. This was attributed to in. hibition of the a-ketoglutarate dehydrogenase complex (Brown, A. M., Kristal, B.S., Effron, M.S., Shestopalov, A. I., Ullucci, P. A., Sheu, K.-F. R., Blass, J. P., and Cooper, A. J. L. (2000) J. Biol. Chem 275,13441-13447). Lipoamide dehydrogenase, a component of the alpha-ketoglutarate dehydrogenase complex and two other mitochondrial complexes, catalyzes the transfer of reducing equivalents from the bound dihydrolipoate of the neighboring dihydrolipoamide acyltransferase subunit to NAD(+). This reversible reaction involves two reaction centers: a thiol pair, which accepts electrons from dihydrolipoate, and a non-covalently bound FAD moiety, which transfers electrons to NAD(+). The lipoamide dehydrogenase reaction catalyzed by the purified pig heart enzyme is strongly inhibited by Zn2+ (K-i similar to0.15 muM) in both directions. Steady-state kinetic studies revealed that Zn2+ competes with oxidized lipoamide for the two-electron-reduced enzyme. Interaction of Zn2+ with the two-electron-reduced enzyme was directly detected in anaerobic stopped-flow experiments. Lipoamide dehydrogenase also catalyzes NADH oxidation by oxygen, yielding hydrogen peroxide as the major product and superoxide radical as a minor product. Zn2+ accelerates the oxidase reaction up to 5-fold with an activation constant of 0.09 +/- 0.02 muM. Activation is a consequence of Zn2+ binding to the reduced catalytic thiols, which prevents delocalization of the reducing equivalents between catalytic disulfide and FAD. A kinetic scheme that satisfactorily describes the observed effects has been developed and applied to determine a number of enzyme kinetic parameters in the oxidase reaction. The distinct effects of Zn2+ on different LADH activities represent a novel example of a reversible switch in enzyme specificity that is modulated by metal ion binding. These results suggest that Zn2+ can interfere with mitochondrial antioxidant production and may also stimulate production of reactive oxygen species by a novel mechanism.	Cornell Univ, Weill Med Coll, Burke Med Res Inst, Dementia Res Serv, White Plains, NY 10605 USA; John Innes Ctr, Norwich NR4 7UH, Norfolk, England; Cornell Univ, Weill Med Coll, Dept Neurosci, White Plains, NY 10605 USA; Cornell Univ, Weill Med Coll, Dept Biochem, White Plains, NY 10605 USA	Cornell University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Cornell University; Cornell University	Brown, AM (corresponding author), Cornell Univ, Weill Med Coll, Burke Med Res Inst, Dementia Res Serv, 785 Mamaroneck Ave, White Plains, NY 10605 USA.		Krasnikov, Boris F/GZG-7807-2022; Gazaryan, Irina G/T-8578-2017; brown, abraham/R-8823-2019; Krasnikov, Boris/R-2244-2019	Krasnikov, Boris F/0000-0001-9525-4385; Gazaryan, Irina G/0000-0002-9670-5579; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038741] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38741, R01 NS038741] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANDO Y, 1991, J BIOCHEM-TOKYO, V109, P450, DOI 10.1093/oxfordjournals.jbchem.a123402; Berry EA, 2000, BBA-BIOENERGETICS, V1459, P440, DOI 10.1016/S0005-2728(00)00182-1; Bourguignon J, 1996, BIOCHEM J, V313, P229, DOI 10.1042/bj3130229; Brown AM, 2000, J BIOL CHEM, V275, P13441, DOI 10.1074/jbc.275.18.13441; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Cornett CR, 1998, NEUROTOXICOLOGY, V19, P339; Danscher G, 1997, J NEUROSCI METH, V76, P53, DOI 10.1016/S0165-0270(97)00079-4; DAWSON RMC, 1986, DATA BIOCH RES, P410; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; HUENNEKENS FM, 1955, J BIOL CHEM, V213, P951; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; MAEDAYORITA K, 1991, BIOCHEMISTRY-US, V30, P11788, DOI 10.1021/bi00115a008; Manev H, 1997, EXP NEUROL, V146, P171, DOI 10.1006/exnr.1997.6510; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1969, BIOCHEM BIOPH RES CO, V36, P891, DOI 10.1016/0006-291X(69)90287-3; MASSEY V, 1960, BIOCHEM J, V77, P341, DOI 10.1042/bj0770341; MATTEVI A, 1991, J MOL BIOL, V220, P975, DOI 10.1016/0022-2836(91)90367-F; MATTHEWS RG, 1976, J BIOL CHEM, V251, P3956; MATUDA S, 1982, J BIOCHEM, V91, P553, DOI 10.1093/oxfordjournals.jbchem.a133727; Packer L, 1997, FREE RADICAL BIO MED, V22, P359, DOI 10.1016/S0891-5849(96)00269-9; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; POPOV VO, 1985, BIOCHIM BIOPHYS ACTA, V827, P466, DOI 10.1016/0167-4838(85)90234-1; SAHLMAN L, 1989, J BIOL CHEM, V264, P8033; SARIS NEL, 1994, FEBS LETT, V356, P195, DOI 10.1016/0014-5793(94)01256-3; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Tirosh O, 1999, FREE RADICAL BIO MED, V26, P1418, DOI 10.1016/S0891-5849(99)00014-3; Toyoda T, 1998, J BIOCHEM-TOKYO, V123, P668; Toyoda T, 1998, ACTA CRYSTALLOGR D, V54, P982, DOI 10.1107/S090744499800033X; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; VEEGER C, 1962, BIOCHIM BIOPHYS ACTA, V64, P83, DOI 10.1016/0006-3002(62)90762-X; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Wudarczyk J, 1999, ARCH BIOCHEM BIOPHYS, V363, P1, DOI 10.1006/abbi.1998.1058	35	134	142	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10064	10072		10.1074/jbc.M108264200	http://dx.doi.org/10.1074/jbc.M108264200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11744691	hybrid			2022-12-27	WOS:000174549200062
J	Linnemann, T; Kiel, C; Herter, P; Herrmann, C				Linnemann, T; Kiel, C; Herter, P; Herrmann, C			The activation of RalGDS can be achieved independently of its Ras binding domain - Implications of an activation mechanism in Ras effector specificity and signal distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; KREV-1 GENE; DISSOCIATION STIMULATOR; MEMBRANE RECRUITMENT; SUPPRESSOR ACTIVITY; PLASMA-MEMBRANE; PROTEIN-KINASE; GOLGI-COMPLEX; DNA-SYNTHESIS; H-RAS	Small GTPases of the Ras family are major players of signal transduction in eukaryotic cells. They receive signals from a number of receptors and transmit them to a variety of effectors. The distribution of signals to different effector molecules allows for the generation of opposing effects like proliferation and differentiation. To understand the specificity of Ras signaling, we investigated the activation of RalGDS, one of the Ras effector proteins with guanine-nucleotide exchange factor activity for Ral. We determined the GTP level on RalA and showed that the highly conserved Ras binding domain (RBD) of RalGDS, which mediates association with Ras, is important but not sufficient to explain the stimulation of the exchange factor. Although a point mutation in the RBD of RalGDS, which abrogates binding to Ras, renders RalGDS independent to activated Ras, an artificially membrane-targeted version of RalGDS lacking its RBD could still be activated by Ras. The switch II region of Ras is involved in the activation, because the mutant Y64W in this region is impaired in the RalGDS activation. Furthermore, it is shown that Rap1, which was originally identified as a Ras antagonist, can block Ras-mediated RalGDS signaling only when RalGDS contains an intact RBD. In addition, kinetic studies of the complex formation between RalGDS-RBD and Ras suggest that the fast association between RalGDS and Ras, which is analogous to the Ras/Raf case, achieves signaling specificity. Conversely, the Ras.RalGDS complex has a short lifetime of 0.1 s and Rap1 forms a long-lived complex with RalGDS, possibly explaining its antagonistic effect on Ras.	Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany	Max Planck Society	Herrmann, C (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.		Herter, Peter/L-7415-2013	Herter, Peter/0000-0001-7437-2200; Kiel, Christina/0000-0001-8454-6008				ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; BERANGER F, 1991, P NATL ACAD SCI USA, V88, P1606, DOI 10.1073/pnas.88.5.1606; BERGER G, 1994, BRIT J HAEMATOL, V88, P372, DOI 10.1111/j.1365-2141.1994.tb05033.x; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNEY TL, 1994, PROSTATE, V25, P177, DOI 10.1002/pros.2990250403; CAAMANO J, 1992, MOL CARCINOGEN, V6, P252, DOI 10.1002/mc.2940060406; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; DAdamo DR, 1997, ONCOGENE, V14, P1295, DOI 10.1038/sj.onc.1200950; Damak S, 1996, MOL CARCINOGEN, V17, P84, DOI 10.1002/(SICI)1098-2744(199610)17:2<84::AID-MC5>3.0.CO;2-T; Feig LA, 1996, TRENDS BIOCHEM SCI, V21, P438, DOI 10.1016/S0968-0004(96)10058-X; FRANZA BR, 1986, CELL, V44, P409, DOI 10.1016/0092-8674(86)90462-9; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Goi T, 1999, MOL CELL BIOL, V19, P1731; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HARIHARAN IK, 1991, CELL, V67, P717, DOI 10.1016/0092-8674(91)90066-8; Hernandez-Munoz I, 2000, ONCOGENE, V19, P2745, DOI 10.1038/sj.onc.1203586; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Ito S, 1997, MOL GEN GENET, V255, P429, DOI 10.1007/s004380050515; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kishida S, 1997, ONCOGENE, V15, P2899, DOI 10.1038/sj.onc.1201473; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Kondoh N, 1996, BBA-MOL CELL RES, V1313, P41, DOI 10.1016/0167-4889(96)00052-3; Leach SD, 1998, PANCREAS, V16, P491, DOI 10.1097/00006676-199805000-00006; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; MARIDONNEAUPARINI I, 1992, J BIOL CHEM, V267, P6396; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; McCormick F, 1996, CURR OPIN BIOTECH, V7, P449, DOI 10.1016/S0958-1669(96)80123-6; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; PIZON V, 1994, J CELL SCI, V107, P1661; Rebstein PJ, 1997, EXP CELL RES, V231, P276, DOI 10.1006/excr.1996.3466; SAKODA T, 1992, ONCOGENE, V7, P1705; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Tamada M, 1997, ONCOGENE, V15, P2959, DOI 10.1038/sj.onc.1201582; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; vanWeering DHJ, 1997, J BIOL CHEM, V272, P249; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Wolthuis RMF, 1999, CURR OPIN GENET DEV, V9, P112, DOI 10.1016/S0959-437X(99)80016-1; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	54	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7831	7837		10.1074/jbc.M110800200	http://dx.doi.org/10.1074/jbc.M110800200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11748241	hybrid			2022-12-27	WOS:000174268000028
J	Sakai, Y; Furuichi, M; Takahashi, M; Mishima, M; Iwai, S; Shirakawa, M; Nakabeppu, Y				Sakai, Y; Furuichi, M; Takahashi, M; Mishima, M; Iwai, S; Shirakawa, M; Nakabeppu, Y			A molecular basis for the selective recognition of 2-hydroxy-dATP and 8-oxo-dGTP by human MTH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MUTT HOMOLOG; C-G TRANSVERSION; ESCHERICHIA-COLI; DNA-SYNTHESIS; INTRACELLULAR-LOCALIZATION; ENCODING 8-OXO-DGTPASE; MUTAGENIC SUBSTRATE; OXIDATIVE STRESS; A-T; PROTEIN	MTH1 hydrolyzes oxidized purine nucleoside triphosphates such as 8-oxo-dGTP, 8-oxo-dATP, 2-hydroxy-dATP, and 2-hydroxy rATP to monophosphates, and thus avoids errors caused by their misincorporation during DNA replication or transcription, which may result in carcinogenesis or neurodegeneration. This substrate specificity for oxidized purine nucleoside triphosphates was investigated by mutation analyses based on the sequence comparison with the Escherichia coli homolog, MutT, which hydrolyzes only 8-oxo-dGTP and 8-oxo-rGTP but not oxidized forms of dATP or ATP. Neither a replacement of the phosphohydrolase module of MTH1 with that of MutT nor deletions of the C-terminal region of MTH1, which is unique for MTH1, altered the substrate specificity of MTH1. In contrast, the substitution of residues at position Trp-117 and Asp-119 of MTH1, which showed apparent chemical shift perturbations with 8-oxo-dGDP in NMR analyses but are not conserved in MutT, affected the substrate specificity. Trp-117 is essential for MTH1 to recognize both 8-oxo-dGTP and 2-hydroxy-dATP, whereas Asp-119 is only essential for recognizing 2-hydroxy-dATP, thus suggesting that origins of the substrate-binding pockets for MTH1 and MutT are different.	Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genomics, Fukuoka 8128582, Japan; Japan Sci & Technol Corp, CREST, Fukuoka 8128582, Japan; Biol Engn Res Inst, Suita, Osaka 5650874, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Div Mol Biophys Sci, Yokohama, Kanagawa 2310045, Japan; Univ Nantes, F-44322 Nantes, France; CNRS, Res Grp FRE 2230, F-44322 Nantes, France	Kyushu University; Japan Science & Technology Agency (JST); Yokohama City University; Nantes Universite; Centre National de la Recherche Scientifique (CNRS)	Nakabeppu, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genomics, Fukuoka 8128582, Japan.		Sakai, Yasunari/S-7965-2018; Nakabeppu, Yusaku/A-8902-2011	Sakai, Yasunari/0000-0002-5747-8692; Nakabeppu, Yusaku/0000-0002-6739-242X				AKIYAMA M, 1987, MOL GEN GENET, V206, P9, DOI 10.1007/BF00326530; AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Boiteux S, 1999, BIOCHIMIE, V81, P59, DOI 10.1016/S0300-9084(99)80039-X; BRUN F, 1975, BIOCHEMISTRY-US, V14, P558, DOI 10.1021/bi00674a015; Cadet J, 1998, FREE RADICAL RES, V29, P541, DOI 10.1080/10715769800300581; CAI JP, 1995, CARCINOGENESIS, V16, P2343, DOI 10.1093/carcin/16.10.2343; Cai JP, 1997, NUCLEIC ACIDS RES, V25, P1170, DOI 10.1093/nar/25.6.1170; CHENG KC, 1992, J BIOL CHEM, V267, P166; COX EC, 1973, GENETICS, V73, P67; Einolf HJ, 1998, BIOCHEMISTRY-US, V37, P13300, DOI 10.1021/bi981346d; Fujii Y, 1999, J BIOL CHEM, V274, P38251, DOI 10.1074/jbc.274.53.38251; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; FURUICHI M, 1994, GENOMICS, V24, P485, DOI 10.1006/geno.1994.1657; Furuta A, 2001, NEUROREPORT, V12, P2895, DOI 10.1097/00001756-200109170-00028; Harris TK, 2000, BIOCHEMISTRY-US, V39, P1655, DOI 10.1021/bi9918745; Hayakawa H, 1999, BIOCHEMISTRY-US, V38, P3610, DOI 10.1021/bi982361l; HIGUCHI R, 1999, PCR PROTOCOLS GUIDE, P177; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; Inoue M, 1998, J BIOL CHEM, V273, P11069, DOI 10.1074/jbc.273.18.11069; Jurczyk SC, 1999, HELV CHIM ACTA, V82, P1005, DOI 10.1002/(SICI)1522-2675(19990707)82:7<1005::AID-HLCA1005>3.0.CO;2-5; KAKUMA T, 1995, J BIOL CHEM, V270, P25942, DOI 10.1074/jbc.270.43.25942; Kamiya H, 2000, BIOCHEMISTRY-US, V39, P9508, DOI 10.1021/bi000683v; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Lin J, 1997, BIOCHEMISTRY-US, V36, P1199, DOI 10.1021/bi962619c; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; Nakabeppu Y, 2001, PROG NUCLEIC ACID RE, V68, P75; Nakabeppu Y, 2001, MUTAT RES-FUND MOL M, V477, P59, DOI 10.1016/S0027-5107(01)00096-3; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Oda H, 1997, J BIOL CHEM, V272, P17843, DOI 10.1074/jbc.272.28.17843; Oda H, 1999, NUCLEIC ACIDS RES, V27, P4335, DOI 10.1093/nar/27.22.4335; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; Okamoto K, 1996, INT J CANCER, V65, P437, DOI 10.1002/(SICI)1097-0215(19960208)65:4<437::AID-IJC7>3.0.CO;2-Y; Porter DW, 1997, CARCINOGENESIS, V18, P1785, DOI 10.1093/carcin/18.9.1785; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Sekiguchi M, 1996, GENES CELLS, V1, P139, DOI 10.1046/j.1365-2443.1996.d01-232.x; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Shimura-Miura H, 1999, ANN NEUROL, V46, P920, DOI 10.1002/1531-8249(199912)46:6<920::AID-ANA17>3.0.CO;2-R; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Tsuchimoto D, 2001, NUCLEIC ACIDS RES, V29, P2349, DOI 10.1093/nar/29.11.2349; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Yakushiji H, 1997, MUTAT RES-DNA REPAIR, V384, P181, DOI 10.1016/S0921-8777(97)00025-6	47	70	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8579	8587		10.1074/jbc.M110566200	http://dx.doi.org/10.1074/jbc.M110566200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756418	hybrid			2022-12-27	WOS:000174268000122
J	Veiga-da-Cunha, M; Van Schaftingen, E				Veiga-da-Cunha, M; Van Schaftingen, E			Identification of fructose 6-phosphate- and fructose 1-phosphate-binding residues in the regulatory protein of glucokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DIABETES-MELLITUS; ISOLATED RAT HEPATOCYTES; LIVER GLUCOKINASE; METABOLIC-REGULATION; HEPATIC GLUCOKINASE; TRANSGENIC MICE; CANDIDATE GENES; GLUCOSE; MECHANISM; BINDING	Glucokinase is inhibited in the liver by a regulatory protein (GKRP) whose effects are increased by Fru-6-P and suppressed by Fru-1-P. To identify the binding site of these phosphate esters, we took advantage of the homology of GKRP to the isomerase domain of GlmS (glucosamine-6-phosphate synthase) and created 12 different mutants of rat GERP. Mutations of three residues predicted to bind to Fru-6-P resulted in proteins that were similar to5-fold (S110A) and 50-fold (S179A and K514A) less potent as inhibitors of glucokinase and had an at least 100-fold reduced affinity for the effectors. Mutation of another residue of the putative binding site (T109A) resulted in a 10-fold decrease in the inhibitory power and an inversion of the effect of sorbitol-6-P, a Fru-6-P analog. The replacement of Gly(107), a residue close to the binding site, by cysteine (as in GlmS and Xenopus GKRP) resulted in a protein that had 20 times more affinity for Fru-6-P and 30 times less affinity for Fru-1-P. These results are consistent with GKRP having one single binding site for phosphate esters. They also show that a missense mutation of GKRP can lead to a gain of function.	Christian De Duve Inst Cellular Pathol, Physiol Lab, B-1200 Brussels, Belgium; Univ Catholique Louvain, Physiol Chem Lab, B-1200 Brussels, Belgium	Universite Catholique Louvain	Veiga-da-Cunha, M (corresponding author), Christian De Duve Inst Cellular Pathol, Physiol Lab, 75,Av Hippocrate, B-1200 Brussels, Belgium.		Van+Schaftingen, Emile/AAF-5532-2020	Van Schaftingen, Emile/0000-0002-6199-7647				AGIUS L, 1995, BIOCHEM J, V309, P711, DOI 10.1042/bj3090711; AGIUS L, 1993, BIOCHEM J, V296, P785, DOI 10.1042/bj2960785; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Bateman A, 1999, TRENDS BIOCHEM SCI, V24, P94, DOI 10.1016/S0968-0004(99)01357-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown KS, 1997, DIABETES, V46, P179, DOI 10.2337/diabetes.46.2.179; Cardenas M.L., 1995, GLUCOKINASE ITS REGU; CLARK DG, 1979, BIOCHEM J, V184, P501, DOI 10.1042/bj1840501; DAVIES DR, 1990, EUR J BIOCHEM, V192, P283, DOI 10.1111/j.1432-1033.1990.tb19225.x; de la Iglesia N, 1999, FEBS LETT, V456, P332, DOI 10.1016/S0014-5793(99)00971-0; de la Iglesia N, 2000, J BIOL CHEM, V275, P10597, DOI 10.1074/jbc.275.14.10597; Depiereux E, 1997, COMPUT APPL BIOSCI, V13, P249; DETHEUX M, 1991, EUR J BIOCHEM, V200, P553, DOI 10.1111/j.1432-1033.1991.tb16218.x; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; Fernandez-Novell JM, 1999, FEBS LETT, V459, P211, DOI 10.1016/S0014-5793(99)01249-1; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Moukil MA, 2000, DIABETES, V49, P195, DOI 10.2337/diabetes.49.2.195; Niculescu L, 1997, BIOCHEM J, V321, P239, DOI 10.1042/bj3210239; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; RANDLE PJ, 1993, DIABETOLOGIA, V36, P269, DOI 10.1007/BF00400227; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Teplyakov A, 1998, STRUCTURE, V6, P1047, DOI 10.1016/S0969-2126(98)00105-1; Teplyakov A, 1999, PROTEIN SCI, V8, P596; TOYODA Y, 1994, BIOCHEM BIOPH RES CO, V204, P252, DOI 10.1006/bbrc.1994.2452; VANDERCAMMEN A, 1993, BIOCHEM J, V294, P551, DOI 10.1042/bj2940551; VANDERCAMMEN A, 1990, EUR J BIOCHEM, V191, P483, DOI 10.1111/j.1432-1033.1990.tb19147.x; VANDERCAMMEN A, 1992, BIOCHEM J, V286, P253, DOI 10.1042/bj2860253; VANSCHAFTINGEN E, 1993, DIABETOLOGIA, V36, P581, DOI 10.1007/BF00404065; VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; VANSCHAFTINGEN E, 1995, BIOCHEM J, V308, P23, DOI 10.1042/bj3080023; VANSCHAFTINGEN E, 1994, DIABETOLOGIA, V37, pS43, DOI 10.1007/BF00400825; VAXILLAIRE M, 1994, DIABETES, V43, P389, DOI 10.2337/diabetes.43.3.389; VEIGADACUNHA M, 1994, EUR J BIOCHEM, V225, P43, DOI 10.1111/j.1432-1033.1994.00043.x; VeigadaCunha M, 1996, DIABETOLOGIA, V39, P1173, DOI 10.1007/BF02658503; VeigadaCunha M, 1996, J BIOL CHEM, V271, P6292, DOI 10.1074/jbc.271.11.6292; VELHO G, 1992, LANCET, V340, P444, DOI 10.1016/0140-6736(92)91768-4; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; WHITE MF, 1993, BIOCHEM J, V291, P479, DOI 10.1042/bj2910479	47	51	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8466	8473		10.1074/jbc.M105984200	http://dx.doi.org/10.1074/jbc.M105984200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756407	hybrid			2022-12-27	WOS:000174268000107
J	Yun, CC; Chen, YP; Lang, F				Yun, CC; Chen, YP; Lang, F			Glucocorticoid activation of Na+/H+ exchanger isoform 3 revisited - The roles of SGX1 and NHERF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INHIBITION; PROTEIN-KINASE GENE; PLASMA-MEMBRANE; H+ EXCHANGER; REGULATORY PROTEIN; MESSENGER-RNA; ION-TRANSPORT; CELL-VOLUME; SGK; SERUM	The stimulative effect of glucocorticoids on intestinal salt and water absorption has been known for more than two decades. However, molecular mechanisms underlying this activation remain elusive. Previous studies showed that methylprednisolone specifically increased Na+/H+ exchanger isoform (NHE) 3 mRNA in ileum and kidney without affecting NHE1 mRNA levels. These results suggest that glucocorticoids activate NHE3 activity by induction of NHE3 transcripts. We recently found in PS120 and opossum kidney cells that chronic incubation with dexamethasone activated NHE3 independent of gene induction, indicating that the transcriptional activation may not be the only determining factor in the NHE3 activation. Furthermore, dexamethasone activated NHE3 activity only in the presence of a NHE3 regulatory protein, NHERF2, which was previously shown to confer cAMP-dependent inhibition of NHE3. This activation of NHE3 could not be duplicated by NHERF1. We identified serum- and glucocorticoid-induced protein kinase, SGK1, as the protein interacting with PDZ domains of NHERF2 to regulate NHE3 activity. The expression of SGK1 enhanced NHE3 transport in PS120 fibroblasts. In addition, the "kinase-dead" SGK1 blocked activation of N-HE3 by dexamethasone in opossum kidney cells. These data demonstrated that glucocorticoid activation of NHE3 requires the activation of SGK1 and the presence of NHERF2 acting as a scaffold protein.	Univ Tubingen, Inst Physiol, D-72076 Tubingen, Germany; Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA	Eberhard Karls University of Tubingen; Johns Hopkins University	Yun, CC (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, 201 Whitehead Res Bldg,615 Michael St, Atlanta, GA 30322 USA.				NIDDK NIH HHS [R01 DK061418-01A1, DK-44484, P01 DK044484-10S10006, R01 DK061418, P01 DK044484-10S20006] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044484, R01DK061418] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; ARONSON PS, 1986, CURR TOP MEMBR TRANS, V26, P57; BAUM M, 1994, AM J PHYSIOL, V267, pF437, DOI 10.1152/ajprenal.1994.267.3.F437; BAUM M, 1993, AM J PHYSIOL, V264, pF1027, DOI 10.1152/ajprenal.1993.264.6.F1027; Brennan FE, 2000, MOL CELL ENDOCRINOL, V166, P129, DOI 10.1016/S0303-7207(00)00274-4; Campieri M, 1997, GUT, V41, P209, DOI 10.1136/gut.41.2.209; CHARNEY AN, 1975, J CLIN INVEST, V56, P653, DOI 10.1172/JCI108135; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; CHO JH, 1994, AM J PHYSIOL, V267, pC796, DOI 10.1152/ajpcell.1994.267.3.C796; Cho JH, 1998, AM J PHYSIOL-CELL PH, V274, pC586, DOI 10.1152/ajpcell.1998.274.3.C586; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; DONOWITZ M, 1986, ANNU REV PHYSIOL, V48, P135, DOI 10.1146/annurev.ph.48.030186.001031; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Fouassier L, 2001, HEPATOLOGY, V33, P166, DOI 10.1053/jhep.2001.21143; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Ikuma M, 1999, AM J PHYSIOL-GASTR L, V276, pG539, DOI 10.1152/ajpgi.1999.276.2.G539; KANDASAMY RK, 1995, J BIOL CHEM, V270, P29209, DOI 10.1074/jbc.270.49.29209; Kiela PR, 2000, AM J PHYSIOL-CELL PH, V278, pC629, DOI 10.1152/ajpcell.2000.278.4.C629; KINSELLA JL, 1985, AM J PHYSIOL, V248, pF233, DOI 10.1152/ajprenal.1985.248.2.F233; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kumar JM, 1999, J AM SOC NEPHROL, V10, P2488; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lang F, 2000, P NATL ACAD SCI USA, V97, P8157, DOI 10.1073/pnas.97.14.8157; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; MENEELY R, 1982, PEDIATR RES, V16, P776, DOI 10.1203/00006450-198209000-00014; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; SELLIN JH, 1981, J CLIN INVEST, V67, P770, DOI 10.1172/JCI110094; Snyder P. M., 2001, J BIOL CHEM, V5, P5; SPENCER CM, 1995, DRUGS, V50, P854, DOI 10.2165/00003495-199550050-00006; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; TURNAMIAN SG, 1990, AM J PHYSIOL, V258, pG492, DOI 10.1152/ajpgi.1990.258.3.G492; Wade JB, 2001, AM J PHYSIOL-CELL PH, V280, pC192, DOI 10.1152/ajpcell.2001.280.1.C192; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Wormmeester L, 1998, AM J PHYSIOL-CELL PH, V274, pC1261, DOI 10.1152/ajpcell.1998.274.5.C1261; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; YUN CHC, 1993, J BIOL CHEM, V268, P206	53	150	153	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7676	7683		10.1074/jbc.M107768200	http://dx.doi.org/10.1074/jbc.M107768200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751930	hybrid			2022-12-27	WOS:000174268000010
J	Colas, C; Kuo, JM; de Montellano, PRO				Colas, C; Kuo, JM; de Montellano, PRO			Asp-225 and Glu-375 in autocatalytic attachment of the prosthetic heme group of lactoperoxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EOSINOPHIL PEROXIDASE; HUMAN MYELOPEROXIDASE; PROTOHEME-IX; ESTER BONDS; LINKING; BINDING; LINKAGE	The heme in lactoperoxidase is attached to the protein by ester bonds between the heme 1- and 5-methyl groups and Glu-375 and Asp-275, respectively. To investigate the cross-linking process, we have examined the D225E, E375D, and D225E/E375D mutants of bovine lactoperoxidase. The heme in the E375D mutant is only partially covalently bound, but exposure to H2O2 results in complete covalent binding and a fully active protein. Digestion of this mutant shows that the heme is primarily bound through its 5-methyl group. Excess H2O2 increases the proportion of the doubly linked species without augmenting enzyme activity. The D225E mutant has little covalently bound heme and a much lower activity, neither of which are significantly increased by the addition of heme and H2O2. The heme is linked to this protein through a single bond to the 1-methyl group. The D225E/E375D mutant has no covalently bound heme and no activity. A small amount of iron 1-hydroxymethylprotoporphyrin IX is obtained from the wild-type enzyme along with the predominant dihydroxylated derivative. The results establish that a single covalent link suffices to achieve maximum catalytic activity and suggest that the 5-hydroxymethyl bond may form before the 1-hydroxymethyl bond.	Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, S-926, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032488] Funding Source: NIH RePORTER; NIDDK NIH HHS [5P30 DK 26743] Funding Source: Medline; NIGMS NIH HHS [GM 32488] Funding Source: Medline; OCPHP CDC HHS [PR 01614] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OCPHP CDC HHS		ATOR MA, 1987, J BIOL CHEM, V262, P14954; BOOTH KS, 1989, BIOCHEM BIOPH RES CO, V160, P897, DOI 10.1016/0006-291X(89)92519-9; DeGioia L, 1996, J BIOL INORG CHEM, V1, P476; DePillis GD, 1997, J BIOL CHEM, V272, P8857; Fayadat L, 1999, J BIOL CHEM, V274, P10533, DOI 10.1074/jbc.274.15.10533; FENNA R, 1995, ARCH BIOCHEM BIOPHYS, V316, P653, DOI 10.1006/abbi.1995.1086; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Kooter IM, 1999, J BIOL CHEM, V274, P26794, DOI 10.1074/jbc.274.38.26794; Kooter IM, 1999, EUR J BIOCHEM, V264, P211, DOI 10.1046/j.1432-1327.1999.00606.x; Kooter IM, 1997, J AM CHEM SOC, V119, P11542, DOI 10.1021/ja9725460; Lardinois OM, 1999, J BIOL CHEM, V274, P35441, DOI 10.1074/jbc.274.50.35441; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; NICHOL AW, 1987, BIOCHEM J, V247, P147, DOI 10.1042/bj2470147; OREILLY DR, 1992, BACULOVIRUS EXPRESSI, P128; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; Rae TD, 1996, J AM CHEM SOC, V118, P2103, DOI 10.1021/ja952650m; Rae TD, 1998, J BIOL CHEM, V273, P27968, DOI 10.1074/jbc.273.43.27968; Shin K, 2000, BIOCHEM BIOPH RES CO, V271, P831, DOI 10.1006/bbrc.2000.2713; Shin K, 2001, BIOCHEM BIOPH RES CO, V281, P1024, DOI 10.1006/bbrc.2001.4448; SIEVERS G, 1979, BIOCHIM BIOPHYS ACTA, V579, P181, DOI 10.1016/0005-2795(79)90097-7; TAYLOR KL, 1995, ARCH BIOCHEM BIOPHYS, V316, P635, DOI 10.1006/abbi.1995.1083; Watanabe S, 1998, FEBS LETT, V441, P476, DOI 10.1016/S0014-5793(98)01595-6; WEVER R, 1981, BIOCHIM BIOPHYS ACTA, V661, P235, DOI 10.1016/0005-2744(81)90009-7	23	56	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7191	7200		10.1074/jbc.M109523200	http://dx.doi.org/10.1074/jbc.M109523200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11756449	hybrid			2022-12-27	WOS:000174104300058
J	Guo, ZY; Krucken, J; Benten, WPM; Wunderlich, F				Guo, ZY; Krucken, J; Benten, WPM; Wunderlich, F			Estradiol-induced nongenomic calcium signaling regulates genotropic signaling in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ESTROGEN-INDUCED ACTIVATION; GENE-EXPRESSION; POSTMENOPAUSAL WOMEN; STEROID-HORMONES; PROTEIN-KINASE; T-CELLS; C-FOS; RECEPTOR; CANCER	Estradiol (E-2) exerts not only genotropic but also non-genomic actions through nuclear estrogen receptors (ER). Here, we provide a novel paradigm for non-genomic E-2 signaling independent of nuclear ER. E-2 induces a rapid rise in the intracellular free Ca2+ concentration ([Ca2+](i)) through membrane estrogen receptors in murine RAW 264.7 macrophages. This E-2-induced Ca2+ signaling is not prevented by different ER blockers and cannot directly activate stably transfected c-fos promoter or the mitogen-activated protein kinases p38, ERK1/2, and SAPK/JNK or NO production. However, the E-2-induced rise in [Ca2+](i) specifically down-regulates the serum-stimulated activation of c-fos promoter and ERK1/2, and conversely, it specifically up-regulates lipopolysaccharide-stimulated activation of c-fos promoter, p38, and NO production. The E-2-changed activation of c-fos promoter can be prevented by an intracellular Ca2+ chelator. Our data indicate that E-2-induced nongenomic Ca2+ signaling through membrane ER is able to specifically modulate genotropic signaling pathways with impact on macrophage activation.	Univ Dusseldorf, Div Mol Parasitol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Ctr Biol Med Res, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Wunderlich, F (corresponding author), Univ Dusseldorf, Div Mol Parasitol, Univ Str 1, D-40225 Dusseldorf, Germany.		Krücken, Jürgen/B-6794-2009; Krücken, Jürgen/CAF-6903-2022; Krücken, Jürgen/AAE-3133-2021	Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100				Audy MC, 1996, EUR J ENDOCRINOL, V135, P367, DOI 10.1530/eje.0.1350367; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Benten WPM, 1998, FEBS LETT, V422, P349, DOI 10.1016/S0014-5793(98)00039-8; Benten WPM, 2001, ENDOCRINOLOGY, V142, P1669, DOI 10.1210/en.142.4.1669; Benten WPM, 1999, MOL BIOL CELL, V10, P3113, DOI 10.1091/mbc.10.10.3113; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; CaulinGlaser T, 1997, CIRC RES, V81, P885; Chen BC, 1999, IMMUNOLOGY, V97, P124, DOI 10.1046/j.1365-2567.1999.00747.x; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; COHEN CJ, 1995, CANCER, V76, P2044, DOI 10.1002/1097-0142(19951115)76:10+<2044::AID-CNCR2820761323>3.0.CO;2-N; Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814; COLLART MA, 1987, J IMMUNOL, V139, P949; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; CUTOLO M, 1995, CLIN EXP RHEUMATOL, V13, P217; de Jager T, 2001, J BIOL CHEM, V276, P27873, DOI 10.1074/jbc.M010984200; Duan RQ, 2001, J BIOL CHEM, V276, P11590, DOI 10.1074/jbc.M005492200; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Farhat MY, 1996, J PHARMACOL EXP THER, V276, P652; FAVIT A, 1991, BRAIN RES, V555, P65, DOI 10.1016/0006-8993(91)90860-X; Feng GJ, 1999, J IMMUNOL, V163, P6403; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guzzo JA, 2000, CLIN CARDIOL, V23, P15, DOI 10.1002/clc.4960230104; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HENDERSON VW, 1997, AM J MED S3A, V103, P11; Improta-Brears T, 1999, P NATL ACAD SCI USA, V96, P4686, DOI 10.1073/pnas.96.8.4686; INTRONA M, 1986, J IMMUNOL, V137, P2711; Johnson CM, 1997, J NEUROSCI, V17, P6189; Krucken J, 1999, J BIOL CHEM, V274, P24383, DOI 10.1074/jbc.274.34.24383; LantinHermoso RL, 1997, AM J PHYSIOL-LUNG C, V273, pL119, DOI 10.1152/ajplung.1997.273.1.L119; LIEBERHERR M, 1993, J BONE MINER RES, V8, P1365; Mendelsohn ME, 2000, CIRC RES, V87, P956, DOI 10.1161/01.RES.87.11.956; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; ROCHE E, 1994, CELL CALCIUM, V16, P331, DOI 10.1016/0143-4160(94)90097-3; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; Stevis PE, 1999, ENDOCRINOLOGY, V140, P5455, DOI 10.1210/en.140.11.5455; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Termine JD, 1998, MATURITAS, V30, P241, DOI 10.1016/S0378-5122(98)00092-9; van Haasteren G, 1999, J RECEPT SIGNAL TR R, V19, P481, DOI 10.3109/10799899909036666; Watson CS, 1999, P SOC EXP BIOL MED, V220, P9, DOI 10.1046/j.1525-1373.1999.d01-2.x; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Wyckoff MH, 2001, J BIOL CHEM, V276, P27071, DOI 10.1074/jbc.M100312200	50	59	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7044	7050		10.1074/jbc.M109808200	http://dx.doi.org/10.1074/jbc.M109808200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751857	hybrid			2022-12-27	WOS:000174104300039
J	Karlstrom, H; Bergman, A; Lendahl, U; Naslund, J; Lundkvist, J				Karlstrom, H; Bergman, A; Lendahl, U; Naslund, J; Lundkvist, J			A sensitive and quantitative assay for measuring cleavage of presenilin substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; BETA-PROTEIN; ALZHEIMERS-DISEASE; ASPARTYL PROTEASE; SENILE PLAQUES; NOTCH; MUTATIONS; SIGNALS; DOMAIN	The presenilin (PS) proteins are components of the gamma-secretase activity, which is central in the pathogenesis of Alzheimer's disease. Here we present a novel cell-based reporter gene assay for the quantification of PS-controlled gamma-secretase cleavage of the Alzheimer amyloid precursor protein (APP). We show that this assay offers several advantages, including increased sensitivity and specificity, improved quantification of cleavage, and simultaneous detection of all gamma-secretase cleavages in APP. Furthermore, the APP assay can be used in parallel with a similar assay that records gamma-secretase cleavage of a Notch receptor. The use of these assays to analyze the effects of two known gamma-secretase inhibitors and postulated PS active site mutants on APP and Notch processing demonstrated that inhibitors and mutants that differently affect Notch and APP cleavage can be identified rapidly. The possibility in using these assays for high throughput screening of candidate gamma-secretase inhibitors for APP and Notch in parallel opens up new vistas to systematically search for novel inhibitors that selectively block APP cleavage while not affecting Notch signaling.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Novum, Dept Clin Neurosci Occupat Therapy & Elderly Care, NEUROTEC, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet	Lundkvist, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, Von Eulers Vag 3, SE-17177 Stockholm, Sweden.			Lendahl, Urban/0000-0001-9543-8141; Karlstrom, Helena/0000-0002-0498-2473				Armogida M, 2001, NAT CELL BIOL, V3, P1030, DOI 10.1038/ncb1101-1030; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, J BIOL CHEM, V275, P27348	18	89	98	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6763	6766		10.1074/jbc.C100649200	http://dx.doi.org/10.1074/jbc.C100649200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744687	hybrid			2022-12-27	WOS:000174104300002
J	Booth, RA; Cummings, C; Tiberi, M; Liu, XJ				Booth, RA; Cummings, C; Tiberi, M; Liu, XJ			GIPC participates in G protein signaling downstream of insulin-like growth factor 1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS OOCYTE MATURATION; FACTOR-I RECEPTOR; MAP KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; G(BETA-GAMMA) SUBUNITS; MOLECULAR-CLONING; LAEVIS OOCYTES; ACTIVATION; EXPRESSION; MEIOSIS	Several recent studies have demonstrated that insulin-like growth factor (IGF)-1-induced mitogen-activated protein kinase (MAP kinase) activation is abolished by pertussis toxin, suggesting that trimeric G proteins of the G(i) class are novel cellular targets of the IGF-1 signaling pathway. We report here that the intracellular domain of the Xenopus IGF-1 receptor is capable of binding to the Xenopus homolog of mammalian GIPC, a PDZ domain-containing protein previously identified as a binding partner of G(i)-specific GAP (RGS-GAIP). Binding of xGIPC to xIGF-1 receptor is independent of the kinase activity of the receptor and appears to require the PDZ domain of xGIPC. Injection of two C-terminal truncation mutants that retained the PDZ domain blocked IGF-1-induced Xenopus MAP kinase activation and oocyte maturation. While full-length xGIPC injection did not significantly alter insulin response, it greatly enhanced human RGS-GAIP in stimulating the insulin response in frog oocytes. This represents the first demonstration that GIPC-RGS-GAIP complex acts positively in IGF-1 receptor signal transduction.	Ottawa Hosp, Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Liu, XJ (corresponding author), Ottawa Hosp, Ottawa Hlth Res Inst, Ottawa, ON K1Y 4E9, Canada.	jliu@ohri.ca						Andersen CB, 1998, J BIOL CHEM, V273, P18705, DOI 10.1074/jbc.273.30.18705; Bayaa M, 2000, P NATL ACAD SCI USA, V97, P12607, DOI 10.1073/pnas.220302597; Blackshear PJ, 2001, GENE, V267, P71, DOI 10.1016/S0378-1119(01)00383-3; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Cummings C, 1996, DEV BIOL, V175, P338, DOI 10.1006/dbio.1996.0119; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; DeuterReinhard M, 1997, MOL CELL BIOL, V17, P2559, DOI 10.1128/MCB.17.5.2559; ELETR M, 1979, SCIENCE, V205, P1397, DOI 10.1126/science.472755; Farah S, 1998, J BIOL CHEM, V273, P4740, DOI 10.1074/jbc.273.8.4740; FINIDORILEPICARD J, 1981, NATURE, V292, P255, DOI 10.1038/292255a0; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hallak H, 2000, J BIOL CHEM, V275, P2255, DOI 10.1074/jbc.275.4.2255; HARLOW E, 1988, ANTIBODIES LAB MANUA, P106; Keummerle JF, 2001, J BIOL CHEM, V276, P7187, DOI 10.1074/jbc.M011145200; LIU XJ, 1995, MOL CELL BIOL, V15, P3563; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; Ohan N, 1999, J CELL SCI, V112, P2177; Ohan N, 2000, MOL REPROD DEV, V56, P336; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; SADLER SE, 1987, J BIOL CHEM, V262, P10644; SADLER SE, 1981, J BIOL CHEM, V256, P6368; Schorderet-Slatkine S, 1984, Symp Soc Exp Biol, V38, P67; SCHORDERETSLATKINE S, 1982, ENDOCRINOLOGY, V111, P1385, DOI 10.1210/endo-111-4-1385; Sheng YL, 2001, CURR BIOL, V11, P405, DOI 10.1016/S0960-9822(01)00123-3; SMITH LD, 1989, DEVELOPMENT, V107, P685; Tian JD, 2000, P NATL ACAD SCI USA, V97, P14358, DOI 10.1073/pnas.250492197; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; VALLETTE F, 1989, NUCLEIC ACIDS RES, V17, P723, DOI 10.1093/nar/17.2.723; Zhu L, 1998, ENDOCRINOLOGY, V139, P949, DOI 10.1210/en.139.3.949	34	54	56	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6719	6725		10.1074/jbc.M108033200	http://dx.doi.org/10.1074/jbc.M108033200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751850	hybrid			2022-12-27	WOS:000173989200134
J	del Castill-Olivares, A; Gil, G				del Castill-Olivares, A; Gil, G			Differential effects of sterol regulatory binding proteins 1 and 2 on sterol 12 alpha-hydroxylase - SREBP-2 suppresses the sterol 12 alpha-hydroxylase promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID SYNTHESIS; LIPOPROTEIN RECEPTOR GENE; ORPHAN NUCLEAR RECEPTOR; LEUCINE ZIPPER PROTEIN; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; TRANSCRIPTION FACTOR; INSULIN ACTION; HAMSTER LIVER; ELEMENT; CHOLESTEROL	The most important pathway for the catabolism and excretion of cholesterol in mammals is the formation of bile acids. Improper regulation of this pathway has implications for atherosclerosis, cholesterol gallstone formation, and some lipid storage diseases. Sterol 12alpha-hydroxylase (12a-hydroxylase) is required for cholic acid biosynthesis. The alpha(1)-fetoprotein transcription factor FTF is crucial for the expression and the bile acid-mediated down-regulation of 12alpha-hydroxylase. Cholesterol, on the other hand, down-regulates expression of the 12alpha-hydroxylase gene. In this study, we show that the two sterol regulatory binding proteins (SREBPs) have opposite effects on the 12alpha-hydroxylase promoter. SREBP-1 activated the 12alpha-hydroxylase promoter, as it does with many other cholesterol-regulated genes. In contrast, SREBP-2 suppressed 12alpha-hydroxylase promoter activity. SREBP-1 mediates the cholesterol-down-regulation of 12alpha-hydroxylase promoter by binding to two inverted sterol regulatory elements found similar to300 nucleotides from the transcriptional initiation site. SREBP-2 mediated suppression of 12alpha-hydroxylase without binding to its promoter. Data are presented suggesting that SREBP-2 suppresses the 12alpha-hydroxylase promoter by interacting with FTF. This is the first report of a promoter responding oppositely to two members of the SREBP family of transcription factors. These studies provide a novel function and mode of action of a SREBP protein.	Virginia Commonwealth Univ Med Coll Virginia, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA	Virginia Commonwealth University	Gil, G (corresponding author), Virginia Commonwealth Univ Med Coll Virginia, Dept Biochem & Mol Biophys, POB 980614, Richmond, VA 23298 USA.	ggil@vcu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044218, P01DK038030] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersson U, 1999, BBA-MOL CELL BIOL L, V1438, P167, DOI 10.1016/S1388-1981(99)00036-0; Ausubel F., 1999, CURRENT PROTOCOLS MO; Auwerx J, 1999, CELL, V97, P161; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; del Castillo-Olivares A, 2000, J BIOL CHEM, V275, P17793, DOI 10.1074/jbc.M000996200; del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587; del Castillo-Olivares A, 2001, NUCLEIC ACIDS RES, V29, P4035, DOI 10.1093/nar/29.19.4035; Eggertsen G, 1996, J BIOL CHEM, V271, P32269, DOI 10.1074/jbc.271.50.32269; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; GIL G, 1986, J BIOL CHEM, V261, P3717; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; GIL G, 1988, J BIOL CHEM, V263, P19009; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; HEUMAN DM, 1989, J LIPID RES, V30, P1161; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; JAVITT NB, 1994, FASEB J, V8, P1308, DOI 10.1096/fasebj.8.15.8001744; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pai JT, 1998, J BIOL CHEM, V273, P26138, DOI 10.1074/jbc.273.40.26138; RAMIREZ MI, 1994, MOL CELL BIOL, V14, P2809, DOI 10.1128/MCB.14.4.2809; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Seel WG, 1998, MOL ENDOCRINOL, V12, P1551, DOI 10.1210/mend.12.10.0184; Seol W, 1997, MOL CELL BIOL, V17, P7126, DOI 10.1128/MCB.17.12.7126; SHAW R, 1979, J BIOL CHEM, V254, P7177; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimomura I, 1997, P NATL ACAD SCI USA, V94, P12354, DOI 10.1073/pnas.94.23.12354; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; SMITH JR, 1988, J BIOL CHEM, V263, P18480; STRAVITZ RT, 1993, J BIOL CHEM, V268, P13987; Vlahcevic ZR, 2000, GASTROENTEROLOGY, V118, P599, DOI 10.1016/S0016-5085(00)70267-8; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	45	19	19	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6750	6757		10.1074/jbc.M106785200	http://dx.doi.org/10.1074/jbc.M106785200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741989	hybrid			2022-12-27	WOS:000173989200138
J	Ligos, JM; de Lera, TL; Hinderlich, S; Guinea, B; Sanchez, L; Roca, R; Valencia, A; Bernad, A				Ligos, JM; de Lera, TL; Hinderlich, S; Guinea, B; Sanchez, L; Roca, R; Valencia, A; Bernad, A			Functional interaction between the Ser/Thr kinase PKL12 and N-acetylglucosamine kinase, a prominent enzyme implicated in the salvage pathway for GlcNAc recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; EXPRESSION; PROTEINS; SUBFAMILY; MURINE; MEMBER	PKL12 (STK16) is a ubiquitously expressed Ser/Thr kinase, not structurally related to the well known subfamilies, with a putative role in cell adhesion control. Yeast two-hybrid protein interaction screening was used to search for proteins that associate with PKL12 and to delineate signaling pathways and/or regulatory circuits in which this kinase participates. One positive clone contained an open reading frame highly similar to N-acetylglucosamine kinase (GlcNAcK) of several species. The PKL12/GlcNAcK interaction was further confirmed both in vitro and in vivo. Protein expression analysis of GlcNAcK using a specific rabbit antiserum displayed a ubiquitous pattern in cell lines and animal tissues. Subcellular localization studies showed that GlcNAcK is a cytoplasmic protein with a dual subcellular localization, distributed between the perinuclear and peripheral cell reservoirs. After overexpression, GlcNAcK localizes in vesicular structures associated mainly with the cell membrane and colocalizes with the PKL12 protein. GlcNAcK is not otherwise a substrate for PKL12 activity and PKL12 does not appear to influence GlcNAcK activity either in vitro or in vivo. In vitro kinase assays have nonetheless revealed that functional GlcNAcK, although not able to modulate autophosphorylation of PKL12, greatly influences PKL12 kinase activity on a defined substrate protein. These results are interpreted to indicate a potential in vivo role for GlcNAcK in PKL12 translocation and a tentative regulatory role for PKL12-mediated phosphorylation on substrate proteins.	Spanish Council Sci Res, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, E-28049 Madrid, Spain; Spanish Council Sci Res, Ctr Nacl Biotecnol, Prot Design Grp, E-28049 Madrid, Spain; Free Univ Berlin, Inst Mol Biol & Biochem, D-14195 Berlin, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Free University of Berlin	Bernad, A (corresponding author), Spanish Council Sci Res, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Campus Univ Autonoma Madrid, E-28049 Madrid, Spain.	abernad@cnb.uam.es	Valencia, Alfonso/I-3127-2015; Bernad, Antonio/P-8573-2017	Valencia, Alfonso/0000-0002-8937-6789; Sanchez Pulido, Luis/0000-0002-2300-8502; Bernad, Antonio/0000-0003-0620-9668				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Berson AE, 1999, BIOCHEM BIOPH RES CO, V259, P533, DOI 10.1006/bbrc.1999.0811; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Boehmelt G, 2000, J BIOL CHEM, V275, P12821, DOI 10.1074/jbc.275.17.12821; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; COMER FI, 1999, BIOCHIM BIOPHYS ACTA, V1473, P162; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; DURBIN R, 1998, THEORY BEHIND PROFIL; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kopitz J, 1997, EUR J BIOCHEM, V248, P527, DOI 10.1111/j.1432-1033.1997.00527.x; KORNFELD R, 1976, ANNU REV BIOCHEM, V45, P217, DOI 10.1146/annurev.bi.45.070176.001245; Kurioka K, 1998, BBA-GENE STRUCT EXPR, V1443, P275, DOI 10.1016/S0167-4781(98)00224-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ligos JM, 1998, BIOCHEM BIOPH RES CO, V249, P380, DOI 10.1006/bbrc.1998.9163; McNabb DS, 1996, CURR OPIN BIOTECH, V7, P554, DOI 10.1016/S0958-1669(96)80061-9; Reutter, 1997, GLYCOSCIENCES STATUS, P245; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Stairs DB, 1998, HUM MOL GENET, V7, P2157, DOI 10.1093/hmg/7.13.2157; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wolosker H, 1998, FASEB J, V12, P91, DOI 10.1096/fasebj.12.1.91	25	24	25	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6333	6343		10.1074/jbc.M105766200	http://dx.doi.org/10.1074/jbc.M105766200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741987	hybrid			2022-12-27	WOS:000173989200085
J	Roberts, SC; Scott, J; Gasteier, JE; Jiang, YQ; Brooks, B; Jardim, A; Carter, NS; Heby, O; Ullman, B				Roberts, SC; Scott, J; Gasteier, JE; Jiang, YQ; Brooks, B; Jardim, A; Carter, NS; Heby, O; Ullman, B			S-adenosylmethionine decarboxylase from Leishmania donovani - Molecular, genetic, and biochemical characterization of null mutants and overproducers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI-BRUCEI; ADENOSYL-L-METHIONINE; PENTAMIDINE-RESISTANT LEISHMANIA; ORNITHINE DECARBOXYLASE; METHYLGLYOXAL BIS(GUANYLHYDRAZONE); INTRACELLULAR DEGRADATION; IRREVERSIBLE INHIBITION; TRYPANOTHIONE REDUCTASE; RHODESIENSE INFECTIONS; POLYAMINE BIOSYNTHESIS	The polyamine biosynthetic enzyme, S-adenosylmethionine decarboxylase (ADOMETDC) has been advanced as a potential target for antiparasitic chemotherapy. To investigate the importance of this protein in a model parasite, the gene encoding ADOMETDC has been cloned and sequenced from Leishmania donovani. The Deltaadometdc null mutants were created in the insect vector form of the parasite by double targeted gene replacement. The Deltaadometdc strains were incapable of growth in medium without polyamines; however, auxotrophy could be rescued by spermidine but not by putrescine, spermine, or methylthioadenosine. Incubation of Deltaadometdc parasites in medium lacking polyamines resulted in a drastic increase of putrescine and glutathione levels with a concomitant decrease in the amounts of spermidine and the spermidine-containing thiol trypanothione. Parasites transfected with an episomal ADOMETDC construct were created in both wild type and Deltaadometdc parasites. ADOMETDC overexpression abrogated polyamine auxotrophy in the Deltaadometdc L. donovani. In addition, ADOMETDC overproduction in wild type parasites alleviated the toxic effects of 5'-(((Z)-4-amino -2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811), but not pentamidine, berenil, or methyl-glyoxyl bis(guanylhydrazone), all inhibitors of ADOMETDC activities in vitro. The molecular, biochemical, and genetic characterization of ADOMETDC establishes that it is essential in L. donovani promastigotes and a potential target for therapeutic validation.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden	Oregon Health & Science University; Umea University	Ullman, B (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, L224,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	ullmanb@ohsu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI041622, R01AI041622] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLEN TE, 1993, NUCLEIC ACIDS RES, V21, P5431, DOI 10.1093/nar/21.23.5431; Bacchi C.J., 1987, P317; Bacchi C. J., 1980, Current chemotherapy and infectious disease. Volume 2. (Proc. 11th Internat. Congr. of chemotherapy and the 19th Intersci. Conf. on antimicrobial agents and chemotherapy, Boston, Ma, 1-5 Oct. 1979.), P1119; BACCHI CJ, 1981, J PROTOZOOL, V28, P20, DOI 10.1111/j.1550-7408.1981.tb02798.x; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1992, ANTIMICROB AGENTS CH, V36, P2736, DOI 10.1128/AAC.36.12.2736; Basselin M, 1998, PARASITOL RES, V84, P78, DOI 10.1007/s004360050361; Basselin M, 1998, ACTA TROP, V70, P43, DOI 10.1016/S0001-706X(98)00007-2; BERGER BJ, 1993, ACTA TROP, V54, P215, DOI 10.1016/0001-706X(93)90094-R; BITONTI AJ, 1987, EXP PARASITOL, V64, P237, DOI 10.1016/0014-4894(87)90148-2; BITONTI AJ, 1986, BIOCHEM J, V237, P685, DOI 10.1042/bj2370685; BITONTI AJ, 1990, ANTIMICROB AGENTS CH, V34, P1485, DOI 10.1128/AAC.34.8.1485; BYERS TL, 1991, BIOCHEM J, V274, P527, DOI 10.1042/bj2740527; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; DADara AA, 1996, BIOCHEM J, V320, P519, DOI 10.1042/bj3200519; DANZIN C, 1990, BIOCHEM PHARMACOL, V40, P1499, DOI 10.1016/0006-2952(90)90446-R; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GHODA L, 1990, J BIOL CHEM, V265, P11823; GILLIN FD, 1984, J PROTOZOOL, V31, P161, DOI 10.1111/j.1550-7408.1984.tb04308.x; HANSON S, 1992, J BIOL CHEM, V267, P2350; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Jiang YQ, 1999, J BIOL CHEM, V274, P3781, DOI 10.1074/jbc.274.6.3781; Kandpal M, 1997, LIFE SCI, V60, P1793, DOI 10.1016/S0024-3205(97)00139-2; KARVONEN E, 1985, BIOCHEM J, V231, P165, DOI 10.1042/bj2310165; KASHIWAGI K, 1990, J BIOL CHEM, V265, P22321; KAUR K, 1986, J PROTOZOOL, V33, P518, DOI 10.1111/j.1550-7408.1986.tb05654.x; KELLY JM, 1993, EUR J BIOCHEM, V218, P29, DOI 10.1111/j.1432-1033.1993.tb18348.x; Kinch LN, 1999, MOL BIOCHEM PARASIT, V101, P1, DOI 10.1016/S0166-6851(98)00181-9; Kinch LN, 2000, BIOCHEMISTRY-US, V39, P3336, DOI 10.1021/bi991493r; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; LEON W, 1977, J PROTOZOOL, V24, P444, DOI 10.1111/j.1550-7408.1977.tb04773.x; LU L, 1991, BIOCHEM J, V277, P671, DOI 10.1042/bj2770671; MUKHOPADHYAY R, 1995, INT J BIOCHEM CELL B, V27, P55, DOI 10.1016/1357-2725(95)93432-P; PAJUNEN A, 1988, J BIOL CHEM, V263, P17040; Pegg  A., 1981, POLYAMINES BIOL MED, P3; PEGG AE, 1984, CELL BIOCHEM FUNCT, V2, P11, DOI 10.1002/cbf.290020105; PEGG AE, 1983, METHOD ENZYMOL, V94, P239; Persson K, 1998, BIOCHEM J, V333, P527, DOI 10.1042/bj3330527; PHILLIPS MA, 1987, J BIOL CHEM, V262, P8721; Roberts SC, 2001, MOL BIOCHEM PARASIT, V115, P217, DOI 10.1016/S0166-6851(01)00293-6; RUSSELL DH, 1969, MOL PHARMACOL, V5, P253; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Schechter P. J., 1987, Inhibition of polyamine metabolism. Biological significance and basis for new therapies [edited by McCann, P. P.; Pegg, A. E.; Sjoerdsma, A.], P345; SINGH R, 1995, INDIAN J BIOCHEM BIO, V32, P437; STANLEY BA, 1991, J BIOL CHEM, V266, P18502; STANLEY BA, 1994, J BIOL CHEM, V269, P7901; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tolbert WD, 2001, BIOCHEMISTRY-US, V40, P9484, DOI 10.1021/bi010735w; WHITE MW, 1989, PHYSL POLYAMINES, P331; WILSON K, 1991, J BIOL CHEM, V266, P1665; Xiong HS, 1999, J BIOL CHEM, V274, P35059, DOI 10.1074/jbc.274.49.35059; Xiong HS, 1999, BIOCHEMISTRY-US, V38, P2462, DOI 10.1021/bi9825201	57	63	69	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5902	5909		10.1074/jbc.M110118200	http://dx.doi.org/10.1074/jbc.M110118200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11734561	hybrid			2022-12-27	WOS:000173989200028
J	Watanabe, YH; Motohashi, K; Yoshida, M				Watanabe, YH; Motohashi, K; Yoshida, M			Roles of the two ATP binding sites of ClpB from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; DOT-DNAJ COMPLEX; ESCHERICHIA-COLI; MUTATIONAL ANALYSIS; DEPENDENT PROTEASE; INACTIVATED PROTEINS; REGULATORY SUBUNIT; CHAPERONE SYSTEM; ACTIVATED ATPASE; HSP104	As a member of molecular chaperone Hsp100/Clp family, TCIpB from Thermus thermophilus has two nucleotide binding domains, NBD1 and NBD2, in a single polypeptide, each containing WalkerA and WalkerB consensus motifs. To probe their roles, mutations were introduced into the WalkerA or WalkerB motifs of each or both of the NBDs. The results are as follows. 1) For each of the NBDs, the ability of nucleotide binding is lost by mutations in the WalkerA motif but is retained by mutations in the WalkerB motif. 2) Each NBD has a casein-stimulatable small basic ATPase activity that is lost when the WalkerB motif is mutated. 3) TClpB assembles into a uniform 580-kDa oligomer when ATP is present at 55 degreesC, and only the mutants in the WalkerA motif in NBD1 fail to assemble, indicating that ATP binding to NBD1 but not hydrolysis is necessary and sufficient for the assembly. 4) Chaperone function of TClpB was lost when the WalkerA motif in each of the NBDs was mutated. Mutants in the WalkerB motifs of each NBD retained some chaperone activity.	Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Yoshida, M (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Nagatsuta 4259, Yokohama, Kanagawa 2268503, Japan.	myoshida@res.titech.ac.jp	Motohashi, Ken/I-4970-2019	Motohashi, Ken/0000-0002-8414-2836				BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; GOTTESMAN S, 1990, P NATL ACAD SCI USA, V87, P3513, DOI 10.1073/pnas.87.9.3513; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Kim KI, 2000, J MOL BIOL, V303, P655, DOI 10.1006/jmbi.2000.4165; Kim KI, 1998, BIOCHEM J, V333, P671, DOI 10.1042/bj3330671; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; KITAGAWA M, 1991, J BACTERIOL, V173, P4247, DOI 10.1128/JB.173.14.4247-4253.1991; Krzewska J, 2001, FEBS LETT, V489, P92, DOI 10.1016/S0014-5793(00)02423-6; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; MOTOHASHI K, 1994, J BIOL CHEM, V269, P27074; Motohashi K, 1996, J BIOL CHEM, V271, P17343, DOI 10.1074/jbc.271.29.17343; Motohashi K, 1997, FEBS LETT, V412, P633, DOI 10.1016/S0014-5793(97)00847-8; OKUNO H, 1985, Journal of Applied Biochemistry, V7, P192; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; SANCHEZ Y, 1993, J BACTERIOL, V175, P6484, DOI 10.1128/jb.175.20.6484-6491.1993; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; SEOL JH, 1995, J BIOL CHEM, V270, P8087, DOI 10.1074/jbc.270.14.8087; Shin DH, 1996, FEBS LETT, V398, P151, DOI 10.1016/S0014-5793(96)01223-9; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; SINGH SK, 1994, J BIOL CHEM, V269, P29537; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Thomas JG, 1998, J BACTERIOL, V180, P5165, DOI 10.1128/JB.180.19.5165-5172.1998; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Watanabe YH, 2000, J BIOL CHEM, V275, P12388, DOI 10.1074/jbc.275.17.12388; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 1999, PROTEIN SCI, V8, P1899, DOI 10.1110/ps.8.9.1899	42	74	76	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5804	5809		10.1074/jbc.M109349200	http://dx.doi.org/10.1074/jbc.M109349200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741950	hybrid			2022-12-27	WOS:000173989200016
J	Alonso, A; Merlo, JJ; Na, SQ; Kholod, N; Jaroszewski, L; Kharitonenkov, A; Williams, S; Godzik, A; Posada, JD; Mustelin, T				Alonso, A; Merlo, JJ; Na, SQ; Kholod, N; Jaroszewski, L; Kharitonenkov, A; Williams, S; Godzik, A; Posada, JD; Mustelin, T			Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; CRYSTAL-STRUCTURE; MAP KINASE; SH2 DOMAIN; PROTEIN; ACTIVATION; PYST1; SAP; ERK	A cDNA encoding a novel, human, dual-specific protein phosphatase was identified in the Incyte data base. The open reading frame predicted a protein of 184 amino acids related to the Vaccinia virus VH1 and human VH1-related VHR) phosphatases. Expression VHR-related MKPX (VHX) was highest in thymus, but also detectable in monocytes and lymphocytes. A VHX-specific antiserum detected a protein with an apparent molecular mass of 19 kDa in many cells, including T lymphocytes and monocytes. VHX expression was not induced by T cell activation, but decreased somewhat at later time points. In vitro, VHX dephosphorylated the Erk2 mitogen-activated protein kinase with faster kinetics than did VHR, which is thought to be specific for Erk1 and 2. When expressed in Jurkat T cells, VHX had the capacity to suppress T cell antigen receptor-induced activation of Erk2 and of an NFAT/AP-1 luciferase reporter, but not an NF-kappaB reporter. Thus, VHX is a new member of the VH1/VHR group of small dual-specific phosphatases that act in mitogen-activated protein kinase signaling pathways.	Burnham Inst, Lab Signal Transduct, La Jolla Canc Res Ctr, La Jolla, CA 92037 USA; Eli Lilly & Co, Indianapolis, IN 46285 USA	Sanford Burnham Prebys Medical Discovery Institute; Eli Lilly	Mustelin, T (corresponding author), Burnham Inst, Lab Signal Transduct, La Jolla Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tmustelin@burnham-inst.org	Godzik, Adam/A-7279-2009; Kholod, Natalia S/B-5724-2014; Godzik, Adam/AAW-1467-2020; Alonso, Andrés/L-7523-2014	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Alonso, Andrés/0000-0001-8674-9378; Mustelin, Tomas/0000-0001-5912-8840	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040552, R01AI048032, R01AI041481, R01AI040552, R01AI035603] Funding Source: NIH RePORTER; NIAID NIH HHS [AI35603, AI48032, AI40552, AI41481] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alonso A, 2001, J BIOL CHEM, V276, P4766, DOI 10.1074/jbc.M006497200; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Couture C, 1996, J BIOL CHEM, V271, P24294, DOI 10.1074/jbc.271.39.24294; Couture C, 1996, J BIOL CHEM, V271, P24880, DOI 10.1074/jbc.271.40.24880; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; DENU JM, 1995, J BIOL CHEM, V270, P3796, DOI 10.1074/jbc.270.8.3796; Dowd S, 1998, J CELL SCI, V111, P3389; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; Jascur T, 1997, J BIOL CHEM, V272, P14483, DOI 10.1074/jbc.272.22.14483; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kholod N, 2001, BIOTECHNIQUES, V31, P322, DOI 10.2144/01312st03; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Saxena M, 2000, SEMIN IMMUNOL, V12, P387, DOI 10.1006/smim.2000.0219; Shin DY, 1997, ONCOGENE, V14, P2633, DOI 10.1038/sj.onc.1201106; Smith A, 1997, GENOMICS, V42, P524, DOI 10.1006/geno.1997.4756; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Takagi T, 1997, CELL, V89, P867, DOI 10.1016/S0092-8674(00)80272-X; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; vonWillebrand M, 1996, EUR J BIOCHEM, V235, P828; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	28	67	68	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5524	5528		10.1074/jbc.M107653200	http://dx.doi.org/10.1074/jbc.M107653200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733513	hybrid			2022-12-27	WOS:000173962900125
J	Belova, GI; Prasad, R; Nazimov, IV; Wilson, SH; Slesarev, AI				Belova, GI; Prasad, R; Nazimov, IV; Wilson, SH; Slesarev, AI			The domain organization and properties of individual domains of DNA topoisomerase V, a type 1B topoisomerase with DNA repair activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-BETA; HYPERTHERMOPHILIC PROKARYOTE; PHOSPHATE LYASE; CIRCULAR DNA; BINDING; MECHANISM; PROTEIN; ENZYME; RECOMBINATION; TYROSINE	Topoisomerase V (Topo V) is a type IB (eukaryotic-like) DNA topoisomerase. It was discovered in the hyperthermophilic prokaryote Methanopyrus kandleri and is the only topoisomerase with associated apurinic/apyrimidinic (AP) site-processing activities. The structure of Topo V in the free and DNA-bound states was probed by limited proteolysis at 37 degreesC and 80 degreesC. The Topo V protein is comprised of (i) a 44-kDa NH2-terminal core subdomain, which contains the active site tyrosine residue for topoisomerase activity, (ii) an immediately adjacent 16-kDa subdomain that contains degenerate helix-hairpin-helix (HhH) motifs, (iii) a protease-sensitive 18-kDa HhH "hinge" region, and (iv) a 34-kDa COOH-terminal HhH domain. Three truncated Topo V polypeptides comprising the NH2-terminal 44-kDa and 16-kDa domains (Topo61), the 44-, 16-, and 18-kDa domains (Topo78), and the COOH-terminal 34-kDa domain (Topo34) were cloned, purified, and characterized. Both Topo61 and Topo78 are active topoisomerases, but in contrast to Topo V these enzymes are inhibited by high salt concentrations. Topo34 has strong DNA-binding ability but shows no topoisomerase activity. Finally, we demonstrate that Topo78 and Topo34 possess AP lyase activities that are important in base excision DNA repair. Thus, Topo V has at least two active sites capable of processing AP DNA. The significance of multiple HhH motifs for the Topo V processivity is discussed.	Fidel Syst Inc, Gaithersburg, MD 20879 USA; Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117871, Russia; NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Slesarev, AI (corresponding author), Fidel Syst Inc, 7960 Cessna Ave, Gaithersburg, MD 20879 USA.		Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	NHGRI NIH HHS [1R43HG2186-01A1] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG002186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, ZIAES050158] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Belova GI, 2001, P NATL ACAD SCI USA, V98, P6015, DOI 10.1073/pnas.111040498; Berger JM, 1998, BBA-GENE STRUCT EXPR, V1400, P3, DOI 10.1016/S0167-4781(98)00124-9; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; CRAIG NL, 1983, CELL, V35, P795, DOI 10.1016/0092-8674(83)90112-5; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; HAN YPW, 1994, J MOL BIOL, V235, P908, DOI 10.1006/jmbi.1994.1048; KIKUCHI Y, 1979, P NATL ACAD SCI USA, V76, P3760, DOI 10.1073/pnas.76.8.3760; KOZYAVKIN SA, 1995, J BIOL CHEM, V270, P13593, DOI 10.1074/jbc.270.23.13593; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Musgrave D, 2000, MOL MICROBIOL, V35, P341, DOI 10.1046/j.1365-2958.2000.01689.x; PARGELLIS CA, 1988, J BIOL CHEM, V263, P7678; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; SANDMAN K, 1990, P NATL ACAD SCI USA, V87, P5788, DOI 10.1073/pnas.87.15.5788; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Shuman S, 1998, BBA-GENE STRUCT EXPR, V1400, P321, DOI 10.1016/S0167-4781(98)00144-4; SLESAREV AI, 1991, J BIOL CHEM, V266, P12321; SLESAREV AI, 1994, J BIOL CHEM, V269, P3295; Slesarev AI, 2001, METHOD ENZYMOL, V334, P179; SLESAREV AI, 1993, NATURE, V364, P735, DOI 10.1038/364735a0; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; TSE YC, 1980, J BIOL CHEM, V255, P5560; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223	26	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4959	4965		10.1074/jbc.M110131200	http://dx.doi.org/10.1074/jbc.M110131200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733530	hybrid			2022-12-27	WOS:000173962900055
J	Hawash, IY; Kesavan, KP; Magee, AI; Geahlen, RL; Harrison, ML				Hawash, IY; Kesavan, KP; Magee, AI; Geahlen, RL; Harrison, ML			The Lck SH3 domain negatively regulates localization to lipid rafts through an interaction with c-Cbl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; CELL ANTIGEN RECEPTOR; GLYCOLIPID-ENRICHED MICRODOMAINS; PROTOONCOGENE PRODUCT; SIGNAL-TRANSDUCTION; MEMBRANE RAFTS; S-ACYLATION; SRC; ACTIVATION; BINDING	Lck is a member of the Src family of protein-tyrosine kinases and is essential for T cell development and function. Lck is localized to the inner surface of the plasma membrane and partitions into lipid rafts via dual acylation on its N terminus. We have tested the role of Lck binding domains in regulating Lck localization to lipid rafts. A form of Lck containing a point mutation inactivating the SH3 domain (W97ALck) was preferentially localized to lipid rafts compared with wild type or SH2 domain-inactive (R154K) Lck when expressed in Lck-deficient J.CaM1 cells. W97ALck incorporated more of the radioiodinated version of palmitic acid, 16[I-125]-iodohexadecanoic acid. Overexpression of c-Cbl, a ligand of the Lck SH3 domain, depleted Lck from lipid rafts in Jurkat cells. Additionally, Lck localization to lipid rafts was enhanced in c-Cbl-deficient T cells. The association of Lck with c-Cbl in vivo required a functional SH3 domain. These results suggest a model whereby the SH3 domain negatively regulates basal localization of Lck to lipid rafts via association with c-Cbl.	Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Purdue Univ, Dept Biol, W Lafayette, IN 47907 USA; Natl Inst Med Res, London NW7 1AA, England	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; MRC National Institute for Medical Research	Harrison, ML (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Hansen Life Sci Bldg, W Lafayette, IN 47907 USA.	harrison@pharmacy.purdue.edu	Magee, Anthony/V-8345-2019	Geahlen, Robert/0000-0001-8400-2924	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048099] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-48099] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAND L, 1994, J BIOL CHEM, V269, P16701; AMREIN KE, 1992, P NATL ACAD SCI USA, V89, P3343, DOI 10.1073/pnas.89.8.3343; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Arron JR, 2001, J BIOL CHEM, V276, P30011, DOI 10.1074/jbc.M100414200; August A, 1996, J BIOL CHEM, V271, P10054; Bano MC, 1998, BIOCHEM J, V330, P723, DOI 10.1042/bj3300723; Bell GM, 1996, J EXP MED, V183, P169, DOI 10.1084/jem.183.1.169; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Carey KD, 2000, MOL CELL BIOL, V20, P8409, DOI 10.1128/MCB.20.22.8409-8419.2000; Chen CA, 2000, J BIOL CHEM, V275, P23516, DOI 10.1074/jbc.M003439200; Denny MF, 1999, J BIOL CHEM, V274, P5146, DOI 10.1074/jbc.274.8.5146; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 2001, J BIOL CHEM, V276, P43300, DOI 10.1074/jbc.M104275200; FRA AM, 1994, J BIOL CHEM, V269, P30745; Fusaki N, 1997, J BIOL CHEM, V272, P6214, DOI 10.1074/jbc.272.10.6214; Garcia-Guzman M, 2000, ONCOGENE, V19, P4058, DOI 10.1038/sj.onc.1203750; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hartley D, 1996, J BIOL CHEM, V271, P21939, DOI 10.1074/jbc.271.36.21939; Holdorf AD, 1999, J EXP MED, V190, P375, DOI 10.1084/jem.190.3.375; Ilangumaran S, 2000, IMMUNOL TODAY, V21, P2, DOI 10.1016/S0167-5699(99)01494-2; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kosugi A, 2001, IMMUNOL LETT, V76, P133, DOI 10.1016/S0165-2478(01)00174-2; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Liu YC, 1998, CELL SIGNAL, V10, P377, DOI 10.1016/S0898-6568(97)00179-4; Lupher ML, 1999, IMMUNOL TODAY, V20, P375, DOI 10.1016/S0167-5699(99)01484-X; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Patel VP, 2001, J IMMUNOL, V166, P754, DOI 10.4049/jimmunol.166.2.754; Pathan NI, 1996, J BIOL CHEM, V271, P27517, DOI 10.1074/jbc.271.44.27517; PRASAD KVS, 1993, MOL CELL BIOL, V13, P7708, DOI 10.1128/MCB.13.12.7708; REEDQUIST KA, 1994, P NATL ACAD SCI USA, V91, P4135, DOI 10.1073/pnas.91.10.4135; Rellahan BL, 1997, J BIOL CHEM, V272, P30806, DOI 10.1074/jbc.272.49.30806; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; Sanzenbacher R, 1999, J IMMUNOL, V163, P3143; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Straus DB, 1996, J BIOL CHEM, V271, P9976, DOI 10.1074/jbc.271.17.9976; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Su MWC, 2001, J IMMUNOL, V166, P3975, DOI 10.4049/jimmunol.166.6.3975; TAKEMOTO Y, 1995, EMBO J, V14, P3403, DOI 10.1002/j.1460-2075.1995.tb07346.x; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Viola A, 2001, TRENDS IMMUNOL, V22, P322, DOI 10.1016/S1471-4906(01)01938-X; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yankee TM, 1999, J IMMUNOL, V163, P5827; YURCHAK LK, 1995, MOL CELL BIOL, V15, P6914, DOI 10.1128/mcb.15.12.6914; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zlatkine P, 1997, J CELL SCI, V110, P673	62	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5683	5691		10.1074/jbc.M110002200	http://dx.doi.org/10.1074/jbc.M110002200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741956	hybrid			2022-12-27	WOS:000173962900146
J	Paglia, MJ; Mou, H; Cote, RH				Paglia, MJ; Mou, H; Cote, RH			Regulation of photoreceptor phosphodiesterase (PDE6) by phosphorylation of its inhibitory gamma subunit re-evaluated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; RETINAL CGMP PHOSPHODIESTERASE; DEPENDENT PROTEIN-KINASE; ROD OUTER SEGMENTS; TRANSDUCIN ALPHA-SUBUNIT; BINDING-SITES; ACTIVATION; TURNOFF; IDENTIFICATION; MECHANISM	Phosphorylation of the inhibitory gamma subunit (Pgamma) of rod cGMP phosphodiesterase (PDE6) has been reported to turn off visual excitation without the requirement for inactivation of the photoreceptor G-protein transducin. We evaluated the significance of Pgamma phosphorylation for PDE6 regulation by preparing Pgamma stoichiometrically phosphorylated at Thr(22) or at Thr(35). Phosphorylation of Pgamma at either residue caused a minor decrease-not the previously reported increase-in the ability of Pgamma to inhibit catalysis at the active site of purified PDE6 catalytic dimers. Likewise, Pgamma phosphorylation had little effect on its potency to inhibit transducin-activated PDE6 depleted of its endogenous Pgamma subunits. The strength of Pgamma interaction with the regulatory GAF domain of PDE6 was reduced severalfold upon Pgamma phosphorylation at Thr(22) (but not Thr(35)), as judged by allosteric changes in cGMP binding to these noncatalytic sites on the enzyme (Mou, H., and Cote, R. H. (2001) J. Biol. Chem. 276, 27527-27534). In contrast, the effects of Pgamma phosphorylation on its interactions with activated transducin were much more pronounced. Phosphorylation of Pgamma at either Thr(22) or Thr(35) greatly diminished its ability to bind activated transducin, consistent with earlier work. In situ phosphorylation of Pgamma by endogenous rod outer segment kinases was enhanced severalfold upon light activation, but only similar to10% of the endogenous Pgamma was phosphorylated. This is attributed to Pgamma being a poor substrate for protein kinases when associated with the PDE6 holoenzyme. We conclude that, contrary to previous reports, Pgamma phosphorylation at either Thr(22) or Thr(35) modestly weakens its direct interactions with PDE6. However, Pgamma phosphorylation subsequent to its dissociation from PDE6 is likely to abolish its binding to activated transducin and may serve to make phosphorylated Pgamma available to regulate other signal transduction pathways (e.g. mitogen-activated protein kinase; Wan, K. F., Sambi, B. S., Frame, M., Tate, R., and Pyne, N. J. (2001) J. Biol. Chem. 276, 37802-37808) in photoreceptor cells.	Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Cote, RH (corresponding author), Univ New Hampshire, Dept Biochem & Mol Biol, 46 Coll Rd, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	NEI NIH HHS [R01 EY005798, EY-05798] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; Berger AL, 1999, BIOCHEMISTRY-US, V38, P1293, DOI 10.1021/bi981683m; Bondarenko VA, 1997, J BIOL CHEM, V272, P15856, DOI 10.1074/jbc.272.25.15856; BOWNDS D, 1971, J GEN PHYSIOL, V58, P225, DOI 10.1085/jgp.58.3.225; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Conti M, 2000, MOL ENDOCRINOL, V14, P1317, DOI 10.1210/me.14.9.1317; Cote RH, 2000, METHOD ENZYMOL, V315, P646; D'Amours MR, 1999, BIOCHEM J, V340, P863, DOI 10.1042/0264-6021:3400863; Frame M, 2001, CELL SIGNAL, V13, P735, DOI 10.1016/S0898-6568(01)00193-0; Francis SH, 2001, PROG NUCLEIC ACID RE, V65, P1; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky Alexey E., 1998, Cell Biochemistry and Biophysics, V28, P115, DOI 10.1007/BF02737808; GRAYKELLER MP, 1990, J BIOL CHEM, V265, P15323; HAMILTON SE, 1993, FEBS LETT, V318, P157, DOI 10.1016/0014-5793(93)80012-J; HAMM HE, 1986, BIOCHEMISTRY-US, V25, P4512, DOI 10.1021/bi00364a010; Harada Y, 2000, J BIOL CHEM, V275, P37078, DOI 10.1074/jbc.M004706200; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4333, DOI 10.1073/pnas.88.10.4333; Hayashi F, 2000, J BIOL CHEM, V275, P32958, DOI 10.1074/jbc.M000703200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; Lochhead A, 1997, J BIOL CHEM, V272, P18397, DOI 10.1074/jbc.272.29.18397; Manganiello VC, 1999, THROMB HAEMOSTASIS, V82, P407, DOI 10.1055/s-0037-1615860; Matsuura I, 2000, J BIOL CHEM, V275, P32950, DOI 10.1074/jbc.M000702200; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; PUGH EN, 2000, MOL MECH VISUAL TRAN; QIN N, 1993, FEBS LETT, V321, P6, DOI 10.1016/0014-5793(93)80609-X; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; TAKEMOTO DJ, 1992, BIOCHEM J, V281, P637, DOI 10.1042/bj2810637; Tate Rothwelle J., 1998, Cell Biochemistry and Biophysics, V29, P133, DOI 10.1007/BF02737832; TSUBOI S, 1994, J BIOL CHEM, V269, P15024; TSUBOI S, 1994, J BIOL CHEM, V269, P15016; UDOVICHENKO IP, 1993, BIOCHEM J, V295, P49, DOI 10.1042/bj2950049; UDOVICHENKO IP, 1994, J BIOL CHEM, V269, P9850; Udovichenko IP, 1996, BIOCHEM J, V317, P291, DOI 10.1042/bj3170291; Wan KF, 2001, J BIOL CHEM, V276, P37802; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; Xu LX, 1998, BIOCHEMISTRY-US, V37, P6205, DOI 10.1021/bi973087i; YAMAZAKI A, 1990, J BIOL CHEM, V265, P11539; YAMAZAKI A, 1993, J BIOL CHEM, V268, P8899	53	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5017	5023		10.1074/jbc.M106328200	http://dx.doi.org/10.1074/jbc.M106328200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741972	hybrid			2022-12-27	WOS:000173962900062
J	Singh, IS; He, JR; Calderwood, S; Hasday, JD				Singh, IS; He, JR; Calderwood, S; Hasday, JD			A high affinity HSF-1 binding site in the 5 '-untranslated region of the murine tumor necrosis factor-alpha gene is a transcriptional repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK FACTOR; FEBRILE-RANGE TEMPERATURE; FACTOR-I; PROTECTS MICE; EXPRESSION; ENDOTOXIN; ACTIVATION; CACHECTIN; TNF; INHIBITION	Tumor necrosis factor-alpha (TNFalpha) is a pivotal early mediator of host defenses that is essential for survival in infections. We previously reported that exposing macrophages to febrile range temperatures (FRT) (38.5-40 degreesC) markedly attenuates TNFalpha expression by causing abrupt and premature cessation of transcription. We showed that this inhibitory effect of FRT is mediated by an alternatively activated repressor form of heat shock factor 1 (HSF-1) and that a fragment of the TNFalpha gene comprising a minimal 85-nucleotide (nt) proximal promoter and the 138-nt 5'-untranslated region (UTR) was sufficient for mediating this effect. In the present study we have used an electrophoretic mobility shift assay (EMSA) to identify a high affinity binding site for HSF-1 in the 5'-UTR of the TNFalpha gene and have used a chromosome immunoprecipitation assay to show that HSF-1 binds to this region of the endogenous TNFalpha gene. Mutational inactivation of this site blocks the inhibitory effect of overexpressed HSF-1 on activity of the minimal TNFalpha promoter (-85/+138) in Raw 264.7 murine macrophages, identifying this site as an HSF-1-dependent repressor. However, the same mutation fails to block repression of a full-length (-1080/+138) TNFalpha promoter construct by HSF-1 overexpression, and HSF-1 binds to upstream sequences in the regions -1080/-845, -533/-196, and -326/-39 nt in EMSA, suggesting that additional HSF-1-dependent repressor elements are present upstream of the minimal -85-nt promoter. Furthermore, although mutation of the HSF-1 binding site in the minimal TNFalpha promoter construct abrogates HSF-1-mediated repression, the same mutation fails to abrogate repression of this construct by high levels of HSF-1 overexpression or exposure to 39.5 degreesC. This suggests that HSF-1 might repress TNFalpha transcription through redundant mechanisms, some of which might not require high affinity binding of HSF-1.	Univ Maryland, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Mol Biol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; Univ Maryland, Biopolymer Cytokine Core Lab, Baltimore, MD 21201 USA; Baltimore VA Med Ctr, Res Serv, Baltimore, MD 21201 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA 02115 USA; Baltimore VA Med Ctr, Med Serv, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Singh, IS (corresponding author), Baltimore VA Med Ctr, Med Serv, Rm 3D127,10 N Greene St, Baltimore, MD 21201 USA.				NIAID NIH HHS [AI42117] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042117] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BEUTLER B, 1995, J INVEST MED, V43, P227; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; BIRAGYN A, 1995, J IMMUNOL, V155, P674; Cahill CM, 1996, J BIOL CHEM, V271, P24874; Chen CM, 1997, J BIOL CHEM, V272, P26803, DOI 10.1074/jbc.272.43.26803; CHOLLETMARTIN S, 1993, AM REV RESPIR DIS, V164, P990; Cotto JJ, 1996, J BIOL CHEM, V271, P3355; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; CROSS AS, 1989, J EXP MED, V169, P2021, DOI 10.1084/jem.169.6.2021; ENSOR JE, 1994, AM J PHYSIOL, V266, pC967, DOI 10.1152/ajpcell.1994.266.4.C967; ENSOR JE, 1995, AM J PHYSIOL-CELL PH, V269, pC1140, DOI 10.1152/ajpcell.1995.269.5.C1140; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Gan L, 1999, J NEUROCHEM, V73, P1350, DOI 10.1046/j.1471-4159.1999.0731350.x; Hernandez I, 2000, DNA CELL BIOL, V19, P341, DOI 10.1089/10445490050043317; Jiang QQ, 1999, INFECT IMMUN, V67, P1539; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; JONGENEEL CV, 1989, EUR J IMMUNOL, V19, P549; LIEBERMAN AP, 1990, J EXP MED, V172, P989, DOI 10.1084/jem.172.3.989; Lopez PJ, 1998, J MOL BIOL, V276, P861, DOI 10.1006/jmbi.1997.1576; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARIBAN E, 1988, J CLIN INVEST, V81, P1506, DOI 10.1172/JCI113482; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Stephanou A, 1999, J BIOL CHEM, V274, P1723, DOI 10.1074/jbc.274.3.1723; Stephanou A, 1999, GENE EXPRESSION, V7, P311; WU BJ, 1986, P NATL ACAD SCI USA, V83, P629, DOI 10.1073/pnas.83.3.629; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yuan CX, 2000, CELL STRESS CHAPERON, V5, P229, DOI 10.1379/1466-1268(2000)005<0229:PTFHWT>2.0.CO;2	31	122	134	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4981	4988		10.1074/jbc.M108154200	http://dx.doi.org/10.1074/jbc.M108154200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11734555	hybrid			2022-12-27	WOS:000173962900058
J	Tschuschke, S; Schmitt-Wrede, HP; Greven, H; Wunderlich, F				Tschuschke, S; Schmitt-Wrede, HP; Greven, H; Wunderlich, F			Cadmium resistance conferred to yeast by a non-metallothioneinencoding gene of the earthworm Enchytraeus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; METAL-IONS; SEQUENCE; CLONING; STRESS; IDENTIFICATION; OLIGOCHAETA; SENSITIVITY; EXPRESSION	The earthworm Enchytraeus is able to survive in cadmium (Cd)-polluted environments. Upon Cd exposure, the worms express a gene encoding the putative nonmetallothionein 25-kDa cysteine-rich protein (CRP), which contains eight repeats with highly conserved cysteines in Cys-X-Cys and Cys-Cys arrangements exhibiting 36-53% identities to the 6-7-kDa metallothioneins of different organisms. Here, we demonstrate that the CRP protein confers a highly Cd-resistant phenotype to a Cd-hypersensitive yeast strain. Cd resistance increases with increasing numbers of expressed CRP repeats, but even one 3-kDa CRP repeat still mediates Cd resistance. Site-directed mutagenesis reveals that each single cysteine within a given repeat is important for Cd resistance, though to a different extent. However, replacement of other conserved amino acids such as Pro(136) and Asp(196) at the CRP repeat junctions does not affect Cd resistance. Our data indicate (i) that the non-metallothionein CRP protein is able to detoxify Cd and (ii) that this is dependent on the availability of sulfhydryl groups of the conserved cysteines.	Univ Dusseldorf, Div Mol Parasitol, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Ctr Biol Med Res, D-40225 Dusseldorf, Germany; Univ Dusseldorf, Inst Morphol Cell Biol & Parasitol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Wunderlich, F (corresponding author), Univ Dusseldorf, Div Mol Parasitol, Univ Str 1, D-40225 Dusseldorf, Germany.	frank.wunderlich@uni-duesseldorf.de	Schmitt-Wrede, Hans-Peter/ABD-6206-2021					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAUERHILTY A, 1989, COMP BIOCHEM PHYS C, V94, P373, DOI 10.1016/0742-8413(89)90085-6; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Benten WPM, 1999, MOL BIOL CELL, V10, P3113, DOI 10.1091/mbc.10.10.3113; CHERNAIK ML, 1991, P NATL ACAD SCI USA, V88, P3024, DOI 10.1073/pnas.88.8.3024; CODY CW, 1994, BIOCHEM BIOPH RES CO, V202, P954, DOI 10.1006/bbrc.1994.2022; Dallinger R, 1996, COMP BIOCHEM PHYS C, V113, P125, DOI 10.1016/0742-8413(95)02078-0; DIDDEN WAM, 1993, PEDOBIOLOGIA, V37, P2; DOBSON S, 1992, ENV HLTH CRITERIA, V135; ECKER DJ, 1986, J BIOL CHEM, V261, P6895; FRIBERG L, 1992, ENV HLTH CRITERIA, V134; Gruber C, 2000, EUR J BIOCHEM, V267, P573, DOI 10.1046/j.1432-1327.2000.01035.x; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Jacob ST, 1999, GENE EXPRESSION, V7, P301; JACOBSON KB, 1980, TOXICOLOGY, V16, P1, DOI 10.1016/0300-483X(80)90107-9; KAGI JHR, 1993, ADV LIF SCI, P29; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Krucken J, 1999, J BIOL CHEM, V274, P24383, DOI 10.1074/jbc.274.34.24383; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Miles AT, 2000, CRIT REV BIOCHEM MOL, V35, P35, DOI 10.1080/10409230091169168; MORGAN JE, 1989, COMP BIOCHEM PHYS C, V92, P15, DOI 10.1016/0742-8413(89)90195-3; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; NEJMEDDINE A, 1992, COMP BIOCHEM PHYS C, V101, P601, DOI 10.1016/0742-8413(92)90093-M; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Park KS, 1998, FEMS MICROBIOL LETT, V162, P325; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Perego P, 1997, TOXICOL APPL PHARM, V147, P312, DOI 10.1006/taap.1997.8271; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; RUFFIN P, 1994, BIOCHIMIE, V76, P423, DOI 10.1016/0300-9084(94)90119-8; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STONE H, 1985, COMP BIOCHEM PHYS C, V80, P9, DOI 10.1016/0742-8413(85)90126-4; STOPPLER M, 1991, METALS THEIR COMPOUN, P803; Sturzenbaum SR, 1998, FEBS LETT, V431, P437, DOI 10.1016/S0014-5793(98)00809-6; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Willuhn J, 1996, CHEMOSPHERE, V32, P2205, DOI 10.1016/0045-6535(96)00122-1; Willuhn J, 1996, BIOCHEM BIOPH RES CO, V220, P581, DOI 10.1006/bbrc.1996.0446; WILLUHN J, 1994, ECOTOX ENVIRON SAFE, V29, P93, DOI 10.1016/0147-6513(94)90034-5; WILLUHN J, 1994, J BIOL CHEM, V269, P24688; WINGE DR, 1985, J BIOL CHEM, V260, P4464	46	9	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5120	5125		10.1074/jbc.M108426200	http://dx.doi.org/10.1074/jbc.M108426200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741905	hybrid			2022-12-27	WOS:000173962900075
J	Zhao, X; Lam, JS				Zhao, X; Lam, JS			WaaP of Pseudomonas aeruginosa is a novel eukaryotic type protein-tyrosine kinase as well as a sugar kinase essential for the biosynthesis of core lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CONSERVED FEATURES; INNER-CORE; PHOSPHORYLATION; SEQUENCE; GENE; REGIONS; FAMILY; EXOPOLYSACCHARIDE; PHOSPHATASE	WaaP of P. aeruginosa is a crucial sugar kinase that phosphorylates HepI in the inner core region of lipopolysaccharide (LPS). WaaP shares homology with eukaryotic protein kinases in the conserved functional motifs (I-IX), indicating that it is also a protein kinase. This interpretation is substantiated by several lines of evidence including the following: (i) site-directed mutagenesis on catalytic domain residues abrogated the protein kinase activity; (ii) positive reaction in immunoblotting with anti-phosphotyrosine monoclonal antibody PY20; (iii) matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry and proteolytic peptide mapping showing excess mass equivalent to eight phosphate substituents on the tyrosine residues in WaaP; and (iv) WaaP is capable of catalyzing tyrosine self-phosphorylation as well as phosphorylating an exogenous synthetic co-polymer poly(Glu, Tyr). Thus, WaaP possesses dual kinase functions, and it utilizes a catalytic mechanism similar to that of the eukaryotic protein kinases. WaaP was localized to the cytoplasm, suggesting that phosphorylation of the LPS core occurred prior to translocation to the periplasm and attachment of O-antigen. A chemiluminescence-based enzyme-linked immunosorbent assay (ELISA) was developed to measure the kinetics of the WaaP sugar kinase activity, and the results showed that the K-m was 0.22 mM for ATP and 14.4 muM for hydrofluoric acid-treated LPS, V-max was 408.24 pmol min(-1), and k(cat) was 27.23 min(-1).	Univ Guelph, Dept Microbiol, Canadian Bacterial Dis Network, Guelph, ON N1G 2W1, Canada	University of Guelph	Lam, JS (corresponding author), Univ Guelph, Dept Microbiol, Canadian Bacterial Dis Network, Guelph, ON N1G 2W1, Canada.	jlam@uoguelph.ca						Al-Obeidi FA, 1998, BIOPOLYMERS, V47, P197, DOI 10.1002/(SICI)1097-0282(1998)47:3<197::AID-BIP2>3.0.CO;2-H; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMES BN, 1960, J BIOL CHEM, V235, P769; ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; BANTROCH S, 1994, CLIN DIAGN LAB IMMUN, V1, P55, DOI 10.1128/CDLI.1.1.55-62.1994; BODEY GP, 1983, J INFECT DIS, V148, P892, DOI 10.1093/infdis/148.5.892; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Cozzone AJ, 1998, BIOCHIMIE, V80, P43, DOI 10.1016/S0300-9084(98)80055-2; DEKIEVIT TR, 1994, J BACTERIOL, V176, P7129, DOI 10.1128/JB.176.23.7129-7139.1994; DEKIEVIT TR, 1995, MOL MICROBIOL, V16, P565; Duclos B, 1996, J MOL BIOL, V259, P891, DOI 10.1006/jmbi.1996.0366; GARCIA P, 1993, J BIOL CHEM, V268, P25146; Gervay J, 1999, CURR MED CHEM, V6, P129; Grangeasse C, 1998, J MOL BIOL, V278, P339, DOI 10.1006/jmbi.1998.1650; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; HUANG L, 1990, APPL ENVIRON MICROB, V56, P1229, DOI 10.1128/AEM.56.5.1229-1234.1990; HUFF JP, 1990, BIOTECHNIQUES, V9, P570; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; KESSLER E, 1994, J BIOL CHEM, V269, P22726; KONDO S, 1992, CARBOHYD RES, V231, P55, DOI 10.1016/0008-6215(92)84007-F; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MADHUSUDAN, 1994, PROTEIN SCI, V3, P176; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; MORONA R, 1995, MOL MICROBIOL, V18, P209, DOI 10.1111/j.1365-2958.1995.mmi_18020209.x; OLMSTED JB, 1986, METHOD ENZYMOL, V134, P467; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; Sadovskaya I, 1998, EUR J BIOCHEM, V255, P673, DOI 10.1046/j.1432-1327.1998.2550673.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STRYER L, 1988, BIOCHEMISTRY-US, P178; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Vincent C, 1999, J BACTERIOL, V181, P3472, DOI 10.1128/JB.181.11.3472-3477.1999; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Walsh AG, 2000, MOL MICROBIOL, V35, P718, DOI 10.1046/j.1365-2958.2000.01741.x; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; WILKINSON SG, 1983, REV INFECT DIS, V5, pS941; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Yethon JA, 2001, J BIOL CHEM, V276, P5498, DOI 10.1074/jbc.M008255200; Zhang CC, 1996, MOL MICROBIOL, V20, P9, DOI 10.1111/j.1365-2958.1996.tb02483.x	47	37	40	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4722	4730		10.1074/jbc.M107803200	http://dx.doi.org/10.1074/jbc.M107803200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741974	hybrid			2022-12-27	WOS:000173962900024
J	Proske, D; Hofliger, M; Soll, RM; Beck-Sickinger, AG; Famulok, M				Proske, D; Hofliger, M; Soll, RM; Beck-Sickinger, AG; Famulok, M			A Y2 receptor mimetic aptamer directed against neuropeptide Y	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; INCREASES FOOD-INTAKE; IN-VITRO SELECTION; PANCREATIC-POLYPEPTIDE; PEPTIDE-YY; MOLECULAR CHARACTERIZATION; FUNCTIONAL EXPRESSION; VASCULAR-PERMEABILITY; RNA INHIBITORS; HIGH-AFFINITY	Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that exerts its activity by at least five different receptor subtypes that belong to the family of G-protein coupled receptors. We isolated an aptamer directed against NPY from a nuclease-resistant RNA library. Mapping experiments with N-terminally, C-terminally, and centrally truncated analogues of NPY revealed that the aptamer recognizes the C terminus of NPY. Individual replacement of the four arginine residues at positions 19,25,33, and 35 by L-alanine showed that arginine 33 is essential for binding. The aptamer does not recognize pancreatic polypeptide, a highly homologous Y4 receptor-specific peptide of the gut. Furthermore, the affinity of the aptamer to the Y5 receptor-selective agonist [Alan(31),Aib(32)]Npy and the Y1/Y5 receptor-binding peptide [Leu(31),Pro(34)]NPY was considerably reduced, whereas Y2 receptor-specific NPY mutants were bound well by the aptamer. Accordingly, the NPY epitope was recognized by the Y2 receptor, and the aptamer was highly similar. This Y2 receptor mimicking effect was further confirmed by competition binding studies. Whereas the aptamer competed with the Y2 receptor for binding of [H-3]NPY with high affinity, a low affinity displacement of [H-3]NPY was observed at the Y1 and the Y5 receptors. Consequently, competition at the Y2 receptor occurred with a considerably lower K-i value compared with the Y1 and Y5 receptors. These results indicate that the aptamer mimics the binding of NPY to the Y2 receptor more closely than to the Y1 and Y5 receptors.	Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; LMU Munchen, Inst Biochem, D-81375 Munich, Germany; Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany	University of Bonn; University of Munich; Leipzig University	Famulok, M (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.							ALBERS HE, 1984, SCIENCE, V223, P833, DOI 10.1126/science.6546454; BARD JA, 1995, J BIOL CHEM, V270, P26762, DOI 10.1074/jbc.270.45.26762; BECKSICKINGER AG, 1993, J RECEPTOR RES, V13, P215, DOI 10.3109/10799899309073656; BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; Bischoff A, 1999, TRENDS PHARMACOL SCI, V20, P104, DOI 10.1016/S0165-6147(99)01319-X; Blind M, 1999, P NATL ACAD SCI USA, V96, P3606, DOI 10.1073/pnas.96.7.3606; Cabrele C, 2000, J PEPT SCI, V6, P97, DOI 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E; Cabrele C, 2000, J BIOL CHEM, V275, P36043, DOI 10.1074/jbc.M000626200; CALZA L, 1990, REGUL PEPTIDES, V27, P127, DOI 10.1016/0167-0115(90)90211-E; Cerda-Reverter JM, 2000, BIOCHEM CELL BIOL, V78, P371, DOI 10.1139/bcb-78-3-371; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHRONWALL BM, 1985, NEUROSCIENCE, V15, P1159, DOI 10.1016/0306-4522(85)90260-X; CONLON JM, 1991, EUR J BIOCHEM, V199, P293, DOI 10.1111/j.1432-1033.1991.tb16123.x; EATON BE, 1995, ANNU REV BIOCHEM, V64, P837, DOI 10.1146/annurev.bi.64.070195.004201; Eckard CP, 2001, MOLECULES, V6, P448, DOI 10.3390/60500448; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Famulok M, 1999, CURR TOP MICROBIOL, V243, P123; Famulok M, 2000, ACCOUNTS CHEM RES, V33, P591, DOI 10.1021/ar960167q; FAMULOK M, 1994, J AM CHEM SOC, V116, P1698, DOI 10.1021/ja00084a010; FLOOD JF, 1987, BRAIN RES, V421, P280, DOI 10.1016/0006-8993(87)91297-2; GLOVER ID, 1984, EUR J BIOCHEM, V142, P379, DOI 10.1111/j.1432-1033.1984.tb08298.x; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; Hall AC, 1999, EUR J NEUROSCI, V11, P3424, DOI 10.1046/j.1460-9568.1999.00761.x; HEIDENREICH O, 1993, FASEB J, V7, P90, DOI 10.1096/fasebj.7.1.7678566; HEILIG M, 1987, REGUL PEPTIDES, V19, P221, DOI 10.1016/0167-0115(87)90278-3; Ingenhoven N, 1999, BIOCHEMISTRY-US, V38, P6897, DOI 10.1021/bi982831b; Ingenhoven N, 1997, J RECEPT SIGNAL TR R, V17, P407, DOI 10.3109/10799899709036617; Ingenhoven N, 1999, CURR MED CHEM, V6, P1055; JELLINEK D, 1994, BIOCHEMISTRY-US, V33, P10450, DOI 10.1021/bi00200a028; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Klug SJ, 1997, P NATL ACAD SCI USA, V94, P6676, DOI 10.1073/pnas.94.13.6676; Larhammar D, 1996, REGUL PEPTIDES, V65, P165, DOI 10.1016/0167-0115(96)00110-3; Lee SW, 1997, NAT BIOTECHNOL, V15, P41, DOI 10.1038/nbt0197-41; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; LUNDELL I, 1995, J BIOL CHEM, V270, P29123, DOI 10.1074/jbc.270.49.29123; MORLEY JE, 1987, AM J PHYSIOL, V253, pR516, DOI 10.1152/ajpregu.1987.253.3.R516; Moser C, 2000, CAN J PHYSIOL PHARM, V78, P134, DOI 10.1139/cjpp-78-2-134; NIEUWLANDT D, 1995, BIOCHEMISTRY-US, V34, P5651, DOI 10.1021/bi00016a041; Pagratis NC, 1997, NAT BIOTECHNOL, V15, P68, DOI 10.1038/nbt0197-68; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rist B, 1995, J PEPT SCI, V1, P341, DOI 10.1002/psc.310010509; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; RUDOLF K, 1994, EUR J PHARMACOL, V271, P11; Sautel M, 1996, MOL PHARMACOL, V50, P285; Soll RM, 2001, EUR J BIOCHEM, V268, P2828, DOI 10.1046/j.1432-1327.2001.02161.x; Wieland HA, 1998, EUR J BIOCHEM, V255, P595, DOI 10.1046/j.1432-1327.1998.2550595.x; Williams KP, 1997, P NATL ACAD SCI USA, V94, P11285, DOI 10.1073/pnas.94.21.11285; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Xu W, 1996, P NATL ACAD SCI USA, V93, P7475, DOI 10.1073/pnas.93.15.7475	50	33	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 29	2002	277	13					11416	11422		10.1074/jbc.M109752200	http://dx.doi.org/10.1074/jbc.M109752200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	534WQ	11756401	hybrid			2022-12-27	WOS:000174613100085
J	Arystarkhova, E; Donnet, C; Asinovski, NK; Sweadner, KJ				Arystarkhova, E; Donnet, C; Asinovski, NK; Sweadner, KJ			Differential regulation of renal Na,K-ATPase by splice variants of the gamma subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; CYTOPLASMIC-BINDING SITES; PIG VENTRICULAR MYOCYTES; NA/K PUMP CURRENT; SODIUM-PUMP; ALPHA-SUBUNIT; IMMUNOCYTOCHEMICAL LOCALIZATION; CONVOLUTED TUBULE; COLLECTING DUCT; ION SELECTIVITY	Sodium and Potassium-exchanging adenosine triphosphatase (Na,K-ATPase) in the kidney is associated with the gamma subunit (gamma, FXYD2), a single-span membrane protein that modulates ATPase properties. Rat and human gamma occur in two splice variants, gammaa and gammab, with different N termini. Here we investigated their structural heterogeneity and functional effects on Na,K-ATPase properties. Both forms were post-translationally modified during in vitro translation with microsomes, indicating that there are four possible forms of gamma. Site-directed mutagenesis revealed Thr(2) and Ser(5) as potential sites for post-translational modification. Similar modification can occur in cells, with consequences for Na,K-ATPase properties. We showed previously that stable transfection of gammaa into NRK-52E cells resulted in reduction of apparent affinities for Na+ and K+. Individual clones differed in gamma post-translational modification, however, and the effect on Na affinity was absent in clones with full modification. Here, transfection of gammab also resulted in clones with or without post-translational modification. Both groups showed a reduction in Na+ affinity, but modification was required for the effect on K+ affinity. There were minor increases in ATP affinity. The physiological importance of the reduction in Na+ affinity was shown by the slower growth of gammaa, gammab, and gammab' transfectants in culture. The differential influence of the four structural variants of gamma on affinities of the Na,K-ATPase for Na+ and K+, together with our previous finding of different distributions of gammaa and gammab along the rat nephron, suggests a highly specific mode of regulation of sodium pump properties in kidney.	Massachusetts Gen Hosp, Ctr Neurosci, Lab Membrane Biol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Sweadner, KJ (corresponding author), Massachusetts Gen Hosp, Ctr Neurosci, Lab Membrane Biol, 149 13th St,149-6118, Charlestown, MA 02129 USA.	sweadner@helix.mgh.harvard.edu			NHLBI NIH HHS [HL27653] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Apell HJ, 2001, J MEMBRANE BIOL, V180, P1, DOI 10.1007/s002320010053; Aperia A, 2001, Curr Hypertens Rep, V3, P165, DOI 10.1007/s11906-001-0032-8; Arystarkhova E, 1996, J BIOL CHEM, V271, P23407, DOI 10.1074/jbc.271.38.23407; Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Arystarkhova E, 2002, AM J PHYSIOL-RENAL, V282, pF393, DOI 10.1152/ajprenal.00146.2001; Arystarkhova E, 2000, BIOPHYS J, V78, p279A; Arystarkhova E, 2000, INT CONGR SER, V1207, P489; Arystarkhova Elena, 2000, Journal of the American Society of Nephrology, V11, p24A; ATTALI B, 1995, P NATL ACAD SCI USA, V92, P6092, DOI 10.1073/pnas.92.13.6092; Barmashenko G, 1999, J PHYSIOL-LONDON, V517, P691, DOI 10.1111/j.1469-7793.1999.0691s.x; BAS CB, 1990, AM J PHYSIOL, V259, pF246; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Beguin P, 2001, EMBO J, V20, P3993, DOI 10.1093/emboj/20.15.3993; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BuffinMeyer B, 1996, J PHYSIOL-LONDON, V490, P623, DOI 10.1113/jphysiol.1996.sp021172; Burrow CR, 1999, AM J PHYSIOL-RENAL, V277, pF391, DOI 10.1152/ajprenal.1999.277.3.F391; Capasso JM, 2001, P NATL ACAD SCI USA, V98, P13414, DOI 10.1073/pnas.231309198; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; DETOMASO AW, 1993, J BIOL CHEM, V268, P1470; Domaszewicz W, 1999, FEBS LETT, V458, P241, DOI 10.1016/S0014-5793(99)01162-X; FARMAN N, 1991, AM J PHYSIOL, V260, pC468, DOI 10.1152/ajpcell.1991.260.3.C468; FERAILLE, 1995, AM J PHYSIOL, V268, pC1277; FERAILLE E, 1994, AM J PHYSIOL, V267, pF55, DOI 10.1152/ajprenal.1994.267.1.F55; FERAILLE E, 1995, J PHYSIOL-LONDON, V488, P171, DOI 10.1113/jphysiol.1995.sp020955; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; FREYTAG JW, 1983, FEBS LETT, V159, P280, DOI 10.1016/0014-5793(83)80464-5; Fu XY, 1997, MOL CELL BIOL, V17, P1503, DOI 10.1128/MCB.17.3.1503; GADSBY DC, 1985, NATURE, V315, P63, DOI 10.1038/315063a0; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Hayward AL, 1999, J HYPERTENS, V17, P1081, DOI 10.1097/00004872-199917080-00006; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; HOVING S, 1995, J BIOL CHEM, V270, P29788; Jones DH, 2001, PHYSIOL GENOMICS, V6, P129, DOI 10.1152/physiolgenomics.2001.6.3.129; Jorgensen P L, 1974, Methods Enzymol, V32, P277; Kuster B, 2000, J BIOL CHEM, V275, P18441, DOI 10.1074/jbc.M001411200; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; Lucking K, 1996, AM J PHYSIOL-RENAL, V271, pF253, DOI 10.1152/ajprenal.1996.271.2.F253; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; MORRISON BW, 1995, J BIOL CHEM, V270, P2176, DOI 10.1074/jbc.270.5.2176; NAKAO M, 1989, J GEN PHYSIOL, V94, P539, DOI 10.1085/jgp.94.3.539; Or E, 1996, J BIOL CHEM, V271, P2470, DOI 10.1074/jbc.271.5.2470; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; ROBINSON JD, 1991, BIOCHIM BIOPHYS ACTA, V1061, P267, DOI 10.1016/0005-2736(91)90292-G; ROBINSON JD, 1987, BIOCHIM BIOPHYS ACTA, V912, P343, DOI 10.1016/0167-4838(87)90038-0; ROBINSON JD, 1991, BIOCHIM BIOPHYS ACTA, V1069, P281, DOI 10.1016/0005-2736(91)90136-V; ROSSI RC, 1989, BIOCHIM BIOPHYS ACTA, V981, P105, DOI 10.1016/0005-2736(89)90087-4; SACHS JR, 1986, J PHYSIOL-LONDON, V374, P221, DOI 10.1113/jphysiol.1986.sp016076; SACHS JR, 1988, J PHYSIOL-LONDON, V400, P575, DOI 10.1113/jphysiol.1988.sp017137; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHEINERBOBIS G, 1994, BBA-BIOMEMBRANES, V1193, P226, DOI 10.1016/0005-2736(94)90157-0; Schneeberger A, 1999, J MEMBRANE BIOL, V168, P221, DOI 10.1007/s002329900511; Schneeberger A, 2001, J MEMBRANE BIOL, V179, P263, DOI 10.1007/s002320010051; Shi HK, 2001, AM J PHYSIOL-RENAL, V280, pF505, DOI 10.1152/ajprenal.2001.280.3.F505; Starling AP, 1996, BIOCHEM BIOPH RES CO, V226, P352, DOI 10.1006/bbrc.1996.1360; Sweadner KJ, 2000, INT CONGR SER, V1207, P543; SWEADNER KJ, 1985, J BIOL CHEM, V260, P1508; Sweadner KJ, 2000, BIOCHEM BIOPH RES CO, V279, P196, DOI 10.1006/bbrc.2000.3907; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Tashiro M, 1997, BIOPHYS J, V73, P3358, DOI 10.1016/S0006-3495(97)78360-7; Therien AG, 1999, AM J PHYSIOL-CELL PH, V277, pC891, DOI 10.1152/ajpcell.1999.277.5.C891; Therien AG, 1996, J BIOL CHEM, V271, P7104, DOI 10.1074/jbc.271.12.7104; Therien AG, 1997, J BIOL CHEM, V272, P32628, DOI 10.1074/jbc.272.51.32628; Therien AG, 1999, J BIOL CHEM, V274, P12252, DOI 10.1074/jbc.274.18.12252; Therien AG, 2001, J BIOENERG BIOMEMBR, V33, P407, DOI 10.1023/A:1010619623841; Touyz RM, 2001, J BIOL CHEM, V276, P13657, DOI 10.1074/jbc.M008101200; TUMLIN JA, 1994, AM J PHYSIOL, V266, pF240, DOI 10.1152/ajprenal.1994.266.2.F240; WELLING PA, 1993, J BIOL CHEM, V268, P23469; Wetzel Randall K., 2001, Journal of the American Society of Nephrology, V12, p43A; Wetzel RK, 2001, AM J PHYSIOL-RENAL, V281, pF531, DOI 10.1152/ajprenal.2001.281.3.F531	73	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10162	10172		10.1074/jbc.M111552200	http://dx.doi.org/10.1074/jbc.M111552200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11756431	hybrid			2022-12-27	WOS:000174549200075
J	Berechid, BE; Kitzmann, M; Foltz, DR; Roach, AH; Seiffert, D; Thompson, LA; Olson, RE; Bernstein, A; Donoviel, DB; Nye, JS				Berechid, BE; Kitzmann, M; Foltz, DR; Roach, AH; Seiffert, D; Thompson, LA; Olson, RE; Bernstein, A; Donoviel, DB; Nye, JS			Identification and characterization of presenilin-independent Notch signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE INHIBITORS; CAENORHABDITIS-ELEGANS; NEURONAL DIFFERENTIATION; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; CELL FATES; IN-VIVO; NUCLEAR TRANSLOCATION; DROSOPHILA PRESENILIN; PROTEOLYTIC RELEASE	Presenilin (PS) proteins control the proteolytic cleavage that precedes nuclear access of the Notch intracellular domain. Here we observe that a partial activation of the HES1 promoter can be detected in PS1/PS2 (PS1/2) double null cells using Notch1DeltaE constructs or following Delta1 stimulation, despite an apparent abolition of the production and nuclear accumulation of the Notch intracellular domain. PS1/2-independent Notch activation is sensitive to Numblike, a physiological inhibitor of Notch. PS1/2-independent Notch signaling is also inhibited by an active gamma-secretase inhibitor in the low micromolar range and is not inhibited by an inactive analogue, similar to PS-dependent Notch signaling. However, experiments using a Notch1-Gal4-VP16 fusion protein indicate that the PS1/2-independent activity does not release Gal4-VP16 and is therefore unlikely to proceed via an intramembranous cleavage. These data reveal that a novel PS1/2-independent mechanism plays a partial role in Notch signal transduction.	Northwestern Univ, Dept Mol Pharmacol Biol Chem & Pediat, Chicago, IL 60611 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Bristol Myers Squibb Co, Wilmington, DE 19880 USA	Northwestern University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Bristol-Myers Squibb	Nye, JS (corresponding author), Pharmacia Corp, 7242-209-331-1,301 Henrietta St, Kalamazoo, MI 49007 USA.	jeffrey.s.nye@pharmacia.com	Nye, Jeffrey/G-6520-2012	Nye, Jeffrey/0000-0002-6056-281X	NIA NIH HHS [AG13854] Funding Source: Medline; NIGMS NIH HHS [T32GM08061] Funding Source: Medline; NINDS NIH HHS [NS35566] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013854] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Appel B, 1999, CURR BIOL, V9, P247, DOI 10.1016/S0960-9822(99)80113-4; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baumeister R, 1997, Genes Funct, V1, P149; Berechid BE, 1999, CURR BIOL, V9, P1493, DOI 10.1016/S0960-9822(00)80121-9; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Berezovska O, 2000, ANN NY ACAD SCI, V920, P223; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CHOU CC, 1987, P NATL ACAD SCI USA, V84, P2575, DOI 10.1073/pnas.84.9.2575; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; DELAMO FF, 1992, DEVELOPMENT, V115, P737; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Frank M, 1999, VERHALTENSTHERAPIE, V9, P16; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Guo YQ, 1999, J NEUROSCI, V19, P8435; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Hadland BK, 2001, P NATL ACAD SCI USA, V98, P7487, DOI 10.1073/pnas.131202798; Handler M, 2000, DEVELOPMENT, V127, P2593; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; JOHNSTON J, 1994, NEUROCHEM INT, V25, P73, DOI 10.1016/0197-0186(94)90056-6; Kato H, 1997, DEVELOPMENT, V124, P4133; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Krebs LT, 2000, GENE DEV, V14, P1343; Kulic L, 2000, P NATL ACAD SCI USA, V97, P5913, DOI 10.1073/pnas.100049897; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Levitan D, 1998, DEVELOPMENT, V125, P3599; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Li XJ, 1997, P NATL ACAD SCI USA, V94, P12204, DOI 10.1073/pnas.94.22.12204; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Martys-Zage JL, 2000, J MOL NEUROSCI, V15, P189, DOI 10.1385/JMN:15:3:189; Moore CL, 2000, ANN NY ACAD SCI, V920, P197; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; NYE JS, 1994, DEVELOPMENT, V120, P2421; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; OKA C, 1995, DEVELOPMENT, V121, P3291; Palacino JJ, 2000, J BIOL CHEM, V275, P215, DOI 10.1074/jbc.275.1.215; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; Presente A, 2001, NEUROREPORT, V12, P3321, DOI 10.1097/00001756-200110290-00035; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Westlund B, 1999, P NATL ACAD SCI USA, V96, P2497, DOI 10.1073/pnas.96.5.2497; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhong WM, 1997, DEVELOPMENT, V124, P1887	83	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8154	8165		10.1074/jbc.M108238200	http://dx.doi.org/10.1074/jbc.M108238200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756438	hybrid			2022-12-27	WOS:000174268000068
J	Gardner, AM; Gardner, PR				Gardner, AM; Gardner, PR			Flavohemoglobin detoxifies nitric oxide in aerobic, but not anaerobic, Escherichia coli - Evidence for a novel inducible anaerobic nitric oxide-scavenging activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVOHAEMOGLOBIN HMP; SUPEROXIDE-DISMUTASE; NITROSATIVE STRESS; OXIDATIVE STRESS; GENE; DIOXYGENASE; PROTECTION; ACONITASES; REDUCTASE; BINDING	Nitric-oxide dioxygenase (NOD) and reductase (NOR) activities of flavohemoglobin (flavoHb) have been suggested as mechanisms for NO metabolism and detoxification in a variety of microbes. Mechanisms of NO detoxification were tested in Escherichia coli using flavoHb-deficient mutants and overexpressors. flavoHb showed negligible anaerobic NOR activity and afforded no protection to the NO-sensitive aconitase or the growth of anoxic E. coli, whereas the NOD activity and the protection afforded with O-2 were substantial. A NO-inducible, O-2-sensitive, and cyanide-resistant NOR activity efficiently metabolized NO and protected anaerobic cells from NO toxicity independent of the NOR activity of flavoHb. flavol-Hb possesses nitrosoglutathione and nitrite reductase activities that may account for the protection it affords against these agents. NO detoxification by flavoHb occurs most effectively via O-2-dependent NO dioxygenation.	Childrens Hosp, Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Gardner, PR (corresponding author), Childrens Hosp, Med Ctr, Div Crit Care Med, MLC7006,3333 Burnet Ave, Cincinnati, OH 45229 USA.			Gardner, Paul/0000-0001-8189-0903; Gardner, Anne/0000-0001-7095-772X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065090] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM65090] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; Brown K, 2000, J BIOL CHEM, V275, P41133, DOI 10.1074/jbc.M008617200; BUENO R, 1985, J BACTERIOL, V164, P816, DOI 10.1128/JB.164.2.816-822.1985; CRAMM R, 1994, J BIOL CHEM, V269, P7349; Crawford MJ, 1998, J BIOL CHEM, V273, P12543, DOI 10.1074/jbc.273.20.12543; Crawford MJ, 1998, J BIOL CHEM, V273, P34028, DOI 10.1074/jbc.273.51.34028; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; ESCHENBRENNER M, 1994, BIOCHEM BIOPH RES CO, V198, P127, DOI 10.1006/bbrc.1994.1018; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; FAVEY S, 1995, MICROBIOL-UK, V141, P863, DOI 10.1099/13500872-141-4-863; Frey AD, 2001, APPL ENVIRON MICROB, V67, P680, DOI 10.1128/AEM.67.2.680-687.2001; Fujiwara T, 1996, J BACTERIOL, V178, P1866, DOI 10.1128/jb.178.7.1866-1871.1996; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; GARDNER PR, 1993, J BIOL CHEM, V268, P12958; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; GARDNERPR, 2001, FREE RADIC BIOL MED, V31, P191; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Householder TC, 2000, INFECT IMMUN, V68, P5241, DOI 10.1128/IAI.68.9.5241-5246.2000; Iijima M, 2000, CELL STRUCT FUNCT, V25, P47, DOI 10.1247/csf.25.47; KEELE BB, 1970, J BIOL CHEM, V245, P6176; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; Kudo T, 2001, J BIOL CHEM, V276, P5020, DOI 10.1074/jbc.M007244200; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; MembrilloHernandez J, 1996, FEBS LETT, V382, P141, DOI 10.1016/0014-5793(96)00154-8; Mills CE, 2001, BIOCHEM J, V353, P207, DOI 10.1042/0264-6021:3530207; NAKAHARA K, 1993, J BIOL CHEM, V268, P8350; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; ORII Y, 1992, BIOCHEM BIOPH RES CO, V187, P94, DOI 10.1016/S0006-291X(05)81463-9; PLAMANN MD, 1983, GENE, V22, P9, DOI 10.1016/0378-1119(83)90059-8; POOLE RK, 1994, P ROY SOC B-BIOL SCI, V255, P251, DOI 10.1098/rspb.1994.0036; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	46	145	149	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8166	8171		10.1074/jbc.M110470200	http://dx.doi.org/10.1074/jbc.M110470200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751864	hybrid			2022-12-27	WOS:000174268000069
J	Byron, KL; Lucchesi, PA				Byron, KL; Lucchesi, PA			Signal transduction of physiological concentrations of vasopressin in A7r5 vascular smooth muscle cells - A role for PYK2 and tyrosine phosphorylation of K+ channels in the stimulation of Ca2+ spiking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ANGIOTENSIN-II; ACETYLCHOLINE-RECEPTOR; RHYTHMIC CONTRACTION; COUPLED RECEPTORS; POTASSIUM CHANNEL; GUINEA-PIG; ACTIVATION; ARTERIES; VASOMOTION	The signal transduction pathway linking physiological concentrations of [Arg(8)]vasopressin (AVP) to an increase in frequency of Ca2+ spiking was examined in confluent cultures of A7r5 vascular smooth muscle cells. Immunoprecipitation/Western blot studies revealed a robust increase in tyrosine phosphorylation of the nonreceptor tyrosine kinase, PYK2, in A7r5 cells treated with 4beta-phorbol 12-myristate 13-acetate or ionomycin. 100 pm AVP also induced PYK2 tyrosine phosphorylation, and this effect was inhibited by protein kinase C inhibitors Ro-31-8220 (1-10 muM) or chelerythrine chloride (1-20 muM). In fura-2-loaded A7r5 cells, the stimulation of Ca2+ spiking by 100 pM AVP or 1 nM 4beta-phorbol 12-myristate 13-acetate was completely blocked by PP2 (10 muM, a Src family kinase inhibitor). Salicylate (20 mm, recently identified as a PYK2 inhibitor) and the tyrosine kinase inhibitor, tyrphostin A47 (50 muM), but not its inactive analog, tyrphostin A63, also blocked AVP-stimulated Ca2+ spiking. PYK2 phosphorylation was inhibited by both PP2 and salicylate, whereas tyrphostin A47 failed to inhibit PYK2 tyrosine phosphorylation. ERK1/2 kinases did not appear to be involved because 1) 100 pm AVP did not appreciably increase ERK1/2 phosphorylation and U-0126 (2.5 muM) did not inhibit AVP-stimulated Ca2+ spiking; and 2) epidermal growth factor (10 nM) robustly stimulated ERK1/2 phosphorylation but did not induce Ca2+ spiking. Delayed rectifier K+ channels may mediate the PYK2 activity because Kv1.2 channel protein co-immunoprecipitated with PYK2 and tyrosine phosphorylation of Kv1.2 was stimulated by AVP and inhibited by Ro-31-8220, PP2, and salicylate but not tyrphostin A47. Our findings are consistent with a role for PYK2 and phosphorylation of K+ channels in the stimulation of Ca2+ spiking by physiological concentrations of AVP.	Loyola Univ, Med Ctr, Cardiovasc Inst, Dept Med, Maywood, IL 60153 USA; Univ Alabama Birmingham, Dept Phys & Biophys, Birmingham, AL 35294 USA	Loyola University Chicago; University of Alabama System; University of Alabama Birmingham	Byron, KL (corresponding author), Loyola Univ, Med Ctr, Cardiovasc Inst, Dept Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	kbyron@lumc.edu	Lucchesi, Pamela A/E-3558-2011	Byron, Kenneth/0000-0002-3875-9667	NHLBI NIH HHS [R29 HL 56046, R01 HL 60164] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056046, R01HL060164] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACHAKRI H, 1995, J VASC RES, V32, P237, DOI 10.1159/000159098; Aiello EA, 1996, AM J PHYSIOL-HEART C, V271, pH109, DOI 10.1152/ajpheart.1996.271.1.H109; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; BYRON KL, 1993, J BIOL CHEM, V268, P6945; Byron KL, 1996, CIRC RES, V78, P813, DOI 10.1161/01.RES.78.5.813; BYRON KL, 1989, J BIOL CHEM, V264, P18234; BYRON KL, 1995, J PHYSIOL-LONDON, V485, P455, DOI 10.1113/jphysiol.1995.sp020742; ClementChomienne O, 1996, J PHYSIOL-LONDON, V495, P689, DOI 10.1113/jphysiol.1996.sp021626; Cox RH, 2001, HYPERTENSION, V37, P1315, DOI 10.1161/01.HYP.37.5.1315; Davis MJ, 2001, AM J PHYSIOL-HEART C, V281, pH1835, DOI 10.1152/ajpheart.2001.281.5.H1835; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; DOYLE VM, 1985, BIOCHEM BIOPH RES CO, V131, P469, DOI 10.1016/0006-291X(85)91826-1; DROOGMANS G, 1977, J GEN PHYSIOL, V70, P129, DOI 10.1085/jgp.70.2.129; Eguchi S, 1999, HYPERTENSION, V33, P201, DOI 10.1161/01.HYP.33.1.201; Fan JP, 2000, J PHYSIOL-LONDON, V524, P821, DOI 10.1111/j.1469-7793.2000.00821.x; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; FUJII K, 1990, AM J PHYSIOL, V258, pH1829, DOI 10.1152/ajpheart.1990.258.6.H1829; GERSTBERGER R, 1988, INT J MICROCIRC, V7, P3; Gokina NI, 1996, CIRC RES, V78, P148, DOI 10.1161/01.RES.78.1.148; Gratton RJ, 1998, J APPL PHYSIOL, V85, P2255, DOI 10.1152/jappl.1998.85.6.2255; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HARA Y, 1980, BRIT J PHARMACOL, V68, P99, DOI 10.1111/j.1476-5381.1980.tb10704.x; HARDER DR, 1978, PFLUG ARCH EUR J PHY, V378, P111, DOI 10.1007/BF00584443; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; Inagami T, 1999, J AM SOC NEPHROL, V10, pS57; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; KNOT HJ, 1991, J CARDIOVASC PHARM, V18, pS7; KNOT HJ, 1995, AM J PHYSIOL-HEART C, V269, pH348, DOI 10.1152/ajpheart.1995.269.1.H348; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li X, 1999, J BIOL CHEM, V274, P8917, DOI 10.1074/jbc.274.13.8917; Li YX, 2001, AM J PHYSIOL-HEART C, V280, pH2658, DOI 10.1152/ajpheart.2001.280.6.H2658; MORITA Y, 1995, ACTA PHYSIOL SCAND, V154, P121, DOI 10.1111/j.1748-1716.1995.tb09894.x; NICOLL PA, 1975, IMMUNOCHEMISTRY, V12, P511, DOI 10.1016/0019-2791(75)90076-2; NICOLL PAUL A., 1955, ANGIOLOGY, V6, P291, DOI 10.1177/000331975500600403; POENIE M, 1986, SCIENCE, V233, P886, DOI 10.1126/science.3755550; Rocic P, 2001, AM J PHYSIOL-CELL PH, V280, pC90, DOI 10.1152/ajpcell.2001.280.1.C90; Sabri A, 1998, CIRC RES, V83, P841, DOI 10.1161/01.RES.83.8.841; Salter KJ, 1998, J CARDIOVASC PHARM, V31, pS81, DOI 10.1097/00005344-199800001-00026; Schilling WP, 2001, CIRC RES, V88, P256, DOI 10.1161/01.RES.88.3.256; SHIELS A, 1998, J MOL CELL CARDIOL, V30, P190; STEEDMAN WM, 1966, J PHYSIOL-LONDON, V186, P382, DOI 10.1113/jphysiol.1966.sp008041; STEIN PG, 1984, CIRC RES, V55, P480, DOI 10.1161/01.RES.55.4.480; Tang H, 2000, J BIOL CHEM, V275, P13420, DOI 10.1074/jbc.275.18.13420; Tang H, 2000, J BIOL CHEM, V275, P8389, DOI 10.1074/jbc.275.12.8389; VONDERWEID PY, 1993, J PHYSIOL-LONDON, V471, P13, DOI 10.1113/jphysiol.1993.sp019888; Wang ZY, 2001, HYPERTENSION, V37, P148, DOI 10.1161/01.HYP.37.1.148; Wesselman JPM, 1996, J VASC RES, V33, P32, DOI 10.1159/000159129; YUAN XJ, 1995, CIRC RES, V77, P370, DOI 10.1161/01.RES.77.2.370	52	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7298	7307		10.1074/jbc.M104726200	http://dx.doi.org/10.1074/jbc.M104726200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11739373	hybrid			2022-12-27	WOS:000174104300072
J	Miret, JJ; Rakhilina, L; Silverman, L; Oehlen, B				Miret, JJ; Rakhilina, L; Silverman, L; Oehlen, B			Functional expression of heteromeric calcitonin gene-related peptide and adrenomedullin receptors in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SOMATOSTATIN RECEPTOR; SIGNAL-TRANSDUCTION; IDENTIFICATION; PHARMACOLOGY; DOPAMINE; HETERODIMERIZATION; ANTAGONISTS; TRANSPORT; ASSEMBLE	The ability of G protein-coupled receptors (GPCRs) to form homo- and heteromeric complexes has important implications for the regulation of cellular events. A notable example of heteromer formation is the interaction of the calcitonin receptor-like receptor (CRLR) with different members of the receptor activity modifying protein (RAMP) family, which results in the formation of two different receptors, a calcitonin gene-related peptide (CGRP) receptor and an adrenomedullin receptor. To analyze the role of RAMPs in determining ligand specificity, we have co-expressed CRLR and RAMP proteins in the yeast Saccharomyces cerevisiae, which provides a null system to study the function of mammalian receptors. Co-expression of RAMP1 and CRLR reconstituted a CGRP receptor that was able to activate the pheromone-signaling pathway with pharmacological properties similar to those observed previously in mammalian cells. Co-expression of CRLR with RAMP2 or RAMP3 resulted in a response with the pharmacological properties of an adrenomedullin receptor. These data indicate that RAMP's are necessary and sufficient to determine ligand specificity of CRLR. Contrary to observations in mammalian cells, the glycosylation of CRLR was not affected by the presence of RAMPs in yeast, indicating that glycosylation of CRLR is not the prime determinant of ligand specificity. The first functional reconstitution of a heteromeric seven transmembrane receptor in yeast suggests this organism as a useful research tool to study the molecular nature of other heteromeric receptors.	OSI Pharmaceut Inc, Tarrytown, NY 10591 USA; Cadus Pharmaceut Corp, Tarrytown, NY 10591 USA	Astellas Pharmaceuticals; OSI Pharmaceuticals	Oehlen, B (corresponding author), OSI Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	bert.oehlen@osip.com		Silverman, Lauren/0000-0002-0023-4208				Aiyar N, 1996, J BIOL CHEM, V271, P11325, DOI 10.1074/jbc.271.19.11325; Aldecoa A, 2000, FEBS LETT, V471, P156, DOI 10.1016/S0014-5793(00)01387-9; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Campbell RM, 1999, BIOORG MED CHEM LETT, V9, P2413, DOI 10.1016/S0960-894X(99)00398-4; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; CHIBA T, 1989, AM J PHYSIOL, V256, pE331, DOI 10.1152/ajpendo.1989.256.2.E331; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; DENNIS T, 1990, J PHARMACOL EXP THER, V254, P123; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; Evans BN, 2000, J BIOL CHEM, V275, P31438, DOI 10.1074/jbc.M005604200; FLUHMANN B, 1995, BIOCHEM BIOPH RES CO, V206, P341, DOI 10.1006/bbrc.1995.1047; Foord SM, 1999, TRENDS PHARMACOL SCI, V20, P184, DOI 10.1016/S0165-6147(99)01347-4; Fraser NJ, 1999, MOL PHARMACOL, V55, P1054, DOI 10.1124/mol.55.6.1054; Gumusel B, 1998, AM J PHYSIOL-HEART C, V274, pH1255, DOI 10.1152/ajpheart.1998.274.4.H1255; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Juaneda C, 2000, TRENDS PHARMACOL SCI, V21, P432, DOI 10.1016/S0165-6147(00)01555-8; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KING K, 1990, SCIENCE, V250, P121, DOI 10.1126/science.2171146; Klein C, 1998, NAT BIOTECHNOL, V16, P1334, DOI 10.1038/4310; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; Li Y, 1999, MOL CELL BIOL, V19, P3588; Luebke AE, 1996, P NATL ACAD SCI USA, V93, P3455, DOI 10.1073/pnas.93.8.3455; Manfredi JP, 1996, MOL CELL BIOL, V16, P4700; Mazzocchi G, 1996, LIFE SCI, V58, P839, DOI 10.1016/0024-3205(96)00017-3; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Milligan G, 2001, TRENDS PHARMACOL SCI, V22, P513, DOI 10.1016/S0165-6147(00)01801-0; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pausch MH, 1997, TRENDS BIOTECHNOL, V15, P487, DOI 10.1016/S0167-7799(97)01119-0; Poyner D, 1995, TRENDS PHARMACOL SCI, V16, P424, DOI 10.1016/S0165-6147(00)89093-8; Price LA, 1996, MOL PHARMACOL, V50, P829; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; QUIRION R, 1992, ANN NY ACAD SCI, V657, P88, DOI 10.1111/j.1749-6632.1992.tb22759.x; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Salahpour A, 2000, TRENDS ENDOCRIN MET, V11, P163, DOI 10.1016/S1043-2760(00)00260-5; Tobaben S, 2000, J BIOL CHEM, V275, P36204, DOI 10.1074/jbc.M006448200; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Wimalawansa SJ, 1996, ENDOCR REV, V17, P533, DOI 10.1210/er.17.5.533	45	42	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6881	6887		10.1074/jbc.M107384200	http://dx.doi.org/10.1074/jbc.M107384200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11733510	hybrid			2022-12-27	WOS:000174104300019
J	Phadtare, S; Inouye, M; Severinov, K				Phadtare, S; Inouye, M; Severinov, K			The nucleic acid melting activity of Escherichia coli CspE is critical for transcription antitermination and cold acclimation of cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUTION NMR STRUCTURE; SHOCK PROTEIN CSPA; BINDING PROTEIN; RNA; DNA; MUTAGENESIS; MUTATION; FAMILY; CONDENSATION; SUBUNIT	Members of bacterial Csp (cold-shock protein) family promote cellular adaptation to low temperature and participate in many other aspects of gene expression regulation through mechanisms that are not yet fully elucidated. Csp proteins interact with single-stranded nucleic acids and destabilize nucleic acid secondary structures. Some Csp proteins also act as transcription antiterminators in vivo and in vitro. Here, we selected a mutation in the cloned cspE gene that abolished CspE-induced transcription antitermination. In vitro, mutant CspE showed RNA binding activity similar to that of the wild-type CspE but was unable to destabilize nucleic acid secondary structures. Thus, nucleic acid melting ability of CspE and its transcription antitermination activity are correlated. In vivo, mutant cspE was functional with respect to up-regulation of expression of rpoS, but, unlike the wild-type cspE, it did not complement the cold-sensitive phenotype of the quadruple DeltacspADeltacspBDeltacspGDeltacspE deletion strain. Thus, the nucleic acid-melting activity of Csp is critical for its prototypical function of supporting low temperature survival of the cell.	Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Severinov, K (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Ln, Piscataway, NJ 08854 USA.		Severinov, Konstantin/C-8545-2016		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019043, R01GM019043, R01GM059295] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 19043, GM 59295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; DAMMEL CS, 1995, GENE DEV, V9, P626, DOI 10.1101/gad.9.5.626; DERSCH P, 1994, MOL GEN GENET, V245, P255, DOI 10.1007/BF00283274; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Feng WQ, 1998, BIOCHEMISTRY-US, V37, P10881, DOI 10.1021/bi980269j; Feng Y, 2001, J BIOL CHEM, V276, P31651, DOI 10.1074/jbc.M102855200; FRIEDMAN DI, 1984, MICROBIOL REV, V48, P299, DOI 10.1128/MMBR.48.4.299-325.1984; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Hanna MM, 1998, J MOL BIOL, V282, P227, DOI 10.1006/jmbi.1998.2005; Hillier BJ, 1998, FOLD DES, V3, P87, DOI 10.1016/S1359-0278(98)00014-5; Hu KH, 1996, GENETICS, V143, P1521; Jiang WN, 1997, J BIOL CHEM, V272, P196; JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987; JONES PG, 1992, J BACTERIOL, V174, P5798, DOI 10.1128/jb.174.18.5798-5802.1992; KAJITA Y, 1995, J BIOL CHEM, V270, P22167, DOI 10.1074/jbc.270.38.22167; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; LERNER CG, 1990, J BIOL CHEM, V265, P20085; NEWKIRK K, 1994, P NATL ACAD SCI USA, V91, P5114, DOI 10.1073/pnas.91.11.5114; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; PHADTARE S, 2000, COLD SHOCK RESPONSE, P33; SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119; SCHRODER K, 1995, MOL MICROBIOL, V16, P699, DOI 10.1111/j.1365-2958.1995.tb02431.x; SPEE JH, 1993, NUCLEIC ACIDS RES, V21, P777, DOI 10.1093/nar/21.3.777; TOONE WM, 1991, J BACTERIOL, V173, P3291, DOI 10.1128/jb.173.11.3291-3302.1991; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zakharova N, 1998, J BIOL CHEM, V273, P24912, DOI 10.1074/jbc.273.38.24912	33	122	130	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7239	7245		10.1074/jbc.M111496200	http://dx.doi.org/10.1074/jbc.M111496200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11756430	hybrid			2022-12-27	WOS:000174104300064
J	Zhu, Y; Saunders, MA; Yeh, H; Deng, WG; Wu, KK				Zhu, Y; Saunders, MA; Yeh, H; Deng, WG; Wu, KK			Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; C/EBP-BETA; TRANSCRIPTIONAL REGULATION; NUCLEAR FACTOR; MESSENGER-RNA; GENE; PHOSPHORYLATION; ACTIVATION	To elucidate the mechanism by which isoforms of CCAAT/enhancer-binding proteins regulate cyclooxygenase-2 expression, we determined by a novel technique binding of six isoforms of this transactivator to two sequence-specific CCAAT/enhancer-binding protein (-132/-125) and cyclic AMP (-59/-53) regulatory elements in human foreskin fibroblasts treated with phorbol 12-myristate 13-acetate for 4 h. The delta isoform bound to these two elements at basal state, which was displaced by full-length as well as two truncated beta isoforms, a 41-kDa liver-enriched activating protein and a 16-kDa liver-enriched inhibitory protein, after phorbol ester stimulation. Kinetic analysis shows time-dependent changes in 13 and 5 binding that were concordant with time-dependent increase in cyclooxygenase-2 induction. Overexpression of the 16-kDa beta isoform blocked the promoter activity and protein level induced by phorbol ester. Paradoxically, it increased binding of beta isoforms to the sequence-specific promoter DNA but suppressed cyclooxygenase-2 promoter activation by p300 cotransfection. These findings provide new insight into the regulation of cyclooxygenase-2 promoter by an interplay between two opposite beta isoforms and p300 co-activator.	Univ Texas, Houston Sch Med, Vasc Biol Res Ctr, Inst Mol Med, Houston, TX 77030 USA; Univ Texas, Houston Sch Med, Div Hematol, Houston, TX 77030 USA	University of Texas System; University of Texas System	Wu, KK (corresponding author), Univ Texas, Houston Sch Med, Vasc Biol Res Ctr, Inst Mol Med, 6431 Fannin,MSB 5-016, Houston, TX 77030 USA.		Wu, Kenneth Kun-Yu/B-1070-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023327] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 50675] Funding Source: Medline; NINDS NIH HHS [P50 NS 23327] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; LIAO J, 1999, J BIOL CHEM, V274; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Saunders MA, 2001, J BIOL CHEM, V276, P18897, DOI 10.1074/jbc.M011147200; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; TAZAWA R, 1994, BIOCHEM BIOPH RES CO, V203, P190, DOI 10.1006/bbrc.1994.2167; Thomas B, 2000, EUR J BIOCHEM, V267, P6798, DOI 10.1046/j.1432-1327.2000.01778.x; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; WADEL A, 1995, IMMUNOBIOLOGY, V193, P171; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; Wu K K, 1995, Adv Pharmacol, V33, P179, DOI 10.1016/S1054-3589(08)60669-9; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315	22	84	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6923	6928		10.1074/jbc.M108075200	http://dx.doi.org/10.1074/jbc.M108075200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741938	hybrid			2022-12-27	WOS:000174104300024
J	Brummelkamp, TR; Kortlever, RM; Lingbeek, M; Trettel, F; MacDonald, ME; van Lohuizen, M; Bernards, R				Brummelkamp, TR; Kortlever, RM; Lingbeek, M; Trettel, F; MacDonald, ME; van Lohuizen, M; Bernards, R			TBX-3, the gene mutated in ulnar-mammary syndrome, is a negative regulator of p19(ARF) and inhibits senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; TRANSCRIPTION FACTOR; STABILIZES P53; ONCOGENIC RAS; G(1) CONTROL; INK4A LOCUS; CELL; IMMORTALIZATION; APOPTOSIS; MDM2	Prolonged culturing of rodent cells in vitro activates p19(ARF) (named p14(ARF) in man), resulting in a p53-dependent proliferation arrest known as senescence. The p19(ARF)-Mdm2-p53 pathway also serves to protect primary cells against oncogenic transformation. We have used a genetic screen in mouse neuronal cells, conditionally immortalized by a temperature-sensitive mutant of SV40 large T antigen, to identify genes that allow bypass of senescence. Using retroviral cDNA expression libraries, we have identified TBX-3 as a potent inhibitor of senescence. TBX-3 is a T-box gene, which is found mutated in the human developmental disorder Ulnar-Mammary Syndrome. We have shown that TBX-3 potently represses expression of both mouse p19(ARF) and human P14(ARF). We have also shown here that point mutants of TBX-3, which are found in UInar-Mammary Syndrome, have lost the ability to inhibit senescence and fail to repress mouse p19(ARF) and human p14(ARF) expression. These data suggest that the hypoproliferative features of this genetic disorder may be caused, at least in part, by deregulated expression of p14(ARF).	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Harvard University; Massachusetts General Hospital	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	bernards@nki.nl	Kortlever, Roderik/AAY-9220-2020	Bernards, Rene/0000-0001-8677-3423; trettel, flavia/0000-0002-7983-2955; Kortlever, Roderik/0000-0001-5558-2851	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032765] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alkema MJ, 1997, ONCOGENE, V15, P899, DOI 10.1038/sj.onc.1201262; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Cong F, 1999, ONCOGENE, V18, P7731, DOI 10.1038/sj.onc.1203290; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; HARVEY M, 1993, ONCOGENE, V8, P2457; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Inoue K, 2000, GENE DEV, V14, P1797; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	36	126	135	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6567	6572		10.1074/jbc.M110492200	http://dx.doi.org/10.1074/jbc.M110492200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748239	Green Published, hybrid			2022-12-27	WOS:000173989200115
J	Gwack, Y; Hwang, SM; Lim, C; Won, YS; Lee, CH; Choe, J				Gwack, Y; Hwang, SM; Lim, C; Won, YS; Lee, CH; Choe, J			Kaposi's sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-SEQUENCES; ACTIVATION; GENE; EXPRESSION; BINDING; IDENTIFICATION; REACTIVATION; PATHWAY; CELLS; JUN	Kaposi's sarcoma-associated herpesvirus (KSHV) is an important pathogen in Kaposi's sarcoma and abnormal lymphoproliferation. KSHV open reading frame 50 (ORF50), a homolog of the Epstein-Barr virus immediate-early gene product RTA, activates early and late gene transcription in the KSHV lytic cycle, and its expression is closely correlated with KSHV-related diseases. ORF50 interacts with the cellular proteins CBP and histone deacetylase and represses p53-induced apoptosis through a CBP-related mechanism. We show here that KSHV ORF50 also interacts with STAT3. ORF50 stimulated transcription of STAT-driven reporter genes, and interleukin-6 and v-Sre further activated this stimulating effect of ORF50. Physical association of STAT3 and ORF50 required the carboxyl-terminal transactivation domain of ORF50 and multiple regions within STAT3. ORF50 recruited STAT3 to the nucleus and induced the dimerization of STAT3 monomers in the absence of STAT3 phosphorylation. We show here that KSHV ORF50 activates STAT3-mediated transcription through direct interaction without mediating tyrosine phosphorylation.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Korea Res Inst Biosci & Biotechnol, ICLAS Monitoring Subctr, Taejon 305600, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choe, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	jchoe@mail.kaist.ac.kr	Choe, Joonho/F-3066-2011; Lim, Chunghun/AAB-1253-2020	Lim, Chunghun/0000-0001-8473-9272; Hwang, Seungmin/0000-0003-0846-5462				Aoki Yoshiyasu, 1999, Blood, V93, P4034; Asou H, 1998, BLOOD, V91, P2475, DOI 10.1182/blood.V91.7.2475.2475_2475_2481; BOSHOFF C, 1995, NAT MED, V1, P1274, DOI 10.1038/nm1295-1274; Boshoff C, 1998, ADV CANCER RES, V75, P57, DOI 10.1016/S0065-230X(08)60739-3; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chatterjee-Kishore M, 2000, TRENDS CELL BIOL, V10, P106, DOI 10.1016/S0962-8924(99)01709-2; Chen HL, 2001, J VIROL, V75, P2929, DOI 10.1128/JVI.75.6.2929-2937.2001; Chen J, 2001, P NATL ACAD SCI USA, V98, P4119, DOI 10.1073/pnas.051004198; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Gwack Y, 2001, J VIROL, V75, P6245, DOI 10.1128/JVI.75.13.6245-6248.2001; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; Li H, 2001, J VIROL, V75, P3325, DOI 10.1128/JVI.75.7.3325-3334.2001; Lukac DM, 1998, VIROLOGY, V252, P304, DOI 10.1006/viro.1998.9486; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Lund TC, 1997, J VIROL, V71, P6677, DOI 10.1128/JVI.71.9.6677-6682.1997; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Nicholas J, 1997, NAT MED, V3, P287, DOI 10.1038/nm0397-287; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; WeberNordt RM, 1996, BLOOD, V88, P809; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	32	64	67	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6438	6442		10.1074/jbc.M108289200	http://dx.doi.org/10.1074/jbc.M108289200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741976	hybrid			2022-12-27	WOS:000173989200098
J	Lee, D; Hwang, SG; Kim, J; Choe, J				Lee, D; Hwang, SG; Kim, J; Choe, J			Functional interaction between p/CAF and human papillomavirus E2 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COACTIVATOR; HISTONE ACETYLASE PCAF; TERMINAL DOMAIN; ACETYLTRANSFERASE; TRANSCRIPTION; ACTIVATION; COMPLEX; P300; CBP; DNA	p300/CREB-binding protein-associated factor (p/CAF), a transcriptional co-activator, interacts with co-activator p300/CBP and acidic transcription factors. p/CAF mediates transcriptional activation by acetylating nucleosomal histones and cellular factors. Previously we reported that CBP binds to human papillomavirus E2 and activates E2-dependent transcription (Lee, D., Lee, B., Kim, J., Kim, D. W., and Choe, J. (2000) J. Biol. Chem. 275, 7045-7051). Here we show that p/CAF binds to the human papillomavirus E2 protein in vivo and in vitro and activates E2-dependent transcription. CBP along with p/CAF synergistically activates E2-dependent transcription. In addition, the histone acetylase activity of p/CAF is required for efficient activation of E2 transcriptional activity. These results suggest that p/CAF is a transcriptional co-activator of the human papillomavirus E2 protein.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Choe, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	jchoe@mail.kaist.ac.kr	Choe, Joonho/F-3066-2011; Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823				Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BENSON JD, 1995, J VIROL, V69, P4364, DOI 10.1128/JVI.69.7.4364-4372.1995; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; CHOE J, 1989, J VIROL, V63, P1743, DOI 10.1128/JVI.63.4.1743-1755.1989; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; HAUGEN TH, 1988, EMBO J, V7, P4245, DOI 10.1002/j.1460-2075.1988.tb03322.x; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Lee D, 2000, J BIOL CHEM, V275, P7045, DOI 10.1074/jbc.275.10.7045; Marcello A, 2000, J VIROL, V74, P9090, DOI 10.1128/JVI.74.19.9090-9098.2000; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Massimi P, 1999, ONCOGENE, V18, P7748, DOI 10.1038/sj.onc.1203208; Masumi A, 1999, MOL CELL BIOL, V19, P1810; MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411; MCBRIDE AA, 1988, EMBO J, V7, P533, DOI 10.1002/j.1460-2075.1988.tb02842.x; MCBRIDE AA, 1989, P NATL ACAD SCI USA, V86, P510, DOI 10.1073/pnas.86.2.510; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; RANK NM, 1995, J VIROL, V69, P6323, DOI 10.1128/JVI.69.10.6323-6334.1995; Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Wang L, 2000, P NATL ACAD SCI USA, V97, P430, DOI 10.1073/pnas.97.1.430; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yasugi T, 1997, J VIROL, V71, P891, DOI 10.1128/JVI.71.2.891-899.1997; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	32	32	33	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6483	6489		10.1074/jbc.M105085200	http://dx.doi.org/10.1074/jbc.M105085200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744716	hybrid			2022-12-27	WOS:000173989200104
J	Lindahl, GE; Chambers, RC; Papakrivopoulou, J; Dawson, SJ; Jacobsen, MC; Bishop, JE; Laurent, GJ				Lindahl, GE; Chambers, RC; Papakrivopoulou, J; Dawson, SJ; Jacobsen, MC; Bishop, JE; Laurent, GJ			Activation of fibroblast procollagen alpha 1(I) transcription by mechanical strain is transforming growth factor-beta-dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN GENE-EXPRESSION; SIGNAL-REGULATED KINASE; HUMAN TISSUE INHIBITOR; RAT MESANGIAL CELLS; NUCLEAR FACTOR-I; CARDIAC FIBROBLASTS; TGF-BETA; NF-Y; FUNCTIONAL-CHARACTERIZATION; SYSTEMIC-SCLEROSIS	During normal developmental tissue growth and in a number of diseases of the cardiopulmonary system, adventitial and interstitial fibroblasts are subjected to increased mechanical strain. This leads to fibroblast activation and enhanced collagen synthesis, but the underlying mechanisms involved remain poorly understood. In this study, we have begun to identify and characterize mechanical strain-responsive elements in the rat procollagen alphal(I) (COL1A1) gene and show that the activity of COL1A1 promoter constructs, transiently transfected into cardiac fibroblasts, was increased between 2- and 4-fold by continuous cyclic mechanical strain. This was accompanied by a similar to3-fold increase in the levels of total active transforming growth factor-P (TGF-beta) released into the medium. Inclusion of a pan-specific TGF-beta neutralizing antibody inhibited strain-induced COL1A1 promoter activation. Deletion analysis revealed the presence of two potential strain response regions within the proximal promoter, one of which contains an inverted CCAAT-box overlapping a GC-rich element. Both mechanical strain and exogenously added TGF-beta1 enhanced the binding activity of CCAAT-binding factor, CBF/NF-Y, at this site. Moreover, this element was sufficient to confer strain-responsiveness to an otherwise unresponsive SV40 promoter. In summary, this study demonstrates that strain-induced COL1A1 promoter activation in cardiac fibroblasts is TGF-beta-dependent and involves increased binding of CCAAT-binding factor at the proximal promoter. Furthermore, these findings suggest a novel and potentially important TGF-beta response element in the rat COL1A1 gene.	UCL Royal Free & Univ Coll Med Sch, Rayne Inst, Dept Med, Ctr Cardiopulm Biochem & Resp Med, London WC1E 6JJ, England; UCL Royal Free & Univ Coll Med Sch, Windeyer Inst, Dept Immunol & Mol Pathol, London W1T 4JF, England	University of London; King's College London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Lindahl, GE (corresponding author), UCL Royal Free & Univ Coll Med Sch, Rayne Inst, Dept Med, Ctr Cardiopulm Biochem & Resp Med, 5 Univ St, London WC1E 6JJ, England.	g.lindahl@ucl.ac.uk		Chambers, Rachel/0000-0003-1370-9417; Dawson, Sally/0000-0002-4421-2043				ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Bishop JE, 1999, CARDIOVASC RES, V42, P27, DOI 10.1016/S0008-6363(99)00021-8; Bornstein P, 1996, MATRIX BIOL, V15, P3, DOI 10.1016/S0945-053X(96)90121-3; Breault DT, 1997, J BIOL CHEM, V272, P31241, DOI 10.1074/jbc.272.50.31241; BUTT RP, 1995, EUR J CELL BIOL, V68, P330; Butt RP, 1997, J MOL CELL CARDIOL, V29, P1141, DOI 10.1006/jmcc.1996.0347; CHAMBERS RC, 1997, LUNG SCI FDN, P709; Chen AP, 2000, MOL CELL BIOL, V20, P2818, DOI 10.1128/MCB.20.8.2818-2826.2000; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Clark IM, 1997, BIOCHEM J, V324, P611, DOI 10.1042/bj3240611; Coustry F, 2001, J BIOL CHEM, V276, P40621, DOI 10.1074/jbc.M106918200; Davis BH, 1996, J BIOL CHEM, V271, P11039, DOI 10.1074/jbc.271.19.11039; Galera P, 1996, J BIOL CHEM, V271, P21331, DOI 10.1074/jbc.271.35.21331; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Greenwel P, 1997, J BIOL CHEM, V272, P19738, DOI 10.1074/jbc.272.32.19738; Gutierrez JA, 1999, AM J PHYSIOL-GASTR L, V277, pG1074, DOI 10.1152/ajpgi.1999.277.5.G1074; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; Hori Y, 1998, KIDNEY INT, V53, P1616, DOI 10.1046/j.1523-1755.1998.00908.x; Hu QH, 2000, J BIOL CHEM, V275, P4435, DOI 10.1074/jbc.275.6.4435; Hu Z, 2000, J BIOL CHEM, V275, P2979, DOI 10.1074/jbc.275.4.2979; JIMENEZ SA, 1994, J BIOL CHEM, V269, P12684; Karsenty G, 1995, Int Rev Immunol, V12, P177, DOI 10.3109/08830189509056711; KARSENTY G, 1991, J BIOL CHEM, V266, P24842; KARSENTY G, 1990, J BIOL CHEM, V265, P9934; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; KING SL, 1994, J BIOL CHEM, V269, P13156; Kovacs A, 1996, J BIOL CHEM, V271, P1805, DOI 10.1074/jbc.271.3.1805; Lee AA, 1999, J MOL CELL CARDIOL, V31, P1833, DOI 10.1006/jmcc.1999.1017; LICHTLER A, 1994, J BIOL CHEM, V269, P16518; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667; MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; MCANULTY RJ, 1995, PULMONARY FIBROSIS, P135; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; NEHLS MC, 1991, MOL CELL BIOL, V11, P4065, DOI 10.1128/MCB.11.8.4065; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; ONO S, 1995, CIRCULATION, V91, P1143, DOI 10.1161/01.CIR.91.4.1143; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Qing J, 2000, J BIOL CHEM, V275, P38802, DOI 10.1074/jbc.M004731200; RAISZ LG, 1993, MOL ENDOCRINOL, V7, P17, DOI 10.1210/me.7.1.17; Riser BL, 1996, AM J PATHOL, V148, P1915; RITZENTHALER JD, 1991, BIOCHEM J, V280, P157, DOI 10.1042/bj2800157; Roberts AB, 2001, CHEST, V120, p43S, DOI 10.1378/chest.120.1_suppl.S43-a; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; Saitta B, 2000, ARTHRITIS RHEUM-US, V43, P2219, DOI 10.1002/1529-0131(200010)43:10<2219::AID-ANR9>3.0.CO;2-N; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; SLACK JL, 1993, AM J MED GENET, V45, P140, DOI 10.1002/ajmg.1320450203; Stoddart JH, 2000, J CELL BIOCHEM, V77, P135, DOI 10.1002/(SICI)1097-4644(20000401)77:1<135::AID-JCB14>3.0.CO;2-X; Trojanowska M, 1998, J MOL MED, V76, P266, DOI 10.1007/s001090050216; VARGA J, 1995, ANN INTERN MED, V122, P60, DOI 10.7326/0003-4819-122-1-199501010-00010; WADE DP, 1994, J BIOL CHEM, V269, P19757; WATSON PA, 1991, FASEB J, V5, P2013, DOI 10.1096/fasebj.5.7.1707019; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zhong ZD, 2000, J BIOL CHEM, V275, P18602, DOI 10.1074/jbc.M001389200	62	115	121	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6153	6161		10.1074/jbc.M108966200	http://dx.doi.org/10.1074/jbc.M108966200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748224	hybrid			2022-12-27	WOS:000173989200062
J	Hentze, H; Schmitz, I; Latta, M; Krueger, A; Krammer, PH; Wendel, A				Hentze, H; Schmitz, I; Latta, M; Krueger, A; Krammer, PH; Wendel, A			Glutathione dependence of caspase-8 activation at the death-inducing signaling complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; HYDROGEN-PEROXIDE; NITRIC-OXIDE; APOPTOSIS; NECROSIS; MITOCHONDRIAL; INHIBITION; PREVENTS; RECEPTOR	Apoptosis triggered by the death receptor CD95 (APO-1 or Fas) is pivotal for the homeostasis of the immune system. We investigated differential effects of glutathione depletion on CD95-triggered apoptosis in T and B cell lines as well as the glutathione dependence of caspase-8 activation. In B lymphoblastoid SKW6.4 cells, CD95-mediated apoptosis was prevented upstream of caspase-8 activation and caspase-3-like activity after acute glutathione depletion by diethyl maleate or cis-chloro-dinitrobenzene. Immunoprecipitation of the death-inducing signaling complex (DISC) revealed that the DISC was still formed in the glutathione-depleted state. The first cleavage step of procaspase-8 activation at the DISC, however, was inhibited. Accordingly, under cell-free conditions, radiolabeled procaspase-8 was processed at the immunoprecipitated DISC only after the addition of exogenous dithiothreitol or reduced glutathione. We also observed suppression of CD95-mediated apoptosis in glutathione-depIeted CEM and H9 cells. Notably, Jurkat cells still died upon CD95 engagement under this condition, displaying incomplete nuclear fragmentation and a partial switch to necrosis; this may be explained by reduced cytochrome c/dATP-mediated caspase activation observed in cytosol from glutathione-depleted Jurkat cytosol. Our data indicate that the activation of caspase-8 at the DISC and hence CD95-mediated apoptosis induction shows a cell-specific requirement for intracellular glutathione.	Univ Konstanz, Dept Biol, D-78457 Constance, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany	University of Konstanz; Helmholtz Association; German Cancer Research Center (DKFZ)	Hentze, H (corresponding author), Caspases & Cell Death Grp, Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.		Krueger, Andreas/B-9427-2009; Schmitz, Ingo/G-2093-2013	Krueger, Andreas/0000-0001-7873-7334; Schmitz, Ingo/0000-0002-5360-0419				Anderson M E, 1997, Adv Pharmacol, V38, P65; ANDERSON ME, 1990, FASEB J, V4, P3251, DOI 10.1096/fasebj.4.14.2227215; Baker A, 2000, BIOCHEM BIOPH RES CO, V268, P78, DOI 10.1006/bbrc.1999.1908; Boggs SE, 1998, BIOCHEM BIOPH RES CO, V247, P229, DOI 10.1006/bbrc.1998.8765; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; DROGE W, 1994, FASEB J, V8, P1131; Eguchi Y, 1999, CANCER RES, V59, P2174; Ellerby HM, 1997, J NEUROSCI, V17, P6165; Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01_4808_4818; FERNANDES RS, 1994, BIOCHEM PHARMACOL, V48, P675, DOI 10.1016/0006-2952(94)90044-2; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hall AG, 1999, EUR J CLIN INVEST, V29, P238; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hentze H, 1999, HEPATOLOGY, V30, P177, DOI 10.1002/hep.510300111; Hentze H, 2000, AM J PATHOL, V156, P2045, DOI 10.1016/S0002-9440(10)65076-6; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jones JJ, 1999, HEPATOLOGY, V30, P714, DOI 10.1002/hep.510300324; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; Lee YJ, 2000, FREE RADICAL BIO MED, V29, P684, DOI 10.1016/S0891-5849(00)00366-X; Leist M, 1999, EXP CELL RES, V249, P396, DOI 10.1006/excr.1999.4514; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lizard G, 1998, FASEB J, V12, P1651, DOI 10.1096/fasebj.12.15.1651; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Ma XR, 2001, ONCOGENE, V20, P3703, DOI 10.1038/sj.onc.1204477; Ma XR, 2001, J BIOL CHEM, V276, P24843, DOI 10.1074/jbc.M100380200; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Mehmetcik G, 1997, RES COMMUN MOL PATH, V96, P353; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nobel CSI, 1997, CHEM RES TOXICOL, V10, P1319, DOI 10.1021/tx970131m; Park HS, 2000, J BIOL CHEM, V275, P8487, DOI 10.1074/jbc.275.12.8487; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Samali A, 1999, BIOCHEM BIOPH RES CO, V255, P6, DOI 10.1006/bbrc.1998.0139; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schmitz I, 2000, INT J BIOCHEM CELL B, V32, P1123, DOI 10.1016/S1357-2725(00)00048-0; Sen CK, 1999, CELL DEATH DIFFER, V6, P481, DOI 10.1038/sj.cdd.4400514; Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Slim R, 2000, TOXICOL APPL PHARM, V166, P36, DOI 10.1006/taap.2000.8944; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stefan C, 1997, CHEM RES TOXICOL, V10, P636, DOI 10.1021/tx970006a; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Zhao AP, 2000, CYTOKINE, V12, P1356, DOI 10.1006/cyto.2000.0725	60	59	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5588	5595		10.1074/jbc.M110766200	http://dx.doi.org/10.1074/jbc.M110766200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11734564	hybrid			2022-12-27	WOS:000173962900134
J	Kunz, J; Fuelling, A; Kolbe, L; Anderson, RA				Kunz, J; Fuelling, A; Kolbe, L; Anderson, RA			Stereo-specific substrate recognition by phosphatidylinositol phosphate kinases is swapped by changing a single amino acid residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITIDE PHOSPHORYLATION; SIGNALING MOLECULES; LIPID KINASE; FYVE DOMAIN; 5-KINASE; MEMBRANE; 3-PHOSPHATE; ACTIVATION; FAB1P; CYTOSKELETON	Type I and type II phosphatidylinositol phosphate (PIP) kinases generate the lipid second messenger phosphatidylinositol (PtdIns) 4,5-bisphosphate and thus play fundamental roles in the regulation of many cellular processes. Although the two kinase families are highly homologous, they phosphorylate distinct substrates and are functionally non-redundant. Type I PIP kinases phosphorylate PtdIns 4-phosphate at the D-5 hydroxyl group and are consequently PtdIns 4-phosphate 5-kinases. By contrast, type II PIP kinases are PtdIns 5-phosphate 4-kinases that phosphorylate PtdIns 5-phosphate at the D-4 position. Type I PIP kinases, in addition, also phosphorylate other phosphoinositides in vitro and in vivo and thus have the potential to generate multiple lipid second messengers. To understand how these enzymes differentiate between stereoisomeric substrates, we used a site-directed mutagenesis approach. We show that a single amino acid substitution in the activation loop, A381E in IIbeta and the corresponding mutation E362A in Ibeta, is sufficient to swap substrate specificity between these PIP kinases. In addition to its role in substrate specificity, the type I activation loop is also key in subcellular targeting. The Ibeta(E362A) mutant and other mutants with reduced PtdIns 4-phosphate binding affinity were largely cytosolic when expressed in mammalian cells in contrast to wild-type Ibeta which targets to the plasma membrane. These results clearly establish the role of the activation loop in determining both signaling specificity and plasma membrane targeting of type I PIP kinases.	Univ Wisconsin, Med Sch, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Med Sch, Dept Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.			Anderson, Richard/0000-0001-6265-8359				Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Castellino AM, 1997, J BIOL CHEM, V272, P5861, DOI 10.1074/jbc.272.9.5861; Ciruela A, 2000, BIOCHEM J, V346, P587, DOI 10.1042/0264-6021:3460587; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Halstead JR, 2001, CURR BIOL, V11, P386, DOI 10.1016/S0960-9822(01)00121-X; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hinchliffe KA, 1996, EMBO J, V15, P6516, DOI 10.1002/j.1460-2075.1996.tb01042.x; Hinchliffe KA, 2001, CURR BIOL, V11, pR371, DOI 10.1016/S0960-9822(01)00197-X; Hinchliffe KA, 1999, CURR BIOL, V9, P983, DOI 10.1016/S0960-9822(99)80429-1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hurley JH, 2000, CURR OPIN STRUC BIOL, V10, P737; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 1998, J BIOL CHEM, V273, P20292, DOI 10.1074/jbc.273.32.20292; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Kutateladze TG, 1999, MOL CELL, V3, P805, DOI 10.1016/S1097-2765(01)80013-7; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Martin TFJ, 1997, CURR OPIN NEUROBIOL, V7, P331, DOI 10.1016/S0959-4388(97)80060-8; McEwen RK, 1999, J BIOL CHEM, V274, P33905, DOI 10.1074/jbc.274.48.33905; Mejillano M, 2001, J BIOL CHEM, V276, P1865, DOI 10.1074/jbc.M007271200; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; PIGNATARO OP, 1990, J BIOL CHEM, V265, P1718; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Rozenvayn N, 2001, J BIOL CHEM, V276, P22410, DOI 10.1074/jbc.M008184200; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tolias KF, 1999, CHEM PHYS LIPIDS, V98, P69, DOI 10.1016/S0009-3084(99)00019-5; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756	46	57	57	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5611	5619		10.1074/jbc.M110775200	http://dx.doi.org/10.1074/jbc.M110775200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733501	hybrid			2022-12-27	WOS:000173962900137
J	Liu, C; Glasser, SW; Wan, HJ; Whitsett, JA				Liu, C; Glasser, SW; Wan, HJ; Whitsett, JA			GATA-6 and thyroid transcription factor-1 directly interact and regulate surfactant protein-C gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE NUCLEAR FACTOR-3-BETA; EPITHELIAL-CELL DIFFERENTIATION; LUNG MORPHOGENESIS; FACTOR-I; B GENE; ACTIVATES TRANSCRIPTION; RESPIRATORY EPITHELIUM; TRANSGENIC MICE; MOUSE LUNG; PROMOTER	GATA-6, a member of the GATA family of zinc finger domain containing transcription factors, is expressed in endodermally derived tissues including the lung, where GATA-6 influences the transcription of target genes, TTF-1, and surfactant proteins. Whereas GATA-6 did not directly alter expression of sp-C constructs in, HeLa cells, GATA-6 synergistically activated sp-C gene transcription when co-expressed with TTF-1, supporting the concept that GATA-6 and TTF-1 might directly interact to influence target gene expression. GST-GATA-6 directly co-precipitated with TTF-1 after in vitro translation and directly interacted with the TTF-1-binding element in the sp-C promoter. Binding of TTF-1 to GATA-6 required the homeodomain of TTF-1, but optimal interactions with GATA-6 required the homeodomain and either carboxyl- or amino-terminal domains of TTF-1. Interactions between TTF-1 and GATA-6 required the amino-terminal and zinc finger domains of GATA-6. Although GATA-4 also interacted with TTY-1 in two-hybrid assays, GATA-4 was not as active as GATA-6 in the activation of the sp-C promoter with TTF-1. Deletion and substitution mutations between GATA-4 and GATA-6 demonstrated that the carboxyl-terminal zinc finger domain of GATA-6 contributed to its synergistic activation of the sp-C promoter with TTF-1. GATA-6 influenced the activity of the sp-C promoter, binding and acting synergistically with TTF-1.	Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Whitsett, JA (corresponding author), Childrens Hosp, Med Ctr, Div Neonatol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.							Bingle CD, 1997, INT J BIOCHEM CELL B, V29, P1471, DOI 10.1016/S1357-2725(97)00007-1; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Bruno MD, 2000, J BIOL CHEM, V275, P1043, DOI 10.1074/jbc.275.2.1043; BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531; Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; Dimaline R, 1997, GASTROENTEROLOGY, V112, P1559, DOI 10.1016/S0016-5085(97)70037-4; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Huggins GS, 2001, J BIOL CHEM, V276, P28029, DOI 10.1074/jbc.M103577200; Jiang YM, 1998, DEV GENET, V22, P263, DOI 10.1002/(SICI)1520-6408(1998)22:3<263::AID-DVG8>3.0.CO;2-4; Keijzer R, 2001, DEVELOPMENT, V128, P503; Kelly SE, 1996, J BIOL CHEM, V271, P6881, DOI 10.1074/jbc.271.12.6881; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Muhlhofer A, 1999, Z Gastroenterol, V37, P463; Naltner A, 2000, J BIOL CHEM, V275, P56, DOI 10.1074/jbc.275.1.56; Naltner A, 2000, AM J PHYSIOL-LUNG C, V279, pL1066, DOI 10.1152/ajplung.2000.279.6.L1066; Perl AKT, 1999, CLIN GENET, V56, P14, DOI 10.1034/j.1399-0004.1999.560103.x; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Sever-Chroneos Z, 1999, AM J PHYSIOL-LUNG C, V277, pL79, DOI 10.1152/ajplung.1999.277.1.L79; Shaw-White JR, 1999, J BIOL CHEM, V274, P2658, DOI 10.1074/jbc.274.5.2658; Svensson EC, 2000, J BIOL CHEM, V275, P20762, DOI 10.1074/jbc.M001522200; Tichelaar JW, 1999, DEV BIOL, V213, P405, DOI 10.1006/dbio.1999.9380; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; WIKENHEISER KA, 1992, CANCER RES, V52, P5342; Yan C, 1997, J BIOL CHEM, V272, P17327, DOI 10.1074/jbc.272.28.17327; Yan C, 2001, J BIOL CHEM, V276, P21686, DOI 10.1074/jbc.M011378200; YAN C, 1995, J BIOL CHEM, V270, P24852, DOI 10.1074/jbc.270.42.24852; Yang YS, 2001, AM J RESP CELL MOL, V24, P30, DOI 10.1165/ajrcmb.24.1.4050; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Zhang LQ, 1997, BBA-GENE STRUCT EXPR, V1350, P359, DOI 10.1016/S0167-4781(96)00180-7; Zhou L, 1997, DEV DYNAM, V210, P305, DOI 10.1002/(SICI)1097-0177(199711)210:3<305::AID-AJA10>3.0.CO;2-9; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	38	97	103	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4519	4525		10.1074/jbc.M107585200	http://dx.doi.org/10.1074/jbc.M107585200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733512	hybrid			2022-12-27	WOS:000173813900095
J	Kishima, Y; Yamamoto, H; Izumoto, Y; Yoshida, K; Enomoto, H; Yamamoto, M; Kuroda, T; Ito, H; Yoshizaki, K; Nakamura, H				Kishima, Y; Yamamoto, H; Izumoto, Y; Yoshida, K; Enomoto, H; Yamamoto, M; Kuroda, T; Ito, H; Yoshizaki, K; Nakamura, H			Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; MITOGENIC ACTIVITY; ENDOTHELIAL-CELLS; FACTOR MUTANT; DNA-SYNTHESIS; GENE FAMILY; SEQUENCE; EXPRESSION; PROTEIN; IDENTIFICATION	Hepatoma-derived growth factor (HDGF) is the original member of the HDGF family of proteins, which contains a well-conserved N-terminal amino acid sequence (homologous to the amino terminus of HDGF; hath) and nuclear localization signals (NLSs) in gene-specific regions other than the hath region. In addition to a bipartite NLS in a gene-specific region, an NLS-like sequence is also found in the hath region. In cells expressing green fluorescence protein (GFP)-HDGF, green fluorescence was observed in the nucleus, whereas it was detected in the cytoplasm of cells expressing GFP-HDGF with both NLSs mutated or deleted. GFP-hath protein (GFP-HATH) was distributed mainly in the nucleus, although some was present in the cytoplasm, whereas GFP-HDGF with a deleted hath region (HDGFnonHATH) was found only in the nucleus. Exogenously supplied GFP-HDGF was internalized and translocated to the nucleus. GFP-HATH was internalized, whereas GFP-HDGFnonHATH was not. Overexpression of HDGF stimulated DNA synthesis and cellular proliferation, although HDGF with both NLSs deleted did not. Overexpression of HDGFnonHATH caused a significant stimulation of DNA synthesis, whereas that of hath protein did not. HDGF containing the NLS sequence of p53 instead of the bipartite NLS did not stimulate DNA synthesis, and truncated forms without the C- or N-terminal side of NLS2 did not. These findings suggest that the gene-specific region, at least the bipartite NLS sequence and the N- and C-terminal neighboring portions, is essential for the mitogenic activity of HDGF after nuclear translocation.	Osaka Univ, Grad Sch Med, Dept Mol Med, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Hlth & Sport Sci, Dept Med Sci 1, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Nakamura, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							ADDISON C, 1990, ONCOGENE, V5, P423; ALMARIC F, 1994, BIOCHEM PHARMACOL, V47, P111; AMALRIC F, 1991, ANN NY ACAD SCI, V638, P127, DOI 10.1111/j.1749-6632.1991.tb49023.x; Antoine M, 1997, J BIOL CHEM, V272, P29475, DOI 10.1074/jbc.272.47.29475; Bailly K, 2000, FASEB J, V14, P333, DOI 10.1096/fasebj.14.2.333; Bajetto A, 1999, BRAIN RES, V818, P565, DOI 10.1016/S0006-8993(98)01308-0; BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CAO Y, 1993, J CELL SCI, V104, P77; Everett AD, 2000, J CLIN INVEST, V105, P567, DOI 10.1172/JCI7497; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; HAWKER JR, 1992, AM J PHYSIOL, V262, P1527; Ikegame K, 1999, BIOCHEM BIOPH RES CO, V266, P81, DOI 10.1006/bbrc.1999.1733; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; IMAMURA T, 1992, J BIOL CHEM, V267, P5676; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; JANS DA, 1994, FASEB J, V8, P841, DOI 10.1096/fasebj.8.11.8070633; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; JOHNSON GR, 1991, BIOCHEM BIOPH RES CO, V180, P481, DOI 10.1016/S0006-291X(05)81090-3; JOUANNEAU J, 1991, P NATL ACAD SCI USA, V88, P2893, DOI 10.1073/pnas.88.7.2893; KIMURA H, 1993, P NATL ACAD SCI USA, V90, P2165, DOI 10.1073/pnas.90.6.2165; Klingenberg O, 1998, J BIOL CHEM, V273, P11164, DOI 10.1074/jbc.273.18.11164; Kuroda T, 1999, BIOCHEM BIOPH RES CO, V262, P433, DOI 10.1006/bbrc.1999.1115; Lin YZ, 1996, J BIOL CHEM, V271, P5305, DOI 10.1074/jbc.271.10.5305; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Mehta VB, 1998, J BIOL CHEM, V273, P4197, DOI 10.1074/jbc.273.7.4197; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; MOSEVITSKY MI, 1989, EUR J BIOCHEM, V185, P303, DOI 10.1111/j.1432-1033.1989.tb15116.x; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; NAKAMURA H, 1994, J BIOL CHEM, V269, P25143; NAKAMURA H, 1989, CLIN CHIM ACTA, V183, P273, DOI 10.1016/0009-8981(89)90361-6; NAKANISHI Y, 1992, P NATL ACAD SCI USA, V89, P5216, DOI 10.1073/pnas.89.12.5216; Oliver JA, 1998, J CLIN INVEST, V102, P1208, DOI 10.1172/JCI785; ORNITS DM, 2001, GENOME BIOL, V2; PROCHIANTZ A, 1995, BIOESSAYS, V17, P39, DOI 10.1002/bies.950170109; PRUDOVSKY I, 1994, J BIOL CHEM, V269, P31720; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Singh DP, 2000, BIOCHEM BIOPH RES CO, V267, P373, DOI 10.1006/bbrc.1999.1979; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; WIEDLOCHA A, 1994, CELL, V76, P1039, DOI 10.1016/0092-8674(94)90381-6; Wiedlocha A, 1996, MOL CELL BIOL, V16, P270; ZACKSENHAUS E, 1993, MOL CELL BIOL, V13, P4588, DOI 10.1128/MCB.13.8.4588; ZHAN X, 1993, J BIOL CHEM, V268, P9611	46	112	117	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10315	10322		10.1074/jbc.M111122200	http://dx.doi.org/10.1074/jbc.M111122200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11751870	hybrid			2022-12-27	WOS:000174549200094
J	Nutt, LK; Pataer, A; Pahler, J; Fang, BL; Roth, J; McConkey, DJ; Swisher, SG				Nutt, LK; Pataer, A; Pahler, J; Fang, BL; Roth, J; McConkey, DJ; Swisher, SG			Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca2+ stores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY PROTEINS; CYTOCHROME-C RELEASE; INTRACELLULAR CALCIUM; PROAPOPTOTIC BAX; NUCLEAR-ENVELOPE; MEMBRANE PROTEIN; ION-CHANNEL; ONCOPROTEIN; DYSFUNCTION; HOMEOSTASIS	Alterations in intracellular Ca2+ homeostasis and cytochrome c release from mitochondria have been implicated in the regulation of apoptosis, but the relationship between there events remains unclear. Here we report that enforced expression of either Bax or Bak via adenoviral gene delivery results in the accumulation of the proteins in the endoplasmic reticulum (ER) and mitochondria, resulting in early caspase-independent BCL-2-sensitive release of the ER Ca2+ pool and subsequent Ca2+ accumulation in mitochondria. The inhibition of ER-to-mitochondrial Ca2+ transport with a specific inhibitor of mitochondrial Ca2+ uptake attenuates cytochrome c release and downstream biochemical events associated with apoptosis. Bax and Bak also directly sensitize mitochondria to cytochrome c release induced by immediate emptying of ER Ca2+ pool. Our results demonstrate that the effects of the "multidomain" proapoptotic BCL-2 family members Bak and Bax involve direct effects on the endoplasmic reticular Ca2+ pool with subsequent sensitization of mitochondria to calcium-mediated fluxes and cytochrome c release. These effects modulate the kinetics of cytochrome c release and apoptosis.	UTMD, Anderson Canc Ctr, Dept Canc Biol 173, Houston, TX 77030 USA; UTMD, Dept Thorac & Cardiovasc Surg, Sect Thorac & Mol Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	McConkey, DJ (corresponding author), UTMD, Anderson Canc Ctr, Dept Canc Biol 173, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dmcconke@mdanderson.org			NATIONAL CANCER INSTITUTE [P01CA078778, R29CA069676, T32CA009598] Funding Source: NIH RePORTER; NCI NIH HHS [2P50-CA70970-04, CA09598, CA69676, P01-CA78778-O1A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALNEMRI ES, 1992, P NATL ACAD SCI USA, V89, P7295, DOI 10.1073/pnas.89.16.7295; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; BAFFY G, 1993, J BIOL CHEM, V268, P6511; Chandra J, 1998, BLOOD, V92, P4220, DOI 10.1182/blood.V92.11.4220.423k49_4220_4229; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Don MJ, 2001, MOL PHARMACOL, V59, P784, DOI 10.1124/mol.59.4.784; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; FURUYA Y, 1994, CANCER RES, V54, P6167; Gogvadze V, 2001, J BIOL CHEM, V276, P19066, DOI 10.1074/jbc.M100614200; He HL, 1997, J CELL BIOL, V138, P1219, DOI 10.1083/jcb.138.6.1219; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; JIANG S, 1994, EXP CELL RES, V212, P84, DOI 10.1006/excr.1994.1121; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kagawa S, 2000, CANCER RES, V60, P1157; Kitada S, 1996, ONCOGENE, V12, P187; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; LAM M, 1993, MOL ENDOCRINOL, V7, P686, DOI 10.1210/me.7.5.686; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; McConkey DJ, 1997, BIOCHEM BIOPH RES CO, V239, P357, DOI 10.1006/bbrc.1997.7409; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; MIYASHITA T, 1995, CELL, V80, P293; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Pataer A, 2000, CANCER RES, V60, P788; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; TANAKA S, 1993, J BIOL CHEM, V268, P10920; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	60	259	274	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9219	9225		10.1074/jbc.M106817200	http://dx.doi.org/10.1074/jbc.M106817200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11741880	hybrid			2022-12-27	WOS:000174400600066
J	Schibli, DJ; Hunter, HN; Aseyev, V; Starner, TD; Wiencek, JM; McCray, PB; Tack, BF; Vogel, HJ				Schibli, DJ; Hunter, HN; Aseyev, V; Starner, TD; Wiencek, JM; McCray, PB; Tack, BF; Vogel, HJ			The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; HUMAN BETA-DEFENSIN-1; NMR STRUCTURE; EXPRESSION; DIFFUSION; ALPHA; IDENTIFICATION; ASSIGNMENT; BILAYERS; PROGRAM	The three human beta-defensins, HBD1-3, are 33-47-residue, cationic antimicrobial proteins expressed by epithelial cells. All three proteins have broad spectrum antimicrobial activity, with HBD3 consistently being the most potent. Additionally, HBD3 has significant bactericidal activity against Gram-positive Staphylococcus aureus at physiological salt concentrations. We have compared the multimeric state of the three beta-defensins using NMR diffusion spectroscopy, dynamic and static light scattering, and analysis of the migration of the three beta-defensins on a native gel. All three techniques are in agreement, suggesting that HBD-3 is a dimer, while HBD-1 and HBD-2 are monomeric. Subsequently, the NMR solution structures of HBD1 and HBD3 were determined using standard homonuclear techniques and compared with the previously determined solution structure of HBD2. Both HBD1 and HBD3 form well defined structures with backbone root mean square deviations of 0.451 and 0.616 Angstrom, respectively. The tertiary structures of all three beta-defensins are similar, with a short helical segment preceding a three-stranded anti-parallel beta-sheet. The surface charge density of each of the defensins is markedly different, with the surface of HBD3 significantly more basic. Analysis of the NMR data and structures led us to suggest that HBD3 forms a symmetrical dimer through strand beta2 of the beta-sheet. The increased anti-Staphylococcal activity of HBD3 may be explained by the capacity of the protein to form dimers in solution at low concentrations, an amphipathic dimer structure, and the increased positive surface charge compared with HBD1 and HBD2.	Univ Calgary, Dept Biol Sci, Struct Bill Res Grp, Calgary, AB T2N 1N4, Canada; Univ Iowa, Dept Chem & Biochem Engn, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Calgary; University of Iowa; University of Iowa; University of Iowa	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Struct Bill Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca		McCray, Paul/0000-0002-4067-577X; Starner, Timothy/0000-0002-1933-7477	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL061234] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-61234] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; BONTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756, DOI 10.1021/bi00149a003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callihan D, 1996, J MAGN RESON SER B, V112, P82, DOI 10.1006/jmrb.1996.0114; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Creighton T. E., 1993, PROTEINS STRUCTURE M; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; FUJII G, 1993, PROTEIN SCI, V2, P1301, DOI 10.1002/pro.5560020813; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Hristova K, 1996, BIOCHEMISTRY-US, V35, P11888, DOI 10.1021/bi961100d; Hristova K, 1997, J BIOL CHEM, V272, P24224, DOI 10.1074/jbc.272.39.24224; Jia HP, 2001, GENE, V263, P211; Jia HP, 2001, J PEDIATR-US, V138, P109, DOI 10.1067/mpd.2001.109375; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kaiser V, 2000, J LEUKOCYTE BIOL, V68, P779; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kratochvil P., 1987, CLASSICAL LIGHT SCAT; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; MERRILL MR, 1993, J MAGN RESON SER A, V103, P223, DOI 10.1006/jmra.1993.1157; NICHOLLS A, 1992, GRASP MANUAL; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Nilges M, 1997, FOLD DES, V2, pS53, DOI 10.1016/S1359-0278(97)00064-3; Perez-Canadillas JM, 2001, J BIOL CHEM, V276, P28372, DOI 10.1074/jbc.M103121200; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Redfield C, 1999, NAT STRUCT BIOL, V6, P948, DOI 10.1038/13318; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; Sawai MV, 2001, BIOCHEMISTRY-US, V40, P3810, DOI 10.1021/bi002519d; Schroder JM, 1999, CELL MOL LIFE SCI, V56, P32, DOI 10.1007/s000180050004; SELSTED ME, 1993, J BIOL CHEM, V268, P6641; SHIMODA M, 1995, INFECT IMMUN, V63, P2886, DOI 10.1128/IAI.63.8.2886-2891.1995; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; STEPANEK P, 1993, DYNAMIC LIGHT SCATTE; TANG YQ, 1993, J BIOL CHEM, V268, P6649; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres AM, 2000, BIOCHEM J, V348, P649, DOI 10.1042/0264-6021:3480649; Tunzi CR, 2000, PEDIATR RES, V48, P30, DOI 10.1203/00006450-200007000-00008; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4	62	296	320	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8279	8289		10.1074/jbc.M108830200	http://dx.doi.org/10.1074/jbc.M108830200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741980	hybrid			2022-12-27	WOS:000174268000085
J	Erdman, R; Stahl, RC; Rothblum, K; Chernousov, MA; Carey, DJ				Erdman, R; Stahl, RC; Rothblum, K; Chernousov, MA; Carey, DJ			Schwann cell adhesion to a novel heparan sulfate binding site in the N-terminal domain of alpha 4 type V collagen is mediated by syndecan-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CYTOPLASMIC DOMAIN; MOLECULAR-CLONING; EPITHELIAL-CELLS; PROTEOGLYCAN; MATRIX; INTEGRINS; IDENTIFICATION; ASSOCIATION; EXPRESSION	Previously we reported that type V collagen synthesized by Schwann cells inhibits the outgrowth of axons from rat embryo dorsal root ganglion neurons but promotes Schwann cell migration (Chernousov, M. A., Stahl, R. C., and Carey, D. J. (2001) J. Neurosci. 21, 6125-6135). Analysis of Schwann cell adhesion and spreading on dishes coated with various type V collagen domains revealed that Schwann cells adhered effectively only to the non-collagenous N-terminal domain (NTD) of the alpha4(V) collagen chain. Schwann cell adhesion to alpha4(V)NTD induced actin cytoskeleton assembly, tyrosine phosphorylation, and activation of the Erk1/Erk2 protein kinases. Adhesion to alpha4(V)-NTD is cell type-specific because rat fibroblasts failed to adhere to dishes coated with this polypeptide. Schwann cell adhesion and spreading on a4(V)-NTD was strongly inhibited by soluble heparin (IC50 similar to30 ng/ml) but not by chondroitin sulfate. Analysis of the heparin binding activities of a series of recombinant alpha4(V)-NTD fragments and deletion mutants identified a highly basic region (not present in other type V collagen NTD) as the site responsible for high affinity heparin binding. Schwann cells adhered poorly to dishes coated with alpha4(V)-NTD that lacked the heparin binding site and failed to spread or assemble organized actin-cytoskeletal structures. Soluble alpha4(V)NTD polypeptide that contained the heparin binding site inhibited spreading of Schwann cells on dishes coated with alpha4(V)-NTD. Affinity chromatography of Schwann cell detergent extracts on a column of immobilized alpha4(V)-NTD resulted in the isolation of syndecan-3, a transmembrane heparan sulfate proteoglycan. Together, these results suggest that Schwann cells bind to collagen type V via syndecan-3-dependent binding to a novel high affinity heparin binding site in the alpha4(V)-NTD.	Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Carey, DJ (corresponding author), Weis Ctr Res, Geisinger Clin, 100 N Acad Ave, Danville, PA 17822 USA.							BARONVANEVERCOOREN A, 1986, DEV NEUROSCI-BASEL, V8, P182, DOI 10.1159/000112252; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; CAREY DJ, 1990, J CELL BIOL, V111, P2053, DOI 10.1083/jcb.111.5.2053; CAREY DJ, 1994, EXP CELL RES, V214, P12, DOI 10.1006/excr.1994.1228; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; CAREY DJ, 1992, J CELL BIOL, V117, P191, DOI 10.1083/jcb.117.1.191; Carey DJ, 1997, J BIOL CHEM, V272, P2873, DOI 10.1074/jbc.272.5.2873; Carey DJ, 1997, BIOCHEM J, V327, P1; CAREY DJ, 1986, J CELL BIOL, V102, P2224; Chernousov MA, 2000, J BIOL CHEM, V275, P28208; Chernousov MA, 1999, J NEUROSCI RES, V56, P284, DOI 10.1002/(SICI)1097-4547(19990501)56:3<284::AID-JNR8>3.3.CO;2-H; Chernousov MA, 1996, J BIOL CHEM, V271, P13844, DOI 10.1074/jbc.271.23.13844; Chernousov MA, 2001, J NEUROSCI, V21, P6125, DOI 10.1523/JNEUROSCI.21-16-06125.2001; Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Couchman JR, 1999, J CELL SCI, V112, P3415; Delacoux F, 1998, J BIOL CHEM, V273, P15069, DOI 10.1074/jbc.273.24.15069; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1998, J BIOL CHEM, V273, P10624, DOI 10.1074/jbc.273.17.10624; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; SANANTONIO JD, 1993, BIOCHEMISTRY-US, V32, P4746, DOI 10.1021/bi00069a008; SANDERSON RD, 1992, J IMMUNOL, V148, P3902; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; Stewart HJS, 1997, J NEUROBIOL, V33, P914, DOI 10.1002/(SICI)1097-4695(199712)33:7<914::AID-NEU4>3.0.CO;2-B; Verrecchio A, 2000, J BIOL CHEM, V275, P7701, DOI 10.1074/jbc.275.11.7701; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; WEBSTER HDF, 1973, DEV BIOL, V32, P401, DOI 10.1016/0012-1606(73)90250-9; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183	34	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7619	7625		10.1074/jbc.M111311200	http://dx.doi.org/10.1074/jbc.M111311200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751872	hybrid			2022-12-27	WOS:000174104300109
J	Ziegler, WH; Tigges, U; Zieseniss, A; Jockusch, BM				Ziegler, WH; Tigges, U; Zieseniss, A; Jockusch, BM			A lipid-regulated docking site on vinculin for protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYRISTOYL-ELECTROSTATIC SWITCH; FILAMENT BARBED ENDS; F-ACTIN-BINDING; ALPHA-ACTININ; FOCAL ADHESIONS; CELL-ADHESION; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INTRAMOLECULAR ASSOCIATION; TAIL DOMAIN; PHOSPHORYLATION	During cell spreading, binding of actin-organizing proteins to acidic phospholipids and phosphorylation are important for localization and activity of these proteins at nascent cell-matrix adhesion sites. Here, we report on a transient interaction between the lipid-dependent protein kinase Calpha and vinculin, an early component of these sites, during spreading of HeLa cells on collagen. In vitro binding of protein kinase Calpha to vinculin tail was found dependent on free calcium and acidic phospholipids but independent of a functional kinase domain. The interaction was enhanced by conditions that favor the oligomerization of vinculin. Phosphorylation by protein kinase Calpha reached 1.5 mol of phosphate/mol of vinculin tail and required the C-terminal hydrophobic hairpin, a putative phosphatidylinositol 4,5-bisphosphate-binding site. Mass spectroscopy of peptides derived from in vitro phosphorylated vinculin tail identified phosphorylation of serines 1033 and 1045. Inhibition of C-terminal phospholipid binding at the vinculin tail by mutagenesis or deletion reduced the rate of phosphorylation to less than or equal to50%. We suggest a possible mechanism whereby phospholipid-regulated conformational changes in vinculin may lead to exposure of a docking site for protein kinase Calpha and subsequent phosphorylation of vinculin and/or vinculin interaction partners, thereby affecting the formation of cell adhesion complexes.	Tech Univ Braunschweig, Dept Cell Biol, Inst Zool, D-38092 Braunschweig, Germany	Braunschweig University of Technology	Ziegler, WH (corresponding author), Tech Univ Braunschweig, Dept Cell Biol, Inst Zool, D-38092 Braunschweig, Germany.	w.ziegler@tu-bs.de		Ziegler, Wolfgang H./0000-0003-4529-1916				Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; BARRY ST, 1994, J CELL SCI, V107, P2033; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; CHUN JS, 1993, MOL BIOL CELL, V4, P271; Chun JS, 1996, J BIOL CHEM, V271, P13008, DOI 10.1074/jbc.271.22.13008; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Defilippi P, 1997, J BIOL CHEM, V272, P21726, DOI 10.1074/jbc.272.35.21726; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; FURUHASHI K, 1992, BIOCHEM BIOPH RES CO, V184, P1261, DOI 10.1016/S0006-291X(05)80018-X; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haller H, 1998, CIRC RES, V82, P157; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Hinchliffe K, 2000, CURR BIOL, V10, pR104, DOI 10.1016/S0960-9822(00)00303-1; HINCK L, 1994, TRENDS BIOCHEM SCI, V19, P538, DOI 10.1016/0968-0004(94)90057-4; Horowitz A, 1999, BIOCHEMISTRY-US, V38, P15871, DOI 10.1021/bi991363i; Horowitz A, 1998, J BIOL CHEM, V273, P25548, DOI 10.1074/jbc.273.40.25548; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; HYATT SL, 1994, BIOCHEMISTRY-US, V33, P1223, DOI 10.1021/bi00171a023; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; Jockusch BM, 1996, TRENDS CELL BIOL, V6, P311, DOI 10.1016/0962-8924(96)10022-2; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Johnson RP, 1998, BIOCHEMISTRY-US, V37, P10211, DOI 10.1021/bi9727242; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; KAWAMOTO S, 1984, BIOCHEM BIOPH RES CO, V118, P736, DOI 10.1016/0006-291X(84)91456-6; Korneeva NL, 1996, EUR J CELL BIOL, V71, P351; KROEMKER M, 1994, FEBS LETT, V355, P259, DOI 10.1016/0014-5793(94)01216-4; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; MARAIS RM, 1989, EUR J BIOCHEM, V182, P129, DOI 10.1111/j.1432-1033.1989.tb14809.x; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Massoumi R, 2001, J CELL SCI, V114, P1925; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Miller GJ, 2001, J BIOL CHEM, V276, P11729, DOI 10.1074/jbc.M008646200; Miranti CK, 1999, J BIOL CHEM, V274, P10571, DOI 10.1074/jbc.274.15.10571; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; OHNO S, 1990, J BIOL CHEM, V265, P6296; Perez-Moreno M, 1998, J CELL SCI, V111, P3563; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rudiger M, 1997, BIOTECHNIQUES, V23, P96, DOI 10.2144/97231bm20; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Schwienbacher C, 1996, FEBS LETT, V384, P71, DOI 10.1016/0014-5793(96)00286-4; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; TURNER CE, 1989, J BIOL CHEM, V264, P11938; VUORI K, 1993, J BIOL CHEM, V268, P21459; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; WERTH DK, 1984, J BIOL CHEM, V259, P5264; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winkler J, 1996, J STRUCT BIOL, V116, P270, DOI 10.1006/jsbi.1996.0042; Wittenmayer N, 2000, EUR J BIOCHEM, V267, P5247, DOI 10.1046/j.1432-1327.2000.01600.x; WOODS A, 1992, J CELL SCI, V101, P277; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; YU FX, 1992, J BIOL CHEM, V267, P14616; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	80	50	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7396	7404		10.1074/jbc.M110008200	http://dx.doi.org/10.1074/jbc.M110008200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741957	hybrid			2022-12-27	WOS:000174104300084
J	Amino, R; Martins, RM; Procopio, J; Hirata, IY; Juliano, MA; Schenkman, S				Amino, R; Martins, RM; Procopio, J; Hirata, IY; Juliano, MA; Schenkman, S			Trialysin, a novel pore-forming protein from saliva of hematophagous insects activated by limited proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; TRYPANOSOMA-RANGELI; RHODNIUS-PROLIXUS; STREPTOLYSIN-O; HOST-DEFENSE; TOXIN; MEMBRANE; HEMOLYMPH; CELLS; SPECIFICITY	We have characterized a pore-forming lytic protein from the saliva of the hematophagous insect Triatoma infestans, a vector of Chagas disease. This protein, named trialysin, has 22 kDa and is present in the saliva at about 200 mug/ml. Purified trialysin forms voltage-dependent channels in planar lipid bilayers with conductance of 880 +/- 40 pS. It lyses protozoan parasites and bacteria indicating that it has a role in the control of microorganism growth in the salivary glands. At higher concentrations, but below those found in saliva, trialysin can also permeabilize and lyse mammalian cells, suggesting that it might also facilitate insect blood feeding by interfering with the cell response of the host. The translated cDNA sequence of trialysin shows a basic, lysine-rich protein in which the N-terminal region is predicted to form an amphipathic alpha-helical structure with positive charges on one side and hydrophobic amino acids on the opposite side. A synthetic peptide corresponding to this cationic amphipathic alpha-helix induces protozoan lysis and mammalian cell permeabilization, showing that this region is involved in lytic activity. However, the lytic peptide G6V32 is 10-fold less efficient than trialysin in lysing parasites and 100-fold less efficient in permeabilizing mammalian cells. Trialysin activity is about 10-fold reduced in salivary gland homogenates prepared in the presence of an irreversible serine-protease inhibitor. Since trialysin precursor contains an anionic pro-sequence of 33 amino acids contiguous to the cationic amphipathic putative a-helix, we propose that removal of the acidic pro-sequence by limited proteolysis activates trialysin by exposing this lytic basic amphipathic motif.	Univ Fed Sao Paulo, EPM, Dept Biofis, BR-04023062 Sao Paulo, SP, Brazil; Univ Fed Sao Paulo, EPM, Dept Microbiol Immunol & Parasitol, BR-04023062 Sao Paulo, SP, Brazil; Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, BR-05508900 Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Schenkman, S (corresponding author), Univ Fed Sao Paulo, EPM, Dept Biofis, 862-8A, BR-04023062 Sao Paulo, SP, Brazil.	sergio@ecb.epm.br	Schenkman, Sergio/A-9227-2013	Schenkman, Sergio/0000-0001-9353-8480; miyazawa martins, rafael/0000-0001-7449-0696; Amino, Rogerio/0000-0002-8086-2932				Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; Amino R, 2001, INSECT BIOCHEM MOLEC, V31, P465, DOI 10.1016/S0965-1748(00)00151-X; ASHMARIN IP, 1993, B EXP BIOL MED+, V115, P23, DOI 10.1007/BF00846346; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Cuba Cuba Cesar A., 1998, Revista da Sociedade Brasileira de Medicina Tropical, V31, P207; DALESSANDRO A, 1986, AM J TROP MED HYG, V35, P512, DOI 10.4269/ajtmh.1986.35.512; DALESSANDRO A, 1972, J MED ENTOMOL, V9, P187, DOI 10.1093/jmedent/9.3.187; DEAZAMBUJA P, 1983, J INSECT PHYSIOL, V29, P833, DOI 10.1016/0022-1910(83)90149-X; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Garcia-Olmedo F, 1998, BIOPOLYMERS, V47, P479, DOI 10.1002/(SICI)1097-0282(1998)47:6<479::AID-BIP6>3.0.CO;2-K; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GREGORIO EA, 1991, MEM I OSWALDO CRUZ, V86, P181, DOI 10.1590/S0074-02761991000200007; HALL RH, 1990, INFECT IMMUN, V58, P3375, DOI 10.1128/IAI.58.10.3375-3379.1990; Hirata IY, 1995, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771; KINI RM, 1989, INT J PEPT PROT RES, V34, P277; Korostoff J, 1998, INFECT IMMUN, V66, P4474; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; LEHANE MJ, 1994, INT J PARASITOL, V24, P27, DOI 10.1016/0020-7519(94)90056-6; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Matsuzaki K, 2001, BIOCHEM SOC T, V29, P598, DOI 10.1042/BST0290598; Mello CB, 1996, EXP PARASITOL, V82, P112, DOI 10.1006/expr.1996.0015; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Mitchell TJ, 1997, MICROB DRUG RESIST, V3, P19, DOI 10.1089/mdr.1997.3.19; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OKADA M, 1985, J BIOL CHEM, V260, P7174; OLOFSSON A, 1993, FEBS LETT, V319, P125, DOI 10.1016/0014-5793(93)80050-5; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SEKIYA K, 1993, J BACTERIOL, V175, P5953, DOI 10.1128/JB.175.18.5953-5961.1993; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Stevens JR, 1999, INT J PARASITOL, V29, P749, DOI 10.1016/S0020-7519(99)00016-8; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; Walch M, 2000, ULTRAMICROSCOPY, V82, P259, DOI 10.1016/S0304-3991(99)00135-7; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Wang JF, 1998, MICROB PATHOGENESIS, V25, P317, DOI 10.1006/mpat.1998.0236; WATSON KC, 1972, J CLIN PATHOL, V25, P885, DOI 10.1136/jcp.25.10.885; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375	45	68	69	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6207	6213		10.1074/jbc.M109874200	http://dx.doi.org/10.1074/jbc.M109874200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751887	hybrid			2022-12-27	WOS:000173989200069
J	Kobayashi, M; Kishida, S; Fukui, A; Michiue, T; Miyamoto, Y; Okamoto, T; Yoneda, Y; Asashima, M; Kikuchi, A				Kobayashi, M; Kishida, S; Fukui, A; Michiue, T; Miyamoto, Y; Okamoto, T; Yoneda, Y; Asashima, M; Kikuchi, A			Nuclear localization of Duplin, a beta-catenin-binding protein, is essential for its inhibitory activity on the Wnt signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANSCRIPTION FACTOR TCF; PORE-TARGETING COMPLEX; F-BOX PROTEIN; NEGATIVE REGULATOR; XENOPUS EMBRYOS; GSK-3-BETA-DEPENDENT PHOSPHORYLATION; AXIS SPECIFICATION; GENE-EXPRESSION	Duplin binds to beta-catenin and inhibits the Wnt signaling pathway, thereby leading to repression of the beta-catenin-mediated transactivation and Xenopus axis formation. To find an additional function of Duplin, yeast two-hybrid screening was carried out. Importin a was isolated as a binding protein of Duplin. Importin a bound directly to basic amino acid clusters of Duplin. Although Duplin was present in the nucleus, deletion of the basic amino acid clusters (Duplin(Delta500-584)) retained Duplin in the cytoplasm. Duplin(Delta500-584) bound to beta-catenin as efficiently as wild-type Duplin, but it neither repressed Wnt-dependent Tcf transcriptional activation in mammalian cells nor showed ventralization in Xenopus embryos. The Duplin mutant without a beta-catenin-binding region lost the ability to inhibit the Wnt-dependent Tcf activation, but retained its ventralizing activity. Furthermore, Duplin not only suppressed beta-catenin-dependent axis duplication and expression of siamois, a Wnt-regulated gene, but also inhibited siamois-dependent axis duplication. These results indicate that Duplin is translocated to the nucleus by interacting with importin a, and that nuclear localization is essential for the function of Duplin. Moreover, Duplin has an additional activity of inhibiting the Wnt signaling pathway by affecting the downstream beta-catenin target genes.	Hiroshima Univ, Fac Med, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan; Hiroshima Univ, Fac Dent, Minami Ku, Fac Mol Oral Med & Maxillofacial Surg, Hiroshima 7348551, Japan; PRESTO, Japan Sci & Technol Corp, Hiroshima, Japan; Univ Tokyo, Crest Project, Meguro Ku, Tokyo 1538902, Japan; Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan	Hiroshima University; Hiroshima University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; Osaka University	Kikuchi, A (corresponding author), Hiroshima Univ, Fac Med, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	akikuchi@hiroshima-u.ac.jp	Fukui, Akimasa/F-5284-2011	Miyamoto, Yoichi/0000-0003-4016-1119; kishida, shosei/0000-0003-0405-851X				Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Dale TC, 1998, BIOCHEM J, V329, P209; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hieda M, 2001, J BIOL CHEM, V276, P16824, DOI 10.1074/jbc.M008299200; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Kadoya T, 2000, J BIOL CHEM, V275, P37030, DOI 10.1074/jbc.M005984200; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kotaja N, 2000, MOL ENDOCRINOL, V14, P1986, DOI 10.1210/me.14.12.1986; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Niehrs C, 2001, EMBO J, V20, P631, DOI 10.1093/emboj/20.4.631; Nishinakamura R, 1999, DEV BIOL, V216, P481, DOI 10.1006/dbio.1999.9518; Okazaki M, 1996, CANCER RES, V56, P2387; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Polakis P, 2000, GENE DEV, V14, P1837; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Sasai Y, 2001, CURR OPIN NEUROBIOL, V11, P22, DOI 10.1016/S0959-4388(00)00169-0; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Shibamoto S, 1998, GENES CELLS, V3, P659; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Tsuji L, 1997, FEBS LETT, V416, P30, DOI 10.1016/S0014-5793(97)01092-2; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 2001, J BIOL CHEM, V276, P26875, DOI 10.1074/jbc.M100443200; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	59	18	20	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5816	5822		10.1074/jbc.M108433200	http://dx.doi.org/10.1074/jbc.M108433200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744694	hybrid			2022-12-27	WOS:000173989200018
J	Kovacs, EM; Ali, RG; McCormack, AJ; Yap, AS				Kovacs, EM; Ali, RG; McCormack, AJ; Yap, AS			E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; GREEN FLUORESCENT PROTEIN; RHO-FAMILY GTPASES; EPITHELIAL-CELLS; ACTIVATION; BINDING; CATENIN; ASSOCIATION; MECHANISMS; JUNCTIONS	Classical cadherins mediate cell recognition and cohesion in many tissues of the body. It is increasingly apparent that dynamic cadherin contacts play key roles during morphogenesis and that a range of cell signals are activated as cells form contacts with one another. It has been difficult, however, to determine whether these signals represent direct downstream consequences of cadherin ligation or are juxtacrine signals that are activated when cadherin adhesion brings cell surfaces together but are not direct downstream targets of cadherin signaling. In this study, we used a functional cadherin ligand (hE/Fc) to directly test whether E-cadherin ligation regulates phosphatidylinositol 3-kinase (PI 3-kinase) and Rac signaling. We report that homophilic cadherin ligation recruits Rae to nascent adhesive contacts and specifically stimulates Rae signaling. Adhesion to hE/Fc also recruits PI 3-kinase to the cadherin complex, leading to the production of phosphatidylinositol 3,4,5-trisphosphate in nascent cadherin contacts. Rae activation involved an early phase, which was PI 3-kinase-independent, and a later amplification phase, which was inhibited by wortmannin. PI 3-kinase and Rae activity were necessary for productive adhesive contacts to form following initial homophilic ligation. We conclude that E-cadherin is a cellular receptor that is activated upon homophilic ligation to signal through PI 3-kinase and Rae. We propose that a key function of these cadherin-activated signals is to control adhesive contacts, probably via regulation of the actin cytoskeleton, which ultimately serves to mediate adhesive cell-cell recognition.	Univ Queensland, Dept Physiol & Pharmacol, Sch Biomed Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Australian Res Council, Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland	Yap, AS (corresponding author), Univ Queensland, Dept Physiol & Pharmacol, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	a.yap@mailbox.uq.edu.au	Yap, Alpha S./J-1554-2014; Kovacs, Eva/U-3526-2019	Yap, Alpha S./0000-0002-1038-8956; Kovacs, Eva/0000-0002-7228-4028				ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Braga V, 2000, EXP CELL RES, V261, P83, DOI 10.1006/excr.2000.5050; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Cantrell DA, 2001, J CELL SCI, V114, P1439; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Espada J, 1999, J CELL BIOL, V146, P967, DOI 10.1083/jcb.146.5.967; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Gillham H, 1999, J CELL BIOL, V146, P869, DOI 10.1083/jcb.146.4.869; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Jaumot M, 2002, J BIOL CHEM, V277, P272, DOI 10.1074/jbc.M108423200; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nakagawa M, 2001, J CELL SCI, V114, P1829; NOBES CD, 1995, J CELL SCI, V108, P225; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Yokoyama S, 2001, MOL BIOL CELL, V12, P1595, DOI 10.1091/mbc.12.6.1595; YONEMURA S, 1995, J CELL SCI, V108, P127	46	255	260	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6708	6718		10.1074/jbc.M109640200	http://dx.doi.org/10.1074/jbc.M109640200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744701	hybrid			2022-12-27	WOS:000173989200133
J	Barth, H; Roebling, R; Fritz, M; Aktories, M				Barth, H; Roebling, R; Fritz, M; Aktories, M			The binary Clostridium botulinum C2 toxin as a protein delivery system - Identification of the minimal protein region necessary for interaction of toxin components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLTRANSFERASE; CELLULAR UPTAKE; IOTA-TOXIN; RHO; PURIFICATION; BINDING; SITE; RESIDUES; COMPLEX; ACTIN	The binary Clostridium botulinum C2 toxin is composed of the enzyme component C2I and the binding component C2II, which are individual and non-linked proteins. Activated C2IIa mediates cell binding and translocation of C2I into the cytoplasm. C2I ADP-ribosylates G-actin at Arg-177 to depolymerize actin filaments. A fusion toxin containing the N-terminal domain of C2I (residues 1-225) transports C3 ADP-ribosyltransferase from Clostridium limosum into cells (Birth, H., Hofmann, F., Olenik, C., Just, I., and Aktories, B. (1998) Infect. Immun. 66, 1364-1369). We characterized the adaptor function of C2I and its interaction with C2IIa. The fusion toxin GST-C2I(1-225)-C3 was efficiently transported by C2IIa, indicating that C2IIa translocates proteins into the cytosol even when the C2I(1-225) adaptor was positioned in the middle of a fusion protein. Amino acid residues 1-87 of C2I were sufficient for interaction with C2IIa and for translocation of C2I fusion toxins into HeLa cells. Residues 1-87 were the minimal part of C2I to bind to C2IIa on the cell surface, as detected by fluorescence-activated cytometry. An excess of C2I(1-87) (but not of further truncated C2I fragments) competed with Alexa488-labeled C2I for binding to C2IIa. Also, the fragment C2I(30-431) and the fusion toxin C2I(30-225)-C3 competed with C2I-Alexa488 for binding to C2IIa. C2I(30-225)-C3 did not induce cytotoxic effects on cells when applied together with C2IIa, indicating that amino acid residues 1-29 are involved in translocation of C2I but are not absolutely essential for binding to C2IIa.	Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany	University of Freiburg	Barth, H (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, Albertstr 25, D-79104 Freiburg, Germany.		Barth, Holger/E-7920-2013					AKTORIES K, 1995, METHOD ENZYMOL, V256, P184; AKTORIES K, 1992, CURR TOP MICROBIOL, V175, P115; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; ARORA N, 1993, J BIOL CHEM, V268, P3334; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 1998, J BIOL CHEM, V273, P29506, DOI 10.1074/jbc.273.45.29506; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; JUST I, 1992, J BIOL CHEM, V267, P10274; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kumar P, 2001, INFECT IMMUN, V69, P6532, DOI 10.1128/IAI.69.10.6532-6536.2001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leppla S. H., 1995, Bacterial toxins and virulence factors in disease., P543; Perelle S, 1996, FEBS LETT, V395, P191, DOI 10.1016/0014-5793(96)01035-6; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; SEKINE A, 1989, J BIOL CHEM, V264, P8602; SIMPSON LL, 1989, INFECT IMMUN, V57, P255, DOI 10.1128/IAI.57.1.255-261.1989; STILES BG, 1986, INFECT IMMUN, V54, P683, DOI 10.1128/IAI.54.3.683-688.1986	19	63	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5074	5081		10.1074/jbc.M109167200	http://dx.doi.org/10.1074/jbc.M109167200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741886	hybrid			2022-12-27	WOS:000173962900069
J	Feng, QY; Albeck, JG; Cerione, RA; Yang, WN				Feng, QY; Albeck, JG; Cerione, RA; Yang, WN			Regulation of the Cool/Pix proteins - Key binding partners of the Cdc42/Rac targets, the p21-activated kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH SYNDROME; TYROSINE KINASE; ACTIN; GTPASES; CDC42HS; RAC1; ACTIVATION; FAMILY; PAK; IDENTIFICATION	The Cool (cloned-out of library)/Pix (for PAR-interactive exchange factor) proteins directly bind to members of the PAK family of serine/threonine kinases and regulate their activity. Three members of the Cool/Pix family have shown distinct regulatory activities: (D p50(Cool-1) inhibits Cdc42/Rac-stimulated PAK activity, (ii) p85(Cool-1)/beta-Pix has a permissive effect on Cdc42/Rac-stimulated activity, and (iii) p90(Cool-2)/alpha-Pix strongly activates PAR. We initially suspected that these different functional effects were due to a binding interaction that occurs at the carboxyl-terminal ends of the larger Cool/Pix proteins, thus enabling them to stimulate (or at least permit) rather than inhibit PAK activity. This led to the identification of the Cat proteins (for Cool-associated tyrosine phosphosubstrates). However, here we show that the Cat proteins bind to the carboxyl-terminal ends of p85(Cool-1) (residues 523-546) and Cool-2 (residues 647-670), and that the binding of Cat to Cool-2 in fact is not necessary for the Cool-2-mediated activation of PAY, Rather, an 18-amino acid region, designated T1, that is present in the Cool-1 proteins, but missing in Cool-2, is essential for controlling the regulation of PAK activity by Cool-l/beta-Pix in vivo. Deletion of T1 yielded a p85(Cool-1) molecule that mimicked the Cool-2 protein and was capable of strongly stimulating PAR activity. However, when T1 was added to Cool-2, the ability of Cool-2 to directly activate PAK was lost. We conclude that T1 represents a novel regulatory domain that accounts for the specific functional effects on PAK activity exhibited by the different members of the Cool/Pix family.	Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Yang, WN (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.				NIGMS NIH HHS [GM40654, GM47458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R01GM040654] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HOBES CD, 1995, CELL, V81, P53; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Lee N, 1997, P NATL ACAD SCI USA, V94, P13642, DOI 10.1073/pnas.94.25.13642; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; Oh WK, 1997, BIOCHEM BIOPH RES CO, V235, P794, DOI 10.1006/bbrc.1997.6875; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Song J, 1998, J CELL SCI, V111, P2257; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819	38	88	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5644	5650		10.1074/jbc.M107704200	http://dx.doi.org/10.1074/jbc.M107704200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741931	hybrid			2022-12-27	WOS:000173962900141
J	Lo, HR; Chou, CC; Wu, TY; Yuen, JPY; Chao, YC				Lo, HR; Chou, CC; Wu, TY; Yuen, JPY; Chao, YC			Novel baculovirus DNA elements strongly stimulate activities of exogenous and endogenous promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECT CELLS; GENE-EXPRESSION; HOMOLOGOUS DNA; ENHANCER; REGIONS; GENOME; REPLICATION; INFECTION; SEQUENCE; IDENTIFICATION	A DNA sequence upstream from the polyhedrin gene of baculovirus Autographa californica nucleopolyhedrovirus (AcMNPV) was found to activate strongly the expression of full or minimal promoters derived from AcMNPV and other sources. Promoters tested included the minimal CMV (CMVm) promoter from human cytomegalovirus, the full heat shock 70 promoter from Drosophila, and the minimal p35 promoter from baculovirus. Deletion and mutagenesis analyses showed that this functional polyhedrin upstream (pu) activator sequence contains three open reading frames (ORFs), ORF4, ORF5, and left. In plasmid transfection assays, the pu sequence was able to confer high level luciferase expression driven by all of these full or minimal promoters in insect Sf21 cells. A known baculovirus enhancer, the homologous region (hr) of AcMNPV, further enhanced the expression of these promoters. Experiments showed that although multiple hr sequences function in an additive manner, pu and hr together function synergistically, resulting in as much as 18,000-fold promoter activation. Furthermore, a modified CMVm promoter containing pu and/or hr was inserted into the baculovirus genome to drive the luciferase coding region. The CMVm promoter expressed luciferase much earlier, and although it expressed a bit less than did the p10 promoter, the CMVm promoter gave rise to greater luciferase activity. Therefore, we have uncovered a cryptic viral sequence capable of activating a diverse group of promoters. Finally, these experiments demonstrate that synthetic sequences containing pu, hr, and different full or minimal promoters can generate a set of essentially unlimited novel promoters for weak to very strong expression of foreign proteins using baculovirus.	Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan	Chao, YC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	mbycchao@ccvax.sinica.edu.tw	Chao, Yu-Chan/ABF-6571-2021	Chao, Yu-Chan/0000-0002-9528-8806				AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Barik S, 1997, Methods Mol Biol, V67, P173; Benaroudj N, 2001, BIOCHIMIE, V83, P311, DOI 10.1016/S0300-9084(01)01244-5; BLISSARD GW, 1990, ANNU REV ENTOMOL, V35, P127, DOI 10.1146/annurev.en.35.010190.001015; CHOI J, 1995, J VIROL, V69, P4548, DOI 10.1128/JVI.69.7.4548-4551.1995; COCHRAN MA, 1983, J VIROL, V45, P961, DOI 10.1128/JVI.45.3.961-970.1983; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GUARINO LA, 1986, J VIROL, V60, P224, DOI 10.1128/JVI.60.1.224-229.1986; GUARINO LA, 1991, J VIROL, V65, P3676, DOI 10.1128/JVI.65.7.3676-3680.1991; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; Habib S, 1996, DNA CELL BIOL, V15, P737, DOI 10.1089/dna.1996.15.737; JARVIS DL, 1990, BIO-TECHNOL, V8, P950, DOI 10.1038/nbt1090-950; Jarvis DL, 1996, PROTEIN EXPRES PURIF, V8, P191, DOI 10.1006/prep.1996.0092; JARVIS DL, 1989, MOL CELL BIOL, V9, P214, DOI 10.1128/MCB.9.1.214; KOOL M, 1993, J GEN VIROL, V74, P2661, DOI 10.1099/0022-1317-74-12-2661; KOOL M, 1994, VIROLOGY, V198, P680, DOI 10.1006/viro.1994.1080; Kost TA, 1999, CURR OPIN BIOTECH, V10, P428, DOI 10.1016/S0958-1669(99)00005-1; KOVACS GR, 1992, J VIROL, V66, P7429, DOI 10.1128/JVI.66.12.7429-7437.1992; Lee JC, 1998, J VIROL, V72, P9157, DOI 10.1128/JVI.72.11.9157-9165.1998; Lee JC, 1998, J GEN VIROL, V79, P2293, DOI 10.1099/0022-1317-79-9-2293; Lin CL, 1999, J VIROL, V73, P128, DOI 10.1128/JVI.73.1.128-139.1999; LU A, 1995, J VIROL, V69, P975, DOI 10.1128/JVI.69.2.975-982.1995; Martensen PM, 2001, BIOTECHNIQUES, V30, P782, DOI 10.2144/01304st04; MORRIS TD, 1992, J VIROL, V66, P7397, DOI 10.1128/JVI.66.12.7397-7405.1992; MURPHY CI, 1990, GENET ANAL-BIOMOL E, V7, P160, DOI 10.1016/0735-0651(90)90030-J; NODA Y, 1994, BIOPOLYMERS, V34, P217, DOI 10.1002/bip.360340208; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; PASSARELLI AL, 1993, J VIROL, V67, P2149, DOI 10.1128/JVI.67.4.2149-2158.1993; PEARSON M, 1992, SCIENCE, V257, P1382, DOI 10.1126/science.1529337; PEARSON MN, 1993, VIROLOGY, V197, P715, DOI 10.1006/viro.1993.1647; Pfeifer TA, 1997, GENE, V188, P183, DOI 10.1016/S0378-1119(96)00756-1; Pham MQ, 1999, BIOTECHNOL BIOENG, V62, P175, DOI 10.1002/(SICI)1097-0290(19990120)62:2&lt;175::AID-BIT7&gt;3.0.CO;2-J; Ramachandran A, 2001, J BIOL CHEM, V276, P23440, DOI 10.1074/jbc.M101537200; Rapp JC, 1998, J VIROL, V72, P10197, DOI 10.1128/JVI.72.12.10197-10206.1998; RODEMS SM, 1993, J VIROL, V67, P5776, DOI 10.1128/JVI.67.10.5776-5785.1993; SCHMID G, 1998, NEW DEV NEW APPL ANI, P303; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; TODD JW, 1995, J VIROL, V69, P968, DOI 10.1128/JVI.69.2.968-974.1995; VLAK JM, 1988, J GEN VIROL, V69, P765, DOI 10.1099/0022-1317-69-4-765; WEYER U, 1989, J GEN VIROL, V70, P203, DOI 10.1099/0022-1317-70-1-203; Wu TY, 2000, J BIOTECHNOL, V80, P75, DOI 10.1016/S0168-1656(00)00247-9; Wu YT, 1996, J VIROL, V70, P6967, DOI 10.1128/JVI.70.10.6967-6972.1996	42	38	45	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5256	5264		10.1074/jbc.M108895200	http://dx.doi.org/10.1074/jbc.M108895200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741907	hybrid			2022-12-27	WOS:000173962900091
J	Tridandapani, S; Siefker, K; Teillaud, JL; Carter, JE; Wewers, MD; Anderson, CL				Tridandapani, S; Siefker, K; Teillaud, JL; Carter, JE; Wewers, MD; Anderson, CL			Regulated expression and inhibitory function of Fc gamma RIIb in human monocytic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NEGATIVE REGULATION; MONOCLONAL-ANTIBODIES; INOSITOL PHOSPHATASE; TYROSINE-PHOSPHATASE; CYTOPLASMIC DOMAIN; IN-VIVO; B-CELLS; SHIP; ACTIVATION	Human monocytes/macrophages express three classes of receptors for IgG: FcgammaRI, FcgammaRII, and FcgammaRIII. The expression and function of these receptors has been extensively studied with the exception of one, FcgammaRIIb. While the mRNA for FcgammaRIIb has been detected in human monocytes, the protein has remained elusive. Studies in mouse models indicated that the macrophage FcgammaRIIb serves to down-regulate FcgammaR-mediated phagocytosis and immune complex-induced inflammation. FcgammaRIIb has also been shown to modulate the action of cytotoxic antibodies against tumors in mouse models. Hence, an understanding of how FcgammaRIIb expression is regulated is of great importance. Here we demonstrate for the first time FcgammaRIIb protein expression and function in human monocytes. We also report that the expression of FcgammaRIIb is highly up-regulated by interleukin-4, a Th2 cytokine, and that the up-regulation of FcgammaRIIb results in a decrease in the phagocytic efficiency of interleukin-4-treated THP-1 cells. Furthermore co-clustering FcgammaRIIb with FcgammaRIIa resulted in enhanced phosphorylation of the inositol phosphatase SHIP, association of SHIP with She, and phosphorylation of additional proteins around 120 and 60-65 kDa, with a concomitant. attenuation of Akt activation. We, therefore, propose that FcgammaRIIb serves to inhibit FcgammaRI/IIa-mediated macrophage activation using SHIP as its effector.	Ohio State Univ, Coll Med, HLRI, Dept Internal Med, Columbus, OH 43210 USA; INSERM U 255, F-75270 Paris 06, France	University System of Ohio; Ohio State University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Anderson, CL (corresponding author), Ohio State Univ, Coll Med, HLRI, Dept Internal Med, Rm 430,473 W 12th Ave, Columbus, OH 43210 USA.	anderson.48@osu.edu	Wewers, Mark/AAB-6202-2021; Tridandapani, Susheela/E-4209-2011	Teillaud, Jean-Luc/0000-0003-4442-9565	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035121] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA044983] Funding Source: NIH RePORTER; NCI NIH HHS [CA44983] Funding Source: Medline; NHLBI NIH HHS [HO38764] Funding Source: Medline; NICHD NIH HHS [HD35121] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; BROOKS DG, 1989, J EXP MED, V170, P1369, DOI 10.1084/jem.170.4.1369; Carver DJ, 2000, BLOOD, V96, P1449, DOI 10.1182/blood.V96.4.1449.h8001449_1449_1456; CASSEL DL, 1993, MOL IMMUNOL, V30, P451, DOI 10.1016/0161-5890(93)90113-P; Chacko GW, 1996, J IMMUNOL, V157, P2234; CHOQUET D, 1994, J BIOL CHEM, V269, P6491; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Coggeshall KM, 2000, CURR TOP MICROBIOL, V245, P213; Coggeshall KM, 1998, CURR OPIN IMMUNOL, V10, P306, DOI 10.1016/S0952-7915(98)80169-6; Cooney DS, 2001, J IMMUNOL, V167, P844, DOI 10.4049/jimmunol.167.2.844; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768; IERINO FL, 1993, J IMMUNOL, V150, P1794; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; Lesourne R, 2001, J BIOL CHEM, V276, P6327, DOI 10.1074/jbc.M006537200; Lyden TW, 2001, J IMMUNOL, V166, P3882, DOI 10.4049/jimmunol.166.6.3882; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Maresco DL, 1999, J IMMUNOL, V162, P6458; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; PAN L, 1990, J IMMUNOL, V145, P267; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; ROSSMAN MD, 1993, EXP HEMATOL, V21, P177; Rudd CE, 2000, CURR BIOL, V10, pR344, DOI 10.1016/S0960-9822(00)00463-2; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Tridandapani S, 1997, J IMMUNOL, V158, P1125; Tridandapani S, 1997, MOL CELL BIOL, V17, P4305, DOI 10.1128/MCB.17.8.4305; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; WARMERDAM PAM, 1993, INT IMMUNOL, V5, P239, DOI 10.1093/intimm/5.3.239; Weinrich V, 1996, HYBRIDOMA, V15, P109, DOI 10.1089/hyb.1996.15.109; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223	41	112	130	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5082	5089		10.1074/jbc.M110277200	http://dx.doi.org/10.1074/jbc.M110277200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741917	hybrid			2022-12-27	WOS:000173962900070
J	Adilakshmi, T; Laine, RO				Adilakshmi, T; Laine, RO			Ribosomal protein S25 mRNA partners with MTF-1 and La to provide a p53-mediated mechanism for survival or death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-I; METALLOTHIONEIN GENE-EXPRESSION; ASPARAGINE SYNTHETASE GENE; METAL RESPONSE ELEMENTS; MESSENGER-RNA; NUCLEAR RETENTION; BINDING; CELLS; ACTIVATION; STRESS	Coordinate regulation of the ribosomal protein genes is entrusted to a number of signal transduction pathways that can abruptly induce or silence the ribosomal genes. We have uncovered a cellular model system, which selectively induces the ribosomal protein S25 gene in hepatoma cells that are stressed by nutrient deprivation. Our results indicate that p53 along with two other identified proteins, MTF-1 and La, post-transcriptionally regulate the synthesis of the S25 protein by controlling the nuclear export of the stress-induced S25 mRNA. This system is unique in that the nuclear-retained S25 mRNA is exported to the cytosol only, upon replenishment or alternatively after prolonged starvation to participate in a p53-mediated apoptotic sequence of events. This p53-dependent survival or death pathway involves a previously unreported protein relationship among these three actors, one of which, MTF-1, has not yet been shown to have RNA-binding characteristics.	Univ Florida, Whitney Lab, St Augustine, FL 32080 USA	State University System of Florida; University of Florida	Laine, RO (corresponding author), Univ Florida, Whitney Lab, 9505 Ocean Shore Blvd, St Augustine, FL 32080 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK049644] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK49644] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bichsel VE, 1997, NUCLEIC ACIDS RES, V25, P2417, DOI 10.1093/nar/25.12.2417; BUSSOLATI O, 1995, EXP CELL RES, V220, P283, DOI 10.1006/excr.1995.1317; Carter MS, 2000, J BIOL CHEM, V275, P28301; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Dalton TP, 1997, MOL CELL BIOL, V17, P2781, DOI 10.1128/MCB.17.5.2781; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; DELSAL G, 1995, MOL CELL BIOL, V15, P7152; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; GONG SS, 1991, MOL CELL BIOL, V11, P6059, DOI 10.1128/MCB.11.12.6059; Grombacher T, 1998, ONCOGENE, V17, P845, DOI 10.1038/sj.onc.1202000; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; HUTSON RG, 1994, BIOCHEM J, V304, P745, DOI 10.1042/bj3040745; KILBERG MS, 1994, FASEB J, V8, P13, DOI 10.1096/fasebj.8.1.8299885; Kubota S, 1999, ONCOGENE, V18, P1503, DOI 10.1038/sj.onc.1202429; Laine RO, 1996, PROG NUCLEIC ACID RE, V53, P219, DOI 10.1016/S0079-6603(08)60146-4; LAINE RO, 1994, J BIOL CHEM, V269, P9693; LI ML, 1992, FEBS LETT, V298, P142, DOI 10.1016/0014-5793(92)80041-E; MAGER WH, 1988, BIOCHIM BIOPHYS ACTA, V949, P1, DOI 10.1016/0167-4781(88)90048-6; Maraia RJ, 2001, MOL CELL BIOL, V21, P367, DOI 10.1128/MCB.21.2.367-379.2001; Miller SJ, 2000, MOL CELL BIOL, V20, P8420, DOI 10.1128/MCB.20.22.8420-8431.2000; Moll UM, 2001, FEBS LETT, V493, P65, DOI 10.1016/S0014-5793(01)02284-0; Murphy BJ, 1999, CANCER RES, V59, P1315; Nakielny S, 1996, J CELL BIOL, V134, P1365, DOI 10.1083/jcb.134.6.1365; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Pinol-Roma Serafin, 1993, Trends in Cell Biology, V3, P151, DOI 10.1016/0962-8924(93)90135-N; Politz JC, 2000, J STRUCT BIOL, V129, P252, DOI 10.1006/jsbi.2000.4227; Rodgers JT, 2000, ANAL BIOCHEM, V277, P254, DOI 10.1006/abio.1999.4394; Saavedra C, 1996, GENE DEV, V10, P1608, DOI 10.1101/gad.10.13.1608; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; STORY MD, 1993, CANCER CHEMOTH PHARM, V32, P129, DOI 10.1007/BF00685615; SUN DT, 1995, CANCER LETT, V89, P73, DOI 10.1016/0304-3835(95)90160-4; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Wang W, 2000, TOXICOL SCI, V56, P165, DOI 10.1093/toxsci/56.1.165; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141	37	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4147	4151		10.1074/jbc.M109785200	http://dx.doi.org/10.1074/jbc.M109785200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11741912	hybrid			2022-12-27	WOS:000173813900049
J	Wang, JY; Stuckey, JA; Wishart, MJ; Dixon, JE				Wang, JY; Stuckey, JA; Wishart, MJ; Dixon, JE			A unique carbohydrate binding domain targets the Lafora disease phosphatase to glycogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; AXILLA SKIN BIOPSY; PROTEIN PHOSPHATASE-1; 3T3-L1 ADIPOCYTES; SYNTHASE; GLUCOSE; SPECIFICITY; DIAGNOSIS; TRANSLOCATION; INSULIN	Lafora disease (progressive myoclonus epilepsy of Lafora type) is an autosomal recessive neurodegenerative disorder resulting from defects in the EPM2A gene. EPM2A encodes a 331-amino acid protein containing a carboxyl-terminal phosphatase catalytic domain. We demonstrate that the EPM2A gene product also contains an amino-terminal carbohydrate binding domain (CBD) and that the CBD is critical for association with glycogen both in vitro and in vivo. The CBD domain localizes the phosphatase to specific subcellular compartments that correspond to the expression pattern of glycogen processing enzyme, glycogen synthase. Mutations in the CBD result in mis-localization of the phosphatase and thereby suggest that the CBD targets laforin to intracellular glycogen particles where it is likely to function. Thus naturally occurring mutations within the CBD of laforin likely result in progressive myoclonus epilepsy due to mis-localization of phosphatase expression.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dixon, JE (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.							Brady MJ, 1999, J BIOL CHEM, V274, P27497, DOI 10.1074/jbc.274.39.27497; Brady MJ, 1997, J BIOL CHEM, V272, P29698, DOI 10.1074/jbc.272.47.29698; BUSARD BLSM, 1986, ARCH NEUROL-CHICAGO, V43, P296, DOI 10.1001/archneur.1986.00520030082023; BUSARD HLSM, 1987, ANN NEUROL, V21, P599, DOI 10.1002/ana.410210613; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; FernandezNovell JM, 1997, BIOCHEM J, V321, P227, DOI 10.1042/bj3210227; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Gomez-Garre P, 2000, EUR J HUM GENET, V8, P946, DOI 10.1038/sj.ejhg.5200571; IANNACCONE S, 1993, J NEUROL NEUROSUR PS, V56, P1339, DOI 10.1136/jnnp.56.12.1339-b; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karimipour D, 1999, J AM ACAD DERMATOL, V41, P790, DOI 10.1016/S0190-9622(99)70026-5; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2000, NEUROLOGY, V55, P341, DOI 10.1212/WNL.55.3.341; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Sauer J, 2000, BBA-PROTEIN STRUCT M, V1543, P275, DOI 10.1016/S0167-4838(00)00232-6; Serratosa J M, 1999, Adv Neurol, V79, P383; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; SVENSSON B, 1989, BIOCHEM J, V264, P309, DOI 10.1042/bj2640309; Taylor GS, 2001, ANAL BIOCHEM, V295, P122, DOI 10.1006/abio.2001.5179; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Wolfsdorf JI, 1999, ENDOCRIN METAB CLIN, V28, P801, DOI 10.1016/S0889-8529(05)70103-1	28	137	139	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	2002	277	4					2377	2380		10.1074/jbc.C100686200	http://dx.doi.org/10.1074/jbc.C100686200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514CY	11739371	hybrid			2022-12-27	WOS:000173421500003
J	Chapman, ALP; Hampton, MB; Senthilmohan, R; Winterbourn, CC; Kettle, AJ				Chapman, ALP; Hampton, MB; Senthilmohan, R; Winterbourn, CC; Kettle, AJ			Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOCHLOROUS ACID; HYDROGEN-PEROXIDE; TYROSYL RESIDUES; RESPIRATORY BURST; MYELOPEROXIDASE; OXIDANT; GLUTATHIONE; SUPEROXIDE; CELLS; GRANULOCYTES	Myeloperoxidase is proposed to play a central role in bacterial killing by generating hypochlorous acid within neutrophil phagosomes. However, it has yet to be demonstrated that these inflammatory cells target hypochlorous acid against bacteria inside phagosomes. In this investigation, we treated Staphylococcus aureus with varying concentrations of reagent hypochlorous acid and found that even at sublethal doses, it converted some tyrosine residues in their proteins to 3-chlorotyrosine and 3,5-dichlorotyrosine. To determine whether or not ingested bacteria were exposed to hypochlorous acid in neutrophil phagosomes, we labeled their proteins with [C-13(6)]tyrosine and used gas chromatography with mass spectrometry to identify the corresponding chlorinated isotopes after the bacteria had been phagocytosed. Chlorinated tyrosines were detected in bacterial proteins 5 min after phagocytosis and reached levels of approximately 2.5/1000 mol of tyrosine at 60 min. Inhibitor studies revealed that chlorination was dependent on myeloperoxidase. Chlorinated neutrophil proteins were also detected and accounted for 94% of total chlorinated tyrosine residues formed during phagocytosis. We conclude that hypochlorous acid is a major intracellular product of the respiratory burst. Although some reacts with the bacteria, most reacts with neutrophil components.	Christchurch Sch Med & Hlth Sci, Free Rad Res Grp, Dept Pathol, Christchurch, New Zealand	University of Otago	Kettle, AJ (corresponding author), Christchurch Sch Med & Hlth Sci, Free Rad Res Grp, Dept Pathol, POB 4345, Christchurch, New Zealand.	tony.kettle@chmeds.ac.nz	Kettle, Anthony J/A-8520-2008; Hampton, Mark B/A-8490-2008	Kettle, Anthony J/0000-0002-8218-7766; Hampton, Mark B/0000-0002-7349-3729				BECKSPEIER I, 1988, FEBS LETT, V227, P1, DOI 10.1016/0014-5793(88)81401-7; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Carr AC, 1997, BIOCHEM J, V327, P275, DOI 10.1042/bj3270275; CECH P, 1984, BLOOD, V63, P88; Chapman ALP, 2000, ARCH BIOCHEM BIOPHYS, V377, P95, DOI 10.1006/abbi.2000.1744; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; Fu SL, 2000, J BIOL CHEM, V275, P10851, DOI 10.1074/jbc.275.15.10851; GAZDA M, 1994, INORG CHEM, V33, P118, DOI 10.1021/ic00079a022; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HAMPTON MB, 1995, FREE RADICAL BIO MED, V18, P633, DOI 10.1016/0891-5849(94)00181-I; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; Hampton MB, 1999, J IMMUNOL METHODS, V232, P15, DOI 10.1016/S0022-1759(99)00147-7; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; Heinecke JW, 1999, METHOD ENZYMOL, V300, P124; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; JOINER KA, 1989, J CELL BIOL, V109, P2771, DOI 10.1083/jcb.109.6.2771; KARNOVSKY MJ, 1994, HISTOCHEMISTRY, V102, P15, DOI 10.1007/BF00271045; Kettle AJ, 1999, METHOD ENZYMOL, V300, P111; Kettle AJ, 1996, FEBS LETT, V379, P103, DOI 10.1016/0014-5793(95)01494-2; KETTLE AJ, 1994, J BIOL CHEM, V269, P17146; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; KETTLE AJ, 1993, BIOCHEM PHARMACOL, V45, P2003, DOI 10.1016/0006-2952(93)90010-T; Klebanoff S.J., 1999, INFLAMMATION BASIC P, P721; KLEBANOFF SJ, 1967, J EXP MED, V126, P1063, DOI 10.1084/jem.126.6.1063; LEHRER RI, 1992, CIBA F SYMP, V171, P276; LYMAR SV, 1995, CHEM RES TOXICOL, V8, P833, DOI 10.1021/tx00048a003; METCHNIKOFF E, 1968, IMMUNITY INFECT DIS; ODEBERG H, 1976, INFECT IMMUN, V14, P1276; Ogino T, 1997, FREE RADICAL BIO MED, V23, P445, DOI 10.1016/S0891-5849(97)00115-9; OHNO Y, 1985, J BIOL CHEM, V260, P8438; OLSZOWSKA E, 1989, INT J BIOCHEM, V21, P799, DOI 10.1016/0020-711X(89)90213-9; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; SEGAL AW, 1983, BIOCHEM J, V210, P215, DOI 10.1042/bj2100215; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; THOMAS EL, 1979, INFECT IMMUN, V23, P522, DOI 10.1128/IAI.23.2.522-531.1979; VISSERS MCM, 1995, BIOCHEM J, V307, P57, DOI 10.1042/bj3070057; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; YAZDANBAKHSH M, 1986, INFECT IMMUN, V53, P192, DOI 10.1128/IAI.53.1.192-198.1986; ZGLICZYNSKI JM, 1975, EUR J BIOCHEM, V56, P157, DOI 10.1111/j.1432-1033.1975.tb02218.x	43	156	157	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					9757	9762		10.1074/jbc.M106134200	http://dx.doi.org/10.1074/jbc.M106134200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11733505	hybrid			2022-12-27	WOS:000174549200023
J	Gibson, EM; Henson, ES; Villanueva, J; Gibson, SB				Gibson, EM; Henson, ES; Villanueva, J; Gibson, SB			MEK kinase 1 induces mitochondrial permeability transition leading to apoptosis independent of cytochrome c release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 PROTEIN FAMILY; CELL-DEATH; CASPASE ACTIVATION; EXPRESSION; RECEPTORS; MECHANISM; ETOPOSIDE; SURVIVAL; PATHWAYS	Induction of apoptosis often converges on the mitochondria to induce permeability transition and release of apoptotic proteins into the cytoplasm resulting in the biochemical and morphological alteration of apoptosis. Activation of a serine threonine kinase MEK kinase I (MEKK1) is involved in the induction of apoptosis. Expression of a kinase-inactive MEKK1 blocks genotoxin-induced apoptosis. Upon apoptotic stimulation, MEKK1 is cleaved into a 91-kDa kinase fragment that further induces an apoptotic response. Mutation of a consensus caspase 3 site in MEKK1 prevents its induction of apoptosis. The mechanism of MEKK1-induced apoptosis downstream of its cleavage, however, is unknown. Herein we demonstrate that full-length and cleaved MEKK1 leads to permeability transition in the mitochondria. This permeability transition occurs through opening of the permeability transition (PT) pore. Inhibiting PT pore opening and reactive oxygen species production effectively reduced MEKK1-induced apoptosis. Overexpression of MEKK1, however, failed to release cytochrome c from the mitochondria or activate caspase 9. Since 1102 regulates changes in mitochondria and blocks MEKK1-induced apoptosis, we determined that 1362 blocks MEKK1-induced apoptosis when targeted to the mitochondria. This occurs downstream of MEKK1 cleavage, since Bcl2 fails to block cleavage of MEKK1. In mouse embryonic fibroblast cells lacking caspase 3, the cleaved but not full-length MEKK1 induces apoptosis and permeability transition in the mitochondria. Overall, this suggests that cleaved MEKK1 leads to permeability transition contributing to MEKK1-induced apoptosis independent of cytochrome c release from the mitochondria.	Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Manitoba	Gibson, SB (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada.			Gibson, Spencer/0000-0003-0119-732X				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Annis MG, 2001, ONCOGENE, V20, P1939, DOI 10.1038/sj.onc.1204288; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cizeau J, 2000, ONCOGENE, V19, P5453, DOI 10.1038/sj.onc.1203929; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; Gibson S, 1999, J BIOL CHEM, V274, P10916, DOI 10.1074/jbc.274.16.10916; Gibson SB, 2000, MOL CELL BIOL, V20, P205, DOI 10.1128/MCB.20.1.205-212.2000; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Jarpe MB, 1998, ONCOGENE, V17, P1475, DOI 10.1038/sj.onc.1202183; Kumar S, 1999, CELL DEATH DIFFER, V6, P1060, DOI 10.1038/sj.cdd.4400600; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Lee ST, 1999, ONCOGENE, V18, P3520, DOI 10.1038/sj.onc.1202716; Loeffler M, 2000, EXP CELL RES, V256, P19, DOI 10.1006/excr.2000.4833; Mandic A, 2001, MOL CELL BIOL, V21, P3684, DOI 10.1128/MCB.21.11.3684-3691.2001; Morin D, 2001, ADV DRUG DELIVER REV, V49, P151, DOI 10.1016/S0169-409X(01)00132-6; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Weldon CB, 2001, SURGERY, V130, P143, DOI 10.1067/msy.2001.115512; Widmann C, 1997, ONCOGENE, V15, P2439, DOI 10.1038/sj.onc.1201421; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	36	15	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10573	10580		10.1074/jbc.M108366200	http://dx.doi.org/10.1074/jbc.M108366200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11756439	hybrid			2022-12-27	WOS:000174549200127
J	Sun, XQ; Yin, JP; Starovasnik, MA; Fairbrother, WJ; Dixit, VM				Sun, XQ; Yin, JP; Starovasnik, MA; Fairbrother, WJ; Dixit, VM			Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEATH DOMAIN; KINASE RIP; PYRIN DOMAIN; APOPTOSIS; RECRUITMENT; MEMBER; FAMILY	Receptor-interacting protein (RIP), a Ser/Thr kinase component of the tumor necrosis factor (TNF) receptor-1 signaling complex, mediates activation of the nuclear factor kappaB (NF-kappaB) pathway. RIP2 and RIP3 are related kinases that share extensive sequence homology with the kinase domain of RIP. Unlike RIP, which has a C-terminal death domain, and RIP2, which has a C-terminal caspase activation and recruitment domain, RIP3 possesses a unique C terminus. RIP3 binds RIP through this unique C-terminal segment to inhibit RIP- and TNF receptor-l-mediated NF-kappaB activation. We have identified a unique homotypic interaction motif at the C terminus of both RIP and RIP3 that is required for their association. Sixty-four amino acids within RIP3 and 88 residues within RIP are sufficient for interaction of the two proteins. This interaction is a prerequisite for RIP3-mediated phosphorylation of RIP and subsequent attenuation of TNF-induced NF-kappaB activation.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, M-S40,1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Dixit VM, 1999, COLD SPRING HARB SYM, V64, P359, DOI 10.1101/sqb.1999.64.359; Fairbrother WJ, 2001, PROTEIN SCI, V10, P1911, DOI 10.1110/ps.13801; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Navas TA, 1999, J BIOL CHEM, V274, P33684, DOI 10.1074/jbc.274.47.33684; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Pazdernik NJ, 1999, MOL CELL BIOL, V19, P6500; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	26	236	246	4	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9505	9511		10.1074/jbc.M109488200	http://dx.doi.org/10.1074/jbc.M109488200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11734559	hybrid			2022-12-27	WOS:000174400600103
J	Tone, M; Tone, Y; Babik, JM; Lin, CY; Waldmann, H				Tone, M; Tone, Y; Babik, JM; Lin, CY; Waldmann, H			The role of Sp1 and NF-kappa B in regulating CD40 gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DNA-BINDING ACTIVITY; TRANSCRIPTION FACTORS; PHOSPHORYLATION; ACTIVATION; CELL; INDUCTION; IMMUNITY; PATHWAYS; HELP	CD40 is a member of the tumor necrosis factor receptor superfamily and is a key signaling molecule expressed by antigen-presenting cells of the immune system. In a previous paper, we demonstrated that the expression of CD40 is regulated by both post-transcriptional and post-translational processes. In this paper, we show that basal (constitutive) CD40 gene expression is regulated by a TATA-less promoter, with Sp1 as a key transcription factor. Two Sp1 binding regions were identified in the mouse CD40 promoter at positions -59 to -50 and -74 to -66. Surprisingly, Sp1-mediated CD40 transcription was reduced following lipopolysaccharide stimulation and was associated with a time-dependent reduction in Sp1 DNA binding activity. This reduction seemed to be mediated by phosphorylation of the Sp1 molecule. We also show here that CD40 expression in lipopolysaccharide-stimulated cells is up-regulated by NF-kappaB through two distinct sites. One of these sites (- 128 to - 119) was shown to bind p50 and p65 members of the NF-kappaB family, while the other site (-562 to -553) bound only p65. Transfectants of p65 were generated using RAW 264 cells, and it was shown that the up-regulation of CD40 mRNA expression was dependent on the presence of the p65 molecule.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Tone, M (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		waldmann, herman/W-8051-2019; waldmann, herman/F-7412-2011	Lin, Chun-Yen/0000-0003-3007-3190; Waldmann, Herman/0000-0001-7519-6720				Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Hanissian SH, 1997, IMMUNITY, V6, P379, DOI 10.1016/S1074-7613(00)80281-2; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Leo E, 1999, J BIOL CHEM, V274, P22414, DOI 10.1074/jbc.274.32.22414; Lodie TA, 1997, J IMMUNOL, V158, P1848; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Martin B, 1999, NUCLEIC ACIDS RES, V27, P3402, DOI 10.1093/nar/27.17.3402; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nguyen VT, 2000, J BIOL CHEM, V275, P23674, DOI 10.1074/jbc.M002482200; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Scott DW, 1996, J IMMUNOL, V156, P2352; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Tone M, 2001, P NATL ACAD SCI USA, V98, P1751, DOI 10.1073/pnas.98.4.1751; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; Tsukamoto N, 1999, P NATL ACAD SCI USA, V96, P1234, DOI 10.1073/pnas.96.4.1234; VanKooten C, 1996, ADV IMMUNOL, V61, P1	25	59	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8890	8897		10.1074/jbc.M109889200	http://dx.doi.org/10.1074/jbc.M109889200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11751910	hybrid			2022-12-27	WOS:000174400600022
J	Francis, SC; Sunshine, C; Kirk, KL				Francis, SC; Sunshine, C; Kirk, KL			Coordinate regulation of catecholamine uptake by rab3 and phosphoinositide 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR MONOAMINE TRANSPORTER; PC12 NEUROENDOCRINE CELLS; CHROMAFFIN GRANULES; EPITHELIAL-CELLS; PROTEIN; VESICLES; STIMULATION; EXPRESSION; MUTANTS; STORAGE	Previously we observed that rab3 GTPases modulate both the secretion of catecholamines from PC12 neuroendocrine cells and the steady-state accumulation of exogenous norepinephrine (NE) into these cells (Weber, E., Jilling, T., and Kirk, K. L. (1996) J. Biol. Chem. 271, 6963-6971). Here we addressed the mechanisms by which these monomeric GTPases stimulate NE uptake by PC12 cells including their effects on uptake kinetics, their sites of action (secretory granule membrane versus plasma membrane), and the involvement of rab3-interacting proteins in this process. We observed that rab3B stimulated the rate and maximal accumulation of radiolabeled NE into large dense core vesicles within intact PC12 cells. rab3A and rab3B also increased NE uptake into large dense core vesicles in digitonin-permeabilized PC12 cells, which indicates that these GTPases stimulate catecholamine uptake at the level of the secretory granule membrane. In an attempt to identify rab3B targets that may mediate this effect on NE uptake, we found that rab3B interacts directly with phosphoinositide 3-kinase (PI3K) in a GTP-dependent fashion and that PI3K activity was elevated in PC12 cells overexpressing rab3B. Furthermore, two structurally distinct inhibitors of PI3K (wortmannin and LY294002) inhibited NE uptake in intact as well as digitonin-permeabilized PC12 cells, but had no effect on calcium-evoked NE secretion. Our results indicate that rab3 and PI3K positively and coordinately regulate NE uptake in PC12 neuroendocrine cells at least in part by stimulating the secretory vesicle uptake step.	Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Kirk, KL (corresponding author), Univ Alabama, Dept Physiol & Biophys, 982B MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.			Francis, Sharon/0000-0002-6586-6417				Ahnert-Hilger G, 1998, EMBO J, V17, P406, DOI 10.1093/emboj/17.2.406; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; BLAKELY RD, 1994, J EXP BIOL, V196, P263; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; BUCCI C, 1994, P NATL ACAD SCI USA, V91, P5061, DOI 10.1073/pnas.91.11.5061; Chung SH, 1999, J BIOL CHEM, V274, P18113, DOI 10.1074/jbc.274.25.18113; DESNOS C, 1995, J BIOL CHEM, V270, P16030, DOI 10.1074/jbc.270.27.16030; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KELLY R B, 1991, Current Opinion in Cell Biology, V3, P654, DOI 10.1016/0955-0674(91)90037-Y; KODAKI T, 1994, EUR J BIOCHEM, V219, P775, DOI 10.1111/j.1432-1033.1994.tb18557.x; LAUNAY JM, 1994, AM J PHYSIOL, V266, P526; Li GP, 1996, BIOCELL, V20, P325; NAKANISHI N, 1995, J BIOCHEM, V118, P291, DOI 10.1093/oxfordjournals.jbchem.a124905; NAKANISHI N, 1995, J NEUROCHEM, V64, P600; NAKANISHI S, 1995, CELL SIGNAL, V7, P545, DOI 10.1016/0898-6568(95)00033-L; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SIMONS K, 1993, NEURON, V11, P789, DOI 10.1016/0896-6273(93)90109-5; SIMONSEN A, 1998, NATURE, V394, P426; SMITH DB, 1991, CURRENT PROTOCOLS MO, V2; Sunshine C, 2000, EXP CELL RES, V257, P1, DOI 10.1006/excr.2000.4855; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Weber E, 1996, J BIOL CHEM, V271, P6963, DOI 10.1074/jbc.271.12.6963; WEBER E, 1994, J CELL BIOL, V125, P583, DOI 10.1083/jcb.125.3.583; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	33	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7816	7823		10.1074/jbc.M109743200	http://dx.doi.org/10.1074/jbc.M109743200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11748228	hybrid			2022-12-27	WOS:000174268000026
J	Grammatikakis, N; Vultur, A; Ramana, CV; Siganou, A; Schweinfest, CW; Watson, DK; Raptis, L				Grammatikakis, N; Vultur, A; Ramana, CV; Siganou, A; Schweinfest, CW; Watson, DK; Raptis, L			The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL COMMUNICATION; SEQUENCE-ANALYSIS; PLASMA-MEMBRANE; RAS; PROTEINS; RAF-1; KINASE; DIFFERENTIATION; PREADIPOCYTES; EXPRESSION	The 90-kDa heat shock protein (Hsp90), the target of the ansamycin class of anti-cancer drugs, is required for the conformational activation of a specific group of signal transducers, including Raf-1. In this report we have identified a 75-kDa Raf-associated protein as Hsp90N, a novel member of the Hsp90 family. Intriguingly, the ansamycin-binding domain is replaced in Hsp90N by a much shorter, hydrophobic sequence, preceded by a putative myristylation signal. We demonstrate that, although much less abundant, Hsp90N binds Raf with a higher affinity than Hsp90. In sharp contrast to Hsp90, Hsp90N does not associate with p50(cdc37), the Hsp90 kinase cofactor. Hsp90N was found to activate Raf in transiently transfected cells, while Rat F111 fibroblasts stably transfected with Hsp90N exhibited elevated activity of the Raf and downstream ERK kinases. This may be due to Raf binding to myristylated Hsp90N, followed by Raf translocation to the membrane. To examine whether Hsp90N could therefore substitute for Ras in Raf recruitment to the cell membrane, Hsp90N was transfected in c-Ras-deficient, 10T1/2-derived preadipocytes. Our results indicate that, as shown before for activated Ras or Raf, the introduction of even low levels of Hsp90N through transfection in c-Ras-deficient preadipocytes causes a dramatic block of differentiation. Higher levels of Hsp90N expression resulted in neoplastic transformation, including interruption of gap junctional, intercellular communication, and anchorage-independent proliferation. These results indicate that the observed activation of Raf by Hsp90N has a profound biological effect, which is largely c-Ras-independent. With the recent finding that p50(cdc37) is tumorigenic in transgenic mice, these results reinforce the intriguing observation that the family of heat shock proteins represents a novel class of molecules with oncogenic potential.	Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada; Cleveland Clin Fdn, Dept Mol Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Med Univ S Carolina, Lab Canc Genom, Charleston, SC 29425 USA	Queens University - Canada; Queens University - Canada; Cleveland Clinic Foundation; Medical University of South Carolina	Raptis, L (corresponding author), Queens Univ, Dept Microbiol & Immunol, Botterell Hall, Kingston, ON K7L 3N6, Canada.			Vultur, Adina/0000-0003-0068-9496; chilakamarti, ramana/0000-0002-5153-8252				AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Brownell HL, 1997, CANCER DETECT PREV, V21, P289; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Grammatikakis N, 2001, J BIOL CHEM, V276, P27840, DOI 10.1074/jbc.M101987200; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; MORRISON DK, 1995, MOL REPROD DEV, V42, P507, DOI 10.1002/mrd.1080420420; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Raptis L, 1997, CELL GROWTH DIFFER, V8, P11; Raptis L, 1997, EXP CELL RES, V235, P188, DOI 10.1006/excr.1997.3646; Raptis L, 1997, CELL GROWTH DIFFER, V8, P891; RAPTIS L, 2001, NEOPLASTIC TRANSFORM, P151; RAPTIS LH, 1994, DNA CELL BIOL, V13, P963, DOI 10.1089/dna.1994.13.963; Scheibel T, 1999, MOL MICROBIOL, V34, P701, DOI 10.1046/j.1365-2958.1999.01632.x; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schweinfest CW, 1998, BBA-GENE STRUCT EXPR, V1398, P18, DOI 10.1016/S0167-4781(98)00031-1; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; Smith DF, 1998, PHARMACOL REV, V50, P493; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X	31	79	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8312	8320		10.1074/jbc.M109200200	http://dx.doi.org/10.1074/jbc.M109200200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751906	hybrid			2022-12-27	WOS:000174268000089
J	McDermott, EP; O'Neill, LAJ				McDermott, EP; O'Neill, LAJ			Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE; SIGNAL-TRANSDUCTION PATHWAY; PROTEIN-KINASE; IL-1 RECEPTOR; KAPPA-B; INDUCTION; PHOSPHORYLATION; EXPRESSION; P21(RAS); CASCADE	Interleukin-1 (IL-1) activates p38 MAP kinase via the small G protein Ras, and this activity can be down-regulated by another small G protein Rap. Here we have further investigated the role of Ras and Rap in p38 MAPK activation by IL-1. Transient transfection of cells with constitutively active forms of the known IL-1 signaling components MyD88, IRAK, and TRAF-6, or the upstream kinases MKK6 and MKK3, activated p38 MAPK. Dominant negative forms of these were found to inhibit activation of p38 MAPK by IL-1. Dominant negative RasN17 blocked the effect of the active forms of all but MKK3 and MKK6, indicating that Ras lies downstream of TRAF-6 but upstream of MKK3 and MKK6 on the pathway. Furthermore, the activation of p38 MAPK caused by overexpressing active RasVHa could not be inhibited using dominant negative mutants of MyD88, IRAK, or IRAK-2, or TRAF6, but could be inhibited by dominant negative MKK3 or MKK6. In the same manner, the inhibitory effect of Rap on the activation of p38 by IL-1 occurred at a point downstream of MyD88, IRAK and TRAF6, since the activation of p38 MAPK by these components was inhibited by overexpressing active Rap1AV12, while neither MKK3 nor MKK6 were affected. Active RasVHa associated with IRAK, IRAK2, and TRAF6, but not MyD88. In addition we found a role for TAK-1 in the activation of p38 MAPK by IL-1, with TAK-1 also associating with active Ras. Our study suggests that upon activation Ras becomes associated with IRAK, Traf-6, and TAK-1, possibly aiding the assembly of this multiprotein signaling complex required for p38 MAPK activation by IL-1.	Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Biotechnol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland.			O'Neill, Luke/0000-0002-4333-2748				BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BIRD TA, 1991, BIOCHEM BIOPH RES CO, V177, P61, DOI 10.1016/0006-291X(91)91948-C; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Caunt CJ, 2001, J BIOL CHEM, V276, P6280, DOI 10.1074/jbc.M006772200; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; Hale KK, 1999, J IMMUNOL, V162, P4246; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Han JH, 1997, FEBS LETT, V403, P19, DOI 10.1016/S0014-5793(97)00021-5; Huang WY, 2001, CELL BIOL INT, V25, P309, DOI 10.1006/cbir.2000.0666; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; Iordanov M, 1997, EMBO J, V16, P1009, DOI 10.1093/emboj/16.5.1009; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; Matthews JS, 1999, CYTOKINE, V11, P643, DOI 10.1006/cyto.1998.0478; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; MOYNAGH PN, 1993, BIOCHEM J, V294, P343, DOI 10.1042/bj2940343; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Palsson EM, 2000, J BIOL CHEM, V275, P7818, DOI 10.1074/jbc.275.11.7818; PASTOR MI, 1995, IMMUNOL TODAY, V16, P159, DOI 10.1016/0167-5699(95)80134-0; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Rausch O, 1999, J BIOL CHEM, V274, P4096, DOI 10.1074/jbc.274.7.4096; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Thomas JA, 1999, J IMMUNOL, V163, P978; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; YOUNG P, 1993, AGENTS ACTIONS, V39, pC67, DOI 10.1007/BF01972723; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	53	92	100	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7808	7815		10.1074/jbc.M108133200	http://dx.doi.org/10.1074/jbc.M108133200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11744690	hybrid, Green Published			2022-12-27	WOS:000174268000025
J	Yaar, M; Zhai, S; Fine, RE; Eisenhauer, PB; Arble, BL; Stewart, KB; Gilchrest, BA				Yaar, M; Zhai, S; Fine, RE; Eisenhauer, PB; Arble, BL; Stewart, KB; Gilchrest, BA			Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NF-KAPPA-B; C-JUN; CHOLINERGIC NEURONS; INDUCED APOPTOSIS; ALZHEIMERS; EXPRESSION; IMMUNOREACTIVITY; TRANSDUCTION; INDUCTION	p75(NTR), a nerve growth factor co-receptor that has been implicated in apoptosis of neurons, is structurally related to Fas and the receptors for tumor necrosis factor-alpha that display ligand independent assembly into trimers. Using embryonic day 17 fetal rat cortical neurons and p75(NTR)-expressing NIH-3T3 cells, we now show that p75(NTR) exists as a trimer as well as a monomer. Furthermore, we have reported and others have confirmed that amyloid beta binds p75(NTR), and that this binding leads to apoptotic cell death. We now report that amyloid beta binds to trimers of p75(NTR) as well as to p75(NTR) monomers but not to the p140(trkA), the nerve growth factor co-receptor that mediates neuronal survival. Furthermore, amyloid beta activates p75(NTR), strongly inducing the transcription of c-Jun mRNA and stimulating the stress-activated c-Jun NH2-terminal kinase, as measured by phosphorylation of its substrate (glutathione S-transferase-c-Jun-(1-79)). Our data suggest that p75(NTR) may be present as a preformed trimer that binds amyloid beta to induce receptor activation, and support the hypothesis that p75(NTR) activation by amyloid beta is causally related to Alzheimer's disease.	Boston Univ, Sch Med, Dept Dermatol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; Vet Affairs Med Ctr, Bedford, MA 01730 USA	Boston University; Boston University; Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gilchrest, BA (corresponding author), Boston Univ, Sch Med, Dept Dermatol, J-508,609 Albany St, Boston, MA 02118 USA.	bgilchre@bu.edu						ADAMS RD, 1998, PRINCIPLES NEUROLOGY, pCH39; ANDERSON AJ, 1995, J NEUROCHEM, V65, P1487; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Boissiere F, 1997, DEMENT GERIATR COGN, V8, P1, DOI 10.1159/000106594; Boissiere F, 1996, MOL CHEM NEUROPATHOL, V28, P219, DOI 10.1007/BF02815225; Bothwell M, 1996, SCIENCE, V272, P506, DOI 10.1126/science.272.5261.506; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Frade JM, 1996, NATURE, V383, P166; GRAY CW, 1995, BRAIN RES, V691, P169, DOI 10.1016/0006-8993(95)00669-H; Hock C, 1998, NEUROSCI LETT, V241, P151, DOI 10.1016/S0304-3940(98)00019-6; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KERWIN JM, 1993, ACTA ANAT, V147, P216; KERWIN JM, 1992, NEUROSCI LETT, V143, P101, DOI 10.1016/0304-3940(92)90242-Y; Kondo T, 2000, J BIOL CHEM, V275, P7668, DOI 10.1074/jbc.275.11.7668; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Metsis M, 2001, CELL MOL LIFE SCI, V58, P1014, DOI 10.1007/PL00000916; MUFSON EJ, 1992, P NATL ACAD SCI USA, V89, P569, DOI 10.1073/pnas.89.2.569; Mufson EJ, 1997, EXP NEUROL, V146, P91, DOI 10.1006/exnr.1997.6504; MURASE K, 1993, BIOCHEM MOL BIOL INT, V30, P615; Niederhauser O, 2000, J NEUROSCI RES, V61, P263, DOI 10.1002/1097-4547(20000801)61:3<263::AID-JNR4>3.0.CO;2-M; Otten U, 2001, Prog Brain Res, V132, P545; RABIZADEH S, 1994, P NATL ACAD SCI USA, V91, P10703, DOI 10.1073/pnas.91.22.10703; ROLAND K, 1996, J BIOL CHEM, V271, P18032; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; RUBIN E, 1991, MOL PHARMACOL, V39, P697; SAWAI H, 1995, J BIOL CHEM, V270, P27326, DOI 10.1074/jbc.270.45.27326; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHERMAN ML, 1990, P NATL ACAD SCI USA, V87, P5663, DOI 10.1073/pnas.87.15.5663; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P4304; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; YAAR M, 1994, J CLIN INVEST, V94, P1550, DOI 10.1172/JCI117496; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yaar M, 1997, ARCH DERMATOL, V133, P1287, DOI 10.1001/archderm.133.10.1287; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yano H, 2000, Pharm Acta Helv, V74, P253, DOI 10.1016/S0031-6865(99)00036-9	41	131	136	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7720	7725		10.1074/jbc.M110929200	http://dx.doi.org/10.1074/jbc.M110929200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756426	hybrid			2022-12-27	WOS:000174268000015
J	Gopalan, V; Vioque, A; Altman, S				Gopalan, V; Vioque, A; Altman, S			RNase P: Variations and uses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EXTERNAL GUIDE SEQUENCES; HUMAN RIBONUCLEASE-P; ESCHERICHIA-COLI; GENE-EXPRESSION; PROTEIN SUBUNIT; MESSENGER-RNA; EFFECTIVE INHIBITION; CATALYTIC SUBUNIT; RIBOZYME; CLEAVAGE		Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain	Yale University; University System of Ohio; Ohio State University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Altman, S (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	sidney.altman@yale.edu	Vioque, Agustín/K-1809-2014	Vioque, Agustín/0000-0002-3975-7348	NIGMS NIH HHS [GM 19422] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019422, R37GM019422] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMAN S, 1993, FASEB J, V7, P7, DOI 10.1096/fasebj.7.1.7916700; ALTMAN S, 1993, P NATL ACAD SCI USA, V90, P10898, DOI 10.1073/pnas.90.23.10898; Altman S, 2000, RNA, V6, P1689, DOI 10.1017/S1355838200001783; Altman S., 1999, RNA WORLD, P351; Baum M, 1996, J MOL BIOL, V257, P43, DOI 10.1006/jmbi.1996.0145; Birikh KR, 1997, EUR J BIOCHEM, V245, P1, DOI 10.1111/j.1432-1033.1997.t01-3-00001.x; BRANCH AD, 1991, P NATL ACAD SCI USA, V88, P10163, DOI 10.1073/pnas.88.22.10163; BREN BT, 1999, P NATL ACAD SCI USA, V96, P10349; BROWN J, 2001, IN PRESS RNA; Brown JW, 1999, NUCLEIC ACIDS RES, V27, P314, DOI 10.1093/nar/27.1.314; Brown JW, 1996, P NATL ACAD SCI USA, V93, P3001, DOI 10.1073/pnas.93.7.3001; Cobaleda C, 2000, BLOOD, V95, P731, DOI 10.1182/blood.V95.3.731.003k28_731_737; DANG YL, 1993, J BIOL CHEM, V268, P19791; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Frank DN, 2000, RNA, V6, P1895, DOI 10.1017/S1355838200001461; Guerrier-Takada C, 2000, METHOD ENZYMOL, V313, P442; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; GuerrierTakada C, 1997, P NATL ACAD SCI USA, V94, P8468, DOI 10.1073/pnas.94.16.8468; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; Haas ES, 1998, NUCLEIC ACIDS RES, V26, P4093, DOI 10.1093/nar/26.18.4093; Harris JK, 2001, RNA, V7, P220, DOI 10.1017/S1355838201001777; Kapushoc ST, 2000, J BIOL CHEM, V275, P37907, DOI 10.1074/jbc.M007838200; Kirsebom LA, 1996, MOL BIOL REP, V22, P99, DOI 10.1007/BF00988713; Kren BT, 1998, NAT MED, V4, P285, DOI 10.1038/nm0398-285; Krummel DAP, 1999, P NATL ACAD SCI USA, V96, P11200, DOI 10.1073/pnas.96.20.11200; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; LEE JY, 1991, MOL CELL BIOL, V11, P721, DOI 10.1128/MCB.11.2.721; Lee YC, 1996, EUR J BIOCHEM, V235, P289, DOI 10.1111/j.1432-1033.1996.00289.x; Lewin AS, 2001, TRENDS MOL MED, V7, P221, DOI 10.1016/S1471-4914(01)01965-7; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Ma M, 2000, NAT BIOTECHNOL, V18, P58, DOI 10.1038/71924; Ma MYX, 1998, ANTISENSE NUCLEIC A, V8, P415; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Massire C, 1997, RNA, V3, P553; MCCLAIN WH, 1987, SCIENCE, V238, P527, DOI 10.1126/science.2443980; McKinney J, 2001, P NATL ACAD SCI USA, V98, P6605, DOI 10.1073/pnas.121180398; MORALES MJ, 1989, NUCLEIC ACIDS RES, V17, P6865, DOI 10.1093/nar/17.17.6865; MORALES MJ, 1992, P NATL ACAD SCI USA, V89, P9875, DOI 10.1073/pnas.89.20.9875; MORSE DP, 1992, GENE, V117, P61, DOI 10.1016/0378-1119(92)90490-G; NAKAMURA N, 1908, J BIOCHEM-TOKYO, V129, P755; NIEUWLANDT DT, 1991, J BIOL CHEM, V266, P5689; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Pascual A, 1999, FEBS LETT, V442, P7, DOI 10.1016/S0014-5793(98)01621-4; Pascual A, 1996, EUR J BIOCHEM, V241, P17, DOI 10.1111/j.1432-1033.1996.0017t.x; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Raj MLS, 2001, PLANT PHYSIOL, V125, P1187, DOI 10.1104/pp.125.3.1187; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Salavati R, 2001, MOL BIOCHEM PARASIT, V115, P109, DOI 10.1016/S0166-6851(01)00273-0; SCHEDL P, 1973, P NATL ACAD SCI USA, V70, P2091, DOI 10.1073/pnas.70.7.2091; Shevelev E L, 1995, DNA Res, V2, P231, DOI 10.1093/dnares/2.5.231; Tanabe T, 2000, NATURE, V406, P473, DOI 10.1038/35020190; Thomas BC, 2000, RNA, V6, P545, DOI 10.1017/S1355838200991465; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Trang P, 2000, J MOL BIOL, V301, P817, DOI 10.1006/jmbi.2000.4022; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; van Eenennaam H, 2001, J BIOL CHEM, V276, P31635, DOI 10.1074/jbc.M103399200; van Eenennaam H, 2000, IUBMB LIFE, V49, P265; WANG MJ, 1988, EMBO J, V7, P1567, DOI 10.1002/j.1460-2075.1988.tb02981.x; Warashina M, 2001, P NATL ACAD SCI USA, V98, P5572, DOI 10.1073/pnas.091411398; WARASHINA M, 1999, COMPREHENSIVE NATURA, V6, P235; WISE CA, 1991, J BIOL CHEM, V266, P19154; Xiao SH, 2001, J CELL PHYSIOL, V187, P11, DOI 10.1002/1097-4652(200104)187:1<11::AID-JCP1055>3.0.CO;2-K; Yen LS, 2001, J NEUROCHEM, V76, P1386, DOI 10.1046/j.1471-4159.2001.00153.x; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006	68	84	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6759	6762		10.1074/jbc.R100067200	http://dx.doi.org/10.1074/jbc.R100067200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741968	hybrid, Green Published			2022-12-27	WOS:000174104300001
J	Merkel, M; Heeren, J; Dudeck, W; Rinninger, F; Radner, H; Breslow, JL; Goldberg, IJ; Zechner, R; Greten, H				Merkel, M; Heeren, J; Dudeck, W; Rinninger, F; Radner, H; Breslow, JL; Goldberg, IJ; Zechner, R; Greten, H			Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL it also increases triglyceride hydrolysis and whole particle lipoprotein uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; TRANSGENIC MICE; HEPATIC LIPASE; TERMINAL FRAGMENT; CATALYTIC TRIAD; MEDIATED UPTAKE; CARDIAC-MUSCLE; MESSENGER-RNA; CELLS; METABOLISM	We have previously shown that transgenic expression of catalytically inactive lipoprotein lipase (LPL) in muscle (Mck-N-LPL) enhances triglyceride hydrolysis as well as whole particle lipoprotein and selective cholesterol ester uptake. In the current study, we have examined whether these functions can be performed by inactive LPL alone or require the presence of active LPL expressed in the same tissue. To study inactive LPL in the presence of active LPL in the same tissue, the Mck-N-LPL transgene was bred onto the heterozygous LPL-deficient (LPL1) background. At 18 h of age, Mck-N-LPL reduced triglycerides by 35% and markedly increased muscle lipid droplets. In adult mice, it reduced triglycerides by 40% and increased lipoprotein particle uptake into muscle by 60% and cholesterol ester uptake by 110%. To study inactive LPL alone, the Mck-N-LPL transgene was bred onto the LPL-deficient (LPL0) background. These mice die at similar to24 h of age. At 18 h of age, in the absence of active LPL, inactive LPL expression did not diminish triglycerides nor did it result in the accumulation of muscle lipid droplets. To study inactive LPL in the absence of active LPL in the same tissue in adult animals, the Mck-N-LPL transgene was bred onto mice that only expressed active LPL in the heart (LPLO/HeLPL). In this case, Mck-N-LPL did not reduce triglycerides or increase the uptake of lipoprotein particles but did increase muscle uptake of chylomicron and very low density lipoprotein cholesterol ester by 40%. Thus, in the presence of active LPL in the same tissue, inactive LPL augments triglyceride hydrolysis and increases whole particle triglyceride-rich lipoprotein and selective cholesterol ester uptake. In the absence of active LPL in the same tissue, inactive LPL only mediates selective cholesterol ester uptake.	Univ Hamburg, Hosp Eppendorf, Dept Med, D-20246 Hamburg, Germany; Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany; Karl Franzens Univ Graz, Inst Mol Biol Biochem & Microbiol, A-8010 Graz, Austria; Rockefeller Univ, Biochem Genet & Metab Lab, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA	University of Hamburg; University of Bonn; University of Graz; Rockefeller University; Columbia University	Merkel, M (corresponding author), Univ Hamburg, Hosp Eppendorf, Dept Internal Med, Martinistr 52, D-20246 Hamburg, Germany.		Breslow, Jan L/B-7544-2008	Zechner, Rudolf/0000-0001-5483-1182; Merkel, Martin/0000-0002-2850-5110				BEISIEGEL U, 1995, CURR OPIN LIPIDOL, V6, P117, DOI 10.1097/00041433-199506000-00002; CHAJEK T, 1977, ATHEROSCLEROSIS, V26, P549, DOI 10.1016/0021-9150(77)90122-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLEMAN T, 1995, J BIOL CHEM, V270, P12518, DOI 10.1074/jbc.270.21.12518; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; EMMERICH J, 1992, J BIOL CHEM, V267, P4161; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; Goldberg IJ, 1996, J LIPID RES, V37, P693; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; KRAPP A, 1995, J LIPID RES, V36, P2362; Levak-Frank S, 1999, P NATL ACAD SCI USA, V96, P3165, DOI 10.1073/pnas.96.6.3165; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; Lutz EP, 2001, J CLIN INVEST, V107, P1183, DOI 10.1172/JCI11774; MA YH, 1992, J BIOL CHEM, V267, P1918; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; MULDER M, 1993, J BIOL CHEM, V268, P9369; Nordestgaard BG, 1996, CURR OPIN LIPIDOL, V7, P269, DOI 10.1097/00041433-199610000-00002; NYKJAER A, 1994, J BIOL CHEM, V269, P31747; OBRIEN KD, 1992, J CLIN INVEST, V89, P1544, DOI 10.1172/JCI115747; OBUNIKE JC, 1994, J BIOL CHEM, V269, P13129; OLIVECRONA G, 1995, CURR OPIN LIPIDOL, V6, P291, DOI 10.1097/00041433-199510000-00009; Pang L, 1996, J BIOL CHEM, V271, P19518, DOI 10.1074/jbc.271.32.19518; Pittman R C, 1986, Methods Enzymol, V129, P612; Rinninger F, 1998, ATHEROSCLEROSIS, V141, P273, DOI 10.1016/S0021-9150(98)00181-6; Rinninger F, 1998, J LIPID RES, V39, P1335; Rinninger F, 2001, J LIPID RES, V42, P1740; Rutledge JC, 1997, CIRC RES, V80, P819; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; Saxena Uday, 1994, Current Opinion in Lipidology, V5, P316, DOI 10.1097/00041433-199410000-00002; Semenkovich CF, 1998, J LIPID RES, V39, P1141; SEMENKOVICH CF, 1989, J LIPID RES, V30, P423; Seo T, 2000, J BIOL CHEM, V275, P30355, DOI 10.1074/jbc.M910327199; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Wong H, 1997, METHOD ENZYMOL, V284, P171; YACOUB LK, 1990, J LIPID RES, V31, P1845; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P10143, DOI 10.1073/pnas.88.22.10143	41	77	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7405	7411		10.1074/jbc.M107914200	http://dx.doi.org/10.1074/jbc.M107914200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751882	hybrid			2022-12-27	WOS:000174104300085
J	Pastorino, JG; Shulga, N; Hoek, JB				Pastorino, JG; Shulga, N; Hoek, JB			Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION PORE; BCL-2 FAMILY PROTEINS; CELL-DEATH; BENZODIAZEPINE RECEPTOR; MAMMALIAN HEXOKINASE; BOUND HEXOKINASE; CANCER-CELLS; VDAC; METABOLISM	Proapoptotic proteins such as Bax, undergo translocation to the mitochondria during apoptosis, where they mediate the release of intermembrane space proteins including cytochrome c. Bax binds to the voltage-dependent anion channel (VDAC). VDAC is a beta-barrel protein located in the outer mitochondrial membrane. In planar lipid bilayers, Bax and VDAC form a channel through which cytochrome c can pass. Hexokinase II (HXK II) also binds to VDAC. HXK II catalyzes the first step of glycolysis and is highly expressed in transformed cells, where over 70% of it is bound to the mitochondria. The present study demonstrates that HXK II interferes with the ability of Bax to bind to mitochondria an release cytochrome c. Detachment of HXK II from the mitochondria-enriched fraction isolated from HeLa cells promoted the binding of recombinant Bax-Delta19 and subsequent cytochrome c release. Similarly, the addition of recombinant HXK II to the mitochondria-enriched fraction isolated from hepatocytes, cells that do not express HXK II endogenously, prevented the ability of recombinant Bax-Delta19 to bind to the mitochondria and promote cytochrome c release. Similar results were found in intact cells, in which the detachment of mitochondrial bound HXK II or its overexpression potentiated and inhibited, respectively, Bax-induced mitochondrial dysfunction and cell death.	Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Pastorino, JG (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 269,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.			Hoek, Jan/0000-0001-7127-4218	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA000330] Funding Source: NIH RePORTER; NIAAA NIH HHS [1K01 AA 00330-01] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AKAO Y, 1991, CANCER RES, V51, P1574; Ardehali H, 1999, J BIOL CHEM, V274, P15986, DOI 10.1074/jbc.274.23.15986; ARORA KK, 1988, J BIOL CHEM, V263, P17422; Bathori G, 1998, BIOCHEM BIOPH RES CO, V243, P258, DOI 10.1006/bbrc.1997.7926; BECKER B, 1994, ANAL BIOCHEM, V221, P78, DOI 10.1006/abio.1994.1382; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Bustamente E, 1977, Adv Exp Med Biol, V92, P363; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Colombini M, 1996, Ion Channels, V4, P169; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; FANCIULLI M, 1994, ONCOL RES, V6, P405; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; FORTE M, 1987, J MEMBRANE BIOL, V99, P65, DOI 10.1007/BF01870622; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; GRIFFIN LD, 1991, GENOMICS, V11, P1014, DOI 10.1016/0888-7543(91)90027-C; Hashimoto M, 2000, ARCH BIOCHEM BIOPHYS, V384, P163, DOI 10.1006/abbi.2000.2085; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Mannella CA, 1997, J BIOENERG BIOMEMBR, V29, P525, DOI 10.1023/A:1022489832594; MANNELLA CA, 1992, J BIOENERG BIOMEMBR, V24, P7, DOI 10.1007/BF00769525; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Marchetti P, 1996, J IMMUNOL, V157, P4830; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; MCENERY MW, 1992, J BIOENERG BIOMEMBR, V24, P63, DOI 10.1007/BF00769532; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Montessuit S, 1999, PROTEIN EXPRES PURIF, V15, P202, DOI 10.1006/prep.1998.1010; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Pastorino JG, 1996, J BIOL CHEM, V271, P29792, DOI 10.1074/jbc.271.47.29792; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Qin ZH, 2001, J BIOL CHEM, V276, P8079, DOI 10.1074/jbc.M007028200; Reed JC, 1996, J CELL BIOCHEM, V60, P23, DOI 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3; Rempel A, 1996, CANCER RES, V56, P2468; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wilson MR, 1998, CELL DEATH DIFFER, V5, P646, DOI 10.1038/sj.cdd.4400394; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	56	538	558	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7610	7618		10.1074/jbc.M109950200	http://dx.doi.org/10.1074/jbc.M109950200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751859	hybrid			2022-12-27	WOS:000174104300108
J	Soti, C; Racz, A; Csermely, P				Soti, C; Racz, A; Csermely, P			A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90 - N-terminal nucleotide binding unmasks a C-terminal binding pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; AFFINITY CLEAVAGE; CHAPERONE; HYDROLYSIS; INHIBITION; RADICICOL; SITE; IDENTIFICATION; GELDANAMYCIN; NOVOBIOCIN	In vivo function of the molecular chaperone Hsp90 is ATP-dependent and requires the full-length protein. Our earlier studies predicted a second C-terminal ATP-binding site in Hsp90. By applying direct biochemical approaches, we mapped two ATP-binding sites and unveiled the C-terminal ATP-binding site as the first example of a cryptic chaperone nucleotide-binding site, which is opened by occupancy of the N-terminal site. We identified an N-terminal gamma-phosphate-binding motif in the middle domain of Hsp90 similar to other GHKL family members. This motif is adjacent to the phosphate-binding region of the C-terminal ATP-binding site. Whereas novobiocin disrupts both C- and N-terminal nucleotide binding, we found a selective C-terminal nucleotide competitor, cisplatin, that strengthens the Hsp90-Hsp70 complex leaving the Hsp90-p23 complex intact. Cisplatin may provide a pharmacological tool to dissect C- and N-terminal nucleotide binding of Hsp90. A model is proposed on the interactions of the two nucleotide-binding domains and the charged region of Hsp90.	Semmelweis Univ, Dept Med Chem, H-1444 Budapest, Hungary	Semmelweis University	Csermely, P (corresponding author), Semmelweis Univ, Dept Med Chem, POB 260, H-1444 Budapest, Hungary.	csermely@puskin.sote.hu	Csermely, Peter/J-2067-2017; Sőti, Csaba/O-6070-2017	Csermely, Peter/0000-0001-9234-0659; Sőti, Csaba/0000-0002-4057-7678; Racz, Attila/0000-0002-5952-8294				ALONSO E, 1995, EUR J BIOCHEM, V229, P377, DOI 10.1111/j.1432-1033.1995.tb20478.x; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; BISWAS SB, 1984, J BIOL CHEM, V259, P7990; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chadli A, 1999, J BIOL CHEM, V274, P4133, DOI 10.1074/jbc.274.7.4133; CSERMELY P, 1991, J BIOL CHEM, V266, P4943; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; CSERMELY P, 1993, J BIOL CHEM, V268, P1901; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Hartson SD, 1999, BIOCHEMISTRY-US, V38, P3837, DOI 10.1021/bi983027s; Itoh H, 1999, BIOCHEM J, V343, P697, DOI 10.1042/0264-6021:3430697; Johnson BD, 2000, J BIOL CHEM, V275, P32499, DOI 10.1074/jbc.M005195200; Jordan P, 2000, CELL MOL LIFE SCI, V57, P1229, DOI 10.1007/PL00000762; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Maruya M, 1999, J MOL BIOL, V285, P903, DOI 10.1006/jmbi.1998.2349; MATTHEWS RC, 1991, IMMUNOLOGY, V74, P20; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Nardai G, 2000, ARCH BIOCHEM BIOPHYS, V384, P59, DOI 10.1006/abbi.2000.2075; Nemoto T, 1997, J BIOL CHEM, V272, P26179, DOI 10.1074/jbc.272.42.26179; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Ouimet PM, 1999, BIOCHEM CELL BIOL, V77, P89, DOI 10.1139/bcb-77-2-89; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Scheibel T, 1997, J BIOL CHEM, V272, P18608, DOI 10.1074/jbc.272.30.18608; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Scheibel T, 1999, MOL MICROBIOL, V34, P701, DOI 10.1046/j.1365-2958.1999.01632.x; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Soga S, 1998, J BIOL CHEM, V273, P822, DOI 10.1074/jbc.273.2.822; Soti C, 1998, EUR J BIOCHEM, V255, P611, DOI 10.1046/j.1432-1327.1998.2550611.x; Soti C, 1998, J BIOSCIENCE, V23, P347, DOI 10.1007/BF02936127; SOUNDAR S, 1993, J BIOL CHEM, V268, P5264; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7	52	188	197	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7066	7075		10.1074/jbc.M105568200	http://dx.doi.org/10.1074/jbc.M105568200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751878	Green Submitted, hybrid			2022-12-27	WOS:000174104300042
J	Dos Reis, S; Coulary-Salin, B; Forge, V; Lascu, I; Begueret, J; Saupe, SJ				Dos Reis, S; Coulary-Salin, B; Forge, V; Lascu, I; Begueret, J; Saupe, SJ			The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROKARYON INCOMPATIBILITY; SACCHAROMYCES-CEREVISIAE; IN-VITRO; INHERITANCE; EVOLUTION; DISEASE; URE2P; SUP35; YEAST; GENE	The HET-s protein of Podospora anserina is a fungal prion. This protein behaves as an infectious cytoplasmic element that is transmitted horizontally from one strain to another. Under the prion form, the HET-s protein forms aggregates in vivo. The specificity of this prion model compared with the yeast prions resides in the fact that under the prion form HET-s causes a growth inhibition and cell death reaction when co-expressed with the HET-S protein from which it differs by 13 residues. Herein we describe the purification and initial characterization of recombinant HET-s protein expressed in Escherichia coli. The HET-s protein self-associates over time into high molecular weight aggregates. These aggregates greatly accelerate precipitation of the soluble form. HET-s aggregates appear as amyloid-like fibrils using electron microscopy. They bind Congo Red and show birefringence under polarized light. In the aggregated form, a HET-s fragment of similar to7 kDa is resistant to proteinase K digestion. CD and FTIR analyses indicate that upon transition to the aggregated state, the HET-s protein undergoes a structural rearrangement characterized by an increase in antiparallel beta-sheet structure content. These results suggest that the [Het-s] prion element propagates in vivo as an infectious amyloid.	Univ Bordeaux 2, CNRS,UMR 5095, Lab Genet Mol Champignons, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France; Univ Bordeaux 2, CNRS,UMR 5095, Lab Enzymol Mol, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France; CEA Grenoble, Dept Biol Mol & Structurale, UMR 5090, Lab Biophys Mol & Cellulaire, F-38054 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CEA	Saupe, SJ (corresponding author), Univ Bordeaux 2, CNRS,UMR 5095, Lab Genet Mol Champignons, Inst Biochim & Genet Cellulaires, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	sven.saupe@ibgc.u-bordeaux2.fr		Dos Reis, Suzana/0000-0002-9117-7316; saupe, sven/0000-0002-5589-721X				Beisson-Schecroun J, 1962, ANN GENET-PARIS, V4, P3; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Coustou-Linares V, 2001, MOL MICROBIOL, V42, P1325, DOI 10.1046/j.1365-2958.2001.02707.x; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Nielsen EH, 1999, METHOD ENZYMOL, V309, P491; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; TURCQ B, 1990, CURR GENET, V17, P297, DOI 10.1007/BF00314876; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999	20	88	90	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5703	5706		10.1074/jbc.M110183200	http://dx.doi.org/10.1074/jbc.M110183200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11733532	hybrid, Green Submitted			2022-12-27	WOS:000173989200002
J	Davies, TH; Ning, YM; Sanchez, ER				Davies, TH; Ning, YM; Sanchez, ER			A new first step in activation of steroid receptors - Hormone-induced switching of FKBP51 and FKBP52 immunophilins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; TETRATRICOPEPTIDE REPEAT DOMAIN; GLUCOCORTICOID-RECEPTOR; PROGESTERONE-RECEPTOR; HSP90; ASSOCIATION; HSP56; IDENTIFICATION; COMPONENT; COMPLEX	We have identified a new first step in the hormonal activation of the glucocorticoid receptor (GR). Rather than causing immediate dissociation of the cytoplasmic GR heterocomplex, binding of hormone-induced substitution of one immunophilin (FKBP51) for another (FKBP52), and concomitant recruitment of the transport protein dynein while leaving Hsp90 unchanged. Immunofluorescence and fractionation revealed hormone-induced translocation of the hormone-generated GR(.)Hsp90(.)FKBP52(.)dynein complex from cytoplasm to nucleus, a step that precedes dissociation of the complex within the nucleus and conversion of GR to the DNA-binding form. Taken as a whole, these studies identify immunophilin interchange as the earliest known event in steroid receptor signaling and provide the first evidence of differential roles for FKBP51 and FKBP52 immunophilins in the control of steroid receptor subcellular localization and transport.	Med Coll Ohio, Dept Pharmacol, Toledo, OH 43614 USA		Sanchez, ER (corresponding author), Med Coll Ohio, Dept Pharmacol, 3035 Arlington Ave, Toledo, OH 43614 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043867, R01DK043867] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK043867, DK43867] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BODWELL JE, 1991, J BIOL CHEM, V266, P7549; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; GUIOCHONMANTEL A, 1991, EMBO J, V10, P3851, DOI 10.1002/j.1460-2075.1991.tb04954.x; INANOBE A, 1994, J BIOCHEM, V115, P486, DOI 10.1093/oxfordjournals.jbchem.a124363; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; MADAN AP, 1993, P NATL ACAD SCI USA, V90, P3588, DOI 10.1073/pnas.90.8.3588; MENDEL DB, 1986, J BIOL CHEM, V261, P3758; MESHINCHI S, 1990, J BIOL CHEM, V265, P4863; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; OWENSGRILLO JK, 1995, J BIOL CHEM, V270, P20479, DOI 10.1074/jbc.270.35.20479; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; RADANYI C, 1994, P NATL ACAD SCI USA, V91, P11197, DOI 10.1073/pnas.91.23.11197; RATAJCZAK T, 1993, J BIOL CHEM, V268, P13187; REXIN M, 1992, J BIOL CHEM, V267, P9619; RUFF VA, 1992, J BIOL CHEM, V267, P21285; SANCHEZ ER, 1987, J BIOL CHEM, V262, P6986; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; TAI PKK, 1992, SCIENCE, V256, P1315, DOI 10.1126/science.1376003; TSUBUKI S, 1994, FEBS LETT, V344, P229, DOI 10.1016/0014-5793(94)00388-2; Wadekar SA, 2001, MOL ENDOCRINOL, V15, P1396, DOI 10.1210/me.15.8.1396; YEM AW, 1992, J BIOL CHEM, V267, P2868; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	23	308	321	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4597	4600		10.1074/jbc.C100531200	http://dx.doi.org/10.1074/jbc.C100531200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11751894	hybrid			2022-12-27	WOS:000173962900007
J	Jeanson, L; Mouscadet, JF				Jeanson, L; Mouscadet, JF			Ku represses the HIV-1 transcription - Identification of a putative Ku binding site homologous to the mouse mammary tumor virus Nre1 sequence in the HIV-1 long terminal repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; NF-KAPPA-B; DNA-BINDING; V(D)J RECOMBINATION; T-ANTIGEN; AUTOANTIGEN; ELEMENT; ACTIVATION; PURIFICATION	Ku has been implicated in nuclear processes, including DNA break repair, transcription, V(D)J recombination, and telomere maintenance. Its mode of action involves two distinct mechanisms: one in which a nonspecific binding occurs to DNA ends and a second that involves a specific binding to negative regulatory elements involved in transcription repression. Such elements were identified in mouse mammary tumor virus and human T cell leukemia virus retroviruses. The purpose of this study was to investigate a role for Ku in the regulation of human immunodeficiency virus (HIV)-1 transcription. First, HIV-1 LTR activity was studied in CHO-K1 cells and in CHO-derived xrs-6 cells, which are devoid of Ku80. LTR-driven expression of a reporter gene was significantly increased in xrs-6 cells. This enhancement was suppressed after re-expression of Ku80. Second, transcription of HIV-1 was followed in U1 human cells that were depleted in Ku by using a Ku80 antisense RNA. Ku depletion led to a increase of both HIV-1 mRNA synthesis and viral production compared with the parent cells. These results demonstrate that Ku acts as a transcriptional repressor of HIV-1 expression. Finally, a putative Ku-specific binding site was identified within the negative regulatory region of the HIV-1 long terminal repeat, which may account for this repression of transcription.	Inst Gustave Roussy, CNRS, UMR8532, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy	Mouscadet, JF (corresponding author), Inst Gustave Roussy, CNRS, UMR8532, PR2,39 Rue Camille Desmoulins, F-94805 Villejuif, France.	jfm@igr.fr						Baekelandt V, 2000, J VIROL, V74, P11278, DOI 10.1128/JVI.74.23.11278-11285.2000; Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; CHEN YR, 1991, J VIROL, V65, P5131, DOI 10.1128/JVI.65.10.5131-5140.1991; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; DICROCE PA, 1995, P NATL ACAD SCI USA, V92, P10137, DOI 10.1073/pnas.92.22.10137; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; FALZON M, 1991, MOL CELL BIOL, V11, P117, DOI 10.1128/MCB.11.1.117; Featherstone C, 1999, CURR BIOL, V9, pR759, DOI 10.1016/S0960-9822(00)80005-6; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Galande S, 2000, CRIT REV EUKAR GENE, V10, P63; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; GENERSCH E, 1995, EMBO J, V14, P791, DOI 10.1002/j.1460-2075.1995.tb07057.x; GETTS RC, 1994, J BIOL CHEM, V269, P15981; Giampuzzi M, 2000, J BIOL CHEM, V275, P36341, DOI 10.1074/jbc.M003362200; Giffin W, 1999, MOL CELL BIOL, V19, P4065; Giffin W, 1995, DNA CELL BIOL, V14, P1025, DOI 10.1089/dna.1995.14.1025; Giffin W, 1997, J BIOL CHEM, V272, P5647, DOI 10.1074/jbc.272.9.5647; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Hoover T, 1996, NUCLEIC ACIDS RES, V24, P1895, DOI 10.1093/nar/24.10.1895; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; Kameoka M, 1999, BIOCHEM BIOPH RES CO, V262, P285, DOI 10.1006/bbrc.1999.1146; KIM D, 1995, J BIOL CHEM, V270, P15277, DOI 10.1074/jbc.270.25.15277; KNUTH MW, 1990, J BIOL CHEM, V265, P17911; KUHN A, 1993, NUCLEIC ACIDS RES, V21, P2057, DOI 10.1093/nar/21.9.2057; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Liu YZ, 1997, BIOCHEM J, V322, P155, DOI 10.1042/bj3220155; Majumder S, 1999, J BIOL CHEM, V274, P28584, DOI 10.1074/jbc.274.40.28584; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Marangoni E, 2000, CANCER GENE THER, V7, P339, DOI 10.1038/sj.cgt.7700111; MAY G, 1991, J BIOL CHEM, V266, P3052; MESSIER H, 1993, P NATL ACAD SCI USA, V90, P2685, DOI 10.1073/pnas.90.7.2685; MIMORI T, 1981, J CLIN INVEST, V68, P611, DOI 10.1172/JCI110295; MIMORI T, 1986, J BIOL CHEM, V261, P375; MOROZOV VE, 1994, J BIOL CHEM, V269, P16684; Myung K, 1998, P NATL ACAD SCI USA, V95, P7664, DOI 10.1073/pnas.95.13.7664; Myung K, 1997, EMBO J, V16, P3172, DOI 10.1093/emboj/16.11.3172; Nishishita T, 1998, J BIOL CHEM, V273, P10901, DOI 10.1074/jbc.273.18.10901; Ochem AE, 1997, J BIOL CHEM, V272, P29919, DOI 10.1074/jbc.272.47.29919; OKUMURA K, 1994, FEBS LETT, V356, P94, DOI 10.1016/0014-5793(94)01243-1; Pedley J, 1998, MELANOMA RES, V8, P471, DOI 10.1097/00008390-199812000-00001; Petroski MD, 1998, J VIROL, V72, P8181, DOI 10.1128/JVI.72.10.8181-8190.1998; ROSEN CA, 1985, CELL, V41, P813, DOI 10.1016/S0092-8674(85)80062-3; Sadji Z, 2000, CELL SIGNAL, V12, P745, DOI 10.1016/S0898-6568(00)00126-1; Schild-Poulter C, 2001, J BIOL CHEM, V276, P16848, DOI 10.1074/jbc.M100768200; Shen HX, 1998, BBA-GEN SUBJECTS, V1381, P131, DOI 10.1016/S0304-4165(98)00020-8; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; Singleton BK, 1997, MOL CELL BIOL, V17, P1264, DOI 10.1128/MCB.17.3.1264; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Soubeyrand S, 2001, P NATL ACAD SCI USA, V98, P9605, DOI 10.1073/pnas.171211398; Warriar N, 1996, J BIOL CHEM, V271, P18662, DOI 10.1074/jbc.271.31.18662	56	32	34	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4918	4924		10.1074/jbc.M110830200	http://dx.doi.org/10.1074/jbc.M110830200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733502	hybrid			2022-12-27	WOS:000173962900050
J	Tsai, CD; Liu, HW; Tai, JH				Tsai, CD; Liu, HW; Tai, JH			Characterization of an iron-responsive promoter in the protozoan pathogen Trichomonas vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; MOLECULAR CHARACTERIZATION; ADHESION PROTEINS; GIARDIA-LAMBLIA; GENE-EXPRESSION; C-MYB; CYTOADHERENCE; SEQUENCES; HOST; PHOSPHORYLATION	Iron has been shown to regulate transcription in the protozoan pathogen Trichomonas vaginalis. In this study, a DNA transfection system was developed to monitor ap65-1 promoter activity in response to changing iron supply. In conjunction with electrophoretic mobility shift assay, iron-induced transcription of the ap65-1 gene was shown to be regulated by multiple closely spaced DNA elements spanning an iron-responsive region (-110/-54), including an iron-responsive DNA element ((-98)AGATAACGA(-90)), which overlaps with a 3'-MYB-like protein binding sequence ((-95)TAACGATAT(-87)), and three nearby T-rich sequences ((-110)ATTTTT(-105), (-78)ATTATT(-73), and (-59)ATTTTT(-54)). 5'- and 3'-flanking sequences of the iron-responsive region were shown to regulate basal transcription. A distal DNA regulatory region was shown to enhance both basal and iron-induced transcription. These findings delineate the DNA regulatory elements and nuclear proteins involving in iron-induced transcription of the ap65-1 gene, which provide useful tools for the future study of transcriptional regulation in T. vaginalis.	Acad Sinica, Inst Biomed Sci, Div Infect Dis, Taipei 11529, Taiwan; Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Tai, JH (corresponding author), Acad Sinica, Inst Biomed Sci, Div Infect Dis, Rm 414, Taipei 11529, Taiwan.		Tai, Jung-Hsiang/S-7019-2018					Addis MF, 2000, INFECT IMMUN, V68, P4358, DOI 10.1128/IAI.68.7.4358-4360.2000; ALDERETE JF, 1988, INFECT IMMUN, V56, P28, DOI 10.1128/IAI.56.1.28-33.1988; ALDERETE JF, 1995, MOL MICROBIOL, V17, P69, DOI 10.1111/j.1365-2958.1995.mmi_17010069.x; ALDERETE JF, 1995, MICROB PATHOGENESIS, V19, P93, DOI 10.1006/mpat.1995.0049; Alderete JF, 1999, INFECT IMMUN, V67, P4298, DOI 10.1128/IAI.67.8.4298-4302.1999; Alderete JF, 1998, MICROB PATHOGENESIS, V24, P1, DOI 10.1006/mpat.1997.0167; ALDERETE JF, 1995, PARASITOL TODAY, V11, P70, DOI 10.1016/0169-4758(95)80122-7; An ZQ, 1997, EMBO J, V16, P1742, DOI 10.1093/emboj/16.7.1742; ARROYO R, 1992, MOL MICROBIOL, V6, P853, DOI 10.1111/j.1365-2958.1992.tb01536.x; BAGG A, 1987, MICROBIOL REV, V51, P509, DOI 10.1128/MMBR.51.4.509-518.1987; Brugerolle G, 2000, PARASITOL RES, V86, P30, DOI 10.1007/PL00008503; Delgadillo MG, 1997, P NATL ACAD SCI USA, V94, P4716, DOI 10.1073/pnas.94.9.4716; Engbring JA, 1998, MOL MICROBIOL, V28, P305, DOI 10.1046/j.1365-2958.1998.00784.x; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; GABRIELSEN OS, 1991, SCIENCE, V253, P1140, DOI 10.1126/science.1887237; Gonda TJ, 1998, INT J BIOCHEM CELL B, V30, P547, DOI 10.1016/S1357-2725(98)00003-X; GORRELL TE, 1985, J BACTERIOL, V161, P1228, DOI 10.1128/JB.161.3.1228-1230.1985; GUNDERSON J, 1995, J EUKARYOT MICROBIOL, V42, P411, DOI 10.1111/j.1550-7408.1995.tb01604.x; Honigberg B. M., 1978, PARASITIC PROTOZOA, P275; KATIYAR SK, 1994, MOL BIOCHEM PARASIT, V64, P33, DOI 10.1016/0166-6851(94)90132-5; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kuhn LC, 1998, NUTR REV, V56, pS11; LEHKER MW, 1991, J EXP MED, V174, P311, DOI 10.1084/jem.174.2.311; Liston DR, 1999, MOL CELL BIOL, V19, P2380; Liston DR, 1999, MOL BIOCHEM PARASIT, V104, P323, DOI 10.1016/S0166-6851(99)00137-1; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MEYSICK K, 1995, CURR OPIN INFECT DIS, V8, P22, DOI 10.1097/00001432-199502000-00005; OBrien JL, 1996, MICROB PATHOGENESIS, V20, P335, DOI 10.1006/mpat.1996.0032; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; PETERSON KM, 1984, J EXP MED, V160, P398, DOI 10.1084/jem.160.2.398; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Winge DR, 1998, CURR OPIN CHEM BIOL, V2, P216, DOI 10.1016/S1367-5931(98)80063-X; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x	38	57	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5153	5162		10.1074/jbc.M110234200	http://dx.doi.org/10.1074/jbc.M110234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741916	hybrid			2022-12-27	WOS:000173962900079
J	Lee, J; Pena, MMO; Nose, Y; Thiele, DJ				Lee, J; Pena, MMO; Nose, Y; Thiele, DJ			Biochemical characterization of the human copper transporter Ctr1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; EXTRACELLULAR PH; PLASMA-MEMBRANE; HIGH-AFFINITY; IRON UPTAKE; YEAST; HEPATOCYTES; ATPASE; CELLS	The trace metal copper is an essential cofactor for a number of biological processes including mitochondrial oxidative phosphorylation, free radical detoxification, neurotransmitter synthesis and maturation, and iron metabolism. Consequently, copper transport at the cell surface and the delivery of copper to intracellular proteins are critical events in normal physiology. Little is known about the molecules and biochemical mechanisms responsible for copper uptake at the plasma membrane in mammals. Here, we demonstrate that human Ctr1 (hCtr1) is a component of the copper transport machinery at the plasma membrane. hCtr1 transports copper with high affinity in a time-dependent and saturable manner and is metal-specific. hCtr1-mediated Cu-64 transport is an energy-independent process and is stimulated by extracellular acidic pH and high K+ concentrations. hCtr1 exists as a homomultimer at the plasma membrane in mammalian cells. This is the first report on the biochemical characterization of the human copper transporter hCtr1, which is important for understanding mechanisms for mammalian copper transport at the plasma membrane.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Thiele, DJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	dthiele@umich.edu			NIGMS NIH HHS [5F32GM18089, GM62555] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062555, F32GM018089] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; Culotta VC, 1999, ADV EXP MED BIOL, V448, P247; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; DANKS DM, 1988, ANNU REV NUTR, V8, P235, DOI 10.1146/annurev.nu.08.070188.001315; DARWISH HM, 1983, J BIOL CHEM, V258, P3621; DARWISH HM, 1984, AM J PHYSIOL, V246, pG72, DOI 10.1152/ajpgi.1984.246.1.G72; DiDonato M, 1997, BBA-MOL BASIS DIS, V1360, P3, DOI 10.1016/S0925-4439(96)00064-6; Fernandes AR, 2000, ARCH MICROBIOL, V173, P262, DOI 10.1007/s002030000138; FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Harrison MD, 2000, TRENDS BIOCHEM SCI, V25, P29, DOI 10.1016/S0968-0004(99)01492-9; HARTTER DE, 1988, J BIOL CHEM, V263, P799; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Huang RQ, 1999, J NEUROPHYSIOL, V82, P1233, DOI 10.1152/jn.1999.82.3.1233; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Labbe S, 1999, TRENDS MICROBIOL, V7, P500, DOI 10.1016/S0966-842X(99)01638-8; Lamb TM, 2001, J BIOL CHEM, V276, P1850, DOI 10.1074/jbc.M008381200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Linder M, 1991, BIOCH COPPER; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; MAS A, 1992, BIOCHIM BIOPHYS ACTA, V1135, P123, DOI 10.1016/0167-4889(92)90127-W; MCARDLE HJ, 1988, J CELL PHYSIOL, V136, P373, DOI 10.1002/jcp.1041360223; Moller LB, 2000, GENE, V257, P13, DOI 10.1016/S0378-1119(00)00394-2; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Pena MMO, 1998, MOL CELL BIOL, V18, P2514, DOI 10.1128/MCB.18.5.2514; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Prohaska JR, 2000, NUTRITION, V16, P502, DOI 10.1016/S0899-9007(00)00308-7; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; QIAN YC, 1995, AM J PHYSIOL-CELL PH, V269, pC892, DOI 10.1152/ajpcell.1995.269.4.C892; ROBELLO M, 1994, NEUROSCIENCE, V61, P833, DOI 10.1016/0306-4522(94)90406-5; Rolfs A, 1999, J PHYSIOL-LONDON, V518, P1, DOI 10.1111/j.1469-7793.1999.0001r.x; Saeki T, 1999, J BIOCHEM-TOKYO, V125, P846, DOI 10.1093/oxfordjournals.jbchem.a022358; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG311, DOI 10.1152/ajpgi.1999.276.2.G311; SCHMITT RC, 1983, AM J PHYSIOL, V244, pG183, DOI 10.1152/ajpgi.1983.244.2.G183; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; WALDROP GL, 1990, AM J PHYSIOL, V259, pG219, DOI 10.1152/ajpgi.1990.259.2.G219; WALDROP GL, 1990, AM J PHYSIOL, V259, pG212, DOI 10.1152/ajpgi.1990.259.2.G212; WRIGHT EM, 1993, ANNU REV PHYSIOL, V55, P575, DOI 10.1146/annurev.ph.55.030193.003043; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	52	462	470	4	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4380	4387		10.1074/jbc.M104728200	http://dx.doi.org/10.1074/jbc.M104728200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11734551	hybrid			2022-12-27	WOS:000173813900079
J	Paetzel, M; Dalbey, RE; Strynadka, NCJ				Paetzel, M; Dalbey, RE; Strynadka, NCJ			Crystal structure of a bacterial signal peptidase apoenzyme - Implications for signal peptide binding and the Ser-Lys dyad mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI LEADER PEPTIDASE; CATALYTICALLY ACTIVE FORM; ESCHERICHIA-COLI; UMUD PROTEIN; SITE; PROGRAM; IDENTIFICATION; STABILIZATION; REQUIREMENT; PROTEASES	We report here the x-ray crystal structure of a soluble catalytically active fragment of the Escherichia coli type I signal peptidase (SPase-(Delta2-75)) in the absence of inhibitor or substrate (apoenzyme). The structure was solved by molecular replacement and refined to 2.4 Angstrom resolution in a different space group (P4(1)2(1)2) from that of the previously published acyl-enzyme inhibitor-bound structure (P2(1)2(1)2) (Paetzet, M., Dalbey, R. E., and Strynadka, N. C. J. (1998) Nature 396, 186-190). A comparison with the acyl-enzyme structure shows significant side-chain and main-chain differences in the binding site and active site regions, which result in a smaller S1 binding pocket in the apoenzyme. The apoenzyme structure is consistent with SPase utilizing an unusual oxyanion hole containing one side-chain hydroxyl hydrogen (Ser-88 OgammaH) and one main-chain amide hydrogen (Ser-90 NH). Analysis of the apoenzyme active site reveals a potential deacylating water that was displaced by the inhibitor. It has been proposed that SPase utilizes a Ser-Lys dyad mechanism in the cleavage reaction. A similar mechanism has been proposed for the LexA family of proteases. A structural comparison of SPase and members of the LexA family of proteases reveals a difference in the side-chain orientation for the general base lysine, both of which are stabilized by an adjacent hydroxyl group. To gain insight into how signal peptidase recognizes its substrates, we have modeled a signal peptide into the binding site of SPase. The model is built based on the recently solved crystal structure of the analogous enzyme LexA (Luo, Y., Pfuetzner, R. A., Mosimann, S., Paetzel, M., Frey, E. A., Cherney, M., Kim, B., Little, J. W., and Strynadka, N. C. J. (2001) Cell 106, 1-10) with its bound cleavage site region.	Univ British Columbia, Dept Biochem & Mol Biol, Fac Med, Vancouver, BC V6T 1Z3, Canada; Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University of British Columbia; University System of Ohio; Ohio State University	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Fac Med, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca		Paetzel, Mark/0000-0002-7408-5487				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Black MT, 1998, CURR PHARM DESIGN, V4, P133; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bullock TL, 1996, J MOL BIOL, V255, P714, DOI 10.1006/jmbi.1996.0058; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Carlos J. L., 2001, ENZYMES, V22, P27; Carlos JL, 2000, BIOCHEMISTRY-US, V39, P7276, DOI 10.1021/bi000301l; CHATTERJEE S, 1995, J MOL BIOL, V245, P311, DOI 10.1006/jmbi.1994.0025; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; DATE T, 1981, P NATL ACAD SCI-BIOL, V78, P6106, DOI 10.1073/pnas.78.10.6106; Ferentz AE, 2001, EMBO J, V20, P4287, DOI 10.1093/emboj/20.15.4287; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM YT, 1995, EUR J BIOCHEM, V234, P358, DOI 10.1111/j.1432-1033.1995.358_c.x; KIM YT, 1995, J BIOCHEM-TOKYO, V117, P535, DOI 10.1093/oxfordjournals.jbchem.a124741; Klenotic PA, 2000, J BIOL CHEM, V275, P6490, DOI 10.1074/jbc.275.9.6490; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUO DW, 1993, ARCH BIOCHEM BIOPHYS, V303, P274, DOI 10.1006/abbi.1993.1283; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Maveyraud L, 1996, J AM CHEM SOC, V118, P7435, DOI 10.1021/ja9609718; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MENARD R, 1992, BIOL CHEM H-S, V373, P393, DOI 10.1515/bchm3.1992.373.2.393; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nicolas A, 1996, BIOCHEMISTRY-US, V35, P398, DOI 10.1021/bi9515578; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Paetzel M, 1999, PROTEIN SCI, V8, P2533; Paetzel M, 1997, J BIOL CHEM, V272, P9994; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; PAETZEL M, 1995, PROTEINS, V23, P122, DOI 10.1002/prot.340230115; Paetzel M, 2000, PHARMACOL THERAPEUT, V87, P27, DOI 10.1016/S0163-7258(00)00064-4; Peat TS, 1996, STRUCTURE, V4, P1401, DOI 10.1016/S0969-2126(96)00148-7; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P688, DOI 10.1038/nsb0896-688; SUNG M, 1992, J BIOL CHEM, V267, P13154; TSCHANTZ WR, 1995, BIOCHEMISTRY-US, V34, P3935, DOI 10.1021/bi00012a010; TSCHANTZ WR, 1993, J BIOL CHEM, V268, P27349; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456; Wilmouth RC, 1998, BIOCHEMISTRY-US, V37, P17506, DOI 10.1021/bi9816249; WOLFE PB, 1982, J BIOL CHEM, V257, P7898; [No title captured]	50	85	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9512	9519		10.1074/jbc.M110983200	http://dx.doi.org/10.1074/jbc.M110983200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11741964	hybrid, Green Published			2022-12-27	WOS:000174400600104
J	Takagaki, K; Munakata, H; Kakizaki, I; Iwafune, M; Itabashi, T; Endo, M				Takagaki, K; Munakata, H; Kakizaki, I; Iwafune, M; Itabashi, T; Endo, M			Domain structure of chondroitin sulfate E octasaccharides binding to type V collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPRAY MASS-SPECTROMETRY; MOUSE BONE-MARROW; ENZYMATIC RECONSTRUCTION; HIGH-AFFINITY; TESTICULAR HYALURONIDASE; NEURITE OUTGROWTH; ANTITHROMBIN-III; DERMATAN SULFATE; HEPARIN; PROTEOGLYCANS	We demonstrated previously that chondroitin sulfate E (ChS-E) binds to type V collagen (Munakata, H., Takagaki, K., Majima, M., and Endo, M. (1999) Glycobiology 9, 1023-1027). In this study, we investigated the structure and binding of ChS-E oligosaccharides. Eleven oligosaccharides were isolated from ChS-E by gel filtration chromatography and anion-exchange high performance liquid chromatography after hydrolysis with testicular hyaluronidase. Separately, seven oligosaccharides were custom synthesized using the transglycosylation reaction of testicular hyaluronidase. Structural analysis was performed by enzymatic digestions in conjunction with high performance liquid chromatography and mass spectrometry. This library of IS oligosaccharides was used as a source of model molecules to clarify the structural requirements for binding to type V collagen. Binding was analyzed by a biosensor based on surface plasmon resonance. The results indicated that to bind to type V collagen the oligosaccharides must have the following carbohydrate structures: 1) octasaccharide or larger in size; 2) a continuous sequence of three GlcAbeta1-3GalNAc(4S,6S) units; 3) a GlcAbeta1-3GalNAc(4S,6S) unit, GIcA/3I-3GaINAc(4S) unit or GlcAbeta1-3GalNAc(6S) unit at the reducing terminal; 4) a GlcAbeta1-3GalNAc(4S,6S) unit at the nonreducing terminal. It is likely that these characteristic oligosaccharide sequences play key roles in cell adhesion and extracellular matrix assembly.	Hirosaki Univ, Sch Med, Dept Biochem, Hirosaki, Aomori 0368562, Japan	Hirosaki University	Endo, M (corresponding author), Hirosaki Univ, Sch Med, Dept Biochem, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.		Kakizaki, Ikuko/AAO-5489-2020	Kakizaki, Ikuko/0000-0002-6702-5830				BARDALES RM, 1989, J BIOL CHEM, V264, P19893; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BORDERS CL, 1968, J BIOL CHEM, V243, P3756; CASU B, 1981, BIOCHEM J, V197, P599, DOI 10.1042/bj1970599; CHRISTNER JE, 1979, J BIOL CHEM, V254, P4624; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; FRANSSON LA, 1987, TRENDS BIOCHEM SCI, V12, P406, DOI 10.1016/0968-0004(87)90197-6; GOTO F, 1993, PURE APPL CHEM, V65, P793, DOI 10.1351/pac199365040793; GROOTENHUIS PDJ, 1991, J AM CHEM SOC, V113, P2743, DOI 10.1021/ja00007a058; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; HIMENO M, 1974, J BIOCHEM, V76, P1243, DOI 10.1093/oxfordjournals.jbchem.a130677; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; IWATA H, 1969, J JAP ORTHOP ASSN, V43, P455; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; KON A, 1991, J BIOCHEM-TOKYO, V110, P132, DOI 10.1093/oxfordjournals.jbchem.a123531; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MAJIMA M, 1984, J BIOCHEM BIOPH METH, V10, P143, DOI 10.1016/0165-022X(84)90034-4; Munakata H, 1999, GLYCOBIOLOGY, V9, P1023, DOI 10.1093/glycob/9.10.1023; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; PETITOU M, 1986, CARBOHYD RES, V147, P221, DOI 10.1016/S0008-6215(00)90633-5; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; POOLE AR, 1986, BIOCHEM J, V236, P1; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; RAZIN E, 1982, J BIOL CHEM, V257, P7229; ROME LH, 1973, ARCH BIOCHEM BIOPHYS, V189, P344; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SAIGO K, 1970, J NEUROCHEM, V17, P633, DOI 10.1111/j.1471-4159.1970.tb00543.x; SAITO H, 1968, J BIOL CHEM, V243, P1536; SAITOH H, 1995, J BIOL CHEM, V270, P3741, DOI 10.1074/jbc.270.8.3741; Silbert JE, 1995, BBA-REV BIOMEMBRANES, V1241, P371, DOI 10.1016/0304-4157(95)00011-9; STEVENS RL, 1983, J BIOL CHEM, V258, P5977; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; SUZUKI S, 1968, J BIOL CHEM, V243, P1543; Takagaki K, 1999, BIOCHEM BIOPH RES CO, V258, P741, DOI 10.1006/bbrc.1999.0697; Takagaki K, 1998, GLYCOBIOLOGY, V8, P719, DOI 10.1093/glycob/8.7.719; TAKAGAKI K, 1994, BIOCHEMISTRY-US, V33, P6503, DOI 10.1021/bi00187a017; TAKAGAKI K, 1992, GLYCOCONJUGATE J, V9, P174, DOI 10.1007/BF00731162; Takagaki K, 2000, BIOCHEM BIOPH RES CO, V270, P588, DOI 10.1006/bbrc.2000.2452; THUNBERG L, 1982, CARBOHYD RES, V100, P393, DOI 10.1016/S0008-6215(00)81050-2; Tillet E, 1997, J BIOL CHEM, V272, P10769; Tsuchida K, 2001, J BIOL CHEM, V276, P37155, DOI 10.1074/jbc.M105818200; TYRRELL DJ, 1993, J BIOL CHEM, V268, P4684; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; USUI T, 1988, BIOCHIM BIOPHYS ACTA, V953, P179, DOI 10.1016/0167-4838(88)90022-2; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; YOSHIDA K, 1989, ANAL BIOCHEM, V177, P327, DOI 10.1016/0003-2697(89)90061-4	50	46	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8882	8889		10.1074/jbc.M106479200	http://dx.doi.org/10.1074/jbc.M106479200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11751896	hybrid			2022-12-27	WOS:000174400600021
J	Wu, YF; Delerive, P; Chin, WW; Burris, TP				Wu, YF; Delerive, P; Chin, WW; Burris, TP			Requirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAINS; TISSUE-SPECIFIC COACTIVATOR; NUCLEAR-RECEPTOR; TRANSACTIVATION DOMAIN; TRANSCRIPTIONAL COACTIVATOR; DEPENDENT TRANSACTIVATION; HISTONE ACETYLTRANSFERASE; STEROID-RECEPTORS; ACTIVATION; MOTIF	Although PGC-1 (peroxisome proliferator-activated receptor-gamma coactivator-1) has been previously shown to enhance thyroid hormone receptor (TR)/retinoid X receptor-mediated ucp-1 gene expression in a ligand-induced manner in rat fibroblast cells, the precise mechanism of PGC-1 modulation of TR function has yet to be determined. In this study, we show that PGC-1 can potentiate TR-mediated transactivation of reporter genes driven by natural thyroid hormone response elements both in a ligand-dependent and ligand-independent manner and that the extent of coactivation is a function of the thyroid hormone response element examined. Our data also show that PGC-1 stimulation of TR activity in terms of Gal4 DNA-binding domain fusion is strictly ligand-dependent. In addition, an E457A AF-2 mutation had no effect on the ligand-induced PGC-1 enhancement of TR activity, indicating that the conserved charged residue in AF-2 is not essential for this PGC-1 function. Furthermore, GST pull-down and mammalian two-hybrid assays demonstrated that the PGC-1 LXXLL motif is required for ligand-induced PGC-1/TR interaction. This agonist-dependent PGC-1/TR interaction also requires both helix 1 and the AF-2 region of the TR ligand-binding domain. Taken together, these results support the notion that PGC-1 is a bona fide TR coactivator and that PGC-1 modulates TR activity via a mechanism different from that utilized with peroxisome proliferator activator receptor-gamma.	Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Burris, TP (corresponding author), Lilly Corp Ctr, Lilly Res Labs, DC 0434, Indianapolis, IN 46285 USA.		Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449				Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BANIAHMAD A, 1995, MOL CELL BIOL, V15, P76, DOI 10.1128/MCB.15.1.76; BARETTINO D, 1994, EMBO J, V13, P3039, DOI 10.1002/j.1460-2075.1994.tb06603.x; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; BRENT GA, 1992, MOL ENDOCRINOL, V6, P502, DOI 10.1210/me.6.4.502; BURRIS TP, 2000, NUCL RECEPTORS GENET, P1; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Glass CK, 2000, GENE DEV, V14, P121; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hourton D, 2001, BIOCHEM J, V354, P225, DOI 10.1042/0264-6021:3540225; Jeannin E, 1998, J BIOL CHEM, V273, P24239, DOI 10.1074/jbc.273.37.24239; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Liu Y, 1998, MOL ENDOCRINOL, V12, P34, DOI 10.1210/mend.12.1.0046; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Miyamoto T, 2001, MOL CELL ENDOCRINOL, V181, P229, DOI 10.1016/S0303-7207(01)00483-X; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; ONATE SA, 1995, SCIENCE, V270, P1354; Pissios P, 2000, MOL CELL, V6, P245, DOI 10.1016/S1097-2765(00)00026-5; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; QI JS, 1995, MOL CELL BIOL, V15, P1817; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; SPANJAARD RA, 1991, P NATL ACAD SCI USA, V88, P8587, DOI 10.1073/pnas.88.19.8587; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; TONE Y, 1994, J BIOL CHEM, V269, P31157; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; TOYODA N, 1995, MOL CELL BIOL, V15, P5100; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Wilkinson JR, 1997, J BIOL CHEM, V272, P23824, DOI 10.1074/jbc.272.38.23824; Williams Graham R., 1995, P217; Wu YF, 2000, TRENDS ENDOCRIN MET, V11, P207, DOI 10.1016/S1043-2760(00)00263-0; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439	56	65	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8898	8905		10.1074/jbc.M110761200	http://dx.doi.org/10.1074/jbc.M110761200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11751919	hybrid			2022-12-27	WOS:000174400600023
J	Chen, MY; Samuelson, JC; Jiang, FL; Muller, M; Kuhn, A; Dalbey, RE				Chen, MY; Samuelson, JC; Jiang, FL; Muller, M; Kuhn, A; Dalbey, RE			Direct interaction of YidC with the Sec-independent Pf3 coat protein during its membrane protein insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ESCHERICHIA-COLI; NASCENT FTSQ; TRANSLOCATION; BACTERIAL; MITOCHONDRIAL; RESIDUES; OXA1P; HOMOLOG; LEADER	YidC is a newly defined translocase component that mediates the insertion of proteins into the membrane bilayer. How YidC functions in the insertion process is not known. In this study, we report that the Sec-independent Pf3 coat protein requires the YidC protein specifically for the membrane translocation step. Using photocrosslinking techniques and ribosome-bound Pf3 coat derivatives with an extended carboxyl-terminal region, we found that the transmembrane region of the Pf3 coat protein physically interacts with YidC and the bacterial signal recognition particle Ffh component. We also find that in the insertion pathway, Pf3 coat interacts strongly with YidC only after its transmembrane segment is fully exposed outside the ribosome tunnel. Interaction between Pf3 coat and YidC occurs even in the absence of the proton motive force and with a Pf3 coat mutant that is defective in transmembrane insertion. Our study demonstrates that YidC can directly interact with a Sec-independent membrane protein, and the role of YidC is at the stage of folding the Pf3 protein into a transmembrane configuration.	Ohio State Univ, Dept Chem, Ohio State Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, Prot Res Grp, Columbus, OH 43210 USA; Univ Hohenheim, Inst Microbiol & Mol Biol, D-70593 Stuttgart, Germany; Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University Hohenheim; University of Freiburg	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem, Ohio State Biochem Program, 100 W 18th St, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063862] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63862] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; BOEKE JD, 1980, J MOL BIOL, V144, P103, DOI 10.1016/0022-2836(80)90027-3; Brunner J, 1996, TRENDS CELL BIOL, V6, P154, DOI 10.1016/0962-8924(96)40001-0; Cload ST, 1996, CHEM BIOL, V3, P1033, DOI 10.1016/S1074-5521(96)90169-6; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; Dalbey RE, 2000, CURR OPIN CELL BIOL, V12, P435, DOI 10.1016/S0955-0674(00)00113-7; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Economou A, 1999, TRENDS MICROBIOL, V7, P315, DOI 10.1016/S0966-842X(99)01555-3; GOLD LM, 1971, METHOD ENZYMOL, V20, P537; Graf R, 1998, CELL BIOLOGY - A LABOARATORY HANDBOOK, 2ND EDITION, VOL 4, P495; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Kiefer D, 1999, EMBO J, V18, P6299, DOI 10.1093/emboj/18.22.6299; Kiefer D, 1997, EMBO J, V16, P2197, DOI 10.1093/emboj/16.9.2197; KUHN A, 1995, FEMS MICROBIOL REV, V17, P185; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; Martoglio B, 1996, TRENDS CELL BIOL, V6, P142, DOI 10.1016/0962-8924(96)10001-5; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; RHOADS DB, 1984, J BACTERIOL, V159, P63, DOI 10.1128/JB.159.1.63-70.1984; Ridder ANJA, 2000, BIOCHEMISTRY-US, V39, P6521, DOI 10.1021/bi000073v; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Stuart RA, 2000, NATURE, V406, P575, DOI 10.1038/35020668; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; WHITLEY P, 1994, EMBO J, V13, P4653, DOI 10.1002/j.1460-2075.1994.tb06788.x	33	108	109	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7670	7675		10.1074/jbc.M110644200	http://dx.doi.org/10.1074/jbc.M110644200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751917	hybrid			2022-12-27	WOS:000174268000009
J	Podar, K; Tai, YT; Lin, BK; Narsimhan, RP; Sattler, M; Kijima, T; Salgia, R; Gupta, D; Chauhan, D; Anderson, KC				Podar, K; Tai, YT; Lin, BK; Narsimhan, RP; Sattler, M; Kijima, T; Salgia, R; Gupta, D; Chauhan, D; Anderson, KC			Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta(1) integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FOCAL ADHESION KINASE; TYROSINE KINASE; PHORBOL ESTER; EXPRESSION; RECEPTOR; CALCIUM; MOTILITY; PHOSPHORYLATION; GAMMA	In multiple myeloma (MM), migration is necessary for the homing of tumor cells to bone marrow (BM), for expansion within the BM microenvironment, and for egress into the peripheral blood. In the present study we characterize the role of vascular endothelial growth factor (VEGF) and beta(1) integrin (CD29) in MM cell migration. We show that protein kinase C (PKC) alpha is translocated to the plasma membrane and activated by adhesion of MM cells to fibronectin and VEGF. We identify beta(1) integrin modulating VEGF-triggered MM cell migration on fibronectin. We show that transient enhancement of MM cell adhesion to fibronectin triggered by VEGF is dependent on the activity of both PKC and beta(1) integrin. Moreover, we demonstrate that PKCalpha is constitutively associated with beta(1) integrin. These data are consistent with PKCalpha-dependent exocytosis of activated beta(1) integrin to the plasma membrane, where its increased surface expression mediates binding to fibronectin; conversely, catalytically active PKCalpha-driven internalization of beta(1) integrin results in MM cell de-adhesion. We show that the regulatory subunit of phosphatidylinositol (PI) 3-kinase (p85) is constitutively associated with FMS-like tyrosine kinase-1 (Flt-1). VEGF stimulates activation of PI 3-kinase, and both MM cell adhesion and migration are PI 3-kinase-dependent. Moreover, both VEGF-induced PI 3-kinase activation and beta(1) integrin-mediated binding to fibronectin are required for the recruitment and activation of PKCa. Time-lapse phase contrast video microscopy (TLVM) studies confirm the importance of these signaling components in VEGF-triggered AM cell migration on fibronectin.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Res Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Anderson, KC (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Res Ctr, 44 Binney St, Boston, MA 02115 USA.	kenneth_anderson@dfci.harvard.edu	Podar, Klaus/ABD-1112-2020	Podar, Klaus/0000-0002-7414-3632	PHS HHS [P0-1 78378] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ASAOKA Y, 1992, TRENDS BIOCHEM SCI, V17, P414, DOI 10.1016/0968-0004(92)90011-W; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Bellamy WT, 1999, CANCER RES, V59, P728; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Chauhan D, 1999, ONCOGENE, V18, P6733, DOI 10.1038/sj.onc.1203082; CUNNINGHAM SA, 1995, J BIOL CHEM, V270, P20254, DOI 10.1074/jbc.270.35.20254; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Dankbar B, 2000, BLOOD, V95, P2630, DOI 10.1182/blood.V95.8.2630; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; JENSEN GS, 1993, AM J HEMATOL, V43, P29, DOI 10.1002/ajh.2830430108; Kibler C, 1998, CELL ADHES COMMUN, V5, P307, DOI 10.3109/15419069809040300; Kiley SC, 1999, CANCER RES, V59, P3230; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; KUNDRA V, 1995, J CELL BIOL, V130, P725, DOI 10.1083/jcb.130.3.725; KUZUYA M, 1994, EXP CELL RES, V215, P310, DOI 10.1006/excr.1994.1347; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; Mannion BA, 1996, J IMMUNOL, V157, P2039; MOALLI PA, 1992, BLOOD, V79, P213; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Platet N, 1998, INT J CANCER, V75, P750, DOI 10.1002/(SICI)1097-0215(19980302)75:5<750::AID-IJC14>3.0.CO;2-A; Podar K, 2001, BLOOD, V98, P428, DOI 10.1182/blood.V98.2.428; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; RUBINSTEIN E, 1994, EUR J IMMUNOL, V24, P3005, DOI 10.1002/eji.1830241213; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; SHATTIL SJ, 1987, BLOOD, V70, P307; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704; Timar J, 1996, CANCER RES, V56, P1902; UCHIYAMA H, 1992, BLOOD, V80, P2306; UCHIYAMA H, 1993, BLOOD, V82, P3712; Watson JM, 2001, J BIOL CHEM, V276, P3536, DOI 10.1074/jbc.M006916200; WOODS A, 1992, J CELL SCI, V101, P277; YEBRA M, 1995, MOL BIOL CELL, V6, P841, DOI 10.1091/mbc.6.7.841; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351	54	153	159	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7875	7881		10.1074/jbc.M109068200	http://dx.doi.org/10.1074/jbc.M109068200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751905	hybrid			2022-12-27	WOS:000174268000033
J	Osugi, T; Oshima, Y; Fujio, Y; Funamoto, M; Yamashita, A; Negoro, S; Kunisada, K; Izumi, M; Nakaoka, Y; Hirota, H; Okabe, M; Yamauchi-Takihara, K; Kawase, I; Kishimoto, T				Osugi, T; Oshima, Y; Fujio, Y; Funamoto, M; Yamashita, A; Negoro, S; Kunisada, K; Izumi, M; Nakaoka, Y; Hirota, H; Okabe, M; Yamauchi-Takihara, K; Kawase, I; Kishimoto, T			Cardiac-specific activation of signal transducer and activator of transcription 3 promotes vascular formation in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; STAT3 ACTIVATION; JAK-STAT; ANGIOGENESIS; MYOCYTES; GP130; MICE; CARDIOMYOPATHY; HYPERTROPHY; CELLS	Signal transducer and activator of transcription 3 (STAT3) functions in cell proliferation, differentiation, and cell survival. Previously, we have demonstrated that the activation of STAT3 is required for glycoprotein 130-mediated induction of VEGF in cardiac myocytes, but the functional importance of STAT3 as an angiogenic mediator remains to be determined. To address this issue, we first generated the adenoviral vector expressing constitutively active STAT3 (caSTAT3). Adenoviral gene transfer of caSTAT3 induced an increase in the expression of VEGF in cultured cardiomyocytes. The conditioned medium from caSTAT3-transfected cardiomyocyte culture promoted endothelial tubule formation, which was inhibited by anti-VEGF antibody. Next, we generated the transgenic (TG) mice with cardiac-specific overexpression of caSTAT3 and demonstrated that caSTAT3 TG mice showed evidence of VEGF induction in the hearts. The caSTAT3 TG hearts also demonstrated increased capillary density accompanied by an increase in the expression of VE-cadherin, an endothelial-specific component. These data indicate that caSTAT3 TG hearts exhibit an enriched vascular structure compared with non-transgenic hearts. The study presented here provides the first evidence that activation of STAT3 controls vessel growth in vivo and suggests that STAT3 contributes to cardiac adaptation by regulating vascular function under the conditions of stress.	Osaka Univ, Grad Sch Med, Dept Mol Med, Suita, Osaka 5650871, Japan; Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Fujio, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yfujio@imed3.med.osaka-u.ac.jp	Fujio, Yasushi/H-3421-2017; Kishimoto, Tadamitsu/C-8470-2009; Okabe, Masaru/B-6917-2015	Fujio, Yasushi/0000-0003-0828-2930; Okabe, Masaru/0000-0002-0803-9044				BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; Funamoto M, 2000, J MOL CELL CARDIOL, V32, P1275, DOI 10.1006/jmcc.2000.1161; Funamoto M, 2000, J BIOL CHEM, V275, P10561, DOI 10.1074/jbc.275.14.10561; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KRISHENBAUM LA, 1993, J CLIN INVEST, V92, P381, DOI 10.1172/JCI116577; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Kunisada K, 1996, CIRCULATION, V94, P2626, DOI 10.1161/01.CIR.94.10.2626; Kunisada K, 1998, CIRCULATION, V98, P346, DOI 10.1161/01.CIR.98.4.346; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Negoro S, 2001, CIRCULATION, V103, P555, DOI 10.1161/01.CIR.103.4.555; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Pan J, 1999, CIRC RES, V84, P1127, DOI 10.1161/01.RES.84.10.1127; RAKUSAN K, 1992, CIRCULATION, V86, P38, DOI 10.1161/01.CIR.86.1.38; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; TOMANEK RJ, 1990, J AM COLL CARDIOL, V15, P528, DOI 10.1016/0735-1097(90)90620-5; TOMANEK RJ, 1989, CIRC RES, V65, P352, DOI 10.1161/01.RES.65.2.352; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225	38	122	129	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6676	6681		10.1074/jbc.M108246200	http://dx.doi.org/10.1074/jbc.M108246200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744720	hybrid			2022-12-27	WOS:000173989200128
J	Pfisterer, P; Ehlermann, J; Hegen, M; Schorle, H				Pfisterer, P; Ehlermann, J; Hegen, M; Schorle, H			A subtractive gene expression screen suggests a role of transcription factor AP-2 alpha in control of proliferation and differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR AP-2; DROSOPHILA HOMOLOG; RETINOIC ACID; MICE LACKING; FAMILY; CLONING; SUPPRESSION; PROTEIN; MEMBER; CELLS	The transcription factor AP-2alpha has been implicated as a cell type-specific regulator of gene expression during vertebrate embryogenesis based on its expression pattern in neural crest cells, ectoderm, and the nervous system in mouse and frog embryos. AP-2alpha is prominently expressed in cranial neural crest cells, a population of cells that migrate from the lateral margins of the brain plate during closure of the neural tube at day 8-9 of embryonic development. Homozygous AP-2alpha mutant mice die perinatally with cranio-abdominoschisis, full facial clefting, and defects in cranial ganglia and sensory organs, indicating the importance of this gene for proper development. By using a subtractive cloning approach, we identified a set of genes repressed by AP-2alpha that are described to retard cellular proliferation and induce differentiation and apoptosis. We show that these target genes are prematurely expressed in AP-2alpha mutant mice. One of the genes isolated, the Kruppel-box transcription factor KLF-4 implicated in induction of terminal differentiation and growth regulation, is found expressed in mutant embryonic fibroblasts. We show that fibroblasts lacking AP-2alpha display retarded growth but no enhanced apoptosis. Based on these data we suggest that AP-2alpha might be required for cell proliferation by suppression of genes inducing terminal differentiation, apoptosis, and growth retardation.	Forschungszentrum Karlsruhe, ITG, D-76344 Eggenstein Leopoldshafen, Germany; Univ Bonn, Inst Pathol, Dept Dev Pathol, D-53127 Bonn, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Bonn	Schorle, H (corresponding author), Univ Bonn, Dept Dev Pathol, Siegmund Freud Str 25, D-53127 Bonn, Germany.	Hubert.Schorle@ukb.uni-bonn.de	Schorle, Hubert/S-1713-2019; Schorle, Hubert/M-5001-2016	Schorle, Hubert/0000-0001-8272-0076				Bauer R, 1998, ONCOGENE, V17, P1911, DOI 10.1038/sj.onc.1202114; Bosher JM, 1996, ONCOGENE, V13, P1701; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Diatchenko L, 1999, METHOD ENZYMOL, V303, P349; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Gurskaya NG, 1996, ANAL BIOCHEM, V240, P90, DOI 10.1006/abio.1996.0334; HLGEREVERSHEIM K, 2000, GENE, V260, P1; Hsu SY, 1998, J BIOL CHEM, V273, P30139, DOI 10.1074/jbc.273.46.30139; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Inohara N, 1998, J BIOL CHEM, V273, P8705, DOI 10.1074/jbc.273.15.8705; Kerber B, 2001, DEVELOPMENT, V128, P1231; LECKACZERNIK B, 1995, MOL CELL BIOL, V15, P120, DOI 10.1128/MCB.15.1.120; Maldonado-Saldivia J, 2000, MECH DEVELOP, V96, P121, DOI 10.1016/S0925-4773(00)00370-1; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; Monge I, 1998, MECH DEVELOP, V76, P191, DOI 10.1016/S0925-4773(98)00125-7; Monge I, 2001, DEVELOPMENT, V128, P1239; MOSER M, 1995, DEVELOPMENT, V121, P2779; OuladAbdelghani M, 1996, EXP CELL RES, V225, P338, DOI 10.1006/excr.1996.0184; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; SCHOENWOLF GC, 1990, DEVELOPMENT, V109, P243; SCHOENWOLF GC, 1991, DEVELOPMENT, P157; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Smith JL, 1997, TRENDS NEUROSCI, V20, P510, DOI 10.1016/S0166-2236(97)01121-1; Talbot D, 1999, J INVEST DERMATOL, V113, P816, DOI 10.1046/j.1523-1747.1999.00759.x; Ton-That H, 1997, FEBS LETT, V419, P239, DOI 10.1016/S0014-5793(97)01465-8; Turner BC, 1998, CANCER RES, V58, P5466; vonStein OD, 1997, NUCLEIC ACIDS RES, V25, P2598, DOI 10.1093/nar/25.13.2598; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao F, 2001, J BIOL CHEM, V276, P40755, DOI 10.1074/jbc.M106284200	38	55	56	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6637	6644		10.1074/jbc.M108578200	http://dx.doi.org/10.1074/jbc.M108578200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741941	hybrid			2022-12-27	WOS:000173989200124
J	Song, C; Perides, G; Liu, YF				Song, C; Perides, G; Liu, YF			Expression of full-length polyglutamine-expanded huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE; LOCALIZATION; APOPTOSIS; PROTEIN; ACTIVATION; CANCER; SIZE	We reported previously that normal Huntingtin is associated with epidermal growth factor receptor (EGF) signaling complex (Liu, Y. F., Deth, C. R., and Devys, D. (1997) J. Biol. Chem. 272, 8121-8124). To investigate the potential role of normal and polyglutamine-expanded Huntingtin in the regulation of growth factor receptor-mediated cellular signaling and biological function, we stably transfected full-length Huntingtin containing 16, 48, or 89 polyglutamine repeats into PC12 cells where cellular signaling mechanisms, mediated by nerve growth factor (NGF) or EGF receptors, are well characterized. Expression of polyglutamine-expanded Huntingtin, but not normal Huntingtin, leads to a dramatic morphological change. In clones carrying the mutated Huntingtin, both NGF and EGF receptor-mediated activation of mitogen-activated protein kinase, c-Jun N-terminal kinase, and Akt are significantly attenuated, and NGF receptor-mediated neurite outgrowth is blocked. Co-immunoprecipitation studies show that the associations of NGF or EGF receptors with growth factor receptor-binding protein 2 (Grb2) and phosphoinositide 3-kinase are significantly inhibited. NGF-induced tyrosine phosphorylation of NGF receptors (TrkA) is also consistently suppressed. Our data demonstrate that polyglutamine-expanded Huntingtin disrupts cellular signaling mediated by both EGF and NGF receptors in PC 12 cells. It is known that Huntington's disease patients exhibit an extremely low incidence of a variety of cancers and are deficient in glucose metabolism. Thus, our results may reflect an important molecular mechanism for the pathogenesis of the disease.	Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Liu, YF (corresponding author), Boston Univ, Sch Med, Dept Pharmacol, 715 Albany St, Boston, MA 02118 USA.	yafliu@bu.edu						Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; KREMER HPH, 1992, ARCH NEUROL-CHICAGO, V49, P349, DOI 10.1001/archneur.1992.00530280029014; KUWERT T, 1990, BRAIN, V113, P1405, DOI 10.1093/brain/113.5.1405; Liu YF, 1998, J BIOL CHEM, V273, P28873, DOI 10.1074/jbc.273.44.28873; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Liu YF, 2000, J BIOL CHEM, V275, P19035, DOI 10.1074/jbc.C000180200; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Nasir J, 1996, HUM MOL GENET, V5, P1431, DOI 10.1093/hmg/5.Supplement_1.1431; PAWSON T, 1994, CURR OPIN GENET DEV, V4, P1, DOI 10.1016/0959-437X(94)90084-1; Pawson T, 1999, CELL, V97, P675, DOI 10.1016/S0092-8674(00)80779-5; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Savinainen A, 2001, J BIOL CHEM, V276, P11382, DOI 10.1074/jbc.M100190200; Sheppard D, 1996, BIOESSAYS, V18, P655, DOI 10.1002/bies.950180809; Sorensen SA, 1999, CANCER, V86, P1342, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.3.CO;2-V; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Sun Y, 2001, J BIOL CHEM, V276, P24713, DOI 10.1074/jbc.M103501200; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yasui H, 2001, J BIOL CHEM, V276, P15298, DOI 10.1074/jbc.M008546200	27	60	62	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6703	6707		10.1074/jbc.M110338200	http://dx.doi.org/10.1074/jbc.M110338200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11733534	hybrid			2022-12-27	WOS:000173989200132
J	von der Mark, H; Williams, I; Wendler, O; Sorokin, L; von der Mark, L; Poschl, E				von der Mark, H; Williams, I; Wendler, O; Sorokin, L; von der Mark, L; Poschl, E			Alternative splice variants of alpha(7)beta(1) integrin selectively recognize different laminin isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; ALPHA-7-BETA-1 INTEGRIN; CYTOPLASMIC DOMAINS; ENDOTHELIAL-CELLS; ALPHA-5 CHAIN; EXPRESSION; RECEPTOR; BINDING; MOUSE; MYOBLASTS	The integrin a,p, occurs in several cytoplasmic (alpha(7A), alpha(7B)) and extracellular splice variants (alpha(7X1), alpha(7X2)), which are differentially expressed during development of skeletal and heart muscle. The extracellular variants result from the alternative splicing of exons X1 and X2, corresponding to a segment within the putative ligand binding domain. To study the specificity and affinity of the X1/X2 variants to different laminin isoforms, soluble alpha(7)beta(1) complexes were prepared by recombinant coexpression of the extracellular domains of the alpha- and beta-subunits. The binding of these complexes to purified ligands was measured by solid phase binding assays. Surprisingly, the alternative splice variants revealed different and specific affinities to different laminin isoforms. While the alpha(7X2) variant bound much more strongly to laminin-1 than the alpha(7X1) variant, the latter showed a high affinity binding to laminins-8 and -10/11. Laminin-2, the major laminin isoform in skeletal muscle, was recognized by both variants, whereas none of the two variants were able to interact with laminin-5. A specific blocking antibody inhibited the binding of both variants to all laminins tested, indicating the involvement of common epitopes in alpha(7X1)beta(1), and alpha(7X2)beta(1). Because laminin-8 and -10/11 as well as alpha(7X1) are expressed in developing skeletal and cardiac muscle, these findings suggest that alpha(7X1)beta(1) may represent a physiological receptor with novel specificities for laminin-8 and -10.	Univ Erlangen Nurnberg, LS Expt Med, Nikolaus Fiebiger Zentrum Mol Med, D-91054 Erlangen, Germany; Dept Expt Med 1, D-91054 Erlangen, Germany; Interdisciplinary Ctr Clin Res, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Poschl, E (corresponding author), Univ Erlangen Nurnberg, LS Expt Med, Nikolaus Fiebiger Zentrum Mol Med, I Gluckstr 6, D-91054 Erlangen, Germany.	epoeschl@molmed.uni-erlangen.de		Sorokin, Lydia/0000-0001-7704-7921; Wendler, Olaf/0000-0002-5443-4889				AUMAILLEY M, 1990, EXP CELL RES, V188, P55, DOI 10.1016/0014-4827(90)90277-H; BAO ZZ, 1993, J CELL SCI, V106, P579; Blanco-Bose WE, 2001, DEV BIOL, V233, P148, DOI 10.1006/dbio.2001.0177; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Burkin DJ, 1998, J CELL BIOL, V143, P1067, DOI 10.1083/jcb.143.4.1067; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; COLLO G, 1993, J BIOL CHEM, V268, P19019; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Crawley S, 1997, EXP CELL RES, V235, P274, DOI 10.1006/excr.1997.3671; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; Echtermeyer F, 1996, J BIOL CHEM, V271, P2071, DOI 10.1074/jbc.271.4.2071; Frieser M, 1997, EUR J BIOCHEM, V246, P727, DOI 10.1111/j.1432-1033.1997.t01-1-00727.x; GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; GULLBERG D, 1989, J BIOL CHEM, V264, P12686; HAMILTON RG, 1988, ELISA OTHER SOLID PH, P57; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Kikkawa Y, 2000, J CELL SCI, V113, P869; KRAMER RH, 1991, CELL REGUL, V2, P805, DOI 10.1091/mbc.2.10.805; KRAMER RH, 1989, J BIOL CHEM, V264, P15642; LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Mielenz D, 2001, J BIOL CHEM, V276, P13417, DOI 10.1074/jbc.M011481200; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; Oxvig C, 1998, P NATL ACAD SCI USA, V95, P4870, DOI 10.1073/pnas.95.9.4870; Patton BL, 1999, NEUROMUSCULAR DISORD, V9, P423, DOI 10.1016/S0960-8966(99)00033-4; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PAULSSON M, 1989, J BIOL CHEM, V264, P18726; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; Pouliot N, 2001, EXP CELL RES, V266, P1, DOI 10.1006/excr.2001.5197; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; Schober S, 2000, EXP CELL RES, V255, P303, DOI 10.1006/excr.2000.4806; SCHULER F, 1995, J CELL SCI, V108, P3795; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Sixt M, 2001, J BIOL CHEM, V276, P18878, DOI 10.1074/jbc.M010898200; SONG WK, 1993, J CELL SCI, V106, P1139; SOROKIN L, 1994, EUR J BIOCHEM, V223, P603, DOI 10.1111/j.1432-1033.1994.tb19031.x; Sorokin LM, 2000, EXP CELL RES, V256, P500, DOI 10.1006/excr.2000.4842; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Tiger CF, 1997, J BIOL CHEM, V272, P28590, DOI 10.1074/jbc.272.45.28590; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; Tryggvason K, 1993, CURR OPIN CELL BIOL, V5, P877, DOI 10.1016/0955-0674(93)90038-R; Velling T, 1996, DEV DYNAM, V207, P355, DOI 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G; VONDERMARK H, 1991, J BIOL CHEM, V266, P23593; Yao CC, 1996, J CELL SCI, V109, P3139; Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598; Ziober BL, 1997, MOL BIOL CELL, V8, P1723, DOI 10.1091/mbc.8.9.1723; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773	53	70	73	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6012	6016		10.1074/jbc.M102188200	http://dx.doi.org/10.1074/jbc.M102188200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744715	hybrid			2022-12-27	WOS:000173989200042
J	Ivanov, VN; Krasilnikov, M; Ronai, Z				Ivanov, VN; Krasilnikov, M; Ronai, Z			Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTECTS EPITHELIAL-CELLS; ENDOTHELIAL GROWTH-FACTOR; BINDING PROTEINS RAC1; INDUCED APOPTOSIS; DOWN-REGULATION; AKT ACTIVATION; TYROSINE PHOSPHORYLATION; MALIGNANT-MELANOMA; RELA/P65 SUBUNIT	Cooperation between STAT3 and c-Jun results in suppression of Fas Receptor (FasR) transcription, which is often seen in advanced human tumors. To identify requirements for STAT3-Jun cooperation, we elucidated the role of protein kinases that affect both transcription factors. The phosphatidylinositol 3-kinase (PI3K)-AKT signaling pathway was found capable of down-regulating both STAT3- and c-Jun-dependent transcription, resulting in derepression of FasR transcription. Conversely, inhibition of PI3K-AKT signaling via the specific pharmacological inhibitor LY294002 up-regulated AP1/Jun- and STAT-dependent transcriptional activities, resulting in suppression of the FasR promoter activities and decreased FasR surface expression. PI3K-AKT's ability to affect FasR transcription was not observed in c-jun null fibroblasts, suggesting that c-Jun is required for PI3K/AKT-mediated regulation of FasR transcription. Interestingly, the dominant negative form of Rac1 (RacN17) was also efficient in relieving FasR expression, suggesting that the increase in FasR expression following AKT stimuli could be mediated via AKT ability to elicit suppression of Rac1, which in turn decreases JNK activities and c-Jun phosphorylation. Overall, our findings demonstrate that through its negative effects on both c-Jun and STAT3, the PI3K-AKT pathway disrupts cooperation between c-Jun and STAT3, which is required for silencing the FasR promoter, resulting in increased expression of surface FasR and concomitant sensitization to FasL-mediated programmed cell death.	Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA; Russian Acad Med Sci, Canc Res Ctr, Lab Tumor Biochem, Inst Carcinogenesis, Moscow 115478, Russia	Icahn School of Medicine at Mount Sinai; Russian Academy of Medical Sciences	Ronai, Z (corresponding author), Mt Sinai Sch Med, Ruttenberg Canc Ctr, 1 Gustave Levy Pl,Box 1130, New York, NY 10029 USA.	zeev.ronai@mssm.edu	Ivanov, Vladimir N/A-3081-2008	Ivanov, Vladimir N/0000-0003-3091-9774; Krasil'nikov, Mikhail/0000-0002-5902-7633; RONAI, ZEEV/0000-0002-3859-0400	NATIONAL CANCER INSTITUTE [R01CA051995, R29CA051995] Funding Source: NIH RePORTER; FIC NIH HHS [TW00960] Funding Source: Medline; NCI NIH HHS [CA51995] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cataldi A, 2001, CELL SIGNAL, V13, P369, DOI 10.1016/S0898-6568(01)00147-4; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chakraborty M, 2001, CANCER RES, V61, P7255; Chan H, 1999, MOL CELL BIOL, V19, P2098, DOI 10.1128/mcb.19.3.2098; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Coffer PJ, 1998, BIOCHEM J, V335, P1; Coniglio SJ, 2001, J BIOL CHEM, V276, P28113, DOI 10.1074/jbc.M102299200; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Decaudin D, 2001, EXP CELL RES, V268, P162, DOI 10.1006/excr.2001.5287; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Faruqi TR, 2001, P NATL ACAD SCI USA, V98, P9014, DOI 10.1073/pnas.161281298; Fenton RG, 1998, CANCER RES, V58, P3391; Fukuzawa M, 2001, MOL CELL, V7, P779, DOI 10.1016/S1097-2765(01)00222-2; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Girardin SE, 2001, EMBO J, V20, P3437, DOI 10.1093/emboj/20.13.3437; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Grossman D, 2001, P NATL ACAD SCI USA, V98, P635, DOI 10.1073/pnas.230450097; Gulbins E, 1998, PFLUG ARCH EUR J PHY, V435, P546, DOI 10.1007/s004240050551; Hall A, 1999, BRIT J CANCER, V80, P25; Hausler P, 1998, EUR J IMMUNOL, V28, P57, DOI 10.1002/(SICI)1521-4141(199801)28:01<57::AID-IMMU57>3.0.CO;2-8; Hehner SP, 1999, EUR J BIOCHEM, V264, P132, DOI 10.1046/j.1432-1327.1999.00587.x; Holmstrom TH, 2000, CRIT REV IMMUNOL, V20, P121; Huang CS, 2001, J BIOL CHEM, V276, P40234, DOI 10.1074/jbc.M103684200; Hug H, 1997, BIOL CHEM, V378, P1405; Hyun T, 2000, BLOOD, V96, P3560, DOI 10.1182/blood.V96.10.3560.h8003560_3560_3568; Ivanov VN, 1997, J BIOL CHEM, V272, P8558; Ivanov VN, 1999, J BIOL CHEM, V274, P14079, DOI 10.1074/jbc.274.20.14079; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Ivanov VN, 2000, ONCOGENE, V19, P3003, DOI 10.1038/sj.onc.1203602; Ivanov VN, 2000, ONCOGENE, V19, P933, DOI 10.1038/sj.onc.1203415; Jansen B, 2000, LANCET, V356, P1728, DOI 10.1016/S0140-6736(00)03207-4; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Joneson T, 1999, MOL CELL BIOL, V19, P5892; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Koomagi R, 1999, INT J CANCER, V84, P239, DOI 10.1002/(SICI)1097-0215(19990621)84:3<239::AID-IJC7>3.0.CO;2-S; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krasilnikov M, 1999, MOL CARCINOGEN, V24, P64, DOI 10.1002/(SICI)1098-2744(199901)24:1<64::AID-MC9>3.0.CO;2-2; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Miwa W, 1996, BIOCHEM BIOPH RES CO, V225, P968, DOI 10.1006/bbrc.1996.1280; Mottolese M, 2000, INT J CANCER, V89, P127, DOI 10.1002/(SICI)1097-0215(20000320)89:2<127::AID-IJC5>3.0.CO;2-4; Mouawad R, 2000, MELANOMA RES, V10, P461, DOI 10.1097/00008390-200010000-00008; Mullauer L, 2001, MUTAT RES-REV MUTAT, V488, P211, DOI 10.1016/S1383-5742(01)00057-6; MUTHUKKUMAR S, 1995, MOL CELL BIOL, V15, P6262; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Ning ZQ, 2001, ONCOGENE, V20, P4528, DOI 10.1038/sj.onc.1204590; Owen-Schaub L, 2001, CLIN CANCER RES, V7, P1108; Owen-Schaub LB, 1998, J EXP MED, V188, P1717, DOI 10.1084/jem.188.9.1717; Page C, 2000, INT J ONCOL, V17, P23; Pastorino JG, 1999, J BIOL CHEM, V274, P19411, DOI 10.1074/jbc.274.27.19411; Peli J, 1999, EMBO J, V18, P1824, DOI 10.1093/emboj/18.7.1824; Pfeffer LM, 1997, SCIENCE, V276, P1418, DOI 10.1126/science.276.5317.1418; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Poetsch M, 2001, CANCER GENET CYTOGEN, V125, P21, DOI 10.1016/S0165-4608(00)00353-8; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Ruggeri BA, 1998, MOL CARCINOGEN, V21, P81, DOI 10.1002/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R; Schuringa JJ, 2000, BIOCHEM J, V347, P89, DOI 10.1042/0264-6021:3470089; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Sheng HM, 2001, J BIOL CHEM, V276, P14498, DOI 10.1074/jbc.M010093200; Shin MS, 1999, AM J PATHOL, V154, P1785, DOI 10.1016/S0002-9440(10)65434-X; Simon HU, 1998, BLOOD, V92, P547, DOI 10.1182/blood.V92.2.547.414k02_547_557; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Suhara T, 2001, CIRC RES, V89, P13, DOI 10.1161/hh1301.092506; Suzuki A, 2000, HEPATOLOGY, V32, P796, DOI 10.1053/jhep.2000.17738; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Thompson FH, 1996, CANCER GENET CYTOGEN, V87, P55, DOI 10.1016/0165-4608(95)00248-0; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Tolkacheva T, 2000, ONCOGENE, V19, P680, DOI 10.1038/sj.onc.1203331; Ungefroren H, 1999, ANN NY ACAD SCI, V880, P243, DOI 10.1111/j.1749-6632.1999.tb09529.x; Villunger A, 1997, BLOOD, V90, P12; VUNIC D, 2000, CURR BIOL, V10, P1359; Wan YS, 2001, INT J ONCOL, V18, P461; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5	95	79	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4932	4944		10.1074/jbc.M108233200	http://dx.doi.org/10.1074/jbc.M108233200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733515	Green Published, hybrid			2022-12-27	WOS:000173962900052
J	Kunz, B; Lierheimer, R; Rader, C; Spirig, M; Ziegler, U; Sonderegger, P				Kunz, B; Lierheimer, R; Rader, C; Spirig, M; Ziegler, U; Sonderegger, P			Axonin-1/TAG-1 mediates cell-cell adhesion by a cis-assisted trans-interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; MOLECULE AXONIN-1; FIBRONECTIN DOMAINS; CRYSTAL-STRUCTURE; BINDING; NGCAM; GENE; EXPRESSION; LIGAND	The neural cell adhesion molecule axonin-1/TAG-1 mediates cell-cell interactions via homophilic and heterophilic contacts. It consists of six Ig and four fibronectin type III domains anchored to the membrane by glycosylphosphatidylinositol. The recently solved crystal structure indicates a module composed of the four N-terminal Ig domains as the contact site between trans-interacting axonin-1 molecules from apposed membranes. Here, we have tested domain-specific monoclonal antibodies for their capacity to interfere with homophilic binding in a cell aggregation assay. The results confirmed the existence of a binding region within the N-terminal Ig domains and identified a second region contributing to homophilic binding on the third and fourth fibronectin domains near the C terminus. The perturbation of each region alone resulted in a complete loss of cell aggregation, suggesting that axonin-l-mediated cell-cell contact results from a cooperative action of two homophilic binding regions, The data support that axonin-l-mediated cell-cell contact is formed by cis-assisted trans-binding. The N-terminal binding regions of axonin-1 establish a linear zipper-like string of trans-interacting axonin-1 molecules alternately provided by the two apposed membrane's. The C-terminal binding regions strengthen the cell-cell contact by enhancing the expansion of the linear string into a two-dimensional array via cis-interactions. Cis-assisted trans-binding may be a basic binding mechanism common to many cell adhesion molecules.	Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Sonderegger, P (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Rader, Christoph/0000-0001-9955-3454				Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; FAZEKAS S, 1980, J IMMUNOL METHODS, V35, P1; Fitzli D, 2000, J CELL BIOL, V149, P951, DOI 10.1083/jcb.149.4.951; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Giger RJ, 1997, J NEUROSCI METH, V71, P99, DOI 10.1016/S0165-0270(96)00130-6; GIGER RJ, 1995, EUR J BIOCHEM, V227, P617, DOI 10.1111/j.1432-1033.1995.tb20181.x; HUBER AH, 1994, NEURON, V12, P717, DOI 10.1016/0896-6273(94)90326-3; Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; Kunz S, 1998, J CELL BIOL, V143, P1673, DOI 10.1083/jcb.143.6.1673; Lierheimer R, 1997, EUR J BIOCHEM, V243, P502, DOI 10.1111/j.1432-1033.1997.0502a.x; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; RADER C, 1993, EUR J BIOCHEM, V215, P133, DOI 10.1111/j.1432-1033.1993.tb18015.x; Rader C, 1996, EMBO J, V15, P2056, DOI 10.1002/j.1460-2075.1996.tb00559.x; RUEGG MA, 1989, EMBO J, V8, P55, DOI 10.1002/j.1460-2075.1989.tb03348.x; Sorribas H, 2001, J NEUROSCI METH, V104, P133, DOI 10.1016/S0165-0270(00)00333-2; SUTER DM, 1995, J CELL BIOL, V131, P1067, DOI 10.1083/jcb.131.4.1067; Tsiotra PC, 1996, J BIOL CHEM, V271, P29216, DOI 10.1074/jbc.271.46.29216; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	22	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4551	4557		10.1074/jbc.M109779200	http://dx.doi.org/10.1074/jbc.M109779200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733523	hybrid, Green Accepted			2022-12-27	WOS:000173813900099
J	Blumenstein, Y; Kanevsky, N; Sahar, G; Barzilai, R; Ivanina, T; Dascal, N				Blumenstein, Y; Kanevsky, N; Sahar, G; Barzilai, R; Ivanina, T; Dascal, N			A novel long N-terminal isoform of human L-type Ca2+ channel is up-regulated by protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; ALPHA(1C) SUBUNIT; XENOPUS OOCYTES; FUNCTIONAL EXPRESSION; SPLICE VARIANTS; MODULATION; PHOSPHORYLATION; INHIBITION; CURRENTS; CLONING	Human L-type voltage-dependent Ca2+ channels (alpha(1C), or Ca(v)1.2) are up-regulated by protein kinase C (PKC) in native tissues, but in heterologous systems this modulation is absent. In rat and rabbit, alpha(1C) has two N-terminal (NT) isoforms, long and short, with variable initial segments of 46 and 16 amino acids, respectively. The initial 46 amino acids of the long-NT alpha(1c) are crucial for PKC regulation. However, only a short-NT human a1c is known. We assumed that a Iong-NT isoform of human a,c may exist. By homology screening of human genomic DNA, we identified a stretch (termed exon 1a) highly homologous to rabbit long-NT, separated from the next known exon of alpha(1c) (exon lb, which encodes the alternative, short-NT) by an similar to80 kb-long intron. The predicted 46-amino acid protein sequence is highly homologous to rabbit long-NT. Reverse transcriptase PCR showed the presence of exon la transcript in human cardiac RNA. Expression of human long(.)NT alpha(1c) in Xenopus oocytes produced Ca2+ channel enhanced by a PKC activator, whereas the short-NT alpha(1c) was inhibited. The long-NT isoform may be the Ca2+ channel enhanced by PKC-activating transmitters in human tissues.	Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.		Dascal, Nathan/O-3915-2015	Dascal, Nathan/0000-0002-5397-4146				BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Boixel C, 2000, AM J PHYSIOL-HEART C, V278, pH670, DOI 10.1152/ajpheart.2000.278.2.H670; BOURINET E, 1992, PFLUG ARCH EUR J PHY, V421, P247, DOI 10.1007/BF00374834; Bouron A, 1995, FEBS LETT, V377, P159, DOI 10.1016/0014-5793(95)01327-X; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Dascal N., 1992, METHODS MOL BIOL VOL, VVolume 13, P205; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fearon IM, 2000, CIRC RES, V87, P537, DOI 10.1161/01.RES.87.7.537; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Hernandez ME, 1999, NEUROENDOCRINOLOGY, V70, P31, DOI 10.1159/000054457; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Klockner U, 1997, AM J PHYSIOL-HEART C, V272, pH1372, DOI 10.1152/ajpheart.1997.272.3.H1372; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; LACERDA AE, 1988, NATURE, V335, P249, DOI 10.1038/335249a0; Love JA, 1998, AM J PHYSIOL-GASTR L, V274, pG397, DOI 10.1152/ajpgi.1998.274.2.G397; McHugh D, 2000, P NATL ACAD SCI USA, V97, P12334, DOI 10.1073/pnas.210384297; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; REEVE HL, 1995, PFLUG ARCH EUR J PHY, V429, P729, DOI 10.1007/BF00373996; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; Savignac M, 2001, FASEB J, V15, P1577, DOI 10.1096/fj.00-0733fje; SCHUHMANN K, 1994, FEBS LETT, V341, P208, DOI 10.1016/0014-5793(94)80458-3; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Shistik E, 1999, J BIOL CHEM, V274, P31145, DOI 10.1074/jbc.274.44.31145; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SINGERLAHAT D, 1992, FEBS LETT, V306, P113, DOI 10.1016/0014-5793(92)80980-U; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SOLDATOV NM, 1995, J BIOL CHEM, V270, P10540, DOI 10.1074/jbc.270.18.10540; SOLDATOV NM, 1994, GENOMICS, V22, P77, DOI 10.1006/geno.1994.1347; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; TSENG GN, 1991, AM J PHYSIOL, V261, pH364, DOI 10.1152/ajpheart.1991.261.2.H364; Wang XT, 2000, AM J PATHOL, V157, P1549, DOI 10.1016/S0002-9440(10)64792-X; Yang YB, 2000, J MOL CELL CARDIOL, V32, P973, DOI 10.1006/jmcc.2000.1138; Zuhlke RD, 1998, FEBS LETT, V427, P220, DOI 10.1016/S0014-5793(98)00425-6	35	41	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 1	2002	277	5					3419	3423		10.1074/jbc.C100642200	http://dx.doi.org/10.1074/jbc.C100642200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	518VF	11741969	hybrid			2022-12-27	WOS:000173688000049
J	Delobel, P; Flament, S; Hamdane, M; Jakes, R; Rousseau, A; Delacourte, A; Vilain, JP; Goedert, M; Buee, L				Delobel, P; Flament, S; Hamdane, M; Jakes, R; Rousseau, A; Delacourte, A; Vilain, JP; Goedert, M; Buee, L			Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL DEMENTIA; MICROTUBULE-BINDING; PROTEIN-TAU; MISSENSE MUTATIONS; PROLINE-RICH; PHOSPHORYLATION; KINASE; ISOFORMS; CHROMOSOME-17; DOMAINS	tau gene mutations cause frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Here we have used Xenopus oocyte maturation as an indicator of microtubule function. We show that wildtype four-repeat Tau protein inhibits maturation in a concentration-dependent manner, whereas three-repeat Tau has no effect. Of the seven four-repeat Tau proteins with FTDP-17 mutations tested, five (G272V, DeltaK280, P301L, P301S, and V337M) failed to interfere significantly with oocyte maturation, demonstrating a greatly reduced ability to interact with microtubules. One mutant protein (R406W) almost behaved like wildtype Tau, and one (S305N) inhibited maturation more strongly than wild-type Tau. With the exception of R406W, wild-type Tau and all the mutants studied were similarly phosphorylated during the Xenopus oocyte maturation, and this was independent of their effects on this process. Data obtained with R406W and S305N may be related to charge changes (phosphorylation and basic amino acids). Our results demonstrate variable effects of FTDP-17 mutations on microtubules in an intact cell situation. Those findings establish Xenopus oocyte maturation as a system allowing the study of the functional effects of tau gene mutations in a quantitative manner.	INSERM, U422, IMPRT, F-59045 Lille, France; Univ Lille 1, EA 1033, F-59655 Villeneuve Dascq, France; Univ Nancy 1, EA 3442, F-54505 Vandoeuvre Les Nancy, France; MRC, Lab Mol Biol, Cambridge CB2 2QH, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lorraine; MRC Laboratory Molecular Biology	Buee, L (corresponding author), INSERM, U422, IMPRT, Pl Verdun, F-59045 Lille, France.		BUEE, Luc/B-3126-2010	BUEE, Luc/0000-0002-6261-4230; Hamdane, Malika/0000-0001-7971-8696				Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Bodart JF, 1999, EXP CELL RES, V253, P413, DOI 10.1006/excr.1999.4662; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; DeTure M, 2000, BRAIN RES, V853, P5, DOI 10.1016/S0006-8993(99)02124-1; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; GARD DL, 1987, J CELL BIOL, V105, P2191, DOI 10.1083/jcb.105.5.2191; Goedert M, 2000, J NEUROCHEM, V75, P2155, DOI 10.1046/j.1471-4159.2000.0752155.x; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; Heutink P, 2000, HUM MOL GENET, V9, P979, DOI 10.1093/hmg/9.6.979; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Litman P, 1996, DEV BIOL, V176, P86, DOI 10.1006/dbio.1996.9992; Mailliot C, 2000, J CEREBR BLOOD F MET, V20, P543, DOI 10.1097/00004647-200003000-00013; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Miyasaka T, 2001, AM J PATHOL, V158, P373, DOI 10.1016/S0002-9440(10)63979-X; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Paudel HK, 1997, J BIOL CHEM, V272, P1777; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Preuss U, 1997, J CELL SCI, V110, P789; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741; Varani L, 1999, P NATL ACAD SCI USA, V96, P8229, DOI 10.1073/pnas.96.14.8229; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Yen SH, 1999, BRAIN PATHOL, V9, P695	44	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9199	9205		10.1074/jbc.M107716200	http://dx.doi.org/10.1074/jbc.M107716200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11756436	hybrid			2022-12-27	WOS:000174400600063
J	Kawabata, H; Kawahara, K; Kanekura, T; Araya, N; Daitoku, H; Hatta, M; Miura, N; Fukamizu, A; Kanzaki, T; Maruyama, I; Nakajima, T				Kawabata, H; Kawahara, K; Kanekura, T; Araya, N; Daitoku, H; Hatta, M; Miura, N; Fukamizu, A; Kanzaki, T; Maruyama, I; Nakajima, T			Possible role of transcriptional coactivator P/CAF and nuclear acetylation in calcium-induced keratinocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; LINKING HISTONE ACETYLATION; MYOCYTE ENHANCER FACTOR-2; EPIDERMAL DIFFERENTIATION; MEDIATED TRANSCRIPTION; EXTRACELLULAR CALCIUM; CELL-PROLIFERATION; GENE-EXPRESSION; HUMAN-SKIN; CBP	Several nuclear factors, called coactivators, such as CREB (cAMP response element binding protein)-binding protein (CBP) and p300/CBP associated factor (P/CAF), have intrinsic histone acetyltransferase (HAT) activity. Recent studies have shown that, in addition to histones, transcriptional regulatory molecules are also targets of HATs, and nuclear acetylation is thought to be involved in several biological events. We observed that a high concentration of calcium induced HAT activity in the keratinocyte cell line, HaCaT. The steady-state level of specific acetylated nuclear proteins changed in a dynamic fashion in HaCaT cells induced with 1.2 mM calcium. One (similar to97-kDa acetylated protein designated as ap97) was transiently induced, one (ap78) was induced and then continuously expressed, and one (ap70) disappeared with time. Although the up-regulation of ap70 and ap78 was not influenced by GF109203X, a specific inhibitor of protein kinase C (PKC), the calcium-induced accumulation of ap97 and the induction of P/CAF HAT activity were similarly attenuated by GF109203X. Notably, mutant P/CAF lacking HAT activity repressed the expression of ap97 and involucrin, a keratinocyte differentiation marker. Our results suggest that P/CAF HAT activity and induction of ap97 are involved in calcium-dependent keratinocyte differentiation.	St Marianna Univ, Sch Med, Inst Med Sci, Inst Genome Sci,Miyamae Ku, Kawasaki, Kanagawa 2168512, Japan; Kagoshima Univ, Fac Med, Dept Dermatol, Kagoshima 8908520, Japan; Kagoshima Univ, Fac Med, Mol Med Lab, Kagoshima 8908520, Japan; Univ Tsukuba, Tsukuba Adv Res Alliance Ctr, Inst Appl Biochem, Tsukuba, Ibaraki 3050001, Japan	Saint Marianna University; Kagoshima University; Kagoshima University; University of Tsukuba	Nakajima, T (corresponding author), St Marianna Univ, Sch Med, Inst Med Sci, Inst Genome Sci,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168512, Japan.	nakashit@marianna-u.ac.jp	fukamizu, akiyoshi/J-5350-2012; Miura, Naoki/O-6997-2016; Miura, Naoki/A-5734-2010	fukamizu, akiyoshi/0000-0002-8786-6020; Miura, Naoki/0000-0002-4625-5231; Miura, Naoki/0000-0002-4625-5231				Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Boisvert FM, 2001, J CELL BIOL, V152, P1099, DOI 10.1083/jcb.152.5.1099; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BOYNTON AL, 1977, J CELL PHYSIOL, V92, P241, DOI 10.1002/jcp.1040920212; BOYNTON AL, 1974, IN VITRO CELL DEV B, V10, P12, DOI 10.1007/BF02615333; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DLUGOSZ AA, 1994, J INVEST DERMATOL, V102, P409, DOI 10.1111/1523-1747.ep12372171; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; FISHER GJ, 1993, J INVEST DERMATOL, V101, P553, DOI 10.1111/1523-1747.ep12365967; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Goyette P, 2000, J BIOL CHEM, V275, P16497, DOI 10.1074/jbc.M909382199; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Janknecht R, 1996, CURR BIOL, V6, P951, DOI 10.1016/S0960-9822(02)00636-X; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kawahara K, 1999, BIOCHEM BIOPH RES CO, V266, P417, DOI 10.1006/bbrc.1999.1812; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Miyagishi M, 2000, J BIOL CHEM, V275, P35170, DOI 10.1074/jbc.C000258200; Mizzen CA, 1998, CELL MOL LIFE SCI, V54, P6, DOI 10.1007/s000180050121; Montminy M, 1997, NATURE, V387, P654, DOI 10.1038/42594; MURPHY GF, 1984, J INVEST DERMATOL, V82, P453, DOI 10.1111/1523-1747.ep12260945; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; NAKAJIMA T, 1994, BIOCHEM BIOPH RES CO, V204, P950, DOI 10.1006/bbrc.1994.2552; Ng DC, 2000, J BIOL CHEM, V275, P24080, DOI 10.1074/jbc.M002508200; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seeler JS, 1999, CURR OPIN GENET DEV, V9, P362, DOI 10.1016/S0959-437X(99)80054-9; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; STANLEY JR, 1983, J CELL BIOL, V96, P1809, DOI 10.1083/jcb.96.6.1809; Stempka L, 1997, J BIOL CHEM, V272, P6805, DOI 10.1074/jbc.272.10.6805; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; STUURMAN N, 1992, J CELL SCI, V101, P773; Thomas T, 2000, DEVELOPMENT, V127, P2537; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VOLLBERG TM, 1992, MOL ENDOCRINOL, V6, P667, DOI 10.1210/mend.6.5.1318502; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Yuan LW, 2000, J BIOL CHEM, V275, P40946, DOI 10.1074/jbc.M007832200; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zhou Q, 2000, J BIOL CHEM, V275, P35256, DOI 10.1074/jbc.M003106200	69	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8099	8105		10.1074/jbc.M108250200	http://dx.doi.org/10.1074/jbc.M108250200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741939	hybrid			2022-12-27	WOS:000174268000061
J	Kim, SW; Fang, X; Ji, H; Paulson, AF; Daniel, JM; Ciesiolka, M; van Roy, F; McCrea, PD				Kim, SW; Fang, X; Ji, H; Paulson, AF; Daniel, JM; Ciesiolka, M; van Roy, F; McCrea, PD			Isolation and characterization of XKaiso, a transcriptional repressor that associates with the catenin Xp120(ctn) in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTERACTION MOTIF; HUMAN P120(CTN) CATENIN; FINGER ENCODING GENE; PLZF-RAR-ALPHA; E-CADHERIN; P120 CATENIN; BETA-CATENIN; POZ DOMAIN; BTB/POZ DOMAIN; DROSOPHILA METAMORPHOSIS	The Armadillo family of catenin proteins function in multiple capacities including cadherin-mediated cell-cell adhesion and nuclear signaling. The newest catenin, p120(ctn), differs from the classical catenins and binds to the membrane-proximal domain of cadherins. Recently, a novel transcription factor Kaiso was found to interact with p120(ctn), suggesting that p120(ctn) also possesses a nuclear function. We isolated the Xenopus homolog of Kaiso, XKaiso, from a Xenopus stage 17 cDNA library. XKaiso contains an amino-terminal BTB/POZ domain and three carboxyl-terminal zinc fingers. The XKaiso transcript was present maternally and expressed throughout early embryonic development. XKaiso's spatial expression was defined via in situ hybridization and was found localized to the brain, eye, ear, branchial arches, and spinal cord. Co-immunoprecipitation of Xenopus p120(ctn) and XKaiso demonstrated their mutual association, whereas related experiments employing differentially epitope-tagged XKaiso constructs suggest that XKaiso additionally self-associates. Finally, reporter assays employing a chimera of XKaiso fused to the GAL4 DNA binding domain indicate that XKaiso is a transcriptional repressor. These data suggest that XKaiso functions throughout development and that its repressor functions may be most apparent in the context of neural tissues. The significance of the XKaiso-p120(ctn) interaction has yet to be determined, but it may include transducing information from cadherin-mediated cell-cell contacts to transcriptional processes within the nucleus.	Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA; McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; State Univ Ghent VIB, Dept Mol Biol, B-9000 Ghent, Belgium	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; McMaster University; Flanders Institute for Biotechnology (VIB); Ghent University	McCrea, PD (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Box 117,1515 Holcombe Blvd, Houston, TX 77030 USA.	pmccrea@odin.mdacc.tmc.edu	van Roy, Frans M/C-6123-2009	van Roy, Frans M/0000-0003-4358-1039	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052112] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 52112, R01 GM052112] Funding Source: Medline; ODCDC CDC HHS [CCSG-CA 16672] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ODCDC CDC HHS		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Aho S, 1999, J CELL BIOCHEM, V73, P390, DOI 10.1002/(SICI)1097-4644(19990601)73:3<390::AID-JCB10>3.3.CO;2-T; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; ALMOUZNI G, 1995, EMBO J, V14, P1752, DOI 10.1002/j.1460-2075.1995.tb07164.x; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brennan CA, 2001, DEVELOPMENT, V128, P1; BROWN JL, 1993, DEVELOPMENT, V117, P45; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; CHEN W, 1995, MOL CELL BIOL, V15, P3424; CHEN Z, 1994, P NATL ACAD SCI USA, V91, P1178, DOI 10.1073/pnas.91.3.1178; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 2000, ONCOGENE, V19, P6240, DOI 10.1038/sj.onc.1203976; DOWNING JR, 1991, ONCOGENE, V6, P607; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; EMERY IF, 1994, DEVELOPMENT, V120, P3275; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Fedele M, 2000, J BIOL CHEM, V275, P7894, DOI 10.1074/jbc.275.11.7894; Geis K, 1998, DEV GENES EVOL, V207, P471, DOI 10.1007/s004270050138; GODT D, 1993, DEVELOPMENT, V119, P799; Goto T, 2001, DEV DYNAM, V221, P14, DOI 10.1002/dvdy.1121; Grosheva I, 2001, J CELL SCI, V114, P695; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Gumbiner BM, 1998, CURR OPIN GENET DEV, V8, P430, DOI 10.1016/S0959-437X(98)80114-7; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Hoatlin ME, 1999, BLOOD, V94, P3737, DOI 10.1182/blood.V94.11.3737.423k39_3737_3747; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Kaplan J, 1997, NUCLEIC ACIDS RES, V25, P1108, DOI 10.1093/nar/25.6.1108; Keilhack H, 2000, J BIOL CHEM, V275, P26376, DOI 10.1074/jbc.M001315200; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KINTNER CR, 1987, DEVELOPMENT, V99, P311; Korswagen HC, 1999, COLD SPRING HARB SYM, V64, P141, DOI 10.1101/sqb.1999.64.141; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Li XM, 1999, CANCER RES, V59, P5275; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nieset JE, 1997, J CELL SCI, V110, P1013; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Paulson AF, 2000, J BIOL CHEM, V275, P30124, DOI 10.1074/jbc.M003048200; Paulson AF, 1999, DEV BIOL, V207, P350, DOI 10.1006/dbio.1998.9158; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Polakis P, 2000, GENE DEV, V14, P1837; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SIVE HL, 2000, EARLY DEV XENOPUS LA; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; XU LC, 1993, NUCLEIC ACIDS RES, V21, P2775, DOI 10.1093/nar/21.11.2775; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717; Zondag GCM, 2000, J BIOL CHEM, V275, P11264, DOI 10.1074/jbc.275.15.11264	79	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8202	8208		10.1074/jbc.M109508200	http://dx.doi.org/10.1074/jbc.M109508200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751886	hybrid			2022-12-27	WOS:000174268000074
J	Knochel, T; Pappenberger, A; Jansonius, JN; Kirschner, K				Knochel, T; Pappenberger, A; Jansonius, JN; Kirschner, K			The crystal structure of indoleglycerol-phosphate synthase from Thermotoga maritima - Kinetic stabilization by salt bridges	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; SULFOLOBUS-SOLFATARICUS; BIFUNCTIONAL ENZYME; 3-DIMENSIONAL STRUCTURE; POSSIBLE DETERMINANTS; THERMAL-STABILITY; PROTEIN STABILITY; ESCHERICHIA-COLI; HYPERTHERMOPHILE; DESIGN	The crystal structure of the thermostable indoleglycerol-phosphate synthase from Thermotoga maritima (tIGPS) was determined at 2.5 Angstrom resolution. It was compared with the structures of the thermostable sIGPS from Sulfolobus solfataricus and of the thermolabile eIGPS from Escherichia coli. The main chains of the three (betaalpha)(8)-barrel proteins superimpose closely, and the packing of side chains in the beta-barrel cores, as well as the architecture of surface loops, is very similar. Both thermostable proteins have, however, 17 strong salt bridges, compared with only 10 in eIGPS. The number of additional salt bridges in tIGPS and sIGPS correlates well with their reduced rate of irreversible thermal inactivation at 90 degreesC. Only 3 of 17 salt bridges in tIGPS and sIGPS are topologically conserved. The major difference between the two proteins is the preference for interhelical salt bridges in sIGPS and intrahelical ones in tIGPS. The different implementation of salt bridges in the closely related proteins suggests that the stabilizing effect of salt bridges depends rather on the sum of their individual contributions than on their location. This observation is consistent with a protein unfolding mechanism where the simultaneous breakdown of all salt bridges is the rate-determining step.	Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland; Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland	University of Basel; University of Basel	Knochel, T (corresponding author), Pfizer Global Res & Dev, IPC 636,Ramsgate Rd, Sandwich CT13 9NJ, Kent, England.	thorsten_knoechel@sandwich.pfizer.com						Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294; Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3369, DOI 10.1021/bi9721795; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; EBERHARD M, 1995, BIOCHEMISTRY-US, V34, P5419, DOI 10.1021/bi00016a013; Grimsley GR, 1999, PROTEIN SCI, V8, P1843, DOI 10.1110/ps.8.9.1843; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; HEINZ DW, 1994, PROTEIN ENG, V7, P301, DOI 10.1093/protein/7.3.301; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Hennig M, 1997, BIOCHEMISTRY-US, V36, P6009, DOI 10.1021/bi962718q; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Hough DW, 1999, CURR OPIN CHEM BIOL, V3, P39, DOI 10.1016/S1367-5931(99)80008-8; HUBBARD SJ, 1994, PROTEIN ENG, V7, P613, DOI 10.1093/protein/7.5.613; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; JONES TA, 1985, METHOD ENZYMOL, V115, P157; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; KIEFHABER T, 1995, NATURE, V375, P513, DOI 10.1038/375513a0; Knochel TR, 1996, J MOL BIOL, V262, P502, DOI 10.1006/jmbi.1996.0531; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Loladze VV, 1999, BIOCHEMISTRY-US, V38, P16419, DOI 10.1021/bi992271w; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i; Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709; Mueller U, 2000, J MOL BIOL, V297, P975, DOI 10.1006/jmbi.2000.3602; Nagano N, 1999, PROTEIN SCI, V8, P2072, DOI 10.1110/ps.8.10.2072; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Perl D, 2000, NAT STRUCT BIOL, V7, P380; PRIESTLE JP, 1987, P NATL ACAD SCI USA, V84, P5690, DOI 10.1073/pnas.84.16.5690; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121; Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006; STERNER R, 1995, EMBO J, V14, P4395, DOI 10.1002/j.1460-2075.1995.tb00118.x; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Strop P, 2000, PROTEIN SCI, V9, P1391, DOI 10.1110/ps.9.7.1391; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Thoma R, 2000, STRUCTURE, V8, P265, DOI 10.1016/S0969-2126(00)00106-4; WILMANNS M, 1991, BIOCHEMISTRY-US, V30, P9161, DOI 10.1021/bi00102a006; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; Yamagata Y, 2001, J BIOL CHEM, V276, P11062, DOI 10.1074/jbc.M009987200	56	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8626	8634		10.1074/jbc.M109517200	http://dx.doi.org/10.1074/jbc.M109517200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741953	hybrid			2022-12-27	WOS:000174268000128
J	Sudhof, TC				Sudhof, TC			Synaptotagmins: Why so many?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE-C; GIRDLE MUSCULAR-DYSTROPHY; SYNAPTIC VESICLE; PHOSPHOLIPID-BINDING; CA2+ BINDING; PC12 CELLS; C2B DOMAIN; GENE; MULTIPLE; IV		Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, 6000 Harry Hines Blvd,NA4118, Dallas, TX 75390 USA.	Thomas.Sudhof@UTSouthwestern.edu						Achanzar WE, 1997, J CELL SCI, V110, P1073; Babity JM, 1997, P NATL ACAD SCI USA, V94, P2638, DOI 10.1073/pnas.94.6.2638; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Berton F, 2000, EUR J NEUROSCI, V12, P1294, DOI 10.1046/j.1460-9568.2000.00013.x; Britton S, 2000, GENOMICS, V68, P313, DOI 10.1006/geno.2000.6290; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1996, BIOCHEM BIOPH RES CO, V225, P326, DOI 10.1006/bbrc.1996.1174; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Craxton M, 1999, FEBS LETT, V460, P417, DOI 10.1016/S0014-5793(99)01382-4; CRAXTON M, 1995, FEBS LETT, V361, P196, DOI 10.1016/0014-5793(95)00176-A; Damer CK, 1996, J NEUROCHEM, V67, P1661; DAVLETOV B, 1993, J BIOL CHEM, V268, P6816; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Fergestad T, 2001, J NEUROSCI, V21, P1218; Ferguson GD, 2000, P NATL ACAD SCI USA, V97, P5598, DOI 10.1073/pnas.100104597; Ferguson GD, 1999, J NEUROCHEM, V72, P1821, DOI 10.1046/j.1471-4159.1999.0721821.x; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2000, FEBS LETT, V482, P269, DOI 10.1016/S0014-5793(00)02064-0; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Fukuda M, 2001, J BIOL CHEM, V276, P27670, DOI 10.1074/jbc.M100851200; Fukuda M, 2001, J NEUROCHEM, V77, P730, DOI 10.1046/j.1471-4159.2001.00266.x; Fukuda M, 2001, BIOCHEM J, V354, P249, DOI 10.1042/0264-6021:3540249; Fukuda M, 2000, P NATL ACAD SCI USA, V97, P14715, DOI 10.1073/pnas.260491197; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2001, EMBO J, V20, P1605, DOI 10.1093/emboj/20.7.1605; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; HILBUSH BS, 1994, P NATL ACAD SCI USA, V91, P8195, DOI 10.1073/pnas.91.17.8195; Hilfiker S, 1999, J NEUROCHEM, V73, P921, DOI 10.1046/j.1471-4159.1999.0730921.x; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; Ibata K, 1998, J BIOL CHEM, V273, P12267, DOI 10.1074/jbc.273.20.12267; Kee Y, 1996, J NEUROSCI, V16, P1975; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; LLINAS R, 1994, P NATL ACAD SCI USA, V91, P12990, DOI 10.1073/pnas.91.26.12990; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; MARQUEZE B, 1995, J NEUROSCI, V15, P4906; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; Morris NJ, 1999, BBA-PROTEIN STRUCT M, V1431, P525, DOI 10.1016/S0167-4838(99)00068-0; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Phillips AM, 2000, J NEUROSCI, V20, P8254, DOI 10.1523/JNEUROSCI.20-22-08254.2000; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUGITA S, 2002, IN PRESS EMBO J; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Thomas DM, 1999, MOL BIOL CELL, V10, P2285, DOI 10.1091/mbc.10.7.2285; Thompson CC, 1996, J NEUROSCI, V16, P7832; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200; von Poser C, 2001, EUR J CELL BIOL, V80, P41; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	85	369	390	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7629	7632		10.1074/jbc.R100052200	http://dx.doi.org/10.1074/jbc.R100052200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11739399	hybrid			2022-12-27	WOS:000174268000001
J	Chen, YH; Chen, APC; Chen, CT; Wang, AHJ; Liang, PH				Chen, YH; Chen, APC; Chen, CT; Wang, AHJ; Liang, PH			Probing the conformational change of Escherichia coli undecaprenyl pyrophosphate synthase during catalysis using an inhibitor and tryptophan mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL THYMIDYLATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; DIPHOSPHATE SYNTHASES; CIS-PRENYLTRANSFERASE; MOLECULAR-CLONING; EXPRESSION; PURIFICATION; SYNTHETASE; DOMAIN; GENE	Undecaprenyl pyrophosphate synthase (UPPS) catalyzes the consecutive condensation reactions of eight isopentenyl pyrophosphate (IPP) with farnesyl pyrophosphate (FPP) to generate C-55 undecaprenyl pyrophosphate (UPP). In the present study, site-directed mutagenesis, fluorescence quenching, and stopped-flow methods were utilized to examine the substrate binding and the protein conformational change. (S)-Farnesyl thiopyrophosphate (FsPP), a FPP analogue, was synthesized to probe the enzyme inhibition and events associated with the protein fluorescence change. This compound with a much less labile thiopyrophosphate shows K-i value of 0.2 mum in the inhibition of Escherichia coli UPPS and serves as a poor substrate, with the k(cat) value (3.1 X 10(-7) s(-1)) 10(7) times smaller than using FPP as the substrate. Reduction of protein intrinsic fluorescence was observed upon addition of FPP (or FsPP) to the UPPS solution. Moreover, fluorescence studies carried out using W91F and other mutant UPPS with Trp replaced by Phe indicate that FPP binding mainly quenches the fluorescence of Trp-91, a residue in the alpha3 helix that moves toward the active site during substrate binding. Using stopped-flow apparatus, a three-phase protein fluorescence change with time was observed by mixing the E-FPP complex with IPP in the presence of Mg2+. However, during the binding of E-FsPP with IPP, only the fastest phase was observed. These results suggest that the first phase is due to the IPP binding to E-FPP complex, and the other two slow phases are originated from the protein conformational change. The two slow phases coincide with the time course of FPP chain elongation from C-15 to C-55 and product release.	Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; Natl Taiwan Univ, Dept Chem, Taipei 10098, Taiwan; Natl Taiwan Univ, Inst Biochem Sci, Taipei 10098, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Liang, PH (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.		Hu, Ruogu/B-2203-2008; Liang, Po-Huang/H-6610-2015	Liang, Po-Huang/0000-0003-1207-5256; Chen, Yi-Hung/0000-0001-6731-1119				ALLEN CM, 1985, METHOD ENZYMOL, V110, P281; Apfel CM, 1999, J BACTERIOL, V181, P483, DOI 10.1128/JB.181.2.483-492.1999; FERSHT A, 1984, ENZYME STRUCTURE MEC, P99; Fujihashi M, 2001, P NATL ACAD SCI USA, V98, P4337, DOI 10.1073/pnas.071514398; Fujikura K, 2000, J BIOCHEM, V128, P917, DOI 10.1093/oxfordjournals.jbchem.a022842; HUSSEY H, 1976, ENZYMES BIOLOGICAL M, V2, P227; Kharel Y, 2001, J BIOL CHEM, V276, P28459, DOI 10.1074/jbc.M102057200; Ko TP, 2001, J BIOL CHEM, V276, P47474, DOI 10.1074/jbc.M106747200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liang PH, 1998, BIOCHEMISTRY-US, V37, P12206, DOI 10.1021/bi9803170; Liang PH, 1998, BIOCHEMISTRY-US, V37, P12195, DOI 10.1021/bi9803168; Ogura K, 1998, CHEM REV, V98, P1263, DOI 10.1021/cr9600464; Ogura K, 1997, Subcell Biochem, V28, P57; Oh SK, 2000, J BIOL CHEM, V275, P18482, DOI 10.1074/jbc.M002000200; Pan JJ, 2000, BIOCHEMISTRY-US, V39, P10936, DOI 10.1021/bi000992l; Pan JJ, 2000, BIOCHEMISTRY-US, V39, P13856, DOI 10.1021/bi001226h; Phan RM, 2000, ORG LETT, V2, P2287, DOI 10.1021/ol006055n; ROBYT J, 1998, ESSENTIALS CARBOHYDR, P305; Sato M, 1999, MOL CELL BIOL, V19, P471; Schulbach MC, 2000, J BIOL CHEM, V275, P22876, DOI 10.1074/jbc.M003194200; Segel I. H., 1993, ENZYME KINETICS BEHA, P100; Shimizu N, 1998, J BIOL CHEM, V273, P19476, DOI 10.1074/jbc.273.31.19476	22	36	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7369	7376		10.1074/jbc.M110014200	http://dx.doi.org/10.1074/jbc.M110014200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744728	Green Published, hybrid			2022-12-27	WOS:000174104300081
J	D'Agostino, D; Cordle, RA; Kullman, J; Erlanson-Albertsson, C; Muglia, LJ; Lowe, ME				D'Agostino, D; Cordle, RA; Kullman, J; Erlanson-Albertsson, C; Muglia, LJ; Lowe, ME			Decreased postnatal survival and altered body weight regulation in procolipase-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; PANCREATIC TRIGLYCERIDE LIPASE; BILE-ACID; IN-VIVO; COLIPASE; ACTIVATION; DISRUPTION; OBESITY; ENTEROSTATIN; PURIFICATION	In vitro, pancreatic triglyceride lipase requires colipase to restore activity in the presence of inhibitors, like bile acids. Presumably, colipase performs the same function in vivo, but little data supports that notion. Other studies suggest that colipase or its proform, procolipase, may have additional functions in appetite regulation or in fat digestion during the newborn period when pancreatic triglyceride lipase is not expressed. To identify the physiological role of procolipase, we created a mouse model of procolipase deficiency. The Clps(-/-) mice appeared normal at birth, but unexpectedly 60% died within the first 2 weeks of life. The survivors had fat malabsorption as newborns and as adults, but only when fed a high fat diet. On a low fat diet, the Clps(-/-) mice did not have steatorrhea. The Clps(-/-) pups had impaired weight gain and weighed 30% less than Clps(+/+) or Clps(+/-) littermates. After weaning, the Clps(-/-) mice had normal rate of weight gain, but they maintained a reduced body weight compared with normal littermates even on a low fat diet. Despite the reduced body weight, the Clps(-/-) mice had a normal body temperature. To maintain their weight gain in the presence of steatorrhea, the Clps(-/-) mice had hyperphagia on a high fat diet. Clps(-/-) mice had normal intake on a low fat diet. We conclude that, in addition to its critical role in fat digestion, procolipase has essential functions in postnatal development and in regulating body weight set point.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; St Louis Childrens Hosp, St Louis, MO 63110 USA; Lund Univ, Ctr Biomed, Dept Cell & Mol Biol, S-22184 Lund, Sweden	Washington University (WUSTL); Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Lund University	Lowe, ME (corresponding author), Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.			Erlanson-Albertsson, Charlotte/0000-0002-9752-1149	Intramural NIH HHS [Z01 DK053100] Funding Source: Medline; NIDDK NIH HHS [P30 DK052574, DK 56341, R01 DK053100, R01 DK053100-09, P30 DK056341, DK 52574] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053100, Z01DK053100, P30DK052574, P30DK056341] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BITMAN J, 1981, J LIQ CHROMATOGR, V4, P1023, DOI 10.1080/01483918108059602; BITMAN J, 1981, J LIQ CHROMATOGR, V4, P1007, DOI 10.1080/01483918108059601; BORGSTROM B, 1979, FEBS LETT, V108, P407, DOI 10.1016/0014-5793(79)80574-8; Borgstrom B., 1984, PANCREATIC COLIPASE, P152; BRAY G, 2001, HDB PHYSL ENDOCRINE, P1015; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; COLEMAN T, 1995, J BIOL CHEM, V270, P12518, DOI 10.1074/jbc.270.21.12518; ERLANSONALBERTSSON C, 1992, NUTR REV, V50, P307, DOI 10.1111/j.1753-4887.1992.tb02473.x; GILLER T, 1992, J BIOL CHEM, V267, P16509; HILDEBRAND H, 1982, GUT, V23, P243, DOI 10.1136/gut.23.3.243; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; JENNENS ML, 1995, J LIPID RES, V36, P2374; KEESEY RE, 1977, J NUTR, V127, P1875; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kullman J, 1996, AM J PHYSIOL-GASTR L, V270, pG746, DOI 10.1152/ajpgi.1996.270.5.G746; LOWE ME, 1994, GASTROENTEROLOGY, V107, P1524, DOI 10.1016/0016-5085(94)90559-2; Lowe ME, 1998, J BIOL CHEM, V273, P31215, DOI 10.1074/jbc.273.47.31215; LOWE ME, 1990, BIOCHEMISTRY-US, V29, P823, DOI 10.1021/bi00455a032; LOWE ME, 1992, J BIOL CHEM, V267, P17069; Lowe ME, 1998, METHODS MOL BIOL LIP, P59; MUGLIA LJ, 1994, J CLIN INVEST, V93, P2066, DOI 10.1172/JCI117201; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Rippe C, 2000, AM J PHYSIOL-ENDOC M, V279, pE293, DOI 10.1152/ajpendo.2000.279.2.E293; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Sambrook J., 2002, MOL CLONING LAB MANU; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; Severinsen T, 1999, ACTA PHYSIOL SCAND, V165, P299, DOI 10.1046/j.1365-201x.1999.00488.x; STERNBY B, 1984, BIOCHIM BIOPHYS ACTA, V786, P109, DOI 10.1016/0167-4838(84)90160-2; VERGER R, 1984, PANCREATIC LIPASE, P84; WIELOCH T, 1981, FEBS LETT, V128, P217, DOI 10.1016/0014-5793(81)80084-1; WINZELL SM, 1998, GASTROENTEROLOGY, V115, P1; Yang YQ, 1998, PROTEIN EXPRES PURIF, V13, P36, DOI 10.1006/prep.1998.0874; YORK DA, 2000, NEURAL METABLOIC CON, P301	35	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7170	7177		10.1074/jbc.M108328200	http://dx.doi.org/10.1074/jbc.M108328200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751900	Green Accepted, hybrid			2022-12-27	WOS:000174104300055
J	Lommer, BS; Luo, M				Lommer, BS; Luo, M			Structural plasticity in influenza virus protein NS2 (NEP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; MOLAR HEAT-CAPACITY; KAPPA-B-ALPHA; MOLTEN GLOBULE; VIRAL RIBONUCLEOPROTEINS; SECONDARY STRUCTURE; TRANSACTIVATION DOMAIN; HIV-1 REV; A-STATE; TRANSPORT	The cellular nuclear transport machinery relies on the assembly of specialized transport complexes between soluble transport receptors, transport substrates, and additional accessory proteins. This study focuses on the structural characteristics of influenza virus protein NS2 (NEP), which interacts with the nuclear export machinery during viral replication, and has been proposed to act as an adapter molecule between the nuclear export machinery and the viral ribonucleoprotein complex. For this purpose, we have purified recombinant NS2 under nondenaturing conditions, and have investigated its structure and aggregation state using optical spectroscopy, differential scanning calorimetry, as well as hydrodynamic techniques. Our results indicate that isolated NS2 exists as a monomer in solution, and adopts a compact, but very flexible conformation, which shows characteristics of the molten globule state under near physiological conditions. Proteolytic sensitivity suggests that, despite its overall plasticity, the structure of NS2 is heterogeneous. While the C terminus of the protein adopts a relatively rigid conformation, its N terminus, which is recognized by the nuclear export machinery, exists in a highly mobile and exposed state. It is proposed that the flexibility observed in the nuclear export domain of NS2 is an important element in the recognition of substrate proteins by the nuclear export machinery.	Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Luo, M (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.							AB PB, 1996, UNICORN VERSION 2 30; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; AUER M, 1994, BIOCHEMISTRY-US, V33, P2988, DOI 10.1021/bi00176a031; BAEZ M, 1980, NUCLEIC ACIDS RES, V8, P5845, DOI 10.1093/nar/8.23.5845; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Creighton T. E., 1993, PROTEINS STRUCTURE M; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EFTINK MR, 1984, BIOCHEMISTRY-US, V23, P3891, DOI 10.1021/bi00312a016; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P967; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Gomez-Puertas P, 1999, J GEN VIROL, V80, P1635, DOI 10.1099/0022-1317-80-7-1635; HARDING SE, 1997, PROTEIN STRUCTURE PR, P219; Hauer JA, 1999, PROTEIN SCI, V8, P545; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; JAFFRAY E, 1995, MOL CELL BIOL, V15, P2166; Kay MS, 1996, NAT STRUCT BIOL, V3, P439, DOI 10.1038/nsb0596-439; Komeili A, 2000, CURR OPIN CELL BIOL, V12, P355, DOI 10.1016/S0955-0674(00)00100-9; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LAMB RA, 1978, VIROLOGY, V91, P60, DOI 10.1016/0042-6822(78)90355-0; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Ma K, 2001, VIROLOGY, V282, P215, DOI 10.1006/viro.2001.0833; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; MANCHESTER KL, 1995, BIOTECHNIQUES, V19, P208; Marmorino JL, 1998, J MOL BIOL, V275, P379, DOI 10.1006/jmbi.1997.1450; MARMORINO JL, 1995, BIOCHEMISTRY-US, V34, P3140, DOI 10.1021/bi00010a002; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Mena I, 1996, J VIROL, V70, P5016, DOI 10.1128/JVI.70.8.5016-5024.1996; Mogridge J, 1998, MOL CELL, V1, P265, DOI 10.1016/S1097-2765(00)80027-1; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; MOROZOVA LA, 1995, NAT STRUCT BIOL, V2, P871, DOI 10.1038/nsb1095-871; MURTI KG, 1992, VIROLOGY, V186, P294, DOI 10.1016/0042-6822(92)90084-3; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; ONEILL RE, 1995, VIROLOGY, V206, P116, DOI 10.1016/S0042-6822(95)80026-3; Ossareh-Nazari B, 1999, EXP CELL RES, V252, P236, DOI 10.1006/excr.1999.4599; Pace C N, 1986, Methods Enzymol, V131, P266; PACE NC, 1997, PROTEIN STRUCTURE PR, P299; Paragas J, 2001, J VIROL, V75, P7375, DOI 10.1128/JVI.75.16.7375-7383.2001; Parker D, 1999, MOL CELL BIOL, V19, P5601; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; PRIVALOV PL, 1989, J MOL BIOL, V205, P737, DOI 10.1016/0022-2836(89)90318-5; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Ptitsyn O, 1996, NAT STRUCT BIOL, V3, P488, DOI 10.1038/nsb0696-488; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Ptitsyn OB, 1998, BIOCHEMISTRY-MOSCOW+, V63, P367; PTITSYN OB, 1994, FEBS LETT, V341, P15, DOI 10.1016/0014-5793(94)80231-9; Radhakrishnan I, 1998, FEBS LETT, V430, P317, DOI 10.1016/S0014-5793(98)00680-2; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; REY O, 1992, J VIROL, V66, P5815, DOI 10.1128/JVI.66.10.5815-5824.1992; RICHARDSON JC, 1991, ARCH VIROL, V116, P69, DOI 10.1007/BF01319232; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; SCHMID FX, 1997, PROTEIN STRUCTURE PR, P287; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sha BD, 1997, ACTA CRYSTALLOGR D, V53, P458, DOI 10.1107/S0907444997000152; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Talcott B, 1999, TRENDS CELL BIOL, V9, P312, DOI 10.1016/S0962-8924(99)01608-6; TAN RY, 1994, BIOCHEMISTRY-US, V33, P14579, DOI 10.1021/bi00252a025; Thumb W, 1999, SPECTROCHIM ACTA A, V55, P2729, DOI 10.1016/S1386-1425(99)00162-6; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635; Wang P, 1997, J VIROL, V71, P1850, DOI 10.1128/JVI.71.3.1850-1856.1997; WARD AC, 1995, ARCH VIROL, V140, P2067, DOI 10.1007/BF01322693; Watanabe K, 2001, VIRUS RES, V77, P31, DOI 10.1016/S0168-1702(01)00263-5; Whittaker G, 1996, J VIROL, V70, P2743, DOI 10.1128/JVI.70.5.2743-2756.1996; Whittaker G, 1996, TRENDS CELL BIOL, V6, P67, DOI 10.1016/0962-8924(96)81017-8; Whittaker GR, 1998, VIROLOGY, V246, P1, DOI 10.1006/viro.1998.9165; WILLIAMS RW, 1986, METHOD ENZYMOL, V130, P311; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YANG JT, 1986, METHOD ENZYMOL, V130, P208; YASUDA J, 1993, VIROLOGY, V196, P249, DOI 10.1006/viro.1993.1473; YE J, 1995, J VIROL, V69, P1964; Zhirnov OP, 1997, VIROLOGY, V235, P302, DOI 10.1006/viro.1997.8700; Zurdo J, 1997, BIOCHEMISTRY-US, V36, P9625, DOI 10.1021/bi9702400	88	25	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7108	7117		10.1074/jbc.M109045200	http://dx.doi.org/10.1074/jbc.M109045200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751904	hybrid			2022-12-27	WOS:000174104300047
J	Zhang, GL; Ghosh, S				Zhang, GL; Ghosh, S			Negative regulation of toll-like receptor-mediated signaling by Tollip	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; IL-1 RECEPTOR; INTERLEUKIN-1 RECEPTOR; ADAPTER PROTEIN; KINASE; PATHWAY; IRAK; FAMILY; MYD88; RESPONSIVENESS	Toll-like receptor (TLR)-mediated recognition of pathogens represents one of the most important mechanisms of innate immunity and disease resistance. The adaptor protein Tollip was identified initially as an intermediate in interleukin (IL)-1 signaling. Here we report that Tollip also associates directly with TLR2 and TLR4 and plays an inhibitory role in TLR-mediated cell activation. Inhibition by Tollip is mediated through its ability to potently suppress the activity of IL-1 receptor-associated kinase (IRAK) after TLR activation. In addition, we show for the first time that Tollip is a bona fide substrate for IRAK and is phosphorylated by IRAK upon stimulation with lipopolysaccharide or IL-1. Negative regulation of TLR signaling by Tollip may therefore serve to limit the production of proinflammatory mediators during inflammation and infection.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 310 Cedar St, New Haven, CT 06520 USA.		Zhang, Guolong/HCI-5587-2022; Zhang, Guolong/AAU-8197-2020	Zhang, Guolong/0000-0003-4781-5816	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI033443, R37 AI 33443] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Knop J, 1999, FEBS LETT, V448, P81, DOI 10.1016/S0014-5793(99)00322-1; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Li XX, 1999, MOL CELL BIOL, V19, P4643; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maschera B, 1999, BIOCHEM J, V339, P227, DOI 10.1042/0264-6021:3390227; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	33	467	493	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7059	7065		10.1074/jbc.M109537200	http://dx.doi.org/10.1074/jbc.M109537200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751856	hybrid			2022-12-27	WOS:000174104300041
J	Baez, JM; Barbour, SE; Cohen, DE				Baez, JM; Barbour, SE; Cohen, DE			Phosphatidylcholine transfer protein promotes apolipoprotein A-I-mediated lipid efflux in Chinese hamster ovary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CELLULAR CHOLESTEROL EFFLUX; TISSUE-SPECIFIC EXPRESSION; THIN-LAYER CHROMATOGRAPHY; PRE-BETA-HDL; PHOSPHOLIPID EFFLUX; MIXED MICELLES; GENE STRUCTURE; RECEPTOR; BINDING	Phosphatidylcholine transfer protein (PC-TP) is a cytosolic protein of unknown function that catalyzes intermembrane transfer of phosphatidylcholines in vitro. Using stably transfected CHO cells, we explored the influence of PC-TP on apolipoprotein A-I- and high density lipoprotein 3 (HDL3)-mediated lipid efflux. In proportion to its cellular level of expression, PC-TP accelerated apolipoprotein A-I-mediated phospholipid and cholesterol efflux as pre-beta-HDL particles. PC-TP increased rates of efflux of both lipids by >2-fold but did not affect mRNA levels or the activity of ATP-binding cassette A1, a plasma membrane protein that regulates apolipoprotein A-I-mediated lipid efflux. Overexpression of PC-TP was associated with only slight increases in HDL3-mediated phospholipid efflux and no changes in cholesterol efflux. In scavenger receptor BI-overexpressing cells, PC-TP expression minimally influenced apolipoprotein A-I- or HDL3-mediated lipid efflux. PC-TP did not affect cellular phospholipid compositions, phosphatidylcholine contents, or phosphatidylcholine synthetic rates. These findings suggest that a physiological function of PC-TP is to replenish the plasma membrane with phosphatidylcholines that are removed during pre-beta-HDL particle formation due to the activity of ATP-binding cassette A1.	Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Biochem, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Med, Bronx, NY 10461 USA; Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Virginia Commonwealth University	Cohen, DE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Biochem, 1300 Morris Pk Ave,Ullman Bldg,Rm 625, Bronx, NY 10461 USA.	dcohen@aecom.yu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056626] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barbour SE, 1999, BBA-MOL CELL BIOL L, V1439, P77, DOI 10.1016/S1388-1981(99)00078-5; Barrans A, 1996, BBA-LIPID LIPID MET, V1300, P73, DOI 10.1016/0005-2760(95)00236-7; BIELICKI JK, 1992, J LIPID RES, V33, P1699; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAREY MC, 1978, J CLIN INVEST, V61, P998, DOI 10.1172/JCI109025; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; Chen WG, 2000, J BIOL CHEM, V275, P30794, DOI 10.1074/jbc.M004552200; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; COHEN DE, 1991, J LIPID RES, V32, P1291; Cohen DE, 1999, BBA-GENE STRUCT EXPR, V1447, P265, DOI 10.1016/S0167-4781(99)00163-3; Donovan JM, 1998, HEPATOLOGY, V27, P641, DOI 10.1002/hep.510270301; DONOVAN JM, 1987, BIOCHEMISTRY-US, V26, P8125, DOI 10.1021/bi00399a016; Feng L, 1998, J LIPID RES, V39, P1862; Feng L, 2000, BIOCHEMISTRY-US, V39, P15399, DOI 10.1021/bi001076a; FIELDING CJ, 1995, J LIPID RES, V36, P211; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORTE TM, 1995, J LIPID RES, V36, P148; Geijtenbeek TBH, 1996, BIOCHEM J, V316, P49; Gillotte KL, 1998, J LIPID RES, V39, P1918; GLOMSET JA, 1968, J LIPID RES, V9, P155; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; JOHNSON WJ, 1986, J BIOL CHEM, V261, P5766; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KHAN ZU, 1990, J BIOL CHEM, V265, P700; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 1996, J LIPID RES, V37, P2473; Oram JF, 2001, J BIOL CHEM, V276, P39898, DOI 10.1074/jbc.M106984200; Oram JF, 2000, BBA-MOL CELL BIOL L, V1529, P321, DOI 10.1016/S1388-1981(00)00157-8; PATTON GM, 1987, CHROMATOGRAPHY LIPID, P311; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Rothblat GH, 1999, J LIPID RES, V40, P781; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Shi XY, 2001, J BIOL CHEM, V276, P2075, DOI 10.1074/jbc.M008583200; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Urban S, 2000, J BIOL CHEM, V275, P33409, DOI 10.1074/jbc.M004031200; van Helvoort A, 1999, P NATL ACAD SCI USA, V96, P11501, DOI 10.1073/pnas.96.20.11501; VITIELLO F, 1978, J CHROMATOGR, V166, P637, DOI 10.1016/S0021-9673(00)95654-1; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; WANG N, 2001, IN PRESS J BIOL CHEM; White T, 1998, ANAL BIOCHEM, V258, P109, DOI 10.1006/abio.1997.2545; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Wu MK, 1999, GENE, V235, P111, DOI 10.1016/S0378-1119(99)00204-8; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021; Yokoyama S, 1998, BBA-LIPID LIPID MET, V1392, P1, DOI 10.1016/S0005-2760(98)00032-0; Zhang WW, 1998, J LIPID RES, V39, P1601	54	24	24	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6198	6206		10.1074/jbc.M106799200	http://dx.doi.org/10.1074/jbc.M106799200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751880	hybrid			2022-12-27	WOS:000173989200068
J	He, C; Yan, XX; Zhang, HL; Mirshahi, T; Jin, T; Huang, AJ; Logothetis, DE				He, C; Yan, XX; Zhang, HL; Mirshahi, T; Jin, T; Huang, AJ; Logothetis, DE			Identification of critical residues controlling G protein-gated inwardly rectifying K+ channel activity through interactions with the beta gamma subunits of G proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; MUSCARINIC POTASSIUM CHANNEL; ION CHANNELS; ADENYLYL-CYCLASE; ACH CHANNEL; I-KACH; ACTIVATION; RECTIFIER; G(BETA-GAMMA); GIRK1	G protein-sensitive inwardly rectifying potassium (GIRK) channels are activated through direct interactions of their cytoplasmic N- and C-terminal domains with the betagamma subunits of G proteins. By using a combination of biochemical and electrophysiological approaches, we identified minimal N- and C-terminal Gbetagamma-binding domains responsible for stimulation of GIRK4 channel activity. Within these domains one N-terminal residue, His-64, and one C-terminal residue, Leu-268, proved critical for Gbetagamma-mediated GIRK4 activity. Moreover, mutations at these GIRK4 sites reduced significantly binding of the channel domains to Goy. The corresponding residues in GIRK1 also showed a critical involvement in Gbetagamma sensitivity. In GIRK4/GIRK1 heteromers the GIRK4 His-64 and Leu-268 residues showed greater contributions to Goy sensitivity than did the corresponding GIRK1 His-57 and Leu-262 residues. These results identify functionally important channel interaction sites with the betagamma subunits of G proteins, critical for channel activity.	Second Mil Med Univ, Dept Neurobiol, Shanghai 200433, Peoples R China; CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	Naval Medical University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	He, C (corresponding author), Second Mil Med Univ, Dept Neurobiol, Shanghai 200433, Peoples R China.	chenghe@online.sh.cn			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054185] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Chan KW, 1997, J BIOL CHEM, V272, P6548, DOI 10.1074/jbc.272.10.6548; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Cohen NA, 1996, J BIOL CHEM, V271, P32301, DOI 10.1074/jbc.271.50.32301; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; Kubo Y, 1996, BIOCHEM BIOPH RES CO, V227, P240, DOI 10.1006/bbrc.1996.1496; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Logothetis DE, 1999, J PHYSIOL-LONDON, V520, P630, DOI 10.1111/j.1469-7793.1999.00630.x; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Mirshahi T, 2001, METHOD PHARMACOL TOX, P215; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Sui JL, 1999, ADV SEC MESS PHOSPH, V33, P179; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Yamada M, 1998, PHARMACOL REV, V50, P723; Yan K, 1996, J BIOL CHEM, V271, P17597, DOI 10.1074/jbc.271.30.17597; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	39	79	80	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6088	6096		10.1074/jbc.M104851200	http://dx.doi.org/10.1074/jbc.M104851200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741896	hybrid			2022-12-27	WOS:000173989200053
J	Hung, AY; Sheng, M				Hung, AY; Sheng, M			PDZ domains: Structural modules for protein complex assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NITRIC-OXIDE SYNTHASE; POSTSYNAPTIC DENSITY PROTEINS; EXCHANGER REGULATORY FACTOR; NMDA RECEPTOR SUBUNITS; TYROSINE-PHOSPHATASE; INTERACTING PROTEIN; PHOTORECEPTOR CELLS; SIGNALING PROTEINS; CRYSTAL-STRUCTURES; GUANYLATE KINASES		MIT, Howard Hughes Med Inst, Dept Brain Cognit Sci, RIKEN Ctr Learning & Memory Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Dept Biol, RIKEN Ctr Learning & Memory Neurosci Res Ctr, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Harvard University; Massachusetts General Hospital	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, Dept Brain Cognit Sci, RIKEN Ctr Learning & Memory Neurosci Res Ctr, Cambridge, MA 02139 USA.	msheng@mit.edu	Eckhardt, Erik/G-1567-2010	Sheng, Morgan/0000-0002-8703-5366				Beebe KD, 2000, BIOCHEMISTRY-US, V39, P3149, DOI 10.1021/bi992709s; Bezprozvanny I, 2001, P NATL ACAD SCI USA, V98, P787, DOI 10.1073/pnas.98.3.787; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Cuppen E, 1998, MOL BIOL CELL, V9, P671, DOI 10.1091/mbc.9.3.671; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gee SH, 1998, J BIOL CHEM, V273, P21980, DOI 10.1074/jbc.273.34.21980; Gee SH, 1998, J NEUROSCI, V18, P128; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Hata Y, 1996, J NEUROSCI, V16, P2488; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim SK, 1997, CURR OPIN CELL BIOL, V9, P853, DOI 10.1016/S0955-0674(97)80088-9; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kozlov G, 2000, BIOCHEMISTRY-US, V39, P2572, DOI 10.1021/bi991913c; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Maekawa K, 1999, BIOCHEM J, V337, P179, DOI 10.1042/0264-6021:3370179; Marfatia SM, 1997, J BIOL CHEM, V272, P24191, DOI 10.1074/jbc.272.39.24191; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Montell C, 2000, NAT GENET, V26, P6, DOI 10.1038/79186; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Montell C, 1998, CURR OPIN NEUROBIOL, V8, P389, DOI 10.1016/S0959-4388(98)80066-4; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Ponting CP, 1997, PROTEIN SCI, V6, P464; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Scott K, 1998, CURR OPIN NEUROBIOL, V8, P383, DOI 10.1016/S0959-4388(98)80065-2; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Ullmer C, 1998, FEBS LETT, V424, P63, DOI 10.1016/S0014-5793(98)00141-0; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Zhang Q, 2001, J BIOL CHEM, V276, P43216, DOI 10.1074/jbc.M105996200	76	572	594	0	43	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5699	5702		10.1074/jbc.R100065200	http://dx.doi.org/10.1074/jbc.R100065200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741967	hybrid			2022-12-27	WOS:000173989200001
J	Lyon, GJ; Wright, JS; Christopoulos, A; Novick, RP; Muir, TW				Lyon, GJ; Wright, JS; Christopoulos, A; Novick, RP; Muir, TW			Reversible and specific extracellular antagonism of receptor-histidine kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; VIRULENCE; PHEROMONE; COMPETENCE; INHIBITION; AGRC	Staphylococcal pathogenesis is regulated by a two-component quorum-sensing system, agr, activated by a self-coded autoinducing peptide (AIP). The agr system is widely divergent and is unique in that variant AIPs cross-inhibit agr activation in heterologous combinations. Cross-inhibition, but not self-activation, is widely tolerant of structural diversity in the AIPs so that these two processes must involve different mechanisms of interaction with the respective receptors. Herein, we have utilized this naturally occurring antagonism to demonstrate that both activation and inhibition are reversible and that activators and inhibitors interact at a common site on the receptor. These results suggest that molecules designed to compete with natural agonists for binding at receptor-histidine kinase sensor domains could represent a general approach to the inhibition of receptor-histidine kinase signaling.	NYU, Med Ctr, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA; Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia	New York University; Rockefeller University; University of Melbourne	Novick, RP (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dept Microbiol, 550 1St Ave, New York, NY 10016 USA.	novick@saturn.med.nyu.edu; muirt@mail.rockefeller.edu	Lyon, Gholson/D-2765-2014; Muir, Tom/AHD-0860-2022; Christopoulos, Arthur/B-6207-2013	Lyon, Gholson/0000-0002-5869-0716; Muir, Tom/0000-0001-9635-0344; Christopoulos, Arthur/0000-0003-4442-3294; Novick, richard/0000-0003-4418-7893	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042783] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AXELSSON L, 1995, J BACTERIOL, V177, P2125, DOI 10.1128/jb.177.8.2125-2137.1995; Christopoulos A, 1999, J PHARMACOL EXP THER, V289, P1220; Christopoulos A, 2001, BRIT J PHARMACOL, V132, P1281, DOI 10.1038/sj.bjp.0703930; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; LEW MJ, 1995, TRENDS PHARMACOL SCI, V16, P328, DOI 10.1016/S0165-6147(00)89066-5; Lina G, 1998, MOL MICROBIOL, V28, P655, DOI 10.1046/j.1365-2958.1998.00830.x; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218; McDowell P, 2001, MOL MICROBIOL, V41, P503, DOI 10.1046/j.1365-2958.2001.02539.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Otto M, 1999, FEBS LETT, V450, P257, DOI 10.1016/S0014-5793(99)00514-1; Otto M, 1998, FEBS LETT, V424, P89, DOI 10.1016/S0014-5793(98)00145-8; Sakakibara H, 2000, PLANT MOL BIOL, V42, P273, DOI 10.1023/A:1006334926388; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Tortosa P, 1999, CURR OPIN MICROBIOL, V2, P588, DOI 10.1016/S1369-5274(99)00026-0; Winzer K, 2001, INT J MED MICROBIOL, V291, P131, DOI 10.1078/1438-4221-00110; Wright JS, 2001, J BACTERIOL, V183, P3149, DOI 10.1128/JB.183.10.3149-3159.2001	24	76	81	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6247	6253		10.1074/jbc.M109989200	http://dx.doi.org/10.1074/jbc.M109989200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11733525	hybrid			2022-12-27	WOS:000173989200074
J	Wang, YT; Sun, DP; Davidson, VL				Wang, YT; Sun, DP; Davidson, VL			Use of indirect site-directed mutagenesis to alter the substrate specificity of methylamine dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARTATE-AMINOTRANSFERASE; PARACOCCUS-DENITRIFICANS; COFACTOR; ENZYME	Methylamine dehydrogenase (MADH) is a tryptophan tryptophylquinone-dependent enzyme that catalyzes the oxidative deamination of primary amines. Native MADH exhibits a strong preference for methylamine over longer carbon chain amines. Residue alphaPhe(55) controls this substrate specificity. When alphaPhe(55) is replaced with Ala, this preference is reversed with alphaF55A MADH preferring long-chain amines with at least seven carbons (Zhu, Z., Sun, D., and Davidson, IV. L. (2000) Biochemistry 39,11184-11186). To further modulate the substrate specificity of MADH, the side-chain of alphaPhe(55) was repositioned by site-directed mutagenesis of residue betaIle(107). This residue makes close contact with alphaPhe(55) and restricts its movement. betaI107V MADH exhibits a strong preference for propylamine, and betaI107N MADH exhibits a preference for 1-aminopentane. Thus, it has been possible to create forms of MADH that exhibit a preference for amines with carbon chain lengths of one, three, five, or seven carbons. The ability to discriminate between amines of different chain length was essentially abolished by an alphaF551 mutation. Molecular modeling studies with the known crystal structure are described that provide an explanation for these results. These results provide an example of a design-based approach to protein engineering in which site-directed mutagenesis on one residue can be used to reposition another residue to specifically alter enzyme specificity.	Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Davidson, VL (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, 2500 N State St, Jackson, MS 39216 USA.		Wang, Yongting/C-2916-2014	Davidson, Victor/0000-0002-1966-7302	NIGMS NIH HHS [GM-41574] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041574, R37GM041574] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROOKS HB, 1993, BIOCHEMISTRY-US, V32, P2725, DOI 10.1021/bi00061a034; Chen LY, 1998, J MOL BIOL, V276, P131, DOI 10.1006/jmbi.1997.1511; DAVIDSON VL, 1990, METHOD ENZYMOL, V188, P241; DAVIDSON VL, 1989, BIOCHEM J, V261, P107, DOI 10.1042/bj2610107; Davidson VL, 2001, ADV PROTEIN CHEM, V58, P95; Doyle SA, 2000, BIOCHEMISTRY-US, V39, P14348, DOI 10.1021/bi001458g; Graichen ME, 1999, J BACTERIOL, V181, P4216, DOI 10.1128/JB.181.14.4216-4222.1999; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; HUIZINGA EG, 1992, BIOCHEMISTRY-US, V31, P9789, DOI 10.1021/bi00155a036; Labesse I, 1998, J BIOL CHEM, V273, P25703, DOI 10.1074/jbc.273.40.25703; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; ONUFFER JJ, 1995, PROTEIN SCI, V4, P1750, DOI 10.1002/pro.5560040910; Stoll VS, 1997, BIOCHEMISTRY-US, V36, P6437, DOI 10.1021/bi963074p; Yano T, 1998, P NATL ACAD SCI USA, V95, P5511, DOI 10.1073/pnas.95.10.5511; Zhu ZY, 2000, BIOCHEMISTRY-US, V39, P11184, DOI 10.1021/bi001568n; Zhu ZY, 2000, BIOCHEMISTRY-US, V39, P8830, DOI 10.1021/bi000502p	16	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4119	4122		10.1074/jbc.M109270200	http://dx.doi.org/10.1074/jbc.M109270200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733518	hybrid			2022-12-27	WOS:000173813900044
J	Xu, L; Fukumura, D; Jain, RK				Xu, L; Fukumura, D; Jain, RK			Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway - Mechanism of low pH-induced VEGF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED GENE-EXPRESSION; INDUCED TRANSCRIPTIONAL ACTIVATION; OVARIAN-CARCINOMA CELLS; NIH 3T3 CELLS; PERMEABILITY FACTOR; INTERLEUKIN-8 EXPRESSION; NUCLEAR TRANSLOCATION; INDUCED ELEVATION; IN-VIVO	Overexpression of vascular endothelial growth factor (VEGF) is associated with disease progression in human glioblastomas. We recently showed that VEGF promoter activity is inversely correlated with tumor extracellular pH (pH(o)) in vivo in the human glioma (U87 MG) xenografts. Here we show that substitution of the neutral culture medium (pH 7.3) with acidic pH medium (pH 6.6) up-regulates VEGF mRNA and protein production in human glioblastoma cells as reflected by Northern blot analysis and enzyme-linked immunosorbent assay. Functional analysis of the VEGF promoter reveals that the sequence between -961 bp and -683 bp upstream of the transcription start site is responsible for the transcriptional activation of the VEGF gene by acidic pH. This region contains the binding site for AP-1. Consequently, AP-1 luciferase reporter gene was activated by acidic pH. Gel-shift analysis confirmed that AP-1 DNA binding activity is induced under acidic pH. While investigating the upstream signaling pathways, we found that ERK1/2 MAPK is activated and translocates to the nucleus to activate Elk-1, and inhibition of the activation of ERK by specific inhibitors of MEK1 blocks the up-regulation of VEGF by low pH. Dominant negative forms of Ras and Raf abolished the activation of VEGF promoter by acidic pH. These results show that acidic pH activates Ras and the ERK1/2 MAPK pathway to enhance VEGF transcription via AP-1, leading to increased VEGF production.	Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Jain, RK (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, 100 Blossom St Cox 7, Boston, MA 02114 USA.		Xu, Lei/GRR-9174-2022; Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548	NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA080124] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chan ASY, 1998, AM J SURG PATHOL, V22, P816, DOI 10.1097/00000478-199807000-00004; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; DAREANGELO D, 2000, CIRC RES, V86, P312; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Finkenzeller G, 1997, ONCOGENE, V15, P669, DOI 10.1038/sj.onc.1201219; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frick KK, 1998, AM J PHYSIOL-RENAL, V275, pF840, DOI 10.1152/ajprenal.1998.275.5.F840; Fukumura D, 2001, CANCER RES, V61, P6020; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gille J, 1997, EMBO J, V16, P750, DOI 10.1093/emboj/16.4.750; GRUGEL S, 1995, J BIOL CHEM, V270, P25915, DOI 10.1074/jbc.270.43.25915; Grunstein J, 1999, CANCER RES, V59, P1592; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Jiang BH, 1997, CANCER RES, V57, P5328; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kerbel RS, 1998, MOL MED, V4, P286, DOI 10.1007/BF03401737; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; Lee AH, 1998, CANCER RES, V58, P1901; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; Li YS, 1996, MOL CELL BIOL, V16, P5947; Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322; MINCHENKO A, 1994, LAB INVEST, V71, P374; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Mori K, 2000, FREE RADICAL RES, V33, P157, DOI 10.1080/10715760000300711; Moriguchi T, 1996, Adv Pharmacol, V36, P121, DOI 10.1016/S1054-3589(08)60579-7; Muller JN, 1997, J BIOL CHEM, V272, P23435, DOI 10.1074/jbc.272.37.23435; Oku T, 1998, CANCER RES, V58, P4185; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Park SH, 2001, INT J MOL MED, V7, P91; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Shi Q, 2000, J INTERF CYTOK RES, V20, P1023, DOI 10.1089/10799900050198471; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; SHIMA DT, 1995, FEBS LETT, V370, P203, DOI 10.1016/0014-5793(95)00831-S; SMEAL T, 1989, GENE DEV, V3, P2091, DOI 10.1101/gad.3.12b.2091; Spector A, 2000, EXP EYE RES, V71, P183, DOI 10.1006/exer.2000.0867; Tanaka T, 2000, J MOL CELL CARDIOL, V32, P1955, DOI 10.1006/jmcc.2000.1228; TANNOCK IF, 1989, CANCER RES, V49, P4373; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Treinies I, 1999, MOL CELL BIOL, V19, P321; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Tsuzuki Y, 2000, CANCER RES, V60, P6248; WEINDEL K, 1994, NEUROSURGERY, V35, P439, DOI 10.1227/00006123-199409000-00012; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Xu L, 1999, CANCER RES, V59, P5822; Xu L, 2000, CANCER RES, V60, P4610; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	58	226	235	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 29	2002	277	13					11368	11374		10.1074/jbc.M108347200	http://dx.doi.org/10.1074/jbc.M108347200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	534WQ	11741977	hybrid, Green Published			2022-12-27	WOS:000174613100079
J	Johansson, MU; Frick, IM; Nilsson, H; Kraulis, PJ; Hober, S; Jonasson, P; Linhult, M; Nygren, PA; Uhlen, M; Bjorck, L; Drakenberg, T; Forsen, S; Wikstrom, M				Johansson, MU; Frick, IM; Nilsson, H; Kraulis, PJ; Hober, S; Jonasson, P; Linhult, M; Nygren, PA; Uhlen, M; Bjorck, L; Drakenberg, T; Forsen, S; Wikstrom, M			Structure, specificity, and mode of interaction for bacterial albumin-binding modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCAL PROTEIN-G; HUMAN-SERUM-ALBUMIN; IGG-BINDING; IMMUNOGLOBULIN-G; B-DOMAIN; GROUP-C; X-RAY; NMR; EVOLUTION; IDENTIFICATION	We have determined the solution structure of an albumin binding domain of protein G, a surface protein of group C and G streptococci. We find that it folds into a left handed three-helix bundle similar to the albumin binding domain of protein PAB from Peptostreptococcus magnus. The two domains share 59% sequence identity, are thermally very stable, and bind to the same site on human serum albumin. The albumin binding site, the first determined for this structural motif known as the GA module, comprises residues spanning the first loop to the beginning of the third helix and includes the most conserved region of GA modules. The two GA modules have different affinities for albumin from different species, and their albumin binding patterns correspond directly to the host specificity of C/G streptococci and P. magnus, respectively. These studies of the evolution, structure, and binding properties of the GA module emphasize the power of bacterial adaptation and underline ecological and medical problems connected with the use of antibiotics.	Univ Lund, Dept Biophys Chem, SE-22100 Lund, Sweden; Univ Lund, BMC, Sect Pathogenesis, Dept Cell & Mol Biol, SE-22184 Lund, Sweden; Biovitrum AB, SE-11276 Stockholm, Sweden; Stockholms Ctr Fys Aston Biotekn, Royal Inst Technol KTH, Dept Biotechnol, S-10691 Stockholm, Sweden	Lund University; Lund University; Swedish Orphan Biovitrum; Royal Institute of Technology; Stockholm University	Johansson, MU (corresponding author), Univ Lund, Dept Biophys Chem, POB 124, SE-22100 Lund, Sweden.		Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016; Nygren, Per-Åke/AAM-7888-2020	Uhlen, Mathias/0000-0002-4858-8056; Nygren, Per-Åke/0000-0003-4214-6991; Kraulis, Per/0000-0003-0560-974X				AKERSTROM B, 1987, J BIOL CHEM, V262, P13388; AKKE M, 1995, J MOL BIOL, V252, P102, DOI 10.1006/jmbi.1995.0478; BENJAMIN DC, 1992, BIOCHEMISTRY-US, V31, P9539, DOI 10.1021/bi00155a005; BJORCK L, 1987, MOL IMMUNOL, V24, P1113, DOI 10.1016/0161-5890(87)90080-0; BJORCK L, 1984, J IMMUNOL, V133, P969; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; CEDERGREN L, 1993, PROTEIN ENG, V6, P441, DOI 10.1093/protein/6.4.441; deChateau M, 1996, P NATL ACAD SCI USA, V93, P8490, DOI 10.1073/pnas.93.16.8490; DECHATEAU M, 1994, J BIOL CHEM, V269, P12147; deChateau M, 1996, J BIOL CHEM, V271, P26609, DOI 10.1074/jbc.271.43.26609; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FALKENBERG C, 1992, BIOCHEMISTRY-US, V31, P1451, DOI 10.1021/bi00120a023; FORSGREN A, 1966, J IMMUNOL, V97, P822; Foster MP, 1998, J BIOMOL NMR, V12, P51, DOI 10.1023/A:1008290631575; FRICK IM, 1992, P NATL ACAD SCI USA, V89, P8532, DOI 10.1073/pnas.89.18.8532; GOUDA H, 1992, BIOCHEMISTRY-US, V31, P9665, DOI 10.1021/bi00155a020; Gouda H, 1998, BIOCHEMISTRY-US, V37, P129, DOI 10.1021/bi970923f; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; Johansson MU, 1997, J MOL BIOL, V266, P859, DOI 10.1006/jmbi.1996.0856; JOHANSSON MU, 1995, FEBS LETT, V374, P257, DOI 10.1016/0014-5793(95)01121-T; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kraulis PJ, 1996, FEBS LETT, V378, P190, DOI 10.1016/0014-5793(95)01452-7; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Kuszewski J, 1996, PROTEIN SCI, V5, P1067; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MYHRE EB, 1980, INFECT IMMUN, V27, P6, DOI 10.1128/IAI.27.1.6-14.1980; MYHRE EB, 1984, J MED MICROBIOL, V18, P189, DOI 10.1099/00222615-18-2-189; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; OLSSON A, 1987, EUR J BIOCHEM, V168, P319, DOI 10.1111/j.1432-1033.1987.tb13423.x; Patthy L, 1991, CURR OPIN STRUC BIOL, V1, P351, DOI 10.1016/0959-440X(91)90033-P; REIS KJ, 1984, J IMMUNOL, V132, P3091; SPITZFADEN C, 1992, FEBS LETT, V300, P291, DOI 10.1016/0014-5793(92)80866-F; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423, DOI 10.1110/ps.8.7.1423	40	74	115	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8114	8120		10.1074/jbc.M109943200	http://dx.doi.org/10.1074/jbc.M109943200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751858	hybrid			2022-12-27	WOS:000174268000063
J	Kirito, K; Watanabe, T; Sawada, K; Endo, H; Ozawa, K; Komatsu, N				Kirito, K; Watanabe, T; Sawada, K; Endo, H; Ozawa, K; Komatsu, N			Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MYELOID DIFFERENTIATION; CELL-LINE; APOPTOSIS; BCL-X(L); SURVIVAL; ERYTHROPOIETIN; MEGAKARYOCYTES; PROGENITORS; INHIBITION	Thrombopoietin (TPO), an essential factor for megakaryopoiesis and thrombopoiesis, works as a survival factor for megakaryocytic lineage cells. However, little is known about the molecular mechanism in detail. We show here that TPO supports the survival of TPO-dependent leukemia cell line UT-7/TPO and normal megakaryocytic progenitors via the induction of Bcl-xL, an anti-apoptotic member of the Bcl-2 family. We further analyzed the signal transduction pathways required for TPO-induced Bcl-xL gene expression. A reporter assay with various lengths of Bcl-x gene promoter revealed that both Stat- and nuclear factor kappaB-binding sites are prerequisites for TPO-induced promoter activity. Consistent with these results, TPO induced the binding of Stat5 and subunits of nuclear factor kappaB, p5O, and c-Rel to the Bcl-x gene promoter. AG490, a specific inhibitor for Jak2, and LY294002, a specific inhibitor for phosphatidylinositol (PI) 3-kinase, reduced the protein level of Bcl-xL in UT-7/TPO cells, accompanied by an increase in the ratio of apoptotic cells. Interestingly, LY294002 enhanced the TPO-induced DNA binding activity of Stat5 without affecting the Jak2 activation and tyrosine phosphorylation of Stat5. Concomitantly, confocal microscopy revealed that LY294002 clearly inhibited the nuclear export of Stat5, suggesting that PI 3-kinase regulates the subcellular localization of Stat5. Taken together, our results suggest that both Jak-Stat and PI 3-kinase activation pathways regulate the TPO-induced survival of megakaryocytic cells via Bcl-xL gene expression. In addition, our data suggest possible cross-talk between these two signaling pathways.	Jichi Med Sch, Div Hematol, Dept Med, Minami Kawachi, Tochigi 3290498, Japan; Jichi Med Sch, Dept Biochem, Minami Kawachi, Tochigi 3290498, Japan; Hokkaido Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido 0608638, Japan	Jichi Medical University; Jichi Medical University; Hokkaido University	Komatsu, N (corresponding author), Jichi Med Sch, Div Hematol, Dept Med, Minami Kawachi, Tochigi 3290498, Japan.	nkomatsu@jichi.ac.jp	Kirito, Keita/AEO-6802-2022					Andjelic S, 2000, J IMMUNOL, V165, P3860, DOI 10.4049/jimmunol.165.7.3860; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; DEL PL, 1997, SCIENCE, V278, P687; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; Drachman JG, 1997, BLOOD, V89, P483, DOI 10.1182/blood.V89.2.483; Dumon S, 1999, ONCOGENE, V18, P4191, DOI 10.1038/sj.onc.1202796; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; Ginger RS, 2000, EMBO J, V19, P5483, DOI 10.1093/emboj/19.20.5483; Glasgow JN, 2000, J NEUROCHEM, V75, P1377, DOI 10.1046/j.1471-4159.2000.0751377.x; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Herrington J, 1999, J BIOL CHEM, V274, P5138, DOI 10.1074/jbc.274.8.5138; KAUSHANSKY K, 1995, P NATL ACAD SCI USA, V92, P3234, DOI 10.1073/pnas.92.8.3234; Kaushansky K, 1996, BLOOD, V87, P3066; Kazansky AV, 1999, J BIOL CHEM, V274, P22484, DOI 10.1074/jbc.274.32.22484; Komatsu N, 1996, BLOOD, V87, P4552, DOI 10.1182/blood.V87.11.4552.bloodjournal87114552; KOMATSU N, 2000, PORPHYRINS, V9, P174; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Leverrier Y, 1999, CELL DEATH DIFFER, V6, P290, DOI 10.1038/sj.cdd.4400492; Masuda A, 2001, J BIOL CHEM, V276, P26107, DOI 10.1074/jbc.M011475200; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Miyakawa Y, 2001, J BIOL CHEM, V276, P2494, DOI 10.1074/jbc.M002633200; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Osada M, 1999, EXP HEMATOL, V27, P131, DOI 10.1016/S0301-472X(98)00007-1; Ozes ON, 1999, NATURE, V401, P82; PARK JR, 1995, BLOOD, V86, P868; Peters R, 1998, BLOOD, V92, P2041, DOI 10.1182/blood.V92.6.2041.418k34_2041_2052; Pyatt DW, 1999, BLOOD, V93, P3302, DOI 10.1182/blood.V93.10.3302.410a38_3302_3308; Ritchie A, 1996, STEM CELLS, V14, P330, DOI 10.1002/stem.140330; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sanz C, 2000, BLOOD, V95, P2742, DOI 10.1182/blood.V95.9.2742.009k24_2742_2747; Sanz C, 2001, EXP HEMATOL, V29, P728, DOI 10.1016/S0301-472X(01)00635-X; Sanz C, 1997, BLOOD, V89, P3199, DOI 10.1182/blood.V89.9.3199; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Silva M, 1996, BLOOD, V88, P1576, DOI 10.1182/blood.V88.5.1576.1576; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Tanaka M, 2001, J BIOL CHEM, V276, P15082, DOI 10.1074/jbc.M007958200; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Zhang MY, 1998, BLOOD, V91, P4136, DOI 10.1182/blood.V91.11.4136.411k26_4136_4144	48	83	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8329	8337		10.1074/jbc.M109824200	http://dx.doi.org/10.1074/jbc.M109824200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756417	hybrid			2022-12-27	WOS:000174268000091
J	Pabst, S; Margittai, M; Vainius, D; Langen, R; Jahn, R; Fasshauer, D				Pabst, S; Margittai, M; Vainius, D; Langen, R; Jahn, R; Fasshauer, D			Rapid and selective binding to the synaptic SNARE complex suggests a modulatory role of complexins in neuroexocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER RELEASE; PROTEINS; FUSION; IDENTIFICATION; EXOCYTOSIS; RESOLUTION; TERMINALS; TOOLS; CA2+; CORE	The Ca2+ -triggered release of neurotransmitters is mediated by fusion of synaptic vesicles with the plasma membrane. The molecular machinery that translates the Ca2+ signal into exocytosis is only beginning to emerge. The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins syntaxin, SNAP-25, and synaptobrevin are central components of the fusion apparatus. Assembly of a membrane-bridging ternary SNARE complex is thought to initiate membrane merger, but the roles of other factors are less understood. Complexins are two highly conserved proteins that modulate the Ca2+ responsiveness of neurotransmitter release. In vitro, they bind in a 1:1 stoichiometry to the assembled synaptic SNARE complex, making complexins attractive candidates for controlling the exocytotic fusion apparatus. We have now performed a detailed structural, kinetic, and thermodynamic analysis of complexin binding to the SNARE complex. We found that no major conformational changes occur upon binding and that the complexin helix is aligned antiparallel to the four-helix bundle of the SNARE complex. Complexins bound rapidly (approximate to5 X 10(7) M-1 S-1) and with high affinity (approximate to10 nM), making it one of the fastest protein-protein interactions characterized so far in membrane trafficking. Interestingly, neither affinity nor binding kinetics was substantially altered by Ca2+ ions. No interaction of complexins was detectable either with individual SNARE proteins or with the binary syntaxin.SNAP-25 complex. Furthermore, complexin did not promote the formation of SNARE complex oligomers. Together, our data suggest that complexins modulate neuroexocytosis after assembly of membrane-bridging SNARE complexes.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany; Univ So Calif, Inst Med Genet, Los Angeles, CA 90033 USA; Univ So Calif, Neurogenet Inst, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	Max Planck Society; Max Planck Society; University of Southern California; University of Southern California	Fasshauer, D (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.		Margittai, Martin/D-5039-2014; Fasshauer, Dirk/B-1563-2013	Margittai, Martin/0000-0003-1903-5927; Fasshauer, Dirk/0000-0002-1040-4282; Jahn, Reinhard/0000-0003-1542-3498				Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 2001, CURR OPIN STRUC BIOL, V11, P163, DOI 10.1016/S0959-440X(00)00186-X; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JaresErijman EA, 1996, J MOL BIOL, V257, P597, DOI 10.1006/jmbi.1996.0188; JELESAROV I, 1994, BIOCHEMISTRY-US, V33, P13321, DOI 10.1021/bi00249a019; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Misura KMS, 2000, CURR OPIN STRUC BIOL, V10, P662, DOI 10.1016/S0959-440X(00)00151-2; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; OTTO MR, 1994, BIOPHYS J, V67, P2511, DOI 10.1016/S0006-3495(94)80741-6; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174	36	101	110	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7838	7848		10.1074/jbc.M109507200	http://dx.doi.org/10.1074/jbc.M109507200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751907	Green Published, hybrid			2022-12-27	WOS:000174268000029
J	Lopez-Rubio, JJ; Elias-Arnanz, M; Padmanabhan, S; Murillo, FJ				Lopez-Rubio, JJ; Elias-Arnanz, M; Padmanabhan, S; Murillo, FJ			A repressor-antirepressor pair links two loci controlling light-induced carotenogenesis in Myxococcus xanthus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; RNA-POLYMERASE; BLUE-LIGHT; PROTEIN; BINDING; EXPRESSION; ACTIVATION; GENES; MECHANISM; INDUCTION	The light-inducible carB operon encodes all but one of the structural genes for carotenogenesis in Myxococcus xanthus. It is transcriptionally controlled by two proteins expressed from two unlinked genetic loci: CarS from the light-inducible carQRS operon, and CarA from the light-independent carA operon. CarA represses transcription from the carB promoter (P-B) in the dark, and CarS counteracts this on illumination. The CarA sequence revealed a helix-turn-helix DNA-binding motif of the type found in bacterial MerR transcriptional factors, whereas CarS contains no known DNA-binding motif. Here, we examine the molecular interplay between CarA and CarS. We demonstrate the following. W Whereas CarS exhibits no DNA binding in vitro, CarA binds specifically to a region encompassing PB to form at least two distinct complexes. (ii) A palindrome located between positions -46 and -63 relative to the transcription start point is essential but not sufficient for the formation of the two CarA-DNA complexes observed. (iii) CarS abrogates the specific DNA binding of CarA. CarA is therefore a repressor and CarS an antirepressor. (iv) CarS physically interacts with CarA, thus, the functional interaction between them is mediated by protein-protein interactions.	Univ Murcia, Fac Biol, Dept Genet & Microbiol, Murcia 30071, Spain	University of Murcia	Elias-Arnanz, M (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Murcia 30071, Spain.		Padmanabhan, S./E-8943-2017; Elías-Arnanz, Montserrat/H-4707-2015; lopez-rubio, jose juan/A-4509-2014	Elías-Arnanz, Montserrat/0000-0003-1980-3092; lopez-rubio, jose juan/0000-0002-0555-1122; Padmanabhan, S./0000-0002-8772-0152				ANSARI AZ, 1995, NATURE, V374, P371; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BAI U, 1993, GENE DEV, V7, P139, DOI 10.1101/gad.7.1.139; BALSALOBRE JM, 1987, P NATL ACAD SCI USA, V84, P2359, DOI 10.1073/pnas.84.8.2359; BALSALOBRE JM, 1989, THESIS U MURCIA MURC; Bonnefoy E, 1999, MOL CELL BIOL, V19, P2803; BOTELLA JA, 1995, EUR J BIOCHEM, V233, P238, DOI 10.1111/j.1432-1033.1995.238_1.x; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Burgess R., 1996, STRATEGIES PROTEIN P, P205; DEMPLE B, 1991, CELL, V67, P837, DOI 10.1016/0092-8674(91)90355-3; Duttweiler HM, 1996, TRENDS GENET, V12, P340, DOI 10.1016/S0168-9525(96)80008-4; FONTES M, 1993, EMBO J, V12, P1265, DOI 10.1002/j.1460-2075.1993.tb05771.x; GOLEMIS EA, 2001, MOL CLONING LAB MANU; Goodwin TW, 1980, BIOCH CAROTENOIDS, V1, P77, DOI DOI 10.1007/978-94-009-5860-9_3; Gorham HC, 1996, MOL MICROBIOL, V19, P171, DOI 10.1046/j.1365-2958.1996.360888.x; HANSEN JC, 1994, BIOCHEMISTRY-US, V33, P13155, DOI 10.1021/bi00249a001; HEINZEL T, 1992, J BIOL CHEM, V267, P4183; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hodgson D, 1993, MYXOBACTERIA, VII, P157; Hodgson D. A., 1998, MICROBIAL RESPONSES, P186; KIM B, 1993, CELL, V73, P1165, DOI 10.1016/0092-8674(93)90645-7; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu T, 1998, MOL MICROBIOL, V30, P1041, DOI 10.1046/j.1365-2958.1998.01132.x; LONETTO MA, 1994, P NATL ACAD SCI USA, V91, P7573, DOI 10.1073/pnas.91.16.7573; Martinez-Argudo I, 1998, MOL MICROBIOL, V30, P883, DOI 10.1046/j.1365-2958.1998.01129.x; MARTINEZLABORDA A, 1989, GENETICS, V122, P801; MCGOWAN SJ, 1993, MOL MICROBIOL, V10, P713, DOI 10.1111/j.1365-2958.1993.tb00943.x; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; Moreno AJ, 2001, J BACTERIOL, V183, P557, DOI 10.1128/JB.183.2.557-569.2001; NICOLAS FJ, 1994, GENE DEV, V8, P2375, DOI 10.1101/gad.8.19.2375; Nicolas FJ, 1996, P NATL ACAD SCI USA, V93, P6881, DOI 10.1073/pnas.93.14.6881; OPPENHEIM AB, 1970, NATURE, V226, P31, DOI 10.1038/226031a0; Outten CE, 1999, J BIOL CHEM, V274, P37517, DOI 10.1074/jbc.274.53.37517; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Padmanabhan S, 2001, J BIOL CHEM, V276, P41566, DOI 10.1074/jbc.M106352200; Rau W., 1988, PLANT PIGMENTS, P231; Rose M. D., 1990, METHODS YEAST GENETI, P155; RUIZVAZQUEZ R, 1993, MOL MICROBIOL, V10, P25, DOI 10.1111/j.1365-2958.1993.tb00900.x; RUIZVAZQUEZ R, 1984, J BACTERIOL, V160, P818; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLAX PJ, 1995, J MOL BIOL, V245, P331, DOI 10.1006/jmbi.1994.0028; Shearwin KE, 1998, J BIOL CHEM, V273, P5708, DOI 10.1074/jbc.273.10.5708; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; Zeng XM, 1999, J BACTERIOL, V181, P1719, DOI 10.1128/JB.181.6.1719-1727.1999; Zeng XM, 2000, J BACTERIOL, V182, P1916, DOI 10.1128/JB.182.7.1916-1922.2000; ZHELEZNOVAHELDW.EE, 2001, NATURE, V409, P378	47	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7262	7270		10.1074/jbc.M110351200	http://dx.doi.org/10.1074/jbc.M110351200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11748235	hybrid			2022-12-27	WOS:000174104300067
J	Migliorini, D; Danovi, D; Colombo, E; Carbone, R; Pelicci, PG; Marine, JC				Migliorini, D; Danovi, D; Colombo, E; Carbone, R; Pelicci, PG; Marine, JC			Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING-FINGER DOMAIN; TUMOR-SUPPRESSOR P53; GERM-CELL TUMORS; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; P53-BINDING PROTEIN; UBIQUITIN LIGASE; MDM2; EXPORT; DEGRADATION	The Hdmx gene product is related to the Hdm2 oncoprotein, both of which interact with and regulate p53 stability and function. Like Hdm2, Hdmx is able to inhibit p53 transactivation; however, at variance with Hdm2, which promotes ubiquitination, nuclear export, and degradation of p53, Hdmx increases p53 stability. We report here M that overexpressed Hdmx is cytoplasmic and Hdm2 recruits Hdmx into the nucleus and (ii) that nuclear Hdmx blocks Hdm2-mediated nuclear export of p53 and down-regulates p53-dependent transcription. Furthermore we showed that Hdmx inhibits Hdm2-mediated p53 ubiquitination. It appears, therefore, that a regulatory loop exists in which Hdm2 regulates the intracellular localization of Hdmx, and nuclear Hdmx regulates several functions of Hdm2 (ubiquitin ligase activity and p53 nuclear export).	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; FIRC, Inst Mol Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology	Pelicci, PG (corresponding author), European Inst Oncol, Dept Expt Oncol, 435 Via Ripamonti, I-20141 Milan, Italy.		Pelicci, Pier Giuseppe/AAL-6572-2020; Danovi, Davide/P-2874-2019; Marine, Jean Christophe/J-2237-2015; Marine, Jean-Christophe/K-3292-2016	Danovi, Davide/0000-0003-4119-5337; Marine, Jean-Christophe/0000-0003-2433-9837				Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Freedman DA, 1997, MOL MED, V3, P248, DOI 10.1007/BF03401678; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Guillou L, 1996, AM J PATHOL, V149, P1221; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jackson MW, 2001, J BIOL CHEM, V276, P25336, DOI 10.1074/jbc.M010685200; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Liang SH, 1998, J BIOL CHEM, V273, P19817, DOI 10.1074/jbc.273.31.19817; LUNA RMD, 1995, NATURE, V378, P203; Middeler G, 1997, ONCOGENE, V14, P1407, DOI 10.1038/sj.onc.1200949; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Rallapalli R, 1999, J BIOL CHEM, V274, P8299, DOI 10.1074/jbc.274.12.8299; Ramos YFM, 2001, CANCER RES, V61, P1839; RIOU G, 1995, MOL CARCINOGEN, V12, P124, DOI 10.1002/mc.2940120303; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Stad R, 2000, J BIOL CHEM, V275, P28039; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Wang XQ, 2001, FEBS LETT, V490, P202, DOI 10.1016/S0014-5793(01)02124-X; Yam CH, 1999, CANCER RES, V59, P5075; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980	30	63	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7318	7323		10.1074/jbc.M108795200	http://dx.doi.org/10.1074/jbc.M108795200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744695	hybrid, Green Published			2022-12-27	WOS:000174104300074
J	Podor, TJ; Campbell, S; Chindemi, P; Foulon, DM; Farrell, DH; Walton, PD; Weitz, JI; Peterson, CB				Podor, TJ; Campbell, S; Chindemi, P; Foulon, DM; Farrell, DH; Walton, PD; Weitz, JI; Peterson, CB			Incorporation of vitronectin into fibrin clots - Evidence for a binding interaction between vitronectin and gamma A/gamma ' fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; PLATELET ALPHA-GRANULES; S-PROTEIN VITRONECTIN; PLASMA VITRONECTIN; CELL-ADHESION; VESSEL WALL; IN-VIVO; IDENTIFICATION; THROMBIN; HEPARIN	Vitronectin is an abundant plasma protein that regulates coagulation, fibrinolysis, complement activation, and cell adhesion. Recently, we demonstrated that plasma vitronectin inhibits fibrinolysis by mediating the interaction of type 1 plasminogen activator inhibitor with fibrin (Podor, T. J., Peterson, C. B., Lawrence, D. A., Stefansson, S., Shaughnessy, S. G., Foulon, D. M., Butcher, M., and Weitz, J. I. (2000) J. Biol. Chem. 275, 19788-19794). The current studies were undertaken to further examine the interactions between vitronectin and fibrin(ogen). Comparison of vitronectin levels in plasma with those in serum indicates that similar to20% of plasma vitronectin is incorporated into the clot. When the time course of biotinylated-vitronectin incorporation into clots formed from I-125-fibrinogen is monitored, vitronectin incorporation into the clot parallels that of fibrinogen in the absence or presence of activated factor XIII. Vitronectin binds specifically to fibrin matrices with an estimated K-d of similar to0.6 m. Additional vitronectin subunits are assembled on fibrin-bound vitronectin multimers through self-association. Confocal microscopy of fibrin clots reveals the globular vitronectin aggregates anchored at intervals along the fibrin fibrils. This periodicity raised the possibility that vitronectin interacts with the gammaA/gamma' variant of fibrin(ogen) that represents about 10% of total fibrinogen. In support of this concept, the vitronectin which contaminates fibrinogen preparations co-purifies with the gammaA/gamma' fibrinogen fraction, and clots formed from gammaA/gamma' fibrinogen preferentially bind vitronectin. These studies reveal that vitronectin associates with fibrin during coagulation, and may thereby modulate hemostasis and inflammation.	Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Dept Med, Hamilton, ON L8V 1C3, Canada; Oregon Hlth & Sci Univ, Sch Med, Dept Pathol, Portland, OR 97201 USA; Univ Tennessee, Dept Biochem & Cellular & Mol Med, Knoxville, TN 37996 USA	McMaster University; McMaster University; McMaster University; Oregon Health & Science University; University of Tennessee System; University of Tennessee Knoxville	Podor, TJ (corresponding author), Hamilton Civ Hosp, Res Ctr, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	podort@mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550				AKAMA T, 1989, J BIOCHEM-TOKYO, V100, P1343; BALE MD, 1985, J BIOL CHEM, V260, P7502; BITTORF SV, 1993, J BIOL CHEM, V268, P24838; CHUNG DW, 1984, BIOCHEMISTRY-US, V23, P4232, DOI 10.1021/bi00313a033; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; Eitzman DT, 2000, BLOOD, V95, P577, DOI 10.1182/blood.V95.2.577; Falls LA, 1997, J BIOL CHEM, V272, P14251, DOI 10.1074/jbc.272.22.14251; Fay WP, 1999, BLOOD, V93, P1825, DOI 10.1182/blood.V93.6.1825.406k37_1825_1830; FORNACE AJ, 1984, J BIOL CHEM, V259, P2826; Gibson A, 1997, J BIOL CHEM, V272, P5112, DOI 10.1074/jbc.272.8.5112; GUETTIER C, 1989, VIRCHOWS ARCH A, V414, P309, DOI 10.1007/BF00734084; HANTGAN R, 1983, ANN NY ACAD SCI, V408, P344, DOI 10.1111/j.1749-6632.1983.tb23256.x; HESS S, 1995, THROMB HAEMOSTASIS, V74, P258; HESS S, 1993, INT CONGR SER, V1042, P21; HILDEBRAND A, 1989, J BIOL CHEM, V264, P15429; Hill SA, 1996, BLOOD, V87, P5061, DOI 10.1182/blood.V87.12.5061.bloodjournal87125061; IZUMI M, 1989, BIOCHIM BIOPHYS ACTA, V990, P101, DOI 10.1016/S0304-4165(89)80019-4; Konstantinides S, 2001, CIRCULATION, V103, P576, DOI 10.1161/01.CIR.103.4.576; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang IM, 1996, J BIOL CHEM, V271, P2754, DOI 10.1074/jbc.271.5.2754; Lawrence DA, 1997, J BIOL CHEM, V272, P7676, DOI 10.1074/jbc.272.12.7676; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; MIMURO J, 1989, J BIOL CHEM, V264, P5058; Moaddel M, 2000, J BIOL CHEM, V275, P32135, DOI 10.1074/jbc.M000496200; Mosesson MW, 1997, BLOOD COAGUL FIBRIN, V8, P257, DOI 10.1097/00001721-199707000-00001; NASKI MC, 1993, J BIOL CHEM, V268, P12367; PODOR TJ, 1992, ANN NY ACAD SCI, V667, P173, DOI 10.1111/j.1749-6632.1992.tb51609.x; Podor TJ, 2000, J BIOL CHEM, V275, P19788, DOI 10.1074/jbc.M908079199; Podor TJ, 2000, J BIOL CHEM, V275, P25402, DOI 10.1074/jbc.M000362200; POLLANEN J, 1991, ADV CANCER RES, V57, P273; PREISSNER KT, 1995, HISTOL HISTOPATHOL, V10, P239; PREISSNER KT, 1989, BLOOD, V74, P1989; Robbie LA, 1996, THROMB HAEMOSTASIS, V75, P127; SANE DC, 1988, BIOCHEM BIOPH RES CO, V157, P115, DOI 10.1016/S0006-291X(88)80020-2; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Seiffert D, 1996, BLOOD, V88, P552, DOI 10.1182/blood.V88.2.552.bloodjournal882552; SEIFFERT D, 1991, J BIOL CHEM, V266, P2824; Seiffert D, 1996, J BIOL CHEM, V271, P29644, DOI 10.1074/jbc.271.47.29644; SEIFFERT D, 1995, J IMMUNOL, V155, P3180; SEIFFERT D, 1993, INT CONGR SER, V1042, P75; Seiffert D, 1997, J BIOL CHEM, V272, P13705, DOI 10.1074/jbc.272.21.13705; SIENBENLIST KR, 1996, BIOCHEMISTRY-US, V35, P10448; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; Stoop AA, 2000, ARTERIOSCL THROM VAS, V20, P1143, DOI 10.1161/01.ATV.20.4.1143; THIAGARAJAN P, 1988, J BIOL CHEM, V263, P3035; Tomasini B R, 1991, Prog Hemost Thromb, V10, P269; TOMASINI BR, 1986, BLOOD, V68, P737; TOMASINI BR, 1989, BIOCHEMISTRY-US, V28, P7617, DOI 10.1021/bi00445a017; TOMASINI BR, 1988, BLOOD, V72, P903; Weitz JI, 1998, CIRCULATION, V97, P544; WIMAN B, 1988, FEBS LETT, V242, P125, DOI 10.1016/0014-5793(88)80999-2; Wohn KD, 1999, BRIT J HAEMATOL, V104, P901, DOI 10.1046/j.1365-2141.1999.01242.x; Young E, 1997, ARTERIOSCL THROM VAS, V17, P1568, DOI 10.1161/01.ATV.17.8.1568; Zhuang P, 1996, J BIOL CHEM, V271, P14323, DOI 10.1074/jbc.271.24.14323	55	58	62	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7520	7528		10.1074/jbc.M109677200	http://dx.doi.org/10.1074/jbc.M109677200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744726	hybrid			2022-12-27	WOS:000174104300098
J	Shimoaka, T; Ogasawara, T; Yonamine, A; Chikazu, D; Kawano, H; Nakamura, K; Itoh, N; Kawaguchi, H				Shimoaka, T; Ogasawara, T; Yonamine, A; Chikazu, D; Kawano, H; Nakamura, K; Itoh, N; Kawaguchi, H			Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; BONE-FORMATION; MAP KINASE; ALKALINE-PHOSPHATASE; FACTOR RECEPTOR-1; FACTOR FAMILY; ACTIVATION; PROTEIN; CELLS; GENE	This study investigated the actions of fibroblast growth factor (FGF)-18, a novel member of the FGF family, on osteoblasts, chondrocytes, and osteoclasts and compared them with those of FGF-2 and FGF-10. FGF-18 stimulated the proliferation of cultured mouse primary osteoblasts, osteoblastic MC3T3-E1 cells, primary chondrocytes, and prechondrocytic ATDC5 cells, although it inhibited the differentiation and matrix synthesis of these cells. FGF-18 up-regulated the phosphorylation of extracellular signal-regulated kinase in both osteoblasts and chondrocytes and up-regulated the phosphorylation of p38 mitogen-activated protein kinase only in chondrocytes. FGF-18 mitogenic actions were blocked by a specific inhibitor of extracellular signal-regulated kinase in both osteoblasts and chondrocytes and by a specific inhibitor of p38 mitogen-activated protein kinase in chondrocytes. With regard to the action of FGF-18 on bone resorption, FGF-18 not only induced osteoclast formation through receptor activator of nuclear factor-kappaB ligand and cyclooxygenase-2 but also stimulated osteoclast function to form resorbed pits on a dentine slice in the mouse coculture system. All these effects of FGF-18 bore a close resemblance to those of FGF-2, whereas FGF-10 affects none of these cells. FGF-18 may therefore compensate for the action of FGF-2 on bone and cartilage.	Univ Tokyo, Dept Orthoped Surg, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto 6068501, Japan	University of Tokyo; Kyoto University	Kawaguchi, H (corresponding author), Univ Tokyo, Dept Orthoped Surg, Fac Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.		Ogasawara, Toru/I-1629-2014	Ogasawara, Toru/0000-0002-2996-081X				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ASPENBERG P, 1989, ACTA ORTHOP SCAND, V60, P473, DOI 10.3109/17453678909149323; Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; Chaudhary LR, 1997, BIOCHEM BIOPH RES CO, V238, P134, DOI 10.1006/bbrc.1997.7256; Chikazu D, 2001, J BONE MINER RES, V16, P2074, DOI 10.1359/jbmr.2001.16.11.2074; Chikazu D, 2000, J BIOL CHEM, V275, P31444, DOI 10.1074/jbc.M910132199; Hu MCT, 1999, ONCOGENE, V18, P2635, DOI 10.1038/sj.onc.1202616; Hu MCT, 1998, MOL CELL BIOL, V18, P6063, DOI 10.1128/MCB.18.10.6063; HUMPHRIES DE, 1992, ADV EXP MED BIOL, V313, P59; Hurley MM, 1998, BONE, V22, P309, DOI 10.1016/S8756-3282(97)00292-5; HURLEY MM, 1994, J BIOL CHEM, V269, P9392; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kameda T, 1996, BIOCHEM BIOPH RES CO, V220, P515, DOI 10.1006/bbrc.1996.0436; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774; Kawaguchi H, 2001, J CLIN ENDOCR METAB, V86, P875, DOI 10.1210/jc.86.2.875; KAWAGUCHI H, 1995, J CLIN INVEST, V96, P923, DOI 10.1172/JCI118140; Kawaguchi H, 2000, J BONE MINER RES, V15, P466, DOI 10.1359/jbmr.2000.15.3.466; Klint P, 1999, ONCOGENE, V18, P3354, DOI 10.1038/sj.onc.1202680; KLINT P, 1995, J BIOL CHEM, V270, P23337, DOI 10.1074/jbc.270.40.23337; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Manabe N, 1999, RHEUMATOLOGY, V38, P714, DOI 10.1093/rheumatology/38.8.714; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Ohbayashi N, 1998, J BIOL CHEM, V273, P18161, DOI 10.1074/jbc.273.29.18161; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Ornitz D.M., 2001, GENOME BIOL, V2; RODAN SB, 1989, J BIOL CHEM, V264, P19934; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Suzuki A, 1999, ENDOCRINOLOGY, V140, P3177, DOI 10.1210/en.140.7.3177; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Xu JS, 2000, DEVELOPMENT, V127, P1833; Yamasaki M, 1996, J BIOL CHEM, V271, P15918, DOI 10.1074/jbc.271.27.15918; Yonekura A, 1999, ENDOCR J, V46, P545, DOI 10.1507/endocrj.46.545; ZHAN X, 1994, J BIOL CHEM, V269, P20221; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	44	126	144	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7493	7500		10.1074/jbc.M108653200	http://dx.doi.org/10.1074/jbc.M108653200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741978	hybrid			2022-12-27	WOS:000174104300095
J	Lee, HJ; Jung, KM; Huang, YZ; Bennett, LB; Lee, JS; Mei, L; Kim, TW				Lee, HJ; Jung, KM; Huang, YZ; Bennett, LB; Lee, JS; Mei, L; Kim, TW			Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALPHA-CONVERTING-ENZYME; GROWTH-FACTOR RECEPTOR; TRANSMEMBRANE ASPARTATES; INTRACELLULAR DOMAIN; PROTEOLYTIC RELEASE; ALZHEIMERS-DISEASE; TYROSINE KINASE; NOTCH; ENDOPROTEOLYSIS	An unusual protease gamma-secretase requires functional presenilins and cleaves substrates (e.g. amyloid beta-protein precursor and Notch) with very loose amino acid sequence specificity within the transmembrane region. Here we report that ErbB4, a tyrosine kinase receptor for neuregulins, is a substrate for presenilin-dependent,gamma-secretase. Our studies show that constitutive ectodomain shedding of full-length ErbB4 yields the similar to80-kDa membrane-associated C-terminal fragment (B4-CTF). Subsequent intramembrane cleavage of the B4-CTF was inhibited in the cells devoid of functional presenilins or by treatment of cells with a gamma-secretase inhibitor, leading to enhanced accumulation of B4-CTF. Furthermore, an in vitro gamma-secretase assay demonstrated that the intracellular domain of ErbB4 (B4-ICD) was produced and subsequently released into the soluble fraction in a presenilin-dependent manner. We have also shown that ectopically expressed B4-ICD is localized to the nucleus, suggesting that the presenilin-dependent cleavage of ErbB4 generates the soluble B4-ICD that functions in the nucleus presumably at transcriptionaI level. Our study indicates that ErbB4 represents a first receptor tyrosine kinase that undergoes intramembrane proteolysis and may mediate a novel signaling function independent of its canonical role as a receptor tyrosine kinase. Our studies also support the idea that presenilins play a generic role in intramembrane cleavage of selected type I membrane proteins.	Columbia Univ Coll Phys & Surg, Dept Pathol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; Univ Alabama Birmingham, Sch Med, Dept Neurobiol Pathol & Phys Med & Rehabil, Birmingham, AL 35294 USA	Columbia University; University of Alabama System; University of Alabama Birmingham	Kim, TW (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St,P&S 14-511, New York, NY 10032 USA.	twk16@columbia.edu	Mei, Lin/G-8755-2012; Jung, Kwang-Mook/F-1035-2018	Jung, Kwang-Mook/0000-0003-4096-6953				Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; De Strooper B, 2001, NAT CELL BIOL, V3, pE221, DOI 10.1038/ncb1001-e221; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Junttila TT, 2000, TRENDS CARDIOVAS MED, V10, P304, DOI 10.1016/S1050-1738(01)00065-2; Kimberly WT, 2000, J BIOL CHEM, V275, P3173, DOI 10.1074/jbc.275.5.3173; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Pack-Chung E, 2000, J BIOL CHEM, V275, P14440, DOI 10.1074/jbc.M909882199; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Srinivasan R, 2000, CANCER RES, V60, P1483; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tanzi RE, 1996, NEUROBIOL DIS, V3, P159, DOI 10.1006/nbdi.1996.0016; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vecchi M, 1996, J BIOL CHEM, V271, P18989, DOI 10.1074/jbc.271.31.18989; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200	36	254	267	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6318	6323		10.1074/jbc.M110371200	http://dx.doi.org/10.1074/jbc.M110371200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741961	hybrid			2022-12-27	WOS:000173989200083
J	Ueno, T; Okabe, A; Akaike, N; Fukuda, A; Nabekura, J				Ueno, T; Okabe, A; Akaike, N; Fukuda, A; Nabekura, J			Diversity of neuron-specific K+-Cl- cotransporter expression and inhibitory postsynaptic potential depression in rat motoneurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-DEPENDENT DISINHIBITION; HIPPOCAMPAL PYRAMIDAL CELLS; INTRACELLULAR CHLORIDE; NA-K-2CL COTRANSPORTER; INVITRO; BRAIN; FUROSEMIDE; POTASSIUM; CURRENTS; KCC2	Motoneurons receive a robust recurrent synaptic inhibition by gamma-aminobutyric acid and glycine, which activate Cl- channels. Thus, Cl- homeostasis determines the efficacy of synaptic inhibition in the motoneurons. In situ hybridization reveals that the neuronal K+-Cl- cotransporter isoform 2 (KCC2), a major mechanism in maintaining a low Cl- concentration in neurons, is abundantly expressed in the facial, hypoglossal (XII), and spinal motoneurons innervating striated muscle, whereas the dorsal vagal motoneurons (DMVs) controlling smooth muscle exhibited little expression of KCC2. This raises a general interest in the correlation between KCC2 expression and inhibitory postsynaptic potential (IPSP) performance in the native circuits. Intracellular and whole-cell patch recordings revealed that an activity-dependent depression of IPSPs and positive shift of IPSP reversal potentials were more prominent in the DMV than in the XII. Cl- influx through Cl- channels was extruded more potently in the XII than in the DMV, suggesting that differences in Cl- extrusion account for these dynamic differences of IPSP. Cl- extrusion was inhibited by either furosemide or an increase in extracellular potassium concentrations. Thus, the rigid maintenance of IPSP and rapid Cl- extrusion in the XII reflects an intense expression of KCC2. KCC2 expression may strongly influence the IPSP depression and functional properties of the motoneurons innervating striated muscles.	Kyushu Univ, Grad Sch Med Sci, Dept Cellular & Syst Physiol, Higashi Ku, Fukuoka 8128582, Japan; Hamamatsu Univ Sch Med, Dept Physiol, Shizuoka 4313192, Japan	Kyushu University; Hamamatsu University School of Medicine	Nabekura, J (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Cellular & Syst Physiol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	Nabekura@mailserver.med.kyushu-u.ac.jp	Fukuda, Atsuo/ABA-6843-2020	Fukuda, Atsuo/0000-0001-7112-4834				ALVAREZLEEFMANS FJ, 1990, CHLORIDE CHANNELS AND CARRIERS IN NERVE, MUSCLE, AND GLIAL CELLS, P109; ANDERSEN P, 1980, J PHYSIOL-LONDON, V305, P279, DOI 10.1113/jphysiol.1980.sp013363; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Flatman PW, 1996, AM J PHYSIOL-CELL PH, V271, pC255, DOI 10.1152/ajpcell.1996.271.1.C255; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V404, P83, DOI 10.1113/jphysiol.1988.sp017280; Furukawa Y, 2000, NEUROSCIENCE, V96, P385, DOI 10.1016/S0306-4522(99)00553-9; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; HADDAD GG, 1990, J APPL PHYSIOL, V69, P1509, DOI 10.1152/jappl.1990.69.4.1509; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Inagaki C, 1996, J EXP ZOOL, V275, P262; Jarolimek W, 1999, J NEUROSCI, V19, P4695; JIANG C, 1994, EXP BRAIN RES, V100, P407, DOI 10.1007/BF02738401; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kelsch W, 2001, J NEUROSCI, V21, P8339, DOI 10.1523/JNEUROSCI.21-21-08339.2001; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; MCCARREN M, 1985, J NEUROPHYSIOL, V53, P557, DOI 10.1152/jn.1985.53.2.557; NABEKURA J, 1993, J NEUROPHYSIOL, V70, P1544, DOI 10.1152/jn.1993.70.4.1544; Nabekura J, 1995, J PHYSIOL-LONDON, V489, P519, DOI 10.1113/jphysiol.1995.sp021069; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; RANDLE JCR, 1986, J NEUROPHYSIOL, V56, P1703, DOI 10.1152/jn.1986.56.6.1703; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; STARKE LC, 1993, AM J PHYSIOL, V264, pC118, DOI 10.1152/ajpcell.1993.264.1.C118; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Sung KW, 2000, J NEUROSCI, V20, P7531; Suzuki SO, 1999, BRAIN RES PROTOC, V4, P29, DOI 10.1016/S1385-299X(98)00058-0; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P524, DOI 10.1152/jn.1989.61.3.524; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; THOMPSON SM, 1988, J NEUROPHYSIOL, V60, P105, DOI 10.1152/jn.1988.60.1.105; Ueno T, 2001, J NEUROCHEM, V78, P1009, DOI 10.1046/j.1471-4159.2001.00473.x; Ulrich D, 1997, J NEUROPHYSIOL, V78, P1748, DOI 10.1152/jn.1997.78.3.1748; VIANA F, 1990, NEUROSCIENCE, V38, P829, DOI 10.1016/0306-4522(90)90075-F; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	41	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4945	4950		10.1074/jbc.M109439200	http://dx.doi.org/10.1074/jbc.M109439200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733521	hybrid			2022-12-27	WOS:000173962900053
J	Yoshikawa, N; Makino, Y; Okamoto, K; Morimoto, C; Makino, I; Tanaka, H				Yoshikawa, N; Makino, Y; Okamoto, K; Morimoto, C; Makino, I; Tanaka, H			Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity - Cortivazol is a specific ligand for the glucocorticoid receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MINERALOCORTICOID RECEPTOR; STEROID-HORMONE RECEPTORS; NUCLEAR RECEPTORS; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; H-3 CORTIVAZOL; DNA-BINDING; IN-VIVO; DETERMINANTS; ALDOSTERONE; TRANSACTIVATION	Ligand-receptor coupling is one of the important constituents of signal transduction and is essential for physiological transmission of actions of endogenous substances including steroid hormones. However, molecular mechanisms of the redundancy between glucocorticoid and mineralocorticoid actions remain unknown because of complicated cross-talk among, for example, these adrenal steroids, their cognate receptors, and target genes. Receptor-specific ligand that can distinctly modulate target gene expression should be developed to overcome this issue. In this report, we showed that a pyrazolosteroid cortivazol (CVZ) does not induce either nuclear translocation or transactivation function of the mineralocorticoid receptor (MR) but does both for the glucocorticoid receptor (GR). Moreover, deletion analysis of the C-terminal end of the GR has revealed that CVZ interacts with the distinct portion of the ligand binding-domain (LBD) and differentially modulates the ligand-dependent interaction between transcription intermediary factor 2 and the LBD when compared with cortisol, dexamethasone, and aldosterone. Thus, it is indicated that CVZ may not be only a molecular probe for the analysis of the redundancy between the GR and MR in vivo but also a useful reagent to clarify structure-function relationship of the GR LBD.	Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, Tokyo 1088639, Japan; Asahikawa Med Coll, Dept Internal Med 2, Asahikawa, Hokkaido 0780083, Japan	University of Tokyo; Asahikawa Medical College	Tanaka, H (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	hirotnk@ims.u-tokyo.ac.jp						Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Baulieu EE, 1997, ANN NY ACAD SCI, V828, P47, DOI 10.1111/j.1749-6632.1997.tb48523.x; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bonvalet JP, 1998, KIDNEY INT, pS49; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; CARLSTEDTDUKE J, 1988, J BIOL CHEM, V263, P6842; Cato ACB, 1996, BIOESSAYS, V18, P371, DOI 10.1002/bies.950180507; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; DEKLOET ER, 1987, ANN NY ACAD SCI, V512, P351, DOI 10.1111/j.1749-6632.1987.tb24973.x; DEVREOTES PN, 1994, NEURON, V12, P235, DOI 10.1016/0896-6273(94)90267-4; Dey R, 2001, PROTEIN ENG, V14, P565, DOI 10.1093/protein/14.8.565; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Eggert M, 1997, J BIOL CHEM, V272, P28471, DOI 10.1074/jbc.272.45.28471; Fagart J, 1998, EMBO J, V17, P3317, DOI 10.1093/emboj/17.12.3317; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Fuller PJ, 2000, KIDNEY INT, V57, P1256, DOI 10.1046/j.1523-1755.2000.00959.x; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Glass CK, 2000, GENE DEV, V14, P121; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; GOMEZSANCHEZ CE, 1983, ENDOCRINOLOGY, V113, P1004, DOI 10.1210/endo-113-3-1004; GOVINDAN MV, 1991, J STEROID BIOCHEM, V39, P91, DOI 10.1016/0960-0760(91)90017-Y; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; Hellal-Levy C, 1999, FEBS LETT, V464, P9, DOI 10.1016/S0014-5793(99)01667-1; Hellal-Levy C, 2000, KIDNEY INT, V57, P1250, DOI 10.1046/j.1523-1755.2000.00958.x; Hiramoto M, 1998, J IMMUNOL, V160, P810; HOLLENBERG SM, 1989, CANCER RES, V49, pS2292; Iida T, 2000, KIDNEY INT, V58, P1450, DOI 10.1046/j.1523-1755.2000.00307.x; Kim PJ, 1998, J STEROID BIOCHEM, V67, P213, DOI 10.1016/S0960-0760(98)00095-8; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Kolla V, 1999, BIOCHEM BIOPH RES CO, V266, P5, DOI 10.1006/bbrc.1999.1765; Krozowski Z, 1999, MOL CELL ENDOCRINOL, V151, P121, DOI 10.1016/S0303-7207(98)00256-1; Lim J, 2000, MOL ENDOCRINOL, V14, P1187, DOI 10.1210/me.14.8.1187; LimTio SS, 1997, ENDOCRINOLOGY, V138, P2537, DOI 10.1210/en.138.6.2537; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; LOMAX RB, 1994, AM J PHYSIOL, V267, pG485, DOI 10.1152/ajpgi.1994.267.3.G485; LOMBES M, 1994, ENDOCRINOLOGY, V135, P834, DOI 10.1210/en.135.3.834; Lupo B, 1998, BIOCHEMISTRY-US, V37, P12153, DOI 10.1021/bi980593e; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Naray-Fejes-Toth A, 1998, J STEROID BIOCHEM, V65, P311, DOI 10.1016/S0960-0760(98)00009-0; Okamoto K, 1999, J BIOL CHEM, V274, P10363, DOI 10.1074/jbc.274.15.10363; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; RAFESTINOBLIN ME, 1986, J STEROID BIOCHEM, V25, P527, DOI 10.1016/0022-4731(86)90398-5; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Rogerson FM, 1999, J BIOL CHEM, V274, P36305, DOI 10.1074/jbc.274.51.36305; Rogerson FM, 2000, STEROIDS, V65, P61, DOI 10.1016/S0039-128X(99)00087-2; Roux S, 1996, MOL ENDOCRINOL, V10, P1214, DOI 10.1210/me.10.10.1214; RUPPRECHT R, 1993, EUR J PHARM-MOLEC PH, V247, P145, DOI 10.1016/0922-4106(93)90072-H; Sackey FNA, 1996, MOL ENDOCRINOL, V10, P1191, DOI 10.1210/me.10.10.1191; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; SCHLECHTE JA, 1987, J CLIN ENDOCR METAB, V64, P441, DOI 10.1210/jcem-64-3-441; SCHLECHTE JA, 1985, ENDOCRINOLOGY, V117, P1355, DOI 10.1210/endo-117-4-1355; SCOGGINS BA, 1984, CLIN EXP HYPERTENS A, V6, P315, DOI 10.3109/10641968409062568; SIMONS SS, 1995, METHOD ENZYMOL, V251, P406; SPENCE CD, 1986, J STEROID BIOCHEM, V25, P411, DOI 10.1016/0022-4731(86)90254-2; Tang YT, 1998, MOL ENDOCRINOL, V12, P1420, DOI 10.1210/me.12.9.1420; TEUTSCH G, 1981, STEROIDS, V38, P651, DOI 10.1016/0039-128X(81)90084-2; THOMPSON EB, 1989, CANCER RES, V49, pS2253; Vanden Berghe W, 1999, MOL PHARMACOL, V56, P797; VANSTEENSEL B, 1995, J CELL SCI, V108, P3003; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yang J, 1996, MOL ENDOCRINOL, V10, P3, DOI 10.1210/me.10.1.3; Young M, 2000, TRENDS ENDOCRIN MET, V11, P224, DOI 10.1016/S1043-2760(00)00270-8	71	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5529	5540		10.1074/jbc.M107946200	http://dx.doi.org/10.1074/jbc.M107946200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741935	hybrid			2022-12-27	WOS:000173962900126
J	Jovov, B; Berdiev, BK; Fuller, CM; Ji, HL; Benos, DJ				Jovov, B; Berdiev, BK; Fuller, CM; Ji, HL; Benos, DJ			The serine protease trypsin cleaves C termini of beta- and gamma-subunits of epithelial Na+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNELS; KALLIKREIN; REGULATOR; ENAC	Both extracellular and intracellular proteases can activate epithelial Na+ channels (ENaC). The mechanism by which serine proteases activate ENaC is unknown. We investigated the effect of the serine protease trypsin on in vitro translated and immunopurified alpha-, beta-, and,gamma-rENaC subunits. Immunopurified subunit proteins were exposed to increasing concentrations of trypsin ranging from 0.002 to 2 mug/ml in Tris-buffered saline buffer for 2 h. The proteolytic mixture was subjected to SDS-PAGE and analyzed by autoradiography. Our results demonstrate that the beta- and gamma-subunits of ENaC were most susceptible to trypsin proteolysis, and exposure to as little as 0.002 mug/ml trypsin resulted in a reduction in the size of the alpha- and gamma-transcripts by 7-8 kDa. By using N- and C-terminally truncated beta- and gamma-subunits, we determined that trypsin cleaved the C termini of both subunits, resulting in a channel structure resembling that seen in Liddle's disease. Exposure to 2 mug/ml trypsin completely digested all three subunits. Our results suggest different susceptibilities of proteolytic sites of ENaC subunits to trypsin. Thus, we propose that limited intracellular proteolysis may be one of the potential physiological mechanisms of sodium channel regulation.	Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, 1918 Univ Blvd,MCLM 704, Birmingham, AL 35294 USA.	benos@physiology.uab.edu	Fuller, Cathy/B-4046-2011; JI, HONGLONG/N-7822-2014	JI, HONGLONG/0000-0002-3228-7144	NIDDK NIH HHS [DK37206] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037206, R01DK037206] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; AWAYDA MS, 1995, AM J PHYSIOL-CELL PH, V268, pC1450, DOI 10.1152/ajpcell.1995.268.6.C1450; Chalfant ML, 1999, J BIOL CHEM, V274, P32889, DOI 10.1074/jbc.274.46.32889; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; GARTY H, 1983, J GEN PHYSIOL, V81, P785, DOI 10.1085/jgp.81.6.785; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Ismailov II, 1997, J PHYSIOL-LONDON, V504, P287, DOI 10.1111/j.1469-7793.1997.287be.x; Ismailov II, 1996, AM J PHYSIOL-CELL PH, V270, pC214, DOI 10.1152/ajpcell.1996.270.1.C214; Ji HL, 1999, J BIOL CHEM, V274, P37693, DOI 10.1074/jbc.274.53.37693; JOVOV B, 1990, AM J PHYSIOL, V259, pC869, DOI 10.1152/ajpcell.1990.259.6.C869; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; LEWIS SA, 1986, P NATL ACAD SCI USA, V83, P5345, DOI 10.1073/pnas.83.14.5345; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tamura H, 1996, J CLIN INVEST, V97, P1780, DOI 10.1172/JCI118606; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Tavernarakis N, 2001, CURR BIOL, V11, pR205, DOI 10.1016/S0960-9822(01)00106-3; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329	19	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4134	4140		10.1074/jbc.M108354200	http://dx.doi.org/10.1074/jbc.M108354200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11739385	hybrid			2022-12-27	WOS:000173813900047
J	Zang, MW; Hayne, C; Luo, ZJ				Zang, MW; Hayne, C; Luo, ZJ			Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 3-KINASE; RAS TRANSFORMATION; PLASMA-MEMBRANE; IDENTIFICATION; SERINE-338; PATHWAY; GTPASE; FAMILY	Activation of Raf-1 is a complex process in which phosphorylation of Ser(338)-Tyr(341) is a critical step. Previous studies have shown that Pak1/2 is implicated in both Ras-dependent and -independent activation of Raf-1 by phosphorylating Raf Ser(338). The present, study explores the structural basis of Raf-1 phosphorylation by Pak1. We found that Pak directly, associates with Raf-1 under both physiological and overexpressed conditions. The association is greatly stimulated by 4beta-12-O-tetradecanoylphorbol-13-acetate and nocodazole and by expression of the active mutants of Rac and Ras. The active forms of Pak generated by mutation of Thr(423) to Glu or truncation of the amino-terminal moiety exhibit a greater binding to Raf than the wild type, whereas the kinase-dead mutant Pak barely binds Raf. The extent of binding to Raf-1 is correlated with the ability of Pak to phosphorylate Raf and induce mitogen-activated protein kinase activation. Furthermore, the Raf-1 binding site is defined to the carboxyl terminus of the Pak catalytic domain. In addition, our results suggest that the amino-terminal regulatory region of Raf inhibits the interaction. Taken together, the results indicate that the interaction depends on the active conformations of Pak and Raf. They also argue that Pak1 is a physiological candidate for phosphorylation of Raf Ser(338) during the course of Raf activation.	Boston Univ, Sch Med, Evans Dept Med, Endocrinol Sect,Diabet & Metab Res Unit, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Luo, ZJ (corresponding author), Boston Univ, Sch Med, Evans Dept Med, Endocrinol Sect,Diabet & Metab Res Unit, 650 Albany St,RM 820, Boston, MA 02118 USA.	zluo@medicine.bu.edu	Luo, Zhijun/AAE-9302-2019	Luo, Zhijun/0000-0001-8105-5289; Luo, Zhijun/0000-0003-3509-4046; Zang, Mengwei/0000-0002-2502-2586	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057959] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 57959] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; BOS JL, 1989, CANCER RES, V49, P4682; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; CHAMBERS AF, 1993, CRIT REV ONCOGENESIS, V4, P95; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chiloeches A, 2001, MOL CELL BIOL, V21, P2423, DOI 10.1128/MCB.21.7.2423-2434.2001; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; DENT P, 1995, MOL CELL BIOL, V15, P4125; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Furge KA, 2001, P NATL ACAD SCI USA, V98, P10722, DOI 10.1073/pnas.191067898; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Roig J, 2000, P NATL ACAD SCI USA, V97, P14346, DOI 10.1073/pnas.97.26.14346; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; Webb CP, 1998, P NATL ACAD SCI USA, V95, P8773, DOI 10.1073/pnas.95.15.8773; Winkler DG, 1998, J BIOL CHEM, V273, P21578, DOI 10.1074/jbc.273.34.21578; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zang MW, 2001, J BIOL CHEM, V276, P25157, DOI 10.1074/jbc.M100152200; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565	50	95	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4395	4405		10.1074/jbc.M110000200	http://dx.doi.org/10.1074/jbc.M110000200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733498	hybrid			2022-12-27	WOS:000173813900081
J	Le Stunff, H; Peterson, C; Thornton, R; Milstien, S; Mandala, SM; Spiegel, S				Le Stunff, H; Peterson, C; Thornton, R; Milstien, S; Mandala, SM; Spiegel, S			Characterization of murine sphingosine-1-phosphate phosphohydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SPHINGOLIPID METABOLISM; CELL-GROWTH; SPHINGOSINE; PHOSPHATASE; IDENTIFICATION; APOPTOSIS; RECEPTOR; ACTIVATION; REGULATOR	In the present study we have characterized mammalian sphingosine-1-phosphate phosphohydrolase (SPP1), an enzyme that specifically dephosphorylates sphingosine 1-phosphate (SIP) and which differs from previously described lipid phosphate phosphohydrolases. Based on sequence homology to murine SPP1, we cloned the human homolog. Transfection of human embryonic kidney 293 and Chinese hamster ovary cells with murine or human SPP1 resulted in marked increases in SPP1 activity in membrane fractions that were used to examine its enzymological properties. Unlike other known type 2 lipid phosphate phosphohydrolases (LPPs), but similar to the yeast orthologs, mammalian SPP1s are highly specific toward long chain sphingoid base phosphates and degrade SIP, dihydro-SIP, and phyto-S1P. SPP1 exhibited apparent Michaelis-Menten kinetics with SIP as substrate with an apparent K-m of 38.5 mum and optimum activity at pH 7.5. Similar to other LPPs, SPP1 activity was also independent of any cation requirements, including Mg2+, and was not inhibited by EDTA but was markedly inhibited by NaF and Zn2+. However, SPP1 has some significantly different enzymological properties than the LPPs: the aliphatic cation propanolol, which is an effective inhibitor of type 1 phosphatidate phosphohydrolase activities and is only modestly effective as an inhibitor of LPPs, is a potent inhibitor of SPP1; the activity was partially sensitive to N-ethylmaleimide but not to the thioreactive compound iodoacetamide; and importantly, low concentrations of Triton X-100 and other non-ionic detergents were strongly inhibitory. Thus, in agreement with Cluster analysis which shows that outside of the consensus motif there is very little homology between SPP1s and the other type 2 lipid phosphohydrolases, SPP1s are significantly different and divergent from the mammalian LPPs.	Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA; Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA; Merck Res Labs, Rahway, NJ 07065 USA; NIMH, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	Virginia Commonwealth University; Georgetown University; Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem, Med Coll Virginia Campus,1101 E Marshall St,Rm 2-0, Richmond, VA 23298 USA.		LE STUNFF, Hervé/AAA-6882-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R37GM043880] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43880] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alderton F, 2001, J BIOL CHEM, V276, P13452, DOI 10.1074/jbc.M006582200; Alemany R, 2000, MOL PHARMACOL, V58, P491, DOI 10.1124/mol.58.3.491; BRIGHTWELL R, 1968, ARCH BIOCHEM BIOPHYS, V124, P333, DOI 10.1016/0003-9861(68)90335-4; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Cuvillier O, 2000, J BIOL CHEM, V275, P15691, DOI 10.1074/jbc.M000280200; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Edsall LC, 2001, J NEUROCHEM, V76, P1573, DOI 10.1046/j.1471-4159.2001.00164.x; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Goetzl EJ, 2001, PROSTAG OTH LIPID M, V64, P11, DOI 10.1016/S0090-6980(01)00104-6; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; Heringdorf DMZ, 1998, EMBO J, V17, P2830, DOI 10.1093/emboj/17.10.2830; Hla T, 2001, PROSTAG OTH LIPID M, V64, P135, DOI 10.1016/S0090-6980(01)00109-5; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 1997, J BIOL CHEM, V272, P32709, DOI 10.1074/jbc.272.51.32709; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; MATTIE M, 1994, J BIOL CHEM, V269, P3181; MERRILL AH, 1993, ADV LIPID RES, V25, P1; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Prieschl EE, 1999, J EXP MED, V190, P1, DOI 10.1084/jem.190.1.1; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Qie LX, 1997, J BIOL CHEM, V272, P16110, DOI 10.1074/jbc.272.26.16110; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Spiegel S, 2000, BBA-MOL CELL BIOL L, V1484, P107, DOI 10.1016/S1388-1981(00)00010-X; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Stukey J, 1997, PROTEIN SCI, V6, P469; Van Brocklyn JR, 2000, METHOD ENZYMOL, V312, P401; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; Zhang N, 2000, GENESIS, V27, P137, DOI 10.1002/1526-968X(200008)27:4<137::AID-GENE10>3.0.CO;2-4; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	39	73	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8920	8927		10.1074/jbc.M109968200	http://dx.doi.org/10.1074/jbc.M109968200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11756451	hybrid			2022-12-27	WOS:000174400600026
J	Ficzycz, A; Ovsenek, N				Ficzycz, A; Ovsenek, N			The Yin Yang 1 transcription factor associates with ribonucleoprotein (mRNP) complexes in the cytoplasm of Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; Y-BOX PROTEINS; NUCLEIC-ACID BINDING; COLD SHOCK DOMAIN; MESSENGER-RNA; ADENOVIRUS E1A; FACTOR YY1; IN-VIVO; C-MYC; REPRESSION	Yin Yang 1 (YY1) is a multifunctional transcription factor that activates, represses, or initiates transcription of a diverse assortment of genes. Previous studies suggest a role for YY1 in cellular growth and differentiation, but its biological function during development of the vertebrate oocyte or embryo remains to be determined. We recently showed that YY1 is abundantly expressed throughout oogenesis and early embryonic stages of Xenopus, but it is sequestered in the cytoplasm and does not function directly in transcriptional regulation. In the present study we used a series of biochemical analyses to explore the potential function of YY1 in the oocyte cytoplasm. YY1 was isolated from oocyte lysates by oligo (dT) -cellulose chromatography, suggesting that it associates with maternally expressed mRNA in vivo. RNA mobility shift assays demonstrate that endogenous YY1 binds to labeled histone mRNA. Size exclusion chromatography of oocyte lysates revealed that YY1 exists in high molecular mass complexes in the range of 480 kDa. Destruction of endogenous RNA by RNase treatment of lysates, abolished the binding of YY1 to oligo(dT) -cellulose and resulted in redistribution from 480-kDa complexes to the monomeric form. Microinjection of RNase directly into the cytoplasm released YY1 from 480-kDa complexes and unmasked its DNA-binding activity, but did not promote translocation to the nucleus. These results provide evidence that YY1 is a component of ribonucleoprotein (mRNP) complexes in the Xenopus oocyte, indicating a novel function for YY1 in the storage or metabolism of maternal transcripts.	Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Ovsenek, N (corresponding author), Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.							Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; BOUVET P, 1995, J BIOL CHEM, V270, P28297; BROWN RS, 1988, P NATL ACAD SCI USA, V85, P3802, DOI 10.1073/pnas.85.11.3802; Brzostowski J, 2000, EMBO J, V19, P3683, DOI 10.1093/emboj/19.14.3683; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CUMMINGS A, 1988, J CELL BIOL, V107, P45, DOI 10.1083/jcb.107.1.45; Davidson E. H., 1986, GENE ACTIVITY EARLY; DESCHAMPS S, 1991, FEBS LETT, V282, P110, DOI 10.1016/0014-5793(91)80456-D; DESCHAMPS S, 1992, J BIOL CHEM, V267, P13799; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Ficzycz A, 1997, DEV BIOL, V182, P21, DOI 10.1006/dbio.1996.8459; Ficzycz A, 2001, J BIOL CHEM, V276, P22819, DOI 10.1074/jbc.M011188200; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; GOLDEN L, 1980, CELL, V22, P835, DOI 10.1016/0092-8674(80)90560-7; HEINE MA, 1993, MOL BIOL CELL, V4, P1189, DOI 10.1091/mbc.4.11.1189; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LEE TC, 1994, ONCOGENE, V9, P1047; MARELLO K, 1992, NUCLEIC ACIDS RES, V20, P5593, DOI 10.1093/nar/20.21.5593; Matsumoto K, 1998, TRENDS CELL BIOL, V8, P318, DOI 10.1016/S0962-8924(98)01300-2; Matsumoto K, 1996, J BIOL CHEM, V271, P22706, DOI 10.1074/jbc.271.37.22706; Matsumoto K, 2000, NUCLEIC ACIDS RES, V28, P4689, DOI 10.1093/nar/28.23.4689; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; Oei SL, 2001, BIOCHEM BIOPH RES CO, V284, P450, DOI 10.1006/bbrc.2001.4985; Oei SL, 1997, BIOCHEM BIOPH RES CO, V240, P108, DOI 10.1006/bbrc.1997.7621; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; PISANESCHI G, 1994, BIOCHEM BIOPH RES CO, V205, P1236, DOI 10.1006/bbrc.1994.2797; RICHTER JD, 1991, BIOESSAYS, V13, P179, DOI 10.1002/bies.950130406; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; TAFURI SR, 1993, J BIOL CHEM, V268, P24255; TAFURI SR, 1992, NEW BIOL, V4, P349; TAFURI SR, 1990, P NATL ACAD SCI USA, V87, P9028, DOI 10.1073/pnas.87.22.9028; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; WOLFFE AP, 1992, NEW BIOL, V4, P290; WOODLAND HR, 1980, FEBS LETT, V121, P1, DOI 10.1016/0014-5793(80)81252-X; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yurkova MS, 1997, J BIOL CHEM, V272, P10870	42	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8382	8387		10.1074/jbc.M110304200	http://dx.doi.org/10.1074/jbc.M110304200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11734562	hybrid			2022-12-27	WOS:000174268000097
J	Kelemen, BR; Hsiao, K; Goueli, SA				Kelemen, BR; Hsiao, K; Goueli, SA			Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; MOTIF; DELIVERY; TRANSDUCTION; TRANSPORT; MECHANISM; PATHWAYS; SCAFFOLD; ERK2	The extracellular signal-regulated kinase (ERK), a member of the mitogen-activated protein kinases (MAPKs), is essential for cellular proliferation and differentiation, and thus there exists great interest to develop specific and selective inhibitors of this enzyme. Whereas small molecule inhibitors PD098095 and U0126 have been used to study MAPK/ERK kinase (MEK), their target selectivity has been questioned recently. The cross-reactivity of ATP-directed inhibitors with other protein kinases prompted us to develop structure-based selective peptide inhibitors of ERK activation. Based on a MEK1-derived peptide, we developed inhibitors of ERK activation in vitro and in vivo. The inclusion of either an alkyl moiety or a membrane-translocating peptide sequence facilitated the cellular uptake of the peptide inhibitor and prevented ERK activation in 4-phorbol 12-myristate 13-acetate-stimulated NIH 3T3 cells or nerve growthfactor-treated PC12 cells in a concentration-dependent manner. In addition, cell-permeable peptides inhibited ERK-mediated activation of the transcriptional activity of ELK1. The peptides did not have an inhibitory effect on the activity of two other closely related classes of MAPKs, c-Jun amino-terminal kinase or p38 protein kinase. Thus, these peptides may serve as valuable tools for investigating ERK activation and for selective investigation of ERK-mediated responses. With the knowledge of other kinase interacting domains, it would be possible to design cell-permeable inhibitors for investigating diverse cellular signaling mechanisms and for possible therapeutic applications.	Promega Corp, Madison, WI 53711 USA; Genencor Int, Palo Alto, CA 94304 USA; Univ Chicago, Dept Med, Chicago, IL 60611 USA; Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53711 USA	Promega Corporation; University of Chicago; University of Wisconsin System; University of Wisconsin Madison	Goueli, SA (corresponding author), Promega Corp, Madison, WI 53711 USA.							Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fischer PM, 2000, J PEPT RES, V55, P163, DOI 10.1034/j.1399-3011.2000.00163.x; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Ho A, 2001, CANCER RES, V61, P474; KOLCH W, 2000, BIOCHEM J, V351, P298; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Oess S, 2000, GENE THER, V7, P750, DOI 10.1038/sj.gt.3301154; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Polyakov V, 2000, BIOCONJUGATE CHEM, V11, P762, DOI 10.1021/bc000008y; Prowse CN, 2000, BIOCHEMISTRY-US, V39, P6258, DOI 10.1021/bi000277b; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yasuda J, 1999, MOL CELL BIOL, V19, P7245	25	81	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8741	8748		10.1074/jbc.M108459200	http://dx.doi.org/10.1074/jbc.M108459200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756441	hybrid			2022-12-27	WOS:000174268000141
J	Kubicek, M; Pacher, M; Abraham, D; Podar, K; Eulitz, M; Baccarini, M				Kubicek, M; Pacher, M; Abraham, D; Podar, K; Eulitz, M; Baccarini, M			Dephosphorylation of Ser-259 regulates Raf-1 membrane association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; SIGNAL-TRANSDUCTION; KINASE-ACTIVITY; RAS; PHOSPHORYLATION; ACTIVATION; IDENTIFICATION; 14-3-3-PROTEIN; SERINE-338; PATHWAYS	Mitogenic stimulation of Raf-1 is a complex yet incompletely understood process involving membrane relocalization and phosphorylation of activating residues. We recently reported that Raf-1-associated protein phosphatase 2A contributes to kinase activation, an effect mediated via Ser-259 of Raf-1. Here, we show that mitogens stimulate Ser-259 dephosphorylation and Raf-1/protein phosphatase 2A association concomitantly with membrane accumulation and activation of Raf-1. Blocking Ser-259 dephosphorylation inhibits the two latter events, but it does not prevent activation of a S259A Raf-1 mutant, which is preferentially localized at the membrane independently of mitogenic stimulation. Inhibition of Ser-259 dephosphorylation has no effect on the activation of membrane-tethered Raf-1 (Raf-1CAAX). These data show that Ser-259 dephosphorylation contributes to Raf-1 activation by supporting its membrane accumulation rather than by increasing the specific activity of the kinase and provide a mechanistic basis for the support of kinase activation by Raf-1-associated protein phosphatase 2A.	Vienna Bioctr, Inst Microbiol & Genet, Dept Microbiol & Cell Biol, A-1030 Vienna, Austria; Gesell Strahlenforsch Forschungszentrum Umwelt, Inst Klin Mol Biol & Tumor Genet, D-81377 Munich, Germany	Vienna Biocenter (VBC)	Baccarini, M (corresponding author), Vienna Bioctr, Inst Microbiol & Genet, Dept Microbiol & Cell Biol, Dr Bohr Gasse 9, A-1030 Vienna, Austria.		Podar, Klaus/ABD-1112-2020; Baccarini, Manuela/B-6481-2014	Podar, Klaus/0000-0002-7414-3632; Baccarini, Manuela/0000-0002-3033-391X; Abraham, Dietmar/0000-0001-6337-0058				Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; ALESSI DR, 1995, METHOD ENZYMOL, V255, P279; Baek KH, 1996, DEV BIOL, V175, P191, DOI 10.1006/dbio.1996.0107; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; KOLCH W, 1990, ONCOGENE, V5, P713; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL M, 1995, MOL REPROD DEV, V42, P493, DOI 10.1002/mrd.1080420418; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; MCCORMICK F, 1995, MOL REPROD DEV, V42, P500, DOI 10.1002/mrd.1080420419; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Mischak H, 1996, MOL CELL BIOL, V16, P5409; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Rommel C, 1996, ONCOGENE, V12, P609; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Sendoh H, 2000, BIOCHEM BIOPH RES CO, V271, P596, DOI 10.1006/bbrc.2000.2674; Sidovar MF, 2000, J BIOL CHEM, V275, P28688, DOI 10.1074/jbc.M909351199; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	34	96	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7913	7919		10.1074/jbc.M108733200	http://dx.doi.org/10.1074/jbc.M108733200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756411	hybrid			2022-12-27	WOS:000174268000038
J	Uchiyama, T; Yoshikawa, F; Hishida, A; Furuichi, T; Mikoshiba, K				Uchiyama, T; Yoshikawa, F; Hishida, A; Furuichi, T; Mikoshiba, K			A novel recombinant hyperaffinity inositol 1,4,5-trisphosphate (IP3) absorbent traps IP3, resulting in specific inhibition of IP3-mediated calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SITE; CONTROLLED GENE-EXPRESSION; 2-AMINOETHOXYDIPHENYL BORATE; CREB PHOSPHORYLATION; RECEPTOR; NUCLEAR; CELLS; TRANSLOCATION; ACTIVATION; EFFICACY	We have developed a novel recombinant hyperaffinity inositol 1,4,5-trisphosphate (IP3) absorbent, called the "IP3 sponge," which we constructed on the basis of the ligand-binding site of the mouse type 1 IP3 receptor (IP3R1). The IP3 sponge exhibited similar to1000-fold higher affinity for IP3 than the parental IP3R1 and specifically competed with the endogenous IP3R for binding to IP3-Trapping IP3 with the IP3 sponge inhibited IP3-induced Ca2+ release (IICR) from cerebellar microsomes in a dose-dependent manner. The IP3 sponge expressed in HEK293 cells also inhibited HCR in response to stimulation with carbachol or ATP. Its inhibitory effects were dependent upon the level of its expression over the increased IP3 contents. Moreover, the IP3 sponge significantly reduced the carbachol-induced phosphorylation of cAMP-response element-binding protein in HEK293 cells, indicating that the activation of cAMP-response element-binding protein by Ca2+-dependent phosphorylation may be partly attributable to IICR.	Univ Tokyo, Inst Med Sci, Div Mol Neurobiol, Dept Basic Med Sci, Tokyo 1088639, Japan; Hamamatsu Univ Sch Med, Dept Med 1, Shizuoka 4313192, Japan; RIKEN, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	University of Tokyo; Hamamatsu University School of Medicine; RIKEN; RIKEN	Mikoshiba, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Neurobiol, Dept Basic Med Sci, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	mikosiba@ims.u-tokyo.ac.jp	Mikoshiba, Katsuhiko/N-7943-2015; Furuichi, Teiichi/B-5086-2014	Furuichi, Teiichi/0000-0002-9676-1888				ACKLANDBERGLUND CE, 1995, BIOTECHNIQUES, V18, P196; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bischof G, 1997, CELL CALCIUM, V21, P135, DOI 10.1016/S0143-4160(97)90037-3; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; De Smet P, 1999, CELL CALCIUM, V26, P9; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; EHLRICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fukami K, 1996, J BIOL CHEM, V271, P2646, DOI 10.1074/jbc.271.5.2646; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, BIOTECHNIQUES, V19, P213; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Missiaen L, 2001, CELL CALCIUM, V29, P111, DOI 10.1054/ceca.2000.0163; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Murayama T, 1996, J BIOL CHEM, V271, P5079; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; UEDA S, 1989, BIOCHIM BIOPHYS ACTA, V1012, P254, DOI 10.1016/0167-4889(89)90105-5; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang DX, 2000, J NEUROCHEM, V74, P1418, DOI 10.1046/j.1471-4159.2000.0741418.x; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Yoshikawa F, 1999, J BIOL CHEM, V274, P328, DOI 10.1074/jbc.274.1.328; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yoshikawa F, 1999, BIOCHEM BIOPH RES CO, V257, P792, DOI 10.1006/bbrc.1999.0498; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	42	73	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8106	8113		10.1074/jbc.M108337200	http://dx.doi.org/10.1074/jbc.M108337200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741904	Green Submitted, hybrid			2022-12-27	WOS:000174268000062
J	Gomis-Ruth, FX; Moncalian, G; de la Cruz, F; Coll, M				Gomis-Ruth, FX; Moncalian, G; de la Cruz, F; Coll, M			Conjugative plasmid protein TrwB, an integral membrane type IV secretion system coupling protein - Detailed structural features and mapping of the active site cleft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DNA-TRANSFER; BACTERIAL CONJUGATION; BACILLUS-SUBTILIS; INCW PLASMID-R388; R388 CONJUGATION; GTP HYDROLYSIS; CELL-DIVISION; MECHANISM; HELICASE	Bacterial conjugation is an example of macromolecular trafficking between cells and responsible for the spreading of antibiotic resistance among bacteria. It involves translocation of single-stranded DNA across membranes through a type IV secretion system. A coupling protein links the DNA-processing nucleoprotein complex, the relaxosome, with the transport apparatus during cell mating. In Escherichia coli plasmid R388 such a protein is TrwB, a basic integral inner-membrane nucleoside-triphosphate-binding protein. TrwB is the structural prototype for the type W secretion system coupling proteins, a family of proteins essential for macromolecular transport between cells and export. The structure of a soluble TrwB variant unveils an elongated molecule with six equivalent protein units featuring a spherical quaternary structure, leaving a central channel. The structures of the non-liganded protein and four different complexes with substrate analogues and products allow the precise description of the active site architecture. The active sites are located at the interface between protomers, each of them shaped mainly by residues of one monomer, but including two crucial arginine residues belonging to the adjacent molecule. Upon substrate binding and putative hydrolysis, conformational changes are transferred from the external surface to the interior central channel.	CSIC, Inst Biol Mol Barcelona, ES-08034 Barcelona, Spain; Univ Cantabria, Dept Mol Biol, Santander 39011, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Universidad de Cantabria	Coll, M (corresponding author), CSIC, Inst Biol Mol Barcelona, C Jordi Girona,18-26, ES-08034 Barcelona, Spain.		de la Cruz, Fernando/L-2812-2014; Coll, Miquel/L-5999-2014; Moncalian, Gabriel/K-3493-2014	de la Cruz, Fernando/0000-0003-4758-6857; Coll, Miquel/0000-0003-4471-8674; Moncalian, Gabriel/0000-0002-3007-6490; Gomis-Ruth, F. Xavier/0000-0002-6848-6874				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; BEGG KJ, 1995, J BACTERIOL, V177, P6211, DOI 10.1128/jb.177.21.6211-6222.1995; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; CABEZON E, 1994, J BACTERIOL, V176, P4455, DOI 10.1128/jb.176.14.4455-4458.1994; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Dalal S, 2001, CELL, V104, P5, DOI 10.1016/S0092-8674(01)00186-6; DATTA N, 1972, J GEN MICROBIOL, V72, P349, DOI 10.1099/00221287-72-2-349; DisqueKochem C, 1997, J BACTERIOL, V179, P6133, DOI 10.1128/jb.179.19.6133-6137.1997; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; Evans P. R., 1993, DATA COLLECTION PROC, P114; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Gomis-Ruth FX, 2001, ACTA CRYSTALLOGR D, V57, P800, DOI 10.1107/S0907444901004887; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; HEINEMANN JA, 1991, TRENDS GENET, V7, P181, DOI 10.1016/0168-9525(91)90122-7; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; HIRAYAMA T, 1988, MOL GEN GENET, V213, P229, DOI 10.1007/BF00339586; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Karata K, 2001, MOL MICROBIOL, V39, P890, DOI 10.1046/j.1365-2958.2001.02301.x; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kupelwieser G, 1998, J MOL BIOL, V275, P81, DOI 10.1006/jmbi.1997.1436; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; LESSL M, 1992, NUCLEIC ACIDS RES, V20, P6099, DOI 10.1093/nar/20.22.6099; LESSL M, 1994, CELL, V77, P321, DOI 10.1016/0092-8674(94)90146-5; LLOSA M, 1994, J MOL BIOL, V235, P448, DOI 10.1006/jmbi.1994.1005; LLOSA M, 1995, J MOL BIOL, V246, P54, DOI 10.1006/jmbi.1994.0065; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Moncalian G, 1999, J BIOL CHEM, V274, P36117, DOI 10.1074/jbc.274.51.36117; Moncalian G, 1997, J MOL BIOL, V270, P188, DOI 10.1006/jmbi.1997.1082; Moncalian G, 1999, MOL MICROBIOL, V31, P1643, DOI 10.1046/j.1365-2958.1999.01288.x; MORTON TM, 1993, J BACTERIOL, V175, P4436, DOI 10.1128/JB.175.14.4436-4447.1993; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neuwald AF, 1999, GENOME RES, V9, P27; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; Pansegrau W, 1996, PROG NUCLEIC ACID RE, V54, P197, DOI 10.1016/S0079-6603(08)60364-5; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; SALMOND GPC, 1994, ANNU REV PHYTOPATHOL, V32, P181, DOI 10.1146/annurev.py.32.090194.001145; Santini JM, 1998, J BACTERIOL, V180, P4093, DOI 10.1128/JB.180.16.4093-4101.1998; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Stockner T, 2001, BIOCHEMISTRY-US, V40, P3370, DOI 10.1021/bi002031c; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; SWEDBERG G, 1983, J BACTERIOL, V153, P1228, DOI 10.1128/JB.153.3.1228-1237.1983; SWIFT G, 1981, MOL GEN GENET, V181, P441, DOI 10.1007/BF00428733; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Waksman G, 2000, NAT STRUCT BIOL, V7, P20, DOI 10.1038/71215; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winans SC, 1996, TRENDS MICROBIOL, V4, P64, DOI 10.1016/0966-842X(96)81513-7; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; Yeo HJ, 2000, MOL CELL, V6, P1461, DOI 10.1016/S1097-2765(00)00142-8; Yu X, 1998, J MOL BIOL, V283, P985, DOI 10.1006/jmbi.1998.2141; Yu X, 1997, NAT STRUCT BIOL, V4, P101, DOI 10.1038/nsb0297-101; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; [No title captured]	80	60	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7556	7566		10.1074/jbc.M110462200	http://dx.doi.org/10.1074/jbc.M110462200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11748238	hybrid			2022-12-27	WOS:000174104300102
J	Meima, R; Eschevins, C; Fillinger, S; Bolhuis, A; Hamoen, LW; Dorenbos, R; Quax, WJ; van Dijl, JM; Provvedi, R; Chen, I; Dubnau, D; Bron, S				Meima, R; Eschevins, C; Fillinger, S; Bolhuis, A; Hamoen, LW; Dorenbos, R; Quax, WJ; van Dijl, JM; Provvedi, R; Chen, I; Dubnau, D; Bron, S			The bdbDC operon of Bacillus subtilis encodes thiol-disulfide oxidoreductases required for competence development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BOND FORMATION; TRANSCRIPTION FACTOR; MOLECULAR-CLONING; GENOME SEQUENCE; DNA-BINDING; PROTEIN; GENE; IDENTIFICATION; TRANSFORMATION	The development of genetic competence in the Gram-positive eubacterium Bacillus subtilis is a complex post-exponential process. Here we describe a new bicistronic operon, bdbDC, required for competence development, which was identified by the B. subtilis Systematic Gene Function Analysis program. Inactivation of either the bdbC or bdbD genes of this operon results in the loss of transformability without affecting recombination or the synthesis of ComK, the competence transcription factor. BdbC and BdbD are orthologs of enzymes known to be involved in extracytoplasmic disulfide bond formation. Consistent with this, BdbC and BdbD are needed for the secretion of the Escherichia coli disulfide bond-containing alkaline phosphatase, PhoA, by R subtilis. Similarly, the amount of the disulfide bond-containing competence protein ComGC is severely reduced in bdbC or bdbD mutants. In contrast, the amounts of the competence proteins ComGA and ComEA remain unaffected by bdbDC mutations. Taken together, these observations imply that in the absence of either BdbC or BdbD, ComGC is unstable and that BdbC and BdbD catalyze the formation of disulfide bonds that are essential for the DNA binding and uptake machinery.	Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Genet, NL-9571 NN Haren, Netherlands; INRA, Lab Genet Mol & Cellulaire, INA PG, F-78850 Thiverval Grignon, France; Univ Groningen, Dept Pharmaceut BIol, NL-9713 AV Groningen, Netherlands; Publ Hlth Res Inst City New York Inc, New York, NY 10016 USA	University of Groningen; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Groningen	Bron, S (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Genet, Kerklaan 30, NL-9571 NN Haren, Netherlands.		Quax, Wim/O-2875-2019; Quax, Wim/K-2802-2012; Bolhuis, Albert/E-9932-2010; Provvedi, Roberta/I-8430-2012; van Dijl, Jan Maarten/G-1205-2013	Quax, Wim/0000-0002-5162-9947; Quax, Wim/0000-0002-5162-9947; Bolhuis, Albert/0000-0001-9307-0515; Chen, Ines/0000-0002-1405-9703; PROVVEDI, ROBERTA/0000-0003-1164-9676	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043756] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 43756] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBANO M, 1989, J BACTERIOL, V171, P5376, DOI 10.1128/jb.171.10.5376-5385.1989; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Andersen CL, 1997, MOL MICROBIOL, V26, P121, DOI 10.1046/j.1365-2958.1997.5581925.x; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bolhuis A, 1999, J BIOL CHEM, V274, P24531, DOI 10.1074/jbc.274.35.24531; BREITLING R, 1990, J BACTERIOL, V172, P1499, DOI 10.1128/jb.172.3.1499-1508.1990; BRON S, 1972, MUTAT RES, V15, P1, DOI 10.1016/0027-5107(72)90086-3; CHUNG YS, 1995, MOL MICROBIOL, V15, P543, DOI 10.1111/j.1365-2958.1995.tb02267.x; Chung YS, 1998, MOL MICROBIOL, V29, P905, DOI 10.1046/j.1365-2958.1998.00989.x; CREIGHTON TE, 1993, CURR BIOL, V3, P790, DOI 10.1016/0960-9822(93)90034-L; DUBNAU D, 2001, BACILLUS SUBTILIS IT, P453; Hahn J, 1996, MOL MICROBIOL, V21, P763, DOI 10.1046/j.1365-2958.1996.371407.x; HAMOEN LW, 1995, MOL MICROBIOL, V15, P55, DOI 10.1111/j.1365-2958.1995.tb02220.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Kim L, 1996, GENE, V181, P71, DOI 10.1016/S0378-1119(96)00466-0; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Leskela S, 1996, MICROBIOL-SGM, V142, P71, DOI 10.1099/13500872-142-1-71; MEIMA R, 1995, MOL GEN GENET, V248, P391, DOI 10.1007/BF02191638; MISSIAKAS D, 1995, EMBO J, V14, P3415, DOI 10.1002/j.1460-2075.1995.tb07347.x; Msadek T, 1998, MOL MICROBIOL, V27, P899, DOI 10.1046/j.1365-2958.1998.00735.x; Nicholson W, 1990, MOL BIOL METHODS BAC; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PALVA I, 1982, GENE, V19, P81, DOI 10.1016/0378-1119(82)90191-3; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; Provvedi R, 2001, MOL MICROBIOL, V40, P634, DOI 10.1046/j.1365-2958.2001.02406.x; Raina S, 1997, ANNU REV MICROBIOL, V51, P179, DOI 10.1146/annurev.micro.51.1.179; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Sambrook J., 2002, MOL CLONING LAB MANU; SONE M, 1997, J BIOL CHEM, V272; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tjalsma H, 1998, GENE DEV, V12, P2318, DOI 10.1101/gad.12.15.2318; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; TOMB JF, 1992, P NATL ACAD SCI USA, V89, P10252, DOI 10.1073/pnas.89.21.10252; Urban A, 2001, J BACTERIOL, V183, P587, DOI 10.1128/JB.183.2.587-596.2001; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VANSINDEREN D, 1994, MOL MICROBIOL, V11, P695; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; WERTMAN KF, 1986, GENE, V49, P253, DOI 10.1016/0378-1119(86)90286-6	40	76	88	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6994	7001		10.1074/jbc.M111380200	http://dx.doi.org/10.1074/jbc.M111380200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744713	hybrid, Green Published			2022-12-27	WOS:000174104300033
J	Mysorekar, IU; Mulvey, MA; Hultgren, SJ; Gordon, JI				Mysorekar, IU; Mulvey, MA; Hultgren, SJ; Gordon, JI			Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BONE MORPHOGENETIC PROTEIN-4; CONTROLS CELLULAR-RESPONSES; AUTOCRINE GROWTH-FACTOR; URINARY-TRACT; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; TARGETED DISRUPTION; FRIZZLED HOMOLOGS; GENE-EXPRESSION	Uropathogenic Escherichia coli (UPEC), the principal cause of urinary tract infection in women, attaches to the superficial facet cell layer of the bladder epithelium (urothelium) via its FimH adhesin. Attachment triggers exfoliation of bacteria-laden superficial facet cells, followed by rapid reconstitution of the urothelium through differentiation of underlying basal and intermediate cells. We have used DNA microarrays to define the molecular regulators of urothelial renewal and host defense expressed in adult C57B1/6 female mice during the early phases of infection with isogenic virulent (FimH+) or avirulent (FimH-) UPEC strains. The temporal evolution and cellular origins of selected responses were then characterized by real time quantitative reverse transcriptase-PCR, in situ hybridization, and immunohistochemical analyses. Well before exfoliation is evident, FimH-mediated attachment suppresses transforming growth factor-beta (Bmp4) and Wnt5a/Ca2+ signaling to promote subsequent differentiation of basal/intermediate cells. The early transcriptional responses to attachment also include induction of regulators of proliferation (e.g. epidermal growth factor family members), induction of the ETS transcription factor Elf3, which transactivates genes involved in epithelial differentiation and host defense (inducible nitric-oxide synthase), induction of modulators, and mediators of pro-inflammatory responses (e.g. Socs3, Cebp/delta, Bc13, and CC/CXC chemokines), induction of modulators of apoptotic responses (A20), and induction of intermediate cell tight junction components (claudin-4). Both early and late phases of the host response exhibit remarkable specificity for the FimH+ strain and provide new insights about the molecular cascade mobilized to combat UPEC-associated urinary tract infection.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.		Mysorekar, Indira U./GRS-4574-2022	Mysorekar, Indira U./0000-0003-3917-8677; Mulvey, Matthew/0000-0002-6016-7510	NIDDK NIH HHS [DK 59129] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059129] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Andreoli JM, 1997, NUCLEIC ACIDS RES, V25, P4287, DOI 10.1093/nar/25.21.4287; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baskin LS, 1997, J UROLOGY, V157, P2388, DOI 10.1016/S0022-5347(01)64786-4; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Carmeliet P, 1998, J CELL BIOL, V140, P233, DOI 10.1083/jcb.140.1.233; Claverie JM, 1999, HUM MOL GENET, V8, P1821, DOI 10.1093/hmg/8.10.1821; DEBOER WI, 1994, AM J PATHOL, V145, P1199; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Freeman MR, 1997, J CLIN INVEST, V99, P1028, DOI 10.1172/JCI119230; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; GOLIGER JA, 1995, MOL BIOL CELL, V6, P1491, DOI 10.1091/mbc.6.11.1491; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hang L, 1999, J IMMUNOL, V162, P3037; HARDING GKM, 1994, INT J ANTIMICROB AG, V4, P83, DOI 10.1016/0924-8579(94)90038-8; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; JOST SP, 1989, VIRCHOWS ARCH B, V57, P27, DOI 10.1007/BF02899062; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Krebs DL, 2000, J CELL SCI, V113, P2813; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LEVI PE, 1969, CANCER, V23, P1074, DOI 10.1002/1097-0142(196905)23:5<1074::AID-CNCR2820230511>3.0.CO;2-9; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Mathura JR, 2000, INVEST OPHTH VIS SCI, V41, P592; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Matsuzaki T, 1999, J HISTOCHEM CYTOCHEM, V47, P1275, DOI 10.1177/002215549904701007; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Na SY, 1999, J BIOL CHEM, V274, P28491, DOI 10.1074/jbc.274.40.28491; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Paine-Saunders S, 2000, DEV BIOL, V225, P179, DOI 10.1006/dbio.2000.9831; Park CG, 1996, IMMUNITY, V4, P583, DOI 10.1016/S1074-7613(00)80484-7; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Poljakovic M, 2001, KIDNEY INT, V59, P893; Riedel I, 2001, VIRCHOWS ARCH, V438, P181, DOI 10.1007/s004280000315; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Schwarz EM, 1997, GENE DEV, V11, P187, DOI 10.1101/gad.11.2.187; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; SOBEL JD, 1991, MED CLIN N AM, V75, P253, DOI 10.1016/S0025-7125(16)30452-7; Svanborg C, 1996, ANN NY ACAD SCI, V797, P177, DOI 10.1111/j.1749-6632.1996.tb52959.x; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Wang YX, 1999, FEBS LETT, V445, P269, DOI 10.1016/S0014-5793(99)00136-2; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Zaidi AU, 2000, J HISTOCHEM CYTOCHEM, V48, P1369, DOI 10.1177/002215540004801007	66	158	164	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7412	7419		10.1074/jbc.M110560200	http://dx.doi.org/10.1074/jbc.M110560200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744708	hybrid			2022-12-27	WOS:000174104300086
J	Belogrudov, GI; Hatefi, Y				Belogrudov, GI; Hatefi, Y			Factor B and the mitochondrial ATP synthase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING FACTOR-B; BOVINE HEART-MITOCHONDRIA; ENERGY-LINKED FUNCTIONS; OXIDATIVE-PHOSPHORYLATION; ADENOSINE-TRIPHOSPHATASE; SUBUNIT ROTATION; BEEF-HEART; PURIFICATION; PROTEIN; OLIGOMYCIN	Factor B is a subunit of the mammalian ATP synthase complex, whose existence has been controversial. This paper describes the molecular and functional properties of a recombinant human factor B, which when added to bovine submitochondrial particles depleted of their factor B restores the energy coupling activity of the ATP synthase complexes. The mature human factor B has 175 amino acids and a molecular mass of 20,341 Da. The preparation is water-soluble, monomeric, and is inactivated by monothiol- and especially dithiol-modifying reagents, probably reacting at its cysteine residues Cys-92 and Cys-94. A likely factor B gene composed of 5 exons has been identified on chromosome 14q21.3, and the functional role of factor B in the mammalian ATP synthase complex has been discussed.	Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA	Scripps Research Institute	Hatefi, Y (corresponding author), Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA.	hatefi@scripps.edu						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Belogrudov GI, 1996, J BIOL CHEM, V271, P20340, DOI 10.1074/jbc.271.34.20340; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; GALANTE YM, 1981, BIOCHEMISTRY-US, V20, P2671, DOI 10.1021/bi00512a048; HASHIMOTO T, 1990, J BIOENERG BIOMEMBR, V22, P27, DOI 10.1007/BF00762843; HATEFI Y, 1958, BIOCHIM BIOPHYS ACTA, V27, P83, DOI 10.1016/0006-3002(58)90294-4; Hutcheon ML, 2001, P NATL ACAD SCI USA, V98, P8519, DOI 10.1073/pnas.151236798; ICHIKAWA N, 1990, J BIOL CHEM, V265, P6274; JOSHI S, 1985, FEBS LETT, V179, P143, DOI 10.1016/0014-5793(85)80209-X; Joshi S, 1979, Methods Enzymol, V55, P384; JOSHI S, 1979, J BIOL CHEM, V254, P145; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; KANTHAM L, 1990, FEBS LETT, V277, P105, DOI 10.1016/0014-5793(90)80819-5; LAM KW, 1967, ARCH BIOCHEM BIOPHYS, V119, P477, DOI 10.1016/0003-9861(67)90479-1; LAM KW, 1969, ARCH BIOCHEM BIOPHYS, V130, P175, DOI 10.1016/0003-9861(69)90023-X; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEE CP, 1965, BIOCHEM BIOPH RES CO, V18, P523, DOI 10.1016/0006-291X(65)90785-0; LUTTER R, 1993, BIOCHEM J, V295, P799, DOI 10.1042/bj2950799; MATSUNOYAGI A, 1988, BIOCHEMISTRY-US, V27, P335, DOI 10.1021/bi00401a050; MATSUNOYAGI A, 1984, BIOCHEMISTRY-US, V23, P3508, DOI 10.1021/bi00310a019; MCENERY MW, 1984, J BIOL CHEM, V259, P4642; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; SANADI DR, 1982, BIOCHIM BIOPHYS ACTA, V683, P39; SCHWERZMANN K, 1986, ARCH BIOCHEM BIOPHYS, V250, P1, DOI 10.1016/0003-9861(86)90695-8; SENIOR AE, 1979, ARCH BIOCHEM BIOPHYS, V140, P257; SHANKARAN R, 1975, ARCH BIOCHEM BIOPHYS, V168, P394, DOI 10.1016/0003-9861(75)90268-4; Stiggall D L, 1979, Methods Enzymol, V55, P308; STIGGALL DL, 1979, ARCH BIOCHEM BIOPHYS, V196, P638, DOI 10.1016/0003-9861(79)90318-7; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; TZAGOLOF.A, 1968, J BIOL CHEM, V243, P2405; WALKER JE, 1991, BIOCHEMISTRY-US, V30, P5369, DOI 10.1021/bi00236a007; YOU KS, 1976, BIOCHIM BIOPHYS ACTA, V423, P398, DOI 10.1016/0005-2728(76)90196-1	37	28	31	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6097	6103		10.1074/jbc.M111256200	http://dx.doi.org/10.1074/jbc.M111256200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744738	hybrid			2022-12-27	WOS:000173989200054
J	Coles, B; Bloodsworth, A; Eiserich, JP; Coffey, MJ; McLoughlin, RM; Giddings, JC; Lewis, MJ; Haslam, RJ; Freeman, BA; O'Donnell, VB				Coles, B; Bloodsworth, A; Eiserich, JP; Coffey, MJ; McLoughlin, RM; Giddings, JC; Lewis, MJ; Haslam, RJ; Freeman, BA; O'Donnell, VB			Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE SCAVENGER RECEPTOR; DEPENDENT PROTEIN-KINASES; NITRIC-OXIDE; CYCLIC-NUCLEOTIDES; NITROGEN-DIOXIDE; METHYL LINOLEATE; INTACT-CELLS; IN-VITRO; PEROXYNITRITE; DERIVATIVES	Reactive species formed from nitric oxide (NO) nitrate unsaturated fatty acids such as linoleate (LA) to nitrated derivatives including nitrolinoleate (LNO2). The effect of LNO2 on human platelets was examined to define how nitrated lipids might behave in vivo. LNO2, but not LA or 3-nitrotyrosine, dose dependently (0.5-10 mum) inhibited thrombin-mediated aggregation of washed human platelets, with concomitant attenuation of P-selectin expression and selective phosphorylation of VASP at the cAMP-dependent protein kinase selective site, serine 157. LNO2 caused slight mobilization of calcium (Ca2+) from intracellular stores but significantly inhibited subsequent thrombin-stimulated Ca2+ elevations. LNO2 did not elevate platelet cGMP, and its effects were not blocked with inhibitors of NO signaling (oxyhemoglobin, 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one. 2-fold elevations in cAMP were found following LNO2 treatment of platelets, and the adenylyl cyclase inhibitors 2',5'-dideoxyadenosine and SQ22536 partially restored thrombin-stimulated aggregation. Finally, LNO2 significantly inhibited cAMP hydrolysis to AMP by platelet lysates. These data implicate cAMP in the anti-aggregatory action of LNO2. The platelet inhibitory actions of LNO2 indicate that nitration reactions that occur following NO generation in an oxidizing environment can alter the activity of lipids and lend insight into mechanisms by which NO-derived species may modulate the progression of vascular injury.	Univ Wales Coll Cardiff, Coll Med, Dept Med Biochem & Immunol, Cardiff CF4 4XN, S Glam, Wales; Univ Wales Coll Cardiff, Coll Med, Dept Pharmacol, Cardiff CF4 4XN, S Glam, Wales; Univ Wales Coll Cardiff, Coll Med, Inst Nephrol, Cardiff CF4 4XN, S Glam, Wales; Univ Wales Coll Cardiff, Coll Med, Dept Hematol, Cardiff CF4 4XN, S Glam, Wales; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; Univ Alabama, Dept Anesthesiol Biochem, Birmingham, AL 35233 USA; Univ Alabama, Dept Mol Genet, Birmingham, AL 35233 USA; Univ Alabama, Ctr Free Radical Biol, Birmingham, AL 35233 USA	Cardiff University; Cardiff University; Cardiff University; Cardiff University; McMaster University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	O'Donnell, VB (corresponding author), Univ Wales Coll Cardiff, Coll Med, Dept Med Biochem & Immunol, Heath Pk, Cardiff CF4 4XN, S Glam, Wales.	o-donnellvb@cardiff.ac.uk	Freeman, Bruce A/H-9342-2012; O'Donnell, Valerie/C-6948-2012	/0000-0003-4089-8460; McLoughlin, Rachel/0000-0003-4553-018X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, P60HL058418, R01HL064937] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdalla DSP, 2001, FREE RADICAL BIO MED, V31, pS67; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Balazy M, 2001, J PHARMACOL EXP THER, V299, P611; Baldus S, 2001, AM J RESP CRIT CARE, V163, P308, DOI 10.1164/ajrccm.163.2.ed2000c; Brown AS, 1998, CARDIOVASC RES, V40, P380, DOI 10.1016/S0008-6363(98)00182-5; BUTT E, 1996, PRACT APPROACH SER, P259; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Eiserich Jason P., 1998, Molecular Aspects of Medicine, V19, P221, DOI 10.1016/S0098-2997(99)00002-3; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; GALLON AA, 1993, LIPIDS, V28, P125, DOI 10.1007/BF02535776; GALLON AA, 1994, LIPIDS, V29, P171, DOI 10.1007/BF02536725; GRAHAM A, 1993, FEBS LETT, V330, P181, DOI 10.1016/0014-5793(93)80269-Z; HAMAYA T, 1982, TETRAHEDRON LETT, V23, P4733; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; HASLAM RJ, 1978, BIOCHEM J, V176, P83, DOI 10.1042/bj1760083; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Leeuwenburgh C, 1997, J BIOL CHEM, V272, P1433, DOI 10.1074/jbc.272.3.1433; McNicol A., 1996, PRACT APPROACH SER, P1; MORO MA, 1995, BRIT J PHARMACOL, V116, P1999, DOI 10.1111/j.1476-5381.1995.tb16404.x; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; MORO MA, 1994, P NATL ACAD SCI USA, V91, P6702, DOI 10.1073/pnas.91.14.6702; MUNZEL T, 1995, J CLIN INVEST, V95, P187, DOI 10.1172/JCI117637; Napoli C, 2001, P NATL ACAD SCI USA, V98, P2860, DOI 10.1073/pnas.041602898; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Panasenko OM, 1997, ARCH BIOCHEM BIOPHYS, V343, P254, DOI 10.1006/abbi.1997.0171; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Sage S.O., 1996, PRACT APPROACH SER, P67; SEEBACH D, 1985, TETRAHEDRON, V41, P4861, DOI 10.1016/S0040-4020(01)96725-0; Skinner KA, 1998, J BIOL CHEM, V273, P24491, DOI 10.1074/jbc.273.38.24491; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P8087, DOI 10.1073/pnas.89.17.8087; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Yin K, 1995, PROSTAGLANDINS, V50, P169, DOI 10.1016/0090-6980(95)00119-0	37	86	96	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5832	5840		10.1074/jbc.M105209200	http://dx.doi.org/10.1074/jbc.M105209200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748216	hybrid			2022-12-27	WOS:000173989200020
J	Gatanaga, H; Suzuki, Y; Tsang, H; Yoshimura, K; Kavlick, MF; Nagashima, K; Gorelick, RJ; Mardy, S; Tang, C; Summers, MF; Mitsuya, H				Gatanaga, H; Suzuki, Y; Tsang, H; Yoshimura, K; Kavlick, MF; Nagashima, K; Gorelick, RJ; Mardy, S; Tang, C; Summers, MF; Mitsuya, H			Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MATRIX PROTEIN; TYPE-1; CYCLOPHILIN; REPLICATION; BINDING; TARGET; P7	Amino acid substitutions in human immunodeficiency virus type 1 (HIV-1) Gag cleavage sites have been identified in HIV-1 isolated from patients with AIDS failing chemotherapy containing protease inhibitors (PIs). However, a number of highly PI-resistant HIV-1 variants lack cleavage site amino acid substitutions. In this study we identified multiple novel amino acid substitutions including L75R, H219Q V390D/V390A, R409K, and E468K in the Gag protein at non-cleavage sites in common among HIV-1 variants selected against the following four PIs: amprenavir, JE-2147, RNI-272, and UIC-94003. Analyses of replication profiles of various mutant clones including competitive HIV-1 replication assays demonstrated that these mutations were indispensable for HIV-1 replication in the presence of PIs. When some of these mutations were reverted to wild type amino acids, such HIV-1 clones failed to replicate. However, virtually the same Gag cleavage pattern was seen, indicating that the mutations affected Gag protein functions but not their cleavage sensitivity to protease. These data strongly suggest that non-cleavage site amino acid substitutions in the Gag protein recover the reduced replicative fitness of HIV-1 caused by mutations in the viral protease and may open a new avenue for designing PIs that resist the emergence of PI-resistant HIV-1.	NCI, HIV & AIDS Malignancy Branch, Expt Retrovirol Sect, NIH, Bethesda, MD 20892 USA; Kumamoto Univ, Sch Med, Dept Internal Med 2, Kumamoto 860, Japan; NCI, Sci Applicat Int Corp, AIDS Vaccine Program, Frederick, MD 21701 USA; NCI, Sci Applicat Int Corp, Image Anal Lab, Frederick, MD 21701 USA; Univ Maryland, Howard Hughes Med Inst, Baltimore, MD 21250 USA; Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kumamoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Mitsuya, H (corresponding author), NCI, HIV & AIDS Malignancy Branch, Expt Retrovirol Sect, NIH, Bldg 10,Rm 5A11,9000 Rockville Pike, Bethesda, MD 20892 USA.	hmitsuya@helix.nih.gov	Tsang, Hsinyi/C-9547-2011	Tang, Chun/0000-0001-6477-6500	OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrie KA, 1996, VIROLOGY, V219, P407, DOI 10.1006/viro.1996.0266; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Braaten D, 1996, J VIROL, V70, P5170, DOI 10.1128/JVI.70.8.5170-5176.1996; Bukovsky AA, 1997, P NATL ACAD SCI USA, V94, P10943, DOI 10.1073/pnas.94.20.10943; DARKE PL, 1988, BIOCHEM BIOPH RES CO, V156, P297, DOI 10.1016/S0006-291X(88)80839-8; Dietrich L, 2001, J VIROL, V75, P4721, DOI 10.1128/JVI.75.10.4721-4733.2001; Doyon L, 1996, J VIROL, V70, P3763, DOI 10.1128/JVI.70.6.3763-3769.1996; Erickson JW, 1999, AIDS, V13, pS189; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Ghosh AK, 1998, BIOORG MED CHEM LETT, V8, P687, DOI 10.1016/S0960-894X(98)00098-5; Gorelick RJ, 1999, VIROLOGY, V256, P92, DOI 10.1006/viro.1999.9629; GULNIK SV, 1995, BIOCHEMISTRY-US, V34, P9282, DOI 10.1021/bi00029a002; HAYAT MA, 1989, PRINCIPLES TECHNIQUE, P352; KAGEYAMA S, 1993, ANTIMICROB AGENTS CH, V37, P810, DOI 10.1128/AAC.37.4.810; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kosalaraksa P, 1999, J VIROL, V73, P5356, DOI 10.1128/JVI.73.7.5356-5363.1999; KUIKEN C, 1999, HUMAN RETROVIRUSES A, P201; Massiah MA, 1996, PROTEIN SCI, V5, P2391, DOI 10.1002/pro.5560051202; MIMOTO T, 1992, CHEM PHARM BULL, V40, P2251; Mitsuya H, 1999, TXB AIDS MED, P751; PALMER EL, 1988, ELECT MICROSCOPY VIR, P13; Rose RE, 1996, P NATL ACAD SCI USA, V93, P1648, DOI 10.1073/pnas.93.4.1648; Sei S, 2000, J VIROL, V74, P4621, DOI 10.1128/JVI.74.10.4621-4633.2000; TOZSER J, 1991, FEBS LETT, V281, P77, DOI 10.1016/0014-5793(91)80362-7; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; WONDRAK EM, 1993, FEBS LETT, V333, P21, DOI 10.1016/0014-5793(93)80367-4; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Yoshimura K, 1999, P NATL ACAD SCI USA, V96, P8675, DOI 10.1073/pnas.96.15.8675; Yoshimura K, 2002, J VIROL, V76, P1349, DOI 10.1128/JVI.76.3.1349-1358.2002; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992; Zhang YM, 1997, J VIROL, V71, P6662, DOI 10.1128/JVI.71.9.6662-6670.1997	31	125	136	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5952	5961		10.1074/jbc.M108005200	http://dx.doi.org/10.1074/jbc.M108005200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741936	hybrid			2022-12-27	WOS:000173989200034
J	Jenna, S; Hussain, NK; Danek, EI; Triki, I; Wasiak, S; McPherson, PS; Lamarche-Vane, N				Jenna, S; Hussain, NK; Danek, EI; Triki, I; Wasiak, S; McPherson, PS; Lamarche-Vane, N			The activity of the GTPase-activating protein CdGAP is regulated by the endocytic protein intersectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ACTIN STRESS FIBERS; ADAPTER PROTEIN; EPS15 HOMOLOGY; CDC42 GTPASES; N-CHIMAERIN; RHO-GTPASES; RAC; BINDING; DOMAIN	The Rho GTPases RhoA, Rac1, and Cdc42 play a major role in regulating the reorganization of the actin cytoskeleton. We recently identified CdGAP, a novel GTPase-activating protein with activity toward Rac1 and Cdc42. CdGAP consists of a N-terminal GAP domain, a central domain, and a C-terminal proline-rich domain. Here we show that through a subset of its Src homology 3 domains, the endocytic protein intersectin interacts with CdGAP. In platelet-derived growth factor-stimulated Swiss 3T3 cells, intersectin co-localizes with CdGAP and inhibits its GAP activity toward Rae1. Intersectin-Src homology 3 also inhibits CdGAP activity in GAP assays in vitro. Although the C-terminal proline-rich domain of CdGAP is required for the regulation of its GAP activity by intersectin both in vivo and in vitro, it is not necessary for CdGAP-intersectin interaction. Our data suggest that the central domain of CdGAP is required for CdGAP-intersectin interaction. Thus, we propose a model in which intersectin binding results in a change of CdGAP conformation involving the proline-rich domain that leads to the inhibition of its GAP activity. These observations provide the first demonstration of a direct regulation of RhoGAP activity through a protein-protein interaction and suggest a function for intersectin in Rae1 regulation and actin dynamics.	McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Lamarche-Vane, N (corresponding author), McGill Univ, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	nlamarch@med.mcgill.ca						Adams A, 2000, J BIOL CHEM, V275, P27414; AHMED S, 1990, BIOCHEM J, V272, P767, DOI 10.1042/bj2720767; AHMED S, 1993, J BIOL CHEM, V268, P10709; AHMED S, 1991, BIOCHEM J, V280, P233, DOI 10.1042/bj2800233; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Guipponi M, 1998, GENOMICS, V53, P369, DOI 10.1006/geno.1998.5521; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haskell MD, 2001, J CELL SCI, V114, P1699; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lamarche-Vane N, 1998, J BIOL CHEM, V273, P29172, DOI 10.1074/jbc.273.44.29172; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; Puls A, 1999, J CELL SCI, V112, P2983; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Tong XK, 2000, J BIOL CHEM, V275, P29894, DOI 10.1074/jbc.M004096200; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; VAN AL, 1997, GENE DEV, V11, P2295; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401	38	61	65	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6366	6373		10.1074/jbc.M105516200	http://dx.doi.org/10.1074/jbc.M105516200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744688	hybrid			2022-12-27	WOS:000173989200089
J	Okumura, M; Yamakawa, H; Ohara, O; Owaribe, K				Okumura, M; Yamakawa, H; Ohara, O; Owaribe, K			Novel alternative splicings of BPAG1 (bullous pemphigoid antigen 1) including the domain structure closely related to MACF (microtubule actin cross-linking factor)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC ORGANIZATION; MOLECULAR-CLONING; BINDING PROTEINS; PLAKIN FAMILY; CDNA CLONING; GENE; PLECTIN; HEMIDESMOSOMES; DYSTROPHIN; DYSTONIN	BPAG1 (bullous pemphigoid antigen 1) was originally identified as a 230-kDa hemidesmosomal protein and belongs to the plakin family, because it consists of a plakin domain, a coiled-coil rod domain and a COOH-terminal intermediate filament binding domain. To date, alternatively spliced products of BPAG1, BPAG1e, and BPAG1n are known. BPAG1e is expressed in epithelial tissues and localized to hemidesmosomes, on the other hand, BPAG1n is expressed in neural tissues and muscles and has an actin binding domain at the NH2-terminal of BPAG1e. BPAG1 is also known as a gene responsible for Dystonia musculorum (dt) neurodegeneration syndrome of the mouse. Another plakin family protein MACF (microtubule actin cross-linking factor) has also an actin binding domain and the plakin domain at the NH2-terminal. However, in contrast to its high homology with BPAG1 at the NH2-terminal, the COOH-terminal structure of MACF, including a microtubule binding domain, resembles dystrophin rather than plakins. Here, we investigated RNAs and proteins expressed from the BPAG1 locus and suggest novel alternative splicing variants, which include one consisting of the COOH-terminal domain structure homologous to MACF. The results indicate that BPAG1 has three kinds of cytoskeletal binding domains and seems to play an important role in linking the different types of cytoskeletons.	Nagoya Univ, Unit Biosyst, Grad Sch Human Informat, Nagoya, Aichi 4648601, Japan; Kazusa DNA Res Inst, Dept Human Gene Res, Chiba 2920812, Japan	Nagoya University; Kazusa DNA Research Institute	Okumura, M (corresponding author), Nagoya Univ, Unit Biosyst, Grad Sch Human Informat, Nagoya, Aichi 4648601, Japan.	masayo@info.human.nagoya-u.ac.jp	Ohara, Osamu/A-9119-2012; Ohara, Osamu/G-5448-2015	Ohara, Osamu/0000-0002-3328-9571				Aho S, 1999, GENOMICS, V56, P160, DOI 10.1006/geno.1998.5704; Bernier G, 1996, GENOMICS, V38, P19, DOI 10.1006/geno.1996.0587; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; BROWN A, 1995, GENOMICS, V29, P777, DOI 10.1006/geno.1995.9936; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Elliott CE, 1997, GENOMICS, V42, P115, DOI 10.1006/geno.1997.4724; Fuchs P, 1999, HUM MOL GENET, V8, P2461, DOI 10.1093/hmg/8.13.2461; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; GREEN KJ, 1990, J BIOL CHEM, V265, P2603; Green KJ, 1999, EXP DERMATOL, V8, P462, DOI 10.1111/j.1600-0625.1999.tb00304.x; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; Hirako Y, 1996, J BIOL CHEM, V271, P13739, DOI 10.1074/jbc.271.23.13739; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; KITAJIMA Y, 1994, DERMATOLOGY, V189, P46, DOI 10.1159/000246928; KITAJIMA Y, 1988, CANCER RES, V48, P964; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Leung CL, 2001, J CELL SCI, V114, P3409; Leung CL, 2001, J CELL BIOL, V154, P691, DOI 10.1083/jcb.200012098; Liu CG, 1996, P NATL ACAD SCI USA, V93, P4278, DOI 10.1073/pnas.93.9.4278; Maatta A, 2000, J BIOL CHEM, V275, P19857, DOI 10.1074/jbc.M001028200; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; Ohara O, 1998, MOL BRAIN RES, V57, P181, DOI 10.1016/S0169-328X(98)00068-0; Okuda T, 1999, BIOCHEM BIOPH RES CO, V264, P568, DOI 10.1006/bbrc.1999.1538; OWARIBE K, 1991, EXP CELL RES, V192, P622, DOI 10.1016/0014-4827(91)90084-8; Ruhrberg C, 1997, CURR OPIN GENET DEV, V7, P392, DOI 10.1016/S0959-437X(97)80154-2; SAWAMURA D, 1990, GENOMICS, V8, P722, DOI 10.1016/0888-7543(90)90261-R; SAWAMURA D, 1991, J BIOL CHEM, V266, P17784; STANLEY JR, 1993, ADV IMMUNOL, V53, P291, DOI 10.1016/S0065-2776(08)60503-9; Sun DM, 2001, J CELL SCI, V114, P161; Sun YP, 1999, J BIOL CHEM, V274, P33522, DOI 10.1074/jbc.274.47.33522; TAMAI K, 1993, J CLIN INVEST, V92, P814, DOI 10.1172/JCI116655; VIRATA MLA, 1992, P NATL ACAD SCI USA, V89, P544, DOI 10.1073/pnas.89.2.544; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5	37	39	40	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6682	6687		10.1074/jbc.M109209200	http://dx.doi.org/10.1074/jbc.M109209200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751855	hybrid			2022-12-27	WOS:000173989200129
J	Therien, AG; Deber, CM				Therien, AG; Deber, CM			Interhelical packing in detergent micelles - Folding of a cystic fibrosis transmembrane conductance regulator construct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CONFORMATIONAL CHANGE; PYRENE EXCIMER FLUORESCENCE; MEMBRANE-SPANNING SEGMENT; CHLORIDE CHANNEL; HELIX; PROXIMITY; PROBE; CFTR; LYSOPHOSPHOLIPIDS; IDENTIFICATION	Using a helix-loop-helix construct consisting of the adjacent transmembrane segments 3 and 4 of the cystic fibrosis transmembrane conductance regulator (CFTR) labeled with pyrene at both N and C termini, we describe a system for the study of intramolecular helix-helix interactions within a polytopic membrane protein. Through measurement of pyrene excimer band intensity as a determinant of helix-helix proximity, we show that the helices retain tertiary contacts in detergent micelles. Notably, the nature of the micellar detergent can alter the stability of these contacts, with perfluorooctanoate highly supportive, lysophosphatidylcholine and lysophosphatidylglycerol somewhat less tolerant, and SDS largely intolerant of such interactions. This construct is further employed to study the role of the acyl chain length of micellar detergents in modulating interhelical packing; detergents having acyl chains of 9 carbons display the greatest extent of helical packing. These results provide important information regarding the role of lipids on membrane protein folding and conformation as well as demonstrate the usefulness of a pyrene-based system in studying the forces that govern interhelical packing.	Hosp Sick Children, Res Inst, Div Struct Biol & Biochem, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Struct Biol & Biochem, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	deber@sickkids.on.ca	Therien, Alex/AAS-8437-2021					Akabas MH, 1998, BIOCHEMISTRY-US, V37, P12233, DOI 10.1021/bi980969o; Akabas MH, 1997, J BIOENERG BIOMEMBR, V29, P453, DOI 10.1023/A:1022482923122; Bechinger B, 2000, CURR OPIN CHEM BIOL, V4, P639, DOI 10.1016/S1367-5931(00)00143-5; BERR SS, 1989, J PHYS CHEM-US, V93, P2555, DOI 10.1021/j100343a062; Chen MG, 1999, BIOCHEMISTRY-US, V38, P5471, DOI 10.1021/bi982153t; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Dumas F, 1999, FEBS LETT, V458, P271, DOI 10.1016/S0014-5793(99)01148-5; Fisher LE, 1999, J MOL BIOL, V293, P639, DOI 10.1006/jmbi.1999.3126; Gil T, 1998, BBA-REV BIOMEMBRANES, V1376, P245, DOI 10.1016/S0304-4157(98)00022-7; GRACEFFA P, 1980, J BIOL CHEM, V255, P1296; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; JUNG K, 1993, BIOCHEMISTRY-US, V32, P12273, DOI 10.1021/bi00097a001; Lehrer S S, 1995, Subcell Biochem, V24, P115; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; LEHRER SS, 1989, FLUORESCENT BIOMOLEC, V51, P423; Liu W, 1998, BIOCHEMISTRY-US, V37, P15457, DOI 10.1021/bi980557f; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Melnyk RA, 2001, BIOCHEMISTRY-US, V40, P11106, DOI 10.1021/bi010642e; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Peng SY, 1998, FEBS LETT, V431, P29, DOI 10.1016/S0014-5793(98)00715-7; Petrache HI, 2000, J MOL BIOL, V302, P727, DOI 10.1006/jmbi.2000.4072; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Ren JH, 1999, BIOCHEMISTRY-US, V38, P5905, DOI 10.1021/bi982942a; RIORDAN JR, 1989, SCIENCE, V245, P1066; SHEPHERD FH, 1995, ANAL BIOCHEM, V224, P21, DOI 10.1006/abio.1995.1003; Sheppard DN, 1999, PHYSIOL REV, V79, P23; STAFFORD RE, 1988, COLLOID SURFACE, V30, P47; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Therien AG, 2001, NAT STRUCT BIOL, V8, P597, DOI 10.1038/89631; Wang C, 2000, J BIOL CHEM, V275, P16155, DOI 10.1074/jbc.M000723200; Wigley WC, 1998, BIOCHEMISTRY-US, V37, P844, DOI 10.1021/bi972293n; Xie HB, 2000, BIOCHEMISTRY-US, V39, P15462, DOI 10.1021/bi001432p; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	38	28	28	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6067	6072		10.1074/jbc.M110264200	http://dx.doi.org/10.1074/jbc.M110264200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748233	hybrid			2022-12-27	WOS:000173989200050
J	Thomas, SR; Chen, K; Keaney, JF				Thomas, SR; Chen, K; Keaney, JF			Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GROWTH-FACTOR; SPHINGOSINE 1-PHOSPHATE; DEPENDENT ACTIVATION; OXIDATIVE STRESS; AKT; INSULIN; CELLS; FLOW; REQUIREMENT	Endothelial nitric-oxide synthase (eNOS) is an important component of vascular homeostasis. During vascular disease, endothelial cells are exposed to excess reactive oxygen species that can alter cellular phenotype by inducing various signaling pathways. In the current study, we examined the implications of H2O2-induced signaling for eNOS phosphorylation status and activity in porcine aortic endothelial cells. We found that H2O2 treatment enhanced eNOS activity and NO bioactivity as determined by the conversion of L-[H-3]arginine to L-[H-3]citrulline and cellular eGMP content. Concomitant with eNOS activation, H2O2 also activated Akt, increased eNOS phosphorylation at Ser-1177, and decreased eNOS phosphorylation at Thr-495. H2O2-induced promotion of eNOS activity and modulation of the eNOS phosphorylation status at Ser-1177 and Thr-495 were significantly attenuated by selective inhibitors of Src kinase, the ErbB receptor family, and phosphoinositide 3-kinase (PI 3-K). We found that Akt activation, eNOS Ser-1177 phosphorylation, and eNOS activation by H2O2 were calcium-dependent, whereas eNOS dephosphorylation at Thr-495 was not, suggesting a branch point in the signaling cascade downstream from PI 3-K. Consistent with this, overexpression of a dominant negative isoform of Akt inhibited H2O2-induced phosphorylation of eNOS at Ser-1177 but not dephosphorylation of eNOS at Thr-495. Together, these data indicate that H2O2 promotes calcium-dependent eNOS activity through a coordinated change in the phosphorylation status of the enzyme mediated by Src- and ErbB receptor-dependent PI 3-K activation. In turn, PI 3-K mediates eNOS Ser-1177 phosphorylation via a calcium- and Akt-dependent pathway, whereas eNOS Thr-495 dephosphorylation does not involve calcium or Akt. This response may represent an attempt by endothelial cells to maintain NO bioactivity under conditions of enhanced oxidative stress.	Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Boston Univ, Sch Med, Evans Mem Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Keaney, JF (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,Rm W507, Boston, MA 02118 USA.	jkeaney@bu.edu		Keaney, John/0000-0002-0866-1837	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055656] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; AZUMA H, 1986, BRIT J PHARMACOL, V88, P411, DOI 10.1111/j.1476-5381.1986.tb10218.x; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; DOAN TN, 1994, BIOCHEM J, V297, P209, DOI 10.1042/bj2970209; Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200; Huang A, 2000, J BIOL CHEM, V275, P17399, DOI 10.1074/jbc.M002248200; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; Igarashi J, 2001, J BIOL CHEM, V276, P36281, DOI 10.1074/jbc.M105628200; Keaney JF, 1996, J CLIN INVEST, V98, P386, DOI 10.1172/JCI118804; KEANEY JF, 1995, J CLIN INVEST, V95, P2520, DOI 10.1172/JCI117953; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; LEFROY DC, 1993, CIRCULATION, V88, P43, DOI 10.1161/01.CIR.88.1.43; LEVINE GN, 1995, NEW ENGL J MED, V332, P512, DOI 10.1056/NEJM199502233320807; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; Paxinou E, 2001, P NATL ACAD SCI USA, V98, P11575, DOI 10.1073/pnas.201293198; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; Shimizu S, 1997, RES COMMUN MOL PATH, V95, P227; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; ZEMBOWICZ A, 1993, BRIT J PHARMACOL, V110, P151, DOI 10.1111/j.1476-5381.1993.tb13785.x	48	317	323	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6017	6024		10.1074/jbc.M109107200	http://dx.doi.org/10.1074/jbc.M109107200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744698	hybrid			2022-12-27	WOS:000173989200043
J	Watterson, KR; Johnston, E; Chalmers, C; Pronin, A; Cook, SJ; Benovic, JL; Palmer, TM				Watterson, KR; Johnston, E; Chalmers, C; Pronin, A; Cook, SJ; Benovic, JL; Palmer, TM			Dual regulation of EDG1/S1P(1) receptor phosphorylation and internalization by protein kinase C and G-protein-coupled receptor kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE; ADENOSINE RECEPTOR; LYSOPHOSPHATIDIC ACID; EDG-1; DESENSITIZATION; AGONIST; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; INHIBITOR; ANGIOGENESIS	Here we demonstrate that phosphorylation of the sphingosine 1-phosphate (SSP) receptor "endothelial differentiation gene 1" (EDG1 or S1P(1)) receptor is increased in response to either SSP or phorbol 12-myristate 13-acetate (PMA) exposure but not lysophosphatidic acid. Phosphoamino acid analysis demonstrated that SSP stimulated the accumulation of phosphoserine and phosphothreonine but not phosphotyrosine. An inhibitor of PMA-stimulated EDG1 phosphorylation failed to block SSP-stimulated phosphorylation. Additionally, removal of 12 amino acids from the carboxyl terminus of EDG1 specifically reduced SSP- but not PMA-stimulated phosphorylation, suggesting that SSP and PMA increase EDG1 phosphorylation via distinct mechanisms. In vitro assays revealed that G-protein-coupled receptor kinase 2 may be at least partially responsible for SSP-stimulated EDG1 phosphorylation observed in intact cells. In addition, phosphorylation by PMA and SSP were associated with a loss of EDG1 from the cell surface by distinct mechanisms. Removal of 12 residues from the carboxyl terminus of EDG1 completely inhibited SSP-mediated internalization, suggesting that this domain dictates susceptibility to receptor internalization while retaining sensitivity to SSP-stimulated phosphorylation. Thus, we conclude that (a) EDG1 phosphorylation and internalization are controlled via independent mechanisms by agonist occupation of the receptor and protein kinase C activation, and (b) although determinants within the receptor's carboxyl-terminal tail conferring EDG1 sensitivity to agonist-mediated internalization and G-protein-coupled receptor kinase phosphorylation exhibit a degree of overlap, the two phenomena are separable.	Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland; Babraham Inst, Signalling Programme, Cambridge CB2 4AT, England; Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Jefferson University	Palmer, TM (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland.	T.palmer@bio.gla.ac.uk	Palmer, Timothy/E-7290-2013; Palmer, Timothy/C-4975-2009	Palmer, Timothy/0000-0002-9803-7164; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; Beltman J, 1996, J BIOL CHEM, V271, P27018, DOI 10.1074/jbc.271.43.27018; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Ferguson G, 2000, MOL PHARMACOL, V57, P546, DOI 10.1124/mol.57.3.546; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HLA T, 1990, J BIOL CHEM, V265, P9308; Hla T, 2000, ANN NY ACAD SCI, V905, P16; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Igarashi Y, 1998, ACTA BIOCHIM POL, V45, P299, DOI 10.18388/abp.1998_4226; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; Okamoto H, 1998, J BIOL CHEM, V273, P27104, DOI 10.1074/jbc.273.42.27104; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Palmer TM, 1999, BIOCHEMISTRY-US, V38, P14833, DOI 10.1021/bi990825p; Palmer TM, 2000, MOL PHARMACOL, V57, P539, DOI 10.1124/mol.57.3.539; Palmer TM, 1996, J BIOL CHEM, V271, P15272, DOI 10.1074/jbc.271.25.15272; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Rakhit S, 1999, BIOCHEM J, V338, P643, DOI 10.1042/0264-6021:3380643; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; STRASSER RH, 1986, P NATL ACAD SCI USA, V83, P6362, DOI 10.1073/pnas.83.17.6362; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605	42	73	77	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5767	5777		10.1074/jbc.M110647200	http://dx.doi.org/10.1074/jbc.M110647200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741892	hybrid			2022-12-27	WOS:000173989200012
J	Sonawane, ND; Thiagarajah, JR; Verkman, AS				Sonawane, ND; Thiagarajah, JR; Verkman, AS			Chloride concentration in endosomes measured using a ratioable fluorescent Cl- indicator - Evidence for chloride accumulation during acidification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; KIDNEY-CELLS; ENDOCYTIC VESICLES; PROXIMAL TUBULE; COATED VESICLE; DENTS-DISEASE; GOLGI-COMPLEX; PROTON PUMP; PH; PROTEIN	A novel long wavelength fluorescent Cl- indicator was used to test whether endosomal Cl- conductance provides the principal electrical shunt to permit endosomal acidification. The green fluorescent Cl--sensitive chromophore 10,10'-bis[3-carboxypropyl]-9,9'-biacridinium dinitrate (BAC) was conjugated to aminodextran together with the red fluorescent Cl--insensitive chromophore tetramethylrhodamine (TMR). BAC fluorescence is pH-insensitive and quenched by Cl- with a Stern-Volmer constant of 36 M-1. Endosomes in J774 and Chinese hamster ovary (CHO) cells were pulse-labeled with BAC-TMR-dextran by fluid-phase endocytosis. Endosomal [Cl-] increased over 45 min from 17 to 53 mM in J774 cells and from 28 to 73 mM in CHO cells, during which time endosomal pH decreased from 6.95 to 5.30 (J774) and 6.92 to 5.60 (CHO). The acidification and increased [Cl-] were blocked by bafilomycin. Together with ion substitution and buffer capacity measurements, we conclude that Cl- transport accounts quantitatively for the electrical shunt during vacuolar acidification. Measurements of relative endosomal volume by a novel ratio imaging method involving fluorescence self-quenching indicated a 2.5-fold increase in volume during early acidification and Cl- accumulation, which was blocked by bafilomycin. These experiments provide the first direct measurement of endosomal [Cl-] and indicate that endosomal acidification is accompanied by significant Cl- entry and volume increase.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, 1246 Hlth Sci E Tower,Box 0521, San Francisco, CA 94143 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060288, R01HL059198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R01DK043840, R37DK035124] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59198, HL60288] Funding Source: Medline; NIDDK NIH HHS [DK43840, DK35124] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; BAE HR, 1990, NATURE, V348, P637, DOI 10.1038/348637a0; BARASCH J, 1988, J CELL BIOL, V107, P2137, DOI 10.1083/jcb.107.6.2137; BIWERSI J, 1994, AM J PHYSIOL, V266, pC149, DOI 10.1152/ajpcell.1994.266.1.C149; BLAIR HC, 1991, AM J PHYSIOL, V260, pC1315, DOI 10.1152/ajpcell.1991.260.6.C1315; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brix K, 1998, J CLIN INVEST, V102, P283, DOI 10.1172/JCI1614; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CHAO AC, 1989, BIOPHYS J, V56, P1071, DOI 10.1016/S0006-3495(89)82755-9; CROWE WE, 1995, NEUROSCIENCE, V69, P283, DOI 10.1016/0306-4522(95)00219-9; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Farinas J, 1999, J BIOL CHEM, V274, P7603, DOI 10.1074/jbc.274.12.7603; Forgac M, 1999, J BIOENERG BIOMEMBR, V31, P57, DOI 10.1023/A:1005496530380; FUCHS R, 1989, J BIOL CHEM, V264, P2212; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; GEISOW MJ, 1984, EXP CELL RES, V150, P36, DOI 10.1016/0014-4827(84)90699-2; GEKLE M, 1995, PFLUG ARCH EUR J PHY, V429, P452, DOI 10.1007/BF00374165; GLICKMAN J, 1983, J CELL BIOL, V97, P1303, DOI 10.1083/jcb.97.4.1303; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; GRIFFITHS G, 1989, J CELL BIOL, V109, P2703, DOI 10.1083/jcb.109.6.2703; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Jayaraman S, 2001, J GEN PHYSIOL, V117, P423, DOI 10.1085/jgp.117.5.423; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; LITT MH, 1985, J POLYM SCI POL CHEM, V23, P1307, DOI 10.1002/pol.1985.170230505; Mansoura MK, 1999, HUM GENE THER, V10, P861, DOI 10.1089/10430349950018274; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; MULBERG AE, 1991, J BIOL CHEM, V266, P20590; Obermuller N, 1998, J CLIN INVEST, V101, P635, DOI 10.1172/JCI1496; OVERLY CC, 1995, P NATL ACAD SCI USA, V92, P3156, DOI 10.1073/pnas.92.8.3156; PARTON RG, 1992, J CELL SCI, V103, P335; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Rybak SL, 1997, BIOPHYS J, V73, P674, DOI 10.1016/S0006-3495(97)78102-5; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; SCHMID A, 1989, J MEMBRANE BIOL, V111, P265, DOI 10.1007/BF01871011; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; VANDYKE RW, 1988, J BIOL CHEM, V263, P2603; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99	48	144	144	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5506	5513		10.1074/jbc.M110818200	http://dx.doi.org/10.1074/jbc.M110818200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741919	hybrid			2022-12-27	WOS:000173962900123
J	Andoh, T; Chock, PB; Chiueh, CC				Andoh, T; Chock, PB; Chiueh, CC			The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; CASPASE ACTIVATION; LIPID-PEROXIDATION; REDOX REGULATION; REDUCTASE; BCL-2; INHIBITOR; PROTEIN; DEATH; MANGANESE	Using models of serum deprivation and 1-methyl-4-phenylpyridinium (MPP+), we investigated the mechanism by which thioredoxin (Trx) exerts its antiapoptotic protection in human neuroblastoma cells (SH-SY5Y) and preconditioning-induced neuroprotection. We showed that SH-SY5Y cells are highly sensitive to oxidative stress and responsive to both extracellularly administered and preconditioning-induced Trx. Serum deprivation and MPP+ produced an elevation in the hydroxyl radicals, malondialdehyde and 4-hydroxy-2,3-nonenal (HNE), causing the cells to undergo mitochondria-mediated apoptosis. Trx in the submicromolar range blocked the observed apoptosis via a multiphasic protection mechanism that includes the suppression of cytochrome c release (most likely via the induction of Bcl-2), the inhibition of procaspase-9 and procaspase-3 activation, and the elevated level of Mn-SOD. The reduced form of Trx suppresses the serum-free-induced hydroxyl radicals, lipid peroxidation, and apoptosis, indicating that H2O2 is removed by Trx peroxidase. The participation of Trx in preconditioning-induced neuroprotection is supported by the observation that inhibition of Trx synthesis with antisense oligonucleotides or of Trx reductase drastically reduced the hormesis effect. This effect of Trx-mediated hormesis against oxidative stress-induced apoptosis is striking. It induced a 30-fold shift in LD50 in the MPP+-induced neurotoxicity.	NIMH, Clin Sci Lab, Bethesda, MD 20892 USA; NHLBI, Biochem Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chiueh, CC (corresponding author), NIMH, Clin Sci Lab, Bldg 10,Rm 3D-41, Bethesda, MD 20892 USA.	chiueh@helix.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000202, Z01HL000202] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Andoh T, 2000, FASEB J, V14, P2144; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; BIGUET C, 1994, J BIOL CHEM, V269, P28865; CHIUEH CC, 1993, ADV NEUROL, V60, P251; CHIUEH CC, 1992, FREE RADICAL BIO MED, V13, P581, DOI 10.1016/0891-5849(92)90151-6; CHOI ME, 1995, J BIOL CHEM, V270, P21144, DOI 10.1074/jbc.270.36.21144; Das KC, 1997, AM J RESP CELL MOL, V17, P713, DOI 10.1165/ajrcmb.17.6.2809; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Freemerman AJ, 2000, BIOCHEM BIOPH RES CO, V274, P136, DOI 10.1006/bbrc.2000.3091; Gallegos A, 1996, CANCER RES, V56, P5765; Galter Dagmar, 1994, European Journal of Biochemistry, V221, P639; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Huang Y, 1998, BIOCHEM BIOPH RES CO, V249, P307, DOI 10.1006/bbrc.1998.9139; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ishikawa A, 1999, NEUROSCI LETT, V277, P99, DOI 10.1016/S0304-3940(99)00850-2; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kruman I, 1997, J NEUROSCI, V17, P5089; Malecki A, 2000, J NEUROCHEM, V74, P2278, DOI 10.1046/j.1471-4159.2000.0742278.x; MARKEY SP, 1984, NATURE, V311, P464, DOI 10.1038/311464a0; Moskovitz J, 1999, METHOD ENZYMOL, V300, P239; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; OBLONG JE, 1993, BIOCHEMISTRY-US, V32, P7271, DOI 10.1021/bi00079a025; Rauhala P, 2000, ANN NY ACAD SCI, V899, P238; Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; Sheehan JP, 1997, J NEUROSCI RES, V48, P226, DOI 10.1002/(SICI)1097-4547(19970501)48:3<226::AID-JNR5>3.0.CO;2-H; SPECTOR A, 1988, J BIOL CHEM, V263, P4984; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Stridh H, 1998, FEBS LETT, V429, P351, DOI 10.1016/S0014-5793(98)00630-9; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	41	130	144	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					9655	9660		10.1074/jbc.M110701200	http://dx.doi.org/10.1074/jbc.M110701200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11751890	hybrid			2022-12-27	WOS:000174549200008
J	Braganca, J; Swingler, T; Marques, FIR; Jones, T; Eloranta, JJ; Hurst, HC; Shioda, T; Bhattacharya, S				Braganca, J; Swingler, T; Marques, FIR; Jones, T; Eloranta, JJ; Hurst, HC; Shioda, T; Bhattacharya, S			Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOCYTE-SPECIFIC GENE; MICE LACKING; PROTEIN; MSG1; CBP; EXPRESSION; COACTIVATOR; P300/CBP; DEFECTS; GROWTH	Members of the CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) family bind CREB-binding protein and p300 with high affinity and regulate gene transcription. Gene knockout studies indicate that CITED2 is required for neural crest and neural tube development and that it functions as a co-activator for transcription factor AP-2 (TFAP2). Here we describe human CITED4, a new member of this family, which is encoded by a single exon mapping to chromosome lp34-lp35. CITED4 and p300/CREB-binding protein are present in endogenous naturally occurring complexes, indicating that they interact physiologically. The interaction occurs between the cwysteine-histidine-rich domain 1 of p300 and the carboxyl terminus of CITED4. In keeping with this, CITED4 functions as a transactivator when artificially targeted to a promoter element. CITED4 physically interacts with all TFAP2 isoforms in vitro and strongly co-activates all TFAP2 isoforms in Hep3B cells. Co-activation of TFAP2 requires amino-terminal and carboxyl-terminal residues of CITED4. In HepG2 cells, CITED4 is significantly weaker than CITED2 for TFAP2C co-activation. These results suggest that CITED4 may function as a co-activator for TFAP2. They also suggest the existence of cell type- and TFAP2 isoform-specific co-activation by CITED2 and CITED4, which may result in differential modulation of TFAP2 function.	Massachusetts Gen Hosp, Ctr Canc, Lab Tumor Biol, Charlestown, MA 02129 USA; Hammersmith Hosp, Imperial Canc Res Fund, Mol Oncol Unit, London W12 0NN, England; Imperial Canc Res Fund, Human Cytogenet Lab, London WC2A 3PX, England	Harvard University; Massachusetts General Hospital; Cancer Research UK; Imperial College London; Cancer Research UK	Bhattacharya, S (corresponding author), Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Henry Wellcome Bldg Genomic Med,Roosevelt Dr, Oxford OX3 7BN, England.		Braganca, Jose/F-4410-2012; Corbett-Jones, Tania A/E-4891-2013; Jones, Tania/C-8912-2011; Bhattacharya, Shoumo/F-4127-2010	Braganca, Jose/0000-0001-9566-400X; Corbett-Jones, Tania A/0000-0002-0067-3382; Jones, Tania/0000-0002-0067-3382; Bhattacharya, Shoumo/0000-0002-5571-0478				Andrews JE, 2000, MECH DEVELOP, V95, P305, DOI 10.1016/S0925-4773(00)00362-2; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bosher JM, 1996, ONCOGENE, V13, P1701; Brewer S, 2002, MECH DEVELOP, V110, P139, DOI 10.1016/S0925-4773(01)00579-2; Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Eckner R, 1996, MOL CELL BIOL, V16, P3454; Fenner MH, 1998, GENOMICS, V51, P401, DOI 10.1006/geno.1998.5383; Goodman RH, 2000, GENE DEV, V14, P1553; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Kannan P, 1999, NUCLEIC ACIDS RES, V27, P866, DOI 10.1093/nar/27.3.866; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kung AL, 2000, GENE DEV, V14, P272; Leung MK, 1999, GENOMICS, V61, P307, DOI 10.1006/geno.1999.5970; McPherson LA, 1999, NUCLEIC ACIDS RES, V27, P4040, DOI 10.1093/nar/27.20.4040; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; Newton AL, 2000, J BIOL CHEM, V275, P15128, DOI 10.1074/jbc.M910396199; Oike Y, 1999, BLOOD, V93, P2771; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schuur ER, 2001, J BIOL CHEM, V276, P15519, DOI 10.1074/jbc.M009001200; SENGER G, 1993, CYTOGENET CELL GENET, V64, P49, DOI 10.1159/000133559; Shioda T, 1996, P NATL ACAD SCI USA, V93, P12298, DOI 10.1073/pnas.93.22.12298; Shioda T, 1997, GENE, V204, P235, DOI 10.1016/S0378-1119(97)00551-9; SKINNER A, 1993, ONCOGENE, V8, P3393; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Turner BC, 1998, CANCER RES, V58, P5466; Wang DY, 1997, J BIOL CHEM, V272, P14244, DOI 10.1074/jbc.272.22.14244; Yahata T, 2000, J BIOL CHEM, V275, P8825, DOI 10.1074/jbc.275.12.8825; Yahata T, 2001, GENE DEV, V15, P2598, DOI 10.1101/gad.906301; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410	39	84	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8559	8565		10.1074/jbc.M110850200	http://dx.doi.org/10.1074/jbc.M110850200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11744733	hybrid			2022-12-27	WOS:000174268000119
J	Brass, V; Bieck, E; Montserret, R; Wolk, B; Hellings, JA; Blum, HE; Penin, F; Moradpour, D				Brass, V; Bieck, E; Montserret, R; Wolk, B; Hellings, JA; Blum, HE; Penin, F; Moradpour, D			An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; NS5A PROTEIN; NUCLEAR-LOCALIZATION; MAMMALIAN-CELLS; GENE-EXPRESSION; VIRAL-PROTEINS; REPLICATION; DOMAIN	Hepatitis C virus (HCV) nonstructural protein 5A (NS5A), a phosphoprotein of unknown function, is believed to be a component of a membrane-associated viral replication complex. The determinants for membrane association of NS5A, however, have not been defined. By double label immunofluoreseence analyses, NS5A was found to be associated with the endoplasmic reticulum (ER) or an ER-derived modified compartment both when expressed alone or in the context of the entire HCV polyprotein. Systematic deletion and green fluorescent protein fusion analyses allowed us to map the membrane anchor to the amino-terminal 30 amino acid residues of NS5A. Membrane association occurred by a posttranslational mechanism and resulted in properties of an integral membrane protein. Circular dichroism structural studies of a synthetic peptide corresponding to the NS5A membrane anchor, designated NS5A(1-31), demonstrated the presence of an amphipathic alpha-helix that was found to be highly conserved among 280 HCV isolates of various genotypes. The detergent-binding properties of this helical peptide together with the nature and location of its amino acids suggest a mechanism of membrane insertion via the helix hydrophobic side, yielding a topology parallel to the lipid bilayer in the cytoplasmic leaflet of the ER membrane. These findings have important implications for the structural and functional organization of the HCV replication complex and may define novel targets for antiviral intervention.	Univ Freiburg, Dept Med 2, D-79106 Freiburg, Germany; Inst Biol & Chim Prot, CNRS UMR 5086, F-69367 Lyon 07, France; Organon Teknika BV, NL-5280 AB Boxtel, Netherlands	University of Freiburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Moradpour, D (corresponding author), Univ Hosp Freiburg, Dept Med 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	moradpou@ruf.uni-freiburg.de	PENIN, Francois/A-7315-2008; Moradpour, Darius/G-7918-2017	Moradpour, Darius/0000-0003-1977-6792				Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bechinger B, 2000, CURR OPIN CHEM BIOL, V4, P639, DOI 10.1016/S1367-5931(00)00143-5; BIENZ K, 1992, J VIROL, V66, P2740, DOI 10.1128/JVI.66.5.2740-2747.1992; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Blanchet C, 2000, BIOINFORMATICS, V16, P286, DOI 10.1093/bioinformatics/16.3.286; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; Egger D, 2000, J VIROL, V74, P6570, DOI 10.1128/JVI.74.14.6570-6580.2000; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; EPAND RM, 1995, BIOPOLYMERS, V37, P319, DOI 10.1002/bip.360370504; Fauquet C. M., 2000, VIRUS TAXONOMY; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grassmann CW, 2001, J VIROL, V75, P7791, DOI 10.1128/JVI.75.17.7791-7802.2001; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Ide Y, 1996, GENE, V182, P203, DOI 10.1016/S0378-1119(96)00555-0; Khromykh AA, 2000, J VIROL, V74, P3253, DOI 10.1128/JVI.74.7.3253-3263.2000; Kim JE, 1999, ARCH VIROL, V144, P329, DOI 10.1007/s007050050507; Koch JO, 1999, J VIROL, V73, P7138; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kretzschmar E, 1996, VIROLOGY, V220, P37, DOI 10.1006/viro.1996.0283; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Lampio A, 2000, J BIOL CHEM, V275, P37853, DOI 10.1074/jbc.M004865200; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lin C, 1997, J VIROL, V71, P6465, DOI 10.1128/JVI.71.9.6465-6471.1997; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Montserret R, 1999, BIOCHEMISTRY-US, V38, P6479, DOI 10.1021/bi9900222; Montserret R, 2000, BIOCHEMISTRY-US, V39, P8362, DOI 10.1021/bi000208x; Moradpour D, 1998, HEPATOLOGY, V28, P192, DOI 10.1002/hep.510280125; Moradpour D, 2001, SWISS MED WKLY, V131, P291; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; MOREMEN KW, 1991, J BIOL CHEM, V266, P16876; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Neddermann P, 1999, J VIROL, V73, P9984, DOI 10.1128/JVI.73.12.9984-9991.1999; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Reed KE, 1998, J VIROL, V72, P6199, DOI 10.1128/JVI.72.7.6199-6206.1998; Reed KE, 1997, J VIROL, V71, P7187, DOI 10.1128/JVI.71.10.7187-7197.1997; Ridder ANJA, 2000, BIOCHEMISTRY-US, V39, P6521, DOI 10.1021/bi000073v; Rust RC, 2001, J VIROL, V75, P9808, DOI 10.1128/JVI.75.20.9808-9818.2001; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Satoh S, 2000, VIROLOGY, V270, P476, DOI 10.1006/viro.2000.0287; Schaad MC, 1997, EMBO J, V16, P4049, DOI 10.1093/emboj/16.13.4049; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Snijder EJ, 2001, J GEN VIROL, V82, P985, DOI 10.1099/0022-1317-82-5-985; Song J, 2000, VIRUS RES, V69, P109, DOI 10.1016/S0168-1702(00)00206-9; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; Tan SL, 2001, VIROLOGY, V284, P1, DOI 10.1006/viro.2001.0885; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanKuppeveld FJM, 1996, J VIROL, V70, P3876, DOI 10.1128/JVI.70.6.3876-3886.1996; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yoon MK, 2000, FEBS LETT, V484, P241, DOI 10.1016/S0014-5793(00)02160-8	70	274	283	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8130	8139		10.1074/jbc.M111289200	http://dx.doi.org/10.1074/jbc.M111289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11744739	hybrid			2022-12-27	WOS:000174268000065
J	Ji, HJ; Jovov, B; Fu, J; Bishop, LTR; Mebane, HC; Fuller, CM; Stanton, BA; Benos, DJ				Ji, HJ; Jovov, B; Fu, J; Bishop, LTR; Mebane, HC; Fuller, CM; Stanton, BA; Benos, DJ			Up-regulation of acid-gated Na+ channels (ASICs) by cystic fibrosis transmembrane conductance regulator co-expression in Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; SENSING ION CHANNELS; MUTATIONS CAUSING NEURODEGENERATION; MAMMALIAN DEGENERIN MDEG; MOLECULAR-CLONING; MESSENGER-RNA; HUMAN COLON; CFTR; EXPRESSION; BRAIN	\Cystic fibrosis transmembrane conductance regulator (CFTR) functions as both a chloride channel and an epithelial transport regulator, interacting with Na+ (epithelial sodium channel), Cl-, renal outer medullary potassium channel(+), and H2O channels and some exchangers (i.e. Na+/H+) and co-transporters (Na+-HCO3-, Na+K+-2Cl(-)). Acid-sensitive ion channels (ASICs), members of the epithelial sodium channel/degenerin superfamily, were originally cloned from neuronal tissue, and recently localized in epithelia. Because CFTR has been immunocytochemically and functionally identified in rat, murine, and human brain, the regulation of ASICs by CFTR was tested in oocytes. Our observations show that the proton-gated Na+ current formed by the heteromultimeric ASIC1a/2a channel was up-regulated by wild type but not by DeltaF508-CFTR. In contrast, the acid-gated Na+ current associated with either the homomultimeric ASIC1a or ASIC2a channel was not influenced by wild type CFTR. The apparent equilibrium dissociation constant for extracellular Na+ for ASICia/2a was increased by CFTR, but CFTR had no effect on the gating behavior or acid sensitivity of ASIC1a/2a. CFTR had no effect on the pH activation of ASIC1a/2a. We conclude that wild type CFTR elevates the acid-gated Na+ current of ASIC1a/2a in part by altering the kinetics of extracellular Na+ interaction.	Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; Dartmouth Med Sch, Dept Physiol, Hanover, NH 03755 USA	University of Alabama System; University of Alabama Birmingham; Dartmouth College	Benos, DJ (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, 1918 Univ Blvd,MCLM 704, Birmingham, AL 35294 USA.	benos@physiology.uab.edu	Fuller, Cathy/B-4046-2011; JI, HONGLONG/N-7822-2014	JI, HONGLONG/0000-0002-3228-7144	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034533, R01DK056095] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK34533, DK53468, DK56095] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Awayda MS, 2000, AM J PHYSIOL-CELL PH, V279, pC1896, DOI 10.1152/ajpcell.2000.279.6.C1896; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Berdiev BK, 2001, J BIOL CHEM, V276, P38755, DOI 10.1074/jbc.M107266200; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Chabot H, 1999, J MEMBRANE BIOL, V169, P175, DOI 10.1007/s002329900529; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chan LN, 2000, BIOCHEM BIOPH RES CO, V276, P40, DOI 10.1006/bbrc.2000.3426; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Demolombe S, 1996, GENE THER, V3, P685; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Grunder S, 2000, NEUROREPORT, V11, P1607; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V245, P589, DOI 10.1006/bbrc.1998.8483; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Ji HL, 2001, AM J PHYSIOL-CELL PH, V281, pC64, DOI 10.1152/ajpcell.2001.281.1.C64; Ji HL, 2000, J BIOL CHEM, V275, P27947; Johannesson M, 1997, NEUROREPORT, V8, P535, DOI 10.1097/00001756-199701200-00031; JOHNSON LG, 1995, J CLIN INVEST, V95, P1377, DOI 10.1172/JCI117789; JOVOV B, 1995, J BIOL CHEM, V270, P29194, DOI 10.1074/jbc.270.49.29194; KNOWLES MR, 1981, NEW ENGL J MED, V341, P156; Konstas AA, 2001, PFLUG ARCH EUR J PHY, V442, P752, DOI 10.1007/s004240100597; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; Kunzelmann K, 2001, KIDNEY INT, V60, P455, DOI 10.1046/j.1523-1755.2001.060002455.x; Kunzelmann K, 2001, NEWS PHYSIOL SCI, V16, P167; Kuruma A, 2000, AM J PHYSIOL-CELL PH, V279, pC1401, DOI 10.1152/ajpcell.2000.279.5.C1401; LEAF A, 1964, AM J PHYSIOL, V207, P547, DOI 10.1152/ajplegacy.1964.207.3.547; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mall M, 1999, AM J PHYSIOL-GASTR L, V277, pG709, DOI 10.1152/ajpgi.1999.277.3.G709; Mall M, 1996, FEBS LETT, V381, P47, DOI 10.1016/0014-5793(96)00079-8; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Mall M, 1998, AM J PHYSIOL-GASTR L, V275, pG1274, DOI 10.1152/ajpgi.1998.275.6.G1274; Mulberg AE, 1998, NEUROREPORT, V9, P141, DOI 10.1097/00001756-199801050-00028; MULBERG AE, 1995, J CLIN INVEST, V96, P646, DOI 10.1172/JCI118080; MULBERG AE, 1994, NEUROREPORT, V5, P1684, DOI 10.1097/00001756-199408150-00035; Nagel G, 2001, EMBO REP, V2, P249, DOI 10.1093/embo-reports/kve045; Prabhakar NR, 2000, RESP PHYSIOL, V122, P209, DOI 10.1016/S0034-5687(00)00160-2; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; SCHWIEBERT EM, 1999, PHYSL REV S, V79, P145; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; TABCHARANI JA, 1993, NATURE, V366, P79, DOI 10.1038/366079a0; UENO S, 1992, J PHYSIOL-LONDON, V447, P309, DOI 10.1113/jphysiol.1992.sp019004; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WETSEL WC, 1993, ENDOCRINOLOGY, V132, P2360, DOI 10.1210/en.132.6.2360; Weyler RT, 1999, AM J PHYSIOL-CELL PH, V277, pC563, DOI 10.1152/ajpcell.1999.277.3.C563; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Xu ZD, 1998, GENE, V211, P117, DOI 10.1016/S0378-1119(98)00090-0	59	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8395	8405		10.1074/jbc.M109465200	http://dx.doi.org/10.1074/jbc.M109465200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11748227	hybrid			2022-12-27	WOS:000174268000099
J	Plotkin, LI; Manolagas, SC; Bellido, T				Plotkin, LI; Manolagas, SC; Bellido, T			Transduction of cell survival signals by connexin-43 hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTION PROTEIN CONNEXIN-43; FUNCTIONAL GAP-JUNCTIONS; INTERCELLULAR COMMUNICATION; TYROSINE PHOSPHORYLATION; OSTEOBLASTIC CELLS; C-SRC; V-SRC; BISPHOSPHONATES; APOPTOSIS; BONE	Bisphosphonates, drugs used widely in the treatment of bone diseases, prevent osteoblast and osteocyte apoptosis by a mechanism involving extracellular signal-regulated kinase (ERK) activation. We report herein that hexamerie connexin (Cx)-43 hemichannels, but not gap junctions, are the essential transducers of the ERK-activating/anti-apoptotic effects of bisphosphonates. Transfection of Cx-43, but not other Cxs, into Cx-43 naive cells confers de novo responsiveness to the drugs. The signal-transducing property of Cx-43 requires the pore forming as well as the C-terminal domains of the protein, the activation of both Src and ERK kinases, and the SH2 and SH3 domains of Src. This evidence adds Cx-43 to the list of transmembrane proteins capable of transducing survival signals in response to extracellular cues and raises the possibility that it may serve in this capacity for endogenously produced molecules or even other drugs.	Univ Arkansas Med Sci, Div Endocrinol & Metab, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Cent Arkanasas Vet Healthcare Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Bellido, T (corresponding author), Univ Arkansas Med Sci, Div Endocrinol & Metab, 4301 W Markham,Mail Slot 587, Little Rock, AR 72205 USA.	bellidoteresitam@uams.edu	Plotkin, Lilian/H-7188-2019	Plotkin, Lilian/0000-0002-9537-4544	NIAMS NIH HHS [KO2-AR02127, R29-AR43453] Funding Source: Medline; NIA NIH HHS [P01-AG13918] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR002127, R29AR043453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEYER EC, 1991, J BIOL CHEM, V266, P7971; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; Brumsen C, 1997, MEDICINE, V76, P266, DOI 10.1097/00005792-199707000-00005; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; Cao FL, 1998, J CELL SCI, V111, P31; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; Cotrina ML, 1998, J NEUROSCI, V18, P2520; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; DOTY SB, 1981, CALCIFIED TISSUE INT, V33, P509, DOI 10.1007/BF02409482; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Frith JC, 1997, J BONE MINER RES, V12, P1358, DOI 10.1359/jbmr.1997.12.9.1358; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Homma N, 1998, CIRC RES, V83, P27, DOI 10.1161/01.RES.83.1.27; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSMER DW, 2000, WILEY PS TX, P1; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Ilvesaro J, 2000, J BONE MINER RES, V15, P919, DOI 10.1359/jbmr.2000.15.5.919; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; Kanemitsu MY, 1997, J BIOL CHEM, V272, P22824, DOI 10.1074/jbc.272.36.22824; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Loo LWM, 1999, MOL CARCINOGEN, V25, P187, DOI 10.1002/(SICI)1098-2744(199907)25:3<187::AID-MC5>3.3.CO;2-F; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Marotti G, 1990, ITAL J MIN ELECTROL, V4, P93; Martyn KD, 1997, CELL GROWTH DIFFER, V8, P1015; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Niessen H, 2000, J CELL SCI, V113, P1365; Pfahnl A, 1999, PFLUG ARCH EUR J PHY, V437, P345, DOI 10.1007/s004240050788; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Romanello M, 2001, J BONE MINER RES, V16, P1465, DOI 10.1359/jbmr.2001.16.8.1465; Rozental R, 2001, METH MOL B, V154, P447; SARGIACOMO M, 1989, J MEMBRANE BIOL, V107, P277, DOI 10.1007/BF01871942; SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539; Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; STEINBERG TH, 1994, EMBO J, V13, P744, DOI 10.1002/j.1460-2075.1994.tb06316.x; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; van Beek E, 1999, BIOCHEM BIOPH RES CO, V264, P108, DOI 10.1006/bbrc.1999.1499; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Weinstein RS, 2000, J CLIN ENDOCR METAB, V85, P2907, DOI 10.1210/jc.85.8.2907; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Yellowley CE, 2000, J BONE MINER RES, V15, P209, DOI 10.1359/jbmr.2000.15.2.209; Zhang ZY, 2000, J BIOL CHEM, V275, P37219, DOI 10.1074/jbc.M001818200; Zhou L, 1999, J CELL BIOL, V144, P1033, DOI 10.1083/jcb.144.5.1033	57	282	295	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8648	8657		10.1074/jbc.M108625200	http://dx.doi.org/10.1074/jbc.M108625200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741942	hybrid			2022-12-27	WOS:000174268000130
J	Woo, CH; You, HJ; Cho, SH; Eom, YW; Chun, JS; Yoo, YJ; Kim, JH				Woo, CH; You, HJ; Cho, SH; Eom, YW; Chun, JS; Yoo, YJ; Kim, JH			Leukotriene B-4 stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; FACTOR-ALPHA; INDEPENDENT ACTIVATION; ARACHIDONIC-ACID; NADPH OXIDASE; RECEPTOR; NUCLEAR; TRANSLOCATION	Leukotriene B-4 is a potent chemoattractant known to be involved mainly in inflammation, immune responses, and host defense against infection, although the exact signaling mechanisms by which it exerts its effects are not well understood. Here we show that exogenous leukotriene B-4 induces reactive oxygen species (ROS) generation via a Rac-dependent pathway, and that stable expression of Rac(N17), a dominant negative Rac1 mutant, completely blocks leukotriene B-4-induced ROS generation. In addition, leukotriene B-4-induced ROS generation is selectively blocked by inhibition of ERK or cytosolic phospholipase A(2), but not p38 kinase, which is indicative of its dependence on ERK activation and synthesis of arachidonic acid. Consistent with those findings, leukotriene B-4 Rac-dependently stimulates ERK and cytosolic phospholipase A(2) activity, and transient transfection with plasmid expressing Rac(V12), a constitutively activated Rac1 mutant, also dose-dependently stimulates ERK activity. Our findings suggest that ERK and cytosolic phospholipase A(2) are situated downstream of Rac, and we conclude that Rac, ERK, and cytosolic phospholipase A(2) all play pivotal roles in mediating the ROS generation that appears to be a prerequisite for leukotriene B-4-induced chemotaxis and cell proliferation.	Korea Univ, Grad Sch Biotechnol, Sungbuk Ku, Seoul 136701, South Korea; Kwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	Korea University; Gwangju Institute of Science & Technology (GIST)	Kim, JH (corresponding author), Korea Univ, Grad Sch Biotechnol, Sungbuk Ku, 5-1 Anam Dong, Seoul 136701, South Korea.	jhongkim@korea.ac.kr	Eom, Young/AAW-4659-2021; Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208; Eom, Young Woo/0000-0002-5985-6490				Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; ARAKI R, 1995, BIOCHEM BIOPH RES CO, V210, P837, DOI 10.1006/bbrc.1995.1734; BROCK TG, 1995, J BIOL CHEM, V270, P21652, DOI 10.1074/jbc.270.37.21652; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; Devchand PR, 1999, J BIOL CHEM, V274, P23341, DOI 10.1074/jbc.274.33.23341; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Endres S, 1999, Curr Opin Clin Nutr Metab Care, V2, P117, DOI 10.1097/00075197-199903000-00004; Haribabu B, 1999, J BIOL CHEM, V274, P37087, DOI 10.1074/jbc.274.52.37087; Iversen L, 1997, SKIN PHARMACOL, V10, P169, DOI 10.1159/000211501; Kamohara M, 2000, J BIOL CHEM, V275, P27000; Kim BC, 1999, J BIOL CHEM, V274, P24372, DOI 10.1074/jbc.274.34.24372; Kim BC, 1997, BIOCHEM J, V326, P333, DOI 10.1042/bj3260333; Kim BC, 1998, MOL CELLS, V8, P90; Leff AR, 2000, AM J RESP CRIT CARE, V161, pS125, DOI 10.1164/ajrccm.161.supplement_1.ltta-25; Li YQ, 1996, J CLIN INVEST, V97, P1605, DOI 10.1172/JCI118585; Lindsay MA, 1998, J IMMUNOL, V160, P4526; Lindsay MA, 1998, J LEUKOCYTE BIOL, V64, P555, DOI 10.1002/jlb.64.4.555; Mackarel AJ, 2000, AM J RESP CELL MOL, V23, P154, DOI 10.1165/ajrcmb.23.2.3853; Martin V, 1999, J BIOL CHEM, V274, P8597, DOI 10.1074/jbc.274.13.8597; Matsukawa A, 1999, J IMMUNOL, V163, P6148; ODONNELL VB, 1995, BIOCHEM J, V310, P133, DOI 10.1042/bj3100133; OHBA M, 1994, J CELL BIOL, V126, P1079, DOI 10.1083/jcb.126.4.1079; PERKINS RS, 1995, BIOCHEM J, V310, P795, DOI 10.1042/bj3100795; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Schmidt C, 1996, HEPATO-GASTROENTEROL, V43, P1508; SCHONHARDT T, 1987, BIOCHEM BIOPH RES CO, V149, P769, DOI 10.1016/0006-291X(87)90434-7; Shindo K, 1997, THORAX, V52, P1024, DOI 10.1136/thx.52.12.1024; SUBRAMANIAN N, 1992, BIOCHEM BIOPH RES CO, V187, P670, DOI 10.1016/0006-291X(92)91247-N; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Toda A, 1999, BIOCHEM BIOPH RES CO, V262, P806, DOI 10.1006/bbrc.1999.1284; Turner CR, 1996, J CLIN INVEST, V97, P381, DOI 10.1172/JCI118426; Van Pelt JPA, 1998, BRIT J DERMATOL, V139, P396; Woo CH, 2000, BIOCHEM BIOPH RES CO, V268, P231, DOI 10.1006/bbrc.2000.2102; Woo CH, 2000, BIOCHEM J, V348, P525, DOI 10.1042/0264-6021:3480525; Woo CH, 2000, J BIOL CHEM, V275, P32357, DOI 10.1074/jbc.M005638200; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 2001, LIFE SCI, V68, P2207, DOI 10.1016/S0024-3205(01)01007-4; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200	42	94	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8572	8578		10.1074/jbc.M104766200	http://dx.doi.org/10.1074/jbc.M104766200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756405	hybrid			2022-12-27	WOS:000174268000121
J	Ben-Shabat, S; Parish, CA; Vollmer, HR; Itagaki, Y; Fishkin, N; Nakanishi, K; Sparrow, JR				Ben-Shabat, S; Parish, CA; Vollmer, HR; Itagaki, Y; Fishkin, N; Nakanishi, K; Sparrow, JR			Biosynthetic studies of A2E, a major fluorophore of retinal pigment epithelial lipofuscin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE GENE ABCR; STARGARDT MACULAR DYSTROPHY; CONE-ROD DYSTROPHY; OUTER SEGMENTS; FUNDUS FLAVIMACULATUS; RETINITIS-PIGMENTOSA; TRANSPORTER GENE; RPE CELLS; DEGENERATION; PROTEIN	We have examined questions related to the biosynthesis of A2E, a fluorophore that accumulates in retinal pigment epithelial cells with aging and in some retinal disorders. The use of in vitro preparations revealed that detectable levels of A2-PE, the A2E precursor, are formed within photoreceptor outer segments following light-induced release of endogenous all-trans-retinal. Moreover, experiments in vivo demonstrated that the formation of A2-PE in photoreceptor outer segment membrane was augmented by exposing rats to bright light. Whereas the generation of A2E from A2-PE by acid hydrolysis was found to occur very slowly, the detection in outer segments of a phosphodiesterase activity that can convert A2-PE to A2E may indicate that some portion of the A2-PE that forms in the outer segment membrane may undergo hydrolytic cleavage before internalization by the retinal pigment epithelial cell. The identities of additional minor components of retinal pigment epithelium lipofuscin, A2E isomers with cis olefins at positions other than the C13-C14 double bond, are also described.	Columbia Univ, Dept Chem, New York, NY 10028 USA; Columbia Univ, Dept Ophthalmol, New York, NY 10028 USA	Columbia University; Columbia University	Nakanishi, K (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.			Vollmer-Snarr, Heidi/0000-0002-7312-4907	NEI NIH HHS [EY 34509, EY 12951] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012951] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Andrews B, 2000, BIOCHEM BIOPH RES CO, V273, P302, DOI 10.1006/bbrc.2000.2938; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BRESSLER SB, 2000, PRINCIPLES PRACTICE, V3, P1982; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; ELDRED GE, 1988, EXP EYE RES, V47, P71, DOI 10.1016/0014-4835(88)90025-5; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; ELDRED GE, 1998, RETINAL PIGMENT EPIT, P651; ELDRED GE, 1991, RETINAL DEGENERATION, P173; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Katz ML, 1996, MECH AGEING DEV, V92, P159, DOI 10.1016/S0047-6374(96)01817-9; KATZ ML, 1986, MECH AGEING DEV, V35, P291, DOI 10.1016/0047-6374(86)90131-4; KATZ ML, 1992, INVEST OPHTH VIS SCI, V33, P2612; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; LIU RSH, 1982, METHOD ENZYMOL, V88, P506; LOPEZ PF, 1990, OPHTHALMOLOGY, V97, P798; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; RABB MF, 1986, OPHTHALMOLOGY, V93, P1443; Ren RXF, 1997, J AM CHEM SOC, V119, P3619, DOI 10.1021/ja9700414; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Salvador GA, 1998, LIPIDS, V33, P853, DOI 10.1007/s11745-998-0281-z; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Sciorra VA, 2001, BIOCHEMISTRY-US, V40, P2640, DOI 10.1021/bi002528m; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2001, INVEST OPHTH VIS SCI, V42, P1356; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Sun H, 2001, J BIOL CHEM, V276, P11766, DOI 10.1074/jbc.M010152200; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; WADDELL WH, 1977, J AM CHEM SOC, V99, P6457, DOI 10.1021/ja00461a057; WEINGEIST TA, 1982, ARCH OPHTHALMOL-CHIC, V100, P1108; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yamashita T, 2000, J BIOL CHEM, V275, P34272, DOI 10.1074/jbc.M002954200; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303	43	163	167	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7183	7190		10.1074/jbc.M108981200	http://dx.doi.org/10.1074/jbc.M108981200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11756445	hybrid			2022-12-27	WOS:000174104300057
J	Chang, YJ; Holtzman, MJ; Chen, CC				Chang, YJ; Holtzman, MJ; Chen, CC			Interferon-gamma-induced epithelial ICAM-1 expression and monocyte adhesion - Involvement of protein kinase C-dependent c-Src tyrosine kinase activation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; IFN-GAMMA; MOLECULE-1 ICAM-1; TRANSCRIPTIONAL REGULATION; INFLAMMATORY CYTOKINES; STAT3 ACTIVATION; RESPONSE ELEMENT; PHORBOL ESTER; V-SRC; GENE	Interferon-gamma (IFN-gamma) induced intercellular adhesion molecule-1 (ICAM-1) expression in human NCI-H292 epithelial cells, as shown by enzyme-linked immunosorbent assay and immunofluorescence staining. The enhanced ICAM-1 expression resulted in increased adhesion of U937 cells to NCI-H292 cells. Tyrosine kinase inhibitors (genistein or herbimycin), Sire family inhibitor (PP2), or a phosphatidylinositol-phospho-lipase C inhibitor (U73122) attenuated the IFN-gamma-induced ICAM-1 expression. Protein kinase C (PKC) inhibitors (staurosporine or Ro 31-8220) also inhibited IFN-gamma-induced response. 12-O-Tetradecanoylphorbol-13-acetate (TPA), a PKC activator, stimulated ICAM-1 expression; this effect was inhibited by tyrosine kinase or Src inhibitor. ICAM-1 promoter activity was enhanced by IFN-gamma and TPA in cells transfected with pIC339-Luc, containing the downstream NF-kappaB and gamma-activated site (GAS) sites, but not in cells transfected with GAS-deletion mutant, pIC135 (DeltaAP2). Electrophoretic gel mobility shift assay demonstrated that GAS-binding complexes in IFN-gamma-stimulated cells contained STAT1alpha. The IFN-gamma-induced ICAM-1 promoter activity was inhibited by tyrosine kinase inhibitors, a phosphatidylinositol-phospholipase C inhibitor, or PKC inhibitors, and the TPA-induced ICAM-1 promoter activity was also inhibited by tyrosine kinase inhibitors. Cotransfection with a PLC-gamma2 mutant inhibited IFN-gamma- but not TPA-induced ICAM-1 promoter activity. However, cotransfection. with dominant negative mutants of PKCalpha or c-Src inhibited both IFN-gamma- and TPA-induced ICAM-1 promoter activity. The ICAM-1 promoter activity was stimulated by cotransfection with wild type PLC-gamma2, PKCalpha, c-Src, JAK1, or STAT1. An immunocomplex kinase assay showed that both IFN-gamma and TPA activated c-Src and Lyn activities and that these effects were inhibited by staurosporine and herbimycin. Thus, in NCI-H292 epithelial cells, IFN-gamma activates PLC-gamma2 via an upstream tyrosine kinase to induce activation of PKC-alpha and c-Src or Lyn, resulting in activation of STAT1alpha, and GAS in the ICAM-1 promoter, followed by initiation of ICAM-1 expression and monocyte adhesion.	Natl Taiwan Univ, Coll Med, Dept Pharmacol, Sect 1, Taipei 10018, Taiwan; Washington Univ, Sch Med, Dept Med & Cell Biol, St Louis, MO 63110 USA	National Taiwan University; Washington University (WUSTL)	Chen, CC (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pharmacol, Sect 1, 1 Jen Ai Rd, Taipei 10018, Taiwan.		Chang, Ya-Jen/O-1584-2018	Chang, Ya-Jen/0000-0003-1377-6142; CHEN, CHING-CHOW/0000-0002-7810-0939				Aas V, 1999, CELL SIGNAL, V11, P101, DOI 10.1016/S0898-6568(98)00040-0; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; BLOEMEN PGM, 1993, AM J RESP CELL MOL, V9, P586, DOI 10.1165/ajrcmb/9.6.586; BOUILLON M, 1992, INT J CANCER, V50, P281, DOI 10.1002/ijc.2910500219; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; CALDENHOVEN E, 1994, J BIOL CHEM, V269, P21146; CARLOS T, 1991, BLOOD, V77, P2266; Chaturvedi P, 1998, ONCOGENE, V16, P1749, DOI 10.1038/sj.onc.1201972; Chen CC, 2000, J IMMUNOL, V165, P2719, DOI 10.4049/jimmunol.165.5.2719; Chen CC, 2000, MOL PHARMACOL, V58, P1479, DOI 10.1124/mol.58.6.1479; Chen CC, 2001, CELL SIGNAL, V13, P543, DOI 10.1016/S0898-6568(01)00171-1; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; DEGITZ K, 1991, J BIOL CHEM, V266, P14024; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; Farina AR, 1997, CELL GROWTH DIFFER, V8, P789; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; GREENLUND AC, 1995, IMMUNITY, V2, P677, DOI 10.1016/1074-7613(95)90012-8; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HEIM MH, 1995, SCIENCE, V258, P1808; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; LOOK DC, 1994, J BIOL CHEM, V269, P8952; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lucas DM, 1998, J IMMUNOL, V160, P4337; MATTILA P, 1993, SCAND J IMMUNOL, V38, P197, DOI 10.1111/j.1365-3083.1993.tb01713.x; MATTILA P, 1992, BIOCHEM BIOPH RES CO, V189, P1732, DOI 10.1016/0006-291X(92)90278-S; MORISAKI N, 1994, BIOCHEM BIOPH RES CO, V200, P612, DOI 10.1006/bbrc.1994.1492; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Ping PP, 1999, CIRC RES, V85, P542, DOI 10.1161/01.RES.85.6.542; READ MA, 1995, IMMUNITY, V2, P493, DOI 10.1016/1074-7613(95)90030-6; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; RENKONEN R, 1990, INT IMMUNOL, V2, P719, DOI 10.1093/intimm/2.8.719; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; SANDS WA, 1994, BIOCHEM BIOPH RES CO, V199, P461, DOI 10.1006/bbrc.1994.1251; SCHATTNER A, 1994, CLIN IMMUNOL IMMUNOP, V70, P177, DOI 10.1006/clin.1994.1027; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; TAKATA M, 1995, J EXP MED, V182, P903; Tessitore A, 1998, EUR J BIOCHEM, V258, P968, DOI 10.1046/j.1432-1327.1998.2580968.x; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185; VORABERGER G, 1991, J IMMUNOL, V147, P2777; Walter MJ, 1997, J BIOL CHEM, V272, P28582, DOI 10.1074/jbc.272.45.28582; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200	58	79	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7118	7126		10.1074/jbc.M109924200	http://dx.doi.org/10.1074/jbc.M109924200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751911	hybrid			2022-12-27	WOS:000174104300048
J	Tsunemi, T; Saegusa, H; Ishikawa, K; Nagayama, S; Murakoshi, T; Mizusawa, H; Tanabe, T				Tsunemi, T; Saegusa, H; Ishikawa, K; Nagayama, S; Murakoshi, T; Mizusawa, H; Tanabe, T			Novel Ca(v)2.1 splice variants isolated from Purkinje cells do not generate P-type Ca2+ current	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINOCEREBELLAR ATAXIA TYPE-6; NEURONAL CALCIUM CHANNELS; ALPHA(1A) SUBUNIT GENE; SYNAPTIC TRANSMISSION; BETA-SUBUNIT; PHARMACOLOGICAL PROPERTIES; FUNCTIONAL EXPRESSION; BRAIN; EXPANSIONS; FAMILIES	The alpha(1)2.1 (alpha(1A)) subunits of P-type and Q-type Ca2+ channels are encoded by a single gene, Cacnala. Although these channels differ in the inactivation kinetics and sensitivity to omega-agatoxin IVA, the mechanism underlying these differences remains to be clarified. Alternative splicings of the Cacnala transcript have been postulated to contribute to the respective properties, however, the splice variants responsible for P-type Ca2+ channels have not been identified. To explore P-typespecific splice variants, we aimed at cloning a12.1 from isolated mouse Purkinje cells using single-cell reverse transcription-PCR, because in Purkinje cells P-type currents dominate over the whole currents (>95%) with Q-type currents undetected. As a result, two novel splice variants were cloned. Compared with the previously cloned mouse alpha(1)2.1, two novel variants had additional 48 amino acids at the amino termini, six single amino acid changes, and splicing variations at the exon 46/47 boundary, which produced different carboxyl termini. Furthermore, one variant had one RNA editing site. However, electrophysiological and pharmacological studies indicated that these variants did not generate P-type current in cultured cells. These results suggest that P-type-specific splice variants may exist but that post-translational processing or modification by uncharacterized interacting proteins is also required for generating the P-type current.	Tokyo Med & Dent Univ, Grad Sch Med, Dept Pharmacol & Neurobiol, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo 1138519, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawagauchi, Saitama 3320012, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Tanabe, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Pharmacol & Neurobiol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	t-tanabe.mphm@tmd.ac.jp						Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gillard SE, 1997, NEUROPHARMACOLOGY, V36, P405, DOI 10.1016/S0028-3908(97)00046-4; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Hans M, 1999, BIOPHYS J, V76, P1384, DOI 10.1016/S0006-3495(99)77300-5; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Ishikawa K, 1997, AM J HUM GENET, V61, P336, DOI 10.1086/514867; Ishikawa K, 1999, J NEUROL NEUROSUR PS, V67, P86, DOI 10.1136/jnnp.67.1.86; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Krovetz HS, 2000, J NEUROSCI, V20, P7564; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Ligon B, 1998, J BIOL CHEM, V273, P13905, DOI 10.1074/jbc.273.22.13905; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; Matsuyama Z, 1999, J NEUROSCI, V19 RC, P1; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; MIERA EVS, 1997, P NATL ACAD SCI USA, V94, P7059; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0; Moreno H, 1997, P NATL ACAD SCI USA, V94, P14042, DOI 10.1073/pnas.94.25.14042; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pinto A, 1998, P NATL ACAD SCI USA, V95, P8328, DOI 10.1073/pnas.95.14.8328; RANDALL A, 1995, J NEUROSCI, V15, P2995; REGAN LJ, 1991, J NEUROSCI, V11, P2259; Restituito S, 2000, J NEUROSCI, V20, P6394, DOI 10.1523/JNEUROSCI.20-17-06394.2000; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Takahashi E, 1999, BIOCHEM BIOPH RES CO, V260, P54, DOI 10.1006/bbrc.1999.0857; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Toru S, 2000, J BIOL CHEM, V275, P10893, DOI 10.1074/jbc.275.15.10893; Wheeler DB, 1995, PROG BRAIN RES, V105, P65; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; ZONG ZQ, 1994, BIOCHEM BIOPH RES CO, V201, P1117, DOI 10.1006/bbrc.1994.1821	41	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7214	7221		10.1074/jbc.M108222200	http://dx.doi.org/10.1074/jbc.M108222200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11756409	hybrid			2022-12-27	WOS:000174104300061
J	Gicquiaux, H; Lecat, S; Gaire, M; Dieterlen, A; Mely, Y; Takeda, K; Bucher, B; Galzi, JL				Gicquiaux, H; Lecat, S; Gaire, M; Dieterlen, A; Mely, Y; Takeda, K; Bucher, B; Galzi, JL			Rapid internalization and recycling of the human neuropeptide YY1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-FLUORESCENT PROTEIN; NEUROBLASTOMA CELL-LINE; COATED PIT FORMATION; Y-RECEPTOR; PEPTIDE-YY; ALPHA(2)-ADRENERGIC RECEPTORS; PANCREATIC-POLYPEPTIDE; COUPLED RECEPTORS; OPIOID RECEPTOR; BETA-ARRESTIN	Desensitization of G protein-coupled receptors (GPCRs) involves receptor phosphorylation and reduction in the number of receptors at the cell surface. The neuropeptide Y (NPY) Y-1 receptor undergoes fast desensitization. We examined agonist-induced signaling and internalization using NPY Y-1 receptors fused to green fluorescent protein (EGFP). When expressed in HEK293 cells, EGFP-hNPY Y-1 receptors were localized at the plasma membrane, desensitized rapidly as assessed using calcium responses, and had similar properties compared to hNPY Y-1 receptors. Upon agonist challenge, the EGFP signal decreased rapidly (t(1/2) = 107 +/- 3 s) followed by a slow recovery. This decrease was blocked by BIBP3226, a Y-1 receptor antagonist, or by pertussis toxin, in agreement with Y-1 receptor activation. Internalization of EGFP-hNPY Y-1 receptors to acidic endosomal compartments likely accounts for the decrease in the EGFP signal, being absent after pretreatment with monensin. Concanavalin A and hypertonic sucrose, which inhibit clathrin-mediated endocytosis, blocked the decrease in fluorescence. After agonist, intracellular EGFP signals were punctate and co-localized with transferrin-Texas Red, a marker of clathrin-associated internalization and recycling, but not with LysoTracker Red, a lysosomal pathway marker, supporting receptor trafficking to recycling endosomes rather than the late endosomal/lysosomal pathway. Pulse-chase experiments revealed no receptor degradation after internalization. The slow recovery of fluorescence was unaffected by cycloheximide or actinomycin D, indicating that de novo synthesis of receptors was not limiting. Use of a multicompartment model to fit our fluorescence data allows simultaneous determination of internalization and recycling rate constants. We propose that rapid internalization of receptors via the clathrin-coated pits recycling pathway may largely account for the rapid desensitization of NPY Y-1 receptors.	Univ Louis Pasteur Strasbourg 1, Fac Pharm, Inst Fed Gilbert Laustriat, IFR 85,UMR CNRS 7034, F-67401 Illkirch Graffenstaden, France; Ecole Super Biotecnol Strasbourg, Inst Federatif Gilbert Laustriat, UPR CNRS 9050, Dept Recepteurs & Prot Membrainaires, F-67401 Illkirch Graffenstaden, France; Univ Haute Alsace, IUT Mulhouse, Lab MIPS, GRP LABEL, F-68093 Mulhouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA)	Bucher, B (corresponding author), Univ Louis Pasteur Strasbourg 1, Fac Pharm, Inst Fed Gilbert Laustriat, IFR 85,UMR CNRS 7034, 74 Route Rhin,BP 24, F-67401 Illkirch Graffenstaden, France.	bb@pharma.u-strasbg.fr						Balasubramaniam A, 1997, PEPTIDES, V18, P445, DOI 10.1016/S0196-9781(96)00347-6; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Beaumont V, 1998, J BIOL CHEM, V273, P33174, DOI 10.1074/jbc.273.50.33174; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Bohm SK, 1997, BIOCHEM J, V322, P1; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; CAILLA HL, 1973, ANAL BIOCHEM, V56, P394, DOI 10.1016/0003-2697(73)90205-4; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COX HM, 1995, BRIT J PHARMACOL, V116, P2673, DOI 10.1111/j.1476-5381.1995.tb17225.x; DAUKAS G, 1985, J CELL BIOL, V101, P1673, DOI 10.1083/jcb.101.5.1673; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Drmota T, 1998, J BIOL CHEM, V273, P24000, DOI 10.1074/jbc.273.37.24000; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Fabry M, 2000, EUR J BIOCHEM, V267, P5631, DOI 10.1046/j.1432-1327.2000.01631.x; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FUHLENDORFF J, 1990, P NATL ACAD SCI USA, V87, P182, DOI 10.1073/pnas.87.1.182; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kushi A, 1998, P NATL ACAD SCI USA, V95, P15659, DOI 10.1073/pnas.95.26.15659; Law PY, 2000, J BIOL CHEM, V275, P32057, DOI 10.1074/jbc.M002395200; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; LUNDBERG JM, 1986, PROG BRAIN RES, V68, P241, DOI 10.1016/S0079-6123(08)60242-3; LYNCH JW, 1994, J BIOL CHEM, V269, P8226; MICHEL MC, 1994, BRIT J PHARMACOL, V112, P499, DOI 10.1111/j.1476-5381.1994.tb13101.x; Michel MC, 1998, PHARMACOL REV, V50, P143; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MORIARTY M, 1993, J AUTONOM NERV SYST, V45, P21, DOI 10.1016/0165-1838(93)90358-2; Morrison KJ, 1996, MOL PHARMACOL, V50, P692; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Naveilhan P, 2001, NATURE, V409, P513, DOI 10.1038/35054063; Pak Y, 1999, J BIOL CHEM, V274, P27610, DOI 10.1074/jbc.274.39.27610; Parker SL, 2001, EUR J BIOCHEM, V268, P877, DOI 10.1046/j.1432-1327.2001.01966.x; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; ROSE PM, 1995, J BIOL CHEM, V270, P22661, DOI 10.1074/jbc.270.39.22661; SAWA T, 1995, EUR J PHARMACOL, V276, P223, DOI 10.1016/0014-2999(95)00024-F; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Teter K, 1998, J BIOL CHEM, V273, P19625, DOI 10.1074/jbc.273.31.19625; TOEWS ML, 1984, J BIOL CHEM, V259, P1844; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; VANRIPER DA, 1991, CIRC RES, V68, P568, DOI 10.1161/01.RES.68.2.568; Vohringer C, 2000, BIOCHEM PHARMACOL, V59, P791, DOI 10.1016/S0006-2952(99)00390-1; Voisin T, 2000, J PHARMACOL EXP THER, V292, P638; Vollmer JY, 1999, J BIOL CHEM, V274, P37915, DOI 10.1074/jbc.274.53.37915; WAHLESTEDT C, 1992, LIFE SCI, V50, P7; XIA J, 1992, BRIT J PHARMACOL, V107, P771, DOI 10.1111/j.1476-5381.1992.tb14522.x	58	95	97	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6645	6655		10.1074/jbc.M107224200	http://dx.doi.org/10.1074/jbc.M107224200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741903	hybrid			2022-12-27	WOS:000173989200125
J	Murphy, DM; Ivanenkov, VV; Kirley, TL				Murphy, DM; Ivanenkov, VV; Kirley, TL			Identification of cysteine residues responsible for oxidative crosslinking and chemical inhibition of human nucleoside-triphosphate diphosphohydrolase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAIN ECTO-APYRASE; E-TYPE ATPASES; FUNCTIONAL EXPRESSION; ESCHERICHIA-COLI; PROTEIN ASSAY; MUTAGENESIS; DIPHOSPHATASE; TRANSPORTER; PATHWAY; ENZYME	Cysteine-to-serine mutations were constructed to test the functional and structural significance of the three non-extracellular cysteine residues in ecto-nucleoside-triphosphate diphosphohydrolase 3 (eNTPDase3). None of these cysteines were found to be essential for enzyme activity. However, Cys(10), located on the short N-terminal cytoplasmic tail, was found to be responsible for dimer formation occurring via oxidation during membrane preparation as well as for dimer cross-linking resulting from exogenously added sulfhydryl-specific cross-linking agents. The resistance to further crosslinking of these dimers into higher order oligomers by lysine-specific cross-linkers suggests that this enzyme may form its native tetrameric structure as a "dimer of dimers" with nonequivalent interactions between subunits. Cys(501), located in the hydrophobic C-terminal membrane-spanning domain of eNTPDase3, was found to be the site of chemical modification by a sulfhydryl-specific reagent, p-chloromercuriphenylsulfonic acid (pCMPS), leading to inhibition of enzyme activity. The effect of pCMPS was negligible after dissociation of the enzyme into monomers by Triton X-100, suggesting that the mechanism of inhibition is dependent on the oligomeric structure. Because Cys(501) is accessible for modification by the membrane-impermeant reagent pCMPS, we hypothesize that eNTPDase3 (and possibly other eNTPDases) contains a water-filled crevice allowing access of water and hydrophilic compounds to at least part of the protein's C-terminal membrane-spanning helix.	Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Kirley, TL (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, 231 Albert Sabin Way,POB 670575, Cincinnati, OH 45267 USA.	terry.kirley@uc.edu		Kirley, Terence/0000-0002-6211-1414	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059915] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bragg PD, 2000, ARCH BIOCHEM BIOPHYS, V380, P141, DOI 10.1006/abbi.2000.1923; Braun N, 2000, BIOCHEM J, V351, P639, DOI 10.1042/0264-6021:3510639; Caldwell CC, 1999, ARCH BIOCHEM BIOPHYS, V362, P46, DOI 10.1006/abbi.1998.1008; Caldwell CC, 2001, ARCH BIOCHEM BIOPHYS, V387, P107, DOI 10.1006/abbi.2000.2216; Chadwick BP, 1998, GENOMICS, V50, P357, DOI 10.1006/geno.1998.5317; Ding PZ, 2001, BIOCHEMISTRY-US, V40, P5506, DOI 10.1021/bi002761k; Fiske CH, 1925, J BIOL CHEM, V66, P375; Hicks-Berger CA, 2000, J BIOL CHEM, V275, P34041, DOI 10.1074/jbc.M004723200; Hicks-Berger CA, 2000, IUBMB LIFE, V50, P43; Hicks-Berger CA, 2001, BBA-PROTEIN STRUCT M, V1547, P72, DOI 10.1016/S0167-4838(01)00176-5; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; KIRLEY TL, 1988, J BIOL CHEM, V263, P12682; Kirley TL, 2001, ARCH BIOCHEM BIOPHYS, V395, P94, DOI 10.1006/abbi.2001.2570; Koziak K, 2000, J BIOL CHEM, V275, P2057, DOI 10.1074/jbc.275.3.2057; Mulero JJ, 2000, BIOCHEMISTRY-US, V39, P12924, DOI 10.1021/bi000960y; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; PLESNER L, 1995, INT REV CYTOL, V158, P141; SHI X, 1994, ARCH BIOCHEM BIOPHYS, V35, P177; Smith TM, 1999, BIOCHEMISTRY-US, V38, P1509, DOI 10.1021/bi9821768; Smith TM, 1999, BIOCHEMISTRY-US, V38, P5849, DOI 10.1021/bi990171k; Smith TM, 1998, BBA-PROTEIN STRUCT M, V1386, P65, DOI 10.1016/S0167-4838(98)00063-6; Smith TM, 1999, BIOCHEMISTRY-US, V38, P321, DOI 10.1021/bi9820457; STOSCHECK CM, 1990, ANAL BIOCHEM, V184, P111, DOI 10.1016/0003-2697(90)90021-Z; STOSCHECK CM, 1987, ANAL BIOCHEM, V160, P301, DOI 10.1016/0003-2697(87)90051-0; Stout JG, 1996, BIOCHEMISTRY-US, V35, P8289, DOI 10.1021/bi960563g; Wang TF, 1998, J BIOL CHEM, V273, P24814, DOI 10.1074/jbc.273.38.24814; Williams DB, 2000, MOL PHARMACOL, V58, P1129, DOI 10.1124/mol.58.5.1129; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Yang F, 2001, BIOCHEMISTRY-US, V40, P3943, DOI 10.1021/bi002711f; Yeung G, 2000, BIOCHEMISTRY-US, V39, P12916, DOI 10.1021/bi000959z; ZIMMERMANN H, 1999, 2 INT WORKSH ECT ATP, P1	32	23	23	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6162	6169		10.1074/jbc.M110105200	http://dx.doi.org/10.1074/jbc.M110105200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748229	hybrid			2022-12-27	WOS:000173989200063
J	Numakawa, T; Yamagishi, S; Adachi, N; Matsumoto, T; Yokomaku, D; Yamada, M; Hatanaka, H				Numakawa, T; Yamagishi, S; Adachi, N; Matsumoto, T; Yokomaku, D; Yamada, M; Hatanaka, H			Brain-derived neurotrophic factor-induced potentiation of Ca2+ oscillations in developing cortical neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; INDUCED SYNAPTIC POTENTIATION; CEREBELLAR GRANULE NEURONS; BDNF MESSENGER-RNA; GLUTAMATE TRANSPORTER; NEOCORTICAL DEVELOPMENT; SIGNAL-TRANSDUCTION; CALCIUM REGULATION; VISUAL-CORTEX	Brain-derived neurotrophic factor (BDNF) has been reported to exert an acute potentiation of synaptic activity. Here we examined the action of BDNF on synchronous spontaneous Ca2+ oscillations in cultured cerebral cortical neurons prepared from postnatal 2-3-dayold rats. The synchronous spontaneous Ca2+ oscillations began at approximately DIV5. It was revealed that voltage-dependent Ca2+ channels and ionotropic glutamate receptors were involved in the synchronous spontaneous oscillatory activity. BDNF potentiated the frequency of these oscillations. The BDNT-potentiated activity reached 207 +/- 20.1% of basal oscillatory activity. NT-3 and NT-4/5 also induced the potentiation. However, nerve growth factor did not. We examined the correlation between BDNF-induced glutamate release and the BDNF-potentiated oscillatory activity. Both up-regulation of phospholipase, C-gamma (PLC-gamma) expression and the BDNF-induced glutamate release occurred at approximately DIV 5 when the BDNF-potentiated oscillations appeared. We confirmed that the BDNF-induced glutamate release occurred through a glutamate transporter that was dependent on the PLC-gamma/IP3/Ca2+ pathway. Transporter inhibitors blocked the BDNF-potentiated oscillations, demonstrating that BDNF enhanced the glutamatergic transmissions in the developing cortical network by inducing glutamate release via a glutamate transporter.	Osaka Univ, Inst Prot Res, Div Prot Biosynth, Suita, Osaka 5650871, Japan	Osaka University	Numakawa, T (corresponding author), Osaka Univ, Inst Prot Res, Div Prot Biosynth, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	numakawa@protein.osaka-u.ac.jp		Adachi, Naoki/0000-0002-4850-1467				Akaneya Y, 1997, J NEUROSCI, V17, P6707; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FAVARON M, 1993, NEUROREPORT, V4, P1171; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Flint AC, 1999, P NATL ACAD SCI USA, V96, P12144, DOI 10.1073/pnas.96.21.12144; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gaspary HL, 1998, J NEUROPHYSIOL, V80, P270, DOI 10.1152/jn.1998.80.1.270; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; GWAG BJ, 1993, NEUROREPORT, V5, P125, DOI 10.1097/00001756-199311180-00007; HATANAKA H, 1988, DEV BRAIN RES, V39, P85, DOI 10.1016/0165-3806(88)90069-7; JIN WZ, 1994, BRAIN RES, V642, P237, DOI 10.1016/0006-8993(94)90927-X; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kanai Y, 1995, NEUROREPORT, V6, P2357, DOI 10.1097/00001756-199511270-00020; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Kandler K, 1998, J NEUROSCI, V18, P1419; Kaneko T, 1995, J NEUROSCI, V15, P8362; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Katsumori H, 1999, BRAIN RES, V819, P160, DOI 10.1016/S0006-8993(98)01352-3; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Numakawa T, 1999, BRAIN RES, V842, P431, DOI 10.1016/S0006-8993(99)01867-3; Numakawa T, 2001, J NEUROSCI RES, V66, P96, DOI 10.1002/jnr.1201; Owens DF, 1996, J NEUROSCI, V16, P6414; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Reiners JJ, 1998, MOL PHARMACOL, V53, P438, DOI 10.1124/mol.53.3.438; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sakai N, 1997, BRAIN RES, V778, P318, DOI 10.1016/S0006-8993(97)01052-4; Sherwood NT, 1999, J NEUROSCI, V19, P7025, DOI 10.1523/JNEUROSCI.19-16-07025.1999; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Takei N, 1998, J BIOL CHEM, V273, P27620, DOI 10.1074/jbc.273.42.27620; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; YANO H, 1995, BIOCHEM J, V312, P145, DOI 10.1042/bj3120145; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	58	75	80	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6520	6529		10.1074/jbc.M109139200	http://dx.doi.org/10.1074/jbc.M109139200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741947	hybrid			2022-12-27	WOS:000173989200109
J	Sharkov, NA; Cai, DY				Sharkov, NA; Cai, DY			Discovery of substrate for type I signal peptidase SpsB from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI LEADER PEPTIDASE; ESCHERICHIA-COLI; CLEAVAGE SITES; RAPID IDENTIFICATION; NEURAL NETWORKS; SEQUENCES; SPECIFICITY; SELECTION; PRECURSOR; MECHANISM	Based on the kinetic model of substrate phage proteolysis, we have formulated a strategy for best manipulating the conditions in screening phage display libraries for protease substrates (Sharkov, N. A., Davis, R. M., Reidhaar-Olson, J. F., Navre, M., and Cai, D. (2001) J. Biol. Chem. 276, 10788-10793). This strategy is exploited in the present study with signal peptidase SpsB from Staphylococcus aureus. We demonstrate that highly active substrate phage clones can be isolated from a phage display library by systematically tuning the selection stringency in screening. Several of the selected clones exhibit superior reactivity over a control, the best clone, SIIIRIII-8, showing >100-fold improvement. Because no conserved sequence features were readily revealed that could allow delineation of the active and unreactive clones, the sequences identified in five of the active clones were tested as synthetic dodecamers, Ac-AGX(8)GA-NH2. Using electrospray ionization mass spectrometry, we show that four of these peptides can be cleaved by SpsB and that Ala is the P1 residue exclusively and Ala or Leu the P3 residue, in keeping with the (-3, -1) rule for substrate recognition by signal peptidase. Our successful screening with SpsB demonstrated the general applicability of the screening strategy and allowed us to isolate the first peptide substrates for the enzyme.	Aggymax Res Inst, Palo Alto, CA 94304 USA		Cai, DY (corresponding author), Signature BioSci Inc, 21124 Cabot Blvd, Hayward, CA 94545 USA.	dcai@telik.com						Carlos JL, 2000, J BIOL CHEM, V275, P38813, DOI 10.1074/jbc.M007093200; CHATTERJEE S, 1995, J MOL BIOL, V245, P311, DOI 10.1006/jmbi.1994.0025; Coombs GS, 1998, CHEM BIOL, V5, P475, DOI 10.1016/S1074-5521(98)90004-7; Cregg KM, 1996, J BACTERIOL, V178, P5712, DOI 10.1128/jb.178.19.5712-5718.1996; DATE T, 1983, J BACTERIOL, V154, P76, DOI 10.1128/JB.154.1.76-83.1983; DEV IK, 1990, J BIOL CHEM, V265, P20069; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; KUHN A, 1985, J BIOL CHEM, V260, P5914; KUO D, 1994, BIOCHEMISTRY-US, V33, P8347, DOI 10.1021/bi00193a023; KUO DW, 1993, ARCH BIOCHEM BIOPHYS, V303, P274, DOI 10.1006/abbi.1993.1283; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 2000, PHARMACOL THERAPEUT, V87, P27, DOI 10.1016/S0163-7258(00)00064-4; PALZKILL T, 1994, J BACTERIOL, V176, P563, DOI 10.1128/jb.176.3.563-568.1994; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Rosse G, 2000, J COMB CHEM, V2, P461, DOI 10.1021/cc000019y; SCHNEIDER G, 1994, BIOPHYS J, V66, P335, DOI 10.1016/S0006-3495(94)80782-9; Sharkov NA, 2001, J BIOL CHEM, V276, P10788, DOI 10.1074/jbc.M011772200; SHEN LM, 1991, BIOCHEMISTRY-US, V30, P11775, DOI 10.1021/bi00115a006; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Stein RL, 2000, BIOCHEMISTRY-US, V39, P7973, DOI 10.1021/bi000352i; TALARICO TL, 1993, BIOCHEM BIOPH RES CO, V197, P1154, DOI 10.1006/bbrc.1993.2598; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wrede P, 1998, BIOCHEMISTRY-US, V37, P3588, DOI 10.1021/bi9726032; Zhang YB, 1997, GENE, V194, P249, DOI 10.1016/S0378-1119(97)00198-4	27	4	6	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5796	5803		10.1074/jbc.M106849200	http://dx.doi.org/10.1074/jbc.M106849200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741926	hybrid			2022-12-27	WOS:000173989200015
J	Tice, DA; Soloviev, I; Polakis, P				Tice, DA; Soloviev, I; Polakis, P			Activation of the Wnt pathway interferes with serum response element-driven transcription of immediate early genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOMATOUS POLYPOSIS-COLI; TUMOR-SUPPRESSOR PROTEIN; F-BOX PROTEIN; BETA-CATENIN; C-FOS; GROWTH-FACTORS; BINDING PROTEIN; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; TERNARY COMPLEX	Mutational activation of the Wnt signaling pathway is a common early event in colorectal tumorigenesis, and the identification of target genes regulated by this pathway will provide a better understanding of tumor progression. Gene expression profiling on oligonucleotide microarrays revealed reduced expression of the immediate early genes fos and fosB following stimulation of cells by Wnt-1. Further analysis demonstrated that serum or 12-O-tetradecanoylphorbol-13-acetate activation of several immediate early genes including fos, fosB, junB, and egr1 was inhibited by Wnt signaling. Wnt signaling inhibited transcriptional activation driven by the serum response element without altering the activation of the extracellular signal-regulated kinase cascade or ternary complex formation at the fos serum response element promoter. The Wnt-mediated repression of cFos, FosB, and JunB expression was consistent with a decrease in their binding to an AP-1 promoter element and decreased target gene transcription. The expression of fos, fosB, junB, and egrl was also repressed in human colon tumors relative to patient matched normal tissue. By contrast, the fos family member fra-1 was up-regulated in the human colon tumors, suggesting a compensatory mechanism for the reduction in fos and fosB expression. The results indicate that Wnt signaling can repress the expression of certain immediate early genes, and that this effect is consistent with changes in gene expression observed in human colorectal tumors.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Polakis, P (corresponding author), Genentech Inc, Dept Mol Oncol, DNA Way,MS 40, San Francisco, CA 94080 USA.	ppolakis@gene.com						Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; GACK S, 1994, J BIOL CHEM, V269, P10363; Giarre M, 1998, ANN NY ACAD SCI, V857, P43, DOI 10.1111/j.1749-6632.1998.tb10106.x; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; Gruda MC, 1996, ONCOGENE, V12, P2177; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; JOHANSEN FE, 1995, BBA-REV CANCER, V1242, P1, DOI 10.1016/0304-419X(94)00014-S; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Kim DW, 1998, MOL CELL BIOL, V18, P3310, DOI 10.1128/MCB.18.6.3310; Kim HJ, 1998, J BIOL CHEM, V273, P28564, DOI 10.1074/jbc.273.44.28564; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; MALIK RK, 1991, J BIOL CHEM, V266, P8576; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MCMAHON SB, 1995, MOL CELL BIOL, V15, P1086; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Sealy L, 1997, MOL CELL BIOL, V17, P1744, DOI 10.1128/MCB.17.3.1744; Szeto W, 2001, CANCER RES, V61, P4197; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; THOMPSON MJ, 1994, J BIOL CHEM, V269, P21127; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	65	47	47	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6118	6123		10.1074/jbc.M111255200	http://dx.doi.org/10.1074/jbc.M111255200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751871	hybrid			2022-12-27	WOS:000173989200057
J	Matsushita, H; Takenaka, M; Ogawa, H				Matsushita, H; Takenaka, M; Ogawa, H			Porcine pancreatic alpha-amylase shows binding activity toward N-linked oligosaccharides of glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL MALTASE-GLUCOAMYLASE; SECRETORY GRANULE; PLANT-LECTINS; GLYCOSYLATION; PROTEINS; INHIBITOR; SURFACE; CELLS; GUT; PH	Porcine pancreatic alpha-amylase was shown by interaction analyses using a resonance mirror detector and alpha-amylase-immobilized Sepharose to bind with glycoproteins possessing N-glycans but not O-linked mucin-type glycans. Direct binding of three types of N-glycans to the alpha-amylase was demonstrated by surface plasmon resonance. Binding with biotin-polymer sugar probes revealed that the alpha-amylase has affinity to alpha-mannose, alpha-N-acetylneuraminic acid, and beta-N-acetyllactosamine, which are components of N-glycans. The binding of glycoproteins or carbohydrates enhanced the enzyme activity, indicating that the recognition site for N-glycans is different from its catalytic site. The binding activity was unique to porcine pancreatic alpha-amylase and was not observed for alpha-amylase from saliva, wheat, and fungus.	Ochanomizu Univ, Grad Sch Humanities & Sci, Course Adv Biosci, Bunkyo Ku, Tokyo 1128610, Japan	Ochanomizu University	Ogawa, H (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Course Adv Biosci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.							ABRAMENKO IV, 1992, FEBS LETT, V307, P283, DOI 10.1016/0014-5793(92)80696-E; BEAUPOILABADIE B, 1973, BIOCHIM BIOPHYS ACTA, V297, P436, DOI 10.1016/0304-4165(73)90090-1; BERNFELD P, 1951, ADV ENZYMOL REL S BI, V12, P379; BOVINE NV, 1993, GLYCOCONJ J, V10, P42; BOWMAN DE, 1945, SCIENCE, V102, P358, DOI 10.1126/science.102.2649.358; CHRISPEELS MJ, 1991, PLANT CELL, V3, P1, DOI 10.1105/tpc.3.1.1; Colomer V, 1996, J BIOL CHEM, V271, P48, DOI 10.1074/jbc.271.1.48; FISH BC, 1991, J AGR FOOD CHEM, V39, P727, DOI 10.1021/jf00004a021; ISHIKAWA K, 1993, BIOCHEMISTRY-US, V32, P6259, DOI 10.1021/bi00075a020; ITO Y, 1985, J BIOCHEM, V97, P1689, DOI 10.1093/oxfordjournals.jbchem.a135227; KITAGAKIOGAWA H, 1986, EUR J BIOCHEM, V161, P779, DOI 10.1111/j.1432-1033.1986.tb10507.x; LEBLOND FA, 1993, BIOCHEM J, V291, P289, DOI 10.1042/bj2910289; Liener IE, 1986, LECTINS PROPERTIES F, P527; MIRKOV TE, 1994, PLANT MOL BIOL, V26, P1103, DOI 10.1007/BF00040692; MORENO J, 1989, P NATL ACAD SCI USA, V86, P7885, DOI 10.1073/pnas.86.20.7885; NAIM HY, 1988, J BIOL CHEM, V263, P19709; Nichols BL, 1998, J BIOL CHEM, V273, P3076, DOI 10.1074/jbc.273.5.3076; Powers J. R., 1977, Journal of Food Biochemistry, V1, P239, DOI 10.1111/j.1745-4514.1978.tb00184.x; PUSZTAI A, 1995, GLYCOCONJUGATE J, V12, P22, DOI 10.1007/BF00731865; PUSZTAI A, 1993, EUR J CLIN NUTR, V47, P691; Pusztai A, 1996, TRENDS GLYCOSCI GLYC, V8, P149, DOI 10.4052/tigg.8.149; ROTH J, 1987, BIOCHIM BIOPHYS ACTA, V906, P405, DOI 10.1016/0304-4157(87)90018-9; ROTH J, 1993, HISTOCHEM J, V25, P687; Schmidt K, 2001, J BIOL CHEM, V276, P14315, DOI 10.1074/jbc.M006221200; SGARBIERI VC, 1982, ADV FOOD RES, V28, P93; THOMPSON LU, 1988, FOOD TECHNOL-CHICAGO, V42, P123; Uchibori-Iwaki H, 2000, GLYCOBIOLOGY, V10, P865, DOI 10.1093/glycob/10.9.865; Ueda H, 1999, FEBS LETT, V448, P75, DOI 10.1016/S0014-5793(99)00334-8; YOU XM, 1992, J AGR FOOD CHEM, V40, P638, DOI 10.1021/jf00016a023	29	28	30	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4680	4686		10.1074/jbc.M105877200	http://dx.doi.org/10.1074/jbc.M105877200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741899	hybrid			2022-12-27	WOS:000173962900019
J	Mendrola, JM; Berger, MB; King, MC; Lemmon, MA				Mendrola, JM; Berger, MB; King, MC; Lemmon, MA			The single transmembrane domains of ErbB receptors self-associate in cell membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; TYROSINE KINASE-ACTIVITY; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; EGF RECEPTOR; NEU ONCOGENE; HELIX ASSOCIATION; POINT MUTATION; BINDING-DOMAIN; H-2 NMR	Members of the epidermal growth factor receptor, or ErbB, family of receptor tyrosine kinases have a single transmembrane (TM) alpha-helix that is usually assumed to play a passive role in ligand-induced dimerization and activation of the receptor. However, recent studies with the epidermal growth factor receptor (ErbB1) and the erythropoietin receptor have indicated that interactions between TM alpha-helices do contribute to stabilization of ligand-independent and/or ligand-induced receptor dieters. In addition, not all of the expected ErbB receptor ligand-induced dimerization events can be recapitulated using isolated extracellular domains, suggesting that other regions of the receptor, such as the TM domain, may contribute to dimerization in vivo. Using an approach for analyzing TM domain interactions in Escherichia coli cell membranes, named TOXCAT, we find that the TM domains of ErbB receptors self-associate strongly in the absence of their extracellular domains, with the rank order ErbB4-TM > ErbB1-TM approximate to ErbB2-TM > ErbB3-TM. A limited mutational analysis suggests that dimerization of these TM domains involves one or more GXXXG motifs, which occur frequently in the TM domains of receptor tyrosine kinases and are critical for stabilizing the glycophorin A TM domain dimer. We also analyzed the effect of the valine to glutamic acid mutation in ErbB2 that constitutively activates this receptor. Contrary to our expectations, this mutation reduced rather than increased ErbB2-TM dimerization. Our findings suggest a role for TM domain interactions in ErbB receptor function, possibly in stabilizing inactive ligand-independent receptor dimers that have been observed by several groups.	Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809C, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Johnson Res Fdn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809C, 422 Curie Blvd, Philadelphia, PA 19104 USA.			Berger, Mitchell/0000-0002-4152-1537; Lemmon, Mark/0000-0002-3379-5319	NCI NIH HHS [R01-CA79992, R01 CA079992] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA079992] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BORMANN BJ, 1989, J BIOL CHEM, V264, P4033; BROWN PM, 1994, EUR J BIOCHEM, V225, P223, DOI 10.1111/j.1432-1033.1994.00223.x; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; CAO H, 1992, EMBO J, V11, P923, DOI 10.1002/j.1460-2075.1992.tb05131.x; CARPENTER CD, 1991, J BIOL CHEM, V266, P5750; Chen LI, 1997, J CELL BIOL, V137, P619, DOI 10.1083/jcb.137.3.619; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HORAN T, 1995, J BIOL CHEM, V270, P24604, DOI 10.1074/jbc.270.41.24604; HURWITZ DR, 1991, J BIOL CHEM, V266, P22035; Jones DH, 1997, BIOCHEMISTRY-US, V36, P12616, DOI 10.1021/bi970547z; Jones DH, 2000, BIOCHEMISTRY-US, V39, P1870, DOI 10.1021/bi992495e; KASHLES O, 1988, P NATL ACAD SCI USA, V85, P9567, DOI 10.1073/pnas.85.24.9567; KOLMAR H, 1995, EMBO J, V14, P3895, DOI 10.1002/j.1460-2075.1995.tb00061.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; LAX I, 1991, J BIOL CHEM, V266, P13828; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; LEMMON MA, 1993, THESIS YALE U NEW HA; LOFTS FJ, 1993, ONCOGENE, V8, P2813; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Melnyk RA, 2001, BIOCHEMISTRY-US, V40, P11106, DOI 10.1021/bi010642e; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mingarro I, 1996, PROTEIN SCI, V5, P1339, DOI 10.1002/pro.5560050712; Mingarro I, 1997, J MOL BIOL, V272, P633, DOI 10.1006/jmbi.1997.1276; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Morrow MR, 2000, BIOPHYS J, V79, P2024, DOI 10.1016/S0006-3495(00)76450-2; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SEGATTO O, 1988, MOL CELL BIOL, V8, P5570, DOI 10.1128/MCB.8.12.5570; Sharpe S, 2000, BIOCHEMISTRY-US, V39, P6572, DOI 10.1021/bi000038o; Smith J.A., 2000, CURRENT PROTOCOLS MO; STERNBERG MJE, 1990, PROTEIN ENG, V3, P245, DOI 10.1093/protein/3.4.245; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; Tanner KG, 1999, J BIOL CHEM, V274, P35985, DOI 10.1074/jbc.274.50.35985; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang C, 2000, J BIOL CHEM, V275, P16155, DOI 10.1074/jbc.M000723200; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	55	257	272	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4704	4712		10.1074/jbc.M108681200	http://dx.doi.org/10.1074/jbc.M108681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741943	hybrid			2022-12-27	WOS:000173962900022
J	Miyakawa, T; Obaru, K; Maeda, K; Harada, S; Mitsuya, H				Miyakawa, T; Obaru, K; Maeda, K; Harada, S; Mitsuya, H			Identification of amino acid residues critical for LD78 beta, a variant of human macrophage inflammatory protein-1 alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TONSILLAR LYMPHOCYTES; CHEMOKINE RECEPTOR CXCR4; NON-ALLELIC VARIANT; HIV-1 ENTRY; MONONUCLEAR PHAGOCYTES; ANTI-HIV-1 ACTIVITY; TUMOR PROMOTER; GP120 BINDING; MIP-1-ALPHA; POTENT	In an attempt to determine which amino acid(s) of LD78beta, a variant of human macrophage inflammatory protein-1alpha, plays a critical role in the interaction with CCR5, we generated six LD78beta variants with an amino acid substituted to Ala at the NH2 terminus of LD78beta. There was no significant difference in eliciting Ca2+ flux and chemotaxis among the variants with the exception of LD78beta(T9A) showing a substantially reduced activity. The comparative order for human immunodeficiency virus type 1 (HIV-1) replication inhibition was: LD78beta(P8A) > LD78beta(D6A) > LD78beta(WT), LD78beta(L3A) > LD78beta(T7A), LD78beta(P2A) > LD78beta(T9A). In binding inhibition assays of LD78beta variants using 2D7 monoclonal antibody and I-125-labeled macrophage inflammatory protein-la, the comparative order was: LD78beta(P8A), LD78beta(D6A) > LD78beta(WT) > LD78beta(L3A) > LD78beta(T7A) > LD78beta(T9A), LD78beta(P2A). The order for CCR5 down-regulation induction was comparable to that for binding inhibition. The present data suggest that Pro-2, Asp-6, Pro-8, and Thr-9 are critical for LD78beta binding to CCR5 and HIV-1 replication inhibition, and that LD78beta binding to CCR5, regardless of affinity, is sufficient for the initial signal transduction of LD78beta, whereas the greater anti-HIV-1 activity requires the greater magnitude of binding. The data also suggest that LD78beta variants with appropriate amino acid substitution(s) such as LD78beta(D6A) and LD78beta(P8A) may represent effective chemokine-based anti-HIV-1 therapeutics while preserving LD78beta-CCR5 interactions.	Kumamoto Univ, Sch Med, Dept Internal Med 2, Kumamoto 8600811, Japan; NCI, NIH, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA	Kumamoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mitsuya, H (corresponding author), Kumamoto Univ, Sch Med, Dept Internal Med 2, 1-1-1 Honjo, Kumamoto 8600811, Japan.		Maeda, Kenji/B-7708-2019	Maeda, Kenji/0000-0002-9424-1491				Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berson JF, 1996, J VIROL, V70, P6288, DOI 10.1128/JVI.70.9.6288-6295.1996; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EBINA T, 1990, JPN J CANCER RES, V81, P1307, DOI 10.1111/j.1349-7006.1990.tb02695.x; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Leland D. S., 1988, LAB DIAGNOSIS INFECT, P39, DOI [10.1007/978-1-4612-3900-0_3, DOI 10.1007/978-1-4612-3900-0_3]; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Maeda K, 2001, J BIOL CHEM, V276, P35194, DOI 10.1074/jbc.M105670200; Maeda Y, 2000, J VIROL, V74, P1787, DOI 10.1128/JVI.74.4.1787-1793.2000; Menten P, 1999, J CLIN INVEST, V104, pR1, DOI 10.1172/JCI7318; Newton-Nash DK, 1999, J IMMUNOL, V163, P682; Nibbs RJB, 1999, J BIOL CHEM, V274, P17478, DOI 10.1074/jbc.274.25.17478; OBARU K, 1989, MOL IMMUNOL, V26, P423; OBARU K, 1986, J BIOCHEM-TOKYO, V99, P885, DOI 10.1093/oxfordjournals.jbchem.a135549; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Proost P, 2000, BLOOD, V96, P1674, DOI 10.1182/blood.V96.5.1674.h8001674a_1674_1680; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Townson JR, 2000, J BIOL CHEM, V275, P39254, DOI 10.1074/jbc.M006768200; WOITAS RP, 2001, 8 C RETR OPP INF CHI, P499; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Xin XM, 1999, FEBS LETT, V457, P219, DOI 10.1016/S0014-5793(99)01035-2; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	41	14	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4649	4655		10.1074/jbc.M109198200	http://dx.doi.org/10.1074/jbc.M109198200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11734558	hybrid			2022-12-27	WOS:000173962900015
J	Park, SH; Lee, SR; Kim, BC; Cho, EA; Patel, SP; Kang, HB; Sausville, EA; Nakanishi, O; Trepel, JB; Lee, BI; Kim, SJ				Park, SH; Lee, SR; Kim, BC; Cho, EA; Patel, SP; Kang, HB; Sausville, EA; Nakanishi, O; Trepel, JB; Lee, BI; Kim, SJ			Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT-BINDING-FACTOR; TGF-BETA; MICROSATELLITE INSTABILITY; CHROMATIN STRUCTURE; DNA-BINDING; IN-VIVO; ACETYLATION; REPRESSION; PROMOTER; ACTIVATION	Transcriptional repression of the transforming growth factor-beta (TGF-beta) type II receptor (TbetaRII) gene is one of several mechanisms leading to TGF-beta resistance. Previously, we have shown that MS-275, a synthetic inhibitor of histone deacetylase (HDAC), specifically induces the expression of the TbetaRII gene and restores the TGF-beta signaling in human breast cancer cell lines. However, little is known about the mechanism by which inhibition of HDAC activates TbetaRII expression. MS-275 treatment of cells expressing a wild-type TbetaRII promoter/luciferase construct resulted in a 10-fold induction of the promoter activity. DNA transfection and an electrophoretic mobility shift assay showed that the induction of the TbetaRII promoter by MS-275 requires the inverted CCAAT box and its cognate binding protein, NF-Y. In addition, a DNA affinity pull-down assay indicated that the PCAF protein, a transcriptional coactivator with intrinsic histone acetyltransferase (HAT) activity, is specifically recruited to the NF-Y complex in the presence of either MS-275 or trichostatin A. Based on these results, we suggest that treatment with the HDAC inhibitor induces TbetaRII promoter activity by the recruitment of the PCAF protein to the NF-Y complex, interacting with the inverted CCAAT box in the TbetaRII promoter.	NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; NCI, Dev Therapeut Program, NIH, Bethesda, MD 20892 USA; NCI, Med Branch, NIH, Bethesda, MD 20892 USA; Natl Canc Ctr, Div Basic Sci, Goyang Si 411764, Gyeongi Do, South Korea; Mitsui Pharmaceut, Chiba 2970017, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Cancer Center - Korea (NCC)	Kim, SJ (corresponding author), NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA.			Kang, Hee-Bum/0000-0002-3781-6893				Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Bartsch J, 1996, P NATL ACAD SCI USA, V93, P10741, DOI 10.1073/pnas.93.20.10741; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; Kim DH, 1997, J BIOL CHEM, V272, P688; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Lee BI, 2001, CANCER RES, V61, P931; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; MAITY SN, 1992, J BIOL CHEM, V267, P16574; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MISSERO C, 1991, P NATL ACAD SCI USA, V88, P3489, DOI 10.1073/pnas.88.8.3489; MYEROFF LL, 1995, CANCER RES, V55, P5545; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11576, DOI 10.1073/pnas.91.24.11576; PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265; PARK KC, 1994, P NATL ACAD SCI USA, V91, P8772, DOI 10.1073/pnas.91.19.8772; Park SH, 2001, ONCOGENE, V20, P1235, DOI 10.1038/sj.onc.1204227; Park SH, 2001, CELL GROWTH DIFFER, V12, P9; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Sasaki S, 1999, EMBO J, V18, P5389, DOI 10.1093/emboj/18.19.5389; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; SUN LZ, 1994, J BIOL CHEM, V269, P26449; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	34	72	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5168	5174		10.1074/jbc.M106451200	http://dx.doi.org/10.1074/jbc.M106451200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11744689	hybrid			2022-12-27	WOS:000173962900081
J	Zentrich, E; Han, SY; Pessoa-Brandao, L; Butterfield, L; Heasley, LE				Zentrich, E; Han, SY; Pessoa-Brandao, L; Butterfield, L; Heasley, LE			Collaboration of JNKs and ERKs in nerve growth factor regulation of the neurofilament light chain promoter in PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; JUN NH2-TERMINAL KINASE; N-TERMINAL KINASE; FACTOR INDUCES TRANSCRIPTION; C-JUN; NEURONAL DIFFERENTIATION; GENE-EXPRESSION; MAP KINASE; SIGNALING PATHWAYS; INDUCTION	Nerve growth factor (NGF) induces transcription-dependent neural differentiation of PC12 cells, and the ERK family of MAPKs has been implicated as the dominant signal pathway that mediates this response. We employed a neurofilament light chain (NFLC) promoter-luciferase (NFLC-Luc) reporter to define the role of the ERKs as well as additional MAPK pathways in NGF induction of this neural specific gene. Constitutive active forms of c-Raf-1, MEKK1 and MKK6, proximal regulators of the ERKs, JNKs, and p38 MAPKs, respectively, all stimulated NFLC-Luc activity. NFLC-Luc activity stimulated by NGF, however, was partially (similar to50%) inhibited by the MEK inhibitor, PD098059, or by co-transfection of kinase-inactive MEK1 but not by the p38 MAPK inhibitor, SB203580, indicating a role for the ERKs, but not the p38 MAPKs, in NGF regulation of the NFLC promoter. Importantly, a gain-of-function MKK7-JNK3 fusion protein stimulated NFLC-Luc and synergized with gain-of-function c-Raf-1 to activate the NFLC promoter. In addition, transfection of kinase-inactive forms of MEK1 and MKK7 produced an additive inhibition of NGF-stimulated NFLC-Luc relative to either inhibitor alone. These findings indicate that the ERK and JNK pathways collaborate downstream of the NGF receptor for regulation of the NFLC promoter. Truncation analysis and electromobility shift assays established the requirement for a cAMP-response element/activating transcription factor-like site in the NFLC promoter that minimally interacts with constitutively expressed cAMP-response element-binding protein and JunD as well as c-Jun which is induced by NGF in an ERK-dependent manner. Cumulatively, these findings indicate that the ERK pathway requires collaboration with the JNK pathway for maximal activation of the NFLC gene in PC12 cells through the integrated control of c-Jun function.	Univ Colorado, Hlth Sci Ctr, Div Renal Med, Dept Med, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Heasley, LE (corresponding author), Univ Colorado, Hlth Sci Ctr, Div Renal Med, Dept Med, C-281,4200 E 9th Ave, Denver, CO 80262 USA.				NIDDK NIH HHS [DK59756] Funding Source: Medline; NIGMS NIH HHS [GM61718] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061718] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; BROWN PH, 1993, ONCOGENE, V8, P877; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Butterfield L, 1999, BIOCHEM J, V338, P681, DOI 10.1042/0264-6021:3380681; Charron G, 1995, J BIOL CHEM, V270, P30604, DOI 10.1074/jbc.270.51.30604; CLARK EA, 1991, J NEUROCHEM, V57, P802, DOI 10.1111/j.1471-4159.1991.tb08222.x; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DEFRANCO C, 1993, MOL ENDOCRINOL, V7, P365, DOI 10.1210/me.7.3.365; Fanger GR, 1997, MOL CELL BIOL, V17, P89, DOI 10.1128/MCB.17.1.89; FUKUDA M, 1995, ONCOGENE, V11, P239; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; HAWLEY RJ, 1992, J NEUROSCI, V12, P2573; Heasley LE, 1996, MOL CELL BIOL, V16, P648; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hoffmeyer A, 1999, J BIOL CHEM, V274, P4319, DOI 10.1074/jbc.274.7.4319; Iwasaki S, 1996, J BIOL CHEM, V271, P17360, DOI 10.1074/jbc.271.29.17360; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; Kumahara E, 1999, J BIOCHEM, V125, P541, DOI 10.1093/oxfordjournals.jbchem.a022319; Kuo WL, 1997, MOL CELL BIOL, V17, P4633, DOI 10.1128/MCB.17.8.4633; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Levresse V, 2000, J NEUROSCI RES, V62, P799; LINDENBAUM MH, 1987, J BIOL CHEM, V262, P605; LINDENBAUM MH, 1988, J BIOL CHEM, V263, P5662; Luc PVT, 1997, J MOL NEUROSCI, V8, P223, DOI 10.1007/BF02736835; Malek RL, 1999, J BIOL CHEM, V274, P35499, DOI 10.1074/jbc.274.50.35499; McDonough PM, 1997, J BIOL CHEM, V272, P24046, DOI 10.1074/jbc.272.38.24046; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; REEBEN M, 1993, BIOCHEM BIOPH RES CO, V192, P465, DOI 10.1006/bbrc.1993.1438; REEBEN M, 1995, J NEUROSCI RES, V40, P177, DOI 10.1002/jnr.490400206; SHNEIDMAN PS, 1992, MOL BRAIN RES, V13, P127, DOI 10.1016/0169-328X(92)90052-D; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Tournier C, 1999, MOL CELL BIOL, V19, P1569; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; VAILLANCOURT RR, 1995, MOL CELL BIOL, V15, P3644; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Williams NG, 1998, J BIOL CHEM, V273, P24624, DOI 10.1074/jbc.273.38.24624; WOOD KW, 1993, P NATL ACAD SCI USA, V90, P1041; WU BY, 1989, J BIOL CHEM, V264, P9000; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742; Yan GZ, 1997, J NEUROSCI, V17, P6122; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; YAZDANBAKHSH K, 1993, NUCLEIC ACIDS RES, V21, P455, DOI 10.1093/nar/21.3.455; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	52	44	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4110	4118		10.1074/jbc.M107824200	http://dx.doi.org/10.1074/jbc.M107824200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733514	hybrid			2022-12-27	WOS:000173813900043
J	Shimizu, T; Seto, A; Maita, N; Hamada, K; Tsukita, S; Tsukita, S; Hakoshima, T				Shimizu, T; Seto, A; Maita, N; Hamada, K; Tsukita, S; Tsukita, S; Hakoshima, T			Structural basis for neurofibromatosis type 2 - Crystal structure of the merlin FERM domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; EZRIN/RADIXIN/MOESIN PROTEINS; MEMBRANE; BINDING; ACTIN; GENE; MOESIN; ORGANIZATION; INSIGHTS; PROGRAM	Neurofibromatosis type 2 (NF2) is a dominantly inherited disease associated with the central nervous system. The NF2 gene product merlin is a tumor suppressor, and its mutation or inactivation causes this disease. We report here the crystal structure of the merlin FERM domain containing a 22-residue alpha-helical segment. The structure reveals that the merlin FERM domain consists of three subdomains displaying notable features of the electrostatic surface potentials, although the overall surface potentials similar to those of ezrin/radixin/moesin (ERM) proteins indicate electrostatic membrane association. The structure also is consistent with inactivation mechanisms caused by the pathogenic mutations associated with NF2.	Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300101, Japan; Japan Sci & Technol Corp, CREST, Nara 6300101, Japan; Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Coll Med Technol, Sakyo Ku, Kyoto 6068507, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University	Hakoshima, T (corresponding author), Nara Inst Sci & Technol, Struct Biol Lab, 8916-5 Takayama, Nara 6300101, Japan.		Maita, Nobuo/J-1443-2012	Maita, Nobuo/0000-0003-2260-5783				Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Brault E, 2001, J CELL SCI, V114, P1901; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; EVANS DGR, 1992, Q J MED, V84, P603; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; Gutmann DH, 2001, HUM MOL GENET, V10, P1519, DOI 10.1093/hmg/10.14.1519; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Han BG, 2000, NAT STRUCT BIOL, V7, P871; Hovens CM, 2001, J CLIN NEUROSCI, V8, P4, DOI 10.1054/jocn.2000.0784; Huang LQ, 1998, BIOCHEM BIOPH RES CO, V248, P548, DOI 10.1006/bbrc.1998.9009; Ishikawa H, 2001, J MOL BIOL, V310, P973, DOI 10.1006/jmbi.2001.4818; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Maeda M, 1999, ONCOGENE, V18, P4788, DOI 10.1038/sj.onc.1202871; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nguyen R, 2001, J BIOL CHEM, V276, P7621, DOI 10.1074/jbc.M006708200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Rossmann MG, 1999, ACTA CRYSTALLOGR D, V55, P1631, DOI 10.1107/S0907444999008379; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Stokowski RP, 2000, AM J HUM GENET, V66, P873, DOI 10.1086/302812; TAKESHIMA H, 1994, ONCOGENE, V9, P2135; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7	36	83	88	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10332	10336		10.1074/jbc.M109979200	http://dx.doi.org/10.1074/jbc.M109979200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11756419	hybrid			2022-12-27	WOS:000174549200096
J	Ajayi, WU; Chaudhuri, M; Hill, GC				Ajayi, WU; Chaudhuri, M; Hill, GC			Site-directed mutagenesis reveals the essentiality of the conserved residues in the putative diiron active site of the trypanosome alternative oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANIDE-RESISTANT RESPIRATION; COLI RIBONUCLEOTIDE REDUCTASE; ESCHERICHIA-COLI; PROTEIN R2; HANSENULA-ANOMALA; BRUCEI-BRUCEI; IRON; MITOCHONDRIA; DESATURASE; MUTANTS	Trypanosoma brucei possesses a non-cytochrome, salicylhydroxamic acid (SHAM)-sensitive ubiquinol:oxygen oxidoreductase known as trypanosome alternative oxidase (TAO). TAO and similar SHAM-sensitive alternative oxidases (AOXs) contain 2-3 conserved diiron-binding motifs (EXXH). Site-directed mutagenesis of residues H165A, E214A, E266A, and H269L within the conserved EXXH motif abolished the ability of TAO to complement the heme-deficient Escherichia coli strain GE1387. These mutations also reduced the growth of this E. coli auxotroph to about 85% of the control cells containing wild type TAO. In contrast, mutation of residues outside the EXXH motifs, e.g. V205A, L243A, C261A, and V271A, had little effect on complementation, and the reduction in the cell growth was about 5-10%. Mutations of the putative iron-binding residues within the EXXH motifs of TAO abolished the ability to confer SHAM-sensitive respiration to E. coli heme mutant, whereas mutations of the non-conserved/non-iron binding residues resulted in 20-30% reduction of SHAM-sensitive respiration of the E. coli auxotroph. Immunoblot analysis of the total cellular protein of transformed E. coli revealed that the expression level of mutated and wild type TAO (35 kDa) remained unaltered. Mutation at C261A produced a truncated but functional protein of 28 kDa. The addition of ortho-phenanthroline to the growth medium produces a non-functional TAO. The effect of ortho-phenanthroline on the activity of TAO was completely alleviated by the addition of iron in the medium, which suggests that iron is needed for the activity of TAO. This work demonstrates that His-165, Glu-214, Glu-266, and His-269 and the presence of iron are essential for the activity of TAO.	Meharry Med Coll, Sch Med, Dept Microbiol, Nashville, TN 37208 USA	Meharry Medical College	Hill, GC (corresponding author), Meharry Med Coll, Sch Med, Dept Microbiol, Nashville, TN 37208 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008037] Funding Source: NIH RePORTER; NCRR NIH HHS [G12RR03032] Funding Source: Medline; NIAID NIH HHS [2T32AI07281, 5R01AI21159] Funding Source: Medline; NIGMS NIH HHS [F06GM08037] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albury MS, 1998, J BIOL CHEM, V273, P30301, DOI 10.1074/jbc.273.46.30301; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; BASS HS, 1990, EXP PARASITOL, V70, P486, DOI 10.1016/0014-4894(90)90134-X; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Berthold DA, 1998, BBA-BIOENERGETICS, V1364, P73, DOI 10.1016/S0005-2728(98)00015-2; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Chaudhuri M, 1996, MOL BIOCHEM PARASIT, V83, P125, DOI 10.1016/S0166-6851(96)02754-5; CLARKSON AB, 1976, SCIENCE, V194, P204, DOI 10.1126/science.986688; CLARKSON AB, 1989, J BIOL CHEM, V264, P17770; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; FOX BG, 1994, BIOCHEMISTRY-US, V33, P12776, DOI 10.1021/bi00209a008; FOX BG, 1993, P NATL ACAD SCI USA, V90, P2486, DOI 10.1073/pnas.90.6.2486; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; KUMAR AM, 1992, P NATL ACAD SCI USA, V89, P10842, DOI 10.1073/pnas.89.22.10842; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SY, 1999, BIOCHEMISTRY-US, V38, P4423, DOI 10.1021/bi982712w; LI Q, 1995, GENETICS, V142, P120; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; MEUNIER B, 1995, BIOCHEMISTRY-US, V34, P1076, DOI 10.1021/bi00003a044; MINAGAWA N, 1990, FEBS LETT, V267, P114, DOI 10.1016/0014-5793(90)80302-Y; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; Persson BO, 1996, J BIOL INORG CHEM, V1, P247, DOI 10.1007/s007750050050; RHOADS DM, 1991, P NATL ACAD SCI USA, V88, P2122, DOI 10.1073/pnas.88.6.2122; SAKAJO S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P102; SIEDOW JN, 1995, FEBS LETT, V362, P10, DOI 10.1016/0014-5793(95)00196-G; VERKAMP E, 1993, J BACTERIOL, V175, P1452, DOI 10.1128/JB.175.5.1452-1456.1993	26	54	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8187	8193		10.1074/jbc.M111477200	http://dx.doi.org/10.1074/jbc.M111477200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751873	hybrid			2022-12-27	WOS:000174268000072
J	Garcia-Martin, ML; Garcia-Espinosa, MA; Ballesteros, P; Bruix, M; Cerdan, S				Garcia-Martin, ML; Garcia-Espinosa, MA; Ballesteros, P; Bruix, M; Cerdan, S			Hydrogen turnover and subcellular compartmentation of hepatic [2-C-13]glutamate and [3-C-13]aspartate as detected by C-13 NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICARBOXYLIC-ACID CYCLE; PERFUSED-RAT-LIVER; ASPARTATE-AMINOTRANSFERASE; METABOLITE TRANSPORT; IN-VIVO; GLUTAMATE; HEARTS; WATER; FLUX; SPECTROSCOPY	C-13 NMR monitored the dynamics of exchange from specific hydrogens of hepatic [2-C-13]glutamate and [3-C-13]aspartate with deuterons from intracellular heavy water providing information on alpha-ketoglutarate/glutamate exchange and subcellular compartmentation. Mouse livers were perfused with [3-C-13]alanine in buffer containing or not 50% (H2O)-H-2 for increasing periods of time (I min < t < 30 min). Liver extracts prepared at the end of the perfusions were analyzed by high resolution C-13 NAIR (150.13 MHz) with H-1 decoupling only and with simultaneous H-1 and H-2 decoupling. C-13-H-2 Couplings and H-2-induced isotopic shifts observed in the glutamate C2 resonance, allowed to estimate the apparent rate constants (forward, reverse; min(-1)) for (i) the reversible exchange of [2-C-13]glutamate H2 as catalyzed mainly by aspartate aminotransferase (0.32, 0.56), (ii) the reversible exchange of [2-C-13]glutamate H3(proS) as catalyzed by NAD(P) isocitrate dehydrogenase (0.1, 0.05), and (iii) the irreversible exchanges of glutamate H3(proR) and H3(proS) as catalyzed by the sequential activities of mitochondrial aconitase and NAD isocitrate dehydrogenase of the tricarboxylic acid cycle (0.035), respectively. A similar approach allowed to determine the rates of H-1-H-2 exchange for the H2 (0.4, 0.5) or H3(proR) (0.3, 0.2) or the H2 and H3(proS) hydrogens (0.20, 0.23) of [3-C-13]aspartate isotopomers. The ubiquitous subcellular localization of H-1-H-2 exchange enzymes and the exclusive mitochondrial localization of pyruvate carboxylase and the tricarboxylic acid cycle resulted in distinctive kinetics of deuteration in the H2 and either or both 113 hydrogens of [3-C-13]glutamate and [3-C-13]aspartate, allowing to follow glutamate and aspartate trafficking through cytosol and mitochondria.	CSIC, Inst Invest Biomed, E-28029 Madrid, Spain; Univ Nacl Educ Distancia, Dept Organ Chem & Biol, E-28040 Madrid, Spain; CSIC, Inst Estructura Mat, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad Nacional de Educacion a Distancia (UNED); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Estructura de la Materia (IEM)	Cerdan, S (corresponding author), CSIC, Inst Invest Biomed, C Arturo Duperier 4, E-28029 Madrid, Spain.	scerdan@iib.uam.es	Garcia-Martin, Maria L./R-8177-2017; Bruix, Marta/H-4161-2011; Martín, María Luisa García/L-7988-2019	Garcia-Martin, Maria L./0000-0002-2257-7682; Bruix, Marta/0000-0002-0096-3558; Martín, María Luisa García/0000-0002-2257-7682; Cerdan, Sebastian/0000-0001-9965-0270; Ballesteros, Paloma/0000-0001-7763-8975				CHANCE EM, 1983, J BIOL CHEM, V258, P3785; CHATHAM JC, 1995, J BIOL CHEM, V270, P7999, DOI 10.1074/jbc.270.14.7999; COHEN SM, 1987, BIOCHEMISTRY-US, V26, P563, DOI 10.1021/bi00376a031; COHEN SM, 1983, J BIOL CHEM, V258, P4294; DONNELLY DF, 1985, INT J BIOCHEM, V17, P279, DOI 10.1016/0020-711X(85)90128-4; DUSZYNSKI J, 1978, J BIOL CHEM, V253, P6149; ENGLARD S, 1960, J BIOL CHEM, V235, P1510; FITZPATRICK SM, 1990, J CEREBR BLOOD F MET, V10, P170, DOI 10.1038/jcbfm.1990.32; Garcia-Martin ML, 2001, PROG NUCL MAG RES SP, V39, P41, DOI 10.1016/S0079-6565(01)00031-0; Garcia-Perez AI, 1999, ARCH BIOCHEM BIOPHYS, V362, P329, DOI 10.1006/abbi.1998.1051; GARCIAMARTIN ML, 1999, MAGN RESON MATER PHY, V8, P113; GARCIAMARTIN ML, 1999, P INT SOC MAGN RES M, V7, P37; Griffin JL, 2000, AM J PHYSIOL-CELL PH, V279, pC1704, DOI 10.1152/ajpcell.2000.279.6.C1704; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; HANSEN PE, 1988, PROG NUCL MAG RES SP, V20, P207, DOI 10.1016/0079-6565(88)80002-5; JENKINS WT, 1961, J BIOL CHEM, V236, P1121; Jucker BM, 1998, J BIOL CHEM, V273, P12187, DOI 10.1074/jbc.273.20.12187; JULIN DA, 1989, BIOCHEMISTRY-US, V28, P3815, DOI 10.1021/bi00435a029; JULIN DA, 1989, BIOCHEMISTRY-US, V28, P3825, DOI 10.1021/bi00435a031; KOSICKI GW, 1961, J BIOL CHEM, V236, P2566; Koyama Y, 1997, J BIOL CHEM, V272, P30329, DOI 10.1074/jbc.272.48.30329; KUNNECKE B, 1995, CARBON 13 NMR SPECTR, P155; LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255; LopezBeltran EA, 1996, J BIOL CHEM, V271, P10648, DOI 10.1074/jbc.271.18.10648; LOWENSTEIN JM, 1971, J BIOL CHEM, V246, P629; Mahler H. R., 1967, BIOL CHEM; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; MASON GF, 1992, J CEREBR BLOOD F MET, V12, P434, DOI 10.1038/jcbfm.1992.61; Meijer D K, 1981, Methods Enzymol, V77, P81; MISRA HP, 1976, ANAL BIOCHEM, V70, P632, DOI 10.1016/0003-2697(76)90492-9; MOLDES M, 1994, NMR BIOMED, V7, P249, DOI 10.1002/nbm.1940070602; Moldes M, 1997, CELL MOL BIOL, V43, P731; MOLDES M, 1995, Q MAGN RESON BIOL ME, V2, P5; PICKWORTHGLUSKE.J, 1971, ENZYMES, V5, P413; POPJAK G, 1970, ENZYMES, V2, P116; RIFE JE, 1980, BIOCHEMISTRY-US, V19, P2321, DOI 10.1021/bi00552a007; ROGNSTAD R, 1974, EUR J BIOCHEM, V47, P383, DOI 10.1111/j.1432-1033.1974.tb03703.x; ROSE ZB, 1966, J BIOL CHEM, V241, P2311; SCHLOSS JV, 1984, BIOCHEMISTRY-US, V23, P4572, DOI 10.1021/bi00315a010; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Sherry AD, 1998, AM J PHYSIOL-HEART C, V274, pH591, DOI 10.1152/ajpheart.1998.274.2.H591; Shulman RG, 2001, ANNU REV PHYSIOL, V63, P15, DOI 10.1146/annurev.physiol.63.1.15; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; WALSH CT, 1979, ENZYMATIC REACTION M; WEISS RG, 1995, BBA-GEN SUBJECTS, V1243, P543, DOI 10.1016/0304-4165(95)00031-6; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4617; Yano M, 1996, J BIOL CHEM, V271, P6702, DOI 10.1074/jbc.271.12.6702; YOU KS, 1978, TRENDS BIOCHEM SCI, V3, P265, DOI 10.1016/S0968-0004(78)95849-8; Yu X, 1996, BIOCHEMISTRY-US, V35, P6963, DOI 10.1021/bi960199l; Yu X, 1997, AM J PHYSIOL-CELL PH, V272, pC2037, DOI 10.1152/ajpcell.1997.272.6.C2037; Yu X, 1995, BIOPHYS J, V69, P2090, DOI 10.1016/S0006-3495(95)80080-9	51	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7799	7807		10.1074/jbc.M107501200	http://dx.doi.org/10.1074/jbc.M107501200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11744718	hybrid			2022-12-27	WOS:000174268000024
J	Nakamura, Y; Kawakami, M; Yoshihiro, A; Miyoshi, N; Ohigashi, H; Kawai, K; Osawa, T; Uchida, K				Nakamura, Y; Kawakami, M; Yoshihiro, A; Miyoshi, N; Ohigashi, H; Kawai, K; Osawa, T; Uchida, K			Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; PHENETHYL ISOTHIOCYANATE; HYDROGEN-PEROXIDE; CELL-DEATH; PHENYLETHYL ISOTHIOCYANATE; PERMEABILITY TRANSITION; MEDIATED APOPTOSIS; INHIBITION; CARCINOGENESIS; GLUTATHIONE	In the present study, we studied the molecular mechanism underlying cell death induced by a cancer chemoprotective compound benzyl isothiocyanate (BITC). The cytotoxic effect of BITC was examined in rat liver epithelial RL34 cells. Apoptosis was induced when the cells were treated with 20 muM BITC, characterized by the appearance of phosphatidylserine on the outer surface of the plasma membrane and caspase-3 activation, whereas no caspase activation and propidium iodide incorporation into cell were detected with 50 muM BITC that induced necrosis. The mitochondrial death pathway was suggested to be involved in BITC-induced apoptosis because the treatment of cells with BITC-induced caspase-9-dependent apoptosis and mitochondrial transmembrane potential (DeltaPsim) alteration. We demonstrated here for the first time that BITC directly modifies mitochondrial functions, including inhibition of respiration, mitochondrial swelling, and release of cytochrome c. Moreover, glutathione depletion by diethyl maleate significantly accelerated BITC-triggered apoptosis, suggesting the involvement of a redox-dependent mechanism. This was also implicated by the observations that intracellular accumulation of reactive oxygen species, including superoxide (O-2(.-)) and hydroperoxides (HPOs), was indeed detected in the cells treated with BITC and that the intracellular HPO level was significantly attenuated by pretreatment with N-ace-tylcysteine. The treatment with a pharmacological scavenger of 07 Tiron, also diminished the HPO formation by similar to80%,c, suggesting that most of the HPOs were H2O2 derived from the dismutation of O-2(.-). These results suggest that BITC induces apoptosis through a mitochondial redox-sensitive mechanism.	Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; Chukyo Womens Univ, Fac Wellness, Obu 4740011, Japan; Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan	Nagoya University; Kyoto University	Nakamura, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.	yossan@agr.nagoya-u.ac.jp	Miyoshi, Noriyuki/F-4554-2010	Miyoshi, Noriyuki/0000-0002-4233-4282; Uchida, Koji/0000-0003-3894-5299				ALBRECHT H, 1994, FEBS LETT, V351, P45, DOI 10.1016/0014-5793(94)00817-5; CASCIOLAROSEN LA, 1994, J BIOL CHEM, V269, P30757; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Chen YR, 1998, J BIOL CHEM, V273, P1769, DOI 10.1074/jbc.273.3.1769; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; GUO Z, 1993, CARCINOGENESIS, V14, P1167, DOI 10.1093/carcin/14.6.1167; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Harvey KJ, 1998, MOL CELL BIOL, V18, P2912, DOI 10.1128/MCB.18.5.2912; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; HECHT SS, 1995, J CELL BIOCHEM, P195; Hirose M, 1998, INT J CANCER, V77, P773, DOI 10.1002/(SICI)1097-0215(19980831)77:5<773::AID-IJC17>3.0.CO;2-2; Huang CS, 1998, CANCER RES, V58, P4102; Kantrow SP, 1997, BIOCHEM BIOPH RES CO, V232, P669, DOI 10.1006/bbrc.1997.6353; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Moreno-Manzano V, 2000, J BIOL CHEM, V275, P12684, DOI 10.1074/jbc.275.17.12684; MORSE MA, 1993, CANCER LETT, V72, P103, DOI 10.1016/0304-3835(93)90018-5; MORSE MA, 1993, CARCINOGENESIS, V14, P1737, DOI 10.1093/carcin/14.9.1737; Nakamura Y, 2000, CANCER RES, V60, P219; Nakamura Y, 2000, CANCER LETT, V157, P193, DOI 10.1016/S0304-3835(00)00487-0; Nakamura Y, 2001, FREE RADICAL BIO MED, V30, P967, DOI 10.1016/S0891-5849(01)00481-6; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Ogawa K, 1998, INT J CANCER, V76, P851; Picklo MJ, 2001, BBA-MOL BASIS DIS, V1535, P145, DOI 10.1016/S0925-4439(00)00093-4; SCHNEIDER WC, 1948, J BIOL CHEM, V176, P259; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 1996, ONCOGENE, V13, P21; SHRIEVE DC, 1988, J BIOL CHEM, V263, P14107; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3; STONER GD, 1991, CANCER RES, V51, P2063; Sun XM, 1996, CHEM-BIOL INTERACT, V100, P267, DOI 10.1016/0009-2797(96)03704-0; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; TALALAY P, 1989, ADV ENZYME REGUL, V28, P237; TEDESCHI H, 1955, ARCH BIOCHEM BIOPHYS, V58, P52, DOI 10.1016/0003-9861(55)90092-8; TYLER DD, 1968, BIOCHEM J, V107, P121, DOI 10.1042/bj1070121; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; WATTENBERG LW, 1987, CARCINOGENESIS, V8, P1971, DOI 10.1093/carcin/8.12.1971; WATTENBERG LW, 1981, CANCER RES, V41, P2991; WILLIAMSON P, 1994, MOL MEMBR BIOL, V11, P199, DOI 10.3109/09687689409160430; YAMADA M, 1987, CELL STRUCT FUNCT, V12, P53, DOI 10.1247/csf.12.53; YAMAOKA S, 1990, J NUTR, V120, P415, DOI 10.1093/jn/120.5.415; Yu R, 1998, CANCER RES, V58, P402; Zhang YS, 1998, CANCER RES, V58, P4632	53	144	147	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8492	8499		10.1074/jbc.M109760200	http://dx.doi.org/10.1074/jbc.M109760200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751909	hybrid			2022-12-27	WOS:000174268000110
J	Yoon, YM; Kim, SJ; Oh, CD; Ju, JW; Song, WK; Yoo, YJ; Huh, TL; Chun, JS				Yoon, YM; Kim, SJ; Oh, CD; Ju, JW; Song, WK; Yoo, YJ; Huh, TL; Chun, JS			Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal regulated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUD MESENCHYMAL CELLS; N-CADHERIN EXPRESSION; ALGINATE BEADS; RETINOIC ACID; IN-VITRO; COLLAGEN PHENOTYPE; CHONDROGENESIS; MODULATION; INHIBITOR; CARTILAGE	The differentiated phenotype of chondrocyte is rapidly lost during in vitro culture by a process designated "dedifferentiation." In this study, we investigate the roles of protein kinase C (PKC) and extracellular signal-regulated protein kinase (ERK) in the maintenance of the differentiated chondrocyte phenotype. Chondrocytes isolated from rabbit articular cartilage underwent dedifferentiation upon serial monolayer culture with cessation of type II collagen expression and proteoglycan synthesis, which was reversed by culturing dedifferentiated cells in alginate gel. The expression pattern of PKCalpha was essentially the same as that of type II collagen during de- and redifferentiation, in that expression was decreased during dedifferentiation and increased during redifferentiation. In contrast to PKCalpha, ERK activity increased 15-fold during dedifferentiation. This enhanced activity was terminated during redifferentiation. Down-regulation of PKCalpha in passage 0 chondrocytes resulted in dedifferentiation. However, overexpression of PKCalpha did not affect type II collagen levels, suggesting that PKCalpha expression is not sufficient to maintain the differentiated phenotype. However, inhibition of ERK by PD98059 enhanced type II collagen expression and proteoglycan synthesis in passage 0 cells, retarded dedifferentiation during monolayer cultures, and reversed dedifferentiation caused by down-regulation of PKC. Unlike PKC-dependent ERK regulation of chondrogenesis, PKC and ERK independently modulated chondrocyte dedifferentiation, as confirmed by observations that PKC down-regulation and ERK inhibition did not alter ERK phosphorylation and PKC expression, respectively. In addition, expression of Ncadherin, a-catenin, and beta-catenin, which are oppositely regulated to type II collagen during phenotype alter. ations, were modulated by PKC and ERK during chondrogenesis but not dedifferentiation, supporting distinct mechanisms for the regulation of chondrocyte differentiation and maintenance of differentiated phenotype by these two protein kinases.	Kwangju Inst Sci & Technol, Dept Life Sci, Natl Res Lab, Pook Gu, Kwangju 500712, South Korea; Kyungpook Natl Univ, TG Biotech Co Ltd, Taegu 702701, South Korea	Kyungpook National University	Chun, JS (corresponding author), Kwangju Inst Sci & Technol, Dept Life Sci, Natl Res Lab, Pook Gu, Kwangju 500712, South Korea.			Oh, Chundo/0000-0002-5419-8011				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ARCHER CW, 1990, J CELL SCI, V97, P361; BENYA PD, 1977, BIOCHEMISTRY-US, V16, P865, DOI 10.1021/bi00624a009; BENYA PD, 1988, J CELL BIOL, V106, P161, DOI 10.1083/jcb.106.1.161; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; BROWN PD, 1988, J CELL BIOL, V106, P171, DOI 10.1083/jcb.106.1.171; Chang SH, 1998, J BIOL CHEM, V273, P19213, DOI 10.1074/jbc.273.30.19213; CHOI B, 1995, BIOCHEM BIOPH RES CO, V216, P1034, DOI 10.1006/bbrc.1995.2724; Clancy RM, 1997, J CLIN INVEST, V100, P1789, DOI 10.1172/JCI119706; Demoor-Fossard M, 1998, BBA-GENE STRUCT EXPR, V1398, P179, DOI 10.1016/S0167-4781(98)00044-X; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.0.CO;2-G; Kim JY, 1999, BIOCHEM J, V337, P275, DOI 10.1042/0264-6021:3370275; LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W; Lemare F, 1998, J CELL PHYSIOL, V176, P303, DOI 10.1002/(SICI)1097-4652(199808)176:2<303::AID-JCP8>3.0.CO;2-S; Loty S, 1998, J BIOMED MATER RES, V42, P213, DOI 10.1002/(SICI)1097-4636(199811)42:2<213::AID-JBM6>3.0.CO;2-S; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912; Sanchez M, 1996, BIOCHEM J, V313, P201, DOI 10.1042/bj3130201; Sandell L., 1999, FRONT BIOSCI-LANDMRK, V4, P731; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Solursh M, 1989, CURR OPIN CELL BIOL, V1, P989, DOI 10.1016/0955-0674(89)90070-7; Tavella S, 1997, J CELL SCI, V110, P2261; TAVELLA S, 1994, EXP CELL RES, V215, P354, DOI 10.1006/excr.1994.1352; THENET S, 1992, J CELL PHYSIOL, V150, P158, DOI 10.1002/jcp.1041500121; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TSONIS PA, 1994, EXP CELL RES, V213, P433, DOI 10.1006/excr.1994.1220; Woodward WA, 1999, DEV GENET, V24, P178, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<178::AID-DVG16>3.0.CO;2-M; Yoo MH, 2001, J BIOL CHEM, V276, P24645, DOI 10.1074/jbc.M101975200; Yoon YM, 2000, J BONE MINER RES, V15, P2197, DOI 10.1359/jbmr.2000.15.11.2197; Yoon YM, 2000, J BIOL CHEM, V275, P12353, DOI 10.1074/jbc.275.16.12353	39	142	150	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8412	8420		10.1074/jbc.M110608200	http://dx.doi.org/10.1074/jbc.M110608200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11744731	hybrid			2022-12-27	WOS:000174268000101
J	Paszty, K; Verma, AK; Padanyi, R; Filoteo, AG; Penniston, JT; Enyedi, A				Paszty, K; Verma, AK; Padanyi, R; Filoteo, AG; Penniston, JT; Enyedi, A			Plasma membrane Ca2+ ATPase isoform 4b is cleaved and activated by caspase-3 during the early phase of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CALMODULIN-BINDING; INTRACELLULAR CA2+; CALCIUM-PUMP; ENDOPLASMIC-RETICULUM; MEDIATED PROTEOLYSIS; DNA-DEGRADATION; CELL-DEATH; INHIBITOR; INDUCTION	The plasma membrane Ca2+ pump (PMCA) is an essential element in the complex of mechanisms that maintain low intracellular Ca2+ concentration in the living cell. This pump is tightly regulated by calmodulin through binding to a high affinity calmodulin-binding domain at the C terminus that also serves as an autoinhibitor of the enzyme. Inspection of the C terminus of hPMCA4b, the most widely distributed form of PMCA, revealed a caspase-3 consensus sequence ((DEID1080)-D-1077) just a few residues upstream of the calmodulin-binding domain. We demonstrate here that, in the early phase of apoptosis, hPMCA4b is cleaved at aspartic acid Asp(1080) in hPMCA4b-transfected COS-7 cells or in HeLa cells that naturally express this protein. This cleavage of hPMCA4b produces a single 120-kDa fragment that is fully active in the absence of calmodulin, because the whole inhibitory region downstream of the (DEID1080)-D-1077 sequence is removed. Our experiments show that caspase-3 or a caspase-3-like protease is responsible for the formation of the constitutively active 120-kDa PMCA4b fragment: 1) Pretreatment of the cells with the caspase-3 inhibitor Z-DEVD-FMK (benzyloxycarbonyl-Asp (OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethyl ketone) was able to block the production of the 120-kDa fragment. 2) In vitro treatment of hPMCA4b with recombinant caspase-3 also generated a 120-kDa cleavage product, consistent with that seen in cells undergoing apoptosis. 3) Mutants in which the caspase-3 consensus sequence was altered ((1077)AEID(1080), (1077)DEIA(1080), and (1077)AEIA(1080) mutants) were resistant to proteolysis. Based on these data, we conclude that hPMCA4b is a newly identified, natural caspase-3 substrate. We suggest that a constitutively active form of this protein, responding much faster to an increase in Ca2+ concentration than the autoinhibited form, may have an important role in regulating intracellular Ca2+ concentration in the apoptotic cell.	Natl Inst Haematol & Immunol, H-1113 Budapest, Hungary; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Enyedi, A (corresponding author), Natl Inst Haematol & Immunol, Daroczi Ut 24, H-1113 Budapest, Hungary.	enyedi@biomembrane.hu	Pászty, Katalin/X-3785-2019; Enyedi, Agnes/N-9742-2013	Enyedi, Agnes/0000-0002-7366-9376; Paszty, Katalin/0000-0003-2457-8555	NIGMS NIH HHS [GM 28835] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028835] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bian XP, 1997, AM J PHYSIOL-CELL PH, V272, pC1241, DOI 10.1152/ajpcell.1997.272.4.C1241; Blackshaw S, 2000, FASEB J, V14, P1375, DOI 10.1096/fj.14.10.1375; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; Caride AJ, 2001, CELL CALCIUM, V30, P49, DOI 10.1054/ceca.2001.0212; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Elwess NL, 1997, J BIOL CHEM, V272, P17981, DOI 10.1074/jbc.272.29.17981; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Enyedi A, 1997, J BIOL CHEM, V272, P27525, DOI 10.1074/jbc.272.44.27525; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; ENYEDI A, 1993, J BIOL CHEM, V268, P10621; FODER B, 1992, CELL CALCIUM, V13, P581, DOI 10.1016/0143-4160(92)90038-T; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Garcia ML, 2001, J NEUROSCI RES, V64, P661, DOI 10.1002/jnr.1120; GRAF E, 1981, J BIOL CHEM, V256, P1587; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; He HL, 1997, J CELL BIOL, V138, P1219, DOI 10.1083/jcb.138.6.1219; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; JAMES P, 1989, J BIOL CHEM, V264, P8289; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; JIANG S, 1994, EXP CELL RES, V212, P84, DOI 10.1006/excr.1994.1121; Juin P, 1998, J BIOL CHEM, V273, P17559, DOI 10.1074/jbc.273.28.17559; KEETON TP, 1993, J BIOL CHEM, V268, P2740; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; Khwaja A, 1999, BLOOD, V94, P291, DOI 10.1182/blood.V94.1.291.413k10_291_301; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAJNO G, 1995, AM J PATHOL, V146, P3; McConnell KR, 1997, J IMMUNOL, V158, P2083; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Pan Z, 2000, J BIOL CHEM, V275, P19978, DOI 10.1074/jbc.M908329199; PAPP B, 1989, J BIOL CHEM, V264, P4577; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; PENNISTON JT, 1982, BIOCHIM BIOPHYS ACTA, V688, P735, DOI 10.1016/0005-2736(82)90286-3; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pongracz J, 1999, J BIOL CHEM, V274, P37329, DOI 10.1074/jbc.274.52.37329; Popescu BO, 2001, J NEUROSCI RES, V66, P122, DOI 10.1002/jnr.1204; Qiao L, 1996, CANCER LETT, V107, P83, DOI 10.1016/0304-3835(96)04346-7; Reimertz C, 2001, J NEUROCHEM, V78, P1256, DOI 10.1046/j.1471-4159.2001.00503.x; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SCHARFF O, 1982, BIOCHIM BIOPHYS ACTA, V691, P133, DOI 10.1016/0005-2736(82)90222-X; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Scoltock AB, 2000, J BIOL CHEM, V275, P30586, DOI 10.1074/jbc.M004058200; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; WANG KKW, 1988, ARCH BIOCHEM BIOPHYS, V267, P317, DOI 10.1016/0003-9861(88)90037-9; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614; Zabe M, 2001, J BIOL CHEM, V276, P14704, DOI 10.1074/jbc.M009850200; Zhang FX, 1998, J BIOL CHEM, V273, P26596, DOI 10.1074/jbc.273.41.26596	61	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6822	6829		10.1074/jbc.M109548200	http://dx.doi.org/10.1074/jbc.M109548200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751908	hybrid			2022-12-27	WOS:000174104300011
J	Dellis, O; Gangloff, SC; Paulais, M; Tondelier, D; Rona, JP; Brouillard, F; Bouteau, F; Guenounou, M; Teulou, J				Dellis, O; Gangloff, SC; Paulais, M; Tondelier, D; Rona, JP; Brouillard, F; Bouteau, F; Guenounou, M; Teulou, J			Inhibition of the calcium release-activated calcium (CRAC) current in Jurkat T cells by the HIV-1 envelope protein gp160	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS GP120; CA2+-ACTIVATED K+ CHANNELS; TYROSINE KINASE P56LCK; LYMPHOCYTE-T; INTRACELLULAR CALCIUM; PLASMA-MEMBRANE; CA2+ CURRENT; DEPLETION; CD4; TRANSDUCTION	The HIV-1 envelope glycoprotein gp120/160 has pleiotropic effects on T cell function. We investigated whether Ca2+ signaling, a crucial step for T cell activation, was altered by prolonged exposure of Jurkat T cells to gp160. Microfluorometric measurements showed that Jurkat cells incubated with gp160 had smaller (approximate to40%) increases in [Ca2+](i) in response to phytohemag-glutinin and had a reduced Ca2+ influx (approximate to25%). gp160 had similar effects on Jurkat cells challenged with thapsigargin. We used the patch clamp technique to record the Ca2+ current, which is responsible for Ca2+ influx and has properties of the calcium release-activated Ca2+ current (I-CRAC). gp160 reduced I-CRAC by approximate to40%. The inhibitory effects of gp160 were antagonized by staurosporine (0.1 muM), an inhibitor of protein-tyrosine kinases and protein kinase Cs (PKCs), and by Go 6976 (5 muM), an inhibitor acting especially on PKCalpha and PKCbetaI. 12-O-Tetradecanoyl phorbol 13-acetate (16 nM), a PKC activator, reproduced the effects of gp160 in untreated cells. A Western blotting analysis of PKC isoforms alpha, betaI, delta, and zeta showed that only the cellular distribution of PKCa and -betaI were significantly modified by gp160. In addition, gp160 was able to modify the subcellular distribution of PKCa and PKCPI caused by phytohemagglutinin. Therefore the reduction in I-CRAC caused by prolonged incubation with gp160 is probably mediated by PKCalpha or -betaI.	Univ Paris 07, F-75251 Paris 05, France; Univ Reims, Fac Pharm, Inst Federatif Rech 53, Lab Immunol & Virol, F-51100 Reims, France; Univ Paris 07, Fac Med Xavier Bichat, Inst Federatif Rech 02, INSERM U426, F-75870 Paris 18, France; Fac Med Necker Enfants Malad, INSERM U467, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dellis, O (corresponding author), Case 7069,2 Pl Jussieu, F-75251 Paris 05, France.	odellis@moka.ccr.jussieu.fr	Paulais, Marc/E-5623-2017; Dellis, Olivier/E-8501-2011; Paulais, Marc/Q-6692-2017	Dellis, Olivier/0000-0003-0377-9163; Paulais, Marc/0000-0002-4895-2110; Bouteau, francois/0000-0003-0243-338X; gangloff, sophie/0000-0003-2651-9372; Teulon, Jacques/0000-0003-3923-7366				AMEISEN JC, 1992, IMMUNOL TODAY, V13, P388, DOI 10.1016/0167-5699(92)90086-M; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; BRINCHMANN JE, 1991, J VIROL, V65, P2019, DOI 10.1128/JVI.65.4.2019-2023.1991; BUBIEN JK, 1995, AM J PHYSIOL-CELL PH, V268, pC1440, DOI 10.1152/ajpcell.1995.268.6.C1440; CEFAI D, 1990, J CLIN INVEST, V86, P2117, DOI 10.1172/JCI114950; CHOQUET D, 1993, J CELL BIOL, V121, P355, DOI 10.1083/jcb.121.2.355; Christian EP, 1996, J MEMBRANE BIOL, V150, P63, DOI 10.1007/s002329900030; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; Dellis O, 1999, FEBS LETT, V443, P187, DOI 10.1016/S0014-5793(98)01691-3; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; GRISSMER S, 1992, J GEN PHYSIOL, V99, P63, DOI 10.1085/jgp.99.1.63; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haverstick DM, 1997, J BIOL CHEM, V272, P15426, DOI 10.1074/jbc.272.24.15426; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; HIVROZ C, 1993, EUR J IMMUNOL, V23, P600, DOI 10.1002/eji.1830230303; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HUBERT P, 1995, EUR J IMMUNOL, V25, P1417, DOI 10.1002/eji.1830250542; Jabado N, 1997, J IMMUNOL, V158, P94; JUSZCZAK RJ, 1991, J BIOL CHEM, V266, P11176; KORETZKY GA, 1989, J IMMUNOL, V143, P1692; LAURENTCRAWFORD AG, 1993, AIDS RES HUM RETROV, V9, P761, DOI 10.1089/aid.1993.9.761; Lepple-Wienhues A, 1999, P NATL ACAD SCI USA, V96, P13795, DOI 10.1073/pnas.96.24.13795; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; Lopez-Lago MA, 1999, EUR J IMMUNOL, V29, P466, DOI 10.1002/(SICI)1521-4141(199902)29:02<466::AID-IMMU466>3.0.CO;2-2; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MIEDEMA F, 1988, J CLIN INVEST, V82, P1908, DOI 10.1172/JCI113809; MIRE AR, 1996, BIOCHEM BIOPH RES CO, V137, P128; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Morio T, 1997, INT IMMUNOL, V9, P53, DOI 10.1093/intimm/9.1.53; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Nixon JB, 1999, J IMMUNOL, V163, P4574; NOKTA MA, 1994, P SOC EXP BIOL MED, V207, P284, DOI 10.3181/00379727-207-43818; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PAREKH AB, 1995, P NATL ACAD SCI USA, V92, P7907, DOI 10.1073/pnas.92.17.7907; Parolini I, 1999, J BIOL CHEM, V274, P14176, DOI 10.1074/jbc.274.20.14176; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; PREMACK BA, 1994, J IMMUNOL, V152, P5226; Sasaki M, 1996, VIROLOGY, V224, P18, DOI 10.1006/viro.1996.0502; SOULA M, 1992, INT IMMUNOL, V4, P295, DOI 10.1093/intimm/4.2.295; VERHEUGEN JAH, 1995, J GEN PHYSIOL, V105, P765, DOI 10.1085/jgp.105.6.765; YAMASHITA Y, 1991, FEBS LETT, V288, P46, DOI 10.1016/0014-5793(91)81000-X; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	52	15	17	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6044	6050		10.1074/jbc.M111831200	http://dx.doi.org/10.1074/jbc.M111831200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744714	hybrid			2022-12-27	WOS:000173989200047
J	Harrison, LM; Nerlinger, A; Bungiro, RD; Cordova, JL; Kuzmic, P; Cappello, M				Harrison, LM; Nerlinger, A; Bungiro, RD; Cordova, JL; Kuzmic, P; Cappello, M			Molecular characterization of Ancylostoma inhibitors of coagulation factor Xa - Hookworm anticoagulant activity in vitro predicts parasite bloodfeeding in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE INHIBITOR; CHYMOTRYPSIN ELASTASE; ASCARIS-LUMBRICOIDES; NECATOR-AMERICANUS; ESCHERICHIA-COLI; REACTIVE-SITE; INFECTIONS; CEYLANICUM; CANINUM; NEMATODE	Bloodfeeding hookworms, which currently infect over a billion people in the developing world, are a leading cause of gastrointestinal hemorrhage and iron deficiency anemia. The major anticoagulant inhibitor of coagulation factor Xa has been identified from the hookworm parasite Ancylostoma ceylanicum using reverse transcription PCR and 3'-rapid amplification of cDNA ends. This is the first anticoagulant cloned from a hookworm species for which humans are recognized permissive hosts. Despite similar to50% amino acid similarity, A. ceylanicum anticoagulant peptide 1 (AceAP1) is both immunologically and mechanistically distinct from AcAP5, its homologue isolated from the dog hookworm Ancylostoma caninum. Studies using plasma clotting times and single stage chromogenic assays of factor Xa activity have demonstrated that the recombinant AceAP1 protein is substantially less potent than AcAP5 and that soluble whole worm protein extracts of adult A. ceylanicum possess less anticoagulant activity than extracts of A. caninum. These values correlate with previously reported differences in bloodfeeding capabilities between these two species of hookworm, suggesting that factor Xa inhibitory activity is predictive of hookworm bloodfeeding capabilities in vivo. These fundamental differences in the mechanism of action and immunoreactivity of the major anticoagulant virulence factors from related Ancylostoma hookworm species may have significant implications for human vaccine development.	Yale Univ, Sch Med, Yale Child Hlth Res Ctr, Div Infect Dis,Dept Pediat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Yale Child Hlth Res Ctr, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Fdn Ciencias Vida, Santiago, Chile; Millenium Inst Fundamental & Appl BIol, Santiago, Chile; Biokin Ltd, Pullman, WA 99163 USA	Yale University; Yale University	Cappello, M (corresponding author), Yale Univ, Sch Med, Yale Child Hlth Res Ctr, Div Infect Dis,Dept Pediat, 464 Congress Ave, New Haven, CT 06520 USA.	michael.cappello@yale.edu	Bungiro, Rick/AAJ-1758-2021; Bungiro, Rick/AAJ-1736-2021; Bungiro, Richard/AAH-9406-2021	Kuzmic, Petr/0000-0001-5250-8381; Cappello, Michael/0000-0003-2255-8833				Akowski JP, 1997, BIOCHEMISTRY-US, V36, P15817, DOI 10.1021/bi971135t; Albonico M, 1999, INT J EPIDEMIOL, V28, P591, DOI 10.1093/ije/28.3.591; BABIN DR, 1984, ARCH BIOCHEM BIOPHYS, V232, P143, DOI 10.1016/0003-9861(84)90530-7; BEKTESH S, 1988, GENE DEV, V2, P1277, DOI 10.1101/gad.2.10.1277; Bergum PW, 2001, J BIOL CHEM, V276, P10063, DOI 10.1074/jbc.M009116200; BERNARD VD, 1993, ARCH BIOCHEM BIOPHYS, V303, P367, DOI 10.1006/abbi.1993.1297; Blaxter M, 2000, INT J PARASITOL, V30, P347, DOI 10.1016/S0020-7519(99)00198-8; Blaxter M, 1996, INT J PARASITOL, V26, P1025, DOI 10.1016/S0020-7519(96)00060-4; Bungiro RD, 2002, MOL BIOCHEM PARASIT, V119, P147, DOI 10.1016/S0166-6851(01)00408-X; Bungiro RD, 2001, J INFECT DIS, V183, P1380, DOI 10.1086/319867; CAPPELLO M, 1995, P NATL ACAD SCI USA, V92, P6152, DOI 10.1073/pnas.92.13.6152; Cappello M, 1996, MOL BIOCHEM PARASIT, V80, P113, DOI 10.1016/0166-6851(96)02658-8; CAPPELLO M, 1993, J INFECT DIS, V167, P1474, DOI 10.1093/infdis/167.6.1474; CARROLL SM, 1986, TROP GEOGR MED, V38, P38; CARROLL SM, 1984, THROMB HAEMOSTASIS, V51, P222; Chadderdon RC, 1999, J INFECT DIS, V179, P1235, DOI 10.1086/314724; CHOWDHURY AB, 1972, AM J TROP MED HYG, V21, P300, DOI 10.4269/ajtmh.1972.21.300; Chu V, 2001, THROMB RES, V103, P309, DOI 10.1016/S0049-3848(01)00328-0; Cierpicki T, 2000, PROTEIN SCI, V9, P976, DOI 10.1110/ps.9.5.976; DeClercq D, 1997, AM J TROP MED HYG, V57, P25, DOI 10.4269/ajtmh.1997.57.25; Duggan BM, 1999, EUR J BIOCHEM, V265, P539, DOI 10.1046/j.1432-1327.1999.00781.x; Fiedler E, 2001, J BIOL CHEM, V276, P16051, DOI 10.1074/jbc.M007936200; Furmidge BA, 1996, PARASITOLOGY, V112, P81, DOI 10.1017/S0031182000065100; GILLES HM, 1985, REV INFECT DIS, V7, P111; GRASBERGER BL, 1994, STRUCTURE, V2, P669, DOI 10.1016/S0969-2126(00)00067-8; Harrison LM, 2001, MOL BIOCHEM PARASIT, V115, P101, DOI 10.1016/S0166-6851(01)00276-6; HOTEZ PJ, 1995, SCI AM, V272, P68, DOI 10.1038/scientificamerican0695-68; Hotez PJ, 1999, IMMUNOL REV, V171, P163, DOI 10.1111/j.1600-065X.1999.tb01347.x; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; Karahalios P, 1998, EUR J BIOCHEM, V258, P437, DOI 10.1046/j.1432-1327.1998.2580437.x; KEYMER A, 1989, NATURE, V337, P114, DOI 10.1038/337114a0; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Loeb L, 1910, J INFECT DIS, V7, P625, DOI 10.1093/infdis/7.5.625; Lu CC, 1998, EXP PARASITOL, V89, P257, DOI 10.1006/expr.1998.4284; Milstone AM, 2000, J BIOL CHEM, V275, P29391, DOI 10.1074/jbc.M002715200; Rakus D, 2000, COMP BIOCHEM PHYS B, V127, P123, DOI 10.1016/S0305-0491(00)00245-5; REP BH, 1980, TROP GEOGR MED, V32, P251; Reynoldson JA, 1997, ACTA TROP, V68, P301, DOI 10.1016/S0001-706X(97)00106-X; Rhoads ML, 2000, EXP PARASITOL, V94, P1, DOI 10.1006/expr.1999.4466; Rosengren KJ, 2001, BIOCHEMISTRY-US, V40, P4601, DOI 10.1021/bi002623v; SEGEL IH, 1975, ENZYME KINETICS BEHA, P166; Stanley TB, 1999, J BIOL CHEM, V274, P16940, DOI 10.1074/jbc.274.24.16940; Stanssens P, 1996, P NATL ACAD SCI USA, V93, P2149, DOI 10.1073/pnas.93.5.2149; STEPHENSON LS, 1990, T ROY SOC TROP MED H, V84, P277, DOI 10.1016/0035-9203(90)90286-N; Stoltzfus RJ, 1997, AM J CLIN NUTR, V65, P153, DOI 10.1093/ajcn/65.1.153; Vilkaitis G, 2001, J BIOL CHEM, V276, P20924, DOI 10.1074/jbc.M101429200; WANG ZY, 1983, CHINESE MED J-PEKING, V96, P281; Williams J W, 1979, Methods Enzymol, V63, P437; YOSHIDA Y, 1968, AM J TROP MED HYG, V17, P378, DOI 10.4269/ajtmh.1968.17.378	49	39	44	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6223	6229		10.1074/jbc.M109908200	http://dx.doi.org/10.1074/jbc.M109908200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741914	hybrid			2022-12-27	WOS:000173989200071
J	Reddy, TR; Suhasini, M; Xu, WD; Yeh, LY; Yang, JP; Wu, J; Artzt, K; Wong-Staal, F				Reddy, TR; Suhasini, M; Xu, WD; Yeh, LY; Yang, JP; Wu, J; Artzt, K; Wong-Staal, F			A role for KH domain proteins (Sam68-like mammalian proteins and quaking proteins) in the post-transcriptional regulation of HIV replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REV ACTIVATION DOMAIN; RNA-BINDING PROTEIN; TYPE-1 REV; NUCLEAR EXPORT; POINT MUTATION; SRC SUBSTRATE; T-CELLS; GENE; MITOSIS	Overexpression of Sam68 functionally substitutes for, as well as synergizes with, human immunodeficiency virus type 1 (HIV-1) Rev in RRE (Rev response element)mediated gene expression and virus replication. In addition, COOH-terminal deletion and/or point mutants of Sam68 exhibit a transdominant negative phenotype for HIV replication. Sam68 is a member of KH domain family that includes SLM-1, SLM-2 ((S) under bar am68 (l) under bar ike (m) under bar ammalian); and QKI-5, QKI-6, and QKI-7 (mouse quaking) proteins. The objective of this study was to examine the effects of these KH family proteins on RRE- and CTE ((c) under bar onstitutive (t) under bar ransport (e) under bar lement of type-D retrovirus)-mediated transactivation. We now report that SLM-1 and SLM-2 proteins, which are the closest relatives of Sam68, marginally enhanced RRE-mediated transactivation, while QK isoforms that are distant relatives of Sam68 had no effect. Interestingly, these proteins still enhanced the effect of Rev in RRE-mediated gene expression. The increase in chloramphenicol acetyltransferase activity was also reflected at the levels of cytoplasmic RRE-chloramphenicol acetyltransferase mRNAs, indicating that Sam68 and KH proteins may have been involved in the stability or export of unspliced RNA. The increase in Rev activity was sensitive to leptomycin B, but not to olomoucine, indicating that the effect of SLM-1, SLM-2, QKI-5, QKI-6, and QKI-7 is exerted through a CRM-1-dependent mRNA export pathway. Thus, KH family proteins play an important role in the post-transcriptional regulation of HIV.	Wayne State Univ, Dept Immunol & Microbiol, Detroit, MI 48201 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Texas, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Wayne State University; University of California System; University of California San Diego; University of Texas System; University of Texas Austin	Reddy, TR (corresponding author), Wayne State Univ, Dept Immunol & Microbiol, Detroit, MI 48201 USA.	trreddy@med.wayne.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046240] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOGERD HP, 1995, CELL, V82, P485, DOI 10.1016/0092-8674(95)90437-9; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Chen TP, 2001, J BIOL CHEM, V276, P30803, DOI 10.1074/jbc.M102247200; CRUZALVAREZ M, 1987, J BIOL CHEM, V262, P13377; Di Fruscio M, 1999, P NATL ACAD SCI USA, V96, P2710, DOI 10.1073/pnas.96.6.2710; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; LUO Y, 1994, J VIROL, V68, P3850, DOI 10.1128/JVI.68.6.3850-3856.1994; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; MALIM MH, 1992, J EXP MED, V176, P1197, DOI 10.1084/jem.176.4.1197; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; McBride AE, 1996, P NATL ACAD SCI USA, V93, P2296, DOI 10.1073/pnas.93.6.2296; MYER BE, 1994, GENE DEV, V8, P1538; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Powell DM, 1997, P NATL ACAD SCI USA, V94, P973, DOI 10.1073/pnas.94.3.973; Ranga U, 1998, P NATL ACAD SCI USA, V95, P1201, DOI 10.1073/pnas.95.3.1201; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; Reddy TR, 2000, ONCOGENE, V19, P3110, DOI 10.1038/sj.onc.1203637; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Resnick RJ, 1997, ONCOGENE, V15, P1247, DOI 10.1038/sj.onc.1201289; RUHL M, 1993, J CELL BIOL, V123, P1309, DOI 10.1083/jcb.123.6.1309; Saccomanno L, 1999, P NATL ACAD SCI USA, V96, P12605, DOI 10.1073/pnas.96.22.12605; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; Sambrook J., 1989, IMMUNOLOGY, V2nd; Sanchez-Margalet V, 2001, MOL CELL ENDOCRINOL, V183, P113, DOI 10.1016/S0303-7207(01)00587-1; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Tange TO, 1996, J BIOL CHEM, V271, P10066, DOI 10.1074/jbc.271.17.10066; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Woffendin C, 1996, P NATL ACAD SCI USA, V93, P2889, DOI 10.1073/pnas.93.7.2889; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Xu Yuan, 1996, Journal of Biomedical Science, V3, P82, DOI 10.1007/BF02255535	41	23	26	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5778	5784		10.1074/jbc.M106836200	http://dx.doi.org/10.1074/jbc.M106836200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741900	hybrid			2022-12-27	WOS:000173989200013
J	Capell, A; Meyn, L; Fluhrer, R; Teplow, DB; Walter, J; Haass, C				Capell, A; Meyn, L; Fluhrer, R; Teplow, DB; Walter, J; Haass, C			Apical sorting of beta-secretase limits amyloid beta-peptide production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN VARIANT; CANINE KIDNEY-CELLS; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; MDCK CELLS; CLEAVAGE; PRESENILIN-1; METABOLISM; MUTATION; SITE	Polarized cells such as neurons and endothelial cells appear to be involved in two invariant pathological features of Alzheimer's disease pathology, namely the formation of senile plaques and cerebral amyloid angiopathy. This implicates polarized sorting mechanisms in the production and accumulation of amyloid beta-peptide (Abeta). We have now studied polarized sorting of beta-secretase (BACE) in Madin-Darby canine kidney (MDCK) cells. The majority of BACE is sorted to the apical surface of MDCK cells where very little beta-amyloid precursor protein (betaAPP) is observed, because betaAPP undergoes basolateral sorting. Consistent with the usage of similar mechanisms for polarized sorting, BACE was also found to be targeted to axons of hippocampal neurons. The remaining basolaterally sorted BACE competes with the highly polarized basolateral alpha-secretase activity. Therefore, substantial amounts of BACE are targeted away from betaAPP to a non-amyloidogenic compartment, a cellular mechanism that limits Abeta generation. In addition, no alpha-secretase activity was observed on the apical side whereas gamma-secretase activity is observed on the basolateral and the apical side. Consistent with this finding, substantial amounts of Abeta can be produced apically upon missorting of PAPP to the apical surface. These data demonstrate that Abeta production is limited in polarized cells by differential targeting of BACE and its substrate betaAPP. Moreover, our findings suggest that betaAPP may not be a major physiological substrate of BACE.	Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, D-80336 Munich, Germany; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	University of Munich; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Haass, C (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Alzheimers & Parkinsons Dis Res, Schillerstr 44, D-80336 Munich, Germany.		Walter, Jochen/B-3677-2014; Wang, Caihong/T-5837-2019; Fluhrer, Regina/F-2642-2011	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912				Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; DESTROOPER B, 1995, J BIOL CHEM, V270, P4058, DOI 10.1074/jbc.270.8.4058; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HAASS C, 1991, J NEUROSCI, V11, P3783; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Keller P, 1997, J CELL SCI, V110, P3001; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; LO ACY, 1994, J BIOL CHEM, V269, P30966; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walter J, 1997, P NATL ACAD SCI USA, V94, P5349, DOI 10.1073/pnas.94.10.5349; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108	43	65	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5637	5643		10.1074/jbc.M109119200	http://dx.doi.org/10.1074/jbc.M109119200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741885	Green Published, hybrid			2022-12-27	WOS:000173962900140
J	Stimson, KM; Vertino, PM				Stimson, KM; Vertino, PM			Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; RECRUITMENT DOMAIN PROTEIN; ENHANCER-BLOCKING ACTIVITY; APRT GENE PROMOTER; GROWTH-FACTOR-II; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; BINDING-SITE; IN-VIVO; CTCF	Aberrant methylation of CpG-dense islands in the promoter regions of genes is an acquired epigenetic alteration associated with the silencing of tumor suppressor genes in human cancers. In a screen for endogenous targets of methylation-mediated gene silencing, we identified a novel CpG island-associated gene, TMS1, which is aberrantly methylated and silenced in response to the ectopic expression of DNA methyltransferase-1. TMS1 functions in the regulation of apoptosis and is frequently methylated and silenced in human breast cancers. In this study, we characterized the methylation pattern and chromatin architecture of the TMS1 locus in normal fibroblasts and determined the changes associated with its progressive methylation. In normal fibroblasts expressing TMS1, the CpG island is defined by an unmethylated domain that is separated from densely methylated flanking DNA by distinct 5' and 3' boundaries. Analysis of the nucleoprotein architecture of the locus in intact nuclei revealed three DNase I-hypersensitive sites that map within the CpG island. Strikingly, two of these sites coincided with the 5'- and 3'-methylation boundaries. Methylation of the TMS1 CpG island was accompanied by loss of hypersensitive site formation, hypoacetylation of histones H3 and H4, and gene silencing. This altered chromatin structure was confined to the CpG island and occurred without significant changes in methylation, histone acetylation, or hypersensitive site formation at a fourth DNase I-hypersensitive site 2 kb downstream of the TMS1 CpG island. The data indicate that there are sites of protein binding and/or structural transitions that define the boundaries of the unmethylated CpG island in normal cells and that aberrant methylation overcomes these boundaries to direct a local change in chromatin structure, resulting in gene silencing.	Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Vertino, PM (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, 1365-B Clifton Rd,NE,Rm B5119, Atlanta, GA 30322 USA.	pvertin@emory.edu	Hu, Ruogu/B-2203-2008	Crider, Krista/0000-0001-6997-5955	NATIONAL CANCER INSTITUTE [R01CA077337] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA077337-05, R01 CA077337, R01 CA077337-04, CA77137, R01 CA077337-03, R01 CA077337-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Conway KE, 2000, CANCER RES, V60, P6236; Cui HM, 2001, CANCER RES, V61, P4947; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Esteller M, 2001, CANCER RES, V61, P3225; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; Han L, 2001, MOL CELL BIOL, V21, P3416, DOI 10.1128/MCB.21.10.3416-3424.2001; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hendrich B, 2000, CURR TOP MICROBIOL, V249, P55; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Jaenisch R, 1998, CIBA F SYMP, V214, P200; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Katzenellenbogen RA, 1999, BLOOD, V93, P4347, DOI 10.1182/blood.V93.12.4347.412k31_4347_4353; Kissil JL, 1997, ONCOGENE, V15, P403, DOI 10.1038/sj.onc.1201172; KLADDE MP, 1994, P NATL ACAD SCI USA, V91, P1361, DOI 10.1073/pnas.91.4.1361; Kladde MP, 1996, EMBO J, V15, P6290, DOI 10.1002/j.1460-2075.1996.tb01019.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Mann M, 2000, BERL J SOZIOL, V10, P241, DOI 10.1007/BF03204353; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; McConnell BB, 2000, CANCER RES, V60, P6243; Millar DS, 2000, J BIOL CHEM, V275, P24893, DOI 10.1074/jbc.M906538199; MUMMANENI P, 1993, J BIOL CHEM, V268, P552; Mummaneni P, 1998, NUCLEIC ACIDS RES, V26, P5163, DOI 10.1093/nar/26.22.5163; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Rice JC, 2000, NUCLEIC ACIDS RES, V28, P3233, DOI 10.1093/nar/28.17.3233; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664	53	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4951	4958		10.1074/jbc.M109809200	http://dx.doi.org/10.1074/jbc.M109809200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733524	hybrid			2022-12-27	WOS:000173962900054
J	Tottey, S; Rondet, SAM; Borrelly, GPM; Robinson, PJ; Rich, PR; Robinson, NJ				Tottey, S; Rondet, SAM; Borrelly, GPM; Robinson, PJ; Rich, PR; Robinson, NJ			A copper metallochaperone for photosynthesis and respiration reveals metal-specific targets, interaction with an importer, and alternative sites for copper acquisition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; SYNECHOCYSTIS PCC 6803; CYTOCHROME-BF COMPLEX; SUPEROXIDE-DISMUTASE; SACCHAROMYCES-CEREVISIAE; ATX1 METALLOCHAPERONE; PHOTOSYSTEM-I; ZNTA GENE; CHAPERONE; PROTEINS	A bacterial two-hybrid assay revealed interaction between a protein now designated bacterial Atx1 and amino-terminal domains of copper-transporting ATPases CtaA (cellular import) and PacS (thylakoid import) but not the related zinc (ZiaA) or cobalt (CoaT) transporters from the same organism (Synechocystis PCC 6803). The specificity of metallochaperone interactions coincides with metal specificity. After reconstitution in a N-2 atmosphere, bacterial Atx1 bound 1 mol of copper mol(-1), and apoPacS(N) acquired copper from copper-Atx1. Copper was displaced from Atx1 by p-(hydroxymercuri)phenylsulfonate, indicative of thiol ligands, and two cysteine residues were obligatory for two-hybrid interaction with PacS(N). This organism contains compartments (thylakoids) where the copper proteins plastocyanin and cytochrome oxidase reside. In copper super-supplemented mutants, photooxidation of cytochrome c(6) was greater in Deltaatx1DeltactaA than in DeltactaA, showing that Atx1 contributes to efficient switching from iron in cytochrome c(6) to copper in plastocyanin for photosynthetic electron transport. Cytochrome oxidase activity was also less in membranes purified from low [copper]grown Deltaatx1 or DeltapacS, compared with wild-type, but the double mutant Deltaatx1DeltapacS was non-additive, consistent with Atx1 acting via PacS. Conversely, activity in Deltaatx1DeltactaA was less than in either respective single mutant, revealing that Atx1 can function without the major copper importer and consistent with a role in recycling endogenous copper.	UCL, Dept Biol, Glynn Res Lab Bioenerget, London WC1E 6BT, England; Univ Newcastle, Sch Med, Dept Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of London; University College London; Newcastle University - UK	Robinson, NJ (corresponding author), UCL, Dept Biol, Glynn Res Lab Bioenerget, Mortimer St, London WC1E 6BT, England.	n.j.robinson@newcastle.ac.uk	Robinson, Nigel J/J-6363-2012	Robinson, Nigel J/0000-0001-5586-1092				Arnesano F, 2001, J BIOL CHEM, V276, P41365, DOI 10.1074/jbc.M104807200; Banci L, 2001, J BIOL CHEM, V276, P8415, DOI 10.1074/jbc.M008389200; Beard SJ, 1997, MOL MICROBIOL, V25, P883, DOI 10.1111/j.1365-2958.1997.mmi518.x; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DASILVA JRR, 1991, BIOL CHEM ELEMENTS, P11; DWORSKY A, 1995, BIOELECTROCH BIOENER, V38, P35, DOI 10.1016/0302-4598(95)01787-F; Gatti D, 2000, J BIOL CHEM, V275, P34009, DOI 10.1074/jbc.R000012200; Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545; HAGEMANN M, 1992, ARCH MICROBIOL, V158, P429; Harrison MD, 2000, TRENDS BIOCHEM SCI, V25, P29, DOI 10.1016/S0968-0004(99)01492-9; Heaton DN, 2001, BIOCHEMISTRY-US, V40, P743, DOI 10.1021/bi002315x; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; KANAMARU K, 1994, MOL MICROBIOL, V13, P369, DOI 10.1111/j.1365-2958.1994.tb00430.x; Kaneko T, 1996, DNA Res, V3, P109; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; Lin SJ, 1997, J BIOL CHEM, V272, P9215; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Manna P, 1997, PLANT MOL BIOL, V35, P407, DOI 10.1023/A:1005875124387; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PHUNG LT, 1994, P NATL ACAD SCI USA, V91, P9651, DOI 10.1073/pnas.91.20.9651; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Portnoy ME, 1999, J BIOL CHEM, V274, P15041, DOI 10.1074/jbc.274.21.15041; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; RICH PR, 1987, BIOCHIM BIOPHYS ACTA, V892, P138, DOI 10.1016/0005-2728(87)90256-8; RICH PR, 1991, BIOCHIM BIOPHYS ACTA, V1058, P312, DOI 10.1016/S0005-2728(05)80252-X; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Rutherford JC, 1999, J BIOL CHEM, V274, P25827, DOI 10.1074/jbc.274.36.25827; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmetterer G, 1994, MOL BIOL CYANOBACTER, P409, DOI DOI 10.1007/0-306-48205-3_13; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; TURNER JS, 1993, J BIOL CHEM, V268, P4494; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; ZHANG L, 1992, J BIOL CHEM, V267, P19054	48	83	88	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5490	5497		10.1074/jbc.M105857200	http://dx.doi.org/10.1074/jbc.M105857200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739376	hybrid			2022-12-27	WOS:000173962900121
J	Unsold, C; Pappano, WN; Imamura, Y; Steiglitz, BM; Greenspan, DS				Unsold, C; Pappano, WN; Imamura, Y; Steiglitz, BM; Greenspan, DS			Biosynthetic processing of the pro-alpha 1(V)(2)pro-alpha 2(V) collagen heterotrimer by bone morphogenetic protein-1 and furin-like proprotein convertases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; MAMMALIAN TOLLOID-LIKE; COOH-TERMINAL PROPEPTIDE; EHLERS-DANLOS SYNDROME; V COLLAGEN; XI COLLAGEN; PRO-ALPHA-1(V) COLLAGEN; MATRIX-FORMS; GENE COL5A1; B-CHAINS	The low abundance fibrillar collagen type V is incorporated into and regulates the diameters of type I collagen fibrils. Bone morphogenetic protein-1 (BMP-1) is a metalloprotease that plays key roles in regulating formation of vertebrate extracellular matrix; it cleaves the C-propeptides of the major fibrillar procollagens I-III and processes precursors to produce the mature forms of the cross-linking enzyme prolysyl oxidase, the proteoglycan biglycan, and the basement membrane protein laminin 5. Here we have successfully produced recombinant pro-alpha1(V)(2)pro-alpha2(V) heterotrimers, and we have used these to characterize biosynthetic processing of the most prevalent in vivo form of type V procollagen. In addition, we have compared the processing of endogenous pro-alpha1M chains by wild type mouse embryo fibroblasts and by fibroblasts derived from embryos doubly homozygous null for the Bmp-1 gene and for a gene encoding the closely related metalloprotease mammalian Tolloid-like 1. Together, results presented herein indicate that within pro-alpha1(V)(2)pro-alpha2(V) heterotrimers, pro-alpha1(V) N-propeptides and pro-alpha2(V) C-propeptides are processed by BMP-1-like enzymes, and pro-alpha1(V) C-propeptides are processed by furin-like proprotein convertases in vivo.	Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Greenspan, DS (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.		Imamura, Yasutada/AAI-3078-2020	Imamura, Yasutada/0000-0001-6264-1709; Greenspan, Daniel/0000-0001-8096-7446; Pappano, William/0000-0003-2848-2219	NIAMS NIH HHS [AR47746] Funding Source: Medline; NIGMS NIH HHS [GM63471, T32 GM07215] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047746, R56AR047746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, R01GM063471] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; BENTZ H, 1978, EUR J BIOCHEM, V92, P563, DOI 10.1111/j.1432-1033.1978.tb12778.x; BERNARD M, 1988, J BIOL CHEM, V263, P17159; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1990, J CELL SCI, V95, P649; BROEK DL, 1985, J BIOL CHEM, V260, P555; Clark TG, 1999, DEVELOPMENT, V126, P2631; Eyre D, 1987, STRUCTURE FUNCTION C, P261; FESSLER JH, 1987, STRUCTURE FUNCTION C, P81; Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083; FICHARD A, 1994, MATRIX BIOL, V14, P515; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; GREENSPAN DS, 1989, J BIOL CHEM, V264, P20683; HARALSON MA, 1980, P NATL ACAD SCI-BIOL, V77, P5206, DOI 10.1073/pnas.77.9.5206; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Hulmes DJS, 1992, ESSAYS BIOCHEM, V27, P49; Imamura Y, 2000, J BIOL CHEM, V275, P8749, DOI 10.1074/jbc.275.12.8749; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Kessler E, 2001, J BIOL CHEM, V276, P27051, DOI 10.1074/jbc.M102921200; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; KESSLER E, 1986, COLLAGEN REL RES, V6, P249; KLEMAN JP, 1992, EUR J BIOCHEM, V210, P329, DOI 10.1111/j.1432-1033.1992.tb17425.x; KUMAMOTO CA, 1981, J BIOL CHEM, V256, P7053; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; MAYNE R, 1993, J BIOL CHEM, V268, P9381; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MORADIAMELI M, 1994, EUR J BIOCHEM, V221, P987, DOI 10.1111/j.1432-1033.1994.tb18815.x; MORRIS NP, 1987, J BIOL CHEM, V262, P11345; MYERS JC, 1985, J BIOL CHEM, V260, P1216; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; NIYIBIZI C, 1993, BIOCHIM BIOPHYS ACTA, V1203, P304, DOI 10.1016/0167-4838(93)90099-D; NIYIBIZI C, 1989, FEBS LETT, V242, P314, DOI 10.1016/0014-5793(89)80492-2; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PROCKOP DJ, 1994, EXTRACELLULAR MATRIX, P47; RHODES RK, 1981, COLLAGEN REL RES, V1, P337; Rousseau JC, 1996, J BIOL CHEM, V271, P23743, DOI 10.1074/jbc.271.39.23743; SAGE H, 1981, BIOCHEMISTRY-US, V20, P3778, DOI 10.1021/bi00516a017; SAGE H, 1979, BIOCHEMISTRY-US, V18, P3815, DOI 10.1021/bi00584a027; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Suzuki N, 1996, DEVELOPMENT, V122, P3587; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; TAKAHARA K, 1995, GENOMICS, V29, P588, DOI 10.1006/geno.1995.9961; Takahara K, 1996, GENOMICS, V34, P157, DOI 10.1006/geno.1996.0260; THOM JR, 1991, J BIOL CHEM, V266, P7262; TORIELLO HV, 1996, NAT GENET, V13, P36; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; WEIL D, 1987, NUCLEIC ACIDS RES, V15, P181, DOI 10.1093/nar/15.1.181; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WOODBURY D, 1989, J BIOL CHEM, V264, P2735	58	71	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5596	5602		10.1074/jbc.M110003200	http://dx.doi.org/10.1074/jbc.M110003200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741999	hybrid			2022-12-27	WOS:000173962900135
J	Liu, H; Park, WC; Bentrem, DJ; McKian, KP; De los Reyes, A; Loweth, JA; Schafer, JM; Zapf, JW; Jordan, VC				Liu, H; Park, WC; Bentrem, DJ; McKian, KP; De los Reyes, A; Loweth, JA; Schafer, JM; Zapf, JW; Jordan, VC			Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; POSTMENOPAUSAL WOMEN; NUCLEAR RECEPTOR; ANTI-ESTROGENS; MESSENGER-RNA; ATHYMIC MICE; TAMOXIFEN; ANTIESTROGEN; MCF-7; ANTAGONISM	Amino acid Asp-351 in the ligand binding domain of estrogen receptor alpha (ERalpha) plays an important role in regulating the estrogen-like activity of selective estrogen receptor modulator-ERalpha complexes. 4-Hydroxytamoxifen is a full agonist at a transforming growth factor a target gene in situ in MDA-MB-231 human breast cancer cells stably transfected with the wild-type ERalpha. In contrast, raloxifene (Ral), which is also a selective estrogen receptor modulator, is a complete antiestrogen in this system. Because D351G ERalpha allosterically silences activation function-1 activity in the 4-hydroxytamoxifen-ERalpha complex with the complete loss of estrogen-like activity, we examined the converse interaction of amino acid 351 and the piperidine ring of the antiestrogen side chain of raloxifene to enhance estrogen-like action. MDA-MB-231 cells were either transiently or stably transfected with Asp-351 (the wild type), D351E, D351Y, or D351F ERa expression vectors. Profound differences in the agonist and antagonist actions of Ral-ERalpha complexes were noted only in stable transfectants. The agonist activity of the Ral-ERalpha complex was enhanced with D351E and D351Y ERalpha, but raloxifene lost its agonist activity with D351F ERalpha. The distance between the piperidine nitrogen of raloxifene and the negative charge of amino acid 351 was critical for estrogen-like actions. The role of the piperidine ring in neutralizing Asp-351 was addressed using compound R1h, a raloxifene derivative replacing the nitrogen on its piperidine ring with a carbon to form cyclohexane. The derivative was a potent agonist with wild type ERalpha. These results support the concept that the side chain of raloxifene shields and neutralizes the Asp-351 to produce an antiestrogenic ERalpha complex. Alteration of either the side chain or its relationship with the negative charge at amino acid 351 controls the estrogen-like action at activating function 2b of the selective estrogen receptor modulator ERalpha complex.	Northwestern Univ, Med Sch, Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Northwestern Univ, Med Sch, Dept Surg, Chicago, IL 60611 USA; Maxia Pharmaceut, San Diego, CA 92121 USA	Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University	Jordan, VC (corresponding author), Northwestern Univ, Med Sch, Lurie Comprehens Canc Ctr, Olson Pavil 8258 303 E Chicago Ave, Chicago, IL 60611 USA.		JORDAN, V.Craig/AAX-3562-2020; Jordan, V. Craig/H-4491-2011		NATIONAL CANCER INSTITUTE [P50CA089018] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA089018, CA89018-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anghel SI, 2000, J BIOL CHEM, V275, P20867, DOI 10.1074/jbc.M002098200; Anzano MA, 1996, J NATL CANCER I, V88, P123, DOI 10.1093/jnci/88.2.123; Assikis VJ, 1996, EUR J CANCER, V32A, P1464, DOI 10.1016/0959-8049(96)00184-0; Bentrem DJ, 2001, ENDOCRINOLOGY, V142, P838, DOI 10.1210/en.142.2.838; BLACK LJ, 1994, J CLIN INVEST, V93, P63, DOI 10.1172/JCI116985; BLACK LJ, 1983, LIFE SCI, V32, P1031, DOI 10.1016/0024-3205(83)90935-9; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; BUZDAR AU, 1988, ONCOLOGY, V45, P344, DOI 10.1159/000226637; CATHERINO WH, 1995, MOL ENDOCRINOL, V9, P1053, DOI 10.1210/me.9.8.1053; Clarke M, 1998, LANCET, V351, P1451; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Ekena K, 1997, J BIOL CHEM, V272, P5069, DOI 10.1074/jbc.272.8.5069; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; GOTTARDIS MM, 1988, CANCER RES, V48, P5183; GOTTARDIS MM, 1987, CANCER RES, V47, P4020; Grese TA, 1997, P NATL ACAD SCI USA, V94, P14105, DOI 10.1073/pnas.94.25.14105; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; JIANG SY, 1992, JNCI-J NATL CANCER I, V84, P580, DOI 10.1093/jnci/84.8.580; JORDAN VC, 1987, BREAST CANCER RES TR, V10, P31, DOI 10.1007/BF01806132; JORDAN VC, 1977, J ENDOCRINOL, V75, P305, DOI 10.1677/joe.0.0750305; Jordan VC, 2001, CANCER RES, V61, P6619; JORDAN VC, 1982, MOL CELL ENDOCRINOL, V27, P291, DOI 10.1016/0303-7207(82)90095-8; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Klinge CM, 2001, MOL CELL ENDOCRINOL, V174, P151, DOI 10.1016/S0303-7207(01)00382-3; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Levenson AS, 1998, CANCER RES, V58, P1872; Levenson AS, 1997, J STEROID BIOCHEM, V60, P261, DOI 10.1016/S0960-0760(96)00184-7; Levenson AS, 1999, EUR J CANCER, V35, P1628, DOI 10.1016/S0959-8049(99)00183-5; Levenson AS, 1998, BRIT J CANCER, V77, P1812, DOI 10.1038/bjc.1998.301; LIEBERMAN ME, 1983, J BIOL CHEM, V258, P4741; Liu H, 2001, CANCER RES, V61, P3632; LIU H, 1994, JNCI-J NATL CANCER I, V86, P1758, DOI 10.1093/jnci/86.23.1758; Liu JH, 2001, J AGR FOOD CHEM, V49, P2472, DOI 10.1021/jf0014157; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Pink JJ, 1996, BRIT J CANCER, V74, P1227, DOI 10.1038/bjc.1996.521; Ramsey TL, 2001, J MOL ENDOCRINOL, V27, P275, DOI 10.1677/jme.0.0270275; ROBERTSON DW, 1982, J MED CHEM, V25, P167, DOI 10.1021/jm00344a015; Schafer JIM, 1999, CANCER RES, V59, P4308; Schafer JM, 2000, CANCER RES, V60, P5097; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Snyder KR, 2000, AM J HEALTH-SYST PH, V57, P1669, DOI 10.1093/ajhp/57.18.1669; TATE AC, 1984, CANCER RES, V44, P1012; Valentine JE, 2000, J BIOL CHEM, V275, P25322, DOI 10.1074/jbc.M002497200; Webb P, 2000, J BIOL CHEM, V275, P37552, DOI 10.1074/jbc.M007435200; WOLF DM, 1994, BREAST CANCER RES TR, V31, P129, DOI 10.1007/BF00689683; WOLF DM, 1994, BREAST CANCER RES TR, V31, P117, DOI 10.1007/BF00689682	53	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9189	9198		10.1074/jbc.M108335200	http://dx.doi.org/10.1074/jbc.M108335200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11751902	Green Accepted, hybrid			2022-12-27	WOS:000174400600062
J	Rittling, SR; Chen, YP; Feng, F; Wu, YM				Rittling, SR; Chen, YP; Feng, F; Wu, YM			Tumor-derived osteopontin is soluble, not matrix associated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-ASPARTIC ACID; CELL-ADHESION; PLASMINOGEN-ACTIVATOR; TRANSGENIC MICE; CROSS-LINKING; GROWTH-FACTOR; INTEGRIN; BONE; EXPRESSION; TRANSGLUTAMINASE	The secreted phosphoprotein osteopontin. (OPN), when immobilized on a surface, supports cell adhesion, prevents apoptosis of endothelial cells, and is a ligand for the alpha(v)beta(3) integrin, which is important in endothelial cell biology and neovascularization. OPN synthesized by tumor cells stimulates tumor growth, but the mechanism by which the protein acts remains unclear. One possibility, therefore, is that OPN may exert its effects on tumor growth by enhancing angiogenesis. While OPN is found at high levels in bone, where it is a component of the mineralized matrix, we have asked here whether OPN present in tumors is similarly extracellular matrix associated. We have shown that OPN is detectable in tumor extracts and in serum of tumor-bearing mice, and that the protein in tumors and in serum can be synthesized by both tumor and the host cells. Biochemical fractionation of tumor tissue confirmed that there is little if any association of OPN with the insoluble fraction. Immunochemical analysis of murine mammary tumors shows no co-localization of OPN with the extracellular matrix, identified by laminin staining. Ras-transformed cells in culture produce abundant OPN, however, the protein was found to be associated with the cell fraction but not with the matrix fraction. An enzyme-linked immunosorbent assay was used to demonstrate that OPN in conditioned medium from these cells fails to associate with extracellular matrix components, including laminin and fibronectin, in vitro. Recombinant OPN (GST-OPN) when coated onto a plastic surface can support human umbilical vein endothelial cell adhesion, suppressing apoptosis and allowing cell cycle progression, at concentrations from 1 to 50 mug/ml. Soluble GST-OPN in the same concentration range has no effect on HU-VECs held in suspension. Thus, we conclude that OPN associated with tumors is primarily soluble, and that soluble OPN can neither support endothelial cell proliferation nor prevent apoptosis of these cells in the absence of adhesion.	Rutgers State Univ, Dept Cell Biol & Neurosci, Nelson Labs, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Rittling, SR (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Nelson Labs, 604 Alison Rd, Piscataway, NJ 08854 USA.	rittling@mbcl.rutgers.edu			NATIONAL CANCER INSTITUTE [R01CA072740] Funding Source: NIH RePORTER; NCI NIH HHS [CA-72740] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; BAUTISTA DS, 1994, J BIOL CHEM, V269, P23280; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; BENINATI S, 1994, J BIOCHEM-TOKYO, V115, P675, DOI 10.1093/oxfordjournals.jbchem.a124395; BOURDON MA, 1985, J CELL BIOCHEM, V28, P183, DOI 10.1002/jcb.240280302; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; BROWN LF, 1994, AM J PATHOL, V145, P610; Burgess JW, 1998, J BIOL CHEM, V273, P5645, DOI 10.1074/jbc.273.10.5645; Butler William T., 1996, P167; Caltabiano S, 1999, BIOCHEM PHARMACOL, V58, P1567, DOI 10.1016/S0006-2952(99)00251-8; Casson AG, 1997, INT J CANCER, V72, P739, DOI 10.1002/(SICI)1097-0215(19970904)72:5<739::AID-IJC6>3.0.CO;2-T; CHAMBERS AF, 1993, CANCER RES, V53, P701; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; CHEN Y, 1992, J BIOL CHEM, V267, P24871; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Feng F, 2000, BREAST CANCER RES TR, V63, P71, DOI 10.1023/A:1006466516192; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; Katagiri YU, 1996, J CELL BIOCHEM, V62, P123, DOI 10.1002/(SICI)1097-4644(199607)62:1<123::AID-JCB13>3.0.CO;2-O; Katagiri YU, 1999, CANCER RES, V59, P219; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; Lin YH, 2000, MOL CELL BIOL, V20, P2734, DOI 10.1128/MCB.20.8.2734-2742.2000; LUSCINSKAS FW, 1994, FASEB J, V8, P929, DOI 10.1096/fasebj.8.12.7522194; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W; Nam TJ, 2000, ENDOCRINOLOGY, V141, P1100, DOI 10.1210/en.141.3.1100; O'Regan AW, 1999, J IMMUNOL, V162, P1024; OWENSBY DA, 1989, J BIOL CHEM, V264, P18180; PATTENGALE PK, 1989, AM J PATHOL, V135, P39; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Rittling SR, 1999, EXP NEPHROL, V7, P103; Rittling SR, 1997, CELL GROWTH DIFFER, V8, P1061; Rittling SR, 1998, BIOCHEM BIOPH RES CO, V250, P287, DOI 10.1006/bbrc.1998.9306; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Singhal H, 1997, CLIN CANCER RES, V3, P605; SOMERMAN MJ, 1989, MATRIX, V9, P49, DOI 10.1016/S0934-8832(89)80018-6; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; Tuck AB, 1999, ONCOGENE, V18, P4237, DOI 10.1038/sj.onc.1202799; VANDIJK S, 1993, J BONE MINER RES, V8, P1499; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wu Y, 2000, BRIT J CANCER, V83, P156; XUAN JW, 1995, J CELL BIOCHEM, V57, P680, DOI 10.1002/jcb.240570413; XUAN JW, 1994, J CELL BIOCHEM, V54, P247, DOI 10.1002/jcb.240540213; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	59	47	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9175	9182		10.1074/jbc.M109028200	http://dx.doi.org/10.1074/jbc.M109028200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11741994	hybrid			2022-12-27	WOS:000174400600060
J	Gardner, AM; Helmick, RA; Gardner, PR				Gardner, AM; Helmick, RA; Gardner, PR			Flavorubredoxin, an inducible catalyst for nitric oxide reduction and detoxification Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; PARACOCCUS-DENITRIFICANS; SUPEROXIDE SENSITIVITY; FLAVOHAEMOGLOBIN HMP; NITROSATIVE STRESS; NITROUS-OXIDE; DNA-SEQUENCE; FLAVOHEMOGLOBIN; DIOXYGENASE; PROTECTION	Nitric oxide (NO) is a poison, and organisms employ diverse systems to protect against its harmful effects. In Escherichia coli, ygaA encodes a transcription regulator (b2709) controlling anaerobic NO reduction and detoxification. Adjacent to ygaA and oppositely transcribed are ygaK (encoding a flavorubredoxin (flavoRb) (b2710) with a NO-binding non-heme diiron center) and ygbD (encoding a NADH:(flavo)Rb oxidoreductase (b2711)), which function in NO reduction and detoxification. Mutation of either ygaA or ygaK eliminated inducible anaerobic NO metabolism, whereas ygbD disruption partly impaired the activity. NO-sensitive [4Fe-4S] (de)hydratases, including the Krebs cycle aconitase and the Entner-Doudoroff pathway 6-phosphogluconate dehydratase, were more susceptible to inactivation in ygaK or ygaA mutants than in the parental strain, and these metabolic poisonings were associated with conditional growth inhibitions. flavoRb (NO reductase) and flavohemoglobin (NO dioxygenase) maximally metabolized and detoxified NO in anaerobic and aerobic E. coli, respectively, whereas both enzymes scavenged NO under microaerobic conditions. We suggest designation of the ygaA-ygaK-ygbD gene cluster as the norRVW modulon for NO reduction and detoxification.	Childrens Hosp, Med Ctr, Div Crit Care Med, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Gardner, PR (corresponding author), Childrens Hosp, Med Ctr, Div Crit Care Med, MLC7006,3333 Burnet Ave, Cincinnati, OH 45229 USA.	gardp0@chmcc.org		Helmick, Ryan/0000-0002-8819-9522; Gardner, Anne/0000-0001-7095-772X; Gardner, Paul/0000-0001-8189-0903	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065090] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM65090] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767; BOESE M, 1995, J BIOL CHEM, V270, P29244, DOI 10.1074/jbc.270.49.29244; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CARR GJ, 1990, BIOCHIM BIOPHYS ACTA, V1017, P57, DOI 10.1016/0005-2728(90)90178-7; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; COSTA C, 1990, FEBS LETT, V276, P67, DOI 10.1016/0014-5793(90)80508-G; Cross R, 2001, J BACTERIOL, V183, P3050, DOI 10.1128/JB.183.10.3050-3054.2001; DERMASTIA M, 1991, J BIOL CHEM, V266, P10899; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; Gardner PR, 2001, FREE RADICAL BIO MED, V31, P191, DOI 10.1016/S0891-5849(01)00569-X; GARNER PR, 2002, METHOD ENZYMOL, V349, P9; Gomes CM, 2000, BIOCHEMISTRY-US, V39, P16230, DOI 10.1021/bi001844y; HASKIN CJ, 1995, BIOCHEMISTRY-US, V34, P11090, DOI 10.1021/bi00035a014; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Householder TC, 2000, INFECT IMMUN, V68, P5241, DOI 10.1128/IAI.68.9.5241-5246.2000; Iijima M, 2000, CELL STRUCT FUNCT, V25, P47, DOI 10.1247/csf.25.47; JACKSON MA, 1991, FEBS LETT, V291, P41, DOI 10.1016/0014-5793(91)81099-T; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; KUSHNER SR, 1971, P NATL ACAD SCI USA, V68, P824, DOI 10.1073/pnas.68.4.824; leBrun NE, 1997, BIOCHEM J, V326, P173, DOI 10.1042/bj3260173; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; Liochev SI, 2001, J BIOL CHEM, V276, P35253, DOI 10.1074/jbc.M104237200; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Lumppio HL, 2001, J BACTERIOL, V183, P101, DOI 10.1128/JB.183.1.101-108.2001; Mills CE, 2001, BIOCHEM J, V353, P207, DOI 10.1042/0264-6021:3530207; Miranda KM, 2001, J BIOL CHEM, V276, P1720, DOI 10.1074/jbc.M006174200; NAKAHARA K, 1993, J BIOL CHEM, V268, P8350; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; NOCEK JM, 1988, BIOCHEMISTRY-US, V27, P1014, DOI 10.1021/bi00403a026; Payne WJ, 1997, BIOFACTORS, V6, P47, DOI 10.1002/biof.5520060106; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; RAMSEIER TM, 1994, DNA SEQUENCE, V5, P17, DOI 10.3109/10425179409039700; SANTOS H, 1993, BIOCHEM BIOPH RES CO, V195, P551, DOI 10.1006/bbrc.1993.2081; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; SHIRO Y, 1995, J BIOL CHEM, V270, P1617, DOI 10.1074/jbc.270.4.1617; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Wasserfallen A, 1998, EUR J BIOCHEM, V254, P325, DOI 10.1046/j.1432-1327.1998.2540325.x; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8; ZAFIRIOU OC, 1989, J BIOL CHEM, V264, P5694; ZHAO XJ, 1995, BIOCHEM BIOPH RES CO, V212, P1054, DOI 10.1006/bbrc.1995.2076; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	64	251	256	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8172	8177		10.1074/jbc.M110471200	http://dx.doi.org/10.1074/jbc.M110471200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751865	hybrid			2022-12-27	WOS:000174268000070
J	Ren, Q; Ahuja, U; Thony-Meyer, L				Ren, Q; Ahuja, U; Thony-Meyer, L			A bacterial cytochrome c heme lyase - CcmF forms a complex with the heme chaperone CcmE and CcmH but not with apocytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MATURATION; PROTEIN; BIOGENESIS; GENES; INSIGHTS; PATHWAY; SYSTEMS; MOTIF	Biogenesis of c-type cytochromes in Escherichia coli involves a number of membrane proteins (CcmA-H), which are required for the transfer of heme to the periplasmically located apocytochrome c. The pathway includes (i) covalent, transient binding of heme to the periplasmic domain of the heme chaperone CcmE; (ii) the subsequent release of heme; and (iii) transfer and covalent attachment of heme to apocytochrome c. Here, we report that CcmF is a key player in the late steps of cytochrome c maturation. We demonstrate that the conserved histidines His-173, His-261, His-303, and His-491 and the tryptophan-rich signature motif of the CcmF protein family are functionally required. Co-immunoprecipitation experiments revealed that CcmF interacts directly with the heme donor CcmE and with CcmH but not with apocytochrome c. We propose that CcmFH forms a bacterial heme lyase complex for the transfer of heme from CcmE to apocytochrome c.	ETH Zurich, Inst Mikrobiol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Thony-Meyer, L (corresponding author), ETH Zurich, Inst Mikrobiol, Schmelzbergstr 7, CH-8092 Zurich, Switzerland.		Ren, Qun/A-3532-2016; Ahuja, Umesh/ABC-2954-2020	Ren, Qun/0000-0003-0627-761X; 				CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Eaves DJ, 1998, MOL MICROBIOL, V28, P205, DOI 10.1046/j.1365-2958.1998.00792.x; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Fabianek RA, 1998, J BACTERIOL, V180, P1947, DOI 10.1128/JB.180.7.1947-1950.1998; Goldman BS, 1997, J MOL BIOL, V268, P724, DOI 10.1006/jmbi.1997.0992; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Goldman BS, 2001, RES MICROBIOL, V152, P323, DOI 10.1016/S0923-2508(01)01203-7; Grove J, 1996, MOL GEN GENET, V252, P332; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HUSSAIN H, 1994, MOL MICROBIOL, V12, P153, DOI 10.1111/j.1365-2958.1994.tb01004.x; IOBBINIVOL C, 1994, FEMS MICROBIOL LETT, V119, P89, DOI 10.1016/0378-1097(94)90397-2; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; Page MD, 1998, TRENDS BIOCHEM SCI, V23, P103, DOI 10.1016/S0968-0004(98)01173-6; Ren Q, 2001, J BIOL CHEM, V276, P32591, DOI 10.1074/jbc.M103058200; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Schulz H, 1999, P NATL ACAD SCI USA, V96, P6462, DOI 10.1073/pnas.96.11.6462; Schulz H, 2000, MOL MICROBIOL, V37, P1379, DOI 10.1046/j.1365-2958.2000.02083.x; Thony-Meyer L, 2000, BBA-BIOENERGETICS, V1459, P316, DOI 10.1016/S0005-2728(00)00167-5; THONYMEYER L, 1995, J BACTERIOL, V177, P4321; ThonyMeyer L, 1996, EUR J BIOCHEM, V235, P754, DOI 10.1111/j.1432-1033.1996.00754.x; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; ThroneHolst M, 1997, FEBS LETT, V410, P351, DOI 10.1016/S0014-5793(97)00656-X	24	89	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7657	7663		10.1074/jbc.M110979200	http://dx.doi.org/10.1074/jbc.M110979200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11744735	hybrid			2022-12-27	WOS:000174268000007
J	Dieci, G; Giuliodori, S; Catellani, M; Percudani, R; Ottonello, S				Dieci, G; Giuliodori, S; Catellani, M; Percudani, R; Ottonello, S			Intragenic promoter adaptation and facilitated RNA polymerase III recycling in the transcription of SCR1, the 7SL RNA gene of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; IN-VITRO TRANSCRIPTION; CYTOPLASMIC RNA; SNRNA GENE; YEAST; EXPRESSION; BINDING; DNA; ORGANIZATION; TERMINATION	The SCR1 gene, coding for the 7SL RNA of the signal recognition particle, is the last known class III gene of Saccharomyces cerevisiae that remains to be characterized with respect to its mode of transcription and promoter organization. We show here that SCR1 represents a unique case of a non-tRNA class III gene in which intragenic promoter elements (the TFIIIC-binding A-and B-blocks), corresponding to the D and TPsiC arms of mature tRNAs, have been adapted to a structurally different small RNA without losing their transcriptional function. In fact, despite the presence of an upstream canonical TATA box, SCR1 transcription strictly depends on the presence of functional, albeit quite unusual, A- and B-blocks and requires all the basal components of the RNA polymerase III transcription apparatus, including TFIIIC. Accordingly, TFIIIC was found to protect from DNase I digestion an 80-bp region comprising the A- and B-blocks. B-block inactivation completely compromised TFIIIC binding and transcription capacity in vitro and in vivo. An inactivating mutation in the A-block selectively affected TFIIIC binding to this promoter element but resulted in much more dramatic impairment of in vivo than in vitro transcription. Transcriptional competition and nucleosome disruption experiments showed that this stronger in vivo defect is due to a reduced ability of A-block-mutated SCR1 to compete with other genes for TFIIIC binding and to counteract the assembly of repressive chromatin structures through TFIIIC recruitment. A kinetic analysis further revealed that facilitated RNA polymerase III recycling, far from being restricted to typical small sized class III templates, also takes place on the 522-bp-long SCR1 gene, the longest known class III transcriptional unit.	Univ Parma, Dipartmento Biochim & Biol Mol, I-43100 Parma, Italy	University of Parma	Ottonello, S (corresponding author), Univ Parma, Dipartmento Biochim & Biol Mol, I-43100 Parma, Italy.	s.ottonello@unipr.it	percudani, riccardo/B-4872-2011; Dieci, Giorgio/B-3434-2012	percudani, riccardo/0000-0001-8452-1062; Dieci, Giorgio/0000-0002-8792-3961				Ben-Shlomo H, 1997, NUCLEIC ACIDS RES, V25, P4977, DOI 10.1093/nar/25.24.4977; BREDOW S, 1990, GENE, V86, P217, DOI 10.1016/0378-1119(90)90282-V; BREDOW S, 1990, NUCLEIC ACIDS RES, V18, P6779, DOI 10.1093/nar/18.23.6779; Briand JF, 2001, MOL CELL BIOL, V21, P189, DOI 10.1128/MCB.21.1.189-195.2001; BURNOL AF, 1993, J MOL BIOL, V233, P644, DOI 10.1006/jmbi.1993.1542; CAMIER S, 1985, EMBO J, V4, P491, DOI 10.1002/j.1460-2075.1985.tb03655.x; CHALKER DL, 1993, P NATL ACAD SCI USA, V90, P4927, DOI 10.1073/pnas.90.11.4927; Ching OY, 2000, MOL CELL BIOL, V20, P1329, DOI 10.1128/MCB.20.4.1329-1343.2000; Cloutier TE, 2001, P NATL ACAD SCI USA, V98, P9581, DOI 10.1073/pnas.161292298; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; Dieci G, 2000, J MOL BIOL, V299, P601, DOI 10.1006/jmbi.2000.3783; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dieci G, 2000, PROTEIN EXPRES PURIF, V18, P346, DOI 10.1006/prep.2000.1203; Dieci G, 2001, J BIOL CHEM, V276, P5720, DOI 10.1074/jbc.M009367200; DIECI G, 1993, J BIOL CHEM, V268, P11199; DIRKHEIMER G, 1995, TRNA STRUCTURE BIOSY, P93; Emde G, 1997, RNA, V3, P538; ESCHENLAUER JB, 1993, MOL CELL BIOL, V13, P3015, DOI 10.1128/MCB.13.5.3015; Fan H, 1997, CELL, V88, P707, DOI 10.1016/S0092-8674(00)81913-3; FELICI F, 1989, MOL CELL BIOL, V9, P3260, DOI 10.1128/MCB.9.8.3260; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Gorodkin J, 2001, NUCLEIC ACIDS RES, V29, P169, DOI 10.1093/nar/29.1.169; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HEARD DJ, 1995, NUCLEIC ACIDS RES, V23, P1970, DOI 10.1093/nar/23.11.1970; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Huet J, 1996, METHOD ENZYMOL, V273, P249; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KAISER MW, 1995, J BIOL CHEM, V270, P11398, DOI 10.1074/jbc.270.19.11398; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; KLEINERT H, 1988, J BIOL CHEM, V263, P11511; LEE JY, 1991, P NATL ACAD SCI USA, V88, P6986, DOI 10.1073/pnas.88.16.6986; Lee Y, 1997, J MOL BIOL, V269, P676, DOI 10.1006/jmbi.1997.1071; LOPEZDELEON A, 1992, CELL, V71, P211, DOI 10.1016/0092-8674(92)90350-L; MARSOLIER MC, 1995, GENE DEV, V9, P410, DOI 10.1101/gad.9.4.410; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Muller J, 1999, BIOCHEM CELL BIOL, V77, P431, DOI 10.1139/bcb-77-5-431; NAKAAR V, 1994, MOL CELL BIOL, V14, P6736, DOI 10.1128/MCB.14.10.6736; PAVESI A, 1994, NUCLEIC ACIDS RES, V22, P1247, DOI 10.1093/nar/22.7.1247; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Pizzi S, 1999, J BIOL CHEM, V274, P2539, DOI 10.1074/jbc.274.4.2539; Rodicker F, 1999, GENE EXPRESSION, V8, P165; Ruth J, 1996, EMBO J, V15, P1941, DOI 10.1002/j.1460-2075.1996.tb00545.x; Strub K, 1999, RNA, V5, P1333, DOI 10.1017/S1355838299991045; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; Wang ZX, 1996, MOL CELL BIOL, V16, P6841; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WHITE RJ, 1998, RAN POLYMERASE 3 TRA; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; WISE JA, 1991, METHOD ENZYMOL, V194, P405; Yukawa Y, 2000, PLANT J, V22, P439, DOI 10.1046/j.1365-313X.2000.00752.x	53	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6903	6914		10.1074/jbc.M105036200	http://dx.doi.org/10.1074/jbc.M105036200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741971	hybrid			2022-12-27	WOS:000174104300022
J	Dintilhac, A; Bernues, J				Dintilhac, A; Bernues, J			HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; TRANSCRIPTION FACTORS; MOBILITY; HMG-1; IDENTIFICATION; ASSOCIATION; RECEPTORS; CLEAVAGE; ENHANCE; COMPLEX	The chromatin high mobility group protein 1 (HMGB1) is a very abundant and conserved protein that is structured into two HMG box domains plus a highly acidic C-terminal domain. From the ability to bind DNA nonspecifically and to interact with various proteins, several functions in DNA-related processes have been assigned to HMGB1. Nevertheless, its functional role remains the subject of controversy. Using a phage display approach we have shown that HMGB1 can recognize several peptide motifs. A computer search of the protein data bases found peptide homologies with proteins already known to interact with HMGB1, like p53, and have allowed us to identify new potential candidates. Among them, transcriptional activators like the heterogeneous nuclear ribonucleoprotein K (hnRNP K), repressors like methyl-CpG binding protein 2 (MeCP2), and co-repressors like the retinoblastoma susceptibility protein (pRb) and Groucho-related gene proteins 1 (Grg1) and 5 (Grg5) can be found. A detailed analysis of the interaction of Grg1 with HMGB1 confirmed that the binding region contained the sequence homologous to one of the peptides identified. Our results have led us to propose that HMGB1 may play a central role in the stabilization and/or assembly of several multifunctional complexes through protein-protein interactions.	Consell Super Invest Cient, Cid, Inst Biol Mol Barcelona, Dept Mol & Cellular Biol, E-08034 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Bernues, J (corresponding author), Consell Super Invest Cient, Cid, Inst Biol Mol Barcelona, Dept Mol & Cellular Biol, Jordi Girona 18-26, E-08034 Barcelona, Spain.	jbmbmc@ibmb.csic.es	Bernues, Jordi/ABE-8360-2021	Bernues, Jordi/0000-0001-6218-8254				Aidinis V, 1999, MOL CELL BIOL, V19, P6532; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERNUES J, 1986, BIOCHIM BIOPHYS ACTA, V866, P242, DOI 10.1016/0167-4781(86)90049-7; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Butteroni C, 2000, J MOL BIOL, V304, P529, DOI 10.1006/jmbi.2000.4238; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; CARBALLO M, 1983, EMBO J, V2, P1759, DOI 10.1002/j.1460-2075.1983.tb01654.x; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Costello E, 1997, EMBO J, V16, P5943, DOI 10.1093/emboj/16.19.5943; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; DAS MD, 2001, J BIOL CHEM, V276, P32489; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Ellwood KB, 2000, MOL CELL BIOL, V20, P4359, DOI 10.1128/MCB.20.12.4359-4370.2000; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; GE H, 1994, J BIOL CHEM, V269, P17136; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; Imamura T, 2001, J BIOL CHEM, V276, P7534, DOI 10.1074/jbc.M008143200; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Johns EW, 1982, HMG CHROMOSOMAL PROT; Kay BK, 2000, FEBS LETT, V480, P55, DOI 10.1016/S0014-5793(00)01778-6; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Lu W, 2000, J BIOL CHEM, V275, P35006, DOI 10.1074/jbc.M004735200; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; ONATE SA, 1994, MOL CELL BIOL, V14, P3376, DOI 10.1128/MCB.14.5.3376; PARKKINEN J, 1993, J BIOL CHEM, V268, P19726; Ramstein J, 1999, EUR J BIOCHEM, V260, P692, DOI 10.1046/j.1432-1327.1999.00185.x; Ranatunga W, 1999, BBA-PROTEIN STRUCT M, V1432, P1, DOI 10.1016/S0167-4838(99)00084-9; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; SALVIMIRTA M, 1992, EXP CELL RES, V200, P444; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; Sutrias-Grau M, 1999, J BIOL CHEM, V274, P1628, DOI 10.1074/jbc.274.3.1628; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; TOMONAGA T, 1995, J BIOL CHEM, V270, P4875, DOI 10.1074/jbc.270.9.4875; vanGent DC, 1997, EMBO J, V16, P2665, DOI 10.1093/emboj/16.10.2665; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	51	85	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7021	7028		10.1074/jbc.M108417200	http://dx.doi.org/10.1074/jbc.M108417200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11748221	hybrid, Green Published			2022-12-27	WOS:000174104300036
J	Friedman, P; Horkko, S; Steinberg, D; Witztum, JL; Dennis, EA				Friedman, P; Horkko, S; Steinberg, D; Witztum, JL; Dennis, EA			Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids - Importance of Schiff base formation and aldol condensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATION-SPECIFIC EPITOPES; MONOCLONAL-ANTIBODIES; PEROXIDATION PRODUCTS; PROTEIN MOIETIES; DEFICIENT MICE; IDENTIFICATION; RECEPTOR; AUTOANTIBODIES; PLASMA	The oxidation of low density lipoproteins (LDL) has been correlated with atherogenesis through a variety of pathways. The process involves nonspecific fragmentation, oxidative breakdown, and modification of the lipids and protein of LDL. The process yields a variety of bioactive products, including aldehyde-containing phospholipids, which can cross-react with primary amines (i.e. peptides or phospholipid head groups) to yield Schiff base products. We also demonstrate that such oxidized phospholipid products may further react through a post-oxidation chemical pathway involving aldol condensation. EO6, an IgM monoclonal autoantibody to oxidized phospholipids, blocks the uptake of oxidized LDL (OxLDL) by macrophages. Because the epitope(s) of EO6 also blocks the uptake of OxLDL, a series of oxidized phospholipids, their peptide complexes, and their aldol condensates have been synthesized and characterized, and their antigenicity has been determined. This study defines structural motifs of oxidized phospholipids responsible for antigenicity for EO6. Certain monomeric phospholipids containing short chain fatty acids were antigenic whether oxidized or not in the sn-2 position. However, oxidized phospholipids containing sn-1 long chain fatty acids were not antigenic unless the sn-2 oxidized fatty acid contained an aldehyde that first reacted with a peptide yielding a Schiff base or the sn-2 oxidized fatty acid underwent an aldol type self-condensation. Our data indicate that the phosphorylcholine head group is essential for antigenicity, but its availability depends on the oxidized phospholipid conformation. We suggest that upon oxidation, similar reactions occur in phospholipids on the surface of LDL, generating ligands for macrophage recognition. Synthetic imine adducts of oxidized phospholipids of this type are capable of blocking the uptake of OxLDL.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	edennis@ucsd.edu	Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057505, P50HL056989] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 56989, HL 57505] Funding Source: Medline; NIGMS NIH HHS [GM 20501] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAL BS, 1981, TETRAHEDRON, V37, P2091, DOI 10.1016/S0040-4020(01)97963-3; Bird DA, 1999, P NATL ACAD SCI USA, V96, P6347, DOI 10.1073/pnas.96.11.6347; Boullier A, 2000, J BIOL CHEM, V275, P9163, DOI 10.1074/jbc.275.13.9163; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chisolm GM, 2000, FREE RADICAL BIO MED, V28, P1815, DOI 10.1016/S0891-5849(00)00344-0; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; DITTMER JC, 1964, J LIPID RES, V5, P126; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1987, J LIPID RES, V28, P495; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Frey B, 2000, J LIPID RES, V41, P1145; Gillotte KL, 2000, J LIPID RES, V41, P824; Gillotte-Taylor K, 2001, J LIPID RES, V42, P1474; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; HEERY JM, 1995, J CLIN INVEST, V96, P2322, DOI 10.1172/JCI118288; Heinecke JW, 1997, CURR OPIN LIPIDOL, V8, P268, DOI 10.1097/00041433-199710000-00005; Horkko S, 1996, J CLIN INVEST, V98, P815, DOI 10.1172/JCI118854; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; KAMIDO H, 1995, J LIPID RES, V36, P1876; KAMIDO H, 1993, LIPIDS, V28, P331, DOI 10.1007/BF02536319; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; McIntyre TM, 1999, J BIOL CHEM, V274, P25189, DOI 10.1074/jbc.274.36.25189; NIELSEN AT, 1968, ALDOL CONDENSATION O, P13; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; Salomon RG, 1999, J BIOL CHEM, V274, P20271, DOI 10.1074/jbc.274.29.20271; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; Schlame M, 1996, J LIPID RES, V37, P2608; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; SMILEY PL, 1991, J BIOL CHEM, V266, P11104; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Tsimikas S, 2000, DEV CARDIOVASC MED, V224, P49; Watson AD, 1999, J BIOL CHEM, V274, P24787, DOI 10.1074/jbc.274.35.24787; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Witztum JL, 1998, CURR OPIN LIPIDOL, V9, P441, DOI 10.1097/00041433-199810000-00008; Yla-Herttuala S, 1998, CURR OPIN LIPIDOL, V9, P337	41	164	168	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7010	7020		10.1074/jbc.M108860200	http://dx.doi.org/10.1074/jbc.M108860200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744722	hybrid			2022-12-27	WOS:000174104300035
J	Ma, HT; Venkatachalam, K; Parys, JB; Gill, DL				Ma, HT; Venkatachalam, K; Parys, JB; Gill, DL			Modification of store-operated channel coupling and inositol trisphosphate receptor function by 2-aminoethoxydiphenyl borate in DT40 lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; BASOPHILIC LEUKEMIA-CELLS; 1,4,5-TRISPHOSPHATE RECEPTORS; CA2+ ENTRY; PLASMA-MEMBRANE; HTRP3 CHANNELS; RELEASE; DEPLETION; BINDING; SIGNAL	Store-operated channels (SOCs) provide an important means for mediating longer-term Ca2+ signals and replenishment of Ca2+ stores in a multitude of cell types. However, the coupling mechanism between endoplasmic reticulum stores to activate plasma membrane SOCs remains unknown. In DT40 chicken B lymphocytes, the permeant inositol trisphosphate receptor (InSP3R) modifier, 2-aminoethoxydiphenyl borate (2-APB), was a powerful activator of store-operated Ca2+ entry between 1-10 muM. 2-APB activated authentic SOCs because the entry was totally selective for Ca2+ (no detectable entry of Ba2+ or Sr2+ ions), and highly sensitive to La3+ ions (IC50 30-100 nM). To assess the role of InSP(3)Rs in this response, we used the DT40 triple InsP(3)R-knockout (ko) cell line, DT40InSP(3)R-ko, in which the absence of full-length InSP(3)Rs or InsP(3)R fragments was verified by Western analysis using antibodies cross-reacting with N-terminal epitopes of all three chicken InSP3R subtypes. The 2-APB-induced activation of SOCs was identical in the DT40InSP(3)R-ko, cells indicating InSP(3)Rs were not involved. With both wild type (wt) and ko DT40 cells, 2-APB had no effect on Ca2+ entry in store-replete cells, indicating that its action was restricted to SOCs in a store-coupled state. 2-APB induced a robust activation of Ca2+ release from stores in intact DT40wt cells but not in DT40InSp(3)R-ko cells, indicating an InsP3R-mediated effect. In contrast, 2-APB blocked InsP(3)Rs in permeabilized DT40wt cells, suggesting that the stimulatory action of 2-APB was restricted to functionally coupled InSP(3)Rs in intact cells. Uncoupling of ER/PM interactions in intact cells by calyculin A-induced cytoskeletal rearrangement prevented SOC activation by store-emptying and 2-APB; this treatment completely prevented 2-APB-induced InSP3R activation but did not alter InsP3R activation mediated by phospholipase C-coupled receptor stimulation. The results indicate that the robust bifunctional actions of 2-APB on both SOCs and InSP(3)Rs are dependent on the coupled state of these channels and suggest that 2-APB may target the coupling machinery involved in mediating store-operated Ca2+ entry.	Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Katholieke Univ Leuven, Fysiol Lab, B-3000 Louvain, Belgium	University System of Maryland; University of Maryland Baltimore; KU Leuven	Gill, DL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.		Venkatachalam, Kaliyamurthi/GXM-4890-2022	Parys, Jan/0000-0002-3591-4967	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 55426] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Cardy TJA, 1997, BIOCHEM J, V328, P785, DOI 10.1042/bj3280785; Chorna-Ornan I, 2001, J NEUROSCI, V21, P2622, DOI 10.1523/JNEUROSCI.21-08-02622.2001; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; DeSmedt H, 1997, BIOCHEM J, V322, P575; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; Gill DL, 1996, BIOSCIENCE REP, V16, P139, DOI 10.1007/BF01206203; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Luo DL, 2001, J BIOL CHEM, V276, P20186, DOI 10.1074/jbc.M100327200; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Mery L, 2001, FEBS LETT, V487, P377, DOI 10.1016/S0014-5793(00)02362-0; Missiaen L, 2001, CELL CALCIUM, V29, P111, DOI 10.1054/ceca.2000.0163; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PARYS JB, 1995, CELL CALCIUM, V17, P239, DOI 10.1016/0143-4160(95)90070-5; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Philipp S, 2000, J BIOL CHEM, V275, P23965, DOI 10.1074/jbc.M003408200; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Putney Jr JW, 1997, CAPACITATIVE CALCIUM; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; Putney JW, 2000, CELL MOL LIFE SCI, V57, P1272, DOI 10.1007/PL00000765; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; Rys-Sikora KE, 1998, J BIOL CHEM, V273, P32627, DOI 10.1074/jbc.273.49.32627; RYSSIKORA KE, 1994, J BIOL CHEM, V269, P31607; SHORT AD, 1993, J BIOL CHEM, V268, P25887; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; Sipma H, 1999, J BIOL CHEM, V274, P12157, DOI 10.1074/jbc.274.17.12157; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Vanlingen S, 2000, BIOCHEM J, V346, P275, DOI 10.1042/0264-6021:3460275; Vanlingen S, 1997, CELL CALCIUM, V22, P475, DOI 10.1016/S0143-4160(97)90075-0; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; WALDRON RT, 1995, J BIOL CHEM, V270, P11955, DOI 10.1074/jbc.270.20.11955; Wu J, 2000, MOL PHARMACOL, V58, P1368, DOI 10.1124/mol.58.6.1368; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	55	139	144	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6915	6922		10.1074/jbc.M107755200	http://dx.doi.org/10.1074/jbc.M107755200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741932	hybrid			2022-12-27	WOS:000174104300023
J	Podor, TJ; Singh, D; Chindemi, P; Foulon, DM; McKelvie, R; Weitz, JI; Austin, R; Boudreau, G; Davies, R				Podor, TJ; Singh, D; Chindemi, P; Foulon, DM; McKelvie, R; Weitz, JI; Austin, R; Boudreau, G; Davies, R			Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENTS; BINDING-PROTEIN; NUCLEOTIDE-SEQUENCE; ENDOTHELIAL-CELLS; MEDIATED BINDING; ARTERIAL THROMBI; S-PROTEIN; IN-VITRO; TYPE-1; PLASMA	Type 1 plasminogen activator inhibitor (PAI-1), the primary inhibitor of tissue-type plasminogen activator (t-PA), is found in plasma and platelets. PAI-1 circulates in complex with vitronectin (Vn), an interaction that stabilizes PAI-1 in its active conform. In this study, we examined the binding of platelet-derived Vn and PAI-1 to the surface of isolated platelets. Flow cytometry indicate that, like P-selectin, PAI-1, and Vn are found on the surface of thrombin- or calcium ionophore-activated platelets and platelet microparticles. The binding of PAI-1 to the activated platelet surface is Vn-dependent. Vn mediates the binding of PAI-1 to platelet surfaces through a high affinity K-d of 80 nM) binding interaction with the NH2 terminus of vimentin, and this Vn-binding domain is expressed on the surface of activated platelets and platelet microparticles. Immunological and functional assays indicate that only -5% of the total PAI-1 in platelet releasates is functionally active, and it co-precipitates with Vn, and the vimentin-enriched cytoskeleton fraction of activated platelet debris. The remaining platelet PAI-1 is inactive, and does not associate with the cytoskeletal debris of activated platelets. Confocal microscopic analysis of platelet-rich plasma clots confirm the co-localization of PAI-1 with Vn and vimentin on the surface of activated platelets, and platelet microparticles. These findings suggest that platelet vimentin may regulate fibrinolysis in plasma and thrombi by binding platelet-derived Vn-PAI-1 complexes.	Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8V 1C3, Canada; McMaster Univ, Dept Med, Hamilton, ON L8V 1C3, Canada; Pfizer Pharmaceut Inc, Montreal, PQ, Canada; Univ Ottawa, Ottawa Heart Inst, Ottawa, ON K1Y 4W7, Canada	McMaster University; McMaster University; McMaster University; Pfizer; University of Ottawa; University of Ottawa Heart Institute	Podor, TJ (corresponding author), Hamilton Civ Hosp, Res Ctr, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	podort@mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550				ALESSI MC, 1994, THROMB HAEMOSTASIS, V72, P931; ASCH E, 1990, J CLIN INVEST, V85, P1372, DOI 10.1172/JCI114581; BOOTH NA, 1988, BRIT J HAEMATOL, V70, P327, DOI 10.1111/j.1365-2141.1988.tb02490.x; BOOTH NA, 1992, ANN NY ACAD SCI, V667, P70, DOI 10.1111/j.1749-6632.1992.tb51599.x; BRUCE RA, 1971, ANN CLIN RES, V3, P323; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECLERCK PJ, 1988, BLOOD, V71, P220; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; Eitzman DT, 2000, BLOOD, V95, P577, DOI 10.1182/blood.V95.2.577; FAY WP, 1994, BLOOD, V83, P351; FOX JEB, 1996, PRACT APPROACH SER, P217; HANDT S, 1994, FIBRINOLYSIS, V8, P104, DOI 10.1016/S0268-9499(05)80027-X; HANSSON GK, 1989, ARTERIOSCLEROSIS, V9, P567, DOI 10.1161/01.ATV.9.5.567; HANSSON GK, 1984, P NATL ACAD SCI-BIOL, V81, P3103, DOI 10.1073/pnas.81.10.3103; HANSSON GK, 1979, EXP MOL PATHOL, V30, P12, DOI 10.1016/0014-4800(79)90078-9; Hasan AAK, 1998, P NATL ACAD SCI USA, V95, P3615, DOI 10.1073/pnas.95.7.3615; Hembrough TA, 1996, J BIOL CHEM, V271, P25684, DOI 10.1074/jbc.271.41.25684; Hill SA, 1996, BLOOD, V87, P5061, DOI 10.1182/blood.V87.12.5061.bloodjournal87125061; HOFMANN I, 1992, J CELL SCI, V101, P687; HONORE B, 1990, NUCLEIC ACIDS RES, V18, P6692, DOI 10.1093/nar/18.22.6692; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; JANG IK, 1989, CIRCULATION, V79, P920, DOI 10.1161/01.CIR.79.4.920; Kahr WHA, 2001, BLOOD, V98, P257, DOI 10.1182/blood.V98.2.257; KASSIS J, 1992, BLOOD, V80, P1758; KESTIN AS, 1993, CIRCULATION, V88, P1502, DOI 10.1161/01.CIR.88.4.1502; Konstantinides S, 2001, CIRCULATION, V103, P576, DOI 10.1161/01.CIR.103.4.576; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang IM, 1996, J BIOL CHEM, V271, P2754, DOI 10.1074/jbc.271.5.2754; LEVI M, 1992, CIRCULATION, V85, P305, DOI 10.1161/01.CIR.85.1.305; LINDER E, 1983, AM J PATHOL, V112, P267; LINDER E, 1981, J IMMUNOL, V126, P648; LOSKUTOFF DJ, 1987, PROG HEMOSTASIS THRO, V9, P87; Michelson AD, 1996, BLOOD, V87, P4925, DOI 10.1182/blood.V87.12.4925.bloodjournal87124925; Morgenstern E, 2001, EUR J CELL BIOL, V80, P87, DOI 10.1078/0171-9335-00138; MORGENSTERN E, 1993, P WORKSH VITR THEIR, P99; MUSZBEK L, 1987, EUR J CELL BIOL, V43, P501; PADRO T, 1995, ARTERIOSCL THROM VAS, V15, P893, DOI 10.1161/01.ATV.15.7.893; PARKER CJ, 1989, BRIT J HAEMATOL, V71, P245, DOI 10.1111/j.1365-2141.1989.tb04262.x; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; PERIDES G, 1987, J BIOL CHEM, V262, P13742; PERREAU J, 1988, GENE, V62, P7, DOI 10.1016/0378-1119(88)90575-6; Podor TJ, 2002, J BIOL CHEM, V277, P7520, DOI 10.1074/jbc.M109677200; PODOR TJ, 1992, ANN NY ACAD SCI, V667, P173, DOI 10.1111/j.1749-6632.1992.tb51609.x; Podor TJ, 2000, J BIOL CHEM, V275, P19788, DOI 10.1074/jbc.M908079199; Podor TJ, 2000, J BIOL CHEM, V275, P25402, DOI 10.1074/jbc.M000362200; PREISSNER KT, 1989, BLOOD, V74, P1989; RALTON JE, 1994, J CELL SCI, V107, P1935; Rauch U, 2001, ANN INTERN MED, V134, P224, DOI 10.7326/0003-4819-134-3-200102060-00014; SALONEN EM, 1989, J BIOL CHEM, V264, P6339; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHLEEF RR, 1991, J CELL BIOL, V113, P1413, DOI 10.1083/jcb.113.6.1413; SCHLEEF RR, 1985, J LAB CLIN MED, V106, P408; Seiffert D, 1996, BLOOD, V88, P552, DOI 10.1182/blood.V88.2.552.bloodjournal882552; SEIFFERT D, 1994, J BIOL CHEM, V269, P2659; SEIFFERT D, 1995, J IMMUNOL, V155, P3180; SEIFFERT D, 1991, FIBRINOLYSIS, V5, P225, DOI 10.1016/0268-9499(91)90004-N; Shariat-Madar Z, 1999, J BIOL CHEM, V274, P7137, DOI 10.1074/jbc.274.11.7137; SIMPSON AJ, 1990, BRIT J HAEMATOL, V75, P543, DOI 10.1111/j.1365-2141.1990.tb07796.x; TABLIN F, 1987, CELL MOTIL CYTOSKEL, V8, P61, DOI 10.1002/cm.970080109; THIAGARAJAN P, 1988, J BIOL CHEM, V263, P3035; TORRBROWN SR, 1993, THROMB RES, V72, P413, DOI 10.1016/0049-3848(93)90241-F; TRAUB P, 1992, J CELL SCI, V101, P363; VANLOON BJP, 1992, THROMB HAEMOSTASIS, V67, P101; Wells MJ, 1997, J BIOL CHEM, V272, P28574, DOI 10.1074/jbc.272.45.28574; WIMAN B, 1995, THROMB HAEMOSTASIS, V74, P71; WIMAN B, 1988, THROMB HAEMOSTASIS, V59, P392; Wohn KD, 1999, BRIT J HAEMATOL, V104, P901, DOI 10.1046/j.1365-2141.1999.01242.x	67	95	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7529	7539		10.1074/jbc.M109675200	http://dx.doi.org/10.1074/jbc.M109675200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744725	hybrid			2022-12-27	WOS:000174104300099
J	Van Lierop, JE; Wilson, DP; Davis, JP; Tikunova, S; Sutherland, C; Walsh, MP; Johnson, JD				Van Lierop, JE; Wilson, DP; Davis, JP; Tikunova, S; Sutherland, C; Walsh, MP; Johnson, JD			Activation of smooth muscle myosin light chain kinase by calmodulin - Role of LYS30 and GLY(40)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; PHOSPHORYLATION; PROTEINS; CA2+; IDENTIFICATION; CALCINEURIN; EXCHANGE; ISOFORMS	Calmodulin (CaM)-dependent myosin light chain kinase (MLCK) plays a key role in activation of smooth muscle contraction. A soybean isoform of CaM, SCaM-4 (77% identical to human CaM) fails to activate MLCK, wheras SCaM-1 (90.5% identical to human CaM) is as effective as CaM. We exploited this difference to gain insights into the structural requirements in CaM for activation of MLCK. A chimera (domain I of SCaM-4 and domains II-IV of SCaM-1) behaved like SCaM4, and analysis of site-specific mutants of SCaM-1 indicated that K30E and G40D mutations were responsible for the reduction in activation of MLCK. Competition experiments showed that SCaM-4 binds to the CaM-binding site of MLCK with high affinity. Replacement of CaM in skinned smooth muscle by exogenous CaM or SCaM-1, but not SCaM-4, restored Ca2+-dependent contraction. K30E/M36I/G40D SCaM-1 was a poor activator of contraction, but site-specific mutants, K30E, M361 and G40D, each restored Ca2+-induced contraction to CaM-depleted skinned smooth muscle, consistent with their capacity to activate MLCK. Interpretation of these results in light of the high-resolution structures of (Ca2+)(4)-CaM, free and complexed with the CaM-binding domain of MLCK, indicates that a surface domain containing Lys(30) and Gly(40) and residues from the C-terminal domain is created upon binding to MLCK, formation of which is required for activation of MLCK. Interactions between this activation domain and a region of MLCK distinct from the known CaM-binding domain are required for removal of the autoinhibitory domain from the active site, i.e., activation of MLCK, or this domain may be required to stabilize the conformation of (Ca2+)(4)- CaM necessary for MLCK activation.	Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Canadian Inst Hlth Res Grp Regulat Vasc Contracti, Calgary, AB T2N 4N1, Canada; Ohio State Univ, Med Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University of Calgary; University of Calgary; University System of Ohio; Ohio State University	Walsh, MP (corresponding author), Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	walsh@ucalgary.ca			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033727] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; BLUMENTHAL DK, 1982, BIOCHEMISTRY-US, V21, P2386, DOI 10.1021/bi00539a017; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cho MJ, 1998, BIOCHEMISTRY-US, V37, P15593, DOI 10.1021/bi981497g; DABROWSKA R, 1982, BIOCHEM BIOPH RES CO, V107, P1524, DOI 10.1016/S0006-291X(82)80172-1; Edwards RA, 1998, BIOCHEM J, V331, P149, DOI 10.1042/bj3310149; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; HATHAWAY DR, 1983, ANAL BIOCHEM, V135, P37, DOI 10.1016/0003-2697(83)90726-1; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; KASTURI R, 1993, J BIOL CHEM, V268, P7958; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; NGAI PK, 1984, BIOCHEM J, V218, P863, DOI 10.1042/bj2180863; PERSECHINI A, 1981, SCIENCE, V213, P1383, DOI 10.1126/science.6455737; Persechini A, 1996, J BIOL CHEM, V271, P19279, DOI 10.1074/jbc.271.32.19279; Smith L, 1999, J BIOL CHEM, V274, P29433, DOI 10.1074/jbc.274.41.29433; Smith L, 2000, FEBS LETT, V480, P298, DOI 10.1016/S0014-5793(00)01931-1; Snedden WA, 1998, TRENDS PLANT SCI, V3, P299, DOI 10.1016/S1360-1385(98)01284-9; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; SU ZH, 1994, J BIOL CHEM, V269, P16761; Tsvetkov PO, 1999, J BIOL CHEM, V274, P18161, DOI 10.1074/jbc.274.26.18161; VANBERKUM MFA, 1991, J BIOL CHEM, V266, P21488; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; Weber LP, 2000, BIOCHEM J, V352, P573, DOI 10.1042/0264-6021:3520573; WILLIAMS DA, 1987, SCIENCE, V235, P1644, DOI 10.1126/science.3103219; WILLIAMS DA, 1986, AM J PHYSIOL, V250, pC779, DOI 10.1152/ajpcell.1986.250.5.C779; Wilson DP, 2002, J BIOL CHEM, V277, P2186, DOI 10.1074/jbc.M110056200; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	40	43	46	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6550	6558		10.1074/jbc.M111404200	http://dx.doi.org/10.1074/jbc.M111404200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748245	hybrid			2022-12-27	WOS:000173989200113
J	Chong, JM; Uren, A; Rubin, JS; Speicher, DW				Chong, JM; Uren, A; Rubin, JS; Speicher, DW			Disulfide bond assignments of secreted frizzled-related protein-1 provide insights about frizzled homology and netrin modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; GLYCOGEN-SYNTHASE KINASE-3-BETA; CYSTEINE-RICH DOMAIN; BETA-CATENIN; NEGATIVE REGULATOR; FUNCTIONAL INTERACTION; ENHANCER PROTEIN; CYCLIN D1; AXIN; GENE	Secreted Frizzled-related protein-1 (sFRP-1), a soluble protein that binds to Wnts and modulates Wnt signaling, contains an N-terminal domain homologous to the putative Wnt-binding site of Frizzled (Fz domain) and a C-terminal heparin-binding domain with weak homology to netrin. Both domains are cysteine-rich, having 10 and 6 cysteines in the Fz and heparin-binding domains, respectively. In this study, the disulfide linkages of recombinant sFRP-1 were determined. Numbering sFRP-1 cysteines sequentially from the N terminus, the five disulfide linkages in the Fz domain are 1-5, 2-4, 3-8, 6-10, and 7-9, consistent with the disulfide pattern determined for homologous domains of several other proteins. The disulfide linkages of the heparin-binding domain are 11-14, 12-15, and 13-16. This latter set of assignments provides experimental verification of one of the disulfide patterns proposed for netrin (NTR) modules and thereby supports the prediction that the C-terminal heparin-binding domain of sFRP-1 is an NTR-type domain. Interestingly, two subsets of sFRPs appear to have alternate disulfide linkage patterns compared with sFRP-1, one of which involves the loss of a disulfide due to deletion of a single cysteine from the NTR module, whereas the remaining cysteine may pair with a new cysteine introduced in the Fz domain of the protein. Analysis of glycosylation sites showed that sFRP-1 contains a relatively large carbohydrate moiety on Asn(172) (similar to2.8 kDa), whereas Asn(262), the second potential N-linked glycosylation site, is not modified. No O-linked carbohydrate groups were detected. There was evidence of heterogeneous proteolytic processing at both the N and C termini of the recombinant protein. The predominant N terminus was Ser(31), although minor amounts of the protein with Asp(41) and Phe(50) as the N termini were observed. The major C-terminal processing event was removal of the terminal amino acid (Lys(313)) with only a trace amount of unprocessed protein detected.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; NCI, Canc Res Ctr, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.upenn.edu			NCI NIH HHS [CA74294, CA10815] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA074294, P30CA010815] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bradley L, 2000, DEV BIOL, V227, P118, DOI 10.1006/dbio.2000.9873; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Chang JHT, 1999, HUM MOL GENET, V8, P575, DOI 10.1093/hmg/8.4.575; Dale TC, 1998, BIOCHEM J, V329, P209; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DOLMER K, 1993, FEBS LETT, V315, P85, DOI 10.1016/0014-5793(93)81139-Q; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pfeffer PL, 1997, INT J DEV BIOL, V41, P449; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; REHN M, 1995, J BIOL CHEM, V270, P4705, DOI 10.1074/jbc.270.9.4705; REIM DF, 1997, CURRENT PROTOCOLS PR; Roszmusz E, 2001, J BIOL CHEM, V276, P18485, DOI 10.1074/jbc.M100100200; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Saldanha J, 1998, PROTEIN SCI, V7, P1632, DOI 10.1002/pro.5560070718; Salic AN, 1997, DEVELOPMENT, V124, P4739; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Trexler M, 2001, P NATL ACAD SCI USA, V98, P3705, DOI 10.1073/pnas.061028398; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wang YS, 1996, J BIOL CHEM, V271, P4468; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; WILLIAMSON RA, 1990, BIOCHEM J, V268, P267, DOI 10.1042/bj2680267; Wolf V, 1997, FEBS LETT, V417, P385, DOI 10.1016/S0014-5793(97)01324-0; Xu H, 2000, GENOMICS, V66, P264, DOI 10.1006/geno.2000.6229; Xu QH, 1998, DEVELOPMENT, V125, P4767; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	58	83	92	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5134	5144		10.1074/jbc.M108533200	http://dx.doi.org/10.1074/jbc.M108533200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741940	hybrid			2022-12-27	WOS:000173962900077
J	Reuter, K; Sanderbrand, S; Jomaa, H; Wiesner, J; Steinbrecher, I; Beck, E; Hintz, M; Klebe, G; Stubbs, MT				Reuter, K; Sanderbrand, S; Jomaa, H; Wiesner, J; Steinbrecher, I; Beck, E; Hintz, M; Klebe, G; Stubbs, MT			Crystal structure of 1-deoxy-D-xylulose-5-phosphate reductoisomerase, a crucial enzyme in the non-mevalonate pathway of isoprenoid biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-PHOSPHATE REDUCTOISOMERASE; ISOPENTENYL DIPHOSPHATE; NONMEVALONATE PATHWAY; BACTERIA; NADPH; IONS	We have solved the 2.5-Angstrom crystal structure of 1-deoxy-D-xylulose-5-phosphate reductoisomerase, an enzyme involved in the mevalonate-independent 2-C-methyl-D-erythritol-4-phosphate pathway of isoprenoid biosynthesis. The structure reveals that the enzyme is present as a homodimer. Each monomer displays a V-like shape and is composed of an amino-terminal dinucleotide binding domain, a connective domain, and a carboxyl-terminal four-helix bundle domain. The connective domain is responsible for dimerization and harbors most of the active site. The strictly conserved acidic residues Asp(150), Glu(152), Glu(231), and Glu(234) are clustered at the putative active site and are probably involved in the binding of divalent cations mandatory for enzyme activity. The connective and four-helix bundle domains show significant mobility upon superposition of the dinucleotide binding domains of the three conformational states present in the asymmetric unit of the crystal. A still more pronounced flexibility is observed for a loop spanning residues 186 to 216, which adopts two completely different conformations within the three protein conformers. A possible involvement of this loop in an induced fit during substrate binding is discussed.	Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany; Jomaa Pharmaka GmbH, D-35392 Giessen, Germany; Univ Giessen, Univ Klin, Inst Biochem, D-35392 Giessen, Germany	Philipps University Marburg; Justus Liebig University Giessen	Reuter, K (corresponding author), Univ Marburg, Inst Pharmazeut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.		Stubbs, Milton/ABC-7585-2020	Stubbs, Milton/0000-0003-1278-9013; Reuter, Klaus/0000-0003-3673-7971				Altincicek B, 2001, FEBS LETT, V499, P37, DOI 10.1016/S0014-5793(01)02516-9; Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; Biou V, 1997, EMBO J, V16, P3405, DOI 10.1093/emboj/16.12.3405; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P144; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Eisenreich W, 2001, TRENDS PLANT SCI, V6, P78, DOI 10.1016/S1360-1385(00)01812-4; Halgand F, 1999, BIOCHEMISTRY-US, V38, P6025, DOI 10.1021/bi982412e; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kingston RL, 1996, STRUCTURE, V4, P1413, DOI 10.1016/S0969-2126(96)00149-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuzuyama T, 2000, J BIOL CHEM, V275, P19928, DOI 10.1074/jbc.M001820200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McPherson A., 1999, CRYSTALLIZATION BIOL; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richard SB, 2001, NAT STRUCT BIOL, V8, P641, DOI 10.1038/89691; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Spurgeon S.L., 1981, BIOSYNTHESIS ISOPREN, V1, P1; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012	25	106	115	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5378	5384		10.1074/jbc.M109500200	http://dx.doi.org/10.1074/jbc.M109500200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741911	hybrid			2022-12-27	WOS:000173962900106
J	Tang, H; Hao, Q; Fitzgerald, T; Sasaki, T; Landon, EJ; Inagami, T				Tang, H; Hao, Q; Fitzgerald, T; Sasaki, T; Landon, EJ; Inagami, T			Pyk2/CAK(beta) tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROTEIN; MIGRATION; PYK2; ACTIVATION; P130(CAS); BETA; SRC; PHOSPHORYLATION; IDENTIFICATION	Endothelial cell spreading, migration, and morphogenesis are essential for angiogenesis, the formation of new blood vessels. In the present study, we explored roles of tyrosine kinase Pyk2 in angiogenesis of pulmonary endothelial cells. We found that tyrosine kinase Pyk2 was particularly enriched in pulmonary vascular endothelial cells and lung, a major organ site for tumor metastasis. By using adenovirus-mediated expression of various Pyk2 mutants, we demonstrated that Pyk2 tyrosine kinase activity was essential for the pulmonary vascular endothelial cell spreading, migration, morphogenesis, as well as pulmonary vein and artery angiogenesis ex vivo. We further showed that Pyk2 kinase activity was required for the expression of focal adhesion kinase, p130Crk-associated substrate, and its homologue human enhancer of filamentation 1, thus regulating formation of focal adhesions and cytoskeletal reorganization. These results indicate that Pyk2 plays a crucial role in the pulmonary endothelial cell motility such as spreading and migration necessary for angiogenesis.	Univ Texas Hlth Ctr, Dept Biochem, Lab A1, Tyler, TX 75708 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Sapporo Med Univ, Dept Biochem, Sapporo, Hokkaido 060, Japan	Vanderbilt University; Vanderbilt University; Sapporo Medical University	Tang, H (corresponding author), Univ Texas Hlth Ctr, Dept Biochem, Lab A1, 11937 US Highway 271, Tyler, TX 75708 USA.				NHLBI NIH HHS [HL-69806, HL-58205] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058205, R01HL069806, R01HL058205] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Astier A, 1997, J BIOL CHEM, V272, P228; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Blaukat A, 1999, J BIOL CHEM, V274, P14893, DOI 10.1074/jbc.274.21.14893; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Duong LT, 2001, J BIOL CHEM, V276, P7484, DOI 10.1074/jbc.M008368200; EGUCHI S, 1994, ENDOCRINOLOGY, V134, P222, DOI 10.1210/en.134.1.222; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Ishino M, 2000, FEBS LETT, V474, P179, DOI 10.1016/S0014-5793(00)01597-0; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Law SF, 1996, MOL CELL BIOL, V16, P3327; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Mitaka T, 1997, AM J PATHOL, V150, P267; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nakamura I, 1998, J BIOL CHEM, V273, P11144, DOI 10.1074/jbc.273.18.11144; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Ridyard MS, 2000, CELL BIOL INT, V24, P669, DOI 10.1006/cbir.2000.0532; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Schaller MD, 1997, J BIOL CHEM, V272, P25319, DOI 10.1074/jbc.272.40.25319; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Tang H, 2000, J BIOL CHEM, V275, P8389, DOI 10.1074/jbc.275.12.8389; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Watson JM, 2001, J BIOL CHEM, V276, P3536, DOI 10.1074/jbc.M006916200; YANG EY, 1990, J CELL BIOL, V111, P731, DOI 10.1083/jcb.111.2.731; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384	33	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5441	5447		10.1074/jbc.M110673200	http://dx.doi.org/10.1074/jbc.M110673200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739395	hybrid			2022-12-27	WOS:000173962900114
J	Speck, P; Ikeda, M; Ikeda, A; Lederman, HM; Longnecker, R				Speck, P; Ikeda, M; Ikeda, A; Lederman, HM; Longnecker, R			Signal transduction through the B cell antigen receptor is normal int ataxia-telangiectasia B lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; MEMBRANE-PROTEIN 2A; REGULATES REACTIVATION; ATM GENE; LATENCY; LMP2A; PHOSPHORYLATION	The rare human genetic disorder ataxia-telangiectasia (A-T) has multiple consequences including a variable degree of immunodeficiency. Khanna and co-workers (Khanna, K. K., Yan, J., Watters, D., Hobson, K., Beamish, H., Spring, K., Shiloh, Y., Gatti, R. A., and Lavin, M. F. (1997) J. Biol. Chem. 272,9489-9495) evaluated signaling in Epstein-Barr virus (EBV) immortalized A-T lymphoblastoid cell lines (LCLs), derived from the B cells of A-T patients. They showed that A-T lymphoblastoid cells lack signaling through the B cell antigen receptor and concluded that the fault in A-T encompasses intracellular signaling in B cells. However, it is established that EBV latent membrane protein 2A (LMP2A) blocks signaling in EBV-bearing cells by interaction with cellular tyrosine kinases. To test whether the reported fault in A-T B cells was not inherent in A-T but the result of influence of wild-type EBV, we derived A-T LCLs with wild-type or LMP2A-deleted EBV and studied signaling in these cells in response to cross-linking the B cell antigen receptor. We report that intracellular calcium mobilization and tyrosine phosphorylation in LMP2A-depleted LCLs derived from A-T patients, is indistinguishable from that in LMP2A-depleted LCLs derived from normal controls. Further, signaling is blocked similarly in A-T and normal lymphoblastoid cells bearing wild-type EBV. In conclusion there is no evidence of any defect in B cell receptor signal transduction in A-T B cells.	Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; Johns Hopkins Univ, Sch Med, Endowood Div Pediat Immunol, Baltimore, MD 21287 USA; Inst Med & Vet Sci, Infect Dis Labs, Adelaide, SA 5000, Australia	Northwestern University; Johns Hopkins University; Institute Medical & Veterinary Science Australia	Longnecker, R (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol Immunol, Ward 6-231,303 E Chicago Ave, Chicago, IL 60611 USA.	r-longnecker@northwestern.edu	Speck, Peter G/A-8197-2012	Speck, Peter/0000-0001-9087-258X	NCI NIH HHS [CA62234, CA73507] Funding Source: Medline; NCRR NIH HHS [RR00052] Funding Source: Medline; NIDCR NIH HHS [DE13127] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073507, R01CA062234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013127] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		CHANG RS, 1994, J VIROL METHODS, V46, P167, DOI 10.1016/0166-0934(94)90101-5; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Crawford TO, 2000, NEUROLOGY, V54, P1505, DOI 10.1212/WNL.54.7.1505; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Fruehling S, 1996, J VIROL, V70, P6216, DOI 10.1128/JVI.70.9.6216-6226.1996; Fruehling S, 1998, J VIROL, V72, P7796, DOI 10.1128/JVI.72.10.7796-7806.1998; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; FRUEHLING S, 1998, 4 EBV, P151; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; Ikeda M, 2001, J VIROL, V75, P5711, DOI 10.1128/JVI.75.12.5711-5718.2001; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; Khanna KK, 1997, J BIOL CHEM, V272, P9489; Konishi K, 2001, J GEN VIROL, V82, P1451, DOI 10.1099/0022-1317-82-6-1451; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Longnecker R, 1996, TRENDS MICROBIOL, V4, P38; LONGNECKER R, 1998, HUMAN TUMOR VIRUSES, P141; MEYN MS, 1993, SCIENCE, V260, P1327, DOI 10.1126/science.8493577; MILLER CL, 1994, INFECT AGENT DIS, V3, P128; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; MILLER CL, 1993, J VIROL, V67, P3087, DOI 10.1128/JVI.67.6.3087-3094.1993; OKANO M, 1990, AM J PATHOL, V137, P517; RABINOVITCH PS, 1986, J IMMUNOL, V137, P952; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Speck P, 1999, ARCH VIROL, V144, P1123, DOI 10.1007/s007050050574; Speck P, 1999, J GEN VIROL, V80, P2193, DOI 10.1099/0022-1317-80-8-2193; Vahey Maryanne T., 1995, P17; WALDMANN TA, 1972, LANCET, V2, P1112; WANG F, 1991, J VIROL, V65, P1701, DOI 10.1128/JVI.65.4.1701-1709.1991; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8	33	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4123	4127		10.1074/jbc.M110109200	http://dx.doi.org/10.1074/jbc.M110109200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733529	hybrid			2022-12-27	WOS:000173813900045
J	Neininger, A; Kontoyiannis, D; Kotlyarov, A; Winzen, R; Eckert, R; Volk, HD; Holtmann, H; Kollias, G; Gaestel, M				Neininger, A; Kontoyiannis, D; Kotlyarov, A; Winzen, R; Eckert, R; Volk, HD; Holtmann, H; Kollias, G; Gaestel, M			MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; KINASE-ACTIVATED PROTEIN-KINASE-2; SIGNAL-TRANSDUCTION PATHWAY; MAPKAP KINASE-2; TNF-ALPHA; EXPRESSION; MICE; PHOSPHORYLATION; DEGRADATION; REQUIREMENT	We demonstrate that lipopolysaccharide-induced tumor necrosis factor (TNF) biosynthesis becomes independent of MAPKAP kinase 2 (AM) when the AU-rich element (ARE) of the TNF gene is deleted. In spleen cells and macrophages where TNF biosynthesis is restored as a result of this deletion, interleukin (IL)-6 biosynthesis is still dependent on AM. In AM-deficient macrophages the half-life of IL-6 mRNA is reduced more than 10-fold, whereas the half-life of TNF mRNA is only weakly decreased. It is shown that the stability of a reporter mRNA carrying the AU-rich 3'-untranslated region (3'-UTR) of IL-6 is increased by MK2. The data provide in vivo evidence that the AU-rich 3'-UTRs of TNF and IL-6 are downstream to AM signaling and make AM an essential component of mechanisms that regulate biosynthesis of IL-6 at the levels of mRNA stability, and of TNF mainly through TNF-ARE-dependent translational control.	Univ Halle Wittenberg, Innovat Skolleg Zellspezialisierung, D-06120 Halle Saale, Germany; Helen Pasteur Inst, Athens, Greece; Humboldt Univ, Inst Med Immunol, D-10098 Berlin, Germany; Hannover Med Sch, Inst Pharmakol, D-30623 Hannover, Germany	Martin Luther University Halle Wittenberg; Humboldt University of Berlin; Hannover Medical School	Gaestel, M (corresponding author), Hannover Med Sch, Inst Biochem, Carl Neuberg Str 1, D-30625 Hannover, Germany.		Gaestel, Matthias/A-6560-2013; volk, hans-dieter/AAV-8053-2021; Kollias, George/A-7079-2012	Gaestel, Matthias/0000-0002-4944-4652; volk, hans-dieter/0000-0002-7743-6668; Kollias, George/0000-0003-1867-3150; Kontoyiannis, Dimitris/0000-0003-4682-9490				Alheim K, 1997, P NATL ACAD SCI USA, V94, P2681, DOI 10.1073/pnas.94.6.2681; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; ENGEL K, 1995, J BIOL CHEM, V270, P27213, DOI 10.1074/jbc.270.45.27213; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mijatovic T, 2000, EUR J BIOCHEM, V267, P6004, DOI 10.1046/j.1432-1327.2000.01676.x; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wysk M, 1999, P NATL ACAD SCI USA, V96, P3763, DOI 10.1073/pnas.96.7.3763; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558	28	333	350	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 1	2002	277	5					3065	3068		10.1074/jbc.C100685200	http://dx.doi.org/10.1074/jbc.C100685200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	518VF	11741878	hybrid			2022-12-27	WOS:000173688000002
J	Reschly, EJ; Sorci-Thomas, MG; Davidson, WS; Meredith, SC; Reardon, CA; Getz, GS				Reschly, EJ; Sorci-Thomas, MG; Davidson, WS; Meredith, SC; Reardon, CA; Getz, GS			Apolipoprotein A-I alpha-helices 7 and 8 modulate high density lipoprotein subclass distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; ACUTE-PHASE RESPONSE; LIPID-FREE STRUCTURE; TRANSGENIC MICE; CELLULAR CHOLESTEROL; TERMINAL DELETIONS; WILD-TYPE; APOA-I; EXPRESSION; ACTIVATION	Mice have a monodisperse high density lipoprotein (HDL) profile, whereas humans have two major subfractions designated HDL2 and HDL3. Human apoA-I transgenic mice exhibit a human-like HDL profile, indicating that the amino acid sequence of apoA-I is a determinant of the HDL profile. Comparison of the primary sequence of mouse and human apoA-I and the previously designated "hinge" domain of apoA-I led us to hypothesize that alpha-helices 7 and 8 (7/8) are determinants of HDL subclass distribution. The following proteins were expressed in Escherichia coli: human apoA-I, T7-hAI; mouse apoA-I, T7-mAI; chimeric human apoA-I containing murine helices 7/8 in place of human helices 7/8, T7-hAI(m7/8); and the reciprocal chimera, T7-mAI(h7/8). The recombinant proteins were examined for their association with human plasma HDL subclasses. The results demonstrated that T7-hAI bound HDL2 and HDL3 equally well, whereas T7-mAI bound to HDL2 preferentially. T7-hAI(m7/8) behaved like T7-mAI, and T7-mAI(h7/8) behaved like T7-hAI. Thus, alpha-helices 718 are strong contributors to the pattern of HDL subclass association. Self-association, alpha-helicity, cholesterol efflux, and lecithin-cholesterol acyltransferase activity of the recombinant proteins were also assessed. Human apoA-I self-associates more and activates human lecithin-cholesterol acyltransferase better than mouse apoA-I. These differential characteristics of human and mouse apoA-I are not dependent on helices 7/8.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Wake Forest Univ, Dept Pathol, Winston Salem, NC 27157 USA; Univ Cincinnati, Dept Lab Med & Pathol, Cincinnati, OH 45267 USA	University of Chicago; Wake Forest University; University System of Ohio; University of Cincinnati	Getz, GS (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave,MC 1089, Chicago, IL 60637 USA.			Sorci-Thomas, Mary/0000-0002-6464-5006; Davidson, William/0000-0003-2756-2989	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064163, R01HL057334] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL57334, HL64163] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERGERON J, 1995, J BIOL CHEM, V270, P27429, DOI 10.1074/jbc.270.46.27429; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Cabana VG, 1996, J LIPID RES, V37, P2662; CABANA VG, 1989, J LIPID RES, V30, P39; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Colvin PL, 1999, CURR OPIN LIPIDOL, V10, P309, DOI 10.1097/00041433-199908000-00004; DAVIDSON WS, 1994, J BIOL CHEM, V269, P22975; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Durbin DM, 1997, J BIOL CHEM, V272, P31333, DOI 10.1074/jbc.272.50.31333; FIELDING CJ, 1995, J LIPID RES, V36, P211; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; FRANCONE OL, 1995, J CLIN INVEST, V96, P1440, DOI 10.1172/JCI118180; Frank PG, 2000, J LIPID RES, V41, P853; Frank PG, 1997, BIOCHEMISTRY-US, V36, P1798, DOI 10.1021/bi962118r; Gillotte KL, 1998, J LIPID RES, V39, P1918; GONG EL, 1994, BBA-LIPID LIPID MET, V1213, P335, DOI 10.1016/0005-2760(94)00062-X; Gorshkova IN, 2000, BIOCHEMISTRY-US, V39, P15910, DOI 10.1021/bi0014406; HAVEL RJ, 1995, METABOLIC MOL BASES, P1841; HOLVOET P, 1995, BIOCHEMISTRY-US, V34, P13334, DOI 10.1021/bi00041a009; JI Y, 1995, J BIOL CHEM, V270, P11290, DOI 10.1074/jbc.270.19.11290; JONAS A, 1989, J BIOL CHEM, V264, P4818; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; MINNICH A, 1992, J BIOL CHEM, V267, P16553; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P945, DOI 10.1021/bi9713512; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; SANDKAMP M, 1988, J CLIN CHEM CLIN BIO, V26, P685; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmidt HHJ, 1997, CLIN CHIM ACTA, V268, P41, DOI 10.1016/S0009-8981(97)00155-1; SCHULTZ JR, 1993, NATURE, V365, P762, DOI 10.1038/365762a0; SHEPHERD J, 1977, BIOCHIM BIOPHYS ACTA, V489, P487; Sorci-Thomas MG, 2000, J BIOL CHEM, V275, P12156, DOI 10.1074/jbc.275.16.12156; Sorci-Thomas MG, 1998, J BIOL CHEM, V273, P11776, DOI 10.1074/jbc.273.19.11776; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; SorciThomas MG, 1996, J LIPID RES, V37, P673; SorciThomas MG, 1997, J BIOL CHEM, V272, P7278, DOI 10.1074/jbc.272.11.7278; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; Sviridov D, 1996, J BIOL CHEM, V271, P33277, DOI 10.1074/jbc.271.52.33277; SWANEY JB, 1978, J BIOL CHEM, V253, P7069; Thurberg BL, 1996, J BIOL CHEM, V271, P6062, DOI 10.1074/jbc.271.11.6062; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Williams DL, 2000, ENDOCR RES, V26, P639, DOI 10.3109/07435800009048584	45	34	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					9645	9654		10.1074/jbc.M107883200	http://dx.doi.org/10.1074/jbc.M107883200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11744719	hybrid			2022-12-27	WOS:000174549200007
J	Miller, KA; Yoshikawa, DM; McConnell, IR; Clark, R; Schild, D; Albala, JS				Miller, KA; Yoshikawa, DM; McConnell, IR; Clark, R; Schild, D; Albala, JS			RAD51C interacts with RAD51B and is central to a larger protein complex in vivo exclusive of RAD51	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; STRAND EXCHANGE; MOUSE GENES; REPAIR GENE; XRCC3; PROMOTES; FAMILY; IDENTIFICATION; MEMBER	RAD51B and RAD51C are two of five known paralogs of the human RAD51 protein that are thought to function in both homologous recombination and DNA double-strand break repair. This work describes the in vitro and in vivo identification of the RAD51B/RAD51C heterocomplex. The RAD51B/RAD51C heterocomplex was isolated and purified by immunoaffinity chromatography from insect cells co-expressing the recombinant proteins. Moreover, co-immunoprecipitation of the RAD51B and RAD51C proteins from HeLa, MCF10A, and MCF7 cells strongly suggests the existence of an endogenous RAD5113/RAD51C heterocomplex. We extended these observations to examine the interaction between the RAD51B/RAD51C complex and the other RAD51 paralogs. Immunoprecipitation using protein-specific antibodies showed that RAD51C is central to a single large protein complex and/or several smaller complexes with RAD51B, RAD51D, XRCC2, and XRCC3. However, our experiments showed no evidence for the inclusion of RAD51 within these complexes. Further analysis is required to elucidate the function of the RAD51B/RAD51C heterocomplex and its association with the other RAD51 paralogs in the processes of homologous recombination and DNA double-strand break repair.	Univ Calif Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94550 USA; Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Albala, JS (corresponding author), Univ Calif Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, 700 East Ave,L-448, Livermore, CA 94550 USA.				NATIONAL CANCER INSTITUTE [R55CA081019, R01CA081019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030990] Funding Source: NIH RePORTER; NCI NIH HHS [CA81019-01] Funding Source: Medline; NIGMS NIH HHS [GM30990] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albala JS, 1997, GENOMICS, V46, P476, DOI 10.1006/geno.1997.5062; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; BOLLAG G, 1993, EMBO J, V12, P1923, DOI 10.1002/j.1460-2075.1993.tb05841.x; Braybrooke JP, 2000, J BIOL CHEM, V275, P29100, DOI 10.1074/jbc.M002075200; Brenneman MA, 2000, MUTAT RES-DNA REPAIR, V459, P89, DOI 10.1016/S0921-8777(00)00002-1; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P1653, DOI 10.1093/nar/26.7.1653; Dosanjh MK, 1998, NUCLEIC ACIDS RES, V26, P1179, DOI 10.1093/nar/26.5.1179; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; O'Regan P, 2001, J BIOL CHEM, V276, P22148, DOI 10.1074/jbc.M102396200; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pittman DL, 1998, GENOMICS, V49, P103, DOI 10.1006/geno.1998.5226; Rice MC, 1997, P NATL ACAD SCI USA, V94, P7417, DOI 10.1073/pnas.94.14.7417; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000	25	73	81	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8406	8411		10.1074/jbc.M108306200	http://dx.doi.org/10.1074/jbc.M108306200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11744692	hybrid			2022-12-27	WOS:000174268000100
J	Morii, E; Oboki, K; Kataoka, TR; Igarashi, K; Kitamura, Y				Morii, E; Oboki, K; Kataoka, TR; Igarashi, K; Kitamura, Y			Interaction and cooperation of mi transcription factor (MITF) and myc-associated zinc-finger protein-related factor (MAZR) for transcription of mouse mast cell protease 6 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT MICE; C-KIT; IMPAIRED EXPRESSION; MI/MI GENOTYPE; MICROPHTHALMIA; ALLELE; DIFFERENTIATION; INVOLVEMENT; RECEPTOR; LOCUS	The mi transcription factor (MITF) is a basic-helix-loop-helix leucine zipper (bHLH-Zip) transcription factor that is important for the normal phenotypic expression of mast cells. Most transcription factors function in cooperation with other factors by protein-protein interactions. To search proteins interacting with MITF, we carried out a yeast two-hybrid screen and isolated Myc-associated zinc-finger protein related factor (MAZR) as a partner of MITF. When expressed with MITF in NIH/3T3 cells, MAZR was colocalized with MITE The association of MAZR with MITF was further confirmed by a co-immunoprecipitation study and in vitro binding assay. The zinc-finger domain of MAZR and the Zip domain of MITF were essential for the interaction. MAZR was expressed in cultured mast cells and MST mastocytoma cells containing mouse mast cell protease (mMCP)-6 transcript abundantly. The overexpression of dominant negative MAZR in MST mastocytoma cells reduced the amount of mMCP-6 mRNA. The simultaneous transfection of MAZR and MITF significantly increased the promoter activity of the mMCP-6 gene, indicating that the MAZR and MITF synergistically transactivated the mMCP-6 gene. MAZR appeared to play important roles in the normal phenotypic expression of mast cells in association with MITF.	Osaka Univ, Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; Hiroshima Univ, Sch Med, Dept Biochem, Hiroshima 7348551, Japan	Osaka University; Hiroshima University	Morii, E (corresponding author), Osaka Univ, Sch Med, Dept Pathol, 2-2 Yamadaoka,Room C2, Suita, Osaka 5650871, Japan.	morii@patho.med.osaka-u.ac.jp	Oboki, Keisuke/AAR-1813-2020	Igarashi, Kazuhiko/0000-0002-2470-2475				Adachi S, 2000, J IMMUNOL, V164, P855, DOI 10.4049/jimmunol.164.2.855; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; EBI Y, 1992, BLOOD, V80, P1454; EBI Y, 1990, BLOOD, V75, P1247; GREEN MC, 1981, CATALOGUE MUTANT GEN, P158; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HUGHES MJ, 1993, J BIOL CHEM, V268, P20687; ISOZAKI K, 1994, AM J PATHOL, V145, P827; Ito A, 1998, BLOOD, V91, P3210, DOI 10.1182/blood.V91.9.3210.3210_3210_3221; Ito A, 1999, BLOOD, V93, P1189, DOI 10.1182/blood.V93.4.1189.404k32_1189_1196; Jippo T, 1999, BLOOD, V93, P1942, DOI 10.1182/blood.V93.6.1942.406k08_1942_1950; JIPPO T, 1994, BLOOD, V84, P2977; Jippo T, 1997, BLOOD, V90, P2601, DOI 10.1182/blood.V90.7.2601.2601_2601_2608; KASUGAI T, 1993, AM J PATHOL, V143, P1337; Kim DK, 1999, BLOOD, V93, P4179, DOI 10.1182/blood.V93.12.4179.412k04_4179_4186; Kim DK, 1998, BLOOD, V92, P1973, DOI 10.1182/blood.V92.6.1973.418k23_1973_1980; Kobayashi A, 2000, MOL CELL BIOL, V20, P1733, DOI 10.1128/MCB.20.5.1733-1746.2000; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MONTGOMERY RI, 1992, P NATL ACAD SCI USA, V89, P11327, DOI 10.1073/pnas.89.23.11327; MOORE KJ, 1995, TRENDS GENET, V11, P442, DOI 10.1016/S0168-9525(00)89143-X; Morii E, 1999, BIOCHEM BIOPH RES CO, V261, P53, DOI 10.1006/bbrc.1999.0996; Morii E, 1996, BLOOD, V88, P2488, DOI 10.1182/blood.V88.7.2488.bloodjournal8872488; MORII E, 1994, BIOCHEM BIOPH RES CO, V205, P1299, DOI 10.1006/bbrc.1994.2806; Morii E, 1997, BLOOD, V90, P3057, DOI 10.1182/blood.V90.8.3057; Morii E, 2001, BLOOD, V97, P2038, DOI 10.1182/blood.V97.7.2038; Morii E, 2001, BLOOD, V98, P2577, DOI 10.1182/blood.V98.8.2577; Morii E, 2001, BLOOD, V97, P3032, DOI 10.1182/blood.V97.10.3032; Ogihara H, 2001, BLOOD, V97, P645, DOI 10.1182/blood.V97.3.645; Ogihara H, 1999, ONCOGENE, V18, P4632, DOI 10.1038/sj.onc.1202844; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; SILVERS WK, 1979, COAT COLORS MICE MOD, P268; STECHSCHULTE DJ, 1987, J CELL PHYSIOL, V132, P565, DOI 10.1002/jcp.1041320321; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; STEVENS J, 1982, PROC R SOC SER B-BIO, V215, P405, DOI 10.1098/rspb.1982.0050; Takebayashi K, 1996, MOL CELL BIOL, V16, P1203; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; ZHOU QJ, 1995, J VIROL, V69, P4323, DOI 10.1128/JVI.69.7.4323-4330.1995	41	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8566	8571		10.1074/jbc.M110392200	http://dx.doi.org/10.1074/jbc.M110392200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751862	hybrid			2022-12-27	WOS:000174268000120
J	Yanazume, T; Hasegawa, K; Wada, H; Morimoto, T; Abe, M; Kawamura, T; Sasayama, S				Yanazume, T; Hasegawa, K; Wada, H; Morimoto, T; Abe, M; Kawamura, T; Sasayama, S			Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; MYOSIN HEAVY-CHAIN; BINDING PROTEIN-RHO; SERINE-THREONINE KINASE; CARDIAC GENE-EXPRESSION; NATRIURETIC-FACTOR GENE; SERUM RESPONSE ELEMENT; ACTIN STRESS FIBERS; FOCAL ADHESIONS; PRESSURE-OVERLOAD	The low molecular weight GTPase Rho mediates a variety of cytoskeleton-dependent cell functions and stretch- and G(q) protein-induced hypertrophic responses in cardiac myocytes. Although ROCK, one of Rho's effectors, has been suggested to mediate hypertrophic signals, the relationship of Rho/ROCK with downstream signals is unknown. A zinc finger transcription factor, GATA-4, is activated by extracellular signal-regulated kinase 1/2 and is required for the up-regulation of the endothelin-1 gene during myocardial cell hypertrophy. However, it is unknown whether Rho/ROCK signals are linked to downstream GATA-4. By transient transfection assays using a dominant-negative mutant and an activated derivative of ROCK-I, we showed that ROCK-I participates in GATA-4-dependent endothelin-1 transcription. Inhibition of the Rho/ROCK pathway by Y-27632, a selective inhibitor of ROCK, suppressed phenylephrine-stimulated phosphorylation of extracellular signal-regulated kinase 1/2 and increased the DNA binding activity of cardiac GATA-4. Interestingly, latrunculin B, which inhibits actin polymerization, also prevents phenylephrine-induced responses. These findings demonstrate that the Rho/ROCK pathway is linked to downstream GATA-4 via the activation of extracellular signal-regulated kinases during myocardial cell hypertrophy. The results also suggest that changes in actin dynamics provide a convergence point for Rho/ROCK to the downstream signals during this process.	Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Hasegawa, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Kawara Cho, Kyoto 6068507, Japan.	koj@kuhp.kyoto-u.ac.jp		Wada, Hiromichi/0000-0002-8980-224X				Aikawa R, 1999, CIRC RES, V84, P458, DOI 10.1161/01.RES.84.4.458; Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Aoki H, 2000, NAT MED, V6, P183, DOI 10.1038/72287; Aoki H, 1998, CIRC RES, V82, P666, DOI 10.1161/01.RES.82.6.666; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Chihara K, 1997, J BIOL CHEM, V272, P25121, DOI 10.1074/jbc.272.40.25121; Clerk A, 2000, CIRC RES, V86, P1019, DOI 10.1161/01.RES.86.10.1019; Cooper G, 1997, ANNU REV MED, V48, P13, DOI 10.1146/annurev.med.48.1.13; Hasegawa K, 1997, J BIOL CHEM, V272, P20049, DOI 10.1074/jbc.272.32.20049; Hasegawa K, 1997, CIRCULATION, V96, P3943; Herzig TC, 1997, P NATL ACAD SCI USA, V94, P7543, DOI 10.1073/pnas.94.14.7543; Hines WA, 1998, J MOL CELL CARDIOL, V30, P485, DOI 10.1006/jmcc.1997.0613; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Inada T, 1999, J AM COLL CARDIOL, V33, P565, DOI 10.1016/S0735-1097(98)00564-6; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Kakita T, 1999, J BIOL CHEM, V274, P34096, DOI 10.1074/jbc.274.48.34096; Kakita T, 2001, CIRC RES, V88, P1239, DOI 10.1161/hh1201.091794; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KRAFT R, 1989, NUCLEIC ACIDS RES, V17, P7529, DOI 10.1093/nar/17.18.7529; Kuwahara K, 1999, FEBS LETT, V452, P314, DOI 10.1016/S0014-5793(99)00680-8; LEE RT, 1988, J CLIN INVEST, V81, P431, DOI 10.1172/JCI113337; Leung T, 1996, MOL CELL BIOL, V16, P5313; MACLELLAN WR, 1997, MOL BIOL CARDIOVASCU, P327; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Morimoto T, 1999, J BIOL CHEM, V274, P12811, DOI 10.1074/jbc.274.18.12811; Morimoto T, 2000, J BIOL CHEM, V275, P13721, DOI 10.1074/jbc.275.18.13721; Morissette MR, 2000, AM J PHYSIOL-HEART C, V278, pH1769, DOI 10.1152/ajpheart.2000.278.6.H1769; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Thorburn J, 1997, EMBO J, V16, P1888, DOI 10.1093/emboj/16.8.1888; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Ueyama T, 1997, CIRC RES, V81, P672; Wada H, 2000, J BIOL CHEM, V275, P25330, DOI 10.1074/jbc.M000828200	48	86	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8618	8625		10.1074/jbc.M107924200	http://dx.doi.org/10.1074/jbc.M107924200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11739382	Green Submitted, hybrid			2022-12-27	WOS:000174268000127
J	Garcia-Alles, LF; Flukiger, K; Hewel, J; Gutknecht, R; Siebold, C; Schurch, S; Erni, B				Garcia-Alles, LF; Flukiger, K; Hewel, J; Gutknecht, R; Siebold, C; Schurch, S; Erni, B			Mechanism-based inhibition of enzyme I of the Escherichia coli phosphotransferase system - Cysteine 502 is an essential residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; GLCNAC ENOLPYRUVYL TRANSFERASE; PYRUVATE PHOSPHATE DIKINASE; SITE-DIRECTED MUTAGENESIS; SUGAR-TRANSPORT; PHOSPHOENOLPYRUVATE CARBOXYLASE; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; ACTIVE-SITE; 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE	Four phosphoenolpyruvate (PEP) derivatives, carrying reactive or activable, chemical functions in each of the three chemical regions of PEP, were assayed as alternative substrates of enzyme I (EI) of the Escherichia coli PEP:glucose phosphotransferase system. The Z- and E-isomers of 3-chlorophosphoenolpyruvate (3-Cl-PEP) were substrates, presenting K-m values of 0.08 and 0.12 mm, respectively, very similar to the K-m of 0.14 mm measured for PEP, and k(cat) of 40 and 4 min(-1), compared with 2,200 min(-1), for PEP. The low catalytic efficiency of these substrates permits the study of activity at in vivo El concentrations. Z-Cl-PEP was a competitive inhibitor of PEP with a K-1 of 0.4 mm. E-Cl-PEP was not an inhibitor. Compounds 3 and 4, obtained by modification of the carboxylic and phosphate groups of PEP, were neither substrates nor inhibitors of EI, highlighting the importance of these functionalities for recognition by EL. Z-Cl-PEP is a suicide inhibitor. About 10-50 turnovers sufficed to inactivate EI completely. Such a property can be exploited to reveal and quantitate phosphoryl transfer from EI to other proteins at in vivo concentrations. Inactivation was saturatable in Z-Cl-PEP, with an apparent K-m(inact) of 0.2-0.4 mm. The rate of inactivation increased with the concentration of EI, indicating a preferential or exclusive reaction with the dimeric form of EI. E-Cl-PEP inactivates EI much more slowly, and unlike PEP, it did not protect against inactivation by Z-Cl-PEP. This and the ineffectiveness of E-Cl-PEP as a competitive inhibitor have been related to the presence of two EI active species. Cys-502 of EI was identified by mass spectrometry as the reacting residue. The C502A EI mutant showed less than 0.06% wild-type activity. Sequence alignments and comparisons of x-ray structures of different PEP-utilizing enzymes indicate that Cys-502 might serve as a proton donor during catalysis.	Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; Univ Bern, Mass Spectrometry Lab, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Garcia-Alles, LF (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.		Schürch, Stefan/ABE-4977-2022	Schürch, Stefan/0000-0001-5109-4623; Garcia-Alles, Luis/0000-0002-1141-0393				BEARNE SL, 1992, BIOORG CHEM, V20, P135, DOI 10.1016/0045-2068(92)90034-Z; Benenson Y, 1996, BIOORG MED CHEM LETT, V6, P2901, DOI 10.1016/S0960-894X(96)00539-2; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; Brokx SJ, 2000, BIOCHEMISTRY-US, V39, P3624, DOI 10.1021/bi991250z; CHAUVIN F, 1994, J BIOL CHEM, V269, P20263; CHAUVIN F, 1994, J BIOL CHEM, V269, P20270; Chauvin F, 1996, P NATL ACAD SCI USA, V93, P7028, DOI 10.1073/pnas.93.14.7028; Cragoe E.J., 1960, ORG SYN, V40, P54; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIAZ E, 1988, BIOCHEMISTRY-US, V27, P1336, DOI 10.1021/bi00404a037; DUFFY TH, 1984, BIOCHEMISTRY-US, V23, P661, DOI 10.1021/bi00299a012; FLOSS HG, 1972, J BIOL CHEM, V247, P736; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P2517, DOI 10.1021/bi962924y; HAN MK, 1990, J BIOL CHEM, V265, P1996; HAN MK, 1990, J BIOL CHEM, V265, P1985; HANSEN DE, 1982, J BIOL CHEM, V257, P4795; Hartman F C, 1977, Methods Enzymol, V46, P130; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; HOVING H, 1982, BIOCHEMISTRY-US, V21, P3128, DOI 10.1021/bi00256a015; HOVING H, 1984, BIOCHEMISTRY-US, V23, P4335, DOI 10.1021/bi00314a013; HOVING H, 1983, BIOCHEMISTRY-US, V22, P2832, DOI 10.1021/bi00281a010; HOVING H, 1985, BIOCHEMISTRY-US, V24, P6163, DOI 10.1021/bi00343a020; HOVING H, 1981, BIOCHEMISTRY-US, V20, P87, DOI 10.1021/bi00504a015; Huang K, 1999, STRUCT FOLD DES, V7, P539, DOI 10.1016/S0969-2126(99)80070-7; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; HWANG SH, 1986, BIOCHEMISTRY-US, V25, P5590, DOI 10.1021/bi00367a037; JANC JW, 1992, BIOCHEMISTRY-US, V31, P6432, DOI 10.1021/bi00143a011; Jia Y, 1999, BIOCHEMISTRY-US, V38, P14165, DOI 10.1021/bi990771j; JONES DH, 1992, BIOTECHNIQUES, V12, P528; KIM DH, 1994, J AM CHEM SOC, V116, P6478, DOI 10.1021/ja00093a076; KIM DH, 1995, J AM CHEM SOC, V117, P6380, DOI 10.1021/ja00128a037; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; KIM DH, 1995, J AM CHEM SOC, V117, P1494, DOI 10.1021/ja00110a005; Kim DH, 1996, BIOCHEMISTRY-US, V35, P5435, DOI 10.1021/bi952978s; KUKURUZINSKA MA, 1984, J BIOL CHEM, V259, P1679; KUKURUZINSKA MA, 1982, J BIOL CHEM, V257, P4470; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; Larsen TM, 1996, BIOCHEMISTRY-US, V35, P4349, DOI 10.1021/bi952859c; LEARY MH, 1982, J BIOL CHEM, V257, P14603; LEE BR, 1994, ARCH BIOCHEM BIOPHYS, V312, P121, DOI 10.1006/abbi.1994.1289; Liao DI, 1996, STRUCTURE, V4, P861, DOI 10.1016/S0969-2126(96)00092-5; LICALSI C, 1991, J BIOL CHEM, V266, P19519; LIU J, 1990, ARCH BIOCHEM BIOPHYS, V277, P143, DOI 10.1016/0003-9861(90)90562-D; LUX R, 1995, P NATL ACAD SCI USA, V92, P11583, DOI 10.1073/pnas.92.25.11583; MANCERA RL, 1995, BIOORGAN MED CHEM, V3, P217, DOI 10.1016/0968-0896(95)00017-B; MAO QC, 1995, J BIOL CHEM, V270, P5258, DOI 10.1074/jbc.270.10.5258; Matsumura H, 1999, FEBS LETT, V458, P93, DOI 10.1016/S0014-5793(99)01103-5; MELOCHE HP, 1970, BIOCHEMISTRY-US, V9, P5050, DOI 10.1021/bi00828a002; MISSET O, 1980, BIOCHEMISTRY-US, V19, P883, DOI 10.1021/bi00546a009; MISSET O, 1982, BIOCHEMISTRY-US, V21, P3136, DOI 10.1021/bi00256a016; Mukhija S, 1997, MOL MICROBIOL, V25, P1159, DOI 10.1046/j.1365-2958.1997.5501910.x; Mukhija S, 1998, EUR J BIOCHEM, V254, P433, DOI 10.1046/j.1432-1327.1998.2540433.x; PELISKA JA, 1989, BIOCHEMISTRY-US, V28, P1604, DOI 10.1021/bi00430a027; POCALYKO DJ, 1990, BIOCHEMISTRY-US, V29, P10757, DOI 10.1021/bi00500a006; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; ROSE IA, 1970, J BIOL CHEM, V245, P6052; SAIER MH, 1995, TRENDS BIOCHEM SCI, V20, P267, DOI 10.1016/S0968-0004(00)89041-6; SAIER MH, 1993, J CELL BIOCHEM, V51, P1, DOI 10.1002/jcb.240510102; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Seok YJ, 1996, P NATL ACAD SCI USA, V93, P347, DOI 10.1073/pnas.93.1.347; Seok YJ, 1998, BIOCHEM BIOPH RES CO, V250, P381, DOI 10.1006/bbrc.1998.9323; Seok YJ, 1996, BIOCHEMISTRY-US, V35, P236, DOI 10.1021/bi952052k; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; SIKKEMA KD, 1988, BIOCHEMISTRY-US, V27, P1342, DOI 10.1021/bi00404a038; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; STOLZ B, 1993, J BIOL CHEM, V268, P27094; STUBBE JA, 1972, BIOCHEMISTRY-US, V11, P338, DOI 10.1021/bi00753a005; Sundaram AK, 2000, J ORG CHEM, V65, P5891, DOI 10.1021/jo991529l; TITGEMEYER F, 1994, J BACTERIOL, V176, P543, DOI 10.1128/JB.176.2.543-546.1994; Wagner T, 2000, J MOL BIOL, V301, P389, DOI 10.1006/jmbi.2000.3957; WALKER MC, 1992, J AM CHEM SOC, V114, P7601, DOI 10.1021/ja00045a065; Walsh CT, 1996, CHEM BIOL, V3, P83, DOI 10.1016/S1074-5521(96)90282-3; WAYGOOD EB, 1980, CAN J BIOCHEM CELL B, V58, P40, DOI 10.1139/o80-006; WAYGOOD EB, 1986, BIOCHEMISTRY-US, V25, P4085, DOI 10.1021/bi00362a015; WEIGEL N, 1982, J BIOL CHEM, V257, P4461; XU Y, 1995, BIOCHEMISTRY-US, V34, P2181, DOI 10.1021/bi00007a011; Zhu PP, 1999, BIOCHEMISTRY-US, V38, P15470, DOI 10.1021/bi991680p	80	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6934	6942		10.1074/jbc.M110067200	http://dx.doi.org/10.1074/jbc.M110067200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741915	hybrid			2022-12-27	WOS:000174104300026
J	Kurreck, J; Bieber, B; Jahnel, R; Erdmann, VA				Kurreck, J; Bieber, B; Jahnel, R; Erdmann, VA			Comparative study of DNA enzymes and ribozymes against the same full-length messenger RNA of the vanilloid receptor subtype I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMMERHEAD RIBOZYME; SITE SELECTION; CAPSAICIN RECEPTOR; ACCESSIBLE SITES; GENE-EXPRESSION; TARGET SITES; CLEAVAGE; INHIBITION; PROLIFERATION; SUPPRESSION	The efficiencies of 32 antisense oligodeoxynucleotides, 35 DNA enzymes and 6 ribozymes to bind and cleave the full-length messenger RNA of the vanilloid receptor subtype I were analyzed. Systematic screening of the mRNA revealed that good accessibility of a putative cleavage site for antisense oligodeoxynucleotides is a necessary but not a sufficient prerequisite for efficient DNA enzymes. Comparison of DNA enzymes and ribozymes against the same target sites revealed: 1) DNA enzymes were more active with longer recognition arms (9 nucleotides on either side), whereas ribozymes revealed higher activities with shorter recognition arms (7 nucleotides on either side). 2) It does not only depend on the target site but also on the enzyme sequence, whether a DNA enzyme or a ribozyme is more active. 3) The most efficient DNA enzyme found in this study had an similar to15-fold higher reaction rate, k(react), and a 100-fold higher k(react)/K-m under single turnover conditions compared with the fastest ribozyme. DNA enzymes as well as ribozymes showed significant activity under multiple turnover conditions, the DNA enzymes again being more active. We therefore conclude that DNA enzymes are an inexpensive, very stable and active alternative to ribozymes for the specific cleavage of long RNA molecules.	Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany	Free University of Berlin	Erdmann, VA (corresponding author), Free Univ Berlin, Inst Biochem, Thielallee 63, D-14195 Berlin, Germany.	erdmann@chemie.fu-berlin.de	Kurreck, Jens/B-7785-2008	Kurreck, Jens/0000-0002-1469-0052				Amarzguioui M, 2000, NUCLEIC ACIDS RES, V28, P4113, DOI 10.1093/nar/28.21.4113; Bramlage B, 2000, NUCLEIC ACIDS RES, V28, P4059, DOI 10.1093/nar/28.21.4059; Bramlage B, 1999, NUCLEIC ACIDS RES, V27, P3159, DOI 10.1093/nar/27.15.3159; Cairns MJ, 2000, ANTISENSE NUCLEIC A, V10, P323, DOI 10.1089/oli.1.2000.10.323; Cairns MJ, 1999, NAT BIOTECHNOL, V17, P480, DOI 10.1038/8658; Campbell TB, 1997, NUCLEIC ACIDS RES, V25, P4985, DOI 10.1093/nar/25.24.4985; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHRISTOFFERSEN RE, 1995, J MED CHEM, V38, P2023, DOI 10.1021/jm00012a001; Dash BC, 1998, FEBS LETT, V431, P395, DOI 10.1016/S0014-5793(98)00799-6; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Goila R, 1998, FEBS LETT, V436, P233, DOI 10.1016/S0014-5793(98)01137-5; HEIDENREICH O, 1994, J BIOL CHEM, V269, P2131; Ho SP, 1996, NUCLEIC ACIDS RES, V24, P1901, DOI 10.1093/nar/24.10.1901; Ho SP, 1998, NAT BIOTECHNOL, V16, P59, DOI 10.1038/nbt0198-59; James HA, 1998, BLOOD, V91, P371, DOI 10.1182/blood.V91.2.371.371_371_382; Jarvis TC, 1996, J BIOL CHEM, V271, P29107, DOI 10.1074/jbc.271.46.29107; Jen KY, 2000, STEM CELLS, V18, P307, DOI 10.1634/stemcells.18-5-307; Kuwabara T, 1997, NUCLEIC ACIDS RES, V25, P3074, DOI 10.1093/nar/25.15.3074; LIEBER A, 1995, MOL CELL BIOL, V15, P540, DOI 10.1128/MCB.15.1.540; Matveeva O, 1997, NUCLEIC ACIDS RES, V25, P5010, DOI 10.1093/nar/25.24.5010; Milner N, 1997, NAT BIOTECHNOL, V15, P537, DOI 10.1038/nbt0697-537; Persidis A, 1997, NAT BIOTECHNOL, V15, P921, DOI 10.1038/nbt0997-921; Pierce ML, 1998, NUCLEIC ACIDS RES, V26, P5093, DOI 10.1093/nar/26.22.5093; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; Santiago FS, 1999, NAT MED, V5, P1264, DOI 10.1038/15215; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; Sioud M, 1997, NUCLEIC ACIDS RES, V25, P333, DOI 10.1093/nar/25.2.333; Sohail M, 2000, ADV DRUG DELIVER REV, V44, P23, DOI 10.1016/S0169-409X(00)00081-8; Sriram B, 2000, BIOCHEM J, V352, P667, DOI 10.1042/0264-6021:3520667; Stage-Zimmermann TK, 1998, RNA, V4, P875, DOI 10.1017/S1355838298980876; Sun LQ, 1999, J BIOL CHEM, V274, P17236, DOI 10.1074/jbc.274.24.17236; Sun LQ, 2000, PHARMACOL REV, V52, P325; Thomson JB, 1996, CATALYTIC RNA, P173; Tohda C, 2001, J NEUROCHEM, V76, P1628, DOI 10.1046/j.1471-4159.2001.00193.x; Warashina M, 1999, CHEM BIOL, V6, P237, DOI 10.1016/S1074-5521(99)80039-8; Wedekind JE, 1998, ANNU REV BIOPH BIOM, V27, P475, DOI 10.1146/annurev.biophys.27.1.475; Wu YP, 1999, HUM GENE THER, V10, P2847, DOI 10.1089/10430349950016573; Yen LS, 1999, ANN NEUROL, V46, P366, DOI 10.1002/1531-8249(199909)46:3<366::AID-ANA12>3.0.CO;2-D; Zhang XY, 1999, FEBS LETT, V458, P151, DOI 10.1016/S0014-5793(99)01149-7	42	70	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7099	7107		10.1074/jbc.M107206200	http://dx.doi.org/10.1074/jbc.M107206200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751899	hybrid			2022-12-27	WOS:000174104300046
J	Saeed-Kothe, A; Powers-Lee, SG				Saeed-Kothe, A; Powers-Lee, SG			Specificity determining residues in ammonia- and glutamine-dependent carbamoyl phosphate synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIFUNCTIONAL PROTEIN CAD; COOH-TERMINAL DOMAIN; ACETYL-L-GLUTAMATE; ESCHERICHIA-COLI; AMIDOTRANSFERASE DOMAIN; ALLOSTERIC ACTIVATOR; CATALYTIC TRIAD; LARGE SUBUNIT; BINDING-SITE; SWISS-MODEL	Carbamoyl phosphate synthetases (CPSs) utilize either glutamine or ammonia for the ATP-dependent generation of carbamoyl phosphate. In glutamine-utilizing CPSs (e.g. the single Escherichia coli CPS and mammalian CPS II), the hydrolysis of glutamine to yield ammonia is catalyzed at a triad-type glutamine amidotransferase domain. Non-glutamine-utilizing CPSs (e.g. rat and human CPS I), lacking the catalytic cysteine residue, can generate carbamoyl phosphate only in the presence of free ammonia. Frog CPS I (fCPS I), unlike mam- malian CPS Is, retains most of the glutamine amidotransferase residues conserved in glutamine-utilizing CPSs, including an intact catalytic triad, and could therefore be expected to use glutamine. Our work with native fCPS I provides the first demonstration of the inability of this enzyme to bind/utilize glutamine. To determine why fCPS I is unable to utilize glutamine, we compared sequences of glutamine-using and non-glutamine-using CPSs to identify residues that are present or conservatively substituted in all glutamine-utilizing CPSs but absent in fCPS I. We constructed the site-directed mutants Q273E, L270K, Q273E/N240S, and Q273E/L270K in E. coli CPS and have determined that simultaneous occurrence of the two substitutions, GIn --> Glu and Leu --> Lys, found in the frog CPS I glutamine amidotransferase domain are sufficient to eliminate glutamine utilization by the E. coli enzyme.	Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University	Powers-Lee, SG (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.				NIDDK NIH HHS [DK 54423] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054423] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson P. M., 1970, METHODS ENZYMOL    A, V17A, P235; ANDERSON PM, 1966, BIOCHEMISTRY-US, V5, P3157, DOI 10.1021/bi00874a012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUESO J, 1994, BIOCHEM BIOPH RES CO, V203, P1083, DOI 10.1006/bbrc.1994.2293; Cervera J, 1996, BIOCHEMISTRY-US, V35, P7247, DOI 10.1021/bi952549u; CHAPARIAN MG, 1991, J BIOL CHEM, V266, P3387; COHEN NS, 1985, BIOCHEM J, V229, P205, DOI 10.1042/bj2290205; EVANS DR, 1988, BIOCHIM BIOPHYS ACTA, V953, P185, DOI 10.1016/0167-4838(88)90023-4; FAHIEN LA, 1964, J BIOL CHEM, V239, P1935; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUILLOU F, 1989, P NATL ACAD SCI USA, V86, P8304, DOI 10.1073/pnas.86.21.8304; GUTHOHRL.G, 1968, ANAL BIOCHEM, V26, P188, DOI 10.1016/0003-2697(68)90045-6; GUY HI, 1995, J BIOL CHEM, V270, P2190, DOI 10.1074/jbc.270.5.2190; HARAGUCHI Y, 1991, GENE, V107, P335; HELBING CC, 1994, J BIOL CHEM, V269, P11743; Hewagama A, 1998, BBA-PROTEIN STRUCT M, V1388, P489, DOI 10.1016/S0167-4838(98)00212-X; Huang XY, 1999, BIOCHEMISTRY-US, V38, P15909, DOI 10.1021/bi991805q; Huang XY, 2000, BIOCHEMISTRY-US, V39, P3240, DOI 10.1021/bi9926173; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim AL, 1996, J BIOL CHEM, V271, P11400, DOI 10.1074/jbc.271.19.11400; LIU X, 1994, J BIOL CHEM, V269, P27747; LUSTY CJ, 1992, FEBS LETT, V314, P135, DOI 10.1016/0014-5793(92)80959-K; MARSHALL M, 1988, ARCH BIOCHEM BIOPHYS, V262, P455, DOI 10.1016/0003-9861(88)90397-9; MEISTER A, 1978, ADV ENZYME REGUL, V16, P289; Miles BW, 1998, BIOCHEMISTRY-US, V37, P16773, DOI 10.1021/bi982018g; MORI M, 1978, J BIOL CHEM, V253, P8337; NYUNOYA H, 1983, P NATL ACAD SCI-BIOL, V80, P4629, DOI 10.1073/pnas.80.15.4629; NYUNOYA H, 1985, J BIOL CHEM, V260, P9346; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; POWERSLEE SG, 1986, J BIOL CHEM, V261, P5349; POWERSLEE SG, 1988, LIVER BIOL PATHOBIOL, P317; RODRIGUEZAPARICIO LB, 1989, BIOCHEMISTRY-US, V28, P3070, DOI 10.1021/bi00433a050; RUBINO SD, 1987, J BIOL CHEM, V262, P4382; RUBINO SD, 1986, J BIOL CHEM, V261, P1320; RUBIO V, 1983, EUR J BIOCHEM, V134, P337, DOI 10.1111/j.1432-1033.1983.tb07572.x; Sambrook J., 2002, MOL CLONING LAB MANU; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Thoden JB, 1999, J BIOL CHEM, V274, P22502, DOI 10.1074/jbc.274.32.22502; Thoden JB, 1998, BIOCHEMISTRY-US, V37, P8825, DOI 10.1021/bi9807761; Thoden JB, 1999, ACTA CRYSTALLOGR D, V55, P8, DOI 10.1107/S0907444998006234; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P6305, DOI 10.1021/bi970503q; Tuchman M, 1997, APPL ENVIRON MICROB, V63, P33, DOI 10.1128/AEM.63.1.33-38.1997; WIMMER MJ, 1979, J BIOL CHEM, V254, P1854; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87	45	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7231	7238		10.1074/jbc.M110926200	http://dx.doi.org/10.1074/jbc.M110926200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11756425	hybrid			2022-12-27	WOS:000174104300063
J	Sajithlal, G; Huttunen, H; Rauvala, H; Munch, G				Sajithlal, G; Huttunen, H; Rauvala, H; Munch, G			Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; PROTEIN AMPHOTERIN; PATTERN-FORMATION; NERVOUS-SYSTEM; SH-SY5Y CELLS; BRAIN; EXPRESSION; APOPTOSIS; RAGE; ACTIVATION	The receptor for advanced glycation end products (RAGE), a member of the immunoglobulin superfamily, is known to interact with amphoterin. This interaction has been proposed to play a role in neurite outgrowth and process elongation during neurodifferentiation. However, there is as yet no direct evidence of the relevance of this pathway to neurodifferentiation under physiological conditions. In this study we have investigated a possible role of RAGE and amphoterin in the retinoic acid-induced differentiation of neuroblastoma cells. The functional inactivation of RAGE by dominant negative and antisense strategies showed that RAGE is not required for process outgrowth or differentiation, although overexpression of RAGE accelerates the elongation of neuritic processes. Using the antisense strategy, amphoterin was shown to be essential for process outgrowth and differentiation, suggesting that amphoterin may interact with other molecules to exert its effect in this context. Interestingly, the survival of the neuroblastoma. cells treated with retinoic acid was partly dependent on the expression of RAGE, and inhibition of RAGE function partially blocked the increase in anti-apoptotic protein Bcl-2 following retinoic acid treatment. Based on these results we propose that a combination therapy using RAGE blockers and retinoic acid may prove as a useful approach for chemotherapy for the treatment of neuroblastoma.	Univ Leipzig, IZKF, Dept Neuroimmunol Cell Biol, D-04103 Leipzig, Germany; Univ Helsinki, Inst Biotechnol, Programme Mol Neurobiol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland	Leipzig University; University of Helsinki; University of Helsinki	Munch, G (corresponding author), Univ Leipzig, IZKF, Dept Neuroimmunol Cell Biol, Leipzig Johannisallee 30A, D-04103 Leipzig, Germany.		li, tao/B-2402-2008	Rauvala, Heikki/0000-0001-7809-9811; Huttunen, Henri/0000-0002-9867-4438				Altmann CR, 2001, INT REV CYTOL, V203, P447; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Clagett-Dame M, 1997, CRIT REV EUKAR GENE, V7, P299, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.20; Coffey DC, 2001, CANCER RES, V61, P3591; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; CONLON RA, 1995, TRENDS GENET, V11, P314, DOI 10.1016/S0168-9525(00)89089-7; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Fages C, 2000, J CELL SCI, V113, P611; Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772, DOI 10.1152/ajpcell.2000.279.6.C1772; HANADA M, 1993, CANCER RES, V53, P4978; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hsu SL, 2000, EXP CELL RES, V258, P322, DOI 10.1006/excr.2000.4933; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Irving H, 1998, EUR J CANCER, V34, P111, DOI 10.1016/S0959-8049(97)10027-2; Itano Y, 1996, J NEUROCHEM, V67, P131; Kaba SE, 1997, J NEURO-ONCOL, V34, P145, DOI 10.1023/A:1005743707803; Kohler JA, 2000, BRIT J CANCER, V83, P1124, DOI 10.1054/bjoc.2000.1425; LASORELLA A, 1995, CANCER RES, V55, P4711; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Lombet A, 2001, EUR J BIOCHEM, V268, P1352, DOI 10.1046/j.1432-1327.2001.02002.x; MAY WS, 1994, J BIOL CHEM, V269, P26865; Meister B, 1998, ANTICANCER RES, V18, P1777; Melino G, 1997, J NEURO-ONCOL, V31, P65, DOI 10.1023/A:1005733430435; MELLONI E, 1995, BIOCHEM BIOPH RES CO, V210, P82, DOI 10.1006/bbrc.1995.1630; Middlemas DS, 1999, J BIOL CHEM, V274, P16451, DOI 10.1074/jbc.274.23.16451; MOHAN PS, 1992, BIOCHEM BIOPH RES CO, V182, P689, DOI 10.1016/0006-291X(92)91787-Q; MorrissKay GM, 1996, FASEB J, V10, P961, DOI 10.1096/fasebj.10.9.8801178; Niles RM, 2000, NUTRITION, V16, P1084, DOI 10.1016/S0899-9007(00)00436-6; PAHLMAN S, 1995, EUR J CANCER, V31A, P453, DOI 10.1016/0959-8049(95)00033-F; Papalopulu N, 1996, DEVELOPMENT, V122, P3409; PARKKINEN J, 1993, J BIOL CHEM, V268, P19726; PREISLER HD, 1992, CANCER RES, V52, P4090; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; RIBONI L, 1995, J BIOL CHEM, V270, P26868, DOI 10.1074/jbc.270.45.26868; SALMIVIRTA M, 1992, EXP CELL RES, V200, P444, DOI 10.1016/0014-4827(92)90194-D; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; Szondy Z, 1997, MOL PHARMACOL, V51, P972, DOI 10.1124/mol.51.6.972; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Wang S, 2001, J NEUROCHEM, V76, P1089, DOI 10.1046/j.1471-4159.2001.00142.x; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504	42	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6888	6897		10.1074/jbc.M107627200	http://dx.doi.org/10.1074/jbc.M107627200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11739380	hybrid			2022-12-27	WOS:000174104300020
J	Gonzalez-Lebrero, RM; Kaufman, SB; Montes, MR; Norby, JG; Garrahan, PJ; Rossi, RC				Gonzalez-Lebrero, RM; Kaufman, SB; Montes, MR; Norby, JG; Garrahan, PJ; Rossi, RC			The occlusion of Rb+ in the Na+/K+-ATPase I. The identity of occluded states formed by the physiological or the direct routes: Occlusion/deocclusion kinetics through the direct route	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPID RELEASE; RUBIDIUM IONS; STEADY-STATE; SODIUM-PUMP; TRANSPORT; NA,K-ATPASE; POTASSIUM; (NA++K+)-ATPASE; NA,K-PUMP; MECHANISM	Occlusion of K+ or its congeners in the Na+/K+- ATPase occurs after K+-dependent dephosphorylation (physiological route) or in media lacking ATP and Na+ (direct route). The effects of Pi or ATP on the kinetics of deocclusion of the K+-congener Rb+ formed by each of the above mentioned routes was independent of the route of occlusion, which suggests that both routes lead to the same enzyme intermediate. The time course of occlusion via the direct route can be described by the sum of two exponential functions plus a small component of very high velocity. At equilibrium, occluded Rb+ is a hyperbolic function of free [Rb+] suggesting that the direct route results in enzyme states holding either one or two occluded Rb+. Release of occluded Rb+ follows the sum of two decreasing exponential functions of time, corresponding to two phases with similar sizes. These phases are not caused by independent physical compartments. The rate constant of one of the phases is reduced up to 30 times by free Rb+. When Rb+ is the only pump ligand, the kinetics of occlusion and deocclusion through the direct route are consistent with an ordered-sequential process with additional independent step(s) interposed between the uptake or the release of each occluded Rb+.	Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; Aarhus Univ, Inst Biophys, DK-8000 Aarhus, Denmark	University of Buenos Aires; University of Buenos Aires; Aarhus University	Rossi, RC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	rcr@mail.retina.ar		Gonzalez Lebrero, Rodolfo M./0000-0002-3832-2270; Kaufman, Sergio Benjamin/0000-0002-8763-4086				[Anonymous], [No title captured]; BEAUGE LA, 1979, NATURE, V280, P510, DOI 10.1038/280510a0; ESMANN M, 1994, BIOCHEMISTRY-US, V33, P8558, DOI 10.1021/bi00194a022; FORBUSH B, 1987, J BIOL CHEM, V262, P11116; FORBUSH B, 1987, J BIOL CHEM, V262, P11104; FORBUSH B, 1988, NAPLUS KMINUS PUMP A, P239; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P217, DOI 10.1113/jphysiol.1967.sp008297; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; GLYNN IM, 1985, J PHYSIOL-LONDON, V368, P453, DOI 10.1113/jphysiol.1985.sp015868; GLYNN IM, 1982, J PHYSIOL-LONDON, V330, P17, DOI 10.1113/jphysiol.1982.sp014326; Gonzalez-Lebrero RM, 2002, J BIOL CHEM, V277, P5922, DOI 10.1074/jbc.M105887200; GONZALEZLEBRERE RM, 2001, THESIS U BUENOS AIRE; GONZALEZLEBRERO RM, 2000, EXCERPTA MED INT C S, V120, P433; HASENAUER J, 1993, J BIOL CHEM, V268, P3289; JENSEN J, 1989, BIOCHIM BIOPHYS ACTA, V985, P248, DOI 10.1016/0005-2736(89)90409-4; JENSEN J, 1984, J PHYSIOL-LONDON, V346, P219, DOI 10.1113/jphysiol.1984.sp015018; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; KARLISH SJD, 1982, J PHYSIOL-LONDON, V328, P295, DOI 10.1113/jphysiol.1982.sp014265; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; Kaufman SB, 1999, J BIOL CHEM, V274, P20779, DOI 10.1074/jbc.274.30.20779; PEDEMONTE CH, 1983, BIOCHIM BIOPHYS ACTA, V748, P245, DOI 10.1016/0167-4838(83)90301-1; POST RL, 1974, ANN NY ACAD SCI, V242, P80, DOI 10.1111/j.1749-6632.1974.tb19081.x; POST RL, 1972, J BIOL CHEM, V247, P6530; Rossi RC, 1999, ANAL BIOCHEM, V270, P276, DOI 10.1006/abio.1999.4094; ROSSI RC, 1993, J BIOL CHEM, V268, P12579; SACHS JR, 1988, J PHYSIOL-LONDON, V400, P545, DOI 10.1113/jphysiol.1988.sp017136; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; SHANI M, 1987, BIOCHIM BIOPHYS ACTA, V904, P13, DOI 10.1016/0005-2736(87)90081-2; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450	30	23	23	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5910	5921		10.1074/jbc.M105886200	http://dx.doi.org/10.1074/jbc.M105886200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11739377	hybrid			2022-12-27	WOS:000173989200029
J	Jankowski, A; Scott, CC; Grinstein, S				Jankowski, A; Scott, CC; Grinstein, S			Determinants of the phagosomal pH in neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE; RESPIRATORY BURST; H+-ATPASE; VACUOLAR; MYELOPEROXIDASE; ACIDIFICATION; MACROPHAGES; MECHANISMS	Phagosomes formed by neutrophils are much less acidic than those of other phagoeytic cells. The defective acidification seen in neutrophils has been attributed to consumption of protons during the dismutation of superoxide, because a large, sustained acidification is unmasked when the cells are treated with inhibitors of the NADPH oxidase. Consumption of protons transported into the phagosome by dismutation would tightly couple the activities of the NADPH oxidase and the vacuolar type H+-pump (or V-ATPase). We tested the existence of the predicted coupling using microfluorimetry and digital imaging and found that the rate of superoxide generation was independent of the activity of the H+-pump. Moreover, we failed to detect the alkalinization predicted to develop through dismutation when the pump was inhibited. Instead, two other mechanisms were found to contribute to the inability of neutrophil phagosomes to acidify. First, the insertion of V-ATPases into the phagosomal membrane was found to be reduced when the oxidase is active. Second, the passive proton (equivalent) permeability of the phagosomal membrane increased when the oxidase was activated. The increased permeability cannot be entirely attributed to the conductive H+ channels associated with the oxidase, since it is not eliminated by Zn2+. We conclude that the NADPH oxidase controls the phagosomal pH by multiple mechanisms that include reduced proton delivery to the lumen, increased luminal proton consumption, and enhanced backflux (leak) into the cytosol.	Hosp Sick Children, Cell Biol Program, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Grinstein, S (corresponding author), Hosp Sick Children, Cell Biol Program, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca		Scott, Cameron/0000-0001-5026-3413				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; COHEN HJ, 1981, BLOOD, V58, P975; COHEN MS, 1994, CLIN INFECT DIS   S2, V18, P170; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Doussiere J, 1999, BIOCHEMISTRY-US, V38, P3694, DOI 10.1021/bi9823481; ELSBACH P, 1985, IMMUNOL LETT, V11, P159, DOI 10.1016/0165-2478(85)90163-4; FENG Y, 1994, J BIOL CHEM, V269, P13224; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENSON PM, 1975, J CLIN INVEST, V56, P1053, DOI 10.1172/JCI108152; HURST JK, 1984, J BIOL CHEM, V259, P4812; Jankowski A, 1999, J BIOL CHEM, V274, P26098, DOI 10.1074/jbc.274.37.26098; Levy O, 2000, BLOOD, V96, P2664; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; NAUSEEF WM, 1983, BLOOD, V61, P483; Schapiro F, 2000, J CELL BIOL, V148, P305, DOI 10.1083/jcb.148.2.305; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0	23	127	129	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6059	6066		10.1074/jbc.M110059200	http://dx.doi.org/10.1074/jbc.M110059200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744729	hybrid			2022-12-27	WOS:000173989200049
J	Li, L; Mao, JH; Sun, L; Liu, WZ; Wu, DQ				Li, L; Mao, JH; Sun, L; Liu, WZ; Wu, DQ			Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; RECEPTOR; PROTEINS; FAMILY; TRANSDUCTION; CANCER; LEF-1; DROSOPHILA; XENOPUS; MEMBER	Recent evidence suggests that members of the Dickkopf (Dkk) family can directly bind to LDL-related protein (LRP)-6, resulting in inhibition of Wnt-activated signaling. To further characterize the interactions between Dkk and LRP proteins, conditioned media containing individually conserved cysteine-rich domains of Dkk-1 and Dkk-2 were prepared. Although full-length Dkk-1 and Dkk-2 and the second cysteine-rich domains of both Dkk molecules inhibited Wnt-3a-induced activation of lymphoid enhancing factor (LEF)-1, a downstream target of the canonical pathway, we found that the second cysteine-rich domain of Dkk-2 (Dkk-2C2) was able to stimulate the canonical pathway when LRP-6 was ectopically expressed in NIH3T3 cells. This effect of Dkk-2C2 could be blocked by a monoclonal antibody specific to the second YWTD repeat domain of LRP-5/6, suggesting that Dkk-2C2 acts via LRP-6. We also showed that while both Axin and the DIX domain of Dishevelled (Dvl) could inhibit Dkk-2C2-induced activation of LEF-1, the DEP domain of Dvl, which inhibited Wnt-induced activation of LEF-1, failed to inhibit the activation of LEF-1 by Dkk-2C2 or by an activated form of LRP-5, LRPC2. In addition, glycogen synthase kinase-3beta, a potent inhibitor for both Dvl and Writ, also failed to inhibit LRPC2 or Dkk-2C2. Furthermore, knocking-down the expression of Dvl molecules by short interfering RNAs specific to Dvl inhibited Wnt-induced, but not LRPC2-induced, activation of LEF-1. All the evidence indicates that Dkk-2C2 signals through LRP proteins, which does not require Dvl, while Wnt protein may employ both Dvl, presumably through Fz, and LRP to achieve more efficient signal transduction.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China; Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Univ Rochester, Dept Pharmacol, Rochester, NY 14642 USA; A&G Pharmaceut, Baltimore, MD 21202 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Connecticut; University of Rochester	Li, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China.	lil@sunm.shcnc.ac.cn; dwu@neuron.uchc.edu			NATIONAL CANCER INSTITUTE [R01CA085420] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker N, 2000, BIOESSAYS, V22, P961; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Chen CM, 1999, DEVELOPMENT, V126, P5441; Dale TC, 1998, BIOCHEM J, V329, P209; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gumbiner BM, 1998, CURR OPIN GENET DEV, V8, P430, DOI 10.1016/S0959-437X(98)80114-7; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Yuan HD, 1999, J BIOL CHEM, V274, P30419, DOI 10.1074/jbc.274.43.30419	28	141	173	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5977	5981		10.1074/jbc.M111131200	http://dx.doi.org/10.1074/jbc.M111131200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11742004	hybrid			2022-12-27	WOS:000173989200037
J	Uchida, M; Hanai, S; Uematsu, N; Sawamoto, K; Okano, H; Miwa, M; Uchida, K				Uchida, M; Hanai, S; Uematsu, N; Sawamoto, K; Okano, H; Miwa, M; Uchida, K			Overexpression of poly(ADP-ribose) polymerase disrupts organization of cytoskeletal F-actin and tissue polarity in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSE POLYMERASE; DEVELOPMENTAL STAGES; GENE-EXPRESSION; EYE DEVELOPMENT; DNA-DAMAGE; CELL-DEATH; MELANOGASTER; CLEAVAGE; ROUGH; APOPTOSIS	Poly(ADP-ribose) polymerase (PARP) may play important roles in nuclear events such as cell cycle, cell proliferation, and maintenance of chromosomal stability. However, the exact biological role played by PARP or how PARP is involved in these cellular functions is still unclear. To elucidate the biological functions of PARP in vivo, we have constructed transgenic flies that overexpress Drosophila PARP in the developing eye primordia. These flies showed mild roughening of the normally smooth ommatidial lattice and tissue polarity disruption caused by improper rotation and chirality of the ommatidia. To clarify how this phenotypical. change was induced, here we analyzed transgenic flies overexpressing PARP in the developing eye, embryo, and adult in detail. PARP mRNA level and the phenotype were enhanced in flies carrying more copies of the transgene. Developing eyes from third instar larvae were analyzed by using the neural cell marker to examine the involvement of PARP in cell fate. Morphological disorder of non-neuronal accessory cells was observed in PARP transgenic flies. Interestingly, overexpression of PARP did not interfere with the cell cycle or apoptosis, but it did disrupt the organization of cytoskeletal F-actin, resulting in aberrant cell and tissue morphology. Furthermore, heat-induced PARP expression disrupted organization of cytoskeletal F-actin in embryos and tissue polarity in adult flies. Because these phenotypes closely resembled mutants or transgenic flies of the tissue polarity genes, genetic interaction of PARP with known tissue polarity genes was examined. Transgenic flies expressing either PARP or RhoA GTPase in the eye were crossed, and co-expression of PARP suppressed the effect of RhoA GTPase. Our results indicate that PARP may play a role in cytoskeletal or cytoplasmic events in developmental processes of Drosophila.	Univ Tsukuba, Inst Basic Med Sci, Dept Biochem & Mol Oncol, Tsukuba, Ibaraki 3058575, Japan; Osaka Univ, Grad Sch Med, Dept Neurosci, Div Neuroanat,Biomed Res Ctr, Osaka 5650871, Japan	University of Tsukuba; Osaka University	Uchida, K (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Biochem & Mol Oncol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	kzuchida@md.tsukuba.ac.jp	Okano, Hideyuki/I-7584-2019	Sawamoto, Kazunobu/0000-0003-1984-5129				Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; Bhatia M, 1996, CELL GROWTH DIFFER, V7, P91; Bonini NM, 1997, CELL DEATH DIFFER, V4, P4, DOI 10.1038/sj.cdd.4400209; BRAND AH, 1993, DEVELOPMENT, V118, P401; Butler AJ, 1999, MOL CELL BIOL, V19, P296; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; GEIPEL U, 1989, EUR J BIOCHEM, V179, P229, DOI 10.1111/j.1432-1033.1989.tb14545.x; Hanai S, 1998, J BIOL CHEM, V273, P11881, DOI 10.1074/jbc.273.19.11881; HARDEN N, 1995, DEVELOPMENT, V121, P903; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; HAY BA, 1994, DEVELOPMENT, V120, P2121; Johansson M, 1999, GENOMICS, V57, P442, DOI 10.1006/geno.1999.5799; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; MASUTANI M, 1994, EUR J BIOCHEM, V220, P607, DOI 10.1111/j.1432-1033.1994.tb18662.x; Masutani M, 1999, MOL CELL BIOCHEM, V193, P149; MOLINETE M, 1993, EMBO J, V12, P2109, DOI 10.1002/j.1460-2075.1993.tb05859.x; Pignoni F, 1997, DEVELOPMENT, V124, P271; Poltronieri P, 1997, BIOCHEM CELL BIOL, V75, P445; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Royet J, 1997, DEVELOPMENT, V124, P4793; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Simbulan-Rosenthal CM, 1999, ONCOGENE, V18, P5015, DOI 10.1038/sj.onc.1202900; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thummel CS, 1992, DROS INF SERV, V71, P150; Trucco C, 1999, MOL CELL BIOCHEM, V193, P53, DOI 10.1023/A:1006947707713; UCHIDA K, 1994, MOL CELL BIOCHEM, V138, P25, DOI 10.1007/BF00928439; Uchida M, 2001, MUTAT RES-FUND MOL M, V477, P89, DOI 10.1016/S0027-5107(01)00110-5; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WOLFF T, 1991, DEVELOPMENT, V113, P825; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Yung TMC, 2001, J BIOL CHEM, V276, P11279, DOI 10.1074/jbc.M008044200	44	16	16	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6696	6702		10.1074/jbc.M109826200	http://dx.doi.org/10.1074/jbc.M109826200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744702	hybrid			2022-12-27	WOS:000173989200131
J	Yeh, SD; Chen, YJ; Chang, ACY; Ray, R; She, BR; Lee, WS; Chiang, HS; Cohen, SN; Lin-Chao, S				Yeh, SD; Chen, YJ; Chang, ACY; Ray, R; She, BR; Lee, WS; Chiang, HS; Cohen, SN; Lin-Chao, S			Isolation and properties of Gas8, a growth arrest-specific gene regulated during male gametogenesis to produce a protein associated with the sperm motility apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; AFRICAN TRYPANOSOMES; CELLS; SPERMATOGENESIS; EXPRESSION; MUTATIONS; SEQUENCE; CLEAVAGE; INVITRO; SYSTEM	Growth arrest-specific (Gas) genes are expressed during serum starvation or contact inhibition of cells grown in culture. Here we report the isolation and characterization of Gas8, a novel gene identified on the basis of its growth arrest-specific expression in murine fibroblasts. We show that production of Gas8 mRNA and protein occurs in adult mice predominantly in the testes, where expression is regulated during postmeiotic development of male gametocytes. Whereas a low level of Gas8 mRNA was detected by Northern blotting in testes of murine male neonates and young adolescents, Gas8 mRNA increased rapidly postmeiotically. In adult males, both Gas8 mRNA and protein reached steady state levels in testes that were 10-fold higher than in other tissues. Immunohistochemical analyses showed that Gas8 protein accumulates in gametocytes as they approach the lumen of seminiferous tubules and is localized to the cytoplasm of round spermatids, the tails of elongating spermatids, and mature spermatid tail bundles protruding into the lumen; in epididymal spermatozoa Gas8 protein was present in the flagella. However, premeiotic murine gametocytes lacked detectable Gas8 protein, as did seminiferous tubules in biopsy specimens from seven human males having cytological evidence of non-obstructive azoospermia secondary to Sertoli cell-only syndrome. Our findings, which associate Gas8 production developmentally with the later stages of spermatogenesis and spatially with the sperm motility apparatus, collectively suggest that this growth arrest-specific gene product may have a role in sperm motility. This postulated role for Gas8 is supported by our observation that highly localized production of Gas8 protein occurs also in the cilia of epithelial cells lining pulmonary bronchi and fallopian tubes and by the flagellar association of a Trypanosoma brucei ortholog of Gas8.	Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan; Taipei Med Univ, Dept Urol, Taipei 110, Taiwan; Natl Taiwan Univ, Sch Med, Inst Biochem, Taipei, Taiwan; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University; National Taiwan University; Stanford University	Lin-Chao, S (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	mbsue@ccvax.sinica.edu.tw	Lin-Chao, Sue/AGI-2030-2022; Lin-Chao, Sue/AAZ-8246-2021	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304				BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; BRANCOLINI C, 1995, EMBO J, V14, P5179, DOI 10.1002/j.1460-2075.1995.tb00202.x; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; BRENNER DG, 1989, P NATL ACAD SCI USA, V86, P5517, DOI 10.1073/pnas.86.14.5517; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Cosson J, 1996, CELL BIOL INT, V20, P83, DOI 10.1006/cbir.1996.0012; DELCASTILLO EB, 1947, J CLIN ENDOCRINOL, V7, P493; DELSAL G, 1994, P NATL ACAD SCI USA, V91, P1848, DOI 10.1073/pnas.91.5.1848; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; ELIASSON R, 1977, NEW ENGL J MED, V297, P1, DOI 10.1056/NEJM197707072970101; EVDOKIOU A, 1993, GENOMICS, V18, P731, DOI 10.1016/S0888-7543(05)80388-X; Evdokiou A, 1998, INT J CANCER, V75, P568, DOI 10.1002/(SICI)1097-0215(19980209)75:4<568::AID-IJC13>3.0.CO;2-5; EWING LL, 1983, RECENT PROG HORM RES, V39, P599; FABBRETTI E, 1995, GENE DEV, V9, P1846, DOI 10.1101/gad.9.15.1846; Gibbons IR, 1996, CELL STRUCT FUNCT, V21, P331, DOI 10.1247/csf.21.331; Halbert SA, 1997, HUM REPROD, V12, P55, DOI 10.1093/humrep/12.1.55; Harlow E., 1988, ANTIBODIES LAB MANUA; Hill KL, 1999, J CELL SCI, V112, P3091; HOFFMANLIEBERMANN B, 1986, MOL CELL BIOL, V6, P3632, DOI 10.1128/MCB.6.11.3632; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; KOZAK M, 1991, J BIOL CHEM, V261, P11779; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; Lih CJ, 1996, P NATL ACAD SCI USA, V93, P4617, DOI 10.1073/pnas.93.10.4617; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nakano T, 1997, BIOCHEM J, V323, P387, DOI 10.1042/bj3230387; NEBEL BR, 1961, SCIENCE, V134, P832, DOI 10.1126/science.134.3482.832; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; OHASHI K, 1995, J BIOL CHEM, V270, P22681, DOI 10.1074/jbc.270.39.22681; Schafer M, 1995, DEV BIOL, V172, P344, DOI 10.1006/dbio.1995.8049; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VACHA SJ, 1997, DEV GENET, V21, P213; Vaidya T, 1997, J EXP MED, V186, P433, DOI 10.1084/jem.186.3.433; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; Whitmore SA, 1998, GENOMICS, V52, P325, DOI 10.1006/geno.1998.5457	44	26	29	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6311	6317		10.1074/jbc.M106941200	http://dx.doi.org/10.1074/jbc.M106941200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751847	hybrid, Green Published			2022-12-27	WOS:000173989200082
J	Brennan, JA; Volle, DJ; Chaika, OV; Lewis, RE				Brennan, JA; Volle, DJ; Chaika, OV; Lewis, RE			Phosphorylation regulates the nucleocytoplasmic distribution of kinase suppressor of Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NUCLEAR EXPORT SIGNAL; AMINO-ACID-SEQUENCE; KSR-1 GENE ENCODES; MAP KINASE; INDEPENDENT MANNER; PLASMA-MEMBRANE; GROWTH-FACTORS; C-ELEGANS; RAF-1	KSR (kinase suppressor of Ras) has been proposed as a molecular scaffold regulating the Raf/MEK/ERK kinase cascade. KSR is phosphorylated on multiple phosphorylation sites by associated kinases. To identify potential mechanisms used by KSR to regulate ERK activation, green fluorescent protein was fused to intact and mutated KSR constructs lacking specific phosphorylation sites, and the subcellular distribution of each construct was observed in live cells. Mutation of a subset of KSR phosphorylation sites caused the redistribution of KSR to the nucleus. To determine whether intact KSR is normally imported to the nucleus, REF-52 fibroblasts expressing KSR were treated with 10 nM leptomycin B, which inhibits Crm1-dependent nuclear export. KSR accumulated in the nucleus within 2 h of treatment with leptomycin B, suggesting that KSR cycles continuously through the nucleus. Nuclear import of KSR was blocked by mutations that inhibit the interaction of KSR with MEK. Coexpression of fluorescent forms of KSR and MEK in cells revealed that each protein promoted the localization of the other in the cytoplasm. These data indicate that the subcellular distribution of KSR is dynamically regulated through phosphorylation and MEK interaction in a manner that may affect signaling through ERK.	Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Lewis, RE (corresponding author), Univ Nebraska, Med Ctr 986805, Eppley Canc Inst, Omaha, NE 68198 USA.		Lewis, Robert E./H-3404-2019		NCI NIH HHS [P30 CA36727, CA09476] Funding Source: Medline; NIDDK NIH HHS [DK52809] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA036727, T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052809] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Bar-Sagi D, 2001, MOL CELL BIOL, V21, P1441, DOI 10.1128/MCB.21.5.1441-1443.2001; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Glasgow J, 2000, NEUROCHEM RES, V25, P1373, DOI 10.1023/A:1007612716591; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; NISHI K, 1994, J BIOL CHEM, V269, P6320; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Stewart S, 1999, MOL CELL BIOL, V19, P5523; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tolwinski NS, 1999, J BIOL CHEM, V274, P6168, DOI 10.1074/jbc.274.10.6168; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; VAN AL, 1993, P NATL ACAD SCI USA, V90, P6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Volle DJ, 1999, BIOCHEMISTRY-US, V38, P5130, DOI 10.1021/bi983050d; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	46	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5369	5377		10.1074/jbc.M109875200	http://dx.doi.org/10.1074/jbc.M109875200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741955	hybrid			2022-12-27	WOS:000173962900105
J	Robinson, MJ; Xu, BE; Stippec, S; Cobb, MH				Robinson, MJ; Xu, BE; Stippec, S; Cobb, MH			Different domains of the mitogen-activated protein kinases ERK3 and ERK2 direct subcellular localization and upstream specificity in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; NUCLEAR TRANSLOCATION; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; PHOSPHORYLATION; IDENTIFICATION; TRANSPORT; MECHANISM; REGULATORS; MEMBRANE	Extracellular signal-regulated kinase 3 (ERK3) is a member of the mitogen-activated protein (MAP) kinase family. ERK3 is most similar in its kinase catalytic domain to ERK2, yet it displays many unique properties. Among these, unlike ERK2, which translocates to the nucleus following activation, ERK3 is constitutively localized to the nucleus, despite the lack of a defined nuclear localization sequence. We created two chimeras between ERK2 and the catalytic domain of ERK3 (ERK3DeltaC), and some mutants of these chimeras, to examine the basis for the different behaviors of these two MAP kinase family members. We find the following: 1) the N-terminal folding domain of ERK3 functions in phosphoryl transfer reactions with the C-terminal folding domain of ERK2; 2) the C-terminal halves of ERK2 and ERK3DeltaC are primarily responsible for their subcellular localization in resting cells; and 3) the N-terminal folding domain of ERK2 is required for its activation in cells, its interaction with MEK1, and its accumulation in the nucleus.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mcobb@mednet.swmed.edu		Cobb, Melanie/0000-0003-0833-5473	NIDDK NIH HHS [DK34128] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034128, R01DK034128] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe MK, 1999, MOL CELL BIOL, V19, P1301; Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; Cheng M, 1996, J BIOL CHEM, V271, P12057, DOI 10.1074/jbc.271.20.12057; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; Eblen ST, 2001, MOL CELL BIOL, V21, P249, DOI 10.1128/MCB.21.1.249-259.2001; Emamghoreishi M, 2000, BIOL PSYCHIAT, V48, P665, DOI 10.1016/S0006-3223(00)00884-2; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; English JM, 1999, J BIOL CHEM, V274, P31588, DOI 10.1074/jbc.274.44.31588; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Prowse CN, 2001, J BIOL CHEM, V276, P99, DOI 10.1074/jbc.M008137200; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rubinfeld H, 1999, J BIOL CHEM, V274, P30349, DOI 10.1074/jbc.274.43.30349; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Turgeon B, 2000, BIOCHEM J, V346, P169, DOI 10.1042/0264-6021:3460169; Wilsbacher JL, 1999, J BIOL CHEM, V274, P16988, DOI 10.1074/jbc.274.24.16988; Xu BE, 2001, J BIOL CHEM, V276, P26509, DOI 10.1074/jbc.M102769200; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; ZHU AX, 1994, MOL CELL BIOL, V14, P8202, DOI 10.1128/MCB.14.12.8202	46	14	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5094	5100		10.1074/jbc.M110935200	http://dx.doi.org/10.1074/jbc.M110935200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741894	hybrid			2022-12-27	WOS:000173962900072
J	Kirby, RJ; Zheng, SQ; Tso, P; Howles, PN; Hui, DY				Kirby, RJ; Zheng, SQ; Tso, P; Howles, PN; Hui, DY			Bile salt-stimulated carboxyl ester lipase influences lipoprotein assembly and secretion in intestine - A process mediated via ceramide hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC CHOLESTEROL ESTERASE; PLASMA-MEMBRANE SPHINGOMYELIN; RAT SMALL-INTESTINE; CACO-2 CELLS; APOLIPOPROTEIN-B; HUMAN-MILK; ABSORPTION; HYDROLASE; CHYLOMICRONS; DIGESTION	Bile salt-stimulated carboxyl ester lipase (CEL), also called cholesterol esterase, is one of the major proteins secreted by the pancreas. The physiological role of CEL was originally thought to be its mediation of dietary cholesterol absorption. However, recent studies showed no difference between wild type and CEL knockout mice in the total amount of cholesterol absorbed in a single meal. The current study tests the hypothesis that CEL in the intestinal lumen may influence the type of lipoproteins produced. A lipid emulsion containing 4 mm phospholipid, 13.33 mM [H-3]triolein, and 2.6 mM [C-14]cholesterol in 19 mm taurocholate was infused into the duodenum of lymph fistula CEL(+/+) and CEL(-/-) mice at a rate of 0.3 ml/h. Results showed no difference between CEL(+/+) and CEL(-/-) mice in the rate of cholesterol and triglyceride transport from the intestinal lumen to the lymph. However, CEL(-/-) mice produced predominantly smaller lipoproteins, whereas the CEL(+/+) mice produced primarily large chylomicrons and very low density lipoprotein. The proximal intestine of CEL(-/-) mice was also found to possess significantly less ceramide hydrolytic activity than that present in CEL(+/+) mice. By using Caco2 cells grown on Transwell membranes as a model, sphingomyelinase treatment inhibited the secretion of larger chylomicron-like lipoproteins without affecting total cholesterol secretion. In contrast, the addition of CEL to the apical medium increased the amount of large lipoproteins produced and alleviated the inhibition induced by sphingomyelinase. Taken together, this study identified a novel and physiologically significant role for CEL, namely the promotion of large chylomicron production in the intestine. The mechanism appears to be mediated through CEL hydrolysis of ceramide generated during the lipid absorption process.	Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	Huidy@email.uc.edu			NHLBI NIH HHS [HL66246] Funding Source: Medline; NIDDK NIH HHS [DK54504] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066246] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON LJ, 1989, J LIPID RES, V30, P1819; BHAT SG, 1982, BIOCHEM BIOPH RES CO, V109, P486, DOI 10.1016/0006-291X(82)91747-8; BLACKBERG L, 1981, FEBS LETT, V136, P284, DOI 10.1016/0014-5793(81)80636-9; BOSNER MS, 1988, P NATL ACAD SCI USA, V85, P7438, DOI 10.1073/pnas.85.20.7438; Bruneau N, 2000, J HISTOCHEM CYTOCHEM, V48, P267, DOI 10.1177/002215540004800212; CAMULLI ED, 1989, BIOCHIM BIOPHYS ACTA, V1005, P177, DOI 10.1016/0005-2760(89)90184-7; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; CHAJEKSHAUL T, 1983, J LIPID RES, V24, P831; CHEN H, 1992, BIOCHEM J, V286, P771, DOI 10.1042/bj2860771; DELAPORTE PL, 1987, BIOCHIM BIOPHYS ACTA, V920, P237, DOI 10.1016/0005-2760(87)90100-7; DUAN RD, 1995, BBA-LIPID LIPID MET, V1259, P49, DOI 10.1016/0005-2760(95)00137-2; Duan RD, 2001, LIPIDS, V36, P807, DOI 10.1007/s11745-001-0788-3; Erickson S.K., 1995, INT CONGR SER, P414; Field FJ, 1997, J LIPID RES, V38, P348; FIELD FJ, 1993, J CLIN INVEST, V92, P2609, DOI 10.1172/JCI116876; Field FJ, 1995, J LIPID RES, V36, P2651; Fukunaga T, 2000, J CELL SCI, V113, P3299; GALLO LL, 1984, J LIPID RES, V25, P604; GALLO LL, 1980, J LIPID RES, V21, P537; GALLO LL, 1977, P SOC EXP BIOL MED, V156, P277; GULDUR T, 1992, BIOCHEM SOC T, V20, P104; GUPTA AK, 1991, J LIPID RES, V32, P125; Hamilton RL, 1998, J LIPID RES, V39, P1543; HARRISON EH, 1988, BIOCHIM BIOPHYS ACTA, V963, P28, DOI 10.1016/0005-2760(88)90334-7; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; HERNELL O, 1990, ACTA PAEDIATR SCAND, P20; Hernell O., 1992, SEMINARS GASTROINTES, V3, P189; Howles PN, 1996, J BIOL CHEM, V271, P7196, DOI 10.1074/jbc.271.12.7196; HUANG Y, 1990, J LIPID RES, V31, P2029; HUI DY, 1993, BIOCHEM J, V291, P65, DOI 10.1042/bj2910065; Hui DY, 1996, BBA-LIPID LIPID MET, V1303, P1, DOI 10.1016/0005-2760(96)00085-9; Kumar NS, 1999, AM J PHYSIOL-GASTR L, V276, pG378, DOI 10.1152/ajpgi.1999.276.2.G378; Li F, 1998, BIOCHEM J, V329, P675, DOI 10.1042/bj3290675; Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666; Lin HC, 1996, AM J PHYSIOL-GASTR L, V271, pG62, DOI 10.1152/ajpgi.1996.271.1.G62; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; Mamo JCL, 1998, ATHEROSCLEROSIS, V141, pS63, DOI 10.1016/S0021-9150(98)00220-2; Mansbach CM, 1998, J LIPID RES, V39, P963; Martins IJ, 1996, J LIPID RES, V37, P2696; Nyberg L, 1998, J PEDIATR GASTR NUTR, V27, P560, DOI 10.1097/00005176-199811000-00013; Poorkhalkali N, 1998, HISTOCHEM CELL BIOL, V110, P367, DOI 10.1007/s004180050297; QUARFORD.SH, 1966, BIOCHIM BIOPHYS ACTA, V116, P382, DOI 10.1016/0005-2760(66)90019-1; Richmond BL, 2001, GASTROENTEROLOGY, V120, P1193, DOI 10.1053/gast.2001.23254; RIGTRUP KM, 1992, BIOCHEMISTRY-US, V31, P2920, DOI 10.1021/bi00126a011; ROSENWALD AG, 1993, J BIOL CHEM, V268, P4577; SABESIN SM, 1975, LIPIDS, V10, P840, DOI 10.1007/BF02532330; SHAMIR R, 1995, BIOCHEMISTRY-US, V34, P6351, DOI 10.1021/bi00019a013; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; SYLVEN C, 1970, SCAND J GASTROENTERO, V5, P57; Tso P, 1984, Lab Res Methods Biol Med, V10, P191; WANG CS, 1993, BIOCHIM BIOPHYS ACTA, V1166, P1, DOI 10.1016/0005-2760(93)90277-G; WANG CS, 1983, BIOCHIM BIOPHYS ACTA, V754, P142, DOI 10.1016/0005-2760(83)90155-8; WATT SM, 1981, J LIPID RES, V22, P157; Weng W, 1999, BIOCHEMISTRY-US, V38, P4143, DOI 10.1021/bi981679a; WINKLER KE, 1992, BIOCHIM BIOPHYS ACTA, V1126, P151; WU AL, 1980, AM J CLIN NUTR, V33, P582, DOI 10.1093/ajcn/33.3.582	57	52	52	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4104	4109		10.1074/jbc.M107549200	http://dx.doi.org/10.1074/jbc.M107549200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733511	hybrid			2022-12-27	WOS:000173813900042
J	Garrido-Franco, M; Ehlert, S; Messerschmidt, A; Marinkovic, S; Huber, R; Laber, B; Bourenkov, GP; Clausen, T				Garrido-Franco, M; Ehlert, S; Messerschmidt, A; Marinkovic, S; Huber, R; Laber, B; Bourenkov, GP; Clausen, T			Structure and function of threonine synthase from yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; CYSTATHIONINE BETA-LYASE; ESCHERICHIA-COLI; ASPARTATE-AMINOTRANSFERASE; 3-DIMENSIONAL STRUCTURE; S-ADENOSYLMETHIONINE; HOMOSERINE KINASE; CRYSTAL-STRUCTURE; INHIBITION; BIOSYNTHESIS	Threonine synthase catalyzes the final step of threonine biosynthesis, the pyridoxal 5'-phosphate (PLP)-dependent conversion of O-phosphohomoserine into threonine and inorganic phosphate. Threonine is an essential nutrient for mammals, and its biosynthetic machinery is restricted to bacteria, plants, and fungi; therefore, threonine synthase represents an interesting pharmaceutical target. The crystal structure of threonine synthase from Saccharomyces cerevisiae has been solved at 2.7 Angstrom resolution using multiwavelength anomalous diffraction. The structure reveals a monomer as active unit, which is subdivided into three distinct domains: a small N-terminal domain, a PLP-binding domain that covalently anchors the cofactor and a so-called large domain, which contains the main of the protein body. All three domains show the typical open alpha/beta architecture. The cofactor is bound at the interface of all three domains, buried deeply within a wide canyon that penetrates the whole molecule. Based on structural alignments with related enzymes, an enzyme-substrate complex was modeled into the active site of yeast threonine synthase, which revealed essentials for substrate binding and catalysis. Furthermore, the comparison with related enzymes of the beta-family of PLP-dependent enzymes indicated structural determinants of the oligomeric state and thus rationalized for the first time how a PLP enzyme acts in monomeric form.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Aventis CropSci GmbH, Forsch Biochem, D-65926 Frankfurt, Germany; DESY, Max Planck Gesellsch Arbeitsgrp Strukturelle Mol, AG Proteindynamik, D-22603 Hamburg, Germany	Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society	Clausen, T (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.	clausen@biochem.mpg.de	Messerschmidt, Albrecht/A-8337-2008; Bourenkov, Gleb P/C-7794-2017	Bourenkov, Gleb P/0000-0002-2617-5920; Clausen, Tim/0000-0003-1582-6924				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 1999, ACTA CRYSTALLOGR D, V55, P181, DOI 10.1107/S0907444998006635; ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; BURR B, 1976, EUR J BIOCHEM, V62, P519, DOI 10.1111/j.1432-1033.1976.tb10186.x; Christen P, 1985, TRANSAMINASES; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; Curien G, 1996, FEBS LETT, V390, P85, DOI 10.1016/0014-5793(96)00633-3; Curien G, 1998, BIOCHEMISTRY-US, V37, P13212, DOI 10.1021/bi980068f; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FARRINGTON GK, 1993, ARCH BIOCHEM BIOPHYS, V307, P165, DOI 10.1006/abbi.1993.1575; FLAVIN M, 1960, J BIOL CHEM, V235, P1103; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hayashi H, 1997, BIOCHEMISTRY-US, V36, P13558, DOI 10.1021/bi971638z; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; JONES TA, 1991, O THE MANUAL; JONES TA, 1992, MOL REPLACEMENT, P91; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laber B, 1999, EUR J BIOCHEM, V263, P212, DOI 10.1046/j.1432-1327.1999.00487.x; LABER B, 1994, BIOCHEMISTRY-US, V33, P3413, DOI 10.1021/bi00177a035; LABER B, 1994, ARCH MICROBIOL, V161, P400, DOI 10.1007/BF00288949; LAFORTELLE ED, 1997, CRYSTALLOGR COMPUT, V7, P1; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu GG, 1999, J APPL CRYSTALLOGR, V32, P365, DOI 10.1107/S0021889898015052; MADISON JT, 1976, BIOCHEM BIOPH RES CO, V71, P684, DOI 10.1016/0006-291X(76)90842-1; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARSOT C, 1983, NUCLEIC ACIDS RES, V11, P7331, DOI 10.1093/nar/11.21.7331; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; Schneider TR, 1998, BIOCHEMISTRY-US, V37, P5394, DOI 10.1021/bi9728957; SCHNYDER J, 1975, HELV CHIM ACTA, V58, P518, DOI 10.1002/hlca.19750580221; SHAMES SL, 1984, J BIOL CHEM, V259, P5331; SKARSTEDT MT, 1973, J BIOL CHEM, V248, P1032; THEZE J, 1974, J BACTERIOL, V118, P577, DOI 10.1128/JB.118.2.577-581.1974; THOEN A, 1978, PLANT SCI LETT, V13, P113, DOI 10.1016/0304-4211(78)90238-9; Thomazeau K, 2001, PROTEIN SCI, V10, P638, DOI 10.1110/ps.44301; WATANABE Y, 1956, J BIOCHEM-TOKYO, V43, P283, DOI 10.1093/oxfordjournals.jbchem.a126629; WORMSER EH, 1958, ARCH BIOCHEM BIOPHYS, V78, P416, DOI 10.1016/0003-9861(58)90367-9	50	29	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2002	277	14					12396	12405		10.1074/jbc.M108734200	http://dx.doi.org/10.1074/jbc.M108734200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539AC	11756443	hybrid			2022-12-27	WOS:000174846400105
J	Ciani, B; Hutchinson, EG; Sessions, RB; Woolfson, DN				Ciani, B; Hutchinson, EG; Sessions, RB; Woolfson, DN			A designed system for assessing how sequence affects alpha to beta conformational transitions in proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; SECONDARY STRUCTURE; LEUCINE-ZIPPER; HELIX; PEPTIDES; SHEET; POLAR; PROTOFILAMENTS; PROPENSITIES; AGGREGATION	The role of amino acid sequence in conformational switching observed in prions and proteins associated with amyloid diseases is not well understood. To study a to P conformational transitions, we designed a series of peptides with structural duality; namely, peptides with sequence features of both an a-helical leucine zipper and a beta-hairpin. The parent peptide, Template-alpha, was designed to be a canonical leucine-zipper motif and was confirmed as such using circular dichroism, spectroscopy and analytical ultracentrifugation. To introduce beta-structure character into the peptide, glutamine residues at sites away from the leucine-zipper dimer interface were replaced by threonine to give Template-alphaT. Unlike the parent peptide, Template-alphaT underwent a heat-inducible switch to beta-structure, which reversibly formed gels containing amyloid-like fibrils. In contrast to certain other natural proteins where destabilization of the native states facilitate transitions to amyloid, destabilization of the leucine-zipper form of Template-alphaT did not promote a transformation. Cross-linking the termini of the peptides compatible with the alternative,beta-hairpin design, however, did promote the change. Furthermore, despite screening various conditions, only the internally cross-linked form of the parent, Template -alpha, peptide formed amyloid-like fibrils. These findings demonstrate that, in addition to general properties of the polypeptide backbone, specific residue placements that favor beta-structure promote amyloid formation.	Univ Reading, Sch Anim & Microbial Sci, Div Cell & Mol Biol Biochem, Reading RG6 6AJ, Berks, England; Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; Univ Sussex, Sch Biol Sci, Ctr Biomol Design & Drug Dev, Brighton BN1 9QG, E Sussex, England	University of Reading; University of Bristol; University of Sussex	Woolfson, DN (corresponding author), Univ Sussex, Sch Biol Sci, Ctr Biomol Design & Drug Dev, Brighton BN1 9QG, E Sussex, England.	D.N.Woolfson@sussex.ac.uk	Woolfson, Dek Neil/ABC-4338-2021; Ciani, Barbara/A-1679-2012	Ciani, Barbara/0000-0001-7223-4154; Sessions, Richard/0000-0003-0320-0895; Woolfson, Derek/0000-0002-0394-3202				Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Broome BM, 2000, J MOL BIOL, V296, P961, DOI 10.1006/jmbi.2000.3514; Cerpa R, 1996, FOLD DES, V1, P91, DOI 10.1016/S1359-0278(96)00018-1; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11332, DOI 10.1073/pnas.90.23.11332; CHAKRABARTTY A, 1993, BIOCHEMISTRY-US, V32, P5560, DOI 10.1021/bi00072a010; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; DADO GP, 1993, J AM CHEM SOC, V115, P12609, DOI 10.1021/ja00079a060; Dalal S, 1997, NAT STRUCT BIOL, V4, P548, DOI 10.1038/nsb0797-548; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fezoui Y, 2000, NAT STRUCT BIOL, V7, P1095, DOI 10.1038/81937; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; GREENFIELD NJ, 1994, PROTEIN SCI, V3, P402; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Hutchinson EG, 1998, PROTEIN SCI, V7, P2287, DOI 10.1002/pro.5560071106; Jackson GS, 2000, CURR OPIN STRUC BIOL, V10, P69, DOI 10.1016/S0959-440X(99)00051-2; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 2000, NAT STRUCT BIOL, V7, P824, DOI 10.1038/82815; KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0; Kohn WD, 1998, J MOL BIOL, V283, P993, DOI 10.1006/jmbi.1998.2125; Lashuel HA, 2000, J AM CHEM SOC, V122, P5262, DOI 10.1021/ja9937831; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580; McLaurin J, 2000, EUR J BIOCHEM, V267, P6353, DOI 10.1046/j.1432-1327.2000.01725.x; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Ohnishi S, 2000, J MOL BIOL, V301, P477, DOI 10.1006/jmbi.2000.3980; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Serpell LC, 2000, BIOCHEMISTRY-US, V39, P13269, DOI 10.1021/bi000637v; Serpell LC, 2000, J MOL BIOL, V300, P1033, DOI 10.1006/jmbi.2000.3908; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Takahashi Y, 2000, TETRAHEDRON, V56, P7011, DOI 10.1016/S0040-4020(00)00524-X; Villegas V, 2000, PROTEIN SCI, V9, P1700, DOI 10.1110/ps.9.9.1700; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; WOUTERS MA, 1995, PROTEINS, V22, P119, DOI 10.1002/prot.340220205; Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23; Zou J, 2000, J CHEM SOC PERK T 2, P2135, DOI 10.1039/b002847i	48	89	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10150	10155		10.1074/jbc.M107663200	http://dx.doi.org/10.1074/jbc.M107663200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11751929	hybrid			2022-12-27	WOS:000174549200073
J	Kato, Y; Ito, M; Kawai, K; Nagata, K; Tanokura, M				Kato, Y; Ito, M; Kawai, K; Nagata, K; Tanokura, M			Determinants of ligand specificity in Groups I and IV WW domains as studied by surface plasmon resonance and model building	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; CELL-CYCLE; PROLINE; INTERACTS; BINDING; PIN1; ESS1	WW domains are universal protein modules for binding Pro-rich ligands. They are classified into four groups according to their binding specificity. Arg-14 and Arg-17, on the WW domain of Pin1, are thought to be important for the binding of Group IV ligands that have (Ser(P)/Thr(P))-Pro sequences. We have applied surface plasmon resonance to determine the ligand specificity of several WW domains containing Arg-14. Among these WW domains, Rsp5.2 and mNedd4.3 bound only to the Group I ligand containing Pro-Pro-Xaa-Tyr with K-D values of 11 and 55 muM, respectively. The WW domains of hPin1, Caenorhabditis elegans Pin1 homologue (Y110), PinA and SspI bound to Group IV ligands with KD values ranging from 22 to 700 muM. PinA and SspI do not have Arg-17, unlike Pin1 and Y110. The modeled structures of the WW domains of PinA and SspI revealed that the structure and the network of hydrogen bonds of Loop I, which are also formed in Pin1 and Y110, are conserved. We propose that this configuration of Loop I (referred to as the "p patch") is necessary for binding Group IV ligands and that it can be used to predict the specificity and functions of other WW domains.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Mitsubishi Chem Corp, Yokohama Res Ctr, Ctr Analyt Chem & Sci Inc, Aoba Ku, Yokohama, Kanagawa 2270033, Japan; Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical; University of Tokyo	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp		Nagata, Koji/0000-0002-4704-0603; Tanokura, Masaru/0000-0001-5072-2480				C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kops O, 1998, J BIOL CHEM, V273, P31971, DOI 10.1074/jbc.273.48.31971; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEMMON MA, 1994, J BIOL CHEM, V269, P31653; Lu K P, 2000, Prog Cell Cycle Res, V4, P83; Lu KP, 1996, NATURE, V380, P544; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Oda M, 1999, FEBS LETT, V454, P288, DOI 10.1016/S0014-5793(99)00833-9; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wu XY, 2000, EMBO J, V19, P3727, DOI 10.1093/emboj/19.14.3727; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	21	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10173	10177		10.1074/jbc.M110490200	http://dx.doi.org/10.1074/jbc.M110490200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11751914	hybrid			2022-12-27	WOS:000174549200076
J	Campomanes, CR; Carroll, KI; Manganas, LN; Hershberger, ME; Gong, B; Antonucci, DE; Rhodes, KJ; Trimmer, JS				Campomanes, CR; Carroll, KI; Manganas, LN; Hershberger, ME; Gong, B; Antonucci, DE; Rhodes, KJ; Trimmer, JS			Kv beta subunit oxidoreductase activity and Kv1 potassium channel trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KV2.1 K+ CHANNEL; RAT HIPPOCAMPAL-NEURONS; ALPHA-SUBUNITS; SURFACE EXPRESSION; FUNCTIONAL-CHARACTERIZATION; MAMMALIAN BRAIN; INACTIVATION; REDUCTASE; KV-BETA-1; IDENTIFICATION	Voltage-gated Kv1 potassium channels consist of poreforming alpha subunits and cytoplasmic Kvbeta subunits. The latter play diverse roles in modulating the gating, stability, and trafficking of Kv1 channels. The crystallographic structure of the Kvbeta2 subunit revealed surprising structural homology with aldo-keto reductases, including a triosephosphate isomerase barrel structure, conservation of key catalytic residues, and a bound NADP+ cofactor (Gulbis, J. M., Mann, S., and MacKinnon, R. (1999) Cell 90, 943-952). Each Kv1-associated Kvbeta subunit (Kvbeta1.1, Kvbeta1.2, Kvbeta2, and Kvbeta2) shares striking amino acid conservation in key catalytic and cofactor binding residues. Here, by a combination of structural modeling and biochemical and cell biological analyses of structure-based mutations, we investigate the potential role for putative Kvbeta subunit enzymatic activity in the trafficking of Kv1 channels. We found that all Kvbeta subunits promote cell surface expression of coexpressed Kv1.2 alpha subunits in transfected COS-1 cells. Kvbeta1.1 and Kvbeta2 point mutants lacking a key catalytic tyrosine residue found in the active site of all aldo-keto reductases have wild-type trafficking characteristics. However, mutations in residues within the NADP(+) binding pocket eliminated effects on Kv1.2 trafficking. In cultured hippocampal neurons, Kvbeta2 subunit coexpression led to axonal targeting of Kv1.2, recapitulating the Kv1.2 localization observed in many brain neurons. Similar to the trafficking results in COS-1 cells, mutations within the cofactor binding pocket reduced axonal targeting of Kv1.2, whereas those in the catalytic tyrosine did not. Together, these data suggest that NADP(+) binding and/or the integrity of the binding pocket structure, but not catalytic activity, of Kvbeta subunits is required for intracellular trafficking of Kv1 channel complexes in mammalian cells and for axonal targeting in neurons.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Wyeth Ayerst Res, Neurosci, Princeton, NJ 08543 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Pfizer	Trimmer, JS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Life Sci Bldg,Rm 044, Stony Brook, NY 11794 USA.			Antonucci, Dana/0000-0001-8857-0865	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034383, R01NS034383] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NINDS NIH HHS [NS34383] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Accili EA, 1998, J PHYSIOL-LONDON, V512, P325, DOI 10.1111/j.1469-7793.1998.325be.x; Accili EA, 1997, J BIOL CHEM, V272, P25824, DOI 10.1074/jbc.272.41.25824; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BAHRING R, 1908, J BIOL CHEM, V276, P22923; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; BOHREN KM, 1994, BIOCHEMISTRY-US, V33, P2021, DOI 10.1021/bi00174a007; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; CHOUINARD SW, 1995, P NATL ACAD SCI USA, V92, P6763, DOI 10.1073/pnas.92.15.6763; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; ELKABBANI O, 1995, NAT STRUCT BIOL, V2, P687, DOI 10.1038/nsb0895-687; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Heinemann SH, 1995, FEBS LETT, V377, P383, DOI 10.1016/0014-5793(95)01377-6; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; Hille B., 2001, ION CHANNELS EXCITAB, P131; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; LeMaout S, 1996, MOL MEMBR BIOL, V13, P143; Levin G, 1996, J BIOL CHEM, V271, P29321, DOI 10.1074/jbc.271.46.29321; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Liu SQ, 2001, J BIOL CHEM, V276, P11812, DOI 10.1074/jbc.M008259200; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; MCCORMACK T, 1994, CELL, V79, P1133, DOI 10.1016/0092-8674(94)90004-3; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; MORALES MJ, 1995, J BIOL CHEM, V270, P6272, DOI 10.1074/jbc.270.11.6272; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; Nakahira K, 1998, J MOL NEUROSCI, V11, P199, DOI 10.1385/JMN:11:3:199; PERI R, 2001, J BIOL CHEM, V276, P378; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Rhodes KJ, 1996, J NEUROSCI, V16, P4846; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Sanli G, 2001, J MOL BIOL, V309, P1209, DOI 10.1006/jmbi.2001.4739; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; Shamotienko OG, 1997, BIOCHEMISTRY-US, V36, P8195, DOI 10.1021/bi970237g; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; SHI GY, 1994, J BIOL CHEM, V269, P23204; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Trimmer JS, 1998, CURR OPIN NEUROBIOL, V8, P370, DOI 10.1016/S0959-4388(98)80063-9; Trimmer JS, 2001, POTASSIUM CHANNELS IN CARDIOVASCULAR BIOLOGY, P163; WANG H, 1994, J NEUROSCI, V14, P4588; Xu J, 1998, P NATL ACAD SCI USA, V95, P1846, DOI 10.1073/pnas.95.4.1846; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	55	72	75	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8298	8305		10.1074/jbc.M110276200	http://dx.doi.org/10.1074/jbc.M110276200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11748234	hybrid			2022-12-27	WOS:000174268000087
J	Ceci, P; Giangiacomo, L; Boffi, A; Chiancone, E				Ceci, P; Giangiacomo, L; Boffi, A; Chiancone, E			The mutation K30D disrupts the only salt bridge at the subunit interface of the homodimeric hemoglobin from Scapharca inaequivalvis and changes the mechanism of cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMERIC HEMOGLOBIN; LIGAND-BINDING; TETRAMERIC HEMOGLOBINS; EQUILIBRIA	The subunit interface of the homodimeric hemoglobin from Scapharca inaequivalvis, HbI, is stabilized by a network of interactions that involve several hydrogen-bonded structural water molecules, a hydrophobic patch, and a single, symmetrical salt bridge between residues Lys-30 and Asp-89. Upon mutation of Lys-30 to Asp, the interface is destabilized markedly. Sedimentation equilibrium and velocity experiments allowed the estimate of the dimerization constants for the unliganded (K-1,K-2 D = 8 x 10(4) M-1) and for the CO-bound (K-1,K-2 L = 1 x 10(3) M-1) and oxygenated (K-1,K-2 L = 70 M-1) derivatives. For the oxygenated derivative, the destabilization of the subunit interface with respect to native HbI corresponds to about 8 kcal/mol, an unexpectedly high figure. In the K30D mutant, at variance with the native protein, oxygen affinity and cooperativity are strongly dependent on protein concentration. At low protein concentrations (e.g. 1.2 x 10(-5) M heme), at which the monomeric species becomes significant also in the unliganded derivative, oxygen affinity increases and cooperativity decreases. At protein concentrations where both derivatives are dimeric (e.g. 3.3 x 10(-3) M heme), both cooperativity and oxygen affinity decrease. Taken together, the experimental data indicate that in the K30D mutant, the mechanism of cooperativity is drastically altered and is driven by a ligand-linked monomer-dimer equilibrium rather than being based on a direct heme-heme communication as in native HbI.	Univ Roma La Sapienza, Dept Biochem Sci, CNR, Ctr Mol Biol, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	Chiancone, E (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci, CNR, Ctr Mol Biol, I-00185 Rome, Italy.			Ceci, Pierpaolo/0000-0001-7712-8430				ANDERSEN ME, 1971, J BIOL CHEM, V246, P4790; ANTONINI E, 1984, J BIOL CHEM, V259, P6730; CHIANCONE E, 1993, J BIOL CHEM, V268, P5711; CHIANCONE E, 1981, J MOL BIOL, V152, P577, DOI 10.1016/0022-2836(81)90270-9; Giangiacomo L, 2001, BIOCHEMISTRY-US, V40, P3062, DOI 10.1021/bi002297j; IKEDASAITO M, 1983, J MOL BIOL, V170, P1009, DOI 10.1016/S0022-2836(83)80200-9; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Qiu Y, 2000, J BIOL CHEM, V275, P13517, DOI 10.1074/jbc.275.18.13517; ROSSIFANELLI A, 1958, ARCH BIOCHEM BIOPHYS, V77, P478, DOI 10.1016/0003-9861(58)90094-8; ROUSSEAU DL, 1993, J BIOL CHEM, V268, P5719; ROYER WE, 1994, J MOL BIOL, V235, P657, DOI 10.1006/jmbi.1994.1019; ROYER WE, 1990, SCIENCE, V249, P518, DOI 10.1126/science.2382132; Royer WE, 1997, J BIOL CHEM, V272, P5689, DOI 10.1074/jbc.272.9.5689; SPAGNUOLO C, 1994, J BIOL CHEM, V269, P20441; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; SUMMERFORD CM, 1995, PROTEIN ENG, V8, P593, DOI 10.1093/protein/8.6.593	16	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6929	6933		10.1074/jbc.M107422200	http://dx.doi.org/10.1074/jbc.M107422200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741990	hybrid			2022-12-27	WOS:000174104300025
J	Kegel, KB; Meloni, AR; Yi, Y; Kim, YJ; Doyle, E; Cuiffo, BG; Sapp, E; Wang, YM; Qin, ZH; Chen, JD; Nevins, JR; Aronin, N; DiFiglia, M				Kegel, KB; Meloni, AR; Yi, Y; Kim, YJ; Doyle, E; Cuiffo, BG; Sapp, E; Wang, YM; Qin, ZH; Chen, JD; Nevins, JR; Aronin, N; DiFiglia, M			Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE GENE-PRODUCT; MUTANT HUNTINGTIN; MOLECULAR-CLONING; CELL-NUCLEUS; EXPRESSION; LOCALIZATION; CTBP; MATRIX; BRAIN; DOMAIN	Huntingtin is a protein of unknown function that contains a polyglutamine tract, which is expanded in patients with Huntington's disease (HD). We investigated the localization and a potential function for huntingtin in the nucleus. In human fibroblasts from normal and HD patients, huntingtin localized diffusely in the nucleus and in subnuclear compartments identified as speckles, promyelocytic leukemia protein bodies, and nucleoli. Huntingtin-positive nuclear bodies redistributed after treatment with sodium butyrate. By Western blot, purified nuclei had low levels of full-length huntingtin compared with the cytoplasm but contained big levels of N- and C-terminal huntingtin fragments, which tightly bound the nuclear matrix. Full-length huntingtin co-immunoprecipitated with the transcriptional corepressor C-terminal binding protein, and polyglutamine expansion in huntingtin reduced this interaction. Full-length wild-type and mutant huntingtin repressed transcription when targeted to DNA. Truncated N-terminal mutant huntingtin repressed transcription, whereas the corresponding wild-type fragment did not repress transcription. We speculate that wild-type huntingtin may function in the nucleus in the assembly of nuclear matrix-bound protein complexes involved with transcriptional repression and RNA processing. Proteolysis of mutant huntingtin may alter nuclear functions by disrupting protein complexes and inappropriately repressing transcription in HD.	Massachusetts Gen Hosp E, Dept Neurol, Charlestown, MA 02129 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Genet, Durham, NC 27710 USA; Univ Massachusetts, Sch Med, Dept Pharmacol & Mol Toxicol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	Duke University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kegel, KB (corresponding author), Massachusetts Gen Hosp E, Dept Neurol, 114 CNY 16th St ,Rm 2125, Charlestown, MA 02129 USA.		Kim, Yun Joong/E-7117-2015	Kim, Yun Joong/0000-0002-2956-1552	NIA NIH HHS [T32 AG 00222] Funding Source: Medline; NINDS NIH HHS [NS 38194, NS 35711, NS 16367] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016367, P50NS016367, R01NS035711, R01NS038194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bhide PG, 1996, J NEUROSCI, V16, P5523; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Criqui-Filipe P, 1999, EMBO J, V18, P3392, DOI 10.1093/emboj/18.12.3392; DeRooij KE, 1996, HUM MOL GENET, V5, P1093, DOI 10.1093/hmg/5.8.1093; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FEY EG, 1986, J CELL BIOL, V102, P1654, DOI 10.1083/jcb.102.5.1654; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; HARDIN JA, 1982, AM J KIDNEY DIS, V2, P98; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; KASTNER B, 1992, J CELL BIOL, V116, P839, DOI 10.1083/jcb.116.4.839; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kim M, 1999, J NEUROSCI, V19, P964; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Li SH, 1999, J NEUROSCI, V19, P5159; LISCHWE MA, 1981, EXP CELL RES, V136, P101, DOI 10.1016/0014-4827(81)90041-0; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Molloy DP, 2001, BBA-PROTEIN STRUCT M, V1546, P55, DOI 10.1016/S0167-4838(00)00071-6; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; NICKERSON JA, 1994, CELL BIOL LAB HDB, P622; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; NYMAN U, 1986, J CELL BIOL, V102, P137, DOI 10.1083/jcb.102.1.137; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Phippen TM, 2000, J BIOL CHEM, V275, P37628, DOI 10.1074/jbc.M004234200; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Rega S, 2001, MOL CELL NEUROSCI, V18, P68, DOI 10.1006/mcne.2001.1004; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Sewalt RGAB, 1999, MOL CELL BIOL, V19, P777; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Spanfo S, 1999, J BIOL CHEM, V274, P17705, DOI 10.1074/jbc.274.25.17705; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Stein GS, 2000, CANCER RES, V60, P2067; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Walia H, 1998, J BIOL CHEM, V273, P14516, DOI 10.1074/jbc.273.23.14516; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598; ZHENG C, 1997, EMBO J, V16, P1401; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	60	204	212	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7466	7476		10.1074/jbc.M103946200	http://dx.doi.org/10.1074/jbc.M103946200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11739372	hybrid			2022-12-27	WOS:000174104300092
J	Mandal, AK; Cheung, WD; Arguello, JM				Mandal, AK; Cheung, WD; Arguello, JM			Characterization of a thermophilic P-type Ag+/Cu+-ATPase from the extremophile Archaeoglobus fulgidus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-TRANSPORTING ATPASE; NA,K-ATPASE ALPHA-SUBUNIT; HEAVY-METAL TRANSPORT; WILSON-DISEASE GENE; SARCOPLASMIC-RETICULUM; ESCHERICHIA-COLI; ENTEROCOCCUS-HIRAE; MEMBRANE-VESICLES; MENKES DISEASE; THERMOCOCCUS-LITORALIS	The thermophilic, sulfur metabolizing Archaeoglobus fulgidus contains two genes, AF0473 and AF0152, encoding for PIB-type heavy metal transport ATPases. In this study, we describe the cloning, heterologous expression, purification, and functional characterization of one of these ATPases, CopA (NCB accession number AAB90763), encoded by AF0473. CopA is active at high temperatures (75 degreesC; E-a = 103 kJ/mol) and inactive at 37 degreesC. It is activated by Ag+ (ATPase V-max = 14.82 mumol/ mg(h) and to a lesser extent by Cu+ (ATPase V-max = 3.66 mumol/mg/h). However, Cu+ interacts with the enzyme with higher apparent affinity (ATPase stimulation, Ag+ K-1/2 = 29.4 mum; Cu+ K-1/2 = 2.1 mum). This activation by Ag+ or Cu+ is dependent on the presence of millimolar amounts of cysteine. In the presence of ATP, these metals drive the formation of an acid-stable phosphoenzyme with apparent affinities similar to those observed in the ATPase activity determinations (Ag+, K-1/2 = 23.0 pm; Cu+, K-1/2 = 3.9 mum). However, comparable levels of phosphoenzyme are reached in the presence of both cations (Ag+, 1.40 nmol/mg, Cu+, 1.08 nmol/mg). The stimulation of phosphorylation by the cations suggests that CopA drives the outward movement of the metal. CopA presents additional functional characteristics similar to other P-type ATPases. ATP interacts with the enzyme with two apparent affinities (ATPase K-m = 0.25 mm; phosphorylation K-m = 4.81 pm), and the presence of vanadate leads to enzyme inactivation (IC50 = 24 pm). This is the first Ag+/Cu+-ATPase expressed and purified in a functional form. Thus, it provides a model for structure-functional studies of these transporters. Moreover, its characterization will also contribute to an understanding of thermophilic ion transporters.	Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Arguello, Jose/D-1997-2012	Arguello, Jose/0000-0003-3940-6297				Albers SV, 2000, FRONT BIOSCI, V5, pD813; ARGUELLO JM, 1995, J BIOL CHEM, V270, P22764, DOI 10.1074/jbc.270.39.22764; Arguello JM, 1996, J BIOL CHEM, V271, P24610, DOI 10.1074/jbc.271.40.24610; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BARRABIN H, 1980, BIOCHIM BIOPHYS ACTA, V600, P796, DOI 10.1016/0005-2736(80)90482-4; BARRABIN H, 1990, BIOCHIM BIOPHYS ACTA, V1023, P266, DOI 10.1016/0005-2736(90)90422-K; BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; CANTLEY LC, 1977, J BIOL CHEM, V252, P7421; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Cobine P, 1999, FEBS LETT, V445, P27, DOI 10.1016/S0014-5793(99)00091-5; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; Elferink MGL, 2001, MOL MICROBIOL, V39, P1494, DOI 10.1046/j.1365-2958.2001.02336.x; ESMANN M, 1985, BIOCHIM BIOPHYS ACTA, V815, P196, DOI 10.1016/0005-2736(85)90289-5; FAGAN MJ, 1994, J MOL EVOL, V38, P57; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Greller G, 1999, J BIOL CHEM, V274, P20259, DOI 10.1074/jbc.274.29.20259; HEYSE S, 1994, J GEN PHYSIOL, V104, P197, DOI 10.1085/jgp.104.2.197; Hinrichs M, 1999, BIOL CHEM, V380, P1063, DOI 10.1515/BC.1999.132; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; Jensen PY, 1999, EUR J BIOCHEM, V264, P890, DOI 10.1046/j.1432-1327.1999.00680.x; JOCELYN PC, 1972, BIOCH SH GROUP, P78; Jordan IK, 2000, TRENDS BIOCHEM SCI, V25, P480, DOI 10.1016/S0968-0004(00)01662-5; KANAMARU K, 1994, MOL MICROBIOL, V13, P369, DOI 10.1111/j.1365-2958.1994.tb00430.x; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; KONINGS WN, 1992, J BIOENERG BIOMEMBR, V24, P601, DOI 10.1007/BF00762352; Kuntzweiler TA, 1996, J BIOL CHEM, V271, P29682, DOI 10.1074/jbc.271.47.29682; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Melchers K, 1996, J BIOL CHEM, V271, P446, DOI 10.1074/jbc.271.1.446; Mitra B, 2001, BIOCHEMISTRY-US, V40, P7694, DOI 10.1021/bi010576g; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; Okkeri J, 1999, BIOCHEMISTRY-US, V38, P14109, DOI 10.1021/bi9913956; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Rosenzweig AC, 2000, CURR OPIN CHEM BIOL, V4, P140, DOI 10.1016/S1367-5931(99)00066-6; Scandurra R, 2000, FRONT BIOSCI-LANDMRK, V5, pD787, DOI 10.2741/scan; Schafer G, 1999, MICROBIOL MOL BIOL R, V63, P570; Segel I.H, 1993, ENZYME KINETICS; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; SOLIOZ M, 1996, J BIOL CHEM, V271, P24465; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TSAI KJ, 1992, J BACTERIOL, V174, P116, DOI 10.1128/jb.174.1.116-121.1992; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; van de Vossenberg JLCM, 1998, EXTREMOPHILES, V2, P163, DOI 10.1007/s007920050056; VILSEN B, 1987, EUR J BIOCHEM, V170, P421, DOI 10.1111/j.1432-1033.1987.tb13716.x; Voskoboinik I, 1998, FEBS LETT, V435, P178, DOI 10.1016/S0014-5793(98)01059-X; Voskoboinik N, 1999, J BIOL CHEM, V274, P22008, DOI 10.1074/jbc.274.31.22008; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4; Xavier KB, 1996, J BACTERIOL, V178, P4773, DOI 10.1128/jb.178.16.4773-4777.1996; Yoshimizu T, 1998, BIOSCI BIOTECH BIOCH, V62, P1258, DOI 10.1271/bbb.62.1258	66	113	115	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7201	7208		10.1074/jbc.M109964200	http://dx.doi.org/10.1074/jbc.M109964200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11756450	hybrid			2022-12-27	WOS:000174104300059
J	Owen, BAL; Sullivan, WP; Felts, SJ; Toft, DO				Owen, BAL; Sullivan, WP; Felts, SJ; Toft, DO			Regulation of heat shock protein 90 ATPase activity by sequences in the carboxyl terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; IN-VIVO FUNCTION; PROGESTERONE-RECEPTOR; MUTATIONAL ANALYSIS; SUBSTRATE-BINDING; DNA TOPOISOMERASE; CRYSTAL-STRUCTURE; COGNATE PROTEIN; DOMAIN; HEAT-SHOCK-PROTEIN-90	hsp90, in addition to being an abundant and pivotal cytoplasmic chaperone protein, has been shown to be a weak ATPase. In an effort to characterize the ATPase activity of hsp90, we have observed marked differences in activities among various species of hsp90. Chicken or human hsp90 hydrolyzed ATP with a k(cat) of 0.02 min(-1) and a K-m greater than 300 muM. In contrast, yeast hsp90 and TRAP1, an hsp90 homologue found in mitochondria, were 10-100-fold more active as ATPases. Sedimentation studies confirmed that all are dimeric proteins. Chicken hsp90 mutants were then analyzed to identify regions within the protein that influence ATPase activity. A truncation mutant of chicken hsp90, N1-573, was found to be monomeric, and yet the catalytic efficiency (k(cat)/K-m) was greater than 100 times that of the full-length protein (k(cat) of 0.24 min(-1) and K-m of 60 muM). In contrast, an internal deletion mutant, Delta661-677, was also monomeric but failed to hydrolyze ATP. Finally, deletion of the last 30 amino acids resulted in a dimeric protein with an ATPase activity very similar to full-length hsp90. These data indicate that sequences within the last one-fourth of hsp90 regulate ATP hydrolysis.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Toft, DO (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.		Owen, Barbara/AAD-2322-2021		NIDDK NIH HHS [DK 46249] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046249] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Bjergbaek L, 2000, J BIOL CHEM, V275, P13041, DOI 10.1074/jbc.275.17.13041; Caplan AJ, 1999, TRENDS CELL BIOL, V9, P262, DOI 10.1016/S0962-8924(99)01580-9; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; CYR DM, 1992, J BIOL CHEM, V267, P20927; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; GUPTA RS, 1995, MOL BIOL EVOL, V12, P1063; JAKOB U, 1995, J BIOL CHEM, V270, P14412, DOI 10.1074/jbc.270.24.14412; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Johnson ER, 1999, BIOCHEMISTRY-US, V38, P10823, DOI 10.1021/bi990816g; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; JORDAN R, 1995, J BIOL CHEM, V270, P4563, DOI 10.1074/jbc.270.9.4563; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Maruya M, 1999, J MOL BIOL, V285, P903, DOI 10.1006/jmbi.1998.2349; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 1999, CURR BIOL, V9, pR322, DOI 10.1016/S0960-9822(99)80203-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Meng X, 1996, J CELL SCI, V109, P1677; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REBBE NF, 1989, J BIOL CHEM, V264, P15006; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Scheibel T, 1997, J BIOL CHEM, V272, P18608, DOI 10.1074/jbc.272.30.18608; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; SKOWYRA D, 1995, J BIOL CHEM, V270, P26282, DOI 10.1074/jbc.270.44.26282; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; SULLIVAN WP, 1993, J BIOL CHEM, V268, P20373; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	50	64	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7086	7091		10.1074/jbc.M111450200	http://dx.doi.org/10.1074/jbc.M111450200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751892	hybrid			2022-12-27	WOS:000174104300044
J	Ji, SR; Wu, Y; Sui, SF				Ji, SR; Wu, Y; Sui, SF			Cholesterol is an important factor affecting the membrane insertion of beta-amyloid peptide (A beta 1-40), which may potentially inhibit the fibril formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; PLASMA-MEMBRANES; LIPID-MEMBRANES; BINDING; RECEPTOR; CELLS; ALPHA-2-MACROGLOBULIN; NEUROTOXICITY	beta-Amyloid peptide (Abeta), a normal constituent of neuronal and non-neuronal cells, has been proven to be the major component of extracellular plaque of Alzheimer's disease. Interactions between Abeta and neuronal membranes have been postulated to play an important role in the neuropathology of Alzheimer's disease. Here we show that Abeta is able to insert into lipid bilayer. The membrane insertion ability of Abeta is critically controlled by the ratio of cholesterol to phospholipids. In a low concentration of cholesterol Abeta prefers to stay in membrane surface region mainly in a beta-sheet structure. In contrast, as the ratio of cholesterol to phospholipids rises above 30 mol%, Abeta can insert spontaneously into lipid bilayer by its C terminus. During membrane insertion Abeta generates about 60% alpha-helix and removes almost all beta-sheet structure. Fibril formation experiments show that such membrane insertion can reduce fibril formation. Our findings reveal a possible pathway by which Abeta prevents itself from aggregation and fibril formation by membrane insertion.	Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane, Beijing 100084, Peoples R China	Tsinghua University	Sui, SF (corresponding author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Taylor, Graham/A-4027-2012	Wu, Yi/0000-0003-0365-5590; Ji, Shang-Rong/0000-0001-8595-3756				Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Avdulov NA, 1997, J NEUROCHEM, V69, P1746; BARROW CJ, 1991, SCIENCE, V253, P180; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CHAKRAVARTHY BR, 1985, BIOCHIM BIOPHYS ACTA, V812, P223, DOI 10.1016/0005-2736(85)90542-5; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Christie RH, 1996, J NEUROPATH EXP NEUR, V55, P491, DOI 10.1097/00005072-199604000-00012; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; DEMEL RA, 1973, BIOCHIM BIOPHYS ACTA, V311, P507, DOI 10.1016/0005-2736(73)90126-0; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; DEPAUW H, 1985, BIOCHIM BIOPHYS ACTA, V814, P57, DOI 10.1016/0005-2736(85)90419-5; Eckert GP, 2000, DEMENT GERIATR COGN, V11, P181, DOI 10.1159/000017234; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Igbavboa U, 1996, J NEUROCHEM, V66, P1717; INOUYE H, 1993, BIOPHYS J, V64, P502, DOI 10.1016/S0006-3495(93)81393-6; Janciauskiene S, 1999, NEUROPEPTIDES, V33, P510, DOI 10.1054/npep.1999.0771; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kovacs DM, 2000, EXP GERONTOL, V35, P473, DOI 10.1016/S0531-5565(00)00113-3; LANGE Y, 1989, J BIOL CHEM, V264, P3786; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Martinez-Senac MD, 1999, EUR J BIOCHEM, V265, P744, DOI 10.1046/j.1432-1327.1999.00775.x; MASON RP, 1992, NEUROBIOL AGING, V13, P413, DOI 10.1016/0197-4580(92)90116-F; Mason RP, 1996, BIOCHEM BIOPH RES CO, V222, P78, DOI 10.1006/bbrc.1996.0699; MATTSON MP, 1993, TRENDS NEUROSCI, V16, P409, DOI 10.1016/0166-2236(93)90009-B; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677; Mills J, 1999, J NEUROCHEM, V72, P443, DOI 10.1046/j.1471-4159.1999.0720443.x; Narita M, 1997, J NEUROCHEM, V69, P1904; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; PIKE CJ, 1993, J NEUROSCI, V13, P1676; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROTH GS, 1995, TRENDS NEUROSCI, V18, P203, DOI 10.1016/0166-2236(95)93902-A; SCHROEDER F, 1995, MOL MEMBR BIOL, V12, P113, DOI 10.3109/09687689509038505; SCHROEDER F, 1991, P SOC EXP BIOL MED, V196, P235; SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shinitzky M, 1993, BIOMEMBRANES STRUCTU, P1; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; Smaby JM, 1996, BIOCHEMISTRY-US, V35, P5696, DOI 10.1021/bi953057k; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Sui SF, 2000, ADV COLLOID INTERFAC, V85, P257, DOI 10.1016/S0001-8686(99)00033-0; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Waiter MF, 1997, BIOCHEM BIOPH RES CO, V233, P760, DOI 10.1006/bbrc.1997.6547; YANG JT, 1986, METHOD ENZYMOL, V130, P208; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; ZHUANG P, 1991, BIOPHYS J, V60, P623, DOI 10.1016/S0006-3495(91)82091-4	56	155	165	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6273	6279		10.1074/jbc.M104146200	http://dx.doi.org/10.1074/jbc.M104146200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741923	hybrid			2022-12-27	WOS:000173989200077
J	Czirjak, G; Enyedi, P				Czirjak, G; Enyedi, P			Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMULTIMERIC K+ CHANNELS; POLYUNSATURATED FATTY-ACIDS; RUTHENIUM RED; GLOMERULOSA CELLS; FAMILY; INHIBITION; MEMBER; PH; CONDUCTANCE; EXPRESSION	The potassium channels in the two-pore domain family are widely expressed and regulate the excitability of neurons and other excitable cells. These channels have been shown to function as dimers, but heteromerization between the various channel subunits has not yet been reported. Here we demonstrate that two members of the TASK subfamily of potassium channels, TASK-1 and TASK-3, can form functional heterodimers when expressed in Xenopus laevis oocytes. To recognize the two TASK channel types, we took advantage of the higher sensitivity of TASK-1 over TASK-3 to physiological pH changes and the discriminating sensitivity of TASK-3 to the cationic dye ruthenium red. These features were clearly observed when the channels were expressed individually. However, when TASK-1 and TASK-3 were expressed together, the resulting current showed intermediate pH sensitivity and ruthenium red insensitivity (characteristic of TASK-1), indicating the formation of TASK-1/TASK-3 heterodimers. Expression of a tandem construct in which TASK-3 and TASK-1 were linked together yielded currents with features very similar to those observed when coexpressing the two channels. The tandem construct also responded to AT(1A) angiotensin II receptor stimulation with an inhibition that was weaker than the inhibition of homodimeric TASK-1 and greater than that shown by TASK-3. Expression of epitope-tagged channels in mammalian cells showed their primary presence in the plasma membrane consistent with their function in this location. Heteromerization of two-pore domain potassium channels may provide a greater functional diversity and additional means by which they can be regulated in their native tissues.	Semmelweis Univ, Dept Physiol, H-1444 Budapest, Hungary	Semmelweis University	Enyedi, P (corresponding author), Semmelweis Univ, Dept Physiol, POB 259, H-1444 Budapest, Hungary.	enyedi@puskin.sote.hu		Czirjak, Gabor/0000-0002-5485-2327				Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Boyd DF, 2000, J PHYSIOL-LONDON, V529, P321, DOI 10.1111/j.1469-7793.2000.00321.x; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; Chavez RA, 1999, J BIOL CHEM, V274, P7887, DOI 10.1074/jbc.274.12.7887; Cibulsky SM, 1999, J PHARMACOL EXP THER, V289, P1447; Czirjak G, 2000, MOL ENDOCRINOL, V14, P863, DOI 10.1210/me.14.6.863; Czirjak G, 2001, AM J PHYSIOL-CELL PH, V281, pC700, DOI 10.1152/ajpcell.2001.281.2.C700; Decher N, 2001, FEBS LETT, V492, P84, DOI 10.1016/S0014-5793(01)02222-0; DRAY A, 1990, NEUROSCI LETT, V110, P52, DOI 10.1016/0304-3940(90)90786-9; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hirano M, 1998, PFLUG ARCH EUR J PHY, V435, P645, DOI 10.1007/s004240050565; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Lesage F, 1997, FEBS LETT, V402, P28, DOI 10.1016/S0014-5793(96)01491-3; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; O'Kelly I, 1999, AM J PHYSIOL-LUNG C, V276, pL96, DOI 10.1152/ajplung.1999.276.1.L96; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Rajan S, 2001, J BIOL CHEM, V276, P7302, DOI 10.1074/jbc.M008985200; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Salinas M, 1999, J BIOL CHEM, V274, P11751, DOI 10.1074/jbc.274.17.11751; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Szabadkai G, 1999, BIOCHEM PHARMACOL, V57, P209, DOI 10.1016/S0006-2952(98)00285-8; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Wu SN, 1999, J PHARMACOL EXP THER, V290, P998	44	190	192	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5426	5432		10.1074/jbc.M107138200	http://dx.doi.org/10.1074/jbc.M107138200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733509	hybrid, Green Published			2022-12-27	WOS:000173962900112
J	Kato, H; Tjernberg, A; Zhang, WZ; Krutchinsky, AN; An, WJ; Takeuchi, T; Ohtsuki, Y; Sugano, S; de Bruijn, DR; Chait, BT; Roeder, RG				Kato, H; Tjernberg, A; Zhang, WZ; Krutchinsky, AN; An, WJ; Takeuchi, T; Ohtsuki, Y; Sugano, S; de Bruijn, DR; Chait, BT; Roeder, RG			SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; SWI-SNF COMPLEX; SYNOVIAL SARCOMA TRANSLOCATION; DNA-BINDING; TRANSCRIPTIONAL ACTIVATOR; MULTISUBUNIT COMPLEX; ESTROGEN-RECEPTOR; MOLECULAR-CLONING; SWI/SNF COMPLEX; HUMAN HOMOLOGS	A global transcriptional co-activator, the SNF/SWI complex, has been characterized as a chromatin remodeling factor that enhances accessibility of the transcriptional machinery to DNA within a repressive chromatin structure. On the other hand, mutations in some human SN'F/SWI complex components have been linked to tumor formation. We show here that SYT, a partner protein generating the synovial sarcoma fusion protein SYT-SSX, associates with native human SNF/SWI complexes. The SYT protein has a unique QPGY domain, which is also present in the largest subunits, p250 and the newly identified homolog p250R, of the corresponding SNF/SWI complexes. The C-terminal region (amino acids 310-387) of SSX1, comprising the SSX1 portion of the SYT-SSX1 fusion protein, binds strongly to core histones and oligonucleosomes in vitro and directs nuclear localization of a green fluorescence protein fusion protein. Experiments with serial C-terminal deletion mutants of SSX1 indicate that these properties map to a common region and also correlate with the previously demonstrated anchorage-independent colony formation activity of SYT-SSX in Rat 3Y1 cells. These data suggest that SYT-SSX interferes with the function of either the SNF/SWI complexes or another SYT-interacting co-activator, p300, by changing their targeted localization or by directly inhibiting their chromatin remodeling activities.	Natl Inst Infect Dis, Tokyo 2080011, Japan; Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spect & Gaseous Ion Chem, New York, NY 10021 USA; Kochi Med Sch, Dept Pathol, Kochi 7838505, Japan; Univ Tokyo, Inst Med Sci, Lab Genome Struct Anal, Tokyo 1088639, Japan; Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands	National Institute of Infectious Diseases (NIID); Rockefeller University; Rockefeller University; Kochi University; University of Tokyo; Radboud University Nijmegen	Kato, H (corresponding author), Natl Inst Infect Dis, 4-7-1 Gakuen, Tokyo 2080011, Japan.	hykato@nih.go.jp	de Bruijn, D.R.H./L-4233-2015		NCI NIH HHS [CA42567] Funding Source: Medline; NCRR NIH HHS [RR00862] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042567] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Brett D, 1997, HUM MOL GENET, V6, P1559, DOI 10.1093/hmg/6.9.1559; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Burns LG, 1997, MOL CELL BIOL, V17, P4811, DOI 10.1128/MCB.17.8.4811; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Dallas PB, 2000, MOL CELL BIOL, V20, P3137, DOI 10.1128/MCB.20.9.3137-3146.2000; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; dos Santos NR, 2000, EXP CELL RES, V256, P192, DOI 10.1006/excr.2000.4813; dosSantos NR, 1997, HUM MOL GENET, V6, P1549, DOI 10.1093/hmg/6.9.1549; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Dyson MH, 2001, FRONT BIOSCI, V6, pD853, DOI 10.2741/Dyson; Eid JE, 2000, CELL, V102, P839, DOI 10.1016/S0092-8674(00)00072-6; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Gavin I, 2001, MOL CELL, V7, P97, DOI 10.1016/S1097-2765(01)00158-7; Gregory SL, 1996, MOL CELL BIOL, V16, P792; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Ichinose H, 1997, GENE, V188, P95, DOI 10.1016/S0378-1119(96)00785-8; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jones KA, 2000, GENE DEV, V14, P1992; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Krutchinsky AN, 2000, J AM SOC MASS SPECTR, V11, P493, DOI 10.1016/S1044-0305(00)00114-8; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LAURENT BC, 1991, P NATL ACAD SCI USA, V88, P2687, DOI 10.1073/pnas.88.7.2687; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; MARUYAMA K, 1994, GENE, V138, P171; MUCHARDT C, 1995, NUCLEIC ACIDS RES, V23, P1127, DOI 10.1093/nar/23.7.1127; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Papoulas O, 1998, DEVELOPMENT, V125, P3955; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; Peterson CL, 1996, CURR OPIN GENET DEV, V6, P171, DOI 10.1016/S0959-437X(96)80047-5; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Takeuchi T, 1997, GENE, V204, P71, DOI 10.1016/S0378-1119(97)00525-8; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Treisman JE, 1997, GENE DEV, V11, P1949, DOI 10.1101/gad.11.15.1949; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Wong AKC, 2000, CANCER RES, V60, P6171; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	88	85	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5498	5505		10.1074/jbc.M108702200	http://dx.doi.org/10.1074/jbc.M108702200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11734557	Green Published, hybrid			2022-12-27	WOS:000173962900122
J	Lauth, X; Shike, H; Burns, JC; Westerman, ME; Ostland, VE; Carlberg, JM; Van Olst, JC; Nizet, V; Taylor, SW; Shimizu, C; Bulet, P				Lauth, X; Shike, H; Burns, JC; Westerman, ME; Ostland, VE; Carlberg, JM; Van Olst, JC; Nizet, V; Taylor, SW; Shimizu, C; Bulet, P			Discovery and characterization of two Isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDFLY CERATITIS-CAPITATA; FROG-SKIN; HEMOCYTES; FISH; SEQUENCE; DEFENSE; AMPLIFICATION; EXPRESSION; CLAVANINS; SPECTRUM	We isolated a novel 22-residue, C-terminally amidated antimicrobial peptide, moronecidin, from the skin and gill of hybrid striped bass. Two isoforms, differing by only one amino acid, are derived from each parental species, white bass (Morone chrysops) and striped bass (Morone saxatilis). Molecular masses (2543 and 2571 Da), amino acid sequences (FFHHIFRGIVHVGKTIH(K/R) LVTGT), cDNA, and genomic DNA sequences were determined for each isoform. A predicted 79-residue moronecidin prepropeptide consists of three domains: a signal peptide (22 amino acids), a mature peptide (22 amino acids), and a C-terminal prodomain (35 amino acids). The synthetic, amidated white bass moronecidin exhibited broad spectrum antimicrobial activity that was retained at high salt concentration. An a-helical structure was confirmed by circular dichroism spectroscopy. The moronecidin gene consists of three introns and four exons. Peptide sequence and gene organization were similar to pleurocidin, an antimicrobial peptide from winter flounder. A TATA box and several consensus-binding motifs for transcription factors were found in the region 5' to the transcriptional start site. Moronecidin gene expression was detected in gill, skin, intestine, spleen, anterior kidney, and blood cells by kinetic reverse transcription (RT)-PCR. Thus, moronecidin is a new a-helical, broad spectrum antimicrobial peptide isolated from the skin and gills of hybrid striped bass.	Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; Kent SeaTech Corp, San Diego, CA 92121 USA; Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA; CNRS, Inst Biol Mol & Cellulaire, UPR 9022, Reponse Immunitaire & Dev Insectes, F-67084 Strasbourg, France	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Burns, JC (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.		BULET, Philippe/C-8557-2014; Nizet, Victor/AAF-3190-2019; Burns, Jane C/J-6167-2015	BULET, Philippe/0000-0001-9016-265X; Nizet, Victor/0000-0003-3847-0422; Shimizu, Chisato/0000-0002-3149-2699	NCI NIH HHS [5P0CA23100-16] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amiche M, 1999, FEBS LETT, V456, P352, DOI 10.1016/S0014-5793(99)00964-3; Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; Cole AM, 2000, BIOTECHNIQUES, V29, P822, DOI 10.2144/00294rv01; Cole AM, 2000, ANTIMICROB AGENTS CH, V44, P2039, DOI 10.1128/AAC.44.8.2039-2045.2000; Cole AM, 1997, J BIOL CHEM, V272, P12008, DOI 10.1074/jbc.272.18.12008; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#; Douglas SE, 2001, DEV COMP IMMUNOL, V25, P137, DOI 10.1016/S0145-305X(00)00052-5; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; ELDAR A, 1994, CURR MICROBIOL, V28, P139, DOI 10.1007/BF01571054; Fehlbaum P, 1996, P NATL ACAD SCI USA, V93, P1221, DOI 10.1073/pnas.93.3.1221; Frank P, 1998, J BIOL CHEM, V273, P24498, DOI 10.1074/jbc.273.38.24498; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Ganz T, 1999, MOL MED TODAY, V5, P292, DOI 10.1016/S1357-4310(99)01490-2; Garcia-Olmedo F, 1998, BIOPOLYMERS, V47, P479, DOI 10.1002/(SICI)1097-0282(1998)47:6<479::AID-BIP6>3.0.CO;2-K; HETRU C, 1997, ANTIBACTERIAL PEPTID, P35; KANG JJ, 2000, NUCL ACIDS RES, V28; Kussmann M, 1997, J MASS SPECTROM, V32, P483; Lee IH, 1997, COMP BIOCHEM PHYS B, V118, P515, DOI 10.1016/S0305-0491(97)00109-0; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Lee IH, 1997, FEBS LETT, V400, P158, DOI 10.1016/S0014-5793(96)01374-9; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; MARCHINI D, 1995, J BIOL CHEM, V270, P6199, DOI 10.1074/jbc.270.11.6199; Mitta G, 1999, EUR J BIOCHEM, V265, P71, DOI 10.1046/j.1432-1327.1999.00654.x; MIYATA T, 1989, J BIOCHEM, V106, P663, DOI 10.1093/oxfordjournals.jbchem.a122913; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oren Z, 1998, BIOPOLYMERS, V47, P451; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Park CB, 1997, FEBS LETT, V411, P173, DOI 10.1016/S0014-5793(97)00684-4; Park IY, 1998, FEBS LETT, V437, P258, DOI 10.1016/S0014-5793(98)01238-1; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rosetto M, 1997, INSECT BIOCHEM MOLEC, V27, P1039, DOI 10.1016/S0965-1748(97)00090-8; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Shinnar A.E., 1996, P 14 PEPT AM S COL O, P189; Taylor SW, 2000, J BIOL CHEM, V275, P38417, DOI 10.1074/jbc.M006762200; Tossi A, 2000, BIOPOLYMERS, V55, P4; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Vouille V, 1997, FEBS LETT, V414, P27, DOI 10.1016/S0014-5793(97)00972-1; Weinstein MR, 1997, NEW ENGL J MED, V337, P589, DOI 10.1056/NEJM199708283370902	42	224	255	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5030	5039		10.1074/jbc.M109173200	http://dx.doi.org/10.1074/jbc.M109173200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739390	Green Published, hybrid			2022-12-27	WOS:000173962900064
J	Vigano, C; Julien, M; Carrier, I; Gros, P; Ruysschaert, JM				Vigano, C; Julien, M; Carrier, I; Gros, P; Ruysschaert, JM			Structural and functional asymmetry of the nucleotide-binding domains of P-glycoprotein investigated by attenuated total reflection Fourier transform infrared spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED MULTIDRUG-RESISTANCE; MEMBRANE-PROTEIN STRUCTURE; TERTIARY STRUCTURE CHANGES; ATPASE ACTIVITY; SECONDARY STRUCTURE; DRUG TRANSPORT; CONFORMATIONAL-CHANGES; BIOLOGICAL-MEMBRANES; CATALYTIC SITES; MDR1 GENE	The dynamic changes occurring during the catalytic cycle of MDR3 P-glycoprotein (Pgp) and the role of each nucleotide-binding domain (NBD) in the transport process were investigated using attenuated total reflection Fourier transform infrared spectroscopy. For this purpose, wild-type Pgp and two mutations of homologous residues in each NBD were studied. On the one hand, we demonstrate here that, during its catalytic cycle, Pgp does not undergo secondary structure changes, but only modifications in its stability and accessibility to the external environment. On the other hand, amide H/D exchange kinetics demonstrate that homologous mutations in the two NBDs affect, in a different way, the dynamic properties of Pgp and also the dynamic changes occurring during ATP hydrolysis. These observations led to the conclusion that the NBDs have an asymmetric structure and different functions in the catalytic cycle of Pgp. Our data suggest that the release of drug from the membrane into the extracellular environment is due to decreased stability and/or increased accessibility to the external medium of the membrane-embedded drug-binding site(s). NBD1 would play an important role in this first restructuring of the membrane-embedded domains. NBD2 would be directly implicated in the subsequent restructuring of the membrane-embedded binding sites by which they recover their initial stability and accessibility to the membrane. It is proposed that this restructuring step would allow the binding and transport of another molecule of substrate.	Free Univ Brussels, Ctr Biol Struct & Bioinformat, B-1050 Brussels, Belgium; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Universite Libre de Bruxelles; Vrije Universiteit Brussel; McGill University	Vigano, C (corresponding author), Free Univ Brussels, Ctr Biol Struct & Bioinformat, CP 206-2,Bd Triomphe, B-1050 Brussels, Belgium.	cvigano@ulb.ac.be						AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BAUBICHONCORTAY H, 1994, J BIOL CHEM, V269, P22983; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; CHEN AY, 1993, CANCER RES, V53, P1332; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chiba P, 1996, MOL PHARMACOL, V49, P1122; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Dong M, 1998, BBA-BIOMEMBRANES, V1371, P317, DOI 10.1016/S0005-2736(98)00032-7; Dong MQ, 1996, J BIOL CHEM, V271, P28875, DOI 10.1074/jbc.271.46.28875; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; Fringeli U P, 1981, Mol Biol Biochem Biophys, V31, P270; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Goormaghtigh E, 1994, Subcell Biochem, V23, P363; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; GOTTESMAN MM, 1988, TRENDS PHARMACOL SCI, V9, P54, DOI 10.1016/0165-6147(88)90117-4; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GREENBERGER LM, 1993, J BIOL CHEM, V268, P11417; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hrycyna CA, 1998, BIOCHEMISTRY-US, V37, P13660, DOI 10.1021/bi9808823; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; RONINSON IB, 1992, MUTAT RES, V276, P151, DOI 10.1016/0165-1110(92)90005-T; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sankaran B, 1997, ARCH BIOCHEM BIOPHYS, V341, P160, DOI 10.1006/abbi.1997.9944; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; Saveanu L, 2001, J BIOL CHEM, V276, P22107, DOI 10.1074/jbc.M011221200; SCARBOROUGH GA, 1995, J BIOENERG BIOMEMBR, V27, P37, DOI 10.1007/BF02110329; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shapiro AB, 1997, EUR J BIOCHEM, V250, P115, DOI 10.1111/j.1432-1033.1997.00115.x; SHAPIRO AB, 1995, J BIOL CHEM, V270, P16167, DOI 10.1074/jbc.270.27.16167; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; SHARMA S, 1995, J BIOL CHEM, V270, P14085, DOI 10.1074/jbc.270.23.14085; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Sonveaux N, 1996, J BIOL CHEM, V271, P24617, DOI 10.1074/jbc.271.40.24617; Sonveaux N, 1999, J BIOL CHEM, V274, P17649, DOI 10.1074/jbc.274.25.17649; Takeda Y, 1998, BBA-BIOMEMBRANES, V1373, P131, DOI 10.1016/S0005-2736(98)00099-6; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P14138, DOI 10.1021/bi001128w; URBATSCH IL, 1998, BIOCHEMISTRY-US, V37, P13887; Wang GC, 1997, BIOCHEM J, V328, P897, DOI 10.1042/bj3280897; Wang GC, 1998, EUR J BIOCHEM, V255, P383, DOI 10.1046/j.1432-1327.1998.2550383.x	61	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5008	5016		10.1074/jbc.M107928200	http://dx.doi.org/10.1074/jbc.M107928200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741934	hybrid			2022-12-27	WOS:000173962900061
J	Dietschy, JM; Turley, SD				Dietschy, JM; Turley, SD			Control of cholesterol turnover in the mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HIGH-DENSITY-LIPOPROTEIN; BILE-ACID SYNTHESIS; EXTRAHEPATIC ORGANS; CYNOMOLGUS MONKEY; C PROTEIN; MICE; LIVER; TISSUES; PLASMA; FLUX		Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Dietschy, JM (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	john.dietschy@utsouthwestern.edu	Eckhardt, Erik/G-1567-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL009610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007745] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37-HL 09610] Funding Source: Medline; NIDDK NIH HHS [T32-DK 07745] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGMANN KV, 1979, GASTROENTEROLOGY, V77, P1183; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Drobnik W, 2001, GASTROENTEROLOGY, V120, P1203, DOI 10.1053/gast.2001.23250; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Jolley CD, 1999, AM J PHYSIOL-GASTR L, V276, pG1117, DOI 10.1152/ajpgi.1999.276.5.G1117; Jolley CD, 1998, J LIPID RES, V39, P2143; Jolley CD, 2000, HEPATOLOGY, V32, P1309, DOI 10.1053/jhep.2000.19811; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Mardones P, 2001, J LIPID RES, V42, P170; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 2001, J LIPID RES, V42, P1173; OSONO Y, 1995, J CLIN INVEST, V95, P1124, DOI 10.1172/JCI117760; Osono Y, 1996, P NATL ACAD SCI USA, V93, P4114, DOI 10.1073/pnas.93.9.4114; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Schlegel A, 2001, CYTOKINE GROWTH F R, V12, P41, DOI 10.1016/S1359-6101(00)00022-8; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schwarz M, 1998, J LIPID RES, V39, P1833; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Trigatti BL, 2000, BBA-MOL CELL BIOL L, V1529, P276, DOI 10.1016/S1388-1981(00)00154-2; TURLEY SD, 1995, J LIPID RES, V36, P67; Turley SD, 1998, HEPATOLOGY, V28, P1088, DOI 10.1002/hep.510280425; Turley SD, 1997, J LIPID RES, V38, P1598; Turley SD, 1997, HEPATOLOGY, V25, P797, DOI 10.1002/hep.510250403; Xie CL, 1999, AM J PHYSIOL-ENDOC M, V276, pE336, DOI 10.1152/ajpendo.1999.276.2.E336; Xie CL, 1999, P NATL ACAD SCI USA, V96, P11992, DOI 10.1073/pnas.96.21.11992; Xie CL, 2000, J LIPID RES, V41, P1278; Xie CL, 2000, J NEUROPATH EXP NEUR, V59, P1106, DOI 10.1093/jnen/59.12.1106; Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200	36	206	209	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					3801	3804		10.1074/jbc.R100057200	http://dx.doi.org/10.1074/jbc.R100057200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733542	hybrid			2022-12-27	WOS:000173813900001
J	Deguchi, H; Fernandez, JA; Griffin, JH				Deguchi, H; Fernandez, JA; Griffin, JH			Neutral glycosphingolipid-dependent inactivation of coagulation factor Va by activated protein C and protein S	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENOUS THROMBOSIS; PURPURA FULMINANS; RESISTANCE; ANTICOAGULANT; RISK; MUTATION; PROTHROMBIN; DEFICIENCY; INTERACTS; DOMAIN	To test whether neutral glycosphingolipids can serve as anticoagulant cofactors, the effects of incorporation of neutral glycosphingolipids into phospholipid vesicles on anticoagulant and procoagulant reactions were studied. Glucosylceramide (GlcCer), lactosylceramide (LacCer), and globotriaosylceramide (Gb(3)Cer) in vesicles containing phosphatidylserine (PS) and phosphatidylcholine (PC) dose dependently enhanced factor Va inactivation by the anticoagulant factors, activated protein C (APC) and protein S. Addition of GlcCer to PUPS vesicles enhanced protein S-dependent APC cleavage in factor Va at Arg-506 by 13-fold, whereas PUPS vesicles alone minimally affected protein S enhancement of this reaction. Incorporation into PUPS vesicles of GlcCer, LacCer, or Gb(3)Cer, but not galactosylceramide or globotetraosylceramide, dose dependently prolonged factor Xa-1-stage clotting times of normal plasma in the presence of added APC without affecting baseline clotting times in the absence of APC, showing that certain neutral glycosphingolipids enhance anticoagulant but not procoagulant reactions in plasma. Thus, certain neutral glycosphingolipids (e.g. GlcCer, LacCer, and Gb(3)Cer) can enhance anticoagulant activity of APC/protein S by mechanisms that are distinctly different from those of phospholipids alone. We speculate that under some circumstances certain neutral glycosphingolipids either in lipoprotein particles or in cell membranes may help form antithrombotic microdomains that might enhance down-regulation of thrombin by APC in vivo.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Griffin, JH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, MEM180,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jgriffin@scripps.edu	Fernandez, Jose A/A-3211-2008	Fernandez, Jose A/0000-0002-0804-1865; Griffin, John/0000-0002-4302-2547; Deguchi, Hiroshi/0000-0002-7721-1207	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021544, R37HL052246] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL021544, R01HL21544, R37HL52246] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BRANSON HE, 1983, LANCET, V2, P1165; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; CLARKE JTR, 1981, CAN J BIOCHEM CELL B, V59, P412, DOI 10.1139/o81-057; de Visser MCH, 1999, BLOOD, V93, P1271, DOI 10.1182/blood.V93.4.1271.404k22_1271_1276; Deguchi H, 2001, BLOOD, V97, P1907, DOI 10.1182/blood.V97.7.1907; Deguchi H, 1997, BIOCHEM J, V321, P729, DOI 10.1042/bj3210729; Esmon CT, 2000, J AUTOIMMUN, V15, P113, DOI 10.1006/jaut.2000.0400; Fernandez JA, 1997, BLOOD, V89, P4348, DOI 10.1182/blood.V89.12.4348; Fernandez JA, 2000, BLOOD CELL MOL DIS, V26, P115, DOI 10.1006/bcmd.2000.0285; Fisher M, 1996, STROKE, V27, P1163, DOI 10.1161/01.STR.27.7.1163; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; Gale AJ, 2000, BLOOD, V96, P585; GREENGARD JS, 1994, LANCET, V343, P1361, DOI 10.1016/S0140-6736(94)92497-X; Griffin JH, 1999, J CLIN INVEST, V103, P219, DOI 10.1172/JCI5006; Hakomori S, 1998, GLYCOBIOLOGY, V8, pXI; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; Jalbert LR, 1998, J CLIN INVEST, V102, P1481, DOI 10.1172/JCI3011; Kundu S K, 1981, Methods Enzymol, V72, P185, DOI 10.1016/S0076-6879(81)72012-3; KUNDU SK, 1985, ARCH BIOCHEM BIOPHYS, V238, P388, DOI 10.1016/0003-9861(85)90179-1; MAHASANDANA C, 1990, LANCET, V335, P61, DOI 10.1016/0140-6736(90)90201-F; NELSESTUEN GL, 1978, BIOCHEMISTRY-US, V17, P2134, DOI 10.1021/bi00604a017; Nevard CHF, 1997, THROMB HAEMOSTASIS, V78, P1450; PEI G, 1993, J BIOL CHEM, V268, P3226; Rodeghiero F, 1999, ANN INTERN MED, V130, P643, DOI 10.7326/0003-4819-130-8-199904200-00004; Rosing J, 1999, LANCET, V354, P2036, DOI 10.1016/S0140-6736(99)06092-4; ROSING J, 1988, BIOCHEMISTRY-US, V27, P8, DOI 10.1021/bi00401a002; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; Sakata T, 1996, THROMB RES, V82, P235, DOI 10.1016/0049-3848(96)00070-9; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; SENN HJ, 1989, EUR J BIOCHEM, V181, P657, DOI 10.1111/j.1432-1033.1989.tb14773.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340; SUN X, 1994, BLOOD, V83, P3120; SVENSSON PJ, 1994, NEW ENGL J MED, V330, P517, DOI 10.1056/NEJM199402243300801; Taylor FB, 1999, AM J PATHOL, V154, P1285, DOI 10.1016/S0002-9440(10)65380-1; vanderBom JG, 1996, ANN INTERN MED, V125, P265, DOI 10.7326/0003-4819-125-4-199608150-00002; VOORBERG J, 1994, LANCET, V343, P1535, DOI 10.1016/S0140-6736(94)92939-4; ZHU XH, 1991, J BIOCHEM-TOKYO, V110, P241, DOI 10.1093/oxfordjournals.jbchem.a123564; Zivelin A, 1999, BLOOD, V94, P895, DOI 10.1182/blood.V94.3.895.415k01_895_901	44	17	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8861	8865		10.1074/jbc.M110252200	http://dx.doi.org/10.1074/jbc.M110252200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11741960	hybrid			2022-12-27	WOS:000174400600018
J	Harvey, KF; Shearwin-Whyatt, LM; Fotia, A; Parton, RG; Kumar, S				Harvey, KF; Shearwin-Whyatt, LM; Fotia, A; Parton, RG; Kumar, S			N4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel golgi-associated protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; WW DOMAINS; EXPRESSION; LIGASE; IDENTIFICATION; PROLINE; TRANSCRIPTION; ACTIVATION; INTERACTS; PERMEASE	Nedd4 belongs to a family of ubiquitin-protein ligases that is characterized by 2-4 WW domains, a carboxyl-terminal Hect ((h) under bar omologous to (E) under bar6-AP (C) under bar arboxyl (t) under bar erminus)-domain and in most cases an amino-terminal C2 domain. We had previously identified a series of proteins that associates with the WW domains of Nedd4. In this paper, we demonstrate that one of the Nedd4-binding proteins, N4WBP5, belongs to a small group of evolutionarily conserved proteins with three transmembrane domains. N4WBP5 binds Nedd4 WW domains via the two PPXY motifs present in the amino terminus of the protein. In addition to Nedd4, N4WBP5 can interact with the WW domains of a number of Nedd4 family members and is ubiquitinated. Endogenous N4WBP5 localizes to the Golgi complex. Ectopic expression of the protein disrupts the structure of the Golgi, suggesting that N4WBP5 forms part of a family of integral Golgi membrane proteins. Based on previous observations in yeast, we propose that N4WBP5 may act as an adaptor for Nedd4-like proteins and their putative targets to control ubiquitin-dependent protein sorting and trafficking.	Inst Med & Vet Sci, Hanson Ctr Canc Res, Adelaide, SA 5000, Australia; Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Microscopy & Microanal, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Institute Medical & Veterinary Science Australia; University of Queensland; University of Queensland	Kumar, S (corresponding author), Inst Med & Vet Sci, Hanson Ctr Canc Res, POB 14 Rundle Mall Frome Rd, Adelaide, SA 5000, Australia.	sharad.kumar@imvs.sa.gov.au	Harvey, Kieran/AAD-5268-2022; Parton, Robert G/C-5673-2009; Kumar, Sharad/AAX-7787-2020; Shearwin, Linda/AAD-5594-2020	Parton, Robert G/0000-0002-7494-5248; Kumar, Sharad/0000-0001-7126-9814; Shearwin, Linda/0000-0002-4504-6534; Harvey, Kieran/0000-0001-7845-369X				Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; Glick BS, 2000, CURR OPIN CELL BIOL, V12, P450, DOI 10.1016/S0955-0674(00)00116-2; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Harvey KF, 1998, J BIOL CHEM, V273, P13524, DOI 10.1074/jbc.273.22.13524; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Imhof MO, 1996, MOL CELL BIOL, V16, P2594; Jarousse N, 2000, TRAFFIC, V1, P378, DOI 10.1034/j.1600-0854.2000.010502.x; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lafont F, 2001, P NATL ACAD SCI USA, V98, P3180, DOI 10.1073/pnas.051003498; LIPPINCOTTSCHWARTZ J, 1991, J CELL BIOL, V112, P567, DOI 10.1083/jcb.112.4.567; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Peruzzi F, 2001, J BIOL CHEM, V276, P25990, DOI 10.1074/jbc.M103188200; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Sudol M, 1996, TRENDS BIOCHEM SCI, V21, P161, DOI 10.1016/0968-0004(96)30018-2; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yashiroda H, 1996, MOL CELL BIOL, V16, P3255; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zoladek T, 1997, GENETICS, V145, P595	45	97	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9307	9317		10.1074/jbc.M110443200	http://dx.doi.org/10.1074/jbc.M110443200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11748237	hybrid			2022-12-27	WOS:000174400600078
J	Friesen, WJ; Wyce, A; Paushkin, S; Abel, L; Rappsilber, J; Mann, M; Dreyfuss, G				Friesen, WJ; Wyce, A; Paushkin, S; Abel, L; Rappsilber, J; Mann, M; Dreyfuss, G			A novel WD repeat protein component of the methylosome binds Sm proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; DISEASE GENE-PRODUCT; CRYSTAL-STRUCTURE; SNRNP BIOGENESIS; HUMAN HOMOLOG; IN-VITRO; ARGININE; DOMAIN; IDENTIFICATION; COMPLEX	We have recently described a large (20 S) protein arginine methyltransferase complex, termed the methylosome, that contains the methyltransferase JBP1 (PRMT5) and the pICln protein. The methylosome functions to modify specific arginines to dimethylarginines in the arginine- and glycine-rich domains of several spliceosomal Sm proteins, and this modification targets these proteins to the survival of motor neurons (SMN) complex for assembly into small nuclear ribonucleoprotein (snRNP) core particles. Here, we describe a novel component of the methylosome, a 50-kilodalton WD repeat protein termed methylosome protein 50 (MEP50). We show that MEP50 is important for methylosome activity and binds to JBP1 and to a subset of Sm proteins. Because WD repeat proteins provide a platform for multiple protein interactions, MEP50 may function to mediate the interaction of multiple substrates with the methylosome. Interestingly, all of the known components of the methylosome bind Sm proteins, suggesting that in addition to producing properly methylated substrates for the SMN complex, the methylosome may be involved in Sm protein rearrangements or pre-assembly required for snRNP biogenesis.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ So Denmark, Ctr Expt Bioinformat, Port Interact Lab, DK-5230 Odense M, Denmark; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Southern Denmark	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Dreyfuss, Gideon/D-1218-2013; Rappsilber, Juri/ABF-3328-2020; Mann, Matthias/A-3454-2013; Rappsilber, Juri/B-7265-2015	Dreyfuss, Gideon/0000-0001-8129-8774; Mann, Matthias/0000-0003-1292-4799; Rappsilber, Juri/0000-0001-5999-1310				Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; BALDWIN GS, 1971, SCIENCE, V171, P579, DOI 10.1126/science.171.3971.579; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Collins BM, 2001, J MOL BIOL, V309, P915, DOI 10.1006/jmbi.2001.4693; DREYFUSS G, 1984, J CELL BIOL, V99, pA233, DOI 10.1083/jcb.99.6.1997; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; GarciaHiguera I, 1996, BIOCHEMISTRY-US, V35, P13985, DOI 10.1021/bi9612879; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gilbreth M, 1998, P NATL ACAD SCI USA, V95, P14781, DOI 10.1073/pnas.95.25.14781; Hannus S, 2000, HUM MOL GENET, V9, P663, DOI 10.1093/hmg/9.5.663; Jones KW, 2001, J BIOL CHEM, V276, P38645, DOI 10.1074/jbc.M106161200; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Krapivinsky G, 1998, J BIOL CHEM, V273, P10811, DOI 10.1074/jbc.273.18.10811; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; LUHRMANN R, 1990, MOL BIOL REP, V14, P183, DOI 10.1007/BF00360468; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; Miguel-Aliaga I, 1999, HUM MOL GENET, V8, P2133, DOI 10.1093/hmg/8.12.2133; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; Owen N, 2000, HUM MOL GENET, V9, P675, DOI 10.1093/hmg/9.5.675; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Pellizzoni L, 2001, CURR BIOL, V11, P1079, DOI 10.1016/S0960-9822(01)00316-5; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Sanchez-Olea R, 1998, BBA-GEN SUBJECTS, V1381, P49, DOI 10.1016/S0304-4165(98)00009-9; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; SEGAULT V, 1995, EMBO J, V14, P4010, DOI 10.1002/j.1460-2075.1995.tb00072.x; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang J, 2001, J BIOL CHEM, V276, P9599, DOI 10.1074/jbc.M009162200; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	56	164	173	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8243	8247		10.1074/jbc.M109984200	http://dx.doi.org/10.1074/jbc.M109984200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756452	hybrid			2022-12-27	WOS:000174268000079
J	Goldhaber-Gordon, I; Early, MH; Gray, MK; Baker, TA				Goldhaber-Gordon, I; Early, MH; Gray, MK; Baker, TA			Sequence and positional requirements for DNA sites in a Mu transpososome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-MU; BINDING DOMAIN; POU DOMAIN; PHAGE-MU; STRAND TRANSFER; INVITRO TRANSPOSITION; CRYSTAL-STRUCTURE; PROTEIN; COMPLEX; RECOGNITION	Transposition of bacteriophage Mu uses two DNA cleavage sites and six transposase recognition sites, with each recognition site divided into two half-sites. The recognition sites can activate transposition of non-Mu DNA sequences if a complete set of Mu sequences is not available. We have analyzed 18 sequences from a non-Mu DNA molecule, selected in a functional assay for the ability to be transposed by MuA transposase. These sequences are remarkably diverse. Nonetheless, when viewed as a group they resemble a Mu DNA end, with a cleavage site and a single recognition site. Analysis of these "pseudo-Mu ends" indicates that most positions in the cleavage and recognition sites contribute sequence-specific information that helps drive transposition, though only the strongest contributors are apparent from mutagenesis data. The sequence analysis also suggests variability in the alignment of recognition half-sites. Transposition assays of specifically designed DNA substrates support the conclusion that the transposition machinery is flexible enough to permit variability in half-site spacing and also perhaps variability in the placement of the recognition site with respect to the cleavage site. This variability causes only local perturbations in the protein-DNA complex, as indicated by experiments in which altered and unaltered DNA substrates are paired.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Newbury Networks Inc, Boston, MA 02116 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave,68-523, Cambridge, MA 02139 USA.				NIGMS NIH HHS [R01 GM049224, R01 GM049224-09, GM499224] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049224] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aldaz H, 1996, CELL, V85, P257, DOI 10.1016/S0092-8674(00)81102-2; ALLISON RG, 1992, J BIOL CHEM, V267, P19963; BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; BURLINGAME RP, 1986, P NATL ACAD SCI USA, V83, P6012, DOI 10.1073/pnas.83.16.6012; Chaconas G, 1999, BIOCHEM CELL BIOL, V77, P487, DOI 10.1139/bcb-77-6-487; CLUBB RT, 1994, STRUCTURE, V2, P1041, DOI 10.1016/S0969-2126(94)00107-3; Clubb RT, 1997, J MOL BIOL, V273, P19, DOI 10.1006/jmbi.1997.1312; Coros CJ, 2001, J MOL BIOL, V310, P299; Craig NL, 1996, CURR TOP MICROBIOL, V204, P27; CRAIGIE R, 1984, CELL, V39, P387, DOI 10.1016/0092-8674(84)90017-5; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Embleton ML, 1999, J MOL BIOL, V289, P785, DOI 10.1006/jmbi.1999.2822; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; GALAS PJ, 1989, MOBILE DNA, P110; Goldhaber-Gordon I, 2002, J BIOL CHEM, V277, P7694, DOI 10.1074/jbc.M110341200; GROENEN MAM, 1986, J MOL BIOL, V189, P597, DOI 10.1016/0022-2836(86)90490-0; HARADA R, 1994, J BIOL CHEM, V269, P2062; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; KIM SC, 1988, SCIENCE, V240, P504, DOI 10.1126/science.2833816; Kleckner N, 1996, CURR TOP MICROBIOL, V204, P49; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; Lee I, 2001, J MOL BIOL, V314, P433, DOI 10.1006/jmbi.2001.5177; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; MAXWELL A, 1987, P NATL ACAD SCI USA, V84, P699, DOI 10.1073/pnas.84.3.699; MIZUUCHI M, 1992, CELL, V70, P303, DOI 10.1016/0092-8674(92)90104-K; MIZUUCHI M, 1991, P NATL ACAD SCI USA, V88, P9031, DOI 10.1073/pnas.88.20.9031; MIZUUCHI M, 1993, COLD SPRING HARB SYM, V58, P515, DOI 10.1101/SQB.1993.058.01.058; NAKAYAMA C, 1987, P NATL ACAD SCI USA, V84, P1809, DOI 10.1073/pnas.84.7.1809; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; Schumacher S, 1997, EMBO J, V16, P7532, DOI 10.1093/emboj/16.24.7532; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; Watson MA, 1996, CELL, V85, P435, DOI 10.1016/S0092-8674(00)81121-6; Williams SA, 2001, NUCLEIC ACIDS RES, V29, P1476, DOI 10.1093/nar/29.7.1476; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Yamauchi M, 1998, EMBO J, V17, P5509, DOI 10.1093/emboj/17.18.5509; ZOU A, 1991, J BIOL CHEM, V266, P20476	50	14	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7703	7712		10.1074/jbc.M110342200	http://dx.doi.org/10.1074/jbc.M110342200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756424	hybrid			2022-12-27	WOS:000174268000013
J	Kapila, YL; Wang, SH; Dazin, P; Tafolla, E; Mass, MJ				Kapila, YL; Wang, SH; Dazin, P; Tafolla, E; Mass, MJ			The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; GINGIVAL CREVICULAR FLUID; MOLECULAR-FORMS; INHIBITION; PP125(FAK); EXPRESSION; FRAGMENTS; GROWTH; GENE; ACTIVATION	In apoptosis the tumor suppressor p53 and the c-myc proto-oncogene are usually up-regulated. We show a novel alternative pathway of apoptosis in human primary cells that is mediated by transcriptionally dependent decreases in p53 and c-Myc and decreases in p2l. This pathway is regulated by the alternatively spliced V region and high-affinity heparin-binding domain of fibronectin. Requirements for c-Myc, p53, and p2l signals in maintaining survival and for their decreases in inducing apoptosis were demonstrated by the ability of p53, c-Myc, and p2l ectopic expression to rescue this apoptotic phenotype, and the ability of p53-deficient an c-myc antisense conditions to trigger a faster rate of apoptosis.	Univ Calif San Francisco, Sch Dent, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Howard Hughes Med Inst, San Francisco, CA 94143 USA; US EPA, Natl Hlth & Environm Effects Lab, Environm Carcinogenesis Div MD68, Res Triangle Pk, NC 27711 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; United States Environmental Protection Agency	Kapila, YL (corresponding author), Univ Calif San Francisco, Sch Dent, Dept Stomatol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	ykapila@itsa.ucsf.edu	Kapila, Yvonne/AAG-5418-2021		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013725] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE13725] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; CARSONS S, 1985, ARTHRITIS RHEUM, V28, P601, DOI 10.1002/art.1780280602; CLARKE AS, 1995, J BIOL CHEM, V270, P22673, DOI 10.1074/jbc.270.39.22673; CLEMMENSEN I, 1982, ARTHRITIS RHEUM, V25, P25, DOI 10.1002/art.1780250104; Crouch DH, 1996, ONCOGENE, V12, P2689; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GRIFFITHS AM, 1989, CLIN CHIM ACTA, V184, P133, DOI 10.1016/0009-8981(89)90283-0; Hamel W, 1996, CYTOMETRY, V25, P173, DOI 10.1002/(SICI)1097-0320(19961001)25:2<173::AID-CYTO6>3.0.CO;2-I; HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597; HOMANDBERG GA, 1993, J RHEUMATOL, V20, P1378; HOMER KA, 1992, J CLIN PERIODONTOL, V19, P305, DOI 10.1111/j.1600-051X.1992.tb00649.x; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ilic D, 1998, J CELL BIOL, V143, P547; Kapila YL, 1997, J BIOL CHEM, V272, P18932, DOI 10.1074/jbc.272.30.18932; Kapila YL, 1999, J BIOL CHEM, V274, P30906, DOI 10.1074/jbc.274.43.30906; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; McGill G, 1997, J CELL BIOL, V138, P901, DOI 10.1083/jcb.138.4.901; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; Schroeder M, 1997, BIOCHEM BIOPH RES CO, V235, P403, DOI 10.1006/bbrc.1997.6796; TALONPOIKA J, 1993, SCAND J DENT RES, V101, P375; TALONPOIKA J, 1989, SCAND J DENT RES, V97, P415; Tan MJ, 2000, P NATL ACAD SCI USA, V97, P109, DOI 10.1073/pnas.97.1.109; Wu M, 1996, MOL CELL BIOL, V16, P5015; XIE DL, 1992, J RHEUMATOL, V19, P1448; YUFANG S, 1992, SCIENCE, V257, P212	34	21	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8482	8491		10.1074/jbc.M108932200	http://dx.doi.org/10.1074/jbc.M108932200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751853	hybrid			2022-12-27	WOS:000174268000109
J	Lehtolainen, P; Taskinen, A; Laukkanen, J; Airenne, KJ; Heino, S; Lappalainen, M; Ojala, K; Marjomaki, V; Martin, JF; Kulomaa, MS; Yla-Herttuala, S				Lehtolainen, P; Taskinen, A; Laukkanen, J; Airenne, KJ; Heino, S; Lappalainen, M; Ojala, K; Marjomaki, V; Martin, JF; Kulomaa, MS; Yla-Herttuala, S			Cloning and characterization of scavidin, a fusion protein for the targeted delivery of biotinylated molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE SCAVENGER RECEPTOR; KINASE GENE-THERAPY; TUMOR-CELLS; AVIDIN; GLIOMA; MODEL; CONJUGATE; ALPHA; Y-90; RAT	We have constructed a novel fusion protein "Scavidin" consisting of the macrophage scavenger receptor class A and avidin. The Scavidin fusion protein is transported to plasma membranes where the avidin portion of the fusion protein binds biotin with high affinity and forms the basis for the targeted delivery of biotinylated molecules. Subcellular fractionation analysis, immuno-staining, and electron microscopy demonstrated endosomal localization of the fusion protein. According to pulse-labeling and cross-linking studies Scavidin is found as monomers (55 kDa), dimers, and multimers, of which the 220-kDa form was the most abundant. The biotin binding capacity and active endocytosis of the biotinylated ligands were demonstrated in rat malignant glioma. Local Scavidin gene transfer to target tissues could have general utility as a universal tool to deliver biotinylated molecules at systemic low concentrations for therapeutic and imaging purposes, whereby high local concentration is achieved.	Univ Kuopio, A I Virtanen Inst, FIN-70211 Kuopio, Finland; UCL, Dept Med, London WC1E 6JJ, England; Univ Jyvaskyla, Dept Biol & Environm Sci, FIN-40351 Jyvaskyla, Finland; Kuopio Univ Hosp, Gene Therapy Unit, FIN-70210 Kuopio, Finland; Univ Kuopio, Dept Med, FIN-70210 Kuopio, Finland	University of Eastern Finland; University of London; University College London; University of Jyvaskyla; Kuopio University Hospital; University of Eastern Finland	Yla-Herttuala, S (corresponding author), Univ Kuopio, A I Virtanen Inst, POB 1627,Neulaniementie 2, FIN-70211 Kuopio, Finland.	Seppo.Ylaherttuala@uku.fi	Kulomaa, Markku S/C-9063-2014; Laukkanen, Jari A/I-4528-2017; Laukkanen, Jari Antero/N-2196-2019	Laukkanen, Jari A/0000-0002-3738-1586; Laukkanen, Jari Antero/0000-0002-3738-1586; Tietavainen, Johanna/0000-0003-1882-0691; Yla-Herttuala, Seppo/0000-0001-7593-2708; Marjomaki, Varpu/0000-0002-4592-5926				Airenne KJ, 1997, PROTEIN EXPRES PURIF, V9, P100, DOI 10.1006/prep.1996.0660; ANACHI RB, 1995, FEBS LETT, V368, P551, DOI 10.1016/0014-5793(95)00738-U; Andersson L, 1998, J BIOL CHEM, V273, P19592, DOI 10.1074/jbc.273.31.19592; Axworthy DB, 2000, P NATL ACAD SCI USA, V97, P1802, DOI 10.1073/pnas.97.4.1802; Breitz HB, 2000, J NUCL MED, V41, P131; Corti A, 1998, CANCER RES, V58, P3866; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; GRIFFITHS G, 1990, J CELL SCI, V95, P441; Guttinger M, 2000, CANCER RES, V60, P4211; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Laitinen OH, 2001, J BIOL CHEM, V276, P8219, DOI 10.1074/jbc.M007930200; Lehtolainen P, 2000, ARTERIOSCL THROM VAS, V20, P52, DOI 10.1161/01.ATV.20.1.52; Paganelli G, 1999, EUR J NUCL MED, V26, P348, DOI 10.1007/s002590050397; Penichet ML, 1999, J IMMUNOL, V163, P4421; PENMAN M, 1991, J BIOL CHEM, V266, P23985; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; PUNNONEN EL, 1994, EUR J CELL BIOL, V65, P14; Sandmair AM, 2000, HUM GENE THER, V11, P2197, DOI 10.1089/104303400750035726; Sandmair AM, 2000, CANCER GENE THER, V7, P413, DOI 10.1038/sj.cgt.7700132; Sato Y, 2000, FASEB J, V14, P2108, DOI 10.1096/fj.99-1052com; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; WILCHEK M, 1988, ANAL BIOCHEM, V171, P1, DOI 10.1016/0003-2697(88)90120-0; Xu XC, 2000, CANCER RES, V60, P4475; YLAHERTTUALA S, 1995, J CLIN INVEST, V95, P2692, DOI 10.1172/JCI117971	25	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8545	8550		10.1074/jbc.M109431200	http://dx.doi.org/10.1074/jbc.M109431200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741995	hybrid			2022-12-27	WOS:000174268000117
J	Nishida, W; Nakamura, M; Mori, S; Takahashi, M; Ohkawa, Y; Tadokoro, S; Yoshida, K; Hiwada, K; Hayashi, K; Sobue, K				Nishida, W; Nakamura, M; Mori, S; Takahashi, M; Ohkawa, Y; Tadokoro, S; Yoshida, K; Hiwada, K; Hayashi, K; Sobue, K			A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEOBOX GENE; PHENOTYPIC MODULATION; MOLECULAR-CLONING; AXIAL SKELETON; CELL; EXPRESSION; ALPHA; HEART; ACTIN; ACTIVATION	Serum response factor and the (CC(A/T)(6)GG) (CArG) box interact to promote the transcription of c-fos and muscle genes; this tissue-specific activity may require co-regulators for serum response factor. The a, integrin promoter contains two cis-elements besides the CArG box: a TAAT sequence, a consensus binding site for homeoproteins, and a GATA-binding box. As a candidate TAAT-binding factor, we cloned an NK family homeobox gene, Nkx-3.2, which is expressed mainly in smooth muscle tissues and skeletal structures. Nkx-3.2, serum response factor, and GATA-6 were co-expressed only in the medial smooth muscle layer of arteries. These three transcription factors formed a complex with their corresponding cis-elements and cooperatively transactivated smooth muscle genes, including a, integrin, SM22alpha, and caldesmon. Cardiac muscle-specific members of the NK and GATA families exist, and the triad of Nkx-2.5, serum response factor, and GATA-4 also transactivated the cardiac atrial natriuretic factor gene, which contains a CArG-like box, a GATA-binding box, and an NK-binding element. Our findings demonstrate that smooth and cardiac muscle have a shared transcriptional machinery and that the GATA and NK families confer muscle specificity on the serum response factor/CArG interaction.	Osaka Univ, Grad Sch Med, Dept Neurosci D13, Suita, Osaka 5650871, Japan; Ehime Univ, Sch Med, Dept Internal Med 2, Matsuyama, Ehime 7910295, Japan	Osaka University; Ehime University	Sobue, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sobue@nbiochem.med.osaka-u.ac.jp	Ohkawa, Yasuyuki/C-4087-2016; Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954; Nakamura, Mako/0000-0002-6129-7560				Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; CSERJESI P, 1992, DEVELOPMENT, V115, P1087; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Firulli AB, 1997, TRENDS GENET, V13, P364, DOI 10.1016/S0168-9525(97)01171-2; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; GORSKI DH, 1993, MOL CELL BIOL, V13, P3722, DOI 10.1128/MCB.13.6.3722; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; HELFMAN DM, 1994, SOC GEN PHY, V49, P105; Kashiwada K, 1997, J BIOL CHEM, V272, P15396, DOI 10.1074/jbc.272.24.15396; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; KUROO M, 1989, J BIOL CHEM, V264, P18272; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LEE TC, 1991, MOL CELL BIOL, V11, P5090, DOI 10.1128/MCB.11.10.5090; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Mack CP, 2000, CIRC RES, V86, P221, DOI 10.1161/01.RES.86.2.221; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Miano JM, 1996, P NATL ACAD SCI USA, V93, P900, DOI 10.1073/pnas.93.2.900; MOHAMED SNW, 1983, IN VITRO CELL DEV B, V19, P471; Morin S, 2001, MOL CELL BIOL, V21, P1036, DOI 10.1128/MCB.21.4.1036-1044.2001; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Nakamura M, 2001, J BIOL CHEM, V276, P18313, DOI 10.1074/jbc.M101127200; Narita N, 1996, GENOMICS, V36, P345, DOI 10.1006/geno.1996.0472; Obata H, 1997, J BIOL CHEM, V272, P26643, DOI 10.1074/jbc.272.42.26643; Olson EN, 1998, DEV BIOL, V202, P153, DOI 10.1006/dbio.1998.9020; PATEL CV, 1992, J BIOL CHEM, V267, P26085; Saga H, 1999, EXP CELL RES, V247, P279, DOI 10.1006/excr.1998.4339; SANDALTZOPOULOS R, 1994, NUCLEIC ACIDS RES, V22, P1511, DOI 10.1093/nar/22.8.1511; Schneider A, 1999, CURR BIOL, V9, P911, DOI 10.1016/S0960-9822(99)80397-2; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shanahan CM, 1998, CRIT REV EUKAR GENE, V8, P357, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.60; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tribioli C, 1997, MECH DEVELOP, V65, P145, DOI 10.1016/S0925-4773(97)00067-1; UEKI N, 1987, P NATL ACAD SCI USA, V84, P9049, DOI 10.1073/pnas.84.24.9049; YANO H, 1995, J BIOL CHEM, V270, P23661, DOI 10.1074/jbc.270.40.23661; Zilberman A, 1998, CIRC RES, V82, P566, DOI 10.1161/01.RES.82.5.566	48	85	90	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7308	7317		10.1074/jbc.M111824200	http://dx.doi.org/10.1074/jbc.M111824200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744740	hybrid			2022-12-27	WOS:000174104300073
J	Schubert, LA; Cron, RQ; Cleary, AM; Brunner, M; Song, A; Lu, LS; Jullien, P; Krensky, AM; Lewis, DB				Schubert, LA; Cron, RQ; Cleary, AM; Brunner, M; Song, A; Lu, LS; Jullien, P; Krensky, AM; Lewis, DB			A T cell-specific enhancer of the human CD40 ligand gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FACTOR-ALPHA GENE; HYPER-IGM SYNDROME; TRANSCRIPTIONAL ACTIVATION; DNA-BINDING; INTERLEUKIN-2 GENE; NUCLEAR FACTOR; LYMPHOCYTE-ACTIVATION; INTERFERON-GAMMA; PROTEIN-BINDING	We observed that the human CD40 ligand (CD40L) gene W-flanking region conferred weak promoter activity in activated CD4 T cells, suggesting that additional regions are required for optimal CD40L gene transcription. We therefore examined a W-flanking segment of the CD40L gene, which contained a putative NF-kappaB/Rel cis-element, for its ability to enhance CD40L promoter function. This segment augmented CD40L promoter activity in an orientation-independent manner in CD4 T-lineage cells but not in human B cell or monocyte cell lines. Mapping of CD4 T-lineage cell nuclei identified a DNase I-hypersensitive site in the flanking region near the NF-kappaB/Rel sequence, suggesting a transcriptional regulatory role. This was further supported by truncation analysis and site-directed mutagenesis, which indicated that the CD40L W-flanking NF-kappaB/Rel cis-element was critical for enhancer function. Electrophoretic mobility shift assays showed that the cis-element preferentially bound the p50 form of the NTF-kappaB1 gene contained in human T cell nuclear protein extracts. This binding also appeared to occur in vivo in CD4 T cells based on chromatin immunoprecipitation assays using NF-kappaB p50-specific antiserum. Together, these results suggest that the CD40L gene W-flanking region acts as a T cell-specific classical transcriptional enhancer by a NF-kappaB p50-dependent mechanism.	Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Childrens Hosp Philadelphia, Div Rheumatol, Philadelphia, PA 19104 USA	Stanford University; Stanford University; University of Washington; University of Washington Seattle; University of Pennsylvania; Childrens Hospital of Philadelphia	Lewis, DB (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.	dblewis@leland.stanford.edu		Cron, Randy/0000-0003-2661-3086	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036291] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035008, R01DK035008] Funding Source: NIH RePORTER; HHS [P30 HH 2815-08] Funding Source: Medline; NCI NIH HHS [CA 09537] Funding Source: Medline; NICHD NIH HHS [R01 HD 36291] Funding Source: Medline; NIDDK NIH HHS [DK 35008] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); HHS(United States Department of Health & Human Services); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Barry SC, 2000, HUM GENE THER, V11, P323, DOI 10.1089/10430340050016058; Biancone L, 1999, INT J MOL MED, V3, P343; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Brown MP, 1998, NAT MED, V4, P1253, DOI 10.1038/3233; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Christenson LK, 2001, J BIOL CHEM, V276, P27392, DOI 10.1074/jbc.M101650200; CONLON K, 1995, EUR J IMMUNOL, V25, P644, DOI 10.1002/eji.1830250303; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Cron RQ, 1997, J IMMUNOL METHODS, V205, P145, DOI 10.1016/S0022-1759(97)00065-3; Cron RQ, 1999, J IMMUNOL, V162, P860; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dolganov G, 1996, BLOOD, V87, P3316, DOI 10.1182/blood.V87.8.3316.bloodjournal8783316; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Fuleihan RL, 1998, SEMIN HEMATOL, V35, P321; GAUCHAT JF, 1993, FEBS LETT, V315, P259, DOI 10.1016/0014-5793(93)81175-Y; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; HARA T, 1985, J EXP MED, V161, P1513, DOI 10.1084/jem.161.6.1513; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; Hughes CCW, 1996, J BIOL CHEM, V271, P5369, DOI 10.1074/jbc.271.10.5369; KahnPerles B, 1997, J BIOL CHEM, V272, P21774, DOI 10.1074/jbc.272.35.21774; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; KLAUS SJ, 1994, J IMMUNOL, V152, P5643; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Kuprash DV, 1999, J IMMUNOL, V162, P4045; KUPRASH DV, 1995, ONCOGENE, V11, P97; Kwon B, 1999, CURR OPIN IMMUNOL, V11, P340, DOI 10.1016/S0952-7915(99)80054-5; LARRICK JW, 1980, J IMMUNOL, V125, P6; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; LEWIS DB, 1988, P NATL ACAD SCI USA, V85, P9743, DOI 10.1073/pnas.85.24.9743; LIN RT, 1995, J BIOL CHEM, V270, P3123, DOI 10.1074/jbc.270.7.3123; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Lobo FM, 1999, J IMMUNOL, V162, P2057; Lobo FM, 2000, BIOCHEM BIOPH RES CO, V279, P245, DOI 10.1006/bbrc.2000.3914; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; MELLINS E, 1991, J EXP MED, V174, P1607, DOI 10.1084/jem.174.6.1607; Michaelson JS, 1996, J IMMUNOL, V156, P2828; MOORE PA, 1993, MOL CELL BIOL, V13, P1666, DOI 10.1128/MCB.13.3.1666; NONOYAMA S, 1995, J CLIN INVEST, V95, P66, DOI 10.1172/JCI117677; Nusslein HG, 1996, EUR J IMMUNOL, V26, P846, DOI 10.1002/eji.1830260418; Ortiz BD, 1996, MOL CELL BIOL, V16, P202; Parra E, 2001, J IMMUNOL, V166, P2437, DOI 10.4049/jimmunol.166.4.2437; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PLAKSIN D, 1993, J EXP MED, V177, P1651, DOI 10.1084/jem.177.6.1651; Ramesh N, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P233; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; SCHUBERT LA, 1995, J BIOL CHEM, V270, P29624; Seiler-Tuyns A, 1999, J BIOL CHEM, V274, P21714, DOI 10.1074/jbc.274.31.21714; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Seyama K, 1996, HUM GENET, V97, P180, DOI 10.1007/BF02265262; Shannon MF, 1997, CRIT REV IMMUNOL, V17, P301, DOI 10.1615/CritRevImmunol.v17.i3-4.30; Shapiro VS, 1998, J IMMUNOL, V161, P6455; SHIMADZU M, 1995, BBA-GENE STRUCT EXPR, V1260, P67, DOI 10.1016/0167-4781(94)00179-7; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; Smiley ST, 2000, TRANSPLANTATION, V70, P415, DOI 10.1097/00007890-200008150-00005; Srahna M, 2001, CLIN EXP IMMUNOL, V125, P229, DOI 10.1046/j.1365-2249.2001.01601.x; Suarez A, 1997, EUR J IMMUNOL, V27, P2822, DOI 10.1002/eji.1830271112; Tan JQ, 1999, J IMMUNOL, V163, P21; TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsytsykova AV, 1996, J BIOL CHEM, V271, P3763; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; WILLIAMS JM, 1985, J IMMUNOL, V135, P2249; WOTTON D, 1995, J BIOL CHEM, V270, P7515, DOI 10.1074/jbc.270.13.7515; YELLIN MJ, 1991, J IMMUNOL, V147, P3389; Young HA, 1997, PROG NUCLEIC ACID RE, V56, P109, DOI 10.1016/S0079-6603(08)61004-1	80	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7386	7395		10.1074/jbc.M110350200	http://dx.doi.org/10.1074/jbc.M110350200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751888	hybrid			2022-12-27	WOS:000174104300083
J	Soong, CL; Ogawa, J; Sakuradani, E; Shimizu, S				Soong, CL; Ogawa, J; Sakuradani, E; Shimizu, S			Barbiturase, a novel zinc-containing amidohydrolase involved in oxidative pyrimidine metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO ACID AMIDOHYDROLASE; URACIL PHOSPHORIBOSYLTRANSFERASE; URIDINE PHOSPHORYLASE; STRAIN NRRLB-12227; PSEUDOMONAS-PUTIDA; BACILLUS-SUBTILIS; CYCLIC IMIDES; PURIFICATION; CLONING; DIHYDROOROTASE	Barbiturase, which catalyzes the reversible amidohydrolysis of barbituric acid to ureidomalonic acid in the second step of oxidative pyrimidine degradation, was purified to homogeneity from Rhodococcus erythropolis JCM 3132. The characteristics and gene organization of barbiturase suggested that it is a novel zinc-containing amidohydrolase that should be grouped into a new family of the amidohydrolases superfamily. The amino acid sequence of barbiturase exhibited 48% identity with that of herbicide atrazine-decomposing cyanuric acid amidohydrolase but exhibited no significant homology to other proteins, indicating that cyanuric acid amidohydrolase may have evolved from barbiturase. A putative uracil phosphoribosyltransferase gene was found upstream of the barbiturase gene, suggesting mutual interaction between pyrimidine biosynthesis and oxidative degradation. Metal analysis with an inductively coupled radiofrequency plasma spectrophotometer revealed that barbiturase contains similar to4.4 mol of zinc per mol of enzyme. The homotetrameric enzyme had K-m and V-max values of 1.0 mM and 2.5 mumol/min/mg of protein, respectively, for barbituric acid. The enzyme specifically acted on barbituric acid, and dihydro-L-orotate, alloxan, and cyanuric acid competitively inhibited its activity. The full-length gene encoding the barbiturase (bar) was cloned and overexpressed in Escherichia coli. The kinetic parameters and physicochemical properties of the cloned enzyme were apparently similar to those of the wild-type.	Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Shimizu, S (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan.							Ashour OM, 1996, BIOCHEM PHARMACOL, V51, P1601, DOI 10.1016/0006-2952(96)00102-5; BROOKS KP, 1983, ARCH BIOCHEM BIOPHYS, V226, P469, DOI 10.1016/0003-9861(83)90316-8; COLLINS FS, 1984, P NATL ACAD SCI-BIOL, V81, P6812, DOI 10.1073/pnas.81.21.6812; EATON RW, 1991, J BACTERIOL, V173, P1363, DOI 10.1128/jb.173.3.1363-1366.1991; EATON RW, 1991, J BACTERIOL, V173, P1215, DOI 10.1128/jb.173.3.1215-1222.1991; GERO AM, 1985, BIOCHEM MED METAB B, V34, P60, DOI 10.1016/0006-2944(85)90062-6; HAYAISHI O, 1952, J BIOL CHEM, V197, P717; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; HULL WE, 1988, CANCER RES, V48, P1680; Karns JS, 1999, APPL ENVIRON MICROB, V65, P3512; KIKUGAWA M, 1994, EUR J BIOCHEM, V219, P393, DOI 10.1111/j.1432-1033.1994.tb19951.x; Kim GJ, 1998, BIOCHEM J, V330, P295, DOI 10.1042/bj3300295; LARA FJS, 1952, J BACTERIOL, V64, P279, DOI 10.1128/JB.64.2.279-285.1952; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; MARTINUSSEN J, 1995, J BACTERIOL, V177, P271, DOI 10.1128/jb.177.1.271-274.1995; May O, 1998, BIOL CHEM, V379, P743; May O, 1998, J MOL CATAL B-ENZYM, V4, P211, DOI 10.1016/S1381-1177(97)00038-6; NAGUIB FNM, 1993, BIOCHEM PHARMACOL, V46, P1273, DOI 10.1016/0006-2952(93)90477-E; NAGUIB FNM, 1985, CANCER RES, V45, P5405; OCHMAN H, 1988, GENETICS, V120, P621; Ogawa J, 1997, J MOL CATAL B-ENZYM, V2, P163, DOI 10.1016/S1381-1177(96)00020-3; Ogawa J, 1996, APPL ENVIRON MICROB, V62, P3814, DOI 10.1128/AEM.62.10.3814-3817.1996; OGAWA J, 1994, EUR J BIOCHEM, V223, P625, DOI 10.1111/j.1432-1033.1994.tb19034.x; Ogawa J, 1997, EUR J BIOCHEM, V243, P322, DOI 10.1111/j.1432-1033.1997.0322a.x; Ogawa J, 1995, ARCH MICROBIOL, V164, P353; OGAWA J, 1993, EUR J BIOCHEM, V212, P685, DOI 10.1111/j.1432-1033.1993.tb17706.x; PINSKY L, 1967, P NATL ACAD SCI USA, V57, P1267, DOI 10.1073/pnas.57.5.1267; PLENTL AA, 1944, J BIOL CHEM, V203, P203; POTVIN BW, 1978, BIOCHEM PHARMACOL, V27, P655, DOI 10.1016/0006-2952(78)90501-4; RASMUSSEN UB, 1986, BIOCHIM BIOPHYS ACTA, V881, P268, DOI 10.1016/0304-4165(86)90013-9; RUTMAN RJ, 1954, J BIOL CHEM, V210, P321; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Sambrook J., 2002, MOL CLONING LAB MANU; Soong CL, 1999, APPL ENVIRON MICROB, V65, P1459; Soong CL, 1998, FEMS MICROBIOL LETT, V158, P51, DOI 10.1111/j.1574-6968.1998.tb12799.x; Soong CL, 2001, BIOCHEM BIOPH RES CO, V286, P222, DOI 10.1006/bbrc.2001.5356; Soong CL, 2001, J MOL CATAL B-ENZYM, V12, P61, DOI 10.1016/S1381-1177(00)00204-6; Syldatk C, 1999, APPL MICROBIOL BIOT, V51, P293, DOI 10.1007/s002530051395; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; TSAI CS, 1965, PLANT PHYSIOL, V40, P39, DOI 10.1104/pp.40.1.39; Turner RJ, 1998, J BIOL CHEM, V273, P5932, DOI 10.1074/jbc.273.10.5932; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; WANG TP, 1952, J BIOL CHEM, V194, P775; WASTERNACK C, 1980, PHARMACOL THERAPEUT, V8, P629, DOI 10.1016/0163-7258(80)90079-0; WASTERNACK C, 1978, BIOCH PHYSL PFLANZ, V173, P371; WILLIAMS NK, 1995, BIOCHEMISTRY-US, V34, P11344, DOI 10.1021/bi00036a007; Yuan G, 1999, J BIOL CHEM, V274, P8175, DOI 10.1074/jbc.274.12.8175; ZIMMERMANN BH, 1995, BIOCHEMISTRY-US, V34, P7038, DOI 10.1021/bi00021a015	48	40	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7051	7058		10.1074/jbc.M110784200	http://dx.doi.org/10.1074/jbc.M110784200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11748240	hybrid			2022-12-27	WOS:000174104300040
J	Chen, SC; Gardner, DG				Chen, SC; Gardner, DG			Osmoregulation of natriuretic peptide receptor signaling in inner medullary collecting duct - A requirement for p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; OSMOTIC RESPONSE ELEMENT; HORMONAL-REGULATION; MUSCLE-CELLS; KIDNEY-CELLS; RAT; STRESS; HYPEROSMOLALITY; GROWTH; DEPHOSPHORYLATION	In the inner medullary collecting duct of the terminal nephron, the type A natriuretic peptide receptor (NPR-A) plays a major role in determining urinary sodium content. This nephron segment, by virtue of its medullary location, is subject to very high levels of extracellular tonicity. We have examined the ability of medium tonicity to regulate the activity and expression of this receptor in cultured rat inner medullary collecting duct cells. We found that NaCl (75 mM) and sucrose (150 mM), but not urea (150 mM), increased natriuretic peptide receptor activity, gene expression, and promoter activity. The osmotic stimulus also activated extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK). In the latter instance the P isoform was selectively activated. Inhibition of p38 MAPK with SB203580 blocked the osmotic induction of receptor activity and expression, as well as receptor gene promoter activity, whereas inhibition of ERK with PD98059 had no effect. Cotransfection of p38beta MAPK together with the receptor gene promoter resulted in amplification of the osmotic stimulation of the latter, whereas cotransfection of dominant negative MKK6, but not dominant-negative MEK, completely blocked the osmotic induction of receptor promoter activity. Collectively, the data indicate that extracellular osmolality stimulates receptor activity and receptor gene expression through a specific p38beta-dependent mechanism, raising the possibility that changes in medullary tonicity could play an important role in the regulation of renal sodium handling in the terminal nephron.	Univ Calif San Francisco, Ctr Diabet, Metab Res Unit 1109 HSW, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gardner, DG (corresponding author), Univ Calif San Francisco, Ctr Diabet, Metab Res Unit 1109 HSW, San Francisco, CA 94143 USA.	gardner@itsa.ucsf.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045637] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; BERL T, 1992, KIDNEY INT, V41, P37, DOI 10.1038/ki.1992.5; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; CAO L, 1994, HYPERTENSION, V24, P329, DOI 10.1161/01.HYP.24.3.329; CAO L, 1995, J BIOL CHEM, V270, P24891, DOI 10.1074/jbc.270.42.24891; Choukroun G, 1998, J CLIN INVEST, V102, P1311, DOI 10.1172/JCI3512; Denkert C, 1998, ARCH BIOCHEM BIOPHYS, V354, P172, DOI 10.1006/abbi.1998.0661; Feng WJ, 2001, MOL ENDOCRINOL, V15, P32, DOI 10.1210/me.15.1.32; Frantz B, 1998, BIOCHEMISTRY-US, V37, P13846, DOI 10.1021/bi980832y; FUJIO N, 1994, HYPERTENSION, V23, P908, DOI 10.1161/01.HYP.23.6.908; GRENIER FC, 1981, AM J PHYSIOL, V241, P94; Gutkowska J, 1999, BIOL REPROD, V61, P162, DOI 10.1095/biolreprod61.1.162; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; IIMURA O, 1995, PFLUG ARCH EUR J PHY, V430, P81, DOI 10.1007/BF00373842; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; KOHAN DE, 1993, J CLIN INVEST, V91, P1235, DOI 10.1172/JCI116286; KOLLER KJ, 1992, CIRCULATION, V86, P1081, DOI 10.1161/01.CIR.86.4.1081; Kultz D, 1997, J BIOL CHEM, V272, P13165, DOI 10.1074/jbc.272.20.13165; Kultz D, 1998, J BIOL CHEM, V273, P13645, DOI 10.1074/jbc.273.22.13645; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Levin ER, 1998, NEW ENGL J MED, V339, P321; Nadkarni V, 1999, J BIOL CHEM, V274, P20185, DOI 10.1074/jbc.274.29.20185; Nuglozeh E, 1997, LIFE SCI, V61, P2143, DOI 10.1016/S0024-3205(97)00630-9; POTTER LR, 1992, J BIOL CHEM, V267, P14531; POTTER LR, 1994, J BIOL CHEM, V269, P14636; Roger F, 1999, J BIOL CHEM, V274, P34103, DOI 10.1074/jbc.274.48.34103; SHINOHARA M, 1994, KIDNEY INT, V45, P1362, DOI 10.1038/ki.1994.178; SMARDO FL, 1992, AM J PHYSIOL, V262, pC776, DOI 10.1152/ajpcell.1992.262.3.C776; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; YAMAUCHI A, 1994, J AM SOC NEPHROL, V5, P62; Zanke BW, 1996, J BIOL CHEM, V271, P29876, DOI 10.1074/jbc.271.47.29876; ZEIDEL ML, 1993, AM J PHYSIOL, V265, pF159, DOI 10.1152/ajprenal.1993.265.2.F159	35	28	28	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6037	6043		10.1074/jbc.M111117200	http://dx.doi.org/10.1074/jbc.M111117200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744737	hybrid			2022-12-27	WOS:000173989200046
J	Hou, ZL; Wang, WY; Fromm, HJ; Honzatko, RB				Hou, ZL; Wang, WY; Fromm, HJ; Honzatko, RB			IMP alone organizes the active site of adenylosuccinate synthetase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFINED CRYSTAL-STRUCTURES; LACTATE-DEHYDROGENASE; DIRECTED MUTATION; ISOTOPE EXCHANGE; CATALYSIS; RESIDUES; COMPLEX; LOOP	A complete set of substrate/substrate analogs of adenylosuccinate synthetase from Escherichia coli induces dimer formation and a transition from a disordered to an ordered active site. The most striking of the ligand-induced effects is the movement of loop 40-53 by up to 9 1 Crystal structures of the partially ligated synthetase, which either combine IMP and hadacidin or IMP, hadacidin, and Mg2+-pyrophosphate, have ordered active sites, comparable with the fully ligated enzyme. More significantly, a crystal structure of the synthetase with IMP alone exhibits a largely ordered active site which includes the 9 A movement of loop 40-53 but does not include conformational adjustments to backbone carbonyl 40 (Mg2+ interaction element) and loop 298-304 (L-aspartate binding element). Interactions involving the 5'-phosphoryl group of IMP evidently trigger the formation of salt links some 30 Angstrom away. The above provides a structural basis for ligand binding synergism, effects on k(cat) due to mutations far from the site of catalysis, and the complete loss of substrate efficacy due to minor alterations of the 5'-phosphoryl group of IMP.	Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Honzatko, RB (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	honzatko@iastate.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS010546, R01NS010546] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABADZAPATERO C, 1987, J MOL BIOL, V198, P445, DOI 10.1016/0022-2836(87)90293-2; BASS MB, 1984, J BIOL CHEM, V259, P2330; BRUNGER AT, 1992, XPLOR VERSION 3; Choe JY, 1998, BIOCHEMISTRY-US, V37, P11441, DOI 10.1021/bi981112u; CLARKE AR, 1989, TRENDS BIOCHEM SCI, V14, P101, DOI 10.1016/0968-0004(89)90131-X; COOPER BF, 1986, BIOCHEMISTRY-US, V25, P7323, DOI 10.1021/bi00371a013; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FROMM HJ, 1958, BIOCHIM BIOPHYS ACTA, V29, P255, DOI 10.1016/0006-3002(58)90182-3; Fu ZJ, 1996, J BIOMOL STRUCT DYN, V13, P727, DOI 10.1080/07391102.1996.10508887; HAMPTON A, 1970, BIOCHIM BIOPHYS ACTA, V198, P594, DOI 10.1016/0005-2744(70)90136-1; Honzatko RB, 1999, ADV ENZYMOL RAMB, V73, P57, DOI 10.1002/9780470123195.ch3; Honzatko RB, 1999, ARCH BIOCHEM BIOPHYS, V370, P1, DOI 10.1006/abbi.1999.1383; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Kang CH, 1997, J BIOL CHEM, V272, P11881, DOI 10.1074/jbc.272.18.11881; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIEBERMAN I, 1956, J BIOL CHEM, V223, P327; LIU F, 1992, J BIOL CHEM, V267, P2388; LOLIS E, 1990, BIOCHEMISTRY-US, V29, P6619, DOI 10.1021/bi00480a010; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Poland BW, 1996, J MOL BIOL, V264, P1013, DOI 10.1006/jmbi.1996.0693; Poland BW, 1996, J BIOL CHEM, V271, P15407, DOI 10.1074/jbc.271.26.15407; Poland BW, 1997, J BIOL CHEM, V272, P15200, DOI 10.1074/jbc.272.24.15200; POLAND BW, 1993, J BIOL CHEM, V268, P25233; POLAND BW, 1996, BIOCHEMISTRY-US, V35, P12753; Prade L, 2000, J MOL BIOL, V296, P569, DOI 10.1006/jmbi.1999.3473; RUDOLPH FB, 1969, J BIOL CHEM, V244, P3832; SILVA MM, 1995, J MOL BIOL, V254, P431, DOI 10.1006/jmbi.1995.0629; Soans C, 1991, ARCH BIOCHEM BIOPHYS, V310, P475; STAYTON MM, 1983, CURR TOP CELL REGUL, V22, P103; Wang WY, 1997, J BIOL CHEM, V272, P7078, DOI 10.1074/jbc.272.11.7078; Wang WY, 1997, J BIOL CHEM, V272, P16911, DOI 10.1074/jbc.272.27.16911; Wang WY, 1998, J BIOL CHEM, V273, P16000, DOI 10.1074/jbc.273.26.16000	35	15	18	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5970	5976		10.1074/jbc.M109561200	http://dx.doi.org/10.1074/jbc.M109561200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741996	hybrid			2022-12-27	WOS:000173989200036
J	Kukor, Z; Toth, M; Pal, G; Sahin-Toth, M				Kukor, Z; Toth, M; Pal, G; Sahin-Toth, M			Human cationic trypsinogen - Arg(117) is the reactive site of an inhibitory surface loop that controls spontaneous zymogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY PANCREATITIS; RAT TRYPSINOGEN; PEPTIDE-BONDS; MUTATIONS; GENE; AUTOACTIVATION; PROTEINASES; ENZYME	Mutation of Arg(117), an autocatalytic cleavage site, is the most frequent amino acid change found in the cationic trypsinogen (Tg) of patients with hereditary pancreatitis. In the present study, the role of Arg(117) was investigated in wild-type cationic Tg and in the activation-resistant Lys(15) --> Gln mutant (Kl5Q-Tg), in which Tg-specific properties of Arg(117) can be examined selectively. We found that trypsinolytic cleavage of the Arg(117) -Val(118) bond did not proceed to completion, but due to trypsin-catalyzed re-synthesis an equilibrium was established between intact Tg and its cleaved, two-chain form. In the absence of Ca2+, at pH 8.0, the hydrolysis equilibrium (K-hyd = [cleaved Tg]/[intact Tg]) was 5.4, whereas 5 mm Ca2+ reduced the rate of cleavage at Arg(117) at least 20-fold, and shifted K-hyd to 0.7. These observations indicate that the Arg(117) -Val(118) bond exhibits properties analogous to the reactive site bond of canonical trypsin inhibitors and suggest that this surface loop might serve as a low affinity inhibitor of zymogen activation. Consistent with this notion, autoactivation of cationic Tg was inhibited by the cleaved form of K15Q-Tg, with an estimated K-i of 80 muM, while no inhibition was observed with K15Q-Tg carrying the Arg(117) --> His mutation. Finally, zymogen breakdown due to other trypsinolytic pathways was shown to proceed almost 2000-fold slower than cleavage at Arg(117). Taken together, the findings suggest two independent, successively functional trypsin-mediated mechanisms against pathological Tg activation in the pancreas. At low trypsin concentrations, cleavage at Arg(117) results in inhibition of trypsin, whereas high trypsin concentrations degrade Tg, thus limiting further zymogen activation. Loss of Arg(117)-dependent trypsin inhibition can contribute to the development of hereditary pancreatitis associated with the Arg(117) --> His mutation.	Univ Calif Los Angeles, HHMI, Macdonald Res Labs 5748, Dept Physiol, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Sahin-Toth, M (corresponding author), Univ Calif Los Angeles, HHMI, Macdonald Res Labs 5748, Dept Physiol, Box 951662, Los Angeles, CA 90095 USA.	miklos@hhmi.ucla.edu	Pal, Gabor/A-6244-2009	Pal, Gabor/0000-0001-7868-7971	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK058008] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Applebaum-Shapiro SE, 2001, PANCREATOLOGY, V1, P439, DOI 10.1159/000055844; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Chen JM, 2000, GASTROENTEROLOGY, V119, P277, DOI 10.1016/S0016-5085(00)70073-4; Chen JM, 2001, HUM GENET, V109, P245, DOI 10.1007/s004390100580; Chen JM, 2001, CLIN GENET, V59, P189, DOI 10.1034/j.1399-0004.2001.590308.x; Chen JM, 1999, GASTROENTEROLOGY, V117, P1508, DOI 10.1016/S0016-5085(99)70313-6; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P124, DOI 10.1021/bi00542a019; Ferec C, 1999, J MED GENET, V36, P228; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; GONCZ KK, 1995, CELL TISSUE RES, V280, P519, DOI 10.1007/BF00318356; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; HIGAKI JN, 1985, ANAL BIOCHEM, V148, P111, DOI 10.1016/0003-2697(85)90635-9; HOMANDBERG GA, 1978, BIOCHEMISTRY-US, V17, P5220, DOI 10.1021/bi00617a023; HOMANDBERG GA, 1982, BIOCHEMISTRY-US, V21, P3385, DOI 10.1021/bi00257a021; KASLIK G, 1995, FEBS LETT, V370, P179, DOI 10.1016/0014-5793(95)00816-R; KUMAZAKI T, 1979, J BIOCHEM, V85, P581, DOI 10.1093/oxfordjournals.jbchem.a132367; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Le Marechal C, 2001, MOL GENET METAB, V74, P342, DOI 10.1006/mgme.2001.3246; Le Marechal C, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-19; MAROUX S, 1969, BIOCHIM BIOPHYS ACTA, V181, P59, DOI 10.1016/0005-2795(69)90227-X; Pfutzer R, 2002, GUT, V50, P271, DOI 10.1136/gut.50.2.271; Pfutzer RH, 1999, GASTROENTEROLOGY, V117, P1507, DOI 10.1016/S0016-5085(99)70312-4; RINDERKNECHT H, 1979, GUT, V20, P886, DOI 10.1136/gut.20.10.886; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; RU BG, 1980, SCI SINICA, V23, P1453; Sahin-Toth M, 1999, BIOCHEM BIOPH RES CO, V264, P505, DOI 10.1006/bbrc.1999.1565; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V275, P668, DOI 10.1006/bbrc.2000.3355; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2001, PANCREATOLOGY, V1, P461, DOI 10.1159/000055848; Sahin-Toth M, 1999, J BIOL CHEM, V274, P29699, DOI 10.1074/jbc.274.42.29699; SIMON P, 2001, IN PRESS J BIOL CHEM; SMITH RL, 1969, J BIOL CHEM, V244, P4704; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; Teich N, 2000, GASTROENTEROLOGY, V119, P461, DOI 10.1053/gast.2000.9312; Teich N, 1998, HUM MUTAT, V12, P39, DOI 10.1002/(SICI)1098-1004(1998)12:1<39::AID-HUMU6>3.0.CO;2-P; Varallyay E, 1998, BIOCHEM BIOPH RES CO, V243, P56, DOI 10.1006/bbrc.1997.8058; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3	41	51	51	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6111	6117		10.1074/jbc.M110959200	http://dx.doi.org/10.1074/jbc.M110959200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748242	hybrid			2022-12-27	WOS:000173989200056
J	Minchenko, A; Leshchinsky, I; Opentanova, I; Sang, NL; Srinivas, V; Armstead, V; Caro, J				Minchenko, A; Leshchinsky, I; Opentanova, I; Sang, NL; Srinivas, V; Armstead, V; Caro, J			Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene - Its possible role in the Warburg effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; FACTOR 1-ALPHA; MOLECULAR-CLONING; TUMOR-GROWTH; FACTOR-1-ALPHA; FRUCTOSE-2,6-BISPHOSPHATASE; 6-PHOSPHOFRUCTO-2-KINASE; ANGIOGENESIS; HIF-1-ALPHA; GLYCOLYSIS	One of the key mediators of the hypoxic response in animal cells is the hypoxia-inducible transcription factor-1 (HIF-1) complex, in which the alpha-subunit is highly susceptible to oxygen-dependent degradation. The hypoxic response is manifested in many pathophysiological processes such as tumor growth and metastasis. During hypoxia, cells shift to a primarily glycolytic metabolic mode for their energetic needs. This is also manifested in the HIF-1-dependent up-regulation of many glycolytic genes. Paradoxically, tumor cells growing under conditions of normal oxygen tension also show elevated glycolytic rates that correlate with the increased expression of glycolytic enzymes and glucose transporters (the Warburg effect). A key regulator of glycolytic flux is the relatively recently discovered fructose-2,6-bisphosphate (F-2,6-P2), an allosteric activator of 6-phosphofructo-1-kinase (PFK-1). Steady state levels of F-2,6-P2 are maintained by the bifunctional enzyme PFK-2/F2,6-Bpase, which has both kinase and phosphatase activities. Herein, we show that one isozyme, PFKFB3, is highly induced by hypoxia and the hypoxia mimics cobalt and desferrioxamine. This induction could be replicated by the use of an inhibitor of the prolyl hydroxylase enzymes responsible for the von Hippel Lindau (VHL)-dependent destabilization and tagging of HIF-1alpha. The absolute dependence of the PFKFB3 gene on HIF-1 was confirmed by its overexpression in VHL-deficient cells and by the lack of hypoxic induction in mouse embryonic fibroblasts conditionally nullizygous for HIF-1alpha.	Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn Hematol Res, Dept Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Anesthesiol Physiol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Caro, J (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn Hematol Res, Dept Med, 1015 Walnut St, Philadelphia, PA 19107 USA.	Jaime.Caro@mail.tju.edu	Minchenko, Oleksandr/AAV-5742-2020	Minchenko, Oleksandr/0000-0002-7093-5173	NATIONAL CANCER INSTITUTE [K01CA098809, R01CA089212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM000686] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALGAIER J, 1988, BIOCHEM BIOPH RES CO, V153, P328, DOI 10.1016/S0006-291X(88)81226-9; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Fukasawa M, 2000, BIOCHEM BIOPH RES CO, V267, P703, DOI 10.1006/bbrc.1999.2022; Heine-Suner D, 1998, EUR J BIOCHEM, V254, P103, DOI 10.1046/j.1432-1327.1998.2540103.x; Hirata T, 2000, BIOSCI BIOTECH BIOCH, V64, P2047, DOI 10.1271/bbb.64.2047; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; HUE L, 1993, ADV ENZYME REGUL, V33, P97; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; Manzano A, 1998, CYTOGENET CELL GENET, V83, P214, DOI 10.1159/000015181; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; MINCHENKO A, 1994, LAB INVEST, V71, P374; Navarro-Sabate A, 2001, GENE, V264, P131, DOI 10.1016/S0378-1119(00)00591-6; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Richard DE, 2000, J BIOL CHEM, V275, P26765; Ryan HE, 2000, CANCER RES, V60, P4010; Sakai A, 1996, J BIOCHEM-TOKYO, V119, P506; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WENGER RH, 1999, ENV STRESS GENE REGU, P25; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W	43	241	262	2	34	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6183	6187		10.1074/jbc.M110978200	http://dx.doi.org/10.1074/jbc.M110978200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744734	hybrid, Green Accepted			2022-12-27	WOS:000173989200066
J	Schaffer, C; Wugeditsch, T; Kahlig, H; Scheberl, A; Zayni, S; Messner, P				Schaffer, C; Wugeditsch, T; Kahlig, H; Scheberl, A; Zayni, S; Messner, P			The surface layer (S-layer) glycoprotein of Geobacillus stearothermophilus NRS 2004/3a - Analysis of its glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL POLYMER; BACILLUS-STEAROTHERMOPHILUS; THERMOSACCHAROLYTICUM D120-70; CONTINUOUS-CULTURE; MASS-SPECTROMETRY; SEQUENCE-ANALYSIS; GLYCAN STRUCTURE; PROTEIN; TYROSINE; LINKAGE	Geobacillus stearothermophilus NRS 2004/3a possesses an oblique surface layer (S-layer) composed of glycoprotein subunits as the outermost component of its cell wall. In addition to the elucidation of the complete S-layer glycan primary structure and the determination of the glycosylation sites, the structural gene sgsE encoding the S-layer protein was isolated by polymerase chain reaction-based techniques. The open reading frame codes for a protein of 903 amino acids, including a leader sequence of 30 amino acids. The mature S-layer protein has a calculated molecular mass of 93,684 Da and an isoelectric point of 6.1. Glycosylation of SgsE was investigated by means of chemical analyses, 600-MHz nuclear magnetic resonance spectroscopy, and matrix-assisted laser desorption ionization-time of flight mass spectrometry. Glycopeptides obtained after Pronase digestion revealed the glycan structure [-->2)-alpha-L-Rhap-(1-->3)-beta-L-Rhap-(1-->2)-alpha-L-Rhap-(1-->](n) (= 13-18) with a 2-O-methyl group capping the terminal trisaccharide repeating unit at the non-reducing end of the glycan chains. The glycan chains are bound via the disaccharide core -->3)-alpha-L-Rhap-(1-->3)-alpha-L-Rhap-(1--> and the linkage glycose beta-D-Galp in O-glycosidic linkages to the S-layer protein SgsE at positions threonine 620 and serine 794. This S-layer glycoprotein contains novel linkage regions and is the first one among eubacteria whose glycosylation sites have been characterized.	Univ Bodenkultur Wien, Zentrum Ultrastrukturforsch, A-1180 Vienna, Austria; Univ Bodenkultur Wien, Ludwig Boltzmann Inst Mol Nanotechnol, A-1180 Vienna, Austria; Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Ludwig Boltzmann Institute; University of Natural Resources & Life Sciences, Vienna; University of Vienna	Schaffer, C (corresponding author), Univ Bodenkultur Wien, Zentrum Ultrastrukturforsch, Gregor Mendel Str 33, A-1180 Vienna, Austria.	crs@edv1.boku.ac.at	Schäffer, Christina/V-3404-2018; Messner, Paul/Q-5345-2017	Schäffer, Christina/0000-0003-1613-7258; Kaehlig, Hanspeter/0000-0002-3898-6501; Messner, Paul/0000-0002-3246-5801				ADACHI S, 1965, J CHROMATOGR, V17, P295, DOI 10.1016/S0021-9673(00)99871-6; ALTMAN E, 1995, EUR J BIOCHEM, V229, P308, DOI 10.1111/j.1432-1033.1995.0308l.x; ALTMAN E, 1990, EUR J BIOCHEM, V188, P73, DOI 10.1111/j.1432-1033.1990.tb15373.x; Bahl H, 1997, FEMS MICROBIOL REV, V20, P47, DOI 10.1016/S0168-6445(97)00050-8; BOCK K, 1994, J BIOL CHEM, V269, P7137; CHRISTIAN R, 1986, CARBOHYD RES, V150, P265, DOI 10.1016/0008-6215(86)80021-0; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DISCHE Z, 1948, J BIOL CHEM, V175, P595; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; Egelseer EM, 2000, MICROBIOL-SGM, V146, P2175, DOI 10.1099/00221287-146-9-2175; FOX A, 1993, J CLIN MICROBIOL, V31, P887, DOI 10.1128/JCM.31.4.887-894.1993; Hartl D L, 1996, Methods Mol Biol, V58, P293; HARTMANN E, 1993, J BACTERIOL, V175, P4515, DOI 10.1128/JB.175.14.4515-4519.1993; HURLBERT RE, 1978, EUR J BIOCHEM, V90, P241, DOI 10.1111/j.1432-1033.1978.tb12596.x; Jarosch M, 2000, MICROBIOL-SGM, V146, P273, DOI 10.1099/00221287-146-2-273; Kneidinger B, 2001, J BIOL CHEM, V276, P20935, DOI 10.1074/jbc.M100378200; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Kuen B, 1997, J BACTERIOL, V179, P1664, DOI 10.1128/jb.179.5.1664-1670.1997; KUEN B, 1994, GENE, V145, P115, DOI 10.1016/0378-1119(94)90332-8; KUPCU Z, 1984, FEBS LETT, V173, P185, DOI 10.1016/0014-5793(84)81043-1; LUPAS A, 1994, J BACTERIOL, V176, P1224, DOI 10.1128/jb.176.5.1224-1233.1994; MESSNER P, 1984, INT J SYST BACTERIOL, V34, P202, DOI 10.1099/00207713-34-2-202; MESSNER P, 1995, J BACTERIOL, V177, P2188, DOI 10.1128/jb.177.8.2188-2193.1995; MESSNER P, 1988, FEBS LETT, V228, P317, DOI 10.1016/0014-5793(88)80023-1; MESSNER P, 1986, J ULTRA MOL STRUCT R, V97, P73, DOI 10.1016/S0889-1605(86)80008-8; Messner P, 2000, GLYCOMICROBIOLOGY, P93; MESSNER P, IN PRESS PROGR CHEM, V85; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; PELLERIN P, 1990, CAN J MICROBIOL, V36, P631, DOI 10.1139/m90-109; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sara M, 1996, J BACTERIOL, V178, P2108, DOI 10.1128/jb.178.7.2108-2117.1996; Sara M, 1998, J BACTERIOL, V180, P6780; SARA M, 1994, J BACTERIOL, V176, P7182; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Sara M, 2001, TRENDS MICROBIOL, V9, P47, DOI 10.1016/S0966-842X(00)01905-3; Schaffer C, 1996, MICROB DRUG RESIST, V2, P17, DOI 10.1089/mdr.1996.2.17; Schaffer C, 1999, GLYCOBIOLOGY, V9, P407, DOI 10.1093/glycob/9.4.407; Schaffer C, 1999, MICROBIOL-UK, V145, P1575, DOI 10.1099/13500872-145-7-1575; Schaffer C, 2000, EUR J BIOCHEM, V267, P5482, DOI 10.1046/j.1432-1327.2000.01610.x; Schaffer C, 2000, GLYCOCONJUGATE J, V17, P681, DOI 10.1023/A:1011062302889; Schaffer C, 2001, BIOCHIMIE, V83, P591, DOI 10.1016/S0300-9084(01)01299-8; Schaffer C, 2001, PROTEOMICS, V1, P248; Scholz H, 2000, ARCH MICROBIOL, V174, P97, DOI 10.1007/s002030000181; Scholz HC, 2001, J BACTERIOL, V183, P1672, DOI 10.1128/JB.183.5.1672-1679.2001; Sleytr UB, 1999, ANGEW CHEM INT EDIT, V38, P1035, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1034::AID-ANIE1034>3.0.CO;2-#; STRECKER G, 1995, METHODS GLYCOCONJUGA, P47; SUMPER M, 1995, GLYCOPROTEINS, P455; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WESTERMEIER R, 1990, ELECTROPHORESE PRAKT, P189; WIELAND F, 1982, ZBL BAKT MIK HYG I C, V3, P161, DOI 10.1016/S0721-9571(82)80064-1; Wugeditsch T, 1999, GLYCOBIOLOGY, V9, P787, DOI 10.1093/glycob/9.8.787; Zervosen A, 2001, BIOL CHEM, V382, P299, DOI 10.1515/BC.2001.037	55	59	60	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6230	6239		10.1074/jbc.M108873200	http://dx.doi.org/10.1074/jbc.M108873200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741945	hybrid			2022-12-27	WOS:000173989200072
J	Cabral, ALB; Lee, KS; Martins, VR				Cabral, ALB; Lee, KS; Martins, VR			Regulation of the cellular prion protein gene expression depends on chromatin conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN HISTONE DEACETYLASE; TRICHOSTATIN-A; MESSENGER-RNA; TRANSCRIPTION; CELLS; PROMOTER; BINDING; IDENTIFICATION; INHIBITION; BRAIN	Conversion of the normal cellular prion protein (PrPc), whose physiological function is still under investigation, to an infectious form called prion is the cause of some neurodegenerative diseases. Therefore, the elucidation of PrPc gene regulation is important both to define a strategy to control the infection and to better understand PrPc function. We cloned the rat PrPc gene promoter region into a luciferase reporter vector, transfected C6 and PC-12 cells, and isolated clones with stable enzyme expression. The dependence of chromatin conformation on PrPc promoter activity was evaluated using the histone deacetylase inhibitor, trichostatin A, which was able to highly increase not only promoter activity but also PrPc mRNA and protein levels. The phorbol ester (12-O-tetradecanoylphorbol-13-acetate) and cAMP poorly induced promoter activity; retinoic acid decreased it by 50%, whereas nerve growth factor and dexamethasone had no effect. When 12-O-tetradee. anoylphorbol-13-acetate or cAMP but not retinoic acid was associated with trichostatin A, a potentiation of the primary effects was observed. These new data indicate that PrPc gene regulation is highly dependent on disruption of chromatin fiber assembly, which allows some ubiquitous transcription factors accession to specific DNA elements.	Univ Sao Paulo, Inst Quim, Dept Bioquim, Ludwig Inst Canc Res, BR-01509900 Sao Paulo, Brazil	Ludwig Institute for Cancer Research; Universidade de Sao Paulo	Martins, VR (corresponding author), Ctr Tratamento & Pesquisa Hosp Canc, Rua Prof Antonio, BR-01509010 Sao Paulo, SP, Brazil.		Martins, Vilma R/E-2547-2012; Lee, Kil Sun/AAL-8564-2020; Martins, Vilma/N-5446-2019; Lee, Kil S/D-3678-2012	Martins, Vilma R/0000-0002-2909-8502; Lee, Kil S/0000-0002-2390-2774				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Archer SY, 2001, J SURG RES, V98, P4, DOI 10.1006/jsre.2001.6147; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baybutt H, 1997, GENE, V184, P125, DOI 10.1016/S0378-1119(96)00600-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; Cho JH, 2001, ENDOCRINOLOGY, V142, P3389, DOI 10.1210/en.142.8.3389; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Cosgaya JM, 1998, FEBS LETT, V429, P254, DOI 10.1016/S0014-5793(98)00577-8; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; Dodelet VC, 1998, BLOOD, V91, P1556, DOI 10.1182/blood.V91.5.1556.1556_1556_1561; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FUTAMURA M, 1995, ONCOGENE, V10, P1119; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Graner E, 2000, FEBS LETT, V482, P257, DOI 10.1016/S0014-5793(00)02070-6; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kapatos G, 2000, J BIOL CHEM, V275, P5947, DOI 10.1074/jbc.275.8.5947; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Mahal SP, 2001, GENE, V268, P105, DOI 10.1016/S0378-1119(01)00424-3; MANSON J, 1992, DEVELOPMENT, V115, P117; Martins VR, 2001, BRAZ J MED BIOL RES, V34, P585, DOI 10.1590/S0100-879X2001000500005; MASQUILIER D, 1992, J BIOL CHEM, V267, P22460; Mishra N, 2001, P NATL ACAD SCI USA, V98, P2628, DOI 10.1073/pnas.051507098; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; Newell-Price J, 2001, MOL ENDOCRINOL, V15, P338, DOI 10.1210/me.15.2.338; Ng KW, 1997, EMBO J, V16, P2072, DOI 10.1093/emboj/16.8.2072; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saeki K, 1996, BIOCHEM BIOPH RES CO, V219, P47, DOI 10.1006/bbrc.1996.0179; Schroen DJ, 1996, J CELL PHYSIOL, V169, P320, DOI 10.1002/(SICI)1097-4652(199611)169:2<320::AID-JCP11>3.3.CO;2-Z; Schwab J, 2001, INT IMMUNOL, V13, P705, DOI 10.1093/intimm/13.5.705; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SCOTT MRD, 1988, PROTEIN ENG, V2, P69, DOI 10.1093/protein/2.1.69; SCULLY JL, 1993, NEUROSCI LETT, V155, P11, DOI 10.1016/0304-3940(93)90662-5; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Sutherland JE, 2001, MUTAT RES-FUND MOL M, V479, P225, DOI 10.1016/S0027-5107(01)00163-4; Takahashi I, 1996, J ANTIBIOT, V49, P453, DOI 10.7164/antibiotics.49.453; VanLint C, 1996, GENE EXPRESSION, V5, P245; Waggoner DJ, 2000, J BIOL CHEM, V275, P7455, DOI 10.1074/jbc.275.11.7455; WALTON KM, 1990, MOL NEUROBIOL, V4, P197, DOI 10.1007/BF02780341; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Xiao HY, 1999, J CELL BIOCHEM, V73, P291, DOI 10.1002/(SICI)1097-4644(19990601)73:3<291::AID-JCB1>3.0.CO;2-5; Xie WF, 1998, J BIOL CHEM, V273, P5026, DOI 10.1074/jbc.273.9.5026; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	62	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5675	5682		10.1074/jbc.M104815200	http://dx.doi.org/10.1074/jbc.M104815200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739375	hybrid			2022-12-27	WOS:000173962900145
J	Madesh, M; Antonsson, B; Srinivasula, SM; Alnemri, ES; Hajnoczky, G				Madesh, M; Antonsson, B; Srinivasula, SM; Alnemri, ES; Hajnoczky, G			Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; BCL-2 FAMILY-MEMBERS; CELL-DEATH; BAX; APOPTOSIS; MEMBRANE; PROTEIN; COMPLEX; DOMAIN; DATP	Cleavage of Bid has been shown to promote apoptosis by inducing mitochondrial membrane permeabilization with the resultant release of apoptosis-inducing proteins from the intermembrane space into the cytosol. However, direct visualization of the Bid-induced release of various proteins from the highly compartmentalized intermembrane space and the changes in the mitochondrial metabolic machinery remain elusive. Using green fluorescent protein fusion proteins and immunostaining in individual permeabilized HepG2 cells, first we demonstrated that truncated Bid (15.5-kDa C-terminal fragment, tBid) evoked a rapid and essentially complete release of cytochrome c and Smac/DIABLO from every mitochondrion. To establish at a resolution of seconds the kinetics of tBid-induced cytochrome c and Smac/DIABLO release and depolarization, we monitored the mitochondrial membrane potential (Deltapsi(m)) fluorimetrically in permeabilized cells and applied a rapid filtration method to obtain cytosolic fractions for Western blotting. We found that subnanomolar doses of tBid were sufficient to evoke cytochrome c release and mitochondrial depolarization, whereas full-length Bid was 100-fold less effective. Bcl-x(L) prevented tBid-induced cytochrome c release and depolarization. In response to 2.5 nM tBid, cytochrome c release started after a 10 s delay, displayed rapid progression, and was complete at 50-70 s. Release of Smac/DIABLO was synchronized with cytochrome c release, whereas the loss of Deltapsi(m) lagged slightly behind cytochrome e release. Furthermore, tBid-induced cytochrome c release was insensitive to changes in substrate composition, but tBid-induced depolarization did not occur in the presence of extramitochondrial ATP supply. Thus, tBid-induced permeabilization of the outer membrane permits rapid release of cytochrome c and Smac/DIABLO from all domains of the intermembrane space. The tBid-induced loss of Deltapsi(m) occurs after cytochrome c release and reflects impairment of oxidative metabolism.	Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Serono Pharmaceut Res Inst, Dept Prot Biochem, CH-1228 Geneva, Switzerland; Thomas Jefferson Univ, Kimmel Canc Inst, Ctr Apoptosis Res, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Hajnoczky, G (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 253 JAH, Philadelphia, PA 19107 USA.	Gyorgy.Hajnoczky@mail.tju.edu	Alnemri, Emad S/B-4526-2010		NIA NIH HHS [AG13487] Funding Source: Medline; NIGMS NIH HHS [GM59419] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013487] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bossy-Wetzel E, 1999, J BIOL CHEM, V274, P17484, DOI 10.1074/jbc.274.25.17484; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutz RJ, 2000, BIOCHEM SOC T, V28, P51, DOI 10.1042/bst0280051; Mannella CA, 1997, TRENDS BIOCHEM SCI, V22, P37, DOI 10.1016/S0968-0004(96)30050-9; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Pinkoski MJ, 2001, J BIOL CHEM, V276, P12060, DOI 10.1074/jbc.M009038200; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P577, DOI 10.1073/pnas.97.2.577; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wei MC, 2000, GENE DEV, V14, P2060; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zamzami N, 2000, ONCOGENE, V19, P6342, DOI 10.1038/sj.onc.1204030; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	57	153	159	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5651	5659		10.1074/jbc.M108171200	http://dx.doi.org/10.1074/jbc.M108171200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741882	hybrid			2022-12-27	WOS:000173962900142
J	Watanabe, S; Kokuho, T; Takahashi, H; Takahashi, M; Kubota, T; Inumaru, S				Watanabe, S; Kokuho, T; Takahashi, H; Takahashi, M; Kubota, T; Inumaru, S			Sialylation of N-glycans on the recombinant proteins expressed by a baculovirus-insect cell system under beta-N-acetylglucosaminidase inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; SF9 CELLS; GLYCOSYLATION; RECEPTOR; GLYCOPROTEINS; DEGRADATION; RECOGNITION; LECTIN; CDNA; LINE	We investigated the ability of a baculo-virus-insect cell system to produce sialylated glycoproteins. Despite the presence of enzymes for synthesizing complex-type N-glycans, the most frequent structure of insect N-glycan is the paucimannosidic type, Man(3)GlcNAc(2)(+/-Fuc). The reason for the overwhelming assembly of paucimannosidic N-glycans is not yet well understood. We hypothesized that this predominance might be due to insect-specific, Golgi-associated beta-N-acetylglucosaminidase (GlcNAcase)-mediated removal of N-acetylglucosamine residues from the precursor N-glycan, thereby preventing its galactosylation and terminal sialylation. As we expected, the suppression of intrinsic GlcNAcase activity with a specific inhibitor, 2-acetamido-1,2-dideoxynojirimycin, allowed the accumulation of sialylated glycoproteins in the supernatants of insect cell cultures after baculoviral infection. Our observation indicates that GlcNAcase-dependent depletion of N-acetylglucosamine residues from intermediate N-glycans is critical for the assembly of paucimannosidic N-glycans in insect cells and, more importantly, that insect cells (under specific conditions) retain the ability to construct sialylated N-glycans like those in mammalian cells.	Natl Inst Anim Hlth, Dept Immunol, Tsukuba, Ibaraki 3050856, Japan; Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan; Natl Agr Res Ctr Kyushu Okinawa Reg, Kumamoto 8611192, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Watanabe, S (corresponding author), Natl Inst Anim Hlth, Dept Immunol, 3-1-5 Kannondai, Tsukuba, Ibaraki 3050856, Japan.							ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; BECKER GW, 1994, BIO-TECHNOL, V12, P69, DOI 10.1038/nbt0194-69; BOUCIAS DG, 1993, INSECT BIOCHEM MOLEC, V23, P233, DOI 10.1016/0965-1748(93)90004-C; Breitbach K, 2001, BIOTECHNOL BIOENG, V74, P230, DOI 10.1002/bit.1112; CONZELMANN E, 1987, ADV ENZYMOL RAMB, V60, P89; DAVIDSON DJ, 1991, BIOCHEMISTRY-US, V30, P6165; DIE I, 1996, GLYCOBIOLOGY, V6, P157; HOTCHKISS A, 1988, THROMB HAEMOSTASIS, V60, P255; HOWARD S C, 1991, Glycobiology, V1, P411, DOI 10.1093/glycob/1.4.411; HSIEH P, 1984, J BIOL CHEM, V259, P2375; Inumaru S, 1998, IMMUNOL CELL BIOL, V76, P195, DOI 10.1046/j.1440-1711.1998.00734.x; Inumaru S., 1997, Cytokine, V9, P901; Inumaru S., 2000, BIOTECHNOL BIOPROC E, V5, P146; Jain RK, 1998, GLYCOCONJUGATE J, V15, P951, DOI 10.1023/A:1006977607394; JARVIS DL, 1995, VIROLOGY, V212, P500, DOI 10.1006/viro.1995.1508; Jarvis DL, 2001, J VIROL, V75, P6223, DOI 10.1128/JVI.75.13.6223-6227.2001; Jarvis DL, 1997, GLYCOBIOLOGY, V7, P113, DOI 10.1093/glycob/7.1.113; Kawar Z, 1997, GLYCOBIOLOGY, V7, P433, DOI 10.1093/glycob/7.3.433; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Leonova T, 1996, J BIOL CHEM, V271, P17312, DOI 10.1074/jbc.271.29.17312; LODISH HF, 1991, TRENDS BIOCHEM SCI, V16, P374, DOI 10.1016/0968-0004(91)90154-N; MANNEBERG M, 1994, PROTEIN SCI, V3, P30; Marchal I, 1999, GLYCOBIOLOGY, V9, P645, DOI 10.1093/glycob/9.7.645; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; MARZOWSKI J, 1995, BIOTECHNOL BIOENG, V46, P399; NG GYK, 1993, BIOCHEMISTRY-US, V32, P11727, DOI 10.1021/bi00094a032; PARKER GF, 1991, FEBS LETT, V290, P58, DOI 10.1016/0014-5793(91)81225-W; REN JX, 1995, BIOCHEMISTRY-US, V34, P2489, DOI 10.1021/bi00008a012; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shin SW, 2000, FEBS LETT, V467, P70, DOI 10.1016/S0014-5793(00)01127-3; Takahashi M, 2000, CLONED ANIMAL PLACEN, P146; VELARDO MA, 1993, J BIOL CHEM, V268, P17902; VOSS T, 1993, EUR J BIOCHEM, V217, P913, DOI 10.1111/j.1432-1033.1993.tb18321.x; Wagner R, 1996, J VIROL, V70, P4103, DOI 10.1128/JVI.70.6.4103-4109.1996; WOYNAROWSKA B, 1992, ANTICANCER RES, V12, P161; Zavodzky P, 1996, CYTOTECHNOLOGY, V20, P279, DOI 10.1007/BF00350407	38	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5090	5093		10.1074/jbc.M110548200	http://dx.doi.org/10.1074/jbc.M110548200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741890	hybrid			2022-12-27	WOS:000173962900071
J	Campbell, FM; Kozak, R; Wagner, A; Altarejos, JY; Dyck, JRB; Belke, DD; Severson, DL; Kelly, DP; Lopaschuk, GD				Campbell, FM; Kozak, R; Wagner, A; Altarejos, JY; Dyck, JRB; Belke, DD; Severson, DL; Kelly, DP; Lopaschuk, GD			A role for peroxisome proliferator-activated receptor alpha (PPAR alpha) in the control of cardiac malonyl-CoA levels - Reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPAR alpha are associated with higher concentrations of maloncyl-CoA and reduced expression of malonyl-CoA decarboxlase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; WORKING MOUSE HEART; LIPID-METABOLISM; GENE-EXPRESSION; PROTEIN-KINASE; DECARBOXYLASE; MUSCLE; TRANSCRIPTION; SUBSTRATE; CLONING	Peroxisome proliferator-activated receptor alpha (PPAR)alpha is a nuclear receptor transcription factor that has an important role in controlling cardiac metabolic gene expression. We determined whether mice lacking PPARalpha (PPARalpha (-/-) mice) have alterations in cardiac energy metabolism. Rates of palmitate oxidation were significantly decreased in isolated working hearts from PPARalpha (-/-) hearts compared with hearts from age-matched wild type mice (PPARalpha (+/+) mice), (62 +/- 12 versus 154 +/- 65 nmol/g dry weight/min, respectively, p < 0.05). This was compensated for by significant increases in the rates of glucose oxidation and glycolysis. The decreased fatty acid oxidation in PPARalpha (-/-) hearts was associated with increased levels of cardiac malonyl-CoA compared with PPARalpha (+/+) hearts (15.15 +/- 1.63 versus 7.37 +/- 1.31 nmol/g, dry weight, respectively, p < 0.05). Since malonyl-CoA is an important regulator of cardiac fatty acid oxidation, we also determined if the enzymes that control malonyl-CoA levels in the heart are under transcriptional control of PPARalpha. Expression of both mRNA and protein as well as the activity of malonyl-CoA decarboxylase, which degrades malonyl-CoA, were significantly decreased in the PPARalpha (-/-) hearts. In contrast, the expression and activity of acetyl-CoA carboxylase, which synthesizes malonyl-CoA and 5'-AMP-activated protein kinase, which regulates acetyl-CoA carboxylase, were not altered. Glucose transporter expression (GLUT1 and GLUT4) was not different between PPARalpha (-/-) and PPARalpha (+/+) hearts, suggesting that the increase in glycolysis and glucose oxidation in the PPARalpha null mice was not due to direct effects on glucose uptake but rather was occurring secondary to the decrease in fatty acid oxidation. This study demonstrates that PPARalpha is an important regulator of fatty acid oxidation in the heart and that this regulation of fatty acid oxidation may in part occur due to the transcriptional control of malonyl-CoA decarboxylase.	Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Pediat, Edmonton, AB T6G 2S2, Canada; Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; Washington Univ, Sch Med, Div Cardiovasc, Cardiovasc Res Ctr, St Louis, MO 63110 USA	University of Alberta; University of Alberta; University of Calgary; Washington University (WUSTL)	Lopaschuk, GD (corresponding author), Univ Alberta, Dept Pharmacol, 426 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.		Kelly, Daniel/ABG-2056-2021	Dyck, Jason/0000-0002-7045-2884				Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Belke DD, 2001, AM J PHYSIOL-ENDOC M, V280, pE420, DOI 10.1152/ajpendo.2001.280.3.E420; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Dyck JRB, 2000, BIOCHEM J, V350, P599, DOI 10.1042/0264-6021:3500599; Dyck JRB, 1998, AM J PHYSIOL-HEART C, V275, pH2122, DOI 10.1152/ajpheart.1998.275.6.H2122; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Gao JM, 1999, J LIPID RES, V40, P178; Goodwin GW, 1998, J BIOL CHEM, V273, P29530, DOI 10.1074/jbc.273.45.29530; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; HARDIE DG, 1992, BIOCHIM BIOPHYS ACTA, V1123, P231, DOI 10.1016/0005-2760(92)90001-C; ISSEMANN I, 1992, BIOCHEM SOC T, V20, P824, DOI 10.1042/bst0200824; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kurtz DM, 2000, J LIPID RES, V41, P2063; Larsen TS, 1999, PFLUG ARCH EUR J PHY, V437, P979, DOI 10.1007/s004240050870; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Long SD, 1996, J BIOL CHEM, V271, P1138, DOI 10.1074/jbc.271.2.1138; Lopaschuk GD, 1997, AM J CARDIOL, V80, pA11, DOI 10.1016/S0002-9149(97)00453-0; LOPASCHUK GD, 1994, BBA-LIPID LIPID MET, V1213, P263, DOI 10.1016/0005-2760(94)00082-4; LOPASCHUK GD, 1994, J BIOL CHEM, V269, P25871; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Nugent C, 2001, J BIOL CHEM, V276, P9149, DOI 10.1074/jbc.M009817200; SADDIK M, 1991, J BIOL CHEM, V266, P8162; SADDIK M, 1993, J BIOL CHEM, V268, P25836; Saha AK, 2000, J BIOL CHEM, V275, P24279, DOI 10.1074/jbc.C000291200; Sakamoto J, 2000, AM J PHYSIOL-HEART C, V278, pH1196, DOI 10.1152/ajpheart.2000.278.4.H1196; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Voilley N, 1999, BIOCHEM J, V340, P213, DOI 10.1042/0264-6021:3400213; WALL SR, 1989, BIOCHIM BIOPHYS ACTA, V1006, P97, DOI 10.1016/0005-2760(89)90328-7; Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200; Young ME, 2001, AM J PHYSIOL-ENDOC M, V280, pE471, DOI 10.1152/ajpendo.2001.280.3.E471; Yu GS, 1998, J BIOL CHEM, V273, P32901, DOI 10.1074/jbc.273.49.32901	40	206	224	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4098	4103		10.1074/jbc.M106054200	http://dx.doi.org/10.1074/jbc.M106054200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11734553	hybrid			2022-12-27	WOS:000173813900041
J	Moro, L; Dolce, L; Cabodi, S; Bergatto, E; Erba, EB; Smeriglio, M; Turco, E; Retta, SF; Giuffrida, MG; Venturino, M; Godovac-Zimmermann, J; Conti, A; Schaefer, E; Beguinot, L; Tacchetti, C; Gaggini, P; Silengo, L; Tarone, G; Defilippi, P				Moro, L; Dolce, L; Cabodi, S; Bergatto, E; Erba, EB; Smeriglio, M; Turco, E; Retta, SF; Giuffrida, MG; Venturino, M; Godovac-Zimmermann, J; Conti, A; Schaefer, E; Beguinot, L; Tacchetti, C; Gaggini, P; Silengo, L; Tarone, G; Defilippi, P			Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; HUMAN ENDOTHELIAL-CELLS; ALPHA(V)BETA(3) INTEGRIN; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; FAMILY KINASES; AUTOPHOSPHORYLATION SITES; BIOLOGICAL-ACTIVITY; EPITHELIAL-CELLS	Integrin-mediated cell adhesion cooperates with growth factor receptors in the control of cell proliferation, cell survival, and cell migration. One mechanism to explain these synergistic effects is the ability of integrins to induce phosphorylation of growth factor receptors, for instance the epidermal growth factor (EGF) receptor. Here we define some aspects of the molecular mechanisms regulating integrin-dependent EGF receptor phosphorylation. We show that in the early phases of cell adhesion integrins associate with EGF receptors on the cell membrane in a macromolecular complex including the adaptor protein p130Cas and the c-Src kinase, the latter being required for adhesion-dependent assembly of the macromolecular complex. We also show that the integrin cytoplasmic tail, c-Src kinase, and the p130Cas adaptor protein are required for phosphorylation of EGF receptor in response to integrin-mediated adhesion. We show that integrins induce phosphorylation of EGF receptor on tyrosine residues 845, 1068, 1086, and 1173, but not on residue 1148, a major site of phosphorylation in response to EGF. In addition we find that integrin-mediated adhesion increases the amount of EGF receptor expressed on the cell surface. Therefore these data indicate that integrin-mediated adhesion induces assembly of a macromolecular complex containing c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosine residues.	Univ Turin, Dipartimento Genet Biol & Biochim, I-10126 Turin, Italy; Univ Piemonte Orientale, Dipartimento Sci Med, I-28100 Novara, Italy; BioSource Int, Hopkinton, MA 01748 USA; HS Rarraele, Unita Oncol Mol, I-20100 Milan, Italy; HS Rarraele, Ist Neurosci & Bioimmagini, I-20100 Milan, Italy; Univ Genoa, Sez Anat, Dipartimento Med Sperimentale, I-16100 Genoa, Italy; UCL, Ctr Mol Med, London WCE1 6JJ, England	University of Turin; University of Eastern Piedmont Amedeo Avogadro; University of Genoa; University of London; University College London	Defilippi, P (corresponding author), Univ Turin, Dipartimento Genet Biol & Biochim, Via Santena 5 Bis, I-10126 Turin, Italy.	paola.defilippi@unito.it	Moro, Laura/ABF-2175-2020; Zimmermann, Jasminka Godovac/E-6863-2010; Retta, Saverio Francesco/Q-4770-2019; Erba, Elisabetta Boeri/J-1058-2014; DEFILIPPI, Paola/L-2232-2014; Giuffrida, Maria Gabriella/AAY-6314-2020	Retta, Saverio Francesco/0000-0001-9761-2959; Erba, Elisabetta Boeri/0000-0002-5910-4707; Giuffrida, Maria Gabriella/0000-0002-1297-2558; Defilippi, Paola/0000-0001-6427-4906; Moro, Laura/0000-0003-3421-2522; Tarone, Guido/0000-0003-4805-086X; TACCHETTI, CARLO/0000-0003-4602-000X; Cabodi, Sara/0000-0003-1248-6549				Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; Barberis L, 2000, J BIOL CHEM, V275, P36532, DOI 10.1074/jbc.M002487200; Berditchevski F, 2001, J CELL SCI, V114, P4143; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Chellaiah M, 1996, ENDOCRINOLOGY, V137, P2432, DOI 10.1210/en.137.6.2432; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; CYBULSKY AV, 1994, J CLIN INVEST, V94, P68, DOI 10.1172/JCI117350; Danilkovitch-Miagkova A, 2000, J BIOL CHEM, V275, P14783, DOI 10.1074/jbc.C000028200; Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G; DEFILIPPI P, 1995, EXP CELL RES, V221, P141, DOI 10.1006/excr.1995.1361; DEFILIPPI P, 1994, CELL ADHES COMMUN, V2, P75, DOI 10.3109/15419069409014203; DEFILIPPI P, 1991, J CELL BIOL, V114, P855, DOI 10.1083/jcb.114.4.855; DEFILIPPI P, 1997, MOL B INT U, P1; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; Dolfi F, 1998, P NATL ACAD SCI USA, V95, P15394, DOI 10.1073/pnas.95.26.15394; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guilherme A, 1998, J BIOL CHEM, V273, P22899, DOI 10.1074/jbc.273.36.22899; Habib T, 1998, J BIOL CHEM, V273, P18605, DOI 10.1074/jbc.273.29.18605; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; ILLC D, 1995, NATURE, V377, P539; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lee YJ, 1999, J BIOL CHEM, V274, P22401, DOI 10.1074/jbc.274.32.22401; Li J, 1999, J BIOL CHEM, V274, P11209, DOI 10.1074/jbc.274.16.11209; Malik RK, 1996, BBA-REV CANCER, V1287, P73, DOI 10.1016/0304-419X(96)00008-X; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nojima Y, 1996, Hum Cell, V9, P169; PATCH LA, 1995, J CELL SCI, V108, P1371; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Retta SF, 1998, MOL BIOL CELL, V9, P715, DOI 10.1091/mbc.9.4.715; Rusciano D, 1996, J BIOL CHEM, V271, P20763, DOI 10.1074/jbc.271.34.20763; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; SATO KI, 1995, BIOCHEM BIOPH RES CO, V215, P1078, DOI 10.1006/bbrc.1995.2574; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Schwartz MA, 1999, CURR OPIN CELL BIOL, V11, P197, DOI 10.1016/S0955-0674(99)80026-X; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; SLOT JW, 1984, IMMUNOLABELLING ELEC, P129; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; SORKIN A, 1998, FRONT BIOSCI, V3, P729; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Vuori K, 1996, MOL CELL BIOL, V16, P2606; VUORI K, 1995, J BIOL CHEM, V270, P22259, DOI 10.1074/jbc.270.38.22259; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Yamakita Y, 1999, J CELL BIOL, V144, P315, DOI 10.1083/jcb.144.2.315	70	297	303	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9405	9414		10.1074/jbc.M109101200	http://dx.doi.org/10.1074/jbc.M109101200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11756413	hybrid, Green Published			2022-12-27	WOS:000174400600090
J	Mawal-Dewan, M; Lorenzini, A; Frisoni, L; Zhang, H; Cristofalo, VJ; Sell, C				Mawal-Dewan, M; Lorenzini, A; Frisoni, L; Zhang, H; Cristofalo, VJ; Sell, C			Regulation of collagenase expression during replicative senescence in human fibroblasts by Akt-forkhead signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; TRANSCRIPTION FACTOR FKHR; NUCLEAR EXCLUSION; PROMOTER ACTIVITY; GENE-EXPRESSION; FAMILY-MEMBER; PHOSPHORYLATION; ACTIVATION; INSULIN; TRANSLOCATION	The expression of collagenase (matrix metalloproteinase 1) in human fibroblasts increases during aging both in vivo and in vitro. This age-associated increase in collagenase expression has been postulated to contribute to the age related decline in tissue function by increasing proteolysis of matrix components, but little is known regarding the regulation of collagenase expression. We examined the role that the serine/threonine kinase Akt plays in collagenase expression during in vitro senescence of WI-38 normal human lung fibroblast cells. Our results indicate that Akt-mediated signals, acting through the forkhead transcription factor FKHRL1, can regulate collagenase expression in WI-38 fibroblasts. Dominant negative forms of Akt increase collagenase promoter activity in early passage WI-38 fibroblasts, whereas an active form of Akt suppresses steady state levels of collagenase mRNA in senescent WI-38 fibroblasts. In addition, the activity of a synthetic promoter containing forkhead-specific binding sites, as measured by luciferase activity, is much higher in senescent cells compared with early passage WI-38 fibroblasts. These results indicate that members of the forkhead family of transcription factors play a role in the regulation of the collagenase promoter and that increased activity of forkhead transcription factors may underlie the increase in collagenase expression observed during replicative senescence.	Lankenau Inst Med Res, Wynnewood, PA 19096 USA; MCP Hahnemann Univ, Sch Med, Philadelphia, PA 19429 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Drexel University	Sell, C (corresponding author), Lankenau Inst Med Res, 100 Lancaster Ave, Wynnewood, PA 19096 USA.	sellc@mlhs.org	Lorenzini, Antonello/G-4463-2012; LORENZINI, ANTONELLO/E-6582-2016	LORENZINI, ANTONELLO/0000-0001-9615-9697	NATIONAL CANCER INSTITUTE [R29CA068923] Funding Source: NIH RePORTER; NCI NIH HHS [CA 68923] Funding Source: Medline; NIA NIH HHS [AG 00131, AG 00378] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aho S, 1997, EUR J BIOCHEM, V247, P503, DOI 10.1111/j.1432-1033.1997.00503.x; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Ashcroft GS, 1997, CELL TISSUE RES, V290, P581, DOI 10.1007/s004410050963; Ashcroft GS, 1997, J INVEST DERMATOL, V108, P430, DOI 10.1111/1523-1747.ep12289705; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cristofalo VJ, 1998, CRIT REV EUKAR GENE, V8, P43, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.30; Cristofalo VJ, 1980, J TISSUE CULTURE MET, V6, P117; Didichenko SA, 1996, CURR BIOL, V6, P1271, DOI 10.1016/S0960-9822(02)70713-6; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; IMAI S, 1994, MOL CELL BIOL, V14, P7182, DOI 10.1128/MCB.14.11.7182; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Kaestner KH, 2000, GENE DEV, V14, P142; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Khorramizadeh MR, 1999, MOL CELL BIOCHEM, V194, P99, DOI 10.1023/A:1006909021352; Kim-Kaneyama JR, 2000, J BIOL CHEM, V275, P20685, DOI 10.1074/jbc.M908723199; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Lim IK, 2000, MECH AGEING DEV, V119, P113, DOI 10.1016/S0047-6374(00)00167-6; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; MILLIS AJT, 1992, EXP GERONTOL, V27, P425, DOI 10.1016/0531-5565(92)90076-C; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tresini M, 1998, CANCER RES, V58, P1; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8	38	27	28	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7857	7864		10.1074/jbc.M104515200	http://dx.doi.org/10.1074/jbc.M104515200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751876	hybrid			2022-12-27	WOS:000174268000031
J	Roudier, N; Bailly, P; Gane, P; Lucien, N; Gobin, R; Cartron, JP; Ripoche, P				Roudier, N; Bailly, P; Gane, P; Lucien, N; Gobin, R; Cartron, JP; Ripoche, P			Erythroid expression and oligomeric state of the AQP3 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHIP28 WATER CHANNELS; TRANSMEMBRANE CONDUCTANCE REGULATOR; FRACTURE ELECTRON-MICROSCOPY; FUNCTIONAL EXPRESSION; FREEZE-FRACTURE; STRUCTURAL-ANALYSIS; SECONDARY STRUCTURE; AQUAPORIN FAMILY; XENOPUS OOCYTES; COLLECTING DUCT	Biochemical and biophysical studies have shown that the strictly water-permeable aquaporins have a tetrameric structure, whereas results concerning the oligomeric state of G1pF, the glycerol facilitator of Escherichia coli, are dependent upon the analytical technique used. Here, we analyzed the oligomerization of the AQP3 aquaglyceroporin, which presents a mixed selectivity for water, glycerol, and urea. At first, based on transcript detection by reverse transcription-PCR from human erythroid tissues and membrane expression detected by flow cytometry analysis, we demonstrated that AQP3 is expressed on human and rat but not on mouse red blood cells. Then, the quaternary structure of AQP3 was determined using as models human red blood cell membranes, which carry both AQP1 and AQP3, and two heterologous expression systems: Xenopus laevis oocyte, for density and size estimation of aquaporins, and Saccharomyces cerevisiae yeast, which expressed a non-glycosylated form of AQP3. By velocity sedimentation in sucrose gradient after non-denaturing detergent solubilization, AQP3 was essentially found as mono- and dimeric species in conditions under which AQP1 preserved its tetrameric structure. Freeze-fracture studies on oocyte plasma membranes gave a size of AQP3 particles in favor of a dimeric or trimeric structure. Finally, by cross-linking experiments with red blood cell membranes, AQP3 is visible as different oligomeric structures, including a tetrameric one.	CEA Saclay, Dept Biol Cellulaire & Mol, F-91191 Gif Sur Yvette, France; Inst Natl Transfus Sanguine, INSERM U76, F-75015 Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cartron, JP (corresponding author), CEA Saclay, Dept Biol Cellulaire & Mol, F-91191 Gif Sur Yvette, France.							BEURON F, 1995, J BIOL CHEM, V270, P17414, DOI 10.1074/jbc.270.29.17414; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Bron P, 1999, J STRUCT BIOL, V128, P287, DOI 10.1006/jsbi.1999.4196; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Daniels MJ, 1999, J MOL BIOL, V294, P1337, DOI 10.1006/jmbi.1999.3293; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gerbeau P, 1999, PLANT J, V18, P577, DOI 10.1046/j.1365-313x.1999.00481.x; Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796; Huang PB, 1996, BBA-BIOMEMBRANES, V1281, P80, DOI 10.1016/0005-2736(96)00032-6; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; JACOBS MH, 1950, J EXP ZOOL, V113, P277, DOI 10.1002/jez.1401130203; JAP BK, 1995, J MOL BIOL, V251, P413, DOI 10.1006/jmbi.1995.0444; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; Ko SBH, 1999, BIOCHEM MOL BIOL INT, V47, P309; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Lagree V, 1998, J BIOL CHEM, V273, P33949, DOI 10.1074/jbc.273.51.33949; Lagree V, 1999, J BIOL CHEM, V274, P6817, DOI 10.1074/jbc.274.11.6817; LAIZE V, 1995, FEBS LETT, V373, P269, DOI 10.1016/0014-5793(95)01060-R; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; Manley DM, 2000, BIOCHEMISTRY-US, V39, P12303, DOI 10.1021/bi000703t; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; MITRA AK, 1995, NAT STRUCT BIOL, V2, P726, DOI 10.1038/nsb0995-726; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Schreiber R, 1997, PFLUG ARCH EUR J PHY, V434, P841, DOI 10.1007/s004240050473; SHI LB, 1994, J BIOL CHEM, V269, P10417; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Steck T L, 1974, Methods Enzymol, V31, P172; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; Van Dort HM, 1998, J BIOL CHEM, V273, P14819, DOI 10.1074/jbc.273.24.14819; van Hoek AN, 1998, J MEMBRANE BIOL, V165, P243, DOI 10.1007/s002329900438; VANHOEK AN, 1991, J BIOL CHEM, V266, P16633; VANHOEK AN, 1995, BIOCHEMISTRY-US, V34, P2212, DOI 10.1021/bi00007a015; VANHOEK AN, 1993, BIOCHEMISTRY-US, V32, P11847, DOI 10.1021/bi00095a013; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; WALZ T, 1995, NAT STRUCT BIOL, V2, P730, DOI 10.1038/nsb0995-730; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Yang BX, 2001, J BIOL CHEM, V276, P624, DOI 10.1074/jbc.M008664200; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; ZHANG RB, 1993, BIOCHEMISTRY-US, V32, P2938, DOI 10.1021/bi00063a002	51	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7664	7669		10.1074/jbc.M105411200	http://dx.doi.org/10.1074/jbc.M105411200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751877	hybrid			2022-12-27	WOS:000174268000008
J	Zhao, RX; Guerrah, A; Tang, H; Zhao, ZJ				Zhao, RX; Guerrah, A; Tang, H; Zhao, ZJ			Cell surface glycoprotein PZR is a major mediator of concanavalin A-induced cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE SHP-2; INHIBITORY RECEPTORS; ANIMAL LECTINS; PROTEIN; PURIFICATION	PZR is an immunoglobulin superfamily cell surface protein containing a pair of immunoreceptor tyrosine-based inhibitory motifs. As a glycoprotein, PZR displays a strong association with concanavalin A (ConA), a member of the plant lectin family. Treatment of several cell lines with ConA caused tyrosine phosphorylation of a major cellular protein. Immunoblotting and immuno-precipitation studies indicated that this protein corresponded to PZR. Tyrosine phosphorylation of PZR was accompanied by recruitment of SHP-2 and was inhibited by PP1, a selective inhibitor of the Src family tyrosine kinases. Furthermore, c-Src was constitutively associated with PZR and was activated upon treatment of cells with ConA. Moreover, tyrosine phosphorylation of PZR was markedly enhanced in v-Src-transformed NIH-3T3 cells and was predominant in Escherichia coli cells co-expressing c-Src. Expression of an intracellular domain-truncated form of PZR in HT-1080 cells affected cell morphology and had a dominant negative effect on ConA-induced tyrosine phosphorylation of PZR, activation of c-Src, and agglutination of the cells. Together, the data indicate that PZR is a major receptor of ConA and has an important role in cell signaling via c-Src. Considering the various biological activities of ConA, the study of PZR may have major therapeutic implications.	Vanderbilt Univ, Div Hematol Oncol, Dept Med, Ingram Canc Ctr, Nashville, TN 37232 USA; Univ Texas Hlth Ctr, Dept Biochem, Tyler, TX 75708 USA	Vanderbilt University	Zhao, ZJ (corresponding author), Vanderbilt Univ, Div Hematol Oncol, Dept Med, Ingram Canc Ctr, 777 Preston Res Bldg,2220 Pierce Ave, Nashville, TN 37232 USA.				NCI NIH HHS [CA68485, CA75218] Funding Source: Medline; NHLBI NIH HHS [HL57393, HL69806] Funding Source: Medline; NIDDK NIH HHS [DK15555, T32-DK07186] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA075218] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057393, R01HL069806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007186, R01DK015555] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BITTIGES H, 1976, CONEANAVALIN A TOOL; BOWLES DJ, 1988, TRENDS BIOCHEM SCI, V13, P60, DOI 10.1016/0968-0004(88)90030-8; Cribbs DH, 1996, NEUROSCIENCE, V75, P173, DOI 10.1016/0306-4522(96)80001-P; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Elgavish S, 1997, TRENDS BIOCHEM SCI, V22, P462, DOI 10.1016/S0968-0004(97)01146-8; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Gabius HJ, 1997, EUR J BIOCHEM, V243, P543, DOI 10.1111/j.1432-1033.1997.t01-1-00543.x; GUNTHER GR, 1973, P NATL ACAD SCI USA, V70, P1012, DOI 10.1073/pnas.70.4.1012; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; KALB AJ, 1968, BIOCHIM BIOPHYS ACTA, V168, P366, DOI 10.1016/0005-2795(68)90161-X; Lemmon MA, 1998, METH MOL B, V84, P49; LIN SS, 1991, TRENDS NEUROSCI, V14, P273, DOI 10.1016/0166-2236(91)90136-I; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; REEKE GN, 1974, ANN NY ACAD SCI, V234, P369, DOI 10.1111/j.1749-6632.1974.tb53049.x; Rini JM, 1999, CURR OPIN STRUC BIOL, V9, P578, DOI 10.1016/S0959-440X(99)00008-1; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Streuli M, 1996, CURR OPIN CELL BIOL, V8, P182, DOI 10.1016/S0955-0674(96)80064-0; Tang H, 2000, J BIOL CHEM, V275, P13420, DOI 10.1074/jbc.275.18.13420; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WANG HY, 1989, BIOCHEM J, V263, P533, DOI 10.1042/bj2630533; Xu MJ, 2000, J BIOL CHEM, V275, P17440, DOI 10.1074/jbc.M001313200; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhao RX, 2000, J BIOL CHEM, V275, P5453, DOI 10.1074/jbc.275.8.5453; ZHAO ZZ, 1994, J BIOL CHEM, V269, P8780; ZHAO ZZ, 1995, J BIOL CHEM, V270, P11765, DOI 10.1074/jbc.270.20.11765	32	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7882	7888		10.1074/jbc.M111914200	http://dx.doi.org/10.1074/jbc.M111914200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751924	hybrid			2022-12-27	WOS:000174268000034
J	Brown, NM; Kennedy, MC; Antholine, WE; Eisenstein, RS; Walden, WE				Brown, NM; Kennedy, MC; Antholine, WE; Eisenstein, RS; Walden, WE			Detection of a [3Fe-4S] cluster intermediate of cytosolic aconitase in yeast expressing iron regulatory protein 1 - Insights into the mechanism of Fe-S cluster cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE ELEMENT-BINDING; FERRITIN MESSENGER-RNA; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; UNTRANSLATED REGION; NITRIC-OXIDE; MOLECULAR CONTROL; REDOX REGULATION; SULFUR CLUSTER; IN-VITRO	Interconversion of iron regulatory protein I (IRP1) with cytosolic aconitase (c-aconitase) occurs via assembly/disassembly of a [4Fe-4S] cluster. Recent evidence implicates oxidants in cluster disassembly. We investigated H2O2-initiated Fe-S cluster disassembly in c-aconitase expressed in Saccharomyces cerevisiae. A signal for [3Fe-4S] c-aconitase was detected by whole-cell EPR of aerobically grown, aco1 yeast expressing wild-type IRP1 or a S138A-IRP1 mutant (IRP1(S138A)), providing the first direct evidence of a 3Fe intermediate in vivo. Exposure of yeast to H2O2 increased this 3Fe c-aconitase signal up to 5-fold, coincident with inhibition of c-aconitase activity. Untreated yeast expressing IRP1(S138D) or IRP1(S138E), which mimic phosphorylated IRP1, failed to give a 3Fe signal. H2O2 produced a weak 3Fe signal in yeast expressing IRP1(S138D). Yeast expressing IRP1(S138D) or IRP1(S138E) were the most sensitive to inhibition of aconitase-dependent growth by H2O2 and were more responsive to changes in media iron status. Ferricyanide oxidation of anaerobically reconstituted c-aconitase yielded a strong 3Fe EPR signal with wild-type and S138A c-aconitases. Only a weak 3Fe signal was obtained with S138D c-aconitase, and no signal was obtained with S138E c-aconitase. This, paired with loss of c-aconitase activity, strongly argues that the Fe-S clusters of these phosphomimetic c-aconitase mutants undergo more complete disassembly upon oxidation. Our results demonstrate that 3Fe c-aconitase is an intermediate in H2O2-initiated Fe-S cluster disassembly in vivo and suggest that cluster assembly/disassembly in IRP1 is a dynamic process in aerobically growing yeast. Further, our results support the view that phosphorylation of IRP1 can modulate its response to iron through effects on Fe-S cluster stability and turnover.	Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Biophys Res Inst, Milwaukee, WI 53226 USA; Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison	Walden, WE (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	wwalden@uic.edu			NCRR NIH HHS [RR 01008] Funding Source: Medline; NIDDK NIH HHS [DK 47219, DK 47281] Funding Source: Medline; NIGMS NIH HHS [GM 51831] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047219, R01DK047281, R01DK047219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051831] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; BASILION JP, 1994, ARCH BIOCHEM BIOPHYS, V311, P517, DOI 10.1006/abbi.1994.1270; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; BODANESS RS, 1982, BIOCHEM BIOPH RES CO, V108, P1709, DOI 10.1016/S0006-291X(82)80108-3; Brazzolotto X, 1999, J BIOL CHEM, V274, P21625, DOI 10.1074/jbc.274.31.21625; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; CHITAMBAR CR, 1990, CANCER RES, V50, P4468; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; DIX DR, 1994, J BIOL CHEM, V269, P26092; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; EISENSTEIN RS, 1997, METAL IONS GENE REGU, P157; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; KAPTAIN S, 1991, P NATL ACAD SCI USA, V88, P10109, DOI 10.1073/pnas.88.22.10109; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Minard KI, 1998, J BIOL CHEM, V273, P31486, DOI 10.1074/jbc.273.47.31486; Minard KI, 1999, J BIOL CHEM, V274, P3402, DOI 10.1074/jbc.274.6.3402; Narahari J, 2000, J BIOL CHEM, V275, P16227, DOI 10.1074/jbc.M910450199; Oliveira L, 1999, J BIOL CHEM, V274, P516, DOI 10.1074/jbc.274.1.516; Pantopoulos K, 1998, P NATL ACAD SCI USA, V95, P10559, DOI 10.1073/pnas.95.18.10559; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SWENSON GR, 1991, BIOL MET, V4, P48, DOI 10.1007/BF01135557; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; Toth I, 1999, J BIOL CHEM, V274, P4467, DOI 10.1074/jbc.274.7.4467; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6	53	50	51	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7246	7254		10.1074/jbc.M110282200	http://dx.doi.org/10.1074/jbc.M110282200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744706	hybrid			2022-12-27	WOS:000174104300065
J	Di Mauro, E; Verdone, L; Chiappini, B; Caserta, M				Di Mauro, E; Verdone, L; Chiappini, B; Caserta, M			In vivo changes of nucleosome positioning in the pretranscription state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; EUKARYOTIC RNA-POLYMERASE; SACCHAROMYCES-CEREVISIAE; HISTONE OCTAMER; SWI/SNF COMPLEX; IN-VITRO; TRANSCRIPTION; MOBILITY; GENE; MOBILIZATION	The involvement of chromatin structure and organization in transcriptional regulatory pathways has become evident. One unsolved question concerns the molecular mechanisms of chromatin remodeling during in vivo promoter activation. By using a high resolution in vivo analysis we show that when yeast cells are exposed to a regulatory signal the positions of specific nucleosomes change. The system analyzed consists of the basic elements of the Saccharomyces cerevisiae ADH2 promoter, two nucleosomes of which are shown to change the distribution of their positions by few nucleotides in the direction of transcription when the glucose content of the medium is lowered. Such repositioning does not occur in the absence of the ADH2 transcriptional activator Adr1 or in the presence of its DNA-binding domain alone. A construct consisting of the DNA-binding domain plus a 43-amino acid peptide containing the Adr1 activation domain is sufficient to induce the same effect of the full-length protein. Nucleosome repositioning occurs even when the catalytic activity of the RNA polymerase II is impaired, suggesting that the Adr1 activation domain mediates the recruitment of some factor to correctly preset the relevant sequences for the subsequent transcription steps.	Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, CNR, Ctr Acidi Nucl, I-00185 Rome, Italy; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Sapienza University Rome	Caserta, M (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, CNR, Ctr Acidi Nucl, P Aldo Moro 5, I-00185 Rome, Italy.		CHIAPPINI, BARBARA/C-8324-2015; Verdone, Loredana/AGG-5450-2022	Chiappini, Barbara/0000-0002-5260-5285; Verdone, Loredana/0000-0002-8854-1068; Caserta, Micaela/0000-0003-1647-5118				Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; BEARD P, 1978, CELL, V15, P955, DOI 10.1016/0092-8674(78)90279-9; BEIER DR, 1982, NATURE, V300, P724, DOI 10.1038/300724a0; BUTTINELLI M, 1993, P NATL ACAD SCI USA, V90, P9315, DOI 10.1073/pnas.90.20.9315; COSTANZO G, 1995, J BIOL CHEM, V270, P11091, DOI 10.1074/jbc.270.19.11091; DENIS CL, 1983, MOL CELL BIOL, V3, P360, DOI 10.1128/MCB.3.3.360; Di Mauro E, 2000, J BIOL CHEM, V275, P7612, DOI 10.1074/jbc.275.11.7612; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Gregory PD, 1998, EUR J BIOCHEM, V251, P9, DOI 10.1046/j.1432-1327.1998.2510009.x; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; ODONOHUE MF, 1994, NUCLEIC ACIDS RES, V22, P937, DOI 10.1093/nar/22.6.937; Pazin MJ, 1997, SCIENCE, V276, P809, DOI 10.1126/science.276.5313.809; PENNINGS S, 1991, J MOL BIOL, V220, P101, DOI 10.1016/0022-2836(91)90384-I; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; Tanaka S, 1996, J MOL BIOL, V257, P919, DOI 10.1006/jmbi.1996.0212; Travers A, 1999, CELL, V96, P311, DOI 10.1016/S0092-8674(00)80543-7; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; VARGAWEISZ PD, 1995, EMBO J, V14, P2209, DOI 10.1002/j.1460-2075.1995.tb07215.x; VENDITTI P, 1994, BBA-GENE STRUCT EXPR, V1219, P677, DOI 10.1016/0167-4781(94)90227-5; Verdone L, 1997, J BIOL CHEM, V272, P30828, DOI 10.1074/jbc.272.49.30828; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; XIANYANG Z, 1984, J MOL BIOL, V176, P105	35	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7002	7009		10.1074/jbc.M106719200	http://dx.doi.org/10.1074/jbc.M106719200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11748218	hybrid			2022-12-27	WOS:000174104300034
J	Muenzner, P; Billker, O; Meyer, TF; Naumann, M				Muenzner, P; Billker, O; Meyer, TF; Naumann, M			Nuclear factor-kappa B directs carcinoembryonic antigen-related cellular adhesion molecule 1 receptor expression in Neisseria gonorrhoeae-infected epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GONOCOCCAL OPACITY PROTEINS; ACTIVATED ENDOTHELIAL-CELLS; CROSS-REACTING ANTIGEN; CHINESE-HAMSTER OVARY; BILIARY GLYCOPROTEIN; GENE FAMILY; CEA FAMILY; OPA PROTEINS; IN-VITRO; C-CAM	The human-specific pathogen Neisseria gonorrhoeae expresses opacity-associated (Opa) protein adhesins that bind to various members of the carcinoembryonic antigen-related cellular adhesion molecule (CEACAM) family. In this study, we have analyzed the mechanism underlying N. gonorrhoeae-induced CEACAM up-regulation in epithelial cells. Epithelial cells represent the first barrier for the microbial pathogen. We therefore characterized CEACAM expression in primary human ovarian surface epithelial (HOSE) cells and found that CEACAM1-3 (L, S) and CEACAM1-4 (L, S) splice variants mediate an increased Opa(52)-dependent gonoccocal binding to HOSE cells. Up-regulation of these CEACAM molecules in HOSE cells is a direct process that takes place within 2 h postinfection and depends on close contact between microbial pathogen and HOSE cells. N. gonorrhoeae-triggered CEACAM1 up-regulation involves activation of the transcription factor nuclear factor kappaB (NF-kappaB), which translocates as a p5O/p65 heterodimer into the nucleus, and an NF-kappaB-specific inhibitory peptide inhibited CEACAM1-receptor up-regulation in N. gonorrhoeae-infected HOSE cells. Bacterial lipopolysaccharides did not induce NF-kappaB and CEACAM up-regulation, which corresponds to our findings that HOSE cells do not express toll-like receptor 4. The ability of N. gonorrhoeae to up-regulate its epithelial receptor CEACAM1 through NF-kappaB suggests an important mechanism allowing efficient bacterial colonization during the initial infection process.	Max Planck Inst Infect Biol, Dept Biol Mol, D-10117 Berlin, Germany	Max Planck Society	Meyer, TF (corresponding author), Max Planck Inst Infect Biol, Dept Biol Mol, Schumannstr 21-22, D-10117 Berlin, Germany.		Meyer, Thomas F. F/J-2485-2013; Naumann, Michael/B-5285-2011	Meyer, Thomas F. F/0000-0002-6120-8679; Naumann, Michael/0000-0002-8060-2313; Billker, Oliver/0000-0003-1716-168X				ACHTMAN M, 1988, J EXP MED, V168, P507, DOI 10.1084/jem.168.2.507; BARNETT TR, 1993, MOL CELL BIOL, V13, P1273, DOI 10.1128/MCB.13.2.1273; Beauchemin N, 1999, EXP CELL RES, V252, P243; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; BERLING B, 1990, CANCER RES, V50, P6534; Billker O, 2000, TRENDS MICROBIOL, V8, P258, DOI 10.1016/S0966-842X(00)01771-6; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; BRANDT E, 1991, CYTOKINE, V3, P311, DOI 10.1016/1043-4666(91)90499-4; Chen CJ, 1996, J BIOL CHEM, V271, P28181, DOI 10.1074/jbc.271.45.28181; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; DANIEL S, 1993, INT J CANCER, V55, P303, DOI 10.1002/ijc.2910550222; Dehio C, 1997, J CELL SCI, V110, P2141; Dehio M, 1998, FEBS LETT, V424, P84, DOI 10.1016/S0014-5793(98)00144-6; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Draberova L, 2000, IMMUNOLOGY, V101, P279, DOI 10.1046/j.1365-2567.2000.00113.x; Duensing TD, 1997, INFECT IMMUN, V65, P964, DOI 10.1128/IAI.65.3.964-970.1997; EIDELMAN FJ, 1993, J CELL BIOL, V123, P467, DOI 10.1083/jcb.123.2.467; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hauck CR, 1997, INFECT IMMUN, V65, P1863, DOI 10.1128/IAI.65.5.1863-1869.1997; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HEFTA LJF, 1990, CANCER RES, V50, P2397; HEFTA SA, 1990, J BIOL CHEM, V265, P8618; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HSIEH JT, 1995, CANCER RES, V55, P190; Jantscheff P, 1996, J LEUKOCYTE BIOL, V59, P891, DOI 10.1002/jlb.59.6.891; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Klein ML, 1996, INFECT IMMUN, V64, P4574, DOI 10.1128/IAI.64.11.4574-4579.1996; Kleinerman DI, 1996, CANCER RES, V56, P3431; KLEINERMAN DI, 1995, CANCER RES, V55, P1215; KUIJPERS TW, 1992, J CELL BIOL, V118, P457, DOI 10.1083/jcb.118.2.457; Kunath T, 1995, ONCOGENE, V11, P2375; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; MCGEE ZA, 1983, REV INFECT DIS, V5, P708; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; Muenzner P, 2001, J BIOL CHEM, V276, P24331, DOI 10.1074/jbc.M006883200; NAGEL G, 1993, EUR J BIOCHEM, V214, P27, DOI 10.1111/j.1432-1033.1993.tb17892.x; Naumann M, 1997, J EXP MED, V186, P247, DOI 10.1084/jem.186.2.247; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V142, P511, DOI 10.1016/0006-291X(87)90304-4; OIKAWA S, 1991, J BIOL CHEM, V266, P7995; PAXTON RJ, 1987, P NATL ACAD SCI USA, V84, P920, DOI 10.1073/pnas.84.4.920; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Skubitz KM, 1996, J LEUKOCYTE BIOL, V60, P106, DOI 10.1002/jlb.60.1.106; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Wang J, 1998, MOL MICROBIOL, V30, P657, DOI 10.1046/j.1365-2958.1998.01102.x; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; ZIMMERMANN W, 1988, CANCER RES, V48, P2550	59	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7438	7446		10.1074/jbc.M108135200	http://dx.doi.org/10.1074/jbc.M108135200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751883	hybrid			2022-12-27	WOS:000174104300089
J	Pellizzoni, L; Baccon, J; Rappsilber, J; Mann, M; Dreyfuss, G				Pellizzoni, L; Baccon, J; Rappsilber, J; Mann, M; Dreyfuss, G			Purification of native survival of motor neurons complexes and identification of Gemin6 as a novel component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; DISEASE GENE-PRODUCT; SMN PROTEIN; POLYACRYLAMIDE-GELS; SNRNP BIOGENESIS; COILED BODIES; GEMS; INTERACTS; POMBE; CONSERVATION	The survival of motor neurons (SMN) protein, the product of the gene responsible for the motor neuron degenerative disease spinal muscular atrophy (SMA), is part of a large macromolecular complex. The SMN complex is localized in both the cytoplasm and the nucleus and contains SMN, Gemin2, Gemin3, Gemin4, Gemin5, and a few not yet identified proteins. The SMN complex plays a key role in the biogenesis of spliceosomal small nuclear ribonucleoproteins (snRNPs) and other ribonucleoprotein particles. As a step toward the complete characterization of the components of the SMN complex, we generated stable cell lines that express FLAG-tagged SMN or Gemin2 under the control of a tetracycline-inducible promoter. Native SMN complexes of identical protein composition to those isolated by immunoprecipitation with anti-SMN antibodies were purified by affinity chromatography from extracts of both cell lines. Here we report the identification by mass spectrometry of a novel protein component of the SMN complex termed Gemin6. Co-immunoprecipitation, immunolocalization, and in vitro binding experiments demonstrate that Gemin6 is a component of the SMN complex that localizes to gems and interacts with several Sm proteins of the spliceosomal snRNPs.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ So Denmark, Prot Interact Lab, Ctr Expt Bioinformat, DK-5230 Odense M, Denmark; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Southern Denmark; University of Southern Denmark	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Mann, Matthias/A-3454-2013; Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Dreyfuss, Gideon/D-1218-2013	Mann, Matthias/0000-0003-1292-4799; Rappsilber, Juri/0000-0001-5999-1310; Dreyfuss, Gideon/0000-0001-8129-8774; Pellizzoni, Livio/0000-0002-9168-5628				ANDRADE LEC, 1993, P NATL ACAD SCI USA, V90, P1947, DOI 10.1073/pnas.90.5.1947; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Hannus S, 2000, HUM MOL GENET, V9, P663, DOI 10.1093/hmg/9.5.663; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Jones KW, 2001, J BIOL CHEM, V276, P38645, DOI 10.1074/jbc.M106161200; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; Matera AG, 1998, AM J HUM GENET, V63, P317, DOI 10.1086/301992; Meister G, 2000, HUM MOL GENET, V9, P1977, DOI 10.1093/hmg/9.13.1977; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; Miguel-Aliaga I, 1999, HUM MOL GENET, V8, P2133, DOI 10.1093/hmg/8.12.2133; Miguel-Aliaga I, 2000, FEBS LETT, V486, P99, DOI 10.1016/S0014-5793(00)02243-2; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Owen N, 2000, HUM MOL GENET, V9, P675, DOI 10.1093/hmg/9.5.675; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Pellizzoni L, 2001, CURR BIOL, V11, P1079, DOI 10.1016/S0960-9822(01)00316-5; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Wang J, 2001, J BIOL CHEM, V276, P9599, DOI 10.1074/jbc.M009162200; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186	36	102	107	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7540	7545		10.1074/jbc.M110141200	http://dx.doi.org/10.1074/jbc.M110141200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11748230	hybrid			2022-12-27	WOS:000174104300100
J	Roth, W; Stenner-Liewen, F; Pawlowski, K; Godzik, A; Reed, JC				Roth, W; Stenner-Liewen, F; Pawlowski, K; Godzik, A; Reed, JC			Identification and characterization of DEDD2, a death effector domain-containing protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS; ACTIVATION; RECEPTOR; CASPASE-8; CELLS; INHIBITION; PEA-15; SUBSTRATE; MECHANISM; CLEAVAGE	A novel Death Effector Domain-containing protein was identified, DEDD2, which is closest in amino acid sequence homology to death effector domain-containing DNA-binding protein, DEDD. DEDD2 mRNA is expressed widely in adult human tissues with highest levels in liver, kidney, and peripheral blood leukocytes. DEDD2 interacts with FLIP, but not with Fas-associated death domain (FADD) or caspase-8. Overexpression of DEDD2 induces moderate apoptosis and results in substantial sensitization to apoptosis induced by Fas (CD95/APO-1), tumor necrosis factor-related apoptosis-inducing ligand (TRAIL, Apo2L), or FADD. In contrast, Bax- or staurosporine-mediated cell death is not affected by expression of DEDD2. Fluorescence microscopy showed that overexpressed DEDD2 translocates to the nucleus, which is dependent on the presence of a bipartite nuclear localization signal in the DEDD2 protein. Mutagenesis studies revealed that the translocation of the DED of DEDD2 to the nucleus is essential for its proapoptotic activity. These findings suggest that DEDD2 is involved in the regulation of nuclear events mediated by the extrinsic apoptosis pathway.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Pawłowski, Krzysztof/C-2949-2013; Godzik, Adam/AAW-1467-2020; Pawlowski, Krzysztof/E-3262-2012; Godzik, Adam/A-7279-2009	Pawłowski, Krzysztof/0000-0002-5367-0935; Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Stenner, Frank/0000-0003-4541-8817	NCI NIH HHS [CA 69381] Funding Source: Medline; NIGMS NIH HHS [GM 60554] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060554] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAUJO H, 1993, J BIOL CHEM, V268, P5911; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Casiano CA, 1996, J EXP MED, V184, P765, DOI 10.1084/jem.184.2.765; Chan PK, 1996, CANCER LETT, V100, P191, DOI 10.1016/0304-3835(95)04100-1; French LE, 1999, J EXP MED, V190, P891, DOI 10.1084/jem.190.7.891; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Griffith TS, 1998, J IMMUNOL, V161, P2833; Hackam AS, 2000, J BIOL CHEM, V275, P41299, DOI 10.1074/jbc.M008408200; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Irie Y, 2000, J BIOL CHEM, V275, P2647, DOI 10.1074/jbc.275.4.2647; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Knee DA, 2001, J BIOL CHEM, V276, P12718, DOI 10.1074/jbc.M010841200; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Leo CP, 1998, ENDOCRINOLOGY, V139, P4839, DOI 10.1210/en.139.12.4839; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li WZ, 2000, BIOINFORMATICS, V16, P1105, DOI 10.1093/bioinformatics/16.12.1105; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martelli AM, 2001, J CELL BIOCHEM, V82, P634, DOI 10.1002/jcb.1186; Nadano D, 2000, J BIOL CHEM, V275, P13967, DOI 10.1074/jbc.275.18.13967; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Ramos JW, 2000, MOL BIOL CELL, V11, P2863, DOI 10.1091/mbc.11.9.2863; Ramos JW, 1998, J BIOL CHEM, V273, P33897, DOI 10.1074/jbc.273.51.33897; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zheng LX, 2001, J BIOL CHEM, V276, P31945, DOI 10.1074/jbc.M102799200	32	33	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7501	7508		10.1074/jbc.M110749200	http://dx.doi.org/10.1074/jbc.M110749200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741985	hybrid			2022-12-27	WOS:000174104300096
J	Danielson, SR; Wong, A; Carelli, V; Martinuzzi, A; Schapira, AHV; Cortopassi, GA				Danielson, SR; Wong, A; Carelli, V; Martinuzzi, A; Schapira, AHV; Cortopassi, GA			Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; MITOCHONDRIAL-DNA; GANGLION-CELLS; MTDNA; COMPLEX; NEURORETINOPATHY; ACTIVATION; EXPRESSION; FEATURES; CASPASES	Three prevalent mitochondrial DNA pathogenic mutations at positions 11778, 3460, and 14484, which affect different subunits of Complex I, cause retinal ganglion cell death and optic nerve atrophy in Leber's hereditary optic neuropathy (LHON). The cell death is painless and without inflammation, consistent with an apoptotic mechanism. We have investigated the possibility that the LHON mutation confers a pro-apoptotic stimulus and have tested the sensitivity of osteosarcoma-derived cybrid cells carrying the most common and severe mutations (11778 and 3460) to cell death induced by Fas. We observed that LHON cybrids were sensitized to Fas-dependent death. Control cells that bear the same mitochondrial genetic background (the J haplogroup) without the pathogenic 11778 mutation are no more sensitive than other controls, indicating that increased Fas-dependent death in LHON cybrids was induced by the LHON pathogenic mutations. The type of death was apoptotic by several criteria, including induction by Fas, inhibition by the caspase inhibitor zVAD-fmk (zVal-Ala-Asp-fluoro-methyl ketone), activation of DEVDase activity (Asp-Glu-Val-Asp protease), specific cleavage of caspase-3, DNA fragmentation, and increased Annexin-V labeling. These data indicate that the most common and severe LHON pathogenic mutations 11778 and 3460 predispose cells to apoptosis, which may be relevant for the pathophysiology of cell death in LHON, and potential therapy.	Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; Univ Bologna, Inst Neurol, I-40123 Bologna, Italy; Conegliano Res Ctr, Sci Inst Eurgenio Medea, I-31015 Conegliano, Italy; Royal Free Hosp & Univ Coll, Med Sch, London NW3 2PF, England	University of California System; University of California Davis; University of Bologna; University of London; University College London	Cortopassi, GA (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA.	gacortopassi@ucdavis.edu	Martinuzzi, Andrea/AAC-3127-2022; Martinuzzi, Andrea/K-3887-2016; Schapira, Anthony H V/A-1245-2010	Martinuzzi, Andrea/0000-0002-0319-3579; Schapira, Anthony H V/0000-0002-3018-3966; CARELLI, VALERIO/0000-0003-4923-6404	NATIONAL EYE INSTITUTE [R01EY012245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016719, R01AG011967] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Brown MD, 1999, J NEUROL SCI, V165, P1, DOI 10.1016/S0022-510X(99)00087-8; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623; Chalmers RM, 1999, BBA-BIOENERGETICS, V1410, P147, DOI 10.1016/S0005-2728(98)00163-7; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Greil R, 1998, LEUKEMIA LYMPHOMA, V31, P477, DOI 10.3109/10428199809057607; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Howell N, 1997, J BIOENERG BIOMEMBR, V29, P165, DOI 10.1023/A:1022690030664; Howell N, 1999, INT REV CYTOL, V186, P49; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Levin LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P488, DOI 10.1001/archopht.1996.01100130484027; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LIEBERTHAL W, 1996, AM J PHYSIOL, V271, P477; MACKEY D, 1992, AM J HUM GENET, V51, P1218; MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8; Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223; SADUN AA, 1994, CLIN NEUROSCI, V2, P165; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Torroni A, 1997, AM J HUM GENET, V60, P1107; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; VERGANI L, 1995, BIOCHEM BIOPH RES CO, V210, P880, DOI 10.1006/bbrc.1995.1740; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Walsh GM, 1998, J IMMUNOL METHODS, V217, P153, DOI 10.1016/S0022-1759(98)00103-3; Wyllie A H, 1980, Int Rev Cytol, V68, P251	39	107	112	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5810	5815		10.1074/jbc.M110119200	http://dx.doi.org/10.1074/jbc.M110119200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741983	hybrid			2022-12-27	WOS:000173989200017
J	Lee, S; Kim, JH; Lee, CS; Kim, JH; Kim, YD; Heo, K; Ihara, Y; Goshima, Y; Suh, PG; Ryu, SH				Lee, S; Kim, JH; Lee, CS; Kim, JH; Kim, YD; Heo, K; Ihara, Y; Goshima, Y; Suh, PG; Ryu, SH			Collapsin response mediator protein-2 inhibits neuronal phospholipase D-2 activity by direct interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE COLLAPSE; ADP-RIBOSYLATION FACTOR; C-TERMINAL DOMAINS; KINASE-C; PC12 CELLS; ACTIN POLYMERIZATION; SEMAPHORIN-III; D ACTIVATION; RAT-BRAIN; ASSOCIATION	Although the functional significance of neuronal phospholipase D (PLD) is being recognized, little is known about its regulatory role in neuronal cells. To elucidate the regulatory mechanism of neuronal PLD, we investigated PLD2-binding neuronal protein from rat brain cytosol. During the fractionation of rat brain cytosol by four-column chromatography, a 62-kDa PLD2-interacting protein was detected by PLD2 overlay assay and identified as collapsin response mediator protein-2 (CRMP-2), which controls neuronal axon guidance and outgrowth. Using bacterially expressed glutathione S-transferase fusion proteins, we found that two regions (amino acids 65-192 (the phagocytic oxidase domain) and 724-825) of PLD2 and a single region (amino acids 243-300) of CRMP-2 are required for the direct binding of both proteins. A co-immunoprecipitation study in COS-7 cells also showed an in vivo interaction between CRMP-2 and PLD2. Interestingly, CRMP-2 was found to potently inhibit PLD2 activity in a concentration-dependent manner (IC50 = 30 nM). Overexpression studies also showed that CRMP-2 is an in vivo inhibitor of PLD2 in PC12 cells. Moreover, increasing the concentration of semaphorin 3A, one of the repulsive axon guidance cues, showed that PLD2 activity can be inhibited in PC12 cells. Immunocytochemistry further revealed that PLD2 is co-localized with CRMP-2 in the distal tips of neurites, its possible action site, in differentiated PC12 cells. Taken together, our results indicate that CRMP-2 may interact directly with and inhibit neuronal PLD2, suggesting that this inhibitory mode of regulation may play a role in neuronal pathfinding during the developmental stage.	Pohang Univ Sci & Technol, Div Mol & Life Sci, POSTECH, Pohang 790784, South Korea; Univ Tokyo, Fac Med, Dept Neuropathol, Tokyo 1130033, Japan; Yokohama City Univ, Sch Med, Dept Mol Pharmacol & Neurobiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi 3320012, Japan	Pohang University of Science & Technology (POSTECH); University of Tokyo; Yokohama City University; Japan Science & Technology Agency (JST)	Ryu, SH (corresponding author), Pohang Univ Sci & Technol, Div Mol & Life Sci, POSTECH, San 31 Hyojadong, Pohang 790784, South Korea.	sungho@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010	Kim, Jung Hwan/0000-0001-8548-4435; Ryu, Sung Ho/0000-0003-0913-3048				Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; BROWN HA, 1995, J BIOL CHEM, V270, P14935, DOI 10.1074/jbc.270.25.14935; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Cox DA, 1997, NEUROSCI LETT, V229, P37, DOI 10.1016/S0304-3940(97)00407-2; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; DANNIEL LW, 1999, BIOCHIM BIOPHYS ACTA, V1439, P265; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Fritsche J, 1999, MOL CELL NEUROSCI, V14, P398, DOI 10.1006/mcne.1999.0777; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; HA KS, 1994, BIOCHEM J, V303, P55, DOI 10.1042/bj3030055; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hayakawa K, 1999, NEUROSCI LETT, V265, P127, DOI 10.1016/S0304-3940(99)00228-1; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Hodgkin MN, 1999, BIOCHEM J, V339, P87, DOI 10.1042/0264-6021:3390087; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Iyer SS, 1999, J BIOL CHEM, V274, P2350, DOI 10.1074/jbc.274.4.2350; Jones D, 1999, BBA-MOL CELL BIOL L, V1439, P229, DOI 10.1016/S1388-1981(99)00097-9; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Kamata T, 1998, MOL BRAIN RES, V54, P219, DOI 10.1016/S0169-328X(97)00332-X; Kim JH, 1999, FEBS LETT, V454, P42, DOI 10.1016/S0014-5793(99)00745-0; Kim JH, 1998, FEBS LETT, V430, P231, DOI 10.1016/S0014-5793(98)00661-9; Kim JH, 1999, J IMMUNOL, V163, P5462; Kim Y, 2000, J BIOL CHEM, V275, P13621, DOI 10.1074/jbc.275.18.13621; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee S, 2001, J BIOL CHEM, V276, P28252, DOI 10.1074/jbc.M008521200; Lee SD, 2000, J NEUROCHEM, V75, P1053, DOI 10.1046/j.1471-4159.2000.0751053.x; Lee SD, 2000, NEUROSCI LETT, V294, P130, DOI 10.1016/S0304-3940(00)01563-9; Lee TG, 1997, BBA-LIPID LIPID MET, V1347, P199, DOI 10.1016/S0005-2760(97)00083-0; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Lukowski S, 1996, J BIOL CHEM, V271, P24164, DOI 10.1074/jbc.271.39.24164; Lukowski S, 1998, BIOCHEM BIOPH RES CO, V248, P278, DOI 10.1006/bbrc.1998.8942; Min DS, 1998, J BIOL CHEM, V273, P7044, DOI 10.1074/jbc.273.12.7044; Min DS, 2001, NEUROPHARMACOLOGY, V41, P384, DOI 10.1016/S0028-3908(01)00070-3; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Olson SC, 1996, CHEM PHYS LIPIDS, V80, P3, DOI 10.1016/0009-3084(96)02541-8; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Reza JN, 1999, MOL CELL NEUROSCI, V14, P317, DOI 10.1006/mcne.1999.0786; Sambrook J., 1989, IMMUNOLOGY, V2nd; SOBUE K, 1993, NEUROSCI RES, V18, P91, DOI 10.1016/0168-0102(93)90012-F; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Steed PM, 1996, BIOCHEMISTRY-US, V35, P5229, DOI 10.1021/bi952370j; Sung TC, 1999, J BIOL CHEM, V274, P3659, DOI 10.1074/jbc.274.6.3659; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang LH, 1997, J NEUROCHEM, V69, P2261; Xie Z, 2000, J BIOL CHEM, V275, P24962, DOI 10.1074/jbc.M909745199; Xie Z, 1998, J BIOL CHEM, V273, P34679, DOI 10.1074/jbc.273.52.34679; Zheng LX, 1997, P NATL ACAD SCI USA, V94, P1573, DOI 10.1073/pnas.94.4.1573	60	40	45	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6542	6549		10.1074/jbc.M108047200	http://dx.doi.org/10.1074/jbc.M108047200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741937	hybrid			2022-12-27	WOS:000173989200112
J	Smith, KE; Gu, C; Fagan, KA; Hu, B; Cooper, DMF				Smith, KE; Gu, C; Fagan, KA; Hu, B; Cooper, DMF			Residence of adenylyl cyclase type 8 in caveolae is necessary but not sufficient for regulation by capacitative Ca2+ entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C6-2B GLIOMA-CELLS; CARDIAC MYOCYTES; PLASMA-MEMBRANE; PROTEIN-KINASE; CATION ENTRY; CALCIUM; INHIBITION; RECEPTOR; CHANNELS; SITES	Ca2+-sensitive adenylyl cyclases (ACs) depend on capacitative Ca2+ entry (CCE) for their regulation. Residence of the endogenous Ca2+-inhibitable adenylyl cyclase of C6-2B glioma cells in cholesterol-enriched caveolae is essential for its regulation by CCE (Fagan, K. A., Smith, K. E., and Cooper, D. M. F. (2000) J. Biol. Chem. 275, 26530-26537). In the present study, we established that depletion of cellular cholesterol ablated the regulation by CCE of a Ca2+-stimulable adenylyl cyclase, AC8, heterologously expressed in HEK293 cells. We considered the possibility that a calmodulin-binding domain in the N terminus of AC8, which is not required for in vitro regulation by Ca2+, might play a targeting role. Deletion and mutation of the N terminus did attenuate the enzyme's sensitivity to CCE without altering its in vitro responsiveness to Ca2+/calmodulin. Both N terminus-deleted AC8 and wild type AC8 were expressed at the plasma membrane, as shown by imaging analysis of green fluorescence protein-tagged constructs. However, not only wild type AC8 but also the CCE-insensitive mutants occurred in caveolar fractions of the plasma membranes, even though a Ca2+-insensitive adenylyl cyclase, AC7, was excluded from caveolae. Finally, the AC8 mutants were no more responsive to nonphysiological elevation of Ca2+ than the wild type. We conclude that (i) not all adenylyl cyclases reside in caveolae, (ii) the calmodulin-binding domain in the N terminus of AC8 does not play a role in caveolar targeting, (iii) the N terminus does play a role in associating AC8 with factors that confer sensitivity to CCE, and (iv) residence of Ca2+-sensitive adenylyl cyclases in caveolae is essential but not sufficient for regulation by CCE.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Cooper, DMF (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Box C-236,4200 E 9th Ave, Denver, CO 80262 USA.	dermot.cooper@uchsc.edu	Gu, Chen/E-3163-2011; Hu, Biao/G-6084-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032483] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BLAU L, 1988, BIOCHEMISTRY-US, V27, P5661, DOI 10.1021/bi00415a040; BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995; Burnay MM, 1998, BIOCHEM J, V330, P21, DOI 10.1042/bj3300021; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Fagan KA, 2001, FEBS LETT, V500, P85, DOI 10.1016/S0014-5793(01)02564-9; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Goaillard JM, 2001, J PHYSIOL-LONDON, V530, P79, DOI 10.1111/j.1469-7793.2001.0079m.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu C, 2000, J BIOL CHEM, V275, P6980, DOI 10.1074/jbc.275.10.6980; Gu C, 1999, J BIOL CHEM, V274, P8012, DOI 10.1074/jbc.274.12.8012; Guillou JL, 1999, J BIOL CHEM, V274, P35539, DOI 10.1074/jbc.274.50.35539; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Kukkonen JP, 2001, CELL CALCIUM, V30, P117, DOI 10.1054/ceca.2001.0219; Lasley RD, 2000, J BIOL CHEM, V275, P4417, DOI 10.1074/jbc.275.6.4417; Lin S, 2000, J BIOL CHEM, V275, P17979, DOI 10.1074/jbc.275.24.17979; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Mahmoud SF, 2001, J CELL BIOL, V153, P339, DOI 10.1083/jcb.153.2.339; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Razani B, 1999, J BIOL CHEM, V274, P26353, DOI 10.1074/jbc.274.37.26353; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Schwencke C, 1999, MOL ENDOCRINOL, V13, P1061, DOI 10.1210/me.13.7.1061; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toya Y, 1998, ENDOCRINOLOGY, V139, P2025, DOI 10.1210/en.139.4.2025; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962	42	72	72	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6025	6031		10.1074/jbc.M109615200	http://dx.doi.org/10.1074/jbc.M109615200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744699	hybrid			2022-12-27	WOS:000173989200044
J	Gruninger-Leitch, F; Schlatter, D; Kung, E; Nelbock, P; Dobeli, H				Gruninger-Leitch, F; Schlatter, D; Kung, E; Nelbock, P; Dobeli, H			Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; HUMAN BRAIN; IDENTIFICATION; CLEAVAGE; PURIFICATION; FAMILY; REGION; SITE	The full-length and ectodomain forms of beta-site APP cleavage enzyme (BALE) have been cloned, expressed in Sf9 cells, and purified to homogeneity. This aspartic protease cleaves the amyloid precursor protein at the beta-secretase site, a critical step in the Alzheimer's disease pathogenesis. Comparison of BALE to other aspartic proteases such as cathepsin D and E, napsin A, pepsin, and renin revealed little similarity with respect to the substrate preference and inhibitor profile. On the other hand, these parameters are all very similar for the homologous enzyme BACE2. Based on a collection of decameric substrates, it was found that BACE has a loose substrate specificity and that the substrate recognition site in RACE extends over several amino acids. In common with the aspartic proteases mentioned above, BACE prefers a leucine residue at position P1. Unlike cathepsin D etc., BALE accepts polar or acidic residues at positions P2' and P1 but prefers bulky hydrophobic residues at position P3. BACE displays poor kinetic constants toward its known substrates (wild-type substrate, SEVKM down arrow DAEFR, K-m = 7 muM, K-cat = 0.002 s(-1); Swedish mutant, SEVNL down arrow DAEFR, K-m = 9 muM, K-cat = 0.02 s(-1)). A new substrate (VVEVDA down arrow AVTP, K-m = 1 muM, K-cat = 0.004) was identified by serendipity.	F Hoffmann La Roche & Co Ltd, CNS Res, CH-4070 Basel, Switzerland	Roche Holding	Dobeli, H (corresponding author), F Hoffmann La Roche & Co Ltd, CNS Res, Grenzacherstr 124, CH-4070 Basel, Switzerland.							Acquati F, 2000, FEBS LETT, V468, P59, DOI 10.1016/S0014-5793(00)01192-3; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Ermolieff J, 2000, BIOCHEMISTRY-US, V39, P12450, DOI 10.1021/bi001494f; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; Gruninger-Leitch F, 2000, NAT BIOTECHNOL, V18, P66, DOI 10.1038/71944; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; HILL J, 1993, FEBS LETT, V326, P101, DOI 10.1016/0014-5793(93)81770-Z; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hussain I, 2000, MOL CELL NEUROSCI, V16, P609, DOI 10.1006/mcne.2000.0884; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Marcinkeviciene J, 2001, J BIOL CHEM, V276, P23790, DOI 10.1074/jbc.M101896200; Mathews S, 1996, PROTEIN EXPRES PURIF, V7, P81, DOI 10.1006/prep.1996.0012; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Rosse G, 2000, J COMB CHEM, V2, P461, DOI 10.1021/cc000019y; Schauer-Vukasinovic V, 2000, EUR J BIOCHEM, V267, P2573, DOI 10.1046/j.1432-1327.2000.01268.x; Shi XP, 2001, J BIOL CHEM, V276, P10366, DOI 10.1074/jbc.M009200200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200	28	202	215	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4687	4693		10.1074/jbc.M109266200	http://dx.doi.org/10.1074/jbc.M109266200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741910	hybrid			2022-12-27	WOS:000173962900020
J	Wataya, T; Nunomura, A; Smith, MA; Siedlak, SL; Harris, PLR; Shimohama, S; Szweda, LI; Kaminski, MA; Avila, J; Price, DL; Cleveland, DW; Sayre, LM; Perry, G				Wataya, T; Nunomura, A; Smith, MA; Siedlak, SL; Harris, PLR; Shimohama, S; Szweda, LI; Kaminski, MA; Avila, J; Price, DL; Cleveland, DW; Sayre, LM; Perry, G			High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; IMMUNOCHEMICAL DETECTION; OXIDATIVE DAMAGE; END-PRODUCTS; LYSINE; ANTIBODIES; PATHOLOGY	Protein adducts of the lipid peroxidation product trans-4-hydroxy-2-nonenal (HIVE) are features of oxidative damage in neuronal cell bodies in Alzheimer's disease but are also seen in axons of normal as well as diseased individuals. In this study, focusing on the axons of the mouse sciatic nerve, we found that FINE adducts characterize axons of mice from birth to senility. Immunoblots of axonal proteins showed that FINE adducts are only detected in neurofilament heavy subunit (NFH) and, to a lesser extent, neurofilament medium subunit (NFM), both lysine-rich proteins, consistent with the adducts being limited to lysine residues. In vitro, FINE treatment of permeabilized sciatic nerve showed the same specificity, i.e. NFH and NFM are the only proteins that reacted with FINE, providing they are phosphorylated. Quantitative immunoblot analysis of two strains of mice ages 1-33 months showed that the levels of FINE adducts on NFH are consistent throughout life. Additionally, mice transgenic for human superoxide dismutase-1 with G85R mutation show no difference in FINE adduction to NFH compared with controls. Taken together, these studies indicate that FINE adduction to NFH is physiological, and its constancy from birth to senility as well as its dependence on phosphorylation argues that NFH and NFAT modification may play a role in protecting the membrane-rich axon from toxic aldehydes resulting from oxidative damage.	Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Kyoto Univ, Dept Neurol, Kyoto 6068507, Japan; Kyoto Univ, Dept Neurosurg, Kyoto 6068507, Japan; Asahikawa Med Coll, Dept Psychiat & Neurol, Asahikawa, Hokkaido 0788510, Japan; Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain; Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Univ Calif San Diego, Ludwig Inst, La Jolla, CA 92093 USA	Case Western Reserve University; Case Western Reserve University; Kyoto University; Kyoto University; Asahikawa Medical College; Autonomous University of Madrid; Johns Hopkins University; Johns Hopkins Medicine; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Perry, G (corresponding author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.		Smith, Mark A/A-9053-2009; Perry, George/A-8611-2009; Sayre, Lawrence M/C-8224-2011; Cleveland, Don/AAN-9783-2021; Avila, Jesus/I-2610-2015	Perry, George/0000-0002-6547-0172; Avila, Jesus/0000-0002-6288-0571; Cleveland, Don/0000-0002-1934-3682	NATIONAL INSTITUTE ON AGING [R01AG014249, R01AG009287] Funding Source: NIH RePORTER; NIA NIH HHS [AG09287, AG14249] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Good PF, 1996, AM J PATHOL, V149, P21; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee M, 2001, J NEUROCHEM, V78, P209, DOI 10.1046/j.1471-4159.2001.00417.x; MANETTO V, 1988, J NEUROPATH EXP NEUR, V47, P642, DOI 10.1097/00005072-198811000-00007; Montine TJ, 1996, AM J PATHOL, V148, P89; NADKARNI DV, 1995, CHEM RES TOXICOL, V8, P284, DOI 10.1021/tx00044a014; Nunomura A, 1999, J NEUROSCI, V19, P1959; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Sayre LM, 1997, J NEUROCHEM, V68, P2092; SAYRE LM, 1985, BRAIN RES REV, V10, P69, DOI 10.1016/0165-0173(85)90008-6; Sayre LM, 1996, CHEM RES TOXICOL, V9, P1194, DOI 10.1021/tx960094j; SCHECKET G, 1980, J NEUROCHEM, V35, P1335; SHAW G, 1991, NEURONAL CYTOSKELETO, P185; Smith MA, 1997, J NEUROSCI, V17, P2653; SMITH MA, 1995, J NEUROCHEM, V64, P2660; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsai L, 1998, P NATL ACAD SCI USA, V95, P7975, DOI 10.1073/pnas.95.14.7975; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; Xu GH, 2000, CHEM RES TOXICOL, V13, P406, DOI 10.1021/tx990200s; Xu GZ, 1999, J ORG CHEM, V64, P5732, DOI 10.1021/jo982523j	26	107	116	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4644	4648		10.1074/jbc.M110913200	http://dx.doi.org/10.1074/jbc.M110913200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733539	hybrid			2022-12-27	WOS:000173962900014
J	Vlamis-Gardikas, A; Potamitou, A; Zarivach, R; Hochman, A; Holmgren, A				Vlamis-Gardikas, A; Potamitou, A; Zarivach, R; Hochman, A; Holmgren, A			Characterization of Escherichia coli null mutants for glutaredoxin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; MIXED DISULFIDE; THIOREDOXIN; GLUTATHIONE; CYTOPLASM; PROTEINS	Three Escherichia coli glutaredoxins catalyze GSH-disulfide oxidoreductions, but the atypical 24-kDa glutaredoxin 2 (Grx2, grxB gene), in contrast to the 9-kDa glutaredoxin 1 (Grx1, grxA gene) and glutaredoxin 3 (Grx3, grxC gene), is not a hydrogen donor for ribonucleotide reductase. To improve the understanding of glutaredoxin function, a null mutant for grxB (grxB(-)) was constructed and combined with other mutations. Null mutants for grxB or all three glutaredoxin genes were viable in rich and minimal media with little changes in their growth properties. Expression of leaderless alkaline phosphatase showed that Grx1 and Grx2 (but not Grx3) contributed in the reduction of cytosolic protein disulfides. Moreover, Grx1 could catalyze disulfide formation in the oxidizing cytosol of combined null mutants for glutathione reductase and thioredoxin 1. grxB(-) cells were more sensitive to hydrogen peroxide and other oxidants and showed increased carbonylation of intracellular proteins, particularly in the stationary phase. Significant up-regulation of catalase activity was observed in null mutants for thioredoxin 1 and the three glutaredoxins, whereas up-regulation of glutaredoxin activity was observed in catalase-deficient strains with additional defects in the thioredoxin pathway. The expression of catalases is thus interconnected with the thioredoxin/glutaredoxin pathways in the antioxidant response.	Karolinska Inst, Med Nobel Inst Biochem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel	Karolinska Institutet; Tel Aviv University	Holmgren, A (corresponding author), Karolinska Inst, Med Nobel Inst Biochem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	arne.holmgren@mbb.ki.se	ZARIVACH, RAZ/F-1671-2012; Vlamis, Alexios/AAF-5152-2020; Fernandes, Aristi/D-2507-2015	ZARIVACH, RAZ/0000-0001-6543-0296; Vlamis, Alexios/0000-0001-5068-6459; 				Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Aslund F, 1996, J BIOL CHEM, V271, P6736, DOI 10.1074/jbc.271.12.6736; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; BRADFORD MM, 1976, ANAL BIOCHEM, V141, P515; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Daily D, 2001, J BIOL CHEM, V276, P21618, DOI 10.1074/jbc.M101400200; Daily D, 2001, J BIOL CHEM, V276, P1335, DOI 10.1074/jbc.M008121200; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; GOLDBERG I, 1989, BIOCHIM BIOPHYS ACTA, V991, P330, DOI 10.1016/0304-4165(89)90124-4; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; HUANG DS, 1992, J BIOL CHEM, V267, P2209; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Kodym R, 1999, J BIOL CHEM, V274, P5131, DOI 10.1074/jbc.274.8.5131; KULAKAUSKAS S, 1991, J BACTERIOL, V173, P2633, DOI 10.1128/jb.173.8.2633-2638.1991; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; LOEWEN PC, 1985, J BACTERIOL, V162, P661, DOI 10.1128/JB.162.2.661-667.1985; LOEWEN PC, 1984, J BACTERIOL, V157, P622, DOI 10.1128/JB.157.2.622-626.1984; LOEWEN PC, 1985, ARCH BIOCHEM BIOPHYS, V243, P144, DOI 10.1016/0003-9861(85)90782-9; Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Prieto-Alamo MJ, 2000, J BIOL CHEM, V275, P13398, DOI 10.1074/jbc.275.18.13398; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; RUSSEL M, 1990, J BACTERIOL, V172, P1923, DOI 10.1128/jb.172.4.1923-1929.1990; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; STORZ G, 1994, METHOD ENZYMOL, V236, P196; Takemoto T, 1998, FREE RADICAL BIO MED, V24, P556, DOI 10.1016/S0891-5849(97)00287-6; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; Xia B, 2001, J MOL BIOL, V310, P907, DOI 10.1006/jmbi.2001.4721; YONEI S, 1987, BIOCHEM BIOPH RES CO, V143, P638, DOI 10.1016/0006-291X(87)91401-X; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	47	39	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2002	277	13					10861	10868		10.1074/jbc.M111024200	http://dx.doi.org/10.1074/jbc.M111024200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	534WQ	11741965	hybrid			2022-12-27	WOS:000174613100016
J	Liao, HJ; Kume, T; McKay, C; Xu, MJ; Ihle, JN; Carpenter, G				Liao, HJ; Kume, T; McKay, C; Xu, MJ; Ihle, JN; Carpenter, G			Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-GAMMA; TYROSINE KINASE; GROWTH-FACTOR; VASCULAR ENDOTHELIUM; SIGNAL TRANSDUCTION; PLC-GAMMA; CELL; ACTIVATION; C-GAMMA-1; RECEPTOR	Mice nullizygous for Plcg1 cease growing at early to mid-gestation. An examination of carefully preserved wild-type embryos shows clear evidence of erythropoiesis, but erythropoiesis is not evident in Plcg1 nullizygous embryos at the same stage. The analyses of embryonic materials demonstrate that in the absence of Plcg1, erythroid progenitors cannot be detected in the yolk sac or embryo body by three different assays, burst-forming units, colony-forming units, and analysis for the developmental marker Ter119. However, non-erythroid granulocyte/macrophage colonies are produced by Plcg1 null embryos. Further analysis of these embryos demonstrates significantly diminished vasculogenesis in Plcg1 nullizygous embryos based on the lack of expression of the endothelial marker platelet endothelial cell adhesion molecule-1. In addition, Plcg1 nullizygous embryos express a greatly reduced level of vascular endothelial growth factor receptor-2/Flk-1, consistent with significantly impaired vasculogenesis and erythropoiesis. Interestingly, these early embryos do express phospholipase C-gamma2, however, it is unable to substitute for the absence of phospholipase C-gamma1, which can be detected in its tyrosine-phosphorylated state.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; St Jude Children's Research Hospital	Carpenter, G (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	graham.carpenter@mcmail.vanderbilt.edu			NCI NIH HHS [CA75195] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075195] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; Ausubel F., 1999, CURRENT PROTOCOLS MO; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Daniel TO, 2000, ANNU REV PHYSIOL, V62, P649, DOI 10.1146/annurev.physiol.62.1.649; DOWNING JR, 1989, EMBO J, V8, P3345, DOI 10.1002/j.1460-2075.1989.tb08496.x; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; GREGORY CJ, 1978, BLOOD, V51, P527; GREGORY CJ, 1977, BLOOD, V49, P855; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; HOGAN R, 1994, MANIPULATING MOUSE E, P24; HOMMA Y, 1989, BIOCHEM BIOPH RES CO, V164, P406, DOI 10.1016/0006-291X(89)91734-8; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Keller G, 1999, EXP HEMATOL, V27, P777, DOI 10.1016/S0301-472X(99)00024-7; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Lee YH, 1999, BBA-MOL CELL BIOL L, V1440, P235, DOI 10.1016/S1388-1981(99)00128-6; Liao HJ, 2001, J BIOL CHEM, V276, P8627, DOI 10.1074/jbc.C100030200; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; RHEE SG, 1991, BIOCHEM SOC T, V19, P337, DOI 10.1042/bst0190337; Roche S, 1996, EMBO J, V15, P4940, DOI 10.1002/j.1460-2075.1996.tb00874.x; Sawano A, 1997, BIOCHEM BIOPH RES CO, V238, P487, DOI 10.1006/bbrc.1997.7327; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shirane M, 2001, DEVELOPMENT, V128, P5173; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Thackeray JR, 1998, DEVELOPMENT, V125, P5033; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang S, 1998, FEBS LETT, V441, P261, DOI 10.1016/S0014-5793(98)01518-X; Wang XT, 2001, J BIOL CHEM, V276, P28364, DOI 10.1074/jbc.M102693200; Wang ZX, 1998, MOL CELL BIOL, V18, P590, DOI 10.1128/MCB.18.1.590; WONG PMC, 1986, BLOOD, V67, P716	39	103	110	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9335	9341		10.1074/jbc.M109955200	http://dx.doi.org/10.1074/jbc.M109955200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11744703	hybrid			2022-12-27	WOS:000174400600081
J	Dahan, I; Issaeva, I; Gorzalczany, Y; Sigal, N; Hirshberg, M; Pick, E				Dahan, I; Issaeva, I; Gorzalczany, Y; Sigal, N; Hirshberg, M; Pick, E			Mapping of functional domains in the p22(phox) subunit of flavocytochrome b(559) participating in the assembly of the NADPH oxidase complex by "peptide walking"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; RESPIRATORY BURST OXIDASE; CHRONIC GRANULOMATOUS-DISEASE; DEPENDENT SUPEROXIDE PRODUCTION; NEUTROPHIL CYTOCHROME-B; PHAGE-DISPLAY LIBRARIES; SODIUM DODECYL-SULFATE; SRC HOMOLOGY-3 DOMAINS; SH3 DOMAIN; ACTIVATION DOMAIN	The superoxide-generating NADPH oxidase complex of phagocytes consists of a membranal heterodimeric flavocytochrome (cytochrome b(559)), composed of gp91(phox) and p22(phox) subunits, and four cytosolic proteins, p47(phox), p67(phox), p40(phox), and the small GTPase Rae (1 or 2). All redox stations involved in electron transport from NADPH to oxygen are located in gp91(phox). NADPH oxidase activation is the consequence of assembly of cytochrome b(559) with cytosolic proteins, a process reproducible in a cell-free system, consisting of phagocyte membranes, and recombinant cytosolic components, activated by an anionic amphiphile. p22(phox), is believed to act as a linker between the cytosolic components and gp91(phox). We applied "peptide walking" to mapping of domains in p22(phox) participating in NADPH oxidase assembly. Ninety one synthetic overlapping pentadecapeptides, spanning the p22(phox) sequence, were tested for the ability to inhibit NADPH oxidase activation in the cell-free system and to bind individual cytosolic NADPH oxidase components. We conclude the following. 1) The p22(phox) subunit of cytochrome b(559) serves as an anchor for both p47(phox) and p67(phox). 2) p47(phox) binds not only to the proline-rich region, located at residues 151-160 in the cytosolic C terminus of p22(phox), but also to a domain (residues 51-63) located on a loop exposed to the cytosol. 3) p67(phox) shares with p47(phox), the ability to bind to the proline-rich region (residues 151-160) and also binds to two additional domains, in the cytosolie loop (residues 81-91) and at the start of the cytosolic tail (residues 111-115). 4) The binding affinity of p67(phox),, for p22(phox), peptides is lower than that of p47(phox). 5) Binding of both p47(phox) and p67(phox) to proline-rich p22(phox), peptides occurs in the absence of an anionic amphiphile. A revised membrane topology model of p22(phox) is proposed, the core of which is the presence of a functionally important cytosolic loop (residues 51-91).	Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, Julius Friedrich Cohnheim Minerva Ctr Phagocyte R, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, Ela Kodesz Inst Host Def Infect Dis, IL-69978 Tel Aviv, Israel; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; University of Cambridge	Pick, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, Julius Friedrich Cohnheim Minerva Ctr Phagocyte R, IL-69978 Tel Aviv, Israel.		Pick, Edgar/B-1795-2008	Pick, Edgar/0000-0003-4625-3233				ABO A, 1992, J BIOL CHEM, V267, P16767; Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; Burritt JB, 1998, J BIOL CHEM, V273, P24847, DOI 10.1074/jbc.273.38.24847; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; Dang PMC, 2001, P NATL ACAD SCI USA, V98, P3001, DOI 10.1073/pnas.061029698; Davis AR, 1998, J LEUKOCYTE BIOL, V64, P114, DOI 10.1002/jlb.64.1.114; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; DELEO FR, 1995, P NATL ACAD SCI USA, V92, P7110, DOI 10.1073/pnas.92.15.7110; deMendez I, 1997, MOL CELL BIOL, V17, P2177, DOI 10.1128/MCB.17.4.2177; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; FINAN P, 1994, J BIOL CHEM, V269, P13752; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Hata K, 1998, J BIOL CHEM, V273, P4232, DOI 10.1074/jbc.273.7.4232; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; HOPKINS PJ, 1992, CLIN LAB MED, V12, P277, DOI 10.1016/S0272-2712(18)30516-X; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; JOSEPH G, 1995, J BIOL CHEM, V270, P29079, DOI 10.1074/jbc.270.49.29079; JOSEPH G, 1994, J BIOL CHEM, V269, P29024; Koshkin V, 1996, J BIOL CHEM, V271, P30326, DOI 10.1074/jbc.271.48.30326; Koshkin V, 1997, BBA-BIOENERGETICS, V1319, P139, DOI 10.1016/S0005-2728(96)00154-5; KRECK ML, 1994, J BIOL CHEM, V269, P4161; Lambeth JD, 2000, J BIOCHEM MOL BIOL, V33, P427; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LETO TL, 1991, J BIOL CHEM, V266, P19812; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Leto TL., 1999, INFLAMMATION BASIC P, P769; LEUSEN JHW, 1994, J EXP MED, V180, P2329, DOI 10.1084/jem.180.6.2329; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; Morozov I, 1998, J BIOL CHEM, V273, P15435, DOI 10.1074/jbc.273.25.15435; NAKANISHI A, 1992, J BIOL CHEM, V267, P19072; Nauseef WM, 1999, P ASSOC AM PHYSICIAN, V111, P373, DOI 10.1111/paa.1999.111.5.373; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; PARK MY, 1994, BIOCHEM BIOPH RES CO, V204, P924, DOI 10.1006/bbrc.1994.2548; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Rae J, 2000, BLOOD, V96, P1106, DOI 10.1182/blood.V96.3.1106.015k44_1106_1112; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; SHPUNGIN S, 1989, J BIOL CHEM, V264, P9195; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; SUMIMOTO H, 1997, INT S MEMBR PROT STR, P235; Toporik A, 1998, BIOCHEMISTRY-US, V37, P7147, DOI 10.1021/bi9800404; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993	54	69	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8421	8432		10.1074/jbc.M109778200	http://dx.doi.org/10.1074/jbc.M109778200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11733522	hybrid			2022-12-27	WOS:000174268000102
J	Souza, SC; Muliro, KV; Liscum, L; Lien, P; Yamamoto, MT; Schaffer, JE; Dallal, GE; Wang, XZ; Kraemer, FB; Obin, M; Greenberg, AS				Souza, SC; Muliro, KV; Liscum, L; Lien, P; Yamamoto, MT; Schaffer, JE; Dallal, GE; Wang, XZ; Kraemer, FB; Obin, M; Greenberg, AS			Modulation of hormone-sensitive lipase and protein kinase A-mediated lipolysis by perilipin A in an adenoviral reconstituted system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	60th Scientific Sessions of the American-Diabetes-Association	JUN 09-13, 2000	San Antonio, TX	Amer Diabet Assoc			NECROSIS-FACTOR-ALPHA; DIFFERENTIATION-RELATED PROTEIN; LIPID DROPLETS; DENSITY-LIPOPROTEIN; BRL 49653; STORAGE; EXPRESSION; PHOSPHORYLATION; TRANSLOCATION; FIBROBLASTS	Perilipin (Peri) A is a phosphoprotein located at the surface of intracellular lipid droplets in adipocytes. Activation of cyclic AMP-dependent protein kinase (PKA) results in the phosphorylation of Peri A and hormone-sensitive lipase (HSL), the predominant lipase in adipocytes, with concurrent stimulation of adipocyte lipolysis. To investigate the relative contributions of Peri A and HSL in basal and PKA-mediated lipolysis, we utilized NIH 3T3 fibroblasts lacking Peri A and HSL but stably overexpressing acyl-CoA synthetase 1 (ACS1) and fatty acid transport protein I (FATP1). When incubated with exogenous fatty acids, ACS1/FATP1 cells accumulated 5 times more triacylglycerol (TG) as compared with NIH 3T3 fibroblasts. Adenoviral-mediated expression of Peri A in ACS1/FATP1 cells enhanced TG accumulation and inhibited lipolysis, whereas expression of HSL fused to green fluorescent protein (GFPHSL) reduced TG accumulation and enhanced lipolysis. Forskolin treatment induced Peri A hyperphosphorylation and abrogated the inhibitory effect of Peri A on lipolysis. Expression of a mutated Peri ADelta3 (Ser to Ala substitutions at PKA consensus sites Ser-81, Ser-222, and Ser-276) reduced Peri A hyperphosphorylation and blocked constitutive and forskolin-stimulated lipolysis. Thus, perilipin expression and phosphorylation state are critical regulators of lipid storage and hydrolysis in ACSI/FATP1 cells.	Tufts Univ, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; Washington Univ, Dept Med, St Louis, MO 63110 USA; Washington Univ, Dept Mol Biol, St Louis, MO 63110 USA; Washington Univ, Dept Pharmacol, St Louis, MO 63110 USA; Massachusetts Gen Hosp, Nessel Gene Therapy Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med & Mol Biol, Boston, MA 02114 USA; Stanford Univ, Dept Med, Div Endocrinol, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, Stanford, CA 94305 USA; Tufts Univ New England Med Ctr, Div Endocrinol Metab & Mol Med, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA); Tufts University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Tufts Medical Center	Greenberg, AS (corresponding author), Tufts Univ, USDA, Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	agreenberg@hnrc.tufts.edu	Kraemer, Fredric/AAC-3633-2019	Kraemer, Fredric/0000-0003-2468-7807	NIDDK NIH HHS [DK 46942, P30 DK 34928, DK 50647] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046942, P30DK034928, R01DK050647] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; ARNER P, 1988, DIABETES METAB REV, V4, P507; BARBER T, 1995, MOL BIOL CELL, V6, P2544; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; BRASAEMLE D, 2000, BIOCHIM BIOPHYS ACTA, P251; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Chaudhry A, 1999, AM J PHYSIOL-REG I, V277, pR147, DOI 10.1152/ajpregu.1999.277.1.R147; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; COPPACK SW, 1994, J LIPID RES, V35, P177; deVargas LM, 1997, J BIOL CHEM, V272, P26573, DOI 10.1074/jbc.272.42.26573; DiRusso CC, 2000, EUR J BIOCHEM, V267, P4422, DOI 10.1046/j.1432-1327.2000.01489.x; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Frolov A, 2000, J BIOL CHEM, V275, P12769, DOI 10.1074/jbc.275.17.12769; Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825; Gargiulo CE, 1999, J LIPID RES, V40, P881; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; HILAIRE N, 1995, J BIOL CHEM, V270, P27027, DOI 10.1074/jbc.270.45.27027; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Rosenbaum SE, 1998, MOL ENDOCRINOL, V12, P1150, DOI 10.1210/me.12.8.1150; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Souza SC, 1998, DIABETES, V47, P691, DOI 10.2337/diabetes.47.4.691; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Steinberg D, 1975, Adv Cyclic Nucleotide Res, V5, P549; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Wang XZ, 2000, J VIROL, V74, P11296, DOI 10.1128/JVI.74.23.11296-11303.2000	36	197	206	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8267	8272		10.1074/jbc.M108329200	http://dx.doi.org/10.1074/jbc.M108329200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	528WR	11751901	hybrid			2022-12-27	WOS:000174268000083
J	Hevko, JM; Murphy, RC				Hevko, JM; Murphy, RC			Formation of murine macrophage-derived 5-oxo-7-glutathionyl-8,11,14-eicosatrienoic acid (FOG(7)) is catalyzed by leukotriene C-4 synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-TRANSFERASES; HUMAN-PLATELETS; 5-OXO-6,8,11,14-EICOSATETRAENOIC ACID; METABOLISM; EXPRESSION; IDENTIFICATION; PURIFICATION; SUBSTANCE; OXIDATION; PROTEIN	5-Oxo-7-glutathionyl-8,11,14-eicosatrienoic acid (FOG(7)), a biologically active glutathione (GSH) adduct of the eicosanoid 5-oxo-eicosatrienoic acid (5-oxoETE), is the major metabolite formed within the murine peritoneal macrophage. The conjugation of GSH to electrophilic 5-oxoETE in vitro was found to be catalyzed by both soluble glutathione S-transferase and membrane-bound leukotriene C-4 (LTC4) synthase. The cytosolic glutathione 8-transferase-catalyzed products were not biologically active; however, the adduct formed from recombinant LTC4 synthase had identical mass spectrometric properties and biological activity to the macrophage-derived FOG(7). The biosynthesis of FOG(7) in the macrophage was inhibited by MR-886, a known inhibitor of LTC4 synthase, suggesting that this nuclear membrane-bound enzyme might be responsible for GSH conjugation to 5-oxoETE in the intact cell. Subcellular fractionation revealed that the microsomal fraction from the murine macrophage contained the enzyme responsible for FOG(7) biosynthesis. Western blot analysis confirmed the presence of LTC4 synthase in the microsomal fraction that did not catalyze conjugation of GSH to 1-chloro-2,4-dinitrobenzene, indicating an absence of microsomal glutathione S-transferase activity. These results suggest that LTC4 synthase, thought to be specific for the conjugation of GSH to LTA(4), can also recognize 5-oxoETE as an electrophilic substrate.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA	National Jewish Health	Murphy, RC (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Cell Biol, 1400 Jackson St, Denver, CO 80206 USA.	murphyr@njc.org			NHLBI NIH HHS [HL 36577, HL 64030] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064030, P01HL036577] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABE M, 1992, PROSTAGLANDINS LEUKO, V45, P1; ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; BACH MK, 1984, J ALLERGY CLIN IMMUN, V74, P353, DOI 10.1016/0091-6749(84)90129-5; Bowers RC, 2000, J BIOL CHEM, V275, P29931, DOI 10.1074/jbc.C000502200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTTERFIELD JH, 1995, SAMTERS IMMUNOLOGIC, P501; CARRIER DJ, 1988, PROSTAG LEUKOTR ESS, V34, P27, DOI 10.1016/0952-3278(88)90021-X; DENZLINGER C, 1986, J BIOL CHEM, V261, P5601; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HABIB A, 1992, ARCH BIOCHEM BIOPHYS, V298, P544, DOI 10.1016/0003-9861(92)90448-6; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Haeggstrom JZ, 1999, CLIN REV ALLERG IMMU, V17, P111, DOI 10.1007/BF02737600; Hevko JM, 2001, J PHARMACOL EXP THER, V296, P293; HOLTZMAN MJ, 1991, AM REV RESPIR DIS, V143, P188, DOI 10.1164/ajrccm/143.1.188; HOWARD TH, 1985, J CELL BIOL, V101, P1078, DOI 10.1083/jcb.101.3.1078; HUMES JL, 1986, BIOCHEM J, V233, P199, DOI 10.1042/bj2330199; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Jakobsson PJ, 1996, J BIOL CHEM, V271, P22203, DOI 10.1074/jbc.271.36.22203; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Khaselev N, 2000, FREE RADICAL BIO MED, V29, P620, DOI 10.1016/S0891-5849(00)00361-0; Lam BK, 2000, AM J RESP CRIT CARE, V161, pS16, DOI 10.1164/ajrccm.161.supplement_1.ltta-4; Lam BK, 1996, EUR J BIOCHEM, V238, P606, DOI 10.1111/j.1432-1033.1996.0606w.x; Lee SH, 1999, BBA-GENE STRUCT EXPR, V1446, P389, DOI 10.1016/S0167-4781(99)00112-8; Leff AR, 2001, ANN ALLERG ASTHMA IM, V86, P4, DOI 10.1016/S1081-1206(10)62305-8; MACLOUF J, 1990, BLOOD, V76, P1838; MACLOUF JA, 1988, J BIOL CHEM, V263, P174; Martin LB, 1996, INT ARCH ALLERGY IMM, V109, P207, DOI 10.1159/000237239; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; NICHOLSON DW, 1992, EUR J BIOCHEM, V209, P725, DOI 10.1111/j.1432-1033.1992.tb17341.x; NICHOLSON DW, 1992, J BIOL CHEM, V267, P17849; PATSCHEKE H, 1981, HAEMOSTASIS, V10, P14; PENROSE JF, 1992, P NATL ACAD SCI USA, V89, P11603, DOI 10.1073/pnas.89.23.11603; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; POWELL WS, 1994, J BIOL CHEM, V269, P25373; POWELL WS, 1992, J BIOL CHEM, V267, P19233; Samuelsson B, 2000, AM J RESP CRIT CARE, V161, pS2, DOI 10.1164/ajrccm.161.supplement_1.ltta-1; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Scoggan KA, 1997, J BIOL CHEM, V272, P10182; Sjostrom M, 2001, EUR J BIOCHEM, V268, P2578, DOI 10.1046/j.1432-1327.2001.02142.x; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055	42	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7037	7043		10.1074/jbc.M108942200	http://dx.doi.org/10.1074/jbc.M108942200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11748223	hybrid			2022-12-27	WOS:000174104300038
J	Qu, DB; Li, Q; Lim, HY; Cheung, NS; Li, R; Wang, JH; Qi, RZ				Qu, DB; Li, Q; Lim, HY; Cheung, NS; Li, R; Wang, JH; Qi, RZ			The protein SET binds the neuronal Cdk5 activator p35(nck5a) and modulates Cdk5/p35(nck5a) activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; BRAIN-SPECIFIC ACTIVATOR; PHOSPHATASE 2A; BOVINE BRAIN; MYELOID LEUKEMOGENESIS; POLYACRYLAMIDE GELS; FUNCTIONAL DOMAINS; PUTATIVE ONCOGENE; NEURITE OUTGROWTH; CDC2-LIKE KINASE	The neuronal Cdk5 kinase is composed of the catalytic subunit Cdk5 and the activator protein p35(nck5alpha) or its isoform, p39(nck5ai). To identify novel p35(nck5alpha) - and p39(nck5alphai)-binding proteins, fragments of p35(nck5alpha) and p39(nck5alphai) were utilized in affinity isolation of binding proteins from rat brain homogenates, and the isolated proteins were identified using mass spectrometry. With this approach, the nuclear protein SET was shown to interact with the N-terminal regions of p35(nck5alpha) and p39(nck5alphai). Our detailed characterization showed that the SET protein formed a complex with Cdk5/p35(nck5alpha) through its binding to p35(nck5alpha). The p35(nck5alpha)-interacting region was mapped to a predicted a-helix in SET. When cotransfected into COS-7 cells, SET and p35(nck5alpha) displayed overlapping intracellular distribution in the nucleus. The nuclear co-localization was corroborated by immunostaining data of endogenous SET and Cdk5/p35(nck5alpha) from cultured cortical neurons. Finally, we demonstrated that the activity of Cdk5/p35(nck5alpha), but not that of Cdk5/p25(nck5alpha) was enhanced upon binding to the SET protein. The tail region of SET, which is rich in acidic residues, is required for the stimulatory effect on Cdk5/p25(nck5alpha).	Inst Mol & Cell Biol, Proteom Grp, Singapore 117609, Singapore; Natl Univ Singapore, Dept Biochem, Singapore 119260, Singapore; Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Hong Kong University of Science & Technology	Qi, RZ (corresponding author), Inst Mol & Cell Biol, Proteom Grp, 30 Med Dr, Singapore 117609, Singapore.	mcbqrz@imcb.nus.edu.sg	Qu, Dianbo/C-5121-2011; , Dianbo/AAU-8480-2021	, Dianbo/0000-0002-0435-9585; Qi, Robert Zhong/0000-0001-5596-8172; Lim, Hui-Ying/0000-0001-8084-6337				ADACHI Y, 1994, J BIOL CHEM, V269, P2258; BEAUDETTE KN, 1993, J BIOL CHEM, V268, P20825; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cheung NS, 2000, J NEUROCHEM, V74, P1613, DOI 10.1046/j.1471-4159.2000.0741613.x; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; Chou KC, 1999, BIOCHEM BIOPH RES CO, V259, P420, DOI 10.1006/bbrc.1999.0792; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; EARNSHAW WC, 1987, J CELL BIOL, V105, P1479, DOI 10.1083/jcb.105.4.1479; Estanyol JM, 1999, J BIOL CHEM, V274, P33161, DOI 10.1074/jbc.274.46.33161; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; Homayouni R, 2000, CURR BIOL, V10, pR331, DOI 10.1016/S0960-9822(00)00459-0; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Ino H, 1996, BRAIN RES, V732, P179, DOI 10.1016/0006-8993(96)00523-9; ISHIGURO K, 1994, FEBS LETT, V342, P203, DOI 10.1016/0014-5793(94)80501-6; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Lee KY, 1996, J BIOL CHEM, V271, P1538, DOI 10.1074/jbc.271.3.1538; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Lim HY, 2001, BIOCHEM BIOPH RES CO, V285, P77, DOI 10.1006/bbrc.2001.5086; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Paglini G, 2001, EUR J BIOCHEM, V268, P1528, DOI 10.1046/j.1432-1033.2001.02023.x; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Poon RYC, 1997, J BIOL CHEM, V272, P5703, DOI 10.1074/jbc.272.9.5703; Qi Z, 1998, J BIOL CHEM, V273, P2329, DOI 10.1074/jbc.273.4.2329; Qi Z, 1998, FEBS LETT, V423, P227, DOI 10.1016/S0014-5793(98)00096-9; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tang DM, 1997, J BIOL CHEM, V272, P12318, DOI 10.1074/jbc.272.19.12318; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; VEERANNA, 1995, J NEUROCHEM, V64, P2681; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	53	56	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7324	7332		10.1074/jbc.M107270200	http://dx.doi.org/10.1074/jbc.M107270200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741927	hybrid			2022-12-27	WOS:000174104300075
J	Singh, SK; Miller, SP; Dean, A; Banaszak, LJ; LaPorte, DC				Singh, SK; Miller, SP; Dean, A; Banaszak, LJ; LaPorte, DC			Bacillus subtilis isocitrate dehydrogenase - A substrate analogue for Escherichia coli isocitrate dehydrogenase kinase/phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; ATP-BINDING-SITE; KINASE PHOSPHATASE; ACTIVE-SITE; PROTEIN DATABASE; PHOSPHORYLATION; MECHANISM; ENZYME; IDENTIFICATION; INACTIVATION	In Escherichia coli, the homodimeric Krebs cycle enzyme isocitrate dehydrogenase (EcIDH) is regulated by reversible phosphorylation of a sequestered active site serine. The phosphorylation cycle is catalyzed by a bifunctional protein, IDH kinase/phosphatase (IDH-K/P). To better understand the nature of the interaction between EcIDH and IDH-K/P, we have examined the ability of an IDH homologue from Bacillus subtilis (BsIDH) to serve as a substrate for the kinase and phosphatase activities. BsIDH exhibits extensive sequence and structural similarities with EcIDH, particularly around the phosphorylated serine. Our previous crystallographic analysis revealed that the active site architecture of these two proteins is almost completely conserved. We now expand the comparison to include a number of biochemical properties. Both IDHs display nearly equivalent steady-state kinetic parameters for the dehydrogenase reaction. Both proteins are also phosphorylated by IDH-K/P in the same ratio (1 mole of phosphate per mole of monomer), and this stoichiometric phosphorylation correlates with an equivalent inhibition of IDH activity. Furthermore, tandem electrospray mass spectrometry demonstrates that BsIDH, like EcIDH, is phosphorylated on the corresponding active site serine residue (Ser-104). Despite the high degree of sequence, functional, and structural congruence between these two proteins, BsIDH is surprisingly a much poorer substrate of IDH-K/P than is EcIDH, with Michaelis constants for the kinase and phosphatase activities elevated by 60- and 3,450-fold, respectively. These drastically disparate values might result from restricted access to the active site cavity and/or from the lack of a potential docking site for IDH-K/P.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Biol Proc Technol Inst, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	LaPorte, DC (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	david-l@mail.ahc.umn.edu						BENNETT PM, 1975, J GEN MICROBIOL, V87, P37, DOI 10.1099/00221287-87-1-37; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; Cherbavaz DB, 2000, J MOL BIOL, V295, P377, DOI 10.1006/jmbi.1999.3195; DEAN AM, 1990, SCIENCE, V249, P1044, DOI 10.1126/science.2204110; DEAN AM, 1989, J BIOL CHEM, V264, P20482; DEAN AM, 1993, BIOCHEMISTRY-US, V32, P9302, DOI 10.1021/bi00087a007; DeGnore JP, 1998, J AM SOC MASS SPECTR, V9, P1175, DOI 10.1016/S1044-0305(98)00088-9; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FinerMoore J, 1997, BIOCHEMISTRY-US, V36, P13890, DOI 10.1021/bi9711691; GARNAK M, 1979, SCIENCE, V203, P1111, DOI 10.1126/science.34215; GARNAK M, 1979, J BIOL CHEM, V254, P7915; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; HURLEY JH, 1990, J BIOL CHEM, V265, P3599; IKEDA T, 1991, J BACTERIOL, V173, P1801, DOI 10.1128/jb.173.5.1801-1806.1991; IKEDA TP, 1992, J BACTERIOL, V174, P1414, DOI 10.1128/jb.174.4.1414-1416.1992; KORNBERG HL, 1966, BIOCHEM J, V99, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miller SP, 1996, J BIOL CHEM, V271, P19124, DOI 10.1074/jbc.271.32.19124; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Segel IH, 1975, ENZYME KINETICS BEHA; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; Siuzdak G., 1996, MASS SPECTROMETRY BI; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; STUELAND CS, 1987, J BIOL CHEM, V262, P16095; STUELAND CS, 1989, J BIOL CHEM, V264, P13775; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; VARELA I, 1988, FEBS LETT, V231, P361, DOI 10.1016/0014-5793(88)80850-0; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang XL, 1998, ANAL CHEM, V70, P2050, DOI 10.1021/ac971207m	37	27	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7567	7573		10.1074/jbc.M107908200	http://dx.doi.org/10.1074/jbc.M107908200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751849	hybrid			2022-12-27	WOS:000174104300103
J	Anselmo, AN; Bumeister, R; Thomas, JM; White, MA				Anselmo, AN; Bumeister, R; Thomas, JM; White, MA			Critical contribution of linker proteins to Raf kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KSR-1 GENE ENCODES; MAP KINASE; SIGNAL-TRANSDUCTION; C-ELEGANS; PLASMA-MEMBRANE; GROWTH-FACTOR; BINDING; MEK; ASSOCIATION; CASCADE	Genetic analysis of Ras signaling has unveiled the participation of non-enzymatic accessory proteins in signal transmission. These proteins, KSR, CNK, and Sur-8, can interact with multiple core components of the Ras/MAP kinase cascade and may contribute to the structural organization of this cascade. However, the precise biochemical nature of the contribution of these proteins to Ras signaling is currently unknown. Here we show directly that CNK and KSR are required for stimulus dependent Raf kinase activation. CNK is required for membrane recruitment of Raf, while KSR is likely required to couple Raf to upstream kinases. These results demonstrate that CNK and KSR are integral components of the cellular machinery mediating Raf activation.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75216 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	White, MA (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75216 USA.	michael.white@utsouthwestern.edu			NATIONAL CANCER INSTITUTE [R01CA071443] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chiloeches A, 1999, J BIOL CHEM, V274, P19762, DOI 10.1074/jbc.274.28.19762; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li WQ, 2000, GENE DEV, V14, P895; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Mineo C, 1997, J BIOL CHEM, V272, P10345; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sternberg PW, 1998, CELL, V95, P447, DOI 10.1016/S0092-8674(00)81612-8; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Therrien M, 1998, CELL, V95, P343, DOI 10.1016/S0092-8674(00)81766-3; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; Xing HR, 2001, J BIOL CHEM, V276, P9733, DOI 10.1074/jbc.M008096200; Yao I, 2000, BIOCHEM BIOPH RES CO, V270, P538, DOI 10.1006/bbrc.2000.2475; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X	38	50	55	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5940	5943		10.1074/jbc.M110498200	http://dx.doi.org/10.1074/jbc.M110498200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741918	hybrid			2022-12-27	WOS:000173989200032
J	Guo, Q; Corbett, JT; Yue, GH; Fann, YC; Qian, SY; Tomer, KB; Mason, RP				Guo, Q; Corbett, JT; Yue, GH; Fann, YC; Qian, SY; Tomer, KB; Mason, RP			Electron spin resonance investigation of semiquinone radicals formed from the reaction of ubiquinone 0 with human oxyhemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; VITAMIN-E HOMOLOG; RESPIRATORY-CHAIN; SUPEROXIDE ANION; COENZYME Q(0); GLUTATHIONE; HEMOGLOBIN; ANTIOXIDANT; OXIDATION; QUINONES	The redox properties and thiol reactivity of quinones play critical roles in their therapeutic and toxicological properties. The present study was undertaken to investigate the binding activity of ubiquinone 0 (UQ(0)) to human oxyhemoglobin (HbO(2)) using electron spin resonance (ESR). Addition of UQ(0) to HbO(2) resulted in the immediate detection of a five-line ESR spectrum characteristic of the semiquinone radical of UQ(0) (UQ ((0)) over bar). With time the HbO(2) adduct with UQ(0), which was characterized by a broad immobilized ESR spectrum, was gradually formed. Matrix-assisted laser desorption/ionization time-of-flight mass spectra analysis showed that UQ(0) bound to the beta-chain of HbO(2). Superoxide dismutase dose-dependently suppressed the intensity of the broad spectrum and accelerated its formation. However, N-ethylmaleimide, a thiol-blocking agent, completely eliminated its formation. The nonspecific protease mixture pronase also prevented its formation and resulted in the gradual appearance of a 4-line spectrum from the 5-line spectrum of UQ ((0)) over bar. The structure of the species responsible for the 4-line spectrum was confirmed and identified by the reaction of UQ(0) with reduced glutathione. In human red blood cells, UQ(0) rapidly bound to glutathione but more slowly to HbO(2). These results suggest that UQO reacted with both ferrous heme and the reactive beta-93 cysteinyl residue of HbO(2) to generate its corresponding semiquinone radical. Subsequently UQ(0) bound to the beta-93 cysteinyl residue of HbO(2) to form a covalent-binding adduct responsible for the broad spectrum.	NIEHS, Lab Pharmacol & Chem, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Guo, Q (corresponding author), NIEHS, Lab Pharmacol & Chem, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	guo1@niehs.nih.gov	Tomer, Kenneth B/E-8018-2013; Mason, Ronald P/G-5967-2019	Mason, Ronald P/0000-0002-1859-9109	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050139, Z01ES050153, Z01ES050139] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T; BLUM RH, 1974, ANN INTERN MED, V80, P249, DOI 10.7326/0003-4819-80-2-249; COHEN G, 1964, BIOCHEMISTRY-US, V3, P895, DOI 10.1021/bi00895a006; CRANE FL, 1989, BIOCHIM BIOPHYS ACTA, V1000, P358, DOI 10.1016/S0006-3002(89)80030-7; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; GANT TW, 1986, FEBS LETT, V201, P296, DOI 10.1016/0014-5793(86)80627-5; GOIN J, 1991, ARCH BIOCHEM BIOPHYS, V288, P386, DOI 10.1016/0003-9861(91)90211-Z; GOLDBERG B, 1976, BIOCHIM BIOPHYS ACTA, V437, P628, DOI 10.1016/0304-4165(76)90029-5; GOLDBERG B, 1975, J BIOL CHEM, V250, P2401; GOLDBERG B, 1976, J BIOL CHEM, V251, P6468; Guo Q, 1999, REDOX REP, V4, P105, DOI 10.1179/135100099101534783; KAGAN V, 1990, BIOCHEM BIOPH RES CO, V169, P851, DOI 10.1016/0006-291X(90)91971-T; KAGAN VE, 1990, FREE RADICAL BIO MED, V9, P117, DOI 10.1016/0891-5849(90)90114-X; Kagan VE, 1998, FEBS LETT, V428, P43, DOI 10.1016/S0014-5793(98)00482-7; KOSAKA H, 1987, ENVIRON HEALTH PERSP, V73, P147, DOI 10.2307/3430605; Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7; Kristian T, 2000, J NEUROCHEM, V74, P1999, DOI 10.1046/j.1471-4159.2000.0741999.x; KROGER A, 1973, EUR J BIOCHEM, V34, P358, DOI 10.1111/j.1432-1033.1973.tb02767.x; LANDI L, 1984, BIOCHEM J, V222, P463, DOI 10.1042/bj2220463; LAU SS, 1988, MOL PHARMACOL, V34, P829; LOWE AG, 1991, BIOCHIM BIOPHYS ACTA, V1069, P223, DOI 10.1016/0005-2736(91)90128-U; MAGUIRE JJ, 1992, ARCH BIOCHEM BIOPHYS, V292, P47, DOI 10.1016/0003-9861(92)90049-3; MANS DRA, 1992, BIOCHEM PHARMACOL, V43, P1761, DOI 10.1016/0006-2952(92)90708-Q; MCDONALD TA, 1993, CARCINOGENESIS, V14, P1927, DOI 10.1093/carcin/14.9.1927; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Miranda JJ, 2000, BIOCHEM BIOPH RES CO, V275, P517, DOI 10.1006/bbrc.2000.3326; MORI K, 1990, FUND APPL TOXICOL, V15, P441, DOI 10.1016/0272-0590(90)90030-N; MUKAI K, 1990, BIOCHIM BIOPHYS ACTA, V1035, P77, DOI 10.1016/0304-4165(90)90176-W; NORLING B, 1974, EUR J BIOCHEM, V47, P475, DOI 10.1111/j.1432-1033.1974.tb03715.x; Poderoso JJ, 1999, FREE RADICAL BIO MED, V26, P925, DOI 10.1016/S0891-5849(98)00277-9; POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7; RAO DNR, 1990, J BIOL CHEM, V265, P844; RAO DNR, 1988, J BIOL CHEM, V263, P17981; STOLZE K, 1992, FREE RADICAL RES COM, V16, P159, DOI 10.3109/10715769209049168; Stolze K, 1999, FREE RADICAL RES, V30, P295, DOI 10.1080/10715769900300321; STOYANOVSKY DA, 1995, ARCH BIOCHEM BIOPHYS, V323, P343, DOI 10.1006/abbi.1995.9955; TAKAHASHI N, 1987, ARCH BIOCHEM BIOPHYS, V252, P41, DOI 10.1016/0003-9861(87)90006-3; WAIDYANATHA S, 1994, CHEM RES TOXICOL, V7, P463, DOI 10.1021/tx00039a027; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; WARDMAN P, 1990, FREE RADICAL RES COM, V8, P219, DOI 10.3109/10715769009053355; WINTERBOURN CC, 1985, ENVIRON HEALTH PERSP, V64, P321, DOI 10.2307/3430020; WINTERBOURN CC, 1979, BIOCHEM J, V179, P665, DOI 10.1042/bj1790665	45	22	22	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6104	6110		10.1074/jbc.M106395200	http://dx.doi.org/10.1074/jbc.M106395200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748217	hybrid			2022-12-27	WOS:000173989200055
J	Jahn, TP; Schulz, A; Taipalensuu, J; Palmgren, MG				Jahn, TP; Schulz, A; Taipalensuu, J; Palmgren, MG			Post-translational modification of plant plasma membrane H+-ATPase as a requirement for functional complementation of a yeast transport mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-I; ENDOPLASMIC-RETICULUM MEMBRANE; SINGLE-POINT MUTATIONS; SACCHAROMYCES-CEREVISIAE; DEPENDENT PHOSPHORYLATION; URACIL PERMEASE; PROTEIN; PROLIFERATION; BINDING; EXPRESSION	Many heterologous membrane proteins expressed in the yeast Saccharomyces cerevisiae fail to reach their normal cellular location and instead accumulate in stacked internal membranes. Arabidopsis thaliana plasma membrane H+-ATPase isoform 2 (AHA2) is expressed predominantly in yeast internal membranes and fails to complement a yeast strain devoid of its endogenous H+-ATPase Pma1. We observed that phosphorylation of AHA2 in the heterologous host and subsequent binding of 14-3-3 protein is crucial for the ability of AHA2 to substitute for Pma1. Thus, mutants of AHA2, complementing pma1, showed increased phosphorylation at the penultimate residue (Thr(947)), which creates a binding site for endogenous 14-3-3 protein. Only a pool of ATPase in the plasma membrane is phosphorylated. Double mutants carrying in addition a T947A substitution lost their ability to complement pma1. However, mutants affected in both autoinhibitory regions of the C-terminal regulatory domain complemented pma1 irrespective of their ability to become phosphorylated at Thr(947). This demonstrates that it is the activity status of the mutant enzyme and neither redirection of trafficking nor 14-3-3 binding per se that determines the ability of H+-pumps to rescue pma1.	Royal Vet & Agr Univ, Dept Plant Biol, DK-1871 Frederiksberg C, Denmark	University of Copenhagen	Palmgren, MG (corresponding author), Royal Vet & Agr Univ, Dept Plant Biol, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@biobase.dk	Palmgren, Michael/A-9808-2013; Schulz, Alexander/A-3357-2013	Palmgren, Michael/0000-0002-9982-6114; Schulz, Alexander/0000-0001-6796-3598; Soderman, Jan/0000-0001-7505-7210				Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Baunsgaard L, 1996, PLANT J, V10, P451, DOI 10.1046/j.1365-313X.1996.10030451.x; Becker F, 1999, J CELL BIOL, V146, P273, DOI 10.1083/jcb.146.2.273; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Decottignies A, 1999, J BIOL CHEM, V274, P37139, DOI 10.1074/jbc.274.52.37139; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Menzel R, 1997, YEAST, V13, P1211, DOI 10.1002/(SICI)1097-0061(199710)13:13<1211::AID-YEA168>3.0.CO;2-8; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; PALMGREN MG, 1994, J BIOL CHEM, V269, P3027; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; VOLLAND C, 1992, J BIOL CHEM, V267, P23767; WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101; Young JC, 1998, GENETICS, V149, P501; Zhao RM, 2000, PLANT CELL, V12, P535, DOI 10.1105/tpc.12.4.535	29	30	32	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6353	6358		10.1074/jbc.M109637200	http://dx.doi.org/10.1074/jbc.M109637200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744700	hybrid			2022-12-27	WOS:000173989200087
J	Nakamura, T; Ouchida, R; Kodama, T; Kawashima, T; Makino, Y; Yoshikawa, N; Watanabe, S; Morimoto, C; Kitamura, T; Tanaka, H				Nakamura, T; Ouchida, R; Kodama, T; Kawashima, T; Makino, Y; Yoshikawa, N; Watanabe, S; Morimoto, C; Kitamura, T; Tanaka, H			Cytokine receptor common beta subunit-mediated STAT5 activation confers NF-kappa B activation in murine proB cell line Ba/F3 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; TRANSCRIPTIONAL ACTIVITY; TRANSACTIVATION DOMAIN; SIGNALING PATHWAYS; GENE-EXPRESSION; DNA-BINDING; TYROSINE PHOSPHORYLATION; NUCLEAR TRANSLOCATION; HEMATOPOIETIC-CELLS	The cytokine receptor common 0 subunit (P.) transmits intracellular signals upon binding ligand such as granulocyte-macrophage colony-stimulating factor or interleukin-3 (IL-3); however, transcriptional regulation under the control of signaling events downstream of the P,, is not fully understood. Using murine Ba/F3 cells, here we demonstrate that the beta(c)-mediated signals stimulate NF-kappaB-driven gene expression of not only the reporter construct but also endogenous target genes such as IL-6. Analyzing the effects of several inhibitors or mutant receptors revealed that this NF-kappaB activation is mediated neither by MEK/ERK/MAPK nor by the phosphatidylinositol 3-kinase pathway but by STAT5. Overexpression experiments of the wild-type or constitutive active form of STAT5 further confirmed this notion. In addition, STAT5-dependent NF-kappaB activation is mediated not through an inducible nuclear translocation but via up-regulation of both DNA binding activity and transactivation potential of NF-kappaB. Furthermore, we also show that as yet undefined humoral factor(s) may be involved in this NF-kappaB activation process. Taken together, we may propose that cytokine receptor-mediated STAT5 activation and expression of its target genes culminates in a unique mode of NF-kappaB activation and gene expression.	Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Hematopoiet Factors,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Tanaka, H (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	hirotnk@ims.u-tokyo.ac.jp	Kitamura, Toshio/AAA-2071-2021					ADUNYAH SE, 1991, J BIOL CHEM, V266, P5670; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Ariyoshi K, 2000, J BIOL CHEM, V275, P24407, DOI 10.1074/jbc.M909771199; AZAM M, 1995, EMBO J, V14, P1402, DOI 10.1002/j.1460-2075.1995.tb07126.x; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beraud C, 1999, P NATL ACAD SCI USA, V96, P429, DOI 10.1073/pnas.96.2.429; Berchtold S, 1997, J BIOL CHEM, V272, P30237, DOI 10.1074/jbc.272.48.30237; Besancon F, 1998, P NATL ACAD SCI USA, V95, P8081, DOI 10.1073/pnas.95.14.8081; Brachat A, 2000, ONCOGENE, V19, P5073, DOI 10.1038/sj.onc.1203882; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; COREY S, 1993, EMBO J, V12, P2681, DOI 10.1002/j.1460-2075.1993.tb05929.x; Denk A, 2000, CYTOKINE GROWTH F R, V11, P303, DOI 10.1016/S1359-6101(00)00009-5; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doerre S, 1999, J IMMUNOL, V163, P269; DURONIO V, 1992, J BIOL CHEM, V267, P21856; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; GOUILLEUX F, 1995, EMBO J, V14, P2005, DOI 10.1002/j.1460-2075.1995.tb07192.x; Hiramoto M, 1998, J IMMUNOL, V160, P810; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Itoh T, 1998, MOL CELL BIOL, V18, P742, DOI 10.1128/MCB.18.2.742; Jefferies CA, 2000, J BIOL CHEM, V275, P3114, DOI 10.1074/jbc.275.5.3114; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; Kawashima T, 2001, J IMMUNOL, V167, P3652, DOI 10.4049/jimmunol.167.7.3652; Kistler B, 1998, J IMMUNOL, V160, P2308; Li JM, 1998, MOL CELL BIOL, V18, P110, DOI 10.1128/MCB.18.1.110; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Liu R, 1999, MOL BIOL CELL, V10, P3959, DOI 10.1091/mbc.10.11.3959; Luo GY, 2000, MOL ENDOCRINOL, V14, P114, DOI 10.1210/me.14.1.114; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; MIYAJIMA A, 1993, BLOOD, V82, P1960; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Nishibe T, 2001, BLOOD, V97, P692, DOI 10.1182/blood.V97.3.692; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Ozes ON, 1999, NATURE, V401, P82; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; RAY A, 1988, P NATL ACAD SCI USA, V85, P6701, DOI 10.1073/pnas.85.18.6701; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; SAKAMOTO KM, 1994, MOL CELL BIOL, V14, P5975, DOI 10.1128/MCB.14.9.5975; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Tuyt LML, 1999, J IMMUNOL, V162, P4893; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zhang MY, 1998, BLOOD, V92, P1225, DOI 10.1182/blood.V92.4.1225.416k20_1225_1234; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou YC, 1999, J BIOL CHEM, V274, P29874, DOI 10.1074/jbc.274.42.29874; Zhou YC, 1999, J BIOL CHEM, V274, P2672, DOI 10.1074/jbc.274.5.2672	78	27	27	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6254	6265		10.1074/jbc.M109878200	http://dx.doi.org/10.1074/jbc.M109878200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741913	hybrid			2022-12-27	WOS:000173989200075
J	Namgaladze, D; Hofer, HW; Ullrich, V				Namgaladze, D; Hofer, HW; Ullrich, V			Redox control of calcineurin by targeting the binuclear Fe2+-Zn2+ center at the enzyme active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; HYDROGEN-PEROXIDE; METAL-IONS; SUPEROXIDE; ACTIVATION; DEPHOSPHORYLATION; IDENTIFICATION; OXIDE	The interaction of protein serine/threonine phosphatase calcineurin (CaN) with superoxide and hydrogen peroxide was investigated. Superoxide specifically inhibited phosphatase activity of CaN toward RII (DLDVPIPGRFDRRVSVAAE) phosphopeptide in tissue and cell homogenates as well as the activity of the enzyme purified under reducing conditions. Hydrogen peroxide was an effective inhibitor of CaN at concentrations several orders of magnitude higher than superoxide. Inhibition by superoxide was calcium/calmodulin-dependent. Nitric oxide (NO) antagonized superoxide action on CaN. We provide kinetic and spectroscopic evidence that native, catalytically active CaN has a Fe2+-Zn2+ binuclear center in its active site that is oxidized to Fe3+-Zn2+ by superoxide and hydrogen peroxide. This oxidation is accompanied by a gain of manganese dependence of enzyme activity. CaN isolated by a conventional purification procedure was found in the oxidized, ferric enzyme form, and it became increasingly dependent on divalent cations. These results point to a complex redox regulation of CaN phosphatase activity by superoxide, which is modified by calcium, NO, and superoxide dismutase.	Univ Konstanz, Fachbereich Biol, Math Naturwissensch Sekt, D-78457 Constance, Germany	University of Konstanz	Ullrich, V (corresponding author), Univ Konstanz, Fachbereich Biol, Math Naturwissensch Sekt, D-78457 Constance, Germany.	volker.ullrich@uni-konstanz.de						Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bogumil R, 2000, EUR J BIOCHEM, V267, P1407, DOI 10.1046/j.1432-1327.2000.01133.x; Carballo M, 1999, J BIOL CHEM, V274, P93, DOI 10.1074/jbc.274.1.93; DAWSON TM, 1993, P NATL ACAD SCI USA, V90, P9741; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fruman David A., 1996, Methods (Orlando), V9, P146, DOI 10.1006/meth.1996.0020; Furuke K, 1999, J IMMUNOL, V162, P1988; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/BST0290345; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; KING MM, 1984, J BIOL CHEM, V259, P8847; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopez-Ongil S, 2000, J BIOL CHEM, V275, P26423, DOI 10.1074/jbc.M000767200; Love S, 1999, BRAIN PATHOL, V9, P119; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; Mertz P, 1997, J BIOL CHEM, V272, P21296, DOI 10.1074/jbc.272.34.21296; Morioka M, 1999, BRAIN RES, V828, P135, DOI 10.1016/S0006-8993(99)01349-9; Neese F, 1996, J AM CHEM SOC, V118, P8692, DOI 10.1021/ja960125x; PALLEN CJ, 1984, J BIOL CHEM, V259, P6134; Qin K. -F., 1995, FASEB J, V9, pA1347; Reiter TA, 1999, J BIOL INORG CHEM, V4, P632, DOI 10.1007/s007750050387; Rusnak F, 2000, TRENDS BIOCHEM SCI, V25, P527, DOI 10.1016/S0968-0004(00)01659-5; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; RUSNAK F, 1999, IRON METABOLISM INOR, P275; SHARMA RK, 1983, METHOD ENZYMOL, V102, P210; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Ullrich V, 2000, BIOCHEM BIOPH RES CO, V278, P1, DOI 10.1006/bbrc.2000.3733; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang XT, 1996, NATURE, V383, P434, DOI 10.1038/383434a0; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q; Yu L, 1997, BIOCHEMISTRY-US, V36, P10727, DOI 10.1021/bi970519g; YU L, 1995, J AM CHEM SOC, V117, P10147, DOI 10.1021/ja00145a040	37	92	93	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5962	5969		10.1074/jbc.M111268200	http://dx.doi.org/10.1074/jbc.M111268200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741966	hybrid			2022-12-27	WOS:000173989200035
J	Sommer, F; Drepper, F; Hippler, M				Sommer, F; Drepper, F; Hippler, M			The luminal helix l of PsaB is essential for recognition of plastocyanin or cytochrome c(6) and fast electron transfer to photosystem I in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SYNECHOCOCCUS-ELONGATUS; ANGSTROM RESOLUTION; BINDING; SUBUNIT; CHLOROPLAST; DEFICIENT; PROTEINS; TRANSFORMATION; EXPRESSION	At the lumenal side of photosystem I (PSI) in cyanobacteria, algae, and vascular plants, proper recognition and binding of the donor proteins plastocyanin (pc) and cytochrome (cyt) c(6) are crucial to allow subsequent efficient electron transfer to the photooxidized primary donor. To characterize the surface regions of PSI needed for the correct binding of both donors, loop j of PsaB of Chlamydomonas reinhardtii was modified using site-directed mutagenesis and chloroplast transformation. Mutant strains D624K, E613K/D624K, E613I/W627F, and D624K/W627F accumulated <20% of PSI as compared with wild type and were only able to grow photoautotrophically at low light intensities. Mutant strains E613N, E613K, and W627F accumulated >50% of PSI as compared with wild type. This was sufficient to isolate the altered PSI and perform a detailed analysis of the electron transfer between the modified PSI and the two algal donors using flash-induced spectroscopy. Such an analysis indicated that residue Glu(613) of PsaB has two functions: W it is crucial for an improved unbinding of the two donors from PSI, and (ii) it orientates the positively charged N-terminal domain of PsaF in a way that allows efficient binding of pc or cyt c6 to PSI. Mutation of Trp(627) to Phe completely abolishes the formation of an intermolecular electron transfer complex between pc and PSI and also drastically diminishes the rate of electron transfer between the donor and PSI. This mutation also hinders binding and electron transfer between the altered PSI and cyt c(6). It causes a 10-fold increase of the half-time of electron transfer within the intermolecular complex of cyt c, and PSI. These data strongly suggest that Trp(627) is a key residue of the recognition site formed by the core of PSI for binding and electron transfer between the two soluble electron donors and the photosystem.	Univ Freiburg, Inst Biol 2, Lehrstuhl Biochem Pflanzen, D-79104 Freiburg, Germany	University of Freiburg	Hippler, M (corresponding author), Univ Jena, Inst Allgemeine Bot & Pflanzenphysiol, Dornburger Str 159, D-07743 Jena, Germany.	m.hippler@uni-jena.de		Michael, Hippler/0000-0001-9670-6101; Drepper, Friedel/0000-0002-2043-5795				BOYNTON JE, 1993, METHOD ENZYMOL, V217, P510; CHITNIS PR, 1991, J BIOL CHEM, V266, P20146; Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593; CHOTHIA C, 1975, J MOL BIOL, V105, P1; CHUA NH, 1975, P NATL ACAD SCI USA, V72, P2175, DOI 10.1073/pnas.72.6.2175; De la Cerda B, 1999, J BIOL CHEM, V274, P13292, DOI 10.1074/jbc.274.19.13292; Drepper F, 1996, BIOCHEMISTRY-US, V35, P1282, DOI 10.1021/bi951471e; FARAH J, 1995, EMBO J, V14, P4976, DOI 10.1002/j.1460-2075.1995.tb00180.x; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; HAEHNEL W, 1994, EMBO J, V13, P1028, DOI 10.1002/j.1460-2075.1994.tb06351.x; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Hippler M, 1999, J BIOL CHEM, V274, P4180, DOI 10.1074/jbc.274.7.4180; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; HIPPLER M, 1989, FEBS LETT, V250, P280, DOI 10.1016/0014-5793(89)80738-0; Hippler M, 1998, P NATL ACAD SCI USA, V95, P7339, DOI 10.1073/pnas.95.13.7339; Hippler M, 1996, EMBO J, V15, P6374, DOI 10.1002/j.1460-2075.1996.tb01028.x; Hippler M, 2000, J BIOL CHEM, V275, P5852, DOI 10.1074/jbc.275.8.5852; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KATOH S, 1962, J BIOCHEM-TOKYO, V51, P32, DOI 10.1093/oxfordjournals.jbchem.a127497; KERFELD CA, 1995, J MOL BIOL, V250, P627, DOI 10.1006/jmbi.1995.0404; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE BH, 1995, J BIOCHEM, V117, P1209; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; Molina-Heredia FP, 2001, J BIOL CHEM, V276, P601, DOI 10.1074/jbc.M007081200; NORDLING M, 1991, FEBS LETT, V291, P327, DOI 10.1016/0014-5793(91)81313-W; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Redding K, 1998, EMBO J, V17, P50, DOI 10.1093/emboj/17.1.50; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sambrook J., 1989, IMMUNOLOGY, V2nd; Schubert WD, 1997, J MOL BIOL, V272, P741, DOI 10.1006/jmbi.1997.1269; Sun J, 1999, J BIOL CHEM, V274, P19048, DOI 10.1074/jbc.274.27.19048; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; XU QA, 1994, J BIOL CHEM, V269, P3205	36	49	54	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6573	6581		10.1074/jbc.M110633200	http://dx.doi.org/10.1074/jbc.M110633200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744732	hybrid			2022-12-27	WOS:000173989200116
J	Bjorkegren, J; Beigneux, A; Bergo, MO; Maher, JJ; Young, SG				Bjorkegren, J; Beigneux, A; Bergo, MO; Maher, JJ; Young, SG			Blocking the secretion of hepatic very low density lipoproteins renders the liver more susceptible to toxin-induced injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; TUMOR-NECROSIS-FACTOR; STEAROYL-COA DESATURASE; POLYUNSATURATED FATTY-ACIDS; ELEMENT-BINDING PROTEIN-1; B-CONTAINING LIPOPROTEINS; LIPID-PEROXIDATION; GENE-EXPRESSION; T-CELLS; ENDOTOXIN	Recently, we generated mice lacking microsomal triglyceride transfer protein (MTP) in the liver (Mttp(Delta/Delta)) and demonstrated that very low density lipoprotein secretion from hepatocytes was almost completely blocked. The blockade in lipoprotein production was accompanied by mild to moderate hepatic steatosis, but the mice appeared healthy. Although hepatic MTP deficiency appeared to be innocuous, we hypothesized that a blockade in very low density lipoprotein secretion and the accompanying steatosis might increase the sensitivity of Mttp(Delta/Delta) livers to additional hepatic insults. To address this issue, we compared the susceptibility of Mttp(Delta/Delta) mice and Mttp(flox/flox) controls to hepatic injury from Escherichia coli lipopolysaccharides, concanavalin A, and Pseudomonas aeruginosa exotoxin A. At baseline, neither the Mttp(Delta/Delta) nor the Mttp(flox/flox) mice had elevated serum transaminases or histologic evidence of hepatic inflammation. After the administration of the toxins, however, the Mtt(Delta/Delta) mice manifested higher levels of transaminases and, unlike the Mttp(flox/flox) mice, developed histologic evidence of hepatic inflammation. The toxic challenge induced tumor necrosis factor-alpha to a similar extent in Mttp(Delta/Delta) and Mttp(flox/flox) mice, but other parameters of injury (e.g. chemokine transcript levels and lipid peroxides) were disproportionately increased in the Mttp(Delta/Delta) mice. Our results suggest that blocking lipoprotein secretion in the liver may increase the susceptibility of the liver to certain toxic challenges.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; San Francisco Gen Hosp, Med Serv, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Liver Ctr Lab, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Young, SG (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, POB 419100, San Francisco, CA 94141 USA.	syoung@gladstone.ucsf.edu		Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [HL41633] Funding Source: Medline; NIAAA NIH HHS [AA00215, AA07810] Funding Source: Medline; NIDDK NIH HHS [DK26743, P30 DK026743] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007810] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ADAMSON GM, 1992, ARCH BIOCHEM BIOPHYS, V294, P223, DOI 10.1016/0003-9861(92)90161-O; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; BONDY SC, 1995, FEBS LETT, V375, P53, DOI 10.1016/0014-5793(95)01173-C; Casola A, 2001, J BIOL CHEM, V276, P19715, DOI 10.1074/jbc.M101526200; Chitturi S, 2001, SEMIN LIVER DIS, V21, P27, DOI 10.1055/s-2001-12927; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; Diehl AM, 1999, SEMIN LIVER DIS, V19, P221, DOI 10.1055/s-2007-1007111; Diehl AM, 2000, IMMUNOL REV, V174, P160, DOI 10.1034/j.1600-0528.2002.017411.x; Faggioni R, 2000, P NATL ACAD SCI USA, V97, P2367, DOI 10.1073/pnas.040561297; Faggioni R, 2000, AM J PATHOL, V156, P1781, DOI 10.1016/S0002-9440(10)65049-3; FEINGOLD KR, 1995, INFECT IMMUN, V63, P2041, DOI 10.1128/IAI.63.5.2041-2046.1995; Flier JS, 1998, NAT MED, V4, P1124, DOI 10.1038/2619; GILMAN M, 1993, CURRENT PROTOCOLS MO, V1; GOOSSENS V, 1995, P NATL ACAD SCI USA, V92, P8115, DOI 10.1073/pnas.92.18.8115; GORDON DA, 1995, TRENDS CELL BIOL, V5, P317, DOI 10.1016/S0962-8924(00)89054-6; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; ILLINGWORTH DR, 1980, ARCH NEUROL-CHICAGO, V37, P659, DOI 10.1001/archneur.1980.00500590083015; Jamil H, 1998, J LIPID RES, V39, P1448; Kane J, 2001, METAB MOL BASES INHE, P2717; Kono H, 2000, J CLIN INVEST, V106, P867, DOI 10.1172/JCI9020; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lee JS, 1999, J INTERF CYTOK RES, V19, P761, DOI 10.1089/107999099313613; Leung GK, 2000, J BIOL CHEM, V275, P7515, DOI 10.1074/jbc.275.11.7515; Lieber CS, 2000, J HEPATOL, V32, P113, DOI 10.1016/S0168-8278(00)80420-1; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Mziaut H, 2000, P NATL ACAD SCI USA, V97, P8883, DOI 10.1073/pnas.97.16.8883; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1024, DOI 10.1111/j.1530-0277.1994.tb00077.x; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; NORTH JA, 1994, AM J PHYSIOL, V267, pC177, DOI 10.1152/ajpcell.1994.267.1.C177; Ntambi JM, 1999, J LIPID RES, V40, P1549; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; PARTIN JS, 1974, GASTROENTEROLOGY, V67, P107; Poonawala A, 2000, HEPATOLOGY, V32, P689, DOI 10.1053/jhep.2000.17894; PORTOLES MT, 1993, BIOCHIM BIOPHYS ACTA, V1158, P287, DOI 10.1016/0304-4165(93)90027-6; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Reeves HL, 1996, J HEPATOL, V25, P677, DOI 10.1016/S0168-8278(96)80238-8; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Schumann J, 1998, J IMMUNOL, V161, P5745; SEWERYNEK E, 1995, EUR J PHARM-ENVIRON, V293, P327, DOI 10.1016/0926-6917(95)90052-7; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev; Unger RH, 2000, INT J OBESITY, V24, pS28, DOI 10.1038/sj.ijo.0801498; van Greevenbroek MMJ, 1998, J LIPID RES, V39, P173; Vreugdenhil ACE, 2001, J CLIN INVEST, V107, P225, DOI 10.1172/JCI10832; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; White JE, 2001, AM J RESP CELL MOL, V24, P164, DOI 10.1165/ajrcmb.24.2.4169; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Zhang CJ, 2000, J PHARMACOL EXP THER, V293, P968	64	57	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5476	5483		10.1074/jbc.M108514200	http://dx.doi.org/10.1074/jbc.M108514200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739387	hybrid			2022-12-27	WOS:000173962900119
J	Levit, MN; Abramczyk, BM; Stock, JB; Postel, EH				Levit, MN; Abramczyk, BM; Stock, JB; Postel, EH			Interactions between Escherichia coli nucleoside-diphosphate kinase and DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PHOSPHOTRANSFERASE ACTIVITY; SIGNAL-TRANSDUCTION; PROTEIN; PHOSPHORYLATION; TRANSFECTION; MUTATIONS; HISTIDINE; NM23-H1; SENSOR	Nucleoside-diphosphate (NDP) kinase (NTP:nucleoside-diphosphate phosphotransferase) catalyzes the reversible transfer of gamma-phosphates from nucleoside triphosphates to nucleoside diphosphates through an invariant histidine residue. It has been reported that the high-energy phosphorylated enzyme intermediate exhibits a protein phosphotransferase activity toward the protein histidine kinases CheA and EnvZ, members of the two-component signal transduction systems in bacteria. Here we demonstrate that the apparent protein phosphotransferase activity of NDP kinase occurs only in the presence of ADP, which can mediate the phosphotransfer from the phospho-NDP kinase to the target enzymes in catalytic amounts (similar to1 nM). These findings suggest that the protein kinase activity of NDP kinase is probably an artifact attributable to trace amounts of contaminating ADP. Additionally, we show that Escherichia coli NDP kinase, like its human homologue NM23-H2/PuF/NDP kinase B, can bind and cleave DNA. Previous in vivo functions of E. coli NDP kinase in the regulation of gene expression that have been attributed to a protein phosphotransferase activity can be explained in the context of NDP kinase-DNA interactions. The conservation of the DNA binding and DNA cleavage activities between human and bacterial NDP kinases argues strongly for the hypothesis that these activities play an essential role in NDP kinase function in vivo.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Stock, JB (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Washington Rd, Princeton, NJ 08544 USA.				NCI NIH HHS [CA76496] Funding Source: Medline; NIAID NIH HHS [AI20980] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020980] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERBERICH SJ, 1995, ONCOGENE, V10, P2343; ENGEL M, 1995, EUR J BIOCHEM, V234, P200, DOI 10.1111/j.1432-1033.1995.200_c.x; Freije JMP, 1997, J BIOL CHEM, V272, P5525, DOI 10.1074/jbc.272.9.5525; Hartsough MT, 2000, J BIOENERG BIOMEMBR, V32, P301, DOI 10.1023/A:1005597231776; HIGGINS CF, 1988, CELL, V52, P569, DOI 10.1016/0092-8674(88)90470-9; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; IGO MM, 1988, J BACTERIOL, V170, P5971, DOI 10.1128/jb.170.12.5971-5973.1988; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; Lu Q, 1996, J BIOL CHEM, V271, P32886, DOI 10.1074/jbc.271.51.32886; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; MacDonald NJ, 1996, J BIOL CHEM, V271, P25107, DOI 10.1074/jbc.271.41.25107; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 2000, J BIOENERG BIOMEMBR, V32, P277, DOI 10.1023/A:1005541114029; Postel EH, 1999, J BIOL CHEM, V274, P22821, DOI 10.1074/jbc.274.32.22821; Postel EH, 1998, INT J BIOCHEM CELL B, V30, P1291, DOI 10.1016/S1357-2725(98)00087-9; Postel EH, 2000, P NATL ACAD SCI USA, V97, P14194, DOI 10.1073/pnas.97.26.14194; STOCK A, 1988, P NATL ACAD SCI USA, V85, P1403, DOI 10.1073/pnas.85.5.1403; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Timmons L, 2000, J BIOENERG BIOMEMBR, V32, P293, DOI 10.1023/A:1005545214937; WAGNER PD, 1995, J BIOL CHEM, V270, P21758, DOI 10.1074/jbc.270.37.21758; Wagner PD, 2000, BIOCHEM J, V346, P623, DOI 10.1042/0264-6021:3460623; Wagner PD, 1997, P NATL ACAD SCI USA, V94, P9000, DOI 10.1073/pnas.94.17.9000	26	41	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5163	5167		10.1074/jbc.M111170200	http://dx.doi.org/10.1074/jbc.M111170200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11742005	hybrid			2022-12-27	WOS:000173962900080
J	Wong, CM; Zhou, Y; Ng, RWM; Kung, HF; Jin, DY				Wong, CM; Zhou, Y; Ng, RWM; Kung, HF; Jin, DY			Cooperation of yeast peroxiredoxins Tsa1p and Tsa2p in the cellular defense against oxidative and nitrosative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-SPECIFIC ANTIOXIDANT; ALKYL HYDROPEROXIDE REDUCTASE; NF-KAPPA-B; THIOREDOXIN PEROXIDASE; MAMMALIAN PEROXIREDOXIN; GLUTATHIONE-PEROXIDASE; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; CLONING; ENZYME	Peroxiredoxins are a family of antioxidant enzymes conserved from bacteria to humans. In Saccharomyces cerevisiae, there exist five peroxiredoxins, among which Tsa2p shares striking homology with the well described Tsa1p but has not been extensively studied. Here we report on the functional characterization of yeast tsa2Delta mutants and the comparison of TSA1 with TSA2. The tsa2Delta and tsa1 Delta tsa2Delta cells grew normally under aerobic conditions. However, the tsa1Delta tsa2Delta mutant yeast was more susceptible to oxidants than either tsa1Delta or tsa2Delta cells. Notably, the tsa1 Delta tsa2Delta yeast was also hypersensitive to peroxynitrite and sodium nitroprusside. This phenotype was rescued by the expression of either the TSA1 or TSA2 gene. The demonstration of a peroxynitrite reductase activity of Tsa2p in vitro points to a pivotal role for peroxiredoxins in the protection against nitrosative stress. In yeast cells, Tsa1p and Tsa2p exhibited comparable antioxidant activity. While the basal expression level of TSA1 was significantly higher than that of TSA2, the transcription of TSA2 was stimulated more potently by various oxidants. In addition, TSA2 was activated in tsa1Delta cells in a Yap1p-dependent manner. Taken together, our findings implicate the cooperation of Tsa1p and Tsa2p in the cellular defense against reactive oxygen and nitrogen species.	Univ Hong Kong, Inst Mol Biol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Jin, DY (corresponding author), Univ Hong Kong, Dept Biochem, 3-F New Med Complex,Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	dyjin@hkucc.hku.hk	Wong, Chi-Ming/A-7627-2013	Wong, Chi-Ming/0000-0002-0025-7135				Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Frank S, 1997, ONCOGENE, V14, P915, DOI 10.1038/sj.onc.1200905; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Haridas V, 1998, J IMMUNOL, V161, P1; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jeong JS, 1999, BIOCHEMISTRY-US, V38, P776, DOI 10.1021/bi9817818; Jin DY, 1997, NUCLEIC ACIDS RES, V25, P379, DOI 10.1093/nar/25.2.379; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; JIN DY, 2000, ANTIOXIDANT REDOX RE, P381; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; KIM KW, 1988, J BIOL CHEM, V263, P4704; Knoops B, 1999, J BIOL CHEM, V274, P30451, DOI 10.1074/jbc.274.43.30451; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Lyu MS, 1999, MAMM GENOME, V10, P1017, DOI 10.1007/s003359901150; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Netto LES, 1996, J BIOL CHEM, V271, P15315, DOI 10.1074/jbc.271.26.15315; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Peshenko IV, 2001, FREE RADICAL BIO MED, V31, P292, DOI 10.1016/S0891-5849(01)00579-2; Ross SJ, 2000, MOL BIOL CELL, V11, P2631, DOI 10.1091/mbc.11.8.2631; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Singh AK, 1998, J BIOL CHEM, V273, P26171, DOI 10.1074/jbc.273.40.26171; Squadrito GL, 1998, FREE RADICAL BIO MED, V25, P392, DOI 10.1016/S0891-5849(98)00095-1; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong CM, 2000, ANTIOXID REDOX SIGN, V2, P507, DOI 10.1089/15230860050192288; Yamashita H, 1999, J BIOL CHEM, V274, P29897, DOI 10.1074/jbc.274.42.29897; Zhou Y, 2000, BIOCHEM BIOPH RES CO, V268, P921, DOI 10.1006/bbrc.2000.2231	42	131	135	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5385	5394		10.1074/jbc.M106846200	http://dx.doi.org/10.1074/jbc.M106846200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741925	hybrid			2022-12-27	WOS:000173962900107
J	Burke, C; Croteau, R				Burke, C; Croteau, R			Interaction with the small subunit of geranyl diphosphate synthase modifies the chain length specificity of geranylgeranyl diphosphate synthase to produce geranyl diphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENTENYL PYROPHOSPHATE ISOMERASE; SITE-DIRECTED MUTAGENESIS; MONOTERPENE BIOSYNTHESIS; FUNCTIONAL EXPRESSION; PARTIAL-PURIFICATION; PSEUDOMATURE FORM; MOLECULAR-CLONING; PRENYLTRANSFERASE; DOMAIN; CDNA	Geranyl diphosphate synthase belongs to a subgroup of prenyltransferases, including farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase, that catalyzes the specific formation, from C-5 units, of the respective C-10, C-15, and C-20 precursors of monoterpenes, sesquiterpenes, and diterpenes. Unlike farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase, which are homodimers, geranyl diphosphate synthase from Mentha is a heterotetramer in which the large subunit shares functional motifs and a high level of amino acid sequence identity (56-75%) with geranylgeranyl diphosphate synthases of plant origin. The small subunit, however, shares little sequence identity with other isoprenyl diphosphate synthases; yet it is absolutely required for geranyl diphosphate synthase catalysis. Coexpression in Escherichia coli of the Mentha geranyl diphosphate synthase small subunit with the phylogenetically distant geranylgeranyl diphosphate synthases from Taxus canadensis and Abies grandis yielded a functional hybrid heterodimer that generated geranyl diphosphate as product in each case. These results indicate that the geranyl diphosphate synthase small subunit is capable of modifying the chain length specificity of geranylgeranyl diphosphate synthase (but not, apparently, farnesyl diphosphate synthase) to favor the production of C-10 chains. Comparison of the kinetic behavior of the parent prenyltransferases with that of the hybrid enzyme revealed that the hybrid possesses characteristics of both geranyl diphosphate synthase and geranylgeranyl diphosphate synthase.	Washington State Univ, Inst Biol Chem, Program Plant Physiol, Pullman, WA 99164 USA	Washington State University	Croteau, R (corresponding author), Washington State Univ, Inst Biol Chem, Program Plant Physiol, Pullman, WA 99164 USA.	croteau@mail.wsu.edu						Bohlmann J, 2000, ARCH BIOCHEM BIOPHYS, V375, P261, DOI 10.1006/abbi.1999.1669; Bouvier F, 2000, PLANT J, V24, P241, DOI 10.1046/j.1365-313x.2000.00875.x; Burke CC, 1999, P NATL ACAD SCI USA, V96, P13062, DOI 10.1073/pnas.96.23.13062; CLASTRE M, 1993, PLANT PHYSIOL, V102, P205, DOI 10.1104/pp.102.1.205; CROTEAU R, 1989, ARCH BIOCHEM BIOPHYS, V271, P524, DOI 10.1016/0003-9861(89)90304-4; DOGBO O, 1987, BIOCHIM BIOPHYS ACTA, V920, P140, DOI 10.1016/0005-2760(87)90253-0; ERICSSON J, 1993, J BIOL CHEM, V268, P832; Ericsson J, 1998, J LIPID RES, V39, P1731; Fernandez SMS, 2000, BIOCHEMISTRY-US, V39, P15316, DOI 10.1021/bi0014305; FUJII H, 1983, FEBS LETT, V161, P257, DOI 10.1016/0014-5793(83)81020-5; *GEN COMP GROUP, 1998, PROGR MAN WISC PACK; Hefner J, 1998, ARCH BIOCHEM BIOPHYS, V360, P62, DOI 10.1006/abbi.1998.0926; HEIDE L, 1989, ARCH BIOCHEM BIOPHYS, V273, P331, DOI 10.1016/0003-9861(89)90491-8; HOLLOWAY PW, 1967, BIOCHEM J, V104, P57, DOI 10.1042/bj1040057; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KANDUTSCH AA, 1964, J BIOL CHEM, V239, P2507; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; KUNTZ M, 1992, PLANT J, V2, P25; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LYNEN F, 1959, ANGEW CHEM INT EDIT, V71, P657, DOI 10.1002/ange.19590712102; MARRERO PF, 1992, J BIOL CHEM, V267, P21873; McConkey ME, 2000, PLANT PHYSIOL, V122, P215, DOI 10.1104/pp.122.1.215; Narita K, 1999, J BIOCHEM-TOKYO, V126, P566, DOI 10.1093/oxfordjournals.jbchem.a022487; Ogura K, 1998, CHEM REV, V98, P1263, DOI 10.1021/cr9600464; OHNUMA S, 1992, J BIOCHEM-TOKYO, V112, P743, DOI 10.1093/oxfordjournals.jbchem.a123969; Ohnuma S, 1996, J BIOL CHEM, V271, P18831, DOI 10.1074/jbc.271.31.18831; Ohnuma S, 1997, J BIOL CHEM, V272, P5192, DOI 10.1074/jbc.272.8.5192; Ohnuma S, 1997, J BIOCHEM-TOKYO, V121, P696; OHNUMA S, 1993, BIOCHEM BIOPH RES CO, V192, P407, DOI 10.1006/bbrc.1993.1430; Ohnuma SI, 1996, J BIOL CHEM, V271, P10087, DOI 10.1074/jbc.271.17.10087; Okada K, 2000, PLANT PHYSIOL, V122, P1045, DOI 10.1104/pp.122.4.1045; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; POULTER CD, 1981, BIOSYNTHESIS ISOPREN, V1, P162; SAGAMI H, 1994, J BIOL CHEM, V269, P20561; SAGAMI H, 1981, BIOCHEM INT, V3, P669; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schnell DJ, 1998, ANNU REV PLANT PHYS, V49, P97, DOI 10.1146/annurev.arplant.49.1.97; Shimizu N, 1998, J BACTERIOL, V180, P1578, DOI 10.1128/JB.180.6.1578-1581.1998; SOLER E, 1992, PLANTA, V187, P171, DOI 10.1007/BF00201934; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tarshis LC, 1996, P NATL ACAD SCI USA, V93, P15018, DOI 10.1073/pnas.93.26.15018; Tholl D, 2001, ARCH BIOCHEM BIOPHYS, V386, P233, DOI 10.1006/abbi.2000.2212; Trapp SC, 2001, GENETICS, V158, P811; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Weber K, 1972, Methods Enzymol, V26, P3; Williams DC, 2000, ARCH BIOCHEM BIOPHYS, V379, P137, DOI 10.1006/abbi.2000.1865; Williams DC, 1998, BIOCHEMISTRY-US, V37, P12213, DOI 10.1021/bi980854k; Wise M. L., 1999, COMPREHENSIVE NATURA, P97, DOI DOI 10.1016/B978-0-08-091283-7.00038-2	52	81	90	5	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2002	277	5					3141	3149		10.1074/jbc.M105900200	http://dx.doi.org/10.1074/jbc.M105900200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	518VF	11733504	hybrid			2022-12-27	WOS:000173688000013
J	Graham, TE; Prossnitz, ER; Dorin, RI				Graham, TE; Prossnitz, ER; Dorin, RI			Dexras1/AGS-1 inhibits signal transduction from the G(i)-coupled formyl peptide receptor to Erk-1/2 MAP kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PERTUSSIS-TOXIN; ADP-RIBOSYLATION; TRANSCRIPTION FACTORS; BINDING COMPONENT; ADENYLATE-CYCLASE; RESPONSE ELEMENT; ERK ACTIVATION; GI-PROTEIN; PATHWAYS	Dexras1 is a novel GTP-binding protein (G protein) that was recently discovered on the basis of rapid mRNA up-regulation by glucocorticoids in murine AtT-20 corticotroph cells and in several primary tissues. The human homologue of Dexras1, termed activator of G protein signaling-1 (AGS-1), has been reported to stimulate signaling by G(1) heterotrimeric G proteins independently of receptor activation. The effects of Dexras(1)/AGS-1 on receptor-initiated signaling by G(i) have not been examined. Here we report that Dexras(1) inhibits ligand-dependent signaling by the G(i)-coupled N-formyl peptide receptor (FPR). Dexras1 and FPR were transiently coexpressed in both COS-7 and HEK-293 cells. Activation of FPR by ligand (N-formyl-methionine-leucine-phenylalanine f-MLF)) caused phosphorylation of endogenous Erk-1/2 that was reduced by co-expression of Dexras1. Direct effects of Dexras1 on the activity of coexpressed, epitope-tagged Erk-2 (hemagglutinin (HA)Erk-2) were measured by immune complex in vitro kinase assay. Expression of Dexras1 alone resulted in a 1.9- to 4.9-fold increase in HA-Erk-2 activity; expression of the unliganded FPR alone resulted in a 6.2- to 8.1-fold increase in HA-Erk-2 activity. Stimulation of FPR by f-MLF produced a further 8- to 10-fold increase in HA-Erk-2 activity over the basal (non-ligand-stimulated) state, and this ligand-dependent activity was attenuated at the time points of maximal activity by co-expression of Dexras1 (reduced 31 +/- 6.8% in COS-7 at 10 min and 86 +/- 9.2% in HEK-293 at 5 min, p < 0.01 for each). Expression of Dexras1 did not influence protein expression of FPR or Erk, suggesting that the inhibitory effects of Dexras1 reflect a functional alteration in the signaling cascade from FPR to Erk. Expression of Dexras1 had no effect on expression of G(i)alpha species, but significantly impaired pertussis toxin-catalyzed ADP-ribosylation of membrane-associated G(i)alpha Expression of Dexras1 also significantly decreased in vitro binding of GTPgammaS in f-AMLF-stimulated membranes of cells co-transfected with FPR. These data suggest that Dexras1 inhibits signal transduction from FPR to Erk-1/2 through an effect that is very proximal to receptor-G(i) coupling. While Dexras1 weakly activates Erk in the resting state, more potent effects are evident in the modulation of ligand-stimulated receptor signal transduction, where Dexras1 functions as an inhibitor rather than activator of the Erk mitogen-activated protein kinase signaling cascade.	New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM 87108 USA; Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87108 USA; Univ New Mexico, Hlth Sci Ctr, Dept Biochem Mol Biol, Albuquerque, NM 87108 USA; Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87108 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Dorin, RI (corresponding author), New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM 87108 USA.		Prossnitz, Eric/I-4599-2019; Prossnitz, Eric R./B-4543-2008	Prossnitz, Eric/0000-0001-9190-8302; 	PHS HHS [A143932] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BUTKERAIT P, 1995, J BIOL CHEM, V270, P18691, DOI 10.1074/jbc.270.31.18691; CARTY DJ, 1994, METHOD ENZYMOL, V237, P63; Chen Y, 1998, J BIOL CHEM, V273, P19809, DOI 10.1074/jbc.273.31.19809; Chung KC, 1998, MOL CELL BIOL, V18, P2272, DOI 10.1128/MCB.18.4.2272; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; COBB MH, 1994, SEMIN CANCER BIOL, V5, P261; COTE TE, 1984, J BIOL CHEM, V259, P8693; Daeffler L, 2000, FUND CLIN PHARMACOL, V14, P73, DOI 10.1111/j.1472-8206.2000.tb00395.x; Della Rocca GJ, 1999, J BIOL CHEM, V274, P4749, DOI 10.1074/jbc.274.8.4749; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; GENNITY JM, 1991, BIOCHEM J, V279, P643, DOI 10.1042/bj2790643; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Graham TE, 1998, J IMMUNOL, V161, P6733; Graham TE, 2001, ENDOCRINOLOGY, V142, P2631, DOI 10.1210/en.142.6.2631; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; LEDERER ED, 1994, BIOCHEM BIOPH RES CO, V200, P1604, DOI 10.1006/bbrc.1994.1635; Malkoski SP, 1999, MOL ENDOCRINOL, V13, P1629, DOI 10.1210/me.13.10.1629; PEREZ HD, 1993, J BIOL CHEM, V268, P2292; Prossnitz ER, 1997, J BIOL CHEM, V272, P15213, DOI 10.1074/jbc.272.24.15213; Rane MJ, 1998, J BIOL CHEM, V273, P20916, DOI 10.1074/jbc.273.33.20916; Shore P, 1996, MOL CELL BIOL, V16, P3338; St Croix B, 2000, SCIENCE, V289, P1197; TSAI SC, 1984, J BIOL CHEM, V259, P5320; TSU RC, 1995, BIOCHEM J, V309, P331, DOI 10.1042/bj3090331; Vilven JC, 1998, J RECEPT SIGNAL TR R, V18, P187, DOI 10.3109/10799899809047744; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wenzel-Seifert K, 1998, J BIOL CHEM, V273, P24181, DOI 10.1074/jbc.273.37.24181	36	69	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 29	2002	277	13					10876	10882		10.1074/jbc.M110397200	http://dx.doi.org/10.1074/jbc.M110397200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	534WQ	11751935	hybrid			2022-12-27	WOS:000174613100018
J	Cormier, JW; Rivolta, I; Tateyama, M; Yang, AS; Kass, RS				Cormier, JW; Rivolta, I; Tateyama, M; Yang, AS; Kass, RS			Secondary structure of the human cardiac Na+ channel C terminus - Evidence for a role of helical structures in modulation of channel inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; SHAKER POTASSIUM CHANNEL; SODIUM-CHANNEL; ALPHA-SUBUNIT; MOLECULAR MECHANISMS; LQT-3 MUTATION; ARRHYTHMIA; MOVEMENT; GATE; RECOGNITION	Little is known about the structure of the C terminus of the human cardiac voltage-gated sodium channel a subunit (SCN5A), but disease-linked mutations within this 244-amino acid intracellular region of the channel have marked effects on channel inactivation. Here we report a structural analysis of the C-terminal tail of the cardiac Na+ channel that sheds new light on mechanisms that control its inactivation gating. Homology modeling of the SCN5A C terminus predicts predominant a-helical structure (six helices) in the proximal half of this intracellular tail but little structure in the distal half. Circular dichroism of isolated and purified C terminus supports this prediction. Whole cell and single channel patch clamp recordings of wild type and mutant alpha subunits co-expressed with the hbeta(1) subunit in HEK 293 cells indicate that truncation of the distal, nonstructured, C terminus (L1921stop mutant) reduces current density but does not affect channel gating (n = 6). In contrast, truncation of the sixth helix containing a concentration of positively charged residues along with the distal C terminus (S1885stop mutant) also reduces current density but, in addition, has profound and selective effects on inactivation (no effect on activation). Channel availability is shifted (-11 +/- 0.6 mV), and there is a 10-fold increase in the percentage of channels that burst (fail to inactivate) during prolonged depolarization (0.025% S1885stop (n = 7) versus 0.0028% wild type (n = 9), p < 0.005). These results suggest that the charged structured region of the SCN5A C terminus plays a major role in channel inactivation, stabilizing the inactivated state.	Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University	Kass, RS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St PH 7W 318, New York, NY 10032 USA.	rsk20@columbia.edu		Yang, An-Suei/0000-0002-4699-873X; Cormier, Joseph/0000-0002-7610-2500	NHLBI NIH HHS [HL-56810-4] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056810] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; Akai J, 2000, FEBS LETT, V479, P29, DOI 10.1016/S0014-5793(00)01875-5; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Benhorin J, 1998, Hum Mutat, V12, P72, DOI 10.1002/(SICI)1098-1004(1998)12:1<72::AID-HUMU17>3.0.CO;2-Z; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bezzina C, 1999, CIRC RES, V85, P1206; Catterall WA, 1996, J BIOENERG BIOMEMBR, V28, P219, DOI 10.1007/BF02110697; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kellenberger S, 1996, J BIOL CHEM, V271, P30971, DOI 10.1074/jbc.271.48.30971; Kellenberger S, 1997, J GEN PHYSIOL, V109, P589, DOI 10.1085/jgp.109.5.589; MCPHEE JC, 1995, J BIOL CHEM, V270, P12025, DOI 10.1074/jbc.270.20.12025; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Orengo CA, 1999, PROTEINS, P149; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; Rivolta I, 2001, CELL PHYSL SOURCEBOO, P643; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Sauder JM, 2000, PROTEINS, V40, P6, DOI 10.1002/(SICI)1097-0134(20000701)40:1<6::AID-PROT30>3.0.CO;2-7; Schwartz PJ, 2001, CIRCULATION, V103, P89; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; VALENZUELA C, 1994, BIOPHYS J, V67, P161, DOI 10.1016/S0006-3495(94)80465-5; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Viswanathan PC, 2001, CIRCULATION, V104, P1200, DOI 10.1161/hc3501.093797; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; WANG Q, 1995, HUM MOL GENET, V4, P1603, DOI 10.1093/hmg/4.9.1603; Wehrens XHT, 2000, CIRCULATION, V102, P584; Wei J, 1999, CIRCULATION, V99, P3165, DOI 10.1161/01.CIR.99.24.3165; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yang AS, 2000, J MOL BIOL, V301, P679, DOI 10.1006/jmbi.2000.3974	45	105	107	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9233	9241		10.1074/jbc.M110204200	http://dx.doi.org/10.1074/jbc.M110204200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11741959	hybrid			2022-12-27	WOS:000174400600068
J	Jogi, A; Persson, P; Grynfeld, A; Pahlman, S; Axelson, H				Jogi, A; Persson, P; Grynfeld, A; Pahlman, S; Axelson, H			Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACHAETE-SCUTE HOMOLOG-1; NEUROBLASTOMA-CELLS; NERVOUS-SYSTEM; BLASTOMA CELLS; FACTOR HES-1; GENE; EXPRESSION; ENHANCER; HAIRY; SPLIT	It is assumed that the Id helix-loop-helix (HLH) proteins act by associating with ubiquitously expressed basic HLH (bHLH) transcription factors, such as E47 and E2-2, which prevents these factors from forming functional hetero- or homodimeric DNA binding complexes. Several tissue-specific bHLH proteins, including HASH-1, dHAND, and HES-1, are important for development of the nervous system. Neuroblastoma tumors are derived from the sympathetic nervous system and exhibit neural crest features. In differentiating neuroblastoma cells, HASH-1 is down-regulated, and there its coincident up-regulation of the transcriptional repressor HES-1, which is known to bind the HASH-1 promoter. We found that the three Id proteins expressed in neuroblastoma cells (Id1, Id2, and Id3) were down-regulated during induced differentiation, indicating that Id proteins help keep the tumor cells in an undifferentiated state. Studying interactions, we noted that all four Id proteins could dimerize with E47 or E2-2, but not with HASH-1 or dHAND. However, the Id proteins did complex with HES-1, and increased levels of Id2 reduced the DNA binding activity of HES-1. Furthermore, HES-1 interfered with Id2/E2-2 complex formation. The ability of Id proteins to affect HES-1 activity is of particular interest in neuronal cells, where regulation of HES-1 is essential for the timing of neuronal differentiation.	Lund Univ, Univ Hosp MAS, Dept Lab Med, Div Mol Med, S-20502 Malmo, Sweden	Lund University; Skane University Hospital	Axelson, H (corresponding author), Lund Univ, Univ Hosp MAS, Dept Lab Med, Div Mol Med, Entrance 78, S-20502 Malmo, Sweden.			Jogi, Annika/0000-0003-1697-8030				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baonza A, 2000, DEVELOPMENT, V127, P2383; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BJELFMAN C, 1990, MOL CELL BIOL, V10, P361, DOI 10.1128/MCB.10.1.361; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Brodeur GM, 1997, J PEDIAT HEMATOL ONC, V19, P93, DOI 10.1097/00043426-199703000-00001; Casarosa S, 1999, DEVELOPMENT, V126, P525; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; FINKEL T, 1993, J BIOL CHEM, V268, P5; Gestblom C, 1999, LAB INVEST, V79, P67; Groves AK, 1999, CURR TOP DEV BIOL, V43, P221; Grynfeld A, 2000, INT J CANCER, V88, P401, DOI 10.1002/1097-0215(20001101)88:3<401::AID-IJC12>3.3.CO;2-M; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hoehner JC, 1996, LAB INVEST, V75, P659; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Norton JD, 2000, J CELL SCI, V113, P3897; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; PAHLMAN S, 1981, INT J CANCER, V28, P583, DOI 10.1002/ijc.2910280509; PAHLMAN S, 1983, CELL DIFFER DEV, V12, P165, DOI 10.1016/0045-6039(83)90006-4; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Soderholm H, 1999, BIOCHEM BIOPH RES CO, V256, P557, DOI 10.1006/bbrc.1999.0314; SQUIRE JA, 1995, ONCOGENE, V10, P1417; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150	40	82	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9118	9126		10.1074/jbc.M107713200	http://dx.doi.org/10.1074/jbc.M107713200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11756408	hybrid			2022-12-27	WOS:000174400600052
J	Jones, M; Talfournier, F; Bobrov, A; Grossmann, JG; Vekshin, N; Sutcliffe, MJ; Scrutton, NS				Jones, M; Talfournier, F; Bobrov, A; Grossmann, JG; Vekshin, N; Sutcliffe, MJ; Scrutton, NS			Electron transfer and conformational change in complexes of trimethylamine dehydrogenase and electron transferring flavoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC CYTOCHROME-C; COVALENTLY BOUND COENZYME; METHYLOTROPHIC BACTERIUM; METHYLOPHILUS-METHYLOTROPHUS; METALLOPROTEIN COMPLEX; W3A1; IDENTIFICATION; PLASTOCYANIN; MECHANISM; REDUCTASE	The trimethylamine dehydrogenase-electron transferring flavoprotein (TMADH-ETF) electron transfer complex has been studied by fluorescence and absorption spectroscopies. These studies indicate that a series of conformational changes occur during the assembly of the TMADH-ETF electron transfer complex and that the kinetics of assembly observed with mutant TMADH (Y442F/L/G) or ETF (alphaR237A) complexes are much slower than are the corresponding rates of electron transfer in these complexes. This suggests that electron transfer does not occur in the thermodynamically most favorable state (which takes too long to form), but that one or more metastable states (which are formed more rapidly) are competent in transferring electrons from TMADH to ETF. Additionally, fluorescence spectroscopy studies of the TMADH(.)ETF complex indicate that ETF undergoes a stable conformational change (termed structural imprinting) when it interacts transiently with TMADH to form a second, distinct, structural form. The mutant complexes compromise imprinting of ETF, indicating a dependence on the native interactions present in the wild-type complex. The imprinted form of semiquinone ETF exhibits an enhanced rate of electron transfer to the artificial electron acceptor, ferricenium. Overall molecular conformations as probed by small-angle x-ray scattering studies are indistinguishable for imprinted and non-imprinted ETF, suggesting that changes in structure likely involve confined reorganizations within the vicinity of the FAD. Our results indicate a series of conformational events occur during the assembly of the TMADH-ETF electron transfer complex, and that the properties of electron transfer proteins can be affected lastingly by transient interaction with their physiological redox partners. This may have significant implications for our understanding of biological electron transfer reactions in vivo, because ETF encounters TMADH at all times in the cell. Our studies suggest that caution needs to be exercised in extrapolating the properties of in vitro interprotein electron transfer reactions to those occurring in vivo.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; SERC, Daresbury Lab, Council Cent Lab Res Councils, Warrington WA4 4AD, Cheshire, England; Inst Cell Biophys, Pushchino 142290, Moscow Region, Russia	University of Leicester; University of Leicester; STFC Daresbury Laboratory; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS	Scrutton, NS (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.	nss4@le.ac.uk		Sutcliffe, Mike/0000-0003-0414-1700				Basran J, 1999, J BIOL CHEM, V274, P13155, DOI 10.1074/jbc.274.19.13155; Basran J, 2000, BIOCHEMISTRY-US, V39, P9188, DOI 10.1021/bi0006868; Basran J, 1999, BIOCHEM J, V341, P307, DOI 10.1042/0264-6021:3410307; Basran J, 1997, BIOCHEMISTRY-US, V36, P1989, DOI 10.1021/bi962623o; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; BYRON CM, 1989, BIOCHEMISTRY-US, V28, P8582, DOI 10.1021/bi00447a047; CHEN DW, 1994, J BIOL CHEM, V269, P32120; CHEN LY, 1994, SCIENCE, V264, P86, DOI 10.1126/science.8140419; Chohan KK, 1998, PROTEIN PEPTIDE LETT, V5, P231; Chohan KK, 2001, J BIOL CHEM, V276, P34142, DOI 10.1074/jbc.M101341200; DUPLESSIS ER, 1994, BIOCHEM MOL BIOL INT, V32, P195; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; HARRIS TK, 1994, BIOCHEMISTRY-US, V33, P12600, DOI 10.1021/bi00208a010; HILL CL, 1977, P NATL ACAD SCI USA, V74, P547, DOI 10.1073/pnas.74.2.547; HUANG LX, 1995, J BIOL CHEM, V270, P23958, DOI 10.1074/jbc.270.41.23958; Jang MH, 1999, J BIOL CHEM, V274, P13147, DOI 10.1074/jbc.274.19.13147; Jang MH, 2000, J BIOL CHEM, V275, P12546, DOI 10.1074/jbc.275.17.12546; Jones M, 2000, J BIOL CHEM, V275, P21349, DOI 10.1074/jbc.M001564200; KASPRZAK AA, 1983, BIOCHEM J, V211, P535, DOI 10.1042/bj2110535; LEWIS R, 1994, J SYNCHROTRON RADIAT, V1, P43, DOI 10.1107/S090904959400693X; LIM LW, 1988, J BIOL CHEM, V263, P3075; Nandy A, 1996, BIOCHEMISTRY-US, V35, P12402, DOI 10.1021/bi960785e; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; QIN L, 1994, BIOCHEMISTRY-US, V33, P12592, DOI 10.1021/bi00208a009; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; ROHLFS RJ, 1995, J BIOL CHEM, V270, P22196, DOI 10.1074/jbc.270.38.22196; ROHLFS RJ, 1991, J BIOL CHEM, V266, P15244; Scrutton N S, 2000, Subcell Biochem, V35, P145; STEENKAMP DJ, 1976, BIOCHEM BIOPH RES CO, V71, P1289, DOI 10.1016/0006-291X(76)90794-4; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P2812; STEENKAMP DJ, 1976, BIOCHIM BIOPHYS ACTA, V429, P705, DOI 10.1016/0005-2744(76)90319-3; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P4086; STEENKAMP DJ, 1978, J BIOL CHEM, V253, P2818; Talfournier F, 2001, J BIOL CHEM, V276, P20190, DOI 10.1074/jbc.M010853200; TOWNSANDREWS E, 1989, REV SCI INSTRUM, V60, P2346, DOI 10.1063/1.1140765; Wilson EK, 1997, BIOCHEMISTRY-US, V36, P41, DOI 10.1021/bi961224q; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; ZHOU JS, 1993, J AM CHEM SOC, V115, P10796, DOI 10.1021/ja00076a042; ZHOU JS, 1992, J AM CHEM SOC, V114, P3562, DOI 10.1021/ja00035a065; Ziegler GA, 1999, J MOL BIOL, V289, P981, DOI 10.1006/jmbi.1999.2807	40	18	18	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8457	8465		10.1074/jbc.M111105200	http://dx.doi.org/10.1074/jbc.M111105200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756429	hybrid			2022-12-27	WOS:000174268000106
J	Marchesini, N; Ruiz, FA; Vieira, M; Docampo, R				Marchesini, N; Ruiz, FA; Vieira, M; Docampo, R			Acidocalcisomes are functionally linked to the contractile vacuole of Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-PUMPING PYROPHOSPHATASE; H+-PYROPHOSPHATASE; INORGANIC POLYPHOSPHATE; LEISHMANIA-DONOVANI; CA2+ TRANSPORT; CALCIUM-PUMP; ATPASE; PLANT; LOCALIZATION; ASSOCIATION	The mass-dense granules of Dictyostelium discoideum were shown to contain large amounts of phosphorus, magnesium, and calcium, as determined by x-ray micro. analysis, either in situ or when purified using iodixanol gradient centrifugation. The high phosphorus content was due to the presence of pyrophosphate and polyphosphate, which were also present in the contractile vacuoles. Both organelles also possessed a vacuolar H+-ATPase, an H+-pyrophosphatase, and a Ca2+-ATPase, as determined by biochemical methods or by immunofluorescence microscopy. The H+-pyrophosphatase activity of isolated mass-dense granules was stimulated by potassium ions and inhibited by the pyrophosphate analogs aminomethylenediphosphonate and imidodiphosphate and by KF and N-ethylmaleimide in a dose-dependent manner. The mass-dense granules and the contractile vacuole appeared to contact each other when the cells were submitted to hyposmotic stress. Acetazolamide inhibited the carbonic anhydrase activity of the contractile vacuoles and prolonged their contraction cycle in a dose-dependent manner. Similar effects were observed with the anion exchanger inhibitor 4,4'-diisothiocyanatodihydrostilbene-2, 2'-disulfonic acid and the vacuolar H+-ATPase inhibitor bafilomycin A,. Together, these results suggest that the mass-dense granules of D. discoideum are homologous to the acido-calcisomes described in protozoan parasites and are linked to the function of the contractile vacuole.	Univ Illinois, Coll Vet Med, Dept Pathobiol, Mol Parasitol Lab, Urbana, IL 61802 USA	University of Illinois System; University of Illinois Urbana-Champaign	Docampo, R (corresponding author), Univ Illinois, Coll Vet Med, Dept Pathobiol, Mol Parasitol Lab, 2001 S Lincoln Ave, Urbana, IL 61802 USA.	rodoc@uiuc.edu	Ruiz, Felix A./B-1032-2008	Ruiz, Felix A./0000-0003-0748-5015	NIAID NIH HHS [AI-23259] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023259, R21AI023259] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAN RA, 1980, CAN J MICROBIOL, V26, P912, DOI 10.1139/m80-158; ARMSTRONG JM, 1966, J BIOL CHEM, V241, P5137; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BENAIM G, 1991, BIOCHEM J, V280, P715, DOI 10.1042/bj2800715; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CABANTCHIK ZI, 1992, AM J PHYSIOL, V262, pC803, DOI 10.1152/ajpcell.1992.262.4.C803; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Docampo R, 1999, PARASITOL TODAY, V15, P443, DOI 10.1016/S0169-4758(99)01531-8; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; EUROPEFINNER GN, 1986, BIOCHIM BIOPHYS ACTA, V887, P335, DOI 10.1016/0167-4889(86)90163-1; FLAADT H, 1993, J CELL SCI, V105, P1131; FOK AK, 1993, J CELL SCI, V106, P1103; GEZELIUS K, 1974, ARCH MICROBIOL, V98, P311, DOI 10.1007/BF00425292; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; HEYWOOD P, 1978, J CELL SCI, V31, P213; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; JENKINS WT, 1991, ANAL BIOCHEM, V194, P136, DOI 10.1016/0003-2697(91)90160-U; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Lu HG, 1998, MOL CELL BIOL, V18, P2309, DOI 10.1128/MCB.18.4.2309; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; Luo SH, 2001, EMBO J, V20, P55, DOI 10.1093/emboj/20.1.55; MACDONALD JIS, 1988, FEBS LETT, V238, P9, DOI 10.1016/0014-5793(88)80214-X; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Marchesini N, 2000, BIOCHEM J, V347, P243, DOI 10.1042/0264-6021:3470243; Meyer A., 1904, BOT Z, V62, P113; MILNE JL, 1988, BIOCHEM J, V249, P223, DOI 10.1042/bj2490223; MONIAKIS J, 1995, J BIOL CHEM, V270, P28276; Moniakis J, 1999, J CELL SCI, V112, P405; NOLTA KV, 1994, J BIOL CHEM, V269, P2225; NOLTA KV, 1991, J BIOL CHEM, V266, P18318; PADH H, 1989, BIOCHIM BIOPHYS ACTA, V982, P271, DOI 10.1016/0005-2736(89)90064-3; Rodrigues CO, 1999, BIOCHEM J, V340, P759, DOI 10.1042/0264-6021:3400759; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Rodrigues CO, 2000, BIOCHEM J, V349, P737, DOI 10.1042/bj3490737; ROONEY EK, 1992, P NATL ACAD SCI USA, V89, P8025, DOI 10.1073/pnas.89.17.8025; ROONEY EK, 1994, CELL CALCIUM, V16, P509, DOI 10.1016/0143-4160(94)90081-7; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; SCHLATTERER C, 1994, CELL CALCIUM, V16, P101, DOI 10.1016/0143-4160(94)90005-1; Schlatterer C, 2001, CELL CALCIUM, V29, P171, DOI 10.1054/ceca.2000.0181; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; Vercesi AE, 2000, FEBS LETT, V473, P203, DOI 10.1016/S0014-5793(00)01531-3; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Xie YY, 1996, J CELL SCI, V109, P489; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347	50	76	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8146	8153		10.1074/jbc.M111130200	http://dx.doi.org/10.1074/jbc.M111130200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11748243	hybrid			2022-12-27	WOS:000174268000067
J	Draghi, F; Miele, AE; Travaglini-Allocatelli, C; Vallone, B; Brunori, M; Gibson, QH; Olson, JS				Draghi, F; Miele, AE; Travaglini-Allocatelli, C; Vallone, B; Brunori, M; Gibson, QH; Olson, JS			Controlling ligand binding in myoglobin by mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM-WHALE MYOGLOBIN; DIMERIC BACTERIAL HEMOGLOBIN; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; DISTAL HISTIDINE; ASCARIS-SUUM; STRUCTURAL DYNAMICS; PROTEIN DYNAMICS; OXYGEN MOLECULE; HEME POCKET	A quadruple mutant of sperm whale myoglobin was constructed to mimic the structure found in Ascaris suum hemoglobin. The replacements include His(E7) --> Gln, Leu(B10) --> Tyr, Thr(E10) --> Arg, and Ile(G8) --> Phe. Single, double, and triple mutants were characterized to dissect out the effects of the individual substitutions. The crystal structures of the deoxy and oxy forms of the quadruple mutant were determined and compared with that of native Ascaris hemoglobin. Tyr(B10) myoglobin displays low O-2 affinity, high dissociation rate constants, and heterogeneous kinetic behavior, suggesting unfavorable steric interactions between the B10 phenol side chain and His(E7). In contrast, all mutants containing the Tyr(B10)/Gln(E7) pair show high O-2 affinity, low dissociation rate constants, and simple, monophasic kinetic behavior. Replacement of Ile(107) with Phe enhances nanosecond geminate recombination singly and in combination with the Tyr(B10)/Gln(E7)/Arg(E10) mutation by limiting access to the Xe4 site. These kinetic results and comparisons with native Ascaris hemoglobin demonstrate the importance of distal pocket cavities in governing the kinetics of ligand binding. The similar to150-fold higher O-2 affinity of Ascaris hemoglobin compared with that for Tyr(B10)/Gln(E7)-containing myoglobin mutants appears to be the result of favorable proximal effects in the Ascaris protein, due to a staggered orientation of His(F8), the lack of a hydrogen bonding lattice between the F4, F7, and F8 residues, and the presence of a large polar Trp(G5) residue in the interior portion of the proximal heme pocket.	Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; Univ Roma La Sapienza, CNR, Ctr Mol Biol, I-00185 Rome, Italy; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, Keck Ctr Computat Biol, Houston, TX 77005 USA	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Rice University; Rice University	Brunori, M (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, P A Moro 5, I-00185 Rome, Italy.	maurizio.brunori@uniroma1.it	Miele, Adriana E./F-4083-2011; Vallone, Beatrice/F-4174-2012	Miele, Adriana E./0000-0002-4637-2606; Brunori, Maurizio/0000-0002-7795-1635; VALLONE, Beatrice/0000-0003-0058-9049; Olson, John/0000-0002-0760-5403; Travaglini-Allocatelli, Carlo/0000-0001-8735-1126	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 47020] Funding Source: Medline; NIGMS NIH HHS [GM 35649, GM 14276] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BISIG DA, 1995, J BIOL CHEM, V270, P20754, DOI 10.1074/jbc.270.35.20754; Brunori M, 1999, BIOPHYS J, V76, P1259, DOI 10.1016/S0006-3495(99)77289-9; Brunori M, 2001, EMBO REP, V2, P674, DOI 10.1093/embo-reports/kve159; Brunori M, 2000, P NATL ACAD SCI USA, V97, P2058, DOI 10.1073/pnas.040459697; Brunori M, 1999, TRENDS BIOCHEM SCI, V24, P253, DOI 10.1016/S0968-0004(99)01421-8; Carlson ML, 1996, BIOCHEMISTRY-US, V35, P1125, DOI 10.1021/bi951767k; CARLSON ML, 1994, BIOCHEMISTRY-US, V33, P10597, DOI 10.1021/bi00201a005; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Chu K, 2000, NATURE, V403, P921, DOI 10.1038/35002641; Das TK, 2000, BIOCHEMISTRY-US, V39, P837, DOI 10.1021/bi9922087; DAVENPORT HE, 1949, HAEMOGLOBIN, P295; DEBAERE I, 1994, P NATL ACAD SCI USA, V91, P1594, DOI 10.1073/pnas.91.4.1594; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; EGEBERG KD, 1990, J BIOL CHEM, V265, P11788; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; GIBSON QH, 1992, J BIOL CHEM, V267, P22022; GIBSON QH, 1989, J BIOL CHEM, V264, P100; GIBSON QH, 1993, J BIOL CHEM, V268, P16993; GIBSON QH, 1989, J BIOL CHEM, V264, P20155; GIBSON QH, 1955, PROC R SOC SER B-BIO, V143, P310, DOI 10.1098/rspb.1955.0014; GIBSON QH, 1965, PROC R SOC SER B-BIO, V163, P206, DOI 10.1098/rspb.1965.0067; GOLDBERG DE, 1995, BIOESSAYS, V17, P177, DOI 10.1002/bies.950170213; Hargrove MS, 1997, J MOL BIOL, V266, P1032, DOI 10.1006/jmbi.1996.0833; Hargrove MS, 2000, STRUCTURE, V8, P1005, DOI 10.1016/S0969-2126(00)00194-5; HARUTYUNYAN EH, 1995, J MOL BIOL, V251, P104, DOI 10.1006/jmbi.1995.0419; Hirota S, 1996, J AM CHEM SOC, V118, P7845, DOI 10.1021/ja9608297; Ishikawa H, 2001, BIOPHYS J, V80, P1507, DOI 10.1016/S0006-3495(01)76123-1; KLOEK AP, 1994, J BIOL CHEM, V269, P2377; LAI HH, 1995, PROTEINS, V22, P322, DOI 10.1002/prot.340220404; Lamb DC, 2002, J BIOL CHEM, V277, P11636, DOI 10.1074/jbc.M109892200; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; Nguyen BD, 1998, J BIOL CHEM, V273, P9517, DOI 10.1074/jbc.273.16.9517; Ollesch G, 1999, EUR J BIOCHEM, V262, P396, DOI 10.1046/j.1432-1327.1999.00381.x; Olson J S, 1981, Methods Enzymol, V76, P631; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Ostermann A, 2000, NATURE, V404, P205, DOI 10.1038/35004622; Ota M, 1997, FEBS LETT, V415, P129, DOI 10.1016/S0014-5793(97)01110-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson ES, 1997, BIOCHEMISTRY-US, V36, P13110, DOI 10.1021/bi971156n; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; PHILLIPS SEV, 1980, J MOL BIOL, V142, P531, DOI 10.1016/0022-2836(80)90262-4; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; QUILLIN ML, 1995, THESIS RICE U HOUSTO; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SCOTT TW, 1984, J AM CHEM SOC, V106, P5677, DOI 10.1021/ja00331a044; SMERDON SJ, 1993, BIOCHEMISTRY-US, V32, P5132, DOI 10.1021/bi00070a023; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; Tarricone C, 1997, STRUCTURE, V5, P497, DOI 10.1016/S0969-2126(97)00206-2; TIAN WD, 1993, J MOL BIOL, V233, P155, DOI 10.1006/jmbi.1993.1491; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; TRAVAGLINI ALLOCATELLI C, 1994, FEBS LETT, V352, P63, DOI 10.1016/0014-5793(94)00918-X; WAKABAYASHI S, 1986, NATURE, V322, P481, DOI 10.1038/322481a0; Xia ZC, 1999, J BIOL CHEM, V274, P31819, DOI 10.1074/jbc.274.45.31819; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123; YANG J, 1995, P NATL ACAD SCI USA, V92, P4224, DOI 10.1073/pnas.92.10.4224; ZHAO XF, 1995, J BIOL CHEM, V270, P20763, DOI 10.1074/jbc.270.35.20763; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015	67	95	97	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7509	7519		10.1074/jbc.M109206200	http://dx.doi.org/10.1074/jbc.M109206200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744723	hybrid			2022-12-27	WOS:000174104300097
J	Fan, GH; Yang, W; Sai, JQ; Richmond, A				Fan, GH; Yang, W; Sai, JQ; Richmond, A			Hsc/Hsp70 interacting protein (Hip) associates with CXCR2 and regulates the receptor signaling and trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTORS; COATED VESICLES; TERMINAL DOMAIN; INDUCED INTERNALIZATION; MEDIATED ENDOCYTOSIS; UNCOATING ATPASE; BETA-ARRESTIN; DESENSITIZATION; CLATHRIN; HSC70	The ligand-induced trafficking of chemokine receptors plays a significant role in the regulation of inflammatory processes and human immunodeficiency infection. Although many chemokine receptors have been demonstrated to internalize through clathrin-coated vesicles, a process that involves the binding of arrestins to the receptors, accumulating evidence has suggested the possible existence of other regulators. In a yeast two-hybrid screening using the C-terminal domain of CXCR2 as a bait, the Hsc70-interacting protein (Hip) was identified to interact with CXCR2. Hip binds CXCR2 through its C-terminal domain binding to the C-terminal leucine-rich domain (KILAMGLI) of CXCR2. Hip associates with CXCR2 or CXCR4 in intact cells, and agonist stimulation increases the association. Mutation of the Ile-Leu motif in the C-terminal domain of CXCR2 blocks the agonist-dependent association of the mutant receptor with Hip. Overexpression of a tetratricopeptide repeat (TPR) deletion mutant form of Hip (ATPR), which is unable to bind Hsc70 (Prapapanich, V., Chen, S., Nair, S. C., Rimerman, R. A., and Smith, D. F. (1996) Mol. Endocrinol. 10, 420-431), but retains the ability to bind CXCR2, does not affect CXCR2-mediated mitogen-activated protein kinase activation. However, overexpression of ATPR significantly attenuates the agonist-induced internalization of CXCR2 and CXCR4 and attenuates CXCR2-mediated chemotaxis. These findings open the possibility for regulation of chemokine receptor signaling and trafficking by protein chaperone molecules.	Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Richmond, A (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	ann.richmond@mcmail.vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	NATIONAL CANCER INSTITUTE [P30CA068485, R01CA034590, R23CA034590] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSTIEL L, 1983, CELL, V32, P921, DOI 10.1016/0092-8674(83)90077-6; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Arenberg DA, 1997, J LEUKOCYTE BIOL, V62, P554, DOI 10.1002/jlb.62.5.554; Asagoe K, 1998, J IMMUNOL, V160, P4518; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; BENBARUCH A, 1995, J BIOL CHEM, V270, P11703, DOI 10.1074/jbc.270.20.11703; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Broxmeyer HE, 2001, ANN NY ACAD SCI, V938, P117; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fan GH, 2001, J BIOL CHEM, V276, P16960, DOI 10.1074/jbc.M009292200; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Hannan LA, 1998, MOL BIOL CELL, V9, P2217, DOI 10.1091/mbc.9.8.2217; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; HARPER JW, 1993, CELL, V75, P805; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HOHFELD J, 1995, CELL, V83, P589; HONING S, 1994, J CELL SCI, V107, P1185; Irmer H, 1997, J BIOL CHEM, V272, P2230; Jiang RF, 2000, J BIOL CHEM, V275, P8439, DOI 10.1074/jbc.275.12.8439; Khandaker MH, 1998, J IMMUNOL, V161, P1930; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Nollen EAA, 2001, J BIOL CHEM, V276, P4677, DOI 10.1074/jbc.M009745200; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; PEARSE B, 1980, TRENDS BIOCHEM SCI, V5, P131, DOI 10.1016/0968-0004(80)90055-9; Pohl M, 1997, J BIOL CHEM, V272, P18179, DOI 10.1074/jbc.272.29.18179; Prapapanich V, 1998, MOL CELL BIOL, V18, P944, DOI 10.1128/MCB.18.2.944; Prapapanich V, 1996, MOL ENDOCRINOL, V10, P420, DOI 10.1210/me.10.4.420; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; Sabroe I, 2000, J BIOL CHEM, V275, P25985, DOI 10.1074/jbc.M908864199; Sabroe I, 1997, J IMMUNOL, V158, P1361; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sarrio S, 2000, MOL CELL BIOL, V20, P5164, DOI 10.1128/MCB.20.14.5164-5174.2000; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	51	47	51	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6590	6597		10.1074/jbc.M110588200	http://dx.doi.org/10.1074/jbc.M110588200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751889	Green Accepted, hybrid			2022-12-27	WOS:000173989200118
J	Koide, T; Takahara, Y; Asada, S; Nagata, K				Koide, T; Takahara, Y; Asada, S; Nagata, K			Xaa-Arg-Gly triplets in the collagen triple helix are dominant binding sites for the molecular chaperone HSP47	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS PROTEIN HSP47; FIBRIL FORMATION; PROCOLLAGEN; PEPTIDES; HEAT-SHOCK-PROTEIN-47; REQUIREMENTS; BIOSYNTHESIS; RECOGNITION	HSP47 is an essential procollagen-specific molecular chaperone that resides in the endoplasmic reticulum of procollagen-producing cells. Recent advances have revealed that HSP47 recognizes the (Pro-Pro-Gly)(n) sequence but not (Pro-Hyp-Gly)(n) and that HSP47 recognizes the triple-helical conformation. In this study, to better understand the substrate recognition by HSP47, we synthesized various collagen model peptides and examined their interaction with HSP47 in vitro. We found that the Pro-Arg-Gly triplet forms an HSP47-binding site. The HSP47 binding was observed only when Arg residues were incorporated in the Xaa positions of the Xaa-Yaa-Gly triplets. Amino acids in the Xaa position did not largely affect the interaction. The recognition of the Arg residue by HSP47 was specific to its side-chain structure because replacement of the Arg residue by other basic amino acids decreased the affinity to HSP47. The significance of Arg residues in HSP47 binding was further confirmed by using residue-specific chemical modification of types I and III collagen. Our results demonstrate that Xaa-Arg-Gly sequences in the triple-helical procollagen molecule are dominant binding sites for HSP47 and enable us to predict HSP47-binding sites in homotrimeric procollagen molecules.	Univ Tokushima, Fac Engn, Dept Biol Sci & Technol, Tokushima 7708506, Japan; Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, Kyoto 6068397, Japan	Tokushima University; Kyoto University	Koide, T (corresponding author), Univ Tokushima, Fac Engn, Dept Biol Sci & Technol, Tokushima 7708506, Japan.	tkoide@bio.tokushima-u.ac.jp						BONIFATI L, 1998, CELL, V95, P993; Hu XW, 1996, TISSUE CELL, V28, P215; Knupp C, 2001, EMBO J, V20, P372, DOI 10.1093/emboj/20.3.372; Koide T, 1999, J BIOL CHEM, V274, P34523, DOI 10.1074/jbc.274.49.34523; Koide T, 2000, J BIOL CHEM, V275, P27957; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; NATSUME T, 1994, J BIOL CHEM, V269, P31224; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977; Razzaque MS, 1998, MODERN PATHOL, V11, P1183; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469; Sunamoto M, 1998, INT J EXP PATHOL, V79, P133, DOI 10.1046/j.1365-2613.1998.00061.x; Suzuki Y, 1999, J BIOCHEM, V126, P54, DOI 10.1093/oxfordjournals.jbchem.a022436; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Yang W, 1997, J BIOL CHEM, V272, P28837, DOI 10.1074/jbc.272.46.28837	21	78	80	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6178	6182		10.1074/jbc.M106497200	http://dx.doi.org/10.1074/jbc.M106497200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11751879	hybrid			2022-12-27	WOS:000173989200065
J	Ostrowski, J; Wyrwicz, L; Rychlewski, L; Bomsztyk, K				Ostrowski, J; Wyrwicz, L; Rychlewski, L; Bomsztyk, K			Heterogeneous nuclear ribonucleoprotein K protein associates with multiple mitochondrial transcripts within the organelle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-DELTA; HNRNP-K; BINDING-PROTEIN; 3-HYBRID SYSTEM; RNA-BINDING; IN-VITRO; ACTIVATION; PHOSPHORYLATION; SEQUENCE; HOMOLOG	Heterogeneous nuclear ribonucleoprotein K (hnRNP K) protein interacts with a subset of cellular RNAs. We used K protein as a bait in the yeast three-hybrid screen to identify RNAs that bind K protein in vivo. A large number of K protein-binding RNA clones were identified from a human hybrid RNA library. These sequences consisted of C-rich patches and were G-poor. Unexpectedly, several of the RNA clones were encoded by the mitochondrial genome. In a subsequent three-hybrid screen of a hybrid RNA library generated from a mouse liver mitochondrial genome, K protein bound RNA sequences encoded by different loci spanning nearly the entire mitochondrial genome. Western blot analysis of extracts from mitochondria and mitochondrial fractions showed that K protein is localized within mitoplasts. Reverse transcriptase PCR of RNA co-immunoprecipitated with K protein from lysates of isolated mitochondria showed that K protein is associated with several processed mitochondrial transcripts. In contrast, in the same assay, the polycistronic nascent mtRNA bound K protein weakly or not at all. Results of this study suggest that K protein acts within functional modules that are responsible for expression of genes in mitochondria.	Marie Curie Sklodowska Curie Mem Canc Ctr, Med Ctr Postgrad Educ, Dept Gastroenterol, PL-02781 Warsaw, Poland; Inst Oncol, PL-02781 Warsaw, Poland; Int Inst Mol & Cell Biol, Bioinformat Unit, PL-02102 Warsaw, Poland; Pomeranian Med Acad, Dept Informat & Biocybernet, PL-70204 Szczecin, Poland; BioInfoBank Inst, PL-60744 Poznan, Poland; Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA	Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Pomeranian Medical University; University of Washington; University of Washington Seattle	Ostrowski, J (corresponding author), Ctr Canc, Dept Gastroenterol, Roentgena 5, PL-02781 Warsaw, Poland.	jostrow@warman.com.pl	Wyrwicz, Lucjan/ABD-6558-2021	Wyrwicz, Lucjan/0000-0003-0808-6892; Ostrowski, Jerzy/0000-0003-1363-3766				Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; BURNETTE B, 1985, ANAL BIOCHEM, V145, P80, DOI 10.1016/0003-2697(85)90329-X; Charroux B, 1999, MOL CELL BIOL, V19, P7846, DOI 10.1128/mcb.19.11.7846; Chen CY, 2000, GENE DEV, V14, P1236; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Cuezva JM, 1997, J BIOENERG BIOMEMBR, V29, P365, DOI 10.1023/A:1022450831360; Denisenko O, 2002, MOL CELL BIOL, V22, P286, DOI 10.1128/MCB.22.1.286-297.2002; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; HOBERT O, 1994, J BIOL CHEM, V269, P20225; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; Huang X, 1999, DIABETES, V48, P1508, DOI 10.2337/diabetes.48.8.1508; ITO K, 1994, NUCLEIC ACIDS RES, V22, P53, DOI 10.1093/nar/22.1.53; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Miau LH, 1998, J BIOL CHEM, V273, P10784, DOI 10.1074/jbc.273.17.10784; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; OSTROWSKI J, 1994, J BIOL CHEM, V269, P17626; Ostrowski J, 2000, J BIOL CHEM, V275, P3619, DOI 10.1074/jbc.275.5.3619; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rassow J, 2000, TRAFFIC, V1, P457, DOI 10.1034/j.1600-0854.2000.010603.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; Sengupta DJ, 1999, RNA, V5, P596, DOI 10.1017/S1355838299002113; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Thisted T, 2001, J BIOL CHEM, V276, P17484, DOI 10.1074/jbc.M010594200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANSEUNINGEN I, 1995, BIOCHEMISTRY-US, V34, P5644, DOI 10.1021/bi00016a040; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Wadd S, 1999, J BIOL CHEM, V274, P28991, DOI 10.1074/jbc.274.41.28991; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zuker M., 1999, V70, P11	50	50	52	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6303	6310		10.1074/jbc.M110267200	http://dx.doi.org/10.1074/jbc.M110267200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741984	hybrid			2022-12-27	WOS:000173989200081
J	Ueki, T; Inouye, S				Ueki, T; Inouye, S			Transcriptional activation of a heat-shock gene, lonD, of Myxococcus xanthus by a two component histidine-aspartate phosphorelay system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; ATP-DEPENDENT PROTEASE; MAJOR SIGMA-FACTOR; ESCHERICHIA-COLI; RNA-POLYMERASE; MULTISTEP PHOSPHORELAY; SIGNAL-TRANSDUCTION; BACILLUS-SUBTILIS; STATIONARY-PHASE; DNA-SEQUENCE	In vitro transcription of lonD, a heat-shock gene from Myxococcus xanthus, was stimulated in the presence of extract from heat-shocked cells. For this stimulation the upstream promoter region of lonD was found to be essential. Activation of lonD transcription was also observed when extract from non-heat-shocked cells was heat treated in vitro at 42 degreesC for 10 min. A DNA binding assay and footprinting analysis revealed that a factor(s) binds to the upstream region from -122 to -107 with respect to the transcription initiation site. This region was required for heat-shock induction of lonD expression both in vitro and in vivo. The lonD promoter-binding protein named HsfA was purified, and its gene was cloned. Analysis of the DNA sequence reveals that HsfA is a response regulator of the two-component system and shows high sequence similarity to the NtrC family or the enhancer-binding proteins. Upstream of hsfA, a gene encoding a histidine kinase was identified and named hsfB. HsfB was found to be autophosphorylated and able to phosphorylate HsfA. HsfA with HsfB activated in vitro transcription of lonD in a manner dependent on RNA polymerase containing SigA, the housekeeping sigma factor of M. xanthus.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, S (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	sinouye@waksman.rutgers.edu	Inouye, Sharon/R-7216-2019					APELIAN D, 1993, J BACTERIOL, V175, P3335, DOI 10.1128/jb.175.11.3335-3342.1993; APELIAN D, 1990, GENE DEV, V4, P1396, DOI 10.1101/gad.4.8.1396; Appleby JL, 1996, CELL, V86, P845, DOI 10.1016/S0092-8674(00)80158-0; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Biran D, 1997, MOL MICROBIOL, V25, P463, DOI 10.1046/j.1365-2958.1997.4751843.x; Bowman WC, 1998, GENE DEV, V12, P1884, DOI 10.1101/gad.12.12.1884; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; Cho KY, 1999, MOL MICROBIOL, V34, P268, DOI 10.1046/j.1365-2958.1999.01594.x; Clough SJ, 1997, J BACTERIOL, V179, P3639, DOI 10.1128/jb.179.11.3639-3648.1997; Dworkin M, 1996, MICROBIOL REV, V60, P70, DOI 10.1128/MMBR.60.1.70-102.1996; DWORKIN M, 1993, MYXXOBACTERIA, V2; GILL RE, 1993, J BACTERIOL, V175, P4538, DOI 10.1128/JB.175.14.4538-4544.1993; GROSS C, 1976, J BACTERIOL, V128, P382, DOI 10.1128/JB.128.1.382-389.1976; Gross CA, 1996, ESCHERICHIA COLI SAL, P1382; Hanlon WA, 1997, MOL MICROBIOL, V23, P459, DOI 10.1046/j.1365-2958.1997.d01-1871.x; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hecker M, 1996, MOL MICROBIOL, V19, P417, DOI 10.1046/j.1365-2958.1996.396932.x; Hoch JA, 1995, 2 COMPONENT SIGNAL T; INOUYE S, 1990, J BACTERIOL, V172, P80, DOI 10.1128/JB.172.1.80-85.1990; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KESELER IM, 1995, J BACTERIOL, V177, P4638, DOI 10.1128/jb.177.16.4638-4644.1995; Keseler IM, 1997, P NATL ACAD SCI USA, V94, P1979, DOI 10.1073/pnas.94.5.1979; KOMANO T, 1987, J MOL BIOL, V196, P517, DOI 10.1016/0022-2836(87)90029-5; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LARSON JS, 1988, NATURE, V335, P372, DOI 10.1038/335372a0; MCGOWAN SJ, 1993, MOL MICROBIOL, V10, P713, DOI 10.1111/j.1365-2958.1993.tb00943.x; Miller J.H., 1972, EXPT MOL GENETICS; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; NORTH AK, 1993, J BACTERIOL, V175, P4267, DOI 10.1128/JB.175.14.4267-4273.1993; Perego M, 1998, TRENDS MICROBIOL, V6, P366, DOI 10.1016/S0966-842X(98)01350-X; PLAMANN L, 1995, J BACTERIOL, V177, P2014, DOI 10.1128/jb.177.8.2014-2020.1995; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; RHEE SG, 1985, CURR TOP CELL REGUL, V27, P221; ROMEO JM, 1991, J BACTERIOL, V173, P2969, DOI 10.1128/JB.173.9.2969-2976.1991; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; THONY B, 1989, FEMS MICROBIOL LETT, V63, P341; TOJO N, 1993, J BACTERIOL, V175, P2271, DOI 10.1128/JB.175.8.2271-2277.1993; TOJO N, 1993, J BACTERIOL, V175, P4545, DOI 10.1128/JB.175.14.4545-4549.1993; Ueki T, 1998, GENES CELLS, V3, P371, DOI 10.1046/j.1365-2443.1998.00197.x; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Ward MJ, 1998, J BACTERIOL, V180, P5668, DOI 10.1128/JB.180.21.5668-5675.1998; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3; ZHANG WD, 1992, J BACTERIOL, V174, P5450, DOI 10.1128/JB.174.16.5450-5453.1992	50	40	40	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6170	6177		10.1074/jbc.M110155200	http://dx.doi.org/10.1074/jbc.M110155200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748231	hybrid			2022-12-27	WOS:000173989200064
J	Wojcik, C; DeMartino, GN				Wojcik, C; DeMartino, GN			Analysis of Drosophila 26 S proteasome using RNA interference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-MEDIATED PROTEOLYSIS; CHYMOTRYPSIN-LIKE ACTIVITY; MULTICATALYTIC PROTEINASE COMPLEX; ATP-DEPENDENT ACTIVATOR; DOUBLE-STRANDED-RNA; 20S PROTEASOME; REGULATORY PARTICLE; SACCHAROMYCES-CEREVISIAE; 20-S PROTEASOME; CELL-CYCLE	We have utilized double-stranded RNA interference (RNAi) to examine the effects of reduced expression of individual subunits of the 26 S proteasome in Drosophila S2 cells. RNAi significantly decreased mRNA and protein levels of targeted subunits of both the core 20 S proteasome and the PA700 regulatory complex. Cells deficient in any of several 26 S proteasome subunits (e.g. dbeta5, dRpt1, dRpt2, dRpt5, dRpn2, and dRpn12) displayed decreased proteasome activity (as judged by hydrolysis of succinyl-Leu-Leu-Val-Tyr-aminomethyl-coumarin), increased apoptosis, decreased cell proliferation without a specific block of the cell cycle, and accumulation of ubiquitinated cellular proteins. RNAi of many individual 26 S proteasome subunits promoted increased expression of many non-targeted subunits. This effect was not mimicked by chemical proteasome inhibitors such as lactacystin. Reduced expression of most targeted subunits disrupted the assembly of the 26 S proteasome. RNAi of six of eight targeted PA700 subunits disrupted that structure and caused accumulation of increased levels of uncapped 20 S proteasome. Notable exceptions included RNAi of dRpn10, a polyubiquitin binding subunit, and dUCH37, a ubiquitin isopeptidase. dRpn10-deficient cells showed a significant increase in suceinyl-Leu-Leu-Val-Tyr-aminomethyl-coumarin hydrolyzing activity of the 26 S proteasomes but accumulated polyubiquitinated proteins. dbeta5-Deficient cells had a phenotype similar to that of most PA700-deficient cells but also acclumulated low molecular mass complexes containing subunits of the 20 S proteasome, probably representing unassembled precursors of the 20 S proteasomes. Cells deficient in several of the 26 S proteasome subunits were more resistant to otherwise toxic concentrations of various proteasome inhibitors. Our data suggest that those cells adapted to grow in conditions of impaired ubiquitin and proteasome-dependent protein degradation.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	george.demartino@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL006296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046181, R01DK046181] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Covi JA, 1999, ARCH BIOCHEM BIOPHYS, V368, P85, DOI 10.1006/abbi.1999.1294; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DUBIEL W, 1993, FEBS LETT, V323, P276, DOI 10.1016/0014-5793(93)81356-5; DUBIEL W, 1995, MOL BIOL REP, V21, P27, DOI 10.1007/BF00990967; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; KALTOFT MB, 1992, HYBRIDOMA, V11, P507, DOI 10.1089/hyb.1992.11.507; Kapranov A. B., 2001, Molekulyarnaya Biologiya (Moscow), V35, P420; KATAGIRI M, 1995, J ANTIBIOT, V48, P344, DOI 10.7164/antibiotics.48.344; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kudo Y, 2000, CLIN CANCER RES, V6, P916; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Li TW, 2000, BIOCHEM BIOPH RES CO, V272, P270, DOI 10.1006/bbrc.2000.2767; MA CP, 1994, J BIOL CHEM, V269, P3539; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mykles DL, 1999, MOL BIOL REP, V26, P103, DOI 10.1023/A:1006976524916; Orlowski M, 2000, ARCH BIOCHEM BIOPHYS, V383, P1, DOI 10.1006/abbi.2000.2036; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Schmidt M, 1997, MOL BIOL REP, V24, P103, DOI 10.1023/A:1006826725056; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; SHIBATANI T, 1995, ARCH BIOCHEM BIOPHYS, V321, P160, DOI 10.1006/abbi.1995.1381; Soldatenkov VA, 1997, CANCER RES, V57, P3881; Song XL, 1996, J BIOL CHEM, V271, P26410, DOI 10.1074/jbc.271.42.26410; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Tanahashi N, 1999, MOL BIOL REP, V26, P3, DOI 10.1023/A:1006909522731; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Wojcik C, 1999, CELL MOL LIFE SCI, V56, P908, DOI 10.1007/s000180050483; Wojcik C, 1997, APOPTOSIS, V2, P455, DOI 10.1023/A:1026470027387; Wojcik C, 1996, EUR J CELL BIOL, V70, P172; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	67	88	89	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6188	6197		10.1074/jbc.M109996200	http://dx.doi.org/10.1074/jbc.M109996200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11739392	hybrid			2022-12-27	WOS:000173989200067
J	Xia, B; Ke, HP; Jiang, W; Inouye, M				Xia, B; Ke, HP; Jiang, W; Inouye, M			The cold box stem-loop proximal to the 5 '-end of the Escherichia coli cspA gene stabilizes its mRNA at low temperature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SHOCK PROTEIN; 5'-UNTRANSLATED REGION; UNTRANSLATED REGION; TRANSCRIPTION; ADAPTATION; 37-DEGREES-C; EXPRESSION; INDUCTION; MUTATIONS	The 5'-end region of cspA mRNA contains a Cold Box sequence conserved among several cold-shock mRNAs. This region forms a stable stem-loop structure followed by an AU-rich sequence. Here we show that the Cold Box region is essential for the normal scale of cspA mRNA induction after cold shock because a deletion of the stem-loop significantly destabilizes the mRNA and reduces the cold shock-induced espA mRNA amount by similar to50%. The AU-rich track, however, slightly destabilizes the mRNA. The integrity of the stem is essential for the stabilizing function, whereas that of the loop sequence is less important. Overexpression of a mutant espA mRNA devoid of both the AUG initiation codon and the coding sequence results in a severe growth inhibition at low temperature along with a derepression of the chromosomal cspA expression. Furthermore, the overexpressed RNA is stably associated with the 30 S and 70 S ribosomes. Our results demonstrate that the AUG initiation codon and the coding region containing the down. stream box are not required for cspA mRNA to bind ribosomes and that the 5'-untranslated region by itself has a remarkable affinity to ribosomes at low temperature.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	inouye@umdnj.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019043, R37GM019043] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae W, 1997, J BACTERIOL, V179, P7081, DOI 10.1128/jb.179.22.7081-7088.1997; Brandi A, 1999, EMBO J, V18, P1653, DOI 10.1093/emboj/18.6.1653; Fang L, 1999, FEMS MICROBIOL LETT, V176, P39, DOI 10.1016/S0378-1097(99)00216-5; Fang L, 1998, J BACTERIOL, V180, P90, DOI 10.1128/JB.180.1.90-95.1998; Fang L, 1997, MOL MICROBIOL, V23, P355, DOI 10.1046/j.1365-2958.1997.2351592.x; Goldenberg D, 1997, MOL GEN GENET, V256, P282, DOI 10.1007/s004380050571; Goldenberg D, 1996, MOL MICROBIOL, V19, P241, DOI 10.1046/j.1365-2958.1996.363898.x; GOLDSTEIN J, 1990, P NATL ACAD SCI USA, V87, P283, DOI 10.1073/pnas.87.1.283; HARLOCKER SL, 1993, J BACTERIOL, V175, P1956, DOI 10.1128/JB.175.7.1956-1960.1993; JIANG WN, 1993, J BACTERIOL, V175, P5824, DOI 10.1128/JB.175.18.5824-5828.1993; Jiang WN, 1996, J BACTERIOL, V178, P4919, DOI 10.1128/jb.178.16.4919-4925.1996; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Lim J, 2000, J MOL BIOL, V297, P553, DOI 10.1006/jmbi.2000.3585; LOPILATO J, 1986, MOL GEN GENET, V205, P285, DOI 10.1007/BF00430440; Mitta M, 1997, MOL MICROBIOL, V26, P321, DOI 10.1046/j.1365-2958.1997.5771943.x; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; TANABE H, 1992, J BACTERIOL, V174, P3867, DOI 10.1128/jb.174.12.3867-3873.1992; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; Wang N, 1999, J BACTERIOL, V181, P1603, DOI 10.1128/JB.181.5.1603-1609.1999; Xia B, 2001, MOL MICROBIOL, V40, P179, DOI 10.1046/j.1365-2958.2001.02372.x; Xia B, 2001, J BIOL CHEM, V276, P35581, DOI 10.1074/jbc.M103871200; Yamanaka K, 1999, J BACTERIOL, V181, P6284, DOI 10.1128/JB.181.20.6284-6291.1999; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yamanaka K, 2001, J BACTERIOL, V183, P2808, DOI 10.1128/JB.183.9.2808-2816.2001; Yamanaka K, 2001, GENES CELLS, V6, P279, DOI 10.1046/j.1365-2443.2001.00424.x	25	31	34	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6005	6011		10.1074/jbc.M109700200	http://dx.doi.org/10.1074/jbc.M109700200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741997	hybrid			2022-12-27	WOS:000173989200041
J	Li, LG; He, ZY; Pandey, GK; Tsuchiya, T; Luan, S				Li, LG; He, ZY; Pandey, GK; Tsuchiya, T; Luan, S			Functional cloning and characterization of a plant efflux carrier for multidrug and heavy metal detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; TRANSPORTER; PROTEIN; BINDING; PUMP; RESISTANCE; H+; SUPERFAMILY	We have identified a detoxifying efflux carrier from Arabidopsis using a functional cloning strategy. A bacterial mutant, KAM3, is deficient in multidrug resistance and does not survive on medium containing norfloxacin. After transformation of KAM3 cells with an Arabidopsis cDNA library, transformants were selected for restored growth on the toxic medium. One cDNA clone that complemented KAM3 encodes a novel protein with twelve putative transmembrane domains and contains limited sequence homology to a multidrug and toxin efflux carrier from bacteria. We named this Arabidopsis protein AtDTX1 (for Arabidopsis thaliana Detoxification 1). A large gene family of at least 56 members encoding related proteins was identified from the Arabidopsis genome. Further functional analysis of AtDTX1 protein in KAM3 mutant demonstrated that AtDTX1 serves as an efflux carrier for plant-derived alkaloids, antibiotics, and other toxic compounds. Interestingly, AtDTX1 was also capable of detoxifying Cd2+, a heavy metal. Further experiments suggest that AtDTX1 is localized in the plasma membrane in plant cells thereby mediating the efflux of plant-derived or exogenous toxic compounds from the cytoplasm.	Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA; Okayama Univ, Fac Pharmacol Sci, Dept Microbiol, Okayama 7008530, Japan	University of California System; University of California Berkeley; Okayama University	Luan, S (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA.		he, zhe/GSJ-2307-2022	PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM052826] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-52826] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOLHUIS H, 1994, J BACTERIOL, V176, P6957, DOI 10.1128/JB.176.22.6957-6964.1994; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DH, 1999, LICHENOLOGIST, V31, P1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Davies TGE, 2000, PLANT CELL ENVIRON, V23, P431, DOI 10.1046/j.1365-3040.2000.00577.x; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Dixon DP, 1998, CURR OPIN PLANT BIOL, V1, P258, DOI 10.1016/S1369-5266(98)80114-3; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Gupta R, 1998, PLANT J, V16, P581, DOI 10.1046/j.1365-313x.1998.00327.x; Hsieh PC, 1998, P NATL ACAD SCI USA, V95, P6602, DOI 10.1073/pnas.95.12.6602; JENNINGS BR, 1983, BIOPHYS STRUCT MECH, V10, P71, DOI 10.1007/BF00535543; Liu GS, 2001, J BIOL CHEM, V276, P8648, DOI 10.1074/jbc.M009690200; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Mata MT, 2000, FEMS MICROBIOL LETT, V187, P185, DOI 10.1111/j.1574-6968.2000.tb09158.x; MICHELET B, 1995, PLANT PHYSIOL, V108, P1, DOI 10.1104/pp.108.1.1; Moller SG, 2001, GENE DEV, V15, P90, DOI 10.1101/gad.850101; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; NEYFAKH AA, 1991, P NATL ACAD SCI USA, V88, P4781, DOI 10.1073/pnas.88.11.4781; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; PADAN E, 1994, BBA-BIOENERGETICS, V1187, P206, DOI 10.1016/0005-2728(94)90112-0; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; SHEEN J, 1995, PLANT J, V8, P777, DOI 10.1046/j.1365-313X.1995.08050777.x; SHIOMI N, 1988, APPL MICROBIOL BIOT, V29, P302; Sidler M, 1998, PLANT CELL, V10, P1623, DOI 10.1105/tpc.10.10.1623; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMS B, 1987, J BACTERIOL, V169, P1731, DOI 10.1128/jb.169.4.1731-1736.1987; Yelin R, 1999, J BACTERIOL, V181, P949, DOI 10.1128/JB.181.3.949-956.1999; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	36	212	302	6	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5360	5368		10.1074/jbc.M108777200	http://dx.doi.org/10.1074/jbc.M108777200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739388	hybrid			2022-12-27	WOS:000173962900104
J	Meyer, A; Schmid, A; Held, M; Westphal, AH; Rothlisberger, M; Kohler, HPE; van Berkel, WJH; Witholt, B				Meyer, A; Schmid, A; Held, M; Westphal, AH; Rothlisberger, M; Kohler, HPE; van Berkel, WJH; Witholt, B			Changing the substrate reactivity of 2-hydroxybiphenyl 3-monooxygenase from Pseudomonas azelaica HBP1 by directed evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-HYDROXYBENZOATE HYDROXYLASE; SP STRAIN HBP1; PHENOL HYDROXYLASE; CRYSTAL-STRUCTURE; IN-VITRO; MECHANISM; METABOLISM; ENZYME; FLAVOPROTEIN; PURIFICATION	The substrate reactivity of the flavoenzyme 2-hydroxybiphenyl 3-monooxygenase (EC 1.14.13.44, HbpA) was changed by directed evolution using error-prone PCR. In situ screening of mutant libraries resulted in the identification of proteins with increased activity towards 2-tert-butylphenol and guaiacol (2-methoxyphenol). One enzyme variant contained amino acid substi tutions V368A/L417F, which were inserted by two rounds of mutagenesis. The double replacement improved the efficiency of substrate hydroxylation by reducing the uncoupled oxidation of NADH. With guaiacol as substrate, the two substitutions increased V-max from 0.22 to 0.43 units mg(-1) protein and decreased the K'(m) from 588 to 143 muM, improving k'(catz)/K'(m) by a factor of 8.2. With 2-tert-butylphenol as the substrate, k'(cat) was increased more than 5-fold. Another selected enzyme variant contained amino acid substitution I244V and had a 30% higher specific activity with 2-sec-butylphenol, guaiacol, and the "natural" substrate 2-hydroxybiphenyl. The K'(m) for guaiacol decreased with this mutant, but the K'(m) for 2-hydroxybiphenyl increased. The primary structure of HbpA shares 20.1% sequence identity with phenol 2-monooxygenase from Trichosporon cutaneum. Structure homology modeling with this three-domain enzyme suggests that Ile(244) of HbpA is located in the substrate binding pocket and is involved in accommodating the phenyl substituent of the phenol. In contrast, Val(368) and Leu(417) are not close to the active site and would not have been obvious candidates for modification by rational design.	ETH Honggerberg, Inst Biotech, HTP, ETHZ Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; Wageningen Univ, Dept Agrotechnol & Food Sci, Lab Biochem, Wageningen, Netherlands; EAWAG, Swiss Inst Environm Sci & Technol, CH-8600 Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Witholt, B (corresponding author), ETH Honggerberg, Inst Biotech, HTP, ETHZ Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland.	bw@biotech.biol.ethz.ch	Westphal, Adrie Herman/L-3517-2019; Kohler, Hans-Peter/C-1456-2015; Witholt, Bernard/A-7340-2012; van Berkel, Willem J.H./O-2431-2014	Westphal, Adrie Herman/0000-0003-4264-6267; Kohler, Hans-Peter/0000-0001-7667-0762; van Berkel, Willem J.H./0000-0002-6551-2782				ALLINGER NL, 1976, ORGANIC CHEM, P548; Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P150; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; BOYD SA, 1983, APPL ENVIRON MICROB, V46, P50, DOI 10.1128/AEM.46.1.50-54.1983; CATELANI D, 1973, BIOCHEM J, V134, P1063, DOI 10.1042/bj1341063; DARDAS A, 1985, ARCH BIOCHEM BIOPHYS, V236, P585, DOI 10.1016/0003-9861(85)90662-9; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; DETMER K, 1984, J BIOL CHEM, V259, P1265; Enroth C, 1998, STRUCTURE, V6, P605, DOI 10.1016/S0969-2126(98)00062-8; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; Eppink MHM, 1997, PROTEIN SCI, V6, P2454; GATTI DL, 1994, SCIENCE, V266, P110, DOI 10.1126/science.7939628; GIBSON DT, 1973, BIOCHEM BIOPH RES CO, V50, P211, DOI 10.1016/0006-291X(73)90828-0; Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809; GONZALEZ B, 1993, APPL ENVIRON MICROB, V59, P3424; GRAF L, 1987, BIOCHEMISTRY-US, V26, P2616, DOI 10.1021/bi00383a031; HAGGBLOM MM, 1988, APPL ENVIRON MICROB, V54, P3043; Held M, 1999, BIOTECHNOL BIOENG, V62, P641, DOI 10.1002/(SICI)1097-0290(19990320)62:6<641::AID-BIT3>3.0.CO;2-H; Held M, 1998, J MOL CATAL B-ENZYM, V5, P87, DOI 10.1016/S1381-1177(98)00012-5; HELD M, 2000, BIOCATALYTIC SYNTHES; HINES RN, 1994, TOXICOL APPL PHARM, V125, P1, DOI 10.1006/taap.1994.1042; HOWELL LG, 1972, J BIOL CHEM, V247, P4340; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; KOHLER HPE, 1988, APPL ENVIRON MICROB, V54, P2683, DOI 10.1128/AEM.54.11.2683-2688.1988; KOHLER HPE, 1993, APPL ENVIRON MICROB, V59, P860, DOI 10.1128/AEM.59.3.860-866.1993; KOHLER HPE, 1993, J BACTERIOL, V175, P1621, DOI 10.1128/JB.175.6.1621-1628.1993; Kuchner O, 1997, TRENDS BIOTECHNOL, V15, P523, DOI 10.1016/S0167-7799(97)01138-4; Laden BP, 2000, ARCH BIOCHEM BIOPHYS, V374, P381, DOI 10.1006/abbi.1999.1629; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leung DW, 1989, TECHNIQUE, V1, P11; Lye GJ, 1999, TRENDS BIOTECHNOL, V17, P395, DOI 10.1016/S0167-7799(99)01351-7; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1975, ENZYMES, V12, P191; Mattevi A, 1998, BIOPHYS CHEM, V70, P217, DOI 10.1016/S0301-4622(97)00126-9; May O, 2000, NAT BIOTECHNOL, V18, P317, DOI 10.1038/73773; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Nickerson DP, 1997, FEBS LETT, V405, P153, DOI 10.1016/S0014-5793(97)00174-9; PARKE D, 1992, APPL ENVIRON MICROB, V58, P2694, DOI 10.1128/AEM.58.8.2694-2697.1992; Pikus JD, 1997, BIOCHEMISTRY-US, V36, P9283, DOI 10.1021/bi971049t; Reetz MT, 1997, ANGEW CHEM INT EDIT, V36, P2830, DOI 10.1002/anie.199728301; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAURETIGNAZI G, 1988, BIOCHIMIE, V70, P1385, DOI 10.1016/S0300-9084(88)80001-4; SCHMID A, 1997, THESIS U STUTTGART S; Schmidt-Dannert Claudia, 1999, Trends in Biotechnology, V17, P135, DOI 10.1016/S0167-7799(98)01283-9; SCHREUDER HA, 1994, BIOCHEMISTRY-US, V33, P10161, DOI 10.1021/bi00199a044; SCHREUDER HA, 1989, J MOL BIOL, V208, P679, DOI 10.1016/0022-2836(89)90158-7; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STRYER L, 1981, BIOCHEMISTRY-US, P185; Suske WA, 1999, J BIOL CHEM, V274, P33355, DOI 10.1074/jbc.274.47.33355; Suske WA, 1997, J BIOL CHEM, V272, P24257, DOI 10.1074/jbc.272.39.24257; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Berkel W.J.H., 1991, CHEM BIOCH FLAVOENZY, P1; van den Heuvel RHH, 2000, P NATL ACAD SCI USA, V97, P9455, DOI 10.1073/pnas.160175897; VANBERKEL WJH, 1997, FLAVINS FLAVOPROTEIN, V12, P305; WITHOLT B, 1990, TRENDS BIOTECHNOL, V8, P46, DOI 10.1016/0167-7799(90)90133-I; Xu D, 2001, BIOCHEMISTRY-US, V40, P12369, DOI 10.1021/bi010962y; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhao HM, 1997, CURR OPIN STRUC BIOL, V7, P480, DOI 10.1016/S0959-440X(97)80110-8; Ziechmann W., 1980, HUMINSTOFFE	64	57	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5575	5582		10.1074/jbc.M110018200	http://dx.doi.org/10.1074/jbc.M110018200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733527	Green Published, hybrid			2022-12-27	WOS:000173962900132
J	Stone, JR; Maki, JL; Blacklow, SC; Collins, T				Stone, JR; Maki, JL; Blacklow, SC; Collins, T			The SCAN domain of ZNF174 is a dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; EXPRESSION ANALYSIS; GENE; BOX; IDENTIFICATION; FAMILY; KRAB; OLIGOMERIZATION; ASSOCIATIONS; REPRESSION	The SCAN domain is a conserved region of 84 residues found predominantly in zinc finger DNA-binding proteins in vertebrates. The SCAN domain appears to control the association of SCAN domain containing proteins into noncovalent complexes and may be the primary mechanism underlying partner choice in the oligomerization of these transcription factors. Here we have overexpressed, purified, and characterized the isolated SCAN domain (amino acids 37-132) from ZNF174. Both size exclusion chromatography and equilibrium sedimentation analysis demonstrate that the ZNF174 SCAN domain forms a homodimer. Circular dichroism shows that the isolated SCAN domain dimer has similar to42% alpha-helix. Thermal denaturation experiments indicate that the SCAN domain undergoes a single reversible unfolding transition with a T(m) of over 70 degreesC. The midpoint of the equilibrium unfolding transition increases with increasing protein concentration, consistent with a two-state unfolding transition in which folded dimer is in equilibrium with unfolded monomer. These findings demonstrate that the isolated SCAN domain forms a stable dieter and support a model in which the SCAN domain is capable of mediating the selective dimerization of a large family of vertebrate-specific, zinc finger-containing transcription factors.	Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Collins, T (corresponding author), Childrens Hosp, Dept Pathol, 300 Longwood Ave, Boston, MA 02115 USA.	tcollins@rics.bwh.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066516] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066516-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alders M, 2000, AM J HUM GENET, V66, P1473, DOI 10.1086/302892; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; DARAWSHE S, 1994, ANAL BIOCHEM, V220, P1, DOI 10.1006/abio.1994.1289; Dupuy D, 2000, GENOMICS, V69, P348, DOI 10.1006/geno.2000.6343; Han ZG, 1999, J BIOL CHEM, V274, P35741, DOI 10.1074/jbc.274.50.35741; HONER C, 2001, BIOCHIM BIOPHYS ACTA, V1517, P4741; Kim J, 2000, GENOMICS, V64, P114, DOI 10.1006/geno.1999.6112; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee PL, 1997, GENOMICS, V43, P191, DOI 10.1006/geno.1997.4806; Mavrogiannis LA, 2001, BBA-GENE STRUCT EXPR, V1518, P300, DOI 10.1016/S0167-4781(01)00177-4; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; PENGUE G, 1994, NUCLEIC ACIDS RES, V22, P2908, DOI 10.1093/nar/22.15.2908; Sander TL, 2000, J BIOL CHEM, V275, P12857, DOI 10.1074/jbc.275.17.12857; Schumacher C, 2000, J BIOL CHEM, V275, P17173, DOI 10.1074/jbc.M000119200; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagner S, 2000, J BIOL CHEM, V275, P15685, DOI 10.1074/jbc.M910152199; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P22143, DOI 10.1074/jbc.270.38.22143; Williams AJ, 1999, MOL CELL BIOL, V19, P8526; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	23	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5448	5452		10.1074/jbc.M109815200	http://dx.doi.org/10.1074/jbc.M109815200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741982	Green Accepted, hybrid			2022-12-27	WOS:000173962900115
J	Stegh, AH; Barnhart, BC; Volkland, J; Algeciras-Schimnich, A; Ke, N; Reed, JC; Peter, ME				Stegh, AH; Barnhart, BC; Volkland, J; Algeciras-Schimnich, A; Ke, N; Reed, JC; Peter, ME			Inactivation of caspase-8 on mitochondria of Bcl-x(L)-expressing MCF7-Fas cells - Role for the bifunctional apoptosis regulator protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-FAS ANTIBODY; SIGNALING COMPLEX; CYTOCHROME-C; FAMILY PROTEINS; NECROSIS-FACTOR; DEATH; ACTIVATION; RELEASE; BCL-2; CLEAVAGE	Apoptosis induction through CD95 (APO-1/Fas) critically depends on generation of active caspase-8 at the death-inducing signaling complex (DISC). Depending on the cell type, active caspase-8 either directly activates caspase-3 (type I cells) or relies on mitochondrial signal amplification (type II cells). In MCF7-Fas cells that are deficient for pro-caspase-3, even high amounts of caspase-8 produced at the DISC cannot directly activate downstream effector caspases without mitochondrial help. Overexpression of Bcl-x(L) in these cells renders them resistant to CD95-mediated apoptosis. However, activation of caspase-8 in control (vector) and Bcl-x(L) transfectants of MCF7-Fas cells proceeds with similar kinetics, resulting in a complete processing of cellular caspase-8. Most of the cytosolic caspase-8 substrates are not cleaved in the Bcl-x(L) protected cells, raising the question of how Bcl-x(L)-expressing MCF7-Fas cells survive large amounts of potentially cytotoxic caspase-8. We now demonstrate that active caspase-8 is initially generated at the DISC of both MCF7-Fas-Vec and MCF7-Fas-Bcl-x(L) cells and that the early steps of CD95 signaling such as caspase-8-dependent cleavage of DISC bound c-FLIPL, caspase-8-dependent clustering, and internalization of CD95, as well as processing of pro-caspase-8 bound to mitochondria are very similar in both transfectants. However, events downstream of mitochondria, such as release of cytochrome c, only occur in the vector-transfected MCF7-Fas cells, and no in vivo caspase-8 activity can be detected in the Bcl-x(L)-expressing cells. Our data suggest that, in Bcl-x(L)-expressing MCF7-Fas cells, active caspase-8 is sequestered on the outer mitochondrial surface presumably by association with the protein "bifunctional apoptosis regulator" in a way that does not allow substrates to be cleaved, identifying a novel mechanism of regulation of apoptosis sensitivity by mitochondrial Bcl-x(L).	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Burnham Inst, La Jolla, CA 92037 USA	University of Chicago; Sanford Burnham Prebys Medical Discovery Institute	Peter, ME (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.			Peter, Marcus Ernst/0000-0003-3216-036X	NATIONAL CANCER INSTITUTE [T32CA009594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061712, T32GM007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015393] Funding Source: NIH RePORTER; NCI NIH HHS [5T32CA09594] Funding Source: Medline; NIA NIH HHS [AG15393] Funding Source: Medline; NIGMS NIH HHS [GM61712, 5T32GM07183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; JAATTELA M, 1995, ONCOGENE, V10, P2297; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Krebs JF, 1999, J CELL BIOL, V144, P915, DOI 10.1083/jcb.144.5.915; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; Lacronique V, 1996, NAT MED, V2, P80, DOI 10.1038/nm0196-80; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Medema JP, 1998, J BIOL CHEM, V273, P3388, DOI 10.1074/jbc.273.6.3388; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; PETER ME, 1993, ANAL BIOCHEM, V210, P77, DOI 10.1006/abio.1993.1153; Qin ZH, 2001, J BIOL CHEM, V276, P8079, DOI 10.1074/jbc.M007028200; Rodriguez I, 1996, J EXP MED, V183, P1031, DOI 10.1084/jem.183.3.1031; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Srinivasan A, 1998, J BIOL CHEM, V273, P4523, DOI 10.1074/jbc.273.8.4523; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Stegh AH, 1998, EMBO J, V17, P5974, DOI 10.1093/emboj/17.20.5974; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597	36	98	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					4351	4360		10.1074/jbc.M108947200	http://dx.doi.org/10.1074/jbc.M108947200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733517	hybrid			2022-12-27	WOS:000173813900075
J	Li, Y; Dowbenko, D; Lasky, LA				Li, Y; Dowbenko, D; Lasky, LA			AKT/PKB phosphorylation of p21(Cip/WAF1) enhances protein stability of p21(Cip/WAF1) and promotes cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; TUMOR-SUPPRESSOR; SIGNAL-TRANSDUCTION; DEPENDENT KINASES; CDK INHIBITORS; PCNA BINDING; P21(WAF1/CIP1); P21; CYCLIN; APOPTOSIS	p21(Cip1/WAF1) (p21), a p53-inducible protein, is a critical regulator of cell cycle and cell survival. p21 binds to and inhibits both the DNA synthesis regulator proliferating cell nuclear antigen and cyclin A/E-CDK2 complexes. Recently, p21 has also been shown to be a positive regulator of cell cycle progression as p21 is necessary for the assembly and activation of cyclin D1-CDK4/6 complexes. Furthermore, elevated p21 protein levels have been observed in various aggressive tumors as well as linked to chemoresistance. Here we demonstrate that p21 is directly phosphorylated by AKT/PKB, a survival kinase that is hyperactivated in many late stage tumors. Two sites (Thr(145) and Ser(146)) in the carboxyl terminus of p21 are phosphorylated by AKT/PKB in vitro and in vivo. Phosphorylation of Thr(145) inhibits PCNA binding, whereas phosphorylation of Ser(146) significantly increases p21 protein stability. Glioblastoma cell lines with activated AKT/PKB show enhanced p21 stability, and they are more resistant to taxol-mediated toxicity. Finally, AKT/PKB controls the assembly of cyclin D1-CDK4 complexes through modulation of p21 and cyclin D1 levels. These data imply that enhanced levels of p21 in tumors are due, in part, to phosphorylation by activated AKT/PKB. Furthermore, they suggest that one mechanism of AKT/PKB regulation of tumor cell survival and/or proliferation is to stabilize p21 protein.	Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Lasky, LA (corresponding author), Genentech Inc, Dept Mol Oncol, 460 Pt San Bruno Blvd, San Francisco, CA 94080 USA.	larsky@earthlink.net						Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Barboule N, 1997, ONCOGENE, V15, P2867, DOI 10.1038/sj.onc.1201469; BARBOULE N, 1995, INT J CANCER, V63, P611, DOI 10.1002/ijc.2910630502; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chadebech P, 2000, INT J CANCER, V87, P779, DOI 10.1002/1097-0215(20000915)87:6<779::AID-IJC3>3.3.CO;2-W; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Erber R, 1997, INT J CANCER, V74, P383, DOI 10.1002/(SICI)1097-0215(19970822)74:4<383::AID-IJC4>3.0.CO;2-R; Fang M, 2000, ANTICANCER RES, V20, P103; Fukuchi K, 2000, BBA-MOL CELL RES, V1496, P207, DOI 10.1016/S0167-4889(00)00018-5; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Gorospe M, 1996, MOL CELL BIOL, V16, P6654; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Johannessen LE, 1999, BIOCHEM J, V337, P599, DOI 10.1042/0264-6021:3370599; JUNG JM, 1995, ONCOGENE, V11, P2021; KELMAN Z, 1995, NUCLEIC ACIDS RES, V23, P3613, DOI 10.1093/nar/23.18.3613; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; MICHIELI P, 1994, CANCER RES, V54, P3391; Mitsuuchi Y, 2000, CANCER RES, V60, P5390; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Rousseau D, 1999, ONCOGENE, V18, P3290, DOI 10.1038/sj.onc.1202681; Scott MT, 2000, J BIOL CHEM, V275, P11529, DOI 10.1074/jbc.275.15.11529; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shen SC, 1998, CELL GROWTH DIFFER, V9, P23; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; Tian H, 2000, CANCER RES, V60, P679; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Waldman T, 1997, NAT MED, V3, P1034, DOI 10.1038/nm0997-1034; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang SI, 1997, CANCER RES, V57, P4183; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhang W, 1995, CLIN CANCER RES, V1, P1051; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	52	367	381	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2002	277	13					11352	11361		10.1074/jbc.M109062200	http://dx.doi.org/10.1074/jbc.M109062200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	534WQ	11756412	hybrid			2022-12-27	WOS:000174613100077
J	Calomme, C; Nguyen, TLA; de Launoit, Y; Kiermer, V; Droogmans, L; Burny, A; Van Lint, C				Calomme, C; Nguyen, TLA; de Launoit, Y; Kiermer, V; Droogmans, L; Burny, A; Van Lint, C			Upstream stimulatory factors binding to an E box motif in the R region of the bovine leukemia virus long terminal repeat stimulates viral gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR USF; MAJOR LATE PROMOTER; HUMAN IMMUNODEFICIENCY VIRUS-1; NEGATIVE REGULATORY ELEMENT; CAMP-RESPONSIVE ELEMENT; U5 REPRESSIVE ELEMENT; CIS-ACTING ELEMENTS; I TAX PROTEIN; NF-KAPPA-B	The bovine leukemia virus (BLV) promoter is located in its 5'-long terminal repeat and is composed of the U3, R, and U5 regions. BLV transcription is regulated by cis-acting elements located in the U3 region, including three 21-bp enhancers required for transactivation of the BLV promoter by the virus-encoded transactivator Tax(BLV). In addition to the U3 cis-acting elements, both the R and U5 regions contain stimulatory sequences. To date, no transcription factor-binding site has been identified in the R region. Here sequence analysis of this region revealed the presence of a potential E box motif (5'-CACGTG-3'). By competition and supershift gel shift assays, we demonstrated that the basic helix-loop-helix transcription factors USF1 and USF2 specifically interacted with this R region E box motif. Mutations abolishing upstream stimulatory factor (USF) binding caused a reproducible decrease in basal or Tax-activated BLV promoter-driven gene expression in transient transfection assays of B-lymphoid cell lines. Cotransfection experiments showed that the USF1 and USF2a transactivators were able to act through the BLV R region E box. Taken together, these results physically and functionally characterize a USF-binding site in the R region of BLV. This E box motif located downstream of the transcription start site constitutes a new positive regulatory element involved in the transcriptional activity of the BLV promoter and could play an important role in virus replication.	Free Univ Brussels, Inst Biol & Med Mol, Serv Chim Biol, Lab Virol Mol, B-6041 Gosselies, Belgium; Free Univ Brussels, Fac Med, Microbiol Lab, B-1070 Brussels, Belgium; Inst Pasteur, Inst Biol Lille, CNRS, UMR 8526, F-59021 Lille, France; Free Univ Brussels, Microbiol Lab, Inst Rech CERIA, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Van Lint, C (corresponding author), Free Univ Brussels, Inst Biol & Med Mol, Serv Chim Biol, Lab Virol Mol, Rue Profs Jeener & Brachet,12, B-6041 Gosselies, Belgium.	cvlint@dbm.ulb.ac.be		Kiermer, Veronique/0000-0001-8771-7239				Adam E, 1996, J VIROL, V70, P1990, DOI 10.1128/JVI.70.3.1990-1999.1996; ADAM E, 1994, J VIROL, V68, P5845, DOI 10.1128/JVI.68.9.5845-5853.1994; Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BECKMANN H, 1991, GENE DEV, V5, P1057, DOI 10.1101/gad.5.6.1057; Berger A, 1998, BBA-LIPID LIPID MET, V1390, P225, DOI 10.1016/S0005-2760(97)00180-X; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BLOOM JC, 1979, BLOOD, V53, P899; BLOOM JC, 1980, CANCER RES, V40, P2240; BOUSSET K, 1993, ONCOGENE, V8, P3211; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS PA, 1995, J VIROL, V69, P6005, DOI 10.1128/JVI.69.10.6005-6009.1995; Brooks PA, 1998, VIROLOGY, V243, P94, DOI 10.1006/viro.1998.9035; BURNY A, 1987, CANCER SURV, V6, P139; Burny A., 1980, Viral oncology, P231; BURNY A, 1994, BOVINE LEUKEMIA VIRU, P2132; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; CARR CS, 1990, MOL CELL BIOL, V10, P4384, DOI 10.1128/MCB.10.8.4384; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; CORNELIUSSEN B, 1991, J VIROL, V65, P6084, DOI 10.1128/JVI.65.11.6084-6093.1991; Czernik PJ, 1996, J BIOL CHEM, V271, P9141, DOI 10.1074/jbc.271.15.9141; DASGUPTA P, 1990, P NATL ACAD SCI USA, V87, P8090, DOI 10.1073/pnas.87.20.8090; DATTA PK, 1995, J BIOL CHEM, V270, P8637, DOI 10.1074/jbc.270.15.8637; Davis PL, 1999, ONCOGENE, V18, P6000, DOI 10.1038/sj.onc.1202990; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DERSE D, 1987, J VIROL, V61, P2462, DOI 10.1128/JVI.61.8.2462-2471.1987; DERSE D, 1986, SCIENCE, V231, P1437, DOI 10.1126/science.3006241; Desbarats L, 1996, GENE DEV, V10, P447, DOI 10.1101/gad.10.4.447; DIFAGAGNA FD, 1995, J VIROL, V69, P2765, DOI 10.1128/JVI.69.5.2765-2775.1995; DU H, 1993, EMBO J, V12, P501, DOI 10.1002/j.1460-2075.1993.tb05682.x; EISENMAN RN, 1985, MOL CELL BIOL, V5, P114, DOI 10.1128/MCB.5.1.114; Erickson RH, 2000, GENE, V258, P77, DOI 10.1016/S0378-1119(00)00422-4; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; GIACCA M, 1992, VIROLOGY, V186, P133, DOI 10.1016/0042-6822(92)90067-Y; Giannola DM, 2000, J EXP MED, V192, P1479, DOI 10.1084/jem.192.10.1479; Girardet C, 1996, MOL ENDOCRINOL, V10, P879, DOI 10.1210/me.10.7.879; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; GUPTA P, 1986, CANCER RES, V46, P6295; GUPTA P, 1982, SCIENCE, V215, P405, DOI 10.1126/science.6276975; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; Ismail PM, 1999, ONCOGENE, V18, P5582, DOI 10.1038/sj.onc.1202932; JENSEN WA, 1992, J VIROL, V66, P4427, DOI 10.1128/JVI.66.7.4427-4433.1992; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; KASHANCHI F, 1994, J VIROL, V68, P561, DOI 10.1128/JVI.68.1.561-565.1994; KASHANCHI F, 1993, J VIROL, V67, P2894, DOI 10.1128/JVI.67.5.2894-2902.1993; KATOH I, 1989, EMBO J, V8, P497, DOI 10.1002/j.1460-2075.1989.tb03403.x; Kaytor EN, 1997, J BIOL CHEM, V272, P7525, DOI 10.1074/jbc.272.11.7525; Kerkhofs P, 1996, J VIROL, V70, P2170, DOI 10.1128/JVI.70.4.2170-2177.1996; KETTMANN R, 1980, P NATL ACAD SCI-BIOL, V77, P2577, DOI 10.1073/pnas.77.5.2577; Kettmann R, 1994, BOVINE LEUKEMIA VIRU, P39; Kiermer V, 1997, DNA SEQUENCE, V7, P235, DOI 10.3109/10425179709034042; Kiermer V, 1998, J VIROL, V72, P5526, DOI 10.1128/JVI.72.7.5526-5534.1998; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kingsley-Kallesen ML, 1999, J BIOL CHEM, V274, P34020, DOI 10.1074/jbc.274.48.34020; KISSTOTH E, 1994, BIOCHEM BIOPH RES CO, V202, P1553, DOI 10.1006/bbrc.1994.2108; Kurschner C, 1997, BIOCHEM BIOPH RES CO, V231, P333, DOI 10.1006/bbrc.1997.6097; LEFRANCOISMARTINEZ AM, 1995, J BIOL CHEM, V270, P2640, DOI 10.1074/jbc.270.6.2640; Lemasson I, 1997, J VIROL, V71, P1975, DOI 10.1128/JVI.71.3.1975-1983.1997; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; LITTLEWOOD TD, 1995, PROTEIN PROFILE, V2, P621; LITTLEWOOD TD, 1992, ONCOGENE, V7, P1783; Liu CN, 1996, J VIROL, V70, P2545, DOI 10.1128/JVI.70.4.2545-2555.1996; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; Liu HC, 1999, J BIOL CHEM, V274, P23617, DOI 10.1074/jbc.274.33.23617; LIU ZR, 1993, J BIOL CHEM, V268, P12787; LU YC, 1990, J VIROL, V64, P5226, DOI 10.1128/JVI.64.10.5226-5229.1990; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Luo X, 1996, MOL CELL BIOL, V16, P1367; MAEKAWA T, 1991, NUCLEIC ACIDS RES, V19, P4689, DOI 10.1093/nar/19.17.4689; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MEIER JL, 1994, MOL CELL BIOL, V14, P6896, DOI 10.1128/MCB.14.10.6896; MELLOR J, 1990, EMBO J, V9, P4017, DOI 10.1002/j.1460-2075.1990.tb07623.x; MIYAMOTO NG, 1985, EMBO J, V4, P3563, DOI 10.1002/j.1460-2075.1985.tb04118.x; Morris JK, 1996, J BIOL CHEM, V271, P16633, DOI 10.1074/jbc.271.28.16633; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nielsen AL, 1996, J VIROL, V70, P5893, DOI 10.1128/JVI.70.9.5893-5901.1996; Niermann GL, 1997, VIROLOGY, V239, P249, DOI 10.1006/viro.1997.8868; Ojamaa K, 1995, J BIOL CHEM, V270, P31276, DOI 10.1074/jbc.270.52.31276; Okumura K, 1996, J BIOL CHEM, V271, P12944, DOI 10.1074/jbc.271.22.12944; OKUMURA K, 1994, FEBS LETT, V356, P94, DOI 10.1016/0014-5793(94)01243-1; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pognonec P, 1997, ONCOGENE, V14, P2091, DOI 10.1038/sj.onc.1201046; POGNONEC P, 1991, MOL CELL BIOL, V11, P5125, DOI 10.1128/MCB.11.10.5125; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; READ ML, 1993, BIOCHEM J, V295, P233, DOI 10.1042/bj2950233; Ribeiro A, 1999, J BIOL CHEM, V274, P1216, DOI 10.1074/jbc.274.3.1216; RICCIO A, 1992, MOL CELL BIOL, V12, P1846, DOI 10.1128/MCB.12.4.1846; Riou P, 2000, J BIOL CHEM, V275, P10551, DOI 10.1074/jbc.275.14.10551; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SAGATA N, 1985, P NATL ACAD SCI USA, V82, P677, DOI 10.1073/pnas.82.3.677; SAWADOGO M, 1988, J BIOL CHEM, V263, P11994; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Semmes OJ, 1996, J BIOL CHEM, V271, P9730, DOI 10.1074/jbc.271.16.9730; Sharma S, 1996, J BIOL CHEM, V271, P2294, DOI 10.1074/jbc.271.4.2294; SHIH HM, 1994, J BIOL CHEM, V269, P9380; Sieweke MH, 1998, EMBO J, V17, P1728, DOI 10.1093/emboj/17.6.1728; Sirito M, 1998, P NATL ACAD SCI USA, V95, P3758, DOI 10.1073/pnas.95.7.3758; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Sirito Mario, 1992, Gene Expression, V2, P231; Sjoblom-Hallen A, 1999, J VIROL, V73, P2983; Soares K, 1996, J VIROL, V70, P5384, DOI 10.1128/JVI.70.8.5384-5394.1996; Sommer A, 1998, J BIOL CHEM, V273, P6632, DOI 10.1074/jbc.273.12.6632; Stone DM, 1996, LEUKEMIA, V10, P1629; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; SUN ZM, 1995, J BIOL CHEM, V270, P29507, DOI 10.1074/jbc.270.49.29507; TACHIBANA M, 1994, HUM MOL GENET, V3, P553, DOI 10.1093/hmg/3.4.553; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; UITTENBOGAARD MN, 1995, J BIOL CHEM, V270, P28503, DOI 10.1074/jbc.270.48.28503; UITTENBOGAARD MN, 1994, J BIOL CHEM, V269, P22466; UNK I, 1994, NUCLEIC ACIDS RES, V22, P4872; USHIKAI M, 1994, J VIROL, V68, P6655, DOI 10.1128/JVI.68.10.6655-6666.1994; VANDENBROEKE A, 1988, P NATL ACAD SCI USA, V85, P9263, DOI 10.1073/pnas.85.23.9263; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VANLINT C, 1994, J VIROL, V68, P2632, DOI 10.1128/JVI.68.4.2632-2648.1994; Viollet B, 1996, J BIOL CHEM, V271, P1405, DOI 10.1074/jbc.271.3.1405; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; WATERS CM, 1991, ONCOGENE, V6, P797; WILLEMS L, 1992, J VIROL, V66, P766, DOI 10.1128/JVI.66.2.766-772.1992; Willems L, 2000, AIDS RES HUM RETROV, V16, P1787, DOI 10.1089/08892220050193326; WILLEMS L, 1999, CURRENT TOP VIROL, V1, P139; Xiao JQ, 1998, J VIROL, V72, P5994, DOI 10.1128/JVI.72.7.5994-6003.1998; Xu X, 1996, VIROLOGY, V218, P362, DOI 10.1006/viro.1996.0205; XU X, 1994, MOL CELL BIOL, V14, P5371, DOI 10.1128/MCB.14.8.5371; YI Z, 1992, J VIROL, V66, P5631, DOI 10.1128/JVI.66.9.5631-5634.1992; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	135	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8775	8789		10.1074/jbc.M107441200	http://dx.doi.org/10.1074/jbc.M107441200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11741930	hybrid			2022-12-27	WOS:000174400600006
J	Katahira, J; Straesser, K; Saiwaki, T; Yoneda, Y; Hurt, E				Katahira, J; Straesser, K; Saiwaki, T; Yoneda, Y; Hurt, E			Complex formation between Tap and p15 affects binding to FG-repeat nucleoporins and nucleocytoplasmic shuttling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; CONSTITUTIVE TRANSPORT ELEMENT; NUCLEAR EXPORT; IMPORTIN-BETA; PROTEIN; MEX67P; INTERACTS; DOMAIN; HETERODIMERS; AFFINITY	Mammalian Tap-p15 and yeast Mex67p-Mtr2p are conserved and essential mRNA export factor complexes that transport mRNPs through the nuclear pore. Here, we report that the small subunit p15 affects the binding of the large subunit Tap to repeat nucleoporins. BlAcore measurements revealed that recombinant Tap binds with high affinity (K-d in the nM range) to repeat nucleoporins and dissociates from them very slowly. In contrast, when recombinant Tap was bound to p15, the derived heterodimeric complex exhibited a significant lower affinity to FG-repeat nucleoporins (K-d in the gm range). Furthermore, when recombinant Tap lacking the N-terminal nuclear localization sequences (TapDeltaNLS) was microinjected in mammalian cells, it did not shuttle; however, TapDeltaNLS with bound p15 efficiently shuttles between nucleus and cytoplasm. We conclude that heterodimerization of Tap and p15 is required for shuttling of the functional Tap-p15 mRNA exporter complex.	Osaka Univ, Inst Mol & Cellular Biol, Sect Cellular Interact & Morphogenesis, Div Immunol, Suita, Osaka 5650871, Japan; Heidelberg Univ, Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany; Heidelberg Univ, D-69120 Heidelberg, Germany; Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan	Osaka University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Osaka University	Yoneda, Y (corresponding author), Osaka Univ, Inst Mol & Cellular Biol, Sect Cellular Interact & Morphogenesis, Div Immunol, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	yyoneda@anat3.med.osaka-u.ac.jp	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Katahira, Jun/0000-0001-5188-0368; Strasser, Katja/0000-0003-3533-5516				ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bear J, 1999, MOL CELL BIOL, V19, P6306; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Black BE, 2001, J CELL BIOL, V152, P141, DOI 10.1083/jcb.152.1.141; Braun IC, 2001, J BIOL CHEM, V276, P20536, DOI 10.1074/jbc.M100400200; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; Kang YB, 1999, VIROLOGY, V262, P200, DOI 10.1006/viro.1999.9906; Kang YB, 2000, J VIROL, V74, P5863, DOI 10.1128/JVI.74.13.5863-5871.2000; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kose S, 1999, J BIOL CHEM, V274, P3946, DOI 10.1074/jbc.274.7.3946; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Kose S, 1999, FEBS LETT, V463, P327, DOI 10.1016/S0014-5793(99)01641-5; Kunzler M, 1998, FEBS LETT, V433, P185, DOI 10.1016/S0014-5793(98)00892-8; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Schmitt I, 2001, J BIOL CHEM, V276, P42355, DOI 10.1074/jbc.M103916200; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Strasser K, 1999, FEBS LETT, V452, P77, DOI 10.1016/S0014-5793(99)00537-2; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200; Suyama M, 2000, EMBO REP, V1, P53, DOI 10.1093/embo-reports/kvd009; Thielens NM, 1999, J BIOL CHEM, V274, P9149, DOI 10.1074/jbc.274.14.9149; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	35	40	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9242	9246		10.1074/jbc.M110007200	http://dx.doi.org/10.1074/jbc.M110007200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11756420	hybrid			2022-12-27	WOS:000174400600069
J	Yang, D; Shipman, LW; Roessner, CA; Scott, AI; Sacchettini, JC				Yang, D; Shipman, LW; Roessner, CA; Scott, AI; Sacchettini, JC			Structure of the Methanococcus jannaschii mevalonate kinase, a member of the GHMP kinase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOMORPHOUS REPLACEMENT; IDENTIFICATION; RESIDUES	The mevalonate-dependent pathway is used by many organisms to synthesize isopentenyl pyrophosphate, the building block for the biosynthesis of many biologically important compounds, including farnesyl pyrophosphate, dolichol, and many sterols. Mevalonate kinase (MVK) catalyzes a critical phosphoryl transfer step, producing mevalonate 5'-phosphate. The crystal structure of thermostable MVK from Methanococcus jannaschii has been determined at 2.4 Angstrom. revealing an overall fold similar to the homoserine kinase from M. jannaschii. In addition, the enzyme shows structural similarity with mevalonate 5-diphosphate decarboxylase and domain IV of elongation factor G. The active site of MVK is in the cleft between its N- and C-terminal domains. Several structural motifs conserved among species, including a phosphate-binding loop, have been found in this cavity. Asp(155), an invariant residue among MVK sequences, is located close to the putative phosphate-binding site and has been assumed to play the catalytic role. Analysis of the MVK model in the context of the other members of the GHMP kinase family offers the opportunity to understand both the mechanism of these enzymes and the structural details that may lead to the design of novel drugs.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	sacchett@tamu.edu		Yang, Dong/0000-0001-7585-6215				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonanno JB, 2001, P NATL ACAD SCI USA, V98, P12896, DOI 10.1073/pnas.181466998; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BORK P, 1993, PROTEIN SCI, V2, P31; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hinson DD, 1997, J BIOL CHEM, V272, P26756, DOI 10.1074/jbc.272.42.26756; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang KX, 1999, PROTEIN EXPRES PURIF, V17, P33, DOI 10.1006/prep.1999.1106; Krell T, 1998, J MOL BIOL, V278, P983, DOI 10.1006/jmbi.1998.1755; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; LUTY BA, 1995, J COMPUT CHEM, V16, P454, DOI 10.1002/jcc.540160409; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potter D, 1997, J BIOL CHEM, V272, P5741, DOI 10.1074/jbc.272.9.5741; Potter D, 1997, J BIOL CHEM, V272, P25449, DOI 10.1074/jbc.272.41.25449; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; STOUTEN PFW, 1993, MOL SIMULAT, V10, P97, DOI 10.1080/08927029308022161; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P11, DOI 10.1107/S0907444993008224; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P17, DOI 10.1107/S0907444993008236; TERWILLIGER TC, 1983, ACTA CRYSTALLOGR A, V39, P813, DOI 10.1107/S0108767383001592; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P6, DOI 10.1107/S0108767387099987; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P1, DOI 10.1107/S0108767387099999; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Zhou T, 2000, STRUCTURE, V8, P1247, DOI 10.1016/S0969-2126(00)00533-5; [No title captured]	31	80	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9462	9467		10.1074/jbc.M110787200	http://dx.doi.org/10.1074/jbc.M110787200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11751891	hybrid			2022-12-27	WOS:000174400600097
J	Fanayan, S; Firth, SM; Baxter, RC				Fanayan, S; Firth, SM; Baxter, RC			Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells - Relationship to transforming growth factor-beta 1 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; HEPARIN-BINDING; SURFACE BINDING; AMINO-ACIDS; IGF-I; EXPRESSION; INHIBITION; IDENTIFICATION; PROMOTER; AFFINITY	We previously demonstrated in T47D cells transfected to express the transforming growth factor-beta receptor type II (TGF-betaRII) that insulin-like growth factor binding protein-3 (IGFBP-3) could stimulate Smad2 and Smad3 phosphorylation, potentiate TGF-beta1-stimulated Smad phosphorylation, and cooperate with exogenous TGF-beta1 in cell growth inhibition (Fanayan, S., Firth, S. M., Butt, A. J., and Baxter, R. C. (2000) J. BioL Chem. 275, 39146-39151). This study further explores IGFBP-3 signaling through the Smad pathway. Like TGF-beta1, natural and recombinant IGFBP-3 stimulated the time- and dose-dependent phosphorylation of TGF-betaRI as well as Smad2 and Smad3. This effect required the presence of TGF-betaRII. IGFBP-3 mutated in carboxyl-terminal nuclear localization signal residues retained activity in TGF-betaRI and Smad phosphorylation, whereas IGFBP-5 was inactive. Immunoneutralization of endogenous TGF-beta1 suggested that TGF-beta1 was not essential for IGFBP-3 stimulation of this pathway, but it increased the effect of IGFBP-3. IGFBP-3, like TGF-beta1, elicited a rapid decline in immunodetectable Smad4 and Smad4-Smad2 complexes. IGFBP-3 and nuclear localization signal mutant IGFBP-3 stimulated the activation of the plasminogen activator inhibitor-1 promoter but was not additive with TGF-beta, suggesting that this end point is not a direct marker of the IGFBP-3 effect on cell proliferation. This study defines a signaling pathway for IGFBP-3 from a cell surface receptor to nuclear transcriptional activity, requiring TGF-betaRII but not dependent on the nuclear translocation of IGFBP-3. The precise mechanism by which IGFBP-3 interacts with the TGF-,6 receptor system remains to be established.	Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Baxter, RC (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia.	robaxter@med.usyd.edu.au	Baxter, Robert C/F-3927-2012; Fanayan, Susan/H-1137-2011	Baxter, Robert C/0000-0001-5061-2142; Fanayan, Susan/0000-0003-4369-6987				ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Anders RA, 1997, MOL BIOL CELL, V8, P2133, DOI 10.1091/mbc.8.11.2133; Andress DL, 1998, AM J PHYSIOL-ENDOC M, V274, pE744, DOI 10.1152/ajpendo.1998.274.4.E744; Angelloz-Nicoud P, 1998, GROWTH HORM IGF RES, V8, P71, DOI 10.1016/S1096-6374(98)80324-9; Arai T, 1996, J BIOL CHEM, V271, P6099, DOI 10.1074/jbc.271.11.6099; BAXTER RC, 1993, TRENDS ENDOCRIN MET, V4, P91, DOI 10.1016/1043-2760(93)90085-S; BOOTH BA, 1995, GROWTH REGULAT, V5, P1; Campbell PG, 1998, AM J PHYSIOL-ENDOC M, V275, pE321, DOI 10.1152/ajpendo.1998.275.2.E321; COHEN P, 1993, MOL ENDOCRINOL, V7, P380, DOI 10.1210/me.7.3.380; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fanayan S, 2000, J BIOL CHEM, V275, P39146, DOI 10.1074/jbc.M006964200; Firth SM, 1999, PROTEIN EXPRES PURIF, V16, P202, DOI 10.1006/prep.1999.1075; Firth SM, 1998, J BIOL CHEM, V273, P2631, DOI 10.1074/jbc.273.5.2631; Firth SM, 2001, ENDOCRINOLOGY, V142, P2147, DOI 10.1210/en.142.5.2147; Gucev ZS, 1996, CANCER RES, V56, P1545; Huynh H, 1996, J BIOL CHEM, V271, P1016, DOI 10.1074/jbc.271.2.1016; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LALOU C, 1994, ENDOCRINOLOGY, V135, P2318, DOI 10.1210/en.135.6.2318; Leal SM, 1997, J BIOL CHEM, V272, P20572, DOI 10.1074/jbc.272.33.20572; Leal SM, 1999, J BIOL CHEM, V274, P6711, DOI 10.1074/jbc.274.10.6711; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; MARTIN JL, 1990, ENDOCRINOLOGY, V127, P781, DOI 10.1210/endo-127-2-781; MARTIN JL, 1986, J BIOL CHEM, V261, P8754; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; OH Y, 1993, J BIOL CHEM, V268, P26045; OH Y, 1995, J BIOL CHEM, V270, P13589, DOI 10.1074/jbc.270.23.13589; OH YM, 1993, J BIOL CHEM, V268, P14964; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Pouliot F, 1999, INT J CANCER, V81, P98, DOI 10.1002/(SICI)1097-0215(19990331)81:1<98::AID-IJC17>3.0.CO;2-9; PRATT SE, 1994, BIOCHEM BIOPH RES CO, V198, P292, DOI 10.1006/bbrc.1994.1041; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Song H, 2001, J MOL ENDOCRINOL, V26, P229, DOI 10.1677/jme.0.0260229; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139; Wu RY, 1997, MOL CELL BIOL, V17, P2521, DOI 10.1128/MCB.17.5.2521; Yamanaka Y, 1999, ENDOCRINOLOGY, V140, P1319, DOI 10.1210/en.140.3.1319; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398	44	86	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7255	7261		10.1074/jbc.M108038200	http://dx.doi.org/10.1074/jbc.M108038200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751851	hybrid			2022-12-27	WOS:000174104300066
J	Job, V; Marcone, GL; Pilone, MS; Pollegioni, L				Job, V; Marcone, GL; Pilone, MS; Pollegioni, L			Glycine oxidase from Bacillus subtilis - Characterization of a new flavoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID OXIDASE; MONOMERIC SARCOSINE OXIDASE; RHODOTORULA-GRACILIS; ACTIVE-SITE; FLAVIN; SUBSTRATE; ENZYME; PURIFICATION; RESOLUTION; ANALOG	Glycine oxidase (GO) is a homotetrameric flavoenzyme that contains one molecule of non-covalently bound flavin adenine dinucleotide per 47 kDa protein monomer. GO is active on various amines (sarcosine, N-ethylglycine, glycine) and D-amino acids (D-alanine, D-proline). The products of GO reaction with various substrates have been determined, and it has been clearly shown that GO catalyzes the oxidative deamination of primary and secondary amines, a reaction similar to that of D-amino acid oxidase, although its sequence homology is higher with enzymes such as sarcosine oxidase and N-methyltryptophane oxidase. GO shows properties that are characteristic of the oxidase class of flavoproteins: it stabilizes the anionic flavin semiquinone and forms a reversible covalent flavin-sulfite complex. The similar to300 mV separation between the two FAD redox potentials is in accordance with the high amount of the anionic semiquinone formed on photoreduction. GO can be distinguished from D-amino acid oxidase by its low catalytic efficiency and high apparent K-m value for D-alanine. A number of active site ligands have been identified; the tightest binding is observed with glycolate, which acts as a competitive inhibitor with respect to sarcosine. The presence of a carboxylic group and an amino group on the substrate molecule is not mandatory for binding and catalysis.	Univ Insubria, Dept Struct & Funct Biol, I-21100 Varese, Italy	University of Insubria	Pollegioni, L (corresponding author), Univ Insubria, Dept Struct & Funct Biol, Via JH Dunant 3, I-21100 Varese, Italy.		Marcone, Giorgia Letizia/F-8871-2013	Marcone, Giorgia Letizia/0000-0002-4650-9449; Job, Viviana/0000-0001-8421-5292; POLLEGIONI, LOREDANO/0000-0003-1733-7243				CHLUMSKY LJ, 1993, BIOCHEMISTRY-US, V32, P11132, DOI 10.1021/bi00092a024; Clark W.M., 1960, OXIDATION REDUCTION, P184; COOK RJ, 1985, J BIOL CHEM, V260, P2998; CURTI B, 1992, CHEM BIOCH FLAVOENZY, P69; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; HARBURY HA, 1959, P NATL ACAD SCI USA, V45, P1708, DOI 10.1073/pnas.45.12.1708; Khanna P, 2001, BIOCHEMISTRY-US, V40, P1441, DOI 10.1021/bi0024411; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LIGHT DR, 1980, ANAL BIOCHEM, V109, P87, DOI 10.1016/0003-2697(80)90014-7; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MASSEY V, 1965, BIOCHEMISTRY-US, V4, P1161, DOI 10.1021/bi00882a027; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; MASSEY V, 1969, J BIOL CHEM, V244, P3999; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496; MIHALIK SJ, 1991, J BIOL CHEM, V266, P4822; MINNAERT K, 1965, BIOCHIM BIOPHYS ACTA, V110, P42, DOI 10.1016/S0926-6593(65)80093-5; Mizutani H, 1996, J BIOCHEM-TOKYO, V120, P14; MORI N, 1980, AGR BIOL CHEM TOKYO, V44, P1391, DOI 10.1080/00021369.1980.10864124; NAGATA Y, 1988, INT J BIOCHEM, V20, P1235, DOI 10.1016/0020-711X(88)90225-X; Nishiya Y, 1998, FEBS LETT, V438, P263, DOI 10.1016/S0014-5793(98)01313-1; Pilone MS, 2000, CELL MOL LIFE SCI, V57, P1732, DOI 10.1007/PL00000655; PILONESIMONETTA M, 1989, EUR J BIOCHEM, V180, P199, DOI 10.1111/j.1432-1033.1989.tb14634.x; POLLEGIONI L, 1992, BIOCHEM J, V286, P389, DOI 10.1042/bj2860389; POLLEGIONI L, 1992, BIOCHIM BIOPHYS ACTA, V1120, P11, DOI 10.1016/0167-4838(92)90418-D; Sanders SA, 1999, J BIOL CHEM, V274, P22289, DOI 10.1074/jbc.274.32.22289; STANKOVICH MT, 1991, CHEM BIOCH FLAVOENZY, P401; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Trickey P, 1999, STRUCTURE, V7, P331, DOI 10.1016/S0969-2126(99)80043-4; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8825, DOI 10.1021/bi000350y; Wagner MA, 1999, BIOCHEMISTRY-US, V38, P5588, DOI 10.1021/bi982955o; Wagner MA, 1997, ARCH BIOCHEM BIOPHYS, V342, P176, DOI 10.1006/abbi.1997.0106; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Willie A, 1996, BIOCHEMISTRY-US, V35, P5292, DOI 10.1021/bi952995h; ZELLER HD, 1989, BIOCHEMISTRY-US, V28, P5145, DOI 10.1021/bi00438a035	37	87	91	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6985	6993		10.1074/jbc.M111095200	http://dx.doi.org/10.1074/jbc.M111095200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744710	Green Published, hybrid			2022-12-27	WOS:000174104300032
J	Jorgensen, NR; Henriksen, Z; Sorensen, OH; Eriksen, EF; Civitelli, R; Steinberg, TH				Jorgensen, NR; Henriksen, Z; Sorensen, OH; Eriksen, EF; Civitelli, R; Steinberg, TH			Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW CULTURES; DIFFERENTIATION FACTOR; PLASMA-MEMBRANE; CELL-DEATH; ATP; MACROPHAGES	Signaling between osteoblasts and osteoblasts is important in bone homeostasis. We previously showed that human osteoblasts propagate intercellular calcium signals via two mechanisms: autocrine activation of P2Y receptors, and gap junctional communication. In the current work we identified mechanically induced intercellular calcium signaling between osteoblasts and osteoclasts and among osteoclasts. Intercellular calcium responses in osteoclasts required P2 receptor activation but not gap junctional communication. Pharmacological studies and reverse transcriptase-PCR amplification demonstrated that human osteoclasts expressed functional P2Y1 receptors, but, unexpectedly, desensitization of P2Y1 did not block calcium signaling to osteoclasts. We also found that osteoclasts expressed functional P2X7 receptors and showed that pharmacological inhibition of these receptors blocked calcium signaling to osteoclasts. Thus these studies show that calcium signaling between osteoblasts and osteoclasts occurs via activation of P2 receptors, but that different families of P2 receptors are required for calcium signaling in these two cell types. Intercellular calcium signaling among bone cells is therefore amenable to pharmacological manipulation that will specifically affect only bone-forming or bone-resorbing cells. P2 receptors may be important drug targets for the modulation of bone turnover.	Univ Copenhagen, Hvidovre Hosp, Osteoporosis Res Clin, Dept 545, DK-2650 Hvidovre, Denmark; Aarhus Univ Hosp, Osteoporosis Res Clin, DK-8000 Aarhus, Denmark; Washington Univ, Sch Med, St Louis, MO 63110 USA	University of Copenhagen; Aarhus University; Washington University (WUSTL)	Jorgensen, NR (corresponding author), Univ Copenhagen, Hvidovre Hosp, Osteoporosis Res Clin, Dept 545, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	niklas@dadlnet.dk	Jørgensen, Niklas Rye/B-6003-2012; Civitelli, Roberto/AAA-8260-2019; Eriksen, Erik Fink/AAF-5056-2020	Civitelli, Roberto/0000-0003-4076-4315; Jorgensen, Niklas Rye/0000-0001-9624-5210	NIAMS NIH HHS [AR 43470, AR 41255] Funding Source: Medline; NIDDK NIH HHS [DK 46686] Funding Source: Medline; NIGMS NIH HHS [GM 54660] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR041255, R01AR041255, R01AR043470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054660] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOWLER WB, 1995, J BONE MINER RES, V10, P1137; Bowler WB, 1998, BONE, V22, P195, DOI 10.1016/S8756-3282(97)00280-9; Chiozzi P, 1996, BIOCHEM BIOPH RES CO, V218, P176, DOI 10.1006/bbrc.1996.0031; DIVIRGILIO F, 1989, J IMMUNOL, V143, P1955; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Ferrari D, 1996, J IMMUNOL, V156, P1531; Franceschi C, 1996, DRUG DEVELOP RES, V39, P442, DOI 10.1002/(SICI)1098-2299(199611/12)39:3/4<442::AID-DDR26>3.0.CO;2-1; Jorgensen NR, 1997, J CELL BIOL, V139, P497, DOI 10.1083/jcb.139.2.497; Jorgensen NR, 2000, J BONE MINER RES, V15, P1024, DOI 10.1359/jbmr.2000.15.6.1024; Kassem M, 1997, APMIS Suppl, V71, P1; KASSEM M, 1991, APMIS, V99, P262, DOI 10.1111/j.1699-0463.1991.tb05148.x; KASSEM M, 1991, APMIS, V99, P269, DOI 10.1111/j.1699-0463.1991.tb05149.x; Matsuzaki K, 1998, BIOCHEM BIOPH RES CO, V246, P199, DOI 10.1006/bbrc.1998.8586; Morrison MS, 1998, J PHYSIOL-LONDON, V511, P495, DOI 10.1111/j.1469-7793.1998.495bh.x; NIJWEIDE PJ, 1995, CLIN ORTHOP RELAT R, V313, P92; Quinn JMW, 1998, CALCIFIED TISSUE INT, V62, P527, DOI 10.1007/s002239900473; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Rickard DJ, 1996, J BONE MINER RES, V11, P312; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Weidema AF, 1997, J PHYSIOL-LONDON, V503, P303, DOI 10.1111/j.1469-7793.1997.303bh.x; Wiebe SH, 1999, CELL PHYSIOL BIOCHEM, V9, P323, DOI 10.1159/000016326; YU HS, 1995, J CELL SCI, V108, P3051	22	113	134	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7574	7580		10.1074/jbc.M104608200	http://dx.doi.org/10.1074/jbc.M104608200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11756404	hybrid			2022-12-27	WOS:000174104300104
J	Ancellin, N; Colmont, C; Su, J; Li, Q; Mittereder, N; Chae, SS; Stefansson, S; Liau, G; Hla, T				Ancellin, N; Colmont, C; Su, J; Li, Q; Mittereder, N; Chae, SS; Stefansson, S; Liau, G; Hla, T			Extracellular export of sphingosine kinase-1 enzyme - Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; LYSOPHOSPHATIDIC ACID; SIGNAL-TRANSDUCTION; SPHINGOSINE-1-PHOSPHATE; GROWTH; RELEASE	The enzyme sphingosine kinase (SK) catalyzes the formation of sphingosine 1-phosphate (S1P), a bioactive lipid that acts extracellularly on G protein-coupled receptors of the S1P(1)/EDG-1 subfamily. Although S1P is formed in the cytosol of various cells, S1P release is not understood and is controversial because this lipid mediator is also regarded as a second messenger. In this report, we describe the existence of an extracellular S1P-generating system in vascular endothelial cells. Endothelial cells release SK constitutively and form S1P in the range of receptor stimulation. Levels of sphingosine but not ATP in the extracellular environment are rate-limiting. Treatment of endothelial cells with small interfering RNA for SK-1 transcript specifically inhibited SK export, and SK-1-transfected human embryonic kidney 293 cells exhibited enhanced release of SK-1. The export of SK-1 is constitutive and is inhibited by cytochalasin D and treatment at 4 degreesC but not by brefeldin A or nocodazole, suggesting that a nonclassical secretory pathway that requires the actin cytoskeleton dynamics is involved. Because S1P regulates angiogenesis and vascular maturation, we overexpressed SK-1 using an adenoviral vector in vivo in the Matrigel system of angiogenesis. Overexpression of SK-1 resulted in enhanced release of SK activity and induced angiogenesis and vascular maturation. These findings suggest that SIP is made in the extracellular milieu and that extracellular export of SK contributes to the action of S1P in the vascular system.	Univ Connecticut, Ctr Hlth, Dept Physiol, Ctr Vasc Biol, Farmington, CT 06030 USA; Genet Therapy Inc Novartis, Gaithersburg, MD 20878 USA	University of Connecticut; Novartis	Hla, T (corresponding author), Univ Connecticut, Ctr Hlth, Dept Physiol, Ctr Vasc Biol, 263 Farmington Ave,MC-3505, Farmington, CT 06030 USA.	hla@sun.uchc.edu	Hla, Timothy/G-5873-2012	Hla, Timothy/0000-0001-8355-4065	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL067330, R01HL067330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045659] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Ancellin N, 1998, CELL SIGNAL, V10, P217, DOI 10.1016/S0898-6568(97)00124-1; Baumruker T, 2000, INT ARCH ALLERGY IMM, V122, P85, DOI 10.1159/000024363; Dickson RC, 1999, BBA-MOL CELL BIOL L, V1438, P305, DOI 10.1016/S1388-1981(99)00068-2; Dobrowsky RT, 2000, CELL SIGNAL, V12, P81, DOI 10.1016/S0898-6568(99)00072-8; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; English D, 1999, J HEMATOTH STEM CELL, V8, P627, DOI 10.1089/152581699319795; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Gorziglia MI, 1996, J VIROL, V70, P4173, DOI 10.1128/JVI.70.6.4173-4178.1996; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hirschi K K, 1997, EXS, V79, P419; HLA T, 1990, J BIOL CHEM, V265, P9308; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lanterman MM, 1998, BIOCHEM J, V332, P525, DOI 10.1042/bj3320525; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Melendez AJ, 2000, GENE, V251, P19, DOI 10.1016/S0378-1119(00)00205-5; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; MILNER P, 1990, BIOCHEM BIOPH RES CO, V170, P649, DOI 10.1016/0006-291X(90)92141-L; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Romiti E, 2000, BIOCHEM BIOPH RES CO, V275, P746, DOI 10.1006/bbrc.2000.3370; SA G, 1994, J BIOL CHEM, V269, P3219; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Spiegel S, 1999, J LEUKOCYTE BIOL, V65, P341, DOI 10.1002/jlb.65.3.341; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193	49	237	252	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6667	6675		10.1074/jbc.M102841200	http://dx.doi.org/10.1074/jbc.M102841200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741921	hybrid			2022-12-27	WOS:000173989200127
J	Ayabe, T; Satchell, DP; Pesendorfer, P; Tanabe, H; Wilson, CL; Hagen, SJ; Ouellette, AJ				Ayabe, T; Satchell, DP; Pesendorfer, P; Tanabe, H; Wilson, CL; Hagen, SJ; Ouellette, AJ			Activation of Paneth cell alpha-defensins in mouse small intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH PEPTIDES; INNATE HOST-DEFENSE; CRYPT-VILLUS AXIS; MESSENGER-RNA; ANTIMICROBIAL PEPTIDES; EPITHELIAL-CELLS; GENE-EXPRESSION; METALLOPROTEINASE MATRILYSIN; FAMILY; DIFFERENTIATION	Paneth cells in small intestine crypts secrete microbicidal alpha-defensins, termed cryptdins, as components of enteric innate immunity. The bactericidal activity of cryptdins requires proteolytic activation of precursors by matrix metalloproteinase-7 (MMP-7; matrilysin) (Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., Lopez-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., and Parks, W. C. (1999) Science 286, 113-117). Here, we report on the intracellular processing of cryptdin proforms in mouse Paneth cells. Peptide sequencing of MMP-7 digests of purified natural procryptdins identified conserved cleavage sites in the proregion between Ser(43) and Val(44) as well as at the cryptdin peptide N terminus between Ser(58) and Leu(59). Immunostaining co-localized precursor prosegments and mature cryptdin peptides to Paneth cell granules, providing evidence of their secretion. Extensive MMP-7-dependent procryptdin processing occurs in Paneth cells, as shown by Western blot analyses of intestinal crypt proteins and proteins from granule-enriched subcellular fractions. The addition of soluble prosegments to in vitro antimicrobial peptide assays inhibited the bactericidal activities of cryptdin-3 and -4 in trans, suggesting possible cytoprotective effects by prosegments prior to secretion. Levels of activated cryptdins were normal in small bowel of germ-free mice and in sterile implants of fetal mouse small intestine grown subcutaneously. Thus, the initiation of procryptdin processing by MMP-7 does not require direct bacterial exposure, and the basal MMP-7 content of germ-free Paneth cells is sufficient to process and activate a-defensin precursors. MMP-7-dependent procryptdin activation in vivo provides mouse Paneth cells with functional peptides for apical secretion into the small intestine lumen.	Univ Calif Irvine, Coll Med, Dept Pathol, Irvine, CA 92697 USA; Univ Calif Irvine, Coll Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Karl Franzens Univ Graz, Dept Pediat Surg, A-8036 Graz, Austria; Washington Univ, Sch Med, Dept Pediat, Div Allergy & Pulm Med, St Louis, MO 63110 USA; Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Graz; Washington University (WUSTL); Harvard University; Beth Israel Deaconess Medical Center	Ouellette, AJ (corresponding author), Univ Calif Irvine, Coll Med, Dept Pathol, D440 Med Sci 1, Irvine, CA 92697 USA.		Ayabe, Tokiyoshi/F-5264-2011	Ayabe, Tokiyoshi/0000-0002-8631-5593	NIDCR NIH HHS [DE14040] Funding Source: Medline; NIDDK NIH HHS [DK10184, DK44632, DK15681] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK010184, R55DK044632, R37DK015681, R01DK015681, R01DK044632] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alnadjim Z, 2001, GASTROENTEROLOGY, V120, pA21, DOI 10.1016/S0016-5085(01)80104-9; Alper SL, 1999, AM J PHYSIOL-GASTR L, V277, pG321, DOI 10.1152/ajpgi.1999.277.2.G321; Ariza A, 1996, J CLIN PATHOL, V49, P474, DOI 10.1136/jcp.49.6.474; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bevins CL, 1999, GUT, V45, P911, DOI 10.1136/gut.45.6.911; CANOGAUCI DF, 1993, EXP CELL RES, V208, P344, DOI 10.1006/excr.1993.1255; Cheng H, 1996, ANAT REC, V244, P78; CHENG H, 1974, AM J ANAT, V141, P521, DOI 10.1002/aja.1001410406; Condon MR, 1999, INFECT IMMUN, V67, P4787, DOI 10.1128/IAI.67.9.4787-4793.1999; Darmoul D, 1997, AM J PHYSIOL-GASTR L, V272, pG197, DOI 10.1152/ajpgi.1997.272.1.G197; Darmoul D, 1996, AM J PHYSIOL-GASTR L, V271, pG68, DOI 10.1152/ajpgi.1996.271.1.G68; Fernandes PR, 1997, AM J PHYSIOL-GASTR L, V272, pG751, DOI 10.1152/ajpgi.1997.272.4.G751; Frye M, 2000, J CLIN PATHOL, V53, P770, DOI 10.1136/jcp.53.10.770; GANZ T, 1993, BLOOD, V82, P641; Gordon JI, 1997, AM J PHYSIOL-GASTR L, V273, pG565, DOI 10.1152/ajpgi.1997.273.3.G565; Grandjean V, 1997, BIOL REPROD, V57, P1115, DOI 10.1095/biolreprod57.5.1115; HUTTNER KM, 1994, GENOMICS, V19, P448, DOI 10.1006/geno.1994.1093; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; HUTTNER KM, 1994, GENOMICS, V24, P99, DOI 10.1006/geno.1994.1586; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kamal M, 2001, PARASITE, V8, pS110, DOI 10.1051/parasite/200108s2110; Kamal M, 2001, CLIN EXP IMMUNOL, V126, P117, DOI 10.1046/j.1365-2249.2001.01589.x; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Leis O, 1997, J HISTOCHEM CYTOCHEM, V45, P285, DOI 10.1177/002215549704500213; LIN MY, 1992, GENOMICS, V14, P363, DOI 10.1016/S0888-7543(05)80227-7; Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Morita Y, 2001, BBA-MOL CELL RES, V1540, P43, DOI 10.1016/S0167-4889(01)00118-5; Nyman KM, 2000, J HISTOCHEM CYTOCHEM, V48, P1469, DOI 10.1177/002215540004801104; Ouellette AJ, 1999, INFECT IMMUN, V67, P6643; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; OUELLETTE AJ, 1989, J CELL BIOL, V108, P1687, DOI 10.1083/jcb.108.5.1687; OUELLETTE AJ, 1990, J BIOL CHEM, V265, P9831; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Quayle AJ, 1998, AM J PATHOL, V152, P1247; RUBIN DC, 1992, J BIOL CHEM, V267, P15122; RUBIN DC, 1991, J CELL BIOL, V113, P1183, DOI 10.1083/jcb.113.5.1183; SATOH Y, 1995, GASTROENTEROLOGY, V108, P1345, DOI 10.1016/0016-5085(95)90681-9; SAVIDGE TC, 1995, DIFFERENTIATION, V58, P361, DOI 10.1046/j.1432-0436.1995.5850361.x; Selsted M E, 1993, Genet Eng (N Y), V15, P131; SELSTED ME, 1986, ANAL BIOCHEM, V155, P270, DOI 10.1016/0003-2697(86)90436-7; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; Shimada O, 1998, J HISTOCHEM CYTOCHEM, V46, P833, DOI 10.1177/002215549804600706; Shirafuji Y, 1999, CLIN DIAGN LAB IMMUN, V6, P336, DOI 10.1128/CDLI.6.3.336-340.1999; SIMON TC, 1995, CURR OPIN GENET DEV, V5, P577, DOI 10.1016/0959-437X(95)80026-3; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Wang MSC, 1997, ANAL BIOCHEM, V253, P225, DOI 10.1006/abio.1997.2347; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	54	143	150	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5219	5228		10.1074/jbc.M109410200	http://dx.doi.org/10.1074/jbc.M109410200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733520	hybrid			2022-12-27	WOS:000173962900087
J	Cortes-Canteli, M; Pignatelli, M; Santos, A; Perez-Castillo, A				Cortes-Canteli, M; Pignatelli, M; Santos, A; Perez-Castillo, A			CCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR PROTEIN; NGFI-A GENE; C/EBP-BETA; THYROID-HORMONE; ADIPOCYTE DIFFERENTIATION; HEPATOCYTE PROLIFERATION; NEURONAL DIFFERENTIATION; NUCLEAR-PROTEIN; NERVOUS-SYSTEM; LEUCINE-ZIPPER	The C/EBPbeta (CCAAT/enhancer-binding protein beta) is a transcription factor that belongs to basic region-leucine zipper class DNA-binding proteins. There is a significant body of evidence that suggests that this protein plays a central role in adipocytic and eosinophilic differentiation. However, there is no information available regarding the role of this transcription factor in the development of mammalian neuronal tissues. In this study, we have examined the effect of C/EBPbeta overexpression on the differentiation and survival of mouse Neuro2A cells. We found that C/EBPbeta induces neuronal differentiation and that this process is inhibited by transfection with the C/EBP homologous protein 10 (CHOP), strongly suggesting that the extension of neurites is indeed due to the C/EBPbeta transcriptional activity. As it has been suggested in adipocyte differentiation, here we show that C/EBPbeta induces the expression of the endogenous C/EBPalpha gene and that this protein by itself is also able to induce a differentiated phenotype in Neuro2A cells. Neuronal differentiation induced by C/EBPbeta requires activation of the phosphatidylinositol 3-kinase signaling pathway, whereas inhibition of the mitogen-activated protein kinase signaling does not have any effect. In addition, we show that C/EBPbeta is expressed in the brain of neonatal rats, suggesting that this protein could play an important role in neuronal maturation. Finally, cell death was also induced by C/EBPbeta through activation of the p53 protein and the cdk inhibitor p21.	Univ Complutense, Fac Med, Dept Bioquim & Biol Mol, Madrid 28040, Spain; Univ Autonoma Madrid, Inst Invest Biomed, Consejo Super Invest Cient, Madrid 28029, Spain	Complutense University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Santos, A (corresponding author), Univ Complutense, Fac Med, Dept Bioquim & Biol Mol, Madrid 28040, Spain.		Cortes-Canteli, Marta/L-5449-2014; Santos, Angel/K-3744-2014; Perez-Castillo, Ana/A-9505-2015	Cortes-Canteli, Marta/0000-0001-8802-4338; Santos, Angel/0000-0002-7551-8483; Perez-Castillo, Ana/0000-0002-2632-5853				AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; AVILA J, 1994, INT J DEV BIOL, V38, P13; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; DANIELS MP, 1972, J CELL BIOL, V53, P164, DOI 10.1083/jcb.53.1.164; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; DEGARCINI EM, 1992, FEBS LETT, V1, P10; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; FOPRNACE A, 1988, P NATL ACAD SCI USA, V85, P8800; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; GARCIAVALENZUELA E, 1994, J NEUROBIOL, V25, P431, DOI 10.1002/neu.480250408; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Guo SD, 2001, J BIOL CHEM, V276, P8516, DOI 10.1074/jbc.M008542200; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Jacobson M., 1991, DEV NEUROBIOLOGY; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li Y, 1996, J NEUROSCI, V16, P531; Mao AJ, 2000, J BIOL CHEM, V275, P34407, DOI 10.1074/jbc.M003917200; Menendez-Hurtado A, 2000, ENDOCRINOLOGY, V141, P4164, DOI 10.1210/en.141.11.4164; MenendezHurtado A, 1997, BIOCHEM BIOPH RES CO, V234, P605, DOI 10.1006/bbrc.1997.6635; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muller C, 1995, EMBO J, V14, P6127, DOI 10.1002/j.1460-2075.1995.tb00303.x; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; PEI DQ, 1991, MOL CELL BIOL, V11, P1480, DOI 10.1128/MCB.11.3.1480; Pignatelli M, 1999, FEBS LETT, V461, P37, DOI 10.1016/S0014-5793(99)01420-9; Piwien-Pilipuk G, 2001, J BIOL CHEM, V276, P19664, DOI 10.1074/jbc.M010193200; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Rodriguez-Manzaneque JC, 1998, MOL CELL ENDOCRINOL, V141, P101; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Shastry P, 2001, INT J NEUROSCI, V108, P109, DOI 10.3109/00207450108986509; Sterneck E, 1998, J NEUROCHEM, V70, P2424; TACK LC, 1992, J VIROL, V66, P1312, DOI 10.1128/JVI.66.3.1312-1320.1992; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; ULLOA L, 1993, EMBO J, V12, P1633, DOI 10.1002/j.1460-2075.1993.tb05808.x; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WANG Y, 1992, P NATL ACAD SCI USA, V89, P4231, DOI 10.1073/pnas.89.10.4231; WEGNER M, 1992, SCIENCE, V256, P370, DOI 10.1126/science.256.5055.370; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yukawa K, 1998, J BIOL CHEM, V273, P31345, DOI 10.1074/jbc.273.47.31345; ZHANG W, 1994, CANCER RES, V54, P4448; Zhu MS, 1997, DNA CELL BIOL, V16, P127, DOI 10.1089/dna.1997.16.127	62	75	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5460	5467		10.1074/jbc.M108761200	http://dx.doi.org/10.1074/jbc.M108761200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733516	hybrid			2022-12-27	WOS:000173962900117
J	Harbord, M; Novelli, M; Canas, B; Power, D; Davis, C; Godovac-Zimmermann, J; Roes, J; Segal, AW				Harbord, M; Novelli, M; Canas, B; Power, D; Davis, C; Godovac-Zimmermann, J; Roes, J; Segal, AW			Ym1 is a neutrophil granule protein that crystallizes in p47(phox)-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; CHITINASE FAMILY; EOSINOPHIL RECRUITMENT; MAMMALIAN MEMBER; MACROPHAGE; IDENTIFICATION; CHITOTRIOSIDASE; BINDING; LECTIN; GENE	Crystals were discovered within the aged lung and at sites of chronic inflammation in a mouse model of chronic granulomatous disease. Following re-crystallization at neutral pH, the crystals were identified as the chitinase-like protein Ym1, expressed in organs of the lymphoreticular system, the lung, and distal stomach. Ym1 was shown to be a neutrophil granule protein and to have weak beta-N-acetylglucosaminidase activity, indicating that it might contribute to the digestion of glycosaminoglycans. Crystal formation is likely to be a function of excess neutrophil turnover at sites of inflammation in the chronic granulomatous disease mouse. Failure to remove subcutaneous Ym1 crystals injected into knockout mice indicates that a failure of digestion may also contribute to crystallization.	UCL, Rayne Inst, Dept Med, London WC1E 6JJ, England; UCL, Rayne Inst, Dept Anat, London WC1E 6JJ, England; UCL, Rayne Inst, Dept Histopathol, London WC1E 6JJ, England	University of London; King's College London; University College London; University of London; King's College London; University College London; University of London; King's College London; University College London	Harbord, M (corresponding author), UCL, Rayne Inst, Dept Med, 5 Univ St, London WC1E 6JJ, England.	doc@dircon.co.uk	Zimmermann, Jasminka Godovac/E-6863-2010; CANAS, BENITO/O-9256-2019	Roes, Jurgen/0000-0003-3235-2345; Segal, Anthony/0000-0001-7602-9043				ACKERMAN SJ, 1993, J IMMUNOL, V150, P456; ALI BA, 1981, BRIT J EXP PATHOL, V62, P662; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; COOPER HS, 1993, LAB INVEST, V69, P238; DAVIES DAL, 1978, NATURE, V273, P235, DOI 10.1038/273235a0; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; EDWARDS SW, 1994, BIOCH PHYSL NEUTROPH, P33; ESCOTT GM, 1995, INFECT IMMUN, V63, P4770, DOI 10.1128/IAI.63.12.4770-4773.1995; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; FLACH J, 1992, EXPERIENTIA, V48, P701, DOI 10.1007/BF02124285; FREUND J, 1956, Bibl Tuberc, P130; GREEN GM, 1977, AM REV RESPIR DIS, V115, P479; Gullberg U, 1997, EUR J HAEMATOL, V58, P137; Guo L, 2000, J BIOL CHEM, V275, P8032, DOI 10.1074/jbc.275.11.8032; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Harlow E., 1988, ANTIBODIES LABORATOR, P511; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; Huffnagle GB, 1998, J IMMUNOL, V160, P2393; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jin HM, 1998, GENOMICS, V54, P316, DOI 10.1006/geno.1998.5593; KOSHLAND DE, 1968, ANNU REV BIOCHEM, V37, P359, DOI 10.1146/annurev.bi.37.070168.002043; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; LORD BI, 1991, BLOOD, V77, P2154; MCCREATH KJ, 1992, J MICROBIOL METH, V14, P229, DOI 10.1016/0167-7012(92)90055-9; MURRAY AB, 1990, VET PATHOL, V27, P274, DOI 10.1177/030098589002700409; Overdijk B, 1996, GLYCOBIOLOGY, V6, P627, DOI 10.1093/glycob/6.6.627; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Parmar JS, 2000, J ROY COLL PHYS LOND, V34, P295; Ren Y, 2000, BIOCHEM BIOPH RES CO, V268, P302, DOI 10.1006/bbrc.2000.2118; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; Saito A, 1999, GENE, V239, P325, DOI 10.1016/S0378-1119(99)00394-7; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; THRASHER AJ, 1994, BBA-MOL BASIS DIS, V1227, P1, DOI 10.1016/0925-4439(94)90100-7; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANFURTH R, 1973, J EXP MED, V138, P1314, DOI 10.1084/jem.138.6.1314; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Ward JM, 2001, AM J PATHOL, V158, P323, DOI 10.1016/S0002-9440(10)63972-7; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; 1986, METHODS ENZYMOL, V132, P1	54	77	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5468	5475		10.1074/jbc.M110635200	http://dx.doi.org/10.1074/jbc.M110635200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733538	hybrid			2022-12-27	WOS:000173962900118
J	Meyer, EL; Gahring, LC; Rogers, SW				Meyer, EL; Gahring, LC; Rogers, SW			Nicotine preconditioning antagonizes activity-dependent caspase proteolysis of a glutamate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOCKS TNF-ALPHA; MEDIATED NEUROPROTECTION; ACETYLCHOLINE-RECEPTORS; HIPPOCAMPAL CULTURES; IONOTROPIC RECEPTORS; AMPA RECEPTORS; SUBUNIT GLUR1; MOUSE-BRAIN; RAT-BRAIN; ACTIVATION	Neuronal excitation is required for normal brain function including processes of learning and memory, yet if this process becomes dysregulated there is reduced neurotransmission and possibly death through excitotoxicity. Nicotine, through interaction with neuronal nicotinic acetylcholine receptors, possesses the ability to modulate neurotransmitter systems through numerous mechanisms that define this critical balance. We examined the modulatory role of nicotine in primary mixed cortical neuronal-glial cultures on activity-dependent caspase cleavage of a glutamate receptor, GluR1. We find that GluR1, but not GluR2 or GluR3, is a substrate for agonist (alpha-amino-3-hydroxy-5-methyl-isoxazole-4propionic acid)-initiated rapid proteolytic cleavage at aspartic acid 865 through the activation of caspase 8-like activity that is independent of membrane fusion and is not coincident with apoptosis. Dose-dependent nicotine preconditioning for 24 h antagonizes agonist-initiated caspase cleavage of GluR1 through a mechanism that is coincident with desensitization of both nAChRalpha4beta2 and nAChRalpha7 receptors and the delayed activation of a caspase 8-like activity. The modulation of GluR1 agonist-initiated caspase-mediated cleavage by nicotine preconditioning offers a novel insight into how this agent can impart its numerous effects on the nervous system.	Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Salt Lake City Vet Affairs, Geriat Res Educ & Clin Ctr, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs	Rogers, SW (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, 50 N Med Dr, Salt Lake City, UT 84132 USA.			Meyer, Erin/0000-0003-0704-5861	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035181] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35181] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Bi XN, 1998, BRAIN RES, V781, P355, DOI 10.1016/S0006-8993(97)01365-6; Bi XN, 2000, METH MOL B, V144, P203; Blanchard H, 2000, J MOL BIOL, V302, P9, DOI 10.1006/jmbi.2000.4041; Carlson NG, 1998, J NEUROBIOL, V35, P29, DOI 10.1002/(SICI)1097-4695(199804)35:1<29::AID-NEU3>3.0.CO;2-D; Carlson NG, 1999, J IMMUNOL, V163, P3963; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Fujii S, 2001, BRAIN RES, V894, P347, DOI 10.1016/S0006-8993(01)02057-1; Gahring LC, 1999, ALCOHOL CLIN EXP RES, V23, P1571, DOI 10.1111/j.1530-0277.1999.tb04046.x; Gahring LC, 2001, J IMMUNOL, V166, P1433, DOI 10.4049/jimmunol.166.3.1433; GALZI JL, 1995, NEUROPHARMACOLOGY, V34, P563, DOI 10.1016/0028-3908(95)00034-4; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Garrido R, 2001, J NEUROCHEM, V76, P1395, DOI 10.1046/j.1471-4159.2001.00135.x; Glazner GW, 2000, J NEUROSCI, V20, P3641, DOI 10.1523/JNEUROSCI.20-10-03641.2000; Gould TJ, 1999, BEHAV BRAIN RES, V102, P31, DOI 10.1016/S0166-4328(98)00157-0; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Hishita T, 2001, CANCER RES, V61, P2878; HOUGH R, 1984, P NATL ACAD SCI-BIOL, V81, P90, DOI 10.1073/pnas.81.1.90; Ishisaka R, 2001, J BIOCHEM-TOKYO, V129, P35, DOI 10.1093/oxfordjournals.jbchem.a002833; LIBBY P, 1981, J CELL PHYSIOL, V107, P185, DOI 10.1002/jcp.1041070204; LIBBY P, 1980, CELL, V19, P481, DOI 10.1016/0092-8674(80)90523-1; Lindstrom J, 1996, Ion Channels, V4, P377; Lissin DV, 1999, J NEUROSCI, V19, P1263; LUETJE CW, 1991, J NEUROSCI, V11, P837; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Maggio R, 1998, J NEUROCHEM, V71, P2439; MARKS MJ, 1993, J PHARMACOL EXP THER, V264, P542; Meyer EM, 1998, J PHARMACOL EXP THER, V284, P1026; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Olale F, 1997, J PHARMACOL EXP THER, V283, P675; PABREZA LA, 1991, MOL PHARMACOL, V39, P9; PAPKE RL, 1994, MOL PHARMACOL, V45, P142; Rogers SW, 1998, J NEUROSCI, V18, P4825; ROGERS SW, 1991, J NEUROSCI, V11, P2713; Rogers SW, 1998, J NEUROBIOL, V35, P209; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Ruberti F, 2000, J NEUROSCI, V20, part. no.; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; SCHIMKE RT, 1970, ANNU REV BIOCHEM, V39, P929, DOI 10.1146/annurev.bi.39.070170.004433; Shen L, 2000, J NEUROSCI, V20, P7932; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Varadhachary AS, 2001, J IMMUNOL, V166, P6564, DOI 10.4049/jimmunol.166.11.6564; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Walensky LD, 1999, J NEUROSCI, V19, P6457; Yuan XM, 2000, FREE RADICAL BIO MED, V28, P208, DOI 10.1016/S0891-5849(99)00220-8; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	62	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 29	2002	277	13					10869	10875		10.1074/jbc.M106744200	http://dx.doi.org/10.1074/jbc.M106744200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	534WQ	11751897	hybrid			2022-12-27	WOS:000174613100017
J	Smith, JW; Le Calvez, H; Parra-Gessert, L; Preece, NE; Jia, X; Assa-Munt, N				Smith, JW; Le Calvez, H; Parra-Gessert, L; Preece, NE; Jia, X; Assa-Munt, N			Selection and structure of ion-selective ligands for platelet integrin alpha(IIb)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVALENT-CATION REGULATION; CARBOXY-TERMINAL SEGMENT; PHAGE DISPLAY LIBRARY; CELL-ADHESION; GAMMA-CHAIN; RECOGNITION SITE; HUMAN-FIBRINOGEN; CRYSTAL-STRUCTURE; HUMAN FIBRONECTIN; PEPTIDE LIGANDS	Integrins contain a number of divalent cation binding sites that control ligand binding affinity. Ions such as Ca2+ and Mg2+ bind to distinct sites on integrin and can have opposing effects on ligand binding. These effects are presumably brought about by alterations of the shape of the ligand binding pocket. To gain insight into the nature of these structural differences, we probed the integrin ligand binding site with an RGD-based library of unparalleled complexity. A cysteine-constrained phage library containing six random amino acids and the RGD motif present in seven different registers was used to select for ligands that exhibit ion-selective binding to integrin alpha(IIb)beta(3). The library was used to select for peptides that bind to the integrin alpha(IIb)beta(3) preferentially in Ca2+ versus Mg2+. Peptides were identified which bound selectively in each ion. The Ca2+-selective peptides had a range of sequences, with the only obvious consensus involving a motif that had four cysteine residues bonded in a 1,4:2,3 arrangement. Interestingly though, the Me2+- selective peptides exhibited a well defined consensus motif containing Cys-X-aromatic-L/G-R-G-D-hydrophobic-R-R/K-Cys. As a first step toward understanding the structural basis for this selectivity, solution NMR structures were obtained for representatives of both sets of peptides. All peptides formed turns, with the RGD motif at the apex. The Mg2+-selected peptides contained a unique basic patch that protrudes from the base of the turn.	Burnham Inst, Canc Res Ctr, Program Cell Adhes, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Smith, JW (corresponding author), Burnham Inst, Canc Res Ctr, Program Cell Adhes, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL CANCER INSTITUTE [P01CA082713, R01CA069306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060049] Funding Source: NIH RePORTER; NCI NIH HHS [CA69306, CA82713] Funding Source: Medline; NIGMS NIH HHS [GM60049] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Assa-Munt N, 2001, BIOCHEMISTRY-US, V40, P2373, DOI 10.1021/bi002101f; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P10003, DOI 10.1073/pnas.90.21.10003; BRUNNETT B, 1993, SURVEYS MATH IND, V3, P1; Buck M, 1996, J MOL BIOL, V257, P669, DOI 10.1006/jmbi.1996.0193; Carr PA, 1997, STRUCTURE, V5, P949, DOI 10.1016/S0969-2126(97)00248-7; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DSOUZA SE, 1994, CELL, V79, P659, DOI 10.1016/0092-8674(94)90551-7; Duggan BM, 1999, EUR J BIOCHEM, V265, P539, DOI 10.1046/j.1432-1327.1999.00781.x; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729; GAILIT J, 1988, J BIOL CHEM, V263, P12927; GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644; HEALY JM, 1995, BIOCHEMISTRY-US, V34, P3948, DOI 10.1021/bi00012a012; Hu DD, 1999, J BIOL CHEM, V274, P4633, DOI 10.1074/jbc.274.8.4633; Hu DD, 1996, J BIOL CHEM, V271, P21745, DOI 10.1074/jbc.271.36.21745; HU DD, 1995, J BIOL CHEM, V270, P9917, DOI 10.1074/jbc.270.17.9917; Hufton SE, 2000, FEBS LETT, V475, P225, DOI 10.1016/S0014-5793(00)01701-4; KIRCHHOFER D, 1990, J BIOL CHEM, V265, P18525; KLOCZEWIAK M, 1982, BIOCHEM BIOPH RES CO, V107, P181, DOI 10.1016/0006-291X(82)91686-2; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; KLOCZEWIAK M, 1983, THROMB RES, V29, P249, DOI 10.1016/0049-3848(83)90147-0; KODANDAPANI R, 1995, J BIOL CHEM, V270, P2268, DOI 10.1074/jbc.270.5.2268; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; Kraft S, 1999, J BIOL CHEM, V274, P1979, DOI 10.1074/jbc.274.4.1979; Krezel AM, 2000, PROTEIN SCI, V9, P1428, DOI 10.1110/ps.9.8.1428; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; LEWIS PN, 1973, BIOCHIM BIOPHYS ACTA, V303, P221; Locardi E, 1999, J PEPT SCI, V5, P491, DOI 10.1002/(SICI)1099-1387(199911)5:11<491::AID-PSC218>3.0.CO;2-8; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; MIYAUCHI A, 1990, J CELL BIOL, V111, P2543, DOI 10.1083/jcb.111.6.2543; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; Neuhaus D., 2000, NUCL OVERHAUSER EFFE; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057; RUGGERI ZM, 1986, P NATL ACAD SCI USA, V83, P5708, DOI 10.1073/pnas.83.15.5708; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; SMITH JW, 1994, J BIOL CHEM, V269, P32788; SMITH JW, 1994, J BIOL CHEM, V269, P960; STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917; SUTCLIFFE MJ, 1994, NAT STRUCT BIOL, V1, P802, DOI 10.1038/nsb1194-802; Wang AC, 1996, J AM CHEM SOC, V118, P2483, DOI 10.1021/ja9535524; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yan B, 2000, J BIOL CHEM, V275, P7249, DOI 10.1074/jbc.275.10.7249; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200; ZAIDI M, 1991, J CELL PHYSIOL, V149, P422, DOI 10.1002/jcp.1041490310	50	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10298	10305		10.1074/jbc.M108071200	http://dx.doi.org/10.1074/jbc.M108071200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11748219	hybrid			2022-12-27	WOS:000174549200092
J	Dibas, MI; Gonzales, EB; Das, P; Bell-Horner, CL; Dillon, GH				Dibas, MI; Gonzales, EB; Das, P; Bell-Horner, CL; Dillon, GH			Identification of a novel residue within the second transmembrane domain that confers use-facilitated block by picrotoxin in glycine alpha 1 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA GABA RECEPTOR; GATED CHLORIDE CHANNEL; BETA-SUBUNIT; AMINO-ACID; CYSTEINE MUTANTS; POINT MUTATION; RAT; BICUCULLINE; MECHANISMS; RESISTANCE	The central nervous system convulsant picrotoxin (PTX) inhibits GABA(A) and glutamate-gated Cl- channels in a use-facilitated fashion, whereas PTX inhibition of glycine and GABA(C) receptors displays little or no use-facilitated block. We have identified a residue in the extracellular aspect of the second transmembrane domain that converted picrotoxin inhibition of glycine alpha1 receptors from non-use-facilitated to use-facilitated. In wild type alpha1. receptors, PTX inhibited glycine-gated Cl- current in a competitive manner and had equivalent effects on peak and steady-state currents, confirming a lack of use-facilitated block. Mutation of the second transmembrane domain 15'-serine to glutamine (alpha1(S15'Q) receptors) converted the mechanism of PTX blockade from competitive to non-competitive. However, more notable was the fact that in alpha1(S15'Q) receptors, PTX had insignificant effects on peak current amplitude and dramatically enhanced current decay kinetics. Similar results were found in al(S15'N) receptors. The reciprocal mutation in the 132 subunit of alpha1beta2 GABA(A) receptors (alpha1beta2(N15'S) receptors) decreased the magnitude of use-facilitated PTX inhibition. Our results implicate a specific amino acid at the extracellular aspect of the ion channel in determining use-facilitated characteristics of picrotoxin blockade. Moreover, the data are consistent with the suggestion that picrotoxin may interact with two domains in ligand-gated anion channels.	Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Dillon, GH (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	gdillon@hsc.unt.edu		Gonzales, Eric B./0000-0001-8596-9053	NIEHS NIH HHS [ES 07904] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007904, R29ES007904] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AKAIKE N, 1985, EXPERIENTIA, V41, P70; Cestari IN, 2000, J NEUROCHEM, V74, P827, DOI 10.1046/j.1471-4159.2000.740827.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; DILLON GH, 1995, BRIT J PHARMACOL, V115, P539, DOI 10.1111/j.1476-5381.1995.tb16368.x; Dong CJ, 1996, VISION RES, V36, P3997, DOI 10.1016/S0042-6989(96)00141-1; ENZ R, 1995, NEUROREPORT, V6, P1569, DOI 10.1097/00001756-199507310-00026; Etter A, 1999, J NEUROCHEM, V72, P318, DOI 10.1111/jnc.1999.72.1.318; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; GURLEY D, 1995, RECEPTOR CHANNEL, V3, P13; Huang RQ, 1999, J NEUROPHYSIOL, V82, P1233, DOI 10.1152/jn.1999.82.3.1233; IM WB, 1995, NEUROSCI LETT, V186, P203, DOI 10.1016/0304-3940(95)11293-6; INOUE M, 1988, NEUROSCI RES, V5, P380, DOI 10.1016/0168-0102(88)90024-7; JARBOE CH, 1968, J MED CHEM, V11, P729, DOI 10.1021/jm00310a020; Koltchine VV, 1999, MOL PHARMACOL, V56, P1087, DOI 10.1124/mol.56.5.1087; Krishek BJ, 1996, NEUROPHARMACOLOGY, V35, P1289, DOI 10.1016/S0028-3908(96)00089-5; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LI TB, 2000, SOC NEUR ABSTR, V26, P629; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; Maskell PD, 2001, BRIT J PHARMACOL, V132, P205, DOI 10.1038/sj.bjp.0703824; NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191, DOI 10.1113/jphysiol.1992.sp018998; Perret P, 1999, J BIOL CHEM, V274, P25350, DOI 10.1074/jbc.274.36.25350; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; REDDY GL, 1993, J BIOL CHEM, V268, P14608; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; SIMMONDS MA, 1980, EUR J PHARMACOL, V80, P347; Steward LJ, 2000, MOL PHARMACOL, V57, P1249; TEHRANI MHJ, 1985, J NEUROCHEM, V45, P1311, DOI 10.1111/j.1471-4159.1985.tb05560.x; TRIFILETTI RR, 1984, MOL PHARMACOL, V26, P470; WAFFORD KA, 1994, NEURON, V12, P775, DOI 10.1016/0896-6273(94)90330-1; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; Wang CT, 1999, BIOPHYS J, V77, P691, DOI 10.1016/S0006-3495(99)76924-9; WANG TL, 1995, P NATL ACAD SCI USA, V92, P11751, DOI 10.1073/pnas.92.25.11751; WANG TL, 1994, J NEUROSCI, V14, P6524; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; Ye Q, 1998, J BIOL CHEM, V273, P3314, DOI 10.1074/jbc.273.6.3314; YOON KW, 1993, J PHYSIOL-LONDON, V464, P423, DOI 10.1113/jphysiol.1993.sp019643; ZHANG DX, 1995, P NATL ACAD SCI USA, V92, P11756, DOI 10.1073/pnas.92.25.11756; ZHANG HG, 1994, J PHYSIOL-LONDON, V479, P65, DOI 10.1113/jphysiol.1994.sp020278; Zhorov BS, 2000, BIOPHYS J, V78, P1786, DOI 10.1016/S0006-3495(00)76729-4	43	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9112	9117		10.1074/jbc.M111356200	http://dx.doi.org/10.1074/jbc.M111356200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11744711	hybrid			2022-12-27	WOS:000174400600051
J	Chang, DD; Hoang, BQ; Liu, J; Springer, TA				Chang, DD; Hoang, BQ; Liu, J; Springer, TA			Molecular basis for interaction between Icap1 alpha PTB domain and beta(1) integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FOCAL ADHESION KINASE; CYTOPLASMIC DOMAIN; SIGNAL-TRANSDUCTION; CELL-ADHESION; ALPHA-ACTININ; SUBUNIT; BINDING; MODULATION; BETA-1	Icap1alpha is a 200-amino acid protein that binds to the COOH-terminal 13 amino acids ((788)AVTTVVNPKYE-GK(798)) of the integrin beta(1) subunit. Alanine scanning mutagenesis of this region revealed that Val(787), Val(790), and (NPKY795)-N-792 are critical for Icap1alpha binding. The NPXY motif is a known binding substrate for phosphotyrosine binding (PTB) domain proteins. The sequences of Icap1alpha, residues 58-200, and the beta(1) integrin, residues 786-797, were aligned to the available PTB-peptide structures to generate a high quality structural model. Site-directed mutagenesis showed that Leu(135), Ile(138), and Ile(139) of Icap1alpha, residues predicted by the model to be in close proximity to (NPKY795)-N-792, and LeU(82) and Tyr(144), residues expected to form a hydrophobic pocket near Val(787), are required for the Icap1alpha-beta(1), integrin interaction. These findings indicate that Icap1alpha is a PTB domain protein, which recognizes the NPXY motif of beta(1) integrin. Furthermore, our date suggest that an interaction between Val(787) and the hydrophobic pocket created by Leu(82) and Tyr(144) of Icap1alpha forms the basis for the specificity of Icap1alpha for the beta(1) integrin subunit.	Univ Calif Los Angeles, Sch Med, Div Heme One, Dept Med Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Chang, DD (corresponding author), Univ Calif Los Angeles, Sch Med, Div Heme One, Dept Med Microbiol Immunol & Mol Genet, Factor 11-934,10833 Le Conte Ave, Los Angeles, CA 90095 USA.				NCI NIH HHS [CA78375] Funding Source: Medline; NHLBI NIH HHS [HL48675] Funding Source: Medline; NIDCR NIH HHS [T32DE007926] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE007926, R29DE007926] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Borg JP, 1998, CURR TOP MICROBIOL, V228, P23; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bouvard D, 1998, BIOCHEM BIOPH RES CO, V252, P46, DOI 10.1006/bbrc.1998.9592; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; He WM, 1996, J BIOL CHEM, V271, P11641, DOI 10.1074/jbc.271.20.11641; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; Huang CC, 2000, J BIOL CHEM, V275, P21514, DOI 10.1074/jbc.M002286200; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kashiwagi H, 1997, J CELL BIOL, V137, P1433, DOI 10.1083/jcb.137.6.1433; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; OTEY CA, 1993, J BIOL CHEM, V268, P21193; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SHATTIL SJ, 1995, J CELL BIOL, V131, P807, DOI 10.1083/jcb.131.3.807; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; TRUB T, 1995, J BIOL CHEM, V270, P18205; VanNhieu GT, 1996, J BIOL CHEM, V271, P7665, DOI 10.1074/jbc.271.13.7665; VRIEND G, 1990, PROTEIN ENG, V4, P221, DOI 10.1093/protein/4.2.221; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000; Wilson KS, 1998, J MOL BIOL, V276, P417; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	50	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8140	8145		10.1074/jbc.M109031200	http://dx.doi.org/10.1074/jbc.M109031200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741908	hybrid			2022-12-27	WOS:000174268000066
J	Donaldson, SH; Hirsh, A; Li, DC; Holloway, G; Chao, J; Boucher, RC; Gabriel, SE				Donaldson, SH; Hirsh, A; Li, DC; Holloway, G; Chao, J; Boucher, RC; Gabriel, SE			Regulation of the epithelial sodium channel by serine proteases in human airways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; NA+ CHANNEL; LIDDLES-SYNDROME; PERICILIARY LIQUID; CLONING; LOCALIZATION; EXPRESSION; DOMAINS; NEDD4; TRANSMEMBRANE	The epithelial sodium channel (ENaC) constitutes the rate-limiting step for sodium absorption across airway epithelia, which in turn regulates airway surface liquid (ASL) volume and the efficiency of mucociliary clearance. This role in ASL volume regulation suggests that ENaC activity is influenced by local factors rather than systemic signals indicative of total body volume homeostasis. Based on reports that ENaC may be regulated by extracellular serine protease activity in Xenopus and mouse renal epithelia, we sought to identify proteases that serve similar functions in human airway epithelia. Homology screening of a human airway epithelial cDNA library identified two trypsin-like serine proteases (prostasin and TMPRSS2) that, as revealed by in situ hybridization, are expressed in airway epithelia. Functional studies in the Xenopas oocyte expression system demonstrated that prostasin increased ENaC currents 60-80%, whereas TMPRSS2 markedly decreased ENaC currents and protein levels. Studies of primary nasal epithelial cultures in Ussing chambers revealed that inhibition of endogenous serine protease activity with aprotinin markedly decreased ENaC-mediated currents and sensitized the epithelia to subsequent channel activation by exogenous trypsin. These data, therefore, suggest that protease-mediated regulation of sodium absorption is a function of human airway epithelia, and prostasin is a likely candidate for this activity.	Univ N Carolina, Cyst Fibrosis Res & Treatment Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Medical University of South Carolina	Donaldson, SH (corresponding author), Univ N Carolina, Cyst Fibrosis Res & Treatment Ctr, 6019 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.		Donaldson, Scott H./ABG-5157-2021	Donaldson, Scott H./0000-0003-4802-0388	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062564, K08HL068617] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62564, K08 HL068617] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; FRINDT G, 1995, AM J PHYSIOL-RENAL, V268, pF480, DOI 10.1152/ajprenal.1995.268.3.F480; Frindt G, 1996, AM J PHYSIOL-RENAL, V271, pF1086; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; JIANG CW, 1993, SCIENCE, V262, P424, DOI 10.1126/science.8211164; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; KNOWLES MR, 1985, PEDIATR RES, V19, P676, DOI 10.1203/00006450-198507000-00008; Lin BY, 1999, CANCER RES, V59, P4180; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; PaoloniGiacobino A, 1997, GENOMICS, V44, P309, DOI 10.1006/geno.1997.4845; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Schwiebert EM, 1997, AM J PHYSIOL-CELL PH, V272, pC911, DOI 10.1152/ajpcell.1997.272.3.C911; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Stutts MJ, 1997, J BIOL CHEM, V272, P14037, DOI 10.1074/jbc.272.22.14037; STUTTS MJ, 1998, PEDIAT PULMONAL S, V15, pA77; Talbot CL, 1999, AM J RESP CELL MOL, V20, P398, DOI 10.1165/ajrcmb.20.3.3283; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; YU JX, 1994, J BIOL CHEM, V269, P18843	29	195	202	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8338	8345		10.1074/jbc.M105044200	http://dx.doi.org/10.1074/jbc.M105044200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756432	hybrid, Green Published			2022-12-27	WOS:000174268000092
J	Williams, NK; Prosselkov, P; Liepinsh, E; Line, I; Sharipo, A; Littler, DR; Curmi, PMG; Otting, G; Dixon, NE				Williams, NK; Prosselkov, P; Liepinsh, E; Line, I; Sharipo, A; Littler, DR; Curmi, PMG; Otting, G; Dixon, NE			In vivo protein cyclization promoted by a circularly permuted Synechocystis sp PCC6803 DnaB mini-intein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; TUBERCULOSIS RECA INTEIN; MOLAR HEAT-CAPACITY; ESCHERICHIA-COLI; DISULFIDE BONDS; NMR-SPECTROSCOPY; AQUEOUS-SOLUTION; SPLIT INTEIN; STABILITY; GENE	A synthetic Synechocystis sp. PCC6803 DnaB split mini-intein gene was constructed for the in vivo cyclization of recombinant proteins expressed in Escherichia coli. The system was used to cyclize the NH2-terminal domain of E. coli DnaB, the structure of which had been determined previously by NMR spectroscopy. Cyclization was found to proceed efficiently, with little accumulation of precursor, and the product was purified in high yield. The solution structure of cyclic DnaB-N is not significantly different from that of linear DnaB-N and it unfolds reversibly at temperatures similar to14 degreesC higher. Improved hydrogen bonding was observed in the first and last helices, and the length of the last helix was increased, while the 9-amino acid linker used to join the NH2 and COOH termini was found to be highly mobile. The measured thermodynamic stabilization of the structure (DeltaDeltaG approximate to 2 kcal/mol) agrees well with the value estimated from the reduced conformational entropy in the unfolded form. Simple polymer theory can be used to predict likely free energy changes resulting from protein cyclization and how the stabilization depends on the size of the protein and the length of the linker used to connect the termini.	Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Latvian State Univ, Biomed Res & Study Ctr, LV-1067 Riga, Latvia; Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia	Australian National University; Karolinska Institutet; Latvian Biomedical Research & Study Centre; University of Latvia; University of New South Wales Sydney	Dixon, NE (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia.		Otting, Gottfried/H-8413-2014; Curmi, Paul/G-7185-2011; Dixon, Nicholas E/A-1226-2008	Otting, Gottfried/0000-0002-0563-0146; Curmi, Paul/0000-0001-5762-7638; Dixon, Nicholas E/0000-0002-5958-6945; Prosselkov, Pavel/0000-0002-9617-0877; Littler, Dene/0000-0001-5904-1905				BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Camarero JA, 2001, J MOL BIOL, V308, P1045, DOI 10.1006/jmbi.2001.4631; Casimiro DR, 1997, STRUCTURE, V5, P1407, DOI 10.1016/S0969-2126(97)00291-8; CHAN HS, 1989, J CHEM PHYS, V90, P492, DOI 10.1063/1.456500; Christopher JA, 1996, J MOL BIOL, V257, P175, DOI 10.1006/jmbi.1996.0154; DAMASCHUN G, 1993, BIOCHEMISTRY-US, V32, P7739, DOI 10.1021/bi00081a019; DAMASCHUN G, 1991, BIOCHIM BIOPHYS ACTA, V1078, P289, DOI 10.1016/0167-4838(91)90571-G; DOIG AJ, 1991, J MOL BIOL, V217, P389, DOI 10.1016/0022-2836(91)90551-G; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; ELVIN CM, 1990, GENE, V87, P123, DOI 10.1016/0378-1119(90)90503-J; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Fass D, 1999, STRUCTURE, V7, P691, DOI 10.1016/S0969-2126(99)80090-2; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; GERTHSEN C, 2002, GERTHSEN PHYSIK, P798; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOLDENBERG DP, 1985, J CELL BIOCHEM, V29, P321, DOI 10.1002/jcb.240290406; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRIGBAUM WR, 1975, BIOCHEMISTRY-US, V14, P2542, DOI 10.1021/bi00682a038; Ladurner AG, 1997, J MOL BIOL, V273, P330, DOI 10.1006/jmbi.1997.1304; Liu L, 2000, BIOPHYS CHEM, V84, P239, DOI 10.1016/S0301-4622(00)00130-7; Love CA, 1996, GENE, V176, P49, DOI 10.1016/0378-1119(96)00208-9; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; Miles CS, 1997, BIOCHEM BIOPH RES CO, V231, P126, DOI 10.1006/bbrc.1997.6059; Mills KV, 1998, P NATL ACAD SCI USA, V95, P3543, DOI 10.1073/pnas.95.7.3543; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; PACE CN, 1988, J BIOL CHEM, V263, P11820; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Shingledecker K, 1998, GENE, V207, P187, DOI 10.1016/S0378-1119(97)00624-0; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VASUDEVAN SG, 1991, MOL GEN GENET, V226, P49, DOI 10.1007/BF00273586; Weigelt J, 1999, STRUCT FOLD DES, V7, P681, DOI 10.1016/S0969-2126(99)80089-6; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o	44	67	88	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7790	7798		10.1074/jbc.M110303200	http://dx.doi.org/10.1074/jbc.M110303200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11742000	hybrid			2022-12-27	WOS:000174268000023
J	Grangeasse, C; Doublet, P; Cozzone, AJ				Grangeasse, C; Doublet, P; Cozzone, AJ			Tyrosine phosphorylation of protein kinase Wzc from Escherichia coli K12 occurs through a two-step process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULAR POLYSACCHARIDE BIOSYNTHESIS; EPS GENE-CLUSTER; MOLECULAR CHARACTERIZATION; AUTOPHOSPHORYLATING PROTEIN; SEQUENCE-ANALYSIS; EXPRESSION; PLASMID; CPSD; IDENTIFICATION; SUCCINOGLYCAN	In bacteria, several proteins have been shown to autophosphorylate on tyrosine residues, but little is known on the molecular mechanism of this modification. To get more information on this matter, we have analyzed in detail the phosphorylation of a particular autokinase, protein Wzc, from Escherichia coli K12. The analysis of the hydropathic profile of this protein indicates that it is composed of two main domains: an N-terminal domain, including two transmembrane alpha-helices, and a C-terminal cytoplasmic domain. The C-terminal domain alone can undergo autophosphorylation and thus appears to harbor the protein-tyrosine kinase activity. By contrast, the N-terminal domain is not phosphorylated when incubated either alone or in the presence of the C-domain, and does not influence the extent of phosphorylation of the C-domain. The C-domain contains six different sites of phosphorylation. Among these, five are located at the C-terminal end of the molecule in the form of a tyrosine cluster (Tyr(708), Tyr(710), Tyr(711), Tyr(713), and Tyr(715)), and one site is located upstream, at Tyr(569). The Tyr(569) residue can autophosphorylate through an intramolecular process, whereas the tyrosine cluster cannot. The phosphorylation of Tyr(569) results in an increased protein kinase activity of Wzc, which can, in turn, phosphorylate the five terminal tyrosines through an intermolecular process. It is concluded that protein Wzc autophosphorylates by using a cooperative two-step mechanism that involves both intra- and interphosphorylation. This mechanism may be of biological significance in the signal transduction mediated by Wzc.	Univ Lyon, CNRS, Inst Biol & Chim Prot, F-69367 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS)	Cozzone, AJ (corresponding author), Univ Lyon, CNRS, Inst Biol & Chim Prot, 7 Passage Vercors, F-69367 Lyon 07, France.	aj.cozzone@ibcp.fr	Doublet, Patricia/L-9480-2014	Doublet, Patricia/0000-0001-5848-4317; Grangeasse, Christophe/0000-0002-5484-4589				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BECKER A, 1995, MOL MICROBIOL, V16, P191, DOI 10.1111/j.1365-2958.1995.tb02292.x; Bender MH, 2001, J BIOL CHEM, V276, P47966, DOI 10.1074/jbc.M105448200; BUGERT P, 1995, MOL MICROBIOL, V15, P917, DOI 10.1111/j.1365-2958.1995.tb02361.x; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; CORTAY JC, 1986, EUR J BIOCHEM, V159, P227, DOI 10.1111/j.1432-1033.1986.tb09858.x; Cozzone AJ, 1998, BIOCHIMIE, V80, P43, DOI 10.1016/S0300-9084(98)80055-2; COZZONE AJ, 1993, J CELL BIOCHEM, V51, P7, DOI 10.1002/jcb.240510103; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; DARDEL F, 1988, COMPUT APPL BIOSCI, V4, P483; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Doublet P, 1999, FEBS LETT, V445, P137, DOI 10.1016/S0014-5793(99)00111-8; Duclos B, 1996, J MOL BIOL, V259, P891, DOI 10.1006/jmbi.1996.0366; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Grangeasse C, 1997, GENE, V204, P259, DOI 10.1016/S0378-1119(97)00554-4; GUIDOLIN A, 1994, INFECT IMMUN, V62, P5384, DOI 10.1128/IAI.62.12.5384-5396.1994; HUANG JZ, 1995, MOL MICROBIOL, V16, P977, DOI 10.1111/j.1365-2958.1995.tb02323.x; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN WS, 1994, J BACTERIOL, V176, P7005, DOI 10.1128/JB.176.22.7005-7016.1994; Morona JK, 1999, J BACTERIOL, V181, P3599, DOI 10.1128/JB.181.11.3599-3605.1999; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Niemeyer D, 2001, J BACTERIOL, V183, P5163, DOI 10.1128/JB.183.17.5163-5170.2001; Preneta R, 2002, COMP BIOCHEM PHYS B, V131, P103, DOI 10.1016/S1096-4959(01)00490-0; RUBENS CE, 1993, MOL MICROBIOL, V8, P843, DOI 10.1111/j.1365-2958.1993.tb01631.x; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; Stingele F, 1996, J BACTERIOL, V178, P1680, DOI 10.1128/jb.178.6.1680-1690.1996; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Vincent C, 1999, J BACTERIOL, V181, P3472, DOI 10.1128/JB.181.11.3472-3477.1999; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Yamamoto S, 1999, J BACTERIOL, V181, P5176, DOI 10.1128/JB.181.17.5176-5184.1999; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	39	68	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7127	7135		10.1074/jbc.M110880200	http://dx.doi.org/10.1074/jbc.M110880200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751920	hybrid			2022-12-27	WOS:000174104300049
J	Fischer, DD; Cai, R; Bhatia, U; Asselbergs, FAM; Song, CZ; Terry, R; Trogani, N; Widmer, R; Atadja, P; Cohen, D				Fischer, DD; Cai, R; Bhatia, U; Asselbergs, FAM; Song, CZ; Terry, R; Trogani, N; Widmer, R; Atadja, P; Cohen, D			Isolation and characterization of a novel class II histone deacetylase, HDAC10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COREPRESSORS; TRANSCRIPTIONAL REPRESSION; SIR2-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; N-COR; COMPLEX; YEAST; SIR2; DOMAIN; ACTIVATION	A novel histone deacetylase, HDAC10, was isolated from a mixed tissue human cDNA library. HDAC10 was classified as a class II subfamily member based upon similarity to MUM The genomic structure of HDAC10 was found to consist of 20 exons. HDAC10 has two sequence variants, HDAC10v1 and HDAC10v2, and two transcripts were detectable by Northern blot analysis. HDAC10v1 and HDAC10v2 were found to be identical through exon 17 but diverged after this exon. HDAC10v2 has an 82-bp alternate exon that generates a frameshift and shortens the sequence by 11 amino acids. In this study, the characterization of HDAC10v1 was performed. HDAC10v1 has an N-terminal catalytic domain, two putative C-terminal retinoblastoma protein binding domains, and a nuclear hormone receptor binding motif. The BDAC10v1 enzyme was found to be catalytically active based upon its ability to deacetylate a 3 H-acetylated histone H4 N-terminal peptide. Immunofluorescence detection of transfected HDAC10v1-FLAG indicated that the enzyme is a nuclear protein. Furthermore, coimmunoprecipitation experiments indicated that HDAC10v1 associated with HDAC2 and SMRT (silencing mediator for retinoid and thyroid hormone receptors). In addition, based upon the public data base, a single nucleotide polymorphism. was found in the C terminus of HDAC10 which changes a Gly residue to Cys, suggesting that HDAC10 molecules containing these single nucleotide polymorphisms may be folded improperly. HDAC10 extends the HDAC superfamily and adds to a growing number of HDACs that have been found to have splice variants, suggesting that RNA processing may play a role in mediating the activity of HDACs.	Nova Pharmaceut Corp, Dept Funct Genom, Summit, NJ 07901 USA; Nova Pharmaceut Corp, Dept Oncol, Summit, NJ 07901 USA; Novartis Pharma AG, Dept Funct Genom, CH-4056 Basel, Switzerland	Novartis; Novartis; Novartis	Cohen, D (corresponding author), Nova Pharmaceut Corp, Dept Funct Genom, 556 Morris Ave,Bldg 130A, Summit, NJ 07901 USA.	dalia.cohen@pharma.novartis.com						Afshar G, 1999, GENE, V234, P161, DOI 10.1016/S0378-1119(99)00162-6; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; AUSUBEL FM, 1993, CURR PROTOCOLS MO S1, V23; AUSUBEL FM, 1993, CURR PROTOCOLS MO S1, V26; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; Davie JR, 1999, J CELL BIOCHEM, P141; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischle W, 2001, BIOCHEM CELL BIOL, V79, P337, DOI 10.1139/bcb-79-3-337; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; GERARD GF, 1992, FOCUS, V14, P91; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Huang EY, 2000, GENE DEV, V14, P45; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Isaksson Anders, 2000, European Journal of Human Genetics, V8, P154, DOI 10.1038/sj.ejhg.5200424; Jones KA, 2000, GENE DEV, V14, P1992; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kao HY, 2000, GENE DEV, V14, P55; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; Krude T, 2001, CELL MOL LIFE SCI, V58, P665, DOI 10.1007/PL00000890; Kuzmichev A, 2001, CURR TOP MICROBIOL, V254, P35; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Minucci S, 1999, SEMIN CELL DEV BIOL, V10, P215, DOI 10.1006/scdb.1999.0303; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; van Holde K.E., 1988, HISTONE MODIFICATION; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	63	101	115	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6656	6666		10.1074/jbc.M108055200	http://dx.doi.org/10.1074/jbc.M108055200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11739383	hybrid			2022-12-27	WOS:000173989200126
J	Wellbrock, C; Weisser, C; Geissinger, E; Troppmair, J; Schartl, M				Wellbrock, C; Weisser, C; Geissinger, E; Troppmair, J; Schartl, M			Activation of p59(Fyn) leads to melanocyte dedifferentiation by influencing MKP-1-regulated mitogen-activated protein kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; MICROPHTHALMIA GENE-PRODUCT; TRANSCRIPTION FACTOR MICROPHTHALMIA; WAARDENBURG SYNDROME TYPE-2; IMMEDIATE-EARLY GENE; MAP KINASE; CYCLIC-AMP; MURINE MELANOCYTES; MALIGNANT-MELANOMA; PC12 CELLS	Malignant melanoma is a cancer whose incidence is rising rapidly, but the mechanism by which normal melanocytes become malignant in vivo is still little understood. In the course of melanoma progression, a fraction of cells often becomes depigmented, which reflects the loss of the balance between mitogenic activities and differentiation in those pigment cells. A key factor involved in differentiation in pigment cells is mitogenactivated protein kinase (MAPK). However, because both activation and inhibition of MAPK signaling is known to correlate with differentiation, its function in pigment cells is still unclear. We investigated the role of MAPK signaling in pigment cells using the melanoma-inducing receptor tyrosine kinase Xmrk. Xmrk signaling in mouse melanocytes suppressed differentiation and induced a transformed phenotype. We found that this was based on sustained MAPK activation caused by low and transient expression of MAPK-phosphatase MKP-1. The Src kinase P59(Fyn) was thereby identified as being crucial for the receptor-mediated suppression of differentiation by down-regulating MKP-1 expression. Our findings reveal a novel mechanism of regulating the balance between differentiation and proliferation based on a Src kinase-modified MAPK activity. Moreover, they point to a new role for Src kinases in dedifferentiation and transformation of pigment cells.	Univ Wurzburg, Inst Physiol Chem 1, Biozentrum, Theodor Boveri Inst, D-97074 Wurzburg, Germany; Univ Wurzburg, Inst Pathol, D-97094 Wurzburg, Germany; Univ Wurzburg, Inst Med Strahlenkunde & Zellforschung, D-97094 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Wellbrock, C (corresponding author), Univ Wurzburg, Inst Physiol Chem 1, Biozentrum, Theodor Boveri Inst, Hubland, D-97074 Wurzburg, Germany.	wellbrock@biozentrum.uni-wuerzburg.de		Troppmair, Jakob/0000-0002-0611-3837; Schartl, Manfred/0000-0001-9882-5948; Wellbrock, Claudia/0000-0002-3825-6381				BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Burgun C, 2000, FEBS LETT, V484, P189, DOI 10.1016/S0014-5793(00)02153-0; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; CHARLES CH, 1992, ONCOGENE, V7, P187; DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X; DOTTO GP, 1989, J CELL BIOL, V109, P3115, DOI 10.1083/jcb.109.6.3115; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Evans DRH, 1998, NATURE, V394, P23, DOI 10.1038/27782; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; GANSS R, 1994, J BIOL CHEM, V269, P29808; Halaban R, 1996, J INVEST DERMATOL, V106, P1266, DOI 10.1111/1523-1747.ep12348972; Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; KLUPPEL M, 1991, P NATL ACAD SCI USA, V88, P3777, DOI 10.1073/pnas.88.9.3777; Kusari AB, 1997, MOL ENDOCRINOL, V11, P1532, DOI 10.1210/me.11.10.1532; LASSAM N, 1992, ONCOGENE, V7, P51; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Lister JA, 1999, DEVELOPMENT, V126, P3757; LOGANZO F, 1993, ONCOGENE, V8, P2637; LOWINGS P, 1992, MOL CELL BIOL, V12, P3653, DOI 10.1128/MCB.12.8.3653; Marchetti D, 1998, ONCOGENE, V16, P3253, DOI 10.1038/sj.onc.1201877; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Planque N, 1999, CELL GROWTH DIFFER, V10, P525; Plevin R, 1997, CELL SIGNAL, V9, P323, DOI 10.1016/S0898-6568(96)00193-3; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; von Gise A, 2001, MOL CELL BIOL, V21, P2324, DOI 10.1128/MCB.21.7.2324-2336.2001; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WELLBROCK C, 1995, ONCOGENE, V10, P2135; Wellbrock C, 2000, EUR J BIOCHEM, V267, P3513, DOI 10.1046/j.1432-1327.2000.01378.x; WILSON RE, 1989, CANCER RES, V49, P711; WITTBRODT J, 1992, EMBO J, V11, P4239, DOI 10.1002/j.1460-2075.1992.tb05518.x; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Wu M, 2000, GENE DEV, V14, P301; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; YAVUZER U, 1995, ONCOGENE, V10, P123; Yayon A, 1997, ONCOGENE, V14, P2999, DOI 10.1038/sj.onc.1201159	50	69	71	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6443	6454		10.1074/jbc.M110684200	http://dx.doi.org/10.1074/jbc.M110684200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11734563	hybrid			2022-12-27	WOS:000173989200099
J	Yazaki, K; Kunihisa, M; Fujisaki, T; Sato, F				Yazaki, K; Kunihisa, M; Fujisaki, T; Sato, F			Geranyl diphosphate : 4-hydroxybenzoate geranyltransferase from Lithospermum erythrorhizon - Cloning and characterization of a key enzyme in shikonin biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION CULTURES; ESCHERICHIA-COLI; GENE-EXPRESSION; IN-VITRO; TRANSFERASE; YEAST; ACID; PRENYLATION; INHIBITION; POLYPRENYLTRANSFERASE	Two cDNAs encoding geranyl diphosphate:4-hydroxy-benzoate 3-geranyltransferase were isolated from Lithospermum erythrorhizon by nested PCR using the conserved amino acid sequences among polyprenyl-transferases for ubiquinone biosynthesis. They were functionally expressed in yeast COQ2 disruptant and showed a strict substrate specificity for geranyl diphosphate as the prenyl donor, in contrast to ubiquinone biosynthetic enzymes, suggesting that they are involved in the biosynthesis of shikonin, a naphthoquinone secondary metabolite. Regulation of their expression by various culture conditions coincided with that of geranyltransferase activity and the secondary metabolites biosynthesized via this enzyme. This is the first established plant prenyltransferase that transfers the prenyl chain to an aromatic substrate.	Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan	Kyoto University	Yazaki, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kitashirakawa, Kyoto 6068502, Japan.	yazaki@kais.kyoto-u.ac.jp	Sato, Fumihiko/C-1078-2011	Sato, Fumihiko/0000-0001-9497-4452				ASHBY MN, 1992, J BIOL CHEM, V267, P4128; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; BIGGS DR, 1987, FEBS LETT, V220, P223, DOI 10.1016/0014-5793(87)80909-2; BOUTRY M, 1985, EMBO J, V4, P2159, DOI 10.1002/j.1460-2075.1985.tb03910.x; Brigham LA, 1999, PLANT PHYSIOL, V119, P417, DOI 10.1104/pp.119.2.417; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; DHILLON DS, 1976, ARCH BIOCHEM BIOPHYS, V177, P74, DOI 10.1016/0003-9861(76)90417-3; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fellermeier M, 1998, FEBS LETT, V427, P283, DOI 10.1016/S0014-5793(98)00450-5; Fristedt U, 1996, ARCH BIOCHEM BIOPHYS, V330, P133, DOI 10.1006/abbi.1996.0235; Fujita Y, 1981, Plant Cell Rep, V1, P61, DOI 10.1007/BF00269273; Gaisser S, 1996, PHYTOCHEMISTRY, V41, P1065, DOI 10.1016/0031-9422(95)00633-8; GRUNLER J, 1994, BBA-LIPID LIPID MET, V1212, P259, DOI 10.1016/0005-2760(94)90200-3; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HAMERSKI D, 1988, EUR J BIOCHEM, V171, P369, DOI 10.1111/j.1432-1033.1988.tb13800.x; HEIDE L, 1989, PHYTOCHEMISTRY, V28, P1873, DOI 10.1016/S0031-9422(00)97877-4; Henderson MC, 2000, XENOBIOTICA, V30, P235, DOI 10.1080/004982500237631; INOUYE H, 1979, PHYTOCHEMISTRY, V18, P1301, DOI 10.1016/0031-9422(79)83012-5; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; LAFLAMME P, 1993, PHYTOCHEMISTRY, V34, P147, DOI 10.1016/S0031-9422(00)90796-9; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Miranda CL, 2000, J AGR FOOD CHEM, V48, P3876, DOI 10.1021/jf0002995; Morandi D, 1996, PLANT SOIL, V185, P241, DOI 10.1007/BF02257529; Muhlenweg A, 1998, PLANTA, V205, P407, DOI 10.1007/s004250050337; OKAMOTO T, 1995, PHYTOCHEMISTRY, V38, P83, DOI 10.1016/0031-9422(94)00621-Y; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; SCHRODER G, 1979, ARCH BIOCHEM BIOPHYS, V194, P635, DOI 10.1016/0003-9861(79)90659-3; Sommer S, 1999, PLANT MOL BIOL, V39, P683, DOI 10.1023/A:1006185806390; SUZUKI K, 1994, BIOSCI BIOTECH BIOCH, V58, P1814, DOI 10.1271/bbb.58.1814; Tabata M., 1985, BIOTECHNOLOGY PLANT, P207; Tabata M., 1996, PLANT TISSUE CULTURE, V13, P117, DOI DOI 10.5511/PLANTBIOTECHNOLOGY1984.13.117; TAHARA S, 1995, PHYTOCHEMISTRY, V38, P1073, DOI 10.1016/0031-9422(94)00788-U; TANI M, 1993, PHYTOCHEMISTRY, V34, P1285, DOI 10.1016/0031-9422(91)80017-U; Uchida N, 2000, J BACTERIOL, V182, P6933, DOI 10.1128/JB.182.24.6933-6939.2000; Wang BH, 1997, PHYTOCHEMISTRY, V44, P787, DOI 10.1016/S0031-9422(96)00664-4; WELLE R, 1991, PHYTOCHEMISTRY, V30, P479, DOI 10.1016/0031-9422(91)83709-T; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; YAMAGA Y, 1993, PHYTOCHEMISTRY, V32, P633, DOI 10.1016/S0031-9422(00)95147-1; Yamamoto H, 1997, PHYTOCHEMISTRY, V44, P23, DOI 10.1016/S0031-9422(96)00484-0; Yamamoto H, 2000, PHYTOCHEMISTRY, V54, P649, DOI 10.1016/S0031-9422(00)00198-9; Yamamoto H, 2000, PHYTOCHEMISTRY, V53, P651, DOI 10.1016/S0031-9422(99)00623-8; Yamamoto H, 2000, J CHROMATOGR B, V738, P3, DOI 10.1016/S0378-4347(99)00473-9; Yazaki K, 1997, PLANT CELL PHYSIOL, V38, P776, DOI 10.1093/oxfordjournals.pcp.a029235; YAZAKI K, 1995, PLANT CELL PHYSIOL, V36, P1319; Yazaki K, 2001, PLANT PHYSIOL, V125, P1831, DOI 10.1104/pp.125.4.1831; Yazaki K, 1997, BIOSCI BIOTECH BIOCH, V61, P1995, DOI 10.1271/bbb.61.1995; Yazaki K., 1999, PLANT BIOTECHNOL-NAR, V16, P335, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.16.335	49	118	139	6	39	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6240	6246		10.1074/jbc.M106387200	http://dx.doi.org/10.1074/jbc.M106387200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744717	hybrid			2022-12-27	WOS:000173989200073
J	Hou, YX; Cui, LY; Riordan, JR; Chang, XB				Hou, YX; Cui, LY; Riordan, JR; Chang, XB			ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; S-CONJUGATE TRANSPORT; CANCER CELL-LINE; CRYSTAL-STRUCTURE; ABC TRANSPORTER; LEUKOTRIENE C-4; CATALYTIC CYCLE; GENE; GLUTATHIONE; SITES	Multidrug resistance protein (MRP1) utilizes two nonequivalent nucleotide-binding domains (NBDs) to bind and hydrolyze ATP. ATP hydrolysis by either one or both NBDs is essential to drive transport of solute. Mutations of either NBD1 or NBD2 reduce solute transport, but do not abolish it completely. How events at these two domains are coordinated during the transport cycle have not been fully elucidated. Earlier reports (Gao, M., Cui, H. R., Loe, D. W., Grant, C. E., Almquist, g. C., Cole, S. P., and Deeley, R. G. (2000) J. Biol. Chem. 275,13098-13108; Hou, Y., Cui, L., Riordan, J. R., and Chang, X. (2000) J. Biol. Chem. 275, 20280-20287) indicate that intact ATP is observed bound at NBD1, whereas trapping of the ATP hydrolysis product, ADP, occurs predominantly at NBD2 and that trapping of ADP at NBD2 enhances ATP binding at NBD1 severalfold. This suggested transmission of a positive allosteric interaction from NBD2 to NBD1. To assess whether ATP binding at NBD1 can enhance the trapping of ADP at NBD2, photoaffinity labeling experiments with [alpha-P-32]8-N(3)ADP were performed and revealed that when presented with this compound labeling of MRP1 occurred at both NBDs. However, upon addition of ATP, this labeling was enhanced 4-fold mainly at NBD2. Furthermore, the nonhydrolyzable ATP analogue, 5'-adenylylimidodiphosphate (AMP-PNP), bound preferentially to NBD1, but upon addition of a low concentration of 8-N(3)ATP, the binding at NBD2 increased severalfold. This suggested that the positive allosteric stimulation from NBD1 actually involves an increase in ATP binding at NBD2 and hydrolysis there leading to the trapping of ADP. Mutations of Walker A or B motifs in either NBD greatly reduced their ability to be labeled by [alpha-P-32]8-N(3)ADP as well as by either [alpha-P-32]or [gamma-P-32]8-N(3)ATP (Hou et al. (2000), see above). These mutations also strongly diminished the enhancement by ATP of [alpha-P-32]8-N(3)ADP labeling and the transport activity of the protein. Taken together, these results demonstrate directly that events at NBD1 positively influence those at NBD2. The interactions between the two asymmetric NBDs of MRP1 protein may enhance the catalytic efficiency of the MRP1 protein and hence of its ATP-dependent transport of conjugated anions out of cells.	Mayo Clin Scottsdale, S C Johnson Med Res Ctr, Mayo Clin & Mayo Fdn, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix	Chang, XB (corresponding author), Mayo Clin Scottsdale, S C Johnson Med Res Ctr, Mayo Clin & Mayo Fdn, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	xbchang@mayo.edu			NCI NIH HHS [CA89078] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089078] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cui LY, 2001, ARCH BIOCHEM BIOPHYS, V392, P153, DOI 10.1006/abbi.2001.2441; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gao M, 1996, J BIOL CHEM, V271, P27782, DOI 10.1074/jbc.271.44.27782; GEORGES E, 1993, J BIOL CHEM, V268, P1792; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Keppler D, 1996, ADV ENZYME REGUL, V36, P17, DOI 10.1016/0065-2571(95)00011-9; Lautier D, 1996, BIOCHEM PHARMACOL, V52, P967, DOI 10.1016/0006-2952(96)00450-9; LEIER I, 1994, J BIOL CHEM, V269, P27807; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1998, CANCER RES, V58, P5130; MIRSKI SEL, 1987, CANCER RES, V47, P2594; Muller M, 1996, J HEPATOL, V24, P100; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2001, J BIOL CHEM, V276, P21199, DOI 10.1074/jbc.M100886200; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; Schinkel A H, 1991, Semin Cancer Biol, V2, P213; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; Senior AE, 1998, ACTA PHYSIOL SCAND, V163, P213; Senior AE, 1998, METHOD ENZYMOL, V292, P514; Sharom FJ, 1998, BIOCHEM CELL BIOL, V76, P695, DOI 10.1139/bcb-76-5-695; Stride BD, 1997, MOL PHARMACOL, V52, P344, DOI 10.1124/mol.52.3.344; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956	35	55	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5110	5119		10.1074/jbc.M107133200	http://dx.doi.org/10.1074/jbc.M107133200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741902	hybrid			2022-12-27	WOS:000173962900074
J	Kim, HH; Wolfe, A; Smith, GR; Tobet, SA; Radovick, S				Kim, HH; Wolfe, A; Smith, GR; Tobet, SA; Radovick, S			Promoter sequences targeting tissue-specific gene expression of hypothalamic and ovarian gonadotropin-releasing hormone in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURON-SPECIFIC ENHANCER; MESSENGER-RIBONUCLEIC-ACID; GRANULOSA-LUTEAL CELLS; GNRH RECEPTOR; RAT OVARY; TRANSCRIPTION; OCT-1; MOUSE; PROGESTERONE; PROTEIN	Molecular mechanisms directing tissue-specific expression of gonadotropin-releasing hormone (GnRH) are difficult to study due to the paucity and scattered distribution of GnRH neurons. To identify regions of the mouse GnRH (mGnRH) promoter that are critical for appropriate tissue-specific gene expression, we generated transgenic mice with fragments (-3446/+23 bp, -2078/+23 bp, and -1005/+28 bp) of mGnRH promoter fused to the luciferase reporter gene. The pattern of mGnRH promoter activity was assessed by measuring luciferase activity in tissue homogenates. All three 5'-fragments of mGnRH promoter targeted hypothalamic expression of the luciferase transgene, but with the exception of the ovary, luciferase expression was absent in non-neural tissues. High levels of ovarian luciferase activity were observed in mice generated with both -2078 and -1005 by of promoter. Our study is the first to define a region of the GnRH gene promoter that directs expression to both neural and non-neural tissues in vivo. We demonstrate that DNA sequences contained within the proximal -1005 by of the mGnRH promoter are sufficient to direct mGnRH gene expression to both the ovary and hypothalamus. Our results also suggest that DNA sequences distal to -2078 by mediate the repression of ovarian GnRH.	Univ Chicago, Dept Obstet & Gynecol, Sect Reproduct Endocrinol & Infertil, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Endocrinol Sect, Chicago, IL 60637 USA; Eunice Kennedy Shriver Ctr Mental Retardat Inc, Dept Biomed Sci, Waltham, MA 02452 USA	University of Chicago; University of Chicago	Kim, HH (corresponding author), Univ Chicago, Dept Obstet & Gynecol, Sect Reproduct Endocrinol & Infertil, 5841 S Maryland Ave,MC 2050, Chicago, IL 60637 USA.			Tobet, Stuart/0000-0002-1615-7331	NICHD NIH HHS [R01 HD34551] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034551] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALSHAWI R, 1990, MOL CELL BIOL, V10, P1192, DOI 10.1128/MCB.10.3.1192; Belsham DD, 2000, MOL ENDOCRINOL, V14, P212, DOI 10.1210/me.14.2.212; BILLIG H, 1994, ENDOCRINOLOGY, V134, P245, DOI 10.1210/en.134.1.245; Botte MC, 1998, J ENDOCRINOL, V159, P179, DOI 10.1677/joe.0.1590179; Chandran UR, 1999, J BIOL CHEM, V274, P2372, DOI 10.1074/jbc.274.4.2372; Chandran UR, 1999, BEHAV BRAIN RES, V105, P29, DOI 10.1016/S0166-4328(99)00080-7; CLARK ME, 1995, MOL CELL BIOL, V15, P6169; CLAYTON RN, 1992, J MOL ENDOCRINOL, V9, P189, DOI 10.1677/jme.0.0090189; CLAYTON RN, 1979, NATURE, V282, P90, DOI 10.1038/282090a0; CORBIN A, 1981, LIFE SCI, V29, P185, DOI 10.1016/0024-3205(81)90287-3; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DONG KW, 1993, MOL ENDOCRINOL, V7, P1654, DOI 10.1210/me.7.12.1654; ERALY SA, 1995, MOL ENDOCRINOL, V9, P848, DOI 10.1210/me.9.7.848; Eraly SA, 1998, MOL ENDOCRINOL, V12, P469, DOI 10.1210/me.12.4.469; GOUBAU S, 1992, ENDOCRINOLOGY, V130, P3098, DOI 10.1210/en.130.5.3098; HILLENSJO T, 1980, NATURE, V287, P145, DOI 10.1038/287145a0; HSUEH AJW, 1979, SCIENCE, V204, P854, DOI 10.1126/science.375393; JONES PBC, 1980, LIFE SCI, V27, P2125, DOI 10.1016/0024-3205(80)90494-4; KAKAR SS, 1994, MOL CELL ENDOCRINOL, V101, P151, DOI 10.1016/0303-7207(94)90229-1; Kang SK, 2000, ENDOCRINOLOGY, V141, P72, DOI 10.1210/en.141.1.72; Kelley CG, 2000, MOL ENDOCRINOL, V14, P1246, DOI 10.1210/me.14.8.1246; KING JC, 1994, SERONA SYMPOSIA MODE; Lawson MA, 1996, MOL CELL BIOL, V16, P3596; Lawson MA, 1998, MOL ENDOCRINOL, V12, P364, DOI 10.1210/me.12.3.364; MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276; MINARETZIS D, 1995, J CLIN ENDOCR METAB, V80, P430, DOI 10.1210/jc.80.2.430; MORRIS JK, 1993, ENDOCRINOLOGY, V133, P770, DOI 10.1210/en.133.2.770; Nathwani PS, 2000, ENDOCRINOLOGY, V141, P1754, DOI 10.1210/en.141.5.1754; Nelson SB, 2000, MOL ENDOCRINOL, V14, P1509, DOI 10.1210/me.14.9.1509; NY T, 1987, J BIOL CHEM, V262, P11790; OIKAWA M, 1990, ENDOCRINOLOGY, V127, P2350, DOI 10.1210/endo-127-5-2350; Pape JR, 1999, MOL ENDOCRINOL, V13, P2203, DOI 10.1210/me.13.12.2203; PENG C, 1994, ENDOCRINOLOGY, V135, P1740, DOI 10.1210/en.135.5.1740; RADOVICK S, 1990, MOL ENDOCRINOL, V4, P476, DOI 10.1210/mend-4-3-476; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; SEEBURG PH, 1987, RECENT PROG HORM RES, V43, P69; Skynner MJ, 1999, J NEUROSCI, V19, P5955, DOI 10.1523/JNEUROSCI.19-14-05955.1999; Suter KJ, 2000, ENDOCRINOLOGY, V141, P412, DOI 10.1210/en.141.1.412; TILLY JL, 1992, ENDOCRINOLOGY, V130, P1296, DOI 10.1210/en.130.3.1296; TURECK RW, 1982, J CLIN ENDOCR METAB, V54, P1078, DOI 10.1210/jcem-54-5-1078; Vaananen JE, 1997, BIOL REPROD, V57, P1346, DOI 10.1095/biolreprod57.6.1346; WHITELAW PF, 1995, ENDOCRINOLOGY, V136, P172, DOI 10.1210/en.136.1.172; WHYTE DB, 1995, MOL ENDOCRINOL, V9, P467, DOI 10.1210/me.9.4.467; Wierman ME, 1997, MOL CELL BIOL, V17, P1652, DOI 10.1128/MCB.17.3.1652; Wolfe AM, 1996, J BIOL CHEM, V271, P20018, DOI 10.1074/jbc.271.33.20018; WONG WYL, 1992, ENDOCRINOLOGY, V130, P3512, DOI 10.1210/en.130.6.3512; WOOD WM, 1989, J BIOL CHEM, V264, P14840; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132	48	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5194	5202		10.1074/jbc.M110535200	http://dx.doi.org/10.1074/jbc.M110535200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733536	hybrid			2022-12-27	WOS:000173962900084
J	Krishnan, P; Fu, Q; Lam, W; Liou, JY; Dutschman, G; Cheng, YC				Krishnan, P; Fu, Q; Lam, W; Liou, JY; Dutschman, G; Cheng, YC			Phosphorylation of pyrimidine deoxynucleoside analog Diphosphates - Selective phosphorylation of L-nucleoside analog diphosphates by 3-phosphoglycerate kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-DIOXOLANE-CYTIDINE; NUCLEAR-LOCALIZATION; PHOSPHATE TRANSFER; VIRUS-REPLICATION; CELLULAR ENZYMES; PYRUVATE-KINASE; GENE FAMILY; CELLS; METABOLISM; MECHANISM	D-Nucleoside analogs, which are in the natural configuration, as well as the L-nucleoside analogs, are clinically relevant antiviral and anticancer agents. Metabolism of L-nucleoside analog diphosphates to the triphosphates, however, remains unexplored. Studies with recombinant nm23-H1 and -H2 isoforms indicated that L-nucleoside analog diphosphates were not phosphorylated by their nucleoside diphosphate kinase (NDPK) activity. Therefore, roles of creatine kinase, 3-phosphoglycerate kinase, and pyruvate kinase were evaluated using preparations from commercial sources and human HepG2 cells. Phosphorylation of L-OddC, L-SddC, L-Fd4C, L-FMAU, and L-ddC were compared with D-deoxynucleoside analogs, AraC, dFdC, and D-FMAU, and D-dideoxynucleoside analogs, ddC and d4T. Results based on preparations from HepG2 cells showed that L-nucleoside analog diphosphates were selectively phosphorylated by 3-phosphoglycerate kinase, whereas, D-deoxynucleoside analog diphosphates were phosphorylated by NDPK. Interestingly, ddCDP and d4TDP were substrates for creatine kinase, but were not phosphorylated by NDPK. In conclusion, it is proposed that specificity of the phosphorylating enzymes toward the nucleoside analog diphosphates is dependent on the configuration of the analog (L or D) and the presence or absence of 3'-hydroxyl group in the sugar moiety. The enzymatic process of phosphorylation of L- and D-nucleoside analog diphosphates is different in cells.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Cheng, YC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.				NCI NIH HHS [CA 63477] Funding Source: Medline; NIAID NIH HHS [AI 38204] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA063477, R01CA063477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038204] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAIS R, 1982, CRC CR REV CL LAB SC, V16, P291, DOI 10.3109/10408368209107030; BALZARINI J, 1988, BIOCHEM PHARMACOL, V37, P897, DOI 10.1016/0006-2952(88)90178-5; BLAKLEY RL, 1989, MOL PHARMACOL, V37, P328; Bourdais J, 1996, J BIOL CHEM, V271, P7887, DOI 10.1074/jbc.271.14.7887; BRIDGES EG, 1996, PROG LIV DIS, V13, P231; CHANG CN, 1992, J BIOL CHEM, V267, P13938; CHENG YC, 2001, CANC LETT, V162, pS35; Cihlar T, 1996, MOL PHARMACOL, V50, P1502; DOONG SL, 1991, P NATL ACAD SCI USA, V88, P8495, DOI 10.1073/pnas.88.19.8495; Dutschman GE, 1998, ANTIMICROB AGENTS CH, V42, P1799, DOI 10.1128/AAC.42.7.1799; FARRAR G, 1995, INT J BIOCHEM CELL B, V27, P1145, DOI 10.1016/1357-2725(95)00090-C; Foudraine NA, 1998, AIDS, V12, P1513, DOI 10.1097/00002030-199812000-00014; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Giles FJ, 2001, J CLIN ONCOL, V19, P762, DOI 10.1200/JCO.2001.19.3.762; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Gonin P, 1999, BIOCHEMISTRY-US, V38, P7265, DOI 10.1021/bi982990v; GROVE KL, 1995, CANCER RES, V55, P3008; HESS JW, 1968, AM J CLIN PATHOL, V50, P89; IMAMURA K, 1972, J BIOCHEM-TOKYO, V72, P1001, DOI 10.1093/oxfordjournals.jbchem.a129962; Jain RG, 2001, ANTIVIR RES, V51, P151, DOI 10.1016/S0166-3542(01)00148-6; JOAO HC, 1993, EUR J BIOCHEM, V216, P1, DOI 10.1111/j.1432-1033.1993.tb18110.x; JOHNSON PE, 1976, BIOCHEMISTRY-US, V15, P2893, DOI 10.1021/bi00658a030; KHADIM SA, 1997, CANCER RES, V57, P4803; Kraeft SK, 1996, EXP CELL RES, V227, P63, DOI 10.1006/excr.1996.0250; Kreimeyer A, 2001, ANTIVIR RES, V50, P147, DOI 10.1016/S0166-3542(01)00139-5; KRIETSCH WKG, 1979, ARCH BIOCHEM BIOPHYS, V198, P415; Le Guerhier F, 2000, ANTIMICROB AGENTS CH, V44, P111, DOI 10.1128/AAC.44.1.111-122.2000; Le Guerhier F, 2001, ANTIMICROB AGENTS CH, V45, P1065, DOI 10.1128/AAC.45.4.1065-1077.2001; LECROISEY A, 1995, BIOCHEMISTRY-US, V34, P12445, DOI 10.1021/bi00038a043; Liu SH, 1998, ANTIMICROB AGENTS CH, V42, P833, DOI 10.1128/AAC.42.4.833; MATHEWS CK, 1996, CARBOHYD METABOL, V1, P446; Mehus JG, 1999, HUM GENET, V104, P454, DOI 10.1007/s004390050987; MILLER WH, 1992, J BIOL CHEM, V267, P21220; MILLER WH, 1982, BIOCHEM PHARMACOL, V31, P3879, DOI 10.1016/0006-2952(82)90305-7; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Moore LE, 1997, CANCER CHEMOTH PHARM, V39, P532, DOI 10.1007/s002800050609; MORERA S, 1995, BIOCHEMISTRY-US, V34, P11062, DOI 10.1021/bi00035a011; Munier A, 1998, FEBS LETT, V434, P289, DOI 10.1016/S0014-5793(98)00996-X; Pinon VPB, 1999, EXP CELL RES, V246, P355, DOI 10.1006/excr.1998.4318; PIZZORNO GHR, 2000, PYRIMIDINE PURINE AN, P625; Plunkett W, 1996, SEMIN ONCOL, V23, P3; RUTH JL, 1981, MOL PHARMACOL, V20, P415; Schneider B, 1998, J BIOL CHEM, V273, P11491, DOI 10.1074/jbc.273.19.11491; Schneider B, 2000, MOL PHARMACOL, V57, P948; Schneider B, 1999, NUCLEOS NUCLEOT, V18, P829, DOI 10.1080/15257779908041571; SHINAZI RF, 1992, ANTIMICROB AGENTS CH, V36, P672; VENTURELLI D, 1995, P NATL ACAD SCI USA, V92, P7435, DOI 10.1073/pnas.92.16.7435; Yao GQ, 1996, BIOCHEM PHARMACOL, V51, P941, DOI 10.1016/0006-2952(96)00049-4; Zemlicka J, 2000, PHARMACOL THERAPEUT, V85, P251, DOI 10.1016/S0163-7258(99)00062-5; Zhu YL, 1998, ANTIMICROB AGENTS CH, V42, P1805, DOI 10.1128/AAC.42.7.1805	50	89	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5453	5459		10.1074/jbc.M109025200	http://dx.doi.org/10.1074/jbc.M109025200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741981	hybrid			2022-12-27	WOS:000173962900116
J	Li, ZB; Na, X; Wang, DK; Schoen, SR; Messing, EM; Wu, G				Li, ZB; Na, X; Wang, DK; Schoen, SR; Messing, EM; Wu, G			Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOMATIC MUTATIONS; RENAL-CARCINOMA; GENE; DISEASE; LIGASE; VHL; COMPONENT; COMPLEX; PARADIGM	von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome caused by germline mutations of the VHL gene. Recent studies suggest that VHL protein (pVHL) is a component of an E3 ubiquitin ligase, but the detailed biological function of pVHL remains to be determined. To further elucidate the biological functions of pVHL, we searched pVHL-interacting proteins using yeast two-hybrid screening. A novel protein named VEIL-interacting deubiquitinating enzyme 1 (VDU1) was identified as being able to directly interact with pVHL in vitro and in vivo. We have determined the full-length cDNA of this enzyme, which includes two putative subtypes. Type I consists of 942 amino acids, and type II consists of 911 amino acids with predicted molecular masses of 107 and 103 kDa, respectively. We have also cloned a mouse homologue of this enzyme. Sequence analysis reveals that this protein is conserved between human and mouse and contains the signature motifs of the ubiquitin-specific processing protease family. Enzymatic function studies demonstrate its deubiquitinating activity. We have determined that the VDU1-interacting region in pVHL is located in its beta-domain, and several naturally occurring mutations located in this domain disrupt the interaction between pVHL and VDU1 protein. Co-immunoprecipitation demonstrates that VDU1 can be recruited into the pVHL-elongin C-elongin B complex. Finally, we demonstrate that VDU1 is able to be ubiquitinated via a pVHL-dependent pathway for proteasomal degradation, and VEIL mutations that disrupt the interaction between VDU1 and pVHL abrogate the ubiquitination of VDU1. Our findings indicate that VDU1, a novel ubiquitin-specific processing protease, is a downstream target for ubiquitination and degradation by pVHL E3 ligase. Targeted degradation of VDU1 by pVHL could be crucial for regulating the ubiquitin-proteasome degradation pathway.	Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Dept Pathol & Lab Med, Rochester, NY 14642 USA; Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Wu, G (corresponding author), Univ Rochester, Med Ctr, Dept Urol, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.	Guan_Wu@urmc.rochester.edu	高, 雨莉/HGU-8187-2022					Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; FOSTER K, 1994, HUM MOL GENET, V3, P2169, DOI 10.1093/hmg/3.12.2169; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Krieg M, 1998, BLOOD, V92, P3388, DOI 10.1182/blood.V92.9.3388.421a09_3388_3393; Lin HJ, 2001, J BIOL CHEM, V276, P20357, DOI 10.1074/jbc.M008761200; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Semenza GL, 2000, GENE DEV, V14, P1983; SHUIN T, 1994, CANCER RES, V54, P2852; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Sloper-Mould KE, 1999, J BIOL CHEM, V274, P26878, DOI 10.1074/jbc.274.38.26878; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stolle C, 1998, HUM MUTAT, V12, P417, DOI 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K; Tyers M, 1999, P NATL ACAD SCI USA, V96, P12230, DOI 10.1073/pnas.96.22.12230; Vortmeyer AO, 1997, HUM PATHOL, V28, P540, DOI 10.1016/S0046-8177(97)90075-7; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543	26	126	138	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4656	4662		10.1074/jbc.M108269200	http://dx.doi.org/10.1074/jbc.M108269200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739384	hybrid			2022-12-27	WOS:000173962900016
J	Poghosyan, Z; Robbins, SM; Houslay, MD; Webster, A; Murphy, G; Edwards, DR				Poghosyan, Z; Robbins, SM; Houslay, MD; Webster, A; Murphy, G; Edwards, DR			Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; METALLOPROTEASE-DISINTEGRIN; SH3 DOMAIN; SIGNAL-TRANSDUCTION; CELL-CELL; BINDING; ECTODOMAIN; RECEPTOR; CLEAVAGE; HCK	The adamalysins (ADAMS) are transmembrane glycoproteins involved in cell adhesion and proteolytic ectodomain processing of cytokines and adhesion molecules. Many ADAM cytoplasmic domains are proline-rich and have potential phosphorylation sites. We show here that the cytoplasmic domain of ADAM15, metargidin, can interact specifically with Src family protein-tyrosine kinases (PTKs) and the adaptor protein Grb2 in hematopoietic cells (Jurkat, THP-1, U937, and K562 cell lines). Src homology 3 domains from several Src family PTKs including Lek, Fyn, Abl, and Src associate with ADAM15 in vitro. Dephosphorylation of cell extracts resulted in decreased association of ADAM15 with Src family PTK SH3 domains, indicating that phosphorylation influences ADAM15 interactions with its binding partners. This was confirmed in vitro for Hck, Lek, and Grb2, which showed enhanced association with tyrosine-phosphorylated glutathione S-transferase-ADAM15 cytoplasmic domain compared with unphosphorylated protein. In contrast, binding of MAD2 to ADAM15 was slightly reduced by phosphorylation of the ADAM. Immunoprecipitation of ADAM15 from Jurkat cells confirmed the association with Lek in vivo, and upon PMA stimulation, the phosphorylation level of ADAM15 was increased. Cotransfection of ADAM15 and Hck showed Hck-dependent phosphorylation of ADAM15 in vivo. Hck, and to a lesser extent Lek, phosphorylated the ADAM15 cytoplasmic domain in vitro in immune complex kinase assays. Binding of ADAM15 cytoplasmic domain to Hck and Lek was also shown by Far Western analysis. In contrast to Hck, Lek activity was not required for binding to ADAM15, as shown by treatment of cells with PP1. Deletion and point mutation analysis of the ADAM15 cytoplasmic domain confirmed the importance of the proline-rich motifs for Grb2 and Lek binding and indicated the regulatory nature of Tyr(715) and Tyr(735) These data demonstrate selective, phosphorylation-dependent interactions of ADAM15 with Src family PTKs and Grb2, which highlight the potential for integration of ADAM functions and cellular signaling.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Univ Glasgow, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland; Celltech Therapeut Ltd, Slough SK1 4EN, Berks, England	University of East Anglia; University of Calgary; University of Glasgow; Celltech Group Ltd	Edwards, DR (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	dylan.edwards@uea.ac.uk	Houslay, Miles D/A-6825-2011; Houslay, Miles/AAM-5281-2020; Edwards, Dylan R/B-4734-2009	Edwards, Dylan R/0000-0002-3292-2064; Houslay, Miles/0000-0002-3826-8091; Robbins, Stephen/0000-0001-7475-1665				Alfandari D, 2001, CURR BIOL, V11, P918, DOI 10.1016/S0960-9822(01)00263-9; Beard MB, 1999, FEBS LETT, V460, P173, DOI 10.1016/S0014-5793(99)01335-6; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Brown PD, 2001, DRUG DISCOV TODAY, V6, P615, DOI 10.1016/S1359-6446(01)01845-1; CAO HY, 2001, BIOCHEM J, V357, P353; Chiaradonna F, 1999, EMBO J, V18, P3013, DOI 10.1093/emboj/18.11.3013; Codony-Servat J, 1999, CANCER RES, V59, P1196; Cousin H, 2000, DEV BIOL, V227, P197, DOI 10.1006/dbio.2000.9871; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Herren B, 1997, FASEB J, V11, P173, DOI 10.1096/fasebj.11.2.9039960; Herren B, 2001, EXP CELL RES, V271, P152, DOI 10.1006/excr.2001.5353; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Howlett CJ, 1999, BIOCHEM BIOPH RES CO, V257, P129, DOI 10.1006/bbrc.1999.0427; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kang Q, 2001, J BIOL CHEM, V276, P24466, DOI 10.1074/jbc.M101162200; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Ma GZ, 1997, ONCOGENE, V14, P2367, DOI 10.1038/sj.onc.1201053; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nath D, 2001, J CELL SCI, V114, P1213; Nath D, 1999, J CELL SCI, V112, P579; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; OConnell JC, 1996, BIOCHEM J, V318, P255, DOI 10.1042/bj3180255; Orlicek SL, 1999, SHOCK, V12, P350, DOI 10.1097/00024382-199911000-00004; Patel VP, 2001, J IMMUNOL, V166, P754, DOI 10.4049/jimmunol.166.2.754; Pawson T, 2000, GENE DEV, V14, P1027; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Schlondorff J, 1999, J CELL SCI, V112, P3603; Smithgall TE, 1998, PHARMACOL REV, V50, P1; Suzuki A, 2000, ONCOGENE, V19, P5842, DOI 10.1038/sj.onc.1203986; Vecchi M, 1998, J BIOL CHEM, V273, P20589, DOI 10.1074/jbc.273.32.20589; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; Wolfsberg TG, 1996, DEV BIOL, V180, P389, DOI 10.1006/dbio.1996.0313; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0	50	90	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4999	5007		10.1074/jbc.M107430200	http://dx.doi.org/10.1074/jbc.M107430200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741929	hybrid			2022-12-27	WOS:000173962900060
J	Ohara-Imaizumi, M; Nakamichi, Y; Tanaka, T; Ishida, H; Nagamatsu, S				Ohara-Imaizumi, M; Nakamichi, Y; Tanaka, T; Ishida, H; Nagamatsu, S			Imaging exocytosis of single insulin secretory granules with evanescent wave microscopy - Distinct behavior of granule motion in biphasic insulin release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; PANCREATIC BETA-CELLS; B-CELL; ISLETS; EXPRESSION; TRANSPORT; PROTEIN; LINE	To study insulin exocytosis by monitoring the single insulin secretory granule motion, evanescent wave microscopy was used to quantitatively analyze the final stage of insulin exocytosis with biphasic release. Green fluorescent protein-tagged insulin transfected in MIN6 beta cells was packed in insulin secretory granules, which appeared to preferentially dock to the plasma membrane. Upon fusion evoked by secretagogues, evanescent wave microscopy revealed that fluorescence of green fluorescent protein-tagged insulin brightened, spread (within 300 ms), and then vanished. Under KCl stimulation, which represents the 1st phase of release, the successive fusion events were seen mostly from previously docked granules for the first minute; followed by the recruitment of new granules to the plasmalemmal docking sites. Stimulation with glucose, in contrast, caused the fusion events from previously docked granules for the first 120 s, thereafter a continuous fusion (2nd phase of release) was observed over 10 min mostly from newly recruited granules that progressively accumulated on the plasma membrane. Thus, our data revealed the distinct behavior of the insulin granule motion during the 1st and 2nd phase of release.	Kyorin Univ, Sch Med, Dept Biochem, Mitaka, Tokyo 1818611, Japan; Kyorin Univ, Sch Med, Dept Internal Med 3, Mitaka, Tokyo 1818611, Japan	Kyorin University; Kyorin University	Nagamatsu, S (corresponding author), Kyorin Univ, Sch Med, Dept Biochem, Shinkawa 6-20-2, Mitaka, Tokyo 1818611, Japan.	shinya@kyorin-u.ac.jp						AXELROD D, 1989, METHOD CELL BIOL, V30, P245; BERGSTEN P, 1993, DIABETES, V42, P670, DOI 10.2337/diabetes.42.5.670; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; GILON P, 1993, J BIOL CHEM, V268, P22265; Grodsky G M, 1969, Acta Diabetol Lat, V6 Suppl 1, P554; Grodsky G. M., 2000, DIABETES MELLITUS FU, V2nd, P2; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Kawano Y, 2000, P SOC PHOTO-OPT INS, V4098, P142, DOI 10.1117/12.401623; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; Mears D, 2000, DIABETES MELLITUS FU, P47; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nagamatsu S, 1999, J BIOL CHEM, V274, P8053, DOI 10.1074/jbc.274.12.8053; Nagamatsu S, 1996, J BIOL CHEM, V271, P1160, DOI 10.1074/jbc.271.2.1160; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; ORCI L, 1974, DIABETOLOGIA, V10, P163, DOI 10.1007/BF00423031; Proks P, 1996, J PHYSIOL-LONDON, V496, P255, DOI 10.1113/jphysiol.1996.sp021682; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; WOLLHEIM CB, 1996, DIABETES REV, V4, P276; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	23	134	137	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					3805	3808		10.1074/jbc.C100712200	http://dx.doi.org/10.1074/jbc.C100712200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11751926	hybrid			2022-12-27	WOS:000173813900002
J	Zahner, G; Wolf, G; Ayoub, M; Reinking, R; Panzer, U; Shankland, SJ; Stahl, RAK				Zahner, G; Wolf, G; Ayoub, M; Reinking, R; Panzer, U; Shankland, SJ; Stahl, RAK			Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21(waf-1/cip-1) and p27(kip-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; EXPERIMENTAL GLOMERULONEPHRITIS; GLOMERULAR PROSTAGLANDIN; EXPRESSION; APOPTOSIS; THROMBOXANE-A2; PROSTACYCLIN; CULTURE; ACID; CDNA	Cyclooxygenase-2 (COX-2) is an inducible enzyme and serves as a source of paracrine prostaglandin E2 (PGE2) formation in many tissues. In glomerular immune injury COX-2 formation is up-regulated in association with increased mesangial cell growth. To examine whether COX-2 exerts growth modulating effects on glomerular cells, we established two separate COX-2-overexpressing mesangial cell lines (COX-2+) and assessed their proliferative response to the potent mesangial cell growth-promoting factor, platelet-derived growth factor (PDGF). PDGF increased proliferation in mock-transfected cells. In contrast, PDGF did not induce proliferation in COX-2+ cells. Our results also showed that the tumor suppressor protein p53 and the cyclin-dependent kinase inhibitors p21(cip-1) and p27(kip-1) were up-regulated in COX-2+ cells de novo as well as under PDGF-stimulated conditions. To study whether COX-2 products are required for these effects, COX-2+ cells were treated with indomethacin (1 mug/ml) or NS-398 (3 mum). Unexpectedly, both COX inhibitors had no significant effect on cell proliferation, not on the protein levels of p53, p21(cip-1), or p27(kip-1). To evaluate the role of p21(kip-1) and p27(kip-1), COX-2 was overexpressed in mesangial cells derived from p21(kip-1) (p21 -/- COX-2+) and p27(kip-1) (p27-/- COX-2+) null mice. In contrast to the wild type COX-2+ cells, p21-/- COX-2+ and p27-/- COX-2+ cells proliferated in response to PDGF. These data suggest that COX-2 inhibits mesangial cell proliferation by a novel mechanism that is independent of prostaglandin synthesis, but involves p53, p21(cip-1), and p27(kip-1).	Univ Hamburg, Dept Med, Div Nephrol & Osteol, D-20246 Hamburg, Germany; Univ Washington, Sch Med, Dept Med, Div Nephrol, Seattle, WA 98104 USA	University of Hamburg; University of Washington; University of Washington Seattle	Zahner, G (corresponding author), Univ Hamburg, Dept Med, Div Nephrol & Osteol, Martinistr 52, D-20246 Hamburg, Germany.							ABBOUD HE, 1992, KIDNEY INT, V41, P581, DOI 10.1038/ki.1992.86; BORDER WA, 1990, KIDNEY INT, V37, P689, DOI 10.1038/ki.1990.35; Brock TG, 1999, J BIOL CHEM, V274, P11660, DOI 10.1074/jbc.274.17.11660; Chang YWE, 2000, MOL CELL BIOL, V20, P8571, DOI 10.1128/MCB.20.22.8571-8579.2000; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; HLA T, 1993, ANN NY ACAD SCI, V696, P197; Hla T, 1999, INT J BIOCHEM CELL B, V31, P551, DOI 10.1016/S1357-2725(98)00152-6; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Kawamori T, 1998, CANCER RES, V58, P409; KENNEDY BP, 1993, BIOCHEM BIOPH RES CO, V197, P494, DOI 10.1006/bbrc.1993.2506; Kim YG, 1999, KIDNEY INT, V55, P2349, DOI 10.1046/j.1523-1755.1999.00504.x; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; LIANOS EA, 1983, J CLIN INVEST, V72, P1439, DOI 10.1172/JCI111100; McGinty A, 2000, J BIOL CHEM, V275, P12095, DOI 10.1074/jbc.275.16.12095; MENE P, 1990, KIDNEY INT, V38, P232, DOI 10.1038/ki.1990.191; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; RZYMKIEWICZ D, 1994, AM J PHYSIOL, V266, pF39, DOI 10.1152/ajprenal.1994.266.1.F39; RZYMKIEWICZ DM, 1995, KIDNEY INT, V47, P1354, DOI 10.1038/ki.1995.191; Shankland SJ, 1997, KIDNEY INT, V51, P1088, DOI 10.1038/ki.1997.151; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; STAHL RAK, 1987, KIDNEY INT, V31, P1126, DOI 10.1038/ki.1987.118; STAHL RAK, 1986, NEPHRON, V42, P252, DOI 10.1159/000183676; STAHL RAK, 1990, AM J PHYSIOL, V259, pF419, DOI 10.1152/ajprenal.1990.259.3.F419; STORK JE, 1985, J PHARMACOL EXP THER, V233, P672; Subbaramaiah K, 1999, J BIOL CHEM, V274, P10911, DOI 10.1074/jbc.274.16.10911; Trifan OC, 1999, J BIOL CHEM, V274, P34141, DOI 10.1074/jbc.274.48.34141; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Wolf G, 1996, KIDNEY INT, V50, P2112, DOI 10.1038/ki.1996.537; Wolf G, 1998, KIDNEY INT, V53, P869, DOI 10.1046/j.1523-1755.1998.00829.x; Wolf G, 1997, AM J PHYSIOL, V273, P348	37	49	56	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					9763	9771		10.1074/jbc.M106307200	http://dx.doi.org/10.1074/jbc.M106307200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11756433	hybrid			2022-12-27	WOS:000174549200024
J	Sum, EYM; Peng, B; Yu, X; Chen, JJ; Byrne, J; Lindeman, GJ; Visvader, JE				Sum, EYM; Peng, B; Yu, X; Chen, JJ; Byrne, J; Lindeman, GJ; Visvader, JE			The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC BREAST-CANCER; LOOP-HELIX PROTEIN; C-TERMINAL REGION; T-CELL LEUKEMIA; TRANSCRIPTIONAL ACTIVATION; BINDING-PROTEIN; OVARIAN-CANCER; HOMEODOMAIN PROTEINS; SUSCEPTIBILITY GENE; MOLECULAR-CLONING	LMO4 belongs to the LIM-only (LMO) group of transcriptional regulators that appear to function as molecular adaptors for protein-protein interactions. Expression of the LMO4 gene is developmentally regulated in the mammary gland and is up-regulated in primary breast cancers. Using LMO4 in a yeast two-hybrid screen, we have identified the cofactor CtIP as an LMO4-binding protein. Interaction with CtIP appeared to be specific for the LMO subclass of LIM domain proteins and could be mediated by a single LIM motif of LMO4. We further identified the breast tumor suppressor BRCA1 as an LMO4-associated protein. The C-terminal BRCT domains of BRCA1, previously shown to bind CtIP, also mediated interaction with LMO4. Tumor-associated mutations within the BRCT repeats that abolish interaction between BRCA1 and CtIP had no effect on the association of BRCA1 with LMO4. A stable complex comprising LMO4, BRCA1, and CtIP was demonstrated in vivo. The LIM domain binding-protein Ldb1 also participated in this multiprotein complex. In functional assays, LMO4 was shown to repress BRCA1-mediated transcriptional activation in both yeast and mammalian cells. These findings reveal a novel complex between BRCA1, LMO4, and CtIP and indicate a role for LMO4 as a repressor of BRCA1 activity in breast tissue.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Bone Marrow Res Labs, Melbourne, Vic 3050, Australia; Rockefeller Univ, New York, NY 10021 USA; Mayo Clin, Rochester, MN 55905 USA; New Childrens Hosp, Westmead, NSW 2145, Australia; Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; Rockefeller University; Mayo Clinic; University of Sydney; University of Melbourne	Visvader, JE (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.			Byrne, Jennifer Anne/0000-0002-8923-0587; Lindeman, Geoffrey/0000-0001-9386-2416				Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Byrne JA, 1998, ONCOGENE, V16, P873, DOI 10.1038/sj.onc.1201604; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Deng CX, 2000, BIOESSAYS, V22, P728; Dobrovic A, 1997, CANCER RES, V57, P3347; Douglas AM, 1998, INT J CANCER, V75, P64, DOI 10.1002/(SICI)1097-0215(19980105)75:1<64::AID-IJC11>3.0.CO;2-D; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; FUTREAL PA, 1992, CANCER RES, V52, P2624; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Grutz G, 1998, ONCOGENE, V17, P2799, DOI 10.1038/sj.onc.1202502; Hu YF, 1999, GENE DEV, V13, P637, DOI 10.1101/gad.13.6.637; Hu YF, 2000, J BIOL CHEM, V275, P40910, DOI 10.1074/jbc.C000607200; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Jurata LW, 1998, CURR TOP MICROBIOL, V228, P75; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Kenny DA, 1998, P NATL ACAD SCI USA, V95, P11257, DOI 10.1073/pnas.95.19.11257; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 2000, TRENDS BIOCHEM SCI, V25, P469, DOI 10.1016/S0968-0004(00)01632-7; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Orkin SH, 1997, ANNU REV GENET, V31, P33, DOI 10.1146/annurev.genet.31.1.33; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Racevskis J, 1999, BBA-GENE STRUCT EXPR, V1445, P148, DOI 10.1016/S0167-4781(99)00037-8; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; SANCHEZGARCIA I, 1993, EMBO J, V12, P4243, DOI 10.1002/j.1460-2075.1993.tb06108.x; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Schmutzler RK, 1997, INT J CANCER, V74, P322, DOI 10.1002/(SICI)1097-0215(19970620)74:3<322::AID-IJC15>3.3.CO;2-J; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sugihara TM, 1998, P NATL ACAD SCI USA, V95, P15418, DOI 10.1073/pnas.95.26.15418; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; VISVADER JE, 1992, EMBO J, V11, P4557, DOI 10.1002/j.1460-2075.1992.tb05557.x; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707; Visvader JE, 2001, P NATL ACAD SCI USA, V98, P14452, DOI 10.1073/pnas.251547698; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu X, 2000, J BIOL CHEM, V275, P18541, DOI 10.1074/jbc.M909494199; YU X, 2000, THESIS U TEXAS SW ME; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932	59	129	146	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7849	7856		10.1074/jbc.M110603200	http://dx.doi.org/10.1074/jbc.M110603200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751867	hybrid			2022-12-27	WOS:000174268000030
J	Karchner, SI; Franks, DG; Powell, WH; Hahn, ME				Karchner, SI; Franks, DG; Powell, WH; Hahn, ME			Regulatory interactions among three members of the vertebrate aryl hydrocarbon receptor family: AHR repressor, AHR1, and AHR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIOXIN SIGNAL-TRANSDUCTION; FISH FUNDULUS-HETEROCLITUS; HEAT-SHOCK-PROTEIN; TRANSCRIPTION FACTOR; LIGAND-BINDING; SPINELESS-ARISTAPEDIA; TARSAL DEVELOPMENT; CDNA CLONING; MICE LACKING; CYP1A1 GENE	The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds occur via the aryl hydrocarbon receptor (AHR), a member of the basic helix-loop-helix-Per-ARNT-Sim homology (bHLH-PAS) protein superfamily. A single AHR gene has been identified in mammals, whereas many fish species, including the Atlantic killifish (Fundulus heteroclitus) possess two distinct AHR genes (AHR1 and a novel form, AHR2). A mouse bHLH-PAS protein closely related to AHR and designated AHR repressor (AHRR) is induced by 3-methylcholanthrene and represses the transcriptional activity of the AHR. To determine whether AHRR is the mammalian ortholog of fish AHR2 and to investigate the mechanisms by which AHRR regulates AHR function, we cloned an AHRR ortholog in F. heteroclitus with high sequence identity to the mouse and human AHRRs. Killifish AHRR encodes a 680-residue protein with a predicted molecular mass of 75.2 kDa. We show that in vitro expressed AHRR proteins from human, mouse, and killifish all fail to bind [H-3]TCDD or [H-3]beta-naphthoflavone. In transient transfection experiments using a luciferase reporter gene under control of AHR response elements, killifish AHRR inhibited the TCDD-dependent transactivation function of both AHR1 and AHR2. AHRR mRNA is widely expressed in killifish tissues and is inducible by TCDD or polychlorinated biphenyls, but its expression is not altered in a population of fish exhibiting genetic resistance to these compounds. The F. heteroclitus AHRR promoter contains three putative AHR response elements. Both AHR1 and AHR2 activated transcription of luciferase driven by the AHRR promoter, and AHRR could repress its own promoter. Thus, AHRR is an evolutionarily conserved, TCDD-inducible repressor of AHR1 and AHR2 function. Phylogenetic analysis shows that AHRR, AHR1, and AHR2 are distinct genes, members of an AHR gene family; these three vertebrate AHR-like genes descended from a single invertebrate AHR.	Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Hahn, ME (corresponding author), Woods Hole Oceanog Inst, Dept Biol, MS 32, Woods Hole, MA 02543 USA.	mhahn@whoi.edu	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082; Powell, Wade H./0000-0002-3727-2822	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381, F32ES005800, R01ES006272] Funding Source: NIH RePORTER; NIEHS NIH HHS [F32 ES005800, R01 ES006272, R01 ES 06272, R01 ES006272-13, F32 ES 05800, P42 ES 07381] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abnet CC, 1999, J BIOL CHEM, V274, P15159, DOI 10.1074/jbc.274.21.15159; Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bello SM, 2001, TOXICOL SCI, V60, P77, DOI 10.1093/toxsci/60.1.77; BOUCHER PD, 1995, MOL CELL BIOL, V15, P5144; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; CARRIER F, 1992, MOL CELL BIOL, V12, P1856, DOI 10.1128/MCB.12.4.1856; CARVER LA, 1994, J BIOL CHEM, V269, P30109; Chan WK, 1999, J BIOL CHEM, V274, P12115, DOI 10.1074/jbc.274.17.12115; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; DOLWICK KM, 1993, MOL PHARMACOL, V44, P911; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Elskus AA, 1999, AQUAT TOXICOL, V45, P99, DOI 10.1016/S0166-445X(98)00102-7; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; Emmons RB, 1999, DEVELOPMENT, V126, P3937; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; GASIEWICZ TA, 1979, TOXICOL APPL PHARM, V51, P329, DOI 10.1016/0041-008X(79)90475-7; Gradin K, 1999, J BIOL CHEM, V274, P13511, DOI 10.1074/jbc.274.19.13511; GRADIN K, 1993, J BIOL CHEM, V268, P4061; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hahn ME, 1997, P NATL ACAD SCI USA, V94, P13743, DOI 10.1073/pnas.94.25.13743; Hahn ME, 2001, MAR BIOTECHNOL, V3, pS224, DOI 10.1007/s10126-001-0045-Y; Hahn ME, 1998, COMP BIOCHEM PHYS C, V121, P23, DOI 10.1016/S0742-8413(98)10028-2; HAHN ME, 1998, REV TOXICOL, V2, P395; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Jensen BA, 2001, TOXICOL SCI, V64, P41, DOI 10.1093/toxsci/64.1.41; Karchner SI, 1999, J BIOL CHEM, V274, P33814, DOI 10.1074/jbc.274.47.33814; Karchner SI, 2000, MAR ENVIRON RES, V50, P51, DOI 10.1016/S0141-1136(00)00045-3; Ke S, 2001, J BIOL CHEM, V276, P39638, DOI 10.1074/jbc.M106286200; Kumar MB, 1999, J BIOL CHEM, V274, P22155, DOI 10.1074/jbc.274.32.22155; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Lees MJ, 1999, MOL CELL BIOL, V19, P5811; Long WP, 1998, MOL PHARMACOL, V53, P691, DOI 10.1124/mol.53.4.691; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Ma Q, 1997, J BIOL CHEM, V272, P8878; Ma Q, 1996, MOL CELL BIOL, V16, P2144; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Morrison HG, 1998, COMP BIOCHEM PHYS C, V121, P231, DOI 10.1016/S0742-8413(98)10044-0; Nacci D, 1999, MAR BIOL, V134, P9, DOI 10.1007/s002270050520; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; NEBERT DW, 1990, ENVIRON HEALTH PERSP, V88, P13, DOI 10.2307/3431045; OKEY AB, 1994, TRENDS PHARMACOL SCI, V15, P226, DOI 10.1016/0165-6147(94)90316-6; Peters JM, 1999, TOXICOL SCI, V47, P86, DOI 10.1093/toxsci/47.1.86; POLAND A, 1976, J BIOL CHEM, V251, P4936; Powell WH, 2000, TOXICOL SCI, V57, P229, DOI 10.1093/toxsci/57.2.229; Powell WH, 1999, ARCH BIOCHEM BIOPHYS, V361, P156, DOI 10.1006/abbi.1998.0992; POWELL WH, 2002, IN PRESS J EXP ZOOL; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; PRINCE R, 1995, ENVIRON TOXICOL CHEM, V14, P579, DOI 10.1002/etc.5620140405; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Roy NK, 1997, ARCH BIOCHEM BIOPHYS, V344, P373, DOI 10.1006/abbi.1997.0238; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; Sterling K, 1996, MOL PHARMACOL, V49, P329; SWOFFORD DL, 1998, PAUP ASTERISK ANAL U; Tanguay RL, 1999, BBA-GENE STRUCT EXPR, V1444, P35, DOI 10.1016/S0167-4781(98)00252-8; TANGUAY RL, 2001, TOXICOLOGIST, V60, P67; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toomey BH, 2001, AQUAT TOXICOL, V53, P127, DOI 10.1016/S0166-445X(00)00161-2; Vaziri C, 1996, J BIOL CHEM, V271, P25921, DOI 10.1074/jbc.271.42.25921; Walker MK, 2000, COMP BIOCHEM PHYS C, V126, P305, DOI 10.1016/S0742-8413(00)00119-5; Walsh AA, 1996, J BIOL CHEM, V271, P22746, DOI 10.1074/jbc.271.37.22746; Watanabe T, 2001, J HUM GENET, V46, P342, DOI 10.1007/s100380170070; WATSON AJ, 1992, MOL CELL BIOL, V12, P2115, DOI 10.1128/MCB.12.5.2115; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; White JA, 1997, GENOMICS, V45, P468, DOI 10.1006/geno.1997.4979; WHITELAW ML, 1993, EMBO J, V12, P4169, DOI 10.1002/j.1460-2075.1993.tb06101.x; WHITELAW ML, 1995, P NATL ACAD SCI USA, V92, P4437, DOI 10.1073/pnas.92.10.4437; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; WIRGIN II, 1990, BIOCHEM GENET, V28, P459, DOI 10.1007/BF00554374; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903	83	104	112	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6949	6959		10.1074/jbc.M110779200	http://dx.doi.org/10.1074/jbc.M110779200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11742002	hybrid			2022-12-27	WOS:000174104300028
J	Ruiz, R; Ramos, JL				Ruiz, R; Ramos, JL			Residues 137 and 153 at the N terminus of the XylS protein influence the effector profile of this transcriptional regulator and the sigma factor used by RNA polymerase to stimulate transcription from its cognate promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE PATHWAY OPERON; TOL PLASMID PWW53; ESCHERICHIA-COLI; BINDING-SITE; PSEUDOMONAS-PUTIDA; POSITIVE REGULATOR; GENE-EXPRESSION; PM PROMOTER; ARAC FAMILY; IN-VIVO	The 321-residue XylS and Xy1S1 proteins, encoded by the pWW0 and pWW53 plasmids respectively, differ in only 5 residues at positions 4, 53, 90, 137, and 153. As a result, the effector profile of XylS is wider than that of XylS1, and XylS mediates higher levels of transcription from its cognate-regulatable promoter than does XylS1. We generated a series of XylS-pWW0 mutants and found that the single mutants Asp-137 --> Glu and His-153 --> Asn exhibited an activation pattern different from that of the wild-type regulator. In the double-mutant XylSD137E,H153N the effector profile for benzoates was similar to that of XylS1. This suggests that these two residues are crucial for effector recognition and regulator activation to stimulate transcription. XylS-dependent transcription from its cognate promoter is mediated by RNA polymerase with sigma(32) or sigma(38), whereas XylS1 uses RNA polymerase with sigma(32) or sigma(70). We also found that point mutations at positions 137 and 153 of XylS led RNA polymerase to mediate transcription with sigma(70) rather than with sigma(38), as demonstrated by primer extension analysis in a sigma(70)-thermosensitive background proficient and deficient in sigma(38). This suggests that a positive transcriptional regulator can choose the RNA polymerase complex that mediates transcription from a given promoter.	CSIC, Estacion Expt Zaidin, Dept Biochem & Mol & Cellular Biol Plants, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Ramos, JL (corresponding author), CSIC, Estacion Expt Zaidin, Dept Biochem & Mol & Cellular Biol Plants, Apartado Correos 419, E-18008 Granada, Spain.			Ramos, Juan L./0000-0002-8731-7435				Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; ASSINDER SJ, 1988, J GEN MICROBIOL, V134, P2769; Ausubel FM., 2006, ENZYMATIC MANIPULATI; BRUNELLE A, 1989, J MOL BIOL, V209, P606; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; EGAN SM, 1994, J MOL BIOL, V243, P821, DOI 10.1006/jmbi.1994.1684; Egan SM, 2000, J BACTERIOL, V182, P7075, DOI 10.1128/JB.182.24.7075-7077.2000; FAWCETT WP, 1994, MOL MICROBIOL, V14, P669, DOI 10.1111/j.1365-2958.1994.tb01305.x; Gallegos MT, 1997, J BACTERIOL, V179, P5024, DOI 10.1128/jb.179.16.5024-5029.1997; Gallegos MT, 1996, J BACTERIOL, V178, P6427, DOI 10.1128/jb.178.22.6427-6434.1996; GOLDBERG RB, 1974, J BACTERIOL, V118, P810, DOI 10.1128/JB.118.3.810-814.1974; Gonzalez-Perez MM, 1999, J BIOL CHEM, V274, P2286, DOI 10.1074/jbc.274.4.2286; Hansen LH, 1997, GENE, V186, P167, DOI 10.1016/S0378-1119(96)00688-9; HARRIS JD, 1978, P NATL ACAD SCI USA, V75, P6177, DOI 10.1073/pnas.75.12.6177; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; JONES EL, 1989, ANTIBODIES PRACTICAL, V2, P155; KEIL H, 1985, J BACTERIOL, V164, P887, DOI 10.1128/JB.164.2.887-895.1985; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Manzanera M, 2000, FEBS LETT, V476, P312, DOI 10.1016/S0014-5793(00)01749-X; Marques S, 1999, MOL MICROBIOL, V31, P1105, DOI 10.1046/j.1365-2958.1999.01249.x; MICHAN C, 1992, J BIOL CHEM, V267, P22897; MICHAN C, 1992, MOL GEN GENET, V235, P406, DOI 10.1007/BF00279387; Niland P, 1996, J MOL BIOL, V264, P667, DOI 10.1006/jmbi.1996.0668; Ohnuma M, 2000, J BACTERIOL, V182, P4628, DOI 10.1128/JB.182.16.4628-4631.2000; OSBORNE DJ, 1988, J GEN MICROBIOL, V134, P2965; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; RAMOS JL, 1986, P NATL ACAD SCI USA, V83, P8467, DOI 10.1073/pnas.83.22.8467; RAMOS JL, 1990, J MOL BIOL, V211, P373, DOI 10.1016/0022-2836(90)90358-S; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Ramos JL, 2001, CURR OPIN MICROBIOL, V4, P166, DOI 10.1016/S1369-5274(00)00183-1; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Ruiz R, 2001, FEBS LETT, V491, P207, DOI 10.1016/S0014-5793(01)02192-5; ZHOU YN, 1988, J BACTERIOL, V170, P3640, DOI 10.1128/jb.170.8.3640-3649.1988	35	18	19	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7282	7286		10.1074/jbc.M110226200	http://dx.doi.org/10.1074/jbc.M110226200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751934	hybrid			2022-12-27	WOS:000174104300069
J	Ueda, T; Bruchovsky, N; Sadar, MD				Ueda, T; Bruchovsky, N; Sadar, MD			Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; PROTEIN-KINASE-A; LIGAND-INDEPENDENT ACTIVATION; EPIDERMAL GROWTH-FACTOR; CANCER CELL-LINES; GENE-EXPRESSION; CARCINOMA-CELLS; SYNERGISTIC ACTIVATION; SERINE PHOSPHORYLATION; ESTROGEN-RECEPTOR	The androgen receptor (AR) is a ligand-activated transcription factor that mediates the biological responses of androgens. However, non-androgenic pathways have also been shown to activate the AR. The mechanism of cross-talk between the interleukin-6 (IL-6) and AR signal transduction pathways was investigated in LNCaP human prostate cancer cells. IL-6 induced several androgen-response element-driven reporters that are dependent upon the AR, increased the phosphorylation of mitogen-activated protein kinase (MAPK), and activated the AR N-terminal domain (NTD). Inhibitors to MAPK and JAK decreased the IL-6-induced phosphorylation of MAPK and activation of the AR NTD. Immunoprecipitation and transactivation studies showed a direct interaction between amino acids 234-558 of the AR NTD and STAT3 following IL-6 treatment of LNCaP cells. These results demonstrate that activation of the human AR NTD by IL-6 was mediated through MAPK and STAT3 signal transduction pathways in LNCaP prostate cancer cells.	British Columbia Canc Agcy, Dept Canc Endocrinol, Vancouver, BC V5Z 4E6, Canada	British Columbia Cancer Agency	Sadar, MD (corresponding author), British Columbia Canc Agcy, Dept Canc Endocrinol, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	msadar@bccancer.bc.ca	Sadar, Marianne/E-9136-2012	Sadar, Marianne/0000-0003-0599-9215	NIDDK NIH HHS [P50 DK 47656] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK047656] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z; ANTRAS J, 1991, J BIOL CHEM, V266, P1157; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Blok LJ, 1996, ENDOCR RES, V22, P197, DOI 10.3109/07435809609030508; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chamberlain NL, 1996, J BIOL CHEM, V271, P26772, DOI 10.1074/jbc.271.43.26772; Chen TS, 1999, CANCER RES, V59, P213; Chen TS, 2000, CANCER RES, V60, P2132; Chung TDK, 1999, PROSTATE, V38, P199; Chung TDK, 2000, PROSTATE, V42, P1; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Culig Z, 1997, PROSTATE, V32, P106, DOI 10.1002/(SICI)1097-0045(19970701)32:2<106::AID-PROS5>3.0.CO;2-K; CULIG Z, 1994, CANCER RES, V54, P5474; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; DERUITER PE, 1995, MOL CELL ENDOCRINOL, V110, pR1, DOI 10.1016/0303-7207(95)03534-E; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; ElTanani MKK, 1997, MOL ENDOCRINOL, V11, P928, DOI 10.1210/me.11.7.928; Gioeli D, 1999, CANCER RES, V59, P279; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; HENTTU P, 1993, CANCER RES, V53, P1051; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hirano T, 1998, Int Rev Immunol, V16, P249; Hobisch A, 1998, CANCER RES, V58, P4640; IgnarTrowbridge DM, 1996, ENDOCRINOLOGY, V137, P1735, DOI 10.1210/en.137.5.1735; Ihara S, 1997, EMBO J, V16, P5345, DOI 10.1093/emboj/16.17.5345; IKONEN T, 1994, ENDOCRINOLOGY, V135, P1359, DOI 10.1210/en.135.4.1359; Irvine RA, 2000, HUM MOL GENET, V9, P267, DOI 10.1093/hmg/9.2.267; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; KLEIN B, 1989, BLOOD, V73, P517; KUIL CW, 1995, J BIOL CHEM, V270, P27569, DOI 10.1074/jbc.270.46.27569; Levesque E, 1998, ENDOCRINOLOGY, V139, P2375, DOI 10.1210/en.139.5.2375; Lin DL, 2001, CLIN CANCER RES, V7, P1773; Lin JQ, 1999, CANCER RES, V59, P2891; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MATSUDA T, 1994, BIOCHEM BIOPH RES CO, V200, P821, DOI 10.1006/bbrc.1994.1525; MIKI S, 1989, FEBS LETT, V250, P607, DOI 10.1016/0014-5793(89)80805-1; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Ni Z, 2000, CANCER RES, V60, P1225; Nielsen M, 1997, P NATL ACAD SCI USA, V94, P6764, DOI 10.1073/pnas.94.13.6764; Okamoto M, 1997, CANCER RES, V57, P141; PALVIMO JJ, 1993, MOL ENDOCRINOL, V7, P1399, DOI 10.1210/me.7.11.1399; PURNELL DM, 1984, CANCER RES, V44, P285; Putz T, 1999, CANCER RES, V59, P227; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Rana S, 1999, J MOL BIOL, V286, P669, DOI 10.1006/jmbi.1998.2505; RICHIE CK, 1997, ENDOCRINOLOGY, V138, P1145; RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921, DOI 10.1210/mend-5-12-1921; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Sadar MD, 2000, CANCER RES, V60, P5825; Sato N, 1997, J BIOL CHEM, V272, P17485, DOI 10.1074/jbc.272.28.17485; Schuur ER, 1996, J BIOL CHEM, V271, P7043, DOI 10.1074/jbc.271.12.7043; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SIEGALL CB, 1990, CANCER RES, V50, P7786; SIEGSMUND MJ, 1994, J UROLOGY, V151, P1396, DOI 10.1016/S0022-5347(17)35267-9; Smith PC, 2001, PROSTATE, V48, P47; Snoek R, 1998, PROSTATE, V36, P256; Snoek R, 1996, J STEROID BIOCHEM, V59, P243, DOI 10.1016/S0960-0760(96)00116-1; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Tan JA, 2000, ENDOCRINOLOGY, V141, P3440, DOI 10.1210/en.141.9.3440; TERANISHI T, 1982, J IMMUNOL, V128, P1903; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Weigel NL, 1996, BIOCHEM J, V319, P657, DOI 10.1042/bj3190657; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; YEE C, 1989, BLOOD, V74, P798; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607; ZILLIACUS J, 1995, MOL ENDOCRINOL, V9, P389, DOI 10.1210/me.9.4.389; ZOPPI S, 1993, J CLIN INVEST, V91, P1105, DOI 10.1172/JCI116269	82	298	320	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7076	7085		10.1074/jbc.M108255200	http://dx.doi.org/10.1074/jbc.M108255200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751884	hybrid			2022-12-27	WOS:000174104300043
J	Gonzalez-Lebrero, RM; Kaufman, SB; Garrahan, PJ; Rossi, RC				Gonzalez-Lebrero, RM; Kaufman, SB; Garrahan, PJ; Rossi, RC			The occlusion of Rb+ in the Na+/K+-ATPase II. The effects of Rb+, Na+, Mg2+, or ATP on the equilibrium between free and occluded Rb+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE; SODIUM; BINDING; IONS; STATES; STOICHIOMETRY; NUCLEOTIDES; NA,K-ATPASE; FLUORESCEIN; MECHANISM	We used the direct route of occlusion to study the equilibrium between free and occluded Rb+ in the Na-divided by/K+-ATPase, in media with different concentrations of ATP,Mg2+, or Na+. An empirical equation, with the restrictions imposed by the stoichiometry of ligand binding was fitted to the data. This allowed us to identify which states of the enzyme were present in each condition and to work out the schemes and equations that describe the equilibria between the ATPase, Rb+, and ATP,Mg2+, or Na-divided by. These equations were fitted to the corresponding experimental data to find out the values of the equilibrium constants of the reactions connecting the different enzyme states. The three ligands decreased the apparent affinity for Rb+ occlusion without affecting the occlusion capacity. With [ATP] tending to infinity, enzyme species with one or two occluded Rb+ seem to be present and full occlusion seems to occur in enzymes saturated with the nucleotide. In contrast, when either [Mg2+] or [Na+] tended to infinity no occlusion was detectable. Both Mg2+ and Na+ are displaced by Rb+ through a process that seems to need the binding and occlusion of two Rb+, which suggests that in these conditions Rb+ occlusion regains the stoichiometry of the physiological operation of the Na+ pump.	Univ Buenos Aires, Inst Quim & Fisicoquim Biol, Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Rossi, RC (corresponding author), Univ Buenos Aires, Inst Quim & Fisicoquim Biol, Junin 956,C1113AAD, Buenos Aires, DF, Argentina.	rcr@mail.retina.ar		Gonzalez Lebrero, Rodolfo M./0000-0002-3832-2270; Kaufman, Sergio Benjamin/0000-0002-8763-4086				ESMANN M, 1994, BIOCHEMISTRY-US, V33, P8558, DOI 10.1021/bi00194a022; FORBUSH B, 1987, J BIOL CHEM, V262, P11104; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P217, DOI 10.1113/jphysiol.1967.sp008297; GLYNN IM, 1982, J PHYSIOL-LONDON, V330, P17, DOI 10.1113/jphysiol.1982.sp014326; Gonzalez-Lebrero RM, 2002, J BIOL CHEM, V277, P5910, DOI 10.1074/jbc.M105886200; HASENAUER J, 1993, J BIOL CHEM, V268, P3289; HEGYVARY C, 1971, J BIOL CHEM, V246, P5234; KARLISH SJD, 1982, J PHYSIOL-LONDON, V328, P295, DOI 10.1113/jphysiol.1982.sp014265; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; Kaufman SB, 1999, J BIOL CHEM, V274, P20779, DOI 10.1074/jbc.274.30.20779; MATSUI H, 1982, J BIOCHEM-TOKYO, V92, P193, DOI 10.1093/oxfordjournals.jbchem.a133916; MOCZYDLOWSKI EG, 1981, J BIOL CHEM, V256, P2346; MOCZYDLOWSKI EG, 1981, J BIOL CHEM, V256, P2357; NORBY JG, 1983, CURR TOP MEMBR TRANS, V19, P281; NORBY JG, 1971, BIOCHIM BIOPHYS ACTA, V233, P104, DOI 10.1016/0005-2736(71)90362-2; ROSSI RC, 1993, J BIOL CHEM, V268, P12579; Schneeberger A, 2001, J MEMBRANE BIOL, V179, P263, DOI 10.1007/s002320010051; SHANI M, 1987, BIOCHIM BIOPHYS ACTA, V904, P13, DOI 10.1016/0005-2736(87)90081-2; SKOU JC, 1983, BIOCHIM BIOPHYS ACTA, V727, P101, DOI 10.1016/0005-2736(83)90373-5; SKOU JC, 1983, BIOCHIM BIOPHYS ACTA, V746, P101, DOI 10.1016/0167-4838(83)90016-X; SMIRNOVA IN, 1993, BIOCHEMISTRY-US, V32, P5967, DOI 10.1021/bi00074a007; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450	23	11	11	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5922	5928		10.1074/jbc.M105887200	http://dx.doi.org/10.1074/jbc.M105887200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11739378	hybrid			2022-12-27	WOS:000173989200030
J	Paillart, JC; Skripkin, E; Ehresmann, B; Ehresmann, C; Marquet, R				Paillart, JC; Skripkin, E; Ehresmann, B; Ehresmann, C; Marquet, R			In vitro evidence for a long range pseudoknot in the 5 '-untranslated and matrix coding regions of HIV-1 genomic RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MAJOR SPLICE DONOR; KISSING-LOOP HAIRPIN; REVERSE TRANSCRIPTION; PACKAGING SIGNAL; NUCLEOCAPSID PROTEIN; STEM-LOOP; MUTATIONAL ANALYSIS; DIMER LINKAGE; NMR STRUCTURE	The 5'-untranslated leader region of human immunodeficiency virus type 1 (HIV-1) RNA contains multiple signals that control distinct steps of the viral replication cycle such as transcription, reverse transcription, genomic RNA dimerization, splicing, and packaging. It is likely that fine tuned coordinated regulation of these functions is achieved through specific RNA-protein and RNA-RNA interactions. In a search for cis-acting elements important for the tertiary structure of the 5'-untranslated region of HIV-1 genomic RNA, we identified, by ladder selection experiments, a short stretch of nucleotides directly downstream of the poly(A) signal that interacts with a nucleotide sequence located in the matrix region. Confirmation of the sequence of the interacting sites was obtained by partial or complete inhibition of this interaction by antisense oligonucleotides and by nucleotide substitutions. In the wild type RNA, this long range interaction was intramolecular, since no intermolecular RNA association was detected by gel electrophoresis with an RNA mutated in the dimerization initiation site and containing both sequences involved in the tertiary interaction. Moreover, the functional importance of this interaction is supported by its conservation in all HIV-1 isolates as well as in HIV-2 and simian immunodeficiency virus. Our results raise the possibility that this long range RNA-RNA interaction might be involved in the full-length genomic RNA selection during packaging, repression of the 5' polyadenylation signal, and/or splicing regulation.	Inst Biol Mol & Cellulaire, UPR 9002 CNRS, F-67094 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Paillart, JC (corresponding author), Inst Biol Mol & Cellulaire, UPR 9002 CNRS, 15 Rue Rene Descartes, F-67094 Strasbourg, France.	JC.Paillart@ibmc.u-strasbg.fr	Paillart, Jean-Christophe/A-4171-2010	Paillart, Jean-Christophe/0000-0003-1647-8917; Marquet, Roland/0000-0002-4209-3976				ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; Amarasinghe GK, 2000, J MOL BIOL, V299, P145, DOI 10.1006/jmbi.2000.3710; Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; ANDERGLON CW, 1993, EMBO J, V12, P2119; Ashe MP, 1997, EMBO J, V16, P5752, DOI 10.1093/emboj/16.18.5752; Ashe MP, 2000, RNA, V6, P170, DOI 10.1017/S1355838200991957; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; BERKHOUT B, 1995, VIROLOGY, V207, P276, DOI 10.1006/viro.1995.1077; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Berkhout B, 2000, RNA, V6, P282, DOI 10.1017/S1355838200991684; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Butsch M, 2000, J VIROL, V74, P11531, DOI 10.1128/JVI.74.24.11531-11537.2000; Clever JL, 1999, J VIROL, V73, P101, DOI 10.1128/JVI.73.1.101-109.1999; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Clever JL, 1996, J VIROL, V70, P5902, DOI 10.1128/JVI.70.9.5902-5908.1996; Coffin J, 1997, RETROVIRUSES; Das AT, 1998, J VIROL, V72, P9217, DOI 10.1128/JVI.72.11.9217-9223.1998; Das AT, 1999, J VIROL, V73, P81, DOI 10.1128/JVI.73.1.81-91.1999; Das AT, 1997, J VIROL, V71, P2346, DOI 10.1128/JVI.71.3.2346-2356.1997; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Dorman N, 2000, J VIROL, V74, P11413, DOI 10.1128/JVI.74.23.11413-11417.2000; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; GLON CWAD, 1991, GENE DEV, V5, P244, DOI 10.1101/gad.5.2.244; Graveley BR, 1996, J BIOL CHEM, V271, P33654, DOI 10.1074/jbc.271.52.33654; Harrich D, 1996, J VIROL, V70, P4017, DOI 10.1128/JVI.70.6.4017-4027.1996; HARRISON GP, 1992, J VIROL, V66, P4144, DOI 10.1128/JVI.66.7.4144-4153.1992; Helga-Maria C, 1999, J VIROL, V73, P4127, DOI 10.1128/JVI.73.5.4127-4135.1999; Honda M, 1999, J VIROL, V73, P4941, DOI 10.1128/JVI.73.6.4941-4951.1999; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; Jossinet F, 1999, RNA, V5, P1222, DOI 10.1017/S1355838299990982; Kaye JF, 1999, J VIROL, V73, P3023, DOI 10.1128/JVI.73.4.3023-3031.1999; Klasens BIF, 1998, NUCLEIC ACIDS RES, V26, P1870, DOI 10.1093/nar/26.8.1870; Klasens BIF, 1999, NUCLEIC ACIDS RES, V27, P446, DOI 10.1093/nar/27.2.446; KUIKEN C, 1999, HUMAN RETROVIRUSES A, P201; Lanchy JM, 1996, BIOCHIMIE, V78, P1087, DOI 10.1016/S0300-9084(97)86734-X; Laughrea M, 1997, BIOCHEMISTRY-US, V36, P9501, DOI 10.1021/bi970862l; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; Laughrea M, 2001, VIROLOGY, V281, P109, DOI 10.1006/viro.2000.0778; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; LUBAN J, 1994, J VIROL, V68, P3784, DOI 10.1128/JVI.68.6.3784-3793.1994; MARQUET R, 1994, NUCLEIC ACIDS RES, V22, P145, DOI 10.1093/nar/22.2.145; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; McBride MS, 1997, J VIROL, V71, P2050, DOI 10.1128/JVI.71.3.2050-2058.1997; McBride MS, 1996, J VIROL, V70, P2963, DOI 10.1128/JVI.70.5.2963-2973.1996; MURIAUX D, 1995, J BIOL CHEM, V270, P8209, DOI 10.1074/jbc.270.14.8209; Ohi Y, 2000, J VIROL, V74, P8324, DOI 10.1128/JVI.74.18.8324-8334.2000; Paillart JC, 1996, BIOCHIMIE, V78, P639, DOI 10.1016/S0300-9084(96)80010-1; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Paillart JC, 1996, J VIROL, V70, P8348, DOI 10.1128/JVI.70.12.8348-8354.1996; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Pappalardo L, 1998, J MOL BIOL, V282, P801, DOI 10.1006/jmbi.1998.2046; SCHEPER W, 1995, MOL CELL BIOL, V15, P235, DOI 10.1128/MCB.15.1.235; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zeffman A, 2000, J MOL BIOL, V297, P877, DOI 10.1006/jmbi.2000.3611; Zhang GC, 1999, RNA, V5, P550, DOI 10.1017/S1355838299982080	60	83	89	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5995	6004		10.1074/jbc.M108972200	http://dx.doi.org/10.1074/jbc.M108972200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744696	hybrid			2022-12-27	WOS:000173989200040
J	Sandager, L; Gustavsson, MH; Stahl, U; Dahlqvist, A; Wiberg, E; Banas, A; Lenman, M; Ronne, H; Stymne, S				Sandager, L; Gustavsson, MH; Stahl, U; Dahlqvist, A; Wiberg, E; Banas, A; Lenman, M; Ronne, H; Stymne, S			Storage lipid synthesis is non-essential in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DIACYLGLYCEROL ACYLTRANSFERASE; MOLECULAR-CLONING; PARTICLES; GENE; TRIACYLGLYCEROL; ESTERIFICATION; ENZYME; CELLS	Steryl esters and triacylglycerol (TAG) are the main storage lipids in eukaryotic cells. In the yeast Saccharomyces cerevisiae, these storage lipids accumulate during stationary growth phase within organelles known as lipid bodies. We have used single and multiple gene disruptions to study storage lipid synthesis in yeast. Four genes, ARE1, ARE2, DGA1, and LRO1, were found to contribute to TAG synthesis. The most significant contribution is made by DGA1, which encodes a novel acyl-CoA;diacylglycerol acyltransferase. Two of the genes, ARE1 and ARE2, are also involved in steryl ester synthesis. A yeast strain that lacks all four genes is viable and has no apparent growth defects under standard conditions. The strain is devoid of both TAG and steryl esters, and fluorescence microscopy revealed that it also lacks lipid bodies. We conclude that neither storage lipids nor lipid bodies are essential for growth in yeast.	Swedish Univ Agr Sci, Dept Crop Sci, S-23053 Alnarp, Sweden; Lund Univ, Dept Plant Biochem, S-22100 Lund, Sweden; Swedish Univ Agr Sci, Dept Plant Biol, S-75007 Uppsala, Sweden; Scandinavian Biotechnol Res AB, S-23053 Alnarp, Sweden; Scandinavian Biotechnol Res AB, S-75077 Uppsala, Sweden	Swedish University of Agricultural Sciences; Lund University; Swedish University of Agricultural Sciences	Gustavsson, MH (corresponding author), Swedish Univ Agr Sci, Dept Crop Sci, Box 44, S-23053 Alnarp, Sweden.	maria.g@plantbio.lu.se		Ronne, Hans/0000-0002-1645-6091; Banas, Antoni/0000-0001-9397-7627				BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CLAUSEN MK, 1974, FEBS LETT, V43, P176, DOI 10.1016/0014-5793(74)80994-4; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Rattray J. B. M., 1988, MICROBIAL LIPIDS, P555; Richard MG, 1998, LIPIDS, V33, P1229, DOI 10.1007/s11745-998-0328-1; Routaboul JM, 1999, PLANT PHYSIOL BIOCH, V37, P831, DOI 10.1016/S0981-9428(99)00115-1; Stobart K, 1997, PLANTA, V203, P58, DOI 10.1007/s004250050165; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yu CJ, 1996, J BIOL CHEM, V271, P24157, DOI 10.1074/jbc.271.39.24157; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	22	378	420	6	40	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6478	6482		10.1074/jbc.M109109200	http://dx.doi.org/10.1074/jbc.M109109200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741946	hybrid			2022-12-27	WOS:000173989200103
J	Cleary, SP; Tan, FC; Nakrieko, KA; Thompson, SJ; Mullineaux, PM; Creissen, GP; von Stedingk, E; Glaser, E; Smith, AG; Robinson, C				Cleary, SP; Tan, FC; Nakrieko, KA; Thompson, SJ; Mullineaux, PM; Creissen, GP; von Stedingk, E; Glaser, E; Smith, AG; Robinson, C			Isolated plant mitochondria import chloroplast precursor proteins in vitro with the same efficiency as chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; GLUTATHIONE-REDUCTASE; ARABIDOPSIS; OXIDASE; SEQUENCE; FERROCHELATASE; REQUIREMENT; MATURATION; TRANSPORT; APPARATUS	Most chloroplast and mitochondrial proteins are synthesized with N-terminal presequences that direct their import into the appropriate organelle. In this report we have analyzed the specificity of standard in vitro assays for import into isolated pea chloroplasts and mitochondria. We find that chloroplast protein import is highly specific because mitochondrial proteins are not imported to any detectable levels. Surprisingly, however, pea mitochondria import a range of chloroplast protein precursors with the same efficiency as chloroplasts, including those of plastocyanin, the 33-kDa photosystem II protein, Hcf136, and coproporphyrinogen III oxidase. These import reactions are dependent on the Delta across the inner mitochondrial membrane, and furthermore, marker enzyme assays and Western blotting studies exclude any import by contaminating chloroplasts in the preparation. The pea mitochondria specifically recognize information in the chloroplast-targeting presequences, because they also import a fusion comprising the presequence of coproporphyrinogen III oxidase linked to green fluorescent protein. However, the same construct is targeted exclusively into chloroplasts in vivo indicating that the in vitro mitochondrial import reactions are unphysiological, possibly because essential specificity factors are absent in these assays. Finally, we show that disruption of potential amphipathic helices in one presequence does not block import into pea mitochondria, indicating that other features are recognized.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; John Innes Ctr, Norwich NR4 7UH, Norfolk, England; Univ Stockholm, Dept Biochem & Biophys Arrhenius, Lab Nat Sci, S-10691 Stockholm, Sweden	University of Warwick; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Stockholm University	Robinson, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	Crobinson@bio.warwick.ac.uk	Mullineaux, Philip M/F-7723-2012; Creissen, Gary P/C-7481-2009	Mullineaux, Philip M/0000-0002-1998-3540; Creissen, Gary P/0000-0003-4992-8056; Smith, Alison Gail/0000-0001-6511-5704; Thompson, Simon/0000-0003-0769-8555				Akashi K, 1998, FEBS LETT, V431, P39, DOI 10.1016/S0014-5793(98)00717-0; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BOUTRY M, 1987, NATURE, V328, P340, DOI 10.1038/328340a0; Braun HP, 1999, PLANTA, V209, P267, DOI 10.1007/s004250050632; CHAUMONT F, 1990, J BIOL CHEM, V265, P16856; Chow KS, 1997, J BIOL CHEM, V272, P27565, DOI 10.1074/jbc.272.44.27565; Chow KS, 1998, PLANT J, V15, P531, DOI 10.1046/j.1365-313X.1998.00235.x; CHU TW, 1987, J BIOL CHEM, V262, P15759; CLINE K, 1988, PLANT PHYSIOL, V86, P1120, DOI 10.1104/pp.86.4.1120; CREISSEN G, 1995, PLANT J, V8, P167, DOI 10.1046/j.1365-313X.1995.08020167.x; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Dessi P, 1997, FEBS LETT, V415, P173, DOI 10.1016/S0014-5793(97)01116-2; EDWARDS EA, 1990, PLANTA, V180, P278, DOI 10.1007/BF00194008; ELLIS EM, 1993, GENE, V132, P175, DOI 10.1016/0378-1119(93)90193-7; GAVEL Y, 1990, FEBS LETT, V261, P455, DOI 10.1016/0014-5793(90)80614-O; HACHIYA N, 1993, EMBO J, V12, P1579, DOI 10.1002/j.1460-2075.1993.tb05802.x; HAGEMAN J, 1986, NATURE, V324, P567, DOI 10.1038/324567a0; Heard TS, 1998, J BIOL CHEM, V273, P29389, DOI 10.1074/jbc.273.45.29389; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; JAMES HE, 1989, J BIOL CHEM, V264, P19573; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; KRUSE E, 1995, PLANTA, V196, P796, DOI 10.1007/BF01106776; Lithgow T, 1997, TRENDS BIOCHEM SCI, V22, P110, DOI 10.1016/S0968-0004(97)01007-4; LITTLE RJ, 1976, BIOCHEM J, V150, P309; Macasev D, 2000, PLANT PHYSIOL, V123, P811, DOI 10.1104/pp.123.3.811; May T, 2000, PLANT CELL, V12, P53, DOI 10.1105/tpc.12.1.53; Menand B, 1998, P NATL ACAD SCI USA, V95, P11014, DOI 10.1073/pnas.95.18.11014; Meurer J, 1998, EMBO J, V17, P5286, DOI 10.1093/emboj/17.18.5286; Mould RM, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P286; Mould RM, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P81; Mullineaux PM, 1998, PLANT J, V13, P375, DOI 10.1046/j.1365-313X.1998.00052.x; Ni L, 1999, J BIOL CHEM, V274, P12685, DOI 10.1074/jbc.274.18.12685; Peeters NM, 2000, J MOL EVOL, V50, P413, DOI 10.1007/s002390010044; ROISE D, 1988, J BIOL CHEM, V263, P4509; SANTANA MA, 2002, IN PRESS PLANT PHYSL; SCHLEYER M, 1982, EUR J BIOCHEM, V125, P109, DOI 10.1111/j.1432-1033.1982.tb06657.x; SMITH AG, 1993, BIOCHEM J, V292, P503, DOI 10.1042/bj2920503; Tanudji M, 1999, AUST J PLANT PHYSIOL, V26, P337, DOI 10.1071/PP98122; THEG SM, 1989, J BIOL CHEM, V264, P6730; Tolbert N E, 1974, Methods Enzymol, V31, P734; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Waegemann K, 1996, J BIOL CHEM, V271, P6545, DOI 10.1074/jbc.271.11.6545; WHELAN J, 1995, PLANT MOL BIOL, V27, P769, DOI 10.1007/BF00020229; WHELAN J, 1991, PLANT MOL BIOL, V16, P283, DOI 10.1007/BF00020559; Whelan J, 1997, PLANT MOL BIOL, V33, P771, DOI 10.1023/A:1005755505738; WU R, 1959, J BIOL CHEM, V234, P1029	48	56	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5562	5569		10.1074/jbc.M106532200	http://dx.doi.org/10.1074/jbc.M106532200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733507	hybrid			2022-12-27	WOS:000173962900130
J	Yu, KF; Taghva, A; Lieber, MR				Yu, KF; Taghva, A; Lieber, MR			The cleavage efficiency of the human immunoglobulin heavy chain V-H elements by the RAG complex - Implications for the immune repertoire	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINATION SIGNAL SEQUENCES; VARIABLE REGION LOCUS; CODING END SEQUENCE; V(D)J RECOMBINATION; ANTIBODY REPERTOIRE; HISTONE ACETYLATION; NUCLEOTIDE-SEQUENCE; FUNCTIONAL-ANALYSIS; NUCLEOSOMAL DNA; B-CELLS	The human immunoglobulin heavy chain locus contains 39 functional human V-H elements. All 39 V-H elements (with their adjacent heptamer/nonamer signal) were tested for site-specific cleavage with purified human core RAG1 and RAG2, and HMG1 proteins in a 12/23-coupled cleavage reaction. Both nicking and hairpin formation were measured. The individual V-H cleavage efficiencies vary over nearly a 30-fold range. These measurements will be useful in considering the factors affecting the generation of the immunoglobulin and T-cell receptor repertoires in the adult humans. Interestingly, when these cleavage efficiencies are summed for each of the V-H families, the six V-H family efficiencies correspond closely to the observed profile of unselected V-H family usage in the peripheral B cells of normal adult humans. This correspondence raises the possibility that the dominant factor determining V-H element utilization within the 1-megabase human genomic V-H array is simply the individual RAG cleavage efficiencies.	Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Rm 5428,1441 Eastlake Ave,Mail Code 9176, Los Angeles, CA 90089 USA.	lieber@usc.edu		Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345				AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; BOUBNOV NV, 1995, NUCLEIC ACIDS RES, V23, P1060, DOI 10.1093/nar/23.6.1060; BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; Eastman QM, 1997, NUCLEIC ACIDS RES, V25, P4370, DOI 10.1093/nar/25.21.4370; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B; ENGLER P, 1993, MOL CELL BIOL, V13, P571, DOI 10.1128/MCB.13.1.571; EZEKIEL UR, 1995, IMMUNITY, V2, P381, DOI 10.1016/1074-7613(95)90146-9; Ezekiel UR, 1997, MOL CELL BIOL, V17, P4191, DOI 10.1128/MCB.17.7.4191; Fanning LJ, 1996, CLIN IMMUNOL IMMUNOP, V79, P1, DOI 10.1006/clin.1996.0044; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gallo ML, 2000, EUR J IMMUNOL, V30, P534, DOI 10.1002/1521-4141(200002)30:2<534::AID-IMMU534>3.3.CO;2-G; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; Gokmen E, 1998, BLOOD, V92, P2802, DOI 10.1182/blood.V92.8.2802.420k18_2802_2814; Golding A, 1999, EMBO J, V18, P3712, DOI 10.1093/emboj/18.13.3712; Grawunder U, 1998, CURR OPIN IMMUNOL, V10, P172, DOI 10.1016/S0952-7915(98)80246-X; Haines BB, 2001, MOL IMMUNOL, V38, P9, DOI 10.1016/S0161-5890(01)00049-9; Hansen A, 2000, INT ARCH ALLERGY IMM, V123, P36, DOI 10.1159/000024422; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hassanin A, 2000, P NATL ACAD SCI USA, V97, P11415, DOI 10.1073/pnas.97.21.11415; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; HSIEH CL, 1992, EMBO J, V11, P315, DOI 10.1002/j.1460-2075.1992.tb05054.x; HYUN DJ, 1988, J IMMUNOL, V140, P2436; JEONG HD, 1988, J EXP MED, V168, P589, DOI 10.1084/jem.168.2.589; Kim DR, 1998, MOL CELL BIOL, V18, P4679, DOI 10.1128/MCB.18.8.4679; Kwon J, 2000, MOL CELL, V6, P1037, DOI 10.1016/S1097-2765(00)00102-7; Kwon J, 1998, MOL CELL, V2, P829, DOI 10.1016/S1097-2765(00)80297-X; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lieber MR, 1998, AM J PATHOL, V153, P1323, DOI 10.1016/S0002-9440(10)65716-1; MATHER EL, 1983, P NATL ACAD SCI-BIOL, V80, P4689, DOI 10.1073/pnas.80.15.4689; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Nadel B, 1998, J EXP MED, V187, P1495, DOI 10.1084/jem.187.9.1495; RAMSDEN DA, 1994, NUCLEIC ACIDS RES, V22, P1785, DOI 10.1093/nar/22.10.1785; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Schroeder HW, 1998, VACCINE, V16, P1383, DOI 10.1016/S0264-410X(98)00096-6; SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; STORB U, 1983, P NATL ACAD SCI-BIOL, V80, P6642, DOI 10.1073/pnas.80.21.6642; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; WEI Z, 1993, J BIOL CHEM, V268, P3180; WeisGarcia F, 1997, MOL CELL BIOL, V17, P6379, DOI 10.1128/MCB.17.11.6379; West RB, 1998, MOL CELL BIOL, V18, P6408, DOI 10.1128/MCB.18.11.6408; Williams GS, 2001, J IMMUNOL, V167, P257, DOI 10.4049/jimmunol.167.1.257; Wu G E, 1990, Semin Immunol, V2, P207; Yu KF, 1999, MOL CELL BIOL, V19, P8094; Yu KF, 2000, MOL CELL BIOL, V20, P7914, DOI 10.1128/MCB.20.21.7914-7921.2000	54	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5040	5046		10.1074/jbc.M109772200	http://dx.doi.org/10.1074/jbc.M109772200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739391	hybrid			2022-12-27	WOS:000173962900065
J	Elagoz, A; Benjannet, S; Mammarbassi, A; Wickham, L; Seidah, NG				Elagoz, A; Benjannet, S; Mammarbassi, A; Wickham, L; Seidah, NG			Biosynthesis and cellular trafficking of the convertase SKI-1/S1P - Ectodomain shedding requires SKI-1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ELEMENT-BINDING PROTEINS; CLEAVAGE SITE; MOLECULAR CHARACTERIZATION; PROHORMONE CONVERTASES; PROPROTEIN CONVERTASE; ALZHEIMERS-DISEASE; ENZYME; FURIN; CELLS	Subtilisin kexin isozyme-1 (SKI-1)/site 1 protease is a mammalian subtilase composed of distinct functional domains. Among the major substrates of SKI-1 are the sterol regulatory element-binding proteins, regulating cholesterol and fatty acid homeostasis. Other substrates include the stress response factor activating transcription factor-6, the brain-derived neurotrophic factor, and the surface glycoproteins of highly infectious viruses belonging to the family of Arenaviridae. Domain deletion and/or point mutants were used to gauge the role of the various domains of SKI-1. Biosynthesis, cellular trafficking, and sterol regulatory element-binding protein-2 cleavage activity were used as diagnostic tools. Results revealed that Arg(130) and Arg(134) are critical for the autocatalytic primary processing of the prosegment and for the subsequent efficient exit of SKI-1 from the endoplasmic reticulum. Functional mapping of the growth factor cytokine receptor motif suggested a folding role within the endoplasmic reticulum. Microsequencing of the remaining membrane-bound stub following ectodomain shedding of SKI-1 localized the shedding site to KHQKLL(953)down arrow. Site-directed mutagenesis, in vitro cleavage of a synthetic peptide containing the shedding site, and inhibitor studies favor an autocatalytic event occurring at a non-canonical SKI-1 recognition sequence, with P2 and P1 Leu being very critical. In conclusion, multiple domains ensuring optimal functional characteristics control SKI-1 activity and cellular trafficking.	Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342				Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Boudreault A, 1998, PROTEIN EXPRES PURIF, V14, P353, DOI 10.1006/prep.1998.0964; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cheng D, 1999, J BIOL CHEM, V274, P22805, DOI 10.1074/jbc.274.32.22805; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Fivaz M, 1999, TRENDS CELL BIOL, V9, P212, DOI 10.1016/S0962-8924(99)01567-6; Hooper NM, 2000, BIOCHEM SOC T, V28, P441, DOI 10.1042/0300-5127:0280441; INOUYE M, 1991, ENZYME, V45, P314, DOI 10.1159/000468904; Karaivanova VK, 1998, GLYCOBIOLOGY, V8, P725, DOI 10.1093/glycob/8.7.725; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Lehmann M, 1996, BIOCHEM J, V317, P803, DOI 10.1042/bj3170803; Lenz O, 2000, J VIROL, V74, P11418, DOI 10.1128/JVI.74.23.11418-11421.2000; Lesage G, 2000, MOL BIOL CELL, V11, P1947, DOI 10.1091/mbc.11.6.1947; Lopez-Perez E, 2001, J NEUROCHEM, V76, P1532, DOI 10.1046/j.1471-4159.2001.00180.x; MIGAKI GI, 1995, J EXP MED, V182, P549, DOI 10.1084/jem.182.2.549; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Muller L, 2000, J BIOL CHEM, V275, P39213, DOI 10.1074/jbc.M003547200; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pearton DJ, 2001, EXP DERMATOL, V10, P193, DOI 10.1034/j.1600-0625.2001.010003193.x; PRAT A, 2000, NEUR ANN M NEW ORL N; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Sadhukhan R, 1998, P NATL ACAD SCI USA, V95, P138, DOI 10.1073/pnas.95.1.138; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; SEIDAH NG, 2001, ENZYMES CO POSTTRANS, P237; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SILVA OABDE, 1993, NEUROSCIENCE, V57, P873, DOI 10.1016/0306-4522(93)90031-A; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Tang P, 1996, BIOCHEMISTRY-US, V35, P8226, DOI 10.1021/bi952183l; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wang X, 2001, J BIOL CHEM, V276, P35953, DOI 10.1074/jbc.M103680200; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	46	94	97	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2002	277	13					11265	11275		10.1074/jbc.M109011200	http://dx.doi.org/10.1074/jbc.M109011200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	534WQ	11756446	hybrid			2022-12-27	WOS:000174613100066
J	Asuncion, M; Blankenfeldt, W; Barlow, JN; Gani, D; Naismith, JH				Asuncion, M; Blankenfeldt, W; Barlow, JN; Gani, D; Naismith, JH			The structure of 3-methylaspartase from Clostridium tetanomorphum functions via the common enolase chemical step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; BETA-METHYLASPARTASE; ENZYMATIC AMINATION; ESCHERICHIA-COLI; ASPARTIC ACIDS; ALPHA-PROTONS; EVOLUTION; AMMONIA; SUPERFAMILY; ELIMINATION	Methylaspartate ammonia-lyase (3-methylaspartase, MAL; EC 4.3.1.2) catalyzes the reversible anti elimination of ammonia from L-threo-(2S,3S)-3-methylaspartic acid to give mesaconic acid. This reaction lies on the main catabolic pathway for glutamate in Clostridium tetanomorphum. MAL requires monovalent and divalent cation cofactors for full catalytic activity. The enzyme has attracted interest because of its potential use as a biocatalyst. The structure of C. tetanomorphum MAL has been solved to 1.9-Angstrom resolution by the single-wavelength anomalous diffraction method. A divalent metal ion complex of the protein has also been determined. MAL is a homodimer with each monomer consisting of two domains. One is an alpha/beta-barrel, and the other smaller domain is mainly beta-strands. The smaller domain partially occludes the C terminus of the barrel and forms a large cleft. The structure identifies MAL as belonging to the enolase superfamily of enzymes. The metal ion site is located in a large cleft between the domains. Potential active site residues have been identified based on a combination of their proximity to a metal ion site, molecular modeling, and sequence homology. In common with all members of the enolase superfamily, the carboxylic acid of the substrate is co-ordinated by the metal ions, and a proton adjacent to a carboxylic acid group of the substrate is abstracted by a base. In MAL, it appears that Lys(331) removes the a-proton of methylaspartic acid. This motif is the defining mechanistic characteristic of the enolase superfamily of which all have a common fold. The degree of structural conservation is remarkable given only four residues are absolutely conserved.	Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; Univ Birmingham, Sch Chem Sci, Birmingham B15 2TT, W Midlands, England	University of St Andrews; University of Birmingham	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.	naismith@st-and.ac.uk	Blankenfeldt, Wulf/F-8877-2010; Naismith, James Henderson/H-3408-2012; Naismith, James Henderson/AAB-8614-2020	Blankenfeldt, Wulf/0000-0001-9886-9668; Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061				AKHTAR M, 1987, TETRAHEDRON LETT, V28, P2413, DOI 10.1016/S0040-4039(00)96139-2; AKHTAR M, 1987, TETRAHEDRON, V43, P5899, DOI 10.1016/S0040-4020(01)87795-4; Altamirano MM, 2000, NATURE, V403, P617, DOI 10.1038/35001001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARCHER CH, 1993, TETRAHEDRON-ASYMMETR, V4, P1141, DOI 10.1016/S0957-4166(00)80221-9; Asuncion M, 2001, ACTA CRYSTALLOGR D, V57, P731, DOI 10.1107/S0907444901003225; BABBITT PC, 1995, SCIENCE, V267, P1159, DOI 10.1126/science.7855594; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER HA, 1959, J BIOL CHEM, V234, P320; Bearne SL, 2001, MOL CELL BIOCHEM, V221, P117, DOI 10.1023/A:1010938111292; BOTTING NP, 1992, BIOCHEMISTRY-US, V31, P1509, DOI 10.1021/bi00120a031; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Evans W, 1997, CHEM BRIT, V33, P22; Gani D, 1999, BIOORGAN MED CHEM, V7, P977, DOI 10.1016/S0968-0896(99)00043-7; Gerlt JA, 1998, CURR OPIN CHEM BIOL, V2, P607, DOI 10.1016/S1367-5931(98)80091-4; GODA SK, 1992, BIOCHEMISTRY-US, V31, P10747, DOI 10.1021/bi00159a015; Gulick AM, 2001, BIOCHEMISTRY-US, V40, P10054, DOI 10.1021/bi010733b; GULZAR MS, 1995, J CHEM SOC CHEM COMM, P1061, DOI 10.1039/c39950001061; Gulzar MS, 1997, J CHEM SOC PERK T 1, P649, DOI 10.1039/a605996a; Hasson MS, 1998, P NATL ACAD SCI USA, V95, P10396, DOI 10.1073/pnas.95.18.10396; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Larsen TM, 1996, BIOCHEMISTRY-US, V35, P4349, DOI 10.1021/bi952859c; Leslie A. G. W.., 1992, PROTEIN CRYSTALLOGR, V26; Levy CW, 2002, STRUCTURE, V10, P105, DOI 10.1016/S0969-2126(01)00696-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pollard JR, 1999, BIOORGAN MED CHEM, V7, P949, DOI 10.1016/S0968-0896(99)00044-9; POYNER CH, 2001, J CHEM SOC CHEM COMM, V40, P8009; Schwede TF, 1999, BIOCHEMISTRY-US, V38, P5355, DOI 10.1021/bi982929q; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Thompson TB, 2000, BIOCHEMISTRY-US, V39, P10662, DOI 10.1021/bi000855o; Turner MA, 1998, NAT STRUCT BIOL, V5, P369, DOI 10.1038/nsb0598-369	35	26	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8306	8311		10.1074/jbc.M111180200	http://dx.doi.org/10.1074/jbc.M111180200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11748244	hybrid			2022-12-27	WOS:000174268000088
J	Laprise, P; Chailler, P; Houde, M; Beaulieu, JF; Boucher, MJ; Rivard, N				Laprise, P; Chailler, P; Houde, M; Beaulieu, JF; Boucher, MJ; Rivard, N			Phosphatidylinositol 3-kinase controls human intestinal epithelial cell differentiation by promoting adherens junction assembly and p38 MAPK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCRASE-ISOMALTASE EXPRESSION; E-CADHERIN; PROTEIN-KINASE; BETA-CATENIN; MUSCLE DIFFERENTIATION; SMALL GTPASES; ADHESION; PATHWAY; CACO-2; RHO	The signaling pathways mediating human intestinal epithelial cell differentiation remain largely undefined. Phosphatidylinositol 3-kinase (PI3K) is an important modulator of extracellular signals, including those elicited by E-cadherin-mediated cell-cell adhesion, which plays an important role in maintenance of the structural and functional integrity of epithelia. In this study, we analyzed the involvement of PI3K in the differentiation of human intestinal epithelial cells. We showed that inhibition of PI3K signaling in Caco-2/15 cells repressed sucrase-isomaltase and villin protein expression. Morphological differentiation of enterocyte-like features in Caco-2/15 cells such as epithelial cell polarity and brush-border formation were strongly attenuated by PI3K inhibition. Immunofluoreseence and immunoprecipitation experiments revealed that PI3K was recruited to and activated by E-cadherin-mediated cell-cell contacts in confluent Caeo-2/15 cells, and this activation appears to be essential for the integrity of adherens junctions and association with the cytoskeleton. We provide evidence that the assembly of calcium-dependent adherens junctions led to a rapid and remarkable increase in the state of activation of Akt and p38 MAPK pathways and that this increase was blocked in the presence of anti-E-cadherin antibodies and PI3K inhibitor. Therefore, our results indicate that PI3K promotes assembly of adherens junctions, which, in turn, control p38 MAPK activation and enterocyte differentiation.	Univ Sherbrooke, Fac Med, Canadian Inst,Hlth Res Grp Funct Dev & Physiopath, Dept Anat & Biol Cellulaire,Fac Med, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Rivard, N (corresponding author), Univ Sherbrooke, Fac Med, Canadian Inst,Hlth Res Grp Funct Dev & Physiopath, Dept Anat & Biol Cellulaire,Fac Med, Sherbrooke, PQ J1H 5N4, Canada.	nrivard@courrier.usherb.ca	Beaulieu, Jean-Francois/D-2054-2010	Boucher, Marie-Josee/0000-0002-7615-3121				Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; BABYATSKY MW, 1999, GROWTH DEV GASTROINT, P547; BEAULIEU JF, 1989, J BIOL CHEM, V264, P20000; BEAULIEU JF, 1991, BIOCHEM J, V280, P599, DOI 10.1042/bj2800599; Bergin E, 2000, AM J PHYSIOL-RENAL, V278, pF758, DOI 10.1152/ajprenal.2000.278.5.F758; Braga VMM, 1999, J CLIN PATHOL-MOL PA, V52, P197, DOI 10.1136/mp.52.4.197; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Chun YK, 2000, BIOCHEM BIOPH RES CO, V276, P502, DOI 10.1006/bbrc.2000.3486; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; EVERS BM, 1996, AM J PHYSIOL, V271, pC722; Guay J, 1997, J CELL SCI, V110, P357; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Houde M, 2001, J BIOL CHEM, V276, P21885, DOI 10.1074/jbc.M100236200; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Larue L, 1996, DEVELOPMENT, V122, P3185; Li YQ, 2000, CELL SIGNAL, V12, P751, DOI 10.1016/S0898-6568(00)00120-0; Mimori-Kiyosue Y, 2001, J CELL BIOL, V154, P1105, DOI 10.1083/jcb.200106113; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Peluso JJ, 2001, BIOL REPROD, V64, P1183, DOI 10.1095/biolreprod64.4.1183; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PETERSON MD, 1993, J CELL SCI, V105, P461; PINTO M, 1983, BIOL CELL, V47, P323; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Somasiri A, 2000, DIFFERENTIATION, V66, P116, DOI 10.1046/j.1432-0436.2000.660206.x; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Taupin D, 1999, GASTROENTEROLOGY, V116, P1072, DOI 10.1016/S0016-5085(99)70010-7; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; VOLBERG T, 1986, J CELL BIOL, V102, P1832, DOI 10.1083/jcb.102.5.1832; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	50	135	141	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8226	8234		10.1074/jbc.M110235200	http://dx.doi.org/10.1074/jbc.M110235200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756422	hybrid			2022-12-27	WOS:000174268000077
J	Lorenz, H; Windl, O; Kretzschmar, HA				Lorenz, H; Windl, O; Kretzschmar, HA			Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; GREEN-FLUORESCENT PROTEIN; FATAL FAMILIAL INSOMNIA; CULTURED-CELLS; PROTEASOMAL DEGRADATION; PATHOGENIC MUTATIONS; BINDS COPPER; LIVE CELLS; MUTANT; NEUROBLASTOMA	The pathogenic mechanisms leading from mutations in the prion protein (PrP) gene to infectious disease are not understood. To investigate the possibility that cellular processing of mutant prion protein may contribute to the formation of infectious particles, a mouse PrP model system has been established using the green fluorescent protein. Three novel PrP mutants were examined employing this model system and compared with wild type as well as known mutant PrPs. Two Creutzfeldt-Jakob disease-associated PrP mutants, PrP T188K and PrP T188R, revealed a secretory pathway to the cell membrane and PrPSc-like properties i.e. enhanced proteinase K resistance and detergent insolubility similar to other mutant PrPs associated with familial prion diseases. Moreover, a recently described disease-related truncated PrP mutant, PrP Q160(Stop), showed an almost exclusive localization in the nucleus and a catabolism along the proteasomal pathway. Therefore, various distinct pathological mechanisms may cause prion diseases, and aberrant cellular processing may be included in the pathogenesis of prion diseases.	Univ Munich, Inst Neuropathol, D-81377 Munich, Germany	University of Munich	Kretzschmar, HA (corresponding author), Univ Munich, Inst Neuropathol, Marchioninistr 15, D-81377 Munich, Germany.	Hans.Kretzschmar@inp.med.uni-muenchen.de	Windl, Otto/C-6760-2011					Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; BROWN P, 1991, EUR J EPIDEMIOL, V7, P469, DOI 10.1007/BF00143124; Capellari S, 2000, AM J PATHOL, V157, P613, DOI 10.1016/S0002-9440(10)64572-5; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chapman J, 1996, NEUROLOGY, V46, P758, DOI 10.1212/WNL.46.3.758; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Finckh U, 2000, AM J HUM GENET, V66, P110, DOI 10.1086/302702; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; GABRIEL JM, 1992, P NATL ACAD SCI USA, V89, P9097, DOI 10.1073/pnas.89.19.9097; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Harlow E., 1988, ANTIBODIES LAB MANUA; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Holscher C, 1998, J VIROL, V72, P1153; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Jaegly A, 1998, MOL CELL NEUROSCI, V11, P127, DOI 10.1006/mcne.1998.0675; Kim TW, 1997, J BIOL CHEM, V272, P11006; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Kramer ML, 2001, J BIOL CHEM, V276, P16711, DOI 10.1074/jbc.M006554200; Krasemann S, 1996, MOL MED, V2, P725, DOI 10.1007/BF03401656; KRETZSCHMAR HA, 1992, NEUROLOGY, V42, P809, DOI 10.1212/WNL.42.4.809; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MARKSTEINER J, 1999, MEDGEN, V11, P455; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Narwa R, 1999, BIOCHEMISTRY-US, V38, P8770, DOI 10.1021/bi990736c; Negro A, 2001, MOL CELL NEUROSCI, V17, P521, DOI 10.1006/mcne.2000.0953; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RICK R, 1997, FEBS LETT, V413, P282; RICK R, 1996, NATURE, V382, P180; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; White J, 1999, TRENDS CELL BIOL, V9, P61, DOI 10.1016/S0962-8924(98)01433-0; Windl O, 1999, HUM GENET, V105, P244, DOI 10.1007/s004390051096; Windl O, 1999, J GEN VIROL, V80, P15, DOI 10.1099/0022-1317-80-1-15; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	47	81	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8508	8516		10.1074/jbc.M110197200	http://dx.doi.org/10.1074/jbc.M110197200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756421	hybrid			2022-12-27	WOS:000174268000112
J	Theis, S; Knutter, I; Hartrodt, B; Brandsch, M; Kottra, G; Neubert, K; Daniel, H				Theis, S; Knutter, I; Hartrodt, B; Brandsch, M; Kottra, G; Neubert, K; Daniel, H			Synthesis and characterization of high affinity inhibitors of the H+/peptide transporter PEPT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PICHIA-PASTORIS; FUNCTIONAL-CHARACTERIZATION; EXPRESSION; MEMBRANE	In this study, we describe the rational synthesis and functional analysis of novel high affinity inhibitors for the mammalian peptide transporter PEPT2. Moreover, we demonstrate which structural properties convert a transported compound into a non-translocated inhibitor. Starting from Lys[Z(NO2)]-Pro (where Z is benzyloxycarbonyl), which we recently identified as the first competitive high affinity inhibitor of the intestinal peptide transporter PEPT1, a series of different lysine-containing dipeptide derivatives was synthesized and studied for interaction with PEPT2 based on transport competition assays in Pichia pastoris yeast cells expressing PEPT2 heterologously and in renal SKPT cells expressing PEPT2. In addition, the two-electrode voltage clamp technique in Xenopus laevis oocytes expressing PEPT2 was used to determine whether the compounds are transported electrogenically or block the uptake of dipeptides. Synthesis and functional analysis of Lys-Lys derivatives containing benzyloxycarbonyl or 4-nitrobenzyloxycarbonyl side chain protections provided a set of inhibitors that reversibly inhibited the uptake of dipeptides by PEPT2 with K-i values as low as 10 +/- 1 nM. This is the highest affinity of a ligand of PEPT2 ever reported. Moreover, based on the structure-function relationship, we conclude that the spatial location of the side chain amino protecting group in a dipeptide containing a diaminocarbonic acid and its intramolecular distance from the Calpha atom are key factors for the transformation of a substrate into an inhibitor of PEPT2.	Tech Univ Munich, Inst Nutr Sci, Mol Nutr Unit, D-85350 Freising Weihenstephan, Germany; Univ Halle Wittenberg, Inst Biochem, Dept Biochem Biotechnol, D-06120 Halle Saale, Germany; Univ Halle Wittenberg, Biozentrum, D-06120 Halle Saale, Germany	Technical University of Munich; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Daniel, H (corresponding author), Tech Univ Munich, Inst Nutr Sci, Mol Nutr Unit, Hochfeldweg 2, D-85350 Freising Weihenstephan, Germany.		Daniel, Hannelore/B-8982-2009					Boll M, 1996, P NATL ACAD SCI USA, V93, P284, DOI 10.1073/pnas.93.1.284; BRANDSCH M, 1995, FASEB J, V9, P1489, DOI 10.1096/fasebj.9.14.7589991; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Daniel H, 1997, AM J PHYSIOL-RENAL, V273, pF1, DOI 10.1152/ajprenal.1997.273.1.F1; DANIEL H, 1992, J BIOL CHEM, V267, P9565; Doring F, 1997, BIOCHEM BIOPH RES CO, V232, P656, DOI 10.1006/bbrc.1997.6351; Doring F, 1998, BIOCHEM BIOPH RES CO, V250, P531, DOI 10.1006/bbrc.1998.9342; Doring F, 1998, J CLIN INVEST, V101, P2761, DOI 10.1172/JCI1909; GANAPATHY ME, 1995, J BIOL CHEM, V270, P25672, DOI 10.1074/jbc.270.43.25672; Groneberg DA, 2001, AM J PATHOL, V158, P707, DOI 10.1016/S0002-9440(10)64013-8; Knutter I, 2001, BIOCHEMISTRY-US, V40, P4454, DOI 10.1021/bi0026371	11	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7287	7292		10.1074/jbc.M105028200	http://dx.doi.org/10.1074/jbc.M105028200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751927	hybrid			2022-12-27	WOS:000174104300070
J	Fujimoto, T; Parry, S; Urbanek, M; Sammel, M; Macones, G; Kuivaniemi, H; Romero, R; Strauss, JF				Fujimoto, T; Parry, S; Urbanek, M; Sammel, M; Macones, G; Kuivaniemi, H; Romero, R; Strauss, JF			A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL COLLAGENASE; GENE; ORGANIZATION; MECHANISMS; MATRIX-METALLOPROTEINASE-9; CHROMOSOME-11; LOCALIZATION; ACTIVATION; ASSIGNMENT; IV	Interstitial collagen gives fetal membranes tensile strength, and membrane rupture has been attributed to collagen degradation. A polymorphism at -1607 in the matrix metalloproteinase-1 (MMP-1) promoter (an insertion of a guanine (G)) creates a core Ets binding site and increases promoter activity. We investigated whether this polymorphism is functionally significant for MMP-1 expression in amnion cells and whether it is associated with preterm premature rupture of the membranes (PPROM). The 2G promoter had >2-fold greater activity than the 1G allele in amnion mesenchymal cells and WISH amnion cells. Phorbol 12-myristate 13-acetate (PMA) increased mesenchymal cell nuclear protein binding with greater affinity to the 2G allele. Induction of MMP-1 mRNA by PMA was significantly greater in cells with a 1G/2G or 2G/2G genotype compared with cells homozygous for the 1G allele. When treated with PMA, the 1G/2G and 2G/2G cells produced greater amounts of MMP-1 protein than 1G/1G cells. A significant association was found between fetal carriage of a 2G allele and PPROM. We conclude that the 2G allele has stronger promoter activity in amnion cells, that it confers increased responsiveness of amnion cells to stimuli that induce MMP-1, and that this polymorphism contributes to the risk of PPROM.	Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Dept Biostat & Clin Epidemiol, Philadelphia, PA 19104 USA; Hutzel Hosp, Perinatol Res Branch, NIH, NICHHD, Detroit, MI 48201 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Strauss, JF (corresponding author), 1354 BRB II,421 Curie Blvd, Philadelphia, PA 19104 USA.	jfs3@mail.med.upenn.edu	Kuivaniemi, Helena/Q-8178-2019; Romero, Roberto/A-5268-2019	Kuivaniemi, Helena/0000-0001-5753-8766; Romero, Roberto/0000-0002-4448-5121; Sammel, Mary/0000-0003-1248-4199; Urbanek, Margrit/0000-0001-6994-7110	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034612, Z01HD002400] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; CHURCH RL, 1983, COLLAGEN REL RES, V3, P115; Dunleavey L, 2000, MATRIX BIOL, V19, P175, DOI 10.1016/S0945-053X(00)00059-7; GERHARD DS, 1987, CYTOGENET CELL GENET, V46, P619; Guyer B, 1996, PEDIATRICS, V98, P1007; JUNG JY, 1990, ANN GENET-PARIS, V33, P21; Kanamori Y, 1999, CANCER RES, V59, P4225; Knox JD, 1996, CYTOGENET CELL GENET, V72, P179, DOI 10.1159/000134181; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; LEI HQ, 1995, BIOL REPROD, V53, P339, DOI 10.1095/biolreprod53.2.339; Llano E, 1997, BIOCHEMISTRY-US, V36, P15101, DOI 10.1021/bi972120y; MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P914, DOI 10.1067/mob.2000.108879; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P94, DOI 10.1067/mob.2000.105344; McLaren J, 2000, AM J OBSTET GYNECOL, V182, P409, DOI 10.1016/S0002-9378(00)70232-8; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 1997, BIOL CHEM, V378, P151; Nishioka Y, 2000, JPN J CANCER RES, V91, P612, DOI 10.1111/j.1349-7006.2000.tb00989.x; PAGANO M, 1992, PRINCIPLES BIOSTATIS, P323; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; PENDAS AM, 1995, GENOMICS, V26, P615, DOI 10.1016/0888-7543(95)80186-P; Pendas AM, 1996, GENOMICS, V37, P266, DOI 10.1006/geno.1996.0557; Pierce RA, 1996, J CLIN INVEST, V97, P1890, DOI 10.1172/JCI118620; Roberts AK, 1999, AM J OBSTET GYNECOL, V180, P1297, DOI 10.1016/S0002-9378(99)70632-0; RUSH RW, 1976, BRIT MED J, V2, P965, DOI 10.1136/bmj.2.6042.965; Rutter JL, 1998, CANCER RES, V58, P5321; SAARINEN J, 1994, J BIOL CHEM, V269, P18134; SPURR N K, 1988, Genomics, V2, P119, DOI 10.1016/0888-7543(88)90093-6; STRAUSS WM, 1994, CURRENT PROTOCOLS MO; Uria JA, 2000, CANCER RES, V60, P4745; VADILLOORTEGA F, 1995, AM J PATHOL, V146, P148; VadilloOrtega F, 1996, AM J OBSTET GYNECOL, V174, P1371, DOI 10.1016/S0002-9378(96)70687-7; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; Watari M, 1999, AM J PATHOL, V154, P1755, DOI 10.1016/S0002-9440(10)65431-4; WERNERT N, 1994, CANCER RES, V54, P5683; Whittle WL, 2000, PLACENTA, V21, P394, DOI 10.1053/plac.1999.0482; Woessner JF, 1998, BIOL EXTRAC, P1; YANGFENG TL, 1991, CYTOGENET CELL GENET, V58, P1974	41	135	143	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6296	6302		10.1074/jbc.M107865200	http://dx.doi.org/10.1074/jbc.M107865200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741975	hybrid			2022-12-27	WOS:000173989200080
J	Funes, S; Davidson, E; Claros, MG; van Lis, R; Perez-Martinez, X; Vazquez-Acevedo, M; King, MP; Gonzalez-Halphen, D				Funes, S; Davidson, E; Claros, MG; van Lis, R; Perez-Martinez, X; Vazquez-Acevedo, M; King, MP; Gonzalez-Halphen, D			The typically mitochondrial DNA-encoded ATP6 subunit of the F1F0-ATPase is encoded by a nuclear gene in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; SCENEDESMUS-OBLIQUUS; NUCLEOTIDE-SEQUENCE; PROTEIN-STRUCTURE; GENOME; SYNTHASE; MEMBRANE; CDNA; ASSOCIATION; DISEASES	The atp6 gene, encoding the ATP6 subunit of F1F0-ATP synthase, has thus far been found only as an mtDNA-encoded gene. However, atp6 is absent from mtDNAs of some species, including that of Chlamydomonas reinhardtii. Analysis of C. reinhardtii expressed sequence tags revealed three overlapping sequences that encoded a protein with similarity to ATP6 proteins. PCR and 5'- and 3'-RACE were used to obtain the complete cDNA and genomic sequences of C. reinhardtii atp6. The atp6 gene exhibited characteristics of a nucleus-encoded gene: Southern hybridization signals consistent with nuclear localization, the presence of introns, and a codon usage and a polyadenylation signal typical of nuclear genes. The corresponding ATP6 protein was confirmed as a subunit of the mitochondrial F1F0-ATP synthase from C. reinhardtii by N-terminal sequencing. The predicted ATP6 polypeptide has a 107-amino acid cleavable mitochondrial targeting sequence. The mean hydrophobicity of the protein is decreased in those transmembrane regions that are predicted not to participate directly in proton translocation or in intersubunit contacts with the multimeric ring of c subunits. This is the first example of a mitochondrial protein with more than two transmembrane stretches, directly involved in proton translocation, that is nucleus-encoded.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico; Thomas Jefferson Univ, Dept Biochem & Mol Pharmacol, Philadelphia, PA 19107 USA; Univ Malaga, Fac Ciencias, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain	Universidad Nacional Autonoma de Mexico; Jefferson University; Universidad de Malaga	Gonzalez-Halphen, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Apartado Postal 70-243, Mexico City 04510, DF, Mexico.	dhalphen@ifisiol.unam.mx	Claros, Manuel Gonzalo/K-2274-2014; Gonzalez-Halphen, Diego/C-2664-2013; Funes, Soledad/A-1278-2010	Claros, Manuel Gonzalo/0000-0002-0112-3550; Gonzalez-Halphen, Diego/0000-0003-0654-655X; Funes, Soledad/0000-0003-1815-1977	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059646] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AMATI BB, 1988, J MOL EVOL, V28, P151, DOI 10.1007/BF02143507; Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; ATTEIA A, 1997, BIOCHIM BIOPHYS ACTA, V1320, P75; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Burger G, 2000, J MOL BIOL, V297, P365, DOI 10.1006/jmbi.2000.3529; Choma C, 2000, NAT STRUCT BIOL, V7, P161; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; CLAROS MG, 1995, EUR J BIOCHEM, V228, P762, DOI 10.1111/j.1432-1033.1995.0762m.x; Collombet JM, 1998, MOL MED TODAY, V4, P31, DOI 10.1016/S1357-4310(97)80543-6; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; Davidson E, 1997, TRENDS CARDIOVAS MED, V7, P16, DOI 10.1016/S1050-1738(96)00122-3; de Grey ADNJ, 2000, TRENDS BIOTECHNOL, V18, P394, DOI 10.1016/S0167-7799(00)01476-1; Denovan-Wright  EM, 1998, PLANT MOL BIOL, V36, P285, DOI 10.1023/A:1005995718091; DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3; ERIKSSON M, 1995, PLANT PHYSIOL, V107, P479, DOI 10.1104/pp.107.2.479; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; FRANZEN LG, 1994, BIOL MEMBRANY, V11, P304; FRANZEN LG, 1992, PLANT MOL BIOL, V19, P771, DOI 10.1007/BF00027073; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; GALANIS M, 1991, FEBS LETT, V282, P425, DOI 10.1016/0014-5793(91)80529-C; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; GRAY MW, 1988, PHILOS T R SOC B, V319, P135, DOI 10.1098/rstb.1988.0038; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GRAY RE, 1996, METHOD ENZYMOL, V264, P269; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Kroymann J, 1998, J MOL EVOL, V47, P431, DOI 10.1007/PL00006400; Kuck U, 2000, GENE, V253, P13, DOI 10.1016/S0378-1119(00)00228-6; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MICHAELIS G, 1990, MOL GEN GENET, V223, P211, DOI 10.1007/BF00265056; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Nedelcu AM, 2000, GENOME RES, V10, P819, DOI 10.1101/gr.10.6.819; Nurani G, 1996, PLANT MOL BIOL, V31, P1105, DOI 10.1007/BF00040828; PEDERSEN PL, 1993, J BIOL CHEM, V268, P9937; Perez-Martinez X, 2001, J BIOL CHEM, V276, P11302, DOI 10.1074/jbc.M010244200; Perez-Martinez X, 2000, J BIOL CHEM, V275, P30144, DOI 10.1074/jbc.M003940200; PRITCHARD AE, 1990, NUCLEIC ACIDS RES, V18, P173, DOI 10.1093/nar/18.1.173; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rost B, 1996, METHOD ENZYMOL, V266, P525; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sch?gger, 1994, PRACTICAL GUIDE MEMB, P81; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Silflow Carolyn D., 1998, Advances in Photosynthesis, V7, P25; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Vik SB, 1998, J BIOL CHEM, V273, P16229, DOI 10.1074/jbc.273.26.16229; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	54	68	89	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6051	6058		10.1074/jbc.M109993200	http://dx.doi.org/10.1074/jbc.M109993200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744727	Green Published, hybrid			2022-12-27	WOS:000173989200048
J	Skippen, A; Jones, DH; Morgan, CP; Li, M; Cockcroft, S				Skippen, A; Jones, DH; Morgan, CP; Li, M; Cockcroft, S			Mechanism of ADP ribosylation factor-stimulated phosphatidylinositol 4,5-bisphosphate synthesis in HL60 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; 1-REGULATED PHOSPHOLIPASE-D; LIPID KINASE FAMILY; PLASMA-MEMBRANE; 4-PHOSPHATE 5-KINASE; PHOSPHATIDIC-ACID; TRANSFER PROTEIN; INOSITIDE PHOSPHORYLATION; CA2+-ACTIVATED SECRETION; DOWNSTREAM EFFECTOR	Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) is required both as a substrate for the generation of lipid-derived second messengers as well as an intact lipid for many aspects of cell signaling, endo- and exocytosis, and reorganization of the cytoskeleton. ADP ribosylation factor (ARF) proteins regulate PI(4,5)P, synthesis, and here we have examined whether this is due to direct activation of Type I phosphatidylinositol 4-phosphate (PIP) 5-kinase or indirectly by phosphatidate (PA) derived from phospholipase D (PLD) in HL60 cells. ARF1 and ARF6 are both expressed in HL60 cells and can be depleted from the cells by permeabilization. Both ARFs increased the levels of PIP2 (PI(4,5)P-2, PI(3,5)P-2, or PI(3,4)P-2 isomers) at the expense of PIP when added back to permeabilized cells. The PIP2 could be hydrolyzed by phospholipase C, identifying it as PI(4,5)P-2. However, the ARF1-stimulated pool of PI(4,5)P-2 was accessible to the phospholipase C more efficiently in the presence of phosphatidylinositol transfer protein-a. To examine the role of PLD in the regulation of PI(4,5)P-2 synthesis, we used butanol to diminish the PLD-derived PA. PI(4,5)P2 synthesis stimulated by ARF1 was not blocked by 0.5% butanol but could be blocked by 1.5% butanol. Although 0.5% butanol was optimal for maximal transphosphatidylation, PA production was still detectable. In contrast, 1.5% butanol was found to inhibit the activation of PLD by ARF1 and also decrease PIP levels by 50%. Thus the toxicity of 1.5% butanol prevented us from concluding whether PA was an important factor in raising PI(4,5)P-2 levels. To circumvent the use of alcohols, an ARF1 point mutant was identified (wN52R-ARF1) that could selectively activate PIP 5-kinase a activity but not PLD activity. N52R-ARF1 was still able to increase PI(4,5)P-2 levels but at reduced efficiency. We therefore conclude that both PA derived from the PLD pathway and ARF proteins, by directly activating PIP 5-kinase, contribute to the regulation of PI(4,5)P-2 Synthesis at the plasma membrane in HL60 cells.	UCL, Dept Physiol, London WC1E 6JJ, England	University of London; University College London	Cockcroft, S (corresponding author), UCL, Dept Physiol, Torrington Pl, London WC1E 6JJ, England.	S.Cockeroft@ucl.ac.uk	Cockcroft, Shamshad/F-9480-2011	Cockcroft, Shamshad/0000-0002-5731-476X				Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; Balla T, 1997, J BIOL CHEM, V272, P18358, DOI 10.1074/jbc.272.29.18358; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Batty IH, 1998, BIOCHEM J, V330, P1069; Bird I M, 1998, Methods Mol Biol, V105, P25; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chatah NEH, 2001, J BIOL CHEM, V276, P34059, DOI 10.1074/jbc.M104917200; Cockcroft S, 1998, BIOESSAYS, V20, P423, DOI 10.1002/(SICI)1521-1878(199805)20:5<423::AID-BIES9>3.3.CO;2-U; Cockcroft S, 2001, J MEMBRANE BIOL, V180, P187, DOI 10.1007/s002320010069; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; Cremona O, 2001, J CELL SCI, V114, P1041; CUNNINGHAM E, 1995, CURR BIOL, V5, P775, DOI 10.1016/S0960-9822(95)00154-0; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; Denmat-Ouisse LA, 2001, J BIOL CHEM, V276, P48840, DOI 10.1074/jbc.M104276200; DeSmedt F, 1997, J BIOL CHEM, V272, P17367, DOI 10.1074/jbc.272.28.17367; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; ELLA KM, 1995, BIOCHEM J, V307, P799, DOI 10.1042/bj3070799; Fensome A, 1996, CURR BIOL, V6, P730, DOI 10.1016/S0960-9822(09)00454-0; Gaschet J, 1999, J BIOL CHEM, V274, P20040, DOI 10.1074/jbc.274.28.20040; GENY B, 1993, EUR J BIOCHEM, V215, P389, DOI 10.1111/j.1432-1033.1993.tb18045.x; GENY B, 1992, BIOCHEM J, V284, P531, DOI 10.1042/bj2840531; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Jones DH, 1999, BIOCHEM J, V341, P185, DOI 10.1042/0264-6021:3410185; Jones DR, 2000, FEBS LETT, V476, P160, DOI 10.1016/S0014-5793(00)01702-6; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Katan M, 1997, SEMIN CELL DEV BIOL, V8, P287, DOI 10.1006/scdb.1997.0150; KAUFFMANNZEH A, 1994, J BIOL CHEM, V269, P31243; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Meyers R, 1997, J BIOL CHEM, V272, P4384, DOI 10.1074/jbc.272.7.4384; MILLER SG, 1991, J CELL BIOL, V112, P39, DOI 10.1083/jcb.112.1.39; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Ren XD, 1998, CURR OPIN GENET DEV, V8, P63, DOI 10.1016/S0959-437X(98)80063-4; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Schafer DA, 2000, TRAFFIC, V1, P892; Schmidt M, 1999, J BIOL CHEM, V274, P14648, DOI 10.1074/jbc.274.21.14648; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Sechi AS, 2000, J CELL SCI, V113, P3685; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Shyng SL, 2000, P NATL ACAD SCI USA, V97, P937, DOI 10.1073/pnas.97.2.937; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Song J, 1998, J CELL SCI, V111, P2257; Speed CJ, 1999, J CELL SCI, V112, P669; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Way G, 2000, BIOCHEM J, V346, P63, DOI 10.1042/0264-6021:3460063; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; Whatmore J, 1996, BIOCHEM J, V320, P785, DOI 10.1042/bj3200785; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; Yang CZ, 1998, J BIOL CHEM, V273, P4006, DOI 10.1074/jbc.273.7.4006	67	83	84	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5823	5831		10.1074/jbc.M110274200	http://dx.doi.org/10.1074/jbc.M110274200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744730	hybrid			2022-12-27	WOS:000173989200019
J	Wang, YT; Oram, JF				Wang, YT; Oram, JF			Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; FOAM CELL-FORMATION; TANGIER-DISEASE; CARDIOVASCULAR-DISEASE; R-VERAPAMIL; CHO-CELLS; APOA-I; GENE; RECEPTOR	Abnormal high density lipoprotein metabolism may contribute to the increased atherosclerosis associated with diabetes and insulin resistance. The ATP-binding cassette transporter ABCA1 mediates cholesterol transport from tissue macrophages to apoA-I, the major high density lipoprotein protein component. Because fatty acids are elevated in diabetes, we examined the effects of fatty acids on ABCA1 activity in cultured macrophages. Results showed that unsaturated fatty acids markedly inhibited ABCAI-mediated cholesterol and phospholipid efflux from macrophages when ABCA1 was induced by a cAMP analog. This was accompanied by a reduction in the membrane content of ABCA1 and a decrease in apoA-I binding to whole cells and to ABCA1. In contrast, saturated fatty acids had no effect on these processes. Fatty acids did not alter ABCA1 mRNA abundance or incorporation of methionine into ABCA1, indicating that decreased ABCA1 transcription, enhanced mRNA decay, or impaired translation efficiency did not account for these inhibitory effects. Unsaturated fatty acids, however, increased ABCA1 turnover when protein synthesis was blocked by cycloheximide. We conclude that unsaturated fatty acids reduce the macrophage ABCA1 content by enhancing its degradation rate. These findings raise the possibility that an increased supply of unsaturated fatty acids in the artery wall promotes atherogenesis by impairing the ABCA1 cholesterol secretory pathway in macrophages.	Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Oram, JF (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	joram@u.washington.edu			NHLBI NIH HHS [HL55362, HL18645] Funding Source: Medline; NIDDK NIH HHS [DK02456] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL055362] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASSMAN G, 1995, METABOLIC MOL BASIS, p2053P; Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; BIERMAN EL, 1992, ARTERIOSCLER THROMB, V12, P647, DOI 10.1161/01.ATV.12.6.647; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Clarke SD, 2000, BRIT J NUTR, V83, pS59; Costet P, 2000, J BIOL CHEM, V275, P28240; Dolderer JH, 2000, INT J CLIN PHARM TH, V38, P196; GINSBERG HN, 1991, DIABETES CARE, V14, P839, DOI 10.2337/diacare.14.9.839; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GORDON DJ, 1986, CIRCULATION, V74, P1217, DOI 10.1161/01.CIR.74.6.1217; GRABER R, 1994, J LIPID MEDIAT CELL, V9, P91; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Hayden JM, 2000, CURR OPIN LIPIDOL, V11, P519, DOI 10.1097/00041433-200010000-00010; Hooper L, 2001, BMJ-BRIT MED J, V322, P757, DOI 10.1136/bmj.322.7289.757; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; OAM JF, 2001, J BIOL CHEM, V276, P39898; OBRIEN KD, 1992, J CLIN INVEST, V89, P1544, DOI 10.1172/JCI115747; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 1999, J LIPID RES, V40, P1769; Oram JF, 2001, J LIPID RES, V42, P1173; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Regev R, 1999, EUR J BIOCHEM, V259, P18, DOI 10.1046/j.1432-1327.1999.00037.x; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Repa JJ, 1999, CURR OPIN BIOTECH, V10, P557, DOI 10.1016/S0958-1669(99)00031-2; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Santamarina-Fojo S, 2001, J LIPID RES, V42, P1339; Sartippour MR, 2000, DIABETES, V49, P597, DOI 10.2337/diabetes.49.4.597; Schuldes H, 2001, EUR J CANCER, V37, P660, DOI 10.1016/S0959-8049(00)00450-0; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; SEIGNEUR M, 1994, DIABETES RES CLIN PR, V23, P169, DOI 10.1016/0168-8227(94)90101-5; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Smith JD, 1996, J BIOL CHEM, V271, P30647, DOI 10.1074/jbc.271.48.30647; Van Eck M, 2000, ARTERIOSCL THROM VAS, V20, pE53, DOI 10.1161/01.ATV.20.9.e53; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200	52	181	188	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5692	5697		10.1074/jbc.M109977200	http://dx.doi.org/10.1074/jbc.M109977200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741998	hybrid			2022-12-27	WOS:000173962900147
J	Bryson, JM; Coy, PE; Gottlob, K; Hay, N; Robey, RB				Bryson, JM; Coy, PE; Gottlob, K; Hay, N; Robey, RB			Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ELECTRON-TRANSPORT; PROXIMAL TUBULE; INTRAMITOCHONDRIAL COMPARTMENTS; OXIDATIVE-PHOSPHORYLATION; GLUCOSE-TRANSPORT; NEONATAL RAT; HUMAN KIDNEY; BROMIDE MTT; GROWTH; APOPTOSIS	Glucose (Glc) metabolism protects cells against oxidant injury. By virtue of their central position in both Glc uptake and utilization, hexokinases (HKs) are ideally suited to contribute to these effects. Compatible with this hypothesis, endogenous HK activity correlates inversely with injury susceptibility in individual renal cell types. We recently reported that ectopic HK expression mimics the anti-apoptotic effects of growth factors in cultured fibroblasts, but anti-apoptotic roles for HKs have not been examined in other cell types or in a cellular injury model. We therefore evaluated HK overexpression for the ability to mitigate acute oxidant-induced cell death in an established epithelial cell culture injury model. In parallel, we examined salutary heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) treatment for the ability to 1) increase endogenous HK activity and 2) mimic the protective effects of ectopic H-K expression. Both HK overexpression and HB-EGF increased Glc-phosphorylating capacity and metabolism, and these changes were associated with markedly reduced susceptibility to acute oxidant-induced apoptosis. The uniform Glc dependence of these effects suggests an important adaptive role for Glc metabolism, and for HK activity in particular, in the promotion of epithelial cell survival. These findings also support the contention that HKs contribute to the protective effects of growth factors.	Univ Illinois, Coll Med, Nephrol Sect, Dept Med, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60612 USA; Vet Affairs Chicago Hlth Care Syst, West Side Div, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Robey, RB (corresponding author), Univ Illinois, Coll Med, Nephrol Sect, Dept Med, 820 S Wood St Rm 418W Clin Sci North, Chicago, IL 60612 USA.		Robey, R. Brooks/J-7099-2013	Robey, R. Brooks/0000-0001-5059-3965	NATIONAL INSTITUTE ON AGING [R01AG016927] Funding Source: NIH RePORTER; NIA NIH HHS [AG-16927] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen CB, 1998, AM J PHYSIOL-LUNG C, V274, pL320, DOI 10.1152/ajplung.1998.274.3.L320; Allen CB, 1998, AM J PHYSIOL-LUNG C, V274, pL159, DOI 10.1152/ajplung.1998.274.1.L159; ANDERSON JW, 1973, AM J PHYSIOL, V224, P930, DOI 10.1152/ajplegacy.1973.224.4.930; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BELTRANDELRIO H, 1991, ARCH BIOCHEM BIOPHYS, V286, P183, DOI 10.1016/0003-9861(91)90026-F; BELTRANDELRIO H, 1992, ARCH BIOCHEM BIOPHYS, V296, P667, DOI 10.1016/0003-9861(92)90625-7; BELTRANDELRIO H, 1992, ARCH BIOCHEM BIOPHYS, V299, P116, DOI 10.1016/0003-9861(92)90252-R; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAITHWAITE SS, 1995, DIABETES, V44, P43, DOI 10.2337/diabetes.44.1.43; COIMBRA TM, 1990, AM J PHYSIOL, V259, pF438, DOI 10.1152/ajprenal.1990.259.3.F438; COURJAULTGAUTIER F, 1995, J AM SOC NEPHROL, V5, P1949; DUBACH UC, 1960, J CLIN INVEST, V39, P1364, DOI 10.1172/JCI104155; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; GROSSBARD L, 1966, J BIOL CHEM, V241, P3546; HAMMERMAN MR, 2000, AM J PHYSIOL-RENAL, V279, pF3; HATTORI H, 1990, ANN NEUROL, V28, P122, DOI 10.1002/ana.410280203; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; HUMES HD, 1989, J CLIN INVEST, V84, P1757, DOI 10.1172/JCI114359; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; KAN O, 1994, J EXP MED, V180, P917, DOI 10.1084/jem.180.3.917; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; KELLEHER JA, 1993, STROKE, V24, P855, DOI 10.1161/01.STR.24.6.855; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kurata M, 2000, COMP HAEMATOL INT, V10, P59, DOI 10.1007/s005800070009; LAWRENCE GM, 1984, HISTOCHEM J, V16, P697, DOI 10.1007/BF01095276; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Moley KH, 2000, APOPTOSIS, V5, P99, DOI 10.1023/A:1009697908332; Muzi M, 2001, NUCL MED BIOL, V28, P107, DOI 10.1016/S0969-8051(00)00201-8; NEELY JR, 1984, CIRC RES, V55, P816, DOI 10.1161/01.RES.55.6.816; NORMAN J, 1990, CLIN SCI, V78, P445, DOI 10.1042/cs0780445; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; PRELLER A, 1992, ARCH BIOCHEM BIOPHYS, V294, P482, DOI 10.1016/0003-9861(92)90715-9; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Riddle SR, 2000, AM J PHYSIOL-LUNG C, V278, pL407, DOI 10.1152/ajplung.2000.278.2.L407; Robey RB, 1998, BIOCHEMISTRY-US, V37, P9894, DOI 10.1021/bi980857x; Robey RB, 1999, AM J PHYSIOL-RENAL, V277, pF742, DOI 10.1152/ajprenal.1999.277.5.F742; Robey RB, 2000, KIDNEY INT, V57, P2308, DOI 10.1046/j.1523-1755.2000.00091.x; Robey RB, 1996, BIOTECHNIQUES, V20, P40; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; SCHAEFER S, 1995, J MOL CELL CARDIOL, V27, P2167, DOI 10.1016/S0022-2828(95)91407-2; SCHMIDT U, 1975, FEBS LETT, V53, P26, DOI 10.1016/0014-5793(75)80673-9; Segu VBG, 1998, METABOLISM, V47, P824, DOI 10.1016/S0026-0495(98)90120-2; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; SOCHOR M, 1988, HORM METAB RES, V20, P676, DOI 10.1055/s-2007-1010915; SRERE P, 1994, TRENDS BIOCHEM SCI, V19, P519, DOI 10.1016/0968-0004(94)90048-5; STANTON RC, 1988, AM J PHYSIOL, V254, pC267, DOI 10.1152/ajpcell.1988.254.2.C267; STEER KA, 1982, FEBS LETT, V150, P494, DOI 10.1016/0014-5793(82)80797-7; Tian WN, 1999, AM J PHYSIOL-CELL PH, V276, pC1121, DOI 10.1152/ajpcell.1999.276.5.C1121; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; VANDEWALLE A, 1981, AM J PHYSIOL, V240, pF492, DOI 10.1152/ajprenal.1981.240.6.F492; VISTICA DT, 1991, CANCER RES, V51, P2515; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yonekura K, 2000, BASIC RES CARDIOL, V95, P343, DOI 10.1007/s003950070032; Zager RA, 1997, KIDNEY INT, V51, P728, DOI 10.1038/ki.1997.104; ZAGER RA, 1992, J CLIN INVEST, V90, P711, DOI 10.1172/JCI115942; Zager RA, 1998, KIDNEY INT, V53, P1661, DOI 10.1046/j.1523-1755.1998.00919.x	60	108	110	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 29	2002	277	13					11392	11400		10.1074/jbc.M110927200	http://dx.doi.org/10.1074/jbc.M110927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	534WQ	11751868	hybrid			2022-12-27	WOS:000174613100082
J	Sriskanda, V; Shuman, S				Sriskanda, V; Shuman, S			Role of nucleotidyl transferase motif V in strand joining by Chlorella virus DNA ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA CAPPING ENZYME; CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; NICK; MECHANISM; DOMAIN	ATP-dependent DNA ligases, NAD(+)-dependent DNA ligases, and GTP-dependent RNA capping enzymes are members of a covalent nucleotidyl transferase superfamily defined by a common fold and a set of conserved peptide motifs. Here we examined the role of nucleotidyl transferase motif V ((184)LLKMKQFKDAEAT(196)) in the nick joining reaction of Chlorella virus DNA ligase, an exemplary ATP-dependent enzyme. We found that alanine substitutions at Lys(186), Lys(188), ASp(192), and Glu(194) reduced ligase specific activity by at least an order of magnitude, whereas substitutions at Lys(191) and Thr(196) were benign. The K186A, D192A, and E194A changes had no effect on the rate of single-turnover nick joining by preformed ligase-adenylate but affected subsequent rounds of nick joining at the ligase adenylation step. Conservative substitutions K186R, D192E, and E194D partially restored activity, whereas K186Q, D192N, and E194Q substitutions did not. Alanine mutation of Lys(188) elicited distinctive catalytic defects, whereby singleturnover nick joining by K188A-adenylate was slowed by an order of magnitude, and high levels of the DNA-adenylate intermediate accumulated. The rate of phosphodiester bond formation at a pre-adenylated nick (step 3 of the ligation pathway) was slowed by the K188A change. Replacement of Lys(188) by arginine reversed the step 3 arrest, whereas glutamine substitution was ineffective. Gel-shift analysis showed that the Lys(188) mutants bound stably to DNA-adenylate. We infer that Lys(188) is involved in the chemical step of phosphodiester bond formation.	Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NIGMS NIH HHS [GM63611] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; LEHMAN IR, 1974, SCIENCE, V186, P790; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Sekiguchi J, 1997, J VIROL, V71, P9679, DOI 10.1128/JVI.71.12.9679-9684.1997; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; SHUMAN S, 1994, P NATL ACAD SCI USA, V91, P12046, DOI 10.1073/pnas.91.25.12046; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; Singleton MR, 1999, STRUCTURE, V7, P35, DOI 10.1016/S0969-2126(99)80007-0; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; SRISKANDA V, 2002, IN PRESS NUCL ACIDS; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; Wang SP, 1997, P NATL ACAD SCI USA, V94, P9573, DOI 10.1073/pnas.94.18.9573	17	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					9661	9667		10.1074/jbc.M110613200	http://dx.doi.org/10.1074/jbc.M110613200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11751916	hybrid			2022-12-27	WOS:000174549200009
J	Bailey, KA; Marc, F; Sandman, K; Reeve, JN				Bailey, KA; Marc, F; Sandman, K; Reeve, JN			Both DNA and histone fold sequences contribute to archaeal nucleosome stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOTHERMUS-FERVIDUS; POSITIONING SEQUENCES; (H3-H4)(2) TETRAMER; CORE PARTICLE; BINDING; RESOLUTION; PROTEIN; GENOME; TRACTS; HMF	The roles and interdependence of DNA sequence and archaeal histone fold structure in determining archaeal nucleosome stability and positioning have been determined and quantitated. The presence of four tandem copies of TTTAAAGCCG in the polylinker region of pLITMUS28 resulted in a DNA molecule with increased affinity (DeltaDeltaG of similar to700 cal mol(-1)) for the archaeal histone HAM relative to the polylinker sequence, and the dominant, quantitative contribution of the helical repeats of the dinucleotide TA to this increased affinity has been established. The rotational and translational positioning of archaeal nucleosomes assembled on the (TTTAAAGCCG)4 sequence and on DNA molecules selectively incorporated into archaeal nucleosomes by HMfB have been determined. Alternating A/T- and G/C-rich regions were located where the minor and major grooves, respectively, sequentially faced the archaeal nucleosome core, and identical positioning results were obtained using HMfA a closely related archaeal histone also from Methanothermus fervidus. However, HMfA did not have similarly high affinities for the HMfB-selected DNA molecules, and domain-swap experiments have shown that this difference in affinity is determined by residue differences in the C-terminal region of a-helix 3 of the histone fold, a region that is not expected to directly interact with DNA. Rather this region is thought to participate in forming the histone dimer:dimer interface at the center of an archaeal nucleosome histone tetramer core. If differences in this interface do result in archaeal histone cores with different sequence preferences, then the assembly of alternative archaeal nucleosome tetramer cores could provide an unanticipated and novel structural mechanism to regulate gene expression.	Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Reeve, JN (corresponding author), Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA.			Sandman, Kathleen/0000-0002-5222-5864	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053185] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey KA, 1999, NUCLEIC ACIDS RES, V27, P532, DOI 10.1093/nar/27.2.532; Bailey KA, 2000, J MOL BIOL, V303, P25, DOI 10.1006/jmbi.2000.4128; BAILEY KA, 2000, DNA INTERACTIONS ARC; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; BURKHOFF AM, 1987, CELL, V48, P935, DOI 10.1016/0092-8674(87)90702-1; Decanniere K, 2000, J MOL BIOL, V303, P35, DOI 10.1006/jmbi.2000.4104; DONG F, 1991, P NATL ACAD SCI USA, V88, P10596, DOI 10.1073/pnas.88.23.10596; Fitzgerald DJ, 1999, J MOL BIOL, V293, P477, DOI 10.1006/jmbi.1999.3171; Fitzgerald DJ, 1998, NUCLEIC ACIDS RES, V26, P2526, DOI 10.1093/nar/26.11.2526; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Gottesfeld JM, 2001, BIOCHEMISTRY-US, V40, P10927, DOI 10.1021/bi0109966; Hamiche A, 1998, J BIOL CHEM, V273, P9261, DOI 10.1074/jbc.273.15.9261; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Harp JM, 2000, ACTA CRYSTALLOGR D, V56, P1513, DOI 10.1107/S0907444900011847; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; HOWARD MT, 1992, J BACTERIOL, V174, P7864, DOI 10.1128/JB.174.23.7864-7867.1992; Li WT, 2000, EXTREMOPHILES, V4, P43, DOI 10.1007/s007920050136; Li WT, 1998, BIOCHEMISTRY-US, V37, P10563, DOI 10.1021/bi973006i; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MUSGRAVE DR, 1991, P NATL ACAD SCI USA, V88, P10397, DOI 10.1073/pnas.88.23.10397; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Pereira SL, 1999, J MOL BIOL, V289, P675, DOI 10.1006/jmbi.1999.2812; Reeve JN, 1997, CELL, V89, P999, DOI 10.1016/S0092-8674(00)80286-X; Roychoudhury M, 2000, P NATL ACAD SCI USA, V97, P13608, DOI 10.1073/pnas.250476297; Sambrook J., 2002, MOL CLONING LAB MANU; SANDMAN K, 1995, BIO-TECHNOL, V13, P504, DOI 10.1038/nbt0595-504; SANDMAN K, 1994, P NATL ACAD SCI USA, V91, P12624, DOI 10.1073/pnas.91.26.12624; Sandman K, 2001, METHOD ENZYMOL, V334, P116; Sandman K, 2000, ARCH MICROBIOL, V173, P165, DOI 10.1007/s002039900122; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Shimizu M, 1995, BBA-GENE STRUCT EXPR, V1264, P330, DOI 10.1016/0167-4781(95)00173-5; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; SHRADER TE, 1990, J MOL BIOL, V216, P69, DOI 10.1016/S0022-2836(05)80061-0; Soares DJ, 2000, J MOL BIOL, V297, P39, DOI 10.1006/jmbi.2000.3546; Svaren J, 1996, CURR OPIN GENET DEV, V6, P164, DOI 10.1016/S0959-437X(96)80046-3; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Widlund HR, 1997, J MOL BIOL, V267, P807, DOI 10.1006/jmbi.1997.0916; Widlund HR, 1999, J BIOL CHEM, V274, P31847, DOI 10.1074/jbc.274.45.31847; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285	42	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9293	9301		10.1074/jbc.M110029200	http://dx.doi.org/10.1074/jbc.M110029200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11751933	hybrid			2022-12-27	WOS:000174400600076
J	Marchand, C; Pourquier, P; Laco, GS; Jing, NJ; Pommier, Y				Marchand, C; Pourquier, P; Laco, GS; Jing, NJ; Pommier, Y			Interaction of human nuclear topoisomerase I with guanosine quartet-forming and guanosine-rich single-stranded DNA and RNA oligonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERE-BINDING-PROTEIN; DIOL EPOXIDE ADDUCTS; NUCLEOTIDE-SEQUENCE; CLEAVAGE COMPLEXES; RAT HEPATOCYTES; ANTICANCER DRUG; TERMINAL DOMAIN; SPLICING FACTOR; QUADRUPLEX DNA; G4 DNA	Human nuclear DNA topoisomerase I (top1) plays a crucial role in DNA replication, transcription, and chromosome condensation. In this study, we show that intra- and intermolecular guanosine quartets (G-quartets) can inhibit top1-mediated DNA cleavage at a high affinity site. Top1-mediated DNA cleavage was also inhibited by a 16-mer single-stranded oligodeoxynucleotide (ODN) containing a G-rich sequence (G(2)T(2)G(5)TG(2)TG(3)) and by its RNA equivalent, neither of which form G-quartet structures. A comparison of various single-stranded ODN for their ability to inhibit top1-mediated DNA cleavage indicated that G-rich sequences containing repeats of 2 or 3 consecutive guanines interspaced with thymines specifically inhibited top1. We also found that both single-stranded and G-quartet-forming ODNs bind to top1 without being cleaved by the enzyme. These results demonstrate that either DNA or RNA G-rich single-stranded and G-quartet-forming oligonucleotides can bind to top1 and prevent cleavage of duplex DNA.	NIH, Mol Pharmacol Lab, Canc Res Ctr, NCI, Bethesda, MD 20892 USA; Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine	Pommier, Y (corresponding author), NIH, Mol Pharmacol Lab, Canc Res Ctr, NCI, Bldg 37,Rm 5068, Bethesda, MD 20892 USA.		Pourquier, Philippe/O-8030-2018; Marchand, Christophe/D-8559-2016	Pourquier, Philippe/0000-0001-5326-3005; 				Arimondo PB, 2000, NUCLEIC ACIDS RES, V28, P4832, DOI 10.1093/nar/28.24.4832; Arimondo PB, 2000, BIOORGAN MED CHEM, V8, P777, DOI 10.1016/S0968-0896(00)00012-2; Baran N, 1997, NUCLEIC ACIDS RES, V25, P297, DOI 10.1093/nar/25.2.297; BEEN MD, 1984, NUCLEIC ACIDS RES, V12, P3097, DOI 10.1093/nar/12.7.3097; BEEN MD, 1984, J MOL BIOL, V180, P515, DOI 10.1016/0022-2836(84)90025-1; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; BONVEN BJ, 1985, CELL, V41, P541, DOI 10.1016/S0092-8674(85)80027-1; CHAMPOUX JJ, 1981, J BIOL CHEM, V256, P4805; CHEN AY, 1994, ANN REV PHARM TOXICO, V94, P194; Cheng CH, 2000, MOL CELL BIOL, V20, P8059, DOI 10.1128/MCB.20.21.8059-8068.2000; Cushman M, 2000, J MED CHEM, V43, P3688, DOI 10.1021/jm000029d; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; Edwards TK, 2000, J BIOL CHEM, V275, P36181, DOI 10.1074/jbc.M006628200; Erlitzki R, 1997, J BIOL CHEM, V272, P15881, DOI 10.1074/jbc.272.25.15881; EVANS T, 1984, NUCLEIC ACIDS RES, V12, P8043, DOI 10.1093/nar/12.21.8043; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; GIRALDO R, 1994, P NATL ACAD SCI USA, V91, P7658, DOI 10.1073/pnas.91.16.7658; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; GUPTA M, 1995, BBA-GENE STRUCT EXPR, V1262, P1, DOI 10.1016/0167-4781(95)00029-G; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; HENNINGFELD KA, 1995, BIOCHEMISTRY-US, V34, P6120, DOI 10.1021/bi00018a015; JAXEL C, 1991, J BIOL CHEM, V266, P20418; Jing NJ, 2000, J BIOL CHEM, V275, P21460, DOI 10.1074/jbc.M001436200; KILPATRICK MW, 1986, J BIOL CHEM, V261, P1350; KRETZSCHMAR M, 1993, P NATL ACAD SCI USA, V90, P11508, DOI 10.1073/pnas.90.24.11508; Labourier E, 1998, NUCLEIC ACIDS RES, V26, P2955, DOI 10.1093/nar/26.12.2955; Lanza A, 1996, J BIOL CHEM, V271, P6978, DOI 10.1074/jbc.271.12.6978; LETEURTRE F, 1994, J BIOL CHEM, V269, P7893; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; POMMIER Y, 1995, MUTAT RES-DNA REPAIR, V337, P135, DOI 10.1016/0921-8777(95)00019-G; Pommier Y, 2000, P NATL ACAD SCI USA, V97, P2040, DOI 10.1073/pnas.040397497; Pommier Y, 2000, P NATL ACAD SCI USA, V97, P10739, DOI 10.1073/pnas.190312697; POMMIER Y, 1996, SEMIN ONCOL, V23, P1; PORTER SE, 1989, MOL CELL BIOL, V9, P541, DOI 10.1128/MCB.9.2.541; Pourquier P, 2000, P NATL ACAD SCI USA, V97, P1885, DOI 10.1073/pnas.97.4.1885; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Pourquier P, 1999, NUCLEIC ACIDS RES, V27, P1919, DOI 10.1093/nar/27.8.1919; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; Rossi F, 1998, NUCLEIC ACIDS RES, V26, P2963, DOI 10.1093/nar/26.12.2963; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Sarig G, 1997, J BIOL CHEM, V272, P4474, DOI 10.1074/jbc.272.7.4474; Sekiguchi J, 2000, NUCLEIC ACIDS RES, V28, P2658, DOI 10.1093/nar/28.14.2658; Sekiguchi JA, 1996, P NATL ACAD SCI USA, V93, P785, DOI 10.1073/pnas.93.2.785; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; SHUMAN S, 1991, J BIOL CHEM, V266, P1796; Shykind BM, 1997, GENE DEV, V11, P397, DOI 10.1101/gad.11.3.397; Straub T, 1998, J BIOL CHEM, V273, P26261, DOI 10.1074/jbc.273.41.26261; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; SVEJSTRUP JQ, 1991, J MOL BIOL, V222, P669, DOI 10.1016/0022-2836(91)90503-X; Takebayashi Y, 1999, P NATL ACAD SCI USA, V96, P7196, DOI 10.1073/pnas.96.13.7196; Tazi J, 1997, J MOL MED, V75, P786, DOI 10.1007/s001090050168; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wang XY, 1998, BIOCHEMISTRY-US, V37, P2691, DOI 10.1021/bi972707c; Wang ZX, 1998, MOL CELL, V1, P749, DOI 10.1016/S1097-2765(00)80074-X; WEISMANSHOMER P, 1993, J BIOL CHEM, V268, P3306; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; ZHELKOVSKY AM, 1994, PROTEIN EXPRES PURIF, V5, P364, DOI 10.1006/prep.1994.1053	65	48	51	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8906	8911		10.1074/jbc.M106372200	http://dx.doi.org/10.1074/jbc.M106372200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11756434	hybrid			2022-12-27	WOS:000174400600024
J	Parakati, R; DiMario, JX				Parakati, R; DiMario, JX			Sp1- and Sp3-mediated transcriptional regulation of the fibroblast growth factor receptor 1 gene in chicken skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER REGION; FGF RECEPTOR; TERMINAL DIFFERENTIATION; REPRESSES TRANSCRIPTION; CIS-ELEMENTS; ACTIVATION; EXPRESSION; IDENTIFICATION; MYOGENESIS; DOMAINS	Expression of the fibroblast growth factor receptor I (FGFR1) gene in skeletal muscle is positively regulated in proliferating myoblasts and declines during differentiation. We have characterized the cis-regulatory elements in the proximal region of the FGFR1 promoter which render positive transcriptional activity. Multiple elements between -69 and -14 activate the FGFR1 promoter. Myoblast transfections revealed that potential Sp transcription factor binding sites are required for promoter activity. Electromobility shift assays indicated that myoblast nuclear proteins specifically bind to these cis-elements and that differentiated myotube nuclear extracts do not form these same complexes. In addition, Southwestern blot analysis detected binding of the most proximal Sp motif to a Sp1-like protein present in myoblast nuclear extracts but not in myotubes. In corroboration, Sp1 and Sp3 proteins were detected only in myoblasts and not in differentiated myotubes. Finally, transfection of Drosophila SL2 cells showed that Sp1 is a positive regulator of FGFR1 promoter activity and that Sp3 is a coactivator via the proximal Sp binding sites. These studies demonstrate that the FGFR1 promoter is activated by Sp transcription factors in proliferating myoblasts and demonstrate at least part of the mechanism by which FGFR1 gene expression is downregulated in differentiated muscle fibers.	Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA	Chicago Medical School	DiMario, JX (corresponding author), Chicago Med Sch, Dept Cell Biol & Anat, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	dimarioj@finchcms.edu						AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BESSEREAU JL, 1993, EMBO J, V12, P443, DOI 10.1002/j.1460-2075.1993.tb05676.x; Bessereau JL, 1998, J BIOL CHEM, V273, P12786, DOI 10.1074/jbc.273.21.12786; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; COOKE DW, 1991, BIOCHEM BIOPH RES CO, V177, P1113, DOI 10.1016/0006-291X(91)90654-P; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; DATTA PK, 1995, MOL CELL BIOL, V15, P5444; DeLuca P, 1996, J BIOL CHEM, V271, P8533, DOI 10.1074/jbc.271.15.8533; DENNIG J, 1995, J BIOL CHEM, V270, P12737, DOI 10.1074/jbc.270.21.12737; DIMARIO JX, 1995, EXP CELL RES, V216, P431, DOI 10.1006/excr.1995.1054; Douglas DN, 2001, J BIOL CHEM, V276, P25621, DOI 10.1074/jbc.M103874200; Flanagan-Steet H, 2000, DEV BIOL, V218, P21, DOI 10.1006/dbio.1999.9535; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HUMPHRIES DE, 1994, BIOCHEM BIOPH RES CO, V203, P1020, DOI 10.1006/bbrc.1994.2284; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; Itoh N, 1996, DEVELOPMENT, V122, P291; JOHNSON AC, 1988, J BIOL CHEM, V263, P5693; Kumar AP, 1997, NUCLEIC ACIDS RES, V25, P2012, DOI 10.1093/nar/25.10.2012; Kwon HS, 1999, J BIOL CHEM, V274, P20, DOI 10.1074/jbc.274.1.20; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MAMULA PW, 1992, DNA CELL BIOL, V11, P43, DOI 10.1089/dna.1992.11.43; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McEwen DG, 1998, J BIOL CHEM, V273, P5349, DOI 10.1074/jbc.273.9.5349; MOORE JW, 1991, DEVELOPMENT, V111, P741; Motaleb MA, 1999, BIOCHEM BIOPH RES CO, V262, P509, DOI 10.1006/bbrc.1999.1231; OLWIN BB, 1988, J CELL BIOL, V107, P761, DOI 10.1083/jcb.107.2.761; ONEILL MC, 1972, J CELL BIOL, V52, P52, DOI 10.1083/jcb.52.1.52; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PASQUALE EB, 1989, P NATL ACAD SCI USA, V86, P5449, DOI 10.1073/pnas.86.14.5449; Patel SG, 2001, GENE, V270, P171, DOI 10.1016/S0378-1119(01)00478-4; Patel SG, 1999, GENE, V237, P265, DOI 10.1016/S0378-1119(99)00278-4; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Scata KA, 1999, EXP CELL RES, V250, P10, DOI 10.1006/excr.1999.4506; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; SUZUKI M, 1995, MOL CELL BIOL, V15, P5423; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; WANAKA A, 1991, DEVELOPMENT, V111, P455; WERNER H, 1990, BIOCHEM BIOPH RES CO, V169, P1021, DOI 10.1016/0006-291X(90)91996-6; Zhao LY, 1997, J BIOL CHEM, V272, P4869, DOI 10.1074/jbc.272.8.4869	45	39	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9278	9285		10.1074/jbc.M108411200	http://dx.doi.org/10.1074/jbc.M108411200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11756440	hybrid			2022-12-27	WOS:000174400600074
J	Kloth, MT; Catling, AD; Silva, CM				Kloth, MT; Catling, AD; Silva, CM			Novel activation of STAT5b in response to epidermal growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; IM-9 CELLS; TRANSCRIPTIONAL RESPONSES; SERINE PHOSPHORYLATION; NUCLEAR TRANSLOCATION; SIGNAL-TRANSDUCTION; BREAST-CANCER; EGF RECEPTOR	Of the seven signal transducers and activators of transcription that have been identified, STATs 1, 3, and 5a/5b can be activated not only by a multitude of cytokines but also by some growth factors. The data presented here demonstrate that, in contrast to activation by the cytokine, growth hormone (GH), the activation of STAT5b by the growth factor, epidermal growth factor (EGF), requires overexpression of the EGF receptor (EGFR). We have shown that EGF activates STAT5b not only in a HEK293 cell model in which the EGFR is stably overexpressed but also in the MDA-MB468 breast cancer cell line. Furthermore, EGF (but not GH) is able to activate tyrosine phospborylation of a Tyr-699 mutant of STAT5b. Using metabolic labeling studies as well as site-directed mutagenesis, we have identified three novel EGF-induced tyrosine phosphorylation sites, Tyr-725, Tyr-740, and Tyr-743. Luciferase assays using a STAT5- specific DNA sequence demonstrate that, although Tyr-699 is absolutely required for transcriptional activation, tyrosines 725, 740, and 743 may be involved in a negative regulation of transcription. Because overexpression of the EGFR is common in many cancers, including advanced breast cancer, characterization of EGF-induced STAT5b may have direct implications in therapeutic applications.	Univ Virginia, Hlth Syst, Dept Internal Med, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Syst, Ctr Canc, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Silva, CM (corresponding author), Univ Virginia, Hlth Syst, Dept Internal Med, POB 800746, Charlottesville, VA 22908 USA.			Silva, Corinne/0000-0002-3707-2919	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA085462] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA85462] Funding Source: Medline; NICHD NIH HHS [U54 HD28934] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BATTAGLIA F, 1988, EUR J CANCER CLIN ON, V24, P1685, DOI 10.1016/0277-5379(88)90068-5; Beuvink I, 2000, J BIOL CHEM, V275, P10247, DOI 10.1074/jbc.275.14.10247; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; CATLING AD, 1994, J BIOL CHEM, V269, P30014; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Horvath CM, 1997, CURR OPIN CELL BIOL, V9, P233, DOI 10.1016/S0955-0674(97)80067-1; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Kazansky AV, 1999, J BIOL CHEM, V274, P22484, DOI 10.1074/jbc.274.32.22484; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Park SH, 1999, J BIOL CHEM, V274, P7421, DOI 10.1074/jbc.274.11.7421; QUELLE FW, 1995, J BIOL CHEM, V270, P20775, DOI 10.1074/jbc.270.35.20775; RUFFJAMISON S, 1995, P NATL ACAD SCI USA, V92, P4215, DOI 10.1073/pnas.92.10.4215; SAINSBURY J, 1987, J CLIN PATHOL, V38, P1225; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Sehgal PB, 2000, CELL SIGNAL, V12, P525, DOI 10.1016/S0898-6568(00)00098-X; SILVA CM, 1993, ENDOCRINOLOGY, V133, P2307, DOI 10.1210/en.133.5.2307; SILVA CM, 1994, J BIOL CHEM, V269, P27532; Silva CM, 1996, MOL ENDOCRINOL, V10, P508, DOI 10.1210/me.10.5.508; SILVA CM, 1998, P 80 ANN END SOC M N, pP1; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; TOI M, 1991, EUR J CANCER, V27, P977, DOI 10.1016/0277-5379(91)90262-C; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; Wood TJJ, 1997, MOL CELL ENDOCRINOL, V130, P69, DOI 10.1016/S0303-7207(97)00075-0; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218	35	55	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8693	8701		10.1074/jbc.M111884200	http://dx.doi.org/10.1074/jbc.M111884200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751923	hybrid			2022-12-27	WOS:000174268000135
J	Marini, F; Wood, RD				Marini, F; Wood, RD			A human DNA helicase homologous to the DNA cross-link sensitivity protein Mus308	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; SYNDROME GENE-PRODUCT; ESCHERICHIA-COLI; POLYMERASE; HYPERSENSITIVITY; REMOVAL; MUTANTS; CLONING; ROLES	Repair of DNA interstrand cross-links is a challenging problem for cells. Many human gene products influence sensitivity to DNA cross-linking agents, but the mechanisms of cross-link repair are unknown. In Drosophila melanogaster, the mus308 mutation leads to marked sensitivity to DNA cross-linking agents. The C-terminal portion of the Mus308 polypeptide encodes a DNA polymerase, whereas a putative DNA helicase is encoded by the N-terminal portion. As a step toward isolating proteins involved in DNA cross-link repair, we searched for mammalian genes similar to the DNA helicase portion of Mus308. Human and mouse homologs were isolated from cDNA expression libraries and designated HEL308. Human HEL308 is on chromosome 4q21 and encodes a polypeptide of 1101 amino acids. The protein was expressed in insect cells and purified. REL308 is a single-stranded DNA-dependent ATPase and DNA helicase. Mutation of a highly conserved lysine to methionine in helicase domain I eliminated both activities. The protein readily displaces 20- to 40-mer duplex oligonucleotides. Displacement of longer substrates was less efficient but was stimulated by the single-stranded DNA-binding protein RPA. Activity was supported by ATP or dATP but not other nucleotide triphosphates. The enzyme translocates on DNA with 3' to 5' polarity and behaves as a multimer upon gel filtration.	Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wood, RD (corresponding author), S867 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	rdwood@pitt.edu	Wood, Richard D/M-6319-2018; Marini, Federica/A-9841-2017	Wood, Richard D/0000-0002-9495-6892; Marini, Federica/0000-0002-9495-2349	Fondazione Telethon Funding Source: Custom	Fondazione Telethon(Fondazione Telethon)		Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; BOYD JB, 1990, GENETICS, V125, P813; CHENG S, 1988, J BIOL CHEM, V263, P15110; COLE RS, 1973, P NATL ACAD SCI USA, V70, P1064, DOI 10.1073/pnas.70.4.1064; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GEORGE JW, 1994, J MOL BIOL, V235, P424, DOI 10.1006/jmbi.1994.1003; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Harris PV, 1996, MOL CELL BIOL, V16, P5764; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; HOY CA, 1985, CANCER RES, V45, P1737; JACHYMCZYK WJ, 1981, MOL GEN GENET, V182, P196, DOI 10.1007/BF00269658; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kim DE, 1999, J BIOL CHEM, V274, P11623, DOI 10.1074/jbc.274.17.11623; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Koberle B, 1997, INT J CANCER, V70, P551, DOI 10.1002/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MAGANASCHWENCKE N, 1982, P NATL ACAD SCI-BIOL, V79, P1722, DOI 10.1073/pnas.79.6.1722; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Morris PD, 2001, J BIOL CHEM, V276, P19691, DOI 10.1074/jbc.M010928200; Nakagawa T, 2001, J BIOL CHEM, V276, P31487, DOI 10.1074/jbc.M104003200; Ozsoy AZ, 2001, NUCLEIC ACIDS RES, V29, P2986, DOI 10.1093/nar/29.14.2986; Sharief FS, 1999, GENOMICS, V59, P90, DOI 10.1006/geno.1999.5843; SLADEK FM, 1989, J BIOL CHEM, V264, P6755; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; Thompson LH, 1996, MUTAT RES-DNA REPAIR, V363, P77, DOI 10.1016/0921-8777(96)00008-0; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; Vanloock MS, 2001, J MOL BIOL, V311, P951, DOI 10.1006/jmbi.2001.4932; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; VILPO JA, 1995, MOL CELL BIOL, V15, P290, DOI 10.1128/MCB.15.1.290; Winkler GS, 1998, J BIOL CHEM, V273, P1092, DOI 10.1074/jbc.273.2.1092; YOAKUM GH, 1977, J BIOL CHEM, V252, P7023	38	68	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8716	8723		10.1074/jbc.M110271200	http://dx.doi.org/10.1074/jbc.M110271200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11751861	hybrid			2022-12-27	WOS:000174268000138
J	Erbe, DV; Wang, S; Xing, YZ; Tobin, JF				Erbe, DV; Wang, S; Xing, YZ; Tobin, JF			Small molecule Ligands define a binding site on the immune regulatory protein B7.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ACTIVATION; SOLUBLE FORM; CTLA-4; COSTIMULATION; INTEGRIN; AFFINITY; B7-1; CD28; IDENTIFICATION; RECOGNITION	The interaction of co-stimulatory molecules on T cells with B7 molecules on antigen presenting cells plays an important role in the activation of naive T cells. Consequently, agents that disrupt these interactions should have applications in treatment of transplant rejection as well as autoimmune diseases. To this end, specific small molecule inhibitors of human B7.1 were identified and characterized. These compounds inhibit the binding of B7.1 to both CD28 and CTLA4. Both classes of compounds appear to bind the same site, a relatively small portion of the GFCC'C" face of the N-terminal V-set domain of human B7.1, not present in the homolo" gous B7.2 or even mouse B7.1. This site may represent a rare hot spot for small molecule antagonist design of inhibitors of cell-cell interactions, whose ligands may yield leads for the development of novel immunomodulatory medicines.	Wyeth Res, Cambridge, MA 02140 USA	Pfizer	Erbe, DV (corresponding author), Wyeth Res, Cambridge, MA 02140 USA.							Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Allen KN, 1996, J PHYS CHEM-US, V100, P2605, DOI 10.1021/jp952516o; Chen LL, 1999, J BIOL CHEM, V274, P13167, DOI 10.1074/jbc.274.19.13167; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; FARGEAS CA, 1995, J EXP MED, V182, P667, DOI 10.1084/jem.182.3.667; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Greenfield EA, 1998, CRIT REV IMMUNOL, V18, P389, DOI 10.1615/CritRevImmunol.v18.i5.10; Guinan EC, 1999, NEW ENGL J MED, V340, P1704, DOI 10.1056/NEJM199906033402202; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; JANIN J, 1990, J BIOL CHEM, V265, P16027; Kaila N, 2001, BIOORGAN MED CHEM, V9, P801, DOI 10.1016/S0968-0896(00)00298-4; Kelly TA, 1999, J IMMUNOL, V163, P5173; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lin KC, 1999, J MED CHEM, V42, P920, DOI 10.1021/jm980673g; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Miller WH, 2000, DRUG DISCOV TODAY, V5, P397, DOI 10.1016/S1359-6446(00)01545-2; MIRANKER A, 1991, PROTEINS, V11, P29, DOI 10.1002/prot.340110104; Ringe D, 1999, MED RES REV, V19, P321, DOI 10.1002/(SICI)1098-1128(199907)19:4<321::AID-MED5>3.0.CO;2-F; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Slee DH, 2001, J MED CHEM, V44, P2094, DOI 10.1021/jm000508c; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tibaduiza EC, 2001, J BIOL CHEM, V276, P37787; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985	34	38	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7363	7368		10.1074/jbc.M110162200	http://dx.doi.org/10.1074/jbc.M110162200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741888	hybrid			2022-12-27	WOS:000174104300080
J	Lee, HC; Hon, T; Zhang, L				Lee, HC; Hon, T; Zhang, L			The molecular chaperone Hsp90 mediates heme activation of the yeast transcriptional activator Hap1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; EIF-2 ALPHA KINASE; STEROID-RECEPTOR; GENE-EXPRESSION; DNA-BINDING; SIGNAL-TRANSDUCTION; CELLULAR FACTOR; SEQUENCE; COMPLEX; MECHANISM	Hsp90 plays critical roles in the proper functioning of a wide array of eukaryotic signal transducers such as steroid receptors and tyrosine kinases. Hap1 is a naturally occurring substrate of Hsp90 in Saccharomyces cerevisiae. Hapl1 transcriptional activity is precisely and stringently controlled by heme. Previous biochemical studies suggest that in the absence of heme, Hapl1 is bound to Hsp90 and other proteins, forming a higher order complex termed HMC (high molecular weight complex), and is repressed. Heme promotes the disruption of the HWC and activates Hap1, permitting Hap1 to bind to DNA with high affinity and to stimulate transcription. By lowering the expression levels of wild-type Hsp90, using a highly specific Hsp90 inhibitor, and by examining the effects of various Hsp90 mutants on Hap1, we show that Hsp90 is critical for Hap1 activation by heme. Furthermore, we show that many Hsp90 mutants exert differential effects on Hap1 and steroid receptors. Notably, mutant G313N weakens Hsp90 steroid receptor interaction but strongly enhances Hsp90-Hap1 interaction and increases Hap1 resistance to protease digestion. Additionally, we found that a heme-independent Hap1 mutant still depends on Hsp90 for high activity. These experiments together suggest that Hsp90 promotes Hap1 activation by inducing or maintaining Hap1 in a transcriptionally active conformation.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University	Zhang, L (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	li.zhang@med.nyu.edu	Zhang, Li/L-5206-2013	Zhang, Li/0000-0001-9242-0763	NIGMS NIH HHS [GM 53453] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053453] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Bohen SP, 1998, MOL CELL BIOL, V18, P3330, DOI 10.1128/MCB.18.6.3330; BOHEN SP, 1995, J BIOL CHEM, V270, P29433, DOI 10.1074/jbc.270.49.29433; BOHEN SP, 1993, P NATL ACAD SCI USA, V90, P11424, DOI 10.1073/pnas.90.23.11424; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Caplan AJ, 1999, TRENDS CELL BIOL, V9, P262, DOI 10.1016/S0962-8924(99)01580-9; CHANG HCJ, 1994, J BIOL CHEM, V269, P24983; CREUSOT F, 1988, J MOL BIOL, V204, P263, DOI 10.1016/0022-2836(88)90574-8; DALMAN FC, 1991, BIOCHEMISTRY-US, V30, P5605, DOI 10.1021/bi00236a038; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; FYTLOVICH S, 1993, EMBO J, V12, P1209, DOI 10.1002/j.1460-2075.1993.tb05762.x; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Hach A, 1999, MOL CELL BIOL, V19, P4324; HALDI M, 1989, J BIOL CHEM, V264, P17107; HALDI ML, 1995, MOL GEN GENET, V248, P229, DOI 10.1007/BF02190805; Hen T, 2000, BIOCHEM BIOPH RES CO, V273, P584, DOI 10.1006/bbrc.2000.2995; HOLLEY SJ, 1995, MOL BIOL CELL, V6, P1833, DOI 10.1091/mbc.6.12.1833; Hon T, 2001, MOL CELL BIOL, V21, P7923, DOI 10.1128/MCB.21.23.7923-7932.2001; Hon T, 1999, J BIOL CHEM, V274, P22770, DOI 10.1074/jbc.274.32.22770; Kang KI, 1999, P NATL ACAD SCI USA, V96, P1439, DOI 10.1073/pnas.96.4.1439; King DA, 1999, NAT STRUCT BIOL, V6, P64; Louvion JF, 1998, MOL BIOL CELL, V9, P3071, DOI 10.1091/mbc.9.11.3071; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; Mayer MP, 1999, CURR BIOL, V9, pR322, DOI 10.1016/S0960-9822(99)80203-6; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Picard Didier, 1998, P1; PINA B, 1993, MOL CELL BIOL, V13, P5981, DOI 10.1128/MCB.13.10.5981; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Reddy SV, 1998, BLOOD, V91, P1793, DOI 10.1182/blood.V91.5.1793.1793_1793_1801; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sabbah M, 1996, BIOCHEM J, V314, P205, DOI 10.1042/bj3140205; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Toft DO, 1998, TRENDS ENDOCRIN MET, V9, P238, DOI 10.1016/S1043-2760(98)00060-5; TURCOTTE B, 1992, GENE DEV, V6, P2001, DOI 10.1101/gad.6.10.2001; Uma S, 1997, J BIOL CHEM, V272, P11648; Xu ZY, 1997, EUR J BIOCHEM, V246, P461, DOI 10.1111/j.1432-1033.1997.t01-1-00461.x; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; ZHANG L, 1994, J BIOL CHEM, V269, P14643; ZHANG L, 1993, P NATL ACAD SCI USA, V90, P2851, DOI 10.1073/pnas.90.7.2851; Zhang L, 1996, EMBO J, V15, P4676, DOI 10.1002/j.1460-2075.1996.tb00844.x; ZHANG L, 1994, GENE DEV, V8, P2110, DOI 10.1101/gad.8.17.2110; Zhang L, 1998, MOL CELL BIOL, V18, P3819, DOI 10.1128/MCB.18.7.3819; ZITOMER RS, 1992, MICROBIOL REV, V56, P1; Zitomer RS, 1997, KIDNEY INT, V51, P507, DOI 10.1038/ki.1997.71	48	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7430	7437		10.1074/jbc.M106951200	http://dx.doi.org/10.1074/jbc.M106951200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751848	hybrid			2022-12-27	WOS:000174104300088
J	Subbanagounder, G; Wong, JW; Lee, H; Faull, KF; Miller, E; Witztum, JL; Berliner, JA				Subbanagounder, G; Wong, JW; Lee, H; Faull, KF; Miller, E; Witztum, JL; Berliner, JA			Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis - Formation of these oxidized phospholipids in response to interleukin-1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR-DEFICIENT MICE; ENDOTHELIAL-CELLS; CHEMOATTRACTANT PROTEIN-1; MASS-SPECTROMETRY; IN-VIVO; 14,15-EPOXYEICOSATRIENOIC ACID; STRUCTURAL IDENTIFICATION; ATHEROSCLEROSIS; AUTOANTIBODIES	Monocyte recruitment to the vessel wall, mediated by monocyte chemotactic protein-1 (MCP-1) and interleukin-8 (IL-8), plays an important role in atherogenesis. We have shown previously that minimally oxidized low density lipoprotein, oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphoryleholine (Ox-PAPC), activates endothelial cells to produce MCP-1 and IL-8. By using liquid chromatography/mass spectrometry methods coupled with bioassay, we report a family of epoxyisoprostane (PEIPC) and epoxycyclopentenone (PECPC) phospholipids that are the components of Ox-PAPC responsible for the majority of this activity. Ox-PAPC contains five chromatographically distinguishable active PEIPC components (m/z 825.5) and four PECPC components (m/z 810.5). All nine components induced endothelial cell synthesis of IL-8 and MCP-1 in a dose-dependent fashion between 0.1 and 5 muM concentrations. The five PEIPC components had identical functional groups and all underwent dehydration to produce m/z 810.5. We present evidence that these phospholipids are regioisomers with epoxide groups at the 5,6-,8,9-,11,12-, or 14,15-positions of the sn-2 fatty acid and their epoxide groups is important for biological activity. We have shown previously that peroxisome proliferator-activated receptor a is involved in MCP-1 synthesis in response to Ox-PAPC. We now show that PEIPC and PECPC isomers are potent activators of peroxisome proliferator-activated receptor a. PEIPC and PECPC isomers are strongly recognized by specific circulating murine natural autoantibodies (EO6) and accumulate in cells treated with IL-1beta. These studies demonstrate that PEIPC and PECPC isomers are potent activators of endothelial cells increasing synthesis of IL-8 and MCP-1. Their accumulation in cells exposed to cytokines and in atherosclerotic lesions suggests that these lipids may play a role in a number of chronic disease processes.	Univ Calif Los Angeles, Ctr Med, Hlth Sci Ctr, Dept Med Cardiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Passarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90024 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Subbanagounder, G (corresponding author), Univ Calif Los Angeles, Ctr Med, Hlth Sci Ctr, Dept Med Cardiol, Rm 47-123, Los Angeles, CA 90095 USA.				NHLBI NIH HHS [HL 64731, HL 30568] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064731, P01HL030568] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; BERLINER JA, 1990, J CLIN INVEST, V85, P1260, DOI 10.1172/JCI114562; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697; Fiske CH, 1925, J BIOL CHEM, V66, P375; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FRIEDMAN J, 2002, J BIOL CHEM, V277; GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0; Gargiulo P, 1999, CLIN EXP IMMUNOL, V118, P30; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Harrison DG, 1997, CLIN CARDIOL, V20, P11; Harrison KA, 2000, J MASS SPECTROM, V35, P224, DOI 10.1002/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Horkko S, 2001, CIRCULATION, V103, P941; JOHNSON MR, 1970, J ORG CHEM, V35, P1041, DOI 10.1021/jo00829a039; KOCH AE, 1993, AM J PATHOL, V142, P1423; Lee H, 2000, CIRC RES, V87, P516; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; Merkel PA, 1999, J RHEUMATOL, V26, P591; Morrow JD, 1996, BIOCHEM PHARMACOL, V51, P1, DOI 10.1016/0006-2952(95)02072-1; Nakamura T, 1997, J MASS SPECTROM, V32, P888, DOI 10.1002/(SICI)1096-9888(199708)32:8<888::AID-JMS548>3.0.CO;2-W; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Nithipatikom K, 1997, ANAL BIOCHEM, V246, P253, DOI 10.1006/abio.1997.2014; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; PATEL KD, 1992, J BIOL CHEM, V267, P15168; Porter NA, 1998, J ORG CHEM, V63, P5547, DOI 10.1021/jo980654e; Rokach J, 1997, PROSTAG OTH LIPID M, V54, P823, DOI 10.1016/S0090-6980(97)00183-4; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 1999, CIRC RES, V85, P311, DOI 10.1161/01.RES.85.4.311; Subbanagounder G, 1997, J ORG CHEM, V62, P7658, DOI 10.1021/jo970858f; Takahara N, 1996, METABOLISM, V45, P559, DOI 10.1016/S0026-0495(96)90024-4; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Tsimikas S, 2001, CIRCULATION, V103, P1930; VANROLLINS M, 1993, J LIPID RES, V34, P1931; Watson AD, 1999, J BIOL CHEM, V274, P24787, DOI 10.1074/jbc.274.35.24787; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Waugh RJ, 1997, FREE RADICAL BIO MED, V23, P943, DOI 10.1016/S0891-5849(97)00133-0; Wohlfeil ER, 1999, ARTERIOSCL THROM VAS, V19, P2901, DOI 10.1161/01.ATV.19.12.2901	45	156	163	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7271	7281		10.1074/jbc.M107602200	http://dx.doi.org/10.1074/jbc.M107602200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751881	hybrid			2022-12-27	WOS:000174104300068
J	Cattaruzza, M; Schafer, K; Hecker, M				Cattaruzza, M; Schafer, K; Hecker, M			Cytokine-induced down-regulation of zfm1/splicing factor-1 promotes smooth muscle cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL REPRESSOR; PROTEIN; ACTIVATION; ATHEROSCLEROSIS; EXPRESSION; INDUCTION; INTERACTS; MCP-1; CDNA	One hallmark of inflammation is the proliferation of bystander cells such as vascular smooth muscle cells (SMC), a process governed by growth factors and cytokines. Whereas cytokine induction of gene products promoting inflammation and proliferation is well characterized, little is known about the concomitant down-regulation of potentially counter-regulatory gene products in these cells. By employing the suppression subtractive hybridization-PCR technique, RNA isolated from rat aortic SMC treated with the cytokines interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNFalpha) was subtracted from RNA of control cells. Eleven genes were identified, the expression of which fell by 44-77%. One, the transcriptional repressor splicing factor-1 or zfm1, was characterized further. Antisense oligonucleotide suppression of zfm1 protein synthesis mimicked the stimulatory effects of IL-1beta and TNFalpha on SMC proliferation and expression of the chemokine MCP-1 and the vascular cell adhesion molecule-1. Moreover, in an in vivo mouse model of atherosclerosis, zfm1 abundance was decreased in proliferating arterial SMC. These findings suggest a role for zfm1 in controlling both proliferation and expression of pro-inflammatory gene products in SMC. Therefore, cytokine-induced down-regulation of zfm1 expression may contribute to the pathogenesis of hyperproliferative inflammatory diseases.	Univ Gottingen, Dept Cardiovasc Physiol, D-37073 Gottingen, Germany; Univ Gottingen, Dept Cardiol & Pneumol, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen	Hecker, M (corresponding author), Univ Gottingen, Dept Cardiovasc Physiol, HUmboldtallee 23, D-37073 Gottingen, Germany.	hecker@veg-physiol.med.uni-goet-tingen.de	Schäfer, Katrin/P-4728-2015	Schafer, Katrin/0000-0003-0846-4718				Bogdanov VY, 1998, J BIOL CHEM, V273, P24932, DOI 10.1074/jbc.273.38.24932; BUSTIN M, 1995, SEMIN CELL BIOL, V6, P247, DOI 10.1006/scel.1995.0033; Cattaruzza M, 2000, BRIT J PHARMACOL, V129, P1155, DOI 10.1038/sj.bjp.0703192; CLAUSELL N, 1994, CIRCULATION, V89, P2768, DOI 10.1161/01.CIR.89.6.2768; Denger S, 1999, ATHEROSCLEROSIS, V144, P15, DOI 10.1016/S0021-9150(99)00033-7; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dimitrova DS, 2000, EXP CELL RES, V254, P321, DOI 10.1006/excr.1999.4770; Elhage R, 1998, CIRCULATION, V97, P242, DOI 10.1161/01.CIR.97.3.242; Fukumoto Y, 1997, J CARDIOVASC PHARM, V29, P222, DOI 10.1097/00005344-199702000-00011; Gharaee-Kermani M, 2001, CURR PHARM DESIGN, V7, P1083, DOI 10.2174/1381612013397573; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Guth S, 2000, J BIOL CHEM, V275, P38059, DOI 10.1074/jbc.M001483200; Hammermann R, 2000, MOL PHARMACOL, V58, P1294, DOI 10.1124/mol.58.6.1294; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Konstantinides S, 2001, CIRCULATION, V103, P576, DOI 10.1161/01.CIR.103.4.576; Ladomery M, 1997, BIOESSAYS, V19, P903, DOI 10.1002/bies.950191010; LI H, 1993, ARTERIOSCLER THROMB, V13, P197, DOI 10.1161/01.ATV.13.2.197; Macalma T, 1996, J BIOL CHEM, V271, P31470, DOI 10.1074/jbc.271.49.31470; Nath C, 1998, ACTA HAEMATOL-BASEL, V99, P175, DOI 10.1159/000040833; NILSSON J, 1993, CARDIOVASC RES, V27, P1184, DOI 10.1093/cvr/27.7.1184; Porreca E, 1997, J VASC RES, V34, P58, DOI 10.1159/000159202; Simon AD, 2000, J THROMB THROMBOLYS, V9, P217, DOI 10.1023/A:1018758409934; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Tyson JJ, 1996, TRENDS BIOCHEM SCI, V21, P89; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Yamit-Hezi A, 1998, EMBO J, V17, P5161, DOI 10.1093/emboj/17.17.5161; Zhang D, 1998, J BIOL CHEM, V273, P6868, DOI 10.1074/jbc.273.12.6868; Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086	28	21	22	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6582	6589		10.1074/jbc.M108283200	http://dx.doi.org/10.1074/jbc.M108283200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11748220	hybrid			2022-12-27	WOS:000173989200117
J	Cole, NB; Murphy, DD; Grider, T; Rueter, S; Brasaemle, D; Nussbaum, RL				Cole, NB; Murphy, DD; Grider, T; Rueter, S; Brasaemle, D; Nussbaum, RL			Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY BODIES; SYNAPSIN-I; NACP/ALPHA-SYNUCLEIN; SYNAPTIC VESICLES; OXIDATIVE STRESS; NERVOUS-SYSTEM; BRAIN; LOCALIZATION; EXPRESSION; PERILIPIN	alpha-Synuclein is a major component of the fibrillary lesion known as Lewy bodies and Lewy neurites that are the pathologic hallmarks of Parkinson's disease (PD). In addition, point mutations in the alpha-synuclein gene imply a-synuclein dysfunction in the pathology of inherited forms of PD. alpha-Synuclein is a member of a family of proteins found primarily in the brain and is concentrated within presynaptic terminals. Here, we address the localization and membrane binding characteristics of wild type and PD mutants of alpha-synuclein in cultured cells. In cells treated with high concentrations of fatty acids, wild type alpha-synuclein accumulated on phospholipid monolayers surrounding triglyceride-rich lipid droplets and was able to protect stored triglycerides from hydrolysis. PD mutant synucleins showed variable distributions on lipid droplets and were less effective in regulating triglyceride turnover. Chemical cross-linking demonstrated that synuclein formed small oligomers within cells, primarily dimers and trimers, that preferentially associated with lipid droplets and cell membranes. Our results suggest that the initial phases of synuclein aggregation may occur on the surfaces of membranes and that pathological conditions that induce cross-linking of synuclein may enhance the propensity for subsequent synuclein aggregation.	NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; NINCDS, Div Extramural Activ, NIH, Bethesda, MD 20982 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Pennsylvania; Pennsylvania Medicine; Rutgers State University New Brunswick	Cole, NB (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Rm 4B67,49 Convent Dr, Bethesda, MD 20892 USA.	ncole@nhgri.nih.gov		Brasaemle, Dawn/0000-0002-8553-8285	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000117] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baba M, 1998, AM J PATHOL, V152, P879; BENFENATI F, 1993, J CELL BIOL, V123, P1845, DOI 10.1083/jcb.123.6.1845; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Buchman VL, 1998, J NEUROSCI, V18, P9335; Cheetham JJ, 2001, BIOCHEM J, V354, P57, DOI 10.1042/0264-6021:3540057; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cole NB, 1998, J CELL BIOL, V140, P1, DOI 10.1083/jcb.140.1.1; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DEUTSCH JW, 1981, BIOCHEMISTRY-US, V20, P378, DOI 10.1021/bi00505a024; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; GIASSON BI, 2000, NEURODEGENERATIVE DE, P219; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; HO MF, 1991, J BIOL CHEM, V266, P5600; Holm C, 1999, METH MOL B, V109, P109; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Igal RA, 1996, J BIOL CHEM, V271, P16644, DOI 10.1074/jbc.271.28.16644; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jensen PH, 1999, EUR J NEUROSCI, V11, P3369, DOI 10.1046/j.1460-9568.1999.00754.x; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Khoo J C, 1975, Methods Enzymol, V35, P181, DOI 10.1016/0076-6879(75)35154-9; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lavedan C, 1998, HUM GENET, V103, P106, DOI 10.1007/s004390050792; Lee D, 2001, EUR J BIOCHEM, V268, P295, DOI 10.1046/j.1432-1327.2001.01877.x; LEE HJ, 2001, J BIOL CHEM, V25, P25; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; NAKAJO S, 1994, MOL BRAIN RES, V27, P81, DOI 10.1016/0169-328X(94)90187-2; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Surguchov A, 1999, MOL CELL NEUROSCI, V13, P95, DOI 10.1006/mcne.1999.0735; Takenouchi T, 2001, MOL CELL NEUROSCI, V17, P141, DOI 10.1006/mcne.2000.0923; Tiunova AA, 2000, MECH DEVELOP, V99, P195, DOI 10.1016/S0925-4773(00)00484-6; van Meer G, 2001, J CELL BIOL, V152, pF29, DOI 10.1083/jcb.152.5.F29; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	61	341	347	0	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6344	6352		10.1074/jbc.M108414200	http://dx.doi.org/10.1074/jbc.M108414200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11744721	hybrid			2022-12-27	WOS:000173989200086
J	Mouche, F; Gontero, B; Callebaut, I; Mornon, JP; Boisset, N				Mouche, F; Gontero, B; Callebaut, I; Mornon, JP; Boisset, N			Striking conformational change suspected within the phosphoribulokinase dimer induced by interaction with GAPDH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII CHLOROPLASTS; CALVIN CYCLE ACTIVITY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MULTIENZYME COMPLEXES; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; INFORMATION-TRANSFER; ESCHERICHIA-COLI; 3-DIMENSIONAL RECONSTRUCTION; BIENZYME COMPLEX	A multitechnique approach was used to study the [glyceraldehyde-3-phosphate dehydrogenase](2x4)-[phosphoribulokinase](2x2) multienzymatic complex of the alga Chlamydomonas reinhardtii. On the one hand, each component of the complex was compared with known atomic structures of related enzymes or of similar enzymes originating from different organisms. On the other hand, the overall low resolution architecture of the whole complex was studied using cryoelectron microscopy and image processing techniques. The dimers of phosphoribulokinase are suspected to undergo a dramatic change in activity during a cycle of binding and detaching from tetramers of glyceraldehyde-3-phosphate dehydrogenase. This is likely supported by strong structural differences between the modeled phosphoribulokinase dimers and the counterpart in the three-dimensional reconstruction volume of the whole complex obtained from cryoelectron microscope images.	Univ Paris 06, Lab Mineral Cristallog Paris, UMR 7590, F-75252 Paris 05, France; Univ Paris 07, Lab Mineral Cristallog Paris, UMR 7590, F-75252 Paris 05, France; Univ Paris 06, CNRS, UMR 7592, Inst Jacques Monod,Lab Ingn Prot & Controle Metab, F-75251 Paris 05, France; Univ Paris 07, CNRS, UMR 7592, Inst Jacques Monod,Lab Ingn Prot & Controle Metab, F-75251 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Boisset, N (corresponding author), Univ Paris 06, Lab Mineral Cristallog Paris, UMR 7590, Case 115,4 Pl Jussieu, F-75252 Paris 05, France.	Nicolas.Boisset@lmcp.jussieu.fr						ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avilan L, 1997, EUR J BIOCHEM, V246, P78, DOI 10.1111/j.1432-1033.1997.00078.x; Avilan L, 1997, EUR J BIOCHEM, V250, P296, DOI 10.1111/j.1432-1033.1997.0296a.x; Avilan L, 2000, J BIOL CHEM, V275, P9447, DOI 10.1074/jbc.275.13.9447; Baalmann E, 1996, PLANT MOL BIOL, V32, P505, DOI 10.1007/BF00019102; Boisset N, 1998, ULTRAMICROSCOPY, V74, P201, DOI 10.1016/S0304-3991(98)00042-4; BOISSET N, 1993, J MOL BIOL, V232, P522, DOI 10.1006/jmbi.1993.1408; Boisset N, 2000, J MOL BIOL, V296, P459, DOI 10.1006/jmbi.1999.3460; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; CLASPER S, 1991, EUR J BIOCHEM, V202, P1239, DOI 10.1111/j.1432-1033.1991.tb16496.x; CYRKLAFF M, 1990, J ELECTRON MICR TECH, V16, P351, DOI 10.1002/jemt.1060160407; Didierjean C, 1997, J MOL BIOL, V268, P739, DOI 10.1006/jmbi.1997.0998; DUBOCHET J, 1982, J MICROSC-OXFORD, V128, P219, DOI 10.1111/j.1365-2818.1982.tb04625.x; EASTERBY JS, 1989, BIOCHEM J, V264, P605, DOI 10.1042/bj2640605; FRANK J, 1995, OPTIK, V98, P125; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GONTERO B, 1988, EUR J BIOCHEM, V173, P437, DOI 10.1111/j.1432-1033.1988.tb14018.x; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Harrison DHT, 1998, BIOCHEMISTRY-US, V37, P5074, DOI 10.1021/bi972805y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebreton S, 1997, EUR J BIOCHEM, V246, P85, DOI 10.1111/j.1432-1033.1997.t01-2-00085.x; Lebreton S, 1997, EUR J BIOCHEM, V250, P286, DOI 10.1111/j.1432-1033.1997.0286a.x; Lebreton S, 1999, J BIOL CHEM, V274, P20879, DOI 10.1074/jbc.274.30.20879; Leegood R.C., 1990, METHODS PLANT BIOCH, P15; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mouche F, 2001, J STRUCT BIOL, V133, P176, DOI 10.1006/jsbi.2001.4362; NICHOLSON S, 1987, EUR J BIOCHEM, V162, P423, DOI 10.1111/j.1432-1033.1987.tb10619.x; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Penczek PA, 1996, ULTRAMICROSCOPY, V63, P205, DOI 10.1016/0304-3991(96)00037-X; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; PETTERSSON G, 1991, J THEOR BIOL, V152, P65, DOI 10.1016/S0022-5193(05)80512-0; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Ricard J, 1998, CELL MOL LIFE SCI, V54, P1231, DOI 10.1007/s000180050250; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; SUSS KH, 1995, PLANT PHYSIOL, V107, P1387, DOI 10.1104/pp.107.4.1387; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; WOLOSIUK RA, 1976, J BIOL CHEM, V251, P6456; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Wriggers W, 1998, J MOL BIOL, V284, P1247, DOI 10.1006/jmbi.1998.2232; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; WU XM, 1991, P NATL ACAD SCI USA, V88, P497, DOI 10.1073/pnas.88.2.497	51	21	23	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6743	6749		10.1074/jbc.M106401200	http://dx.doi.org/10.1074/jbc.M106401200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741988	hybrid			2022-12-27	WOS:000173989200137
J	Ficker, E; Obejero-Paz, CA; Zhao, S; Brown, AM				Ficker, E; Obejero-Paz, CA; Zhao, S; Brown, AM			The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTIVE PROTEIN TRAFFICKING; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; K+-CHANNEL; I-KR; MOLECULAR-BASIS; RECEPTOR-SITE; MECHANISM; INACTIVATION; BLOCKADE	Mutations in the human ether-a-gogo-related gene (HERG) K+ channel gene cause chromosome 7-linked long QT syndrome type 2 (LQT2), which is characterized by a prolonged QT interval in the electrocardiogram and an increased susceptibility to life-threatening cardiac arrhythmias. LQT2 mutations produce loss-of-function phenotypes and reduce I-Kr currents either by the heteromeric assembly of non- or malfunctioning channel subunits with wild type subunits at the cell surface or by retention of misprocessed mutant HERG channels in the endoplasmic reticulum. Misprocessed mutations often encode for channel proteins that are functional upon incorporation into the plasma membrane. As a result the pharmacological correction of folding defects and restoration of protein function are of considerable interest. Here we report that the trafficking-deficient pore mutation HERG G601S was rescued by a series of HERG channel blockers that increased cell surface expression. Rescue by these pharmacological chaperones varied directly with their blocking potency. We used structure-activity relationships and site-directed mutagenesis to define the binding site of the pharmacological chaperones. We found that binding occurred in the inner cavity and correlated with hydrophobicity and cationic charge. Rescue was domain-restricted because the trafficking of two misprocessed mutations in the C terminus, HERG F805C and HERG R823W, was not restored by channel blockers. Our findings represent a first step toward the design of pharmacological chaperones that will rescue HERG K+ channels without block.	Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University	Ficker, E (corresponding author), Metrohlth Med Ctr, Rammelkamp Ctr, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	eficker@metrohealth.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061642, R01HL036930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK054178] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 61642, HL 36930] Funding Source: Medline; NIDDK NIH HHS [DK 54178] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; Cui J, 2001, J BIOL CHEM, V276, P17244, DOI 10.1074/jbc.M010904200; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Hrnjez BJ, 1999, AM J PHYSIOL-GASTR L, V277, pG521, DOI 10.1152/ajpgi.1999.277.3.G521; JAROLIMEK W, 1995, PFLUG ARCH EUR J PHY, V430, P672, DOI 10.1007/BF00386161; Kagan A, 2000, J BIOL CHEM, V275, P11241, DOI 10.1074/jbc.275.15.11241; Kiehn J, 1996, CIRCULATION, V94, P2572, DOI 10.1161/01.CIR.94.10.2572; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Lees-Miller JP, 2000, CIRC RES, V86, P507, DOI 10.1161/01.RES.86.5.507; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Mohammad S, 1997, AM J PHYSIOL-HEART C, V273, pH2534, DOI 10.1152/ajpheart.1997.273.5.H2534; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Numaguchi H, 2000, CIRC RES, V87, P1012, DOI 10.1161/01.RES.87.11.1012; Po SS, 1999, J CARDIOVASC PHARM, V33, P181, DOI 10.1097/00005344-199902000-00002; Rampe D, 1997, FEBS LETT, V417, P28, DOI 10.1016/S0014-5793(97)01249-0; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; SWENSON RP, 1981, J GEN PHYSIOL, V77, P255, DOI 10.1085/jgp.77.3.255; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Wang SM, 1997, FEBS LETT, V417, P43, DOI 10.1016/S0014-5793(97)01245-3; Yang T, 1996, CIRCULATION, V93, P407, DOI 10.1161/01.CIR.93.3.407; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Zerr P, 1998, J NEUROSCI, V18, P2842; Zhang MQ, 1997, CURR MED CHEM, V4, P171; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou ZF, 1999, J CARDIOVASC ELECTR, V10, P836, DOI 10.1111/j.1540-8167.1999.tb00264.x; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	42	140	147	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4989	4998		10.1074/jbc.M107345200	http://dx.doi.org/10.1074/jbc.M107345200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741928	hybrid			2022-12-27	WOS:000173962900059
J	Fukuda, M; Kowalchyk, JA; Zhang, XD; Martin, TFJ; Mikoshiba, K				Fukuda, M; Kowalchyk, JA; Zhang, XD; Martin, TFJ; Mikoshiba, K			Synaptotagmin IX regulates Ca2+-dependent secretion in PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-POLYPHOSPHATE BINDING; ADRENAL CHROMAFFIN CELLS; SQUID GIANT SYNAPSE; C2A DOMAIN; PHOSPHOLIPID-BINDING; TRANSMITTER RELEASE; EXOCYTOSIS; CALCIUM; PROTEIN; MACHINERY	Synaptotagmin (Syt) I-deficient phaeochromocytoma (PC12) cell lines show normal Ca2+-dependent norepinephrine (NE) release (Shoji-Kasai, Y., Yoshida, A., Sato, K., Hoshino, T., Ogura, A., Kondo, S., Fujimoto, Y., Kuwahara, R., Kato, R., and Takahashi, M. (1992) Science 256, 1821-1823). To identify an alternative Ca2+ sensor, we searched for other Syt isoforms in Syt I-deficient PC12 cells and identified Syt IX, an isoform closely related to Syt I, as an abundantly expressed dense-core vesicle protein. Here we show that Syt IX is required for the Ca2+-dependent release of NE from PC12 cells. Antibodies directed against the C2A domain of either Syt IX or Syt I inhibited Ca2+-dependent NE release in permeable PC12 cells indicating that both Syt proteins function in dense-core vesicle exocytosis. Our results support the idea that Syt family proteins that co-reside on secretory vesicles may function cooperatively and redundantly as potential Ca2+ sensors for exocytosis.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Mol Neurobiol, Tokyo 1087639, Japan	RIKEN; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo	Fukuda, M (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mnfukuda@brain.riken.go.jp	Mikoshiba, Katsuhiko/N-7943-2015; Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025861, R01DK025861] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK25861] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Bennett MR, 1999, PROG NEUROBIOL, V59, P243, DOI 10.1016/S0301-0082(99)00004-0; Chen YA, 1999, J BIOL CHEM, V274, P26469, DOI 10.1074/jbc.274.37.26469; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; CRAXTON M, 1995, FEBS LETT, V361, P196, DOI 10.1016/0014-5793(95)00176-A; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; Fukuda M, 1997, BIOCHEM J, V323, P421, DOI 10.1042/bj3230421; Fukuda M, 2001, BIOCHEM J, V354, P249, DOI 10.1042/0264-6021:3540249; Fukuda M, 2000, J BIOCHEM, V128, P637, DOI 10.1093/oxfordjournals.jbchem.a022796; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; Ibata K, 2000, J NEUROCHEM, V74, P518, DOI 10.1046/j.1471-4159.2000.740518.x; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; LOMNETH R, 1991, J NEUROCHEM, V57, P1413, DOI 10.1111/j.1471-4159.1991.tb08308.x; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; MARTIN TFJ, 1989, METHOD ENZYMOL, V168, P225; Martin Thomas F. J., 1994, Current Opinion in Neurobiology, V4, P626, DOI 10.1016/0959-4388(94)90002-7; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; Mochida S, 1997, NEUROSCIENCE, V77, P937; OharaImaizumi M, 1997, P NATL ACAD SCI USA, V94, P287, DOI 10.1073/pnas.94.1.287; Orita S, 1996, J BIOL CHEM, V271, P7257, DOI 10.1074/jbc.271.13.7257; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; Sugimori M, 1998, NEUROSCIENCE, V86, P39, DOI 10.1016/S0306-4522(97)00689-1; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200	38	117	123	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4601	4604		10.1074/jbc.C100588200	http://dx.doi.org/10.1074/jbc.C100588200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11751925	hybrid			2022-12-27	WOS:000173962900008
J	Uittenbogaard, A; Everson, WV; Matveev, SV; Smart, EJ				Uittenbogaard, A; Everson, WV; Matveev, SV; Smart, EJ			Cholesteryl ester is transported from caveolae to internal membranes as part of a caveolin-annexin II lipid-protein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; PLASMA-MEMBRANE; CHAPERONE COMPLEX; TYROSINE KINASES; SELECTIVE UPTAKE; SR-BI; CELLS; METABOLISM; RECEPTOR; MEDIATE	We previously demonstrated that in Chinese hamster ovary cells scavenger receptor, class B, type I-dependent selective cholesteryl ester uptake occurs in caveolae. In the present study we hypothesized that cholesteryl ester is transported from caveolae through the cytosol to an internal membrane by a caveolin chaperone complex similar to the one we originally described for the transport of newly synthesized cholesterol. To test this hypothesis we incubated Chinese hamster ovary cells expressing scavenger receptor, class B, type I with [H-3]cholesteryl ester-labeled high density lipoprotein, subfractionated the cells and looked for a cytosolic pool of [H-3]cholesteryl ester. The radiolabeled sterol initially appeared in the caveolae fraction, then in the cytosol, and finally in the internal membrane fraction. Caveolin IgG precipitated all of the [H-3]cholesteryl ester associated with the cytosol. Co-immunoprecipitation studies demonstrated that in the presence of high density lipoprotein, but not low density lipoprotein or lipoprotein-deficient serum, caveolin IgG precipitated four proteins: annexin II, cyclophilin 40, caveolin, and cyclophilin A. Caveolin acylation-deficient mutants were used to demonstrate that acylation of cysteine 133 but not cysteine 143 or 156 is required for annexin II association with caveolin and the rapid transport of cholesteryl esters out of caveolae. We conclude that a caveolin-annexin II lipid-protein complex facilitates the rapid internalization of cholesteryl esters from caveolae.	Univ Kentucky, Sch Med, Dept Physiol, Lexington, KY 40536 USA	University of Kentucky	Smart, EJ (corresponding author), Univ Kentucky, Sch Med, Dept Physiol, 800 Rose St,MS 508 C, Lexington, KY 40536 USA.		Eckhardt, Erik/G-1567-2010		NHLBI NIH HHS [HL58475, HL62844, HL64056] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062844, R01HL064056, R01HL058475, R29HL058475] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BROWN MS, 1980, J BIOL CHEM, V255, P9344; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; FIELDING PE, 1995, BIOCHEMISTRY-US, V34, P14288, DOI 10.1021/bi00044a004; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Graf GA, 1999, J BIOL CHEM, V274, P12043, DOI 10.1074/jbc.274.17.12043; GWYNNE JT, 1989, J BIOL CHEM, V264, P8141; HARDER T, 1994, BBA-MOL CELL RES, V1223, P375, DOI 10.1016/0167-4889(94)90098-1; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; KNECHT TP, 1989, BIOCHIM BIOPHYS ACTA, V1002, P365, DOI 10.1016/0005-2760(89)90351-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li WP, 2001, J CELL SCI, V114, P1397; Matveev S, 1999, J LIPID RES, V40, P1647; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Silver DL, 2000, J CLIN INVEST, V105, P151, DOI 10.1172/JCI8087; Silver DL, 2000, ANN NY ACAD SCI, V902, P103; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; STRACHAN AF, 1988, BIOCHEM J, V250, P203, DOI 10.1042/bj2500203; Trigatti B, 2000, CURR OPIN LIPIDOL, V11, P123, DOI 10.1097/00041433-200004000-00004; Uittenbogaard A, 2000, J BIOL CHEM, V275, P25595, DOI 10.1074/jbc.M003401200; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Zeuschner D, 2001, EUR J CELL BIOL, V80, P499, DOI 10.1078/0171-9335-00184	28	89	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4925	4931		10.1074/jbc.M109278200	http://dx.doi.org/10.1074/jbc.M109278200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733519	Green Published, hybrid			2022-12-27	WOS:000173962900051
J	Vargas, L; Nore, BF; Berglof, A; Heinonen, JE; Mattsson, PT; Smith, CIE; Mohamed, AJ				Vargas, L; Nore, BF; Berglof, A; Heinonen, JE; Mattsson, PT; Smith, CIE; Mohamed, AJ			Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; TEC FAMILY; PHOSPHORYLATION CASCADE; INSULIN-RECEPTOR; PROTEIN-KINASE; LIPID RAFTS; MEMBRANE; ACTIVATION; GENE; EXPRESSION	Bruton's tyrosine kinase (Btk), a member of the Tec family of protein-tyrosine kinases, has been shown to be crucial for B cell development, differentiation, and signaling. Mutations in the Btk gene lead to X-linked agammaglobulinemia in humans and X-linked immunodeficiency in mice. Using a co-transfection approach, we present evidence here that Btk interacts physically with caveolin-1, a 22-kDa integral membrane protein, which is the principal structural and regulatory component of caveolae membranes. In addition, we found that native Bmx, another member of the Tec family kinases, is associated with endogenous caveolin-1 in primary human umbilical vein endothelial cells. Second, in transient transfection assays, expression of caveolin-1 leads to a substantial reduction in the in vivo tyrosine phosphorylation of both Btk and its constitutively active form, E41K. Furthermore, a caveolin-1 scaffolding peptide (amino acids 82-101) functionally suppressed the autokinase activity of purified recombinant Btk protein. Third, we demonstrate that mouse splenic B-lymphocytes express substantial amounts of caveolin-1. Interestingly, caveolin-1 was found to be constitutively phosphorylated on tyrosine 14 in these cells. The expression of caveolin-1 in B-lymphocytes and its interaction with Btk may have implications not only for B cell activation and signaling, but also for antigen presentation.	Karolinska Inst, Huddinge Univ Hosp, Clin Res Ctr, SE-14186 Huddinge, Sweden; Sodertorns Hogskola Univ Coll, Nat Sci Sect, SE-14104 Huddinge, Sweden	Karolinska Institutet; Sodertorn University	Smith, CIE (corresponding author), Karolinska Inst, Huddinge Univ Hosp, Clin Res Ctr, SE-14186 Huddinge, Sweden.	edvard.smith@crc.ki.se; abdalla.mohamed@cbt.ki.se	Nore, Beston F./N-9288-2016	Nore, Beston F./0000-0003-3865-2920; SMITH, C. I. Edvard/0000-0003-1907-3392				Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Conley ME, 1998, AM J HUM GENET, V62, P1034, DOI 10.1086/301828; CONLEY ME, 1994, HUM MOL GENET, V3, P1751, DOI 10.1093/hmg/3.10.1751; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DEWEERS M, 1993, EUR J IMMUNOL, V23, P3109, DOI 10.1002/eji.1830231210; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Gargalovic P, 2001, J BIOL CHEM, V276, P26164, DOI 10.1074/jbc.M011291200; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Hamm-Alvarez SF, 2001, AM J PHYSIOL-CELL PH, V280, pC1657, DOI 10.1152/ajpcell.2001.280.6.C1657; Hatanaka M, 1998, BIOCHEM BIOPH RES CO, V253, P382, DOI 10.1006/bbrc.1998.9744; IWANISHI M, 1993, DIABETOLOGIA, V36, P414, DOI 10.1007/BF00402277; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jang IH, 2001, FEBS LETT, V491, P4, DOI 10.1016/S0014-5793(01)02165-2; Kim Y, 2000, J BIOL CHEM, V275, P13621, DOI 10.1074/jbc.275.18.13621; Kim YN, 2000, J BIOL CHEM, V275, P7481, DOI 10.1074/jbc.275.11.7481; Kogo H, 2000, BIOCHEM BIOPH RES CO, V268, P82, DOI 10.1006/bbrc.1999.2058; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li WP, 2001, J CELL SCI, V114, P1397; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Mano H, 1999, INT J HEMATOL, V69, P6; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Mattsson PT, 2000, J IMMUNOL, V164, P4170, DOI 10.4049/jimmunol.164.8.4170; Mohamed AJ, 2000, J BIOL CHEM, V275, P40614, DOI 10.1074/jbc.M006952200; Mohamed AJ, 1999, SCAND J IMMUNOL, V49, P113; MOLLER DE, 1990, MOL ENDOCRINOL, V4, P1183, DOI 10.1210/mend-4-8-1183; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; NORE BF, 2000, ALLERGY CLIN IMMUNOL, V12, P126; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Pol A, 2000, J BIOL CHEM, V275, P30566, DOI 10.1074/jbc.M001131200; Rajantie I, 2001, MOL CELL BIOL, V21, P4647, DOI 10.1128/MCB.21.14.4647-4655.2001; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2000, J CELL SCI, V113, P2103; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SMITH CIE, 1994, J IMMUNOL, V152, P557; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Smith RM, 1998, CELL SIGNAL, V10, P355, DOI 10.1016/S0898-6568(97)00170-8; Song KS, 1997, CELL MOL BIOL, V43, P293; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; van Meer G, 2001, J CELL BIOL, V152, pF29, DOI 10.1083/jcb.152.5.F29; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Vihinen M, 1996, CRIT REV IMMUNOL, V16, P251, DOI 10.1615/CritRevImmunol.v16.i3.20; Vihinen M, 1999, HUM MUTAT, V13, P280, DOI 10.1002/(SICI)1098-1004(1999)13:4<280::AID-HUMU3>3.0.CO;2-L; Vihinen M, 2000, FRONT BIOSCI-LANDMRK, V5, pD917, DOI 10.2741/vihinen; Vihinen M, 2001, ADV GENET, V43, P103, DOI 10.1016/S0065-2660(01)43005-7; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; Yang WC, 2000, IMMUNITY, V12, P373, DOI 10.1016/S1074-7613(00)80189-2	64	44	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					9351	9357		10.1074/jbc.M108537200	http://dx.doi.org/10.1074/jbc.M108537200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11751885	hybrid			2022-12-27	WOS:000174400600083
J	Chang, SY; Park, SG; Kim, S; Kang, CY				Chang, SY; Park, SG; Kim, S; Kang, CY			Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase - Its functional implication in endothelial cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING-POLYPEPTIDE-II; TUMOR-NECROSIS-FACTOR; EMAP-II; IN-VIVO; CYTOKINE; APOPTOSIS; ANGIOSTATIN; ANGIOGENESIS; EXPRESSION; COMPONENT	Human p43 is associated with macromolecular tRNA synthase complex and known as a precursor of endothelial monocyte-activating polypeptide II (EMAP II). Interestingly, p43 is also secreted to induce proinflammatory genes. Although p43 itself seems to be a cytokine working at physiological conditions, most of the functional studies have been obtained with its C-terminal equivalent, EMAP H. To gain an insight into the working mechanism of p43/EMAP II, we used EMAP II and searched for an interacting cell surface molecule. The level of EMAP II-binding molecule(s) was significantly increased in serum-starved tumor cells. Thus, the EMAP H-binding molecule was isolated from the membrane of the serum-starved CEM cell. The isolated protein was determined to be the a subunit of ATP synthase. The interaction of EMAP II and alpha-ATP synthase was confirmed by enzyme-linked immunosorbent assay and in vitro pull down assays and blocked with the antibodies raised against EMAP II and a-ATP synthase. The binding of EMAP II to the surface of serum-starved cells was inhibited in the presence of soluble a-ATP synthase. EMAP II inhibited the growth of endothelial cells, and this effect was relieved by soluble a-ATP synthase. Antia-ATP synthase antibody also showed an inhibitory effect on the proliferation of endothelial cells mimicking the activity of EMAP II. These results suggest the potential interaction of p43/EMAP II with a-ATP synthase and its role in the proliferation of endothelial cells.	Seoul Natl Univ, Coll Pharm, Immunol Lab, Kwanak Gu, Seoul 151742, South Korea; Seoul Natl Univ, Coll Pharm, Natl Creat Res Initiat Ctr ARS Network, Kwanak Gu, Seoul 151742, South Korea; PanGenom Inc, Kwang Gu, Seoul 151057, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kang, CY (corresponding author), Seoul Natl Univ, Coll Pharm, Immunol Lab, Kwanak Gu, San 56-1,Shillimdong, Seoul 151742, South Korea.		Kim, Sunghoon/AAE-8314-2020					Barinaga M, 1999, SCIENCE, V283, P1831, DOI 10.1126/science.283.5409.1831; Barnett G, 2000, CANCER RES, V60, P2850; Behrensdorf HA, 2000, FEBS LETT, V466, P143, DOI 10.1016/S0014-5793(99)01777-9; Berger AC, 2000, CYTOKINE, V12, P992, DOI 10.1006/cyto.2000.0687; Berger AC, 2000, MICROVASC RES, V60, P70, DOI 10.1006/mvre.2000.2249; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; KAO J, 1992, J BIOL CHEM, V267, P20239; KAO J, 1994, J BIOL CHEM, V269, P25106; KAO J, 1994, J BIOL CHEM, V269, P9774; Knies UE, 1998, P NATL ACAD SCI USA, V95, P12322, DOI 10.1073/pnas.95.21.12322; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Liu SH, 1999, INVEST OPHTH VIS SCI, V40, P3152; Martinez-Zaguilan R, 1999, SCIENCE, V284, P433; Marvin MR, 1996, J SURG RES, V63, P248, DOI 10.1006/jsre.1996.0256; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Murray JC, 2000, AM J PATHOL, V157, P2045, DOI 10.1016/S0002-9440(10)64843-2; OLD LJ, 1961, CANCER RES, V21, P1281; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Schwarz MA, 1999, J EXP MED, V190, P341, DOI 10.1084/jem.190.3.341; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Wu PC, 1999, CANCER RES, V59, P205; WU PC, 1998, SURG FORUM, V49, P436; YOUNG TN, 1995, J BIOL CHEM, V270, P999, DOI 10.1074/jbc.270.3.999; Zhang FR, 2000, DEV DYNAM, V218, P490, DOI 10.1002/1097-0177(200007)218:3<490::AID-DVDY1005>3.0.CO;2-C	27	62	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8388	8394		10.1074/jbc.M108792200	http://dx.doi.org/10.1074/jbc.M108792200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741979	hybrid			2022-12-27	WOS:000174268000098
J	Han, JM; Kim, JH; Lee, BD; Lee, SD; Kim, Y; Jung, YW; Lee, S; Cho, W; Ohba, M; Kuroki, T; Suh, PG; Ryu, SH				Han, JM; Kim, JH; Lee, BD; Lee, SD; Kim, Y; Jung, YW; Lee, S; Cho, W; Ohba, M; Kuroki, T; Suh, PG; Ryu, SH			Phosphorylation-dependent regulation of phospholipase D2 by protein kinase C delta in rat pheochromocytoma PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION-FACTOR; PLASMA-MEMBRANE; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; HUMAN NEUTROPHILS; D ISOENZYMES; ACTIVATION; ALPHA; CLONING; EXPRESSION	Many studies have shown that protein kinase C (PKC) is an important physiological regulator of phospholipase D (PLD). However, the role of PKC in agonist-induced PLD activation has been mainly investigated with a focus on the PLD1, which is one of the two PLD isoenzymes (PLD1 and PLD2) cloned to date. Since the expression of PLD2 significantly enhanced phorbol 12-myristate 13-acetate (PMA)- or bradykinin-induced PLD activity in rat pheochromocytoma PC12 cells, we investigated the regulatory mechanism of PLD2 in PC 12 cells. Two different PKC inhibitors, GF109203X and Ro-318220, completely blocked PMA-induced PLD2 activation. In addition, specific inhibition of PKCdelta by rottlerin prevented PLD2 activation in PMA-stimulated PC12 cells. Concomitant with PLD2 activation, PLD2 became phosphorylated upon PMA or bradykinin treatment of PC12 cells. Moreover, rottlerin blocked PMA- or bradykinin-induced PLD2 phosphorylation in PC 12 cells. Expression of a kinase-deficient mutant of PKCdelta using adenovirus-mediated gene transfer inhibited the phosphorylation and activation of PLD2 induced by PMA in PC12 cells, suggesting the phosphorylation-dependent regulation of PLD2 mediated by PKCdelta kinase activity in PC12 cells. PKCdelta co-immunoprecipitated with PLD2 from PC 12 cell extracts, and associated with PLD2 in vitro in a PMA-dependent manner. Phospho-PLD2 immunoprecipitated from PMA-treated PC12 cells and PLD2 phosphorylated in vitro by PKCdelta were resolved by two-dimensional phosphopeptide mapping and compared. At least seven phosphopeptides co-migrated, indicating the direct phosphorylation of PLD2 by PKCdelta inside the cells. Immunocytochemical studies of PC12 cells revealed that after treatment with PMA, PKCdelta was translocated from the cytosol to the plasma membrane where PLD2 is mainly localized. These results suggest that PKCS-dependent direct phosphorylation plays an important role in the regulation of PLD2 activity in PC12 cells.	Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; Univ Illinois, Dept Chem MC 111, Chicago, IL 60607 USA; Showa Univ, Sch Med, Inst Mol Oncol, Shinagawa Ku, Tokyo 1428666, Japan	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Showa University	Ryu, SH (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.		Kuroki, Toshio/A-9500-2011; Suh, Pann-Ghill/F-3610-2010	Kuroki, Toshio/0000-0001-6369-4351; lee, sang do/0000-0003-1778-6575; Kim, Yong/0000-0002-1387-2962; Ryu, Sung Ho/0000-0003-0913-3048; Han, Jung Min/0000-0003-3372-7575				BALBOA MA, 1995, J BIOL CHEM, V270, P29843; BILLAH MM, 1993, CURR OPIN IMMUNOL, V5, P114; BROWN HA, 1995, J BIOL CHEM, V270, P14935, DOI 10.1074/jbc.270.25.14935; Chung JK, 1997, J BIOL CHEM, V272, P15980, DOI 10.1074/jbc.272.25.15980; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; CONRICODE KM, 1994, FEBS LETT, V342, P149, DOI 10.1016/0014-5793(94)80490-7; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Decker C, 1996, BIOCHEM J, V320, P885, DOI 10.1042/bj3200885; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; Frohman MA, 1996, CURR BIOL, V6, P945, DOI 10.1016/S0960-9822(02)00634-6; Gibbs TC, 2000, J CELL PHYSIOL, V182, P77, DOI 10.1002/(SICI)1097-4652(200001)182:1<77::AID-JCP9>3.0.CO;2-B; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; HIRAI S, 1994, EMBO J, V13, P2331, DOI 10.1002/j.1460-2075.1994.tb06517.x; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; KANOH H, 1992, J NEUROCHEM, V59, P1786, DOI 10.1111/j.1471-4159.1992.tb11011.x; Katayama K, 1998, BIOCHEM J, V329, P647, DOI 10.1042/bj3290647; Kim JH, 1998, FEBS LETT, V430, P231, DOI 10.1016/S0014-5793(98)00661-9; Kim Y, 2000, J BIOL CHEM, V275, P13621, DOI 10.1074/jbc.275.18.13621; Kim Y, 1999, BIOCHEMISTRY-US, V38, P10344, DOI 10.1021/bi990579h; Kodaki T, 1997, J BIOL CHEM, V272, P11408; KTISTAKIS NT, 1995, P NATL ACAD SCI USA, V92, P4952, DOI 10.1073/pnas.92.11.4952; Kuroki T, 1999, J INVEST DERM SYMP P, V4, P153, DOI 10.1038/sj.jidsp.5640200; Lee C, 2000, J BIOL CHEM, V275, P18751, DOI 10.1074/jbc.M001695200; Lee SD, 2000, J NEUROCHEM, V75, P1053, DOI 10.1046/j.1471-4159.2000.0751053.x; Lee SD, 2000, NEUROSCI LETT, V294, P130, DOI 10.1016/S0304-3940(00)01563-9; Lee TG, 1997, BBA-LIPID LIPID MET, V1347, P199, DOI 10.1016/S0005-2760(97)00083-0; LEE YH, 1994, J BIOL CHEM, V269, P26842; LOPEZ I, 1995, J BIOL CHEM, V270, P19465, DOI 10.1074/jbc.270.33.19465; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Morash SC, 1998, BIOCHEM J, V332, P321, DOI 10.1042/bj3320321; ODRISCOLL KR, 1995, MOL BIOL CELL, V6, P449, DOI 10.1091/mbc.6.4.449; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Olson SC, 1996, CHEM PHYS LIPIDS, V80, P3, DOI 10.1016/0009-3084(96)02541-8; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Provost JJ, 1996, BIOCHEM J, V319, P285, DOI 10.1042/bj3190285; Sciorra VA, 2001, BIOCHEMISTRY-US, V40, P2640, DOI 10.1021/bi002528m; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Shome K, 1998, J BIOL CHEM, V273, P30836, DOI 10.1074/jbc.273.46.30836; Siddiqi AR, 2000, BBA-MOL CELL RES, V1497, P103, DOI 10.1016/S0167-4889(00)00049-5; Singer WD, 1996, J BIOL CHEM, V271, P4504; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; Steed PM, 1998, FASEB J, V12, P1309, DOI 10.1096/fasebj.12.13.1309; Sung TC, 1999, J BIOL CHEM, V274, P494, DOI 10.1074/jbc.274.1.494; WATANABE H, 2000, BIOCHIM BIOPHYS ACTA, V495, P121; Whatmore J, 1996, BIOCHEM J, V320, P785, DOI 10.1042/bj3200785; YEO EJ, 1995, J BIOL CHEM, V270, P3980, DOI 10.1074/jbc.270.8.3980	53	46	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8290	8297		10.1074/jbc.M108343200	http://dx.doi.org/10.1074/jbc.M108343200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11744693	hybrid			2022-12-27	WOS:000174268000086
J	Lee, S; Tarn, C; Wang, WH; Chen, SG; Hullinger, RL; Andrisani, OM				Lee, S; Tarn, C; Wang, WH; Chen, SG; Hullinger, RL; Andrisani, OM			Hepatitis B virus X protein differentially regulates cell cycle progression in X-transforming versus nontransforming hepatocyte (AML12) cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; HBX PROTEIN; HEPATOCELLULAR-CARCINOMA; MAMMALIAN FIBROBLASTS; TRANSCRIPTION FACTORS; KINASE-ACTIVITY; GENE-PRODUCT; FACTOR-ALPHA; GROWTH; LIVER	Hepatitis B virus (HBV) X protein (pX) is implicated in hepatocarcinogenesis of chronically infected HBV patients. To understand mechanism(s) of pX-mediated cellular transformation, we employed two tetracycline-regulated, pX-expressing cell lines, constructed in AML12 immortalized hepatocytes: one a differentiated (3pX-1) and the other a de-differentiated (4pX-1) hepatocyte cell line. Only 3pX-1 cells undergo pX-mediated transformation, via sustained Ras-Raf-mitogen-activated protein kinase pathway activation. pX-nontransforming 4pX-1 cells display sustained, pX-dependent JNK pathway activation. To understand how pX mediates different growth characteristics in 3pX-1 and 4pX-1 cells, we report, herein, comparative cell cycle analyses. pX-transforming 3pX-1 cells display pX-dependent G(1), S, and G(2)/M progression evidenced by cyclin D-1, A, and B-1 induction, and Cdc2 kinase activation. pX-nontransforming 4pX-1 cells display pX-dependent G(1) and S phase entry, followed by S phase pause and absence of Cdc2 kinase activation. Interestingly, 4pX-1 cells exhibit selective pX-induced expression of cyclin-dependent kinase inhibitor p21(Cip1), tumor suppressor pl9(ARF), and proapoptotic genes bax and IGFBP-3. Despite the pX-mediated induction of growth arrest and apoptotic genes and the absence of pX-dependent Cdc2 activation, 4pX-1 cells do not undergo pX-dependent G(2)/M arrest or apoptosis. Nocodazole-treated, G(2)/M-arrested 4pX-1 cells exhibit pX-dependent formation of multinucleated cells, similar to human T-cell lymphotropic virus type I Tax-expressing cells. We propose that in 4pX-1 cells, pX deregulates the G(2)/M checkpoint, thus rescuing cells from pX-mediated apoptosis.	Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Andrisani, OM (corresponding author), Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA.		Chen, Sigeng/G-1678-2014	Andrisani, Ourania/0000-0002-6230-0303	NIDDK NIH HHS [DK44533] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK044533, R01DK044533] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Andrisani OM, 1999, INT J ONCOL, V15, P373; Barnabas S, 1997, J BIOL CHEM, V272, P20684, DOI 10.1074/jbc.272.33.20684; Barnabas S, 2000, J VIROL, V74, P83, DOI 10.1128/JVI.74.1.83-90.2000; BATES S, 1996, CURRENT OPIN GENET D, V6, P1; BEASLEY RP, 1981, LANCET, V2, P1129; BEEN J, 1994, P NATL ACAD SCI USA, V91, P10350; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; BENN J, 1996, J VIROL, V70, P4798; BOUBER RN, 1997, J BIOL CHEM, V272, P22300; Bouchard M, 2001, J VIROL, V75, P4247, DOI 10.1128/JVI.75.9.4247-4257.2001; BRAUN L, 1987, CANCER RES, V47, P4116; Buendia MA, 1998, BIOMED PHARMACOTHER, V52, P34, DOI 10.1016/S0753-3322(97)86239-7; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; Crosby HA, 1998, AM J PATHOL, V152, P771; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; Dandri M, 1996, J VIROL, V70, P5246, DOI 10.1128/JVI.70.8.5246-5254.1996; DORIA M, 1995, EMBO J, V14, P4747, DOI 10.1002/j.1460-2075.1995.tb00156.x; Draetta G, 1997, BBA-REV CANCER, V1332, pM53, DOI 10.1016/S0304-419X(96)00049-2; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; FU XX, 1988, J VIROL, V62, P3422, DOI 10.1128/JVI.62.9.3422-3430.1988; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Haviv I, 1998, MOL CELL BIOL, V18, P1562, DOI 10.1128/MCB.18.3.1562; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; HIXSON DC, 1985, CANCER RES, V45, P3750; HOHNE M, 1990, EMBO J, V9, P1137, DOI 10.1002/j.1460-2075.1990.tb08220.x; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang JK, 1996, J VIROL, V70, P5582, DOI 10.1128/JVI.70.8.5582-5591.1996; HUANG TS, 1995, P NATL ACAD SCI USA, V92, P4793, DOI 10.1073/pnas.92.11.4793; HWANG A, 1995, J BIOL CHEM, V270, P28419; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kim H, 1998, J BIOL CHEM, V273, P381, DOI 10.1074/jbc.273.1.381; Klein NP, 1999, EMBO J, V18, P5019, DOI 10.1093/emboj/18.18.5019; Klein NP, 1997, MOL CELL BIOL, V17, P6427, DOI 10.1128/MCB.17.11.6427; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Lee YH, 1998, J BIOL CHEM, V273, P25510, DOI 10.1074/jbc.273.39.25510; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Libbrecht L, 2001, AM J SURG PATHOL, V25, P1388, DOI 10.1097/00000478-200111000-00006; Lin Y, 1997, J BIOL CHEM, V272, P7132, DOI 10.1074/jbc.272.11.7132; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Matsumura I, 2000, J BIOL CHEM, V275, P5553, DOI 10.1074/jbc.275.8.5553; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; MIYASHITA T, 1995, CELL, V80, P293; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Okabe H, 2001, CANCER RES, V61, P2129; OKUDA T, 1992, ONCOGENE, V7, P2249; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PITTERLIN D, 1997, J VIROL, V71, P6194; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUADRI I, 1996, P NATL ACAD SCI USA, V93, P10578; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; SELL S, 1987, ADV CANCER RES, V48, P37, DOI 10.1016/S0065-230X(08)60690-9; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sirma H, 1999, ONCOGENE, V18, P4848, DOI 10.1038/sj.onc.1202867; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Su F, 2001, J VIROL, V75, P215, DOI 10.1128/JVI.75.1.215-225.2001; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Tarn C, 1999, J BIOL CHEM, V274, P2327, DOI 10.1074/jbc.274.4.2327; Tarn C, 2001, J BIOL CHEM, V276, P34671, DOI 10.1074/jbc.M104105200; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tsuiki H, 2001, ONCOGENE, V20, P420, DOI 10.1038/sj.onc.1204126; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; YSHIMURA MD, 1983, AM J PATHOL, V110, P322; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677	91	61	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8730	8740		10.1074/jbc.M108025200	http://dx.doi.org/10.1074/jbc.M108025200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756437	hybrid			2022-12-27	WOS:000174268000140
J	Li, DX; Sirakova, T; Rogers, L; Ettinger, WF; Kolattukudy, PE				Li, DX; Sirakova, T; Rogers, L; Ettinger, WF; Kolattukudy, PE			Regulation of constitutively expressed and induced cutinase genes by different zinc finger transcription factors in Fusarium solani f. sp pisi (Nectria haematococca)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT CUTICLE; SUBSTRATE-SPECIFICITY; ASPERGILLUS-NIDULANS; NONSPECIFIC ESTERASE; FUNGAL CUTINASE; PROTEIN; SEQUENCE; DNA; PROMOTER; PATHWAY	Cutin monomers, generated by the low levels of constitutively expressed cutinase, induce high levels of cutinase that can help pathogenic fungi to penetrate into the host through the cuticle whose major structural polymer is cutin. We cloned three highly homologous cutinase genes, cut1, cut2, and cut3, from Fusarium solani f. pisi (Nectria haematococca). Amino acid sequence deduced from the nucleotide sequence of cut1 and cut2/3 matched with that of the peptides from cutinase 1 and cutinase 2, respectively, isolated from F. solani pisi grown on cutin as the sole carbon source. Induction of beta-glucuronidase gene fused to the promoters of the cutinases integrated into F. solani pisi genome indicates that cut2 is constitutively expressed and induced under starvation, whereas cut1 is highly induced by cutin monomers. A palindrome binding protein (PBP) previously cloned binds only to palindrome 1 of cut1 promoter but not palindrome 1 of cut2/3 which contains two base substitutions. PBP is thought to interfere with the binding of CTF1alpha, the transcription factor involved in induction, to cut1 promoter and thus keep cut1 gene repressed until induced by cutin monomers. Because PBP cannot bind palindrome 1 of cut2, this gene is not repressed. CTF1alpha does not transactivate cut2 promoter. A new Cys(6)Zn(2) motif-containing transcription factor, CTF1beta, that binds palindrome 2 was cloned and sequenced. In yeast, CTF1beta transactivates cut2 promoter but not cut1 promoter unless its palindrome 1 is mutated, unlike CTF1alpha which transactivates cut1. Thus, CTF1beta is involved in the constitutive expression of cut2 that causes production of low levels of cutin monomers that strongly induce cut1 using CTF1alpha as the transcription factor.	Ohio State Univ, Neurobiotechnol Ctr, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kolattukudy, PE (corresponding author), Ohio State Univ, Neurobiotechnol Ctr, 206 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	kolattukudy.2@osu.edu	kolattukudy, pappachan e/A-1350-2012					Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRE B, 1990, MOL GEN GENET, V220, P269; ANDRIANOPOULOS A, 1990, MOL CELL BIOL, V10, P3194, DOI 10.1128/MCB.10.6.3194; BAJAR A, 1991, P NATL ACAD SCI USA, V88, P8208, DOI 10.1073/pnas.88.18.8208; BALZI E, 1987, J BIOL CHEM, V262, P16871; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BERI RK, 1987, NUCLEIC ACIDS RES, V15, P7991, DOI 10.1093/nar/15.19.7991; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGER G, 1991, MOL CELL BIOL, V11, P5746, DOI 10.1128/MCB.11.11.5746; HANKIN L, 1968, J GEN MICROBIOL, V51, P457, DOI 10.1099/00221287-51-3-457; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KAMMERER B, 1984, J MOL BIOL, V180, P239, DOI 10.1016/S0022-2836(84)80002-9; KAMPER JT, 1994, J BIOL CHEM, V269, P9195; KIM J, 1988, CURR GENET, V14, P319, DOI 10.1007/BF00419988; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; KOLATTUKUDY PE, 1995, P NATL ACAD SCI USA, V92, P4080, DOI 10.1073/pnas.92.10.4080; KOLLER W, 1982, PHYSIOL PLANT PATHOL, V20, P47, DOI 10.1016/0048-4059(82)90023-6; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LAUGHON A, 1984, MOL CELL BIOL, V4, P260, DOI 10.1128/MCB.4.2.260; LI D, 1995, J BIOL CHEM, V270, P11753, DOI 10.1074/jbc.270.20.11753; Li DX, 1997, J BIOL CHEM, V272, P12462, DOI 10.1074/jbc.272.19.12462; MARCZAK JE, 1991, MOL CELL BIOL, V11, P2609, DOI 10.1128/MCB.11.5.2609; MARMORSTEIN R, 1994, GENE DEV, V8, P2504, DOI 10.1101/gad.8.20.2504; MESSENGUY F, 1986, EUR J BIOCHEM, P15777; MOHAN R, 1993, PLANT MOL BIOL, V21, P341, DOI 10.1007/BF00019949; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2824, DOI 10.1021/bi00684a006; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2832, DOI 10.1021/bi00684a007; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SOLIDAY CL, 1984, P NATL ACAD SCI-BIOL, V81, P3939, DOI 10.1073/pnas.81.13.3939; SOLIDAY CL, 1989, J BACTERIOL, V171, P1942, DOI 10.1128/jb.171.4.1942-1951.1989; SUAREZ T, 1995, EMBO J, V14, P1453, DOI 10.1002/j.1460-2075.1995.tb07132.x; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WOLOSHUK CP, 1986, P NATL ACAD SCI USA, V83, P1704, DOI 10.1073/pnas.83.6.1704; WOLOSHUK CP, 1994, APPL ENVIRON MICROB, V60, P2408, DOI 10.1128/AEM.60.7.2408-2414.1994; WOLOSHUK CP, 1986, CUTINASE FUSARIUM SO; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; Worthington C., 1988, ENZYME MANUAL, P155; WRAY LV, 1987, MOL CELL BIOL, V7, P1111, DOI 10.1128/MCB.7.3.1111; YUAN GF, 1991, MOL CELL BIOL, V11, P5735, DOI 10.1128/MCB.11.11.5735; ZHANG L, 1994, GENE DEV, V8, P2110, DOI 10.1101/gad.8.17.2110	45	61	67	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					7905	7912		10.1074/jbc.M108799200	http://dx.doi.org/10.1074/jbc.M108799200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11756444	hybrid			2022-12-27	WOS:000174268000037
J	Huang, YF; Komoto, J; Takata, Y; Powell, DR; Gomi, T; Ogawa, H; Fujioka, M; Takusagawa, F				Huang, YF; Komoto, J; Takata, Y; Powell, DR; Gomi, T; Ogawa, H; Fujioka, M; Takusagawa, F			Inhibition of S-adenosylhomocysteine hydrolase by acyclic sugar adenosine analogue D-eritadenine - Crystal structure of S-adenosylhomocysteine hydrolase complexed with D-eritadenine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-HOMOCYSTEINE HYDROLASE; ALIPHATIC NUCLEOSIDE ANALOG; ANTI-VIRAL ACTIVITY; RAT-LIVER; ANTIVIRAL ACTIVITY; NEPLANOCIN-A; BINDING-SITE; VIRUS; CELLS; MUTAGENESIS	D-Eritadenine (DEA) is a potent inhibitor (IC50 = 7 nm) of S-adenosyl-L-homocysteine hydrolase (AdoHcyase). Unlike cyclic sugar Ado analogue inhibitors, including mechanism-based inhibitors, DEA is an acyclic sugar Ado analogue, and the C2' and C3' have opposite chirality to those of the cyclic sugar Ado inhibitors. Crystal structures of DEA alone and in complex with AdoHcyase have been determined to elucidate the DEA binding scheme to AdoHcyase. The DEA-complexed structure has been analyzed by comparing it with two structures of AdoHcyase complexed with cyclic sugar Ado analogues. The DEA-complexed structure has a closed conformation, and the DEA is located near the bound NAD(+). However, a UV absorption measurement shows that DEA is not oxidized by the bound NAD(+), indicating that the open-closed conformational change of AdoHeyase is due to the substrate/inhibitor binding, not the oxidation state of the bound NAD. The adenine ring of DEA is recognized by four essential hydrogen bonds as observed in the cyclic sugar Ado complexes. The hydrogen bond network around the acyclic sugar moiety indicates that DEA is more tightly connected to the protein than the cyclic sugar Ado analogues. The C3'-H of DEA is pointed toward C4 of the bound NAD(+) (C3'---C4 = 3.7 Angstrom), suggesting some interaction between DEA and NAD(+). By placing DEA into the active site of the open structure, the major forces to stabilize the closed conformation of AdoHeyase are identified as the hydrogen bonds between the backbone of His-352 and the adenine ring, and the C3'-H C4 interaction. DEA has been believed to be an inactivator of AdoHcyase, but this study indicates that DEA is a reversible inhibitor. On the basis of the complexed structure, selective inhibitors of AdoHcyase have been designed.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; Toyama Med & Pharmaceut Univ, Dept Biochem, Fac Med, Sugitani, Toyama 9300194, Japan	University of Kansas; University of Toyama	Takusagawa, F (corresponding author), Univ Kansas, Dept Mol Biosci, 3004 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.				NIGMS NIH HHS [GM 37233] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; Borchardt R. T., 1986, BIOL METHYLATION DRU, P227; BORCHARDT RT, 1984, J BIOL CHEM, V259, P4353; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; BRUNNETT B, 1993, SURVEYS MATH IND, V3, P1; CANTONI GL, 1954, J AM CHEM SOC, V76, P4744, DOI 10.1021/ja01647a081; CHIANG PK, 1978, BIOCHEM BIOPH RES CO, V82, P417, DOI 10.1016/0006-291X(78)90892-6; COWARD JK, 1973, BIOCHEMISTRY-US, V12, P2291, DOI 10.1021/bi00736a017; DECLERCQ E, 1978, SCIENCE, V200, P563, DOI 10.1126/science.200.4341.563; DECLERCQ E, 1979, J MED CHEM, V22, P510, DOI 10.1021/jm00191a010; DECLERCQ E, 1990, MICROBIOLOGICA, V13, P165; DECLERCQ E, 1984, ANTIVIR RES, V4, P119, DOI 10.1016/0166-3542(84)90012-3; DECLERCQ E, 1985, ANTIMICROB AGENTS CH, V28, P84, DOI 10.1128/AAC.28.1.84; DECLERCQ E, 1985, J MED CHEM, V28, P282, DOI 10.1021/jm00381a004; DEGUCHI T, 1971, J BIOL CHEM, V246, P3175; FUJIOKA M, 1981, J BIOL CHEM, V256, P1631; GOMI T, 1989, J BIOL CHEM, V264, P16138; GURANOWSKI A, 1981, BIOCHEMISTRY-US, V20, P110, DOI 10.1021/bi00504a019; HASEBE M, 1989, ANTIMICROB AGENTS CH, V33, P828; HILL DL, 1971, MOL PHARMACOL, V7, P375; HOLY A, 1982, COLLECT CZECH CHEM C, V47, P1392, DOI 10.1135/cccc19821392; Hu YB, 1999, BIOCHEMISTRY-US, V38, P8323, DOI 10.1021/bi990332k; HURWITZ J, 1964, J BIOL CHEM, V239, P3474; Komoto J, 2000, J BIOL CHEM, V275, P32147, DOI 10.1074/jbc.M003725200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MERTA A, 1983, COLLECT CZECH CHEM C, V48, P2701, DOI 10.1135/cccc19832701; MORCH MD, 1987, NUCLEIC ACIDS RES, V15, P4123, DOI 10.1093/nar/15.10.4123; NARAYANAN SR, 1988, J MED CHEM, V31, P500, DOI 10.1021/jm00398a002; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; OKUMURA K, 1974, J MED CHEM, V17, P846, DOI 10.1021/jm00254a014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER JL, 1979, J BIOL CHEM, V254, P1217; PALMER JL, 1976, J BIOL CHEM, V251, P5817; PUGH CSG, 1977, BIOCHEMISTRY-US, V16, P3928, DOI 10.1021/bi00636a032; RICHARDS HH, 1978, J BIOL CHEM, V253, P4476; SCHANCHE JS, 1984, MOL PHARMACOL, V26, P553; Turner MA, 1998, NAT STRUCT BIOL, V5, P369, DOI 10.1038/nsb0598-369; VOTRUBA I, 1982, COLLECT CZECH CHEM C, V47, P167, DOI 10.1135/cccc19820167; VOTRUBA I, 1980, COLLECT CZECH CHEM C, V45, P3039, DOI 10.1135/cccc19803039; YAGINUMA S, 1981, J ANTIBIOT, V34, P359, DOI 10.7164/antibiotics.34.359	40	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7477	7482		10.1074/jbc.M109187200	http://dx.doi.org/10.1074/jbc.M109187200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11741948	hybrid			2022-12-27	WOS:000174104300093
J	Brandlin, I; Hubner, S; Eiseler, T; Martinez-Moya, M; Horschinek, A; Hausser, A; Link, G; Rupp, S; Storz, P; Pfizenmaier, K; Johannes, FJ				Brandlin, I; Hubner, S; Eiseler, T; Martinez-Moya, M; Horschinek, A; Hausser, A; Link, G; Rupp, S; Storz, P; Pfizenmaier, K; Johannes, FJ			Protein kinase C (PKC) eta-mediated PKC mu activation modulates ERK and JNK signal pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PHOSPHORYLATION SITES; TRANSDUCTION PATHWAY; DOWN-REGULATION; AUTOPHOSPHORYLATION; IDENTIFICATION; ENDOTHELIN; EXPRESSION; ISOFORM; MEMBER	Protein kinase C (PKC), a family of lipid-activated serine kinases, is involved in multiple functions in the regulation of growth control. The PKC-related isoform PKCmu/PKD has been implicated in mitogenic signal cascades because of the activation of p42/p44 MAPK leading to Elk1-mediated gene transcription, and PKCmu/PKD has been shown to be activated via a PKC-dependent pathway. By using confocal analyses, we demonstrate here that PKCmu partially colocalizes with PKC-eta in different cell types. Colocalization depends on the presence of the PKCmu pleckstrin homology domain. Coexpression of constitutively active PKC-eta with PKCmu leads to a significant enhancement of the PKCmu substrate phosphorylation capacity as a result of an increased phosphorylation of the activation loop Ser(738/742) of PKCmu, whereas Ser(910) autophosphorylation remains unaffected. In vitro phosphorylation experiments show that PKCeta directly phosphorylates PKCmu on activation loop serines. Consequently, the p42 MAPK cascade is triggered leading to an increase in reporter gene activity driven by a serum-responsive element in HEK293 cells. At the same time, PKCeta-mediated JNK activation is reduced, providing evidence for a mutual regulation of PKCmu/PKCeta affecting different arms of the p38/ERK/ JNK pathways. Our data provide evidence for the sequential involvement of selective PKC isoforms in kinase cascades and identify the relevant domains in PKCmu for interaction with and activation by PKCeta as pleckstrin homology domain and activation loop.	Fraunhofer Inst Interfacial Engn, D-70569 Stuttgart, Germany; Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Fraunhofer Gesellschaft; University of Stuttgart; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Johannes, FJ (corresponding author), Fraunhofer Inst Interfacial Engn, Nobelstr 12, D-70569 Stuttgart, Germany.	FJJ@IGB.FhG.de	Hausser, Angelika/AAC-4531-2021					Bagowski CP, 1999, EMBO J, V18, P5567, DOI 10.1093/emboj/18.20.5567; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Cadwallader K, 1997, BIOCHEM J, V321, P795, DOI 10.1042/bj3210795; CHIDA K, 1994, MOL CELL BIOL, V14, P3782, DOI 10.1128/MCB.14.6.3782; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Dieterich S, 1996, FEBS LETT, V381, P183, DOI 10.1016/0014-5793(96)00116-0; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; Gschwendt M, 1997, J BIOL CHEM, V272, P20742, DOI 10.1074/jbc.272.33.20742; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Johannes FJ, 1999, FEBS LETT, V461, P68, DOI 10.1016/S0014-5793(99)01424-6; JOHANNES FJ, 1995, EUR J BIOCHEM, V227, P303, DOI 10.1111/j.1432-1033.1995.tb20389.x; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Johannes FJ, 1998, EUR J BIOCHEM, V257, P47, DOI 10.1046/j.1432-1327.1998.2570047.x; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; OHNO S, 1990, J BIOL CHEM, V265, P6296; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Storz P, 2000, J BIOL CHEM, V275, P24601, DOI 10.1074/jbc.M002964200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Toker Alex, 1998, Frontiers in Bioscience, V3, pD1134; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; Vertommen D, 2000, J BIOL CHEM, V275, P19567, DOI 10.1074/jbc.M001357200; Wajant H, 1998, CURR BIOL, V8, P113, DOI 10.1016/S0960-9822(98)70042-9; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	36	115	115	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6490	6496		10.1074/jbc.M106083200	http://dx.doi.org/10.1074/jbc.M106083200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741879	hybrid			2022-12-27	WOS:000173989200105
J	Francis, N; Deneris, ES				Francis, N; Deneris, ES			Retinal neuron activity of ETS domain-binding sites in a nicotinic acetylcholine receptor gene cluster enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; SUBUNIT MESSENGER-RNAS; CHICK RETINA; BETA-4 SUBUNIT; RAT; EXPRESSION; CELLS; ALPHA; TRANSCRIPTION; PROMOTER	Nicotinic acetylcholine receptors (nAchRs) mediate amacrine to ganglion cell synaptic transmission in the developing mammalian retina. The clustered neuronal nAchRs subunit genes, alpha3 and beta4, are expressed in amacrine and ganglion cells where they are used to assemble functional receptor subtypes. The transcriptional mechanisms underlying expression of these subunits in retina are not yet known but may involve enhancers that are selectively active in retinal neurons. We previously identified a neuron-selective enhancer, beta43', whose activity in neural cell lines is dependent on ETS domain-binding sites. To determine whether beta43' is active in retinal neurons that express the alpha3 and beta4 genes, we investigated beta43' activity in primary dissociated rat retinal cultures. We found that beta43' is selectively active in retinal neurons compared with retinal non-neuronal cells. This activity was derived primarily from amacrine and ganglion neurons, which are the retinal neuron cell types that express the clustered genes. Moreover, beta43' was selectively active in retinal neurons compared with cerebral cortical neurons suggesting that it is not a panneuronal enhancer. ETS factor-binding sites in the enhancer are required for its retinal neuron activity. These findings suggest that ETS factor interactions with beta43' control retinal neuron expression of certain nAchR subtypes.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Deneris, ES (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	esd@po.cwru.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029123] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Bansal A, 2000, J NEUROSCI, V20, P7672; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Bigger CB, 1996, J BIOL CHEM, V271, P32842, DOI 10.1074/jbc.271.51.32842; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; BRITTO LRG, 1994, VISUAL NEUROSCI, V11, P569, DOI 10.1017/S0952523800002479; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; Campos-Caro A, 1999, J BIOL CHEM, V274, P4693, DOI 10.1074/jbc.274.8.4693; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; DINELEYMILLER K, 1992, MOL BRAIN RES, V16, P339, DOI 10.1016/0169-328X(92)90244-6; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Flora A, 2000, J NEUROCHEM, V75, P18, DOI 10.1046/j.1471-4159.2000.0750018.x; Francis NJ, 1997, DEV BIOL, V182, P76, DOI 10.1006/dbio.1996.8464; Fyodorov D, 1998, J NEUROBIOL, V34, P151, DOI 10.1002/(SICI)1097-4695(19980205)34:2<151::AID-NEU5>3.0.CO;2-1; GALANG CK, 1994, ONCOGENE, V9, P2913; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; HAMASSAKIBRITTO DE, 1991, J COMP NEUROL, V313, P394, DOI 10.1002/cne.903130213; HAMASSAKIBRITTO DE, 1994, J COMP NEUROL, V347, P161, DOI 10.1002/cne.903470202; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; HOOVER F, 1992, EXP EYE RES, V54, P561, DOI 10.1016/0014-4835(92)90135-F; Jeon CJ, 1998, J NEUROSCI, V18, P8936; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; KEYSER KT, 1993, J NEUROSCI, V13, P442; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LEMMON V, 1986, J NEUROSCI, V6, P2987; Liu W, 2000, DEV DYNAM, V217, P320, DOI 10.1002/(SICI)1097-0177(200003)217:3<320::AID-DVDY10>3.0.CO;2-F; MANDEL G, 1993, ANNU REV NEUROSCI, V16, P323, DOI 10.1146/annurev.ne.16.030193.001543; MANDELZYS A, 1994, J NEUROSCI, V14, P2357; MATTERSADZINSKI L, 1992, EMBO J, V11, P4529, DOI 10.1002/j.1460-2075.1992.tb05554.x; McDonough J, 1997, J NEUROSCI, V17, P2273; McDonough J, 2000, J BIOL CHEM, V275, P28962, DOI 10.1074/jbc.M004181200; McGehee DS, 1996, CURR OPIN NEUROBIOL, V6, P342, DOI 10.1016/S0959-4388(96)80118-8; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Terzano S, 2000, J BIOL CHEM, V275, P41495, DOI 10.1074/jbc.M006197200; Vailati S, 2000, EUR J PHARMACOL, V393, P23, DOI 10.1016/S0014-2999(00)00067-4; Vailati S, 1999, MOL PHARMACOL, V56, P11, DOI 10.1124/mol.56.1.11; WADA E, 1990, BRAIN RES, V526, P45, DOI 10.1016/0006-8993(90)90248-A; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; Weber JRM, 1997, J NEUROSCI, V17, P7583; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Xia ZG, 1996, J NEUROSCI, V16, P5425; XIN JH, 1992, GENE DEV, V6, P481, DOI 10.1101/gad.6.3.481; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514; ZOLI M, 1995, J NEUROSCI, V15, P1912, DOI 10.1523/JNEUROSCI.15-03-01912.1995	53	9	9	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6511	6519		10.1074/jbc.M105616200	http://dx.doi.org/10.1074/jbc.M105616200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11734552	hybrid			2022-12-27	WOS:000173989200108
J	Hirschi, KK; Lai, LH; Belaguli, NS; Dean, DA; Schwartz, RJ; Zimmer, WE				Hirschi, KK; Lai, LH; Belaguli, NS; Dean, DA; Schwartz, RJ; Zimmer, WE			Transforming growth factor-beta induction of smooth muscle cell phenotpye requires transcriptional and post-transcriptional control of serum response factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-ACTIN GENE; TGF-BETA; DNA-BINDING; MESSENGER-RNA; 3'-UNTRANSLATED REGION; ENDOTHELIAL-CELLS; PATHOGENIC ROLES; CIS-ELEMENT; EXPRESSION; PROMOTER	Transforming growth factor-beta induces a smooth muscle cell phenotype in undifferentiated mesenchymal cells. To elucidate the mechanism(s) of this phenotypic induction, we focused on the molecular regulation of smooth muscle-gamma-actin, whose expression is induced at late stages of smooth muscle differentiation and developmentally restricted to this lineage. Transforming growth factor-beta induced smooth muscle-gamma-actin protein, cytoskeletal localization, and mRNA expression in mesenchymal cells. Smooth muscle-gamma-actin promoter-luciferase reporter activity was enhanced by transforming growth factor-beta, and deletion analysis revealed that CArG box 2 in the promoter was necessary for this transcriptional activation. CArG motifs bind transcriptional activator serum response factor; gel shift analyses revealed increased binding of serum response factor-containing complexes to this site in response to transforming growth factor-beta, paralleled by increased serum response factor protein expression. Serum response factor expression was found to be up-regulated by transforming growth factor-beta via transcriptional activation of the gene and post-transcriptional regulation. Using mesenchymal cells stably transfected with wild type or dominant-negative serum response factor, we demonstrated that its expression is sufficient for induction of a smooth muscle phenotype in mesenchymal cells and is necessary for transforming growth factor-beta-mediated smooth muscle induction.	Baylor Coll Med, Ctr Cell & Gene Therapy, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cell & Gene Therapy, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of South Alabama	Hirschi, KK (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Dept Pediat, 1 Baylor Plaza, Houston, TX 77030 USA.	khirschi@bcm.tmc.edu		Zimmer, Warren/0000-0002-0668-6096	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059956, P01HL049953, R01HL061408] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amara FM, 1996, J BIOL CHEM, V271, P15279, DOI 10.1074/jbc.271.25.15279; AMARA FM, 1995, NUCLEIC ACIDS RES, V23, P1461, DOI 10.1093/nar/23.9.1461; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; BABIJ P, 1991, P NATL ACAD SCI USA, V88, P10676, DOI 10.1073/pnas.88.23.10676; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; BLANK RS, 1995, CIRC RES, V76, P742, DOI 10.1161/01.RES.76.5.742; BLANK RS, 1988, J CELL BIOL, V107, P299, DOI 10.1083/jcb.107.1.299; BLANK RS, 1992, J BIOL CHEM, V267, P984; Browning CL, 1998, DEV BIOL, V194, P18, DOI 10.1006/dbio.1997.8808; CARROLL SL, 1988, MOL CELL BIOL, V8, P241, DOI 10.1128/MCB.8.1.241; Carson JA, 2000, J BIOL CHEM, V275, P39061, DOI 10.1074/jbc.M006532200; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; COLLINGE M, 1992, MOL CELL BIOL, V12, P2359, DOI 10.1128/MCB.12.5.2359; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; GAZIT D, 1993, MOL ENDOCRINOL, V7, P189, DOI 10.1210/me.7.2.189; Germain S, 2000, GENE DEV, V14, P435; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hua XX, 1999, P NATL ACAD SCI USA, V96, P13130, DOI 10.1073/pnas.96.23.13130; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Jester JV, 1996, CORNEA, V15, P505; Kallmeier RC, 1995, J BIOL CHEM, V270, P30949, DOI 10.1074/jbc.270.52.30949; KIM E, 1989, MOL CELL BIOL, V9, P1875, DOI 10.1128/MCB.9.5.1875; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Kovacs AM, 1998, GENE EXPRESSION, V7, P115; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Landerholm TE, 1999, DEVELOPMENT, V126, P2053; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; MACDERMOT RP, 1988, INFLAMMATORY BOWEL D; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; MCHUGH KM, 1988, MOL CELL BIOL, V8, P5224, DOI 10.1128/MCB.8.12.5224; McHugh KM, 1996, J PEDIATR GASTR NUTR, V23, P379, DOI 10.1097/00005176-199611000-00001; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; MIWA T, 1991, MOL CELL BIOL, V11, P3296, DOI 10.1128/MCB.11.6.3296; MOSSE PRL, 1986, ARTERIOSCLEROSIS, V6, P664, DOI 10.1161/01.ATV.6.6.664; MOSSLER H, 1996, DEVELOPMENT, V122, P2415; Nakajima Y, 1999, CELL TISSUE RES, V295, P257, DOI 10.1007/s004410051232; Neurath MF, 1996, J INVEST MED, V44, P516; Nunes I, 1996, INT J OBESITY, V20, pS4; NURRISH SJ, 1995, MOL CELL BIOL, V15, P4076; Okuno M, 1997, HEPATOLOGY, V26, P913, DOI 10.1002/hep.510260417; OWENS GK, 1995, PHYSIOL REV, V75, P487; Parks WC, 1997, AM J RESP CELL MOL, V17, P1; Phiel CJ, 2001, J BIOL CHEM, V276, P34637, DOI 10.1074/jbc.M105826200; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Qian J, 1996, DEV DYNAM, V207, P135; Roberts Anita B., 1995, Wound Repair and Regeneration, V3, P408, DOI 10.1046/j.1524-475X.1995.30405.x; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; RUCH RJ, 1994, CARCINOGENESIS, V15, P301, DOI 10.1093/carcin/15.2.301; Rydziel S, 1997, J CELL PHYSIOL, V170, P145, DOI 10.1002/(SICI)1097-4652(199702)170:2<145::AID-JCP6>3.0.CO;2-O; Samaha FF, 1996, J BIOL CHEM, V271, P395, DOI 10.1074/jbc.271.1.395; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smith AF, 1998, AM J PHYSIOL-CELL PH, V274, pC1188, DOI 10.1152/ajpcell.1998.274.5.C1188; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Spencer JA, 1996, J BIOL CHEM, V271, P16535, DOI 10.1074/jbc.271.28.16535; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Willis AE, 1999, INT J BIOCHEM CELL B, V31, P73, DOI 10.1016/S1357-2725(98)00133-2; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070; Wong C, 1999, MOL CELL BIOL, V19, P1821; YAMAGUCHI M, 1994, BIOCHEM BIOPH RES CO, V204, P1206, DOI 10.1006/bbrc.1994.2591; Yamamoto K, 1997, CELL BIOL INT, V21, P605, DOI 10.1006/cbir.1997.0192; ZIMMER WE, 1996, DEV BIOL, V175, P399	75	71	75	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6287	6295		10.1074/jbc.M106649200	http://dx.doi.org/10.1074/jbc.M106649200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741973	hybrid, Green Accepted			2022-12-27	WOS:000173989200079
J	Raney, A; Law, GL; Mize, GJ; Morris, DR				Raney, A; Law, GL; Mize, GJ; Morris, DR			Regulated translation termination at the upstream open reading frame in S-adenosylmethionine decarboxylase mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; INHIBITION; CYCLOHEXIMIDE; ANTIBIOTICS; HYDROLYSIS; RELEASE; BINDING; SYSTEM	The upstream open reading frame (uORF) in the mRNA encoding S-adenosylmethionine decarboxylase is a cis-acting element that confers feedback control by cellular polyamines on translation of this message. Recent studies demonstrated that elevated polyamines inhibit synthesis of the peptide encoded by the uORF by stabilizing a ribosome paused in the vicinity of the termination codon. These studies suggested that polyamines act at the termination step of uORF translation. In this paper, we demonstrate that elevated polyamines stabilize an intermediate in the termination process, the complete nascent peptide linked to the tRNA that decodes the final codon. The peptidyl-tRNA molecule is found associated with the ribosome fraction, and decay of this molecule correlated with release of the paused ribosome from the message. Furthermore, the stability of this complex is influenced by the same parameters that influence regulation by the uORF in vivo, namely the concentration of polyamines and the sequence of the uORF-encoded peptide. These results suggest that the regulated step in uORF translation is after formation of the peptidyl-tRNA molecule but before hydrolysis of the peptidyl-tRNA bond. This regulation may involve an interaction between the peptide, polyamines, and a target in the translational apparatus.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Morris, DR (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	dmorris@u.washington.edu	Morris, David/G-4503-2011		NATIONAL CANCER INSTITUTE [R01CA039053] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON CW, 1983, METHOD ENZYMOL, V101, P635; ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Cao JH, 1996, MOL CELL BIOL, V16, P603; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Cao JH, 1998, RNA, V4, P181; CARRASCO L, 1976, MOL CELL BIOCHEM, V10, P97, DOI 10.1007/BF01742203; CELMA ML, 1970, FEBS LETT, V6, P273, DOI 10.1016/0014-5793(70)80076-X; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; Enriquez JA, 1996, P NATL ACAD SCI USA, V93, P8300, DOI 10.1073/pnas.93.16.8300; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; HILL JR, 1993, J BIOL CHEM, V268, P726; Jerinic O, 2000, J MOL BIOL, V304, P707, DOI 10.1006/jmbi.2000.4269; KOZAK M, 1978, J BIOL CHEM, V253, P6568; Law GL, 2001, J BIOL CHEM, V276, P38036; MARTON LJ, 1987, MOL CELLULAR FUNCTIO, P79; McClain WH, 1999, J MOL BIOL, V290, P391, DOI 10.1006/jmbi.1999.2884; Mize GJ, 1998, J BIOL CHEM, V273, P32500, DOI 10.1074/jbc.273.49.32500; Mize GJ, 2001, RNA, V7, P374, DOI 10.1017/S1355838201001972; MORCH MD, 1986, METHOD ENZYMOL, V118, P154; MORRIS DR, 1991, J CELL BIOCHEM, V46, P102, DOI 10.1002/jcb.240460203; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; MUNRO HN, 1968, NATURE, V219, P944, DOI 10.1038/219944a0; Raney A, 2000, J BIOL CHEM, V275, P24444, DOI 10.1074/jbc.M003364200; ROSE JK, 1976, NATURE, V262, P32, DOI 10.1038/262032a0; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; Welch EM, 2000, COLD SPRING HARBOR M, V39, P467	28	70	73	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					5988	5994		10.1074/jbc.M108375200	http://dx.doi.org/10.1074/jbc.M108375200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741992	hybrid			2022-12-27	WOS:000173989200039
J	Serna-Rico, A; Salas, M; Meijer, WJJ				Serna-Rico, A; Salas, M; Meijer, WJJ			The Bacillus subtilis phage phi 29 protein p16.7, involved in phi 29 DNA replication, is a membrane-localized single-stranded DNA-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GA-1 SSB PROTEINS; TERMINAL PROTEIN; POLYMERASE; COMPLEX; INITIATION; MUTANTS; NF	The functional role of the phi29-encoded integral membrane protein p16.7 in phage DNA replication was studied using a soluble variant, p16.7A, lacking the N-terminal membrane-spanning domain. Because of the protein-primed mechanism of DNA replication, the bacteriophage phi29 replication intermediates contain long stretches of single-stranded DNA (ssDNA). Protein p16.7A was found to be an ssDNA-binding protein. In addition, by direct and functional analysis we show that protein p16.7A binds to the stretches of ssDNA of the phi29 DNA replication intermediates. Properties of protein p16.7A were compared with those of the phi29-encoded single-stranded DNA-binding protein p5. The results obtained show that both proteins have different, non-overlapping functions. The likely role of p16.7 in attaching phi29 DNA replication intermediates to the membrane of the infected cell is discussed. Homologues of gene 16.7 are present in phi29-related phages, suggesting that the proposed role of p16.7 is conserved in this family of phages.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, UAM, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, UAM, Canto Blanco, E-28049 Madrid, Spain.	Msalas@cbm.uam.es	Salas, Margarita/J-9873-2014	Salas, Margarita/0000-0001-5939-3441; Meijer, Wilfried/0000-0003-1842-0049				BLANCO L, 1985, P NATL ACAD SCI USA, V82, P6404, DOI 10.1073/pnas.82.19.6404; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1992, J BIOL CHEM, V267, P1225; BLANCO L, 1994, P NATL ACAD SCI USA, V91, P12198, DOI 10.1073/pnas.91.25.12198; Bravo A, 1997, J MOL BIOL, V269, P102, DOI 10.1006/jmbi.1997.1032; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Esteban JA, 1997, P NATL ACAD SCI USA, V94, P2921, DOI 10.1073/pnas.94.7.2921; FIRSHEIN W, 1989, ANNU REV MICROBIOL, V43, P89, DOI 10.1146/annurev.micro.43.1.89; Gascon I, 2000, J MOL BIOL, V296, P989, DOI 10.1006/jmbi.2000.3521; Gascon I, 2000, NUCLEIC ACIDS RES, V28, P2034, DOI 10.1093/nar/28.10.2034; GUTIERREZ C, 1991, J MOL BIOL, V222, P983, DOI 10.1016/0022-2836(91)90589-X; GUTIERREZ C, 1991, J BIOL CHEM, V266, P2104; IVARIE RD, 1973, VIROLOGY, V52, P351, DOI 10.1016/0042-6822(73)90330-9; JIMENEZ F, 1977, EUR J BIOCHEM, V73, P57, DOI 10.1111/j.1432-1033.1977.tb11291.x; KELMAN Z, 1994, CURR OPIN GENET DEV, V4, P185, DOI 10.1016/S0959-437X(05)80044-9; Kornberg A., 1992, DNA REPLICATION; MARTIN G, 1989, NUCLEIC ACIDS RES, V17, P3663, DOI 10.1093/nar/17.10.3663; Meijer WJJ, 2000, EMBO J, V19, P4182, DOI 10.1093/emboj/19.15.4182; Meijer WJJ, 2001, MOL MICROBIOL, V39, P731, DOI 10.1046/j.1365-2958.2001.02260.x; Meijer WJJ, 2001, MICROBIOL MOL BIOL R, V65, P261, DOI 10.1128/MMBR.65.2.261-287.2001; MELLADO RP, 1980, VIROLOGY, V104, P84, DOI 10.1016/0042-6822(80)90367-0; MELLADO RP, 1976, J VIROL, V19, P495, DOI 10.1128/JVI.19.2.495-500.1976; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MORENO F, 1974, VIROLOGY, V62, P1, DOI 10.1016/0042-6822(74)90298-0; Rojo F, 1998, PROG NUCLEIC ACID RE, V60, P29, DOI 10.1016/S0079-6603(08)60888-0; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; SALAS M, 1995, FEMS MICROBIOL REV, V17, P73; SALAS M, 1996, DNA REPLICATION EUKA, P131; Salas Margarita, 1993, P843; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Serna-Rico A, 2000, J BIOL CHEM, V275, P40529, DOI 10.1074/jbc.M007855200; SOENGAS MS, 1994, J MOL BIOL, V239, P213, DOI 10.1006/jmbi.1994.1364; SOENGAS MS, 1995, J MOL BIOL, V253, P517, DOI 10.1006/jmbi.1995.0570; SOGO JM, 1989, METHOD ENZYMOL, V170, P142; SOGO JM, 1987, ELECTRON MICROS, P61; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; WOLLENZIEN PL, 1988, PSORALEN DNA PHOTOBI, P51	37	16	18	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6733	6742		10.1074/jbc.M109312200	http://dx.doi.org/10.1074/jbc.M109312200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11741949	hybrid			2022-12-27	WOS:000173989200136
J	Shen, AL; O'Leary, KA; Kasper, CB				Shen, AL; O'Leary, KA; Kasper, CB			Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome p450 oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; P-450 OXIDOREDUCTASE; HEME OXYGENASE; REDUCTASE; GENE; IDENTIFICATION; REGION; ENZYME; MICE	The microsomal flavoprotein NADPH-cytochrome P450 oxidoreductase (CYPOR) is believed to function as the primary, if not sole, electron donor for the microsomal cytochrome P450 mixed-function oxidase system. Development of the mammalian embryo is dependent upon temporally and spatially regulated expression of signaling factors, many of which are synthesized and/or degraded via the cytochromes P450 and other pathways involving NADPH-cytochrome P450 oxidoreductase as the electron donor. Expression of CYPOR as early as the two-cell stage of embryonic development (The Institute for Genomic Research Mouse Gene Index, version 5.0, www.tigr.org/tdb/mgi) suggests that CYPOR is essential for normal cellular functions and/or early embryogenesis. Targeted deletion of the translation start site and membrane-binding domain of CYPOR abolished microsomal CYPOR expression and led to production of a truncated, 66-kDa protein localized to the cytoplasm. Although early embryogenesis was not affected, a variety of embryonic defects was observable by day 10.5 of gestation, leading to lethality by day 13.5. Furthermore, a deficiency of heterozygotes was observed in 2-week-old mice as well as late gestational age embryos, suggesting that loss of one CYPOR allele produced some embryonic lethality. CYPOR -/- embryos displayed a marked friability, consistent with defects in cell adhesion. Ninety percent of CYPOR -/- embryos isolated at days 10.5 or 11.5 of gestation could be classified as either Type I, characterized by grossly normal somite formation but having neural tube, cardiac, eye, and limb abnormalities, or Type II, characterized by a generalized retardation of development after approximately day 8.5 of gestation. No CYPOR -/- embryos were observed after day 13.5 of gestation. These studies demonstrate that loss of microsomal CYPOR does not block early embryonic development but is essential for progression past mid-gestation.	Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kasper, CB (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 421,1400 Univ Ave, Madison, WI 53706 USA.	kasper@oncology.wisc.edu			NATIONAL CANCER INSTITUTE [P30CA007175, P01CA022484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009090] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Anandatheerthavarada HK, 2001, EMBO J, V20, P2394, DOI 10.1093/emboj/20.10.2394; BENVENISTE I, 1991, BIOCHEM BIOPH RES CO, V177, P105, DOI 10.1016/0006-291X(91)91954-B; BLACK SD, 1979, BIOCHEM BIOPH RES CO, V91, P1528, DOI 10.1016/0006-291X(79)91238-5; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; FILLER R, 1981, P NATL ACAD SCI-BIOL, V78, P6991, DOI 10.1073/pnas.78.11.6991; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; ILAN Z, 1981, J BIOL CHEM, V256, P66; Lamb DC, 1999, FEBS LETT, V462, P283, DOI 10.1016/S0014-5793(99)01548-3; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MASTERS BSS, 1980, ENZYMATIC BASIS DETO, P183; Moebius FF, 2000, TRENDS ENDOCRIN MET, V11, P106, DOI 10.1016/S1043-2760(00)00235-6; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; OLEARY KA, 1994, ARCH BIOCHEM BIOPHYS, V310, P452, DOI 10.1006/abbi.1994.1192; ONO T, 1975, J BIOL CHEM, V250, P1571; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Pikuleva I, 1999, Mol Aspects Med, V20, P33; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; PORTER TD, 1990, BIOCHEMISTRY-US, V29, P9814, DOI 10.1021/bi00494a009; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Seidman J, 1994, CURRENT PROTOCOLS MO; Shen A.L., 1993, HDB EXPT PHARM, P35; SHEN AL, 1989, J BIOL CHEM, V264, P7584; SIMMONS DL, 1985, J BIOL CHEM, V260, P515; Strobel Henry W., 1995, P225; Stromstedt M, 1996, ARCH BIOCHEM BIOPHYS, V329, P73, DOI 10.1006/abbi.1996.0193; Stromstedt M, 1996, MOL REPROD DEV, V43, P428, DOI 10.1002/(SICI)1098-2795(199604)43:4&lt;428::AID-MRD4&gt;3.0.CO;2-R; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; TRUAN G, 1994, GENE, V142, P123, DOI 10.1016/0378-1119(94)90366-2; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397	34	165	171	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2002	277	8					6536	6541		10.1074/jbc.M111408200	http://dx.doi.org/10.1074/jbc.M111408200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524AF	11742006	hybrid			2022-12-27	WOS:000173989200111
J	Ansieau, S; Leutz, A				Ansieau, S; Leutz, A			The conserved Mynd domain of BS69 binds cellular and oncoviral proteins through a common PXLXP motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RBP-J-KAPPA; ADENOVIRUS E1A; LARGE-T; TRANSCRIPTION; TRANSACTIVATION; SUPPRESSOR; INTERACTS; ELEMENTS; PROMOTER; COMPLEX	BS69 is a transcriptional co-repressor protein and a potential tumor suppressor that binds to the adenoviral oncoprotein E1A. We show that the C-terminal Mynd domain of BS69 (amino acids 516-561) or the closely related Mynd domains of the Caenorhabditis elegans proteins Bra-1 and Bra-2 bind not only to E1A but also to the Epstein-Barr virus EBNA2 oncoprotein and the Myc-related cellular protein MGA. Interaction depends on intact PXLXP motifs present in all three proteins. Moreover, viral proteins compete for binding of BS69 to MGA in a PXLXP-dependent fashion. Because deletions in E1A or EBNA2 that cover the PXLXP motifs are nontransforming, our observations suggest a role for BS69 in cell growth control that is reminiscent of abrogation of the Rb function by various oncoproteins.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ansieau, S (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.		Leutz, Achim/K-9643-2013; Ansieau, Stephane/I-6195-2016	Leutz, Achim/0000-0001-8259-927X; ANSIEAU, Stephane/0000-0003-0989-2108				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Ansieau S, 2001, GENE DEV, V15, P380, DOI 10.1101/gad.189301; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAUTISTA DS, 1991, VIROLOGY, V182, P578, DOI 10.1016/0042-6822(91)90599-7; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; COHEN JI, 1991, J VIROL, V65, P2545, DOI 10.1128/JVI.65.5.2545-2554.1991; Egan SE, 1998, CURR TOP MICROBIOL, V228, P273; FIGGE J, 1988, J VIROL, V62, P1814, DOI 10.1128/JVI.62.5.1814-1818.1988; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Gross CT, 1996, EMBO J, V15, P1961, DOI 10.1002/j.1460-2075.1996.tb00547.x; GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568; HATEBOER G, 1995, EMBO J, V14, P3159, DOI 10.1002/j.1460-2075.1995.tb07318.x; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Kurozumi K, 1998, GENES CELLS, V3, P257, DOI 10.1046/j.1365-2443.1998.00186.x; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; Morita K, 2001, P NATL ACAD SCI USA, V98, P6284, DOI 10.1073/pnas.111409798; Rowe David T., 1999, Frontiers in Bioscience, V4, pD346, DOI 10.2741/Rowe; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; WALTZER L, 1994, EMBO J, V13, P5633, DOI 10.1002/j.1460-2075.1994.tb06901.x; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Zalvide J, 1998, MOL CELL BIOL, V18, P1408, DOI 10.1128/MCB.18.3.1408; ZIMBERSTROBL U, 1993, EMBO J, V12, P167, DOI 10.1002/j.1460-2075.1993.tb05642.x; ZIMBERSTROBL U, 1994, EMBO J, V13, P4973, DOI 10.1002/j.1460-2075.1994.tb06824.x	29	75	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					4906	4910		10.1074/jbc.M110078200	http://dx.doi.org/10.1074/jbc.M110078200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11733528	hybrid			2022-12-27	WOS:000173962900048
J	Guo, HT; Cai, CQ; Kuo, PC				Guo, HT; Cai, CQ; Kuo, PC			Hepatocyte nuclear factor-4 alpha mediates redox sensitivity of inducible nitric-oxide synthase gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HEPATOCYTES; OXIDATIVE INJURY; BINDING-PROTEIN; ANTIOXIDANT; COACTIVATOR; ACTIVATION; RECEPTORS; PROMOTER; CULTURE; STRESS	The underlying redox-sensitive mechanisms that regulate hepatocyte expression of inducible nitric-oxide synthase (iNOS) and its antioxidant functions are largely unknown. We have demonstrated previously that oxidative stress induced by benzenetriol-mediated superoxide production increases interleukin-1beta-induced iNOS protein synthesis, steady state iNOS mRNA expression, NO production, iNOS gene transcription, and trans-activation of the iNOS promoter in primary cultures of rat hepatocytes. In this study, we extend these studies by establishing the sequence specificity and binding of nuclear protein to the previously described 15-base cis-regulatory element of the rat hepatocyte iNOS promoter, isolating and identifying the cis-regulatory element transcription factor as hepatocyte nuclear factor-4alpha (HNF-4alpha), and confirming the functional role of HNF-4alpha in mediating redox-sensitive iNOS promoter trans-activation. In addition, we demonstrate that binding of HNF-4alpha to the transcriptional coactivator, PC4, in the presence of oxidative stress and interleukin-1beta stimulation is essential for increased iNOS promoter activity in this setting. Our results indicate that HNF-4alpha is the transcription factor that mediates redox regulation of hepatocyte iNOS gene transcription.	Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University	Kuo, PC (corresponding author), Duke Univ, Med Ctr, Dept Surg, 110 Bell Bldg,Box 3522, Durham, NC 27710 USA.				NIAID NIH HHS [AI44629] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044629, R29AI044629] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chowdhury S, 1996, EUR J BIOCHEM, V236, P500, DOI 10.1111/j.1432-1033.1996.00500.x; Farsetti A, 1998, ENDOCRINOLOGY, V139, P4581, DOI 10.1210/en.139.11.4581; Fraser JD, 1998, NUCLEIC ACIDS RES, V26, P2702, DOI 10.1093/nar/26.11.2702; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Green VJ, 1998, J BIOL CHEM, V273, P29950, DOI 10.1074/jbc.273.45.29950; HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539; HALLIWELL B, 1995, BIOCHEM PHARMACOL, V49, P1341, DOI 10.1016/0006-2952(95)00088-H; HARRIS ED, 1992, FASEB J, V6, P2675, DOI 10.1096/fasebj.6.9.1612291; JAISWAL AK, 1994, BIOCHEM PHARMACOL, V48, P439, DOI 10.1016/0006-2952(94)90272-0; Jiang GQ, 1997, J BIOL CHEM, V272, P1218, DOI 10.1074/jbc.272.2.1218; JIANG GQ, 1995, MOL CELL BIOL, V15, P5131; Kumar BRP, 2001, J BIOL CHEM, V276, P16804, DOI 10.1074/jbc.M100934200; Kuo PC, 1997, BIOCHEM BIOPH RES CO, V234, P289, DOI 10.1006/bbrc.1997.6562; Kuo PC, 1997, J PHARMACOL EXP THER, V282, P1072; KUO PC, 1994, J SURG RES, V56, P594, DOI 10.1006/jsre.1994.1094; KUO PC, 1995, GASTROENTEROLOGY, V109, P206, DOI 10.1016/0016-5085(95)90286-4; Kuo PC, 2000, GASTROENTEROLOGY, V118, P608, DOI 10.1016/S0016-5085(00)70268-X; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; MAYER B, 1995, J BIOL CHEM, V270, P17355, DOI 10.1074/jbc.270.29.17355; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; MESZAROS K, 1995, INFECT IMMUN, V63, P363; POWIS G, 1995, PHARMACOL THERAPEUT, V68, P149, DOI 10.1016/0163-7258(95)02004-7; SCHUETZ EG, 1986, BIOCHEMISTRY-US, V25, P1124, DOI 10.1021/bi00353a027; SCHULZEOSTHOFF K, 1995, BIOCHEM PHARMACOL, V50, P735, DOI 10.1016/0006-2952(95)02011-Z; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Sergent O, 1997, HEPATOLOGY, V25, P122, DOI 10.1002/hep.510250123; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sladek R, 2000, ADV PHARMACOL, V47, P23; Yoon JH, 2000, FEBS LETT, V474, P175, DOI 10.1016/S0014-5793(00)01599-4; ZHONG WM, 1994, MOL CELL BIOL, V14, P7276, DOI 10.1128/MCB.14.11.7276	30	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5054	5060		10.1074/jbc.M109017200	http://dx.doi.org/10.1074/jbc.M109017200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741883	hybrid			2022-12-27	WOS:000173962900067
J	Jonca, N; Guerrin, M; Hadjiolova, K; Caubet, C; Gallinaro, H; Simon, M; Serre, G				Jonca, N; Guerrin, M; Hadjiolova, K; Caubet, C; Gallinaro, H; Simon, M; Serre, G			Corneodesmosin, a component of epidermal corneocyte desmosomes, displays homophilic adhesive properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S GENE; DIFFERENTIATION; ASSOCIATION; CADHERINS; MUTATION; MHC; HLA	Corneodesmosomes, the modified desmosomes of the uppermost layers of the epidermis, play an important role in corneocyte cohesion. Corneodesmosin is a secreted glycoprotein located in the corneodesmosomal core and covalently linked to the cornified envelope of corneocytes. Its glycine- and serine-rich NH2-terminal domain may fold to give structural motifs similar to the glycine loops described in epidermal cytokeratins and loricrin and proposed to display adhesive properties. A chimeric protein comprising human corneodesmosin linked to the transmembrane and cytoplasmic domains of mouse E-cadherin was expressed in mouse fibroblasts to test the ability of corneodesmosin to promote cell-cell adhesion. Classic aggregation assays indicated that corneodesmosin mediates homophilic cell aggregation. Moreover, Ca2+ depletion showed a moderate effect on aggregation. To assess the involvement of the glycine loop domain in adhesion, full-length corneodesmosin, corneodesmosin lacking this domain, or this domain alone were expressed as glutathione S-transferase fusion proteins and tested for protein-protein interactions by overlay binding assays. The results confirmed that corneodesmosin presents homophilic interactions and indicated that its NH2-terminal glycine loop domain is sufficient but not strictly necessary to promote binding. Altogether, these results provide the first experimental evidence for the adhesive properties of corneodesmosin and for the involvement of its glycine loop domain in adhesion.	Univ Toulouse 3, INSERM, Dept Pathol & Cell Biol, Toulouse Purpan Sch Med,CNRS, F-31073 Toulouse, France; CHU Toulouse, F-31073 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Serre, G (corresponding author), CHU Purpan, Lab Biol Cellulaire & Cytol, Pl Dr Baylac, F-31059 Toulouse, France.	serre.g@chu-toulouse.fr	Jonca, Nathalie/AAX-3870-2020; Simon, Michel/B-7308-2011	Jonca, Nathalie/0000-0003-3602-0102; Simon, Michel/0000-0003-3655-6329				Ahnini RT, 1999, HUM MOL GENET, V8, P1135, DOI 10.1093/hmg/8.6.1135; Allen E, 1996, J CELL BIOL, V133, P1367, DOI 10.1083/jcb.133.6.1367; Allen MH, 1999, LANCET, V353, P1589, DOI 10.1016/S0140-6736(99)01618-9; Egelrud T, 2000, CRC DERMAT, P109; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Guerrin M, 1998, J BIOL CHEM, V273, P22640, DOI 10.1074/jbc.273.35.22640; HAFTEK M, 1991, J HISTOCHEM CYTOCHEM, V39, P1531, DOI 10.1177/39.11.1717544; Jenisch S, 1999, TISSUE ANTIGENS, V54, P439, DOI 10.1034/j.1399-0039.1999.540501.x; LUNDSTROM A, 1994, ARCH DERMATOL RES, V286, P369, DOI 10.1007/BF00371795; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; SERRE G, 1991, J INVEST DERMATOL, V97, P1061, DOI 10.1111/1523-1747.ep12492589; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; SIMON M, 1994, KERATINOCYTE HDB, P275; Sprecher E, 2001, J INVEST DERMATOL, V116, P511, DOI 10.1046/j.1523-1747.2001.01292.x; Steinert PM, 2000, J CELL BIOL, V151, pF5, DOI 10.1083/jcb.151.2.F5; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Terrinoni A, 2000, J INVEST DERMATOL, V114, P1136, DOI 10.1046/j.1523-1747.2000.00983.x	20	78	81	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5024	5029		10.1074/jbc.M108438200	http://dx.doi.org/10.1074/jbc.M108438200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11739386	hybrid			2022-12-27	WOS:000173962900063
J	Proenza, C; Angoli, D; Agranovich, E; Macri, V; Accili, EA				Proenza, C; Angoli, D; Agranovich, E; Macri, V; Accili, EA			Pacemaker channels produce an instantaneous current	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CATION CURRENT; MINK-RELATED PEPTIDE-1; SINOATRIAL NODE CELLS; K+-CHANNEL; POTASSIUM CHANNELS; BACKGROUND CURRENT; VOLTAGE SENSOR; BETA-SUBUNIT; HERG; PROTEIN	Spontaneous rhythmic activity in mammalian heart and brain depends on pacemaker currents (I-h), which are produced by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Here, we report that the mouse HCN2 pacemaker channel isoform also produced a large instantaneous current (I-inst(HCN2)) in addition to the well characterized, slowly activating I-h. I-inst(HCN2) was specific to expression of HCN2 on the plasma membrane and its amplitude was correlated with that of I-h. The two currents had similar reversal potentials, and both were modulated by changes in intracellular Cl- and cAMP. A mutation in the S4 domain of HCN2 (S306Q) decreased I-h but did not alter I-inst(HCN2), and instantaneous currents in cells expressing either wild type HCN2 or mutant S306Q channels were insensitive to block by Cs+. Co-expression of HCN2 with the accessory subunit, MiRP1, decreased I-h and increased I-inst(HCN2), suggesting a mechanism for modulation of both currents in vivo. These data suggest that expression of HCN channels may be accompanied by a background conductance in native tissues and are consistent with at least two open states of HCN channels: I-inst(HCN2) is produced by a Cs+-open state; hyperpolarization produces an additional Cs+-sensitive open state, which results in I-h.	Simon Fraser Univ, Sch Kinesiol, Ion Channel Lab, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Accili, EA (corresponding author), Simon Fraser Univ, Sch Kinesiol, Ion Channel Lab, Burnaby, BC V5A 1S6, Canada.	eaaccili@sfu.ca		Macri, Vincenzo/0000-0003-3463-2877; Proenza, Catherine/0000-0003-4324-6206				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Accili EA, 1996, PFLUG ARCH EUR J PHY, V431, P757; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; DENYER JC, 1990, J PHYSIOL-LONDON, V429, P401, DOI 10.1113/jphysiol.1990.sp018264; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P359, DOI 10.1113/jphysiol.1981.sp013713; Dreyer I, 2001, FEBS LETT, V505, P233, DOI 10.1016/S0014-5793(01)02832-0; FRACE AM, 1992, J PHYSIOL-LONDON, V453, P307, DOI 10.1113/jphysiol.1992.sp019230; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Graf EM, 2001, N-S ARCH PHARMACOL, V364, P131, DOI 10.1007/s002100100431; HAGIWARA N, 1992, J PHYSIOL-LONDON, V448, P53, DOI 10.1113/jphysiol.1992.sp019029; Horn R, 2000, BIOCHEMISTRY-US, V39, P15653, DOI 10.1021/bi0020473; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Lacombe B, 2000, PLANT CELL, V12, P837, DOI 10.1105/tpc.12.6.837; Lenz RA, 1997, J NEUROSCI, V17, P6133; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Macri V, 2001, BIOPHYS J, V80, p113A; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Moroni A, 2000, PFLUG ARCH EUR J PHY, V439, P618, DOI 10.1007/s004240050985; NOBLE D, 1992, P ROY SOC B-BIOL SCI, V250, P199, DOI 10.1098/rspb.1992.0150; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Vaca L, 2000, FEBS LETT, V479, P35, DOI 10.1016/S0014-5793(00)01837-8; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	43	87	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5101	5109		10.1074/jbc.M106974200	http://dx.doi.org/10.1074/jbc.M106974200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11741901	hybrid			2022-12-27	WOS:000173962900073
J	Nelson, BA; Robinson, KA; Buse, MG				Nelson, BA; Robinson, KA; Buse, MG			Insulin acutely regulates Munc18-c subcellular trafficking - Altered response in insulin-resistant 3T3-L1 adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE TRANSPORTERS; TYROSINE PHOSPHORYLATION; GLUT4 TRANSLOCATION; STORAGE-VESICLES; PROTEINS; CELLS; SYNTAXIN-4; EXOCYTOSIS; INHIBITION; CAVEOLIN	Preincubation of 3T3-L1 adipocytes in high glucose or glucosamine decreases acute insulin (100 nM)-stimulated glucose transport provided that insulin (0.6 nM) is included during preincubation. GLUT4 expression is unchanged (Nelson, B. A., Robinson, K. A., and Buse, M. G. (2000) Diabetes 49,981-991). Munc18-c, a Syntaxin 4-binding protein, is a proposed regulator of the docking/fusion of GLUT4-containing vesicles with the plasma membrane. We examined the subcellular distribution of Munc18-c in response to acute (15-min) insulin (100 nM) stimulation after preincubation in 5 or 25 mm glucose 0.6 nm insulin. Immunoblotting detected Munc18-c mainly in the Triton X-100-soluble plasma membrane (TS-PM) and the Triton X-100-insoluble low density microsomal (TI-LDM) fraction. Under each condition except high glucose + insulin preincubation, acute insulin increased Munc18-c (similar to50-200%) in TS-PM and decreased Munc18-c (similar to60%) in TI-LDM. Munc18-c traffic was time-dependent with a lag time of similar to3 min compared with GLUT4. Preincubation with high glucose + 0.6 nM insulin significantly impaired acute insulin-stimulated Munc18-c trafficking and decreased basal Munc18-c in the TI-LDM. Preincubation with glucosamine + insulin had similar effects. Total cellular Munc18-c remained unchanged. In conclusion, acute insulin stimulation promotes the translocation of Munc18-c, apparently from a TI-LDM-associated compartment to the TS-PM. Chronically increased glucose flux or exposure to glucosamine disrupts this process, which may negatively impact the fusion of GLUT4-containing vesicles with the plasma membrane.	Med Univ S Carolina, Dept Med Endocrinol Diabetes, Charleston, SC 29425 USA; Med Univ S Carolina, Med Genet Div, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Med, Div Endocrinol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem Mol Biol Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Buse, MG (corresponding author), Med Univ S Carolina, Dept Med Endocrinol Diabetes, 96 Jonathan Lucas St Ste 323, Charleston, SC 29425 USA.	busemg@musc.edu		Nelson, Bryce/0000-0003-2400-5415	NIDDK NIH HHS [DK-02001] Funding Source: Medline; NIGMS NIH HHS [GM-08716] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK002001, R56DK002001] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; CALDERHEAD DM, 1990, J BIOL CHEM, V265, P13800; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Clark SF, 2000, J BIOL CHEM, V275, P3819, DOI 10.1074/jbc.275.6.3819; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; Muller G, 2001, MOL CELL BIOL, V21, P4553, DOI 10.1128/MCB.21.14.4553-4567.2001; Nelson BA, 2002, AM J PHYSIOL-ENDOC M, V282, pE497, DOI 10.1152/ajpendo.00438.2001; Nelson BA, 2000, DIABETES, V49, P981, DOI 10.2337/diabetes.49.6.981; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Proietto J, 1999, MOL CELL ENDOCRINOL, V151, P143, DOI 10.1016/S0303-7207(99)00050-7; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; YANG J, 1992, BIOCHEM J, V281, P809, DOI 10.1042/bj2810809; YANG J, 1993, J BIOL CHEM, V268, P4600; YANG J, 1992, J BIOL CHEM, V267, P10393	33	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					3809	3812		10.1074/jbc.C100645200	http://dx.doi.org/10.1074/jbc.C100645200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11751846	hybrid			2022-12-27	WOS:000173813900003
J	Sizemore, N; Lerner, N; Dombrowski, N; Sakurai, H; Stark, GR				Sizemore, N; Lerner, N; Dombrowski, N; Sakurai, H; Stark, GR			Distinct roles of the I kappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF kappa B) from I kappa B and in phosphorylating the p65 subunit of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; IKK-ALPHA; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTIONAL ACTIVITY; DEPENDENT TRANSCRIPTION; TRANSACTIVATION DOMAIN; LIVER DEGENERATION; DEFICIENT MICE; ACTIVATION	Phosphatidylinositol 3'-kinase (PI3K) and the serine/threonine kinase AKT have critical roles in phosphorylating and transactivating the p65 subunit of nuclear factor kappaB (NF-kappaB) in response to the pro-inflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor (TNF). Mouse embryo fibroblasts (MEFs) lacking either the alpha or beta subunit of IkappaB kinase (IKK) were deficient in NF-kappaB-dependent transcription following treatment with IL-1 or TNF. However, in contrast to IKKbeta-null MEFs, IKKalpha-null MEFs were not substantially defective in the cytokine-stimulated degradation of Ikappabetaalpha or in the nuclear translocation of NF-kappaB The IKK complexes from IKKalpha- or IKKbeta-null MEFs were both deficient in PI3K-mediated phosphorylation of the transactivation domain of the p65 subunit of NF-kappaB in response to IL-1 and TNF, and constitutively activated forms of PI3K or AKT did not potentiate cytokine-stimulated activation of NF-kappaB in either IKKalpha- or IKKbeta-null MEFs. Collectively, these data indicate that, in contrast to IKKbeta, which is required for both NF-kappaB liberation and p65 phosphorylation, IKKalpha is required solely for the cytokine-induced phosphorylation and activation of the p65 subunit of NF-kappaB that are mediated by the PI3K/AKT pathway.	Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, Cleveland, OH 44195 USA; Tanabe Seiyaku Co Ltd, Discovery Res Lab, Biol & Pharmacol Dept, Osaka 5328505, Japan	Cleveland Clinic Foundation; Mitsubishi Tanabe Pharma Corporation	Stark, GR (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Sakurai, Hiroaki/AAE-4294-2019	Sakurai, Hiroaki/0000-0003-0657-9570				Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; DIEHL JA, 1995, J BIOL CHEM, V270, P2703, DOI 10.1074/jbc.270.6.2703; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; Koul D, 2001, J BIOL CHEM, V276, P11402, DOI 10.1074/jbc.M007806200; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Martin AG, 2000, J BIOL CHEM, V275, P24383, DOI 10.1074/jbc.M909396199; Martin AG, 2001, J BIOL CHEM, V276, P15840, DOI 10.1074/jbc.M011313200; McKenzie FR, 2000, MOL CELL BIOL, V20, P2635, DOI 10.1128/MCB.20.8.2635-2649.2000; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Ozes ON, 1999, NATURE, V401, P82; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tang Y, 2000, J BIOL CHEM, V275, P9106, DOI 10.1074/jbc.275.13.9106; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	42	343	365	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					3863	3869		10.1074/jbc.M110572200	http://dx.doi.org/10.1074/jbc.M110572200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733537	hybrid			2022-12-27	WOS:000173813900011
J	Andley, UP; Patel, HC; Xi, JH				Andley, UP; Patel, HC; Xi, JH			The R116C mutation in alpha A-crystallin diminishes its protective ability against stress-induced lens epithelial cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; INTERMEDIATE FILAMENT PROTEINS; DESMIN-RELATED MYOPATHY; CHAPERONE-LIKE FUNCTION; B-CRYSTALLIN; IN-VIVO; MASS-SPECTROMETRY; MISSENSE MUTATION; HUMAN HSP27; PHOSPHORYLATION	alphaA-crystallin is a small heat-shock protein expressed preferentially in the lens and is detected during the early stages of lens development. Recent work indicates that the expression of alphaA-crystallin enhances lens epithelial cell growth and resistance to stress conditions. Mutation of the arginine 116 residue to cysteine (R116C) in alphaA-crystallin has been associated with congenital cataracts in humans. However, the physiological consequences of this mutation have not been analyzed in lens epithelial cells. In the present study, we expressed wild type or R116C alphaA-crystallin in the human lens epithelial cell line HLE B-3. Immunonuorescence and confocal microscopy indicated that both wild type and R116C alphaA-crystallin were distributed mainly in the cytoplasm of lens epithelial cells. Size-exclusion chromatography indicated that the size of the aA-crystallin aggregate in lens epithelial cells increased from 500 to 600 kDa for the wild type protein to >2 MDa in the R116C mutant. When cells were exposed to physiological levels of UVA radiation, wild type aA-crystallin protected cells from apoptotic death as shown by annexin labeling and flow cytometric analysis, whereas the R116C mutant had a 4- to 10-fold lower protective ability. UVA-irradiated cells expressing the wild type protein had very low TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) staining, whereas cells expressing R116C mutant had a high level of TUNEL staining. F-actin was protected in UVA-treated cells expressing the wild type aA-crystallin but was either clumped around the apoptotic cells or was absent in apoptotic cells in cultures expressing the R116C mutant. Structural changes caused by the R116C mutation could be responsible for the reduced ability of the mutant to protect cells from stress. Our study shows that comparing the stress-induced apoptotic cell death is an effective way to compare the protective abilities of wild type and mutant auk-crystallin. We propose that the diminished protective ability of the R116C mutant in lens epithelial cells may contribute to the pathogenesis of cataract.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.			Andley, Usha/0000-0001-7049-7591	NEI NIH HHS [EY02687, R01EY05681] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005681, P30EY002687] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Andley UP, 1998, J BIOL CHEM, V273, P31252, DOI 10.1074/jbc.273.47.31252; ANDLEY UP, 1994, INVEST OPHTH VIS SCI, V35, P3094; Andley UP, 2001, FASEB J, V15, P221, DOI 10.1096/fj.00-0296com; Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; Bettelheim FA, 1999, BIOCHEM BIOPH RES CO, V261, P292, DOI 10.1006/bbrc.1999.1031; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; CHIESI M, 1990, MOL CELL BIOCHEM, V97, P129; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Das KP, 1999, J BIOL CHEM, V274, P33209, DOI 10.1074/jbc.274.47.33209; DELVECCHIO PJ, 1984, CURR EYE RES, V3, P1213; Djabali K, 1997, J CELL SCI, V110, P2759; Djabali K, 1999, EXP CELL RES, V253, P649, DOI 10.1006/excr.1999.4679; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; FITZGERALD PG, 1991, CURR EYE RES, V10, P417, DOI 10.3109/02713689109001750; Fleming TP, 1998, INVEST OPHTH VIS SCI, V39, P1387; GOPALAKRISHNAN S, 1992, CURR EYE RES, V11, P929, DOI 10.3109/02713689209033490; Head MW, 2000, NEUROPATH APPL NEURO, V26, P304, DOI 10.1046/j.1365-2990.2000.00269.x; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; IWAKI T, 1994, J CELL BIOL, V125, P1385, DOI 10.1083/jcb.125.6.1385; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; KANTOROW M, 1994, P NATL ACAD SCI USA, V91, P3112, DOI 10.1073/pnas.91.8.3112; Khan IU, 1998, P NATL ACAD SCI USA, V95, P10425, DOI 10.1073/pnas.95.18.10425; Kumar LVS, 1999, J BIOL CHEM, V274, P24137, DOI 10.1074/jbc.274.34.24137; KUSZAK J, 2000, PRINCIPLES PRACTICE, V2, P1355; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; MEHLEN P, 1995, J CELL BIOCHEM, V58, P248, DOI 10.1002/jcb.240580213; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Muchowski PJ, 1999, INVEST OPHTH VIS SCI, V40, P951; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Perng MD, 1999, J CELL SCI, V112, P2099; Prasad S, 1999, INT J ONCOL, V14, P563; Rafferty NS, 1997, CURR EYE RES, V16, P310, DOI 10.1076/ceyr.16.4.310.10687; RAO PV, 1994, J BIOL CHEM, V269, P13266; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; Rodriguez P, 1997, GENOMICS, V44, P253, DOI 10.1006/geno.1997.4868; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; Sidjanin D, 1996, PHOTOCHEM PHOTOBIOL, V63, P79, DOI 10.1111/j.1751-1097.1996.tb02995.x; Sun TX, 1998, J BIOL CHEM, V273, P286, DOI 10.1074/jbc.273.1.286; van den IJssel P, 1999, CURR BIOL, V9, pR103, DOI 10.1016/S0960-9822(99)80061-X; VANDENIJSSEL P, 1999, EXP CELL RES, V9, pR103; VERMORKEN AJM, 1978, J CELL BIOL, V76, P175, DOI 10.1083/jcb.76.1.175; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; WANG KY, 1994, J BIOL CHEM, V269, P13601; Wang KY, 1996, EUR J BIOCHEM, V242, P56, DOI 10.1111/j.1432-1033.1996.0056r.x	58	71	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10178	10186		10.1074/jbc.M109211200	http://dx.doi.org/10.1074/jbc.M109211200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11756414	hybrid			2022-12-27	WOS:000174549200077
J	Downie, DL; Vicente-Agullo, F; Campos-Caro, A; Bushell, TJ; Lieb, WR; Franks, NP				Downie, DL; Vicente-Agullo, F; Campos-Caro, A; Bushell, TJ; Lieb, WR; Franks, NP			Determinants of the anesthetic sensitivity of neuronal nicotinic acetylcholine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; GATED ION CHANNELS; GENERAL-ANESTHETICS; AMINO-ACID; GLYCINE RECEPTORS; HOMOMER FORMATION; A RECEPTOR; M2-M3 LOOP; RESIDUE; PROPOFOL	Some neurotransmitter-gated ion channels are very much more sensitive to general anesthetics than others, even when they are genetically and structurally related. The most striking example of this is the extreme sensitivity of heteromeric neuronal nicotinic acetylcholine receptors to inhalational general anesthetics compared with the marked insensitivity of the closely related homomeric neuronal nicotinic receptors. Here we investigate the role of the a subunit in determining the anesthetic sensitivity of these receptors by using alpha(3)/alpha(7), chimeric subunits that are able to form functional homomeric receptors. By comparing the sensitivities of a number of chimeras to the inhalational agent halothane we show that the short (13 amino acids) putative extracellular loop connecting the second and third transmembrane segments is a critical determinant of anesthetic sensitivity. In addition, using site-directed mutagenesis, we show that two particular amino acids in this loop play a dominant role. When mutations are made in this loop, there is a good correlation between increasing anesthetic sensitivity and decreasing acetylcholine sensitivity. We conclude that this extracellular loop probably does not participate directly in anesthetic binding, but rather determines receptor sensitivity indirectly by playing a critical role in transducing anesthetic binding into an effect on channel gating.	Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Grp, London SW7 2BW, England; Univ Miguel Hernandez, Inst Neurociencias, E-03550 Alicante, Spain	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Franks, NP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Biophys Grp, Prince Consort Rd, London SW7 2BW, England.	n.franks@ic.ac.uk	Campos-Caro, Antonio/T-2807-2019	Campos-Caro, Antonio/0000-0001-8532-2153; Franks, Nicholas/0000-0003-4874-4212				Amin J, 1999, MOL PHARMACOL, V55, P411; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Belelli D, 1999, TRENDS PHARMACOL SCI, V20, P496, DOI 10.1016/S0165-6147(99)01405-4; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; CamposCaro A, 1997, J NEUROCHEM, V68, P488; CamposCaro A, 1997, BIOCHEMISTRY-US, V36, P2709, DOI 10.1021/bi9623486; Flood P, 1997, ANESTHESIOLOGY, V86, P859, DOI 10.1097/00000542-199704000-00016; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1996, J CLIN ANESTH, V8, pS3, DOI 10.1016/S0952-8180(96)90004-5; FRANKS NP, 1993, BRIT J ANAESTH, V71, P65, DOI 10.1093/bja/71.1.65; GARCIAGUZMAN M, 1994, BIOCHEMISTRY-US, V33, P15198, DOI 10.1021/bi00254a031; HARRIS RA, 1995, FASEB J, V9, P1454, DOI 10.1096/fasebj.9.14.7589987; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Moody EJ, 1998, TOXICOL LETT, V101, P209, DOI 10.1016/S0378-4274(98)00187-8; Moorhouse AJ, 1999, MOL PHARMACOL, V55, P386, DOI 10.1124/mol.55.2.386; O'Shea SM, 2000, J BIOL CHEM, V275, P22764, DOI 10.1074/jbc.M001299200; QUASHA AL, 1980, ANESTHESIOLOGY, V53, P315, DOI 10.1097/00000542-198010000-00008; RAVENTOS J, 1956, BRIT J PHARM CHEMOTH, V11, P394, DOI 10.1111/j.1476-5381.1956.tb00007.x; Rovira JC, 1998, FEBS LETT, V433, P89, DOI 10.1016/S0014-5793(98)00889-8; Rovira JC, 1999, PFLUG ARCH EUR J PHY, V439, P86, DOI 10.1007/s004240051131; UNWIN N, 1993, NEURON S, V10, P31; VicenteAgullo F, 1996, FEBS LETT, V399, P83, DOI 10.1016/S0014-5793(96)01291-4; Violet JM, 1997, ANESTHESIOLOGY, V86, P866, DOI 10.1097/00000542-199704000-00017; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Yamakura T, 2000, J BIOL CHEM, V275, P40879, DOI 10.1074/jbc.M005771200; Zhang L, 1997, BRIT J PHARMACOL, V120, P353, DOI 10.1038/sj.bjp.0700934; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466	29	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10367	10373		10.1074/jbc.M107847200	http://dx.doi.org/10.1074/jbc.M107847200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11741933	hybrid			2022-12-27	WOS:000174549200101
J	Taricani, L; Tejada, ML; Young, PG				Taricani, L; Tejada, ML; Young, PG			The fission yeast ES2 homologue, Bis1, interacts with the Ish1 stress-responsive nuclear envelope protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTION FACTOR; MAP KINASE; SACCHAROMYCES-CEREVISIAE; SEXUAL DEVELOPMENT; DIGEORGE-SYNDROME; STATIONARY-PHASE; CELL-CYCLE; GENE; EXPRESSION	In fission yeast, nutrient starvation induces physiological, biochemical, and morphological changes that enable survival. Collectively these changes are referred to as stationary phase. We have used a green fluorescent protein random insertional mutagenesis system to isolate two novel stress-response proteins required in stationary phase. Ish1 is a nuclear envelope protein that is present throughout the cell cycle and whose expression is increased in response to stresses such as glucose and nitrogen starvation, as well as osmotic stress. Expression of Ish1 is regulated by the Spc1 MAPK pathway through the Atf1 transcription factor. Although overexpression of Ish1 is lethal, cells lacking ish1 exhibit reduced viability in stationary phase. Bis1 is a novel interacting partner of Ish1. Bis1 is the Schizosaccharomyces pombe member of the ES2 nuclear protein family found in Mus musculus, Drosophila melanogaster, Homo sapiens, and Arabidopsis thaliana. Overexpression of Bis1 results in a cell elongation phenotype, whereas bis1(-) cells exhibit a reduced viability in stationary phase similar to that seen in ish1(-) cells.	Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Young, PG (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	youngpg@biology.quensu.ca						Alfa C, 1993, EXPT FISSION YEAST L; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Banuett F, 1998, MICROBIOL MOL BIOL R, V62, P249, DOI 10.1128/MMBR.62.2.249-274.1998; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BATAILLE N, 1991, YEAST, V7, P367, DOI 10.1002/yea.320070407; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BENTON BK, 1993, EMBO J, V12, P135, DOI 10.1002/j.1460-2075.1993.tb05639.x; Bonnet C, 2000, YEAST, V16, P23, DOI 10.1002/(SICI)1097-0061(20000115)16:1<23::AID-YEA503>3.0.CO;2-A; CHUA G, 2000, NUCLEIC ACIDS RES, V138, pE53; COSTELLO G, 1986, CURR GENET, V11, P119, DOI 10.1007/BF00378203; DALSSANTO P, 1996, J CELL SCI, V16, P3356; Degols G, 1996, MOL CELL BIOL, V16, P2870; Dure L, 1993, CUR TOP PL, V10, P91; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Egel R., 1989, MOL BIOL FISSION YEA, P31; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gong WL, 1997, HUM MOL GENET, V6, P267, DOI 10.1093/hmg/6.2.267; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HOFFMAN CS, 1990, GENETICS, V124, P807; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; HUGHES DA, 1994, J CELL SCI, V107, P3635; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; JOHNSTON GC, 1977, J BACTERIOL, V132, P723, DOI 10.1128/JB.132.2.723-730.1977; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Kaur R, 1997, NUCLEIC ACIDS RES, V25, P1080, DOI 10.1093/nar/25.5.1080; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Lindsay EA, 1998, HUM MOL GENET, V7, P629, DOI 10.1093/hmg/7.4.629; Lindsay EA, 1996, GENOMICS, V32, P104, DOI 10.1006/geno.1996.0082; MAEDA T, 1990, P NATL ACAD SCI USA, V87, P7814, DOI 10.1073/pnas.87.20.7814; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; OCHMAN H, 1988, GENETICS, V120, P621; PETERSEN J, 1995, MOL CELL BIOL, V15, P3697; Rhind N, 1998, MOL CELL BIOL, V18, P3782, DOI 10.1128/MCB.18.7.3782; Rizzu P, 1996, MAMM GENOME, V7, P639, DOI 10.1007/s003359900197; SAWIN KE, 1998, J CELL SCI, V97, P509; Shiozaki K, 1997, MOL BIOL CELL, V8, P409, DOI 10.1091/mbc.8.3.409; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Stettler S, 1996, J CELL SCI, V109, P1927; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Taricani L, 2001, NUCLEIC ACIDS RES, V29, P3030, DOI 10.1093/nar/29.14.3030; Thompson DA, 1999, GENETICS, V153, P621; Toone WM, 1998, GENES CELLS, V3, P485, DOI 10.1046/j.1365-2443.1998.00211.x; Turi TG, 1996, J BIOL CHEM, V271, P9166, DOI 10.1074/jbc.271.15.9166; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993	52	26	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2002	277	12					10562	10572		10.1074/jbc.M110686200	http://dx.doi.org/10.1074/jbc.M110686200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	533UR	11751918	hybrid			2022-12-27	WOS:000174549200126
J	Oelkers, P; Cromley, D; Padamsee, M; Billheimer, JT; Sturley, SL				Oelkers, P; Cromley, D; Padamsee, M; Billheimer, JT; Sturley, SL			The DGA1 gene determines a second triglyceride synthetic pathway in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COENZYME-A; COA-DIACYLGLYCEROL ACYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; CHOLESTEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; IDENTIFICATION; ESTERIFICATION; BIOSYNTHESIS	Diacylglycerol esterification provides an excellent target for the pharmacological reduction of triglyceride accumulation in several human disease states. We have used Saccharomyces cerevisiae as a model system to study this critical component of triglyceride synthesis. Recent studies of an oleaginous fungus, Mortierella ramanniana, identified a new family of enzymes with in vitro acyl-CoA:diacylglycerol acyltransferase activity. We show here that DGA1, the sole member of this gene family in yeast, has a physiological role in triglyceride synthesis. Metabolic labeling of DGA1 deletion strains with triglyceride precursors detected significant reductions in triglyceride synthesis. Triglyceride synthesis was virtually abolished in four different growth conditions when DGA1 was deleted in concert with LRO1, an enzyme that esterifies diacylglycerol from a phospholipid acyl donor. The relative contributions of the two enzymes depended on growth conditions. The residual synthesis was lost when ARE2, encoding an acyl-CoA. sterol acyltransferase, was deleted. In vitro microsomal assays verified that DGA1 and ARE2 mediate acyl-CoA. diacylglycerol acyltransferase reactions. Three enzymes can thus account for diacylglycerol esterification in yeast. Yeast strains deficient in both diacylglycerol and sterol esterification showed only a slight growth defect indicating that neutral lipid synthesis is dispensable under common laboratory conditions.	Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Bristol Myers Squibb Co, Expt Stn, Wilmington, DE 19880 USA	Columbia University; Columbia University; Bristol-Myers Squibb; DuPont	Sturley, SL (corresponding author), Columbia Univ Coll Phys & Surg, Inst Human Nutr, 650 W 168th St, New York, NY 10032 USA.			Padamsee, Mahajabeen/0000-0002-0741-3014; Oelkers, Peter/0000-0002-2421-472X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL007343] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07343] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; CASEY WM, 1993, BIOCHEM BIOPH RES CO, V193, P1297, DOI 10.1006/bbrc.1993.1766; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CHRISTIANSEN K, 1978, BIOCHIM BIOPHYS ACTA, V530, P78, DOI 10.1016/0005-2760(78)90128-5; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gotto AM, 1998, AM J CARDIOL, V82, p22Q; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jensen-Pergakes K, 2001, J BACTERIOL, V183, P4950, DOI 10.1128/JB.183.17.4950-4957.2001; Karpichev IV, 1997, MOL CELL BIOL, V17, P69, DOI 10.1128/MCB.17.1.69; KENNEDY EP, 1961, FED PROC, V20, P934; Krauss Ronald M., 1998, American Journal of Medicine, V105, p58S, DOI 10.1016/S0002-9343(98)00213-7; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; LARDIZABEL KD, 2000, Patent No. 15243; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; LIANG JS, 1999, CIRCULATION, V99; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 1998, INTRACELLULAR CHOLESTEROL TRAFFICKING, P43; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; RUSTAN AC, 1988, J LIPID RES, V29, P1417; Sandager L, 2000, BIOCHEM SOC T, V28, P700; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; STEINER MR, 1972, BIOCHIM BIOPHYS ACTA, V260, P222, DOI 10.1016/0005-2760(72)90035-5; Sturley SL, 1997, CURR OPIN LIPIDOL, V8, P167, DOI 10.1097/00041433-199706000-00007; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; Taskinen MR, 1997, DIABETES METAB REV, V13, P93, DOI 10.1002/(SICI)1099-0895(199706)13:2&lt;93::AID-DMR187&gt;3.0.CO;2-6; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang HY, 1997, J BIOL CHEM, V272, P3980, DOI 10.1074/jbc.272.7.3980; Yu CJ, 1996, J BIOL CHEM, V271, P24157, DOI 10.1074/jbc.271.39.24157; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	44	242	253	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	2002	277	11					8877	8881		10.1074/jbc.M111646200	http://dx.doi.org/10.1074/jbc.M111646200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531DK	11751875	hybrid			2022-12-27	WOS:000174400600020
J	Adnane, J; Seijo, E; Chen, Z; Bizouarn, F; Leal, M; Sebti, SM; Munoz-Antonia, T				Adnane, J; Seijo, E; Chen, Z; Bizouarn, F; Leal, M; Sebti, SM; Munoz-Antonia, T			RhoB, not RhoA, represses the transcription of the transforming growth factor beta type II receptor by a mechanism involving activator protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; HUMAN TUMOR-GROWTH; TGF-BETA; CELL-LINES; GENE-EXPRESSION; CANCER-CELLS; RAS; INHIBITION; GTPASES; FARNESYLTRANSFERASE	The transforming growth factor-beta (TGF-beta) type I (TbetaR-I) and type II (TbetaR-II) receptors are responsible for transducing TGF-beta signals. We have previously shown that inhibition of farnesyltransferase activity results in an increase in TbetaR-II expression, leading to enhanced TGF-beta binding, signaling, and inhibition of tumor cell growth, suggesting that a farnesylated protein(s) exerts a repressive effect on TbetaR-II expression. Likely candidates are farnesylated proteins such as Ras and RhoB, which are both farnesylated and involved in cell growth control. Neither a dominant negative Ha-Ras, constitutively activated Ha-Ras, or a pharmacological inhibitor of MEK1 affected TbetaR-II transcription. However, ectopic expression of RhoB, but not the closely related family member RhoA, resulted in a 5-fold decrease of TbetaR-II promoter activity. Furthermore, ectopic expression of RhoB, but not RhoA, resulted in a significant decrease of TbetaR-II protein expression and resistance of tumor cells to TGF-beta-mediated cell growth inhibition. Deletion analysis of the TbetaR-II promoter identified a RhoB-responsive region, and mutational analysis of this region revealed that a site for the transcription factor activator protein 1 (AP1) is critical for RhoB-mediated repression of TbetaR-II transcription. Electrophoretic mobility shift assays clearly showed that the binding of AP1 to its DNA-binding site is strongly inhibited by RhoB. Consequently, transcription assays using an AP1 reporter showed that AP1-mediated transcription is down-regulated by RhoB. Altogether, these results identify a mechanism by which RhoB antagonizes TGF-beta action through transcriptional down-regulation of AP1 in TbetaR-II promoter.	Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Mol Oncol Program, Dept Oncol, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Mol Oncol Program, Dept Mol Biol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Munoz-Antonia, T (corresponding author), Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Drug Discovery Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.	antoniat@moffitt.usf.edu			NCI NIH HHS [CA 67771] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U19CA067771] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adnane J, 2000, ONCOGENE, V19, P5525, DOI 10.1038/sj.onc.1203920; ADNANE J, 1995, J BIOL CHEM, V270, P8837, DOI 10.1074/jbc.270.15.8837; Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; BAE HW, 1995, J BIOL CHEM, V270, P29460, DOI 10.1074/jbc.270.49.29460; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Chang J, 2000, ONCOGENE, V19, P151, DOI 10.1038/sj.onc.1203252; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Choi SG, 1998, J BIOL CHEM, V273, P110, DOI 10.1074/jbc.273.1.110; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Du W, 1999, CANCER RES, V59, P5492; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; FILMUS J, 1992, ONCOGENE, V7, P521; Fralix KD, 2000, CANCER, V88, P2010, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2010::AID-CNCR5>3.0.CO;2-5; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; GAME SM, 1992, INT J CANCER, V52, P461, DOI 10.1002/ijc.2910520322; GarrigueAntar L, 1996, LAB INVEST, V75, P263; GARRIGUEANTAR L, 1995, CANCER RES, V55, P3982; GAUTHIERROUVIERE C, 1990, EMBO J, V9, P171, DOI 10.1002/j.1460-2075.1990.tb08093.x; GEISER AG, 1992, J BIOL CHEM, V267, P2588; Goggins M, 1998, CANCER RES, V58, P5329; Grady WM, 1998, CANCER RES, V58, P3101; Grady WM, 1999, CANCER RES, V59, P320; Guo Y. P., 1996, Proceedings of the American Association for Cancer Research Annual Meeting, V37, P245; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hernandez-Perera O, 2000, CIRC RES, V87, P616, DOI 10.1161/01.RES.87.7.616; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hougaard S., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P250; HUMPHRIES DE, 1994, BIOCHEM BIOPH RES CO, V203, P1020, DOI 10.1006/bbrc.1994.2284; Jackson RJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P290, DOI 10.1006/abbi.1999.1459; JI HJ, 1994, J CELL BIOCHEM, V54, P332, DOI 10.1002/jcb.240540309; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kelly D, 1998, J BIOL CHEM, V273, P21115, DOI 10.1074/jbc.273.33.21115; Kim DH, 1997, J BIOL CHEM, V272, P688; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; LEBOWITZ PF, 1995, MOL CELL BIOL, V15, P6613; Lebowitz PF, 1998, CELL ADHES COMMUN, V6, P277, DOI 10.3109/15419069809010787; Lebowitz PF, 1997, J BIOL CHEM, V272, P15591, DOI 10.1074/jbc.272.25.15591; Lebowitz PF, 1997, J BIOL CHEM, V272, P16093, DOI 10.1074/jbc.272.26.16093; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MunozAntonia T, 1996, CANCER RES, V56, P4831; Muro-Cacho CA, 1999, ARCH OTOLARYNGOL, V125, P76, DOI 10.1001/archotol.125.1.76; Muro-Cacho CA, 1999, CLIN CANCER RES, V5, P1243; NORGAARD P, 1994, BRIT J CANCER, V69, P802, DOI 10.1038/bjc.1994.158; Ohue M, 1996, INT J CANCER, V68, P203, DOI 10.1002/(SICI)1097-0215(19961009)68:2<203::AID-IJC11>3.0.CO;2-B; Park HJ, 1999, P NATL ACAD SCI USA, V96, P11525, DOI 10.1073/pnas.96.20.11525; PARK KC, 1994, P NATL ACAD SCI USA, V91, P8772, DOI 10.1073/pnas.91.19.8772; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SERRERO G, 1991, J CELL PHYSIOL, V149, P503, DOI 10.1002/jcp.1041490321; Shellman YG, 2000, J INVEST DERMATOL, V114, P1200, DOI 10.1046/j.1523-1747.2000.00988.x; SKOLEW SB, 1997, P AM ASSOC CANC RES, V38, P2511; Sun JZ, 1998, ONCOGENE, V16, P1467, DOI 10.1038/sj.onc.1201656; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Turco A, 1999, INT J CANCER, V80, P85, DOI 10.1002/(SICI)1097-0215(19990105)80:1<85::AID-IJC17>3.0.CO;2-P; Venkatasubbarao K, 1998, GENE CHROMOSOME CANC, V22, P138, DOI 10.1002/(SICI)1098-2264(199806)22:2<138::AID-GCC8>3.0.CO;2-Y; Venkatasubbarao K, 2000, ANTICANCER RES, V20, P43; Wang D, 1997, CARCINOGENESIS, V18, P2285, DOI 10.1093/carcin/18.11.2285; Wang J, 1996, J BIOL CHEM, V271, P17366, DOI 10.1074/jbc.271.29.17366; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; ZALCMAN G, 1995, ONCOGENE, V10, P1935	69	38	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2002	277	10					8500	8507		10.1074/jbc.M104367200	http://dx.doi.org/10.1074/jbc.M104367200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528WR	11741970	hybrid			2022-12-27	WOS:000174268000111
J	Briggs, MW; Li, ZG; Sacks, DB				Briggs, MW; Li, ZG; Sacks, DB			IQGAP1-mediated stimulation of transcriptional co-activation by beta-catenin is modulated by calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE; SMALL GTPASES; GENE-PRODUCT; CYCLIN D1; CGS 9343B; CDC42; IQGAP1; PROTEIN; COMPLEX; TARGET	beta-Catenin, an oncoprotein integral to cell-cell adhesion and proliferative signaling, is increased in several malignancies. The recently discovered calmodulin-binding protein IQGAP1 binds stoichiometrically to beta-catenin and regulates the association of beta-catenin with the cell-cell adhesion complex. In the present work, we investigated the role of IQGAP1 on the transcriptional co-activator function of beta-catenin, and whether calmodulin modulated the functional interaction between IQGAP1 and beta-catenin. In vitro competition assays revealed that both Ca2+/calmodulin and apo-calmodulin, when pre-bound to IQGAP1, prevented binding of beta-catenin to IQGAP1, and partially displaced beta-catenin pre-bound to IQGAP1 when added subsequently. Conversely, beta-catenin partially displaced apo-calmodulin, but not Ca2+/calmodulin, from IQGAP1. Overexpression of IQGAP1 in SW480 colon carcinoma cells enhanced beta-catenin-mediated transcriptional co-activation by 1.72-fold, and this stimulation was significantly attenuated upon antagonism of calmodulin using the cell-permeable antagonist CGS9343B. Moreover, an IQGAP1 mutant that does not bind calmodulin was unable to stimulate beta-catenin transcriptional function. Results of pulse-chase analyses suggested that IQGAP1 slowed the turnover of soluble, but not total, beta-catenin. Immunocytochemistry revealed that IQGAP1 overexpression increased the amount of beta-catenin located in the nucleus, whereas incubation of cells with CGS9343B blocked this accumulation. Together, our results imply that IQGAP1 enhances the function of beta-catenin in the nucleus and that calmodulin regulates this stimulation.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St,Thorn 530, Boston, MA 02115 USA.			Sacks, David/0000-0003-3100-0735	NCI NIH HHS [CA 75205] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA075205, R01CA075205] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bullions LC, 1997, MOL CELL BIOL, V17, P4501, DOI 10.1128/MCB.17.8.4501; Bullions Linda C., 1998, Current Opinion in Oncology, V10, P81, DOI 10.1097/00001622-199801000-00013; Chun KY, 2000, CALCIUM: THE MOLECULAR BASIS OF CALCIUM ACTION IN BIOLOGY AND MEDICINE, P541; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cohen P, 1988, CALMODULIN; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Espada J, 1999, J CELL BIOL, V146, P967, DOI 10.1083/jcb.146.5.967; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Goruppi S, 2001, MOL CELL BIOL, V21, P902, DOI 10.1128/MCB.21.3.902-915.2001; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NORMAN JA, 1987, MOL PHARMACOL, V31, P535; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; SHASHKIN P, 1995, J BIOL CHEM, V270, P25613, DOI 10.1074/jbc.270.43.25613; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Xu QH, 1998, DEVELOPMENT, V125, P4767; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	45	95	100	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7453	7465		10.1074/jbc.M104315200	http://dx.doi.org/10.1074/jbc.M104315200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11734550	hybrid			2022-12-27	WOS:000174104300091
J	Chu, JL; Jeffries, S; Norton, JE; Capobianco, AJ; Bresnick, EH				Chu, JL; Jeffries, S; Norton, JE; Capobianco, AJ; Bresnick, EH			Repression of activator protein-1-mediated transcriptional activation by the notch-1 intracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; KAPPA-B ACTIVITY; C-JUN; GENE-EXPRESSION; DNA-BINDING; CELL FATE; NEOPLASTIC TRANSFORMATION; SIGNALING PATHWAY; COP9 SIGNALOSOME; PHORBOL ESTERS	Developmental decisions that control cell fate are commonly regulated by the Notch signaling pathway. Activation of transmembrane Notch receptors results in proteolytic liberation of the intracellular domain of Notch, which translocates into the nucleus, binds a repressor (C promoter binding factor 1/RBP-Jkappa, Su(H), and Lag-1 (CSL)), and induces target genes. We found that the intracellular domain of human Notch-1 (NIC-1) represses activator protein-1 (AP-1)-mediated transactivation. Because numerous genes that control immune and inflammatory responses are AP-1-dependent and Notch regulates immune cell function, we investigated the underlying molecular mechanisms. Repression of AP-1 by NIC-1 did not represent a general inhibitory effect on transcription because nuclear factor kappaB-dependent transcription and transcription driven by a constitutive promoter and enhancer were not affected by NIC-1. The physiological relevance of the repression was supported by the facts that repression was apparent in multiple cell lines, endogenous AP-1 target genes were repressed, and similar concentrations of NIC-1 were required for CSL-dependent activation and AP-1 repression. The RBP-Jkappa-associated molecule domain of NIC-1 that mediates CSL binding and distinct sequences necessary for transactivation were required for repression. However, there was not a strict correlation between the sequence requirements for CSL-dependent activation and AP-1 repression. Repression correlated with predominant nuclear localization of NIC-1 and was not accompanied by disruption of c-Jun amino-terminal kinase-dependent signaling events required for AP-1 activation or by defective AP-1 DNA binding activity. These results provide evidence for negative cross-talk between Notch and AP-1, which may have important consequences for controlling diverse biological processes.	Univ Wisconsin, Sch Med, Dept Pharmacol, Mol & Cellular Pharmacol Program,Med Sci Ctr 387, Madison, WI 53706 USA; Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; University of Cincinnati	Bresnick, EH (corresponding author), Univ Wisconsin, Sch Med, Dept Pharmacol, Mol & Cellular Pharmacol Program,Med Sci Ctr 387, 1300 Univ Ave, Madison, WI 53706 USA.	ehbresni@facstaff.wisc.edu		Capobianco, Anthony/0000-0002-3706-6797	NIDDK NIH HHS [DK 50107] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050107] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1991, ANNU REV CELL BIOL, V7, P427; Aster JC, 2001, CURR OPIN HEMATOL, V8, P237, DOI 10.1097/00062752-200107000-00010; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Bidder M, 2000, BIOCHEMISTRY-US, V39, P8917, DOI 10.1021/bi000343+; Bigas A, 1998, MOL CELL BIOL, V18, P2324, DOI 10.1128/MCB.18.4.2324; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; BRESNICK EH, 1993, J BIOL CHEM, V268, P18824; Bresnick EH, 2000, J CELL BIOCHEM, P46; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; Carter AB, 2001, J BIOL CHEM, V276, P33826, DOI 10.1074/jbc.M100209200; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Deftos ML, 2000, CURR OPIN IMMUNOL, V12, P166, DOI 10.1016/S0952-7915(99)00067-9; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; Fitzgerald K, 2000, ONCOGENE, V19, P4191, DOI 10.1038/sj.onc.1203766; Forsberg EC, 1999, J BIOL CHEM, V274, P26850, DOI 10.1074/jbc.274.38.26850; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; HING HK, 1994, MECH DEVELOP, V47, P261, DOI 10.1016/0925-4773(94)90044-2; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2000, MOL CELL BIOL, V20, P3928, DOI 10.1128/MCB.20.11.3928-3941.2000; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kato H, 1997, DEVELOPMENT, V124, P4133; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kojika S, 2001, EXP HEMATOL, V29, P1041, DOI 10.1016/S0301-472X(01)00676-2; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Lam LT, 1996, J BIOL CHEM, V271, P32421, DOI 10.1074/jbc.271.50.32421; Lam LT, 2000, J BIOL CHEM, V275, P19676, DOI 10.1074/jbc.M002866200; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li JJ, 1996, CANCER RES, V56, P483; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakielny S, 1997, CURR OPIN CELL BIOL, V9, P420, DOI 10.1016/S0955-0674(97)80016-6; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Osborne BA, 2000, CURR OPIN IMMUNOL, V12, P301, DOI 10.1016/S0952-7915(00)00091-1; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Robey E, 1999, ANNU REV IMMUNOL, V17, P283, DOI 10.1146/annurev.immunol.17.1.283; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Roehl H, 1996, EMBO J, V15, P7002, DOI 10.1002/j.1460-2075.1996.tb01092.x; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Ross DA, 2001, MOL CELL BIOL, V21, P7537, DOI 10.1128/MCB.21.22.7537-7544.2001; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Uyttendaele H, 1998, DEV BIOL, V196, P204, DOI 10.1006/dbio.1998.8863; Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YASUMOTO K, 1992, J BIOL CHEM, V267, P22506; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414; Zecchini V, 1999, CURR BIOL, V9, P460, DOI 10.1016/S0960-9822(99)80211-5; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	81	44	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7587	7597		10.1074/jbc.M111044200	http://dx.doi.org/10.1074/jbc.M111044200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11739397	hybrid			2022-12-27	WOS:000174104300106
J	Eriksson, M; Nielsen, PE; Good, L				Eriksson, M; Nielsen, PE; Good, L			Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; PSEUDOMONAS-AERUGINOSA; ANTIBIOTICS; INHIBITION; BACTERIA; RNA	Peptide nucleic acid (PNA) is a DNA mimic with promising properties for the development of antisense agents. Antisense PNAs targeted to Escherichia coli genes can specifically inhibit gene expression, and attachment of PNA to the cell-permeabilizing peptide KFFKFFKFFK dramatically improves antisense potency. The improved potency observed earlier was suggested to be due to better cell uptake; however, the uptake kinetics of standard or modified PNAs into bacteria had not been investigated. Here we monitored outer and inner membrane permeabilization by using chemical probes that normally are excluded from cells but can gain access at points where membrane integrity is disturbed. Membrane permeabilization was much more rapid in the presence of peptide-PNA conjugates relative to the free components used alone or in combination. Indeed, peptide-PNAs permeabilized E. coli nearly as quickly as antimicrobial peptides. Furthermore, as expected for outer membrane-active compounds, added MgCl2 reduced cell-permeabilization. Concurrent monitoring of outer and inner membrane permeabilization indicated that passage across the outer membrane is rate-limiting for uptake. The enhanced cell-permeation properties of peptide-PNAs can explain their potent antisense activity, and the results indicate an unanticipated synergy between the peptide and PNA components.	Karolinska Inst, Ctr Genom & Bioinformat, SE-17177 Stockholm, Sweden; Chalmers Univ Technol, Dept Phys Chem, SE-41296 Gothenburg, Sweden; Univ Copenhagen, Panum Inst, Inst Med Biochem & Genet, Ctr Biomol Recognit,Biochem Lab B, DK-2200 Copenhagen, Denmark; Pantheco AS, DK-2970 Horsholm, Denmark	Karolinska Institutet; Chalmers University of Technology; University of Copenhagen	Good, L (corresponding author), Karolinska Inst, Ctr Genom & Bioinformat, SE-17177 Stockholm, Sweden.			Good, Liam/0000-0002-2798-8640; Eriksson, Magdalena/0000-0002-6548-6019				ANGUS BL, 1982, ANTIMICROB AGENTS CH, V21, P299, DOI 10.1128/AAC.21.2.299; Christensen L, 1995, J Pept Sci, V1, P175; Cutrona G, 2000, NAT BIOTECHNOL, V18, P300, DOI 10.1038/73745; Good L, 1998, NAT BIOTECHNOL, V16, P355, DOI 10.1038/nbt0498-355; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Good L, 2000, MICROBIOL-SGM, V146, P2665, DOI 10.1099/00221287-146-10-2665; Good L, 1998, P NATL ACAD SCI USA, V95, P2073, DOI 10.1073/pnas.95.5.2073; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Larsen HJ, 1999, BBA-GENE STRUCT EXPR, V1489, P159, DOI 10.1016/S0167-4781(99)00145-1; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Vaara M, 1996, ANTIMICROB AGENTS CH, V40, P1801, DOI 10.1128/AAC.40.8.1801; WITTUNG P, 1995, FEBS LETT, V365, P27, DOI 10.1016/0014-5793(95)00409-3; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299	19	128	149	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7144	7147		10.1074/jbc.M106624200	http://dx.doi.org/10.1074/jbc.M106624200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11739379	hybrid			2022-12-27	WOS:000174104300051
J	Piserchio, A; Pellegrini, M; Mehta, S; Blackman, SM; Garcia, EP; Marshall, J; Mierke, DF				Piserchio, A; Pellegrini, M; Mehta, S; Blackman, SM; Garcia, EP; Marshall, J; Mierke, DF			The PDZ1 domain of SAP90 - Characterization of structure and binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; DENSITY PROTEIN PSD-95; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; CHEMICAL-SHIFT; RECOGNITION; RECEPTOR; DYNAMICS; CHANNELS; COMPLEX	The structural features of the PDZ1 domain of the synapse-associated protein SAP90 have been characterized by NMR. A comparison with the structures of the PDZ2 and PDZ3 domains of SAP90 illustrates significant differences, which may account for the unique binding properties of these homologous domains. Within the postsynaptic density, SAP90 functions as a molecular scaffold with a number of the protein-protein interactions mediated through the PDZ1 domain. Here, using fluorescence anisotropy and NMR chemical shift analysis, we have characterized the association of PDZ1 to the C-terminal peptides of the GluR6 subunit of the kainate receptor, voltage-gated K+ channel Kv1.4, and microtubule-associate protein CRIPT, all of which are known to associate with SAP90. The latter two, which possess the consensus sequence for binding to PDZ domains (T/S-X-V-oh), have low micromolar binding affinities (1.5-15 mum). The C terminus of GluR6, RLPGKETMA-oh, lacking the consensus sequence, binds to PDZ1 of SAP90 with an affinity of 160 muM. The NMR data illustrate that although all three peptides occupy the binding groove capped by the GLGF loop of PDZ1, specific differences are present, consistent with the variation in binding affinities.	Brown Univ, Dept Mol Pharmacol, Div Biol & Med, Providence, RI 02912 USA; Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Brown University	Mierke, DF (corresponding author), Brown Univ, Dept Mol Pharmacol, Div Biol & Med, Box G-B4, Providence, RI 02912 USA.		Pellegrini, Maria/W-6005-2019	Pellegrini, Maria/0000-0003-3817-4412; Blackman, Scott/0000-0002-4532-6421				Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUSTEDT EJ, 1993, BIOPHYS J, V64, P614, DOI 10.1016/S0006-3495(93)81420-6; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kuhlendahl S, 1998, EUR J BIOCHEM, V252, P305, DOI 10.1046/j.1432-1327.1998.2520305.x; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Mehta S, 2001, J BIOL CHEM, V276, P16092, DOI 10.1074/jbc.M100643200; Missler M, 1998, J NEUROCHEM, V71, P1339; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; PRESS WH, 1986, NUMERICAL RECIPES AR; Schepens J, 1997, FEBS LETT, V409, P53, DOI 10.1016/S0014-5793(97)00481-X; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	45	38	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					6967	6973		10.1074/jbc.M109453200	http://dx.doi.org/10.1074/jbc.M109453200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11744724	hybrid			2022-12-27	WOS:000174104300030
J	Rathore, D; Sacci, JB; de la Vega, P; McCutchan, TF				Rathore, D; Sacci, JB; de la Vega, P; McCutchan, TF			Binding and invasion of liver cells by Plasmodium falciparum sporozoites - Essential involvement of the amino terminus of circumsporozoite protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; MALARIA SPOROZOITES; CRYSTAL-STRUCTURE; HEPARINASE-I; THROMBOSPONDIN; ADHESION; EXPRESSION; RECEPTORS; MEMBRANE	Plasmodium sporozoites display circumsporozoite (CS) protein on their surface, which is involved in the attachment of sporozoites to liver cells. CS protein is a member of the thrombospondin type I repeat (TSR) domain family and possess a single copy of TSR domain toward its carboxyl terminus. We show by a direct measurement the correlation between the binding activity of various segments of the CS protein and their ability to inhibit the invasion of liver cells by the sporozoites. We made eight truncated versions of Plasmodium falciparum CS protein to elucidate the role of various regions in the binding and invasion process. Deletion of the TSR domain actually enhanced binding activity by 2-3-fold without the loss of receptor specificity, indicating that TSR may not be the only domain in defining the specificity of binding. These same deletions blocked invasion of live sporozoites more efficiently than proteins that include the TSR domain. Deletion of as little as six amino acids from amino terminus of the protein, however, renders it incapable of binding to liver cells and as an inhibitor of sporozoite invasion. Hence, the binding of CS protein to liver cells and its ability to inhibit the invasion process are affected in a parallel manner, both positively and negatively, by sequence changes in the encoded CS gene. This indicates that both assays are measuring interrelated phenomenon and points to the essential involvement for the amino-terminal portion of the CS protein in these processes.	NIAID, Natl Inst Hlth, Lab Malaria & Vector Res, Growth & Dev Sect, Bethesda, MD 20892 USA; USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA; Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Navy; University System of Maryland; University of Maryland Baltimore	McCutchan, TF (corresponding author), NIAID, Natl Inst Hlth, Lab Malaria & Vector Res, Growth & Dev Sect, 4 Ctr Dr,MSC 0425,Rm 126,Bldg 4, Bethesda, MD 20892 USA.	tmccutchan@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000208, Z01AI000208] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JC, 2000, DEV DYNAM, V218, P280; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Crisp RJ, 2000, J BIOL CHEM, V275, P19628, DOI 10.1074/jbc.M909172199; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Godavarti R, 1996, BIOCHEMISTRY-US, V35, P6846, DOI 10.1021/bi960356g; GU KN, 1995, BIOCHEM J, V312, P569, DOI 10.1042/bj3120569; HAHN M, 1994, P NATL ACAD SCI USA, V91, P10417, DOI 10.1073/pnas.91.22.10417; HOLLINGDALE MR, 1981, SCIENCE, V213, P1021, DOI 10.1126/science.7022652; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; Kilpelainen I, 2000, J BIOL CHEM, V275, P13564, DOI 10.1074/jbc.275.18.13564; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LOVE DC, 1993, J CELL BIOL, V123, P759, DOI 10.1083/jcb.123.3.759; McCormick CJ, 2000, BLOOD, V96, P327, DOI 10.1182/blood.V96.1.327.013k29_327_333; McCutchan TF, 1996, P NATL ACAD SCI USA, V93, P11889, DOI 10.1073/pnas.93.21.11889; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Naitza S, 1998, PARASITOL TODAY, V14, P479, DOI 10.1016/S0169-4758(98)01346-5; Nardin EH, 2000, J INFECT DIS, V182, P1486, DOI 10.1086/315871; Ortega-Barria E, 1999, J BIOL CHEM, V274, P1267, DOI 10.1074/jbc.274.3.1267; PACHECO ND, 1979, J PARASITOL, V65, P414, DOI 10.2307/3280286; PANCAKE SJ, 1992, J CELL BIOL, V117, P1351, DOI 10.1083/jcb.117.6.1351; Pinzon-Ortiz C, 2001, J BIOL CHEM, V276, P26784, DOI 10.1074/jbc.M104038200; Rathore D, 2000, P NATL ACAD SCI USA, V97, P8530, DOI 10.1073/pnas.140224597; Rathore D, 2000, MOL BIOCHEM PARASIT, V108, P253, DOI 10.1016/S0166-6851(00)00214-0; Rathore D, 2000, INFECT IMMUN, V68, P740, DOI 10.1128/IAI.68.2.740-743.2000; Rathore D, 2001, MOL BIOCHEM PARASIT, V118, P75, DOI 10.1016/S0166-6851(01)00369-3; Rathore D, 2001, BIOCHEMISTRY-US, V40, P11518, DOI 10.1021/bi0105476; SASISEKHARAN R, 1993, P NATL ACAD SCI USA, V90, P3660, DOI 10.1073/pnas.90.8.3660; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shi YP, 1999, P NATL ACAD SCI USA, V96, P1615, DOI 10.1073/pnas.96.4.1615; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; VOSS T, 1994, BIOCHEM J, V298, P719, DOI 10.1042/bj2980719; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Wengelnik K, 1999, EMBO J, V18, P5195, DOI 10.1093/emboj/18.19.5195; Ying P, 1997, EXP PARASITOL, V85, P168, DOI 10.1006/expr.1996.4134	41	69	78	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2002	277	9					7092	7098		10.1074/jbc.M106862200	http://dx.doi.org/10.1074/jbc.M106862200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	525ZQ	11751898	hybrid			2022-12-27	WOS:000174104300045
J	Karcher, D; Bock, R				Karcher, D; Bock, R			The amino acid sequence of a plastid protein is developmentally regulated by RNA editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ELECTRON-TRANSPORT; READING FRAME REVEALS; PSBL MESSENGER-RNA; TARGETED INACTIVATION; GENETIC INFORMATION; NADH DEHYDROGENASE; INITIATION CODON; PHOTOSYSTEM-I; NDH GENES; TOBACCO	RNA editing in plant organelles post-transcriptionally alters single nucleotides by C-to-U or U-to-C conversions at highly specific sites. Plant editing is generally viewed as a repair mechanism acting at the transcript level by restoring conserved amino acid residues. Here we report that an editing reaction within the ndhB transcript (encoding a pIastid NAD(P)H dehydrogenase subunit) is strictly dependent on active photosynthesis. Employing non-photosynthetic mutants, we show that in the absence of photosynthesis, the site remains unedited, whereas it is fully edited when the photosynthetic apparatus is intact. Moreover, the site also remains unedited during the etiolated stage of seedling development, suggesting that two different NdhB proteins are synthesized under photosynthetic versus non-photosynthetic conditions. This is the first case where RNA editing in plants appears to regulate gene expression qualitatively, resulting in the production of two different proteins from one and the same gene in a developmental stage-dependent manner.	Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany; Univ Munster, Inst Biochem & Biotechnol Pflanzen, D-48143 Munster, Germany	University of Freiburg; University of Munster	Bock, R (corresponding author), Univ Freiburg, Inst Biol 3, Schanzlestr 1, D-79104 Freiburg, Germany.		Bock, Ralph/B-4352-2009	Bock, Ralph/0000-0001-7502-6940; Karcher, Daniel/0000-0001-6393-7376				BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; Bock R, 1996, EMBO J, V15, P5052, DOI 10.1002/j.1460-2075.1996.tb00885.x; Bock R, 2000, BIOCHIMIE, V82, P549, DOI 10.1016/S0300-9084(00)00610-6; BOCK R, 1994, EMBO J, V13, P4623, DOI 10.1002/j.1460-2075.1994.tb06784.x; Bock R, 1997, EMBO J, V16, P3282, DOI 10.1093/emboj/16.11.3282; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Casano LM, 2000, J BIOL CHEM, V275, P942, DOI 10.1074/jbc.275.2.942; CHAUDHURI S, 1995, EMBO J, V14, P2951, DOI 10.1002/j.1460-2075.1995.tb07295.x; COVELLO PS, 1993, TRENDS GENET, V9, P265, DOI 10.1016/0168-9525(93)90011-6; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; Fischer M, 1997, Z NATURFORSCH C, V52, P481; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Freyer R, 1995, PLANT MOL BIOL, V29, P679, DOI 10.1007/BF00041158; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Guera A, 2000, PLANT CELL PHYSIOL, V41, P49, DOI 10.1093/pcp/41.1.49; Hager M, 1999, EMBO J, V18, P5834, DOI 10.1093/emboj/18.21.5834; Hanson MR, 1996, TRENDS PLANT SCI, V1, P57, DOI 10.1016/S1360-1385(96)80030-6; Hirose T, 1999, MOL GEN GENET, V262, P462, DOI 10.1007/s004380051106; HOCH B, 1991, NATURE, V353, P178, DOI 10.1038/353178a0; Karcher D, 1998, NUCLEIC ACIDS RES, V26, P1185, DOI 10.1093/nar/26.5.1185; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Kofer W, 1998, MOL GEN GENET, V258, P166, DOI 10.1007/s004380050719; Kubicki A, 1996, PLANTA, V199, P276, DOI 10.1007/BF00196569; KUDLA J, 1992, EMBO J, V11, P1099, DOI 10.1002/j.1460-2075.1992.tb05149.x; MAIER RM, 1992, PLANT CELL, V4, P609, DOI 10.1105/tpc.4.5.609; Maier RM, 1996, PLANT MOL BIOL, V32, P343, DOI 10.1007/BF00039390; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; MATSUBAYASHI T, 1987, MOL GEN GENET, V210, P385, DOI 10.1007/BF00327187; MAXWELL DP, 1995, PLANT PHYSIOL, V109, P787, DOI 10.1104/pp.109.3.787; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P493, DOI DOI 10.1111/J.1399-3054.1962.TB08052.X; Mustilli AC, 1997, EMBO J, V16, P5801, DOI 10.1038/sj.emboj.7590554; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Ruf S, 1997, J CELL BIOL, V139, P95, DOI 10.1083/jcb.139.1.95; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766	38	36	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5570	5574		10.1074/jbc.M107074200	http://dx.doi.org/10.1074/jbc.M107074200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11734554	hybrid			2022-12-27	WOS:000173962900131
J	Shen, X; Sayer, JM; Kroth, H; Ponten, I; O'Donnell, M; Woodgate, R; Jerina, DM; Goodman, MF				Shen, X; Sayer, JM; Kroth, H; Ponten, I; O'Donnell, M; Woodgate, R; Jerina, DM; Goodman, MF			Efficiency and accuracy of SOS-induced DNA polymerases replicating benzo[a]pyrene-7,8-diol 9,10-epoxide A and G adducts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POL-II; BACTERIOPHAGE-LAMBDA; ADAPTIVE MUTATION; UV MUTAGENESIS; MOUSE HOMOLOGS; RECA PROTEIN; DAMAGE; GENE; PURIFICATION	Nucleotide incorporation fidelity, mismatch extension, and translesion DNA synthesis efficiencies were determined using SOS-induced Escherichia coli DNA polymerases (pol) II, IV, and V to copy 10R and 10S isomers of trans-opened benzo[a]pyrene-7,8-diol 9,10-epoxide (BaP DE) A and G adducts. A-BaP DE adducts were bypassed by pol V with moderate accuracy and considerably higher efficiency than by pol II or IV. Error-prone pol V copied G-BaP DE-adducted DNA poorly, forming A(.)G-BaP DE-S and -R mismatches over C(.)G-BaP DE-S and -R correct matches by factors of similar to350- and 130-fold, respectively, even favoring G(.)G-BaP DE mismatches over correct matches by factors of 2-4-fold. In contrast, pol IV bypassed G-BaP DE adducts with the highest efficiency and fidelity, making misincorporations with a frequency of 10(-2) to 10(-4) depending on sequence context. G-BaP DE-S-adducted M13 DNA yielded 4-fold fewer plaques when transfected into SOS-induced DeltadinB (pol IV-deficient) mutant cells compared with the isogenic wild-type E. coli strain, consistent with the in vitro data showing that pol IV was most effective by far at copying the G-BaP DE-S adduct. SOS polymerases are adept at copying a variety of lesions, but the relative contribution of each SOS polymerase to copying damaged DNA appears to be determined by the lesion's identity.	Univ So Calif, Hedco Mol Biol Lab, Dept Biol Sci & Chem, Los Angeles, CA 90089 USA; NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA; NCI, Frederick Canc Res & Dev Ctr, Chem Carcinogenesis Lab, Frederick, MD 21702 USA; Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Rockefeller University; Howard Hughes Medical Institute	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, SHS Rm 172,Univ Pk, Los Angeles, CA 90089 USA.	mgoodman@mizar.usc.edu		Kroth, Heiko/0000-0002-6936-3921; Woodgate, Roger/0000-0001-5581-4616	NIGMS NIH HHS [GM38839, GM42554, GM21422] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021422, R37GM038839, R37GM021422, R01GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; BONNER CA, 1988, J BIOL CHEM, V263, P18946; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; BROTCORNELANNOYE A, 1986, P NATL ACAD SCI USA, V83, P3904, DOI 10.1073/pnas.83.11.3904; Bruck I, 1996, J BIOL CHEM, V271, P10767, DOI 10.1074/jbc.271.18.10767; BUENING MK, 1978, P NATL ACAD SCI USA, V75, P5358, DOI 10.1073/pnas.75.11.5358; CAI H, 1995, J BIOL CHEM, V270, P15327, DOI 10.1074/jbc.270.25.15327; CHARY P, 1995, NUCLEIC ACIDS RES, V23, P1398, DOI 10.1093/nar/23.8.1398; CHRISTNER DF, 1994, BIOCHEMISTRY-US, V33, P14297, DOI 10.1021/bi00251a043; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Efrati E, 1997, J BIOL CHEM, V272, P2559; ESCARCELLER M, 1994, J BACTERIOL, V176, P6221, DOI 10.1128/jb.176.20.6221-6228.1994; Fijalkowska IJ, 1997, J BACTERIOL, V179, P7435, DOI 10.1128/jb.179.23.7435-7445.1997; FOSTER PL, 1995, P NATL ACAD SCI USA, V92, P7951, DOI 10.1073/pnas.92.17.7951; Foster PL, 2000, COLD SPRING HARB SYM, V65, P21, DOI 10.1101/sqb.2000.65.21; Frank EG, 1996, P NATL ACAD SCI USA, V93, P10291, DOI 10.1073/pnas.93.19.10291; Frank EG, 2000, J MOL BIOL, V297, P585, DOI 10.1006/jmbi.2000.3591; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gerlach VL, 1999, P NATL ACAD SCI USA, V96, P11922, DOI 10.1073/pnas.96.21.11922; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; Goodman MF, 2000, CURR OPIN GENET DEV, V10, P162, DOI 10.1016/S0959-437X(00)00057-5; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; HRUSZKEWYCZ A, 1992, CARCINOGENESIS, V13, P2347, DOI 10.1093/carcin/13.12.2347; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; IWASAKI H, 1990, J BACTERIOL, V172, P6268, DOI 10.1128/jb.172.11.6268-6273.1990; Jerina D M, 1991, Adv Exp Med Biol, V283, P533; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; McDonald JP, 1999, GENOMICS, V60, P20, DOI 10.1006/geno.1999.5906; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Page JE, 1999, CHEM RES TOXICOL, V12, P258, DOI 10.1021/tx980244l; Page JE, 1998, BIOCHEMISTRY-US, V37, P9127, DOI 10.1021/bi980273v; Pham P, 2001, NATURE, V409, P366, DOI 10.1038/35053116; Qiu ZH, 1997, J BIOL CHEM, V272, P8611, DOI 10.1074/jbc.272.13.8611; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; SHIBUTANI S, 1993, BIOCHEMISTRY-US, V32, P7531, DOI 10.1021/bi00080a027; Smith BT, 1998, GENETICS, V148, P1599; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; TESSMAN I, 1994, GENETICS, V136, P439; Tippin B, 2001, PHILOS T R SOC B, V356, P47, DOI 10.1098/rstb.2000.0747; Virbasius CMA, 1999, MOL CELL, V4, P219, DOI 10.1016/S1097-2765(00)80369-X; WOOD AW, 1976, CANCER RES, V36, P3358; Woodgate R, 1996, CANCER SURV, V28, P117; WOODGATE R, 1992, MUTAT RES, V281, P221, DOI 10.1016/0165-7992(92)90012-7	58	92	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2002	277	7					5265	5274		10.1074/jbc.M109575200	http://dx.doi.org/10.1074/jbc.M109575200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	523NX	11734560	hybrid			2022-12-27	WOS:000173962900092
J	Woo, MH; Vance, JR; Marcos, ARO; Bailly, C; Bjornsti, MA				Woo, MH; Vance, JR; Marcos, ARO; Bailly, C; Bjornsti, MA			Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST; DRUG; SENSITIVITY; INHIBITION; MECHANISMS; RESISTANT; COVALENT; NB-506; CELLS; MODEL	DNA topoisomerase I (Top1p) catalyzes topological changes in DNA and is the cellular target of the antitumor agent camptothecin (CPT). Non-CPT drugs that target Top1p, such as indolocarbazoles, are under clinical development. However, whether the cytotoxicity of indolocarbazoles derives from Top1p poisoning remains unclear. To further investigate indolocarbazole mechanism, rebeccamycin R-3 activity was examined in vitro and in yeast. Using a series of Top1p mutants, where substitution of residues around the active site tyrosine has well-defined effects on enzyme catalysis, we show that catalytically active, CPT-resistant enzymes remain sensitive to R-3. This indolocarbazole did not inhibit yeast Top1p activity, yet was effective in stabilizing Top1p-DNA complexes. Similar results were obtained with human Top1p, when Ser or His were substituted for Asn-722. The mutations altered enzyme function and sensitivity to CPT, yet R-3 poisoning of Top1p was unaffected. Moreover, top1Delta, rad52Delta yeast cells expressing human Top1p, but not catalytically inactive Top1Y723Fp, were sensitive to R-3. These data support hTop1p as the cellular target of R-3 and indicate that distinct drug-enzyme interactions at the active site are required for efficient poisoning by R-3 or CPT. Furthermore, resistance to one poison may potentiate cell sensitivity to structurally distinct compounds that also target Top1p.	St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; Univ Leon, Dept Farmacol Toxicol & Enfermeria, Leon, Spain; INSERM, U524, Lab Pharmacol Antitumorale, Ctr Oscar Lambert, F-59045 Lille, France	St Jude Children's Research Hospital; Universidad de Leon; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Oscar Lambret	Bjornsti, MA (corresponding author), St Jude Childrens Res Hosp, Dept Mol Pharmacol, 332 N Lauderdale, Memphis, TN 38105 USA.	Mary-Ann.Bjornsti@stjude.org			NCI NIH HHS [CA09346, CA70406, CA21675, CA58755] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009346, R01CA070406, R01CA058755] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailly C, 1998, MOL PHARMACOL, V53, P77, DOI 10.1124/mol.53.1.77; Bailly C, 1999, BIOCHEMISTRY-US, V38, P8605, DOI 10.1021/bi983052y; Bailly C, 1999, CANCER RES, V59, P2853; Bailly C, 1997, BIOCHEMISTRY-US, V36, P3917, DOI 10.1021/bi9624898; Bailly C, 2000, CURR MED CHEM, V7, P39, DOI 10.2174/0929867003375489; BJORNSTI MA, 1989, CANCER RES, V49, P6318; Burke D., 2000, METHODS YEAST GENETI; Champoux JJ, 2000, ANN NY ACAD SCI, V922, P56; Edwards TK, 2000, J BIOL CHEM, V275, P36181, DOI 10.1074/jbc.M006628200; ENG WK, 1988, MOL PHARMACOL, V34, P755; Fertala J, 2000, J BIOL CHEM, V275, P15246, DOI 10.1074/jbc.275.20.15246; Fiorani P, 1999, MOL PHARMACOL, V56, P1105, DOI 10.1124/mol.56.6.1105; Fiorani P, 2000, METH MOL B, V95, P291; Fiorani P, 2000, ANN NY ACAD SCI, V922, P65; FUJIMORI A, 1995, CANCER RES, V55, P1339; Hann C, 1998, J BIOL CHEM, V273, P8425, DOI 10.1074/jbc.273.14.8425; Hann CL, 1998, J BIOL CHEM, V273, P31519, DOI 10.1074/jbc.273.47.31519; KAUH EA, 1995, P NATL ACAD SCI USA, V92, P6299, DOI 10.1073/pnas.92.14.6299; KNAB AM, 1993, J BIOL CHEM, V268, P22322; KNAB AM, 1995, J BIOL CHEM, V270, P6141, DOI 10.1074/jbc.270.11.6141; Labourier E, 1999, CANCER RES, V59, P52; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Long Byron H., 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P414; LYNN RM, 1989, P NATL ACAD SCI USA, V86, P3559, DOI 10.1073/pnas.86.10.3559; Maliepaard M, 1999, CANCER RES, V59, P4559; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Morham SG, 1996, MOL CELL BIOL, V16, P6804; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; NITISSJL, 1991, DNA TOPOISOMERASES C, P77; Ohkubo M, 1999, BIOORG MED CHEM LETT, V9, P3307, DOI 10.1016/S0960-894X(99)00595-8; Pereira ER, 1996, J MED CHEM, V39, P4471; Pilch B, 2001, CANCER RES, V61, P6876; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Qu XG, 1999, ANTI-CANCER DRUG DES, V14, P433; Redinbo Matthew R., 1999, Current Opinion in Structural Biology, V9, P29, DOI 10.1016/S0959-440X(99)80005-0; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Reid RJD, 1998, BBA-GENE STRUCT EXPR, V1400, P289, DOI 10.1016/S0167-4781(98)00142-0; Reid RJD, 1997, J BIOL CHEM, V272, P12091, DOI 10.1074/jbc.272.18.12091; Reid RJD, 1999, P NATL ACAD SCI USA, V96, P11440, DOI 10.1073/pnas.96.20.11440; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Urasaki Y, 2001, CANCER RES, V61, P504; Walowsky C, 1999, J BIOL CHEM, V274, P7302, DOI 10.1074/jbc.274.11.7302; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Yoshinari T, 1999, CANCER RES, V59, P4271; YOSHINARI T, 1995, CANCER RES, V55, P1310; Zembower DE, 1999, BIOORG MED CHEM LETT, V9, P145, DOI 10.1016/S0960-894X(98)00710-0	47	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2002	277	6					3813	3822		10.1074/jbc.M110484200	http://dx.doi.org/10.1074/jbc.M110484200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	520ZP	11733535	hybrid			2022-12-27	WOS:000173813900004
